PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Moomau, C; Musalgaonkar, S; Khan, YA; Jones, JE; Dinman, JD				Moomau, Christine; Musalgaonkar, Sharmishtha; Khan, Yousuf A.; Jones, John E.; Dinman, Jonathan D.			Structural and Functional Characterization of Programmed Ribosomal Frameshift Signals in West Nile Virus Strains Reveals High Structural Plasticity Among cis-Acting RNA Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUDING PSEUDOKNOTS; MESSENGER-RNA; YEAST; EVOLUTION; FLAVIVIRUSES; INTERFERON; PREDICTION; ALGORITHM; VIRULENCE; SEQUENCE	West Nile virus (WNV) is a prototypical emerging virus for which no effective therapeutics currently exist. WNV uses programmed -1 ribosomal frameshifting (-1 PRF) to synthesize the NS1' protein, a C terminally extended version of its nonstructural protein 1, the expression of which enhances neuro-invasiveness and viral RNA abundance. Here, the NS1' frameshift signals derived from four WNV strains were investigated to better understand -1 PRF in this quasispecies. Sequences previously predicted to promote -1 PRF strongly promote this activity, but frameshifting was significantly more efficient upon inclusion of additional 3' sequence information. The observation of different rates of -1 PRF, and by inference differences in the expression of NS1', may account for the greater degrees of pathogenesis associated with specific WNV strains. Chemical modification and mutational analyses of the longer and shorter forms of the -1 PRF signals suggests dynamic structural rear-rangements between tandem stem-loop and mRNA pseudoknot structures in two of the strains. A model is suggested in which this is employed as a molecular switch to fine tune the relative expression of structural to non-structural proteins during different phases of the viral replication cycle.	[Moomau, Christine; Musalgaonkar, Sharmishtha; Khan, Yousuf A.; Jones, John E.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Moomau, Christine] MIT, Dept Biol, Biol Grad Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Musalgaonkar, Sharmishtha] Univ Texas Austin, Mol Biosci Dept, Austin, TX 78712 USA	University System of Maryland; University of Maryland College Park; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin	Dinman, JD (corresponding author), 4062 Campus Dr, College Pk, MD 20742 USA.	dinman@umd.edu		Khan, Yousuf/0000-0003-0201-2796; Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [R01HL119439, R01GM117177]; Defense Threat Reduction Agency [HDTRA1-13-1-0005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL119439 and R01GM117177 (to J. D. D.) and Defense Threat Reduction Agency Grant HDTRA1-13-1-0005. The authors declare that they have no conflicts of interest with the contents of this article. The content of this article does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baer A, 2016, J VIROL, V90, P3558, DOI 10.1128/JVI.02827-15; Baranov PV, 2003, NUCLEIC ACIDS RES, V31, P87, DOI 10.1093/nar/gkg024; Bekaert M, 2010, NUCLEIC ACIDS RES, V38, pD69, DOI 10.1093/nar/gkp788; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Craven RB, 2001, JAMA-J AM MED ASSOC, V286, P651, DOI 10.1001/jama.286.6.651; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dirks RM, 2004, J COMPUT CHEM, V25, P1295, DOI 10.1002/jcc.20057; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023; Grentzmann G, 1998, RNA, V4, P479; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Hollidge BS, 2011, VIRUSES-BASEL, V3, P629, DOI 10.3390/v3060629; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; JACOBSON AB, 1993, J MOL BIOL, V233, P261, DOI 10.1006/jmbi.1993.1504; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Melian EB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004447; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Powell D. G., 2010, EQUINE VET EDUC, V15, P66; Prow NA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00146; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Ren JH, 2005, RNA, V11, P1494, DOI 10.1261/rna.7284905; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006	36	27	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15788	15795		10.1074/jbc.M116.735613	http://dx.doi.org/10.1074/jbc.M116.735613			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226636	Green Published, hybrid			2022-12-26	WOS:000380584200031
J	Han, C; Wu, WH; Ale, A; Kim, MS; Cai, DS				Han, Cheng; Wu, Wenhe; Ale, Albert; Kim, Min Soo; Cai, Dongsheng			Central Leptin and Tumor Necrosis Factor-alpha (TNF alpha) in Diurnal Control of Blood Pressure and Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBESITY-RELATED HYPERTENSION; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; HYPOTHALAMIC INFLAMMATION; INTRACEREBROVENTRICULAR LEPTIN; MECHANISMS; RESISTANCE; MICE; RATS; PROLIFERATION	Leptin and TNF alpha can individually work in the brain to affect blood pressure; however, it remains unknown whether these two cytokines might have an interactive role in this process and, if so, how. In this work, we found that leptin stimulation led to TN-F alpha production under both in vitro and in vivo conditions, and diurnal fluctuation of leptin concentrations in the cerebrospinal fluid predicted the circadian changes of TN-F alpha gene expression in the hypothalamus. Signaling analysis showed that leptin stimulation led to a rapid and strong STAT3 activation followed by a second-phase moderate STAT3 activation, which was selectively abolished by anti-inflammatory chemical PS1145 or TNFa antagonist WP9QY. Physiological study in normal mice revealed that diurnal rise of blood pressure was abrogated following central administration of PS1145 or a leptin receptor antagonist. Central TNFa pretreatment was found to potentiate the effect of leptin in elevating blood pressure in normal mice. In pathophysiology, dietary obesity mimicked TNFa pretreatment in promoting leptin-induced blood pressure rise, and this effect was blocked by central treatment with either PS1145 or WP9QY. Hence, central leptin employs TNFa to mediate the diurnal blood pressure elevation in physiology while enhancement of this mechanism can contribute to hypertension development.	[Han, Cheng; Wu, Wenhe; Ale, Albert; Kim, Min Soo; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Diabet Res Ctr, Inst Aging, Bronx, NY 10461 USA; [Wu, Wenhe] Wenzhou Med Univ, Key Lab Lab Med, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Zhejiang, Peoples R China	Yeshiva University; Albert Einstein College of Medicine; Wenzhou Medical University	Cai, DS (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu			National Institutes of Health [R01 DK078750, R01 AG031774, R01 HL113180, R01 DK099136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750, R01DK099136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health Grants R01 DK078750, R01 AG031774, R01 HL113180, and R01 DK099136 (all to D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aizawa-Abe M, 2000, J CLIN INVEST, V105, P1243, DOI 10.1172/JCI8341; Aoki K, 2006, J CLIN INVEST, V116, P1525, DOI 10.1172/JCI22513; Bates SH, 2005, CELL METAB, V1, P169, DOI 10.1016/j.cmet.2005.02.001; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Brown RJ, 2015, CELL, V162, P465, DOI 10.1016/j.cell.2015.07.007; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Cai DS, 2013, VITAM HORM, V91, P195, DOI 10.1016/B978-0-12-407766-9.00008-0; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; da Silva AA, 2013, CURR OPIN NEPHROL HY, V22, P135, DOI 10.1097/MNH.0b013e32835d0c05; De Wardener HE, 2001, PHYSIOL REV, V81, P1599, DOI 10.1152/physrev.2001.81.4.1599; Dunbar JC, 1997, DIABETES, V46, P2040, DOI 10.2337/diabetes.46.12.2040; Gao JC, 2009, CANCER SCI, V100, P389, DOI 10.1111/j.1349-7006.2008.01053.x; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Kim MS, 2015, NAT IMMUNOL, V16, P525, DOI 10.1038/ni.3133; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Loraine YC, 2015, MOL METAB, V4, P287, DOI 10.1016/j.molmet.2015.01.011; Lu HQ, 1998, BRAIN RES BULL, V47, P331, DOI 10.1016/S0361-9230(98)00086-0; Maness LM, 1998, ENDOCRINOLOGY, V139, P4556, DOI 10.1210/en.139.11.4556; Mark AL, 2013, AM J PHYSIOL-REG I, V305, pR566, DOI 10.1152/ajpregu.00180.2013; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Rahmouni K, 2003, HYPERTENSION, V41, P763, DOI 10.1161/01.HYP.0000048342.54392.40; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Rahmouni K, 2002, HYPERTENSION, V39, P486, DOI 10.1161/hy0202.102836; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Shin JI, 2014, NAT REV ENDOCRINOL, V10, DOI 10.1038/nrendo.2014.44-c1; Shiraishi T, 1999, NUTRITION, V15, P576, DOI 10.1016/S0899-9007(99)00088-X; Simonds SE, 2014, CELL, V159, P1404, DOI 10.1016/j.cell.2014.10.058; Tang YZ, 2013, CELL CYCLE, V12, P2711, DOI 10.4161/cc.26054; Tanida M, 2015, J NEUROSCI, V35, P474, DOI 10.1523/JNEUROSCI.1828-14.2015; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Toffanin S, 2010, CANCER CELL, V17, P115, DOI 10.1016/j.ccr.2010.01.018; Tumer N, 2007, J HYPERTENS, V25, P2471, DOI 10.1097/HJH.0b013e3282e9a9fd; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Yemelyanov A, 2006, ONCOGENE, V25, P387, DOI 10.1038/sj.onc.1209066; Zarkesh-Esfahani H, 2004, J IMMUNOL, V172, P1809, DOI 10.4049/jimmunol.172.3.1809; Zarkesh-Esfahani H, 2001, J IMMUNOL, V167, P4593, DOI 10.4049/jimmunol.167.8.4593; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhao T, 2005, CELL IMMUNOL, V238, P19, DOI 10.1016/j.cellimm.2005.12.002; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4	58	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15131	15142		10.1074/jbc.M116.730408	http://dx.doi.org/10.1074/jbc.M116.730408			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226618	hybrid, Green Published			2022-12-26	WOS:000380583200023
J	Lokhandwala, J; de la Vega, RISY; Hopkins, HC; Britton, CW; Rodriguez-Iglesias, A; Bogomolni, R; Schmoll, M; Zoltowski, BD				Lokhandwala, Jameela; Silverman y de la Vega, Rafael I.; Hopkins, Hilary C.; Britton, Collin W.; Rodriguez-Iglesias, Aroa; Bogomolni, Roberto; Schmoll, Monika; Zoltowski, Brian D.			A Native Threonine Coordinates Ordered Water to Tune Light-Oxygen-Voltage (LOV) Domain Photocycle Kinetics and Osmotic Stress Signaling in Trichoderma reesei ENVOY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinetics; molecular dynamics; optogenetics; photobiology; structure-function; LOV domain; osmotic stress	BLUE-LIGHT; TRANSFORMATION SYSTEM; MOLECULAR SIMULATION; MUTATIONAL ANALYSIS; HYDRATION DYNAMICS; STRUCTURAL-CHANGES; INTEGRATING LIGHT; HIGH-THROUGHPUT; PROTEIN; MECHANISM	Light-oxygen-voltage (LOV) domain-containing proteins function as small light-activated modules capable of imparting blue light control of biological processes. Their small modular nature has made them model proteins for allosteric signal transduction and optogenetic devices. Despite intense research, key aspects of their signal transduction mechanisms and photochemistry remain poorly understood. In particular, ordered water has been identified as a possible key mediator of photocycle kinetics, despite the lack of ordered water in the LOV active site. Herein, we use recent crystal structures of a fungal LOV protein ENVOY to interrogate the role of Thr(101) in recruiting water to the flavin active site where it can function as an intrinsic base to accelerate photocycle kinetics. Kinetic and molecular dynamic simulations confirm a role in solvent recruitment to the active site and identify structural changes that correlate with solvent recruitment. In vivo analysis of T101I indicates a direct role of the Thr(101) position in mediating adaptation to osmotic stress, thereby verifying biological relevance of ordered water in LOV signaling. The combined studies identify position 101 as a mediator of both allostery and photocycle catalysis that can impact organism physiology.	[Lokhandwala, Jameela; Hopkins, Hilary C.; Britton, Collin W.; Zoltowski, Brian D.] Southern Methodist Univ, Dept Chem, Fondren Sci Bldg,Rm 321, Dallas, TX 75275 USA; [Silverman y de la Vega, Rafael I.; Bogomolni, Roberto] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Rodriguez-Iglesias, Aroa; Schmoll, Monika] Austrian Inst Technol, Dept Hlth & Environm, Bioresources, A-3430 Tulln, Austria	Southern Methodist University; University of California System; University of California Santa Cruz	Zoltowski, BD (corresponding author), Southern Methodist Univ, Dept Chem, Fondren Sci Bldg,Rm 321, Dallas, TX 75275 USA.	bzoltowski@smu.edu	Schmoll, Monika/I-6541-2016	Schmoll, Monika/0000-0003-3918-0574	Herman Frasch Foundation [739-HF12]; Austrian Science Fund Project [P24350-B20]; Austrian Science Fund (FWF) [P 24350] Funding Source: researchfish	Herman Frasch Foundation; Austrian Science Fund Project(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant 739-HF12 from the Herman Frasch Foundation (to B. D. Z.) and Austrian Science Fund Project Grant P24350-B20 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Bazafkan H, 2015, MOL MICROBIOL, V96, P1103, DOI 10.1111/mmi.12993; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bocola M, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00055; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carr D., 2015, HEXBIN HEXAGONAL BIN; Chan RH, 2012, J PHYS CHEM B, V116, P10609, DOI 10.1021/jp304934t; CHANDLER D, 1987, CHEM PHYS LETT, V140, P108, DOI 10.1016/0009-2614(87)80425-6; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Dasgupta A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005215; Demarsy E, 2009, CURR OPIN PLANT BIOL, V12, P69, DOI 10.1016/j.pbi.2008.09.002; Diensthuber RP, 2014, ACS SYNTH BIOL, V3, P811, DOI 10.1021/sb400205x; El-Arab KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124874; Foreman R, 2012, J BACTERIOL, V194, P3038, DOI 10.1128/JB.00182-12; Freddolino PL, 2013, PHOTOCH PHOTOBIO SCI, V12, P1158, DOI 10.1039/c3pp25400c; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kawano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082693; Krauss U, 2010, MICROB BIOTECHNOL, V3, P15, DOI 10.1111/j.1751-7915.2009.00140.x; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lokhandwala J, 2015, STRUCTURE, V23, P116, DOI 10.1016/j.str.2014.10.020; Losi A, 2015, PHOTOCHEM PHOTOBIOL, V91, P1021, DOI 10.1111/php.12489; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moriconi V, 2013, PLANT J, V76, P322, DOI 10.1111/tpj.12289; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Nucci NV, 2011, J AM CHEM SOC, V133, P12326, DOI 10.1021/ja202033k; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; Ogura Y, 2008, J PLANT RES, V121, P97, DOI 10.1007/s10265-007-0118-8; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pudasaini A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00018; Pudasaini A, 2013, BIOCHEMISTRY-US, V52, P7150, DOI 10.1021/bi401027n; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; Rani R, 2013, BIOCHEMISTRY-US, V52, P4460, DOI 10.1021/bi400311r; Schmoll M, 2016, MICROBIOL MOL BIOL R, V80, P205, DOI 10.1128/MMBR.00040-15; Schmoll M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-127; Schuster A, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-1; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Tisch D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-657; Vaidya AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001945; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yee EF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10079; Zayner JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087074; Zayner JP, 2013, BIOPHYS J, V105, P1027, DOI 10.1016/j.bpj.2013.07.010; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2013, BIOCHEMISTRY-US, V52, P6653, DOI 10.1021/bi401040m; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	63	17	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14839	14850		10.1074/jbc.M116.731448	http://dx.doi.org/10.1074/jbc.M116.731448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226624	Green Published, hybrid			2022-12-26	WOS:000380366700035
J	Iizuka, K; Yokomizo, T; Watanabe, N; Tanaka, Y; Osato, M; Takaku, T; Komatsu, N				Iizuka, Kazuhide; Yokomizo, Tomomasa; Watanabe, Naoki; Tanaka, Yosuke; Osato, Motomi; Takaku, Tomoiku; Komatsu, Norio			Lack of Phenotypical and Morphological Evidences of Endothelial to Hematopoietic Transition in the Murine Embryonic Head during Hematopoietic Stem Cell Emergence	PLOS ONE			English	Article							AORTIC ENDOTHELIUM; MOUSE EMBRYO; AGM REGION; YOLK-SAC; DEFINITIVE HEMATOPOIESIS; RUNX1; CIRCULATION; GENERATION; LINEAGE; VASCULATURE	During mouse ontogeny, hematopoietic cells arise from specialized endothelial cells, i.e., the hemogenic endothelium, and form clusters in the lumen of arterial vessels. Hemogenic endothelial cells have been observed in several embryonic tissues, such as the dorsal aorta, the placenta and the yolk sac. Recent work suggests that the mouse embryonic head also produces hematopoietic stem cells (HSCs)/progenitors. However, a histological basis for HSC generation in the head has not yet been determined because the hematopoietic clusters and hemogenic endothelium in the head region have not been well characterized. In this study, we used whole-mount immunostaining and 3D confocal reconstruction techniques to analyze both c-Kit(+) hematopoietic clusters and Runx1(+) hemogenic endothelium in the whole-head vasculature. The number of c-Kit(+) hematopoietic cells was 20-fold less in the head arteries than in the dorsal aorta. In addition, apparent nascent hematopoietic cells, which are characterized by a "budding" structure and a Runx1(+) hemogenic endothelium, were not observed in the head. These results suggest that head HSCs may not be or are rarely generated from the endothelium in the same manner as aortic HSCs.	[Iizuka, Kazuhide; Yokomizo, Tomomasa; Watanabe, Naoki; Takaku, Tomoiku; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Yokomizo, Tomomasa; Osato, Motomi] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan; [Tanaka, Yosuke] RIKEN, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan; [Osato, Motomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Osato, Motomi] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore	Juntendo University; Kumamoto University; RIKEN; National University of Singapore; National University of Singapore	Yokomizo, T; Takaku, T (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan.; Yokomizo, T (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan.	tmyokomi@kumamoto-u.ac.jp; ttakaku@juntendo.ac.jp	Osato, Motomi/N-5056-2014	Osato, Motomi/0000-0003-3982-9054	Research Institute for Diseases of Old Age; Center for Biomedical Research Resources at the Juntendo University School of Medicine	Research Institute for Diseases of Old Age; Center for Biomedical Research Resources at the Juntendo University School of Medicine	This work was funded by Research Institute for Diseases of Old Age and the Center for Biomedical Research Resources at the Juntendo University School of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Dieterlen-Lievre F, 2007, CR BIOL, V330, P504, DOI 10.1016/j.crvi.2007.05.003; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Li ZA, 2012, CELL STEM CELL, V11, P663, DOI 10.1016/j.stem.2012.07.004; Lopez MLSS, 2003, AM J PHYSIOL-REG I, V284, pR1126, DOI 10.1152/ajpregu.00543.2002; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Nakano H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2569; Ng CEL, 2010, STEM CELLS, V28, P1869, DOI 10.1002/stem.507; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Tanaka Y, 2014, CELL REP, V8, P31, DOI 10.1016/j.celrep.2014.05.055; Tanaka Y, 2012, P NATL ACAD SCI USA, V109, P4515, DOI 10.1073/pnas.1115828109; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Wilson YM, 2004, DEVELOPMENT, V131, P6153, DOI 10.1242/dev.01533; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Yoshimoto M, 2008, CELL STEM CELL, V3, P583, DOI 10.1016/j.stem.2008.11.002; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	37	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156427	10.1371/journal.pone.0156427	http://dx.doi.org/10.1371/journal.pone.0156427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227884	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500134
J	Kumbhar, BV; Borogaon, A; Panda, D; Kunwar, A				Kumbhar, Bajarang Vasant; Borogaon, Anubhaw; Panda, Dulal; Kunwar, Ambarish			Exploring the Origin of Differential Binding Affinities of Human Tubulin Isotypes alpha beta II, alpha beta III and alpha beta IV for DAMA-Colchicine Using Homology Modelling, Molecular Docking and Molecular Dynamics Simulations	PLOS ONE			English	Article							BIOMOLECULAR SIMULATIONS; MUTATIONS; RESISTANCE; EXPRESSION; INSIGHT; SITE; MICROTUBULES; CHEMOTHERAPY; MECHANISM; KINETICS	Tubulin isotypes are found to play an important role in regulating microtubule dynamics. The isotype composition is also thought to contribute in the development of drug resistance as tubulin isotypes show differential binding affinities for various anti-cancer agents. Tubulin isotypes alpha beta(III) and alpha beta(IV) show differential binding affinity for colchicine. However, the origin of differential binding affinity is not well understood at the molecular level. Here, we investigate the origin of differential binding affinity of a colchicine analogue N-deacetyl-N-(2-mercaptoacetyl)-colchicine (DAMA-colchicine) for human alpha beta(II), alpha beta(III) and alpha beta(IV) isotypes, employing sequence analysis, homology modeling, molecular docking, molecular dynamics simulation and MM-GBSA binding free energy calculations. The sequence analysis study shows that the residue compositions are different in the colchicine binding pocket of apii and , alpha beta(III) whereas no such difference is present in alpha beta(IV) tubulin isotypes. Further, the molecular docking and molecular dynamics simulations results show that residue differences present at the colchicine binding pocket weaken the bonding interactions and the correct binding of DAMA-colchicine at the interface of apii and alpha beta(III) tubulin isotypes. Post molecular dynamics simulation analysis suggests that these residue variations affect the structure and dynamics of apii and alpha beta(III) tubulin isotypes, which in turn affect the binding of DAMA-colchicine. Further, the binding free-energy calculation shows that alpha beta IV tubulin isotype has the highest binding free-energy and apiii has the lowest binding free-energy for DAMA-colchicine. The order of binding free-energy for DAMA-colchicine is alpha beta(IV) similar or equal to alpha beta(II) alpha beta(III). Thus, our computational approaches provide an insight into the effect of residue variations on differential binding of apii, apiii and apiv tubulin isotypes with DAMA-colchicine and may help to design new analogues with higher binding affinities for tubulin isotypes.	[Kumbhar, Bajarang Vasant; Borogaon, Anubhaw; Panda, Dulal; Kunwar, Ambarish] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kumbhar, BV (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	akunwar@iitb.ac.in	Kunwar, Ambarish/AAD-3618-2022; Kumbhar, Bajarang/AAR-3309-2020	Kunwar, Ambarish/0000-0002-8671-7816; Kumbhar, Bajarang/0000-0002-3839-9809	Indian Institute of Technology Bombay; DAE-SRC fellowship; Department of Biotechnology, Govt. of India, Innovative Young Biotechnologist Award, New Delhi, India [BT/06/IYBA/2012]	Indian Institute of Technology Bombay; DAE-SRC fellowship; Department of Biotechnology, Govt. of India, Innovative Young Biotechnologist Award, New Delhi, India	BVK is supported by the Postdoctoral Fellowship at Indian Institute of Technology Bombay. DP is supported by a DAE-SRC fellowship. AK is supported by Department of Biotechnology, Govt. of India, Innovative Young Biotechnologist Award (Grant Number BT/06/IYBA/2012), New Delhi, India.	Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; BAI RL, 1989, BIOCHEMISTRY-US, V28, P5606, DOI 10.1021/bi00439a040; BANERJEE A, 1992, J BIOL CHEM, V267, P13335; BANERJEE A, 1994, J BIOL CHEM, V269, P10324; Banerjee S, 1997, BIOCHEMISTRY-US, V36, P5600, DOI 10.1021/bi962648n; Berrieman HK, 2004, LANCET ONCOL, V5, P158, DOI 10.1016/S1470-2045(04)01411-1; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Case D.A., 2012, AMBER 12 REFERENCE M, P350; Chakraborti S, 2012, BIOCHEMISTRY-US, V51, P7138, DOI 10.1021/bi300474q; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dumortier C, 1997, BIOCHEM J, V327, P685, DOI 10.1042/bj3270685; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; Ge Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035941; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; HASTIE SB, 1991, PHARMACOL THERAPEUT, V51, P377, DOI 10.1016/0163-7258(91)90067-V; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jani V, 2014, J MOL MODEL, P20; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Karthick V, 2014, CELL BIOCHEM BIOPHYS, V68, P291, DOI 10.1007/s12013-013-9709-2; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao SY, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2070-6; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Ma C, 2007, MOL BIOL CELL, V18, P4711, DOI 10.1091/mbc.E07-04-0379; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Natarajan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042351; Perakyla M, 2001, PROTEIN ENG, V14, P753, DOI 10.1093/protein/14.10.753; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Rai A, 2013, BIOCHEM PHARMACOL, V86, P378, DOI 10.1016/j.bcp.2013.05.024; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santoshi S, 2014, J COMPUT AID MOL DES, V28, P751, DOI 10.1007/s10822-014-9756-9; Sharma S, 2010, BIOCHEMISTRY-US, V49, P2932, DOI 10.1021/bi100159p; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tseng CY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-131; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Varzhabetyan LR, 2012, MOL BIOL+, V46, P316, DOI 10.1134/S0026893312020185; Verdier-Pinard P, 2005, BIOCHEMISTRY-US, V44, P15858, DOI 10.1021/bi051004p; Zhang YL, 2013, ONCOL LETT, V6, P220, DOI 10.3892/ol.2013.1323	48	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156048	10.1371/journal.pone.0156048	http://dx.doi.org/10.1371/journal.pone.0156048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227832	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500058
J	McNally, R; Toms, AV; Eck, MJ				McNally, Randall; Toms, Angela V.; Eck, Michael J.			Crystal Structure of the FERM-SH2 Module of Human Jak2	PLOS ONE			English	Article							KINASE DOMAINS; PROTEIN-KINASE; RECEPTOR INTERACTION; PSEUDOKINASE-DOMAIN; JANUS KINASES; N-TERMINUS; CYTOKINE; RECOGNITION; LOCALIZATION; CONSERVATION	Jak-family tyrosine kinases mediate signaling from diverse cytokine receptors. Binding of Jaks to their cognate receptors is mediated by their N-terminal region, which contains FERM and SH2 domains. Here we describe the crystal structure of the FERM-SH2 region of Jak2 at 3.0 angstrom resolutn. The structure reveals that these domains and their flanking linker segments interact intimately to form an integrated structural module. The Jak2 FERM-SH2 structure closely resembles that recently described for Tyk2, another member of the Jak family. While the overall architecture and interdomain orientations are preserved between Jak2 and Tyk2, we identify residues in the putative receptor-binding groove that differ between the two and may contribute to the specificity of receptor recognition. Analysis of Jak mutations that are reported to disrupt receptor binding reveals that they lie in the hydrophobic core of the FERM domain, and are thus expected to compromise the structural integrity of the FERM-SH2 unit. Similarly, analysis of mutations in Jak3 that are associated with severe combined immunodeficiency suggests that they compromise Jak3 function by destabilizing the FERM-SH2 structure.	[McNally, Randall; Toms, Angela V.; Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [McNally, Randall; Toms, Angela V.; Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Toms, Angela V.] Forma Therapeut, Watertown, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Eck, MJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Eck, MJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@crystal.harvard.edu		McNally, Randall/0000-0002-1919-2466	National Institutes of Health [GM110352, 5-T32-CA009361-33]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM110352 (MJE) and National Institutes of Health training grant 5-T32-CA009361-33 (RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Bricogne G, 2011, BUSTER 2 10; Cacalano NA, 1999, EMBO J, V18, P1549, DOI 10.1093/emboj/18.6.1549; Candotti F, 1997, BLOOD, V90, P3996, DOI 10.1182/blood.V90.10.3996; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Gorantla SP, 2010, BLOOD, V116, P4600, DOI 10.1182/blood-2009-07-236133; Haan C, 2001, J BIOL CHEM, V276, P37451, DOI 10.1074/jbc.M106135200; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Haan S, 2008, J IMMUNOL, V180, P998, DOI 10.4049/jimmunol.180.2.998; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Liu BA, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-27; Lupardus PJ, 2014, P NATL ACAD SCI USA, V111, P8025, DOI 10.1073/pnas.1401180111; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNally R, 2014, NAT STRUCT MOL BIOL, V21, P431, DOI 10.1038/nsmb.2824; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; Notorangelo LD, 2001, HUM MUTAT, V18, P255; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Shan YB, 2014, NAT STRUCT MOL BIOL, V21, P579, DOI 10.1038/nsmb.2849; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Toms AV, 2013, NAT STRUCT MOL BIOL, V20, P1221, DOI 10.1038/nsmb.2673; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Valiev M, 2007, J PHYS CHEM B, V111, P13455, DOI 10.1021/jp074853q; Vihinen M, 2000, CLIN IMMUNOL, V96, P108, DOI 10.1006/clim.2000.4880; Viny AD, 2014, CANCER J, V20, P61, DOI 10.1097/PPO.0000000000000013; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhao LQ, 2010, BIOCHEM J, V426, P91, DOI 10.1042/BJ20090615; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	47	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156218	10.1371/journal.pone.0156218	http://dx.doi.org/10.1371/journal.pone.0156218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227461	Green Submitted, gold, Green Published			2022-12-26	WOS:000376882500084
J	Wang, RX; Jiao, HC; Zhao, JP; Wang, XJ; Lin, H				Wang, Ruxia; Jiao, Hongchao; Zhao, Jingpeng; Wang, Xiaojuan; Lin, Hai			Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; UP-REGULATION; ATROPHY; HYPERTROPHY; FOLLISTATIN; MECHANISMS; GENE; CORTICOSTERONE	Myostatin, a member of the TGF-beta superfamily of secreted proteins, is expressed primarily in skeletal muscle. It negatively regulates muscle mass and is associated with glucocorticoid-induced muscle atrophy. However, it remains unclear whether myostatin is involved in glucocorticoid-induced muscle protein turnover. The aim of the present study was to investigate the role of myostatin in protein metabolism during dexamethasone (DEX) treatment. Protein synthesis rates and the expression of the genes for myostatin, ubiquitin-proteasome atrogin-1, MuRF1, FoxO1/3a and mTOR/p70S6K were determined. The results show that DEX decreased (P<0.05) protein synthesis rates while increasing the abundance of myostatin. DEX increased (P<0.05) the level of phospho-FoxO1/3a (Thr 24/32) and the expression of MuRF1. In contrast, DEX treatment had no detectable effect on atrogin-1 protein levels (P>0.05). The phosphorylation levels of mTOR and p70S6K were decreased by DEX treatment (P<0.05). Follistatin treatment inhibited the DEX-induced increase in myostatin (P<0.05) and the activation of phosphor-FoxO1/3a (Thr 24/32) (P<0.05) and MuRF1 (P<0.05). Follistatin treatment had no influence on the protein synthesis rate or on the phosphorylation levels of mTOR (Ser 2448) and p70S6K (Thr 389) (P>0.05). In conclusion, the present study suggests that the myostatin signalling pathway is associated with glucocorticoid-induced muscle protein catabolism at the beginning of exposure. Myostatin is not a main pathway associated with the suppression of muscle protein synthesis by glucocorticoids.	[Wang, Ruxia; Jiao, Hongchao; Zhao, Jingpeng; Wang, Xiaojuan; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Shandong Key Lab Anim Biotechnol & Dis Control, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University	Lin, H (corresponding author), Shandong Agr Univ, Dept Anim Sci, Shandong Key Lab Anim Biotechnol & Dis Control, Tai An 271018, Shandong, Peoples R China.	hailin@sdau.edu.cn			National Basic Research Program of China [2012CB124706]; National Natural Science Foundation of China [31272467, 31472114]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by 2012CB124706, the National Basic Research Program of China ( http://www.most.gov.cn/) and 31272467 and 31472114, the National Natural Science Foundation of China ( http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2011, AM J PHYSIOL-CELL PH, V300, pC124, DOI 10.1152/ajpcell.00142.2010; Allen DL, 2010, AM J PHYSIOL-REG I, V299, pR889, DOI 10.1152/ajpregu.00296.2010; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Barbe C, 2015, AM J PHYSIOL-ENDOC M, V309, pE557, DOI 10.1152/ajpendo.00098.2015; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Castillero E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059726; Gao J, 2008, POULTRY SCI, V87, P1609, DOI 10.3382/ps.2007-00007; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; GOLDBERG AL, 1980, FED PROC, V39, P31; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Liu XS, 2004, ANTICANCER RES, V24, P2697; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; Lokireddy S, 2011, AM J PHYSIOL-CELL PH, V301, pC1316, DOI 10.1152/ajpcell.00114.2011; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Macedo AG, 2016, STEROIDS, V107, P30, DOI 10.1016/j.steroids.2015.12.016; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mosler S, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.262; Qin J, 2013, RES VET SCI, V94, P84, DOI 10.1016/j.rvsc.2012.07.018; Qin WP, 2014, BIOCHEM BIOPH RES CO, V450, P979, DOI 10.1016/j.bbrc.2014.06.080; Retamales A, 2015, BIOCHEM BIOPH RES CO, V464, P596, DOI 10.1016/j.bbrc.2015.07.018; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Salehian B, 1999, Endocr Pract, V5, P277; Salehian B, 2006, METABOLISM, V55, P1239, DOI 10.1016/j.metabol.2006.05.009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Savary I, 1998, BRIT J NUTR, V79, P297, DOI 10.1079/BJN19980047; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; TOMAS FM, 1984, BIOCHEM J, V220, P469, DOI 10.1042/bj2200469; Tsuchida K, 2006, MINI-REV MED CHEM, V6, P1255, DOI 10.2174/138955706778742759; Tsuchida K, 2006, EXPERT OPIN BIOL TH, V6, P147, DOI 10.1517/14712598.6.2.147; Umeki D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128263; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Yuan L, 2008, BRIT POULTRY SCI, V49, P487, DOI 10.1080/00071660802251731; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008	53	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156225	10.1371/journal.pone.0156225	http://dx.doi.org/10.1371/journal.pone.0156225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227776	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500087
J	Hsieh, VCR; Liu, CC; Hsiao, YC; Wu, TN				Hsieh, Vivian Chia-Rong; Liu, Chin-Chen; Hsiao, Yu-Chen; Trong-Neng Wu			Risk of Allergic Rhinitis, Allergic Conjunctivitis, and Eczema in Children Born to Mothers with Gum Inflammation during Pregnancy	PLOS ONE			English	Article							CORD BLOOD IGE; ATOPIC-DERMATITIS; MATERNAL PERIODONTITIS; ORAL PATHOGENS; EARLY-LIFE; ASTHMA; DISEASE; PREVALENCE; TAIWAN; UPDATE	Purpose Despite links between maternal and child health status, evidence on the association between gum infection in pregnant mothers and childhood allergies is scarce. We aim to evaluate the risk of developing allergy in children born to periodontal mothers in a nationwide study. Methods We conducted a 9-year population-based, retrospective cohort study using Taiwan's National Health Insurance database. A study cohort of 42,217 newborns born to mothers with periodontal disease during pregnancy was identified in 2001 and matched with 42,334 babies born to mothers without any infection (control) by mother's age at delivery and baby sex. With a follow-up period from 2001 to 2010, we observed the incidence of allergic rhinitis (AR), allergic conjunctivitis (AC), and eczema in these children. Cox proportional hazards regression models were performed with premature deaths as competing risk for the estimation of allergic disease risks. Results Nine-year cumulative incidences were the highest among children born to periodontal mothers; they reached 46.8%, 24.2%, and 40.4%(vs. 39.5%, 18.3% and 34.8% in control) for AR, AC, and eczema, respectively. Our results showed moderately increased risks for the allergies in children born to periodontal mothers relative to their matched non-inflammatory control (adjusted HRs: 1.17, 95% CI: 1.15-1.20; 1.27, 1.24-1.31; 1.14, 1.12-1.17, respectively). Because the impact of food consumption and living environment cannot be considered using insurance data, we attempted to control it by adjusting for parental income and mother's residential area. Conclusions Overall cumulative incidence and risks of children born to periodontal mothers for AR, AC, and eczema are significantly higher than those born to non-inflammatory mothers. Gum infection in women during pregnancy is an independent risk factor for allergic diseases in children, thus its intergenerational consequences should be considered in gestational care.	[Hsieh, Vivian Chia-Rong] China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan; [Liu, Chin-Chen] E Da Hosp, Dept Family Med, Kaohsiung, Taiwan; [Hsiao, Yu-Chen] Asia Univ, Ctr Gen Educ, Wufeng, Taiwan; [Trong-Neng Wu] Hungkuang Univ, Dept Nursing, Coll Med & Nursing, Taichung, Taiwan; [Trong-Neng Wu] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan; [Trong-Neng Wu] Asia Univ, Dept Healthcare Adm, Wufeng, Taiwan	China Medical University Taiwan; E-Da Hospital; Asia University Taiwan; Hungkuang University; National Health Research Institutes - Taiwan; Asia University Taiwan	Wu, TN (corresponding author), Hungkuang Univ, Dept Nursing, Coll Med & Nursing, Taichung, Taiwan.; Wu, TN (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan.; Wu, TN (corresponding author), Asia Univ, Dept Healthcare Adm, Wufeng, Taiwan.	tnwu@sunrise.hk.edu.tw			Ministry of Science and Technology, ROC [NSC 101-2314-B-039-016]	Ministry of Science and Technology, ROC	This work was made possible with the support of a research grant from the Ministry of Science and Technology, ROC (NSC 101-2314-B-039-016).	Apfelbacher CJ, 2011, ALLERGY, V66, P206, DOI 10.1111/j.1398-9995.2010.02464.x; Arbes SJ, 2006, J ALLERGY CLIN IMMUN, V118, P1169, DOI 10.1016/j.jaci.2006.07.029; Arbes SJ, 2011, J ALLERGY CLIN IMMUN, V127, P1119, DOI 10.1016/j.jaci.2011.03.023; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Borish L, 2003, J ALLERGY CLIN IMMUN, V112, P1021, DOI 10.1016/j.jaci.2003.09.015; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Estes TS, 2010, J THEORY CONSTRUCTIO, V14, P33; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Friedrich N, 2006, CLIN EXP ALLERGY, V36, P495, DOI 10.1111/j.1365-2222.2006.02455.x; Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x; Gomes-Filho IS, 2014, J PERIODONTOL, V85, pE82, DOI [10.1902/jop.2013.130369, 10.1902/jop.2013.130509]; Gustafsson D, 2000, ALLERGY, V55, P240, DOI 10.1034/j.1398-9995.2000.00391.x; Haake SK, 2002, CARRANZAS CLIN PERIO, P132; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Hsieh VC, 2014, J RES PRACTICE DENT; Hsieh VCR, 2015, ASIA-PAC J PUBLIC HE, V27, P497, DOI 10.1177/1010539515583503; Hujoel PP, 2008, J PERIODONTOL, V79, P1330, DOI [10.1902/jop.2008.070648, 10.1902/jop.2008.070648 ]; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Kaan A, 2000, ANN ALLERG ASTHMA IM, V84, P37, DOI 10.1016/S1081-1206(10)62738-X; Lai H, 2007, J CLIN PERIODONTOL, V34, P851, DOI 10.1111/j.1600-051X.2007.01121.x; Lee ML, 2014, J MICROBIOL IMMUNOL; MAGNUSSON CGM, 1988, ALLERGY, V43, P241, DOI 10.1111/j.1398-9995.1988.tb00896.x; Matula K, 2012, AM J PERINAT, V29, P815, DOI 10.1055/s-0032-1316449; Michalowicz BS, 2011, PEDIATRICS, V127, pE1212, DOI 10.1542/peds.2010-3129; Rigato PO, 2009, IMMUNOTHERAPY-UK, V1, P141, DOI 10.2217/1750743X.1.1.141; Scirica CV, 2007, J ALLERGY CLIN IMMUN, V119, P81, DOI 10.1016/j.jaci.2006.09.002; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; TSUBOTA K, 1991, CORNEA, V10, P525, DOI 10.1097/00003226-199111000-00011; Wang JY, 2013, INT J EPIDEMIOL, V42, P1087, DOI 10.1093/ije/dyt121; Wollenberg A, 2013, ALLERGY, V68, P1509, DOI 10.1111/all.12324; Wong GWK, 2013, ALLERGY ASTHMA IMMUN, V5, P251, DOI 10.4168/aair.2013.5.5.251	35	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156185	10.1371/journal.pone.0156185	http://dx.doi.org/10.1371/journal.pone.0156185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224053	gold, Green Submitted, Green Published			2022-12-26	WOS:000376881700071
J	Steiner, LA; Schulz, V; Makismova, Y; Lezon-Geyda, K; Gallagher, PG				Steiner, Laurie A.; Schulz, Vincent; Makismova, Yelena; Lezon-Geyda, Kimberly; Gallagher, Patrick G.			CTCF and Cohesin(SA-1) Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells	PLOS ONE			English	Article							INSULATOR PROTEIN CTCF; CHIP-SEQ DATA; GENE-EXPRESSION; BINDING-SITES; ENHANCER-BLOCKING; GENOME-WIDE; METHYLATION; CHROMOSOME; IDENTIFICATION; LOCUS	Background CTCF and cohesin(SA-1) are regulatory proteins involved in a number of critical cellular processes including transcription, maintenance of chromatin domain architecture, and insulator function. To assess changes in the CTCF and cohesin(SA-1) interactomes during erythropoiesis, chromatin immunoprecipitation coupled with high throughput sequencing and mRNA transcriptome analyses via RNA-seq were performed in primary human hematopoietic stem and progenitor cells (HSPC) and primary human erythroid cells from single donors. Results Sites of CTCF and cohesin(SA-1) co-occupancy were enriched in gene promoters in HSPC and erythroid cells compared to single CTCF or cohesin sites. Cell type-specific CTCF sites in erythroid cells were linked to highly expressed genes, with the opposite pattern observed in HSPCs. Chromatin domains were identified by ChIP-seq with antibodies against trimethylated lysine 27 histone H3, a modification associated with repressive chromatin. Repressive chromatin domains increased in both number and size during hematopoiesis, with many more repressive domains in erythroid cells than HSPCs. CTCF and cohesin(SA-1) marked the boundaries of these repressive chromatin domains in a cell-type specific manner. Conclusion These genome wide data, changes in sites of protein occupancy, chromatin architecture, and related gene expression, support the hypothesis that CTCF and cohesin(SA-1) have multiple roles in the regulation of gene expression during erythropoiesis including transcriptional regulation at gene promoters and maintenance of chromatin architecture. These data from primary human erythroid cells provide a resource for studies of normal and perturbed erythropoiesis.	[Steiner, Laurie A.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Schulz, Vincent; Makismova, Yelena; Lezon-Geyda, Kimberly; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	University of Rochester; Yale University; Yale University; Yale University	Steiner, LA (corresponding author), Univ Rochester, Dept Pediat, Rochester, NY USA.	Laurie_Steiner@urmc.rochester.edu		Lezon-Geyda, Kimberly/0000-0002-1958-0354; Steiner, Laurie/0000-0002-2923-4105; Schulz, Vincent/0000-0001-6333-4284	National Institutes of Health [K12HD000850, HL65448, HL106184]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448, R01HL106184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants K12HD000850 (LAS), HL65448 (PGG), and HL106184 (PGG). There was no additional external support received for this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by National Institutes of Health Grants K12HD000850, HL65448, and HL106184.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Dorsett D, 2013, CURR OPIN CELL BIOL, V25, P327, DOI 10.1016/j.ceb.2013.02.003; Epstein Douglas J., 2009, Briefings in Functional Genomics & Proteomics, V8, P310, DOI 10.1093/bfgp/elp021; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Gallagher PG, 2010, J CLIN INVEST, V120, P4453, DOI 10.1172/JCI42240; Gallagher PG, 2010, J CLIN INVE IN PRESS; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Koller MR, 1996, EXP HEMATOL, V24, P1484; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Marinov GK, 2014, G3-GENES GENOM GENET, V4, P209, DOI 10.1534/g3.113.008680; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Remeseiro S, 2013, DEVELOPMENT, V140, P3715, DOI 10.1242/dev.090605; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Skibbens RV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004036; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Steiner L. A., 2009, MOL CELL BIOL; Steiner LA, 2011, J BIOL CHEM, V286, P39457, DOI 10.1074/jbc.M111.243006; Su MY, 2013, J BIOL CHEM, V288, P8433, DOI 10.1074/jbc.M112.413260; Sudo K, 2010, BIOCHEM BIOPH RES CO, V397, P697, DOI 10.1016/j.bbrc.2010.06.010; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yao YG, 2013, STEM CELL RES, V10, P361, DOI 10.1016/j.scr.2013.01.006; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155378	10.1371/journal.pone.0155378	http://dx.doi.org/10.1371/journal.pone.0155378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219007	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700007
J	Skaria, T; Burgener, J; Bachli, E; Schoedon, G				Skaria, Tom; Burgener, Julia; Bachli, Esther; Schoedon, Gabriele			IL-4 Causes Hyperpermeability of Vascular Endothelial Cells through Wnt5A Signaling	PLOS ONE			English	Article							T-CELLS; INTERLEUKIN-4; RECEPTOR	Microvascular leakage due to endothelial barrier dysfunction is a prominent feature of T helper 2 (Th2) cytokine mediated allergic inflammation. Interleukin-4 (IL-4) is a potent Th2 cytokine, known to impair the barrier function of endothelial cells. However, the effectors mediating IL-4 induced cytoskeleton remodeling and consequent endothelial barrier dysfunction remain poorly defined. Here we have used whole genome transcriptome profiling and gene ontology analyses to identify the genes and processes regulated by IL-4 signaling in human coronary artery endothelial cells (HCAEC). The study revealed Wnt5A as an effector that can mediate actin cytoskeleton remodeling in IL-4 activated HCAEC through the regulation of LIM kinase (LIMK) and Cofilin (CFL). Following IL-4 treatment, LIMK and CFL were phosphorylated, thereby indicating the possibility of actin stress fiber formation. Imaging of actin showed the formation of stress fibers in IL-4 treated live HCAEC. Stress fiber formation was notably decreased in the presence of Wnt inhibitory factor 1 (WIF1). Non-invasive impedance measurements demonstrated that IL-4 increased the permeability and impaired the barrier function of HCAEC monolayers. Silencing Wnt5A significantly reduced permeability and improved the barrier function of HCAEC monolayers upon IL-4 treatment. Our study identifies Wnt5A as a novel marker of IL-4 activated vascular endothelium and demonstrates a critical role for Wnt5A in mediating IL-4 induced endothelial barrier dysfunction. Wnt5A could be a potential therapeutic target for reducing microvascular leakage and edema formation in Th2 driven inflammatory diseases.	[Skaria, Tom; Burgener, Julia; Schoedon, Gabriele] Univ Zurich Hosp, Dept Med, Div Internal Med, Inflammat Res Unit, CH-8091 Zurich, Switzerland; [Bachli, Esther] Uster Hosp, Dept Med, Uster, Switzerland	University of Zurich; University Zurich Hospital	Schoedon, G (corresponding author), Univ Zurich Hosp, Dept Med, Div Internal Med, Inflammat Res Unit, CH-8091 Zurich, Switzerland.	klinsog@usz.uzh.ch			Swiss National Science Foundation [31124861]; Novartis Stiftung fur Biologisch-Medizinische Forschung [12B35]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Stiftung fur Biologisch-Medizinische Forschung	GS received the following grants for this study: 1. Swiss National Science Foundation (No. 31124861; http://www.snf.ch/en/Pages/default.aspx); 2. Novartis Stiftung fur Biologisch-Medizinische Forschung (No. 12B35; http://www.stiftungmedbiol.novartis.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Li-Weber M, 2003, NAT REV IMMUNOL, V3, P534, DOI 10.1038/nri1128; Luzina IG, 2012, J LEUKOCYTE BIOL, V92, P753, DOI 10.1189/jlb.0412214; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091	6	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156002	10.1371/journal.pone.0156002	http://dx.doi.org/10.1371/journal.pone.0156002			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214384	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000376880200043
J	Rao, PSS; Ande, A; Sinha, N; Kumar, A; Kumar, S				Rao, P. S. S.; Ande, Anusha; Sinha, Namita; Kumar, Anil; Kumar, Santosh			Effects of Cigarette Smoke Condensate on Oxidative Stress, Apoptotic Cell Death, and HIV Replication in Human Monocytic Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYCYCLIC AROMATIC-HYDROCARBONS; ENDOPLASMIC-RETICULUM STRESS; LC-MS/MS METHOD; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; CONCURRENT DETERMINATION; ALVEOLAR MACROPHAGES; METABOLIC-ACTIVATION; NICOTINE METABOLITES	While cigarette smoking is prevalent amongst HIV-infected patients, the effects of cigarette smoke constituents in cells of myeloid lineage are poorly known. Recently, we have shown that nicotine induces oxidative stress through cytochrome P450 (CYP) 2A6-mediated pathway in U937 monocytic cells. The present study was designed to examine the effect of cigarette smoke condensate (CSC), which contains majority of tobacco constituents, on oxidative stress, cytotoxicity, expression of CYP1A1, and/or HIV-1 replication in HIV-infected (U1) and uninfected U937 cells. The effects of CSC on induction of CYP1 enzymes in HIV-infected primary macrophages were also analyzed. The results showed that the CSC-mediated increase in production of reactive oxygen species (ROS) in U937 cells is dose-and time-dependent. Moreover, CSC treatment was found to induce cytotoxicity in U937 cells through the apoptotic pathway via activation of caspase-3. Importantly, pretreatment with vitamin C blocked the CSC-mediated production of ROS and induction of caspase-3 activity. In U1 cells, acute treatment of CSC increased ROS production at 6H (>2fold) and both ROS (>2 fold) and HIV-1 replication (>3-fold) after chronic treatment. The CSC mediated effects were associated with robust induction in the expression of CYP1A1 mRNA upon acute CSC treatment of U937 and U1 cells (>20-fold), and upon chronic CSC treatment to U1 cells (>30-fold). In addition, the CYP1A1 induction in U937 cells was mediated through the aromatic hydrocarbon receptor pathway. Lastly, CSC, which is known to increase viral replication in primary macrophages, was also found to induce CYP1 enzymes in HIV-infected primary macrophages. While mRNA levels of both CYP1A1 and CYP1B1 were elevated following CSC treatment, only CYP1B1 protein levels were increased in HIV-infected primary macrophages. In conclusion, these results suggest a possible association between oxidative stress, CYP1 expression, and viral replication in CSC-treated cells of myeloid lineage. This study warrants a closer examination of the role of CYP1B1 in smoking-mediated enhanced HIV replication.	[Rao, P. S. S.; Sinha, Namita; Kumar, Santosh] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Coll Pharm, Memphis, TN USA; [Ande, Anusha; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Missouri System; University of Missouri Kansas City	Kumar, S (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Coll Pharm, Memphis, TN USA.	ksantosh@uthsc.edu	Boothapati, Anil Kumar/HHS-1813-2022; KUMAR, ANIL/ACD-8340-2022		National Institute of Health [NIH AA-022063]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022063] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by grant from the National Institute of Health to Santosh Kumar (NIH AA-022063). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBUD RA, 1995, J INFECT DIS, V172, P859, DOI 10.1093/infdis/172.3.859; Ande A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122402; Ande A, 2012, DRUG ALCOHOL DEPEN, V125, P49, DOI 10.1016/j.drugalcdep.2012.03.015; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Aquaro S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-76; Bryant VE, 2013, AIDS CARE, V25, P1308, DOI 10.1080/09540121.2013.764965; Calvo-Sanchez M, 2015, HIV MED, V16, P201, DOI 10.1111/hiv.12193; Campbell JH, 2014, AIDS, V28, P2175, DOI 10.1097/QAD.0000000000000408; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Castro SM, 2008, TOXICOL SCI, V106, P509, DOI 10.1093/toxsci/kfn175; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Earla R, 2014, DRUG METAB DISPOS, V42, P282, DOI 10.1124/dmd.113.055186; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; FOLKS TM, 1988, J IMMUNOL, V140, P1117; Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003; Gorantla Santhi, 2005, Methods Mol Biol, V304, P35; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; HuangFu WC, 2008, FEBS LETT, V582, P3206, DOI 10.1016/j.febslet.2008.08.013; JARSTRAND C, 1994, CHEM-BIOL INTERACT, V91, P141, DOI 10.1016/0009-2797(94)90034-5; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Jin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035505; Jin MY, 2012, J NEUROIMMUNE PHARM, V7, P289, DOI 10.1007/s11481-011-9283-6; Jin MY, 2011, ALCOHOL CLIN EXP RES, V35, P132, DOI 10.1111/j.1530-0277.2010.01330.x; Kawajiri K, 2007, ARCH BIOCHEM BIOPHYS, V464, P207, DOI 10.1016/j.abb.2007.03.038; Khan SZ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0169-1; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Kulkarni R, 2010, INFECT IMMUN, V78, P2146, DOI 10.1128/IAI.01410-09; Kusao I, 2012, J NEUROPSYCH CLIN N, V24, P71, DOI 10.1176/appi.neuropsych.11050109; Lerner L, 2009, J PHYSIOL PHARMACOL, V60, P81; Marinkovic N, 2013, BIOCHEM MEDICA, V23, P255; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nagai F, 2002, BIOL PHARM BULL, V25, P383, DOI 10.1248/bpb.25.383; Niaura R, 2012, CURR HIV-AIDS REP, V9, P375, DOI 10.1007/s11904-012-0138-4; Penning TM, 2014, CHEM RES TOXICOL, V27, P1901, DOI 10.1021/tx500298n; Pierson T, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-10; POLYAKOV VM, 1994, FREE RADICAL BIO MED, V16, P15, DOI 10.1016/0891-5849(94)90236-4; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; PRYOR WA, 1983, ENVIRON HEALTH PERSP, V47, P345, DOI 10.1289/ehp.8347345; Rao PSS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00550; Samikkannu T, 2014, FREE RADICAL BIO MED, V69, P136, DOI 10.1016/j.freeradbiomed.2013.12.025; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schuitemaker Hanneke, 2005, Methods Mol Biol, V304, P17, DOI 10.1385/1-59259-907-9:017; Shikuma CM, 2012, ANTIVIR THER, V17, P1233, DOI 10.3851/IMP2411; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Shuter J, 2012, AM J HEALTH BEHAV, V36, P75, DOI 10.5993/AJHB.36.1.8; Skolnik PR, 2002, JAIDS-J ACQ IMM DEF, V31, P1, DOI 10.1097/00126334-200209010-00001; SONNERBORG A, 1988, SCAND J INFECT DIS, V20, P287, DOI 10.3109/00365548809032453; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tanni SE, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-45; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Wang HW, 2008, J VIROL, V82, P7591, DOI 10.1128/JVI.00768-08; Wang WY, 2014, ARTERIOSCL THROM VAS, V34, P526, DOI 10.1161/ATVBAHA.113.302544; Zhao LJ, 2010, TOXICOLOGY, V278, P242, DOI 10.1016/j.tox.2010.09.010	56	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155791	10.1371/journal.pone.0155791	http://dx.doi.org/10.1371/journal.pone.0155791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203850	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291500023
J	Yu, J; Liang, Q; Wang, J; Wang, K; Gao, J; Zhang, J; Zeng, Y; Chiu, PWY; Ng, EKW; Sung, JJY				Yu, J.; Liang, Q.; Wang, J.; Wang, K.; Gao, J.; Zhang, J.; Zeng, Y.; Chiu, P. W. Y.; Ng, E. K. W.; Sung, J. J. Y.			REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype	ONCOGENE			English	Article							PROMOTER HYPERMETHYLATION; CELL-PROLIFERATION; DNA METHYLATION; E-CADHERIN; EXPRESSION; CARCINOMA; PATHWAY; GENE; AGGRESSIVENESS; INHIBITION	REC8 meiotic recombination protein (REC8) was found to be preferentially methylated in gastric cancer (GC) using promoter methylation array. We aimed to elucidate the epigenetic alteration and biological function of REC8 in GC. REC8 was downregulated in 100% (3/3) of Epstein Barr virus (EBV)-positive and 80% (8/10) of EBV-negative GC cell lines by promoter methylation, but the expression could be restored through demethylation treatment. Protein expression of REC8 was significantly lower in human primary gastric tumors than in adjacent non-tumor tissues. A negative correlation between methylation and mRNA expression of REC8 was observed in 223 gastric samples of The Cancer Genome Atlas study (r= 0.7018, P < 0.001). The methylation level (%) of the REC8 promoter was significantly higher in EBV-positive gastric tumors than in EBV-negative gastric tumors, as shown by bisulfite genomic sequencing (77.6 (69.3-80.5) vs 51.4 (39.5-62.3), median (interquartile range); P < 0.001); methylation levels in both subtypes of tumors were significantly higher than in normal stomach tissues (14.8 (4.2-24.0)) (both P < 0.001). Multivariate analysis revealed that REC8 methylation was an independent factor for poor survival in GC patients (hazard ratio = 1.68, P < 0.05). REC8 expression significantly suppressed cell viability, clonogenicity and cell cycle progression; it induced apoptosis and inhibited migration of AGS-EBV (EBV-positive) and BGC823 (EBV-negative) GC cells, and it suppressed tumorigenicity in nude mice. In contrast, knockdown of REC8 in gastric epithelial immortalized GES-1 cells significantly increased cell viability, clonogenicity and migration ability. The tumor-suppressive effect of REC8 is mediated at least in part by the downregulation of genes involved in cell growth (G6PD, SLC2A1, NOL3, MCM2, SNAI7 and SNAI2), and the upregulation of apoptosis/migration inhibitors (GADD45G and LDHA) and tumor suppressors (PinX7, IGFBP3 and ETS2). In conclusion, REC8 is a novel tumor suppressor that is commonly downregulated by promoter methylation in GC, especially in the EBV-associated subtype. Promoter methylation of REC8 is an independent risk factor for the shortened survival of GC patients.	[Yu, J.; Liang, Q.; Wang, J.; Wang, K.; Zhang, J.; Zeng, Y.; Sung, J. J. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, J.; Liang, Q.; Wang, J.; Wang, K.; Zhang, J.; Zeng, Y.; Sung, J. J. Y.] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Gao, J.] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing, Peoples R China; [Chiu, P. W. Y.; Ng, E. K. W.] Chinese Univ Hong Kong, Dept Surg, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Peking University; Chinese University of Hong Kong	Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Room 707A,7-F,Li Ka Shing Med Sci Bldg, Shatin, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk	Chiu, Philip/A-4019-2009; ZHANG, Jingwan/AIC-2560-2022; Liang, Qiaoyi Jessie/G-9612-2019; Sung, Joseph J. Y./R-3203-2018; Ng, Enders Kwok Wai/E-8276-2016; Chiu, Philip/ABB-1454-2020; WANG, JIA/A-2799-2019; Jun, Yu/D-8569-2015	Chiu, Philip/0000-0001-9292-112X; Liang, Qiaoyi Jessie/0000-0001-8496-3442; Sung, Joseph J. Y./0000-0003-3125-5199; Chiu, Philip/0000-0001-9292-112X; Jun, Yu/0000-0001-5008-2153; ZHANG, Jingwan/0000-0002-0344-3398; WANG, JIA/0000-0001-5339-8954	HMRF [11100022]; RGC-GRF Hong Kong [766613]; National Natural Science Foundation of China [81272304]; China 863 Program [2012AA02A504]; Shenzhen Municipal Science and Technology R D fund [JCYJ20130401151108652]; Shenzhen Virtual University Park Support Scheme	HMRF; RGC-GRF Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China 863 Program(National High Technology Research and Development Program of China); Shenzhen Municipal Science and Technology R D fund; Shenzhen Virtual University Park Support Scheme	This project was supported by research funds of HMRF (11100022), RGC-GRF Hong Kong (766613), National Natural Science Foundation of China (81272304), China 863 Program (2012AA02A504), Shenzhen Municipal Science and Technology R & D fund (JCYJ20130401151108652) and Shenzhen Virtual University Park Support Scheme to CUHK Shenzhen Research Institute. The results shown here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Arseneault R, 2013, CANCER LETT, V338, P255, DOI 10.1016/j.canlet.2013.03.034; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Camargo MC, 2014, GUT, V63, P236, DOI 10.1136/gutjnl-2013-304531; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Deep G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-37; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Feng WH, 2007, J VIROL, V81, P10113, DOI 10.1128/JVI.00692-07; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Kabbout M, 2013, CLIN CANCER RES, V19, P3383, DOI 10.1158/1078-0432.CCR-13-0341; Kim MO, 2012, BBA-GEN SUBJECTS, V1820, P1636, DOI 10.1016/j.bbagen.2012.05.008; Liang QY, 2014, GASTROENTEROLOGY, V147, P1350, DOI 10.1053/j.gastro.2014.08.036; Liu DX, 2015, ONCOTARGET, V6, P39211, DOI 10.18632/oncotarget.5391; Liu JY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-148; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; Mikeska T, 2010, EPIGENOMICS-UK, V2, P561, DOI 10.2217/EPI.10.32; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Okamoto Y, 2012, GUT, V61, P392, DOI 10.1136/gut.2011.241034; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Regel I, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-9; Sudo M, 2004, INT J CANCER, V109, P194, DOI 10.1002/ijc.11701; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang SY, 2013, GUT, V62, P833, DOI 10.1136/gutjnl-2011-301776; Wockner LF, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.177; Xu LX, 2012, GUT, V61, P977, DOI 10.1136/gutjnl-2011-300411; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yu J, 2013, ONCOGENE, V32, P307, DOI 10.1038/onc.2012.54; Yu J, 2002, BRIT J CANCER, V87, P91, DOI 10.1038/sj.bjc.6600421; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743; Zhao J, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/241913; Zhao JH, 2013, CANCER-AM CANCER SOC, V119, P304, DOI 10.1002/cncr.27724; Zhao JH, 2012, CANCER-AM CANCER SOC, V118, P924, DOI 10.1002/cncr.26184	34	34	37	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					182	193		10.1038/onc.2016.187	http://dx.doi.org/10.1038/onc.2016.187			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27212034	Green Published, hybrid			2022-12-26	WOS:000393938100004
J	Flach, RJR; Danai, LV; DiStefano, MT; Kelly, M; Menendez, LG; Jurczyk, A; Sharma, RB; Jung, DY; Kim, JH; Kim, JK; Bortell, R; Alonso, LC; Czech, MP				Flach, Rachel J. Roth; Danai, Laura V.; DiStefano, Marina T.; Kelly, Mark; Menendez, Lorena Garcia; Jurczyk, Agata; Sharma, Rohit B.; Jung, Dae Young; Kim, Jong Hun; Kim, Jason K.; Bortell, Rita; Alonso, Laura C.; Czech, Michael P.			Protein Kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Promotes Obesity-induced Hyperinsulinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; INSULIN-SECRETION; PROLIFERATION; GLUCOSE; MASS; SENSITIVITY; DYSFUNCTION; RESISTANCE; CLEARANCE; REGULATOR	Previous studies revealed a paradox whereby mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) acted as a negative regulator of insulin sensitivity in chronically obese mice, yet systemic deletion of Map4k4 did not improve glucose tolerance. Here, we report markedly reduced glucose-responsive plasma insulin and C-peptide levels in whole body Map4k4-depleted mice (M4K4 iKO) as well as an impaired first phase of insulin secretion from islets derived from M4K4 iKO mice ex vivo. After long-term high fat diet (HFD), M4K4 iKO mice pancreata also displayed reduced beta cell mass, fewer proliferating beta cells and reduced islet-specific gene mRNA expression compared with controls, although insulin content was normal. Interestingly, the reduced plasma insulin in M4K4 iKO mice exposed to chronic (16 weeks) HFD was not observed in response to acute HFD challenge or short term treatment with the insulin receptor antagonist S961. Furthermore, the improved insulin sensitivity in obese M4K4iKO mice was abrogated by high exogenous insulin over the course of a euglycemic clamp study, indicating that hypoinsulinemia promotes insulin sensitivity in chronically obese M4K4 iKO mice. These results demonstrate that protein kinase Map4k4 drives obesity-induced hyperinsulinemia and insulin resistance in part by promoting insulin secretion from beta cells in mice.	[Flach, Rachel J. Roth; Danai, Laura V.; DiStefano, Marina T.; Menendez, Lorena Garcia; Jurczyk, Agata; Jung, Dae Young; Kim, Jong Hun; Kim, Jason K.; Bortell, Rita; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Ste 100, Worcester, MA 01605 USA; [Sharma, Rohit B.; Kim, Jason K.; Alonso, Laura C.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA; [Kelly, Mark] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01605 USA; [Flach, Rachel J. Roth; Menendez, Lorena Garcia] Pfizer, Cambridge, MA 02139 USA; [Danai, Laura V.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Pfizer; Massachusetts Institute of Technology (MIT)	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Ste 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu	Sharma, Rohit/ABC-1785-2020	Sharma, Rohit/0000-0002-1435-7612; kelly, mark/0000-0001-9018-594X; Kim, Jason/0000-0002-7185-042X	National Institutes of Health [U24-DK093000, R01-DK080756, DK095140, DK030898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030898, R01DK080756, U2CDK093000, U24DK093000, R01DK095140, R01DK030898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Grants from the National Institutes of Health: U24-DK093000 and R01-DK080756 (to J. K. K.), DK095140 (to L. C. A.), and DK030898 (to M. P. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardestani A, 2014, NAT MED, V20, P385, DOI 10.1038/nm.3482; Boucher J, 2014, COLD SPRING HARB PER, V6; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Byrne MM, 1996, DIABETES, V45, P1503, DOI 10.2337/diabetes.45.11.1503; Campbell JE, 2015, NAT REV ENDOCRINOL, V11, P329, DOI 10.1038/nrendo.2015.51; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; CRYER PE, 1981, DIABETES, V30, P261, DOI 10.2337/diab.30.3.261; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Danai LV, 2015, MOL CELL BIOL, V35, P2356, DOI 10.1128/MCB.00150-15; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Meneghini LF, 2013, AM J MED, V126, pS28, DOI 10.1016/j.amjmed.2013.06.011; Pascoe J, 2012, DIABETES, V61, P632, DOI 10.2337/db11-0991; Pedersen DJ, 2015, MOL METAB, V4, P507, DOI 10.1016/j.molmet.2015.04.003; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Sharma RB, 2015, J CLIN INVEST, V125, P3831, DOI 10.1172/JCI79264; Sharma RB, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0492-2; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Thorens B, 2014, DIABETES OBES METAB, V16, P87, DOI 10.1111/dom.12346; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhao XM, 2012, J BIOL CHEM, V287, P31155, DOI 10.1074/jbc.M112.362632	33	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16221	16230		10.1074/jbc.M116.718932	http://dx.doi.org/10.1074/jbc.M116.718932			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226575	Green Published, hybrid			2022-12-26	WOS:000380585400026
J	Colombo, SF; Cardani, S; Maroli, A; Vitiello, A; Soffientini, P; Crespi, A; Bram, RF; Benfante, R; Borgese, N				Colombo, Sara Francesca; Cardani, Silvia; Maroli, Annalisa; Vitiello, Adriana; Soffientini, Paolo; Crespi, Arianna; Bram, Richard F.; Benfante, Roberta; Borgese, Nica			Tail-anchored Protein Insertion in Mammals FUNCTION AND RECIPROCAL INTERACTIONS OF THE TWO SUBUNITS OF THE TRC40 RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATING CYCLOPHILIN LIGAND; ENDOPLASMIC-RETICULUM MEMBRANE; ACTIVATED T-CELLS; ER MEMBRANE; PHOSPHOLIPID-BILAYERS; TARGETING FACTOR; STRUCTURAL BASIS; TRANSLOCATION; COMPLEX; CAML	The GET (guided entry of tail-anchored proteins)/TRC (transmembrane recognition complex) pathway for tail-anchored protein targeting to the endoplasmic reticulum (ER) has been characterized in detail in yeast and is thought to function similarly in mammals, where the orthologue of the central ATPase, Get3, is known as TRC40 or Asnal. Get3/TRC40 function requires an ER receptor, which in yeast consists of the Get' / Get2 heterotetramer and in mammals of the WRB protein (tryptophan-rich bask protein), homologous to yeast Getl, in combination with CAME (calcium-modulating cyclophilin ligand), which is not homologous to Get2. To better characterize the mammalian receptor, we investigated the role of endogenous WRB and CAML in tail -anchored protein insertion as well as their association, concentration, and stoichiometry in rat liver microsomes and cultured cells. Functional proteoliposomes, reconstituted from a microsomal detergent extract, lost their activity when made with an extract depleted of TRC40-associated proteins or of CAML itself, whereas in vitro synthesized CAML and WRB together were sufficient to confer insertion competence to liposomes. CAML was found to be in 5 -fold excess over WRB, and alteration of this ratio did not inhibit insertion. Depletion of each subunit affected the levels of the other one; in the case of CAML silencing, this effect was attributable to destabilization of the WRB transcript and not of WRB protein itself. These results reveal unanticipated complexity in the mutual regulation of the TRC40 receptor subunits and raise the question as to the role of the excess CAM I, in the mammalian ER.	[Colombo, Sara Francesca; Cardani, Silvia; Maroli, Annalisa; Vitiello, Adriana; Crespi, Arianna; Benfante, Roberta; Borgese, Nica] Univ Milan, Inst Neurosci, CNR, I-20100 Milan, Italy; [Colombo, Sara Francesca; Cardani, Silvia; Maroli, Annalisa; Vitiello, Adriana; Crespi, Arianna; Benfante, Roberta; Borgese, Nica] Univ Milan, BIOMETRA Dept, I-20100 Milan, Italy; [Soffientini, Paolo] FIRC Inst Mol Oncol Fdn, IFOM, I-20100 Milan, Italy; [Bram, Richard F.] Mayo Clin, Rochester, MN 55905 USA	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; IFOM - FIRC Institute of Molecular Oncology; Mayo Clinic	Colombo, SF; Borgese, N (corresponding author), Univ Milan, Inst Neurosci, CNR, I-20100 Milan, Italy.; Colombo, SF; Borgese, N (corresponding author), Univ Milan, BIOMETRA Dept, I-20100 Milan, Italy.	s.colombo@in.cnr.it; n.borgese@in.cnr.it	Benfante, Roberta/C-1513-2015; Borgese, Nica/GWZ-8895-2022	Benfante, Roberta/0000-0001-5396-5429; Borgese, Nica/0000-0002-7537-3974; Soffientini, Paolo/0000-0002-1730-5615; COLOMBO, SARA FRANCESCA/0000-0001-9714-3961	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme [607072]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme	This work was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA Grant 607072. See The Tampting Network for further details. This work reflects only the author's views; the union is not liable for any use that may he made of the information contained therein. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; Borgese N., 2015, MEMBRANE INSERTION T, DOI [10.1002/9780470015902.a0021876.pub2, DOI 10.1002/9780470015902.A0021876.PUB2]; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Borgese N, 2010, TRAFFIC, V11, P877, DOI 10.1111/j.1600-0854.2010.01068.x; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Brambillasca S, 2012, J BIOL CHEM, V287, P41808, DOI 10.1074/jbc.M112.376558; Chan SL, 2015, J IMMUNOL, V195, P5648, DOI 10.4049/jimmunol.1500308; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Denic V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013334; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Edgar CE, 2010, CELL DEATH DIFFER, V17, P1566, DOI 10.1038/cdd.2010.30; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Guo SD, 2005, J BIOL CHEM, V280, P12536, DOI 10.1074/jbc.M500296200; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Holloway MP, 1998, J BIOL CHEM, V273, P16346, DOI 10.1074/jbc.273.26.16346; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Liu F, 2016, P NATL ACAD SCI USA, V113, P4859, DOI 10.1073/pnas.1521577113; Liu Y, 2009, CELL CYCLE, V8, P940, DOI 10.4161/cc.8.6.7948; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; NICCHITTA CV, 1991, CELL, V65, P587, DOI 10.1016/0092-8674(91)90091-C; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Vilardi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085033; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	47	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15292	15306		10.1074/jbc.M115.707752	http://dx.doi.org/10.1074/jbc.M115.707752			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226539	Green Published, hybrid			2022-12-26	WOS:000380583200035
J	Oh, J; Hwang, I; Rhee, S				Oh, Juntaek; Hwang, Ingyu; Rhee, Sangkee			Structural Insights into an Oxalate -producing Serine Hydrolase with an Unusual Oxyanion Hole and Additional Lyase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKHOLDERIA-GLUMAE; QUORUM; MODEL; METABOLISM; PREDICTION; EVOLUTION; PATHOGEN; FEATURES; SERVER	In Burkholderia species, the production of oxalate, an acidic molecule, is a key event for bacterial growth in the stationary phase. Oxalate plays a central role in maintaining environmental pH, which counteracts inevitable population-collapsing alkaline toxicity in amino acid-based culture medium. In the phytopathogen Burkholderia glurnae, two enzymes are responsible for oxalate production. First, the enzyme oxalate biosynthetic component A (ObcA) catalyzes the formation of a tetrahedral C6-CoA adduct from the substrates acetyl-CoA and oxaloacetate. Then the ObcB enzyme liberates three products from the C6-CoA adduct: oxalate, acetoacetate, and CoA. Interestingly, these two stepwise reactions are catalyzed by a single bifunctional enzyme, Obc1, from Burkholderia thailandensis and Burkholderia pseudornallei. Obc1 has an ObcA-like N-terminal domain and shows ObcB activity in its C-terminal domain despite no sequence homology with ObcB. We report the crystal structure of Obcl in its apo and glycerol-bound form at 2.5 A and 2.8 A resolution, respectively. The Obcl N-terminal domain is essentially identical both in structure and function to that of ObcA. Its C-terminal domain has an alpha/beta hydrolase fold that has a catalytic triad for oxalate production and a novel oxyanion hole distinct from the canonical HGGG motif in other a/0 hydrolases. Functional analyses through mutagenesis studies suggested that His -934 is an additional catalytic acid/base for its lyase activity and liberates two additional products, acetoacetate and CoA. These results provide structural and functional insights into bacterial oxalogenesis and an example of divergent evolution of the a/13 hydrolase fold, which has both hydrolase and lyase activity.	[Oh, Juntaek; Hwang, Ingyu; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea	Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	srheesnu@snu.ac.kr	Oh, Juntaek/AFM-0371-2022; Oh, Juntaek/AAH-2692-2022	Oh, Juntaek/0000-0002-7625-2779	Next-Generation BioGreen 21 Program of Rural Development Administration (Plant Molecular Breeding Center) of Republic of Korea [PJ01101901]	Next-Generation BioGreen 21 Program of Rural Development Administration (Plant Molecular Breeding Center) of Republic of Korea	This work was supported by Next-Generation BioGreen 21 Program of Rural Development Administration (Plant Molecular Breeding Center no. PJ01101901; to S. R.) of Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Eydoux C, 2008, BIOCHEMISTRY-US, V47, P9553, DOI 10.1021/bi8005576; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goo E, 2015, TRENDS MICROBIOL, V23, P567, DOI 10.1016/j.tim.2015.05.007; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Heilmann S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00767; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jones AJY, 2013, ANAL BIOCHEM, V442, P19, DOI 10.1016/j.ab.2013.07.018; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Lee SG, 2014, TRENDS PARASITOL, V30, P241, DOI 10.1016/j.pt.2014.03.001; Lee SG, 2013, STRUCTURE, V21, P1778, DOI 10.1016/j.str.2013.07.023; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Li HQ, 1999, J BIOCHEM, V126, P243, DOI 10.1093/oxfordjournals.jbchem.a022429; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nakamura H, 2008, ANAL CHIM ACTA, V620, P127, DOI 10.1016/j.aca.2008.05.008; Nakata PA, 2011, MICROBIOL RES, V166, P531, DOI 10.1016/j.micres.2010.11.002; Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Oh J, 2014, J BIOL CHEM, V289, P11465, DOI 10.1074/jbc.M113.543462; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Raychaudhuri A, 2005, BIOCHEMISTRY-US, V44, P2974, DOI 10.1021/bi048005m; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	38	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15185	15195		10.1074/jbc.M116.727180	http://dx.doi.org/10.1074/jbc.M116.727180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226606	Green Published, hybrid			2022-12-26	WOS:000380583200027
J	Orlando, BJ; Malkowski, MG				Orlando, Benjamin J.; Malkowski, Michael G.			Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN H SYNTHASE; ENDOCANNABINOID OXYGENATION; ARACHIDONIC-ACID; HUMAN CYCLOOXYGENASE-2; STRUCTURAL BASIS; CROSS-TALK; PROTEIN; MECHANISM; PATHWAYS; MONOMERS	Cyclooxygenase-2 (COX-2) catalyzes the oxygenation of arachidonic acid (AA) and endocannabinoid substrates, placing the enzyme at a unique junction between the eicosanoid and endocannabinoid signaling pathways. COX-2 is a sequence homodimer, but the enzyme displays half-of-site reactivity, such that only one monomer of the dimer is active at a given time. Certain rapid reversible, competitive nonsteroidal anti-inflammatory drugs (NSAIlls) have been shown to inhibit COX-2 in a substrate-selective manner, with the binding of inhibitor to a single monomer sufficient to inhibit the oxygenation of endo-cannabinoids but not arachidonic acid. The underlying mechanism responsible for substrate-selective inhibition has remained elusive, We utilized structural and biophysical methods to evaluate flufenamic acid, meclofenamic acid, mefenamic acid, and tolfenamic acid for their ability to act as substrate selective inhibitors. Crystal structures of each drug in complex with human COX-2 revealed that the inhibitor binds within the cyclooxygenase channel in an inverted orientation, with the carboxylate group interacting with Tyr-385 and Ser-530 at the top of the channel. Tryptophan fluorescence quenching, continuous -wave electron spin resonance, and UV-visible spectroscopy demonstrate that flufenamic acid, mefenamic acid, and tolfenamic acid are substrate-selective inhibitors that bind rapidly to COX-2, quench tyrosyl radicals, and reduce higher oxidation states of the heme moiety. Substrate-selective inhibition was attenuated by the addition of the lipid peroxide 15-hydroperoxyeicosatertaenoic acid. Collectively, these studies implicate peroxide tone as an important mechanistic component of substrate -selective inhibition by flufenamic acid, mefenamic acid, and tolfenamic acid.	[Orlando, Benjamin J.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute	Malkowski, MG (corresponding author), SUNY Buffalo, Dept Biol Struct, Hauptman Woodward Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	mgm22@buffalo.edu		Malkowski, Michael/0000-0002-1203-7463	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115386, P41GM103521] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Elka R. Georgieva and Peter P. Borbat for assistance with ESR spectroscopic measurements. X-ray diffraction experiments were conducted at the Advanced Photon Source. Use of IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Bambai B, 2000, J BIOL CHEM, V275, P27608; Bisogno T, 2008, J NEUROENDOCRINOL, V20, P1, DOI 10.1111/j.1365-2826.2008.01676.x; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GRAFF G, 1990, ANAL BIOCHEM, V188, P38, DOI 10.1016/0003-2697(90)90525-E; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Koszelak-Rosenblum M, 2009, PROTEIN SCI, V18, P1828, DOI 10.1002/pro.193; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lucido MJ, 2016, BIOCHEMISTRY-US, V55, P1226, DOI 10.1021/acs.biochem.5b01378; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muraoka S, 2003, LIFE SCI, V72, P1897, DOI 10.1016/S0024-3205(03)00012-2; Musee J, 2012, J BIOL CHEM, V287, P37383, DOI 10.1074/jbc.M112.381202; Orlando BJ, 2015, BIOCHEMISTRY-US, V54, P7309, DOI 10.1021/acs.biochem.5b00979; Orlando BJ, 2015, J STRUCT BIOL, V189, P62, DOI 10.1016/j.jsb.2014.11.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rogge CE, 2004, BIOCHEMISTRY-US, V43, P1560, DOI 10.1021/bi035717o; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; WEI CH, 1995, BIOCHEMISTRY-US, V34, P8499, DOI 10.1021/bi00026a034; Windsor MA, 2013, BIOORG MED CHEM LETT, V23, P5860, DOI 10.1016/j.bmcl.2013.08.097; Windsor MA, 2012, ACS MED CHEM LETT, V3, P759, DOI 10.1021/ml3001616; Wu G, 2009, BIOCHEMISTRY-US, V48, P11902, DOI 10.1021/bi901600f; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200	54	86	95	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15069	15081		10.1074/jbc.M116.725713	http://dx.doi.org/10.1074/jbc.M116.725713			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226593	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000380583200018
J	Chen, LQ; Song, YJ; He, L; Wan, XP; Lai, LH; Dai, F; Liu, Y; Wang, QQ				Chen, Luoquan; Song, Yinjing; He, Li; Wan, Xiaopeng; Lai, Lihua; Dai, Feng; Liu, Yang; Wang, Qingqing			MicroRNA-223 Promotes Type I Interferon Production in Antiviral Innate Immunity by Targeting Forkhead Box Protein O3 (FOXO3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; innate immunity; interferon; interferon regulatory factor (IRF); microRNA (miRNA); FOXO3; IRF7; type I interferon; microRNA-223	TRANSCRIPTION FACTORS; PROINFLAMMATORY CYTOKINE; POSITIVE FEEDBACK; VIRUS-REPLICATION; ACTIVATION; GENE; EXPRESSION; MIR-223; PHOSPHORYLATION; MACROPHAGES	Effective recognition of viral infection and subsequent triggering of antiviral innate immune responses are essential for the host antiviral defense, which is tightly regulated by multiple regulators, including microRNAs. Previous reports have shown that some microRNAs are induced during virus infection and participate in the regulation of the innate antiviral response. However, whether the type I IFN response is regulated by miR-223 is still unknown. Here, we reported that vesicular stomatitis virus (VSV) infection induced significant up-regulation of miR-223 in murine macrophages. We observed that miR-223 overexpression up-regulated type I IFN expression levels in VSV-infected macrophages. We also demonstrated that miR-223 directly targets FOXO3 to regulate the type I IFN production. Furthermore, type I IFN, which is triggered by VSV infection, is responsible for the up-regulation of miR-223, thus forming a positive regulatory loop for type I IFN production. Our results uncovered a novel mechanism of miR-223-mediated regulation of type I IFN production in the antiviral innate immunity for the first time.	[Chen, Luoquan; Song, Yinjing; He, Li; Wan, Xiaopeng; Lai, Lihua; Dai, Feng; Liu, Yang; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Liu, Y; Wang, QQ (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	liuyang0620@zju.edu.cn; wqq@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		National Natural Science Foundation of China [81230074, 81571524]; National Key Basic Research Program of China [2013CB530502]; Zhejiang Provincial Program for Cultivation of High Level Innovative Health Talents; Zhejiang Provincial Program for Innovative Research Team in Zhejiang Province [2010R50046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Program for Cultivation of High Level Innovative Health Talents; Zhejiang Provincial Program for Innovative Research Team in Zhejiang Province	This work was supported by National Natural Science Foundation of China Grants 81230074 and 81571524, National Key Basic Research Program of China Grant 2013CB530502, and Zhejiang Provincial Program for Cultivation of High Level Innovative Health Talents and for Innovative Research Team in Zhejiang Province Grant 2010R50046. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Choi EJ, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0252-0; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Fernandez M, 2002, J VIROL, V76, P895, DOI 10.1128/JVI.76.2.895-904.2002; Fiorucci G, 2015, CYTOKINE GROWTH F R, V26, P183, DOI 10.1016/j.cytogfr.2014.11.002; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Killip MJ, 2015, VIRUS RES, V209, P11, DOI 10.1016/j.virusres.2015.02.003; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YK, 2012, CELL MOL IMMUNOL, V9, P497, DOI 10.1038/cmi.2012.35; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Luron L, 2012, EUR J IMMUNOL, V42, P1030, DOI 10.1002/eji.201141969; Mallick B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007837; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008; Moran JM, 2005, J VIROL, V79, P10226, DOI 10.1128/JVI.79.16.10226-10236.2005; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P1001, DOI 10.1016/j.bbadis.2014.03.005; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wu N, 2014, MICROBES INFECT, V16, P911, DOI 10.1016/j.micinf.2014.08.011; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712	52	38	40	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14706	14716		10.1074/jbc.M115.700252	http://dx.doi.org/10.1074/jbc.M115.700252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226534	Green Published, hybrid			2022-12-26	WOS:000380366700024
J	Hollands, A; Corriden, R; Gysler, G; Dahesh, S; Olson, J; Ali, SR; Kunkel, MT; Lin, AE; Forli, S; Newton, AC; Kumar, GB; Nair, BG; Perry, JJP; Nizet, V				Hollands, Andrew; Corriden, Ross; Gysler, Gabriela; Dahesh, Samira; Olson, Joshua; Ali, Syed Raza; Kunkel, Maya T.; Lin, Ann E.; Forli, Stefano; Newton, Alexandra C.; Kumar, Geetha B.; Nair, Bipin G.; Perry, J. Jefferson P.; Nizet, Victor			Natural Product Anacardic Acid from Cashew Nut Shells Stimulates Neutrophil Extracellular Trap Production and Bactericidal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; innate immunity; neutrophil; reactive oxygen species (ROS); sphingosine-1-phosphate (S1P); Anacardic Acid; Neutrophil extracellular traps; PI3 kinase	HISTONE ACETYLTRANSFERASE; ANTIBACTERIAL; INDUCTION; AUTOPHAGY; AUGMENTS; KINASE; CELLS	Emerging antibiotic resistance among pathogenic bacteria is an issue of great clinical importance, and new approaches to therapy are urgently needed. Anacardic acid, the primary active component of cashew nut shell extract, is a natural product used in the treatment of a variety of medical conditions, including infectious abscesses. Here, we investigate the effects of this natural product on the function of human neutrophils. We find that anacardic acid stimulates the production of reactive oxygen species and neutrophil extracellular traps, two mechanisms utilized by neutrophils to kill invading bacteria. Molecular modeling and pharmacological inhibitor studies suggest anacardic acid stimulation of neutrophils occurs in a PI3K-dependent manner through activation of surface-expressed G protein-coupled sphingosine-1-phosphate receptors. Neutrophil extracellular traps produced in response to anacardic acid are bactericidal and complement select direct antimicrobial activities of the compound.	[Hollands, Andrew; Gysler, Gabriela; Dahesh, Samira; Olson, Joshua; Ali, Syed Raza; Lin, Ann E.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Corriden, Ross; Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Forli, Stefano] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kumar, Geetha B.; Nair, Bipin G.; Perry, J. Jefferson P.] Amrita Univ, Sch Biotechnol, Kollam 690525, Kerala, India; [Perry, J. Jefferson P.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri; University of California System; University of California Riverside	Nizet, V (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019; Forli, Stefano/AFR-7638-2022	Forli, Stefano/0000-0002-5964-7111; nair, bipin/0000-0002-4944-8805; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [AI057153, HD71600, GM43154, AR059968, AI124316]; Amrita Vishwa Vidyapeetham University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI124316, U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR059968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amrita Vishwa Vidyapeetham University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI057153, HD71600, GM43154, AR059968, and AI124316 and by funds from Amrita Vishwa Vidyapeetham University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cavalcante AAM, 2003, ENVIRON MOL MUTAGEN, V41, P360, DOI 10.1002/em.10158; Corriden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9369; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Guerrero M, 2011, BIOORG MED CHEM LETT, V21, P3632, DOI 10.1016/j.bmcl.2011.04.097; Hemshekhar M, 2012, BASIC CLIN PHARMACOL, V110, P122, DOI 10.1111/j.1742-7843.2011.00833.x; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kubo J, 1999, J AGR FOOD CHEM, V47, P533, DOI 10.1021/jf9808980; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Mamidyala SK, 2013, BIOORG MED CHEM LETT, V23, P1667, DOI 10.1016/j.bmcl.2013.01.074; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Omanakuttan A, 2012, MOL PHARMACOL, V82, P614, DOI 10.1124/mol.112.079020; Pandey D, 2011, ARTERIOSCL THROM VAS, V31, P1634, DOI 10.1161/ATVBAHA.111.226621; Pietrocola F, 2015, CELL DEATH DIFFER, V22, P509, DOI 10.1038/cdd.2014.215; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Raj MH, 2016, APOPTOSIS, V21, P578, DOI 10.1007/s10495-016-1223-8; Seong YA, 2014, CELL BIOCHEM BIOPHYS, V68, P369, DOI 10.1007/s12013-013-9717-2; Sharma R, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-292; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; World Health Organization, 2014, ANT RES GLOB REP SUR	29	43	46	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13964	13973		10.1074/jbc.M115.695866	http://dx.doi.org/10.1074/jbc.M115.695866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226531	hybrid, Green Published			2022-12-26	WOS:000379975100006
J	Ali, F; Wharton, DA				Ali, Farman; Wharton, David A.			Ice-Active Substances from the Infective Juveniles of the Freeze Tolerant Entomopathogenic Nematode, Steinernema feltiae	PLOS ONE			English	Article							THERMAL HYSTERESIS PROTEINS; ANTARCTIC-NEMATODE; PANAGROLAIMUS-DAVIDI; COLD TOLERANCE; ANTIFREEZE PROTEINS; ECTOTHERMIC ANIMALS; RECRYSTALLIZATION; NUCLEATION; CRYOPROTECTANTS; INHIBITION	Steinernema feltiae is a moderately freezing tolerant nematode, that can withstand intracellular ice formation. We investigated recrystallization inhibition, thermal hysteresis and ice nucleation activities in the infective juveniles of S. feltiae. Both the splat cooling assay and optical recrystallometry indicate the presence of ice active substances that inhibit recrystallization in the nematode extract. The substance is relatively heat stable and largely retains the recrystallization inhibition activity after heating. No thermal hysteresis activity was detected but the extract had a typical hexagonal crystal shape when grown from a single seed crystal and weak ice nucleation activity. An ice active substance is present in a low concentration, which may be involved in the freezing survival of this species by inhibiting ice recrystallization.	[Ali, Farman; Wharton, David A.] Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand; [Ali, Farman] Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan	University of Otago	Ali, F (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.; Ali, F (corresponding author), Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan.	drfarman@gmail.com	Ali, Farman/GVT-3127-2022					Ali F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141810; Ali F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094179; Ali F, 2013, CRYOBIOLOGY, V66, P24, DOI 10.1016/j.cryobiol.2012.10.004; Barrett J, 2001, INT J BIOCHEM CELL B, V33, P105, DOI 10.1016/S1357-2725(00)00083-2; Block W, 2003, EUR J ENTOMOL, V100, P305, DOI 10.14411/eje.2003.049; Davies PL, 2014, TRENDS BIOCHEM SCI, V39, P548, DOI 10.1016/j.tibs.2014.09.005; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; GREENAWAY P, 1970, J EXP BIOL, V53, P147; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; KNIGHT CA, 1986, CRYOBIOLOGY, V23, P256, DOI 10.1016/0011-2240(86)90051-9; KNIGHT CA, 1995, CRYOBIOLOGY, V32, P23, DOI 10.1006/cryo.1995.1002; KNIGHT CA, 1988, CRYOBIOLOGY, V25, P55, DOI 10.1016/0011-2240(88)90020-X; Lee RE, 1998, ANNU REV PHYSIOL, V60, P55, DOI 10.1146/annurev.physiol.60.1.55; Perry RN, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P1, DOI 10.1079/9781845936877.0000; Ramlov H, 1996, CRYOBIOLOGY, V33, P607, DOI 10.1006/cryo.1996.0064; Ramlov H, 2000, HUM REPROD, V15, P26, DOI 10.1093/humrep/15.suppl_5.26; Sidebottom C, 2000, NATURE, V406, P256, DOI 10.1038/35018639; Smith T, 2008, J COMP PHYSIOL B, V178, P93, DOI 10.1007/s00360-007-0202-3; Wharton DA, 2009, J INSECT PHYSIOL, V55, P27, DOI 10.1016/j.jinsphys.2008.09.007; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wharton DA, 1998, CRYOBIOLOGY, V36, P279, DOI 10.1006/cryo.1998.2087; Wharton DA, 2000, J COMP PHYSIOL B, V170, P321, DOI 10.1007/s003600000106; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 1999, PARASITOLOGY, V119, pS7, DOI 10.1017/S0031182000084614; Wharton DA, 2004, CRYOLETTERS, V25, P335; Wharton DA, 2002, CRYOLETTERS, V23, P5; Wharton DA, 2007, CRYOLETTERS, V28, P61; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	30	3	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156502	10.1371/journal.pone.0156502	http://dx.doi.org/10.1371/journal.pone.0156502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227961	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500150
J	Luo, H; Zhou, DF; Liu, XH; Nie, ZH; Quiroga-Sanchez, DL; Chang, YH				Luo, Hui; Zhou, Dafeng; Liu, Xiaohui; Nie, Zhihua; Quiroga-Sanchez, Diego Leandro; Chang, Yanhong			Production of 3-Hydroxypropionic Acid via the Propionyl-CoA Pathway Using Recombinant Escherichia coli Strains	PLOS ONE			English	Article							COENZYME-A-TRANSFERASE; AUTOTROPHIC CARBON FIXATION; BETA-HYDROXYPROPIONIC ACID; METABOLIC PATHWAYS; OXIDIZING SYSTEM; ANIMAL-TISSUES; ACTIVE-SITE; BIOSYNTHESIS; CYCLE; CLOSTRIDIUM	Our study aimed to produce the commercially promising platform chemical 3-hydroxypropionic acid (3-HP) via the propionyl-CoA pathway in genetically engineered Escherichia coli. Recombinant E. coli Ec-P overexpressing propionyl-CoA dehydrogenase (PACD, encoded by the pacd gene from Candida rugosa) under the T7 promoter produced 1.33 mM of 3-HP in a shake flask culture supplemented with 0.5% propionate. When propionate CoA-transferase (PCT, encoded by the pct gene from Megasphaera elsdenii) and 3-hydroxypropionyl-CoA dehydratase (HPCD, encoded by the hpcd gene from Chloroflexus aurantiacus) were expressed along with PACD, the 3-HP titer of the resulting E. coli Ec-PPH strain was improved by 6-fold. The effect of the cultivation conditions on the 3-HP yield from propionate in the Ec-PPH strain was also investigated. When cultured at 30 degrees C with 1% glucose in addition to propionate, 3-HP production by Ec-PPH increased 2-fold and 12-fold compared to the cultivation at 37 degrees C (4.23 mM) or without glucose (0.68 mM). Deletion of the ygfH gene encoding propionyl-CoA: succinate CoA-transferase from Ec-PPH (resulting in the strain Ec-.Y-PPH) led to increase of 3-HP production in shake flask experiments (15.04 mM), whereas the strain Ec-.Y-PPH with deletion of the prpC gene (encoding methylcitrate synthase in the methylcitrate cycle) produced 17.76 mM of 3-HP. The strain Ec-Delta Y-Delta P-PPH with both ygfH and prpC genes deleted produced 24.14 mM of 3-HP, thus showing an 18-fold increase in the 3-HP titer in compare to the strain Ec-P.	[Luo, Hui; Zhou, Dafeng; Liu, Xiaohui; Quiroga-Sanchez, Diego Leandro] Univ Sci & Technol Beijing, Dept Biol Sci & Engn, Beijing 100083, Peoples R China; [Nie, Zhihua; Chang, Yanhong] Univ Sci & Technol Beijing, Dept Environm Engn, Beijing 100083, Peoples R China; [Nie, Zhihua; Chang, Yanhong] Univ Sci & Technol Beijing, Key Lab Educ Minist High Efficient Min & Safety M, Beijing 100083, Peoples R China	University of Science & Technology Beijing; University of Science & Technology Beijing; University of Science & Technology Beijing	Luo, H (corresponding author), Univ Sci & Technol Beijing, Dept Biol Sci & Engn, Beijing 100083, Peoples R China.; Chang, YH (corresponding author), Univ Sci & Technol Beijing, Dept Environm Engn, Beijing 100083, Peoples R China.; Chang, YH (corresponding author), Univ Sci & Technol Beijing, Key Lab Educ Minist High Efficient Min & Safety M, Beijing 100083, Peoples R China.	luohui@ustb.edu.cn; yhchang@ustb.edu.cn			National Science foundation of China [21276023]	National Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science foundation of China Grant number: 21276023, http://www.nsfc.gov.cn/. HL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SHG, 1963, J BIOL CHEM, V238, P1637; ASH R, 1973, BIOCHEM J, V136, P311, DOI 10.1042/bj1360311; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Bar-Even A, 2012, NAT CHEM BIOL, V8, P509, DOI [10.1038/NCHEMBIO.971, 10.1038/nchembio.971]; BARKER HA, 1978, J BIOL CHEM, V253, P1219; Berry A, 2009, Methods for producing 3-hydroxypropionic acid and compounds thereof, Patent No. [WO 2009/089457, 2009089457]; Chen Q, 2011, APPL ENVIRON MICROB, V77, P4886, DOI 10.1128/AEM.00091-11; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Della Pina C, 2011, GREEN CHEM, V13, P1624, DOI 10.1039/c1gc15052a; Finley SD, 2009, BIOTECHNOL BIOENG, V103, P532, DOI 10.1002/bit.22285; Gokarn R. R., 2007, US Pat., Patent No. [US 7186541 B2, 7186541, US7186541]; GOKARN RR, 2001, Patent No. 2001043607; GREEN DE, 1954, J BIOL CHEM, V206, P1; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; HASEGAWA J, 1982, J FERMENT TECHNOL, V60, P591; Henry CS, 2010, BIOTECHNOL BIOENG, V106, P462, DOI 10.1002/bit.22673; Hoffmann F, 2002, BIOTECHNOL BIOENG, V80, P313, DOI 10.1002/bit.10379; Hugler M, 2003, EUR J BIOCHEM, V270, P736, DOI 10.1046/j.1432-1033.2003.03434.x; Jessen HJ, 2011, Beta-alanine/alpha-ketoglutarate aminotransferase for 3-hydroxypropionic acid production, Patent No. [US 2011/8030045, 20118030045]; Jiang XL, 2009, APPL MICROBIOL BIOT, V82, P995, DOI 10.1007/s00253-009-1898-7; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Lindenkamp N, 2013, APPL MICROBIOL BIOT, V97, P7699, DOI 10.1007/s00253-012-4624-9; Luo LH, 2012, BIORESOURCE TECHNOL, V103, P1, DOI 10.1016/j.biortech.2011.09.099; Lynch MD, 2011, Patent application, Patent No. [2011038364, WO2011038364 A1]; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Nikolau BJ, 2008, PLANT J, V54, P536, DOI 10.1111/j.1365-313X.2008.03484.x; Park SJ, 2013, J BIOTECHNOL, V165, P93, DOI 10.1016/j.jbiotec.2013.03.005; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rathnasingh C, 2012, J BIOTECHNOL, V157, P633, DOI 10.1016/j.jbiotec.2011.06.008; Rathnasingh C, 2009, BIOTECHNOL BIOENG, V104, P729, DOI 10.1002/bit.22429; Saini R, 2011, BIOTECHNOL ADV, V29, P949, DOI 10.1016/j.biotechadv.2011.08.009; Sambrook J., 2001, MOL CLONING LAB MANU; Selmer T, 2002, EUR J BIOCHEM, V269, P372, DOI 10.1046/j.0014-2956.2001.02659.x; SRAMEK SJ, 1975, ARCH BIOCHEM BIOPHYS, V171, P14, DOI 10.1016/0003-9861(75)90002-8; TAKAMIZAWA K, 1993, APPL MICROBIOL BIOT, V40, P196; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; TUNG KK, 1975, J BACTERIOL, V124, P1462, DOI 10.1128/JB.124.3.1462-1474.1975; UCHIYAMA H, 1976, AGR BIOL CHEM TOKYO, V40, P1411, DOI 10.1080/00021369.1976.10862223; WAKIL SJ, 1956, BIOCHIM BIOPHYS ACTA, V19, P497, DOI 10.1016/0006-3002(56)90473-5; Wang ZQ, 2015, METAB ENG, V27, P46, DOI 10.1016/j.ymben.2014.10.005; Warnecke-Lipscomb TE, 2010, PCT patent, Patent No. [WO 2010/011874 A2, 2010011874]; WIESENBORN DP, 1989, APPL ENVIRON MICROB, V55, P323, DOI 10.1128/AEM.55.2.323-329.1989; Yang JE, 2014, APPL MICROBIOL BIOT, V98, P95, DOI 10.1007/s00253-013-5285-z; YANG SY, 1993, J BIOL CHEM, V268, P6588; Yuzawa S, 2012, BIOCHEMISTRY-US, V51, P9779, DOI 10.1021/bi301414q; Zhang HR, 2010, BIOTECHNOL BIOENG, V105, P567, DOI 10.1002/bit.22560; Zhou FL, 2011, APPL BIOCHEM BIOTECH, V165, P1770, DOI 10.1007/s12010-011-9393-x	49	19	22	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156286	10.1371/journal.pone.0156286	http://dx.doi.org/10.1371/journal.pone.0156286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227837	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500103
J	Ross, EG; Shah, N; Leeper, N				Ross, Elsie Gyang; Shah, Nigam; Leeper, Nicholas			Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PROPENSITY SCORE; CARDIOVASCULAR-DISEASE; PARTICIPANTS; METAANALYSIS; EFFICACY; EVENTS; TRIALS; SAFETY	Background The recently updated American College of Cardiology/American Heart Association cholesterol treatment guidelines outline a paradigm shift in the approach to cardiovascular risk reduction. One major change included a recommendation that practitioners prescribe fixed dose statin regimens rather than focus on specific LDL targets. The goal of this study was to determine whether achieved LDL or statin intensity was more strongly associated with major adverse cardiac events (MACE) using practice-based data from electronic health records (EHR). Methods We analyzed the EHR data of more than 40,000 adult patients on statin therapy between 1995 and 2013. Demographic and clinical variables were extracted from coded data and unstructured clinical text. To account for treatment selection bias we performed propensity score stratification as well as 1: 1 propensity score matched analyses. Conditional Cox proportional hazards modeling was used to identify variables associated with MACE. Results We identified 7,373 adults with complete data whose cholesterol appeared to be actively managed. In a stratified propensity score analysis of the entire cohort over 3.3 years of follow-up, achieved LDL was a significant predictor of MACE outcome (Hazard Ratio 1.1; 95% confidence interval, 1.05-1.2; P < 0.0004), while statin intensity was not. In a 1: 1 propensity score matched analysis performed to more aggressively control for covariate balance between treatment groups, achieved LDL remained significantly associated with MACE (HR 1.3; 95% CI, 1.03-1.7; P = 0.03) while treatment intensity again was not a significant predictor. Conclusions Using EHR data we found that on-treatment achieved LDL level was a significant predictor of MACE. Statin intensity alone was not associated with outcomes. These findings imply that despite recent guidelines, achieved LDL levels are clinically important and LDL titration strategies warrant further investigation in clinical trials.	[Ross, Elsie Gyang; Leeper, Nicholas] Stanford Univ Hosp & Clin, Div Vasc Surg, Stanford, CA USA; [Shah, Nigam] Stanford Ctr Biomed Informat Res, Stanford, CA USA	Stanford University	Leeper, N (corresponding author), Stanford Univ Hosp & Clin, Div Vasc Surg, Stanford, CA USA.; Shah, N (corresponding author), Stanford Ctr Biomed Informat Res, Stanford, CA USA.	nigam@stanford.edu; nleeper@stanford.edu			National Heart, Lung and Blood Institute, T32 Mechanisms Innovations in Vascular Disease [1T32HL098049-06]; National Heart, Lung and Blood Institute, R01 Grant [5R01HL12522402]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, T32 Mechanisms Innovations in Vascular Disease; National Heart, Lung and Blood Institute, R01 Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart, Lung and Blood Institute, T32 Mechanisms Innovations in Vascular Disease, http://www.nhlbi.nih.gov, Grant number: 1T32HL098049-06 and the National Heart, Lung and Blood Institute, R01 Grant, http://www.nhlbi.nih.gov, Grant number: 5R01HL12522402, Recipient: Nicholas Leeper.	[Anonymous], 2012, EUR J PREV CARDIOL, V19, P585, DOI [10.1177/2047487312450228, DOI 10.1177/2047487312450228]; [Anonymous], 2011, J STAT SOFTW, DOI DOI 10.18637/JSS.V042.I07; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Chu D, 2007, BIONLP 2007 BIOL TRA, P81, DOI 10.3115/1572392.1572408; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Guo S, 2015, PROPENSITY SCORE ANA; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Leeper NJ, 2007, CIRCULATION, V116, P613, DOI 10.1161/CIRCULATIONAHA.107.694117; Leeper NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063499; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Lependu Paea, 2012, J Biomed Semantics, V3 Suppl 1, pS5, DOI 10.1186/2041-1480-3-S1-S5; LePendu Paea, 2011, J Biomed Inform, V44 Suppl 1, pS31, DOI 10.1016/j.jbi.2011.04.007; Lopez-Jimenez F, 2014, MAYO CLIN PROC, V89, P1257, DOI 10.1016/j.mayocp.2014.06.016; Lowe HJ, 2009, STRIDE INTEGRATED ST, P391; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Parai Gautam K, 2010, AMIA Annu Symp Proc, V2010, P587; Pedersen TR, 2004, ATHEROSCLEROSIS SUPP, V5, P81, DOI 10.1016/j.atherosclerosissup.2004.08.027; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shah NH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002827; Shrank WH, 2015, JAMA-J AM MED ASSOC, V314, P1443, DOI 10.1001/jama.2015.10017; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wu ST, 2012, J AM MED INFORM ASSN, V19, pE149, DOI 10.1136/amiajnl-2011-000744	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0154952	10.1371/journal.pone.0154952	http://dx.doi.org/10.1371/journal.pone.0154952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227451	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500009
J	Upasani, ML; Gurjar, GS; Kadoo, NY; Gupta, VS				Upasani, Medha L.; Gurjar, Gayatri S.; Kadoo, Narendra Y.; Gupta, Vidya S.			Dynamics of Colonization and Expression of Pathogenicity Related Genes in Fusarium oxysporum f.sp ciceri during Chickpea Vascular Wilt Disease Progression	PLOS ONE			English	Article							PROTEIN BETA-SUBUNIT; TARGETED DISRUPTION; REDUCED PATHOGENICITY; PLANT COLONIZATION; RESISTANCE; INFECTION; VIRULENCE; GROWTH; ALPHA; PCR	Fusarium wilt caused by Fusarium oxysporum f.sp. ciceri (Foc) is a constant threat to chickpea productivity in several parts of the world. Understanding the molecular basis of chickpea-Foc interaction is necessary to improve chickpea resistance to Foc and thereby the productivity of chickpea. We transformed Foc race 2 using green fluorescent protein (GFP) gene and used it to characterize pathogen progression and colonization in wilt-susceptible (JG62) and wilt-resistant (Digvijay) chickpea cultivars using confocal microscopy. We also employed quantitative PCR (qPCR) to estimate the pathogen load and progression across various tissues of both the chickpea cultivars during the course of the disease. Additionally, the expression of several candidate pathogen virulence genes was analyzed using quantitative reverse transcriptase PCR (qRT-PCR), which showed their characteristic expression in wilt-susceptible and resistant chickpea cultivars. Our results suggest that the pathogen colonizes the susceptible cultivar defeating its defense; however, albeit its entry in the resistant plant, further proliferation is severely restricted providing an evidence of efficient defense mechanism in the resistant chickpea cultivar.	[Upasani, Medha L.; Gurjar, Gayatri S.; Kadoo, Narendra Y.; Gupta, Vidya S.] CSIR Natl Chem Lab, Div Biochem Sci, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Kadoo, NY; Gupta, VS (corresponding author), CSIR Natl Chem Lab, Div Biochem Sci, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	ny.kadoo@ncl.res.in; vs.gupta@ncl.res.in	Kadoo, Narendra/G-2492-2010	Kadoo, Narendra/0000-0002-9079-1226	Council of Scientific and Industrial Research (CSIR), India [BSC0117]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Grant Number: BSC0117 (Council of Scientific and Industrial Research (CSIR), India (http://www.csir.res.in/) to NYK; and Junior and Senior Research fellowships of Council of Scientific and Industrial Research (CSIR), India (http://www.csir.res.in/) to MLU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Soud MAM, 2004, MYCOPATHOLOGIA, V158, P475, DOI 10.1007/s11046-005-5370-7; Belenkiy R, 2000, BBA-BIOMEMBRANES, V1467, P207, DOI 10.1016/S0005-2736(00)00222-4; Bolwerk A, 2005, MOL PLANT MICROBE IN, V18, P710, DOI 10.1094/MPMI-18-0710; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caracuel Z, 2005, MOL PLANT MICROBE IN, V18, P1140, DOI 10.1094/MPMI-18-1140; Cardinale M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00094; Charoensopharat K, 2008, WORLD J MICROB BIOT, V24, P345, DOI 10.1007/s11274-007-9476-6; Cho Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127140; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Dave K, 2011, J BIOTECHNOL, V155, P173, DOI 10.1016/j.jbiotec.2011.06.012; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dhingra O.D., 1995, BASIC PLANT PATHOLOG, V2, P355; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Duyvesteijn RGE, 2005, MOL MICROBIOL, V57, P1051, DOI 10.1111/j.1365-2958.2005.04751.x; Fang XL, 2012, PLANT SOIL, V358, P71, DOI 10.1007/s11104-012-1205-8; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; GOW NAR, 1994, SCANNING MICROSCOPY, V8, P705; Gowda SJM, 2009, MOL BREEDING, V24, P177, DOI 10.1007/s11032-009-9282-y; Gurjar G. S., 2012, American Journal of Plant Sciences, V3, P190, DOI 10.4236/ajps.2012.32023; Hardham AR, 2001, MYCOTA, V8, P91; Haware M. P., 1996, Phytopathologia Mediterranea, V35, P9; HAWARE MP, 1982, PLANT DIS, V66, P809, DOI 10.1094/PD-66-809; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Imazaki I, 2007, MOL MICROBIOL, V63, P737, DOI 10.1111/j.1365-2958.2006.05554.x; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Jain S, 2003, CURR GENET, V43, P79, DOI 10.1007/s00294-003-0372-9; Jain S, 2002, CURR GENET, V41, P407, DOI 10.1007/s00294-002-0322-y; Jimenez-Diaz RM, 1993, SEM FUS MYC TAX PATH; Jimenez-Fernandez D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061360; Jimenez-Fernandez D, 2011, PHYTOPATHOLOGY, V101, P250, DOI 10.1094/PHYTO-07-10-0190; Jorge I, 2006, CAN J BOT, V84, P1395, DOI 10.1139/B06-103; Josefsen L, 2012, AUTOPHAGY, V8, P326, DOI 10.4161/auto.18705; Kasahara S, 1997, MOL PLANT MICROBE IN, V10, P984, DOI 10.1094/MPMI.1997.10.8.984; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Kumar Y, 2015, PHYTOCHEMISTRY, V116, P120, DOI 10.1016/j.phytochem.2015.04.001; Lagopodi AL, 2002, MOL PLANT MICROBE IN, V15, P172, DOI 10.1094/MPMI.2002.15.2.172; Lakshman DK, 2012, EUR J PLANT PATHOL, V133, P729, DOI 10.1007/s10658-012-9953-0; Lee H, 2010, EUKARYOT CELL, V9, P558, DOI 10.1128/EC.00316-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; MCDONNELL K., 1962, TRANS BRIT MYCOL SOC, V45, P55; Mobius N, 2009, CURR OPIN PLANT BIOL, V12, P390, DOI 10.1016/j.pbi.2009.06.004; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Narasimhan ML, 2003, PLANT J, V36, P390, DOI 10.1046/j.1365-313X.2003.01886.x; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Noda J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-38; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Redden RJ, 2007, CHICKPEA BREEDING AND MANAGEMENT, P1, DOI 10.1079/9781845932138.001; Sagaram US, 2007, MOL PLANT PATHOL, V8, P375, DOI 10.1111/J.1364-3703.2007.00398.X; Shih J, 2000, GENE, V243, P139, DOI 10.1016/S0378-1119(99)00546-6; Singh KB, 1997, FIELD CROP RES, V53, P161, DOI 10.1016/S0378-4290(97)00029-4; Tullu A, 1998, EUPHYTICA, V102, P227, DOI 10.1023/A:1018373412281; Tzima AK, 2012, FUNGAL GENET BIOL, V49, P271, DOI 10.1016/j.fgb.2012.02.005; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; Wang K., 2006, AGROBACTERIUM PROTOC; Wubben JP, 2000, CURR GENET, V37, P152, DOI 10.1007/s002940050022; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Zhang SZ, 2011, APPL ENVIRON MICROB, V77, P2676, DOI 10.1128/AEM.02747-10; Zvirin T, 2010, PLANT PATHOL, V59, P576, DOI 10.1111/j.1365-3059.2009.02225.x	62	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156490	10.1371/journal.pone.0156490	http://dx.doi.org/10.1371/journal.pone.0156490			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227745	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500147
J	Kota, V; Sommer, G; Durette, C; Thibault, P; van Niekerk, EA; Twiss, JL; Heise, T				Kota, Venkatesh; Sommer, Gunhild; Durette, Chantal; Thibault, Pierre; van Niekerk, Erna A.; Twiss, Jeffery L.; Heise, Tilman			SUMO-Modification of the La Protein Facilitates Binding to mRNA In Vitro and in Cells	PLOS ONE			English	Article							HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; IRES-MEDIATED TRANSLATION; AUTOANTIGEN LA; FUNCTIONAL-CHARACTERIZATION; MESENCHYMAL TRANSITION; AKT PHOSPHORYLATION; LAMININ B1; VIRUS-RNA; SUMOYLATION; TRANSCRIPTION	The RNA-binding protein La is involved in several aspects of RNA metabolism including the translational regulation of mRNAs and processing of pre-tRNAs. Besides its well-described phosphorylation by Casein kinase 2, the La protein is also posttranslationally modified by the Small Ubiquitin-like MOdifier (SUMO), but the functional outcome of this modification has not been defined. The objective of this study was to test whether sumoylation changes the RNA-binding activity of La. Therefore, we established an in vitro sumoylation assay for recombinant human La and analyzed its RNA-binding activity by electrophoretic mobility shift assays. We identified two novel SUMO-acceptor sites within the La protein located between the RNA recognition motif 1 and 2 and we demonstrate for the first time that sumoylation facilitates the RNA-binding of La to small RNA oligonucleotides representing the oligopyrimidine tract (TOP) elements from the 5' untranslated regions (UTR) of mRNAs encoding ribosomal protein L22 and L37 and to a longer RNA element from the 5' UTR of cyclin D1 (CCND1) mRNA in vitro. Furthermore, we show by RNA immunoprecipitation experiments that a La mutant deficient in sumoylation has impaired RNA-binding activity in cells. These data suggest that modulating the RNA-binding activity of La by sumoylation has important consequences on its functionality.	[Kota, Venkatesh; Sommer, Gunhild; Heise, Tilman] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Durette, Chantal; Thibault, Pierre] Univ Montreal, Inst Res Immunol & Canc, Stn Ctr Ville, Montreal, PQ, Canada; [van Niekerk, Erna A.] Univ Calif San Diego, Dept Neurosci 0626, La Jolla, CA 92093 USA; [Twiss, Jeffery L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Medical University of South Carolina; Universite de Montreal; University of California System; University of California San Diego; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Heise, T (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	heise@musc.edu			Protein Science Translation Core, part of the South Carolina Lipidomics and Pathology Center of Biomedical Research Excellence, National Institutes of Health Grant [MUCR-2211000-89623-2021-02]; American Cancer Society Institutional Research Grant [IRG-97-219-11]; National Institutes of Health/National Cancer Institute, NIH/NCI [1R01CA172567-01A1]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [1R01-NS041596]; Natural Sciences and Engineering Research Council of Canada; Canadian Government through a Genome Canada grant; NATIONAL CANCER INSTITUTE [R01CA172567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596] Funding Source: NIH RePORTER	Protein Science Translation Core, part of the South Carolina Lipidomics and Pathology Center of Biomedical Research Excellence, National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Institutional Research Grant(American Cancer Society); National Institutes of Health/National Cancer Institute, NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Government through a Genome Canada grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by Protein Science Translation Core, part of the South Carolina Lipidomics and Pathology Center of Biomedical Research Excellence, National Institutes of Health Grant MUCR-2211000-89623-2021-02, http://www.nih.gov; American Cancer Society Institutional Research Grant #IRG-97-219-11, http://www.cancer.org, to TH; 1R01CA172567-01A1 (National Institutes of Health/National Cancer Institute, NIH/NCI, http://www.nih.gov, to TH); 1R01-NS041596 (National Institutes of Health/National Institute of Neurological Disorders and Stroke, http://www.nih.gov, to JLT); and Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca, to PT. Proteomics analyses were performed at the Center for Advanced Proteomic Analyses (CAPA), a Node of the Canadian Genomic Innovation Network supported by the Canadian Government through a Genome Canada grant (PT).	Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Bachmann M, 1996, J AUTOIMMUN, V9, P747, DOI 10.1006/jaut.1996.0097; BACHMANN M, 1990, EXP CELL RES, V191, P171, DOI 10.1016/0014-4827(90)90002-R; BACHMANN M, 1986, BIOL CHEM H-S, V367, P671, DOI 10.1515/bchm3.1986.367.2.671; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Bretes H, 2014, NUCLEIC ACIDS RES, V42, P5043, DOI 10.1093/nar/gku124; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; Cordes S, 2008, BIOCHEM BIOPH RES CO, V368, P1014, DOI 10.1016/j.bbrc.2008.01.163; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Desterro JMP, 2005, MOL BIOL CELL, V16, P5115, DOI 10.1091/mbc.E05-06-0536; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Ehlers I, 2004, J BIOL CHEM, V279, P43437, DOI 10.1074/jbc.M402227200; Eifler K, 2015, TRENDS BIOCHEM SCI, V40, P779, DOI 10.1016/j.tibs.2015.09.006; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Fan H, 1997, CELL, V88, P707, DOI 10.1016/S0092-8674(00)81913-3; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heise T, 2016, ONCOTARGET; Hendriks IA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8289; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Horke S, 2002, J BIOL CHEM, V277, P34949, DOI 10.1074/jbc.M201911200; Iadevaia V, 2008, RNA, V14, P1730, DOI 10.1261/rna.1037108; Intine RV, 2004, MOL CELL BIOL, V24, P10894, DOI 10.1128/MCB.24.24.10894-10904.2004; Intine RV, 2002, MOL CELL, V9, P1113, DOI 10.1016/S1097-2765(02)00533-6; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; Kenan DJ, 2004, NAT STRUCT MOL BIOL, V11, P303, DOI 10.1038/nsmb0404-303; Kucera NJ, 2011, P NATL ACAD SCI USA, V108, P1308, DOI 10.1073/pnas.1017085108; Kuehnert J, 2015, NUCLEIC ACIDS RES, V43, P581, DOI 10.1093/nar/gku1309; Lamoliatte F, 2013, MOL CELL PROTEOMICS, V12, P2536, DOI 10.1074/mcp.M112.025569; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Martino L, 2012, NUCLEIC ACIDS RES, V40, P1381, DOI 10.1093/nar/gkr890; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Nuro-Gyina PK, 2016, WIRES RNA, V7, P105, DOI 10.1002/wrna.1318; Petz M, 2012, NUCLEIC ACIDS RES, V40, P9738, DOI 10.1093/nar/gks760; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Schlatter S, 2003, BIOTECHNOL BIOENG, V81, P1, DOI 10.1002/bit.10549; Schwartz EI, 2004, MOL CELL BIOL, V24, P9580, DOI 10.1128/MCB.24.21.9580-9591.2004; SIMONS FHM, 1994, J CELL BIOL, V125, P981, DOI 10.1083/jcb.125.5.981; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; Sommer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025402; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Subramonian D, 2014, J PROTEOME RES, V13, P3905, DOI 10.1021/pr500119a; SVITKIN YV, 1994, J VIROL, V68, P7001, DOI 10.1128/JVI.68.11.7001-7007.1994; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; Vassileva MT, 2004, MOL CELL BIOL, V24, P3623, DOI 10.1128/MCB.24.9.3623-3632.2004; Vethantham V, 2008, GENE DEV, V22, P499, DOI 10.1101/gad.1628208; Vethantham V, 2007, MOL CELL BIOL, V27, P8848, DOI 10.1128/MCB.01186-07; Weser S, 2000, NUCLEIC ACIDS RES, V28, P3935, DOI 10.1093/nar/28.20.3935; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18; Zhang DY, 2015, J BIOL CHEM, V290, P4784, DOI 10.1074/jbc.M114.598219; Zhu JF, 2001, BBA-GENE STRUCT EXPR, V1521, P19, DOI 10.1016/S0167-4781(01)00277-9	71	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156365	10.1371/journal.pone.0156365	http://dx.doi.org/10.1371/journal.pone.0156365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224031	Green Submitted, gold, Green Published			2022-12-26	WOS:000376881700090
J	Sandquist, EJ; Somji, S; Dunlevy, JR; Garrett, SH; Zhou, XD; Slusser-Nore, A; Sens, DA				Sandquist, Elizabeth J.; Somji, Seema; Dunlevy, Jane R.; Garrett, Scott H.; Zhou, Xu Dong; Slusser-Nore, Andrea; Sens, Donald A.			Loss of N-Cadherin Expression in Tumor Transplants Produced From As+3 - and Cd+2 - Transformed Human Urothelial (UROtsa) Cell Lines	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC-SIGNIFICANCE; INTERNAL CANCERS; BLADDER-CANCER; KERATIN 6; CADMIUM; METASTASIS; EXPOSURE; PROFILE; SWITCH	Background Epithelial to mesenchymal transition is a process in which a cell experiences a loss of epithelial cell characteristics and acquires a more mesenchymal cell phenotype. In cancer, epithelial to mesenchymal transition has been proposed to play an important role during specific stages of tumor progression. The role epithelial to mesenchymal transition and mesenchymal to epithelial transition might play in toxicant-induced urothelial cancer is unknown. Methods Real-time PCR, Western blotting, immuno-histochemistry and immuno-fluorescence were used to determine the expression of E-and N-cadherin in the UROtsa parent, the As+3 - and Cd+2 - transformed cell lines, the spheroids isolated from these cell lines as well as the tumor heterotransplants that were produced by the injection of the transformed cells into immune compromised mice. Results This study showed that N-cadherin expression was increased in 6 As+3 - and 7 Cd+2 - transformed cell lines generated from human urothelial cells (UROtsa). The expression varied within each cell line, with 10% to 95% of the cells expressing N-cadherin. Tumors produced from these cell lines showed no expression of the N-cadherin protein. Spheroids which are made up of putative cancer initiating cells produced from these cell lines showed only background expression of N-cadherin mRNA, increased expression of aldehyde dehydrogenase 1 mRNA and produced tumors which did not express N-cadherin. There was no change in the expression of E-cadherin in the tumors, and the tumors formed by all the As+3 and Cd+2 - transformed cell lines and cancer initiating cells stained intensely and uniformly for E-cadherin. Conclusions The finding that the cells expressing N-cadherin gave rise to tumors with no expression of N-cadherin is in agreement with the classical view of epithelial to mesenchymal transition. Epithelial to mesenchymal transition and N-cadherin are associated with dissemination and not with the ability to establish new tumor growth. Mesenchymal to epithelial transition and E-cadherin are viewed as necessary for a cell to establish a new metastatic site. The lack of N-cadherin expression in tumor transplants is consistent with E-cadherin expressing cells "seeding" a site for tumor growth. The study shows that a minority population of cultured cells can be the initiators of tumor growth.	[Sandquist, Elizabeth J.; Somji, Seema; Garrett, Scott H.; Zhou, Xu Dong; Slusser-Nore, Andrea; Sens, Donald A.] Univ N Dakota, Dept Pathol, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Dunlevy, Jane R.] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks	Sens, DA (corresponding author), Univ N Dakota, Dept Pathol, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA.	donald.sens@med.und.edu		Sandquist, Elizabeth/0000-0003-1322-1550	Department of Pathology and the School of Medicine and Health Science, University of North Dakota; ND INBRE program from the National Institute of General Medicine Sciences, National Institute of Health [P20 GM103442]	Department of Pathology and the School of Medicine and Health Science, University of North Dakota; ND INBRE program from the National Institute of General Medicine Sciences, National Institute of Health	Funds were provided by the Department of Pathology and the School of Medicine and Health Science, University of North Dakota. Undergraduate research, student mentoring and core facilities for bioinformatics and statistics were supported by the ND INBRE program project P20 GM103442 from the National Institute of General Medicine Sciences, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Ajjimaporn A, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-16; Avital I, 2014, CANCER GENOM PROTEOM, V11, P57; Bathula CS, 2008, TOXICOL SCI, V102, P310, DOI 10.1093/toxsci/kfn004; Baumgart E, 2007, CLIN CANCER RES, V13, P1685, DOI 10.1158/1078-0432.CCR-06-2330; Bischoff CJ, 2009, CURR OPIN ONCOL, V21, P272, DOI 10.1097/CCO.0b013e328329f184; Bryan RT, 2010, J UROLOGY, V184, P423, DOI 10.1016/j.juro.2010.04.016; Cantor KP, 2007, TOXICOL APPL PHARM, V222, P252, DOI 10.1016/j.taap.2007.01.026; Cao H, 2015, PATHOL RES PRACT, V211, P557, DOI 10.1016/j.prp.2015.05.010; Cao L, 2010, J APPL TOXICOL, V30, P416, DOI 10.1002/jat.1513; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; CHIOU HY, 1995, CANCER RES, V55, P1296; Garrett SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085614; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Jadaan DY, 2015, PROSTATE CANCER, V2015, DOI 10.1155/2015/651580; Jager T, 2010, ONCOL REP, V23, P1125, DOI 10.3892/or_00000741; Jolly MK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00155; Kellen E, 2007, CANCER DETECT PREV, V31, P77, DOI 10.1016/j.cdp.2006.12.001; Larson J, 2010, TOXICOL LETT, V199, P166, DOI 10.1016/j.toxlet.2010.08.020; Liu B, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.08.012; Luster MI, 2004, TOXICOL APPL PHARM, V198, P419, DOI 10.1016/j.taap.2003.07.017; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Michailidi C, 2015, CANCER PREV RES, V8, P208, DOI 10.1158/1940-6207.CAPR-14-0251; Muramaki M, 2012, UROL ONCOL-SEMIN ORI, V30, P161, DOI 10.1016/j.urolonc.2010.01.005; Muramaki M, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.07.1388; Rieger-Christ KM, 2001, HUM PATHOL, V32, P18, DOI 10.1053/hupa.2001.21140; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Saint-Jacques N, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-44; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Shimazui T, 1996, CANCER RES, V56, P4154; SIEMIATYCKI J, 1994, AM J EPIDEMIOL, V140, P1061, DOI 10.1093/oxfordjournals.aje.a117207; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; Soh M, 2012, TOXICOL LETT, V212, P66, DOI 10.1016/j.toxlet.2012.05.003; Somji S, 2011, CELL BIOL TOXICOL, V27, P381, DOI 10.1007/s10565-010-9169-z; Somji S, 2010, CHEM RES TOXICOL, V23, P348, DOI 10.1021/tx900346q; Steinmaus C, 2000, CANCER INVEST, V18, P174, DOI 10.3109/07357900009038249; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; TSUDA T, 1995, AM J EPIDEMIOL, V141, P198, DOI 10.1093/oxfordjournals.aje.a117421; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Zhao J, 2014, INT BRAZ J UROL, V40, P179, DOI 10.1590/S1677-5538.IBJU.2014.02.07	45	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156310	10.1371/journal.pone.0156310	http://dx.doi.org/10.1371/journal.pone.0156310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224422	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700083
J	Wlodarczyk-Biegun, MK; Farbod, K; Werten, MWT; Slingerland, CJ; de Wolf, FA; van den Beucken, JJJP; Leeuwenburgh, SCG; Stuart, MAC; Kamperman, M				Wlodarczyk-Biegun, Malgorzata K.; Farbod, Kambiz; Werten, Marc W. T.; Slingerland, Cornelis J.; de Wolf, Frits A.; van den Beucken, Jeroen J. J. P.; Leeuwenburgh, Sander C. G.; Stuart, Martien A. Cohen; Kamperman, Marleen			Fibrous Hydrogels for Cell Encapsulation: A Modular and Supramolecular Approach	PLOS ONE			English	Article							OSTEOBLAST-ADHESIVE PEPTIDES; CROSS-LINKING DENSITY; I COLLAGEN GEL; EXTRACELLULAR-MATRIX; CULTURE SYSTEMS; 3D MATRICES; PROTEIN; CANCER; BIOMATERIALS; NETWORKS	Artificial 3-dimensional (3D) cell culture systems, which mimic the extracellular matrix (ECM), hold great potential as models to study cellular processes under controlled conditions. The natural ECM is a 3D structure composed of a fibrous hydrogel that provides both mechanical and biochemical cues to instruct cell behavior. Here we present an ECM-mimicking genetically engineered protein-based hydrogel as a 3D cell culture system that combines several key features: (1) Mild and straightforward encapsulation meters (1) ease of ut I am not so sure. encapsulation of the cells, without the need of an external crosslinker. (2) Supramolecular assembly resulting in a fibrous architecture that recapitulates some of the unique mechanical characteristics of the ECM, i. e. strain-stiffening and self-healing behavior. (3) A modular approach allowing controlled incorporation of the biochemical cue density (integrin binding RGD domains). We tested the gels by encapsulating MG-63 osteoblastic cells and found that encapsulated cells not only respond to higher RGD density, but also to overall gel concentration. Cells in 1% and 2% (weight fraction) protein gels showed spreading and proliferation, provided a relative RGD density of at least 50%. In contrast, in 4% gels very little spreading and proliferation occurred, even for a relative RGD density of 100%. The independent control over both mechanical and biochemical cues obtained in this modular approach renders our hydrogels suitable to study cellular responses under highly defined conditions.	[Wlodarczyk-Biegun, Malgorzata K.; Slingerland, Cornelis J.; Stuart, Martien A. Cohen; Kamperman, Marleen] Wageningen Univ & Res, Phys Chem & Soft Matter, Wageningen, Netherlands; [Farbod, Kambiz; van den Beucken, Jeroen J. J. P.; Leeuwenburgh, Sander C. G.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6525 ED Nijmegen, Netherlands; [Werten, Marc W. T.; de Wolf, Frits A.] Wageningen UR Food & Biobased Res, Wageningen, Netherlands	Wageningen University & Research; Radboud University Nijmegen; Wageningen University & Research	Kamperman, M (corresponding author), Wageningen Univ & Res, Phys Chem & Soft Matter, Wageningen, Netherlands.	marleen.kamperman@wur.nl	van den Beucken, Jeroen J. J. P./N-2910-2013; Kamperman, Marleen/O-1810-2016; Leeuwenburgh, S.C.G./L-4483-2015; Włodarczyk-Biegun, Małgorzata/AAH-5592-2020; de Wolf, Frits A/J-2517-2014; Farbod, Kambiz/A-4907-2016	van den Beucken, Jeroen J. J. P./0000-0002-0301-1966; Kamperman, Marleen/0000-0002-0520-4534; Leeuwenburgh, S.C.G./0000-0003-1471-6133; Włodarczyk-Biegun, Małgorzata/0000-0003-1419-6166; de Wolf, Frits A/0000-0002-5416-1171; Farbod, Kambiz/0000-0003-4451-6183; Slingerland, Cornelis Jacob/0000-0003-0027-7491	Netherlands Institute for Regenerative Medicine (NIRM); ERC [267254]; Netherlands Organization of Scientific Research (NWO)	Netherlands Institute for Regenerative Medicine (NIRM); ERC(European Research Council (ERC)European Commission); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work was financially supported by the Netherlands Institute for Regenerative Medicine (NIRM; www.nirmresearch.nl). Financial support to M. W. T. Werten, F. A. de Wolf and M. A. Cohen Stuart was provided by ERC Advanced Grant 267254 "BioMate" (https://erc.europa.eu). Financial support to M. Kamperman was provided by the Netherlands Organization of Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Beun LH, 2015, THESIS WAGENINGEN; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chung C, 2012, BIOMACROMOLECULES, V13, P3912, DOI 10.1021/bm3015279; Chung C, 2012, SOFT MATTER, V8, P10141, DOI 10.1039/c2sm26082d; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Czekanska EM, 2012, EUR CELLS MATER, V24, P1; Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C; Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Erk KA, 2010, BIOMACROMOLECULES, V11, P1358, DOI 10.1021/bm100136y; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Golinska MD, 2014, BIOMACROMOLECULES, V15, P699, DOI 10.1021/bm401682n; Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179; KOUTSILIERIS M, 1994, J BONE MINER RES, V9, P1823; Kyburz KA, 2013, ACTA BIOMATER, V9, P6381, DOI 10.1016/j.actbio.2013.01.026; Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Li LQ, 2013, SOFT MATTER, V9, P665, DOI 10.1039/c2sm26812d; Liu YX, 2009, BIOMATERIALS, V30, P196, DOI 10.1016/j.biomaterials.2008.09.041; Martens AA, 2009, MACROMOLECULES, V42, P1002, DOI 10.1021/ma801955q; McKinnon DD, 2014, ADV MATER, V26, P865, DOI 10.1002/adma.201303680; Mitsiades C., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P153; Motte S, 2013, BIOPOLYMERS, V99, P35, DOI 10.1002/bip.22133; Palchesko RN, 2012, J BIOMED MATER RES A, V100A, P1229, DOI 10.1002/jbm.a.33303; Parreno J, 2008, MOL CELL BIOCHEM, V317, P21, DOI 10.1007/s11010-008-9801-x; Parreno J, 2009, BIOCHEM CELL BIOL, V87, P895, DOI [10.1139/O09-052, 10.1139/o09-052]; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Razzokov J, 2014, SOFT MATTER, V10, P5362, DOI 10.1039/c4sm00384e; Ribeiro A, 2012, TISSUE ENG PT A, V18, P93, DOI 10.1089/ten.tea.2011.0221; Romano NH, 2015, SMALL, V11, P722, DOI 10.1002/smll.201401574; Romano NH, 2011, BBA-GEN SUBJECTS, V1810, P339, DOI 10.1016/j.bbagen.2010.07.005; Rudnicki MS, 2013, BIOPHYS J, V105, P11, DOI 10.1016/j.bpj.2013.05.032; Sala A, 2011, INTEGR BIOL-UK, V3, P1102, DOI 10.1039/c1ib00045d; Schor M, 2009, SOFT MATTER, V5, P2658, DOI 10.1039/b902952d; Suenaga A, 1996, PLACENTA, V17, P583, DOI 10.1016/S0143-4004(96)80075-0; Sun J, 2014, BIOMATERIALS, V35, P4759, DOI 10.1016/j.biomaterials.2014.02.041; Themistocleous GS, 2007, IN VIVO, V21, P69; Themistocleous GS, 2004, IN VIVO, V18, P687; Turgeon M.L., 2005, CLIN HEMATOLOGY THEO; Wang HY, 2014, BIOMACROMOLECULES, V15, P3421, DOI 10.1021/bm500969d; Wen Q, 2013, EXP CELL RES, V319, P2481, DOI 10.1016/j.yexcr.2013.05.017; Wickstead B, 2011, J CELL BIOL, V194, P513, DOI 10.1083/jcb.201102065; Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382; Wlodarczyk-Biegun MK, 2014, ACTA BIOMATER, V10, P3620, DOI 10.1016/j.actbio.2014.05.006; Wlodarczyk-Biegun MK, 2016, NANOFIBRILLAR HYDROG; Worthington P, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00092; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Yan Y, 2008, ANGEW CHEM INT EDIT, V47, P4192, DOI 10.1002/anie.200705242; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	53	11	12	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155625	10.1371/journal.pone.0155625	http://dx.doi.org/10.1371/journal.pone.0155625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223105	gold, Green Published			2022-12-26	WOS:000376881700025
J	Arif, M; Busot, GY; Mann, R; Rodoni, B; Liu, SZ; Stack, JP				Arif, Mohammad; Busot, Grethel Y.; Mann, Rachel; Rodoni, Brendan; Liu, Sanzhen; Stack, James P.			Emergence of a New Population of Rathayibacter toxicus: An Ecologically Complex, Geographically Isolated Bacterium	PLOS ONE			English	Article							ANNUAL RYEGRASS TOXICITY; CLAVIBACTER-TOXICUS; MITOCHONDRIAL-DNA; CAUSATIVE AGENTS; GENETIC-ANALYSIS; LOLIUM-RIGIDUM; IDENTIFICATION; CORYNETOXINS; LIVESTOCK; DISEASE	Rathayibacter toxicus is a gram-positive bacterium that infects the floral parts of several Poaceae species in Australia. Bacterial ooze is often produced on the surface of infected plants and bacterial galls are produced in place of seed. R. toxicus is a regulated plant pathogen in the U.S. yet reliable detection and diagnostic tools are lacking. To better understand this geographically-isolated plant pathogen, genetic variation as a function of geographic location, host species, and date of isolation was determined for isolates collected over a forty-year period. Discriminant analyses of recently collected and archived isolates using Multi-Locus Sequence Typing (MLST) and Inter-Simple Sequence Repeats (ISSR) identified three populations of R. toxicus; RT-I and RT-II from South Australia and RT-III from Western Australia. Population RT-I, detected in 2013 and 2014 from the Yorke Peninsula in South Australia, is a newly emerged population of R. toxicus not previously reported. Commonly used housekeeping genes failed to discriminate among the R. toxicus isolates. However, strategically selected and genome-dispersed MLST genes representing an array of cellular functions from chromosome replication, antibiotic resistance and biosynthetic pathways to bacterial acquired immunity were discriminative. Genetic variation among isolates within the RT-I population was less than the within-population variation for the previously reported RT-II and RT-III populations. The lower relative genetic variation within the RT-I population and its absence from sampling over the past 40 years suggest its recent emergence. RT-I was the dominant population on the Yorke Peninsula during the 2013-2014 sampling period perhaps indicating a competitive advantage over the previously detected RT-II population. The potential for introduction of this bacterial plant pathogen into new geographic areas provide a rationale for understanding the ecological and evolutionary trajectories of R. toxicus.	[Arif, Mohammad; Busot, Grethel Y.; Liu, Sanzhen; Stack, James P.] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Mann, Rachel; Rodoni, Brendan] Dept Econ Dev Jobs Transport & Resources, Biosci Res Div, Bundoora, Vic, Australia; [Arif, Mohammad; Busot, Grethel Y.; Mann, Rachel; Rodoni, Brendan; Stack, James P.] Plant Biosecur Cooperat Res Ctr, Canberra, ACT, Australia	Kansas State University	Stack, JP (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.; Stack, JP (corresponding author), Plant Biosecur Cooperat Res Ctr, Canberra, ACT, Australia.	jstack@ksu.edu	Arif, Mohammad/M-5755-2013	Arif, Mohammad/0000-0002-5887-2050	Australian Government's Cooperative Research Centres Program, Canberra, Australia; Kansas Agricultural Experiment Station [16-130-J, 27765]	Australian Government's Cooperative Research Centres Program, Canberra, Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Kansas Agricultural Experiment Station	The authors would like to acknowledge the support of the Australian Government's Cooperative Research Centres Program, Canberra, Australia. Contribution no. 16-130-J, (grant 27765) to JPS from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014792; Agarkova IV, 2006, PHYTOPATHOLOGY, V96, P1270, DOI 10.1094/PHYTO-96-1270; [Anonymous], PHYTOPATHOLOGY; [Anonymous], 2005, STANDARD MINIMISING; Arif M, 2015, MOL BIOL REP, V42, P1107, DOI 10.1007/s11033-014-3849-3; Arif M, 2013, MOL BIOTECHNOL, V55, P17, DOI 10.1007/s12033-012-9617-5; Arif M, 2009, PLANT MOL BIOL REP, V27, P488, DOI 10.1007/s11105-009-0097-0; Baysal O, 2011, PHYSIOL MOL PLANT P, V75, P113, DOI 10.1016/j.pmpp.2010.10.002; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; EDGAR JA, 1982, J CHEM SOC CHEM COMM, P222, DOI 10.1039/c39820000222; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finnie JW, 2006, AUST VET J, V84, P271, DOI 10.1111/j.1751-0813.2006.00019.x; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Grewar JD, 2009, J S AFR VET ASSOC, V80, P220; Guerrero-Ferreira RC, 2011, BIODIVERSITY BOOK, V3; HUFF DR, 1993, THEOR APPL GENET, V86, P927, DOI 10.1007/BF00211043; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Johnston MS, 1996, EPIDEMIOL INFECT, V117, P393, DOI 10.1017/S0950268800001588; Kowalski MC, 2007, AUST J EXP AGR, V47, P177, DOI 10.1071/EA05162; Mann RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055644; MANTEL N, 1967, CANCER RES, V27, P209; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; MCKAY AC, 1993, ANNU REV PHYTOPATHOL, V31, P151, DOI 10.1146/annurev.py.31.090193.001055; MCKAY AC, 1993, PLANT DIS, V77, P635, DOI 10.1094/PD-77-0635; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Parker JK, 2012, APPL ENVIRON MICROB, V78, P1385, DOI 10.1128/AEM.06679-11; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Ping OY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081647; Rahkila R, 2015, APPL ENVIRON MICROB, V81, P2474, DOI 10.1128/AEM.04013-14; Riley Ian T., 1992, Australasian Plant Pathology, V21, P147, DOI 10.1071/APP9920147; RILEY IT, 1991, NEMATOLOGICA, V37, P447, DOI 10.1163/187529291X00439; RILEY IT, 1993, AUST J EXP AGR, V33, P861, DOI 10.1071/EA9930861; RILEY IT, 1992, INT J SYST BACTERIOL, V42, P64, DOI 10.1099/00207713-42-1-64; RILEY IT, 1991, J APPL BACTERIOL, V71, P302, DOI 10.1111/j.1365-2672.1991.tb03794.x; RILEY IT, 1988, J GEN MICROBIOL, V134, P3025; RILEY IT, 1987, INT J SYST BACTERIOL, V37, P153, DOI 10.1099/00207713-37-2-153; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHNEIDER DJ, 1981, ONDERSTEPOORT J VET, V48, P251; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	47	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156182	10.1371/journal.pone.0156182	http://dx.doi.org/10.1371/journal.pone.0156182			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219107	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700049
J	Lima, K; Leal, ED; Cavalcanti, AMS; Salustiano, DM; de Medeiros, LB; da Silva, SP; Lacerda, HR				Lima, Kledoaldo; Leal, Elcio de Souza; Salustiano Cavalcanti, Ana Maria; Salustiano, Daniela Medeiros; de Medeiros, Luzidalva Barbosa; da Silva, Sirleide Pereira; Lacerda, Heloisa Ramos			Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil	PLOS ONE			English	Article							HIV-1 SUBTYPE; RESISTANCE MUTATIONS; SOUTHERN BRAZIL; GENETIC DIVERSITY; DRUG-RESISTANCE; NAIVE PATIENTS; RISK-FACTORS; TYPE-1; PREVALENCE; THERAPY	Background HIV-1 diversity causes important differences in the virus' biological properties and their interactions with hosts, such as cell tropism, responses to antiretroviral therapy, drug-resistance, and disease progression. Objectives We evaluated the interrelationship of phylogenetic inference with epidemiological and laboratory data for HIV-1 isolates circulating in Pernambuco, Northeast Region-Brazil. Study design A total of 168 HIV-1 pol sequences were analysed, 64 were obtained from 2002-2003, and 104, from 2007-2009. Socio-demographic, clinical, and behavioural data were obtained from medical records. Laboratory testing enabled the determination of recent HIV-1 infections and co-infections with HBV, HCV, HTLV, or syphilis. Surveillance drug-resistance mutation analysis and antiretroviral susceptibility profiling were performed using HIV Drug-Resistance Database. Results HIV-1 non-B was associated with female, lower education, lower viral loads, and higher T cell counts mean. Frequencies of co-infection HIV-HBV, HIV-HCV, and HIV-syphilis were 27.8% (95% CI: 19.8-37.7), 1.04% (95% CI: 0.05-5.00) and 14.7% (95% CI: 8.6-23.0), respectively. Drug-resistant mutations rate was 2.98%(95% CI: 1.10-6.47). HIV-HBV subtype B co-infection was associated with men who have sex with men (MSM), higher education, higher viral loads and males. HIV-syphilis subtype non-B co-infection was associated with MSM status, lower T cell counts and males. Conclusions Data showed the importance of molecular characterisations of the HIV-1 epidemic and its relation with epidemiological and clinical characteristics of the population, as well as its association with other infectious diseases, so they can effort to improve preventive measures for health services and more information about the progress and effects of the epidemic in Northeastern-Brazil.	[Lima, Kledoaldo; Lacerda, Heloisa Ramos] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil; [Leal, Elcio de Souza] Fed Univ Para, Inst Biotechnol, BR-66059 Belem, Para, Brazil; [Salustiano Cavalcanti, Ana Maria; Salustiano, Daniela Medeiros; da Silva, Sirleide Pereira] Cent Publ Hlth Lab Pernambuco, Sect Virol, Recife, PE, Brazil; [de Medeiros, Luzidalva Barbosa] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Para; Universidade Federal de Pernambuco	Lima, K (corresponding author), Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.	kledoaldo@gmail.com	Leal, Elcio/M-5275-2019; Leal, Elcio/J-6236-2016	Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Ministerio da Educacao (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Ministerio da Educacao (CAPES)	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Ministerio da Educacao (CAPES) (http://www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SEM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-306; Arruda E, 2011, AIDS RES HUM RETROV, V27, P153, DOI 10.1089/aid.2010.0028; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brigido LFM, 2011, AIDS RES HUM RETROV, V27, P339, DOI 10.1089/aid.2010.0157; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Clementi M, 2010, CLIN MICROBIOL INFEC, V16, P1532, DOI 10.1111/j.1469-0691.2010.03335.x; Cooley LA, 2015, SEX TRANSM DIS, V42, P226, DOI 10.1097/OLQ.0000000000000256; de Brito A, 2006, CLIN INFECT DIS, V43, P1476, DOI 10.1086/508875; de Medeiros LB, 2006, MEM I OSWALDO CRUZ, V101, P845, DOI 10.1590/S0074-02762006000800004; de Oliveira SB, 2014, CAD SAUDE PUBLICA, V30, P433, DOI 10.1590/0102-311X00010413; De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145; Dias CF, 2009, REV INST MED TROP SP, V51, P191, DOI 10.1590/S0036-46652009000400003; Dras A, 2015, INT J STD, V26, P145; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Ferreira Valeria, 2012, Open AIDS J, V6, P289, DOI 10.2174/1874613601206010289; Freitas SZ, 2014, BRAZ J INFECT DIS, V18, P473, DOI 10.1016/j.bjid.2014.01.005; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Graf T, 2011, J CLIN VIROL, V51, P186, DOI 10.1016/j.jcv.2011.04.011; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hawke KG, 2013, AIDS RES HUM RETROV, V29, P311, DOI 10.1089/aid.2012.0082; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Leal E, 2008, VIROLOGY, V381, P222, DOI 10.1016/j.virol.2008.08.029; Leal E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011833; Li XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089462; Martins S, 2014, REV SOC BRAS MED TRO, V47, P552, DOI 10.1590/0037-8682-0109-2014; Moreira M, 2013, BRAZ J INFECT DIS, V17, P661, DOI 10.1016/j.bjid.2013.04.009; Munerato P, 2010, AIDS RES HUM RETROV, V26, P265, DOI 10.1089/aid.2009.0288; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112674; Pinto Mônica Edelenyi, 2006, Cad. Saúde Pública, V22, P473, DOI 10.1590/S0102-311X2006000300002; de Carvalho FHP, 2009, REV SAUDE PUBL, V43, P133, DOI 10.1590/S0034-89102009000100017; Rodrigues R, 2006, VIRUS RES, V116, P201, DOI 10.1016/j.virusres.2005.10.004; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Cavalcanti AMS, 2012, MEM I OSWALDO CRUZ, V107, P450, DOI 10.1590/S0074-02762012000400002; Sampaio AS, 2009, ACTUALIZADIONES SID, V17, P12; Santos AF, 2006, AIDS, V20, P2011; Soares EAJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000730; Tanuri A, 1999, ANTIMICROB AGENTS CH, V43, P253, DOI 10.1093/jac/43.2.253; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Velasco-de-Castro CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087622	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155854	10.1371/journal.pone.0155854	http://dx.doi.org/10.1371/journal.pone.0155854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218259	Green Published, gold			2022-12-26	WOS:000376880700023
J	Moscatelli, F; Messina, G; Valenzano, A; Monda, V; Viggiano, A; Messina, A; Petito, A; Triggiani, AI; Ciliberti, MAP; Monda, M; Capranica, L; Cibelli, G				Moscatelli, Fiorenzo; Messina, Giovanni; Valenzano, Anna; Monda, Vincenzo; Viggiano, Andrea; Messina, Antonietta; Petito, Annamaria; Triggiani, Antonio Ivano; Ciliberti, Michela Anna Pia; Monda, Marcellino; Capranica, Laura; Cibelli, Giuseppe			Functional Assessment of Corticospinal System Excitability in Karate Athletes	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MUSCLE FATIGUE; HUMAN MOTOR CORTEX; ELECTRICAL-STIMULATION; VOLUNTARY CONTRACTION; SOCCER PLAYERS; PLASTICITY; HAND; COORDINATION; RESPONSES	Objectives To investigate the involvement of the primary motor cortex (M1) in the coordination performance of karate athletes through transcranial magnetic stimulation (TMS). Methods Thirteen right-handed male karate athletes (25.0 +/- 5.0 years) and 13 matched non-athlete controls (26.7 +/- 6.2 years) were enrolled. A single-pulse TMS was applied using a figure-eight coil stimulator. Resting motor threshold (rMT) was determined. Surface electromyography was recorded from the first dorsal interosseous muscle. Motor evoked potential (MEP) latencies and amplitudes at rMT, 110%, and 120% of rMT were considered. Functional assessment of the coordination performance was assessed by in-phase (IP) and antiphase (AP) homolateral hand and foot coordination tasks performed at 80, 120, and 180 bpm. Results Compared to controls, athletes showed lower rMT (p<0.01), shorter MEP latency (p<0.01) and higher MEP amplitude (p<0.01), with a significant correlation (r = 0.50, p<0.01) between rMT and MEP latency. Coordination decreased with increasing velocity, and better IP performances emerged compared to AP ones (p<0.001). In general, a high correlation between rMT and coordination tasks was found for both IP and AP conditions. Conclusion With respect to controls, karate athletes present a higher corticospinal excitability indicating the presence of an activity-dependent alteration in the balance and interactions between inhibitory and facilitatory circuits determining the final output from the M1. Furthermore, the high correlation between corticospinal excitability and coordination performance could support sport-specific neurophysiological arrangements.	[Moscatelli, Fiorenzo; Messina, Giovanni; Valenzano, Anna; Petito, Annamaria; Triggiani, Antonio Ivano; Ciliberti, Michela Anna Pia; Cibelli, Giuseppe] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Moscatelli, Fiorenzo; Capranica, Laura] Univ Rome Foro Ital, Dept Motor Human & Hlth Sci, Rome, Italy; [Messina, Giovanni; Monda, Vincenzo; Messina, Antonietta; Monda, Marcellino] Univ Naples 2, Dept Expt Med, Naples, Italy; [Viggiano, Andrea] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy	University of Foggia; Foro Italico University of Rome; Universita della Campania Vanvitelli; University of Salerno	Cibelli, G (corresponding author), Univ Foggia, Dept Clin & Expt Med, Foggia, Italy.	giuseppe.cibelli@unifg.it	Messina, Giovanni/AAE-8668-2022; Messina, Antonietta/AHH-2383-2022; triggiani, antonio ivano/Q-4701-2019; Triggiani, Antonio Ivano/M-6252-2015; Laura, Capranica/AFW-3460-2022; MESSINA, ANTONIETTA/K-9366-2016; Moscatelli, Fiorenzo/ABC-9536-2020; Cibelli, Giuseppe/AAC-2635-2019	Messina, Giovanni/0000-0002-0011-867X; Messina, Antonietta/0000-0001-8343-432X; triggiani, antonio ivano/0000-0003-3291-9452; Moscatelli, Fiorenzo/0000-0003-1274-0332; Monda, Vincenzo/0000-0002-6083-5814; Monda, Marcellino/0000-0002-7184-218X; CIBELLI, GIUSEPPE/0000-0002-5371-2584; Capranica, Laura/0000-0003-3073-7655				Adkins DL, 2006, NEURAL CHANGES ASS T, P1776; Babiloni C, 2011, INT J PSYCHOPHYSIOL, V82, P153, DOI 10.1016/j.ijpsycho.2011.08.001; Borckardt JJ, 2006, J ECT, V22, P169, DOI 10.1097/01.yct.0000235923.52741.72; Capranica L, 2005, GERONTOLOGY, V51, P309, DOI 10.1159/000086367; Capranica L, 2004, GERONTOLOGY, V50, P399, DOI 10.1159/000080178; Chaabene H, 2012, SPORTS MED, V42, P829, DOI 10.2165/11633050-000000000-00000; Chieffi S, 2014, EXP BRAIN RES, V232, P3659, DOI 10.1007/s00221-014-4056-0; Cirillo J, 2011, EUR J NEUROSCI, V34, P1847, DOI 10.1111/j.1460-9568.2011.07870.x; Cortis C, 2013, J STRENGTH COND RES, V27, P2989, DOI 10.1519/JSC.0b013e3182897a46; Cortis C, 2011, J STRENGTH COND RES, V25, P135, DOI 10.1519/JSC.0b013e3181bde2ec; Cortis C, 2009, J STRENGTH COND RES, V23, P2458, DOI 10.1519/JSC.0b013e3181bc1b39; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Golaszewski SM, 2004, NEUROLOGY, V62, P2262, DOI 10.1212/WNL.62.12.2262; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Jensen JL, 2005, J APPL PHYSIOL, V99, P1558, DOI 10.1152/japplphysiol.01408.2004; Kim HS, 1998, PERCEPT MOTOR SKILL, V87, P96, DOI 10.2466/pms.1998.87.1.96; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; Ljubisavljevic M, 1996, ELECTROMYOGR MOTOR C, V101, P281, DOI 10.1016/0924-980X(96)95627-1; Manto M, 2006, J NEUROSCI RES, V83, P177, DOI 10.1002/jnr.20733; McIntyre-Robinson AJK, 2013, J NEUROPHYSIOL, V110, P1039, DOI 10.1152/jn.00266.2013; McKay WB, 1996, MUSCLE NERVE, V19, P1017, DOI 10.1002/mus.880190803; McNevin NH, 2000, PHYS THER, V80, P373, DOI 10.1093/ptj/80.4.373; MILL KR, 1995, NEUROREPORT, V6, P1966, DOI 10.1097/00001756-199510010-00004; Missitzi J, 2011, J PHYSIOL-LONDON, V589, P297, DOI 10.1113/jphysiol.2010.200600; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Mori S, 2002, HUM MOVEMENT SCI, V21, P213, DOI 10.1016/S0167-9457(02)00103-3; Moscatelli F, 2015, BIOL MED ALIGARH, V1, DOI [10.4172/0974-8369.1000s3008, DOI 10.4172/0974-8369.1000S3008]; Nielsen JB, 2008, J PHYSIOL-LONDON, V586, P65, DOI 10.1113/jphysiol.2007.142661; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pearce AJ, 2000, EXP BRAIN RES, V130, P238, DOI 10.1007/s002219900236; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; Pesce C, 2001, J PSYCHOPHYSIOL, V15, P256, DOI 10.1027//0269-8803.15.4.256; Rinaldi B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/265967; Roberts RE, 2013, NEUROSCIENTIST, V19, P8, DOI 10.1177/1073858411421218; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schieber MH, 2001, J NEUROPHYSIOL; Selvanayagam VS, 2011, J APPL PHYSIOL, V111, P367, DOI 10.1152/japplphysiol.00064.2011; Serrien DJ, 2000, J GERONTOL B-PSYCHOL, V55, pP295, DOI 10.1093/geronb/55.5.P295; Svensson P, 2006, EXP BRAIN RES, V173, P165, DOI 10.1007/s00221-006-0380-3; Tan KSY, 2004, J SPORT SOC ISSUES, V28, P169, DOI 10.1177/0193723504264772; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Tergau F, 2000, MED SCI SPORT EXER, V32, P1942, DOI 10.1097/00005768-200011000-00019; Tessitore A, 2011, J STRENGTH COND RES, V25, P3059, DOI 10.1519/JSC.0b013e318212e3e3; Todd G, 2009, J APPL PHYSIOL, V106, P1593, DOI 10.1152/japplphysiol.91364.2008; Tyc F, 2005, EUR J NEUROSCI, V21, P259, DOI 10.1111/j.1460-9568.2004.03835.x; Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-0035; Veldman MP, 2015, EUR J APPL PHYSIOL, V115, P2505, DOI 10.1007/s00421-015-3248-z; Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.805236; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wu CWH, 2005, NEUROIMAGE, V27, P872, DOI 10.1016/j.neuroimage.2005.05.055	51	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155998	10.1371/journal.pone.0155998	http://dx.doi.org/10.1371/journal.pone.0155998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218465	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880700034
J	Rigby, CL; White, WT; Simpfendorfer, CA				Rigby, Cassandra L.; White, William T.; Simpfendorfer, Colin A.			Deepwater Chondrichthyan Bycatch of the Eastern King Prawn Fishery in the Southern Great Barrier Reef, Australia	PLOS ONE			English	Article							SPURDOG SQUALUS-MEGALOPS; SKATE DIPTURUS-POLYOMMATA; REPRODUCTIVE-BIOLOGY; LIFE-HISTORY; GUMMY SHARK; CATSHARKS CHONDRICHTHYES; MUSTELUS-ANTARCTICUS; REDUCTION DEVICES; GROWTH BANDS; SCHOOL SHARK	The deepwater chondrichthyan fauna of the Great Barrier Reef is poorly known and life history information is required to enable their effective management as they are inherently vulnerable to exploitation. The chondrichthyan bycatch from the deepwater eastern king prawn fishery at the Swain Reefs in the southern Great Barrier Reef was examined to determine the species present and provide information on their life histories. In all, 1533 individuals were collected from 11 deepwater chondrichthyan species, with the Argus skate Dipturus polyommata, piked spurdog Squalus megalops and pale spotted catshark Asymbolus pallidus the most commonly caught. All but one species is endemic to Australia with five species restricted to waters offshore from Queensland. The extent of life history information available for each species varied but the life history traits across all species were characteristic of deep water chondrichthyans with relatively large length at maturity, small litters and low ovarian fecundity; all indicative of low biological productivity. However, variability among these traits and spatial and bathymetric distributions of the species suggests differing degrees of resilience to fishing pressure. To ensure the sustainability of these bycatch species, monitoring of their catches in the deepwater eastern king prawn fishery is recommended.	[Rigby, Cassandra L.; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Rigby, Cassandra L.; Simpfendorfer, Colin A.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [White, William T.] Natl Res Collect Australia, CSIRO Australian Natl Fish Collect, Hobart, Tas 7001, Australia	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rigby, CL (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.; Rigby, CL (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia.	Cassandra.rigby@my.jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011; White, William T/B-9748-2009	Simpfendorfer, Colin A/0000-0002-0295-2238; White, William T/0000-0001-9705-2453	Australian Postgraduate Award; Oceania Chondrichthyan Society; Passions of Paradise via a Student Research Award	Australian Postgraduate Award(Australian Government); Oceania Chondrichthyan Society; Passions of Paradise via a Student Research Award	CLR was supported by an Australian Postgraduate Award, and the Oceania Chondrichthyan Society and Passions of Paradise provided funding via a Student Research Award (http://oceaniasharks.org.au/). Water temperature data was sourced from the Integrated Marine Observing System (IMOS) - IMOS is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy and the Super Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett LAK, 2009, MAR BIOL, V156, P301, DOI 10.1007/s00227-008-1084-y; Braccini JM, 2007, MAR FRESHWATER RES, V58, P24, DOI 10.1071/MF06064; Braccini JM, 2005, ICES J MAR SCI, V62, P1076, DOI 10.1016/j.icesjms.2005.04.004; Braccini JM, 2006, MAR FRESHWATER RES, V57, P105, DOI 10.1071/MF05076; Brewer D, 2006, FISH RES, V81, P176, DOI 10.1016/j.fishres.2006.07.009; Bridge NF, 1998, MAR FRESHWATER RES, V49, P679, DOI 10.1071/MF97075; Bubley WJ, 2012, J FISH BIOL, V80, P1300, DOI 10.1111/j.1095-8649.2011.03171.x; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 1990, SHARKS RAYS CHIMAERA, P12; Capape C, 2008, J MAR BIOL ASSOC UK, V88, P415, DOI 10.1017/S002531540800060X; Capape C, 2005, CYBIUM, V29, P147; Capape C, 2002, J MAR BIOL ASSOC UK, V82, P635, DOI 10.1017/S0025315402005994; CASTRO JI, 1988, COPEIA, P740; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Clarke M. W., 2003, Journal of Northwest Atlantic Fishery Science, V31, P401; Correia JP, 1997, ENVIRON BIOL FISH, V50, P225, DOI 10.1023/A:1007368025164; Cortes E, 2004, CRC MAR BIOL SER, P449; Courtney AJ, 2014, FISH RES, V157, P113, DOI 10.1016/j.fishres.2014.03.021; Courtney AJ, 2007, 2000170 FISH RES DEV; Courtney AJ, 2014, 2008019 FISH RES DEV; Daley RK, 2015, DEEP-SEA RES PT II, V115, P127, DOI 10.1016/j.dsr2.2014.05.017; DAVENPORT S, 1988, AUST J MAR FRESH RES, V39, P417; Dulvy NK, 2010, CRC MAR BIOL SER, P639; Ebert DA, 2005, J FISH BIOL, V66, P618, DOI 10.1111/j.0022-1112.2005.00628.x; Ebert DA, 2008, ICES J MAR SCI, V65, P81, DOI 10.1093/icesjms/fsm169; Ebert DA, 2007, ENVIRON BIOL FISH, V80, P107, DOI 10.1007/s10641-007-9244-3; Ebert DA, 2007, ZOOTAXA, P1; Ebert DA, 2006, ICES J MAR SCI, V63, P1053, DOI 10.1016/j.icesjms.2006.04.016; FERREIRA BP, 1991, FISH B-NOAA, V89, P19; Flammang BE, 2008, ENVIRON BIOL FISH, V81, P35, DOI 10.1007/s10641-006-9162-9; Francis MP, 2006, ENVIRON BIOL FISH, V77, P407, DOI 10.1007/s10641-006-9109-1; Francis MP, 2006, ENVIRON BIOL FISH, V75, P295, DOI 10.1007/s10641-006-0026-0; Francis MP, 2000, MAR FRESHWATER RES, V51, P35, DOI 10.1071/MF99012; Frisk MG, 2002, ICES J MAR SCI, V59, P576, DOI 10.1006/jmsc.2002.1177; Frisk MG, 2001, CAN J FISH AQUAT SCI, V58, P969, DOI 10.1139/cjfas-58-5-969; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; GBRMPA, 2009, GREAT BARR REEF OUTL GREAT BARR REEF OUTL; GBRMPA (Great Barrier Reef Marine Park Authority), 2014, GREAT BARR REEF OUTL; Gennari E, 2007, MAR BIOL, V152, P1207, DOI 10.1007/s00227-007-0769-y; Graham KJ, 2011, MAR FRESHWATER RES, V62, P583, DOI 10.1071/MF10158; Graham KJ, 2001, MAR FRESHWATER RES, V52, P549, DOI 10.1071/MF99174; HOENIG JM, 1988, B MAR SCI, V42, P334; IMOS, OC CURR TEMP SAL 200; Irvine SB, 2012, J FISH BIOL, V80, P1181, DOI 10.1111/j.1095-8649.2012.03262.x; Jaine FRA, 2014, MAR ECOL PROG SER, V510, P73, DOI 10.3354/meps10910; Kyne PM, 2008, J FISH BIOL, V72, P61, DOI 10.1111/j.1095-8649.2007.01655.x; Kyne PM, 2011, J MAR BIOL ASSOC UK, V91, P1157, DOI 10.1017/S0025315410001670; Kyne PM, 2010, CRC MAR BIOL SER, P37; Kyne PM, 2007, COLLATION SUMMARIZAT; Kynoch RJ, 2015, ICES J MAR SCI, V72, P1861, DOI 10.1093/icesjms/fsv037; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Last PR, 2014, ZOOTAXA, V3887, P191, DOI 10.11646/zootaxa.3887.2.4; Last Peter R., 2008, CSIRO Marine and Atmospheric Research Paper, V021, P53; Last PR, 1999, AUSTR CATSHARKS GENU, P19; Last PR, 2006, IUCN RED LIST THREAT; Moura T, 2004, J MAR BIOL ASSOC UK, V84, P801, DOI 10.1017/S002531540400997Xh; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Naylor G. J. P, 2020, CHONDRICHTHYAN TREE; Officer RA, 1996, CAN J FISH AQUAT SCI, V53, P1765, DOI 10.1139/cjfas-53-8-1765; Pears RJ, 2012, ECOLOGICAL RISK ASSE; Pogonoski J, 2003, IUCN RED LIST THREAT; R Development Core Team, 2014, R LANG ENV STAT COMP; Richardson AJ, 2000, J FISH BIOL, V56, P552, DOI 10.1111/j.1095-8649.2000.tb00755.x; Rigby CL, 2016, J FISH BIOL, V88, P1149, DOI 10.1111/jfb.12891; Rigby C, 2015, DEEP-SEA RES PT II, V115, P30, DOI 10.1016/j.dsr2.2013.09.004; Rigby CL, 2015, MARINE FRESHWATER RE; Ruocco NL, 2006, ICES J MAR SCI, V63, P105, DOI 10.1016/j.icesjms.2005.08.007; Schwartz FJ, 1983, P INT WORKSH AG DET; Seret B, 2003, CYBIUM, V27, P307; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Simpfendorfer CA, 2009, ENVIRON CONSERV, V36, P97, DOI 10.1017/S0376892909990191; Sumpton W., 2013, 2010053 FRDC DEP AGR; Treloar MA, 2008, ASPECTS LIFE HIST SK; Trinnie FI, 2012, J FISH BIOL, V80, P1267, DOI 10.1111/j.1095-8649.2012.03259.x; Vooren CM, 2015, IUCN RED LIST THREAT; Walker TI, 2007, MAR FRESHWATER RES, V58, P67, DOI 10.1071/MF06074; Weeks SJ, 2010, CORAL REEFS, V29, P975, DOI 10.1007/s00338-010-0644-z; Wetherbee BM, 2012, CRC MAR BIOL SER, P239; White W. T., 2008, DESCRIPTIONS NEW AUS, P189; White WT, 2005, MAR FRESHWATER RES, V56, P101, DOI 10.1071/MF04225; White WT, 2001, MAR BIOL, V138, P135, DOI 10.1007/s002270000436; Yearsley Gordon K., 2008, CSIRO Marine and Atmospheric Research Paper, V022, P23	82	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156036	10.1371/journal.pone.0156036	http://dx.doi.org/10.1371/journal.pone.0156036			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218654	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000376880700035
J	Sarkar, D; Patra, P; Ghosh, A; Saha, S				Sarkar, Debasree; Patra, Piya; Ghosh, Abhirupa; Saha, Sudipto			Computational Framework for Prediction of Peptide Sequences That May Mediate Multiple Protein Interactions in Cancer-Associated Hub Proteins	PLOS ONE			English	Article							INTERACTION NETWORKS; LINEAR MOTIFS; BINDING SITES; WEB SERVER; INTERFACES; ROLES; MYC; IDENTIFICATION; RECOGNITION; DISCOVERY	A considerable proportion of protein-protein interactions (PPIs) in the cell are estimated to be mediated by very short peptide segments that approximately conform to specific sequence patterns known as linear motifs (LMs), often present in the disordered regions in the eukaryotic proteins. These peptides have been found to interact with low affinity and are able bind to multiple interactors, thus playing an important role in the PPI networks involving date hubs. In this work, PPI data and de novo motif identification based method (MEME) were used to identify such peptides in three cancer-associated hub proteins-MYC, APC and MDM2. The peptides corresponding to the significant LMs identified for each hub protein were aligned, the overlapping regions across these peptides being termed as overlapping linear peptides (OLPs). These OLPs were thus predicted to be responsible for multiple PPIs of the corresponding hub proteins and a scoring system was developed to rank them. We predicted six OLPs in MYC and five OLPs in MDM2 that scored higher than OLP predictions from randomly generated protein sets. Two OLP sequences from the C-terminal of MYC were predicted to bind with FBXW7, component of an E3 ubiquitin-protein ligase complex involved in proteasomal degradation of MYC. Similarly, we identified peptides in the C-terminal of MDM2 interacting with FKBP3, which has a specific role in auto-ubiquitinylation of MDM2. The peptide sequences predicted in MYC and MDM2 look promising for designing orthosteric inhibitors against possible disease-associated PPIs. Since these OLPs can interact with other proteins as well, these inhibitors should be specific to the targeted interactor to prevent undesired side-effects. This computational framework has been designed to predict and rank the peptide regions that may mediate multiple PPIs and can be applied to other disease-associated date hub proteins for prediction of novel therapeutic targets of small molecule PPI modulators.	[Sarkar, Debasree; Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, India; [Patra, Piya; Ghosh, Abhirupa] Maulana Abdul Kalam Azad Univ Technol, Kolkata, India	Department of Science & Technology (India); Bose Institute; Maulana Abul Kalam Azad University of Technology	Saha, S (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, India.	ssaha4@jcbose.ac.in	Sarkar, Debasree/K-1343-2019; Ghosh, Abhirupa/GWC-7986-2022; Saha, Sudipto/AAF-1034-2020	Sarkar, Debasree/0000-0002-3228-9131; Ghosh, Abhirupa/0000-0002-3980-4749; Saha, Sudipto/0000-0001-9433-8894	Department of Biotechnology-Ramalingaswami Re-entry Fellowship [BT/RLF/Re-entry/11/2011]	Department of Biotechnology-Ramalingaswami Re-entry Fellowship	The work was supported by Department of Biotechnology-Ramalingaswami Re-entry Fellowship (No. BT/RLF/Re-entry/11/2011) to SS.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bornert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056336; Bowler EH, 2015, EXPERT REV PROTEOMIC, P1; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; Dasgupta B, 2011, J MOL BIOL, V411, P713, DOI 10.1016/j.jmb.2011.06.027; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2010, NUCLEIC ACIDS RES, V38, pW534, DOI 10.1093/nar/gkq440; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Gururaja TL, 2003, J PEPT RES, V61, P163, DOI 10.1034/j.1399-3011.2003.00044.x; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hormozdiari F, 2007, PLOS COMPUT BIOL, V3, P1373, DOI 10.1371/journal.pcbi.0030118; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Ochocka AM, 2009, FEBS LETT, V583, P621, DOI 10.1016/j.febslet.2009.01.009; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Palopoli N, 2015, BIOINFORMATICS, V31, P2284, DOI 10.1093/bioinformatics/btv155; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Polakis P, 2000, GENE DEV, V14, P1837; Rosal R, 2004, BIOCHEMISTRY-US, V43, P1854, DOI 10.1021/bi035718g; Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sarkar D, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav014; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Trabuco LG, 2012, NUCLEIC ACIDS RES, V40, pW423, DOI 10.1093/nar/gks398; Tyagi M, 2009, PROTEIN SCI, V18, P1674, DOI 10.1002/pro.181; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155911	10.1371/journal.pone.0155911	http://dx.doi.org/10.1371/journal.pone.0155911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218803	Green Submitted, gold, Green Published			2022-12-26	WOS:000376880700026
J	Steinbrenner, I; Houdek, P; Pollok, S; Brandner, JM; Daniels, R				Steinbrenner, Isabel; Houdek, Pia; Pollok, Simone; Brandner, Johanna M.; Daniels, Rolf			Influence of the Oil Phase and Topical Formulation on the Wound Healing Ability of a Birch Bark Dry Extract	PLOS ONE			English	Article							BETULINIC ACID; OUTER BARK; HYDROXYPROPYL METHYLCELLULOSE; CHORIOALLANTOIC MEMBRANE; TRITERPENE EXTRACT; ACTINIC KERATOSES; OLEANOLIC ACID; IN-VITRO; EMULSIONS; TRIAL	Triterpenes from the outer bark of birch are known for various pharmacological effects including enhanced wound healing (WH). A birch bark dry extract (TE) obtained by accelerated solvent extraction showed the ability to form oleogels when it is suspended in oils. Consistency of the oleogels and the dissolved amount of triterpenes varies largely with the used oil. Here we wanted to know to what extent different oils and formulations (oleogel versus o/w emulsion) influence WH. Looking at the plain oils, medium-chain triglycerides (MCT) enhanced WH (ca. 1.4-fold), while e.g. castor oil (ca. 0.3-fold) or light liquid paraffin (LLP; ca. 0.5-fold) significantly decreased WH. Concerning the respective oleogels, TE-MCT showed no improvement although the solubility of the TE was high. In contrast, the oleogel of sunflower oil which alone showed a slight tendency to impair WH, enhanced WH significantly (ca. 1.6-fold). These results can be explained by release experiments where the release rate of betulin, the main component of TE, from MCT oleogels was significantly lower than from sunflower oil oleogels. LLP impaired WH as plain oil and even though it released betulin comparable to sunflower oil it still results in an overall negative effect of the oleogel on WH. As a further formulation option also surfactant free o/w emulsions were prepared using MCT, sunflower oil and LLP as a nonpolar oil phase. Depending on the preparation method (suspension or oleogel method) the distribution of the TE varied markedly and affected also release kinetics. However, the released betulin was clearly below the values measured with the respective oleogels. Consequently, none of the emulsions showed a significantly positive effect on WH. In conclusion, our data show that the oil used as a vehicle influences wound healing not only by affecting the release of the extract, but also by having its own vehicle effect on wound healing. This is also of importance for other applications where drugs have to be applied in non-polar vehicles because these solvents likely influence the outcome of the experiment substantially.	[Steinbrenner, Isabel; Daniels, Rolf] Univ Tubingen, Dept Pharmaceut Technol, Tubingen, Germany; [Houdek, Pia; Pollok, Simone; Brandner, Johanna M.] Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany	Eberhard Karls University of Tubingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Daniels, R (corresponding author), Univ Tubingen, Dept Pharmaceut Technol, Tubingen, Germany.	rolf.daniels@uni-tuebingen.de	Daniels, Rolf/B-9010-2011	Daniels, Rolf/0000-0002-9553-0033	Arbeitsgemeinschaft fur industrielle Forschungsforderung, AIF Projekt GmbH [KF2387901SK9]	Arbeitsgemeinschaft fur industrielle Forschungsforderung, AIF Projekt GmbH	This work was supported by Arbeitsgemeinschaft fur industrielle Forschungsforderung, AIF Projekt GmbH, www.zimbmwi.de, Grant Number: KF2387901SK9. RD and JMB received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agra LC, 2015, J DERMATOL TREAT, V26, P465, DOI 10.3109/09546634.2015.1021663; Akinosho HO, 2015, LWT-FOOD SCI TECHNOL, V63, P582, DOI 10.1016/j.lwt.2015.02.024; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Altinier G, 2007, J AGR FOOD CHEM, V55, P1718, DOI 10.1021/jf062610+; Beitz JM, 2005, OSTOMY WOUND MANAG, V51, P52; Chudzik M, 2015, MOLECULES, V20, P1610, DOI 10.3390/molecules20011610; DANIELS R, 1994, EUR J PHARM BIOPHARM, V40, P128; Daniels R, 1993, PHARM LETT, V3, P80; Dehelean CA, 2013, J BIOMED NANOTECHNOL, V9, P577, DOI 10.1166/jbn.2013.1563; Dehelean CA, 2011, J BIOMED NANOTECHNOL, V7, P317, DOI 10.1166/jbn.2011.1297; Dixon AJ, 2006, BRIT J SURG, V93, P937, DOI 10.1002/bjs.5400; Ebeling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086147; EKMAN R, 1983, HOLZFORSCHUNG, V37, P205, DOI 10.1515/hfsg.1983.37.4.205; FERDOUS AJ, 1993, DRUG DEV IND PHARM, V19, P1083, DOI 10.3109/03639049309063002; Gheorgheosu D, 2014, ANTI-CANCER AGENT ME, V14, P936, DOI 10.2174/1871520614666140223192148; Gray M, 2004, OSTOMY WOUND MANAG, V50, P40; Gray M, 2004, OSTOMY WOUND MANAG, V50, P42; Gray Mikel, 2004, Ostomy Wound Manage, V50, P34; Grysko M, 2013, PHARMAZIE, V68, P572, DOI 10.1691/ph.2013.6515; Grysko M., 2012, THESIS EBERHARD KARL; Huyke C, 2009, J DTSCH DERMATOL GES, V7, P128, DOI 10.1111/j.1610-0387.2008.06865.x; Jager S, 2008, MOLECULES, V13, P3224, DOI 10.3390/molecules13123224; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; Jyoti MA, 2010, APPL SURF SCI, V257, P1533, DOI 10.1016/j.apsusc.2010.08.091; Laszczyk M., 2007, THESIS ALBERT LUDWIG; Laszczyk M, 2006, PLANTA MED, V72, P1389, DOI 10.1055/s-2006-951723; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Loeffelbein DJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/572183; McBride CA, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0557-9; Metelmann HR, 2012, J CRANIO MAXILL SURG, V40, pE150, DOI 10.1016/j.jcms.2011.07.020; Metelmann HR, 2015, SKIN PHARMACOL PHYS, V28, P1, DOI 10.1159/000357501; Moura-Letts G, 2006, J NAT PROD, V69, P978, DOI 10.1021/np0601152; Mukherjee Rama, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P271, DOI 10.2174/187152006776930846; Pavlova NI, 2003, FITOTERAPIA, V74, P489, DOI 10.1016/S0367-326X(03)00123-0; Pfarr K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118802; Pflugfelder A, 2015, BRIT J DERMATOL, V172, P926, DOI 10.1111/bjd.13342; Pollok S, 2011, J CELL MOL MED, V15, P861, DOI 10.1111/j.1582-4934.2010.01057.x; ROLLAND A, 1992, PHARMACEUT RES, V9, P82, DOI 10.1023/A:1018935912097; Romeo C, 2013, J WOUND OSTOMY CONT, V40, P195, DOI 10.1097/WON.0b013e3182800322; Schulz MB, 2000, EUR J PHARM BIOPHARM, V49, P231, DOI 10.1016/S0939-6411(00)00069-2; Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020; Soica C, 2012, INT J MOL SCI, V13, P14992, DOI 10.3390/ijms131114992; Woelfle U, 2010, J INVEST DERMATOL, V130, P113, DOI 10.1038/jid.2009.248; Zhang WS, 2014, J CANCER RES THER, V10, P14, DOI 10.4103/0973-1482.139746	44	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155582	10.1371/journal.pone.0155582	http://dx.doi.org/10.1371/journal.pone.0155582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219110	gold, Green Submitted, Green Published			2022-12-26	WOS:000376880700009
J	Gerbino, A; Schena, G; Milano, S; Milella, L; Barbosa, AF; Armentano, F; Procino, G; Svelto, M; Carmosino, M				Gerbino, Andrea; Schena, Giorgia; Milano, Serena; Milella, Luigi; Barbosa, Alan Franco; Armentano, Francesca; Procino, Giuseppe; Svelto, Maria; Carmosino, Monica			Spilanthol from Acmella Oleracea Lowers the Intracellular Levels of cAMP Impairing NKCC2 Phosphorylation and Water Channel AQP2 Membrane Expression in Mouse Kidney	PLOS ONE			English	Article							THICK ASCENDING LIMBS; ADENYLYL-CYCLASE; COLLECTING DUCT; COTRANSPORTER NKCC2; STIMULATION; VASOPRESSIN; CELL; RECEPTOR; EXTRACT; FLOWERS	Acmella oleracea is well recognized in Brazilian traditional medicine as diuretic, although few scientific data have been published to support this effect. Aim of this study was to determine the molecular effect of Acmella oleracea extract and its main alkylamide spilanthol on two major processes involved in the urine concentrating mechanism: Na-K-2Cl symporter (NKCC2) activity in the thick ascending limb and water channel aquaporin 2 accumulation at the apical plasma membrane of collecting duct cells. Phosphorylation of NKCC2 was evaluated as index of its activation by Western blotting. Rate of aquaporin 2 apical expression was analyzed by confocal laser microscopy. Spilanthol-induced intracellular signalling events were dissected by video-imaging experiments. Exposure to spilanthol reduced the basal phosphorylation level of NKCC2 both in freshly isolated mouse kidney slices and in NKCC2-expresing HEK293 cells. In addition, exposure to spilanthol strongly reduced both desmopressin and low Cl--dependent increase in NKCC2 phosphorylation in mouse kidney slices and NKCC2-expressing HEK293 cells, respectively. Similarly, spilanthol reduced both desmopressin-and forskolin-stimulated aquaporin 2 accumulation at the apical plasma membrane of collecting duct in mouse kidney slice and MCD4 cells, respectively. Of note, when orally administered, spilanthol induced a significant increase in both urine output and salt urinary excretion associated with a markedly reduced urine osmolality compared with control mice. Finally, at cellular level, spilanthol rapidly reduced or reversed basal and agonist- increased cAMP levels through a mechanism involving increases in intracellular [Ca2+]. In conclusion, spilanthol-induced inhibition of cAMP production negatively modulates urine-concentrating mechanisms thus holding great promise for its use as diuretic.	[Gerbino, Andrea; Milano, Serena; Procino, Giuseppe; Svelto, Maria] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy; [Schena, Giorgia; Milella, Luigi; Armentano, Francesca; Carmosino, Monica] Univ Basilicata, Dept Sci, Viale Ateneo Lucano 10, I-85100 Potenza, Italy; [Barbosa, Alan Franco] Univ Fed Rural Rio de Janeiro, Dept Food Technol, BR 465 Km 07, Rio De Janeiro, Brazil	Universita degli Studi di Bari Aldo Moro; Italfarmaco; University of Basilicata; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Carmosino, M (corresponding author), Univ Basilicata, Dept Sci, Viale Ateneo Lucano 10, I-85100 Potenza, Italy.	monica.carmosino@unibas.it	Gerbino, Andrea/Y-6526-2018; milano, serena/L-3912-2019; Armentano, Maria F/K-8052-2016; Milella, Luigi/AAA-4431-2021; Carmosino, Monica/O-2594-2014	Gerbino, Andrea/0000-0002-2839-0130; Milella, Luigi/0000-0002-5874-1237; Milano, Serena/0000-0002-2616-0446; Schena, Giorgia/0000-0001-5504-4834; ARMENTANO, MARIA FRANCESCA/0000-0001-5607-5288; Carmosino, Monica/0000-0001-7600-8816	Ricerca di interesse locale RIL; University of Basilicata; Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica [RBRN07BMCT_009]	Ricerca di interesse locale RIL; University of Basilicata; Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by the 'Ricerca di interesse locale RIL' to M.C., University of Basilicata and by Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica to M. S. (grant number RBRN07BMCT_009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Boonen J, 2010, J PHARMACEUT BIOMED, V53, P243, DOI 10.1016/j.jpba.2010.02.010; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Carmosino M, 2015, BIOL CELL, V107, P98, DOI 10.1111/boc.201400069; De Spiegeleer B, 2013, J ETHNOPHARMACOL, V148, P117, DOI 10.1016/j.jep.2013.03.076; Di Mise A, 2015, AM J PHYSIOL-RENAL, V308, pF1200, DOI 10.1152/ajprenal.00352.2014; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; Dubey S, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/423750; Ferreira MCD, 1998, J BIOL CHEM, V273, P15192, DOI 10.1074/jbc.273.24.15192; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; FUSHIMI K, 1994, AM J PHYSIOL-RENAL, V267, pF573, DOI 10.1152/ajprenal.1994.267.4.F573; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Haque MZ, 2012, AM J PHYSIOL-RENAL, V303, pF1307, DOI 10.1152/ajprenal.00019.2012; Helies-Toussaint C, 2000, AM J PHYSIOL-RENAL, V279, pF185, DOI 10.1152/ajprenal.2000.279.1.F185; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Iolascon A, 2007, NEPHRON PHYSIOL, V105, P33, DOI 10.1159/000098136; Ley JP, 2006, NAT PROD RES, V20, P798, DOI 10.1080/14786410500246733; Ludwig MG, 2002, J RECEPT SIGNAL TR R, V22, P79, DOI 10.1081/RRS-120014589; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; MARTIN R, 1984, PHYTOCHEMISTRY, V23, P1781, DOI 10.1016/S0031-9422(00)83490-1; Mbeunkui F, 2011, J CHROMATOGR B, V879, P1886, DOI 10.1016/j.jchromb.2011.05.013; MOREIRA VMTS, 1989, BRAZ J MED BIOL RES, V22, P65; Nomura ECO, 2013, J ETHNOPHARMACOL, V150, P583, DOI 10.1016/j.jep.2013.09.007; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Prachayasittikul S, 2009, MOLECULES, V14, P850, DOI 10.3390/molecules14020850; Procino G, 2008, J CELL SCI, V121, P2097, DOI 10.1242/jcs.022210; Ratnasooriya WD, 2004, J ETHNOPHARMACOL, V91, P317, DOI 10.1016/j.jep.2004.01.006; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Shankar SS, 2003, AM J PHYSIOL-RENAL, V284, pF11, DOI 10.1152/ajprenal.00119.2002; Sharma V, 2011, PHYTOMEDICINE, V18, P1161, DOI 10.1016/j.phymed.2011.06.001; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Tahraoui A, 2007, J ETHNOPHARMACOL, V110, P105, DOI 10.1016/j.jep.2006.09.011; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; WAYMAN GA, 1995, J BIOL CHEM, V270, P24108, DOI 10.1074/jbc.270.41.24108; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Wongsawatkul O, 2008, INT J MOL SCI, V9, P2724, DOI 10.3390/ijms9122724; Wright CI, 2007, J ETHNOPHARMACOL, V114, P1, DOI 10.1016/j.jep.2007.07.023; Wu LC, 2008, J AGR FOOD CHEM, V56, P2341, DOI 10.1021/jf073057e; Zhou P, 2014, ACTA PHARM SIN B, V4, P37, DOI 10.1016/j.apsb.2013.12.005	48	29	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156021	10.1371/journal.pone.0156021	http://dx.doi.org/10.1371/journal.pone.0156021			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213818	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200049
J	Gugger, A; Barnhill, RL; Seifert, B; Dehler, S; Moch, H; Lugassy, C; Marques-Maggio, E; Rushing, EJ; Mihic-Probst, D				Gugger, Alenka; Barnhill, Raymond L.; Seifert, Burkhardt; Dehler, Silvia; Moch, Holger; Lugassy, Claire; Marques-Maggio, Ewerton; Rushing, Elisabeth J.; Mihic-Probst, Daniela			Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations	PLOS ONE			English	Article							THIN MALIGNANT-MELANOMA; TUMOR-INFILTRATING LYMPHOCYTES; HISTOLOGIC REGRESSION; EUROPEAN ORGANIZATION; POOLED ANALYSIS; SURVIVAL; NRAS; ASSOCIATION; EXPERIENCE; MUTATIONS	Background Brain metastasis is a common endpoint in patients suffering from malignant melanoma. However, little is known about factors that predispose to brain metastases. Objective We performed a retrospective clinical and pathological investigation of melanoma patients with brain metastases in order to better characterise this patient population. Methods 193 melanoma patients with brain metastasis histologically diagnosed between 1990 and 2015 at the University Hospital Zurich were retrospectively identified and further specified for sex, age at diagnosis and detection of brain metastasis, and localisation. In addition, data were extracted regarding the subtype of primary melanoma, Breslow tumour thickness, Clark Level, mutation status, extent of metastatic spread and history of a second melanoma. Results We found a significant male predominance (n = 126/193;65%; p < 0.001). Breslow tumour thickness showed a wide range from 0.2 to 12.0 mm (n = 99; median 2.3 mm). 14 of 101 melanomas (14%) were classified as T1, thereof 11 (79%) were found in men. In 32 of 193 patients (17%), the primary melanoma was unknown. Conclusions Of special interest in our series is the high incidence of male predominance (79%) in cases of thin metastasing melanoma (14%), implicating genetic or epigenetic (hormonal) gender differences underlying tumour progression. Additionally, the high percentage of unknown primary melanoma (17%), at least partly representing completely regressed melanomas, indicates the importance of immune surveillance in melanoma progression.	[Gugger, Alenka; Moch, Holger; Marques-Maggio, Ewerton; Mihic-Probst, Daniela] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Barnhill, Raymond L.; Lugassy, Claire] Inst Curie, Dept Pathol, Paris, France; [Barnhill, Raymond L.; Lugassy, Claire] Inst Curie, Dept Translat Res, Paris, France; [Seifert, Burkhardt] Univ Zurich, Dept Biostat, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Dehler, Silvia] Univ Zurich, Univ Zurich Hosp, Inst Surg Pathol, Canc Registry Zurich & Zug, Zurich, Switzerland; [Dehler, Silvia] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Rushing, Elisabeth J.] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital	Mihic-Probst, D (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	daniela.mihic@usz.ch	Mihic-Probst, Daniela/AAB-6374-2021					Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barnhill RL, 2004, PATHOLOGY, V36, P485, DOI 10.1080/00313020412331282708; CHASON JL, 1963, CANCER, V16, P781, DOI 10.1002/1097-0142(196306)16:6<781::AID-CNCR2820160614>3.0.CO;2-M; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; Cook MG, 2002, J PATHOL, V197, P188, DOI 10.1002/path.1093; CROWLEY NJ, 1992, ARCH SURG-CHICAGO, V127, P1303; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Ekedahl H, 2013, BRIT J DERMATOL, V169, P1049, DOI 10.1111/bjd.12504; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Geller AC, 2013, J CLIN ONCOL, V31, P4172, DOI 10.1200/JCO.2012.47.3728; GROMET MA, 1978, CANCER-AM CANCER SOC, V42, P2282, DOI 10.1002/1097-0142(197811)42:5<2282::AID-CNCR2820420528>3.0.CO;2-V; Guitart J, 2002, ARCH DERMATOL, V138, P603, DOI 10.1001/archderm.138.5.603; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Joosse A, 2015, ANN SURG ONCOL, V22, P1598, DOI 10.1245/s10434-014-4166-8; Joosse A, 2013, J CLIN ONCOL, V31, P2337, DOI 10.1200/JCO.2012.44.5031; Joosse A, 2012, J CLIN ONCOL, V30, P2240, DOI 10.1200/JCO.2011.38.0584; Joosse A, 2011, J INVEST DERMATOL, V131, P719, DOI 10.1038/jid.2010.354; Kaal EC, 2005, LANCET NEUROL, V4, P289, DOI 10.1016/S1474-4422(05)70072-7; Kalady MF, 2003, ANN SURG, V238, P528, DOI 10.1097/01.sla.0000090446.63327.40; Kamposioras K, 2011, CRIT REV ONCOL HEMAT, V78, P112, DOI 10.1016/j.critrevonc.2010.04.007; KANG SW, 1993, J CUTAN PATHOL, V20, P126, DOI 10.1111/j.1600-0560.1993.tb00228.x; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Lasithiotakis K, 2008, CANCER, V112, P1795, DOI 10.1002/cncr.23359; MADAJEWICZ S, 1984, CANCER, V53, P2550, DOI 10.1002/1097-0142(19840601)53:11<2550::AID-CNCR2820531129>3.0.CO;2-B; MCGOVERN VJ, 1983, HISTOPATHOLOGY, V7, P673, DOI 10.1111/j.1365-2559.1983.tb02279.x; McKinnon JG, 2003, CANCER, V98, P1223, DOI 10.1002/cncr.11624; Morris KT, 2008, ANN SURG ONCOL, V15, P316, DOI 10.1245/s10434-007-9675-2; Ribero S, 2013, BRIT J DERMATOL, V169, P1240, DOI 10.1111/bjd.12586; Ribero S, 2015, JAMA DERMATOL, V151, P1301, DOI 10.1001/jamadermatol.2015.2235; Sahin S, 1997, CANCER-AM CANCER SOC, V80, P1426, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1426::AID-CNCR9>3.3.CO;2-U; Scoggins CR, 2006, ANN SURG, V243, P693, DOI 10.1097/01.sla.0000216771.81362.6b; SHAW HM, 1980, CANCER-AM CANCER SOC, V45, P1604, DOI 10.1002/1097-0142(19800401)45:7<1604::AID-CNCR2820450715>3.0.CO;2-O; SHAW HM, 1989, HISTOPATHOLOGY, V15, P257, DOI 10.1111/j.1365-2559.1989.tb03076.x; SLINGLUFF CL, 1988, ANN SURG, V208, P150, DOI 10.1097/00000658-198808000-00004; Taylor RC, 2007, J CLIN ONCOL, V25, P869, DOI 10.1200/JCO.2006.08.9755; Thomas NE, 2015, JAMA ONCOL, V1, P359, DOI 10.1001/jamaoncol.2015.0493; Thumar J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-45; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; White RL, 2011, ANN SURG ONCOL, V18, P3593, DOI 10.1245/s10434-011-1826-9	41	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156115	10.1371/journal.pone.0156115	http://dx.doi.org/10.1371/journal.pone.0156115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213536	Green Published, gold			2022-12-26	WOS:000376880200057
J	Immel, F; Broussard, C; Catherinet, B; Plasseraud, L; Alcaraz, G; Bundeleva, I; Marin, F				Immel, Francoise; Broussard, Cedric; Catherinet, Bastien; Plasseraud, Laurent; Alcaraz, GRard; Bundeleva, Irina; Marin, Frederic			The Shell of the Invasive Bivalve Species Dreissena polymorpha: Biochemical, Elemental and Textural Investigations	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; ORGANIC MATRIX; ZEBRA MUSSEL; INFRARED-SPECTROSCOPY; MANTLE TRANSCRIPTOME; POLYACRYLAMIDE-GELS; BIOACCUMULATION; PROTEINS; NACRE; MARGARITIFERA	The zebra mussel Dreissena polymorpha is a well-established invasive model organism. Although extensively used in environmental sciences, virtually nothing is known of the molecular process of its shell calcification. By describing the microstructure, geochemistry and biochemistry/proteomics of the shell, the present study aims at promoting this species as a model organism in biomineralization studies, in order to establish a bridge with ecotoxicology, while sketching evolutionary conclusions. The shell of D. polymorpha exhibits the classical crossed-lamellar/complex crossed lamellar combination found in several heterodont bivalves, in addition to an external thin layer, the characteristics of which differ from what was described in earlier publication. We show that the shell selectively concentrates some heavy metals, in particular uranium, which predisposes D. polymorpha to local bioremediation of this pollutant. We establish the biochemical signature of the shell matrix, demonstrating that it interacts with the in vitro precipitation of calcium carbonate and inhibits calcium carbonate crystal formation, but these two properties are not strongly expressed. This matrix, although overall weakly glycosylated, contains a set of putatively calcium-binding proteins and a set of acidic sulphated proteins. 2D-gels reveal more than fifty proteins, twenty of which we identify by MS-MS analysis. We tentatively link the shell protein profile of D. polymorpha and the peculiar recent evolution of this invasive species of Ponto-Caspian origin, which has spread all across Europe in the last three centuries.	[Immel, Francoise] Univ Bordeaux, CNRS, Lab Biogenese Membranaire, UMR5200, Villenave Dornon, France; [Immel, Francoise; Catherinet, Bastien; Bundeleva, Irina; Marin, Frederic] Univ Bourgogne Franche Comte, CNRS, Biogeosci UMR6282, Dijon, France; [Broussard, Cedric] Univ Paris 05, Inst Cochin, INSERM U1016, CNRS UMR8104, Paris, France; [Broussard, Cedric] Univ Paris 05, Sorbonne Paris Cite, Plateforme Prote 3P5, Paris, France; [Plasseraud, Laurent] Univ Bourgogne Franche Comte, CNRS, ICMUB UMR6302, Dijon, France; [Alcaraz, GRard] AgroSupDijon, Dept Agron Environm, UPSP PROXISS, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Bourgogne; Institut Agro; AgroSup Dijon	Immel, F (corresponding author), Univ Bordeaux, CNRS, Lab Biogenese Membranaire, UMR5200, Villenave Dornon, France.; Immel, F; Marin, F (corresponding author), Univ Bourgogne Franche Comte, CNRS, Biogeosci UMR6282, Dijon, France.	francoise.immel@u-bordeaux.fr; frederic.marin@u-bourgogne.fr	Immel, Françoise/N-7079-2019; Plasseraud, Laurent/ABD-5845-2020; Immel, Françoise/GNP-4167-2022	Plasseraud, Laurent/0000-0002-7870-1881; Immel, Françoise/0000-0002-2028-902X; Marin, Francisco/0000-0001-7246-7708; Broussard, Cedric/0000-0001-9508-2341	CNRS' FM	CNRS' FM	'INSU 2013-InterrVie program (Comite Thematique 4) grant from CNRS' FM. '2013-2014 recurrent yearly CNRS/uB budget' FI, FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005; Ameye L, 2001, J STRUCT BIOL, V134, P56, DOI 10.1006/jsbi.2001.4361; ARCHAMBAULTGUEZOU J, 1982, MALACOLOGIA, V22, P325; Artigaud S, 2014, MAR GENOM, V15, P3, DOI 10.1016/j.margen.2014.03.006; Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; BIAS R, 1985, INT REV GES HYDROBIO, V70, P113, DOI 10.1002/iroh.19850700110; Boggs S, 2009, PETROLOGY SEDIMENTAR, V2nd; Bouetard A, 2012, ECOTOXICOLOGY, V21, P2222, DOI 10.1007/s10646-012-0977-1; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Camusso M, 2001, CHEMOSPHERE, V44, P263, DOI 10.1016/S0045-6535(00)00169-7; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; de Paula SM, 2009, MICRON, V40, P669, DOI 10.1016/j.micron.2009.05.006; DEBRAY H, 1986, CARBOHYD RES, V151, P359, DOI 10.1016/S0008-6215(00)90355-0; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; DeVol RT, 2015, J AM CHEM SOC, V137, P13325, DOI 10.1021/jacs.5b07931; Frank H, 2007, AMBIO, V36, P571, DOI 10.1579/0044-7447(2007)36[571:DPOFPM]2.0.CO;2; Garaud M, 2015, AQUAT TOXICOL, V158, P63, DOI 10.1016/j.aquatox.2014.11.004; GOFFINET G, 1979, CAH BIOL MAR, V20, P341; HAGIWARA K, 1988, MOL IMMUNOL, V25, P69, DOI 10.1016/0161-5890(88)90092-2; HARZHAUSER M, 2010, ZEBRA MUSSEL EUROPE, P11; Hendriks AJ, 1998, ENVIRON TOXICOL CHEM, V17, P1885, DOI [10.1002/etc.5620171001, 10.1897/1551-5028(1998)017&lt;1885:AOMPHA&gt;2.3.CO;2]; Immel F, 2015, KEY ENG MATER, V672, P191; Jaouen A, 2000, B SOC ZOOL FR, V125, P239; Jastrzebski W, 2011, SPECTROCHIM ACTA A, V79, P722, DOI 10.1016/j.saa.2010.08.044; Jones GC., 1993, INFRARED TRANSMISSIO; KALADAS PM, 1981, MOL IMMUNOL, V18, P969, DOI 10.1016/0161-5890(81)90114-0; Kanold JM, 2015, FEBS J, V282, P1891, DOI 10.1111/febs.13242; Kanold JM, 2015, COMP BIOCHEM PHYS D, V13, P24, DOI 10.1016/j.cbd.2014.12.002; KAWASHIMA H, 1990, GLYCOCONJUGATE J, V7, P323, DOI 10.1007/BF01073376; Kirkeby S, 2001, IMMUNOL CELL BIOL, V79, P121, DOI 10.1046/j.1440-1711.2001.00992.x; Le Roy N, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0075-8; Leung PTY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-804; Loreau JP, 1982, MEMOIRE MUSEUM NAT C; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marie B, 2009, MATER RES SOC SYMP P, V1187, P3; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marin Frederic, 2011, P353, DOI 10.1007/978-3-642-21230-7_13; Marin Frederic, 2012, Front Biosci (Schol Ed), V4, P1099; MCCOY JP, 1983, ANAL BIOCHEM, V130, P437, DOI 10.1016/0003-2697(83)90613-9; McDougall C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0041; MCINTIRE WL, 1963, GEOCHIM COSMOCHIM AC, V27, P1209, DOI 10.1016/0016-7037(63)90049-8; McLaughlan C, 2014, ENVIRON MANAGE, V54, P1102, DOI 10.1007/s00267-014-0335-6; Menadakis M, 2009, J MATH CHEM, V46, P484, DOI 10.1007/s10910-008-9490-4; Minchin D, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P135; MONSIGNY M, 1979, EUR J BIOCHEM, V98, P39, DOI 10.1111/j.1432-1033.1979.tb13157.x; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Morton B., 1992, Developments in Aquaculture and Fisheries Science, V25, P21; MORTON B, 1970, Palaeontology (Oxford), V13, P563; Moura G, 2000, COMP BIOCHEM PHYS B, V127, P105, DOI 10.1016/S0305-0491(00)00241-8; Muller P, 1999, LETHAIA, V32, P47; Niu DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067456; Notten MJM, 2006, ECOTOXICOLOGY, V15, P295, DOI 10.1007/s10646-006-0059-3; Oguri S, 2005, GLYCOCONJUGATE J, V22, P453, DOI 10.1007/s10719-005-5329-4; Osuna-Mascaro A, 2014, COMP BIOCHEM PHYS B, V168, P76, DOI 10.1016/j.cbpb.2013.11.009; Osuna-Mascaro AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122934; PALMER AR, 1983, MAR BIOL, V75, P287, DOI 10.1007/BF00406014; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Pavat C, 2012, COMP BIOCHEM PHYS B, V161, P303, DOI 10.1016/j.cbpb.2011.12.003; Poustka AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r85; Puente X, 1996, SCI TOTAL ENVIRON, V183, P205, DOI 10.1016/0048-9697(96)05066-8; Ramos-Silva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097454; REEDERS HH, 1989, FRESHWATER BIOL, V22, P133, DOI 10.1111/j.1365-2427.1989.tb01088.x; REEDERS HH, 1990, HYDROBIOLOGIA, V200, P437, DOI 10.1007/BF02530361; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shi MJ, 2013, MAR BIOTECHNOL, V15, P706, DOI 10.1007/s10126-013-9517-0; Shi YH, 2013, MAR BIOTECHNOL, V15, P175, DOI 10.1007/s10126-012-9476-x; Taylor J. D., 1973, B BR MUS NAT HIST D, V22, P255; Theodory RG, 1999, THESIS DEP EARTH SCI; Therriault TW, 2004, MOL PHYLOGENET EVOL, V30, P479, DOI 10.1016/S1055-7903(03)00240-9; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; WALL RS, 1988, ANAL BIOCHEM, V175, P298, DOI 10.1016/0003-2697(88)90392-2; WALSH K, 1995, ARCH ENVIRON CON TOX, V28, P35, DOI 10.1007/BF00213966; Webb K, 2008, NORTHWEST SCI, V82, P163, DOI 10.3955/0029-344X-82.3.163; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; Young MR, 2001, ECOL STU AN, V145, P337; Zemann J., 1969, HDB GEOCHEMISTRY, P12, DOI [10.1007/978-3-642-46300-6_2, DOI 10.1007/978-3-642-46300-6_2]; Zentz F, 2001, MAR BIOTECHNOL, V3, P36, DOI 10.1007/s101260000042; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zuykov M, 2013, CHEMOSPHERE, V93, P201, DOI 10.1016/j.chemosphere.2013.05.001	84	23	23	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0154264	10.1371/journal.pone.0154264	http://dx.doi.org/10.1371/journal.pone.0154264			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213644	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880200004
J	Pedersen, SH; Maretty, L; Ramachandran, R; Sibbesen, JA; Yakimov, V; Elgaard-Christensen, R; Hansen, TF; Krogh, A; Olesen, J; Jansen-Olesen, I				Pedersen, Sara Hougaard; Maretty, Lasse; Ramachandran, Roshni; Sibbesen, Jonas Andreas; Yakimov, Victor; Elgaard-Christensen, Rikke; Hansen, Thomas Folkmann; Krogh, Anders; Olesen, Jes; Jansen-Olesen, Inger			RNA Sequencing of Trigeminal Ganglia in Rattus Norvegicus after Glyceryl Trinitrate Infusion with Relevance to Migraine	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SATELLITE GLIAL-CELLS; GENE-RELATED PEPTIDE; MHC CLASS-I; GLUTAMATE RELEASE; NEURONS; NITROGLYCERIN; INHIBITION; ACTIVATION; MECHANISMS	Introduction Infusion of glyceryl trinitrate (GTN), a donor of nitric oxide, induces immediate headache in humans that in migraineurs is followed by a delayed migraine attack. In order to achieve increased knowledge of mechanisms activated during GTN-infusion this present study aims to investigate transcriptional responses to GTN-infusion in the rat trigeminal ganglia. Methods Rats were infused with GTN or vehicle and trigeminal ganglia were isolated either 30 or 90 minutes post infusion. RNA sequencing was used to investigate transcriptomic changes in response to the treatment. Furthermore, we developed a novel method for Gene Set Analysis Of Variance (GSANOVA) to identify gene sets associated with transcriptional changes across time. Results 15 genes displayed significant changes in transcription levels in response to GTN-infusion. Ten of these genes showed either sustained up-or down-regulation in the 90-minute period after infusion. The GSANOVA analysis demonstrate enrichment of pathways pointing towards an increase in immune response, signal transduction, and neuroplasticity in response to GTN-infusion. Future functional in-depth studies of these mechanisms are expected to increase our understanding of migraine pathogenesis.	[Pedersen, Sara Hougaard; Ramachandran, Roshni; Elgaard-Christensen, Rikke; Hansen, Thomas Folkmann; Olesen, Jes; Jansen-Olesen, Inger] Rigshosp, Dept Neurol, Glostrup Res Inst, Danish Headache Ctr, DK-2100 Copenhagen, Denmark; [Pedersen, Sara Hougaard; Ramachandran, Roshni; Elgaard-Christensen, Rikke; Hansen, Thomas Folkmann; Olesen, Jes; Jansen-Olesen, Inger] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Maretty, Lasse; Sibbesen, Jonas Andreas; Yakimov, Victor; Krogh, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Jansen-Olesen, I (corresponding author), Rigshosp, Dept Neurol, Glostrup Res Inst, Danish Headache Ctr, DK-2100 Copenhagen, Denmark.; Jansen-Olesen, I (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.	inger.jansen-olesen@regionh.dk	Hansen, Thomas/GWZ-2858-2022; Hansen, Thomas Folkmann/O-5965-2014; Krogh, Anders/M-1541-2014	Hansen, Thomas Folkmann/0000-0001-6703-7762; Olesen, Jes/0000-0002-6712-2702; Sibbesen, Jonas Andreas/0000-0002-5528-0236; Maretty, Lasse/0000-0003-4381-8948; Krogh, Anders/0000-0002-5147-6282	Candy's Foundation; EUROHEADPAIN [602633]; Spar Nord Foundation; Lundbeck Foundation [R77-A6952]; Novo Nordisk Foundation; Research Foundation of the Capital Region of Denmark; Novo Nordisk Fonden [NNF10SA1016550] Funding Source: researchfish	Candy's Foundation; EUROHEADPAIN; Spar Nord Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Foundation of the Capital Region of Denmark; Novo Nordisk Fonden(Novo Nordisk Foundation)	The work presented here was financially supported by Candy's Foundation (JO), EUROHEADPAIN (602633, JO), Spar Nord Foundation (IJO), The Lundbeck Foundation (R77-A6952, IJO), the Novo Nordisk Foundation (AK) and Research Foundation of the Capital Region of Denmark (JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Barloese M, 2015, CEPHALALGIA, V35, P969, DOI 10.1177/0333102414564892; Boulanger LM, 2004, NEURON GLIA BIOL, V1, P283, DOI 10.1017/S1740925X05000128; Browning DD, 2000, J BIOL CHEM, V275, P2811, DOI 10.1074/jbc.275.4.2811; Capuano A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-43; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Dieterle A, 2011, CEPHALALGIA, V31, P31, DOI 10.1177/0333102410375725; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; EKBOM K, 1968, ARCH NEUROL-CHICAGO, V19, P487, DOI 10.1001/archneur.1968.00480050057005; Fabbretti E, 2006, J NEUROSCI, V26, P6163, DOI 10.1523/JNEUROSCI.0647-06.2006; Fabbretti E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00236; Fox AW, 1998, HEADACHE, V38, P436, DOI 10.1046/j.1526-4610.1998.3806436.x; Gori Sara, 2005, J Headache Pain, V6, P258; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Iliodromitis EK, 2006, BASIC RES CARDIOL, V101, P327, DOI 10.1007/s00395-006-0594-3; IOANNIDES C, 1982, BRIT J PHARMACOL, V77, P83, DOI 10.1111/j.1476-5381.1982.tb09272.x; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; KUDROW L, 1987, CEPHALALGIA, V7, P197, DOI 10.1046/j.1468-2982.1987.0703197.x; Lassen LH, 1997, LANCET, V349, P401, DOI 10.1016/S0140-6736(97)80021-9; Lassen LH, 1998, CEPHALALGIA, V18, P27, DOI 10.1046/j.1468-2982.1998.1801027.x; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mar JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025445; McNaught KSP, 1998, J NEUROCHEM, V70, P1541; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Okumura M, 2010, J MOL NEUROSCI, V42, P200, DOI 10.1007/s12031-010-9348-7; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Pedersen SH, 2015, CEPHALALGIA, V35, P1287, DOI 10.1177/0333102415574846; Perkins JR, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-7; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; R_Core_Team, 2015, R LANG ENV STAT COMP; Ramachandran R, 2014, CEPHALALGIA, V34, P136, DOI 10.1177/0333102413502735; Ramachandran R, 2012, CEPHALALGIA, V32, P73, DOI 10.1177/0333102411430855; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; Robinson D., 2015, QVALUE Q VALUE ESTIM; Rozen TD, 2012, HEADACHE, V52, P99, DOI 10.1111/j.1526-4610.2011.02028.x; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; Schytz HW, 2009, BRAIN, V132, P16, DOI 10.1093/brain/awn307; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Tfelt-Hansen P, 2009, EUR J NEUROL, V16, P1106, DOI 10.1111/j.1468-1331.2009.02654.x; Thomsen L L, 1994, Eur J Neurol, V1, P73, DOI 10.1111/j.1468-1331.1994.tb00053.x; Wagner L, 2014, NEUROSCI LETT, V578, P143, DOI 10.1016/j.neulet.2014.06.047; Xydous M, 2014, BBA-GENE REGUL MECH, V1839, P866, DOI 10.1016/j.bbagrm.2014.07.011	48	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155039	10.1371/journal.pone.0155039	http://dx.doi.org/10.1371/journal.pone.0155039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213950	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200006
J	Wirsdorfer, F; Bangen, JM; Pastille, E; Schmitz, D; Flohe, S; Schumak, B; Flohe, SB				Wirsdoerfer, Florian; Bangen, Joerg M.; Pastille, Eva; Schmitz, Daniel; Flohe, Sascha; Schumak, Beatrix; Flohe, Stefanie B.			Dendritic Cell-Like Cells Accumulate in Regenerating Murine Skeletal Muscle after Injury and Boost Adaptive Immune Responses Only upon a Microbial Challenge	PLOS ONE			English	Article							CD4 T-CELLS; IFN-GAMMA; INTERFERON-GAMMA; LYMPH-NODES; MACROPHAGES; ANTIGEN; DIFFERENTIATION; INFLAMMATION; MATURATION; MONOCYTES	Skeletal muscle injury causes a local sterile inflammatory response. In parallel, a state of immunosuppression develops distal to the site of tissue damage. Granulocytes and monocytes that are rapidly recruited to the site of injury contribute to tissue regeneration. In this study we used a mouse model of traumatic skeletal muscle injury to investigate the previously unknown role of dendritic cells (DCs) that accumulate in injured tissue. We injected the model antigen ovalbumin (OVA) into the skeletal muscle of injured or sham-treated mice to address the ability of these DCs in antigen uptake, migration, and specific T cell activation in the draining popliteal lymph node (pLN). Immature DC-like cells appeared in the skeletal muscle by 4 days after injury and subsequently acquired a mature phenotype, as indicated by increased expression of the costimulatory molecules CD40 and CD86. After the injection of OVA into the muscle, OVA-loaded DCs migrated into the pLN. The migration of DC-like cells from the injured muscle was enhanced in the presence of the microbial stimulus lipopolysaccharide at the site of antigen uptake and triggered an increased OVA-specific T helper cell type 1 (Th1) response in the pLN. Naive OVA-loaded DCs were superior in Th1-like priming in the pLN when adoptively transferred into the skeletal muscle of injured mice, a finding indicating the relevance of the microenvironment in the regenerating skeletal muscle for increased Th1-like priming. These findings suggest that DC-like cells that accumulate in the regenerating muscle initiate a protective immune response upon microbial challenge and thereby overcome injury-induced immunosuppression.	[Wirsdoerfer, Florian; Bangen, Joerg M.; Pastille, Eva; Schmitz, Daniel; Flohe, Sascha; Flohe, Stefanie B.] Univ Duisburg Essen, Univ Hosp Essen, Dept Orthoped & Trauma Surg, Surg Res, Essen, Germany; [Wirsdoerfer, Florian] Univ Duisburg Essen, Inst Cell Biol Canc Res, Fac Med, Essen, Germany; [Pastille, Eva] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Schumak, Beatrix] Univ Bonn, IMMIP, Bonn, Germany; [Bangen, Joerg M.] Univ Hosp, Dept Med 3, Aachen, Germany; [Schmitz, Daniel] Alfried Krupp Hosp, Dept Orthoped & Trauma Surg, Essen, Germany; [Flohe, Sascha] Klinikum Solingen, Dept Trauma Orthoped & Hand Surg, Solingen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Bonn; RWTH Aachen University; RWTH Aachen University Hospital; Alfried Krupp Hospital	Flohe, SB (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Orthoped & Trauma Surg, Surg Res, Essen, Germany.	stefanie.flohe@uk-essen.de	Flohe, Stefanie/F-9473-2010	Flohe, Stefanie/0000-0001-7032-3380; Flohe, Sascha/0000-0002-8033-1242	Deutsche Forschungsgemeinschaft [FL-391/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by FL-391/1-2 Deutsche Forschungsgemeinschaft dfg.de.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brigitte M, 2010, ARTHRITIS RHEUM-US, V62, P268, DOI 10.1002/art.27183; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Davison AM, 2011, J IMMUNOL, V186, P2382, DOI 10.4049/jimmunol.1002682; Dupuis M, 1998, CELL IMMUNOL, V186, P18, DOI 10.1006/cimm.1998.1283; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Flohe SB, 2008, MOL MED, V14, P247, DOI 10.2119/2007-00120.Flohe; Flohe SB, 2007, SHOCK, V27, P494, DOI 10.1097/SHK.0b013e31802dec51; Frasca L, 2008, J IMMUNOL, V180, P1471, DOI 10.4049/jimmunol.180.3.1471; Friedrichs M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-26; Gallo PM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00138; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jonuleit H, 1996, ARCH DERMATOL RES, V289, P1, DOI 10.1007/s004030050144; Kimura F, 2010, SURG TODAY, V40, P793, DOI 10.1007/s00595-010-4323-z; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Levy RM, 2006, AM J PHYSIOL-REG I, V291, pR970, DOI 10.1152/ajpregu.00793.2005; Liao H, 2012, ARTHRITIS RHEUM-US, V64, P3441, DOI 10.1002/art.34551; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Nace G, 2012, J INNATE IMMUN, V4, P6, DOI 10.1159/000334245; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Schmitz D, 2010, INFLAMM RES, V59, P141, DOI 10.1007/s00011-009-0081-z; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Warren GL, 2004, AM J PHYSIOL-CELL PH, V286, pC1031, DOI 10.1152/ajpcell.00467.2003; Wirsdorfer F, 2015, CLIN SCI, V128, P14; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155870	10.1371/journal.pone.0155870	http://dx.doi.org/10.1371/journal.pone.0155870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196728	gold, Green Published, Green Submitted			2022-12-26	WOS:000376291100122
J	Zhu, QG; Wang, MM; Gong, ZY; Fang, F; Sun, NJ; Li, X; Grierson, D; Yin, XR; Chen, KS				Zhu, Qing-gang; Wang, Miao-miao; Gong, Zi-yuan; Fang, Fang; Sun, Ning-jing; Li, Xian; Grierson, Donald; Yin, Xue-ren; Chen, Kun-song			Involvement of DkTGA1 Transcription Factor in Anaerobic Response Leading to Persimmon Fruit Postharvest De-Astringency	PLOS ONE			English	Article							CARBON-DIOXIDE; ACETALDEHYDE; HYPOXIA; ETHANOL; GENES; DEASTRINGENCY; REMOVAL; STRESS; ATMYB2; VAPOR	Persimmon fruit are unique in accumulating proanthocyanidins (tannins) during development, which cause astringency in mature fruit. In 'Mopanshi' persimmon, astringency can be removed by treatment with 95% CO2, which increases the concentrations of ethanol and acetaldehyde by glycolysis, and precipitates the soluble tannin. A TGA transcription factor, DkTGA1, belonging to the bZIP super family, was isolated from an RNA-seq database and real-time quantitative PCR indicated that DkTGA1 was up-regulated by CO2 treatment, in concert with the removal of astringency from persimmon fruit. Dual-luciferase assay revealed that DkTGA1 had a small (less than 2-fold), but significant effect on the promoters of deastringency-related genes DkADH1, DkPDC2 and DkPDC3, which encode enzymes catalyzing formation of acetaldehyde and ethanol. A combination of DkTGA1 and a second transcription factor, DkERF9, shown previously to be related to de-astringency, showed additive effects on the activation of the DkPDC2 promoter. Yeast one-hybrid assay showed that DkERF9, but not DkTGA1, could bind to the DkPDC2 promoter. Thus, although DkTGA1 expression is positively associated with persimmon fruit de-astringency, trans-activation analyses with DkPDC2 indicates it is likely to act by binding indirectly DkPDC2 promoter, might with helps of DkERF9.	[Zhu, Qing-gang; Wang, Miao-miao; Gong, Zi-yuan; Fang, Fang; Li, Xian; Grierson, Donald; Yin, Xue-ren; Chen, Kun-song] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Qing-gang; Li, Xian; Yin, Xue-ren; Chen, Kun-song] Zhejiang Univ, State Agr Minist Lab Hort Plant Growth Dev & Qual, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Ning-jing] Guangxi Univ, Coll Agr, Dept Hort Sci, Nanning 530004, Peoples R China; [Grierson, Donald] Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Sutton Bonington Campus, Loughborough, Leics, England	Zhejiang University; Zhejiang University; Guangxi University; University of Nottingham	Yin, XR (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.; Yin, XR (corresponding author), Zhejiang Univ, State Agr Minist Lab Hort Plant Growth Dev & Qual, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	xuerenyin@zju.edu.cn	Yin, Xue-ren/B-3893-2008	Yin, Xue-ren/0000-0002-1282-4432; Zhu, Qinggang/0000-0002-8786-2169	Special Fund for Agro-scientific Research in the Public Interest [201203047]; National Natural Science Foundation of China [31372114]; Program of International Science and Technology Cooperation [2011DFB31580]; Natural Science Foundation of Zhejiang Province, China [LR16C150001]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of International Science and Technology Cooperation; Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest [no. 201203047], National Natural Science Foundation of China [no. 31372114], Program of International Science and Technology Cooperation [2011DFB31580] and the Natural Science Foundation of Zhejiang Province, China [LR16C150001]. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Akagi T, 2009, PLANTA, V230, P899, DOI 10.1007/s00425-009-0991-6; Alvarez JM, 2014, PLANT J, V80, P1, DOI 10.1111/tpj.12618; Arnal L, 2003, J FOOD SCI, V68, P1516, DOI 10.1111/j.1365-2621.2003.tb09676.x; Botondi R, 2012, POSTHARVEST BIOL TEC, V64, P83, DOI 10.1016/j.postharvbio.2011.09.017; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Del Bubba M, 2009, J FOOD COMPOS ANAL, V22, P668, DOI 10.1016/j.jfca.2009.02.015; Fang F, 2016, POSTHARVEST BIOL TEC, V111, P161, DOI 10.1016/j.postharvbio.2015.08.012; Gatz C, 2013, MOL PLANT MICROBE IN, V26, P151, DOI 10.1094/MPMI-04-12-0078-IA; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Hoeren FU, 1998, GENETICS, V149, P479; Ikegami A, 2007, PLANT SCI, V172, P1037, DOI 10.1016/j.plantsci.2007.02.010; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kitagawa H, 1969, J JPN SOC HORTIC SCI, V37, P379; Lee TG, 2007, PHYSIOL PLANTARUM, V129, P375, DOI 10.1111/j.1399-3054.2006.00828.x; Licausi F, 2011, NEW PHYTOL, V190, P550, DOI 10.1111/j.1469-8137.2010.03562.x; Liu ChaoPeng, 2008, Acta Horticulturae Sinica, V35, P741; Min T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097043; Min T, 2012, J EXP BOT, V63, P6393, DOI 10.1093/jxb/ers296; Pesis E, 2005, POSTHARVEST BIOL TEC, V37, P1, DOI 10.1016/j.postharvbio.2005.03.001; PESIS E, 1984, J FOOD SCI, V49, P896, DOI 10.1111/j.1365-2621.1984.tb13236.x; Salvador A, 2007, POSTHARVEST BIOL TEC, V46, P181, DOI 10.1016/j.postharvbio.2007.05.003; SCHINDLER U, 1992, PLANT CELL, V4, P1309, DOI 10.1105/tpc.4.10.1309; Shan W, 2014, PLANT CELL ENVIRON, V37, P2116, DOI 10.1111/pce.12303; Taira S, 2001, J JPN SOC FOOD SCI, V48, P684, DOI 10.3136/nskkk.48.684; Tamura F, 1999, J JPN SOC HORTIC SCI, V68, P1178, DOI 10.2503/jjshs.68.1178; Yamada M, 2002, SCI HORTIC-AMSTERDAM, V94, P63, DOI 10.1016/S0304-4238(01)00367-3; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yin XR, 2012, PLANTA, V235, P895, DOI 10.1007/s00425-011-1553-2; Zeng JK, 2015, PLANT BIOTECHNOL J, V13, P1325, DOI 10.1111/pbi.12351	33	10	10	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155916	10.1371/journal.pone.0155916	http://dx.doi.org/10.1371/journal.pone.0155916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196670	gold, Green Published, Green Submitted			2022-12-26	WOS:000376291100133
J	Santos, RAL; Santos, SM; Santos-Reis, M; de Figueiredo, AP; Bager, A; Aguiar, LMS; Ascensao, F				Lima Santos, Rodrigo Augusto; Santos, Sara M.; Santos-Reis, Margarida; de Figueiredo, Almir Picanco; Bager, Alex; Aguiar, Ludmilla M. S.; Ascensao, Fernando			Carcass Persistence and Detectability: Reducing the Uncertainty Surrounding Wildlife-Vehicle Collision Surveys	PLOS ONE			English	Article							ROAD MORTALITY; PREDATORS; DIVERSITY; ABUNDANCE; FOREST; POPULATIONS; ROADKILLS; SURVIVAL; HIGHWAYS; REMOVAL	Carcass persistence time and detectability are two main sources of uncertainty on roadkill surveys. In this study, we evaluate the influence of these uncertainties on roadkill surveys and estimates. To estimate carcass persistence time, three observers (including the driver) surveyed 114km by car on a monthly basis for two years, searching for wildlife-vehicle collisions (WVC). Each survey consisted of five consecutive days. To estimate carcass detectability, we randomly selected stretches of 500m to be also surveyed on foot by two other observers (total 292 walked stretches, 146 km walked). We expected that body size of the carcass, road type, presence of scavengers and weather conditions to be the main drivers influencing the carcass persistence times, but their relative importance was unknown. We also expected detectability to be highly dependent on body size. Overall, we recorded low median persistence times (one day) and low detectability (<10%) for all vertebrates. The results indicate that body size and landscape cover (as a surrogate of scavengers' presence) are the major drivers of carcass persistence. Detectability was lower for animals with body mass less than 100g when compared to carcass with higher body mass. We estimated that our recorded mortality rates underestimated actual values of mortality by 2-10 fold. Although persistence times were similar to previous studies, the detectability rates here described are very different from previous studies. The results suggest that detectability is the main source of bias across WVC studies. Therefore, more than persistence times, studies should carefully account for differing detectability when comparing WVC studies.	[Lima Santos, Rodrigo Augusto; de Figueiredo, Almir Picanco; Aguiar, Ludmilla M. S.] Univ Brasilia UnB, Dept Zool, Brasilia, DF, Brazil; [Lima Santos, Rodrigo Augusto; Santos-Reis, Margarida] Univ Lisbon, Fac Sci, Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal; [Lima Santos, Rodrigo Augusto; de Figueiredo, Almir Picanco] IBRAM Inst Brasilia Ambiental, Brasilia, DF, Brazil; [Santos, Sara M.] Univ Evora, CIBIO UE Res Ctr Biodivers & Genet Resources, Pole Evora, Res Grp Appl Ecol, Evora, Portugal; [Santos, Sara M.] Univ Evora, Dept Biol, UBC Conservat Biol Lab, Evora, Portugal; [Bager, Alex] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Ascensao, Fernando] Univ Porto, Infraestruturas Portugal BiodiversityChair CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao, Vairao, Portugal; [Ascensao, Fernando] Univ Lisbon, CEABN InBio, Ctr Ecol Aplicada Prof Baeta Neves, Inst Super Agron, P-1349017 Lisbon, Portugal	Universidade de Brasilia; Universidade de Lisboa; University of Evora; University of Evora; Universidade Federal de Lavras; Universidade do Porto; Universidade de Lisboa	Santos, RAL (corresponding author), Univ Brasilia UnB, Dept Zool, Brasilia, DF, Brazil.; Santos, RAL (corresponding author), Univ Lisbon, Fac Sci, Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal.; Santos, RAL (corresponding author), IBRAM Inst Brasilia Ambiental, Brasilia, DF, Brazil.	rodrigosaantos@gmail.com	Aguiar, Ludmilla M S/J-7659-2012; de Menezes Montenegro, Fabio Luiz/AAN-9601-2020; Santos, Sara/AAU-4738-2020; Ascensão, Fernando/G-1513-2014; Santos-Reis, Margarida/H-4064-2011; Dominguez, Wagner/AAR-6693-2020; Elias, Rosilene M/J-1099-2012; Moyses, Rosa M A/F-8268-2012; Aguiar, Ludmilla M S/H-7339-2015; Silva, Bruno C/P-8988-2014; Silva, Bruno C/AAE-6350-2020; Montenegro, Fabio LM/F-9741-2011; JORGETTI, VANDA/C-9470-2012; Bager, Alex/I-4204-2015	de Menezes Montenegro, Fabio Luiz/0000-0002-5749-2363; Ascensão, Fernando/0000-0003-1704-0212; Elias, Rosilene M/0000-0003-2212-041X; Moyses, Rosa M A/0000-0002-7902-2127; Aguiar, Ludmilla M S/0000-0002-9180-5052; Silva, Bruno C/0000-0001-9568-0974; Silva, Bruno C/0000-0001-9568-0974; Montenegro, Fabio LM/0000-0002-5749-2363; JORGETTI, VANDA/0000-0002-4824-8879; Bager, Alex/0000-0002-6143-0413; Santos, Sara/0000-0003-4931-1080; Santos-Reis, Margarida/0000-0002-0337-963X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Instituto Brasilia Ambiental - IBRAM; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/70124/2010]; Infraestruturas de Portugal Biodiversity Chair-CIBIO-Research Center in Biodiversity and Genetic Resources (BPD-REFER-NC)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Brasilia Ambiental - IBRAM; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Infraestruturas de Portugal Biodiversity Chair-CIBIO-Research Center in Biodiversity and Genetic Resources (BPD-REFER-NC)	RALS was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq and Instituto Brasilia Ambiental - IBRAM. SMS was supported by a Postdoc grant from Fundacao para a Ciencia e Tecnologia (SFRH/BPD/70124/2010). FA was funded by a postdoc grant from Infraestruturas de Portugal Biodiversity Chair-CIBIO-Research Center in Biodiversity and Genetic Resources (BPD-REFER-NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RALS was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq and Instituto Brasilia Ambiental-IBRAM. We also thank the team GEMON/IBRAM for assistance in data collection and Clarine Rocha for review and giving comments on this manuscript. SMS was supported by a Postdoc grant from Fundacao para a Ciencia e Tecnologia (SFRH/BPD/70124/2010). FA was funded by a postdoc grant from Infraestruturas de Portugal Biodiversity Chair-CIBIO-Research Center in Biodiversity and Genetic Resources (BPD-REFER-NC).	Amaral A, SERPENTES BRASIL ICO; Antworth RL, 2005, SOUTHEAST NAT, V4, P647, DOI 10.1656/1528-7092(2005)004[0647:HAREOS]2.0.CO;2; Barthelmess EL, 2010, BIODIVERS CONSERV, V19, P1611, DOI 10.1007/s10531-010-9791-3; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BURNHAM KP, 1984, ECOLOGY, V65, P105; Cardoso MRD., 2014, ACTA GEOGRAFICA, V8, P40, DOI DOI 10.5654/ACTAGEO2014.0004.0016; Cardoso TR, 2010, THESIS; Carrete M, 2009, BIOL CONSERV, V142, P2002, DOI 10.1016/j.biocon.2009.02.012; Clevenger AP, 2003, BIOL CONSERV, V109, P15, DOI 10.1016/S0006-3207(02)00127-1; Coelho IP, 2008, EUR J WILDLIFE RES, V54, P689, DOI 10.1007/s10344-008-0197-4; Collinson WJ, 2014, ECOL EVOL, V4, P3060, DOI 10.1002/ece3.1097; COX DR, 1972, J R STAT SOC B, V34, P187; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Degregorio Brett A., 2011, Journal of the North Carolina Academy of Science, V127, P184; Denes FV, 2014, THESIS; DeVault TL, 2004, CONDOR, V106, P706, DOI 10.1650/7461; Eduardo C, 2007, BIRD CONSERV INT, V17, P367, DOI 10.1017/S0959270907000822; Enge KM, 2002, SOUTHEAST NAT, V1, P365, DOI 10.1656/1528-7092(2002)001[0365:APRSOA]2.0.CO;2; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; Fahrig L, 2009, ECOL SOC, V14; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Freitas S. R., 2013, INT C TRANS OPT NETW; Gerow Ken, 2010, Human-Wildlife Interactions, V4, P283; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Greenberg CH, 1997, NAT AREA J, V17, P99; Trovati Roberto Guilherme, 2007, Mastozool. neotrop., V14, P61; Guinard E, 2012, BIOL CONSERV, V147, P40, DOI 10.1016/j.biocon.2012.01.019; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; HAVLIN J, 1987, FOLIA ZOOL, V36, P137; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; Hill JK, 2004, J APPL ECOL, V41, P744, DOI 10.1111/j.0021-8901.2004.00926.x; Hobday AJ, 2008, WILDLIFE RES, V35, P712, DOI 10.1071/WR08067; IBRAM, 2015, CLASS TERR DISTR FED; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Korner-Nievergelt F, 2015, WILDLIFE BIOL, V21, P30, DOI 10.2981/wlb.00094; Kostecke RM, 2001, J FIELD ORNITHOL, V72, P439, DOI 10.1648/0273-8570-72.3.439; Langen TA, 2007, J WILDLIFE MANAGE, V71, P1361, DOI 10.2193/2006-385; Laurance WF, 2008, CONSERV BIOL, V22, P721, DOI 10.1111/j.1523-1739.2008.00917.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Litvaitis JA, 2008, ENVIRON MANAGE, V42, P688, DOI 10.1007/s00267-008-9108-4; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; Marques O.A.V., 2004, ESTA O ECOL GICA JUR, P257; Martins Marcio, 1999, Herpetological Natural History, V6, P78; MUNGUIRA ML, 1992, J APPL ECOL, V29, P316, DOI 10.2307/2404501; Peters J. A, 1970, Bull. U.S. natn. Mus., VNo. 297, P1; Planillo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118604; Ponce C, 2010, ANIM CONSERV, V13, P603, DOI 10.1111/j.1469-1795.2010.00387.x; Prosser P, 2008, ECOTOX ENVIRON SAFE, V71, P601, DOI 10.1016/j.ecoenv.2007.10.013; R Core Team, 2006, R LANG ENV STAT COMP; Ramp D, 2005, BIOL CONSERV, V126, P474, DOI 10.1016/j.biocon.2005.07.001; Ratton P, 2014, EUR J WILDLIFE RES, V60, P543, DOI 10.1007/s10344-014-0798-z; Reis N.R., 2011, MAMIFEROS BRASIL; Ribeiro J.F., 2008, CERRADO ECOL FLORA, V1, P151; Rocha CFD., 2000, ECOLOGIA RESTINGAS L, P117; ROLLEY RE, 1992, WILDLIFE SOC B, V20, P313; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; Scheidt M, 1971, MANS IMPACT ENV, P419; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sick H., 2001, ORNITOLOGIA BRASILEI, V3; Slater F.M., 2002, Web Ecology, V3, P33; Smallwood KS, 2007, J WILDLIFE MANAGE, V71, P2781, DOI 10.2193/2007-006; Smith-Patten BD, 2008, ENVIRON MANAGE, V41, P844, DOI 10.1007/s00267-008-9089-3; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; Tabachnick B. G., 2001, USING MULTIVARIATE S; Teixeira FZ, 2013, BIOL CONSERV, V157, P317, DOI 10.1016/j.biocon.2012.09.006; Therneau T.M., 2000, MODELING SURVIVAL DA; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; U. S. Fish and Wildlife Service, 1999, S FLOR MULT REC PLAN; WOBESER G, 1992, J WILDLIFE DIS, V28, P548, DOI 10.7589/0090-3558-28.4.548; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; [No title captured], DOI DOI 10.1016/j.jenvman.2010.11.027; [No title captured]	74	49	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165608	10.1371/journal.pone.0165608	http://dx.doi.org/10.1371/journal.pone.0165608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27196740	Green Published, Green Submitted, gold			2022-12-26	WOS:000386715500042
J	Gelis, L; Jovancevic, N; Veitinger, S; Mandal, B; Arndt, HD; Neuhaus, EM; Hatt, H				Gelis, Lian; Jovancevic, Nikolina; Veitinger, Sophie; Mandal, Bhubaneswar; Arndt, Hans-Dieter; Neuhaus, Eva M.; Hatt, Hanns			Functional Characterization of the Odorant Receptor 51E2 in Human Melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; cell differentiation; cell proliferation; cell signaling; G protein-coupled receptor (GPCR)	PROTEIN-COUPLED RECEPTOR; SIGNAL-TRANSDUCTION SYSTEM; OLFACTORY RECEPTOR; PROSTATE-CANCER; OCULAR ALBINISM; MELANOMA-CELLS; HUMAN KERATINOCYTES; SKIN PIGMENTATION; HUMAN SPERM; EXPRESSION	Olfactory receptors, which belong to the family of G-protein-coupled receptors, are found to be ectopically expressed in non-sensory tissues mediating a variety of cellular functions. In this study we detected the olfactory receptor OR51E2 at the transcript and the protein level in human epidermal melanocytes. Stimulation of primary melanocytes with the OR51E2 ligand -ionone significantly inhibited melanocyte proliferation. Our results further showed that -ionone stimulates melanogenesis and dendritogenesis. Using RNA silencing and receptor antagonists, we demonstrated that OR51E2 activation elevated cytosolic Ca2+ and cAMP, which could mediate the observed increase in melanin synthesis. Co-immunocytochemical stainings using a specific OR51E2 antibody revealed subcellular localization of the receptor in early endosomes associated with EEA-1 (early endosome antigen 1). Plasma membrane preparations showed that OR51E2 protein is present at the melanocyte cell surface. Our findings thus suggest that activation of olfactory receptor signaling by external compounds can influence melanocyte homeostasis.	[Gelis, Lian; Jovancevic, Nikolina; Veitinger, Sophie; Hatt, Hanns] Ruhr Univ Bochum, Cell Physiol, Univ Str 150, D-44801 Bochum, Germany; [Mandal, Bhubaneswar; Arndt, Hans-Dieter] Univ Jena, Organ Chem 1, Humboldtstr 10, D-07743 Jena, Germany; [Neuhaus, Eva M.] Univ Hosp Jena, Pharmacol & Toxicol, Drackendorfer Str 1, D-07747 Jena, Germany; [Mandal, Bhubaneswar] IIT Guwahati, Dept Chem, North Guwahati 781039, Assam, India	Ruhr University Bochum; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Gelis, L (corresponding author), Ruhr Univ Bochum, Cell Physiol, Univ Str 150, D-44801 Bochum, Germany.	lian.gelis@rub.de	Mandal, Bhubaneswar/K-8885-2019; Neuhaus, Eva/L-1428-2015	Mandal, Bhubaneswar/0000-0003-3435-5443; Neuhaus, Eva/0000-0003-3363-1231	Deutsche Forschungsgemeinschaft [SFB642]; Heinrich-and-Alma-Vogelsang-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinrich-and-Alma-Vogelsang-Stiftung	This study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB642; to E. M. N. and H. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Heinrich-and-Alma-Vogelsang-Stiftung.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Andreeva Alexandra V, 2007, J Mol Signal, V2, P13, DOI 10.1186/1750-2187-2-13; Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Bellono NW, 2014, ARCH BIOCHEM BIOPHYS, V563, P35, DOI 10.1016/j.abb.2014.06.020; Bellono NW, 2013, P NATL ACAD SCI USA, V110, P2383, DOI 10.1073/pnas.1215555110; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; CARSBERG CJ, 1995, J DERMATOL SCI, V9, P157, DOI 10.1016/0923-1811(94)00372-L; Choi TY, 2009, J DERMATOL SCI, V56, P128, DOI 10.1016/j.jdermsci.2009.07.002; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; De la Cruz O, 2009, MOL BIOL EVOL, V26, P491, DOI 10.1093/molbev/msn294; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; ENGLARO W, 1995, J BIOL CHEM, V270, P24315, DOI 10.1074/jbc.270.41.24315; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Falletta P, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12239; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Ghosh R, 2005, J BIOL CHEM, V280, P5812, DOI 10.1074/jbc.M411429200; Giordano F, 2011, P NATL ACAD SCI USA, V108, P11906, DOI 10.1073/pnas.1103381108; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Guo HZ, 2012, EXP DERMATOL, V21, P650, DOI 10.1111/j.1600-0625.2012.01565.x; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; HIROBE T, 1992, PIGM CELL RES, V5, P1, DOI 10.1111/j.1600-0749.1992.tb00776.x; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; Imokawa G, 1996, BIOCHEM J, V314, P305, DOI 10.1042/bj3140305; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x; Kang HY, 1998, PFLUG ARCH EUR J PHY, V435, P350, DOI 10.1007/s004240050522; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; KARLSSON JOG, 1994, PIGM CELL RES, V7, P61, DOI 10.1111/j.1600-0749.1994.tb00019.x; Klasen K, 2010, CELL SIGNAL, V22, P150, DOI 10.1016/j.cellsig.2009.09.026; Lee J, 2007, BIOCHEM PHARMACOL, V74, P960, DOI 10.1016/j.bcp.2007.06.007; LERNER MR, 1988, P NATL ACAD SCI USA, V85, P261, DOI 10.1073/pnas.85.1.261; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Luttrell Louis M., 2006, V332, P3; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Oka M, 1996, J INVEST DERMATOL, V106, P377, DOI 10.1111/1523-1747.ep12343168; Palmisano I, 2008, HUM MOL GENET, V17, P3487, DOI 10.1093/hmg/ddn241; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Piccirillo R, 2006, J CELL SCI, V119, P2003, DOI 10.1242/jcs.02930; Pisano M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-8; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Rigau M, 2010, PROSTATE, V70, P1760, DOI 10.1002/pros.21211; Rodriguez M, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.29; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schiaffino MV, 2005, PIGM CELL RES, V18, P227, DOI 10.1111/j.1600-0749.2005.00240.x; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; Silva MR, 2007, ACTA CRYSTALLOGR E, V63, pO4824, DOI 10.1107/S1600536807057625; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Spehr J, 2011, J BIOL CHEM, V286, P13184, DOI 10.1074/jbc.M110.183525; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Staab H.A., 1962, ANGEW CHEM INT EDIT, V1, P351, DOI [10.1002/anie.196203511, DOI 10.1002/ANIE.196203511]; STAAB HA, 1956, CHEM BER-RECL, V89, P1927, DOI 10.1002/cber.19560890821; Staleva L, 2006, EXP EYE RES, V82, P311, DOI 10.1016/j.exer.2005.07.003; Stanisz H, 2012, J INVEST DERMATOL, V132, P1443, DOI 10.1038/jid.2011.478; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; Vilardaga JP, 2010, J CELL SCI, V123, P4215, DOI 10.1242/jcs.063354; Xia CZ, 2001, ONCOGENE, V20, P5903, DOI 10.1038/sj.onc.1204803; Xu LL, 2000, CANCER RES, V60, P6568; Xu LL, 2006, PROSTATE CANCER P D, V9, P56, DOI 10.1038/sj.pcan.4500836; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055	71	54	58	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17772	17786		10.1074/jbc.M116.734517	http://dx.doi.org/10.1074/jbc.M116.734517			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27226631	Green Published, hybrid			2022-12-26	WOS:000383241300025
J	Monte, E; Rosa-Garrido, M; Karbassi, E; Chen, HD; Lopez, R; Rau, CD; Wang, J; Nelson, SF; Wu, Y; Stefani, E; Lusis, AJ; Wang, YB; Kurdistani, SK; Franklin, S; Vondriska, TM				Monte, Emma; Rosa-Garrido, Manuel; Karbassi, Elaheh; Chen, Haodong; Lopez, Rachel; Rau, Christoph D.; Wang, Jessica; Nelson, Stanley F.; Wu, Yong; Stefani, Enrico; Lusis, Aldons J.; Wang, Yibin; Kurdistani, Siavash K.; Franklin, Sarah; Vondriska, Thomas M.			Reciprocal Regulation of the Cardiac Epigenome by Chromatin Structural Proteins Hmgb and Ctcf IMPLICATIONS FOR TRANSCRIPTIONAL REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR LAMINA INTERACTIONS; DNA METHYLATION; HUMAN GENOME; HISTONE H3; EPIGENETIC REGULATION; INCREASED EXPRESSION; GENE-EXPRESSION; HUMAN-CELLS; IN-VIVO; HYPERTROPHY	Transcriptome remodeling in heart disease occurs through the coordinated actions of transcription factors, histone modifications, and other chromatin features at pathology-associated genes. The extent to which genome-wide chromatin reorganization also contributes to the resultant changes in gene expression remains unknown. We examined the roles of two chromatin structural proteins, Ctcf (CCCTC-binding factor) and Hmgb2 (high mobility group protein B2), in regulating pathologic transcription and chromatin remodeling. Our data demonstrate a reciprocal relationship between Hmgb2 and Ctcf in controlling aspects of chromatin structure and gene expression. Both proteins regulate each others' expression as well as transcription in cardiac myocytes; however, only Hmgb2 does so in a manner that involves global reprogramming of chromatin accessibility. We demonstrate that the actions of Hmgb2 on local chromatin accessibility are conserved across genomic loci, whereas the effects on transcription are loci-dependent and emerge in concert with histone modification and other chromatin features. Finally, although both proteins share gene targets, Hmgb2 and Ctcf, neither binds these genes simultaneously nor do they physically colocalize in myocyte nuclei. Our study uncovers a previously unknown relationship between these two ubiquitous chromatin proteins and provides a mechanistic explanation for how Hmgb2 regulates gene expression and cellular phenotype. Furthermore, we provide direct evidence for structural remodeling of chromatin on a genome-wide scale in the setting of cardiac disease.	[Monte, Emma; Rosa-Garrido, Manuel; Karbassi, Elaheh; Chen, Haodong; Lopez, Rachel; Rau, Christoph D.; Wu, Yong; Stefani, Enrico; Wang, Yibin; Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, BH 557 CHS Bldg,650 Charles Young Dr, Los Angeles, CA 90095 USA; [Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Nelson, Stanley F.; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Wang, Jessica; Lusis, Aldons J.; Wang, Yibin; Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Franklin, Sarah] Univ Utah, Cardiovasc Res & Training Inst, Salt Lake City, UT 84112 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah	Vondriska, TM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, BH 557 CHS Bldg,650 Charles Young Dr, Los Angeles, CA 90095 USA.; Vondriska, TM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Physiol, BH 557 CHS Bldg,650 Charles Young Dr, Los Angeles, CA 90095 USA.	tvondriska@mednet.ucla.edu	Chen, Haodong/G-2277-2012; Wang, Jessica/O-1805-2014; Rosa-Garrido, Manuel/AAE-4188-2019; Rau, Christoph/AAC-3943-2020; Nelson, Stanley F/D-4771-2009	Chen, Haodong/0000-0003-2798-0478; Wang, Jessica/0000-0001-7348-0509; Rosa-Garrido, Manuel/0000-0002-2169-3972; Rau, Christoph/0000-0002-0782-207X; Nelson, Stanley F/0000-0002-2082-3114; Wang, Yibin/0000-0003-0852-0767; Lopez, Rachel/0000-0003-1464-0108	National Institutes of Health [HL105699, HL115238, HL114437, HL129639]; American Heart Association [IRG18870056, PRE14430015, 16POST27780019, PRE22700005, PRE7290056, 14UFEL20130049]; Thermo Fisher Scientific; Department of Anesthesiology at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115238, R01HL105699, R01HL123295, R01HL129639, R01HL114437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262, T32GM065823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Thermo Fisher Scientific; Department of Anesthesiology at UCLA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL105699 (to T. M. V.), HL115238 (to T. M. V.), HL114437 (to A. J. L. and Y. Wang), and HL129639 (to T.M.V. and Y. Wang), American Heart Association Grant IRG18870056 (to T. M. V.), Thermo Fisher Scientific, and the Department of Anesthesiology at UCLA. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of American Heart Association Fellowship PRE14430015.r Recipient of American Heart Association Fellowship 16POST27780019.r Recipient of American Heart Association Fellowship PRE22700005.r Recipient of American Heart Association Fellowship PRE7290056.r Recipient of American Heart Association Fellowship 14UFEL20130049.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BONNEANDREA C, 1984, EMBO J, V3, P1193, DOI 10.1002/j.1460-2075.1984.tb01950.x; Brandenburger Y, 2003, FEBS LETT, V548, P79, DOI 10.1016/S0014-5793(03)00744-0; Brandenburger Y, 2001, FASEB J, V15, P2051, DOI 10.1096/fj.00-0853fje; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086; Chen HD, 2016, CIRC RES, V118, P786, DOI 10.1161/CIRCRESAHA.115.305298; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Farley KI, 2015, CHROMOSOMA, V124, P323, DOI 10.1007/s00412-015-0507-z; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fiorentino FP, 2012, J CELL PHYSIOL, V227, P479, DOI 10.1002/jcp.22780; Franklin S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014258; Furusawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7138; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gaikwad AB, 2010, AM J PATHOL, V176, P1079, DOI 10.2353/ajpath.2010.090528; Gang HY, 2013, AM J PHYSIOL-HEART C, V304, pH1662, DOI 10.1152/ajpheart.00093.2013; Ghazalpour A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20135004; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hoppe G, 2007, J COMP NEUROL, V501, P219, DOI 10.1002/cne.21248; Jarboui MA, 2011, MOL IMMUNOL, V49, P441, DOI 10.1016/j.molimm.2011.09.005; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu JT, 2011, DIS MODEL MECH, V4, P562, DOI 10.1242/dmm.006346; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maurano MT, 2015, CELL REP, V12, P1184, DOI 10.1016/j.celrep.2015.07.024; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mitchell-Jordan S, 2012, J MOL CELL CARDIOL, V53, P552, DOI 10.1016/j.yjmcc.2012.07.009; Moore JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034915; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Papait R, 2013, P NATL ACAD SCI USA, V110, P20164, DOI 10.1073/pnas.1315155110; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raska I, 2004, BIOL CELL, V96, P579, DOI 10.1016/j.biolcel.2004.04.015; Rau CD, 2015, CIRC-CARDIOVASC GENE, V8, P40, DOI 10.1161/CIRCGENETICS.113.000732; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rosa-Garrido M, 2013, CIRC J, V77, P1389, DOI 10.1253/circj.CJ-13-0176; Rosa-Garrido M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039371; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; Ugrinova I, 2009, BIOCHEMISTRY-US, V48, P6502, DOI 10.1021/bi9004304; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; YAMAZAKI F, 1995, BIOCHEM BIOPH RES CO, V210, P1045, DOI 10.1006/bbrc.1995.1762; YEAGER JC, 1981, P SOC EXP BIOL MED, V168, P137; Zhang JY, 2009, NUCLEIC ACIDS RES, V37, P1107, DOI 10.1093/nar/gkn1011; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	81	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15428	15446		10.1074/jbc.M116.719633	http://dx.doi.org/10.1074/jbc.M116.719633			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226577	Green Published, hybrid			2022-12-26	WOS:000380584200002
J	Yamamoto, K; Miki, Y; Sato, H; Nishito, Y; Gelb, MH; Taketomi, Y; Murakami, M				Yamamoto, Kei; Miki, Yoshimi; Sato, Hiroyasu; Nishito, Yasumasa; Gelb, Michael H.; Taketomi, Yoshitaka; Murakami, Makoto			Expression and Function of Group IIE Phospholipase A(2) in Mouse Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY BARRIER; HAIR FOLLICLE; FATTY-ACIDS; STRATUM-CORNEUM; MICE; DEFICIENCY; EPIDERMIS; GENE; INFLAMMATION; HYPERPLASIA	Recent studies using knock-out mice for various secreted phospholipase A(2) (sPLA(2)) isoforms have revealed their non-redundant roles in diverse biological events. In the skin, group IIF sPLA(2) (sPLA(2)-IIF), an "epidermal sPLA(2)" expressed in the suprabasal keratinocytes, plays a fundamental role in epidermal-hyperplasic diseases such as psoriasis and skin cancer. In this study, we found that group IIE sPLA(2) (sPLA(2)-IIE) was expressed abundantly in hair follicles and to a lesser extent in basal epidermal keratinocytes in mouse skin. Mice lacking sPLA(2)-IIE exhibited skin abnormalities distinct from those in mice lacking sPLA(2)-IIF, with perturbation of hair follicle ultrastructure, modest changes in the steady-state expression of a subset of skin genes, and no changes in the features of psoriasis or contact dermatitis. Lipidomics analysis revealed that sPLA(2)-IIE and -IIF were coupled with distinct lipid pathways in the skin. Overall, two skin sPLA(2)s, hair follicular sPLA(2)-IIE and epidermal sPLA(2)-IIF, play non-redundant roles in distinct compartments of mouse skin, underscoring the functional diversity of multiple sPLA(2)s in the coordinated regulation of skin homeostasis and diseases.	[Yamamoto, Kei; Miki, Yoshimi; Sato, Hiroyasu; Taketomi, Yoshitaka; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo 1568506, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Tokyo 1568506, Japan; [Yamamoto, Kei] Univ Tokushima, Fac Biosci & Bioind, Tokushima 7708513, Japan; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Yamamoto, Kei] Japan Agcy Med Res & Dev, PRIME, Tokyo 1000004, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokushima University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp		gelb, michael/0000-0001-7000-5219	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H05905, 16H02613, 26461671, 26860051]; Terumo Foundation; AMED-CREST from Agency for Medical Research and Development; PRIME from Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [16H02613, 26461671, 16K15122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terumo Foundation; AMED-CREST from Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); PRIME from Agency for Medical Research and Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 15H05905 and 16H02613 (to M. M.), 26461671 (to K. Y.), and 26860051 (to Y. M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Terumo Foundation (to M. M.), and by AMED-CREST (to M. M.) and PRIME (to K. Y.) from the Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Bernot KM, 2002, J INVEST DERMATOL, V119, P1137, DOI 10.1046/j.1523-1747.2002.19518.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Chen J, 2008, J INVEST DERMATOL, V128, P270, DOI 10.1038/sj.jid.5701038; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; EATON BR, 1976, ARCH BIOCHEM BIOPHYS, V176, P604, DOI 10.1016/0003-9861(76)90204-6; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P314, DOI 10.1016/j.bbalip.2013.09.011; ELIAS PM, 1978, LAB INVEST, V39, P574; Fluhr JW, 2004, J INVEST DERMATOL, V123, P140, DOI 10.1111/j.0022-202X.2004.22726.x; Fluhr JW, 2001, J INVEST DERMATOL, V117, P44, DOI 10.1046/j.0022-202x.2001.01399.x; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Garza LA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003122; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Krieg P, 2014, BBA-MOL CELL BIOL L, V1841, P390, DOI 10.1016/j.bbalip.2013.08.005; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; MaoQiang M, 1996, J INVEST DERMATOL, V106, P57, DOI 10.1111/1523-1747.ep12327246; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Miki Y., 2016, J BIOL CHEM, V291; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Milora KA, 2015, J INVEST DERMATOL, V135, P2992, DOI 10.1038/jid.2015.289; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murase R, 2016, J BIOL CHEM, V291, P6895, DOI 10.1074/jbc.M116.715672; Nagamachi M, 2007, J EXP MED, V204, P2865, DOI 10.1084/jem.20070773; Nelson AM, 2013, J INVEST DERMATOL, V133, P881, DOI 10.1038/jid.2012.398; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2; PRUZANSKI W, 1991, IMMUNOL TODAY, V12, P143, DOI 10.1016/0167-5699(91)90077-7; Radner FPW, 2014, BBA-MOL CELL BIOL L, V1841, P409, DOI 10.1016/j.bbalip.2013.07.013; Sasaki S, 2005, EXP DERMATOL, V14, P323, DOI 10.1111/j.0906-6705.2005.00270.x; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sato H, 2011, J BIOL CHEM, V286, P11632, DOI 10.1074/jbc.M110.206755; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Taylor K, 2009, EUR J IMMUNOL, V39, P1353, DOI 10.1002/eji.200838566; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamamoto K, 2011, J BIOL CHEM, V286, P11616, DOI 10.1074/jbc.M110.206714	48	15	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15602	15613		10.1074/jbc.M116.734657	http://dx.doi.org/10.1074/jbc.M116.734657			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226633	hybrid, Green Published			2022-12-26	WOS:000380584200016
J	Rastogi, R; Verma, JK; Kapoor, A; Langsley, G; Mukhopadhyay, A				Rastogi, Ruchir; Verma, Jitender Kumar; Kapoor, Anjali; Langsley, Gordon; Mukhopadhyay, Amitabha			Rab5 Isoforms Specifically Regulate Different Modes of Endocytosis in Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; hemoglobin; Leishmania; membrane trafficking; Rab	EPIDERMAL-GROWTH-FACTOR; SMALL GTPASE RAB5; NUCLEOTIDE EXCHANGE FACTOR; TRYPANOSOMA-BRUCEI; HEMOGLOBIN ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; FLAGELLAR POCKET; APPL ENDOSOMES; RECEPTOR; TRAFFICKING	Differential functions of Rab5 isoforms in endocytosis are not well characterized. Here, we cloned, expressed, and characterized Rab5a and Rab5b from Leishmania and found that both of them are localized in the early endosome. To understand the role of LdRab5 isoforms in different modes of endocytosis in Leishmania, we generated transgenic parasites overexpressing LdRab5a, LdRab5b, or their dominant-positive (LdRab5a:Q93L and LdRab5b:Q80L) or dominant-negative mutants (LdRab5a:N146I and LdRab5b:N133I). Using LdRab5a or its mutants overexpressing parasites, we found that LdRab5a specifically regulates the fluid-phase endocytosis of horseradish peroxidase and also specifically induced the transport of dextran-Texas Red to the lysosomes. In contrast, cells overexpressing LdRab5b or its mutants showed that LdRab5b explicitly controls receptor-mediated endocytosis of hemoglobin, and overexpression of LdRab5b:WT enhanced the transport of internalized Hb to the lysosomes in comparison with control cells. To unequivocally demonstrate the role of Rab5 isoforms in endocytosis in Leishmania, we tried to generate null-mutants of LdRab5a and LdRab5b parasites, but both were lethal indicating their essential functions in parasites. Therefore, we used heterozygous LdRab5a(+/-) and LdRab5b(+/-) cells. LdRab5a(+/-)Leishmania showed 50% inhibition of HRP uptake, but hemoglobin endocytosis was uninterrupted. In contrast, about 50% inhibition of Hb endocytosis was observed in LdRab5b(+/-) cells without any significant effect on HRP uptake. Finally, we tried to identify putative LdRab5a and LdRab5b effectors. We found that LdRab5b interacts with clathrin heavy chain and hemoglobin receptor. However, LdRab5a failed to interact with the clathrin heavy chain, and interaction with hemoglobin receptor was significantly less. Thus, our results showed that LdRab5a and LdRab5b differentially regulate fluid phase and receptor-mediated endocytosis in Leishmania.	[Rastogi, Ruchir; Verma, Jitender Kumar; Kapoor, Anjali; Mukhopadhyay, Amitabha] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Langsley, Gordon] CNRS, Cochin Inst, INSERM, U1016,UMR8104, F-75014 Paris, France	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India.	amitabha@nii.res.in			CEFIPRA Grant [3303-3]; Department of Biotechnology; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India; University Grant Commission, Government of India	CEFIPRA Grant; Department of Biotechnology; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, Government of India(University Grants Commission, India)	This work was supported in part by CEFIPRA Grant 3303-3, the Department of Biotechnology, and a J. C. Bose Fellowship from the Department of Science and Technology, Government of India (to A. M). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by fellowships from Council of Scientific and Industrial Research and University Grant Commission, Government of India.	Agarwal S, 2013, BBA-MOL CELL RES, V1833, P1065, DOI 10.1016/j.bbamcr.2013.01.006; Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; Bahl S, 2015, J BIOL CHEM, V290, P29993, DOI 10.1074/jbc.M115.670018; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Ben Rached F, 2012, BIOL CELL, V104, P34, DOI 10.1111/boc.201100081; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Callaghan L, 1999, EUR J BIOCHEM, V265, P361; Chen PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090384; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Ezougou CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087695; Field H, 1998, J BIOL CHEM, V273, P32102, DOI 10.1074/jbc.273.48.32102; Field MC, 2007, TRAFFIC, V8, P629, DOI 10.1111/j.1600-0854.2007.00558.x; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Grab DJ, 1998, ELECTROPHORESIS, V19, P1162, DOI 10.1002/elps.1150190717; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Guha R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006406; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hirota Y, 2007, BIOCHEM BIOPH RES CO, V364, P40, DOI 10.1016/j.bbrc.2007.09.089; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kalaidzidis I, 2015, J CELL BIOL, V211, P123, DOI 10.1083/jcb.201311117; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; LI GP, 1993, J BIOL CHEM, V268, P24475; Li YJ, 2013, AUTOPHAGY, V9, P150, DOI 10.4161/auto.22742; Li YJ, 2014, TRAFFIC, V15, P749, DOI 10.1111/tra.12175; Liu GJ, 2015, GENETICS, V201, P631, DOI 10.1534/genetics.115.180018; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Menard L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4907; Modun B, 2000, TRENDS MICROBIOL, V8, P231, DOI 10.1016/S0966-842X(00)01728-5; Mukhopadhyay A, 1997, J CELL BIOL, V136, P1227, DOI 10.1083/jcb.136.6.1227; Murungi E, 2014, PARASITOL INT, V63, P341, DOI 10.1016/j.parint.2013.11.002; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Pal A, 2002, J BIOL CHEM, V277, P9529, DOI 10.1074/jbc.M110055200; Patel N, 2008, P NATL ACAD SCI USA, V105, P3980, DOI 10.1073/pnas.0800404105; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; Rosenfeld JL, 2001, J CELL SCI, V114, P4499; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Singh SB, 2003, EMBO J, V22, P5712, DOI 10.1093/emboj/cdg557; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Williams RAM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002695; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zheng ZF, 2004, J BIOL CHEM, V279, P42106, DOI 10.1074/jbc.M403780200; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	64	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14732	14746		10.1074/jbc.M116.716514	http://dx.doi.org/10.1074/jbc.M116.716514			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226564	Green Published, hybrid			2022-12-26	WOS:000380366700026
J	Sendler, M; Maertin, S; John, D; Persike, M; Weiss, FU; Kruger, B; Wartmann, T; Wagh, P; Halangk, W; Schaschke, N; Mayerle, J; Lerch, MM				Sendler, Matthias; Maertin, Sandrina; John, Daniel; Persike, Maria; Weiss, F. Ulrich; Krueger, Burkhard; Wartmann, Thomas; Wagh, Preshit; Halangk, Walter; Schaschke, Norbert; Mayerle, Julia; Lerch, Markus M.			Cathepsin B Activity Initiates Apoptosis via Digestive Protease Activation in Pancreatic Acinar Cells and Experimental Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; autophagy; cathepsin B (CTSB); cell death; chymotrypsin; pancreas; pancreatitis; trypsin activation	HUMAN CATIONIC TRYPSINOGEN; HEREDITARY PANCREATITIS; MORPHOLOGICAL-CHANGES; IN-VITRO; MODELS; SECRETION; SEVERITY; NECROSIS; EXPRESSION; PREMATURE	Pancreatitis is associated with premature activation of digestive proteases in the pancreas. The lysosomal hydrolase cathepsin B (CTSB) is a known activator of trypsinogen, and its deletion reduces disease severity in experimental pancreatitis. Here we studied the activation mechanism and subcellular compartment in which CTSB regulates protease activation and cellular injury. Cholecystokinin (CCK) increased the activity of CTSB, cathepsin L, trypsin, chymotrypsin, and caspase 3 in vivo and in vitro and induced redistribution of CTSB to a secretory vesicle-enriched fraction. Neither CTSB protein nor activity redistributed to the cytosol, where the CTSB inhibitors cystatin-B/C were abundantly present. Deletion of CTSB reduced and deletion of cathepsin L increased intracellular trypsin activation. CTSB deletion also abolished CCK-induced caspase 3 activation, apoptosis-inducing factor, as well as X-linked inhibitor of apoptosis protein degradation, but these depended on trypsinogen activation via CTSB. Raising the vesicular pH, but not trypsin inhibition, reduced CTSB activity. Trypsin inhibition did not affect apoptosis in hepatocytes. Deletion of CTSB affected apoptotic but not necrotic acinar cell death. In summary, CTSB in pancreatitis undergoes activation in a secretory, vesicular, and acidic compartment where it activates trypsinogen. Its deletion or inhibition regulates acinar cell apoptosis but not necrosis in two models of pancreatitis. Caspase 3-mediated apoptosis depends on intravesicular trypsinogen activation induced by CTSB, not CTSB activity directly, and this mechanism is pancreas-specific.	[Sendler, Matthias; Maertin, Sandrina; John, Daniel; Persike, Maria; Weiss, F. Ulrich; Wagh, Preshit; Mayerle, Julia; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, D-17489 Greifswald, Germany; [Krueger, Burkhard] Univ Rostock, Div Med Biol, D-18057 Rostock, Germany; [Wartmann, Thomas; Halangk, Walter] Otto Von Guericke Univ, Dept Surg, Div Expt Surg, D-39120 Magdeburg, Germany; [Schaschke, Norbert] Hsch Aalen, Fak Chem, D-73430 Aalen, Germany	Greifswald Medical School; University of Rostock; Otto von Guericke University; Hochschule Aalen	Lerch, MM (corresponding author), Univ Med Greifswald, Dept Med A, D-17489 Greifswald, Germany.	lerch@uni-greifswald.de	Mayerle, Julia/W-7907-2019; Lerch, Markus M./E-2206-2016; Sendler, Matthias/V-9341-2017	Lerch, Markus M./0000-0002-9643-8263; Sendler, Matthias/0000-0001-6494-4105; Mayerle, Julia/0000-0002-3666-6459; Sendler, Matthias/0000-0003-3554-9426	Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung Grant [109102]; Deutsche Forschungsgemeinschaft [GRK1947, A3, MA 4115/1-2/3, WA 2430/2-1]; Federal Ministry of Education and Research (BMBF) [GANI-MED 03IS2061A, BMBF 0314107, 01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; European Union [EU-FP-7 EPC-TM, EU-FP7-REGPOT-2010-1]	Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by Deutsche Krebshilfe/Dr. Mildred-Scheel-Stiftung Grant 109102; Deutsche Forschungsgemeinschaft Grants GRK1947, A3, MA 4115/1-2/3, and WA 2430/2-1; Federal Ministry of Education and Research (BMBF) Grants GANI-MED 03IS2061A and BMBF 0314107, 01ZZ9603, 01ZZ0103, 01ZZ0403, and 03ZIK012; and European Union Grants EU-FP-7 EPC-TM and EU-FP7-REGPOT-2010-1. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055959; Aghdassi AA, 2015, PANCREATOLOGY, V15, pS23, DOI 10.1016/j.pan.2015.05.476; Athwal T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.120; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Cheriyath V, 2011, BRIT J CANCER, V104, P957, DOI 10.1038/bjc.2011.42; Chiari H., 1896, ZEITSCHRIFTFURHEILKU, V17, P69; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Fortunato F, 2009, GASTROENTEROLOGY, V137, P350, DOI 10.1053/j.gastro.2009.04.003; Gaiser S, 2011, GUT, V60, P1379, DOI 10.1136/gut.2010.226175; Gonzalez A, 1997, BIOCHEM BIOPH RES CO, V230, P652, DOI 10.1006/bbrc.1996.6026; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Grasso D, 2011, J BIOL CHEM, V286, P8308, DOI 10.1074/jbc.M110.197301; GREENBAUM LM, 1959, J BIOL CHEM, V234, P2885; GRESS TM, 1994, Z GASTROENTEROL, V32, P221; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; HERNANDEZ CA, 1993, LANCET, V341, P1371, DOI 10.1016/0140-6736(93)90942-A; HIRANO T, 1991, J CLIN INVEST, V87, P865, DOI 10.1172/JCI115091; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Keim V, 2001, AM J MED, V111, P622, DOI 10.1016/S0002-9343(01)00958-5; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; KOIKE H, 1982, AM J PHYSIOL, V242, pG297, DOI 10.1152/ajpgi.1982.242.4.G297; Kruger B, 1998, LAB INVEST, V78, P763; Kukor Z, 2002, J BIOL CHEM, V277, P21389, DOI 10.1074/jbc.M200878200; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Lerch MM, 1997, GASTROENTEROLOGY, V113, P1355, DOI 10.1053/gast.1997.v113.pm9322531; Lerch MM, 2000, MED CLIN N AM, V84, P549, DOI 10.1016/S0025-7125(05)70239-X; LERCH MM, 1992, GASTROENTEROLOGY, V103, P205, DOI 10.1016/0016-5085(92)91114-J; LERCH MM, 1993, GASTROENTEROLOGY, V104, P1768, DOI 10.1016/0016-5085(93)90658-Y; LERCH MM, 1995, J CLIN INVEST, V95, P2222, DOI 10.1172/JCI117912; MACH L, 1994, J BIOL CHEM, V269, P13030; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mareninova OA, 2015, CELL MOL GASTROENTER, V1, P678, DOI 10.1016/j.jcmgh.2015.07.006; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Meister T, 2010, J PHYSIOL PHARMACOL, V61, P565; Mooren FC, 2001, FASEB J, V15, P659, DOI 10.1096/fj.00-0172com; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Neoptolemos JP, 2000, LANCET, V355, P1955, DOI 10.1016/S0140-6736(00)02327-8; Otani T, 1998, AM J PHYSIOL-GASTR L, V275, pG999, DOI 10.1152/ajpgi.1998.275.5.G999; Pallagi P, 2011, GASTROENTEROLOGY, V141, P2228, DOI 10.1053/j.gastro.2011.08.039; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; SAITO I, 1987, AM J PHYSIOL, V253, pG517, DOI 10.1152/ajpgi.1987.253.4.G517; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Schick V, 2014, GUT, V63, P1469, DOI 10.1136/gutjnl-2012-304274; Sendler M, 2015, GASTROENTEROLOGY, V149, P765, DOI 10.1053/j.gastro.2015.05.012; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Taniguchi M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.82; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; WATANABE O, 1984, AM J PHYSIOL, V246, pG457, DOI 10.1152/ajpgi.1984.246.4.G457; Waterford SD, 2005, J BIOL CHEM, V280, P5430, DOI 10.1074/jbc.M413513200; Weiss FU, 2007, GUT, V56, P1322, DOI 10.1136/gut.2007.122507; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141	59	57	59	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14717	14731		10.1074/jbc.M116.718999	http://dx.doi.org/10.1074/jbc.M116.718999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226576	hybrid, Green Published			2022-12-26	WOS:000380366700025
J	Gautam, S; Fatehchand, K; Elavazhagan, S; Reader, BF; Ren, L; Mo, XK; Byrd, JC; Tridandapani, S; Butchar, JP				Gautam, Shalini; Fatehchand, Kavin; Elavazhagan, Saranya; Reader, Brenda F.; Ren, Li; Mo, Xiaokui; Byrd, John C.; Tridandapani, Susheela; Butchar, Jonathan P.			Reprogramming Nurse-like Cells with Interferon to Interrupt Chronic Lymphocytic Leukemia Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-cell interaction; Fc receptor; interferon; signal transduction; tumor immunology	FC-GAMMA-RI; IMMUNE INTERFERON; MYELOID CELLS; TUMOR-CELLS; MACROPHAGES; RECEPTOR; DIFFERENTIATE; GROWTH; MONOCYTES; ANTIBODY	Nurse-like cells (NLCs) play a central role in chronic lymphocytic leukemia (CLL) because they promote the survival and proliferation of CLL cells. NLCs are derived from the monocyte lineage and are driven toward their phenotype via contact-dependent and -independent signals from CLL cells. Because of the central role of NLCs in promoting disease, new strategies to eliminate or reprogram them are needed. Successful reprogramming may be of extra benefit because NLCs express Fc receptors (FcRs) and thus could act as effector cells within the context of antibody therapy. IFN is known to promote the polarization of macrophages toward an M1-like state that is no longer tumor-supportive. In an effort to reprogram the phenotype of NLCs, we found that IFN up-regulated the M1-related markers CD86 and HLA-DR as well as FcRIa. This corresponded to enhanced FcR-mediated cytokine production as well as rituximab-mediated phagocytosis of CLL cells. In addition, IFN down-regulated the expression of CD31, resulting in withdrawal of the survival advantage on CLL cells. These results suggest that IFN can re-educate NLCs and shift them toward an effector-like state and that therapies promoting local IFN production may be effective adjuvants for antibody therapy in CLL.	[Gautam, Shalini; Fatehchand, Kavin; Elavazhagan, Saranya; Reader, Brenda F.; Ren, Li; Byrd, John C.; Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Ren, Li] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130000, Jilin, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Jilin University	Tridandapani, S; Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	tridandapani.2@osu.edu; butchar.2@osu.edu			National Institutes of Health [P01-CA095426, R01 CA162411, T32 HL007946]; Ohio State University College of Medicine McWhinney Bridge Fund [244749]; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA162411, R35CA197734] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University College of Medicine McWhinney Bridge Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01-CA095426 and R01 CA162411 (to S. T. and J. C. B.) and T32 HL007946 (to B. F. R.) and by Ohio State University College of Medicine McWhinney Bridge Fund 244749 (to J. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERGSAGEL DE, 1990, J CLIN ONCOL, V8, P1444, DOI 10.1200/JCO.1990.8.8.1444; Boissard F, 2015, LEUKEMIA LYMPHOMA, V56, P1570, DOI 10.3109/10428194.2014.991731; Burger JA, 2000, BLOOD, V96, P2655; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Giannoni P, 2014, HAEMATOLOGICA, V99, P1078, DOI 10.3324/haematol.2013.091405; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Kane A, 2010, NEUROSURG CLIN N AM, V21, P77, DOI 10.1016/j.nec.2009.08.011; Marchesi F, 2015, HEMATOL ONCOL, V33, P110, DOI 10.1002/hon.2142; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Morande PE, 2012, INVEST NEW DRUG, V30, P1830, DOI 10.1007/s10637-011-9740-3; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; NOTTER M, 1993, BLOOD, V82, P3113; Parihar R, 2004, CLIN CANCER RES, V10, P5027, DOI 10.1158/1078-0432.CCR-04-0265; PERUSSIA B, 1983, J EXP MED, V158, P1092, DOI 10.1084/jem.158.4.1092; PERUSSIA B, 1983, J EXP MED, V158, P2058, DOI 10.1084/jem.158.6.2058; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Roda JM, 2005, J IMMUNOL, V175, P1619, DOI 10.4049/jimmunol.175.3.1619; Schulz A, 2013, BLOOD, V121, P2503, DOI 10.1182/blood-2012-08-447664; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Stephenson RM, 2013, CANCER IMMUNOL IMMUN, V62, P1347, DOI 10.1007/s00262-013-1437-3; Tsukada N, 2002, BLOOD, V99, P1030, DOI 10.1182/blood.V99.3.1030; Ysebaert L, 2011, LEUKEMIA LYMPHOMA, V52, P1404, DOI 10.3109/10428194.2011.568078	25	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14356	14362		10.1074/jbc.M116.723551	http://dx.doi.org/10.1074/jbc.M116.723551			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226587	Green Published, hybrid			2022-12-26	WOS:000379975100037
J	Huang, YK; Chou, RH; Yu, C				Huang, Yen-Kai; Chou, Ruey-Hwang; Yu, Chin			Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; nuclear magnetic resonance (NMR); protein complex; protein purification; receptor for advanced glycation end products (RAGE); S100 proteins; tranilast	NEURITE OUTGROWTH; ANTIALLERGIC DRUG; ANTHRANILIC ACID; BINDING-PROTEINS; SMOOTH-MUSCLE; INFLAMMATION; EXPRESSION; CANCER; ACTIVATION; INSIGHTS	The human S100 calcium-binding protein A11 (S100A11) is a member of the S100 protein family. Once S100A11 proteins bind to calcium ions at EF-hand motifs, S100A11 changes its conformation, promoting interaction with target proteins. The receptor for advanced glycation end products (RAGE) consists of three extracellular domains, including the V domain, C1 domain, and C2 domain. In this case, the V domain is the target for mutant S100A11 (mS100A11) binding. RAGE binds to the ligands, resulting in cell proliferation, cell growth, and several signal transduction cascades. We used NMR and fluorescence spectroscopy to demonstrate the interactions between mS100A11and RAGE V domain. The tranilast molecule is a drug used for treating allergic disorders. We discovered that the RAGE V domain and tranilast would interact with mS100A11 by using H-1-N-15 HSQC NMR titrations. According to the results, we obtained two binary complex models from the HADDOCK program, S100A11-RAGE V domain and S100A11-tranilast, respectively. We overlapped two binary complex models with the same orientation of S100A11 homodimer and demonstrated that tranilast would block the binding site between S100A11 and the RAGE V domain. We further utilized a water-soluble tetrazolium-1 assay to confirm this result. We think that the results will be potentially useful in the development of new anti-cancer drugs.	[Huang, Yen-Kai; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Canc Biol, Taichung 40454, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung 40454, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.	cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180	Ministry of Science and Technology (MOST) Taiwan [103-2113-M-007-017-MY3, 104-2320-B-039-031]; China Medical University Hospital, Taiwan [CMU104-S-02]	Ministry of Science and Technology (MOST) Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital, Taiwan	This work was supported by Ministry of Science and Technology (MOST) Taiwan Grants 103-2113-M-007-017-MY3 (to C. Y.) and 104-2320-B-039-031 (to R.-H. C.) and China Medical University Hospital, Taiwan, Grant CMU104-S-02 (to R.-H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen BG, 1996, BIOCHEM CELL BIOL, V74, P687, DOI 10.1139/o96-075; Anania MC, 2013, J CLIN ENDOCR METAB, V98, pE1591, DOI 10.1210/jc.2013-1652; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Cecil DL, 2005, J IMMUNOL, V175, P8296, DOI 10.4049/jimmunol.175.12.8296; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dempsey AC, 2003, STRUCTURE, V11, P887, DOI 10.1016/S0969-2126(03)00126-6; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Gospodarska E, 2011, BBA-PROTEINS PROTEOM, V1814, P592, DOI 10.1016/j.bbapap.2011.02.011; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Hung KW, 2012, J BIOMOL NMR, V54, P211, DOI 10.1007/s10858-012-9661-2; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; KOMATSU H, 1988, JPN J PHARMACOL, V46, P43, DOI 10.1254/jjp.46.43; KONDO N, 1992, CLIN EXP ALLERGY, V22, P447, DOI 10.1111/j.1365-2222.1992.tb00146.x; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P533, DOI [DOI 10.1016/J.CANLET.2011.08.028, 10.1016/j.canlet.2011.08.028]; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu XG, 2010, ONCOL REP, V23, P1301, DOI 10.3892/or_00000764; Liu YQ, 2015, EXP THER MED, V9, P1460, DOI 10.3892/etm.2015.2257; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Meding S, 2012, J PATHOL, V228, P459, DOI 10.1002/path.4021; Memon AA, 2005, CLIN CANCER RES, V11, P606; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; Murakami Y, 2006, BIOINFORMATICS, V22, P1794, DOI 10.1093/bioinformatics/btl171; Murzik U, 2008, MOL BIOL CELL, V19, P2926, DOI 10.1091/mbc.E07-11-1167; Nakamura K, 2005, MICROVASC RES, V70, P137, DOI 10.1016/j.mvr.2005.10.002; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; OKUDA M, 1984, ANN ALLERGY, V53, P178; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Rintala-Dempsey AC, 2006, BIOCHEMISTRY-US, V45, P14695, DOI 10.1021/bi061754e; Rouhiainen Ari, 2013, Methods Mol Biol, V963, P239, DOI 10.1007/978-1-62703-230-8_15; Sakaguchi M, 2008, MOL BIOL CELL, V19, P78, DOI 10.1091/mbc.E07-07-0682; Saleh A, 2013, EXP NEUROL, V249, P149, DOI 10.1016/j.expneurol.2013.08.018; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schonekess BO, 1997, BIOCHEM CELL BIOL, V75, P771, DOI 10.1139/bcb-75-6-771; SHIODA H, 1979, ALLERGY, V34, P213; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Xiao MB, 2012, MED ONCOL, V29, P1886, DOI 10.1007/s12032-011-0058-y; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yamamoto M, 2009, TOHOKU J EXP MED, V217, P193, DOI 10.1620/tjem.217.193; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	65	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14300	14310		10.1074/jbc.M116.722215	http://dx.doi.org/10.1074/jbc.M116.722215			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226584	Green Published, hybrid			2022-12-26	WOS:000379975100033
J	Khan, I; Crouch, JD; Bharti, SK; Sommers, JA; Carney, SM; Yakubovskaya, E; Garcia-Diaz, M; Trakselis, MA; Brosh, RM				Khan, Irfan; Crouch, Jack D.; Bharti, Sanjay Kumar; Sommers, Joshua A.; Carney, Sean M.; Yakubovskaya, Elena; Garcia-Diaz, Miguel; Trakselis, Michael A.; Brosh, Robert M., Jr.			Biochemical Characterization of the Human Mitochondrial Replicative Twinkle Helicase: SUBSTRATE SPECIFICITY, DNA BRANCH MIGRATION, AND ABILITY TO OVERCOME BLOCKADES TO DNA UNWINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA repair; DNA replication; genetic disease; mitochondria; Twinkle; branch migration; helicase	SINGLE-MOLECULE FRET; DUPLEX DNA; TRANSCRIPTION INITIATION; DELETION BREAKPOINTS; HUMAN-DISEASE; PROTEIN-A; COMPLEX; BINDING; STRAND; MTDNA	Mutations in the c10orf2 gene encoding the human mitochondrial DNA replicative helicase Twinkle are linked to several rare genetic diseases characterized by mitochondrial defects. In this study, we have examined the catalytic activity of Twinkle helicase on model replication fork and DNA repair structures. Although Twinkle behaves as a traditional 5 to 3 helicase on conventional forked duplex substrates, the enzyme efficiently dissociates D-loop DNA substrates irrespective of whether it possesses a 5 or 3 single-stranded tailed invading strand. In contrast, we report for the first time that Twinkle branch-migrates an open-ended mobile three-stranded DNA structure with a strong 5 to 3 directionality preference. To determine how well Twinkle handles potential roadblocks to mtDNA replication, we tested the ability of the helicase to unwind substrates with site-specific oxidative DNA lesions or bound by the mitochondrial transcription factor A. Twinkle helicase is inhibited by DNA damage in a unique manner that is dependent on the type of oxidative lesion and the strand in which it resides. Novel single molecule FRET binding and unwinding assays show an interaction of the excluded strand with Twinkle as well as events corresponding to stepwise unwinding and annealing. TFAM inhibits Twinkle unwinding, suggesting other replisome proteins may be required for efficient removal. These studies shed new insight on the catalytic functions of Twinkle on the key DNA structures it would encounter during replication or possibly repair of the mitochondrial genome and how well it tolerates potential roadblocks to DNA unwinding.	[Khan, Irfan; Crouch, Jack D.; Bharti, Sanjay Kumar; Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Carney, Sean M.; Trakselis, Michael A.] Univ Pittsburgh, Mol Biophys & Struct Biol Program, Pittsburgh, PA 15260 USA; [Yakubovskaya, Elena; Garcia-Diaz, Miguel] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Trakselis, Michael A.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor University	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020; Trakselis, Michael/V-3806-2019	Trakselis, Michael/0000-0001-7054-8475	National Institutes of Health; NIA; University of Pittsburgh; Baylor University from American Cancer Society [RSG-11-049-01-DMC]; National Institutes of Health [GM100021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Pittsburgh(University of Pittsburgh); Baylor University from American Cancer Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health, NIA, University of Pittsburgh, Baylor University, Research Scholar Grant RSG-11-049-01-DMC (to M. A. T.) from the American Cancer Society, and National Institutes of Health Grant GM100021 (to M. G.-D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berquist BR, 2012, CANCER LETT, V327, P61, DOI 10.1016/j.canlet.2012.02.001; Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073; Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Fagerburg MV, 2011, METHODS MOL BIOL, V749, P273, DOI 10.1007/978-1-61779-142-0_19; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Fernandez-Millan P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189; Graham BW, 2011, NUCLEIC ACIDS RES, V39, P6585, DOI 10.1093/nar/gkr345; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Huang H, 2011, J AM CHEM SOC, V133, P20357, DOI 10.1021/ja207407n; Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804; Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653; Khan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113293; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Kung HC, 1997, J BIOL CHEM, V272, P9227; Lee W, 2013, BIOCHEMISTRY-US, V52, P3157, DOI 10.1021/bi400231s; Manhart CM, 2015, J BIOL CHEM, V290, P10828, DOI 10.1074/jbc.M115.642066; McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI [10.1590/S1415-47572013000300002, 10.1590/s1415-47572013000300002]; Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077; Pohjoismaki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Rasband W, 2009, IMAGEJ; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sage JM, 2013, MITOCHONDRION, V13, P350, DOI 10.1016/j.mito.2013.04.004; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; San Martin C, 1998, STRUCTURE, V6, P501; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Sen D, 2016, NUCLEIC ACIDS RES, V44, P4200, DOI 10.1093/nar/gkw098; Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468; Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sommers JA, 2014, J BIOL CHEM, V289, P19928, DOI 10.1074/jbc.M113.542456; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Stein A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005664; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Wang KZQ, 2014, MITOCHONDRION, V17, P132, DOI 10.1016/j.mito.2014.04.008; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; Yakubovskaya E, 2014, NUCLEIC ACIDS RES, V42, P4100, DOI 10.1093/nar/gkt1360; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Zaliznyak T, 2012, CHEM RES TOXICOL, V25, P2103, DOI 10.1021/tx300193k; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	57	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14324	14339		10.1074/jbc.M115.712026	http://dx.doi.org/10.1074/jbc.M115.712026			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226550	Green Published, hybrid			2022-12-26	WOS:000379975100035
J	Mikolajczak, K; Ogrodowicz, P; Gudys, K; Krystkowiak, K; Sawikowska, A; Frohmberg, W; Gorny, A; Kedziora, A; Jankowiak, J; Jozefczyk, D; Karg, G; Andrusiak, J; Krajewski, P; Szarejko, I; Surma, M; Adamski, T; Guzy-Wrobelska, J; Kuczynska, A				Mikolajczak, Krzysztof; Ogrodowicz, Piotr; Gudys, Kornelia; Krystkowiak, Karolina; Sawikowska, Aneta; Frohmberg, Wojciech; Gorny, Andrzej; Kedziora, Andrzej; Jankowiak, Janusz; Jozefczyk, Damian; Karg, Grzegorz; Andrusiak, Joanna; Krajewski, Pawel; Szarejko, Iwona; Surma, Maria; Adamski, Tadeusz; Guzy-Wrobelska, Justyna; Kuczynska, Anetta			Quantitative Trait Loci for Yield and Yield-Related Traits in Spring Barley Populations Derived from Crosses between European and Syrian Cultivars	PLOS ONE			English	Article							RECOMBINANT INBRED LINES; DENSITY CONSENSUS MAP; AGRONOMIC TRAITS; QTL ANALYSIS; LINKAGE MAP; DRYLAND CONDITIONS; PARTIAL RESISTANCE; DROUGHT TOLERANCE; MALTING QUALITY; PUCCINIA-HORDEI	In response to climatic changes, breeding programmes should be aimed at creating new cultivars with improved resistance to water scarcity. The objective of this study was to examine the yield potential of barley recombinant inbred lines (RILs) derived from three cross-combinations of European and Syrian spring cultivars, and to identify quantitative trait loci (QTLs) for yield-related traits in these populations. RILs were evaluated in field experiments over a period of three years (2011 to 2013) and genotyped with simple sequence repeat (SSR) and single nucleotide polymorphism (SNP) markers; a genetic map for each population was constructed and then one consensus map was developed. Biological interpretation of identified QTLs was achieved by reference to Ensembl Plants barley gene space. Twelve regions in the genomes of studied RILs were distinguished after QTL analysis. Most of the QTLs were identified on the 2H chromosome, which was the hotspot region in all three populations. Syrian parental cultivars contributed alleles decreasing traits' values at majority of QTLs for grain weight, grain number, spike length and time to heading, and numerous alleles increasing stem length. The phenomic and molecular approaches distinguished the lines with an acceptable grain yield potential combining desirable features or alleles from their parents, that is, early heading from the Syrian breeding line (Cam/B1/CI08887//CI05761) and short plant stature from the European semidwarf cultivar (Maresi).	[Mikolajczak, Krzysztof; Ogrodowicz, Piotr; Krystkowiak, Karolina; Sawikowska, Aneta; Frohmberg, Wojciech; Gorny, Andrzej; Krajewski, Pawel; Surma, Maria; Adamski, Tadeusz; Kuczynska, Anetta] Polish Acad Sci, Inst Plant Genet, Strzeszynska 34, PL-60479 Poznan, Poland; [Gudys, Kornelia; Szarejko, Iwona; Guzy-Wrobelska, Justyna] Univ Silesia, Fac Biol & Environm Protect, Dept Genet, Jagiellonska 28, PL-40032 Katowice, Poland; [Kedziora, Andrzej; Jankowiak, Janusz; Jozefczyk, Damian; Karg, Grzegorz; Andrusiak, Joanna] Polish Acad Sci, Inst Agr & Forest Environm, Bukowska 19, PL-60809 Poznan, Poland	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; University of Silesia in Katowice; Polish Academy of Sciences	Kuczynska, A (corresponding author), Polish Acad Sci, Inst Plant Genet, Strzeszynska 34, PL-60479 Poznan, Poland.; Guzy-Wrobelska, J (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Genet, Jagiellonska 28, PL-40032 Katowice, Poland.	justyna.guzy-wrobelska@us.edu.pl; akuc@igr.poznan.pl	Mikołajczak, Krzysztof/AAP-8992-2020; Frohmberg, Wojciech/O-4212-2014; Kuczynska, Anetta/AAG-2610-2022; Kuczynska, Anetta/AFK-3837-2022; Ogrodowicz, Piotr/ABG-2508-2020	Mikołajczak, Krzysztof/0000-0003-3821-4461; Frohmberg, Wojciech/0000-0003-0064-1775; Gudys, Kornelia/0000-0001-6795-8051; Szarejko, Iwona/0000-0001-7390-7234; Krystkowiak, Karolina/0000-0002-7541-5126; Guzy-Wrobelska, Justyna/0000-0002-1886-2587; Krajewski, Pawel/0000-0001-5318-9896; Ogrodowicz, Piotr/0000-0002-9044-8137; Sawikowska, Aneta/0000-0001-5050-8513	European Regional Development Fund through the Innovative Economy Program for Poland [WND-POIG.01.03.01-00-101/08]	European Regional Development Fund through the Innovative Economy Program for Poland	This work was supported by the European Regional Development Fund through the Innovative Economy Program for Poland 2007-2013, project WND-POIG.01.03.01-00-101/08 POLAPGEN-BD "Biotechnological tools for breeding cereals with increased resistance to drought". The project was realized by POLAPGEN Consortium coordinated by Institute of Plant Genetics, Polish Academy of Sciences in Poznan. All information about the project can be found at www.polapgen.pl.	[Anonymous], 2013, GENSTAT WINDOWS; BACKES G, 1995, THEOR APPL GENET, V90, P294, DOI 10.1007/BF00222217; Baum M, 2003, THEOR APPL GENET, V107, P1215, DOI 10.1007/s00122-003-1357-2; BECKER J, 1995, GENOME, V38, P991, DOI 10.1139/g95-130; Bezant J, 1997, MOL BREEDING, V3, P29, DOI 10.1023/A:1009648220852; Calinski T, 2009, STAT PAP, V50, P735, DOI 10.1007/s00362-009-0249-1; Calinski T, 1996, SERGEN ANALYSIS OF S, P1; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Cuesta-Marcos A, 2009, PLANT BREEDING, V128, P46, DOI 10.1111/j.1439-0523.2008.01510.x; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Gorny AG, 2001, EUPHYTICA, V117, P59, DOI 10.1023/A:1004061709964; Gorny AG, 2008, J APPL GENET, V49, P349, DOI 10.1007/BF03195633; GOULDEN C. H., 1939, Proceedings 7th Int. Genet. Congr., P132; HACKETT CA, 1992, THEOR APPL GENET, V85, P120, DOI 10.1007/BF00223854; HAYES PM, 1993, THEOR APPL GENET, V87, P392, DOI 10.1007/BF01184929; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Hellewell KB, 2000, CROP SCI, V40, P352, DOI 10.2135/cropsci2000.402352x; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Jia QJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2116-x; Jia QJ, 2011, THEOR APPL GENET, V122, P1451, DOI 10.1007/s00122-011-1544-5; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Ponce-Molina LJ, 2012, CROP SCI, V52, P2469, DOI 10.2135/cropsci2012.01.0029; Kjaer B, 1996, EUPHYTICA, V90, P39; Kleinhofs A., 1988, Proceedings of the seventh international wheat genetics symposium held at Cambridge, UK, 13-19 July 1988., P541; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kota R, 2008, FUNCT INTEGR GENOMIC, V8, P223, DOI 10.1007/s10142-007-0060-9; Kota R, 2003, MOL GENET GENOMICS, V270, P24, DOI 10.1007/s00438-003-0891-6; Krzeminska A, 2003, J APPL GENET, V44, P481; Kuczynska A, 2014, ELECTRON J BIOTECHN, V17, P217, DOI 10.1016/j.ejbt.2014.07.005; Kuczynska A, 2013, J APPL GENET, V54, P381, DOI 10.1007/s13353-013-0165-x; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; LAURIE DA, 1994, HEREDITY, V72, P619, DOI 10.1038/hdy.1994.85; Li HB, 2010, MOL GENET GENOMICS, V284, P319, DOI 10.1007/s00438-010-0570-3; Li J, 2005, THEOR APPL GENET, V110, P356, DOI 10.1007/s00122-004-1847-x; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li JZ, 2006, GENOME, V49, P454, DOI 10.1139/G05-128; Li JZ, 2003, THEOR APPL GENET, V107, P1021, DOI 10.1007/s00122-003-1345-6; Malosetti M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00044; Malosetti M, 2011, THEOR APPL GENET, V122, P1605, DOI 10.1007/s00122-011-1558-z; Maluszynski M., 2005, P INT CONG WAK DOUBL, P403; Mansour E, 2014, MOL BREEDING, V33, P249, DOI 10.1007/s11032-013-9946-5; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Marquez-Cedillo LA, 2001, THEOR APPL GENET, V103, P625, DOI 10.1007/PL00002919; Mathews S, 2010, PLANT CELL, V22, P4, DOI 10.1105/tpc.109.072280; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OLEJNIK J, 1991, EARTH SURF PROCESSES, V16, P601, DOI 10.1002/esp.3290160705; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Peighambari SA, 2005, PLANT SCI, V169, P1008, DOI 10.1016/j.plantsci.2005.05.018; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; Qi XQ, 1996, GENOME, V39, P379, DOI 10.1139/g96-049; Qin X, 2013, MOL PLANT MICROBE IN, V26, P227, DOI 10.1094/MPMI-05-12-0138-R; Ramsay L, 2000, GENETICS, V156, P1997; Ren XiFeng, 2013, Australian Journal of Crop Science, V7, P878; Rollins JA, 2013, THEOR APPL GENET, V126, P2803, DOI 10.1007/s00122-013-2173-y; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Russell J, 2004, GENOME, V47, P389, DOI [10.1139/G03-125, 10.1139/g03-125]; Sameri M, 2006, BREEDING SCI, V56, P243, DOI 10.1270/jsbbs.56.243; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Teulat B, 2001, THEOR APPL GENET, V103, P774, DOI 10.1007/s001220100619; THOMAS WTB, 1991, HEREDITY, V66, P381, DOI 10.1038/hdy.1991.48; THOMAS WTB, 1995, THEOR APPL GENET, V91, P1037, DOI 10.1007/BF00223917; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Ooijen JW, 2001, JOINMAPR 3 0 SOFTWAR; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; von Korff M, 2008, THEOR APPL GENET, V117, P653, DOI 10.1007/s00122-008-0787-2; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Wang JM, 2010, EUPHYTICA, V175, P331, DOI 10.1007/s10681-010-0175-2; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wojcik-Jagla M, 2013, THEOR APPL GENET, V126, P3021, DOI 10.1007/s00122-013-2190-x; Xu Y, 2010, MOLECULAR PLANT BREEDING, P1, DOI [10.1079/9781845933920.0001, 10.1079/9781845933920.0000]	84	33	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155938	10.1371/journal.pone.0155938	http://dx.doi.org/10.1371/journal.pone.0155938			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227880	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500044
J	Petersen, BK; Ropella, GEP; Hunt, CA				Petersen, Brenden K.; Ropella, Glen E. P.; Hunt, C. Anthony			Virtual Experiments Enable Exploring and Challenging Explanatory Mechanisms of Immune-Mediated P450 Down-Regulation	PLOS ONE			English	Article							CYTOCHROMES P450; IN-VITRO; INFLAMMATORY MEDIATORS; HEPATIC DISPOSITION; HUMAN HEPATOCYTES; DRUG DISPOSITION; ACETAMINOPHEN; RAT; METABOLISM; HEPATOTOXICITY	Hepatic cytochrome P450 levels are down-regulated during inflammatory disease states, which can cause changes in downstream drug metabolism and hepatotoxicity. Long-term, we seek sufficient new insight into P450-regulating mechanisms to correctly anticipate how an individual's P450 expressions will respond when health and/or therapeutic interventions change. To date, improving explanatory mechanistic insight relies on knowledge gleaned from in vitro, in vivo, and clinical experiments augmented by case reports. We are working to improve that reality by developing means to undertake scientifically useful virtual experiments. So doing requires translating an accepted theory of immune system influence on P450 regulation into a computational model, and then challenging the model via in silico experiments. We build upon two existing agent-based models-an in silico hepatocyte culture and an in silico liver-capable of exploring and challenging concrete mechanistic hypotheses. We instantiate an in silico version of this hypothesis: in response to lipopolysaccharide, Kupffer cells down-regulate hepatic P450 levels via inflammatory cytokines, thus leading to a reduction in metabolic capacity. We achieve multiple in vitro and in vivo validation targets gathered from five wet-lab experiments, including a lipopolysaccharidecytokine dose-response curve, time-course P450 down-regulation, and changes in several different measures of drug clearance spanning three drugs: acetaminophen, antipyrine, and chlorzoxazone. Along the way to achieving validation targets, various aspects of each model are falsified and subsequently refined. This iterative process of falsification-refinement-validation leads to biomimetic yet parsimonious mechanisms, which can provide explanatory insight into how, where, and when various features are generated. We argue that as models such as these are incrementally improved through multiple rounds of mechanistic falsification and validation, we will generate virtual systems that embody deeper credible, actionable, explanatory insight into immune system-drug metabolism interactions within individuals.	[Petersen, Brenden K.; Hunt, C. Anthony] Univ Calif Berkeley, UCSF UCB Joint Grad Grp Bioengn, Berkeley, CA 94720 USA; [Ropella, Glen E. P.] Tempus Dictum Inc, Portland, OR USA; [Hunt, C. Anthony] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California San Francisco; University of California System; University of California San Francisco	Hunt, CA (corresponding author), Univ Calif Berkeley, UCSF UCB Joint Grad Grp Bioengn, Berkeley, CA 94720 USA.; Hunt, CA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	a.hunt@ucsf.edu		Hunt, C. Anthony/0000-0001-9372-6860; Petersen, Brenden/0000-0002-1841-3888	UC Berkeley-UC San Francisco Bioengineering Graduate Group; UCSF BioSystems Group; UC San Francisco Discovery Fellows Program; Tempus Dictum, Inc.; UCSF	UC Berkeley-UC San Francisco Bioengineering Graduate Group; UCSF BioSystems Group; UC San Francisco Discovery Fellows Program; Tempus Dictum, Inc.; UCSF	This work was supported by the UC Berkeley-UC San Francisco Bioengineering Graduate Group (BKP), the UCSF BioSystems Group (BKP and CAH), and the UC San Francisco Discovery Fellows Program (BKP). Tempus Dictum, Inc. supported GEPR's effort but imposed no commercial restrictions or constraints. The funding organizations did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BKP is the recipient of a UCSF Discovery Fellowship. We thank members of the BioSystems Group for helpful discussion and commentary.	Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; Aitken AE, 2007, DRUG METAB DISPOS, V35, P1687, DOI 10.1124/dmd.107.015511; CARRIERE V, 1993, CHEM RES TOXICOL, V6, P852, DOI 10.1021/tx00036a015; Hunt CA, 2006, J PHARMACOKINET PHAR, V33, P737, DOI 10.1007/s10928-006-9031-3; Hunt CA, 2013, WIRES SYST BIOL MED, V5, P461, DOI 10.1002/wsbm.1222; Hunt CA, 2009, PHARM RES-DORDR, V26, P2369, DOI 10.1007/s11095-009-9958-3; INABA T, 1980, LIFE SCI, V26, P1977, DOI 10.1016/0024-3205(80)90629-3; Kirschner DE, 2014, WIRES SYST BIOL MED, V6, P225, DOI 10.1002/wsbm.1270; Kobayashi K, 2002, BIOCHEM PHARMACOL, V63, P889, DOI 10.1016/S0006-2952(01)00843-7; LASKIN DL, 1995, HEPATOLOGY, V21, P1045, DOI 10.1002/hep.1840210424; Li X, 2004, J LEUKOCYTE BIOL, V75, P443, DOI 10.1189/jlb.0603297; Liu J, 2000, TOXICOLOGY, V147, P167, DOI 10.1016/S0300-483X(00)00193-1; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Luke S., 2004, P 2004 SWARMF WORKSH, V8, P44; Milosevic N, 1999, EUR J PHARMACOL, V368, P75, DOI 10.1016/S0014-2999(98)00988-1; Moon YJ, 2003, DRUG METAB DISPOS, V31, P776, DOI 10.1124/dmd.31.6.776; Morgan ET, 2009, CLIN PHARMACOL THER, V85, P434, DOI 10.1038/clpt.2008.302; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; MORGAN ET, 1994, BBA-GENE STRUCT EXPR, V1219, P475, DOI 10.1016/0167-4781(94)90074-4; Morgan ET, 2002, TOXICOLOGY, V181, P207, DOI 10.1016/S0300-483X(02)00283-4; Naritomi Y, 2003, DRUG METAB DISPOS, V31, P580, DOI 10.1124/dmd.31.5.580; Nicola NA, 2000, EXP HEMATOL, V28, P1105, DOI 10.1016/S0301-472X(00)00525-7; Park S, 2010, J PHARMACOL EXP THER, V334, P124, DOI 10.1124/jpet.110.168526; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; Peck SL, 2004, TRENDS ECOL EVOL, V19, P530, DOI 10.1016/j.tree.2004.07.019; Petersen BK, 2016, P 2016 SPRING SIM MU; Petersen BK, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0095-1; Pogson M, 2006, BIOSYSTEMS, V85, P37, DOI 10.1016/j.biosystems.2006.02.004; Popper K. R., 1963, CONJECTURES REFUTAT; PRICE VF, 1982, J PHARMACOL EXP THER, V220, P504; Rockich K, 1999, DRUG METAB DISPOS, V27, P1074; Ropella Glen E. P., 2012, International Journal of Agent Technologies and Systems, V4, P1, DOI 10.4018/jats.2012070101; Ropella GEP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-168; Sharer JE, 1996, DRUG METAB DISPOS, V24, P487; Sheikh-Bahaei S, 2011, DRUG METAB DISPOS, V39, P1910, DOI 10.1124/dmd.111.038703; Smith AK, 2014, P 2014 SUMM SIM MULT, P16; Smith B., 1996, ORIGIN OBJECTS; Sunman JA, 2004, DRUG METAB DISPOS, V32, P359, DOI 10.1124/dmd.32.3.359; Tang J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000681; Ueyama J, 2005, EUR J PHARMACOL, V510, P127, DOI 10.1016/j.ejphar.2005.01.025; VELIC I, 1995, J CHROMATOGR B, V666, P139, DOI 10.1016/0378-4347(94)00552-G; WATARI N, 1983, J PHARMACOKINET BIOP, V11, P245, DOI 10.1007/BF01061867; Yan L, 2008, PHARM RES, V25, P1023, DOI 10.1007/s11095-007-9494-y; Yan L, 2008, DRUG METAB DISPOS, V36, P759, DOI 10.1124/dmd.107.019067	45	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155855	10.1371/journal.pone.0155855	http://dx.doi.org/10.1371/journal.pone.0155855			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227433	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500039
J	Magnusson, M; Molvin, J; Engstrom, G; Svensson-Farbom, P; Persson, M; Christensson, A; Nilsson, P; Melander, O				Magnusson, Martin; Molvin, John; Engstrom, Gunnar; Svensson-Farbom, Patrik; Persson, Margaretha; Christensson, Anders; Nilsson, Peter; Melander, Olle			Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; PREDICTION; CREATININE; MORTALITY; MARKER	Background We recently reported a relationship between plasma levels of cystatin C and incidence of the metabolic syndrome (MetS) among the first 2,369 subjects who participated in the re-examination study of the population-based Malmo and Diet Cancer Cardiovascular cohort (MDC-CC-re-exam). In this study we aimed to replicate these results and also investigate if cystatin C was causally associated with MetS and diabetes. Methods We estimated the effect size of the strongest GWAS derived cystatin C SNP (major allele of rs13038305) on plasma cystatin C in the now completed MDC-CC-re-exam (n = 3,734) and thereafter examined the association between plasma cystatin C (403 cases of diabetes and 2665 controls) as well as rs13038305 (235 cases and 2425 controls) with incident diabetes. The association of rs13038305 and incident MetS (511 cases of MetS and 1980 controls) was similarly investigated in the whole MDC-CC-re-exam. We also attempted to replicate our previously shown association of cystatin C with incident MetS in subjects from the MDC-CC-re-exam (147 cases and 711 controls) that were not included in our previous report. Results In the entire MDC-CC-re-exam, each copy of the major allele of rs13038305 was associated with approximately 0.30 standard deviation (SD) higher plasma concentration of cystatin C (beta = 0.33, p = 4.2E(-28)) in age and sex adjusted analysis. Cystatin C in plasma was not associated with incident diabetes after adjustment for known diabetes risk factors (OR per 1 SD increment 0.99 (0.86-1.13), p = 0.842). In the replication cohort of MDC-CC-re-exam, the OR (95% CI) for incident MetS in subjects belonging to quartiles 1, 2, 3 and 4 of plasma cystatin C levels was 1.00 (reference), 1.21 (0.70-2.07), 1.62 (0.95-2.78) and 1.72 (1.01-2.93) (p(trend) = 0.026) in age and sex adjusted analysis. In the entire MDC-CC-re-exam the odds ratio for incident MetS and diabetes per copy of the major rs13038305 allele was 1.13, (0.95-1.34), p = 0.160 and 1.07, 95% CI 0.89-1.30, p = 0.478, respectively. Conclusion We were able to replicate our previously shown association between high levels of cystatin C and increased risk of future development of MetS. However, a causal involvement of cystatin C in the etiology of MetS or diabetes seems unlikely since genetic elevation of plasma cystatin C was not significantly related to incidence of these diseases.	[Magnusson, Martin; Molvin, John; Engstrom, Gunnar; Svensson-Farbom, Patrik; Persson, Margaretha; Nilsson, Peter; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Magnusson, Martin; Molvin, John] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden; [Persson, Margaretha; Nilsson, Peter; Melander, Olle] Skane Univ Hosp, Ctr Emergency Med, Malmo, Sweden; [Christensson, Anders] Skane Univ Hosp, Dept Nephrol, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Magnusson, M (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.; Magnusson, M (corresponding author), Skane Univ Hosp, Dept Cardiol, Malmo, Sweden.	martin.magnusson@med.lu.se	Magnusson, Martin/AAE-1185-2020	Magnusson, Martin/0000-0003-1710-5936; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Melander, Olle/0000-0002-2581-484X; Christensson, Anders/0000-0002-7328-8418; Persson, Margaretha/0000-0001-8188-5792	Swedish Medical Research Council; Swedish Heart and Lung Foundation [2015-0322]; Medical Faculty of Lund University [ALFSKANE-432021, ALFSKANE-436111]; Skane University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; Southwest Skanes Diabetes Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Knut and Alice Wallenberg Foundation; Marianne and Marcus Wallenberg Foundation; Research Council of Sweden [521-2007-3533, 521-2010-2917]; E. Lundstrom Foundation; ALF from Region Skane; Novo Nordisk Fonden [NNF13OC0005339] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; Skane University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; Southwest Skanes Diabetes Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Marianne and Marcus Wallenberg Foundation; Research Council of Sweden; E. Lundstrom Foundation; ALF from Region Skane; Novo Nordisk Fonden(Novo Nordisk Foundation)	Drs. Magnusson and Melander were supported by grants from the Swedish Medical Research Council, the Swedish Heart and Lung Foundation (2015-0322), the Medical Faculty of Lund University (ALFSKANE-432021) (ALFSKANE-436111), Skane University Hospital, the Albert Pahlsson Research Foundation, the Crafoord Foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, the Hulda and Conrad Mossfelt Foundation, the Southwest Skanes Diabetes Foundation, the King Gustaf V and Queen Victoria Foundation, the Lennart Hanssons Memorial Fund, Knut and Alice Wallenberg Foundation, and the Marianne and Marcus Wallenberg Foundation. Dr Nilsson was funded by Research Council of Sweden (521-2007-3533, 521-2010-2917), E. Lundstrom Foundation and ALF from Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, J INTERNAL MED, V233, P39; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hoke M, 2010, STROKE, V41, P674, DOI 10.1161/STROKEAHA.109.573162; Ix JH, 2007, CIRCULATION, V115, P173, DOI 10.1161/CIRCULATIONAHA.106.644286; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Lee JG, 2009, CLIN CHIM ACTA, V408, P50, DOI 10.1016/j.cca.2009.07.006; Loew M, 2005, ARTERIOSCL THROM VAS, V25, P1470, DOI 10.1161/01.ATV.0000168416.74206.62; Magnusson M, 2013, J INTERN MED, V274, P192, DOI 10.1111/joim.12051; McGuigan FEA, 2002, PSYCHIATR GENET, V12, P133, DOI 10.1097/00041444-200209000-00003; O'Seaghdha CM, 2014, AM J KIDNEY DIS, V63, P16, DOI 10.1053/j.ajkd.2013.06.015; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; Reutens AT, 2013, NEPHROL DIAL TRANSPL, V28, P1820, DOI 10.1093/ndt/gfs561; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; Servais A, 2008, AM J MED, V121, P426, DOI 10.1016/j.amjmed.2008.01.040; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2006, J AM SOC NEPHROL, V17, P254, DOI 10.1681/ASN.2005050545; Surendar J, 2010, DIABETES TECHNOL THE, V12, P907, DOI 10.1089/dia.2010.0077; Svensson-Farbom P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129269; Taglieri N, 2010, ATHEROSCLEROSIS, V209, P300, DOI 10.1016/j.atherosclerosis.2009.09.022; Vigil L, 2009, J AM SOC HYPERTENS, V3, P201, DOI 10.1016/j.jash.2009.01.002	22	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155735	10.1371/journal.pone.0155735	http://dx.doi.org/10.1371/journal.pone.0155735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218257	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700013
J	Xu, H; Twine, TE; Girvetz, E				Xu, Hong; Twine, Tracy E.; Girvetz, Evan			Climate Change and Maize Yield in Iowa	PLOS ONE			English	Article							STOMATAL CONDUCTANCE; ELEVATED CO2; TRENDS; MODEL; PHOTOSYNTHESIS; AGROECOSYSTEM; MANAGEMENT; IMPACTS	Climate is changing across the world, including the major maize-growing state of Iowa in the USA. To maintain crop yields, farmers will need a suite of adaptation strategies, and choice of strategy will depend on how the local to regional climate is expected to change. Here we predict how maize yield might change through the 21st century as compared with late 20th century yields across Iowa, USA, a region representing ideal climate and soils for maize production that contributes substantially to the global maize economy. To account for climate model uncertainty, we drive a dynamic ecosystem model with output from six climate models and two future climate forcing scenarios. Despite a wide range in the predicted amount of warming and change to summer precipitation, all simulations predict a decrease in maize yields from late 20th century to middle and late 21st century ranging from 15% to 50%. Linear regression of all models predicts a 6% state-averaged yield decrease for every 1 degrees C increase in warm season average air temperature. When the influence of moisture stress on crop growth is removed from the model, yield decreases either remain the same or are reduced, depending on predicted changes in warm season precipitation. Our results suggest that even if maize were to receive all the water it needed, under the strongest climate forcing scenario yields will decline by 10-20% by the end of the 21st century.	[Xu, Hong; Twine, Tracy E.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Girvetz, Evan] Ctr Int Agr Trop, Nairobi, Kenya; [Xu, Hong] Thomson Reuters, Chicago, IL USA	University of Minnesota System; University of Minnesota Twin Cities; Alliance; International Center for Tropical Agriculture - CIAT; Clarivate	Twine, TE (corresponding author), Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA.	twine@umn.edu	Twine, Tracy/H-2337-2013	Twine, Tracy/0000-0002-8457-046X	U.S. Department of Energy [DE-EE0004397]; U.S. Department of Agriculture's Agriculture and Food Research Initiative Competitive Grant [2011-68005-30411]	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Agriculture's Agriculture and Food Research Initiative Competitive Grant	This study was funded in part by the U.S. Department of Energy Award Number DE-EE0004397 (science.energy.gov/ber/) and U.S. Department of Agriculture's Agriculture and Food Research Initiative Competitive Grant No. 2011-68005-30411 (nifa.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, 1203 ESA; Arnell NW, 2002, CLIMATIC CHANGE, V53, P413, DOI 10.1023/A:1015277014327; Boe J, 2007, INT J CLIMATOL, V27, P1643, DOI 10.1002/joc.1602; Challinor AJ, 2007, AGR ECOSYST ENVIRON, V119, P190, DOI 10.1016/j.agee.2006.07.009; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Challinor AJ, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034012; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Dale RF, 1964, J APPL METEOROL, V4, P661; Donner SD, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001808; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Gudmundsson L, 2012, HYDROL EARTH SYST SC, V16, P3383, DOI 10.5194/hess-16-3383-2012; Gutmann E, 2014, WATER RESOUR RES, V50, P7167, DOI 10.1002/2014WR015559; Harding KJ, 2014, J GEOPHYS RES-ATMOS, V119, P13116, DOI 10.1002/2014JD022575; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Iqbal M. M., 2009, SCI J COMS SCI VISIO, V15, P15; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Kucharik C, 2003, J ENVIRON QUAL, P247; Kucharik CJ, 2007, AGR FOREST METEOROL, V146, P134, DOI 10.1016/j.agrformet.2007.05.011; Kucharik CJ, 2003, EARTH INTERACT, V7; Kucharik CJ, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034003; Kucharik CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P795, DOI 10.1029/1999GB001138; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2003, SCIENCE, V299, P1032, DOI 10.1126/science.1077838; Maloney E, 2013, J CLIMATOL, V27, P2230, DOI [10.1175/JCLI-D-13-00273.1, DOI 10.1175/JCLI-D-13-00273.1]; Manderscheid R, 2014, EUR J AGRON, V52, P11, DOI 10.1016/j.eja.2011.12.007; Markelz RJC, 2011, J EXP BOT, V62, P3235, DOI 10.1093/jxb/err056; Miller D., 1998, EARTH INTERACT, V2; Moriondo M, 2011, CLIMATIC CHANGE, V104, P679, DOI 10.1007/s10584-010-9871-0; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Parry M, 2005, PHILOS T R SOC B, V360, P2125, DOI 10.1098/rstb.2005.1751; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pryor SC, 2013, CLIM RES, V56, P61, DOI 10.3354/cr01143; Ruiz-Vera UM, 2015, GLOBAL CHANGE BIOL, V21, P4237, DOI 10.1111/gcb.13013; Sacks WJ, 2011, AGR FOREST METEOROL, V151, P882, DOI 10.1016/j.agrformet.2011.02.010; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Tannura M.A., 2008, WEATHER TECHNOLOGY C; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Twine TE, 2013, GLOBAL CHANGE BIOL, V19, P2838, DOI 10.1111/gcb.12270; Twine TE, 2009, AGR FOREST METEOROL, V149, P2143, DOI 10.1016/j.agrformet.2009.05.012; Twine TE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000599; Ummenhofer CC, 2015, J CLIMATE, V28, P4653, DOI 10.1175/JCLI-D-13-00326.1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; VanLoocke A, 2012, AGR FOREST METEOROL, V164, P82, DOI 10.1016/j.agrformet.2012.05.016; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [DOI 10.7930/J0KW5CXT, 10.7930/J0KW5CXT]	50	35	36	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156083	10.1371/journal.pone.0156083	http://dx.doi.org/10.1371/journal.pone.0156083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219116	gold, Green Submitted, Green Published			2022-12-26	WOS:000376880700039
J	Bai, LQ; Deng, HH; Zhang, XC; Yu, XC; Li, YS				Bai, Longqiang; Deng, Huihui; Zhang, Xiaocui; Yu, Xianchang; Li, Yansu			Gibberellin Is Involved in Inhibition of Cucumber Growth and Nitrogen Uptake at Suboptimal Root-Zone Temperatures	PLOS ONE			English	Article							FIGLEAF GOURD; FUNCTIONAL-CHARACTERIZATION; NITRATE TRANSPORT; PLANT-RESPONSES; ARABIDOPSIS; ACCUMULATION; ACQUISITION; TOLERANCE; DEMAND; AUXIN	Suboptimal temperature stress often causes heavy yield losses of vegetables by suppressing plant growth during winter and early spring. Gibberellin acid (GA) has been reported to be involved in plant growth and acquisition of mineral nutrients. However, no studies have evaluated the role of GA in the regulation of growth and nutrient acquisition by vegetables under conditions of suboptimal temperatures in greenhouse. Here, we investigated the roles of GA in the regulation of growth and nitrate acquisition of cucumber (Cucumis sativus L.) plants under conditions of short-term suboptimal root-zone temperatures (T-r). Exposure of cucumber seedlings to a T-r of 16 degrees C led to a significant reduction in root growth, and this inhibitory effect was reversed by exogenous application of GA. Expression patterns of several genes encoding key enzymes in GA metabolism were altered by suboptimal T-r treatment, and endogenous GA concentrations in cucumber roots were significantly reduced by exposure of cucumber plants to 16 degrees C T-r, suggesting that inhibition of root growth by suboptimal T-r may result from disruption of endogenous GA homeostasis. To further explore the mechanism underlying the GA-dependent cucumber growth under suboptimal T-r, we studied the effect of suboptimal T-r and GA on nitrate uptake, and found that exposure of cucumber seedlings to 16 degrees C T-r led to a significant reduction in nitrate uptake rate, and exogenous application GA can alleviate the down-regulation by up regulating the expression of genes associated with nitrate uptake. Finally, we demonstrated that N accumulation in cucumber seedlings under suboptimal T-r conditions was improved by exogenous application of GA due probably to both enhanced root growth and nitrate absorption activity. These results indicate that a reduction in endogenous GA concentrations in roots due to down-regulation of GA biosynthesis at transcriptional level may be a key event to underpin the suboptimal T-r-induced inhibition of root growth and nitrate uptake. These findings may have important practical implications in effective mitigation of suboptimal temperature-induced vegetable loss under greenhouse conditions.	[Bai, Longqiang; Zhang, Xiaocui; Yu, Xianchang; Li, Yansu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China; [Deng, Huihui] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An 271018, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Shandong Agricultural University	Yu, XC; Li, YS (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China.	xcyu1962@163.com; liyansu@caas.cn			National Natural Science Foundation of China [31272212]; Earmarked fund for Modern Agro-industry Technology Research System [CARS-25-C-01]; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS); Key Laboratory of Horticultural Crop Biology and Germplasm Innovation, Ministry of Agriculture, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked fund for Modern Agro-industry Technology Research System; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS); Key Laboratory of Horticultural Crop Biology and Germplasm Innovation, Ministry of Agriculture, China	This work was supported by the National Natural Science Foundation of China (31272212) to XY, Earmarked fund for Modern Agro-industry Technology Research System (CARS-25-C-01) to XY, Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS) to XY, and Key Laboratory of Horticultural Crop Biology and Germplasm Innovation, Ministry of Agriculture, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Angeles C, 2008, ENV EXPT BOT, V64, P65; Cai HM, 2012, J BIOSCIENCES, V37, P731, DOI 10.1007/s12038-012-9242-2; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Cui DY, 2005, J EXP BOT, V56, P1327, DOI 10.1093/jxb/eri133; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Garnett TP, 1999, PLANT SOIL, V214, P133, DOI 10.1023/A:1004740204876; Garnett T, 2013, NEW PHYTOL, V198, P82, DOI 10.1111/nph.12166; Guo TC, 2014, J PLANT GROWTH REGUL, V33, P837, DOI 10.1007/s00344-014-9435-z; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; Khan NA, 2002, PLANT GROWTH REGUL, V38, P243, DOI 10.1023/A:1021523707239; Kiba T, 2011, J EXP BOT, V62, P1399, DOI 10.1093/jxb/erq410; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Krapp A, 2014, J EXP BOT, V65, P789, DOI 10.1093/jxb/eru001; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Lafitte HR, 2006, FIELD CROP RES, V97, P77, DOI 10.1016/j.fcr.2005.08.017; Lalitha S., 2000, PRIMER PREMIER 5; Lange MJP, 2013, PHYTOCHEMISTRY, V90, P62, DOI 10.1016/j.phytochem.2013.02.006; Liu LY, 2010, SCI HORTIC-AMSTERDAM, V124, P29, DOI 10.1016/j.scienta.2009.11.018; Miao M, 2009, SCI HORTIC-AMSTERDAM, V119, P357, DOI 10.1016/j.scienta.2008.08.028; Migocka M, 2013, PLANT SOIL, V364, P245, DOI 10.1007/s11104-012-1345-x; Nagel OW, 2002, PLANT CELL ENVIRON, V25, P883, DOI 10.1046/j.1365-3040.2002.00871.x; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Schwarz D, 2010, SCI HORTIC-AMSTERDAM, V127, P162, DOI 10.1016/j.scienta.2010.09.016; Silveira JAG, 2012, BIOL PLANTARUM, V56, P575, DOI 10.1007/s10535-012-0065-7; Skirycz A, 2010, CURR OPIN BIOTECH, V21, P197, DOI 10.1016/j.copbio.2010.03.002; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Stitt MA, 2000, HKU THESES ONLINE, V5, P77; TACHIBANA S, 1988, J JPN SOC HORTIC SCI, V57, P440, DOI 10.2503/jjshs.57.440; TACHIBANA S, 1982, J JPN SOC HORTIC SCI, V51, P299, DOI 10.2503/jjshs.51.299; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Ubeda-Tomas S, 2008, NAT CELL BIOL, V10, P625, DOI 10.1038/ncb1726; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; Xu QZ, 2000, CROP SCI, V40, P1368, DOI 10.2135/cropsci2000.4051368x; Yan QY, 2012, SOIL SCI PLANT NUTR, V58, P707, DOI 10.1080/00380768.2012.733925; Zhou YH, 2007, ANN BOT-LONDON, V100, P839, DOI 10.1093/aob/mcm181; Zhuo DG, 1999, PLANT J, V17, P563, DOI 10.1046/j.1365-313X.1999.00396.x	42	24	30	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156188	10.1371/journal.pone.0156188	http://dx.doi.org/10.1371/journal.pone.0156188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213554	gold, Green Submitted, Green Published			2022-12-26	WOS:000376880200068
J	Chang, CY; Lin, HJ; Li, BR; Li, YK				Chang, Chia-Yu; Lin, Hui-Jen; Li, Bor-Ran; Li, Yaw-Kuen			A Novel Metallo-beta-Lactamase Involved in the Ampicillin Resistance of Streptococcus pneumoniae ATCC 49136 Strain	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; GENE; SEQUENCE; CLONING	Streptococcus pneumoniae, a penicillin-sensitive bacterium, is recognized as a major cause of pneumonia and is treated clinically with penicillin-based antibiotics. The rapid increase in resistance to penicillin and other antibiotics affects 450 million people globally and results in 4 million deaths every year. To unveil the mechanism of resistance of S. pneumoniae is thus an important issue to treat streptococcal disease that might consequently save millions of lives around the world. In this work, we isolated a streptococci-conserved L-ascorbate 6-phosphate lactonase, from S. pneumoniae ATCC 49136. This protein reveals a metallo-beta-lactamase activity in vitro, which is able to deactivate an ampicillin-based antibiotic by hydrolyzing the amide bond of the beta-lactam ring. The Michaelis parameter (K-m) = 25 mu M and turnover number (k(cat)) = 2 s(-1) were obtained when nitrocefin was utilized as an optically measurable substrate. Through confocal images and western blot analyses with a specific antibody, the indigenous protein was recognized in S. pneumoniae ATCC 49136. The protein-overexpressed S. pneumonia exhibits a high ampicillin-tolerance ability in vivo. In contrast, the protein-knockout S. pneumonia reveals the ampicillin-sensitive feature relative to the wild type strain. Based on these results, we propose that this protein is a membrane-associated metallo-beta-lactamase (MBL) involved in the antibiotic-resistant property of S. pneumoniae.	[Chang, Chia-Yu; Lin, Hui-Jen; Li, Yaw-Kuen] Natl Chiao Tung Univ, Dept Appl Chem, 1001 Univ Rd, Hsinchu 30050, Taiwan; [Li, Bor-Ran] Natl Chiao Tung Univ, Inst Biomed Engn, 1001 Univ Rd, Hsinchu 30050, Taiwan; [Li, Bor-Ran; Li, Yaw-Kuen] Natl Chiao Tung Univ, Ctr Interdisciplinary Sci, 1001 Univ Rd, Hsinchu 30050, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Li, YK (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, 1001 Univ Rd, Hsinchu 30050, Taiwan.; Li, BR (corresponding author), Natl Chiao Tung Univ, Inst Biomed Engn, 1001 Univ Rd, Hsinchu 30050, Taiwan.; Li, BR; Li, YK (corresponding author), Natl Chiao Tung Univ, Ctr Interdisciplinary Sci, 1001 Univ Rd, Hsinchu 30050, Taiwan.	liborran@gmail.com; ykl@cc.nctu.edu.tw	Li, Bor-Ran/AAG-6213-2022; Li, Bor-Ran/AFL-6209-2022	Chang, Chia-Yu/0000-0002-4077-5607	Ministry of Science and Technology of Taiwan [MOST 104-2119-M-009-007, MOST 103-2113-M-009-021]; Center for Interdisciplinary Science in National Chiao Tung University Taiwan [MOE 5Y50B]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Center for Interdisciplinary Science in National Chiao Tung University Taiwan	Ministry of Science and Technology of Taiwan partially supported this work under grants MOST 104-2119-M-009-007, MOST 103-2113-M-009-021. The Center for Interdisciplinary Science in National Chiao Tung University Taiwan supported this research financially under project MOE 5Y50B.	Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Cao YA, 2012, APPL ENVIRON MICROB, V78, P1899, DOI 10.1128/AEM.06139-11; Chang CY, 2016, INT J ANTIMICROB AG, V47, P416, DOI 10.1016/j.ijantimicag.2016.03.001; Chow C, 2013, BIOCHEMISTRY-US, V52, P4097, DOI 10.1021/bi400177y; Cronau H, 2010, AM FAM PHYSICIAN, V81, P137; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Fernandez FJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-273; FRIEDLAND IR, 1994, NEW ENGL J MED, V331, P377, DOI 10.1056/NEJM199408113310607; Garces F, 2010, J MOL BIOL, V398, P715, DOI 10.1016/j.jmb.2010.03.041; Gould FK, 2011, J ANTIMICROB CHEMOTH, V58, P212; Hakenbeck R, 2012, FUTURE MICROBIOL, V7, P395, DOI [10.2217/FMB.12.2, 10.2217/fmb.12.2]; Henriques IS, 2006, RES MICROBIOL, V157, P938, DOI 10.1016/j.resmic.2006.09.003; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Lacy MK, 1999, ANTIMICROB AGENTS CH, V43, P672, DOI 10.1128/AAC.43.3.672; Lee HJ, 2015, APPL ENVIRON MICROB, V81, P40, DOI 10.1128/AEM.02691-14; Libster R, 2012, PEDIATRICS, V130, pE8, DOI 10.1542/peds.2011-3453; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067507; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Olsen RJ, 2010, ANNU REV PATHOL-MECH, V5, P1, DOI 10.1146/annurev-pathol-121808-102135; Pana J, 2008, MICROBIOL RES, V163, P711, DOI 10.1016/j.micres.2007.12.002; Rudiuk S, 2012, ANGEW CHEM INT EDIT, V51, P12694, DOI 10.1002/anie.201206962; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sevillano D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002717; Sieuwerts S, 2010, APPL ENVIRON MICROB, V76, P7775, DOI 10.1128/AEM.01122-10; Skalet AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000377; SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Thomas K, 2012, BRIT J DERMATOL, V166, P169, DOI 10.1111/j.1365-2133.2011.10586.x; Ubukata K, 2001, ANTIMICROB AGENTS CH, V45, P1693, DOI 10.1128/AAC.45.6.1693-1699.2001; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Yamamoto Y, 1996, INFECT IMMUN, V64, P385, DOI 10.1128/IAI.64.2.385-391.1996; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	38	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155905	10.1371/journal.pone.0155905	http://dx.doi.org/10.1371/journal.pone.0155905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214294	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200031
J	Du, J; Vepachedu, V; Cho, SH; Kumar, M; Nixon, BT				Du, Juan; Vepachedu, Venkata; Cho, Sung Hyun; Kumar, Manish; Nixon, B. Tracy			Structure of the Cellulose Synthase Complex of Gluconacetobacter hansenii at 23.4 angstrom Resolution	PLOS ONE			English	Article							GMP-BINDING PROTEIN; IN-VITRO SYNTHESIS; BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM; BIOSYNTHESIS; IDENTIFICATION; SECRETION; SUBUNIT; OPERON; DOMAIN	Bacterial crystalline cellulose is used in biomedical and industrial applications, but the molecular mechanisms of synthesis are unclear. Unlike most bacteria, which make non-crystalline cellulose, Gluconacetobacter hansenii extrudes profuse amounts of crystalline cellulose. Its cellulose synthase (AcsA) exists as a complex with accessory protein AcsB, forming a 'terminal complex' (TC) that has been visualized by freeze-fracture TEM at the base of ribbons of crystalline cellulose. The catalytic AcsAB complex is embedded in the cytoplasmic membrane. The C-terminal portion of AcsC is predicted to form a translocation channel in the outer membrane, with the rest of AcsC possibly interacting with AcsD in the periplasm. It is thus believed that synthesis from an organized array of TCs coordinated with extrusion by AcsC and AcsD enable this bacterium to make crystalline cellulose. The only structural data that exist for this system are the above mentioned freeze-fracture TEM images, fluorescence microscopy images revealing that TCs align in a row, a crystal structure of AcsD bound to cellopentaose, and a crystal structure of PilZ domain of AcsA. Here we advance our understanding of the structural basis for crystalline cellulose production by bacterial cellulose synthase by determining a negative stain structure resolved to 23.4 angstrom for highly purified AcsAB complex that catalyzed incorporation of UDP-glucose into beta-1,4-glucan chains, and responded to the presence of allosteric activator cyclic diguanylate. Although the AcsAB complex was functional in vitro, the synthesized cellulose was not visible in TEM. The negative stain structure revealed that AcsAB is very similar to that of the BcsAB synthase of Rhodobacter sphaeroides, a non-crystalline cellulose producing bacterium. The results indicate that the crystalline cellulose producing and non-crystalline cellulose producing bacteria share conserved catalytic and membrane translocation components, and support the hypothesis that it is the extrusion mechanism and order in linearly arrayed TCs that enables production of crystalline cellulose.	[Du, Juan; Vepachedu, Venkata; Cho, Sung Hyun; Nixon, B. Tracy] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Kumar, Manish] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Vepachedu, Venkata] BOL, Biol Serv Sect, Dept Environm Protect DEP PA, 2575 Interstate Dr, Harrisburg, PA 17110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Nixon, BT (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Kumar, M (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	manish.kumar@psu.edu; btn1@psu.edu	Kumar, Manish/ABD-7273-2021; Kumar, Manish/HCH-7832-2022	Kumar, Manish/0000-0001-5545-3793; 	Center for Lignocellulose Structure and Formation, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001090]	Center for Lignocellulose Structure and Formation, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the Center for Lignocellulose Structure and Formation (http://www.lignocellulose.org/), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences (grant-no: DE-SC0001090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; ALONI Y, 1983, J BIOL CHEM, V258, P4419; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Anderson WF, 2008, J IND MICROBIOL BIOT, V35, P355, DOI 10.1007/s10295-007-0291-8; Barud HS, 2011, J NANOMATER, V2011, DOI 10.1155/2011/721631; BORZANI W, 1995, BIOTECHNOL LETT, V17, P1271, DOI 10.1007/BF00128400; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; BUREAU TE, 1987, P NATL ACAD SCI USA, V84, P6985, DOI 10.1073/pnas.84.20.6985; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen PH, 2015, J MOL BIOL, V427, P3921, DOI 10.1016/j.jmb.2015.10.003; Cheng KC, 2011, BIOMACROMOLECULES, V12, P730, DOI 10.1021/bm101363t; Cheng Kuan-Chen, 2009, J Biol Eng, V3, P12, DOI 10.1186/1754-1611-3-12; Cho SH, 2015, BIOCHEM J, V470, P195, DOI 10.1042/BJ20141391; Cifuentes C, 2010, J INTEGR PLANT BIOL, V52, P221, DOI 10.1111/j.1744-7909.2010.00919.x; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Dambacher CM, 2016, ELIFE, V5, DOI 10.7554/eLife.13027; Deng Y, 2013, J BACTERIOL, V195, P5072, DOI 10.1128/JB.00767-13; GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107; Iyer PR, 2013, ARCH BIOCHEM BIOPHYS, V529, P92, DOI 10.1016/j.abb.2012.12.002; Iyer PR, 2010, J BACTERIOL, V192, P4256, DOI 10.1128/JB.00588-10; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015; Kimura S, 2001, J BACTERIOL, V183, P5668, DOI 10.1128/JB.183.19.5668-5674.2001; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lin F. C., 1989, CELLULOSE WOOD CHEMI; LIN FC, 1990, J BIOL CHEM, V265, P4782; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; McManus JB, 2016, ENZYME MICROB TECH, V82, P58, DOI 10.1016/j.enzmictec.2015.08.015; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Omadjela O, 2013, P NATL ACAD SCI USA, V110, P17856, DOI 10.1073/pnas.1314063110; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Romling U, 2015, TRENDS MICROBIOL, V23, P545, DOI 10.1016/j.tim.2015.05.005; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; ROSS P, 1985, FEBS LETT, V186, P191, DOI 10.1016/0014-5793(85)80706-7; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; ROSS P, 1990, J BIOL CHEM, V265, P18933; SAXENA IM, 1991, PLANT MOL BIOL, V16, P947, DOI 10.1007/BF00016067; SAXENA IM, 1990, PLANT MOL BIOL, V15, P673, DOI 10.1007/BF00016118; SAXENA IM, 1994, J BACTERIOL, V176, P5735, DOI 10.1128/JB.176.18.5735-5752.1994; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Smirnova TA, 2010, MICROBIOLOGY+, V79, P413, DOI 10.1134/S0026261710040016; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Sunagawa N, 2013, J BIOSCI BIOENG, V115, P607, DOI 10.1016/j.jbiosc.2012.12.021; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vandamme EJ, 1998, POLYM DEGRAD STABIL, V59, P93, DOI 10.1016/S0141-3910(97)00185-7; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; WONG HC, 1990, P NATL ACAD SCI USA, V87, P8130, DOI 10.1073/pnas.87.20.8130; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Yamada Y, 2011, ANN MICROBIOLOGY, V62; Yamada Y, 2008, INT J FOOD MICROBIOL, V125, P15, DOI 10.1016/j.ijfoodmicro.2007.11.077; Yamada Y, 2012, J GEN APPL MICROBIOL, V58, P397, DOI 10.2323/jgam.58.397; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; ZAAR K, 1979, J CELL BIOL, V80, P773, DOI 10.1083/jcb.80.3.773	72	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155886	10.1371/journal.pone.0155886	http://dx.doi.org/10.1371/journal.pone.0155886			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214134	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200029
J	Hilton, JA; Meeks, JC; Zehr, JP				Hilton, Jason A.; Meeks, John C.; Zehr, Jonathan P.			Surveying DNA Elements within Functional Genes of Heterocyst-Forming Cyanobacteria	PLOS ONE			English	Article							NITROGEN-FIXATION GENES; NIFD ELEMENT; ANABAENA; REARRANGEMENT; SEQUENCE; PCC-7120; DIFFERENTIATION; EXCISION; CHROOCOCCIDIOPSIS; IDENTIFICATION	Some cyanobacteria are capable of differentiating a variety of cell types in response to environmental factors. For instance, in low nitrogen conditions, some cyanobacteria form heterocysts, which are specialized for N-2 fixation. Many heterocyst-forming cyanobacteria have DNA elements interrupting key N-2 fixation genes, elements that are excised during heterocyst differentiation. While the mechanism for the excision of the element has been well-studied, many questions remain regarding the introduction of the elements into the cyanobacterial lineage and whether they have been retained ever since or have been lost and reintroduced. To examine the evolutionary relationships and possible function of DNA sequences that interrupt genes of heterocyst-forming cyanobacteria, we identified and compared 101 interruption element sequences within genes from 38 heterocyst-forming cyanobacterial genomes. The interruption element lengths ranged from about 1 kb (the minimum able to encode the recombinase responsible for element excision), up to nearly 1 Mb. The recombinase gene sequences served as genetic markers that were common across the interruption elements and were used to track element evolution. Elements were found that interrupted 22 different orthologs, only five of which had been previously observed to be interrupted by an element. Most of the newly identified interrupted orthologs encode proteins that have been shown to have heterocyst-specific activity. However, the presence of interruption elements within genes with no known role in N-2 fixation, as well as in three nonheterocyst-forming cyanobacteria, indicates that the processes that trigger the excision of elements may not be limited to heterocyst development or that the elements move randomly within genomes. This comprehensive analysis provides the framework to study the history and behavior of these unique sequences, and offers new insight regarding the frequency and persistence of interruption elements in heterocyst-forming cyanobacteria.	[Hilton, Jason A.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Meeks, John C.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Hilton, Jason A.] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA	University of California System; University of California Santa Cruz; University of California System; University of California Davis; Stanford University	Hilton, JA (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.; Hilton, JA (corresponding author), Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA.	hilton.jasona@gmail.com		Hilton, Jason/0000-0002-1196-4871	Gordon and Betty Moore Foundation [493.01]; National Science Foundation Center for Microbial Oceanography: Research and Education [EF0424599]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation Center for Microbial Oceanography: Research and Education(National Science Foundation (NSF))	This work was sponsored in part by a Gordon and Betty Moore Foundation Investigator award (#493.01, J.P.Z.) and the National Science Foundation Center for Microbial Oceanography: Research and Education (EF0424599, J.P.Z.).	Atkinson GC, 2011, MOL BIOL EVOL, V28, P1281, DOI 10.1093/molbev/msq316; BAUER CC, 1993, P NATL ACAD SCI USA, V90, P8812, DOI 10.1073/pnas.90.19.8812; Billi D, 1996, NEW PHYTOL, V133, P563, DOI 10.1111/j.1469-8137.1996.tb01925.x; BRUSCA JS, 1990, J BACTERIOL, V172, P3925, DOI 10.1128/jb.172.7.3925-3931.1990; Campbell EL, 1997, ARCH MICROBIOL, V167, P251, DOI 10.1007/s002030050440; CARRASCO CD, 1994, GENE DEV, V8, P74, DOI 10.1101/gad.8.1.74; CARRASCO CD, 1995, P NATL ACAD SCI USA, V92, P791, DOI 10.1073/pnas.92.3.791; Carrasco CD, 2005, J BACTERIOL, V187, P6031, DOI 10.1128/JB.187.17.6031-6038.2005; CARRASCO CD, 1995, MICROBIOL-UK, V141, P2479, DOI 10.1099/13500872-141-10-2479; CHASTAIN CJ, 1990, J BACTERIOL, V172, P5044, DOI 10.1128/jb.172.9.5044-5051.1990; Christman HD, 2011, J BACTERIOL, V193, P6874, DOI 10.1128/JB.05999-11; Ehira S, 2013, RUSS J PLANT PHYSL+, V60, P443, DOI 10.1134/S1021443713040043; Ermakova M, 2013, FEBS LETT, V587, P82, DOI 10.1016/j.febslet.2012.11.006; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fewer D, 2002, MOL PHYLOGENET EVOL, V23, P82, DOI 10.1006/mpev.2001.1075; GOLDEN JW, 1988, SCIENCE, V242, P1421, DOI 10.1126/science.3144039; GOLDEN JW, 1985, NATURE, V314, P419, DOI 10.1038/314419a0; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HASELKORN R, 1992, ANNU REV GENET, V26, P113, DOI 10.1146/annurev.ge.26.120192.000553; Henson BJ, 2005, CURR MICROBIOL, V50, P129, DOI 10.1007/s00284-004-4338-z; Henson BJ, 2011, INT J SYST EVOL MICR, V61, P2938, DOI 10.1099/ijs.0.028340-0; HERDMAN M, 1988, METHOD ENZYMOL, V167, P232; Hilton JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2748; Hirokawa G, 2005, RNA, V11, P1317, DOI 10.1261/rna.2520405; Howard-Azzeh M, 2014, PHOTOSYNTH RES, V122, P171, DOI 10.1007/s11120-014-0020-x; Hwang WC, PROTEINS STRUCT FUNC; Kaplan-Levy RN, 2010, TOP CURR GENET, V21, P5, DOI 10.1007/978-3-642-12422-8_2; LAMMERS PJ, 1990, J BACTERIOL, V172, P6981, DOI 10.1128/jb.172.12.6981-6990.1990; LAMMERS PJ, 1986, CELL, V44, P905, DOI 10.1016/0092-8674(86)90013-9; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lopez-Gomollon S, 2007, J MOL BIOL, V374, P267, DOI 10.1016/j.jmb.2007.09.010; MARCUS Y, 1982, PLANT PHYSIOL, V69, P1008, DOI 10.1104/pp.69.5.1008; MEEKS JC, 1994, MICROBIOL-UK, V140, P3225, DOI 10.1099/13500872-140-12-3225; Muhling M, 2003, J PHYCOL, V39, P360; MULLIGAN ME, 1989, J BIOL CHEM, V264, P19200; ORGEL LE, 1980, NATURE, V288, P645, DOI 10.1038/288645a0; Pattanaik B, 2010, MICROBIOL-SGM, V156, P731, DOI 10.1099/mic.0.035410-0; RAMASUBRAMANIAN TS, 1994, J BACTERIOL, V176, P1214, DOI 10.1128/jb.176.5.1214-1223.1994; Ramaswamy KS, 1997, MOL MICROBIOL, V23, P1241, DOI 10.1046/j.1365-2958.1997.3081671.x; ROBERTS GP, 1978, J BACTERIOL, V136, P267, DOI 10.1128/JB.136.1.267-279.1978; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; SHAH VK, 1983, J BIOL CHEM, V258, P2064; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ungerer JL, 2010, J BACTERIOL, V192, P3311, DOI 10.1128/JB.00278-10; Valladares A, 2003, MOL MICROBIOL, V47, P1239, DOI 10.1046/j.1365-2958.2003.03372.x; Vintila S, 2011, FEMS MICROBIOL ECOL, V77, P449, DOI 10.1111/j.1574-6941.2011.01127.x; Wang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-613; Wolk CP, 2004, ADV PHOTOSYNTHESIS R, P769; WONG PP, 1972, P NATL ACAD SCI USA, V69, P672, DOI 10.1073/pnas.69.3.672; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0156034	10.1371/journal.pone.0156034	http://dx.doi.org/10.1371/journal.pone.0156034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27206019	gold, Green Published			2022-12-26	WOS:000376291500040
J	Swedberg, JE; Schroeder, CI; Mitchell, JM; Fairlie, DP; Edmonds, DJ; Griffith, DA; Ruggeri, RB; Derksen, DR; Loria, PM; Price, DA; Liras, S; Craik, DJ				Swedberg, Joakim E.; Schroeder, Christina I.; Mitchell, Justin M.; Fairlie, David P.; Edmonds, David J.; Griffith, David A.; Ruggeri, Roger B.; Derksen, David R.; Loria, Paula M.; Price, David A.; Liras, Spiros; Craik, David J.			Truncated Glucagon-like Peptide-1 and Exendin-4 alpha-Conotoxin p114a Peptide Chimeras Maintain Potency and alpha-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; RECEPTOR EXTRACELLULAR DOMAIN; NMR CHEMICAL-SHIFTS; GLP-1 RECEPTOR; DIABETES-MELLITUS; AMINO-ACIDS; AGONISTS; INCRETIN; INSULIN; BINDING	Glucagon-like peptide-1 (GE P-1) signaling through the glucagon-like peptide 1 receptor (GLP-1R) is a key regulator of normal glucose metabolism, and exogenous GLP-1R agonist therapy is a promising avenue for the treatment of type 2 diabetes mellitus. To date, the development of therapeutic GLP-1R agonists has focused on producing drugs with an extended serum half-life. This has been achieved by engineering synthetic analogs of GLP-1 or the more stable exogenous GLP-1R agonist exendin-4 (Ex-4). These synthetic peptide hormones share the overall structure of GLP-1 and Ex-4, with a C-terminal helical segment and a flexible N-terminal tail. Although numerous studies have investigated the molecular determinants underpinning GLP-1 and Ex-4 binding and signaling through the GLP1R, these have primarily focused on the length and composition of the N-terminal tail or on how to modulate the helicity of the full-length peptides. Here, we investigate the effect of C-terminal truncation in GLP-1 and Ex-4 on the cAMP pathway. To ensure helical C-terminal regions in the truncated peptides, we produced a series of chimeric peptides combining the N-terminal portion of GLP-1 or Ex-4 and the C-terminal segment of the helix-promoting peptide alpha-conotoxin p114a. The helicity and structures of the chimeric peptides were confirmed using circular dichroism and NMR, respectively. We found no direct correlation between the fractional helicity and potency in signaling via the cAMP pathway. Rather, the most important feature for efficient receptor binding and signaling was the C-terminal helical segment (residues 22-27) directing the binding of Phe' into a hydrophobic pocket on the GLP-1R.	[Swedberg, Joakim E.; Schroeder, Christina I.; Mitchell, Justin M.; Fairlie, David P.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Edmonds, David J.; Griffith, David A.; Ruggeri, Roger B.; Price, David A.; Liras, Spiros] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Worldwide Med Chem, Cambridge, MA 02139 USA; [Derksen, David R.; Loria, Paula M.] Pfizer Inc, Pharmacokinet Dynam & Metab, Worldwide Res & Dev, Groton, CT 06340 USA	University of Queensland; Pfizer; Pfizer	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Bldg 80,Serv Rd, St Lucia, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Mitchell, justin M/D-2061-2017; Fairlie, David P/F-8865-2014; Schroeder, Cristina I./K-2042-2014; Craik, David/B-1695-2010; swedberg, Joakim/K-1501-2014	Mitchell, justin M/0000-0001-8391-5959; Fairlie, David P/0000-0002-7856-8566; Schroeder, Cristina I./0000-0002-6737-6374; Craik, David/0000-0003-0007-6796; swedberg, Joakim/0000-0003-4243-8660; Griffith, David/0000-0002-7592-2478	Australian Research Council (ARC) [LP110200213]; Queensland Government Department of Science, Information Technology, Innovation, and the Arts Co-investment Fund; National Health and Medical Research Council ECR [APP1069819]; Australian Research Council Center of Excellence in Advanced Molecular Imaging [CE140100011]	Australian Research Council (ARC)(Australian Research Council); Queensland Government Department of Science, Information Technology, Innovation, and the Arts Co-investment Fund; National Health and Medical Research Council ECR; Australian Research Council Center of Excellence in Advanced Molecular Imaging(Australian Research Council)	This work was supported in part by Australian Research Council (ARC) Linkage Grant LP110200213 and a Queensland Government Department of Science, Information Technology, Innovation, and the Arts Co-investment Fund grant. The authors declare that they have no conflicts of interest with the contents of this article.r A National Health and Medical Research Council ECR (Early Career Fellowships) Fellow (APP1069819).r A National Health and Medical Research Council Senior Principal Research Fellow (APP1027369) and funded by the Australian Research Council Center of Excellence in Advanced Molecular Imaging (CE140100011).	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2004, PROTEIN PEPTIDE LETT, V11, P9, DOI 10.2174/0929866043478365; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersen NH, 2002, BIOORGAN MED CHEM, V10, P79, DOI 10.1016/S0968-0896(01)00263-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulheller BM, 2007, PHYS CHEM CHEM PHYS, V9, P2020, DOI 10.1039/b615870f; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; ENG J, 1992, J BIOL CHEM, V267, P7402; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; GALLWITZ B, 1990, J MOL ENDOCRINOL, V5, P33, DOI 10.1677/jme.0.0050033; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haque TS, 2010, PEPTIDES, V31, P950, DOI 10.1016/j.peptides.2010.01.008; Henchey LK, 2008, CURR OPIN CHEM BIOL, V12, P692, DOI 10.1016/j.cbpa.2008.08.019; Hjorth SA, 1996, ACTA PHYSIOL SCAND, V157, P343, DOI 10.1046/j.1365-201X.1996.37259000.x; Hoang HN, 2015, J MED CHEM, V58, P4080, DOI 10.1021/acs.jmedchem.5b00166; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; KREYMANN B, 1987, LANCET, V2, P1300; Mapelli C, 2009, J MED CHEM, V52, P7788, DOI 10.1021/jm900752a; MCINTYRE N, 1964, LANCET, V2, P20, DOI 10.1016/s0140-6736(64)90011-x; Miranda LP, 2008, J MED CHEM, V51, P2758, DOI 10.1021/jm701522b; MOJSOV S, 1992, INT J PEPT PROT RES, V40, P333; Murage EN, 2008, BIOORGAN MED CHEM, V16, P10106, DOI 10.1016/j.bmc.2008.10.006; Murage EN, 2010, J MED CHEM, V53, P6412, DOI 10.1021/jm100602m; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Patgiri A, 2010, NAT PROTOC, V5, P1857, DOI 10.1038/nprot.2010.146; Patterson JT, 2013, MOL METAB, V2, P86, DOI 10.1016/j.molmet.2013.01.003; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Schroeder CI, 2014, CHEM BIOL, V21, P284, DOI 10.1016/j.chembiol.2013.11.014; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; SUZUKI S, 1989, ENDOCRINOLOGY, V125, P3109, DOI 10.1210/endo-125-6-3109; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	48	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15778	15787		10.1074/jbc.M116.724542	http://dx.doi.org/10.1074/jbc.M116.724542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226591	Green Published, hybrid			2022-12-26	WOS:000380584200030
J	Zhang, Y; Bode, A; Nguyen, B; Keramidas, A; Lynch, JW				Zhang, Yan; Bode, Anna; Nguyen, Bindi; Keramidas, Angelo; Lynch, Joseph W.			Investigating the Mechanism by Which Gain-of-function Mutations to the alpha 1 Glycine Receptor Cause Hyperekplexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-HYDROXYTRYPTAMINE(3) RECEPTOR; SYNAPTIC-TRANSMISSION; MOLECULAR-CLONING; NEURONAL FUNCTION; TIME-COURSE; POTENTIATION; SUBUNIT; TARGET; GLRA1; MOTONEURONS	Hyperekplexia is a rare human neuromotor disorder caused by mutations that impair the efficacy of glycinergic inhibitory neurotransmission. Loss-of-function mutations in the GLRA1 or GLRB genes, which encode the al and glycine receptor (GIyR) subunits, are the major cause. Paradoxically, gain -of function GLRAI mutations also cause hyperekplexia, although the mechanism is unknown. Here we identify two new gain -of function mutations (I43F and W170S) and characterize these along with known gain -of -function mutations (Q226E, V280M, and R414H) to identify how they cause hyperekplexia. Using artificial synapses, we show that all mutations prolong the decay of inhibitory postsynaptic currents (IPSCs) and induce spontaneous G1yR activation. As these effects may deplete the chloride electrochemical gradient, hyperekplexia could potentially result from reduced glycinergic inhibitory efficacy. However, we consider this unlikely as the depleted chloride gradient should also lead to pain sensitization and to a hyperekplexia phenotype that correlates with mutation severity, neither of which is observed in patients with GLRA1 hyperekplexia mutations. We also rule out small increases in IPSC decay times (as caused by W170S and R414H) as a possible mechanism given that the clinically important drug, tropisetron, significantly increases glycinergic IPSC decay times without causing motor side effects. A recent study on cultured spinal neurons concluded that an elevated intracellular chloride concentration late during development ablates a.113 glycinergic synapses but spares GABAergic synapses. As this mechanism satisfies all our considerations, we propose it is primarily responsible for the hyperekplexia phenotype.	[Zhang, Yan; Bode, Anna; Nguyen, Bindi; Keramidas, Angelo; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Bldg 79, St Lucia, Qld 4072, Australia.	j.lynch@uq.edu.au	; Keramidas, Angelo/I-1704-2013	Zhang, Yan/0000-0002-4159-2044; Keramidas, Angelo/0000-0003-2846-052X; Lynch, Joseph/0000-0002-1227-2252; Nguyen, Bindi/0000-0003-0898-7439	Australian Research Council [DP150102428]; National Health and Medical Research Council [1058542, 1080976]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Research Grant DP150102428 and National Health and Medical Research Council Grants 1058542 and 1080976. The authors declare that they have no conflict of interest with the contents of this article.	Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Al-Futaisi AM, 2012, PEDIATR NEUROL, V46, P89, DOI 10.1016/j.pediatrneurol.2011.11.008; Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Balansa W, 2013, ORG BIOMOL CHEM, V11, P4695, DOI 10.1039/c3ob40861b; Beato M, 2008, J NEUROSCI, V28, P7412, DOI 10.1523/JNEUROSCI.0581-08.2008; Bhumbra GS, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00008; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; Bode A, 2013, J BIOL CHEM, V288, P33745, DOI 10.1074/jbc.M113.509240; Bode A, 2013, J BIOL CHEM, V288, P33760, DOI 10.1074/jbc.M113.513804; Brune W, 1996, AM J HUM GENET, V58, P989; Carlisle JB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004125.pub2; Choii G, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.5; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Dixon C, 2014, J BIOL CHEM, V289, P5399, DOI 10.1074/jbc.M113.514695; Dixon CL, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00080; Dixon CL, 2015, BRIT J PHARMACOL, V172, P3522, DOI 10.1111/bph.13142; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Elenes S, 2006, J GEN PHYSIOL, V128, P615, DOI 10.1085/jgp.200609570; Gao BX, 2001, J NEUROPHYSIOL, V86, P492, DOI 10.1152/jn.2001.86.1.492; Graham BA, 2006, J NEUROSCI, V26, P4880, DOI 10.1523/JNEUROSCI.3991-05.2006; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Haus U, 2004, SCAND J RHEUMATOL, V33, P12, DOI 10.1080/03009740410006961; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Horvath Emese, 2014, J Med Case Rep, V8, P233, DOI 10.1186/1752-1947-8-233; Jiang J, 2015, J NEUROSCI, V35, P1991, DOI 10.1523/JNEUROSCI.1627-14.2015; Lankiewicz S, 1998, MOL PHARMACOL, V53, P202, DOI 10.1124/mol.53.2.202; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Legendre P, 1998, J NEUROSCI, V18, P2856; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Martin LJ, 2012, MOL NEUROBIOL, V45, P30, DOI 10.1007/s12035-011-8217-x; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; MIYAKE A, 1995, MOL PHARMACOL, V48, P407; Schaefer N, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00098; Schwale C, 2016, HISTOCHEM CELL BIOL, V145, P637, DOI 10.1007/s00418-015-1397-0; Scott S, 2015, J BIOL CHEM, V290, P5621, DOI 10.1074/jbc.M114.616573; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Supplisson S, 2000, MOL PHARMACOL, V58, P763, DOI 10.1124/mol.58.4.763; Thomas RH, 2013, BRAIN, V136, P3085, DOI 10.1093/brain/awt207; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yang Z, 2007, J NEUROCHEM, V100, P758, DOI 10.1111/j.1471-4159.2006.04242.x; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zhang Y, 2015, NEUROPHARMACOLOGY, V89, P391, DOI 10.1016/j.neuropharm.2014.10.026; Zhou N, 2013, J NEUROSCI, V33, P17675, DOI 10.1523/JNEUROSCI.3240-13.2013	53	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15332	15341		10.1074/jbc.M116.728592	http://dx.doi.org/10.1074/jbc.M116.728592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226610	Green Published, hybrid			2022-12-26	WOS:000380583200038
J	Salzer, R; D'Imprima, E; Gold, VAM; Rose, I; Drechsler, M; Vonck, J; Averhoff, B				Salzer, Ralf; D'Imprima, Edoardo; Gold, Vicki A. M.; Rose, Ilona; Drechsler, Moritz; Vonck, Janet; Averhoff, Beate			Topology and Structure/Function Correlation of Ring- and Gate-forming Domains in the Dynamic Secretin Complex of Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						EM; protein domain; protein folding; structure; function; type IV pili; Thermus thermophilus; electron cryotomography; natural transformation; ring and gate forming domains; secretin	IV PILUS BIOGENESIS; GRAM-NEGATIVE BACTERIA; NATURAL-TRANSFORMATION; TWITCHING-MOTILITY; DNA UPTAKE; ATPASE PILF; COMPETENCE; PROTEIN; HB27; IDENTIFICATION	Secretins are versatile outer membrane pores used by many bacteria to secrete proteins, toxins, or filamentous phages; extrude type IV pili (T4P); or take up DNA. Extrusion of T4P and natural transformation of DNA in the thermophilic bacterium Thermus thermophilus requires a unique secretin complex comprising six stacked rings, a membrane-embedded cone structure, and two gates that open and close a central channel. To investigate the role of distinct domains in ring and gate formation, we examined a set of deletion derivatives by cryomicroscopy techniques. Here we report that maintaining the N0 ring in the deletion derivatives led to stable PilQ complexes. Analyses of the variants unraveled that an N-terminal domain comprising a unique fold is essential for the formation of gate 2. Furthermore, we identified four domains essential for the formation of the N2 to N5 rings. Mutant studies revealed that deletion of individual ring domains significantly reduces piliation. The N1, N2, N4, and N5 deletion mutants were significantly impaired in T4P-mediated twitching motility, whereas the motility of the N3 mutant was comparable with that of wild-type cells. This indicates that the deletion of the N3 ring leads to increased pilus dynamics, thereby compensating for the reduced number of pili of the N3 mutant. All mutants exhibit a wild-type natural transformation phenotype, leading to the conclusion that DNA uptake is independent of functional T4P.	[Salzer, Ralf; Rose, Ilona; Drechsler, Moritz; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany; [D'Imprima, Edoardo; Gold, Vicki A. M.; Vonck, Janet] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Max Planck Society	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany.	averhoff@bio.uni-frankfurt.de		Vonck, Janet/0000-0001-5659-8863; D'Imprima, Edoardo/0000-0002-9830-7929; Averhoff, Beate/0000-0003-1460-3649; Gold, Vicki/0000-0002-6908-0745	Deutsche Forschungsgemeinschaft [AV 9/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant AV 9/6-1. The authors declare that they have no conflicts of interest with the contents of this article.	Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Burkhardt J, 2012, J BIOL CHEM, V287, P8484, DOI 10.1074/jbc.M111.334912; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Friedrich A, 2003, APPL ENVIRON MICROB, V69, P3695, DOI 10.1128/AEM.69.7.3695-3700.2003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Gold VAM, 2015, ELIFE, V4, DOI 10.7554/eLife.07380; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; Karuppiah V, 2013, P NATL ACAD SCI USA, V110, pE4638, DOI 10.1073/pnas.1312313110; Karuppiah V, 2011, TRENDS MICROBIOL, V19, P40, DOI 10.1016/j.tim.2010.10.006; Karuppiah V, 2010, PROTEINS, V78, P2049, DOI 10.1002/prot.22720; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Koster M, 2000, INT J MED MICROBIOL, V290, P325; Kowal J, 2013, STRUCTURE, V21, P2152, DOI 10.1016/j.str.2013.09.012; Kruger NJ, 2011, MOL MICROBIOL, V80, P860, DOI 10.1111/j.1365-2958.2011.07647.x; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nudleman E, 2004, J MOL MICROB BIOTECH, V7, P52, DOI 10.1159/000077869; OSHIMA T, 1971, J GEN APPL MICROBIOL, V17, P513, DOI 10.2323/jgam.17.513; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Rose I, 2011, EXTREMOPHILES, V15, P191, DOI 10.1007/s00792-010-0343-2; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Salzer R, 2016, ENVIRON MICROBIOL, V18, P65, DOI 10.1111/1462-2920.12820; Salzer R, 2015, EXTREMOPHILES, V19, P261, DOI 10.1007/s00792-014-0711-4; Salzer R, 2014, J BIOL CHEM, V289, P30343, DOI 10.1074/jbc.M114.598656; Salzer R, 2014, APPL ENVIRON MICROB, V80, P644, DOI 10.1128/AEM.03218-13; Salzer R, 2013, EXTREMOPHILES, V17, P697, DOI 10.1007/s00792-013-0544-6; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Tarry M, 2011, J MOL BIOL, V409, P642, DOI 10.1016/j.jmb.2011.04.034; Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002; Tosi T, 2014, STRUCTURE, V22, P1348, DOI 10.1016/j.str.2014.07.005; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	43	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14448	14456		10.1074/jbc.M116.724153	http://dx.doi.org/10.1074/jbc.M116.724153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226590	Green Published, hybrid			2022-12-26	WOS:000380366700004
J	Lopez, ALO; Johnson, L				Lopez, Ana Lorena Olea; Johnson, Laura			Associations between Restrained Eating and the Size and Frequency of Overall Intake, Meal, Snack and Drink Occasions in the UK Adult National Diet and Nutrition Survey	PLOS ONE			English	Article							ENERGY-INTAKE; BODY-MASS; WEIGHT-GAIN; FOOD; OVERWEIGHT; BEHAVIORS; PATTERNS; BALANCE; HEALTH; STYLE	Obesity is a global public health priority. Restrained eating is related to obesity and total energy intake but associations with the eating patterns are unclear. We examined the associations of restrained eating with the size and frequency of intake occasions among 1213 British adult (19-64 y) participants in a cross-sectional analysis of the UK National Diet and Nutrition Survey 2000. The Dutch Eating Behaviour Questionnaire assessed restrained eating. Overall intake occasions were all energy consumed in a 60 min period. A food-based classification separated intake occasions into meals, snacks, or drinks from seven-day weighed food diaries. Average daily frequency and size (kcal) of overall intake, meal, snack and drink occasions were calculated and associations with restrained eating were modelled using multiple linear regression including under-reporting of energy intake, age, gender, BMI, emotional eating, external eating and physical activity as covariates. Restrained eating was very weakly positively correlated with overall intake (r = 0.08, p<0.05) and meal frequency (r = 0.10, p<0.05) but not snack or drink frequency (r = 0.02 and -0.02 respectively). Adjusted regressions showed a one-point change in restrained eating was associated with 0.07 (95% CI 0.03, 0.11) more meal occasions/day and 0.13 (95% CI 0.01, 0.25) extra overall intake occasions/day. Overall intake occasion size was weakly negatively correlated with restrained eating regardless of type (r = -0.16 to -0.20, all p<0.0001). Adjusted regressions showed each one-point increase in restrained eating was associated with lower-energy meals (-15 kcal 95% CI -5.9, -24.2) and drinks (-4 kcal 95% CI -0.1, -8), but not snacks or overall intake occasions. Among a national sample of UK adults, greater restrained eating was associated with smaller and slightly more frequent eating, suggesting that restrained eaters restrict their energy intake by reducing meal/drink size rather than skipping snacks.	[Lopez, Ana Lorena Olea; Johnson, Laura] Univ Bristol, Sch Policy Studies, Ctr Exercise Nutr & Hlth Sci, Bristol, Avon, England	University of Bristol	Johnson, L (corresponding author), Univ Bristol, Sch Policy Studies, Ctr Exercise Nutr & Hlth Sci, Bristol, Avon, England.	Laura.Johnson@bristol.ac.uk		Johnson, Laura/0000-0001-8985-3154	Centre for Exercise Nutrition and Health Sciences, University of Bristol; Consejo Nacional de Ciencia y Tecnologia (CONACYT)	Centre for Exercise Nutrition and Health Sciences, University of Bristol; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The present analysis was supported by the Centre for Exercise Nutrition and Health Sciences, University of Bristol and was performed as part of ALOL's MSc, which was funded by a scholarship from Consejo Nacional de Ciencia y Tecnologia (CONACYT) http://www.conacyt.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle S, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-41; Anschutz DJ, 2009, APPETITE, V53, P119, DOI 10.1016/j.appet.2009.03.016; Chamontin A, 2003, APPETITE, V41, P21, DOI 10.1016/S0195-6663(03)00036-9; de Lauzon B, 2004, J NUTR, V134, P2372; de Lauzon-Guillain B, 2006, AM J CLIN NUTR, V83, P132; DECASTRO JM, 1995, PHYSIOL BEHAV, V57, P287, DOI 10.1016/0031-9384(94)00229-X; Elfhag K, 2007, PHYSIOL BEHAV, V91, P191, DOI 10.1016/j.physbeh.2007.02.005; Hartmann C, 2013, PUBLIC HEALTH NUTR, V16, P1487, DOI 10.1017/S1368980012003771; HEATHERTON TF, 1991, J ABNORM PSYCHOL, V100, P78, DOI 10.1037/0021-843X.100.1.78; HERMAN CP, 1975, J ABNORM PSYCHOL, V84, P666, DOI 10.1037/0021-843X.84.6.666; Houben K, 2010, APPETITE, V55, P18, DOI 10.1016/j.appet.2010.03.003; Institute of Medicine of the National Academies, 2002, DIET REF INT EN CARB; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; Lluch A, 2000, INT J OBESITY, V24, P1493, DOI 10.1038/sj.ijo.0801425; Macdiarmid J, 2009, EUR J CLIN NUTR, V63, P1297, DOI 10.1038/ejcn.2009.87; Mattes RD, 2006, INT J OBESITY, V30, pS60, DOI 10.1038/sj.ijo.0803494; McGuire MT, 2001, INT J OBESITY, V25, P574, DOI 10.1038/sj.ijo.0801579; Miller R, 2013, NUTR BULL, V38, P302, DOI 10.1111/nbu.12042; Moody A., 2013, ADULT ANTHROPOMETRIC; Murakami K, 2014, INT J OBESITY, V38, P1200, DOI 10.1038/ijo.2014.1; National Diet and Nutrition Survey N, 2001, NAT DIET NUTR SURV A; Office for National Statistics O, 2005, NAT STAT SOC CLASS U; Office for National Statistics O Food Standards Agency F, 2000, NAT DIET NUTR SURV A; Porter Kathryn N., 2011, Journal of Nutrition in Gerontology and Geriatrics, V30, P403, DOI 10.1080/21551197.2011.623960; Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086; Rennie KL, 2006, J AM DIET ASSOC, V106, P1667, DOI 10.1016/j.jada.2006.07.014; Rolls BJ, 1999, AM J CLIN NUTR, V70, P448; SCHULZ LO, 1994, AM J CLIN NUTR, V60, P676, DOI 10.1093/ajcn/60.5.676; Snoek HM, 2007, SCAND J PSYCHOL, V48, P23, DOI 10.1111/j.1467-9450.2006.00568.x; Speechly DP, 1999, INT J OBESITY, V23, P1151, DOI 10.1038/sj.ijo.0801046; Stubbs RJ, 2014, BRIT J NUTR, V111, P2032, DOI 10.1017/S0007114514000154; Tepper BJ, 1996, APPETITE, V27, P51, DOI 10.1006/appe.1996.0033; Tooze JA, 2004, AM J CLIN NUTR, V79, P795; TUSCHL RJ, 1990, AM J CLIN NUTR, V52, P81; TUSCHL RJ, 1990, APPETITE, V14, P9, DOI 10.1016/0195-6663(90)90050-I; van Strien Tatjana, 2003, Eat Behav, V3, P329, DOI 10.1016/S1471-0153(02)00092-2; van Strien T, 2014, APPETITE, V76, P44, DOI 10.1016/j.appet.2014.01.015; van Strien T, 2012, APPETITE, V59, P782, DOI 10.1016/j.appet.2012.08.009; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; WILLIAMSON DA, 1995, APPETITE, V25, P31, DOI 10.1006/appe.1995.0039; Woolhead C, 2015, AM J CLIN NUTR, V102, P316, DOI 10.3945/ajcn.114.106112; World Health Organization W, 2011, GLOB PROGR EL LYMPH, P22	42	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156320	10.1371/journal.pone.0156320	http://dx.doi.org/10.1371/journal.pone.0156320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227409	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500113
J	Na, HJ; Eom, JS; Lee, G; Mok, JH; Kim, MH; Lee, K; Kim, KU; Lee, MK				Na, Hae Jung; Eom, Jung Seop; Lee, Geewon; Mok, Jeong Ha; Kim, Mi Hyun; Lee, Kwangha; Kim, Ki Uk; Lee, Min Ki			Exposure to Mycobacterium tuberculosis during Flexible Bronchoscopy in Patients with Unexpected Pulmonary Tuberculosis	PLOS ONE			English	Article							BRONCHIAL ANTHRACOFIBROSIS; RESPIRATORY-DISEASE; DIAGNOSTIC YIELD; LUNG; SPUTUM	Objective Recent guidelines recommend the use by healthcare personnel of a fit-tested N95 particulate respirator or higher-grade respiratory precaution in a patient undergoing bronchoscopy when pulmonary tuberculosis (PTB) is suspected. However, PTB may be unexpectedly diagnosed in this setting and therefore not evaluated, resulting in the unexpected exposure to Mycobacterium tuberculosis (MTB) of healthcare workers in the bronchoscopy suite. Here, we examined the incidence of unexpected exposure to MTB during flexible bronchoscopy and determined the exposure-related factors. Methods Between 2011 and 2013, a retrospective study was conducted to evaluate unexpected diagnoses of PTB in the bronchoscopy suite. During the study period, 1650 consecutive patients for whom previous CT scans were available and who underwent bronchoscopy for respiratory disease other than PTB were included. The results of bronchial washing, bronchoalveolar lavage, and post-bronchoscopic sputum were reviewed. Results PTB was unexpectedly diagnosed in 76 patients (4.6%). The presence of anthracofibrosis [odds ratio (OR), 3.878; 95% confidence interval (CI), 1.291-11.650; P = 0.016), bronchiectasis (OR, 1.974; 95% CI, 1.095-3.557; P = 0.024), or atelectasis (OR, 1.740; 95% CI, 1.010-2.903; P = 0.046) as seen on chest CT scan was independently associated with unexpected PTB. Patients with both anthracofibrosis and atelectasis were at much higher risk of unexpected PTB (OR, 4.606; 95% CI, 1.383-15.342; P = 0.013). Conclusions The risk of MTB exposure by healthcare personnel in the bronchoscopy suite due to patients with undiagnosed PTB has been underestimated. Therefore, in geographic regions with an intermediate PTB prevalence, such as South Korea (97/100,000 persons per year), higher-grade respiratory precaution, such as a fit-tested N95 particulate respirator, should be considered to prevent occupational exposure to MTB during routine bronchoscopy, especially in patients with CT-confirmed anthracofibrosis, bronchiectasis, or atelectasis.	[Na, Hae Jung; Eom, Jung Seop; Mok, Jeong Ha; Kim, Mi Hyun; Lee, Kwangha; Kim, Ki Uk; Lee, Min Ki] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Lee, Geewon] Pusan Natl Univ, Sch Med, Dept Radiol, Busan, South Korea; [Eom, Jung Seop] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University Hospital	Eom, JS (corresponding author), Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.; Eom, JS (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	ejspulm@gmail.com						Andreu J, 2004, EUR J RADIOL, V51, P139, DOI 10.1016/j.ejrad.2004.03.009; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774; Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016; Denholm R, 2014, AM J RESP CRIT CARE, V190, P549, DOI 10.1164/rccm.201402-0338OC; Eom JS, 2013, EUR J RADIOL, V82, pE867, DOI 10.1016/j.ejrad.2013.08.028; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; George PM, 2011, RESP MED, V105, P1726, DOI 10.1016/j.rmed.2011.07.014; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kala Jaya, 2008, Prim Care Respir J, V17, P51, DOI 10.3132/pcrj.2008.00003; Kim HY, 2000, AM J ROENTGENOL, V174, P523, DOI 10.2214/ajr.174.2.1740523; Kim HJ, 2013, KOREAN J INTERN MED, V28, P330, DOI 10.3904/kjim.2013.28.3.330; Kim MH, 2007, YONSEI MED J, V48, P969, DOI 10.3349/ymj.2007.48.6.969; KVALE PA, 1979, CHEST, V76, P140, DOI 10.1378/chest.76.2.140; Kwak HJ, 2010, TOHOKU J EXP MED, V222, P237, DOI 10.1620/tjem.222.237; Laub RR, 2015, DAN MED J, V62; Long R, 2005, AM J ROENTGENOL, V184, pS33, DOI 10.2214/ajr.184.3_supplement.01840s33; Mehta AC, 2005, CHEST, V128, P1742, DOI 10.1378/chest.128.3.1742; Schoch OD, 2007, AM J RESP CRIT CARE, V175, P80, DOI 10.1164/rccm.200608-1092OC; Slade MG, 2011, EUR RESPIR J, V37, P895, DOI 10.1183/09031936.00097110; World Health Organization, 2014, TUB COUNTR PROF; Wu CY, 2011, INT J TUBERC LUNG D, V15, P125; Yoo H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-404	23	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156385	10.1371/journal.pone.0156385	http://dx.doi.org/10.1371/journal.pone.0156385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227408	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500128
J	Salvalaio, M; Rigon, L; Belletti, D; D'Avanzo, F; Pederzoli, F; Ruozi, B; Marin, O; Vandelli, MA; Forni, F; Scarpa, M; Tomanin, R; Tosi, G				Salvalaio, Marika; Rigon, Laura; Belletti, Daniela; D'Avanzo, Francesca; Pederzoli, Francesca; Ruozi, Barbara; Marin, Oriano; Vandelli, Maria Angela; Forni, Flavio; Scarpa, Maurizio; Tomanin, Rosella; Tosi, Giovanni			Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DRUG-DELIVERY; HUNTER-SYNDROME; MOUSE MODELS; BARRIER; THERAPY; INFLAMMATION; CONVECTION; TRANSPORT; DISEASES	Lysosomal Storage Disorders (LSDs) are a group of metabolic syndromes, each one due to the deficit of one lysosomal enzyme. Many LSDs affect most of the organ systems and overall about 75% of the patients present neurological impairment. Enzyme Replacement Therapy, although determining some systemic clinical improvements, is ineffective on the CNS disease, due to enzymes' inability to cross the blood-brain barrier (BBB). With the aim to deliver the therapeutic enzymes across the BBB, we here assayed biodegradable and biocompatible PLGA-nanoparticles (NPs) in two murine models for LSDs, Mucopolysaccharidosis type I and II (MPS I and MPS II). PLGA-NPs were modified with a 7-aminoacid glycopeptide (g7), yet demonstrated to be able to deliver low molecular weight (MW) molecules across the BBB in rodents. We specifically investigated, for the first time, the g7-NPs ability to transfer a model drug (FITC-albumin) with a high MW, comparable to the enzymes to be delivered for LSDs brain therapy. In vivo experiments, conducted on wild-type mice and knockout mouse models for MPS I and II, also included a whole series of control injections to obtain a broad preliminary view of the procedure efficiency. Results clearly showed efficient BBB crossing of albumin in all injected mice, underlying the ability of NPs to deliver high MW molecules to the brain. These results encourage successful experiments with enzyme-loaded g7-NPs to deliver sufficient amounts of the drug to the brain district on LSDs, where exerting a corrective effect on the pathological phenotype.	[Salvalaio, Marika; Rigon, Laura; D'Avanzo, Francesca; Scarpa, Maurizio; Tomanin, Rosella] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Belletti, Daniela; Pederzoli, Francesca; Ruozi, Barbara; Vandelli, Maria Angela; Forni, Flavio; Tosi, Giovanni] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Marin, Oriano] Univ Padua, Dept Biomed Sci, Padua, Italy; [Salvalaio, Marika; Pederzoli, Francesca] Pediat Res Inst Citta Speranza, Padua, Italy; [Marin, Oriano] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [D'Avanzo, Francesca; Scarpa, Maurizio] Brains Brain Fdn Onlus, Padua, Italy	University of Padua; Universita di Modena e Reggio Emilia; University of Padua; Fondazione Citta della Speranza; University of Padua	Tomanin, R (corresponding author), Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy.; Tosi, G (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.	rosella.tomanin@unipd.it; gtosi@unimore.it	Salvalaio, Marika/G-9538-2014; D'Avanzo, Francesca/H-5081-2016; Rigon, Laura/D-2853-2016; Scarpa, Maurizio/AAC-1467-2019; Belletti, Daniela/L-5288-2016; Tosi, Giovanni/D-4547-2011	D'Avanzo, Francesca/0000-0002-2790-6481; Rigon, Laura/0000-0002-0233-1677; Belletti, Daniela/0000-0003-2872-445X; Salvalaio, Marika/0000-0002-0221-1237; Tosi, Giovanni/0000-0001-8318-667X; SCARPA, MAURIZIO/0000-0002-0382-3251	Fondazione Cassa di Risparmio di Padova e Rovigo-Fondazione Istituto di Ricerca Pediatrica "Citta della Speranza" (Bando Ricerca Pediatrica) [13/09]; Brains for Brain Foundation-Onlus	Fondazione Cassa di Risparmio di Padova e Rovigo-Fondazione Istituto di Ricerca Pediatrica "Citta della Speranza" (Bando Ricerca Pediatrica); Brains for Brain Foundation-Onlus	The project was partly funded by Fondazione Cassa di Risparmio di Padova e Rovigo-Fondazione Istituto di Ricerca Pediatrica "Citta della Speranza" (Bando Ricerca Pediatrica 2012/2014, grant #13/09) and by the Brains for Brain Foundation-Onlus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Dr. Neufeld (UCLA, CA, USA) and Dr. Heard (Pasteur Institute, Paris, France) for kindly providing the MPS I mouse model and Dr. Muenzer (UCLA, CA, USA) for kindly providing the MPS II mouse model. The project was partly funded by Fondazione Cassa di Risparmio di Padova e Rovigo-Fondazione Istituto di Ricerca Pediatrica "Citta della Speranza" (Bando Ricerca Pediatrica 2012/2014, grant #13/09) and by the Brains For Brain Foundation Onlus.	Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Bondioli L, 2011, PARASITOLOGY, V138, P1384, DOI 10.1017/S0031182011001119; Bondioli L, 2010, BIOMATERIALS, V31, P3395, DOI 10.1016/j.biomaterials.2010.01.049; BOVE KE, 1995, HUM PATHOL, V26, P1040, DOI 10.1016/0046-8177(95)90097-7; Boyle J, BIND THERAPEUTICS RE; Cardone M, 2006, HUM MOL GENET, V15, P1225, DOI 10.1093/hmg/ddl038; Chhabra R, 2014, INT J PHARMACEUT, V471, P349, DOI 10.1016/j.ijpharm.2014.05.054; Clarke L.A., 1993, GENEREVIEWS R; Date PV, 2010, AAPS PHARMSCITECH, V11, P304, DOI 10.1208/s12249-010-9382-3; Friso A, 2005, J GENE MED, V7, P1482, DOI 10.1002/jgm.790; Fuller M, 2006, FABRY DIS PERSPECTIV; Garbuzova-Davis S, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-174; Garbuzova-Davis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016601; Garcia AR, 2007, J INHERIT METAB DIS, V30, P924, DOI 10.1007/s10545-007-0641-8; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Kabanov AV, 2007, PROG POLYM SCI, V32, P1054, DOI 10.1016/j.progpolymsci.2007.05.014; Kreuter J, 2014, ADV DRUG DELIVER REV, V71, P2, DOI 10.1016/j.addr.2013.08.008; Kroll RA, 1996, NEUROSURGERY, V38, P746, DOI 10.1227/00006123-199604000-00024; Liu YT, 2010, BIOMATERIALS, V31, P330, DOI 10.1016/j.biomaterials.2009.09.036; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nobs L, 2004, EUR J PHARM BIOPHARM, V58, P483, DOI 10.1016/j.ejpb.2004.04.006; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Pardridge William M, 2005, NeuroRx, V2, P3; Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007; Ruozi B, 2014, CNS NEUROL DISORD-DR, V13, P1475, DOI 10.2174/1871527313666140806145540; Sands MS, 2008, ACTA PAEDIATR, V97, P22, DOI 10.1111/j.1651-2227.2008.00660.x; Scarpa M., 1993, GENEREVIEWS R; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siegal T, 2000, J NEUROSURG, V92, P599, DOI 10.3171/jns.2000.92.4.0599; Tosi G, 2007, J CONTROL RELEASE, V122, P1, DOI 10.1016/j.jconrel.2007.05.022; Tosi G, 2011, J NEURAL TRANSM, V118, P145, DOI 10.1007/s00702-010-0497-1; Tosi G, 2008, EXPERT OPIN DRUG DEL, V5, P155, DOI 10.1517/17425247.5.2.155; Tosi G, 2014, J CONTROL RELEASE, V177, P96, DOI 10.1016/j.jconrel.2014.01.004; Tosi G, 2013, NANOMEDICINE-UK, V8, P1373, DOI [10.2217/nnm.12.172, 10.2217/NNM.12.172]; Tosi G, 2011, NANOMEDICINE-UK, V6, P423, DOI [10.2217/nnm.11.11, 10.2217/NNM.11.11]; Valencia PM, 2011, BIOMATERIALS, V32, P6226, DOI 10.1016/j.biomaterials.2011.04.078; Vilella A, 2014, J CONTROL RELEASE, V174, P195, DOI 10.1016/j.jconrel.2013.11.023; Vitner EB, 2012, BRAIN, V135, P1724, DOI 10.1093/brain/aws095; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Werner ME, 2013, INT J RADIAT ONCOL, V86, P463, DOI 10.1016/j.ijrobp.2013.02.009; Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017	43	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156452	10.1371/journal.pone.0156452	http://dx.doi.org/10.1371/journal.pone.0156452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228099	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500139
J	Su, CH; Cheng, C; Tzeng, TY; Lin, IH; Hsu, MT				Su, Chia-Hsin; Cheng, Ching; Tzeng, Tsai-Yu; Lin, I-Hsuan; Hsu, Ming-Ta			An H2A Histone Isotype, H2ac, Associates with Telomere and Maintains Telomere Integrity	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; END-PROTECTION; POT1; PROTEIN; TRF2; CHROMATIN; REPAIR; LENGTH	Telomeres are capped at the ends of eukaryotic chromosomes and are composed of TTAGGG repeats bound to the shelterin complex. Here we report that a replication-dependent histone H2A isotype, H2ac, was associated with telomeres in human cells and co-immunoprecipitates with telomere repeat factor 2 (TRF2) and protection of telomeres protein 1 (POT1), whereas other histone H2A isotypes and mutations of H2ac did not bind to telomeres or these two proteins. The amino terminal basic domain of TRF2 was necessary for the association with H2ac and for the recruitment of H2ac to telomeres. Depletion of H2ac led to loss of telomeric repeat sequences, the appearance of dysfunctional telomeres, and chromosomal instability, including chromosomal breaks and anaphase bridges, as well as accumulation of telomere-associated DNA damage factors in H2ac depleted cells. Additionally, knockdown of H2ac elicits an ATM-dependent DNA damage response at telomeres and depletion of XPF protects telomeres against H2ac-deficiency-induced G-strand overhangs loss and DNA damage response, and prevents chromosomal instability. These findings suggest that the H2A isotype, H2ac, plays an essential role in maintaining telomere functional integrity.	[Su, Chia-Hsin; Cheng, Ching; Lin, I-Hsuan; Hsu, Ming-Ta] Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Tzeng, Tsai-Yu; Hsu, Ming-Ta] Univ Syst Taiwan, Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 11221, Taiwan; [Hsu, Ming-Ta] Chien Tien Hsu Canc Res Fdn, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hsu, MT (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 11221, Taiwan.; Hsu, MT (corresponding author), Univ Syst Taiwan, Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 11221, Taiwan.; Hsu, MT (corresponding author), Chien Tien Hsu Canc Res Fdn, Taipei 11221, Taiwan.	mth@ym.edu.tw	Lin, I-Hsuan/N-6501-2013	Lin, I-Hsuan/0000-0002-6207-1299; Tzeng, Tsai-Yu/0000-0001-7334-6270	Ministry of Education, Aim for the Top University Plan	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by a grant from the Ministry of Education, Aim for the Top University Plan.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gomez D, 2004, J BIOL CHEM, V279, P41487, DOI 10.1074/jbc.M406123200; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; McNeil EM, 2012, NUCLEIC ACIDS RES, V40, P9990, DOI 10.1093/nar/gks818; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Ortega LM, 2011, BIOTECHNIQUES, V50, P407, DOI 10.2144/000113687; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Su CH, 2014, NUCLEIC ACIDS RES, V42, P3073, DOI 10.1093/nar/gkt1341; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wan BB, 2013, CELL REP, V4, P861, DOI 10.1016/j.celrep.2013.08.017; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wu YL, 2007, DNA REPAIR, V6, P157, DOI 10.1016/j.dnarep.2006.09.005; Wu YL, 2008, MECH AGEING DEV, V129, P602, DOI 10.1016/j.mad.2008.08.004; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Zhou BO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001272; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	63	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156378	10.1371/journal.pone.0156378	http://dx.doi.org/10.1371/journal.pone.0156378			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228173	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500126
J	Keiter, DA; Cunningham, FL; Rhodes, OE; Irwin, BJ; Beasley, JC				Keiter, David A.; Cunningham, Fred L.; Rhodes, Olin E., Jr.; Irwin, Brian J.; Beasley, James C.			Optimization of Scat Detection Methods for a Social Ungulate, the Wild Pig, and Experimental Evaluation of Factors Affecting Detection of Scat	PLOS ONE			English	Article							BOAR SUS-SCROFA; POPULATION-SIZE; SOUTH-CAROLINA; FECAL DNA; DEER; SELECTION; GENETICS; IMPACT; RANGE; FECES	Collection of scat samples is common in wildlife research, particularly for genetic capture-mark-recapture applications. Due to high degradation rates of genetic material in scat, large numbers of samples must be collected to generate robust estimates. Optimization of sampling approaches to account for taxa-specific patterns of scat deposition is, therefore, necessary to ensure sufficient sample collection. While scat collection methods have been widely studied in carnivores, research to maximize scat collection and noninvasive sampling efficiency for social ungulates is lacking. Further, environmental factors or scat morphology may influence detection of scat by observers. We contrasted performance of novel radial search protocols with existing adaptive cluster sampling protocols to quantify differences in observed amounts of wild pig (Sus scrofa) scat. We also evaluated the effects of environmental (percentage of vegetative ground cover and occurrence of rain immediately prior to sampling) and scat characteristics (fecal pellet size and number) on the detectability of scat by observers. We found that 15- and 20-m radial search protocols resulted in greater numbers of scats encountered than the previously used adaptive cluster sampling approach across habitat types, and that fecal pellet size, number of fecal pellets, percent vegetative ground cover, and recent rain events were significant predictors of scat detection. Our results suggest that use of a fixed-width radial search protocol may increase the number of scats detected for wild pigs, or other social ungulates, allowing more robust estimation of population metrics using noninvasive genetic sampling methods. Further, as fecal pellet size affected scat detection, juvenile or smaller-sized animals may be less detectable than adult or large animals, which could introduce bias into abundance estimates. Knowledge of relationships between environmental variables and scat detection may allow researchers to optimize sampling protocols to maximize utility of noninvasive sampling for wild pigs and other social ungulates.	[Keiter, David A.; Rhodes, Olin E., Jr.; Beasley, James C.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Keiter, David A.; Beasley, James C.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Cunningham, Fred L.] US Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, USDA, Starkville, MS USA; [Rhodes, Olin E., Jr.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Irwin, Brian J.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Georgia Cooperat Fish & Wildlife Res Unit, US Geol Survey, Athens, GA 30602 USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; United States Department of the Interior; United States Geological Survey; University System of Georgia; University of Georgia	Keiter, DA (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA.; Keiter, DA (corresponding author), Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	david.keiter@gmail.com			United States Department of Energy [DE-FC09-07SR22506]; United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center; U.S. Geological Survey; Georgia Department of Natural Resources; U.S. Fish and Wildlife Service; University of Georgia; Wildlife Management Institute; United States Government	United States Department of Energy(United States Department of Energy (DOE)); United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center(United States Department of Agriculture (USDA)); U.S. Geological Survey(United States Geological Survey); Georgia Department of Natural Resources; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); University of Georgia; Wildlife Management Institute; United States Government	Funding for this research was provided by the United States Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation and the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center (https://www.aphis.usda.gov/wps/portal/aphis/ourfocus/wildlifedamage?urile=wcm%3Apath%3A%2FAPHIS_Content_Library%2FSA_Our_Focus%2FSA_Wildlife_Damage%2FSA_Programs%2FSA_NWRC). Researchers at the USDA-APHIS National Wildlife Research Center participated in design of this study and preparation of the manuscript.; We thank the volunteers in the fall 2014 Wildlife Techniques course at the University of Georgia who assisted with this research and L. Lee for her photograph of bottomland hardwood habitat at the Savannah River Site. All other photographs were provided by D. Keiter. The Georgia Cooperative Fish and Wildlife Research Unit is sponsored jointly by the U.S. Geological Survey, the Georgia Department of Natural Resources, the U.S. Fish and Wildlife Service, the University of Georgia, and the Wildlife Management Institute. This paper was prepared as an account of work sponsored by an agency of the United States Government. Neither the U.S. Department of Agriculture, nor any of its employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The views and opinions of authors expressed herein do not necessarily state or reflect those of the U.S. Department of Agriculture. Although these data have been processed successfully on a computer system at the U.S. Geological Survey (USGS), no warranty expressed or implied is made regarding the display or utility of the data or associated code on any other system or for general or scientific purposes, nor shall the act of distribution constitute any such warranty. The USGS or the U.S. Government shall not be held liable for improper or incorrect use of the data or code described and/or contained herein.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Bevins SN, 2014, BIOSCIENCE, V64, P291, DOI 10.1093/biosci/biu015; Brinkman TJ, 2010, CONSERV GENET, V11, P1547, DOI 10.1007/s10592-009-9928-7; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; DeVault TL, 2004, CONDOR, V106, P706, DOI 10.1650/7461; Ebert C, 2012, WILDLIFE BIOL, V18, P142, DOI 10.2981/11-002; Ebert C, 2010, WILDLIFE BIOL, V16, P225, DOI 10.2981/09-108; Ebert Cornelia, 2009, Acta Silvatica & Lignaria Hungarica, V5, P167; Ferretti F, 2015, WILDLIFE SOC B, V39, P65, DOI 10.1002/wsb.494; Gabor TM, 1999, J ZOOL, V247, P311, DOI 10.1111/j.1469-7998.1999.tb00994.x; Gaines KF, 2005, HUM ECOL RISK ASSESS, V11, P567, DOI 10.1080/10807030590949654; Guthlin D, 2012, WILDLIFE BIOL, V18, P374, DOI 10.2981/11-065; Imm D.W., 2005, ECOLOGY MANAGEMENT F, P106; Irwin BJ, 2013, T AM FISH SOC, V142, P171, DOI 10.1080/00028487.2012.728163; Jadeja S, 2013, OIKOS, V122, P1441, DOI 10.1111/j.1600-0706.2013.00320.x; Jeffress MR, 2011, J WILDLIFE MANAGE, V75, P144, DOI 10.1002/jwmg.12; Keiter DA, 2016, WILDLIFE SO IN PRESS; Kerley LL, 2015, INTEGR ZOOL, V10, P354, DOI 10.1111/1749-4877.12135; Kluever BM, 2015, WILDLIFE RES, V42, P75, DOI 10.1071/WR14244; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; KURZ JC, 1972, J WILDLIFE MANAGE, V36, P1240, DOI 10.2307/3799254; Lonsinger RC, 2015, MOL ECOL RESOUR, V15, P831, DOI 10.1111/1755-0998.12356; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; Massei Giovanna, 2004, Galemys, V16, P135; Meisingset EL, 2013, J WILDLIFE MANAGE, V77, P181, DOI 10.1002/jwmg.469; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Murphy MA, 2007, CONSERV GENET, V8, P1219, DOI 10.1007/s10592-006-9264-0; Oldham AR, 2009, NW NAT, V90, P207, DOI DOI 10.1898/NWN08-20.1; PHILLIPS MK, 1991, J WILDLIFE DIS, V27, P498, DOI 10.7589/0090-3558-27.3.498; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Rodgers TW, 2014, TROP CONSERV SCI, V7, P690, DOI 10.1177/194008291400700408; SAWYER TG, 1990, WILDLIFE SOC B, V18, P16; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Steenweg R, 2015, MAMMAL RES, V60, P207, DOI 10.1007/s13364-015-0222-4; Switzer GL., 1980, FOREST COVER TYPES U, P61; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; THOMPSON SK, 1991, BIOMETRICS, V47, P1103, DOI 10.2307/2532662; Torres RT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129379; Tredick CA, 2007, URSUS, V18, P179, DOI 10.2192/1537-6176(2007)18[179:SGDTEB]2.0.CO;2; Vynne C, 2012, ANIM CONSERV, V15, P184, DOI 10.1111/j.1469-1795.2011.00503.x; Woodruff SP, 2015, MOL ECOL RESOUR, V15, P843, DOI 10.1111/1755-0998.12362	43	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155615	10.1371/journal.pone.0155615	http://dx.doi.org/10.1371/journal.pone.0155615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224453	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700023
J	Ramanathan, B; Poh, CL; Kirk, K; McBride, WJH; Aaskov, J; Grollo, L				Ramanathan, Babu; Poh, Chit Laa; Kirk, Kristin; McBride, William John Hannan; Aaskov, John; Grollo, Lara			Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine	PLOS ONE			English	Article							VIRUS ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; DOMAIN-III; REACTIVE ANTIBODIES; MASS-SPECTROMETRY; IMMUNE-RESPONSE; PROTEIN; IDENTIFICATION; PEPTIDES; INFECTION	Dengue virus (DENV) is a major public health threat worldwide. A key element in protection from dengue fever is the neutralising antibody response. Anti-dengue IgG purified from DENV-2 infected human sera showed reactivity against several peptides when evaluated by ELISA and epitope extraction techniques. A multi-step computational approach predicted six antigenic regions within the E protein of DENV-2 that concur with the 6 epitopes identified by the combined ELISA and epitope extraction approach. The selected peptides representing B-cell epitopes were attached to a known dengue T-helper epitope and evaluated for their vaccine potency. Immunization of mice revealed two novel synthetic vaccine constructs that elicited good humoral immune responses and produced cross-reactive neutralising antibodies against DENV-1, 2 and 3. The findings indicate new directions for epitope mapping and contribute towards the future development of multi-epitope based synthetic peptide vaccine.	[Ramanathan, Babu; Poh, Chit Laa] Sunway Univ, Biomed Sci Res Ctr, Kuala Lumpur, Malaysia; [Kirk, Kristin] Swinburne Univ Technol, Melbourne, Vic, Australia; [McBride, William John Hannan] James Cook Univ, Sch Clin, Cairns Base Hosp, Cairns, Qld, Australia; [Aaskov, John] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Grollo, Lara] Australian Catholic Univ, Melbourne, Vic, Australia	Sunway University; Swinburne University of Technology; James Cook University; Queensland University of Technology (QUT); Australian Catholic University	Ramanathan, B (corresponding author), Sunway Univ, Biomed Sci Res Ctr, Kuala Lumpur, Malaysia.	babur@sunway.edu.my	McBride, William John Hannan/B-9145-2008; Ramanathan, Babu/M-5959-2015	McBride, William John Hannan/0000-0001-8894-533X; Ramanathan, Babu/0000-0002-8216-3916	Swinburne University of Technology: Researcher Development Scheme, Melbourne, Australia; Grollo Ruzzene Foundation; International Post-graduate Research Scholarship (IPRS); Sunway University, Kuala Lumpur, Malaysia [INT-VCO-2016-01]	Swinburne University of Technology: Researcher Development Scheme, Melbourne, Australia; Grollo Ruzzene Foundation; International Post-graduate Research Scholarship (IPRS)(Australian Government); Sunway University, Kuala Lumpur, Malaysia	The work was supported by Swinburne University of Technology: Researcher Development Scheme, Melbourne, Australia, and Grollo Ruzzene Foundation Research Grant. Babu Ramanathan was supported by an International Post-graduate Research Scholarship (IPRS). Support of a Research Fellowship to Babu Ramanathan and funding from internal research grant (INT-VCO-2016-01) from Sunway University, Kuala Lumpur, Malaysia is gratefully acknowledged.	AASKOV JG, 1989, ARCH VIROL, V105, P209, DOI 10.1007/BF01311358; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amexis G, 2007, VIRAL IMMUNOL, V20, P657, DOI 10.1089/vim.2007.0029; Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chen YF, 2004, J VIROL, V78, P1333, DOI 10.1128/JVI.78.3.1333-1343.2004; Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Dunn MD, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-95; ESWAR N, 2001, COMP PROTEIN STRUCTU; Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646; Falconar AKI, 2008, J GEN VIROL, V89, P1616, DOI 10.1099/vir.0.83648-0; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341; Frei JC, 2015, VIROLOGY, V485, P371, DOI 10.1016/j.virol.2015.08.011; Ghosh S, 1999, INT IMMUNOL, V11, P1103, DOI 10.1093/intimm/11.7.1103; Grollo L, 2006, ANTIVIR THER, V11, P1005; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Hager-Braun C, 2005, EXPERT REV PROTEOMIC, V2, P745, DOI 10.1586/14789450.2.5.745; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Kirk K, 2012, VACCINE, V30, P7105, DOI 10.1016/j.vaccine.2012.09.030; Kuprianova MA, 2000, BIOORG KHIM+, V26, P926; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004; Li SF, 2011, VACCINE, V29, P3695, DOI 10.1016/j.vaccine.2011.03.002; Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Mazumder R, 2007, VIRUS GENES, V35, P175, DOI 10.1007/s11262-007-0103-2; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Ng LC, 2015, AM J TROP MED HYG, V92, P1150, DOI 10.4269/ajtmh.14-0588; Parker CE, 2002, MOL BIOTECHNOL, V20, P49, DOI 10.1385/MB:20:1:049; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poh CL, 2015, METHODS MOL BIOL, V1348, P341, DOI 10.1007/978-1-4939-2999-3_29; Rajamanonmani R, 2009, J GEN VIROL, V90, P799, DOI 10.1099/vir.0.006874-0; da Silva ANMR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007425; Rocha RP, 2014, VIRUS RES, V188, P122, DOI 10.1016/j.virusres.2014.04.009; ROEHRIG JT, 1994, VIROLOGY, V198, P31, DOI 10.1006/viro.1994.1005; ROEHRIG JT, 1992, J VIROL, V66, P3385, DOI 10.1128/JVI.66.6.3385-3390.1992; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sanchez-Burgos G, 2010, VIRUS RES, V153, P113, DOI 10.1016/j.virusres.2010.07.014; Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10; Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Testa JS, 2012, FUTURE VIROL, V7, P1077, DOI 10.2217/FVL.12.108; Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Zeng WG, 2005, VACCINE, V23, P4427, DOI 10.1016/j.vaccine.2005.04.015	58	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155900	10.1371/journal.pone.0155900	http://dx.doi.org/10.1371/journal.pone.0155900			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223692	Green Accepted, Green Published, gold			2022-12-26	WOS:000376881700038
J	Xie, Y; Li, M; Chang, WR				Xie, Yuan; Li, Mei; Chang, Wenrui			Crystal Structures of Putative Sugar Kinases from Synechococcus Elongatus PCC 7942 and Arabidopsis Thaliana	PLOS ONE			English	Article							GLYCEROL KINASE; ESCHERICHIA-COLI; XYLULOSE KINASE; MECHANISM; CONFORMATION; REVEAL; ENZYME	The genome of the Synechococcus elongatus strain PCC 7942 encodes a putative sugar kinase (SePSK), which shares 44.9% sequence identity with the xylulose kinase-1 (AtXK-1) from Arabidopsis thaliana. Sequence alignment suggests that both kinases belong to the ribulokinase-like carbohydrate kinases, a sub-family of FGGY family carbohydrate kinases. However, their exact physiological function and real substrates remain unknown. Here we solved the structures of SePSK and AtXK-1 in both their apo forms and in complex with nucleotide substrates. The two kinases exhibit nearly identical overall architecture, with both kinases possessing ATP hydrolysis activity in the absence of substrates. In addition, our enzymatic assays suggested that SePSK has the capability to phosphorylate D-ribulose. In order to understand the catalytic mechanism of SePSK, we solved the structure of SePSK in complex with D-ribulose and found two potential substrate binding pockets in SePSK. Using mutation and activity analysis, we further verified the key residues important for its catalytic activity. Moreover, our structural comparison with other family members suggests that there are major conformational changes in SePSK upon substrate binding, facilitating the catalytic process. Together, these results provide important information for a more detailed understanding of the cofactor and substrate binding mode as well as the catalytic mechanism of SePSK, and possible similarities with its plant homologue AtXK-1.	[Xie, Yuan; Li, Mei; Chang, Wenrui] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Xie, Yuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, M; Chang, WR (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	meili@moon.ibp.ac.cn; wrchang@sun5.ibp.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020302]; National Natural Science Foundation of China [31270793]; Ministry of Science and Technology of the People's Republic of China [2011CBA00902]; CAS Cross and Cooperation Team for Scientific Innovation [Y31102110A]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); CAS Cross and Cooperation Team for Scientific Innovation	This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020302), the National Natural Science Foundation of China (31270793), the Ministry of Science and Technology of the People's Republic of China (2011CBA00902) and the CAS Cross and Cooperation Team for Scientific Innovation (Y31102110A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Agarwal R, 2012, PROTEINS, V80, P261, DOI 10.1002/prot.23202; Bunker RD, 2013, J BIOL CHEM, V288, P1643, DOI 10.1074/jbc.M112.427997; Bystrom CE, 1999, BIOCHEMISTRY-US, V38, P3508, DOI 10.1021/bi982460z; DeLano W.L., PYMOL MOL GRAPHICS S; Di Luccio E, 2007, J MOL BIOL, V365, P783, DOI 10.1016/j.jmb.2006.10.068; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feese MD, 1998, STRUCTURE, V6, P1407, DOI 10.1016/S0969-2126(98)00140-3; Grueninger D, 2006, J MOL BIOL, V359, P787, DOI 10.1016/j.jmb.2006.04.013; Hemmerlin A, 2006, PLANT PHYSIOL, V142, P441, DOI 10.1104/pp.106.086652; Higgins MA, 2014, J MOL BIOL, V426, P1469, DOI 10.1016/j.jmb.2013.12.006; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettigrew DW, 1998, ARCH BIOCHEM BIOPHYS, V349, P236, DOI 10.1006/abbi.1997.0444; Sanghera J, 2009, ASSAY DRUG DEV TECHN, V7, P615, DOI 10.1089/adt.2009.0237; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Yeh JI, 2004, BIOCHEMISTRY-US, V43, P362, DOI 10.1021/bi034258o; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002318	23	0	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156067	10.1371/journal.pone.0156067	http://dx.doi.org/10.1371/journal.pone.0156067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223615	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700057
J	Inui, K; Nakagawa, K; Nishihara, M; Motomura, E; Kakigi, R				Inui, Koji; Nakagawa, Kei; Nishihara, Makoto; Motomura, Eishi; Kakigi, Ryusuke			Inhibition in the Human Auditory Cortex	PLOS ONE			English	Article							GABAERGIC CELL SUBTYPES; PREPULSE INHIBITION; POSTSYNAPTIC POTENTIALS; RAT; INTERNEURONS; GABA; STARTLE; NEURONS; CONNECTIVITY; DEPRESSION	Despite their indispensable roles in sensory processing, little is known about inhibitory interneurons in humans. Inhibitory postsynaptic potentials cannot be recorded non-invasively, at least in a pure form, in humans. We herein sought to clarify whether prepulse inhibition (PPI) in the auditory cortex reflected inhibition via interneurons using magnetoencephalography. An abrupt increase in sound pressure by 10 dB in a continuous sound was used to evoke the test response, and PPI was observed by inserting a weak (5 dB increase for 1 ms) prepulse. The time course of the inhibition evaluated by prepulses presented at 10-800 ms before the test stimulus showed at least two temporally distinct inhibitions peaking at approximately 20-60 and 600 ms that presumably reflected IPSPs by fast spiking, parval-bumin-positive cells and somatostatin-positive, Martinotti cells, respectively. In another experiment, we confirmed that the degree of the inhibition depended on the strength of the prepulse, but not on the amplitude of the prepulse-evoked cortical response, indicating that the prepulse-evoked excitatory response and prepulse-evoked inhibition reflected activation in two different pathways. Although many diseases such as schizophrenia may involve deficits in the inhibitory system, we do not have appropriate methods to evaluate them; therefore, the easy and non-invasive method described herein may be clinically useful.	[Inui, Koji; Nakagawa, Kei; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Tokyo, Japan; [Nishihara, Makoto] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi, Japan; [Motomura, Eishi] Mie Univ, Grad Sch Med, Dept Neuropsychiat, Tsu, Mie, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Aichi Medical University; Mie University	Inui, K (corresponding author), Natl Inst Physiol Sci, Dept Integrat Physiol, Tokyo, Japan.	inui@nips.ac.jp			Smoking Research Foundation (Tokutei); JSPS KAKENHI [25351001]	Smoking Research Foundation (Tokutei); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Smoking Research Foundation (Tokutei) (http://www.srf.or.jp/) and JSPS KAKENHI (25351001) (https://www.jsps.go.jp/j-grantsinaid/) to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVOLI M, 1986, BRAIN RES, V370, P165, DOI 10.1016/0006-8993(86)91118-2; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; BENARDO LS, 1994, J PHYSIOL-LONDON, V476, P203, DOI 10.1113/jphysiol.1994.sp020124; Berger TK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000473; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; EMRICH HM, 1980, ARCH PSYCHIAT NERVEN, V229, P1, DOI 10.1007/BF00343800; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; Fino E, 2013, NEUROSCIENTIST, V19, P228, DOI 10.1177/1073858412456743; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gironell A, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8SF2T9C; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Inui K, 2006, CEREB CORTEX, V16, P18, DOI 10.1093/cercor/bhi080; Inui K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-588; Inui K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-135; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-135; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-80; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Karnani MM, 2014, CURR OPIN NEUROBIOL, V26, P96, DOI 10.1016/j.conb.2013.12.015; KAWAGUCHI Y, 1992, EXP BRAIN RES, V88, P33, DOI 10.1007/BF02259126; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kodaira M, 2013, BEHAV BRAIN RES, V256, P27, DOI 10.1016/j.bbr.2013.07.045; Kofler M, 2013, CLIN NEUROPHYSIOL, V124, P126, DOI 10.1016/j.clinph.2012.07.001; Kumari V, 2011, CURR TOP BEHAV NEURO, V8, P141, DOI 10.1007/7854_2010_117; Lewis DA, 2014, CURR OPIN NEUROBIOL, V26, P22, DOI 10.1016/j.conb.2013.11.003; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MCCORMICK DA, 1989, J NEUROPHYSIOL, V62, P1018, DOI 10.1152/jn.1989.62.5.1018; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; MEINECKE DL, 1987, J COMP NEUROL, V261, P388, DOI 10.1002/cne.902610305; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Moore AK, 2013, J NEUROSCI, V33, P13713, DOI 10.1523/JNEUROSCI.0663-13.2013; Nakagawa K, 2014, NEUROIMAGE, V86, P131, DOI 10.1016/j.neuroimage.2013.07.082; Nishihara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106553; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Okada Y., 1983, BIOMAGNETISM INTERDI; Otsuru N, 2012, PSYCHOPHARMACOLOGY, V224, P327, DOI 10.1007/s00213-012-2757-2; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Pehrson AL, 2015, DRUG DES DEV THER, V9, P603, DOI 10.2147/DDDT.S62912; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Swerdlow NR, 2004, BIOL PSYCHIAT, V55, P1195, DOI 10.1016/j.biopsych.2004.02.030; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tanahashi M, 2016, NEUROSCI RES, V103, P34, DOI 10.1016/j.neures.2015.08.005; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Yamashiro K, 2011, PSYCHOPHYSIOLOGY, V48, P23, DOI 10.1111/j.1469-8986.2010.01038.x	68	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155972	10.1371/journal.pone.0155972	http://dx.doi.org/10.1371/journal.pone.0155972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219470	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700031
J	Salinas, DB; Sosnay, PR; Azen, C; Young, S; Raraigh, KS; Keens, TG; Kharrazi, M				Salinas, Danieli B.; Sosnay, Patrick R.; Azen, Colleen; Young, Suzanne; Raraigh, Karen S.; Keens, Thomas G.; Kharrazi, Martin			Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California	PLOS ONE			English	Article							CFTR-RELATED DISORDERS; PSEUDOMONAS-AERUGINOSA; PRACTICE GUIDELINES; GENE MUTATION; INFANTS; DIAGNOSIS; VARIANTS; DISEASE; MANAGEMENT; RECOMMENDATIONS	Background Of the 2007 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutations, 202 have been assigned disease liability. California's racially diverse population, along with CFTR sequencing as part of newborn screening model, provides the opportunity to examine the phenotypes of children with uncategorized mutations to help inform disease liability and penetrance. Methods We conducted a retrospective cohort study based on children screened from 2007 to 2011 and followed for two to six years. Newborns that screened positive were divided into three genotype groups: those with two CF-causing mutations (CF-C); those with one mutation of varying clinic consequence (VCC); and those with one mutation of unknown disease liability (Unknown). Sweat chloride tests, pancreatic sufficiency status, and Pseudomonas aeruginosa colonization were compared. Results Children with two CF-causing mutations had a classical CF phenotype, while 5% of VCC (4/78) and 11% of Unknown (27/244) met diagnostic criteria of CF. Children carrying Unknown mutations 2215insG with D836Y, and T1036N had early and classical CF phenotype, while others carrying 1525-42G> A, L320V, L967S, R170H, and 296+28A>G had a benign clinical presentation, suggesting that these are non-CF causing. Conclusions While most infants with VCC and Unknown CFTR mutations do not meet diagnostic criteria for CF, a small proportion do. These findings highlight the range of genotypes and phenotypes in the first few years of life following CF newborn screening when CFTR sequencing is performed.	[Salinas, Danieli B.; Keens, Thomas G.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pediat,Div Pediat Pulmonol, Los Angeles, CA 90033 USA; [Sosnay, Patrick R.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Sosnay, Patrick R.; Raraigh, Karen S.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Med Genet, Baltimore, MD USA; [Azen, Colleen] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Biostat,Southern Calif Clin & Translat Sci I, Los Angeles, CA 90033 USA; [Young, Suzanne] Sequoia Fdn, La Jolla, CA USA; [Kharrazi, Martin] Calif Dept Publ Hlth, Div Environm & Occupat Dis Control, Environm Hlth Investigat Branch, Environm Epidemiol Sect, Richmond, CA USA	Children's Hospital Los Angeles; University of Southern California; Johns Hopkins University; Johns Hopkins University; Children's Hospital Los Angeles; University of Southern California; California Department of Public Health	Salinas, DB (corresponding author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pediat,Div Pediat Pulmonol, Los Angeles, CA 90033 USA.	dsalinas@chla.usc.edu			National Institute of Health: SC-CTSI (NIH/NCRR/NCATS) [KL2TR000131]; Division of Pediatric Pulmonology at the Children's Hospital Los Angeles; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000131] Funding Source: NIH RePORTER	National Institute of Health: SC-CTSI (NIH/NCRR/NCATS); Division of Pediatric Pulmonology at the Children's Hospital Los Angeles; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study received support from the National Institute of Health: SC-CTSI (NIH/NCRR/NCATS; Grant # KL2TR000131) and the Division of Pediatric Pulmonology at the Children's Hospital Los Angeles.	Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Borowitz D, 2009, J PEDIATR-US, V155, pS73, DOI 10.1016/j.jpeds.2009.09.001; Borowitz D, 2009, J PEDIATR-US, V155, pS106, DOI 10.1016/j.jpeds.2009.09.003; Burgel PR, 2010, CLIN GENET, V77, P355, DOI 10.1111/j.1399-0004.2009.01294.x; Carlson D, 2009, PEDIATR PULM, V44, P497, DOI 10.1002/ppul.21029; CLAUSTRES M, 1993, HUM MOL GENET, V2, P1209, DOI 10.1093/hmg/2.8.1209; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; Dequeker E, 2009, EUR J HUM GENET, V17, P51, DOI 10.1038/ejhg.2008.136; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; Hayes D, 2010, PEDIATR PULM, V45, P708, DOI 10.1002/ppul.21263; Kharrazi M, 2015, PEDIATRICS, V136, P1062, DOI 10.1542/peds.2015-0811; LaRusch J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004376; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Massie J, 2014, PEDIATR PULM, V49, P1, DOI 10.1002/ppul.22933; Mayell SJ, 2009, J CYST FIBROS, V8, P71, DOI 10.1016/j.jcf.2008.09.005; O'Sullivan BP, 2013, J PEDIATR-US, V162, P808, DOI 10.1016/j.jpeds.2012.10.008; Ooi CY, 2015, PEDIATRICS, V135, pE1377, DOI 10.1542/peds.2014-2081; Ooi CY, 2012, THORAX, V67, P618, DOI 10.1136/thoraxjnl-2011-201454; Pelletier AL, 2010, PANCREATOLOGY, V10, P158, DOI 10.1159/000231976; Pont-Kingdon G, 2004, J MOL DIAGN, V6, P264, DOI 10.1016/S1525-1578(10)60520-X; Prach L, 2013, J MOL DIAGN, V15, P710, DOI 10.1016/j.jmoldx.2013.05.006; Ren CL, 2015, PEDIATRICS, V135, pE1386, DOI 10.1542/peds.2014-3698; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; Rosenfeld M, 2012, J CYST FIBROS, V11, P456, DOI 10.1016/j.jcf.2012.04.004; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Salinas DB, 2015, J CYST FIBROS, V14, P714, DOI 10.1016/j.jcf.2015.03.006; Schrijver I, 2005, J MOL DIAGN, V7, P289, DOI 10.1016/S1525-1578(10)60557-0; Schrijver I, 2016, J MOL DIAGN, V18, P39, DOI 10.1016/j.jmoldx.2015.07.005; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Wagener JS, 2012, CURR OPIN PEDIATR, V24, P329, DOI 10.1097/MOP.0b013e328353489a; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C	35	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155624	10.1371/journal.pone.0155624	http://dx.doi.org/10.1371/journal.pone.0155624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214204	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200020
J	Wang, CH; Yu, J; Cai, YX; Zhu, PP; Liu, CY; Zhao, AC; Lu, RH; Li, MJ; Xu, FX; Yu, MD				Wang, Chuan-Hong; Yu, Jian; Cai, Yu-Xiang; Zhu, Pan-Pan; Liu, Chang-Ying; Zhao, Ai-Chun; Lu, Rui-Hua; Li, Meng-Jiao; Xu, Feng-Xiang; Yu, Mao-De			Characterization and Functional Analysis of 4-Coumarate: CoA Ligase Genes in Mul-berry	PLOS ONE			English	Article							DIVERGENT MEMBERS; FAMILY; BIOSYNTHESIS; EXPRESSION; RESVERATROL; MULBERRY; LIGNIN; DISTINCT; SUPPRESSION; STILBENES	A small, multigene family encodes 4-coumarate: CoA ligases (4CLs) that catalyze the ligation of CoA to hydroxycinnamic acids, a branch point directing metabolites to flavonoid or monolignol pathways. In this study, we characterized four 4CL genes from M. notabilis Genome Database, and cloned four Ma4CL genes from M. atropurpurea cv. Jialing No. 40. A tissue-specific expression analysis indicated that Ma4CL3 was expressed at higher levels than the other genes, and that Ma4CL3 was strongly expressed in root bark, stem bark, and old leaves. Additionally, the expression pattern of Ma4CL3 was similar to the trend of the total flavonoid content throughout fruit development. A phylogenetic analysis suggested that Mn4CL1, Mn4CL2, and Mn4CL4 belong to class I 4CLs, and Mn4CL3 belongs to class II 4CLs. Ma4CL genes responded differently to a series of stresses. Ma4CL3 expression was higher than that of the other Ma4CL genes following wounding, salicylic acid, and ultraviolet treatments. An in vitro enzyme assay indicated that 4-coumarate acid was the best substrate among cinnamic acid, 4-coumarate acid, and caffeate acid, but no catalytic activity to sinapate acid and ferulate acid. The results of subcellular localization experiments showed that Ma4CL3 localized to the cytomembrane, where it activated transcription. We used different vectors and strategies to fuse Ma4CL3 with stilbene synthase (STS) to construct four Ma4CL-MaSTS co-expression systems to generate resveratrol. The results indicated that only a transcriptional fusion vector, pET-Ma4CL3-T-MaSTS, which utilized a T7 promoter and lac operator for the expression of MaSTS, could synthesize resveratrol.	[Wang, Chuan-Hong; Yu, Jian; Cai, Yu-Xiang; Zhu, Pan-Pan; Liu, Chang-Ying; Zhao, Ai-Chun; Lu, Rui-Hua; Li, Meng-Jiao; Xu, Feng-Xiang; Yu, Mao-De] Southwest Univ, State Key Lab Silkworm Genome Biol, Coll Biotechnol, Chongqing 400716, Peoples R China	Southwest University - China	Yu, MD (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Coll Biotechnol, Chongqing 400716, Peoples R China.	yumd@163.com	Zhao, Aichun/T-4308-2018	Zhao, Aichun/0000-0001-6140-0102	Fundamental Research Funds for the Central Universities [XDJK2016D024]; China Special Fund for Agroscientific Research in the Public Interest [201403064]; China Agriculture Research System [CARS-22]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Special Fund for Agroscientific Research in the Public Interest; China Agriculture Research System	Funded by Fundamental Research Funds for the Central Universities (grant No. XDJK2016D024), the China Special Fund for Agroscientific Research in the Public Interest (grant No. 201403064), and the China Agriculture Research System (grant No. CARS-22).	Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beekwilder J, 2006, APPL ENVIRON MICROB, V72, P5670, DOI 10.1128/AEM.00609-06; BEGGS CJ, 1985, PHOTOCHEM PHOTOBIOL, V41, P481, DOI 10.1111/j.1751-1097.1985.tb03515.x; Chang LW, 2011, FOOD CHEM TOXICOL, V49, P785, DOI 10.1016/j.fct.2010.11.045; CHAPPELL J, 1984, NATURE, V311, P76, DOI 10.1038/311076a0; Checker VG, 2013, PLANT CELL REP, V32, P1729, DOI 10.1007/s00299-013-1483-5; de Bruxelles GL, 2001, CRIT REV PLANT SCI, V20, P487, DOI 10.1016/S0010-8545(02)00029-2; Donnez D, 2009, TRENDS BIOTECHNOL, V27, P706, DOI 10.1016/j.tibtech.2009.09.005; Dore S, 2005, NEUROSIGNALS, V14, P61, DOI 10.1159/000085386; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Eyles A, 2010, NEW PHYTOL, V185, P893, DOI 10.1111/j.1469-8137.2009.03127.x; Gaid MM, 2011, J PLANT PHYSIOL, V168, P944, DOI 10.1016/j.jplph.2010.11.021; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Halliwell B, 2007, CARDIOVASC RES, V73, P341, DOI 10.1016/j.cardiores.2006.10.004; Hamberger B, 2004, P NATL ACAD SCI USA, V101, P2209, DOI 10.1073/pnas.0307307101; HAUFFE KD, 1991, PLANT CELL, V3, P435, DOI 10.1105/tpc.3.5.435; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; Hu WJ, 1998, P NATL ACAD SCI USA, V95, P5407, DOI 10.1073/pnas.95.9.5407; Jenkins ME, 1997, PLANT PHYSIOL, V115, P1351, DOI 10.1104/pp.115.4.1351; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kajita S, 1996, PLANT CELL PHYSIOL, V37, P957, DOI 10.1093/oxfordjournals.pcp.a029045; Katsuyama Y, 2007, CHEM BIOL, V14, P613, DOI 10.1016/j.chembiol.2007.05.004; Kumar A, 2003, PLANT MOL BIOL, V51, P327, DOI 10.1023/A:1022004923982; Lee D, 1997, PLANT CELL, V9, P1985, DOI 10.1105/tpc.9.11.1985; Lee D, 1996, PLANT PHYSIOL, V112, P193, DOI 10.1104/pp.112.1.193; Li Jun, 2011, Acta Agronomica Sinica, V37, P641, DOI 10.3724/SP.J.1006.2011.00641; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Li Y, 2015, PLANT PHYSIOL, V169, P2409, DOI 10.1104/pp.15.00838; Lin JS, 2013, PLANT J, V75, P781, DOI 10.1111/tpj.12238; Lindermayr C, 2002, EUR J BIOCHEM, V269, P1304, DOI 10.1046/j.1432-1033.2002.02775.x; Liu XM, 2004, J BIOMED BIOTECHNOL, P326, DOI 10.1155/S1110724304403052; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Silber MV, 2008, PHYTOCHEMISTRY, V69, P2449, DOI 10.1016/j.phytochem.2008.06.014; Soltani BM, 2006, PLANTA, V224, P1226, DOI 10.1007/s00425-006-0296-y; Sutela S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114434; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Wang ChuanHong, 2014, Scientia Silvae Sinicae, V50, P53; Wang YC, 2011, J AM CHEM SOC, V133, P20684, DOI 10.1021/ja2085993; Watts KT, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-22; Xu WR, 2011, J EXP BOT, V62, P2745, DOI 10.1093/jxb/erq447; Yan YJ, 2008, BIOTECHNOL BIOENG, V100, P126, DOI 10.1002/bit.21721; Yang JM, 2011, PLANT PHYSIOL BIOCH, V49, P103, DOI 10.1016/j.plaphy.2010.10.004; Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094; Zhang ZF, 2008, ENVIRON TOXICOL PHAR, V26, P325, DOI 10.1016/j.etap.2008.06.008	49	31	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155814	10.1371/journal.pone.0155814	http://dx.doi.org/10.1371/journal.pone.0155814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213624	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200025
J	Zhang, Y; Raychaudhuri, S; Wildsoet, CF				Zhang, Yan; Raychaudhuri, Suravi; Wildsoet, Christine F.			Imposed Optical Defocus Induces Isoform-Specific Up-Regulation of TGF beta Gene Expression in Chick Retinal Pigment Epithelium and Choroid but Not Neural Retina	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA; RECEPTOR EXPRESSION; INDUCED MYOPIA; EYE GROWTH; TGF-BETA-2; BFGF; PREVALENCE; SIGNATURES; PROTEIN	Purpose This study investigated the gene expression of TGF beta isoforms and their receptors in chick retina, retinal pigment epithelium (RPE), and choroid and the effects of short-term imposed optical defocus. Methods The expression of TGF beta isoforms (TGF-beta 1, 2, 3) and TGF beta receptors (TGFBR1, 2, 3) was examined in the retina, RPE, and choroid of young White-Leghorn untreated chicks (19 days-old). The effects on the expression of the same genes of monocular + 10 and -10 D defocusing lenses, worn for either 2 or 48 h by age-matched chicks, were also examined by comparing expression in treated and untreated fellow eyes. RNA was purified, characterized and then reverse transcribed to cDNA. Differential gene expression was quantified using real-time PCR. Results All 3 isoforms of TGF beta and all 3 receptor subtypes were found to be expressed in all 3 ocular tissues, with apparent tissue-dependent differences in expression profiles. Data are reported as mean normalized expression relative to GAPDH. Sign-dependent optical defocus effects were also observed. Optical defocus did not affect retinal gene expression but in the RPE, TGF-beta 2 expression was significantly up-regulated with + 10 D lenses, worn for either 2 h (349% increase +/- 88%, p < 0.01) or 48 h (752% increase +/- 166%, p < 0.001), and in the choroid, the expression of TGF-beta 3 was up-regulated with -10 D lenses, worn for 48 h (147% increase +/- 9%, p < 0.01). Conclusions The effects of short term exposure to optical defocus on TGF beta gene expression in the RPE and choroid, which were sign-dependent and isoform specific, provide further supporting evidence for important roles of members of the TGF beta family and these two tissues in local signal cascades regulating ocular growth.	[Zhang, Yan] Univ Calif Berkeley, Ctr Eye Dis & Dev, Vis Sci Program, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zhang, Y (corresponding author), Univ Calif Berkeley, Ctr Eye Dis & Dev, Vis Sci Program, Berkeley, CA 94720 USA.	yanzhang@berkeley.edu		Raychaudhuri, Suravi/0000-0001-6516-5293	National Eye Institute/National Institute of Health; NATIONAL EYE INSTITUTE [T32EY007043, K08EY023609, R01EY012392] Funding Source: NIH RePORTER	National Eye Institute/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute/National Institute of Health, https://nei.nih.gov/ (YZ CFW).	Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P3726, DOI 10.1167/iovs.09-4615; Brown NP, 1999, EYE, V13, P83, DOI 10.1038/eye.1999.16; Buck C, 2004, INVEST OPHTH VIS SCI, V45, P402, DOI 10.1167/iovs.03-0789; Chen BY, 2013, GRAEF ARCH CLIN EXP, V251, P1133, DOI 10.1007/s00417-013-2269-8; Dunker N, 2001, DEVELOPMENT, V128, P1933; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Franke AG, 2006, J COMP NEUROL, V495, P263, DOI 10.1002/cne.20869; FRIEDMAN Z, 1988, BRAIN RES, V446, P11, DOI 10.1016/0006-8993(88)91291-7; Gao H, 2011, MOL VIS, V17, P903; Garside VC, 2013, CELL MOL LIFE SCI, V70, P2899, DOI 10.1007/s00018-012-1197-9; Grosvenor Theodore, 2003, Clin Exp Optom, V86, P273; Guo L, 2013, INVEST OPHTH VIS SCI, V54, P6806, DOI 10.1167/iovs.13-12551; He L, 2014, VISION RES, V102, P52, DOI 10.1016/j.visres.2014.07.005; He L, 2014, EXP EYE RES, V123, P56, DOI 10.1016/j.exer.2014.04.005; Hefferan TE, 2000, J CELL BIOCHEM, V78, P380, DOI 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L; Honda S, 1996, INVEST OPHTH VIS SCI, V37, P2519; Ikeda T, 1998, CURR EYE RES, V17, P546, DOI 10.1076/ceyr.17.5.546.5197; IRVING EL, 1991, OPTOMETRY VISION SCI, V68, P364, DOI 10.1097/00006324-199105000-00007; Jobling AI, 2004, J BIOL CHEM, V279, P18121, DOI 10.1074/jbc.M400381200; Jobling AI, 2009, J BIOL CHEM, V284, P2072, DOI 10.1074/jbc.M807521200; Jobling AI, 2009, EXP EYE RES, V88, P458, DOI 10.1016/j.exer.2008.10.022; Kahata K, 2004, GENES CELLS, V9, P143, DOI 10.1111/j.1365-2443.2004.00706.x; KOH SWM, 1984, J NEUROCHEM, V43, P1522, DOI 10.1111/j.1471-4159.1984.tb06072.x; Kusakari T, 2001, EXP EYE RES, V73, P533, DOI 10.1006/exer.2001.1064; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; LUTTY G, 1991, CURR EYE RES, V10, P61, DOI 10.3109/02713689109007611; LUTTY GA, 1993, INVEST OPHTH VIS SCI, V34, P477; Maneu V, 2010, VISUAL NEUROSCI, V27, P139, DOI 10.1017/S0952523810000246; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mathis U, 2010, EXP EYE RES, V90, P780, DOI 10.1016/j.exer.2010.03.014; McBrien NA, 2013, EXP EYE RES, V114, P128, DOI 10.1016/j.exer.2013.01.014; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; MIYAZONO K, 1991, CIBA F SYMP, V157, P81; Ono K, 2010, AM J PUBLIC HEALTH, V100, P1784, DOI 10.2105/AJPH.2009.187930; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Penha AM, 2011, MOL VIS, V17, P1436; PFEFFER BA, 1994, EXP EYE RES, V59, P323, DOI 10.1006/exer.1994.1114; ROHRER B, 1994, EXP EYE RES, V58, P553, DOI 10.1006/exer.1994.1049; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; SCHAEFFEL F, 1990, VISUAL NEUROSCI, V4, P177, DOI 10.1017/S0952523800002327; Schippert R, 2006, EXP EYE RES, V82, P710, DOI 10.1016/j.exer.2005.09.010; SEKO Y, 1995, OPHTHALMIC RES, V27, P144, DOI 10.1159/000267651; SEKO Y, 1995, INVEST OPHTH VIS SCI, V36, P1183; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simon P, 2004, MOL VIS, V10, P588; Smith EL, 2014, EYE, V28, P180, DOI 10.1038/eye.2013.277; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; TANIHARA H, 1993, INVEST OPHTH VIS SCI, V34, P413; TROILO D, 1987, CURR EYE RES, V6, P993, DOI 10.3109/02713688709034870; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; Wildsoet CE, 2003, CURR EYE RES, V27, P371, DOI 10.1076/ceyr.27.6.371.18188; WILDSOET CF, 1988, INVEST OPHTH VIS SCI, V29, P311; Zamiri Parisa, 2007, Chem Immunol Allergy, V92, P86, DOI 10.1159/000099259; Zhang HL, 2011, CLIN EXP OPTOM, V94, P528, DOI 10.1111/j.1444-0938.2011.00611.x; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51; Zhang Y, 2013, EXP EYE RES, V109, P98, DOI 10.1016/j.exer.2013.02.010; Zhang Y, 2012, INVEST OPHTH VIS SCI, V53, P6072, DOI 10.1167/iovs.12-9917	62	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155356	10.1371/journal.pone.0155356	http://dx.doi.org/10.1371/journal.pone.0155356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214233	Green Published, gold			2022-12-26	WOS:000376880200010
J	Ahrensberg, JM; Fenger-Gron, M; Vedsted, P				Ahrensberg, Jette Moller; Fenger-Gron, Morten; Vedsted, Peter			Primary Care Use before Cancer Diagnosis in Adolescents and Young Adults - A Nationwide Register Study	PLOS ONE			English	Article							SYMPTOM INTERVAL; CHILDREN; SURVIVAL; RISK	Introduction Survival rates of cancer patients have generally improved in recent years. However, children and older adults seem to have experienced more significant clinical benefits than adolescents and young adults (AYAs). Previous studies suggest a prolonged diagnostic pathway in AYAs, but little is known about their pre-diagnostic healthcare use. This study investigates the use of primary care among AYAs during the two years preceding a cancer diagnosis. Methods The study is a retrospective population-based matched cohort study using Danish nationwide registry data. All persons diagnosed with cancer during 2002-2011 in the age group 15-39 years were included (N = 12,306); each participant was matched on gender, age and general practice with 10 randomly selected references (N = 123,060). The use of primary healthcare services (face-to-face contacts, blood tests and psychometric tests) was measured during the two years preceding the diagnosis (index date), and collected data were analysed in a negative binomial regression model. Results The cases generally increased their use of primary care already from 8 months before a cancer diagnosis, whereas a similar trend was not found for controls. The increase was observed for all cancer types, but it started at different times: 17 months before a diagnosis of CNS tumour, 12 months before a diagnosis of soft tissue sarcoma, 9 months before a diagnosis of lymphoma, 5-6 months before a diagnosis of leukaemia, bone tumour or GCT, and 3 months before a diagnosis of malignant melanoma. Conclusion The use of primary care among AYAs increase several months before a cancer diagnosis. The diagnostic intervals are generally short for malignant melanomas and long for brain tumours. A prolonged diagnostic pathway may indicate non-specific or vague symptomatology and low awareness of cancer among AYAs primary-care personnel. The findings suggest potential of faster cancer diagnosis in AYAs.	[Ahrensberg, Jette Moller; Fenger-Gron, Morten; Vedsted, Peter] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Ahrensberg, Jette Moller; Fenger-Gron, Morten; Vedsted, Peter] Aarhus Univ, Dept Publ Hlth, Ctr Canc Diag Primary Care, Aarhus, Denmark	Aarhus University; Aarhus University	Ahrensberg, JM (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.; Ahrensberg, JM (corresponding author), Aarhus Univ, Dept Publ Hlth, Ctr Canc Diag Primary Care, Aarhus, Denmark.	jette.ahrensberg@ph.au.dk	Vedsted, Peter/C-2583-2008	Vedsted, Peter/0000-0003-2113-5599; Fenger-Gron, Morten/0000-0002-6354-5871	Novo Nordisk Foundation [9107]; Novo Nordisk Fonden [NNF14OC0009107, NNF12OC1016030] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by The Novo Nordisk Foundation, grant number 9107. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrensberg JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059098; Albritton K, 2009, SEMIN ONCOL, V36, P478, DOI 10.1053/j.seminoncol.2009.07.007; Allemani C, 2014, LANCET, DOI S0140-6736(14)62038-9; Ansell P, 2010, PEDIATRICS, V125, P112, DOI 10.1542/peds.2009-0254; Benros ME, 2009, INT J CANCER, V124, P2917, DOI 10.1002/ijc.24274; Bleyer A, 2006, CANCER-AM CANCER SOC, V107, P1645, DOI 10.1002/cncr.22102; Bleyer A, 2006, ONCOLOGIST, V11, P590, DOI 10.1634/theoncologist.11-6-590; Bleyer A, 2009, SEMIN ONCOL, V36, P460, DOI 10.1053/j.seminoncol.2009.07.004; Christensen KG, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-224; Dang-Tan T, 2007, CANCER-AM CANCER SOC, V110, P703, DOI 10.1002/cncr.22849; Dommett RM, 2012, BR J CANC, V10; Ferrari A, 2010, CANCER-AM CANCER SOC, V116, P177, DOI 10.1002/cncr.24695; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Goyal S, 2004, EUR J CANCER, V40, P2280, DOI 10.1016/j.ejca.2004.05.017; Lethaby CD, 2013, ARCH DIS CHILD, V98, P349, DOI 10.1136/archdischild-2012-303034; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; National Board of Health, 2005, NAT CANC PLAN 2 DENM; National Collaborating Centre for Cancer, 2015, SUSP CANC REC REF; National Institute for Health and Clinical Excellence, 2005, REF GUID SUCP CANC A; Oeffinger KC, 2011, CANCER-AM CANCER SOC, V117, P2250, DOI 10.1002/cncr.26051; Olivarius ND, 1997, DAN MED BULL, V44, P449; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Rubin G, 2015, LANCET ONCOL, V16, P1231, DOI 10.1016/S1470-2045(15)00205-3; Rugbjerg K, 2016, JAMA ONCOL, V2, P193, DOI 10.1001/jamaoncol.2015.4393; Smith S., 2004, EUROPEAN J ONCOLOGY, V11, P362; Thomsen JL, 2006, FAM PRACT, V23, P407, DOI 10.1093/fampra/cml012; Torring ML, 2011, BR J CANC; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Veneroni L, 2013, PEDIATR BLOOD CANCER, V60, P605, DOI 10.1002/pbc.24312; Weller D, 2012, BR J CANC, V10; World Health Organization, 2015, INT CLASS DIS ICD	31	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155933	10.1371/journal.pone.0155933	http://dx.doi.org/10.1371/journal.pone.0155933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203083	Green Submitted, Green Published, gold			2022-12-26	WOS:000376291500033
J	Burgess, M; Adar, E; Cafarella, M				Burgess, Matthew; Adar, Eytan; Cafarella, Michael			Link-Prediction Enhanced Consensus Clustering for Complex Networks	PLOS ONE			English	Article							COMMUNITIES	Many real networks that are collected or inferred from data are incomplete due to missing edges. Missing edges can be inherent to the dataset (Facebook friend links will never be complete) or the result of sampling (one may only have access to a portion of the data). The consequence is that downstream analyses that "consume" the network will often yield less accurate results than if the edges were complete. Community detection algorithms, in particular, often suffer when critical intra-community edges are missing. We propose a novel consensus clustering algorithm to enhance community detection on incomplete networks. Our framework utilizes existing community detection algorithms that process networks imputed by our link prediction based sampling algorithm and merges their multiple partitions into a final consensus output. On average our method boosts performance of existing algorithms by 7% on artificial data and 17% on ego networks collected from Facebook.	[Burgess, Matthew; Adar, Eytan; Cafarella, Michael] Univ Michigan, Comp Sci & Engn, Ann Arbor, MI 48109 USA; [Adar, Eytan] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Burgess, M (corresponding author), Univ Michigan, Comp Sci & Engn, Ann Arbor, MI 48109 USA.	mattburg@umich.edu			National Science Foundation grant [IGERT-0903629]; Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center [D11PC20155]	National Science Foundation grant(National Science Foundation (NSF)); Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center	This work was supported by National Science Foundation grant IGERT-0903629 (http://www.nsf.gov/awardsearch/showAward?AWD ID=0903629) and Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center contract number D11PC20155 (http://www.iarpa.gov/index.php/ research-programs/fuse). the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Aldecoa R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02216; Aldecoa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024195; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Carley K.M., 2013, 7 INT AAAI C WEBL SO; Conover M., 2011, POLITICAL POLARIZATI; Dahlin J, 2013, ARXIV EPRINTS; Delvenne JC, 2010, P NATL ACAD SCI USA, V107, P12755, DOI 10.1073/pnas.0903215107; Dudoit S, 2003, BIOINFORMATICS; Fern XZ, 2004, SOLVING CLUSTER ENSE; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gfeller D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056135; Ghaemi R., 2009, SURVEY CLUSTERING EN; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hu YQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066106; Huang H, 2007, PLOS COMPUTATIONAL B, V3, DOI 10.1371/journal.pcbi.0030214; Jonsson PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-2; Karrer B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046119; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Lancichinetti A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046110; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Li ZP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036109; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; McAuley J, 2014, ACM T KNOWL DISCOV D, V8, P73, DOI 10.1145/2556612; Mirshahvalad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053943; Mirshahvalad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033721; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Newman M, POLITICAL BOOKS NETW; Orman GK, 2009, LECT NOTES ARTIF INT, V5808, P242, DOI 10.1007/978-3-642-04747-3_20; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Prat-Perez A, 2014, PROCEEDINGS OF THE 2; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ronhovde P, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046114; Rosvall M, 2008, PROCEEDINGS OF THE N, DOI 10.1073/pnas.0706851105; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Traag VA, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022816; Traag VA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02930; Xiang J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30301-2; Zachary WW, 1977, JOURNAL OF ANTHROPOL, DOI 10.1086/jar.33.4.3629752	45	27	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0153384	10.1371/journal.pone.0153384	http://dx.doi.org/10.1371/journal.pone.0153384			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203750	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500006
J	Gabreski, NA; Vaghasia, JK; Novakova, SS; McDonald, NQ; Pierchala, BA				Gabreski, Nicole A.; Vaghasia, Janki K.; Novakova, Silvia S.; McDonald, Neil Q.; Pierchala, Brian A.			Exon Skipping in the RET Gene Encodes Novel Isoforms That Differentially Regulate RET Protein Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; MICE LACKING GDNF; DEVELOPING SYMPATHETIC NEURONS; ENTERIC NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; CELL-LINE; C-RET; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSFORMING ACTIVITY; SELF-ASSOCIATION	Rearranged during transfection (RET), a receptor tyrosine kinase that is activated by the glial cell line-derived neurotrophic factor family ligands (GFLs), plays a crucial role in the development and function of the nervous system and additionally is required for kidney development and spermatogenesis. RET encodes a transmembrane receptor that is 20 exons long and produces two known protein isoforms differing in C-terminal amino acid composition, referred to as RET9 and RET51. Studies of human pheochromocytomas identified two additional novel transcripts involving the skipping of exon 3 or exons 3, 4, and 5 and are referred to as RET Delta E3 and RET Delta E345, respectively. Here we report the presence of Ret(Delta E3) and Ret(Delta E345) in zebrafish, mice, and rats and show that these transcripts are dynamically expressed throughout development of the CNS, peripheral nervous system, and kidneys. We further explore the biochemical properties of these isoforms, demonstrating that, like full-length RET, RET Delta E3 and RET Delta E345 are trafficked to the cell surface, interact with all four GFR alpha co-receptors, and have the ability to heterodimerize with full-length RET. Signaling experiments indicate that RET Delta E3 is phosphorylated in a similar manner to full-length RET. RET Delta E345, in contrast, displays higher baseline autophosphorylation, specifically on the catalytic tyrosine, Tyr(905), and also on one of the most important signaling residues, Tyr(1062). These data provide the first evidence for a physiologic role of these isoforms in RET pathway function.	[Gabreski, Nicole A.; Vaghasia, Janki K.; Novakova, Silvia S.; Pierchala, Brian A.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1011 N Univ Ave, Ann Arbor, MI 48109 USA; [Gabreski, Nicole A.; Pierchala, Brian A.] Univ Michigan, Sch Med, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [McDonald, Neil Q.] Francis Crick Inst, Struct Biol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England; [McDonald, Neil Q.] Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Francis Crick Institute; University of London; Birkbeck University London	Pierchala, BA (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	pierchal@umich.edu		Gabreski, Nicole/0000-0002-1688-6059	National Institutes of Health [R01 NS089585]; University of Michigan Cellular and Molecular Biology Predoctoral Fellowship [T32-GM007315]; Cancer Research UK [19344, 10747] Funding Source: researchfish; The Francis Crick Institute [10115] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cellular and Molecular Biology Predoctoral Fellowship; Cancer Research UK(Cancer Research UK); The Francis Crick Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS089585 (to B. A. P.). Additional funding support came from the University of Michigan Cellular and Molecular Biology Predoctoral Fellowship T32-GM007315 (to N. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Amoresano A, 2005, CELL SIGNAL, V17, P717, DOI 10.1016/j.cellsig.2004.10.012; Anders J, 2001, J BIOL CHEM, V276, P35808, DOI 10.1074/jbc.M104968200; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Arighi E, 1997, ONCOGENE, V14, P773, DOI 10.1038/sj.onc.1200896; Asai N, 1996, J BIOL CHEM, V271, P17644, DOI 10.1074/jbc.271.30.17644; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Bonanomi D, 2012, CELL, V148, P568, DOI 10.1016/j.cell.2012.01.024; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Carter MT, 2001, CYTOGENET CELL GENET, V95, P169, DOI 10.1159/000059341; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Durick K, 1996, J BIOL CHEM, V271, P12691, DOI 10.1074/jbc.271.22.12691; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Franck MCM, 2011, EUR J NEUROSCI, V33, P1385, DOI 10.1111/j.1460-9568.2011.07634.x; Goodman KM, 2014, CELL REP, V8, P1894, DOI 10.1016/j.celrep.2014.08.040; Gould TW, 2008, J NEUROSCI, V28, P2131, DOI 10.1523/JNEUROSCI.5185-07.2008; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Horger BA, 1998, J NEUROSCI, V18, P4929; Iwashita T, 1996, ONCOGENE, V12, P481; Kjaer S, 2006, ONCOGENE, V25, P7086, DOI 10.1038/sj.onc.1209698; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kurokawa K, 2001, ONCOGENE, V20, P1929, DOI 10.1038/sj.onc.1204290; LORENZO MJ, 1995, ONCOGENE, V10, P1377; Lorenzo MJ, 1997, ONCOGENE, V14, P763, DOI 10.1038/sj.onc.1200894; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Melillo RM, 2001, MOL CELL BIOL, V21, P4177, DOI 10.1128/MCB.21.13.4177-4187.2001; Melillo RM, 2001, ONCOGENE, V20, P209, DOI 10.1038/sj.onc.1204049; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; MYERS SM, 1995, ONCOGENE, V11, P2039; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pandey A, 1996, J BIOL CHEM, V271, P10607, DOI 10.1074/jbc.271.18.10607; PANDEY A, 1995, J BIOL CHEM, V270, P21461, DOI 10.1074/jbc.270.37.21461; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pierchala BA, 2006, J NEUROSCI, V26, P2777, DOI 10.1523/JNEUROSCI.3420-05.2006; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; TAHIRA T, 1990, ONCOGENE, V5, P97; Tsui CC, 2010, J NEUROSCI, V30, P5149, DOI 10.1523/JNEUROSCI.5246-09.2010; Tsui-Pierchala B, 2002, NEURON, V33, P261, DOI 10.1016/S0896-6273(01)00585-2; Tsui-Pierchala BA, 2002, J BIOL CHEM, V277, P34618, DOI 10.1074/jbc.M203580200; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742	58	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16249	16262		10.1074/jbc.M115.709675	http://dx.doi.org/10.1074/jbc.M115.709675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226544	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000380585400029
J	Rhein, VF; Carroll, J; Ding, SJ; Fearnley, IM; Walker, JE				Rhein, Virginie F.; Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.			NDUFAF5 Hydroxylates NDUFS7 at an Early Stage in the Assembly of Human Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; Complex I; electron transport; hydroxylase; mitochondria; assembly; methyltransferase; protein hydroxylation	ADENOSYL-L-METHIONINE; BOVINE HEART-MITOCHONDRIA; CRYSTAL-STRUCTURE; ANTHRACYCLINE BIOSYNTHESIS; STREPTOMYCES-PURPURASCENS; NADH DEHYDROGENASE; ENCODED SUBUNITS; METHYLTRANSFERASE; UBIQUINONE; MUTATIONS	Complex I (NADH ubiquinone oxidoreductase) in mammalian mitochondria is an L-shaped assembly of 45 proteins. One arm lies in the inner membrane, and the other extends about 100 into the matrix of the organelle. The extrinsic arm contains binding sites for NADH, the primary electron acceptor FMN, and seven iron-sulfur clusters that form a pathway for electrons linking FMN to the terminal electron acceptor, ubiquinone, which is bound in a tunnel in the region of the junction between the arms. The membrane arm contains four antiporter-like domains, energetically coupled to the quinone site and involved in pumping protons from the matrix into the intermembrane space contributing to the proton motive force. Seven of the subunits, forming the core of the membrane arm, are translated from mitochondrial genes, and the remaining subunits, the products of nuclear genes, are imported from the cytosol. Their assembly is coordinated by at least thirteen extrinsic assembly factor proteins that are not part of the fully assembled complex. They assist in insertion of co-factors and in building up the complex from smaller sub-assemblies. One such factor, NDUFAF5, belongs to the family of seven--strand S-adenosylmethionine-dependent methyltransferases. However, similar to another family member, RdmB, it catalyzes the introduction of a hydroxyl group, in the case of NDUFAF5, into Arg-73 in the NDUFS7 subunit of human complex I. This modification occurs early in the pathway of assembly of complex I, before the formation of the juncture between peripheral and membrane arms.	[Rhein, Virginie F.; Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.] MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0XY, England		Walker, JE (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk		Walker, John/0000-0001-7929-2162	Medical Research Council [U105663150, MR/M009858/1]; Medical Research Council [MC_EX_MR/M009858/1] Funding Source: researchfish; MRC [MC_EX_MR/M009858/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council via Intramural Program U105663150 and Program Grant MR/M009858/1 (to J. E. W.). The authors declare that they have no conflicts of interest with the contents of this publication.	Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110; Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Carilla-Latorre S, 2013, MOL BIOL CELL, V24, P1519, DOI 10.1091/mbc.E12-11-0796; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Gerards M, 2010, J MED GENET, V47, P507, DOI 10.1136/jmg.2009.067553; Grocholski T, 2015, P NATL ACAD SCI USA, V112, P9866, DOI 10.1073/pnas.1501765112; Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Jansson A, 2005, J BIOL CHEM, V280, P3636, DOI 10.1074/jbc.M412095200; Jansson A, 2004, J BIOL CHEM, V279, P41149, DOI 10.1074/jbc.M407081200; Jansson A, 2003, J MOL BIOL, V334, P269, DOI 10.1016/j.jmb.2003.09.061; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; McKenzie M, 2011, J MOL BIOL, V414, P413, DOI 10.1016/j.jmb.2011.10.012; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Ploumakis A, 2015, MOL CELL, V58, P729, DOI 10.1016/j.molcel.2015.05.026; Rendon OZ, 2014, HUM MOL GENET, V23, P5159, DOI 10.1093/hmg/ddu239; Rendon OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Saada A, 2012, J INHERIT METAB DIS, V35, P125, DOI 10.1007/s10545-011-9348-y; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wang YL, 2000, BBA-PROTEIN STRUCT M, V1480, P191, DOI 10.1016/S0167-4838(00)00089-3; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zhu JP, 2015, P NATL ACAD SCI USA, V112, P12087, DOI 10.1073/pnas.1510577112; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	55	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14851	14860		10.1074/jbc.M116.734970	http://dx.doi.org/10.1074/jbc.M116.734970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226634	Green Published, hybrid			2022-12-26	WOS:000380366700036
J	Tang, SJ; Luo, SF; Ho, JXJ; Ly, PT; Goh, E; Roca, X				Tang, Sze Jing; Luo, Shufang; Ho, Jia Xin Jessie; Phuong Thao Ly; Goh, Eling; Roca, Xavier			Characterization of the Regulation of CD46 RNA Alternative Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; complement system; exonic splicing enhancer; lymphocyte; molecular genetics; exonic splicing silencer	MEMBRANE COFACTOR PROTEIN; TRACT BINDING-PROTEIN; CELLULAR PILUS RECEPTOR; MEASLES-VIRUS RECEPTOR; T-CELLS; COMPLEMENT REGULATOR; EXON DEFINITION; 5'-SPLICE SITES; U1 SNRNA; NEURONAL DIFFERENTIATION	Here we present a detailed analysis of the alternative splicing regulation of human CD46, which generates different isoforms with distinct functions. CD46 is a ubiquitous membrane protein that protects host cells from complement and plays other roles in immunity, autophagy, and cell adhesion. CD46 deficiency causes an autoimmune disorder, and this protein is also involved in pathogen infection and cancer. Before this study, the mechanisms of CD46 alternative splicing remained unexplored even though dysregulation of this process has been associated with autoimmune diseases. We proved that the 5 splice sites of CD46 cassette exons 7 and 8 encoding extracellular domains are defined by noncanonical mechanisms of base pairing to U1 small nuclear RNA. Next we characterized the regulation of CD46 cassette exon 13, whose inclusion or skipping generates different cytoplasmic tails with distinct functions. Using splicing minigenes, we identified multiple exonic and intronic splicing enhancers and silencers that regulate exon 13 inclusion via trans-acting splicing factors like PTBP1 and TIAL1. Interestingly, a common splicing activator such as SRSF1 appears to repress CD46 exon 13 inclusion. We also report that expression of CD46 mRNA isoforms is further regulated by non-sense-mediated mRNA decay and transcription speed. Finally, we successfully manipulated CD46 exon 13 inclusion using antisense oligonucleotides, opening up opportunities for functional studies of the isoforms as well as for therapeutics for autoimmune diseases. This study provides insight into CD46 alternative splicing regulation with implications for its function in the immune system and for genetic disease.	[Tang, Sze Jing; Luo, Shufang; Ho, Jia Xin Jessie; Phuong Thao Ly; Goh, Eling; Roca, Xavier] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Roca, X (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	xroca@ntu.edu.sg	Roca, Xavier/C-5838-2011	Roca, Xavier/0000-0003-3853-5273; Ly, Phuong Thao/0000-0002-5986-2735	School of Biological Sciences, Nanyang Technological University; Singapore's Ministry of Education Academic Research Fund [RG 20/11]	School of Biological Sciences, Nanyang Technological University(Nanyang Technological University); Singapore's Ministry of Education Academic Research Fund	This work was supported by School of Biological Sciences, Nanyang Technological University Startup Grant 2011 and Singapore's Ministry of Education Academic Research Fund Tier 1 RG 20/11 (2011). The authors declare that they have no conflicts of interest with the contents of this article.	Akerman M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r30; Anczukow O, 2015, MOL CELL, V60, P105, DOI 10.1016/j.molcel.2015.09.005; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Aznarez I, 2008, GENOME RES, V18, P1247, DOI 10.1101/gr.073155.107; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonomi S, 2013, NUCLEIC ACIDS RES, V41, P8665, DOI 10.1093/nar/gkt579; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cardone J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00028; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chiou NT, 2013, MOL CELL, V49, P972, DOI 10.1016/j.molcel.2012.12.025; Choileain SN, 2011, ARCH IMMUNOL THER EX, V59, P49, DOI 10.1007/s00005-010-0109-7; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Cui W, 2010, CANCER BIOL THER, V10, P232; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dujardin G, 2014, MOL CELL, V54, P683, DOI 10.1016/j.molcel.2014.03.044; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Erkelenz S, 2013, RNA, V19, P96, DOI 10.1261/rna.037044.112; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Fuchs A, 2009, EUR J IMMUNOL, V39, P3097, DOI 10.1002/eji.200939392; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; Jabara HH, 2011, INT IMMUNOL, V23, P215, DOI 10.1093/intimm/dxq474; JOHNSTONE RW, 1993, MOL IMMUNOL, V30, P1231, DOI 10.1016/0161-5890(93)90038-D; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 2001, CELL MICROBIOL, V3, P133, DOI 10.1046/j.1462-5822.2001.00095.x; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kurita-Taniguchi M, 2000, J IMMUNOL, V165, P5143, DOI 10.4049/jimmunol.165.9.5143; Le Friec G, 2011, ANN RHEUM DIS, V70, pA48, DOI 10.1136/ard.2010.148981.15; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; LISZEWSKI MK, 1994, J BIOL CHEM, V269, P10776; Liszewski MK, 1996, J IMMUNOL, V156, P4415; Ludford-Menting MJ, 2002, J BIOL CHEM, V277, P4477, DOI 10.1074/jbc.M108479200; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Maisner A, 1996, J VIROL, V70, P4973, DOI 10.1128/JVI.70.8.4973-4977.1996; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McLaughlin BJ, 2003, INVEST OPHTH VIS SCI, V44, P3669, DOI 10.1167/iovs.02-0813; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Ni Choileain S., 2011, PLOS ONE, V6; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Paz I, 2010, NUCLEIC ACIDS RES, V38, pW281, DOI 10.1093/nar/gkq444; POST TW, 1991, J EXP MED, V174, P93, DOI 10.1084/jem.174.1.93; Price JD, 2005, J IMMUNOL, V175, P677, DOI 10.4049/jimmunol.175.2.677; PURCELL DFJ, 1991, IMMUNOGENETICS, V33, P335, DOI 10.1007/BF00216692; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Riley RC, 2002, MOL REPROD DEV, V62, P534, DOI 10.1002/mrd.10144; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; Roca X, 2009, NAT STRUCT MOL BIOL, V16, P176, DOI 10.1038/nsmb.1546; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; RUSSELL SM, 1992, EUR J IMMUNOL, V22, P1513, DOI 10.1002/eji.1830220625; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Smith A, 2003, BLOOD, V102, P2877, DOI 10.1182/blood-2002-10-3152; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Tan JZ, 2016, NUCLEIC ACIDS RES, V44, P3908, DOI 10.1093/nar/gkw163; Tan JZ, 2016, METHODS MOL BIOL, V1421, P243, DOI 10.1007/978-1-4939-3591-8_19; Tsai YG, 2012, LAB INVEST, V92, P1260, DOI 10.1038/labinvest.2012.86; Venables JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3480; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Zhu J, 2000, GENE DEV, V14, P3166, DOI 10.1101/gad.189500	87	19	20	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14311	14323		10.1074/jbc.M115.710350	http://dx.doi.org/10.1074/jbc.M115.710350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226545	Green Published, hybrid			2022-12-26	WOS:000379975100034
J	Ohashi, N; Isobe, S; Ishigaki, S; Suzuki, T; Iwakura, T; Ono, M; Fujikura, T; Tsuji, T; Otsuka, A; Ishii, Y; Furuse, H; Kato, A; Ozono, S; Yasuda, H				Ohashi, Naro; Isobe, Shinsuke; Ishigaki, Sayaka; Suzuki, Takahisa; Iwakura, Takamasa; Ono, Masafumi; Fujikura, Tomoyuki; Tsuji, Takayuki; Otsuka, Atsushi; Ishii, Yasuo; Furuse, Hiroshi; Kato, Akihiko; Ozono, Seiichiro; Yasuda, Hideo			Plasma Soluble (Pro)renin Receptor Reflects Renal Damage	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; AT(1) RECEPTOR; PRORENIN; HYPERTENSION; ACTIVATION; RATS	Background (Pro)renin receptor [(P)RR], a specific receptor for renin and prorenin, was identified as a member of the renin-angiotensin system (RAS). (P)RR is cleaved by furin, and soluble (P) RR [s(P)RR] is secreted into the extracellular space. Previous reports have indicated that plasma s(P)RR levels show a significant positive relationship with urinary protein levels, which represent renal damage. However, it is not fully known whether plasma s(P)RR reflects renal damage. Methods We recruited 25 patients who were admitted to our hospital to undergo heminephrectomy. Plasma s(P)RR levels were examined from blood samples drawn before nephrectomy. The extent of renal damage was evaluated by the levels of tubulointerstitial fibrosis. Immunohistochemical analysis of intrarenal (P)RR and cell surface markers (cluster of differentiation [CD] 3, CD19, and CD68) was performed on samples taken from the removed kidney. Moreover, double staining of (P)RR and cell surface markers was also performed. Results There were significant positive relationships between plasma s(P)RR and tubulointerstitial fibrosis in all the patients and those not receiving RAS blocker therapy. Significant positive relationships were found between plasma s(P)RR levels and the extent of tubulointerstitial fibrosis after adjustment for age, sex, body weight, blood pressure, and plasma angiotensin II, in all the patients and those not receiving RAS blockers. Moreover, (P)RR expression was elevated in infiltrated mononuclear cells but not connecting tubules or collecting ducts and vessels. Infiltrated cells positive for (P)RR consisted of CD3 and CD68 but not CD19. Conclusions These data suggest that plasma s(P) RR levels may reflect (P)RR expression levels in infiltrated mononuclear cells, which can be a surrogate marker of renal damage.	[Ohashi, Naro; Isobe, Shinsuke; Ishigaki, Sayaka; Iwakura, Takamasa; Fujikura, Tomoyuki; Tsuji, Takayuki; Yasuda, Hideo] Hamamatsu Univ Sch Med, Internal Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Suzuki, Takahisa; Otsuka, Atsushi; Ishii, Yasuo; Furuse, Hiroshi; Ozono, Seiichiro] Hamamatsu Univ Sch Med, Urol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Ono, Masafumi; Kato, Akihiko] Hamamatsu Univ Sch Med, Blood Purificat Unit, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Ohashi, N (corresponding author), Hamamatsu Univ Sch Med, Internal Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ohashi-n@hama-med.ac.jp	Fujikura, Tomoyuki/HDO-2837-2022					Batenburg WW, 2007, J HYPERTENS, V25, P2441, DOI 10.1097/HJH.0b013e3282f05bae; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Hamada K, 2013, CLIN EXP NEPHROL, V17, P848, DOI 10.1007/s10157-013-0803-y; Hirose T, 2010, REGUL PEPTIDES, V159, P93, DOI 10.1016/j.regpep.2009.11.006; Huang YJ, 2012, AM J PHYSIOL-RENAL, V303, pF130, DOI 10.1152/ajprenal.00275.2011; Ichihara A, 2008, J AM SOC HYPERTENS, V2, P15, DOI 10.1016/j.jash.2007.08.001; Isobe S, 2015, CLIN EXP NEPHROL, V19, P231, DOI 10.1007/s10157-014-0973-2; Kobori H, 2005, J AM SOC NEPHROL, V16, P2073, DOI 10.1681/ASN.2004080676; Kobori H, 2009, HYPERTENSION, V53, P344, DOI 10.1161/HYPERTENSIONAHA.108.123802; Macconi D, 2011, KIDNEY INT S, V2014, P58, DOI DOI 10.1038/KISUP.2014.11; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morimoto S, 2014, HYPERTENS RES, V37, P642, DOI 10.1038/hr.2014.46; Narumi K, 2015, AM J PHYSIOL-RENAL, V308, pF487, DOI 10.1152/ajprenal.00206.2014; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2014, HYPERTENSION, V63, P297, DOI 10.1161/HYPERTENSIONAHA.113.02217; Nguyen G, 2011, CURR HYPERTENS REP, V13, P79, DOI 10.1007/s11906-010-0172-9; Nishijima T, 2014, PEPTIDES, V56, P14, DOI 10.1016/j.peptides.2014.03.008; Ohashi N, 2008, AM J PHYSIOL-RENAL, V295, pF1512, DOI 10.1152/ajprenal.00058.2008; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P750, DOI 10.1111/j.1440-1681.2009.05172.x; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P509, DOI 10.1111/j.1440-1681.2008.05107.x; Oshima Yoichi, 2014, World J Nephrol, V3, P302, DOI 10.5527/wjn.v3.i4.302; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; Privratsky JR, 2003, HYPERTENSION, V42, P206, DOI 10.1161/01.HYP.0000082814.62655.85; Siragy HM, 2008, EXP PHYSIOL, V93, P709, DOI 10.1113/expphysiol.2007.040550; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418	26	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156165	10.1371/journal.pone.0156165	http://dx.doi.org/10.1371/journal.pone.0156165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228084	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500075
J	Yang, QS; Shen, GC; Liu, HM; Wang, ZH; Ma, ZP; Fang, XF; Zhang, J; Wang, XH				Yang, Qing-Song; Shen, Guo-Chun; Liu, He-Ming; Wang, Zhang-Hua; Ma, Zun-Ping; Fang, Xiao-Feng; Zhang, Jian; Wang, Xi-Hua			Detangling the Effects of Environmental Filtering and Dispersal Limitation on Aggregated Distributions of Tree and Shrub Species: Life Stage Matters	PLOS ONE			English	Article							BROAD-LEAVED FOREST; HABITAT ASSOCIATIONS; SPATIAL-PATTERNS; SUBTROPICAL FOREST; COMMUNITY MODELS; SOIL NUTRIENTS; BETA DIVERSITY; HETEROGENEITY; COEXISTENCE; PLOT	The pervasive pattern of aggregated tree distributions in natural communities is commonly explained by the joint effect of two clustering processes: environmental filtering and dispersal limitation, yet little consensus remains on the relative importance of the two clustering processes on tree aggregations. Different life stages of examined species were thought to be one possible explanation of this disagreement, because the effect of environmental filtering and dispersal limitation are expected to increase and decrease with tree life stages, respectively. However, few studies have explicitly tested these expectations. In this study, we evaluated these expectations by three different methods (species-habitat association test based on Poisson Clustering model and spatial point pattern analyses based on Heterogeneous Poisson model and the jointly modeling approach) using 36 species in a 20-ha subtropical forest plot. Our results showed that the percentage of species with significant habitat association increased with life stages, and there were fewer species affected by dispersal limitation in later life stages compared with those in earlier stages. Percentage of variance explained by the environmental filtering and dispersal limitation also increases and decreases with life stages. These results provided a promising alternative explanation on the existing mixed results about the relative importance of the two clustering processes. These findings also highlighted the importance of plant life stages for fully understanding species distributions and species coexistence.	[Yang, Qing-Song; Shen, Guo-Chun; Liu, He-Ming; Ma, Zun-Ping; Fang, Xiao-Feng; Zhang, Jian; Wang, Xi-Hua] E China Normal Univ, Sch Ecol & Environm Sci, Shanghai 200062, Peoples R China; [Yang, Qing-Song; Shen, Guo-Chun; Liu, He-Ming; Ma, Zun-Ping; Fang, Xiao-Feng; Zhang, Jian; Wang, Xi-Hua] Chinese Natl Ecosyst Observat & Res Network, Tiantong Natl Stn Forest Ecosyst, Ningbo, Zhejiang, Peoples R China; [Wang, Zhang-Hua] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai Chenshan Bot Garden, Shanghai, Peoples R China	East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, XH (corresponding author), E China Normal Univ, Sch Ecol & Environm Sci, Shanghai 200062, Peoples R China.	xhwang@des.ecnu.edu.cn	Zhang, Jian/A-7878-2008	Zhang, Jian/0000-0003-0589-6267; Liu, Heming/0000-0002-6873-4735; Shen, Guochun/0000-0001-9853-6062; Yang, QingSong/0000-0003-0531-5418	National Natural Science Foundation of China [31210103920, 31470487]; Division Of Environmental Biology [1545761, 1354741] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Natural Science Foundation of China (Grant No. 31210103920 to XHW and 31470487 to GCS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2014, ECOL MONOGR, V84, P477, DOI 10.1890/13-2042.1; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Chang LW, 2013, ECOLOGY, V94, P2145, DOI 10.1890/12-2053.1; Chase J.M., 2009, ECOLOGICAL NICHES; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; CRESSIE N, 1990, MATH GEOL, V22, P239, DOI 10.1007/BF00889887; Diggle P. J., 2003, STAT ANAL POINT PATT; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; Hu YH, 2012, OIKOS, V121, P952, DOI 10.1111/j.1600-0706.2011.19831.x; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; Illian J, 2008, STAT ANAL MODELLING; Jabot F, 2008, OIKOS, V117, P1308, DOI 10.1111/j.0030-1299.2008.16724.x; Jalilian A, 2013, SCAND J STAT, V40, P119, DOI 10.1111/j.1467-9469.2012.00795.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jara-Guerrero A, 2015, OIKOS, V124, P1360, DOI 10.1111/oik.02098; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; [雷霄 Lei Xiao], 2015, [华东师范大学学报. 自然科学版, Journal of East China Normal University. Natural Science], P122; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Lin YC, 2011, OECOLOGIA, V165, P175, DOI 10.1007/s00442-010-1718-x; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Moller J, 2004, J R STAT SOC A STAT, V168, P258; Murrell DJ, 2009, J ECOL, V97, P256, DOI 10.1111/j.1365-2745.2008.01475.x; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; PARRISH JAD, 1985, ECOLOGY, V66, P1296; Pinto SM, 2010, AM NAT, V175, P675, DOI 10.1086/652467; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Plotkin JB, 2002, AM NAT, V160, P629, DOI 10.1086/342823; Quero JL, 2008, BASIC APPL ECOL, V9, P635, DOI 10.1016/j.baae.2007.06.012; R Core Team, 2014, R 3 1 1 R LANG ENV S; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Shen GC, 2013, ECOLOGY, V94, P2436, DOI 10.1890/12-1983.1; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Song YC, 2013, EVERGREEN BROAD LEVA; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Stoyan D., 1994, FRACTALS RANDOM SHAP; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Waagepetersen R, 2009, J R STAT SOC B, V71, P685, DOI 10.1111/j.1467-9868.2008.00702.x; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, ECOLOGY, V88, P3088, DOI 10.1890/06-1350.1; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Wu Z.Y., 1994, FLORA CHINA; Xie YuBin, 2012, Biodiversity Science, V20, P159, DOI 10.3724/SP.J.1003.2012.09242; Yamada T, 2006, J VEG SCI, V17, P559, DOI 10.1658/1100-9233(2006)17[559:HAOSTI]2.0.CO;2; Yamakura T., 1995, TROPICS, V5, P41, DOI [10.3759/tropics.5.41, DOI 10.3759/tropics.5.41, DOI 10.3759/TROPICS.5.41]; Yan ER, 2006, PLANT SOIL, V289, P187, DOI 10.1007/s11104-006-9128-x; Yang QingSong, 2011, Biodiversity Science, V19, P215, DOI 10.3724/SP.J.1003.2011.09013; Zhang Na, 2012, Yingyong Shengtai Xuebao, V23, P2361; Zhu Y, 2010, OIKOS, V119, P109, DOI 10.1111/j.1600-0706.2009.17758.x	68	19	20	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156326	10.1371/journal.pone.0156326	http://dx.doi.org/10.1371/journal.pone.0156326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227538	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500115
J	Airik, R; Schueler, M; Airik, M; Cho, J; Ulanowicz, KA; Porath, JD; Hurd, TW; Bekker-Jensen, S; Schroder, JM; Andersen, JS; Hildebrandt, F				Airik, Rannar; Schueler, Markus; Airik, Merlin; Cho, Jang; Ulanowicz, Kelsey A.; Porath, Jonathan D.; Hurd, Toby W.; Bekker-Jensen, Simon; Schroder, Jacob M.; Andersen, Jens S.; Hildebrandt, Friedhelm			SDCCAG8 Interacts with RAB Effector Proteins RABEP2 and ERC1 and Is Required for Hedgehog Signaling	PLOS ONE			English	Article							BARDET-BIEDL SYNDROME; PRIMARY CILIUM; MOTHER CENTRIOLE; GTPASE RAB8; CILIOGENESIS; COMPLEX; CILIOPATHIES; DOCKING; CEP164; MOUSE	Recessive mutations in the SDCCAG8 gene cause a nephronophthisis-related ciliopathy with Bardet-Biedl syndrome-like features in humans. Our previous characterization of the orthologous Sdccag8(gt/gt) mouse model recapitulated the retinal-renal disease phenotypes and identified impaired DNA damage response signaling as an underlying disease mechanism in the kidney. However, several other phenotypic and mechanistic features of Sdccag8(gt/gt) mice remained unexplored. Here we show that Sdccag8(gt/gt) mice exhibit developmental and structural abnormalities of the skeleton and limbs, suggesting impaired Hedgehog (Hh) signaling. Indeed, cell culture studies demonstrate the requirement of SDCCAG8 for ciliogenesis and Hh signaling. Using an affinity proteomics approach, we demonstrate that SDCCAG8 interacts with proteins of the centriolar satellites (OFD1, AZI1), of the endosomal sorting complex (RABEP2, ERC1), and with non-muscle myosin motor proteins (MYH9, MYH10, MYH14) at the centrosome. Furthermore, we show that RABEP2 localization at the centrosome is regulated by SDCCAG8. siRNA mediated RABEP2 knockdown in hTERT-RPE1 cells leads to defective ciliogenesis, indicating a critical role for RABEP2 in this process. Together, this study identifies several centrosome-associated proteins as novel SDCCAG8 interaction partners, and provides new insights into the function of SDCCAG8 at this structure.	[Airik, Rannar; Schueler, Markus; Airik, Merlin; Cho, Jang; Porath, Jonathan D.; Hildebrandt, Friedhelm] Boston Childrens Hosp, Div Nephrol, Dept Med, Boston, MA USA; [Airik, Rannar; Ulanowicz, Kelsey A.] Childrens Hosp Pittsburgh UPMC, Div Nephrol, Dept Pediat, Pittsburgh, PA USA; [Hurd, Toby W.] Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Bekker-Jensen, Simon] Univ Copenhagen, Fac Hlth Sci, NNF Ctr Prot Res, Copenhagen, Denmark; [Schroder, Jacob M.; Andersen, Jens S.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Boston Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; University of Copenhagen; University of Southern Denmark; Howard Hughes Medical Institute	Airik, R; Hildebrandt, F (corresponding author), Boston Childrens Hosp, Div Nephrol, Dept Med, Boston, MA USA.; Hildebrandt, F (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	airikr@pitt.edu; Friedhelm.Hildebrandt@childrens.harvard.edu	Andersen, Jens S/L-2100-2015; Schueler, Markus/AAF-6057-2021; Airik, Rannar/AAS-7810-2021	Andersen, Jens S/0000-0002-6091-140X; Airik, Rannar/0000-0002-7055-6325; Schroder, Jacob Morville/0000-0002-6178-0528	National Institute of Diabetes and Digestive and Kidney Diseases [DK099434, DK1069274, DK1068306, DK064614]; Howard Hughes Medical Institute; European Commission Seventh Framework Programme [HEALTH-F4-2008-201648/PROSPECTS]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, R00DK099434] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Commission Seventh Framework Programme(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by The National Institute of Diabetes and Digestive and Kidney Diseases to RA, (DK099434) [http://www.niddk.nih.gov]; The National Institute of Diabetes and Digestive and Kidney Diseases to FH, (DK1069274, DK1068306, DK064614) [http://www.niddk.nih.gov]; Howard Hughes Medical Institute to FH, (HHMI) [http://www.hhmi.org]; European Commission Seventh Framework Programme to JSA, (HEALTH-F4-2008-201648/PROSPECTS) [http://cordis.europa.eu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2014, J AM SOC NEPHROL, V25, P2573, DOI 10.1681/ASN.2013050565; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baudoin JP, 2012, NEURON, V76, P1108, DOI 10.1016/j.neuron.2012.10.027; Bochtler T, 2012, LEUKEMIA, V26, P728, DOI 10.1038/leu.2011.283; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chamling X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004083; Cui C, 2011, DIS MODEL MECH, V4, P43, DOI 10.1242/dmm.006262; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Forsythe E, 2013, EUR J HUM GENET, V21, P8, DOI 10.1038/ejhg.2012.115; Furniss D, 2008, HUM MOL GENET, V17, P2417, DOI 10.1093/hmg/ddn141; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hirota Y, 2010, DEVELOPMENT, V137, P3037, DOI 10.1242/dev.050120; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Insolera R, 2014, NEURON, V83, P805, DOI 10.1016/j.neuron.2014.06.029; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ohara-Imaizumi M, 2005, MOL BIOL CELL, V16, P3289, DOI 10.1091/mbc.E04-09-0816; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Rao YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114087; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schaefer E, 2011, EUR J MED GENET, V54, P157, DOI 10.1016/j.ejmg.2010.10.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Staples CJ, 2012, J CELL SCI, V125, P4770, DOI 10.1242/jcs.104059; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Wang J, 2014, PROG RETIN EYE RES, V38, P1, DOI 10.1016/j.preteyeres.2013.08.004; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010	46	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156081	10.1371/journal.pone.0156081	http://dx.doi.org/10.1371/journal.pone.0156081			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224062	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700061
J	Toonen, JA; Ronchetti, A; Sidjanin, DJ				Toonen, Joseph A.; Ronchetti, Adam; Sidjanin, D. J.			A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development	PLOS ONE			English	Article							CELL-CELL ADHESION; N-CADHERIN; MOUSE RETINA; BETA-CATENIN; DISINTEGRIN/METALLOPROTEINASE ADAM10; PROTEOLYTIC ACTIVATION; DIFFERENTIATION; CLEAVAGE; FATE; NEUROGENESIS	ADAM10 and ADAM17 are two closely related members of the ADAM (a disintegrin and metalloprotease) family of membrane-bound sheddases, which proteolytically cleave surface membrane proteins. Both ADAM10 and ADAM17 have been implicated in the proteolytic cleavage of NOTCH receptors and as such regulators of NOTCH signaling. During retinal development, NOTCH signaling facilitates retinal neurogenesis by maintaining progenitor cells in a proliferative state and by mediating retinal cell fates. However, the roles of ADAM10 and ADAM17 in the retina are not well defined. In this study, we set out to clarify the roles of ADAM10 and ADAM17 during early retinal development. The retinal phenotype of conditionally abated Adam17 retinae (Adam17 CKO) did not differ from the controls whereas conditionally ablated Adam10 retinae (Adam10 CKO) exhibited abnormal morphogenesis characterized by the formation of rosettes and a loss of retinal laminae phenotypically similar to morphological abnormalities identified in mice with retinal NOTCH signaling deficiency. Additionally, Adam10 CKO retinae exhibited abnormal neurogenesis characterized by fewer proliferating progenitor cells and greater differentiation of early photoreceptors and retinal ganglion cells. Moreover, constitutive activation of the NOTCH1-intracellular domain (N1-ICD) rescued Adam10 CKO abnormal neurogenesis, as well as abnormal retinal morphology by maintaining retinal cells in the progenitor state. Collectively these findings provide in vivo genetic evidence that ADAM10, and not ADAM17, is indispensable for proper retinal development as a regulator of NOTCH signaling.	[Toonen, Joseph A.; Ronchetti, Adam; Sidjanin, D. J.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Sidjanin, D. J.] Med Coll Wisconsin, Human & Mol Genet Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Toonen, Joseph A.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Medical College of Wisconsin; Medical College of Wisconsin; Washington University (WUSTL)	Sidjanin, DJ (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Sidjanin, DJ (corresponding author), Med Coll Wisconsin, Human & Mol Genet Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	dsidjani@mcw.edu			National Eye Institute, National Institutes of Health [EY018872, EY001931, EY014537]	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by EY018872, EY001931, EY014537, and EY018872, National Eye Institute, National Institutes of Health, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cepko C, 2014, NAT REV NEUROSCI, V15, P615, DOI 10.1038/nrn3767; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Erdmann B, 2003, DEV DYNAM, V226, P570, DOI 10.1002/dvdy.10266; Esteve P, 2011, NAT NEUROSCI, V14, P562, DOI 10.1038/nn.2794; Fogerty J, 2011, INVEST OPHTH VIS SCI, V52, P7256, DOI 10.1167/iovs.11-8112; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Galli-Resta L, 2008, PROG RETIN EYE RES, V27, P260, DOI 10.1016/j.preteyeres.2008.02.001; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Glomski K, 2011, BLOOD, V118, P1163, DOI 10.1182/blood-2011-04-348557; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hassemer EL, 2010, GENETICS, V185, P245, DOI 10.1534/genetics.109.113167; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jarriault S, 2005, DEV BIOL, V287, P1, DOI 10.1016/j.ydbio.2005.08.014; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Malicki J, 2003, DEV BIOL, V259, P95, DOI 10.1016/S0012-1606(03)00181-7; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Maurer KA, 2014, DEVELOPMENT, V141, P3243, DOI 10.1242/dev.106245; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reese BE, 2011, VISION RES, V51, P613, DOI 10.1016/j.visres.2010.07.010; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Rocha SF, 2009, DEV BIOL, V328, P54, DOI 10.1016/j.ydbio.2009.01.011; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Sel S, 2012, ANN ANAT, V194, P334, DOI 10.1016/j.aanat.2011.10.008; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Takatsuka K, 2004, BRAIN RES, V1004, P148, DOI 10.1016/j.brainres.2004.01.045; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Toonen J, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-76; Tsai YH, 2014, GASTROENTEROLOGY, V147, P822, DOI 10.1053/j.gastro.2014.07.003; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Yan X, 2011, DEV GROWTH DIFFER, V53, P726, DOI 10.1111/j.1440-169X.2011.01282.x; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zheng MH, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-38	57	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156184	10.1371/journal.pone.0156184	http://dx.doi.org/10.1371/journal.pone.0156184			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224017	gold, Green Published, Green Submitted			2022-12-26	WOS:000376881700070
J	Zhou, HF; Luo, CP; Fang, XW; Xiang, YP; Wang, XY; Zhang, RS; Chen, ZY				Zhou, Huafei; Luo, Chuping; Fang, Xianwen; Xiang, Yaping; Wang, Xiaoyu; Zhang, Rongsheng; Chen, Zhiyi			Loss of GltB Inhibits Biofilm Formation and Biocontrol Efficiency of Bacillus subtilis Bs916 by Altering the Production of gamma-Polyglutamate and Three Lipopeptides	PLOS ONE			English	Article							BACILLOMYCIN L; SURFACTIN; PSEUDOMONAS; BIOSYNTHESIS; ANTIBIOTICS; STRAIN; ROOTS; COLONIZATION; REGULATOR; CLONING	Aims This study examined the contribution of GltB on biofilm formation and biocontrol efficiency of B. subtilis Bs916. Methods and Results The gltB gene was identified through a biofilm phenotype screen and a bioinformatics analysis of serious biofilm formation defects, and then a gltB single knockout mutant was constructed using homologous recombination. This mutant demonstrated severe deficits in biofilm formation and colonisation along with significantly altered production of.-polyglutamate (gamma-PGA) and three lipopeptide antibiotics (LPs) as measured by a transcriptional analysis of both the wild type B. subtilis Bs916 and the gltB mutant. Consequently, the mutant strain retained almost no antifungal activity against Rhizoctonia solani and exhibited decreased biocontrol efficiency against rice sheath blight. Very few gltB mutant cells colonised the rice stem, and they exhibited no significant nutrient chemotaxis compared to the wild type B. subtilis Bs916. The mechanism underlying these deficits in the gltB mutant appears to be decreased significantly in production of gamma-PGA and a reduction in the production of both bacillomycin L and fengycin. Biofilm restoration of gltB mutant by addition gamma-PGA in the EM medium demonstrated that biofilm formation was able to restore significantly at 20 g/L. Conclusions GltB regulates biofilm formation by altering the production of gamma-PGA, the LPs bacillomycin L and fengcin and influences bacterial colonisation on the rice stem, which consequently leads to poor biocontrol efficiency against rice sheath blight. Significance and Impact of Study This is the first report of a key regulatory protein (GltB) that is involved in biofilm regulation and its regulation mechanism and biocontrol efficiency by B. subtilis.	[Zhou, Huafei; Luo, Chuping; Xiang, Yaping; Chen, Zhiyi] Nanjing Agr Univ, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China; [Zhou, Huafei; Fang, Xianwen; Xiang, Yaping; Wang, Xiaoyu; Zhang, Rongsheng; Chen, Zhiyi] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing 210014, Jiangsu, Peoples R China; [Luo, Chuping] Huaiyin Inst Technol, Sch Life Sci & Chem Engn, Huaiyin 223003, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Huaiyin Institute of Technology	Luo, CP; Chen, ZY (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China.; Chen, ZY (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing 210014, Jiangsu, Peoples R China.; Luo, CP (corresponding author), Huaiyin Inst Technol, Sch Life Sci & Chem Engn, Huaiyin 223003, Peoples R China.	luochuping@163.com; chzy84390393@163.com			National Natural Science Foundation of China [31570061]; National High-tech R&D Program of China [2011AA10A201]; Science Foundation of the Jiangsu Academy of Agricultural Sciences [CX (14)2128]; public welfare industry (agriculture) research special funds [201103002-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Science Foundation of the Jiangsu Academy of Agricultural Sciences; public welfare industry (agriculture) research special funds	This work was supported by National Natural Science Foundation of China (grant 31570061); National High-tech R&D Program of China (2011AA10A201); Science Foundation of the Jiangsu Academy of Agricultural Sciences [grant CX (14)2128]; public welfare industry (agriculture) research special funds (201103002-3).	Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Bianciotto V, 2001, MOL PLANT MICROBE IN, V14, P255, DOI 10.1094/MPMI.2001.14.2.255; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; ESHITA SM, 1995, J ANTIBIOT, V48, P1240, DOI 10.7164/antibiotics.48.1240; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Guttenplan SB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001243; Haggag WM, 2008, J APPL MICROBIOL, V104, P961, DOI 10.1111/j.1365-2672.2007.03611.x; Hamon MA, 2004, MOL MICROBIOL, V52, P847, DOI 10.1111/j.1365-2958.2004.04023.x; Hamon NR, 2005, MOL MICROBIOL, V57, P1143, DOI [10.1111/j.1365-2958.2005.04746.x, DOI 10.1111/J.1365-2958.2005.04746.X]; Hofemeister J, 2004, MOL GENET GENOMICS, V272, P363, DOI 10.1007/s00438-004-1056-y; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Julkowska D, 2005, J BACTERIOL, V187, P65, DOI 10.1128/JB.187.1.65-76.2005; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Leclere V, 2006, ARCH MICROBIOL, V186, P475, DOI 10.1007/s00203-006-0163-z; Liu J, 2011, CURR MICROBIOL, V62, P235, DOI 10.1007/s00284-010-9696-0; Liu J, 2010, INT J FOOD MICROBIOL, V142, P190, DOI 10.1016/j.ijfoodmicro.2010.06.023; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Luo CP, 2015, APPL MICROBIOL BIOT, V99, P1897, DOI 10.1007/s00253-014-6195-4; Luo CP, 2015, APPL ENVIRON MICROB, V81, P422, DOI 10.1128/AEM.02921-14; Luo ChuPing, 2010, Scientia Agricultura Sinica, V43, P4624; McLoon AL, 2011, J BACTERIOL, V193, P2027, DOI 10.1128/JB.01542-10; Morikawa M, 2006, MICROBIOL-SGM, V152, P2801, DOI 10.1099/mic.0.29060-0; Murray EJ, 2009, J BACTERIOL, V191, P6822, DOI 10.1128/JB.00618-09; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Ramey BE, 2004, CURR OPIN MICROBIOL, V7, P602, DOI 10.1016/j.mib.2004.10.014; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Roongsawang N, 2003, CHEM BIOL, V10, P869, DOI 10.1016/j.chembiol.2003.09.004; Saifuddin N, 2009, E-J CHEM, V6, P61, DOI 10.1155/2009/734264; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stowe SD, 2014, BIOMOL NMR ASSIGN, V8, P155, DOI 10.1007/s12104-013-9473-7; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang PP, 2015, MICROBIOL RES, V178, P42, DOI 10.1016/j.micres.2015.06.006; Wang XY, 2012, J BACTERIOL, V194, P5467, DOI 10.1128/JB.01266-12; Weng J, 2013, APPL MICROBIOL BIOT, V97, P8823, DOI 10.1007/s00253-012-4572-4; Xu ZH, 2013, APPL ENVIRON MICROB, V79, P808, DOI 10.1128/AEM.02645-12; Zeriouh H, 2014, ENVIRON MICROBIOL, V16, P2196, DOI 10.1111/1462-2920.12271; [张荣胜 Zhang Rongsheng], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P2014; [周华飞 Zhou Huafei], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P2232; Zou JH, 2000, THEOR APPL GENET, V101, P569, DOI 10.1007/s001220051517	50	9	12	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156247	10.1371/journal.pone.0156247	http://dx.doi.org/10.1371/journal.pone.0156247			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223617	gold, Green Published			2022-12-26	WOS:000376881700077
J	Eriksson, K; Nise, L; Kats, A; Luttropp, E; Catrina, AI; Askling, J; Jansson, L; Alfredsson, L; Klareskog, L; Lundberg, K; Yucel-Lindberg, T				Eriksson, Kaja; Nise, Lena; Kats, Anna; Luttropp, Elin; Catrina, Anca Irinel; Askling, Johan; Jansson, Leif; Alfredsson, Lars; Klareskog, Lars; Lundberg, Karin; Yucel-Lindberg, Tulay			Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; CITRULLINATED PROTEINS; ALPHA-ENOLASE; TOOTH LOSS; DISEASE; RISK; ASSOCIATION; AUTOIMMUNITY; PATHOGENESIS; INTERLEUKIN-1	Introduction The possible hypothesis of a link between periodontitis and rheumatoid arthritis (RA), specifically anti-citrullinated protein antibody (ACPA) positive RA, prompted us to investigate the prevalence of periodontitis in the Swedish Epidemiological Investigation of RA (EIRA), a well-characterised population-based RA case-control cohort. Methods Periodontal status of 2,740 RA cases and 3,942 matched controls was retrieved through linking EIRA with the National Dental Health Registry (DHR), where dental diagnostic-and treatment codes on the adult Swedish population have been registered. Dental records from 100 cases and controls were reviewed to validate the periodontal diagnostic codes in DHR. Results The reviewed dental records confirmed 90% of the periodontitis diagnoses in DHR among RA cases, and 88% among controls. We found the positive predictive value of periodontitis diagnoses in the DHR to be 89% (95% CI 78 to 95%) with a sensitivity of 77% (95% CI: 65 to 86%). In total, 86% of EIRA participants were identified in DHR. The risk for periodontitis increased by age and current smoking status in both cases as well as controls. No significant differences in prevalence of periodontal disease in terms of gingivitis, periodontitis, peri-implantitis or increased risk for periodontitis or peri-implantitis were observed between RA cases and controls. In addition, there was no difference on the basis of seropositivity, ACPA or rheumatoid factor (RF), among patients with RA. Conclusions Our data verify that smoking and ageing are risk factors for periodontitis, both in RA and controls. We found no evidence of an increased prevalence of periodontitis in patients with established RA compared to healthy controls, and no differences based on ACPA or RF status among RA subjects.	[Eriksson, Kaja; Kats, Anna; Luttropp, Elin; Jansson, Leif; Yucel-Lindberg, Tulay] Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden; [Nise, Lena; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, Solna, Sweden; [Catrina, Anca Irinel; Askling, Johan; Klareskog, Lars; Lundberg, Karin] Karolinska Univ Hosp, Rheumatol Unit, Dept Med, Stockholm, Sweden; [Jansson, Leif] Stockholm Cty Council, Dept Periodontol, Eastmaninst, Stockholm, Sweden; [Alfredsson, Lars] Stockholm Cty Council, Ctr Environm & Occupat Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stockholm County Council; Stockholm County Council	Eriksson, K (corresponding author), Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden.	Kaja.Eriksson@ki.se; Tulay.Lindberg@ki.se	Alfredsson, Lars/AAC-9007-2019	Alfredsson, Lars/0000-0003-1688-6697; Yucel-Lindberg, Tulay/0000-0003-0129-8809	European Union's FP7 Research Project -GUMS AND JOINTS [FP7-HEALTH-2010-261460]; European Union's FP7 Research Project TRIGGER [FP7-Health-2013-306029]; Stockholm County Council (SOF); Stockholm County Council (ALF); Swedish Research Council (VR); Karolinska Institutet; Swedish Dental Society; Swedish Rheumatic Foundation	European Union's FP7 Research Project -GUMS AND JOINTS; European Union's FP7 Research Project TRIGGER; Stockholm County Council (SOF)(Stockholm County Council); Stockholm County Council (ALF)(Stockholm County Council); Swedish Research Council (VR)(Swedish Research Council); Karolinska Institutet(Karolinska Institutet); Swedish Dental Society; Swedish Rheumatic Foundation	The study was financially supported by the collaborative European Union's FP7 Research Projects -GUMS AND JOINTS (grant agreement number: FP7-HEALTH-2010-261460) and TRIGGER (grant agreement number: FP7-Health-2013-306029), the Stockholm County Council (SOF and ALF), the Swedish Research Council (VR), Karolinska Institutet, the Swedish Dental Society, and the Swedish Rheumatic Foundation. The funding was received by TYL, KL, LK, LA, and KE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arajo VMA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/259074; [Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; Arkema EV, 2010, J RHEUMATOL, V37, P1800, DOI 10.3899/jrheum.091398; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartold PM, 2005, J PERIODONTOL, V76, P2066, DOI 10.1902/jop.2005.76.11-S.2066; Bascones A, 2005, QUINTESSENCE INT, V36, P299; Bengtsson C, 2005, ANN RHEUM DIS, V64, P1588, DOI 10.1136/ard.2004.031666; Biyikoglu B, 2006, J CLIN PERIODONTOL, V33, P605, DOI 10.1111/j.1600-051X.2006.00961.x; Blicher B, 2005, J DENT RES, V84, P881, DOI 10.1177/154405910508401003; Bozkurt FY, 2000, J PERIODONTOL, V71, P1756, DOI 10.1902/jop.2000.71.11.1756; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Coburn BW, 2015, J PERIODONTOL, V86, P16, DOI 10.1902/jop.2014.140339; de Pablo P, 2008, J RHEUMATOL, V35, P70; de Smit M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4061; Delima AJ, 2001, J CLIN PERIODONTOL, V28, P233, DOI 10.1034/j.1600-051x.2001.028003233.x; Demmer RT, 2011, J CLIN PERIODONTOL, V38, P998, DOI 10.1111/j.1600-051X.2011.01776.x; Dissick A, 2010, J PERIODONTOL, V81, P223, DOI 10.1902/jop.2009.090309; Fuggle NR, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00080; Garib BT, 2011, J ORAL MAXIL SURG, V69, P2971, DOI 10.1016/j.joms.2011.02.131; Gerlag DM, 2015, RHEUMATOLOGY OXFORD; Gonzalez SM, 2015, J PERIODONTOL, V86, P222, DOI 10.1902/jop.2014.140425; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Harvey GP, 2013, J PERIODONTAL RES, V48, P252, DOI 10.1111/jre.12002; Hendler A, 2010, J DENT RES, V89, P1389, DOI 10.1177/0022034510381903; HOWELL TH, 1993, J PERIODONTOL, V64, P828, DOI 10.1902/jop.1993.64.8s.828; Janssen KMJ, 2013, CURR OPIN RHEUMATOL, V25, P241, DOI 10.1097/BOR.0b013e32835d833d; Joseph R, 2013, RHEUMATOL INT, V33, P103, DOI 10.1007/s00296-011-2284-1; Kallberg H, 2013, SCAND J RHEUMATOL, V42, P337, DOI 10.3109/03009742.2013.769062; Kasser U, 1997, ARTHRITIS RHEUM, V40, P2248; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kobayashi T, 2007, J PERIODONTOL, V78, P2311, DOI 10.1902/jop.2007.070136; Lappin DF, 2013, J CLIN PERIODONTOL, V40, P907, DOI 10.1111/jcpe.12138; Liao KP, 2009, ARTHRITIS RHEUM-US, V60, P653, DOI 10.1002/art.24362; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; Llambes F, 2015, WORLD J DIABETES, V6, P927, DOI 10.4239/wjd.v6.i7.927; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mercado FB, 2001, J PERIODONTOL, V72, P779, DOI 10.1902/jop.2001.72.6.779; Mikuls TR, 2014, ARTHRITIS RHEUM; Mirrielees J, 2010, J CLIN PERIODONTOL, V37, P1068, DOI 10.1111/j.1600-051X.2010.01625.x; Okada M, 2011, J PERIODONTOL, V82, P1433, DOI 10.1902/jop.2011.110020; Ortiz P, 2009, J PERIODONTOL, V80, P535, DOI 10.1902/jop.2009.080447; Payne Jeffrey B, 2015, Curr Oral Health Rep, V2, P20; Pihlstrom BL, 2001, PERIODONTOL 2000, V25, P37, DOI 10.1034/j.1600-0757.2001.22250104.x; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Potikuri D, 2012, ANN RHEUM DIS, V71, P1541, DOI 10.1136/annrheumdis-2011-200380; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Rutger Persson G, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.11829; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Shiau HJ, 2010, J PERIODONTOL, V81, P1379, DOI 10.1902/jop.2010.100044; SJOSTROM L, 1989, COMMUNITY DENT ORAL, V17, P234, DOI 10.1111/j.1600-0528.1989.tb00623.x; Stabholz A, 2010, PERIODONTOL 2000, V53, P138, DOI 10.1111/j.1600-0757.2010.00340.x; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Susanto H, 2013, J PERIODONTOL, V84, P1067, DOI 10.1902/jop.2012.110321; Tomar SL, 2007, J PERIODONTOL, V78, P1380, DOI 10.1902/jop.2007.060340; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wolff B, 2014, RHEUMATOLOGY, V53, P526, DOI 10.1093/rheumatology/ket362; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8	64	57	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155956	10.1371/journal.pone.0155956	http://dx.doi.org/10.1371/journal.pone.0155956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203435	gold, Green Published, Green Submitted			2022-12-26	WOS:000376291500035
J	Kubota, M; Yanagita, M; Mori, K; Hasegawa, S; Yamashita, M; Yamada, S; Kitamura, M; Murakami, S				Kubota, Mikiko; Yanagita, Manabu; Mori, Kenta; Hasegawa, Shiori; Yamashita, Motozo; Yamada, Satoru; Kitamura, Masahiro; Murakami, Shinya			The Effects of Cigarette Smoke Condensate and Nicotine on Periodontal Tissue in a Periodontitis Model Mouse	PLOS ONE			English	Article							LIGATURE-INDUCED PERIODONTITIS; ALVEOLAR BONE LOSS; LIGAMENT CELLS; IN-VITRO; EXPRESSION; DISEASE; RANKL; RATS; FIBROBLASTS; ATTACHMENT	Cigarette smoking is a major lifestyle-related risk factor for periodontal diseases. However, the pathophysiological role of cigarette smoking in periodontal disease has yet to be fully elucidated. Here we report that the systemic administration of cigarette smoke condensate or nicotine, which is the major ingredient of cigarette smoke, augmented alveolar bone loss. Concomitantly, the number of osteoclasts in periodontal tissues increased and the expression of receptor activator of nuclear factor kappa B ligand was upregulated at the ligated side in mice with periodontitis. Nicotine also attenuated alveolar bone repair after ligature removal. These observations highlight the destruction of periodontal tissue by smoking and the unfavorable clinical course of periodontal disease in patients with a cigarette smoking habit. The present study demonstrates that periodontal disease models are useful for elucidating the pathogenesis of cigarette smoking-related periodontal diseases.	[Kubota, Mikiko; Yanagita, Manabu; Mori, Kenta; Hasegawa, Shiori; Yamashita, Motozo; Yamada, Satoru; Kitamura, Masahiro; Murakami, Shinya] Osaka Univ, Dept Periodontol, Div Oral Biol & Dis Control, Suita, Osaka, Japan	Osaka University	Yanagita, M (corresponding author), Osaka Univ, Dept Periodontol, Div Oral Biol & Dis Control, Suita, Osaka, Japan.	yanagita@dent.osaka-u.ac.jp		Murakami, Shinya/0000-0002-5230-452X	KAKENHI from Japanese Society for the Promotion of Science [2643133, 23659975, 15H05034]	KAKENHI from Japanese Society for the Promotion of Science	This study was supported by KAKENHI Grants-in-Aid for Scientific Research 2643133 to Manabu Yanagita and 23659975 and 15H05034 to Masahiro Kitamura from the Japanese Society for the Promotion of Science.	Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Bosco AF, 2007, J PERIODONTOL, V78, P527, DOI 10.1902/jop.2007.060149; BRECX MC, 1985, J PERIODONTAL RES, V20, P165, DOI 10.1111/j.1600-0765.1985.tb00423.x; Breivik T, 2009, J PERIODONTAL RES, V44, P297, DOI 10.1111/j.1600-0765.2009.01223.x; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Buduneli N, 2008, J CLIN PERIODONTOL, V35, P846, DOI 10.1111/j.1600-051X.2008.01310.x; CARBONE D, 1992, AM J MED, V93, pS13, DOI 10.1016/0002-9343(92)90621-H; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Festing Michael F W, 2002, ILAR J, V43, P244; Giannopoulou C, 1999, J CLIN PERIODONTOL, V26, P49, DOI 10.1034/j.1600-051X.1999.260109.x; Han XZ, 2006, J IMMUNOL, V176, P625, DOI 10.4049/jimmunol.176.1.625; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; JOHNSON DA, 1976, J PERIODONTAL RES, V11, P349, DOI 10.1111/j.1600-0765.1976.tb00089.x; Lee HJ, 2009, J PERIODONTOL, V80, P1281, DOI 10.1902/jop.2009.090098; Lin XP, 2011, INFECT IMMUN, V79, P911, DOI 10.1128/IAI.00944-10; Liu YF, 2010, J PERIODONTAL RES, V45, P714, DOI 10.1111/j.1600-0765.2010.01290.x; Malcolm J, 2015, J DENT RES, V94, P968, DOI 10.1177/0022034515577815; Mariotti A, 1999, Ann Periodontol, V4, P7, DOI 10.1902/annals.1999.4.1.7; Nociti FH, 2000, J PERIODONTOL, V71, P1460, DOI 10.1902/jop.2000.71.9.1460; Nociti FH, 2015, PERIODONTOL 2000, V67, P187, DOI 10.1111/prd.12063; Palmer RM, 1999, J PERIODONTAL RES, V34, P363, DOI 10.1111/j.1600-0765.1999.tb02267.x; RAULIN LA, 1988, J PERIODONTOL, V59, P318, DOI 10.1902/jop.1988.59.5.318; Ryder MI, 2007, PERIODONTOL 2000, V43, P267, DOI 10.1111/j.1600-0757.2006.00163.x; Ryder MI, 1998, J PERIODONTAL RES, V33, P359, DOI 10.1111/j.1600-0765.1998.tb02211.x; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Takahashi S, 2014, J PERIODONTAL RES, V49, P390, DOI 10.1111/jre.12118; Wang LY, 2014, J PERIODONTOL, V85, P740, DOI 10.1902/jop.2013.130132; Wu LZ, 2013, INT J MOL MED, V31, P938, DOI 10.3892/ijmm.2013.1259; Yanagita M, 1999, J IMMUNOL, V162, P3559; Yanagita M, 2010, ORAL DIS, V16, P812, DOI 10.1111/j.1601-0825.2010.01693.x; Yanagita M, 2008, J ENDODONT, V34, P1061, DOI 10.1016/j.joen.2008.06.005; Yanagita M, 2012, CELL IMMUNOL, V274, P26, DOI 10.1016/j.cellimm.2012.02.007; Yanagita M, 2009, BIOCHEM BIOPH RES CO, V388, P91, DOI 10.1016/j.bbrc.2009.07.124; Yokota K, 2014, ARTHRITIS RHEUMATOL, V66, P121, DOI 10.1002/art.38218; Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y	36	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155594	10.1371/journal.pone.0155594	http://dx.doi.org/10.1371/journal.pone.0155594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203240	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291500018
J	Miller, MJ; Esser, HJ; Loaiza, JR; Herre, EA; Aguilar, C; Quintero, D; Alvarez, E; Bermingham, E				Miller, Matthew J.; Esser, Helen J.; Loaiza, Jose R.; Herre, Edward Allen; Aguilar, Celestino; Quintero, Diomedes; Alvarez, Eric; Bermingham, Eldredge			Molecular Ecological Insights into Neotropical Bird-Tick Interactions	PLOS ONE			English	Article							MOUNTAIN-SPOTTED-FEVER; ACARI IXODIDAE; WILD BIRDS; RICKETTSIAL INFECTION; AMBLYOMMA-AUREOLATUM; MIGRATORY BIRDS; BORNE PATHOGENS; RAIN-FOREST; MAMMALS; PANAMA	In the tropics, ticks parasitize many classes of vertebrate hosts. However, because many tropical tick species are only identifiable in the adult stage, and these adults usually parasitize mammals, most attention on the ecology of tick-host interactions has focused on mammalian hosts. In contrast, immature Neotropical ticks are often found on wild birds, yet difficulties in identifying immatures hinder studies of birds' role in tropical tick ecology and tick-borne disease transmission. In Panama, we found immature ticks on 227 out of 3,498 individually-sampled birds representing 93 host species (24% of the bird species sampled, and 13% of the Panamanian land bird fauna). Tick parasitism rates did not vary with rainfall or temperature, but did vary significantly with several host ecological traits. Likewise, Neotropical-Nearctic migratory birds were significantly less likely to be infested than resident species. Using a molecular library developed from morphologically-identified adult ticks specifically for this study, we identified eleven tick species parasitizing birds, indicating that a substantial portion of the Panamanian avian species pool is parasitized by a diversity of tick species. Tick species that most commonly parasitized birds had the widest diversity of avian hosts, suggesting that immature tick species are opportunistic bird parasites. Although certain avian ecological traits are positively associated with parasitism, we found no evidence that individual tick species show specificity to particular avian host ecological traits. Finally, our data suggest that the four principal vectors of Rocky Mountain Spotted Fever in the Neotropics rarely, if ever, parasitize Panamanian birds. However, other tick species that harbor newly-discovered rickettsial parasites of unknown pathogenicity are frequently found on these birds. Given our discovery of broad interaction between Panamanian tick and avian biodiversity, future work on tick ecology and the dynamics of emerging tropical tick-borne pathogens should explicitly consider wild bird as hosts.	[Miller, Matthew J.; Esser, Helen J.; Loaiza, Jose R.; Herre, Edward Allen; Aguilar, Celestino; Alvarez, Eric; Bermingham, Eldredge] Smithsonian Trop Res Inst, Panama City, Panama; [Miller, Matthew J.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Esser, Helen J.] Wageningen Univ, Dept Environm Sci, NL-6700 AP Wageningen, Netherlands; [Loaiza, Jose R.; Aguilar, Celestino] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama; [Alvarez, Eric] Univ Panama, Centralamer Masters Program Entomol, Panama City, Panama; [Quintero, Diomedes] Univ Panama, GB Fairchild Invertebrate Museum, Panama City, Panama; [Bermingham, Eldredge] Patricia & Phillip Frost Museum Sci, Miami, FL USA; [Miller, Matthew J.] Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73019 USA; [Miller, Matthew J.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Villanova University; Wageningen University & Research; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidad de Panama; Universidad de Panama; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Miller, MJ (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.; Miller, MJ (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.; Miller, MJ (corresponding author), Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73019 USA.; Miller, MJ (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	mjmiller@ou.edu	Esser, Helen/ABB-8025-2021; Miller, Matthew/B-4560-2008	Esser, Helen/0000-0003-3236-8021; Miller, Matthew/0000-0002-2939-0239; Aguilar, Celestino/0000-0003-1627-0374	US Centers for Disease Control; Smithsonian Grand Challenges Award; graduate school of Production Ecology and Resource Conservation of Wageningen University; NIH/NSF Ecology and Evolution of Infectious Diseases Award from the Fogarty International Center [3R01-TW005869-05S1]; Smithsonian Institution's DNA Barcoding Network; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER	US Centers for Disease Control; Smithsonian Grand Challenges Award; graduate school of Production Ecology and Resource Conservation of Wageningen University; NIH/NSF Ecology and Evolution of Infectious Diseases Award from the Fogarty International Center; Smithsonian Institution's DNA Barcoding Network; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was partially funded by an interagency award from the US Centers for Disease Control ("Effect of Anthropogenic Climate Change on the Ecology of Zoonotic and Vector-borne Diseases"; http://www.cdc.gov/), and a Smithsonian Grand Challenges Award ("Tropical Vertebrate Diversity Loss and the Emergence of Tick-borne Diseases"; https://www.si.edu/consortia). HJE was supported by the graduate school of Production Ecology and Resource Conservation of Wageningen University (https://www.pe-rc.nl/). The STRI Bird Collection was supported by an NIH/NSF Ecology and Evolution of Infectious Diseases Award from the Fogarty International Center (3R01-TW005869-05S1; http://www.fic.nih.gov/). DNA barcode sequencing was supported from a grant from the Smithsonian Institution's DNA Barcoding Network (http://barcoding.si.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperson CS, 2008, VECTOR-BORNE ZOONOT, V8, P597, DOI 10.1089/vbz.2007.0271; Arguello AP, 2012, AM J TROP MED HYG, V87, P345, DOI 10.4269/ajtmh.2012.12-0153; Bermudez SE, 2012, EXP APPL ACAROL, V58, P81, DOI 10.1007/s10493-012-9564-7; Bermudez CSE, 2011, VET PARASITOL, V177, P134, DOI 10.1016/j.vetpar.2010.11.020; Bermudez SE, 2010, EXP APPL ACAROL, V52, P439, DOI 10.1007/s10493-010-9374-8; Bermudez SE, 2009, J MED ENTOMOL, V46, P856, DOI 10.1603/033.046.0417; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clayton DH, 2001, J PARASITOL, V87, P1291, DOI 10.1645/0022-3395(2001)087[1291:CEOFMF]2.0.CO;2; Cohen EB, 2015, APPL ENVIRON MICROB, V81, P8366, DOI 10.1128/AEM.02656-15; Colwell R.K., 2016, ESTIMATES STAT ESTIM; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Combes Claude., 2001, PARASITISM ECOLOGY E; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; DERODANICHE EC, 1950, AM J TROP MED, V30, P511; DERODANICHE EC, 1953, AM J TROP MED HYG, V2, P696, DOI 10.4269/ajtmh.1953.2.696; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Eremeeva ME, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2008.02638.x; Eremeeva ME, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00055; Estrada-Pena A, 2004, ANN TROP MED PARASIT, V98, P283, DOI 10.1179/000349804225003316; Estripeaut D, 2007, EMERG INFECT DIS, V13, P1763, DOI 10.3201/eid1311.070931; Fairchild G., 1966, ECTOPARASITES PANAMA, P167; Ginsberg HS, 2005, J MED ENTOMOL, V42, P445, DOI 10.1603/0022-2585(2005)042[0445:RCONNA]2.0.CO;2; Guglielmone AA, 2003, VET PARASITOL, V113, P273, DOI 10.1016/S0304-4017(03)00083-9; Hamer SA, 2012, EMERG INFECT DIS, V18, P1589, DOI 10.3201/eid1810.120511; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hidalgo M, 2011, MEM I OSWALDO CRUZ, V106, P117, DOI 10.1590/S0074-02762011000100019; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Labruna MB, 2007, EXP APPL ACAROL, V43, P147, DOI 10.1007/s10493-007-9106-x; Labruna MB, 2011, REV MVZ CORDOBA, V16, P2435, DOI 10.21897/rmvz.282; Labruna MB, 2004, J MED ENTOMOL, V41, P533, DOI 10.1603/0022-2585-41.3.533; Leger E, 2013, EXP APPL ACAROL, V59, P219, DOI 10.1007/s10493-012-9615-0; Lindeborg M, 2012, EMERG INFECT DIS, V18, P2095, DOI 10.3201/eid1812.120718; Madinah A, 2014, COMMUNITY ECOL, V15, P113, DOI [10.1556/COMEC.15.2014.1.12, 10.1556/ComEc.15.2014.1.12]; Marini Miguel Angelo, 1996, Ararajuba, V4, P93; Martins TF, 2010, TICKS TICK-BORNE DIS, V1, P75, DOI 10.1016/j.ttbdis.2010.03.002; McCoy KD, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00057; Miranda J, 2012, J MED ENTOMOL, V49, P960, DOI 10.1603/ME11195; Nava S, 2008, ANN TROP MED PARASIT, V102, P409, DOI 10.1179/136485908X278883; Nava S, 2013, B ENTOMOL RES, V103, P216, DOI 10.1017/S0007485312000557; Nava S, 2014, TICKS TICK-BORNE DIS, V5, P252, DOI 10.1016/j.ttbdis.2013.11.004; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogrzewalska M, 2015, TICKS TICK-BORNE DIS, V6, P478, DOI 10.1016/j.ttbdis.2015.03.016; Ogrzewalska M, 2013, TICKS TICK-BORNE DIS, V4, P145, DOI 10.1016/j.ttbdis.2012.07.001; Ogrzewalska M, 2012, TICKS TICK-BORNE DIS, V3, P254, DOI 10.1016/j.ttbdis.2012.05.003; Ogrzewalska M, 2011, ECOHEALTH, V8, P320, DOI 10.1007/s10393-011-0726-6; Ogrzewalska M, 2010, PARASITOL RES, V106, P809, DOI 10.1007/s00436-010-1733-1; Ogrzewalska M, 2009, J MED ENTOMOL, V46, P1225, DOI 10.1603/033.046.0534; Onofrio V, CARRAPATOS IMPORTANC, P53; Pacheco RC, 2012, J MED ENTOMOL, V49, P710, DOI 10.1603/ME11217; Parola P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000338; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Pinter A, 2006, ANN NY ACAD SCI, V1078, P523, DOI 10.1196/annals.1374.103; Poulin R., 2011, EVOL ECOL; R Core Team, 2021, R LANGUAGE ENV STAT; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Rappole JH, 2003, J APPL MICROBIOL, V94, p47S; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Robinson WD, 2000, ECOL MONOGR, V70, P209, DOI 10.1890/0012-9615(2000)070[0209:FBCSIC]2.0.CO;2; Rocha LA, 2014, SCIENCE, V344, P814, DOI 10.1126/science.344.6186.814; Romer Y, 2011, EMERG INFECT DIS, V17, P1169, DOI 10.3201/eid1707.101857; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tribaldos M, 2011, J INFECT DEV COUNTR, V5, P737, DOI 10.3855/jidc.2189; Wells K, 2013, OECOLOGIA, V172, P307, DOI 10.1007/s00442-012-2511-9	66	13	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155989	10.1371/journal.pone.0155989	http://dx.doi.org/10.1371/journal.pone.0155989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203693	Green Submitted, Green Published, gold			2022-12-26	WOS:000376291500037
J	Zhang, LY; Xiang, WP; Wang, GL; Yan, ZZ; Zhu, ZW; Guo, Z; Sengupta, R; Chen, AF; Loughran, PA; Lu, B; Wang, QD; Billiar, TR				Zhang, Liyong; Xiang, Wenpei; Wang, Guoliang; Yan, Zhengzheng; Zhu, Zhaowei; Guo, Zhong; Sengupta, Rajib; Chen, Alex F.; Loughran, Patricia A.; Lu, Ben; Wang, Qingde; Billiar, Timothy R.			Interferon beta (IFN-beta) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HEPATITIS-C VIRUS; ISCHEMIA-REPERFUSION INJURY; LIVER-INJURY; TYROSINE RESIDUES; INNATE IMMUNITY; TNF RECEPTOR; MACROPHAGES; ACTIVATION; EXPRESSION	The sensing of double-stranded RNA (dsRNA) in the liver important for antiviral defenses but can also contribute to sterile inflammation during liver injury. Hepatocytes are often the target of viral infection and are easily injured by inflammatory insults. Here we sought to establish the pathways involved in the production of type I interferons (IFN-I) in response to extracellular poly(I:C), a dsRNA mimetic, in hepatocytes. This was of interest because hepatocytes are long-lived and, unlike most immune cells that readily die after activation with dsRNA, are not viewed as cells with robust antimicrobial capacity. We found that poly(LC) leads to rapid up-regulation of inducible nitric oxide synthase (iNOS), double-stranded RNA-dependent protein kinase (PKR), and Src. The production of IFN-I3 was dependent on iNOS, PKR, and Src and partially dependent on TLR3/Trif. iNOS and Src up-regulation was partially dependent on TLR3/Trif but entirely dependent on PKR. The phosphorylation of TLR3 on tyrosine 759 was shown to increase in parallel to IFN-fl production in an iNOS- and Src-dependent manner, and Src was found to directly interact with TLR3 in the endosomal compartment of poly(I:C)-treated cells. Furthermore, we identified a robust NO/cGMP/PKG-dependent feedforward pathway for the amplification of iNOS expression. These data identify iNOS/NO as an integral component of IFN-beta production in response to dsRNA in hepatocytes in a pathway that involves the coordinated activities of TLR3/Trif and PKR.	[Zhang, Liyong; Xiang, Wenpei; Wang, Guoliang; Yan, Zhengzheng; Zhu, Zhaowei; Guo, Zhong; Sengupta, Rajib; Chen, Alex F.; Loughran, Patricia A.; Wang, Qingde; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Xiang, Wenpei] Huazhong Univ Sci & Technol, Family Planning Res Inst, Tongji Med Coll, Wuhan, Peoples R China; [Loughran, Patricia A.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Lu, Ben] Xiangya Third Hosp, Changsha, Hunan, Peoples R China; [Lu, Ben] Cent S Univ, Sch Med, Changsha, Hunan, Peoples R China; [Sengupta, Rajib] Sardar Bhagwan Singh PG Inst, Dept Biochem & Biotechnol, Dehra Dun, Uttarakhand, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Huazhong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University	Billiar, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	billiartr@upmc.edu	Lu, Ben/AAN-1068-2021; SENGUPTA, RAJIB/AGY-3587-2022; Loughran, Patricia/AAB-1184-2021	Lu, Ben/0000-0002-8597-0406; SENGUPTA, RAJIB/0000-0002-9665-8784; Zhang, Liyong/0000-0002-6952-7463; Yan, Zheng-Zheng/0000-0003-3082-6762	National Institutes of Health [R37-GM-044100, R01-GM-050441]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050441, R01GM044100, R37GM044100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37-GM-044100 and R01-GM-050441. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BILLIAR TR, 1992, AM J PHYSIOL, V262, pC1077, DOI 10.1152/ajpcell.1992.262.4.C1077; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Broering R, 2014, J VIRAL HEPATITIS, V21, P480, DOI 10.1111/jvh.12174; Cavassani KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065899; Chanthaphavong RS, 2012, J BIOL CHEM, V287, P35887, DOI 10.1074/jbc.M112.365171; CURRAN RD, 1989, J EXP MED, V170, P1769, DOI 10.1084/jem.170.5.1769; delaTorre A, 1999, J IMMUNOL, V162, P4101; Deng M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005548; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Eum HA, 2011, AM J PATHOL, V179, P1221, DOI 10.1016/j.ajpath.2011.05.046; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P3491, DOI 10.1073/pnas.90.8.3491; GELLER DA, 1995, J IMMUNOL, V155, P4890; Guidotti LG, 2000, J EXP MED, V191, P1247, DOI 10.1084/jem.191.7.1247; Hato T, 2015, CLIN J AM SOC NEPHRO, V10, P1459, DOI 10.2215/CJN.04680514; He Y, 2013, EUR J IMMUNOL, V43, P1147, DOI 10.1002/eji.201243187; Heydtmann M, 2009, J VIROL, V83, P2796, DOI 10.1128/JVI.00996-08; Hsieh MY, 2014, J BIOL CHEM, V289, P9208, DOI 10.1074/jbc.M113.508663; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kanda T, 2007, J VIROL, V81, P12375, DOI 10.1128/JVI.01695-07; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Lee VG, 2001, SHOCK, V16, P355, DOI 10.1097/00024382-200116050-00006; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Loi P, 2013, HEPATOLOGY, V57, P351, DOI 10.1002/hep.26022; Ma ZY, 2015, CELL MOL IMMUNOL, V12, P273, DOI 10.1038/cmi.2014.112; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; McAllister CS, 2013, J IMMUNOL, V190, P418, DOI 10.4049/jimmunol.1202756; Mehta DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031688; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mihm S, 1997, HEPATOLOGY, V26, P451, DOI 10.1002/hep.510260228; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moore TC, 2013, FEBS LETT, V587, P3014, DOI 10.1016/j.febslet.2013.07.025; Newton K., 2012, COLD SPRING HARB PER, V4; NUSSLER AK, 1992, J EXP MED, V176, P261, DOI 10.1084/jem.176.1.261; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; Sarkar SN, 2007, J BIOL CHEM, V282, P3423, DOI 10.1074/jbc.C600226200; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Shears LL, 1997, J CLIN INVEST, V100, P2035, DOI 10.1172/JCI119736; Shen XD, 2012, AM J TRANSPLANT, V12, P1730, DOI 10.1111/j.1600-6143.2012.04021.x; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20248; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Xiao XY, 2009, J IMMUNOL, V183, P3712, DOI 10.4049/jimmunol.0901221; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamashita M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002581; Yang SY, 2014, J IMMUNOL, V193, P3436, DOI 10.4049/jimmunol.1401136; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhai YA, 2008, HEPATOLOGY, V47, P199, DOI 10.1002/hep.21970; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhang LM, 2013, VIROLOGY, V438, P28, DOI 10.1016/j.virol.2013.01.015; Zorde-Khvalevsky E, 2009, HEPATOLOGY, V50, P198, DOI 10.1002/hep.22973	63	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15093	15107		10.1074/jbc.M116.717942	http://dx.doi.org/10.1074/jbc.M116.717942			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226571	Green Published, hybrid			2022-12-26	WOS:000380583200020
J	Qi, HS; Liu, MQ; Zhang, LH; Wang, DH				Qi, Hongsheng; Liu, Meiqi; Zhang, Lihui; Wang, Dianhai			Tracing Road Network Bottleneck by Data Driven Approach	PLOS ONE			English	Article							TRAFFIC FLOW	Urban road congestions change both temporally and spatially. They are essentially caused by network bottlenecks. Therefore, understanding bottleneck dynamics is critical in the goal of reasonably allocating transportation resources. In general, a typical bottleneck experiences the stages of formation, propagation and dispersion. In order to understand the three stages of a bottle neck and how the bottleneck moves on a road network, traffic flow data can be used to reconstruct these dynamics. However, raw traffic flow data is usually flawed in many ways. For instance some portion of data may be missing due to the failure of data collection devices, or some random factors in the data make it hard to identify real bottlenecks. In this paper a "user voting method" is proposed to deal with such raw-data-related issues. In this method, road links are ranked according to the weighed sum of certain performance measures and the links that are ranked relatively high are regarded as recurrent bottlenecks in a network, and several bottlenecks form a bottleneck area. A series of bottleneck parameters can be defined based on the identified bottleneck areas, such as bottleneck coverage, bottleneck link length, etc. Identifying bottleneck areas and calculating the bottleneck parameters for each time interval can reflect the evolution of the bottlenecks and also help trace how the bottlenecks move.	[Qi, Hongsheng; Liu, Meiqi; Zhang, Lihui; Wang, Dianhai] Zhejiang Univ, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhang, LH (corresponding author), Zhejiang Univ, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	lihuizhang@zju.edu.cn			State Key Development Program for Basic Research of China [2012CB725402]; National Natural Science Foundation of China [51338008, 51408538, 51278454]; Key Science and Technology Innovation Team of Zhejiang Province [2013TD09]; Fundamental Research Funds for the Central Universities [2015QNA4025]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Innovation Team of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by the State Key Development Program for Basic Research of China ( Grant No. 2012CB725402); the National Natural Science Foundation of China ( Grant No. 51338008, 51408538, 51278454); Key Science and Technology Innovation Team of Zhejiang Province ( 2013TD09); Fundamental Research Funds for the Central Universities: ( 2015QNA4025).	Chen DJ, 2015, TRANSPORT RES C-EMER, V51, P210, DOI 10.1016/j.trc.2014.10.015; Dong SJ, 2015, J TRANSP ENG, V141, DOI 10.1061/(ASCE)TE.1943-5436.0000788; Hino Y, 2014, PHYSICA A, V395, P425, DOI 10.1016/j.physa.2013.10.044; John W, 2014, P 93 TRANSP RES BOAR; Kerner BS, 2015, PHYSICA A, V438, P365, DOI 10.1016/j.physa.2015.05.102; Li D, 2014, P 93 TRANSP RES BOAR; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Nakata M, 2010, PHYSICA A, V389, P5353, DOI 10.1016/j.physa.2010.08.005; Schrank DL, 2013, P 92 TRANSP RES BOAR; Seeherman J, 2013, P 92 TRANSP RES BOAR; Sun J, 2014, TRANSPORT RES REC, P64, DOI 10.3141/2421-08; Tang TQ, 2012, COMMUN THEOR PHYS, V58, P300, DOI 10.1088/0253-6102/58/2/23; VICKREY WS, 1969, AM ECON REV, V59, P251; Xiao LL, 2014, TRANSPORT RES E-LOG, V64, P48, DOI 10.1016/j.tre.2014.02.003; Yang, 2014, SCI REP-UK, V4, P1, DOI DOI 10.1038/SREP03735; Zhang J, 2012, PHYSICA A, V391, P2381, DOI 10.1016/j.physa.2011.11.045	16	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156089	10.1371/journal.pone.0156089	http://dx.doi.org/10.1371/journal.pone.0156089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228150	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500065
J	Thuy, B; Stohr, S				Thuy, Ben; Stohr, Sabine			A New Morphological Phylogeny of the Ophiuroidea (Echinodermata) Accords with Molecular Evidence and Renders Microfossils Accessible for Cladistics	PLOS ONE			English	Article							BRITTLE STARS ECHINODERMATA; ATLANTIC-OCEAN; CLASSIFICATION; PERSPECTIVES; SYSTEMATICS; TAXONOMY; GENES	Ophiuroid systematics is currently in a state of upheaval, with recent molecular estimates fundamentally clashing with traditional, morphology-based classifications. Here, we attempt a long overdue recast of a morphological phylogeny estimate of the Ophiuroidea taking into account latest insights on microstructural features of the arm skeleton. Our final estimate is based on a total of 45 ingroup taxa, including 41 recent species covering the full range of extant ophiuroid higher taxon diversity and 4 fossil species known from exceptionally preserved material, and the Lower Carboniferous Aganaster gregarius as the outgroup. A total of 130 characters were scored directly on specimens. The tree resulting from the Bayesian inference analysis of the full data matrix is reasonably well resolved and well supported, and refutes all previous classifications, with most traditional families discredited as poly-or paraphyletic. In contrast, our tree agrees remarkably well with the latest molecular estimate, thus paving the way towards an integrated new classification of the Ophiuroidea. Among the characters which were qualitatively found to accord best with our tree topology, we selected a list of potential synapomorphies for future formal clade definitions. Furthermore, an analysis with 13 of the ingroup taxa reduced to the lateral arm plate characters produced a tree which was essentially similar to the full dataset tree. This suggests that dissociated lateral arm plates can be analysed in combination with fully known taxa and thus effectively unlocks the extensive record of fossil lateral arm plates for phylogenetic estimates. Finally, the age and position within our tree implies that the ophiuroid crown-group had started to diversify by the Early Triassic.	[Thuy, Ben] Nat Hist Museum Luxembourg, Dept Palaeontol, Luxembourg, Luxembourg; [Stohr, Sabine] Swedish Museum Nat Hist, Dept Zool, S-10405 Stockholm, Sweden	Swedish Museum of Natural History	Thuy, B (corresponding author), Nat Hist Museum Luxembourg, Dept Palaeontol, Luxembourg, Luxembourg.; Stohr, S (corresponding author), Swedish Museum Nat Hist, Dept Zool, S-10405 Stockholm, Sweden.	bthuy@mnhn.lu; sabine.stohr@nrm.se	Stöhr, Sabine/B-8629-2011	Stöhr, Sabine/0000-0002-2586-7239	Riksmusei Vanner (Friends of the Swedish Museum of Natural History)	Riksmusei Vanner (Friends of the Swedish Museum of Natural History)	SS received funding from the Riksmusei Vanner (Friends of the Swedish Museum of Natural History). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Thuy B, 2011, ZOOTAXA, P1; Bremer B, 1999, SYST BIOL, V48, P413, DOI 10.1080/106351599260085; Fell H. B., 1962, Publications of the Seto Marine Biological Laboratory, V10, P145; FELL H. BARRACLOUGH, 1960, ZOOL PUBL VICTORIA UNIV WELLINGTON, V26, P1; FELL HB, 1963, PHILOS T ROY SOC B, V246, P381, DOI 10.1098/rstb.1963.0010; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gondim AI, 2015, ZOOTAXA, V3925, P341, DOI 10.11646/zootaxa.3925.3.2; Hess H., 1965, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V5, P151; HESS HANS, 1962, ECLOGAE GEOL HELV, V55, P595; Hotchkiss FHC, 2004, ECH MUNCH P 11 INT E, P425; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunter RL, 2016, J ZOOL SYST EVOL RES, V54, P269, DOI 10.1111/jzs.12135; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; LeClair EE, 1996, J ZOOL, V240, P245, DOI 10.1111/j.1469-7998.1996.tb05283.x; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Martynov A, 2010, ZOOTAXA, P1; Matsumoto H., 1915, P ACAD NAT SCI PHILA, V67, P43; Matsumoto H, 1917, MONOGRAPH JAPANESE O, V38, P1; Mortensen T, 1927, HDB ECHINODERMS BRIT; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Hara TD, 2014, CURR BIOL, V24, P1874, DOI 10.1016/j.cub.2014.06.060; Okanishi M, 2013, MOL PHYLOGENET EVOL, V69, P566, DOI 10.1016/j.ympev.2013.07.021; Okanishi M, 2011, MOL PHYLOGENET EVOL, V61, P392, DOI 10.1016/j.ympev.2011.07.003; Parameswaran UV, 2016, MAR BIODIVERS, V46, P151, DOI 10.1007/s12526-015-0344-6; SMITH AB, 1995, ZOOL J LINN SOC-LOND, V114, P213, DOI 10.1006/zjls.1995.0024; SPENCER WK, 1966, ECHINODERMATA, V3, pU4; Stohr S, 2005, J MAR BIOL ASSOC UK, V85, P383, DOI 10.1017/S0025315405011318h; Stohr S, 2005, ZOOL J LINN SOC-LOND, V143, P543, DOI 10.1111/j.1096-3642.2005.00155.x; Stohr S., 2015, WORLD OPHIUROIDEA DA; Stohr S, 2012, ECHINODERM RES 2010, P147; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Stohr Sabine, 2006, Species Diversity, V11, P7; Sumida PYG, 1998, ZOOL J LINN SOC-LOND, V124, P267, DOI 10.1111/j.1096-3642.1998.tb00577.x; Thuy B, 2015, ACTA PALAEONTOL POL, V60, P923, DOI 10.4202/app.00093.2014; Thuy B, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2624; Thuy B, 2013, EUR J TAXON, V48, P1, DOI 10.5852/ejt.2013.48; Thuy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046913; Thuy B, 2011, PALAEONTOLOGY, V54, P215, DOI 10.1111/j.1475-4983.2010.00981.x; Ung V, 2010, BIOINFORMATICS, V26, P703, DOI 10.1093/bioinformatics/btp715; Wortley AH, 2006, SYST BIOL, V55, P677, DOI 10.1080/10635150600899798; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210	41	59	62	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156140	10.1371/journal.pone.0156140	http://dx.doi.org/10.1371/journal.pone.0156140			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227685	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500071
J	Tuncel, J; Haag, S; Hoffmann, MH; Yau, ACY; Hultqvist, M; Olofsson, P; Backlund, J; Nandakumar, KS; Weidner, D; Fischer, A; Leichsenring, A; Lange, F; Haase, C; Lu, S; Gulko, PS; Steiner, G; Holmdahl, R				Tuncel, Jonatan; Haag, Sabrina; Hoffmann, Markus H.; Yau, Anthony C. Y.; Hultqvist, Malin; Olofsson, Peter; Backlund, Johan; Nandakumar, Kutty Selva; Weidner, Daniela; Fischer, Anita; Leichsenring, Anna; Lange, Franziska; Haase, Claus; Lu, Shemin; Gulko, Percio S.; Steiner, Gunter; Holmdahl, Rikard			Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; AUTOIMMUNE ARTHRITIS; T-CELLS; DA RATS; DISEASE; SUSCEPTIBILITY; IDENTIFICATION; RESISTANCE	Background To facilitate the development of therapies for rheumatoid arthritis ( RA), the Innovative Medicines Initiative BTCure has combined the experience from several laboratories worldwide to establish a series of protocols for different animal models of arthritis that reflect the pathogenesis of RA. Here, we describe chronic pristane-induced arthritis (PIA) model in DA rats, and provide detailed instructions to set up and evaluate the model and for reporting data. Methods We optimized dose of pristane and immunization procedures and determined the effect of age, gender, and housing conditions. We further assessed cage-effects, reproducibility, and frequency of chronic arthritis, disease markers, and efficacy of standard and novel therapies. Results Out of 271 rats, 99.6% developed arthritis after pristane-administration. Mean values for day of onset, day of maximum arthritis severity and maximum clinical scores were 11.8 +/- 2.0 days, 20.3 +/- 5.1 days and 34.2 +/- 11 points on a 60-point scale, respectively. The mean frequency of chronic arthritis was 86% but approached 100% in long-term experiments over 110 days. Pristane was arthritogenic even at 5 microliters dose but needed to be administrated intradermally to induce robust disease with minimal variation. The development of arthritis was age-dependent but independent of gender and whether the rats were housed in conventional or barrier facilities. PIA correlated well with weight loss and acute phase reactants, and was ameliorated by etanercept, dexamethasone, cyclosporine A and fingolimod treatment. Conclusions PIA has high incidence and excellent reproducibility. The chronic relapsing-remitting disease and limited systemic manifestations make it more suitable than adjuvant arthritis for long-term studies of joint-inflammation and screening and validation of new therapeutics.	[Tuncel, Jonatan; Haag, Sabrina; Yau, Anthony C. Y.; Backlund, Johan; Nandakumar, Kutty Selva; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Div Med Inflammat Res, Stockholm, Sweden; [Hoffmann, Markus H.; Weidner, Daniela] Univ Erlangen Nurnberg, Dept Internal Med 3, Erlangen, Germany; [Hoffmann, Markus H.; Fischer, Anita; Steiner, Gunter] Med Univ Vienna, Div Rheumatol, Vienna, Austria; [Hultqvist, Malin; Olofsson, Peter] Redoxis AB, Lund, Sweden; [Leichsenring, Anna; Lange, Franziska] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Haase, Claus] Novo Nordisk AS, Dept Immunopharmacol, Malov, Denmark; [Lu, Shemin] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Xian 710049, Shaanxi, Peoples R China; [Gulko, Percio S.] Icahn Sch Med Mt Sinai, Dept Med, Div Rheumatol, New York, NY 10029 USA; [Tuncel, Jonatan] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Karolinska Institutet; University of Erlangen Nuremberg; Medical University of Vienna; Fraunhofer Gesellschaft; Novo Nordisk; Xi'an Jiaotong University; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School	Tuncel, J; Holmdahl, R (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Med Inflammat Res, Stockholm, Sweden.; Tuncel, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA.	jonatan_tuncel@hms.harvard.edu; rikard.holmdahl@ki.se	Yau, Anthony CY/P-5379-2016; Lu, Shemin/M-3350-2018; Nandakumar, Kutty Selva/D-5438-2011; Lu, Shemin/AAI-6479-2021; Holmdahl, Rikard/AAI-7682-2020; Fischer, Anita/AAD-7766-2020	Yau, Anthony CY/0000-0002-1570-7813; Lu, Shemin/0000-0001-8250-850X; Nandakumar, Kutty Selva/0000-0001-7790-8197; Lu, Shemin/0000-0002-5535-8320; Fischer, Anita/0000-0001-6728-7649; Steiner, Guenter/0000-0002-5089-7405; Olofsson, Peter/0000-0003-4849-8541; Hoffmann, Markus/0000-0001-9698-9922	Innovative Medicines Initiative (IMI); European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA); Swedish Strategic Science Foundation; Knut and Alice Wallenberg Foundation; Konung Gustaf V:s 80-ars fond; Swedish Research Council; Swedish Rheumatism Association; European Union FP7 Neurinox	Innovative Medicines Initiative (IMI); European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA); Swedish Strategic Science Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Konung Gustaf V:s 80-ars fond; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; European Union FP7 Neurinox	BTCure is funded by the Innovative Medicines Initiative (IMI), a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). This study was also supported by the Swedish Strategic Science Foundation, the Knut and Alice Wallenberg Foundation, the Konung Gustaf V:s 80-ars fond, the Swedish Research Council, the Swedish Rheumatism Association, and European Union FP7 Neurinox to RH. Redoxis provided support in the form of salaries for authors MH and PO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; AVIGAN J, 1967, BIOCHIM BIOPHYS ACTA, V144, P127, DOI 10.1016/0005-2760(67)90084-7; Avigan J, 1968, J LIPID RES; Backdahl L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-391; Bakharevski O, 1998, J RHEUMATOL, V25, P1945; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P377; BJORK J, 1994, SCAND J IMMUNOL, V40, P648, DOI 10.1111/j.1365-3083.1994.tb03518.x; Bolon B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569068; Brenner M, 2007, ANN RHEUM DIS, V66, P952, DOI 10.1136/ard.2006.066225; BRODERSON JR, 1989, LAB ANIM SCI, V39, P400; CANNON GW, 1993, J RHEUMATOL, V20, P7; Finzel S, 2011, ANN RHEUM DIS, V70, P122, DOI 10.1136/ard.2010.132423; Guo XS, 2013, GENETICS, V194, P1017, DOI 10.1534/genetics.113.153049; Haag S, 2015, J IMMUNOL, V194, P2539, DOI 10.4049/jimmunol.1402238; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Herman S, 2012, AUTOIMMUNITY, V45, P602, DOI 10.3109/08916934.2012.719948; Hoffmann MH, 2007, J IMMUNOL, V179, P7568, DOI 10.4049/jimmunol.179.11.7568; Hoffmann MH, 2013, ANN RHEUM DIS, V72, P1239, DOI 10.1136/annrheumdis-2012-202218; Hoffmann MH, 2011, J AUTOIMMUN, V36, P288, DOI 10.1016/j.jaut.2011.02.007; Holmberg J, 2006, J IMMUNOL, V176, P1172, DOI 10.4049/jimmunol.176.2.1172; HOLMDAHL R, 1992, IMMUNOLOGY, V76, P197; Kawahito Y, 1998, J IMMUNOL, V161, P4411; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KLEINAU S, 1995, INT J IMMUNOPHARMACO, V17, P393, DOI 10.1016/0192-0561(95)00020-3; KOHASHI O, 1979, INFECT IMMUN, V26, P791, DOI 10.1128/IAI.26.3.791-794.1979; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Kuroda Y, 2004, TOXICOL SCI, V78, P222, DOI 10.1093/toxsci/kfh063; Lange F, 2005, ANN RHEUM DIS, V64, P599, DOI 10.1136/ard.2004.026120; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Meng HC, 2004, ARTHRITIS RHEUM-US, V50, P2695, DOI 10.1002/art.20366; Mikulowska A., 1997, HUMAN GENOME METHODS, V215, P215; Nicklas W, 2010, LAB ANIMAL, V39, P43, DOI 10.1038/laban0210-43; Olofsson P, 2002, ARTHRITIS RHEUM, V46, P259, DOI 10.1002/1529-0131(200201)46:1<259::AID-ART10035>3.0.CO;2-2; PEARSON CM, 1963, J CHRON DIS, V16, P863, DOI 10.1016/0021-9681(63)90136-X; Rintisch C, 2008, MAMM GENOME, V19, P420, DOI 10.1007/s00335-008-9125-x; Rintisch C, 2008, P NATL ACAD SCI USA, V105, P14005, DOI 10.1073/pnas.0803956105; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Roubenoff R, 1997, ARTHRITIS RHEUM, V40, P534, DOI 10.1002/art.1780400320; SAMUELSON CO, 1984, ARTHRITIS RHEUM, V27, P689, DOI 10.1002/art.1780270613; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schett G, 2009, ARTHRITIS RHEUM-US, V60, P2644, DOI 10.1002/art.24767; Tuncel J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004151; Tuncel J, 2012, ARTHRITIS RHEUM-US, V64, P2537, DOI 10.1002/art.34461; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; VANDENBROEK MF, 1992, CLIN EXP IMMUNOL, V88, P313; VANEDEN W, 1989, CURR TOP MICROBIOL, V145, P27; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Vossenaar ER, 2004, ARTHRITIS RHEUM, V50, P2370, DOI 10.1002/art.20296; WARD JR, 1962, ARTHRITIS RHEUM, V5, P557, DOI 10.1002/art.1780050604; Wekerle H, 2012, NAT MED, V18, P66, DOI 10.1038/nm.2635; Wooley PH, 2004, BEST PRACT RES CL RH, V18, P47, DOI 10.1016/j.berh.2003.09.007; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	54	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155936	10.1371/journal.pone.0155936	http://dx.doi.org/10.1371/journal.pone.0155936			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227821	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500043
J	Yang, KC; Rozycki, B; Cui, FC; Shi, C; Chen, WD; Li, YQ				Yang, Kecheng; Rozycki, Bartosz; Cui, Fengchao; Shi, Ce; Chen, Wenduo; Li, Yunqi			Sampling Enrichment toward Target Structures Using Hybrid Molecular Dynamics-Monte Carlo Simulations	PLOS ONE			English	Article							X-RAY-SCATTERING; PROTEIN-STRUCTURE PREDICTION; STRUCTURE REFINEMENT; CHEMICAL-SHIFTS; BIOLOGY; CASP10; SAXS; CONFORMATIONS; INTEGRATION; ASSEMBLIES	Sampling enrichment toward a target state, an analogue of the improvement of sampling efficiency (SE), is critical in both the refinement of protein structures and the generation of near-native structure ensembles for the exploration of structure-function relationships. We developed a hybrid molecular dynamics (MD)-Monte Carlo (MC) approach to enrich the sampling toward the target structures. In this approach, the higher SE is achieved by perturbing the conventional MD simulations with a MC structure-acceptance judgment, which is based on the coincidence degree of small angle x-ray scattering (SAXS) intensity profiles between the simulation structures and the target structure. We found that the hybrid simulations could significantly improve SE by making the top-ranked models much closer to the target structures both in the secondary and tertiary structures. Specifically, for the 20 mono-residue peptides, when the initial structures had the root-mean-squared deviation (RMSD) from the target structure smaller than 7 angstrom, the hybrid MD-MC simulations afforded, on average, 0.83 angstrom and 1.73 angstrom in RMSD closer to the target than the parallel MD simulations at 310K and 370K, respectively. Meanwhile, the average SE values are also increased by 13.2% and 15.7%. The enrichment of sampling becomes more significant when the target states are gradually detectable in the MD-MC simulations in comparison with the parallel MD simulations, and provide >200% improvement in SE. We also performed a test of the hybrid MD-MC approach in the real protein system, the results showed that the SE for 3 out of 5 real proteins are improved. Overall, this work presents an efficient way of utilizing solution SAXS to improve protein structure prediction and refinement, as well as the generation of near native structures for function annotation.	[Yang, Kecheng; Cui, Fengchao; Shi, Ce; Chen, Wenduo; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China; [Yang, Kecheng; Cui, Fengchao; Shi, Ce; Chen, Wenduo; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, Changchun 130022, Peoples R China; [Rozycki, Bartosz] Polish Acad Sci, Inst Phys, Aleja Lotnikow 32-46, PL-02668 Warsaw, Poland; [Yang, Kecheng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, FC; Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China.; Cui, FC; Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, Changchun 130022, Peoples R China.	fccui@ciac.ac.cn; yunqi@ciac.ac.cn	Rozycki, Bartosz/B-7005-2009; Yang, kecheng/Y-8236-2018; Li, Yunqi/C-8372-2016	Rozycki, Bartosz/0000-0001-5938-7308; Li, Yunqi/0000-0002-5190-3037; Yang, Kecheng/0000-0001-9664-1395	National Natural Science Foundation of China [21374117, 21404105, 21504092]; 100 Talents Program of the Chinese Academy of Sciences; grant FiberFuel - National Centre for Research and Development in Poland [ERA-NET-IB/06/2013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); grant FiberFuel - National Centre for Research and Development in Poland	This work was supported by National Natural Science Foundation of China (21374117, 21404105, 21504092; http://www.nsfc.gov.cn/publish/portal1/), the 100 Talents Program of the Chinese Academy of Sciences (no grant number), and grant FiberFuel funded by the National Centre for Research and Development in Poland (ERA-NET-IB/06/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bjorling A, 2015, J CHEM THEORY COMPUT, V11, P780, DOI 10.1021/ct5009735; Chen PC, 2015, BIOPHYS J, V108, P2573, DOI 10.1016/j.bpj.2015.03.062; DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forster F, 2008, J MOL BIOL, V382, P1089, DOI 10.1016/j.jmb.2008.07.074; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gabel F, 2008, J BIOMOL NMR, V41, P199, DOI 10.1007/s10858-008-9258-y; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MR, 2010, J AM CHEM SOC, V132, P1270, DOI 10.1021/ja909973n; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kryshtafovych A, 2014, PROTEINS, V82, P26, DOI 10.1002/prot.24489; Kryshtafovych A, 2014, PROTEINS, V82, P164, DOI 10.1002/prot.24448; Li YQ, 2013, J PHYS CHEM B, V117, P2615, DOI 10.1021/jp309135m; Li YQ, 2012, J PHYS CHEM B, V116, P12057, DOI 10.1021/jp305709y; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAIOROV VN, 1995, PROTEINS, V22, P273, DOI 10.1002/prot.340220308; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mirjalili V, 2014, PROTEINS, V82, P196, DOI 10.1002/prot.24336; Neylon C, 2008, EUR BIOPHYS J BIOPHY, V37, P531, DOI 10.1007/s00249-008-0259-2; Nugent T, 2014, PROTEINS, V82, P98, DOI 10.1002/prot.24377; Orzechowski M, 2008, BIOPHYS J, V95, P5692, DOI 10.1529/biophysj.108.139451; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; Prevelige P., 1989, PREDICTION PROTEIN S, P391; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Ravikumar KM, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4774148; Reva BA, 1998, FOLD DES, V3, P141, DOI 10.1016/S1359-0278(98)00019-4; Robustelli P, 2010, STRUCTURE, V18, P923, DOI 10.1016/j.str.2010.04.016; Rozycki B, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/46/463103; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Weinbach Y, 2005, J COMPUT PHYS, V209, P193, DOI 10.1016/j.jcp.2005.03.015; Yang SC, 2014, ADV MATER, V26, P7902, DOI 10.1002/adma.201304475; Yang SC, 2011, STRUCTURE, V19, P3, DOI 10.1016/j.str.2010.12.008; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zheng WJ, 2011, BIOPHYS J, V101, P2981, DOI 10.1016/j.bpj.2011.11.003; Zhou HY, 2009, BIOPHYS J, V96, P2119, DOI 10.1016/j.bpj.2008.12.3898; Zuckerman DM, 2011, ANNU REV BIOPHYS, V40, P41, DOI 10.1146/annurev-biophys-042910-155255	56	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156043	10.1371/journal.pone.0156043	http://dx.doi.org/10.1371/journal.pone.0156043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227775	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500057
J	Campos, Z; Magnusson, WE				Campos, Zilca; Magnusson, William E.			Density and Biomass Estimates by Removal for an Amazonian Crocodilian, Paleosuchus palpebrosus	PLOS ONE			English	Article							DWARF CAIMAN; RAIN-FOREST; GEOGRAPHIC-VARIATION; BRAZIL; SIZE; ECOLOGY; CUVIER	Direct counts of crocodilians are rarely feasible and it is difficult to meet the assumptions of mark-recapture methods for most species in most habitats. Catch-out experiments are also usually not logistically or morally justifiable because it would be necessary to destroy the habitat in order to be confident that most individuals had been captured. We took advantage of the draining and filling of a large area of flooded forest during the building of the Santo Antnio dam on the Madeira River to obtain accurate estimates of the density and biomass of Paleosuchus palpebrosus. The density, 28.4 non-hatchling individuals per km(2), is one of the highest reported for any crocodilian, except for species that are temporarily concentrated in small areas during dry-season drought. The biomass estimate of 63.15 kg*km(-2) is higher than that for most or even all mammalian carnivores in tropical forest. P. palpebrosus may be one of the World's most abundant crocodilians.	[Campos, Zilca] Embrapa Pantanal, Lab Vida Selvagem, Corumba, MS, Brazil; [Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Institute Nacional de Pesquisas da Amazonia	Campos, Z (corresponding author), Embrapa Pantanal, Lab Vida Selvagem, Corumba, MS, Brazil.	zilca.campos@embrapa.br			Santo Antonio Energia; EMBRAPA; CNPq	Santo Antonio Energia; EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was funded by Santo Antonio Energia, EMBRAPA and CNPq. The funders had no role in study design and, data collection and analysis, decision to publish.	Bayliss P., 1987, P157; Campos Z, 2012, J NAT HIST, V46, P2979, DOI 10.1080/00222933.2012.724723; CAMPOS Z, 1995, HERPETOL J, V5, P321; Campos Z, 2015, CROCODILE SPECIALIST, V34, P6; Campos Zilca, 2013, Biodiversidade Brasileira, V3, P40; Campos Z, 2015, HERPETOZOA, V28, P101; Campos Z, 2015, J HERPETOL, V49, P95, DOI 10.1670/11-224; Campos Z, 2013, HERPETOLOGICA, V69, P405; Campos Z, 2010, AMPHIBIA-REPTILIA, V31, P439, DOI 10.1163/156853810791769392; Campos Zilca, 2006, Herpetological Review, V37, P343; Coutinho M, 1996, J TROP ECOL, V12, P741, DOI 10.1017/S0266467400009950; Da Silveira Ronis, 2002, P61; Eisenberg J.F., 1999, MAMMALS NEOTROPICS C, V3; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; EMMONS LH, 1984, BIOTROPICA, V16, P210, DOI 10.2307/2388054; Fisch G, ACTA AMAZONICA, V28, P101; GORZULA SJ, 1978, OECOLOGIA, V35, P21, DOI 10.1007/BF00345539; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; MAGNUSSON W. E., 1992, CATALOGUE AM AMPHIBI, P5541; MAGNUSSON WE, 1991, J HERPETOL, V25, P41, DOI 10.2307/1564793; Mourao G, 2000, BIOL CONSERV, V92, P175, DOI 10.1016/S0006-3207(99)00051-8; Muniz F, 2015, CROCODILE SPECIALIST, V34, P8; PRINS HHT, 1989, J ANIM ECOL, V58, P851, DOI 10.2307/5128; Seijas A.E., 1986, Vida Silvestre Neotropical, V1, P24; Thorbjarnarson J, IUCN CROCODILE SPECI; Webb G, 1977, J WILDLIFE MANAGE, V41, P228	26	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156406	10.1371/journal.pone.0156406	http://dx.doi.org/10.1371/journal.pone.0156406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224473	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700093
J	Dong, HR; Wang, YY; Cheng, XH; Wang, GQ; Sun, LJ; Cheng, H; Chen, YP				Dong, Hong-rui; Wang, Yan-yan; Cheng, Xiao-hong; Wang, Guo-qing; Sun, Li-jun; Cheng, Hong; Chen, Yi-pu			Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy	PLOS ONE			English	Article							A(2) RECEPTOR; ANTIBODIES; LUPUS; GLOMERULONEPHRITIS; CLASSIFICATION; AUTOANTIBODIES; PATHOGENESIS; NEPHRITIS; CRITERIA	Background and objectives The research work in the past years showed that detection of phospholipase A2 receptor (PLA2R) antigen and its dominant IgG4 autoantibody in glomerular deposits of patients with membranous nephropathy (MN) was useful for the differentiation between primary MN (PMN) and secondary MN (SMN), but so far such research data from large Chinese patient series is little. Here, we are going to report a research work in a Chinese cohort. Design, setting, participants, & measurements This study enrolled 179 patients with PMN, 40 patients with membranous lupus nephritis (LN-MN), 26 patients with hepatitis B virus-associated MN (HBV-MN), 2 patients with malignancy-associated MN (M-MN) and one patient with IgG4-related MN (IgG4-MN). PLA2R and IgG subclasses in glomerular deposits of these patients were examined by immunofluorescence and/or immunohistochemical staining, and the potential value of the above examinations for differential diagnosis of PMN and SMN was evaluated. Results Glomerular PLA2R deposition was present in 92.2% patients with PMN and 7.7% patients with HBV-MN, but none of the patients with LN-MN. Predominant/codominant IgG4 deposition was found in 93.3% patients with PMN and 11.5% patients with HBV-MN, but none of the patients with LN-MN. The two M-MN patients both had glomerular PLA2R and predominant/codominant IgG4 deposition. The one IgG4-MN patient had deeply staining IgG4 but no PLA2R in glomeruli. Conclusions The glomerular PLA2R and predominant/codominant IgG4 deposition is frequently observed in Chinese patients with PMN. Immunofluorescence and immunohistochemical staining of renal biopsy tissue for detection of glomerular PLA2R and IgG subclasses deposition can help to distinguish PMN from LN-MN and most of HBV-MN.	[Dong, Hong-rui; Wang, Yan-yan; Wang, Guo-qing; Sun, Li-jun; Cheng, Hong; Chen, Yi-pu] Capital Med Univ, Beijing Anzhen Hosp, Div Nephrol, Beijing, Peoples R China; [Cheng, Xiao-hong] Shanxi Tradit Chinese Med Hosp, Div Nephrol, Xian, Peoples R China	Capital Medical University	Cheng, H (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Div Nephrol, Beijing, Peoples R China.	drchengh@163.com	Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022; Wang, Yuan/HHC-1520-2022	Chen, Yi-pu/0000-0002-5079-4334; Cheng, Hong/0000-0002-7908-3333	fund project of "National 'Twelve Five-Year' Plan for Science and Technology Support" [2011BAI10B006]	fund project of "National 'Twelve Five-Year' Plan for Science and Technology Support"	The research was supported by the fund project of "National 'Twelve Five-Year' Plan for Science and Technology Support" (2011BAI10B006).	Akiyama S, 2015, CLIN EXP NEPHROL, V19, P653, DOI 10.1007/s10157-014-1054-2; Alexander MP, 2013, KIDNEY INT, V83, P455, DOI 10.1038/ki.2012.382; Allison Susan J, 2015, Nat Rev Nephrol, V11, P63, DOI 10.1038/nrneph.2014.227; Ardalan Mohammadreza, 2013, J Nephropathol, V2, P241, DOI 10.12860/JNP.2013.38; Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2014, J CLIN INVEST, V124, P2307, DOI 10.1172/JCI72270; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Cornell LD, 2012, SEMIN DIAGN PATHOL, V29, P245, DOI 10.1053/j.semdp.2012.07.004; Cossey LN, 2013, PEDIATR NEPHROL, V28, P2307, DOI 10.1007/s00467-013-2574-9; Cravedi P, 2011, AM J KIDNEY DIS, V58, P272, DOI 10.1053/j.ajkd.2011.05.002; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; di Belgiojoso GB, 2002, J NEPHROL, V15, P469; Editorial board, 1990, CHINESE J INTERN MED, V29, P519; Fervenza FC, 2011, AM J KIDNEY DIS, V58, P320, DOI 10.1053/j.ajkd.2011.05.006; Filippone EJ, 2014, CLIN NEPHROL, V82, P7, DOI 10.5414/CN107768; Glassock RJ, 2013, CONTRIB NEPHROL, V181, P131, DOI 10.1159/000348472; HAAS M, 1994, AM J KIDNEY DIS, V23, P358, DOI 10.1016/S0272-6386(12)80997-8; Hayashi N, 2015, CLIN EXP NEPHROL, V19, P797, DOI 10.1007/s10157-014-1064-0; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2012, KIDNEY INT, V82, P797, DOI 10.1038/ki.2012.209; Hoxha E, 2011, NEPHROL DIAL TRANSPL, V26, P2526, DOI 10.1093/ndt/gfr247; Huang CC, 2013, MODERN PATHOL, V26, P799, DOI 10.1038/modpathol.2012.237; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Kuroki A, 2002, INTERNAL MED, V41, P936, DOI 10.2169/internalmedicine.41.936; Larsen CP, 2013, MODERN PATHOL, V26, P709, DOI 10.1038/modpathol.2012.207; Lhotta K, 1999, NEPHROL DIAL TRANSPL, V14, P881, DOI 10.1093/ndt/14.4.881; Li XL, 2014, CLIN RHEUMATOL, V33, P145, DOI 10.1007/s10067-013-2406-0; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Nirula A, 2011, CURR OPIN RHEUMATOL, V23, P119, DOI 10.1097/BOR.0b013e3283412fd4; Obrisca B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/249740; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; Ohtani H, 2004, NEPHROL DIAL TRANSPL, V19, P574, DOI 10.1093/ndt/gfg616; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Prabhakar D, 2015, NEPHROL DIAL TRANSPL, V30; Qin WS, 2011, J AM SOC NEPHROL, V22, P1137, DOI 10.1681/ASN.2010090967; Qu Z, 2012, NEPHROL DIAL TRANSPL, V27, P1931, DOI 10.1093/ndt/gfr534; Ronco P, 2012, NAT REV NEPHROL, V8, P203, DOI 10.1038/nrneph.2012.35; Segal PE, 2012, ADV CHRONIC KIDNEY D, V19, P114, DOI 10.1053/j.ackd.2012.01.007; Segarra-Medrano A, 2014, NEFROLOGIA, V34, P353, DOI 10.3265/Nefrologia.pre2013.Dec.12291; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; VanBeek C, 2015, CLIN NEPHROL, V84, P1, DOI 10.5414/CN108602; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Xie QH, 2015, AM J NEPHROL, V41, P345, DOI 10.1159/000431331	48	29	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156263	10.1371/journal.pone.0156263	http://dx.doi.org/10.1371/journal.pone.0156263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223897	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700079
J	Wang, GY; Sun, SX; Zhang, Z				Wang, Guangyu; Sun, Shixiang; Zhang, Zhang			Randomness in Sequence Evolution Increases over Time	PLOS ONE			English	Article							AMINO-ACID-SEQUENCES; ESSENTIAL GENES; PROTEIN SEQUENCES; GC CONTENT; ORGANIZATION; DATABASE; CANCER; PRINCIPLE; DYNAMICS; LENGTHS	The second law of thermodynamics states that entropy, as a measure of randomness in a system, increases over time. Although studies have investigated biological sequence randomness from different aspects, it remains unknown whether sequence randomness changes over time and whether this change consists with the second law of thermodynamics. To capture the dynamics of randomness in molecular sequence evolution, here we detect sequence randomness based on a collection of eight statistical random tests and investigate the randomness variation of coding sequences with an application to Escherichia coli. Given that core/essential genes are more ancient than specific/non-essential genes, our results clearly show that core/essential genes are more random than specific/non-essential genes and accordingly indicate that sequence randomness indeed increases over time, consistent well with the second law of thermodynamics. We further find that an increase in sequence randomness leads to increasing randomness of GC content and longer sequence length. Taken together, our study presents an important finding, for the first time, that sequence randomness increases over time, which may provide profound insights for unveiling the underlying mechanisms of molecular sequence evolution.	[Wang, Guangyu; Sun, Shixiang; Zhang, Zhang] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, BIG, Beijing 100101, Peoples R China; [Wang, Guangyu; Sun, Shixiang; Zhang, Zhang] Chinese Acad Sci, BIG Data Ctr, BIG, Beijing 100101, Peoples R China; [Wang, Guangyu; Sun, Shixiang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Z (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, BIG, Beijing 100101, Peoples R China.; Zhang, Z (corresponding author), Chinese Acad Sci, BIG Data Ctr, BIG, Beijing 100101, Peoples R China.	zhangzhang@big.ac.cn	Sun, Shixiang/GQA-4872-2022; zhang, zhang/GQZ-6804-2022; zhang, zheng/HCH-9684-2022	Sun, Shixiang/0000-0001-5499-2963; zhang, zhang/0000-0001-6603-5060; Wang, Guangyu/0000-0003-4803-7200				Acevedo-Rocha CG, 2013, TRENDS GENET, V29, P273, DOI 10.1016/j.tig.2012.11.001; Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Alba MM, 2005, MOL BIOL EVOL, V22, P598, DOI 10.1093/molbev/msi045; Annila A, 2010, J NON-EQUIL THERMODY, V35, P301, DOI [10.1515/JNETDY.2010.019, 10.1515/JNETDY.2010.19]; De Lucrezia D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036634; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gladyshev GP, 2006, INT J MOL SCI, V7, P98, DOI 10.3390/i7030098; Gladyshev GP, 2003, PROG REACT KINET MEC, V28, P157, DOI 10.3184/007967403103165495; Gladyshev GP, 1999, ENTROPY, V1999, P9; Gryder BE, 2013, J MED CHEM, V56, P5782, DOI 10.1021/jm400467w; Jaakkola S, 2008, BIOPHYS CHEM, V134, P232, DOI 10.1016/j.bpc.2008.02.006; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Jun Yu, 2007, Genomics Proteomics & Bioinformatics, V5, P1, DOI 10.1016/S1672-0229(07)60008-4; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Lavelle DT, 2010, BIOINFORMATICS, V26, P310, DOI 10.1093/bioinformatics/btp660; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; McShea D. W., 2010, BIOL 1 LAW TENDENCY; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Munteanu CR, 2008, J THEOR BIOL, V254, P775, DOI 10.1016/j.jtbi.2008.07.018; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; PANDE VS, 1994, P NATL ACAD SCI USA, V91, P12972, DOI 10.1073/pnas.91.26.12972; Rackovsky S, 1998, P NATL ACAD SCI USA, V95, P8580, DOI 10.1073/pnas.95.15.8580; Rukhin A., 2001, STAT TEST SUITE RAND; SAUNDERS PT, 1981, J THEOR BIOL, V90, P515, DOI 10.1016/0022-5193(81)90303-9; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shih MY, 2010, J APPL SCI ENG, V13, P11; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; van Wieringen WN, 2011, BIOINFORMATICS, V27, P556, DOI 10.1093/bioinformatics/btq704; Waterhouse RM, 2011, GENOME BIOL EVOL, V3, P75, DOI 10.1093/gbe/evq083; Weiss O, 2000, J THEOR BIOL, V206, P379, DOI 10.1006/jtbi.2000.2138; WHITE SH, 1993, J MOL EVOL, V36, P79, DOI 10.1007/BF02407307; WHITE SH, 1994, J MOL EVOL, V38, P383, DOI 10.1007/BF00163155; Xia XH, 2006, MOL BIOL EVOL, V23, P1450, DOI 10.1093/molbev/msl012; Xia XH, 2003, J MOL EVOL, V56, P362, DOI 10.1007/s00239-002-2406-1; Xiao Jing-Fa, 2007, Genomics Proteomics & Bioinformatics, V5, P143, DOI 10.1016/S1672-0229(08)60001-7; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhang Zhang, 2012, Genomics Proteomics & Bioinformatics, V10, P175, DOI 10.1016/j.gpb.2012.08.002; Zhang Zhang, 2011, Genomics Proteomics & Bioinformatics, V9, P21, DOI 10.1016/S1672-0229(11)60004-1	41	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155935	10.1371/journal.pone.0155935	http://dx.doi.org/10.1371/journal.pone.0155935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224236	gold, Green Published, Green Submitted			2022-12-26	WOS:000376881700042
J	Seo, Y; Lee, HK; Park, J; Jeon, DK; Jo, S; Jo, M; Namkung, W				Seo, Yohan; Lee, Ho K.; Park, Jinhong; Jeon, Dong-Kyu; Jo, Sungwoo; Jo, Minjae; Namkung, Wan			Ani9, A Novel Potent Small-Molecule ANO1 Inhibitor with Negligible Effect on ANO2	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; AGE-DEPENDENT DIARRHEA; AIRWAY SMOOTH-MUSCLE; ANOCTAMIN 1; CANCER PROGRESSION; TUMOR-GROWTH; RED WINE; TMEM16A; ANO1/TMEM16A	Anoctamin1 (ANO1)/transmembrane protein 16A (TMEM16A), a calcium-activated chloride channel (CaCC), is involved in many physiological functions such as fluid secretion, smooth muscle contraction, nociception and cancer progression. To date, only a few ANO1 inhibitors have been described, and these have low potency and selectivity for ANO1. Here, we performed a high-throughput screening to identify highly potent and selective small molecule inhibitors of ANO1. Three novel ANO1 inhibitors were discovered from screening of 54,400 synthetic small molecules, and they were found to fully block ANO1 channel activity with an IC50 < 3 mu M. Electrophysiological analysis revealed that the most potent inhibitor, 2-(4-chloro-2-methylphenoxy)-N-[(2-methoxyphenyl)methylideneamino]-acetamide (Ani9), completely inhibited ANO1 chloride current with submicromolar potency. Notably, unlike previous small-molecule ANO1 inhibitors identified to date, Ani9 displayed high selectivity for ANO1 as compared to ANO2, which shares a high amino acid homology to ANO1. In addition, Ani9 did not affect the intracellular calcium signaling and CFTR chloride channel activity. Our results suggest that Ani9 may be a useful pharmacological tool for studying ANO1 and a potential development candidate for drug therapy of cancer, hypertension, pain, diarrhea and asthma.	[Seo, Yohan; Park, Jinhong; Jeon, Dong-Kyu; Jo, Sungwoo; Jo, Minjae; Namkung, Wan] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon 406840, South Korea; [Seo, Yohan; Lee, Ho K.; Park, Jinhong; Namkung, Wan] Yonsei Univ, Grad Sch, WCU Program, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea	Yonsei University; Yonsei University	Namkung, W (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon 406840, South Korea.; Namkung, W (corresponding author), Yonsei Univ, Grad Sch, WCU Program, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea.	wnamkung@yonsei.ac.kr	서, 요한/AAZ-6433-2020	Seo, Yohan/0000-0002-9335-8604; Lee, Ho Kyun/0000-0003-1707-3217	Grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [HI08C2149]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1040142, NRF-2015R1D1A1A01057695]	Grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by a Grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [HI08C2149]; and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology [NRF-2012R1A1A1040142] and [NRF-2015R1D1A1A01057695].	Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Berg J, 2012, J CELL SCI, V125, P1367, DOI 10.1242/jcs.093260; Bill A, 2015, ONCOTARGET, V6, P9173, DOI 10.18632/oncotarget.3277; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Boedtkjer DMB, 2015, BRIT J PHARMACOL, V172, P4158, DOI 10.1111/bph.13201; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Burow P, 2015, PFLUG ARCH EUR J PHY, V467, P1215, DOI 10.1007/s00424-014-1561-8; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cha JY, 2015, P NATL ACAD SCI USA, V112, P9722, DOI 10.1073/pnas.1423827112; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Davis AJ, 2013, BRIT J PHARMACOL, V168, P773, DOI 10.1111/j.1476-5381.2012.02199.x; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Deba F, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0061-y; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Gallos G, 2013, AM J PHYSIOL-LUNG C, V305, pL625, DOI 10.1152/ajplung.00068.2013; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Ko EA, 2014, GUT, V63, P1120, DOI 10.1136/gutjnl-2013-305663; Lee SN, 2013, EUR RESPIR J, V42, P1379, DOI 10.1183/09031936.00100412; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Matsuba S, 2014, J PHARMACOL EXP THER, V351, P510, DOI 10.1124/jpet.114.217315; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Oh SJ, 2013, MOL PHARMACOL, V84, P726, DOI 10.1124/mol.113.087502; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Picollo A, 2015, J MOL BIOL, V427, P94, DOI 10.1016/j.jmb.2014.09.028; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Sauter DRP, 2015, PFLUG ARCH EUR J PHY, V467, P1495, DOI 10.1007/s00424-014-1598-8; Scudieri P, 2012, EXP PHYSIOL, V97, P177, DOI 10.1113/expphysiol.2011.058198; Seo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133656; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Shiwarski DJ, 2014, CLIN CANCER RES, V20, P4673, DOI 10.1158/1078-0432.CCR-14-0363; Sirianant L, 2016, PFLUG ARCH EUR J PHY, V468, P335, DOI 10.1007/s00424-015-1739-8; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wang BX, 2015, J MOL CELL CARDIOL, V82, P22, DOI 10.1016/j.yjmcc.2015.02.020; Wang J, 2013, AM J PHYSIOL-CELL PH, V304, pC673, DOI 10.1152/ajpcell.00196.2012; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	42	84	87	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155771	10.1371/journal.pone.0155771	http://dx.doi.org/10.1371/journal.pone.0155771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219012	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700017
J	Nelson, JW; Das, AJ; Barnes, AP; Alkayed, NJ				Nelson, Jonathan W.; Das, Anjali J.; Barnes, Anthony P.; Alkayed, Nabil J.			Disrupting Dimerization Translocates Soluble Epoxide Hydrolase to Peroxisomes	PLOS ONE			English	Article							GENETIC-VARIATION; ISCHEMIC-STROKE; QUATERNARY STRUCTURE; THERAPEUTIC TARGET; EPHX2; POLYMORPHISMS; DISEASE; PROTEIN; RISK; LOCALIZATION	The epoxyeicosatrienoic acid (EET) neutralizing enzyme soluble epoxide hydrolase (sEH) is a neuronal enzyme, which has been localized in both the cytosol and peroxisomes. The molecular basis for its dual localization remains unclear as sEH contains a functional peroxisomal targeting sequence (PTS). Recently, a missense polymorphism was identified in human sEH (R287Q) that enhances its peroxisomal localization. This same polymorphism has also been shown to generate weaker sEH homo-dimers. Taken together, these observations suggest that dimerization may mask the sEH PTS and prevent peroxisome translocation. In the current study, we test the hypothesis that dimerization is a key regulator of sEH subcellular localization. Specifically, we altered the dimerization state of sEH by introducing substitutions in amino acids responsible for the dimer-stabilizing salt-bridge. Green Fluorescent Protein (GFP) fusions of each of mutants were co-transfected into mouse primary cultured cortical neurons together with a PTS-linked red fluorescent protein to constitutively label peroxisomes. Labeled neurons were analyzed using confocal microscopy and co-localization of sEH with peroxisomes was quantified using Pearson's correlation coefficient. We find that dimer-competent sEH constructs preferentially localize to the cytosol, whereas constructs with weakened or disrupted dimerization were preferentially targeted to peroxisomes. We conclude that the sEH dimerization status is a key regulator of its peroxisomal localization.	[Nelson, Jonathan W.; Das, Anjali J.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA; [Nelson, Jonathan W.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Nelson, Jonathan W.; Barnes, Anthony P.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97239 USA; [Barnes, Anthony P.] Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Res Ctr, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Alkayed, NJ (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA.; Alkayed, NJ (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97239 USA.	alkayedn@ohsu.edu		Nelson, Jonathan/0000-0003-1456-9399; Das, Anjali/0000-0002-7420-0174; Barnes, Anthony/0000-0002-4598-9591	National Institutes of Health (NIH) [R01 NS44313, R01 NS079433, P30 NS061800]; American Heart Association (AHA) [11PRE5710008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079433, R01NS070837, P30NS061800, R01NS044313] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH, http://www.nih.gov/) grants R01 NS44313 (NJA), R01 NS079433 (APB) and P30 NS061800 (Aicher SA, PI), and the American Heart Association (AHA, http://www.heart.org/) Predoctoral Fellowship 11PRE5710008 to JWN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdon KP, 2008, DIABETES VASC DIS RE, V5, P128, DOI 10.3132/dvdr.2008.021; Enayetallah AE, 2006, J HISTOCHEM CYTOCHEM, V54, P329, DOI 10.1369/jhc.5A6808.2005; Fairbanks SL, 2012, NEUROSCIENCE, V219, P183, DOI 10.1016/j.neuroscience.2012.05.048; Fava C, 2010, PHARMACOGENET GENOM, V20, P94, DOI 10.1097/FPC.0b013e3283349ec9; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Lee CR, 2011, HYPERTENSION, V57, P116, DOI 10.1161/HYPERTENSIONAHA.110.161695; Luo B, 2008, J MOL BIOL, V380, P31, DOI 10.1016/j.jmb.2008.04.064; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANNAERTS GP, 1993, BIOCHIMIE, V75, P147, DOI 10.1016/0300-9084(93)90072-Z; Maynard EL, 2004, PROTEINS, V55, P856, DOI 10.1002/prot.20112; Monosov EZ, 1996, J HISTOCHEM CYTOCHEM, V44, P581, DOI 10.1177/44.6.8666743; Nelson JW, 2015, J CEREBR BLOOD F MET, V35, P1416, DOI 10.1038/jcbfm.2015.159; Nelson JW, 2013, J BIOL CHEM, V288, P7697, DOI 10.1074/jbc.M112.429258; Ohtoshi K, 2005, BIOCHEM BIOPH RES CO, V331, P347, DOI 10.1016/j.bbrc.2005.03.171; Pahan K, 1996, J LIPID RES, V37, P159; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Srivastava PK, 2004, ARCH BIOCHEM BIOPHYS, V427, P164, DOI 10.1016/j.abb.2004.05.003; Sura P, 2008, J HISTOCHEM CYTOCHEM, V56, P551, DOI 10.1369/jhc.2008.950659; Wiemer EAC, 1997, J CELL BIOL, V136, P71, DOI 10.1083/jcb.136.1.71; Zhang L, 2008, PHARMACOGENET GENOM, V18, P45, DOI 10.1097/FPC.0b013e3282f313e8; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494	26	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0152742	10.1371/journal.pone.0152742	http://dx.doi.org/10.1371/journal.pone.0152742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203283	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291500002
J	Tang, N; Sun, B; Gupta, A; Rempel, H; Pulliam, L				Tang, Norina; Sun, Bing; Gupta, Archana; Rempel, Hans; Pulliam, Lynn			Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-B in endothelial cells	FASEB JOURNAL			English	Article						CCL2; ICAM-1; atherosclerosis; HIV; miRNA	KAPPA-B; INTERFERON-ALPHA; GENE-EXPRESSION; HIV-INFECTION; MICROPARTICLES; ATHEROSCLEROSIS; MICRORNA-155; INFLAMMATION; BLOOD; DIFFERENTIATION	HIV-infected individuals have activated monocytes with an IFN phenotype and elevated levels of circulating LPS. These individuals also have a risk of premature cardiovascular disease. The effect of activated monocyte exosomes (Exos) on endothelial cells is unknown. To determine whether Exos from immune-activated monocytes could alter endothelial cell expression and contribute to monocyte/macrophage transmigration and adhesion, we isolated Exos from monocytes stimulated with IFN, LPS, or both (I/L). We show that monocyte Exos contain different inflammatory microRNA cargo depending on stimulation. When LPS Exos or I/L Exos were added to HUVECs, we found a significant increase in adhesion molecule ICAM-1, chemokine ligand (CCL)-2, and cytokine IL-6 mRNAs and proteins compared with cells treated with IFN Exos or Exos derived from unstimulated monocytes. Inhibition of transcription factor NF-B, a common inflammatory cytokine pathway, prevented induction of CCL2, IL6, and ICAM1. Inhibition of TLR4 resulted in differential blockage of the targets. Our results demonstrate for the first time that primary human monocyte Exos enter endothelial cells and cause dysfunction via the TLR4 and NF-B pathways, which may contribute to heart disease in HIV infection and other diseases involving chronic immune activation.Tang, N., Sun, B., Gupta, A., Rempel, H., Pulliam, L. Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-B in endothelial cells.	[Tang, Norina; Sun, Bing; Rempel, Hans; Pulliam, Lynn] Vet Adm Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA; [Gupta, Archana] Syst Biosci Inc, Mountain View, CA USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pulliam, L (corresponding author), Vet Affairs Med Ctr 113A, Dept Lab Med, San Francisco, CA 94121 USA.	lynn.pulliam@ucsf.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R21HL129853]; NIH National Institute of Mental Health [R01MH096673]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH112483, R01MH096673] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Ivy Hsieh (Veterans Administration Medical Center) for performing the electron microscopy, Dr. Kang Li [University of California, San Francisco (UCSF)] for technical assistance with the NF-kappa B microscopy studies, Dr. Robert Raffai (UCSF) for helpful discussions, and Dr. Craig Meyer (UCSF) for assistance with statistical analyses. These studies were supported in part by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R21HL129853 and NIH National Institute of Mental Health Grant R01MH096673 (both to L.P.). Author contributions: N. Tang, B. Sun, and A. Gupta performed the research; N. Tang, H. Rempel, and L. Pulliam analyzed the data; N. Tang and L. Pulliam wrote the manuscript; and B. Sun performed the statistical analyses. The authors declare no conflicts of interest.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Conti L, 1997, CELL GROWTH DIFFER, V8, P435; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Distler JHW, 2005, ARTHRITIS RHEUM, V52, P3337, DOI 10.1002/art.21350; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Goetzl EJ, 2016, FASEB J, V30, P2058, DOI 10.1096/fj.201500150R; Golias C, 2007, IN VIVO, V21, P757; Gupta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-68; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Huber HJ, 2015, CURR OPIN LIPIDOL, V26, P412, DOI 10.1097/MOL.0000000000000214; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Ilhan F, 2015, WORLD J CLIN CASES, V3, P345, DOI 10.12998/wjcc.v3.i4.345; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; McDonald MK, 2014, PAIN, V155, P1527, DOI 10.1016/j.pain.2014.04.029; Montoro-Garcia S, 2011, BASIC RES CARDIOL, V106, P911, DOI 10.1007/s00395-011-0198-4; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Pulliam L, 2015, DNA CELL BIOL, V34, P459, DOI 10.1089/dna.2015.2884; Pulliam L, 2014, J INTERF CYTOK RES, V34, P822, DOI 10.1089/jir.2013.0152; Ramakrishnan DP, 2016, ARTERIOSCL THROM VAS, V36, P534, DOI 10.1161/ATVBAHA.115.307085; Rangrez A.Y., 2013, MICRORNAS CARDIOVASC, V1, P23, DOI 10.2478/micrnacr-2013-0003; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; SICA A, 1990, J IMMUNOL, V144, P3034; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Swaminathan G, 2014, J MOL BIOL, V426, P1178, DOI 10.1016/j.jmb.2013.12.017; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian FJ, 2014, CARDIOVASC RES, V103, P100, DOI 10.1093/cvr/cvu070; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	52	109	115	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3097	3106		10.1096/fj.201600368RR	http://dx.doi.org/10.1096/fj.201600368RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27226520	Green Published			2022-12-26	WOS:000382816300010
J	Dolino, DM; Adariani, SR; Shaikh, SA; Jayaraman, V; Sanabria, H				Dolino, Drew M.; Adariani, Soheila Rezaei; Shaikh, Sana A.; Jayaraman, Vasanthi; Sanabria, Hugo			Conformational Selection and Submillisecond Dynamics of the Ligand-binding Domain of the N-methyl-D-aspartate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROBABILITY-DISTRIBUTION ANALYSIS; FLUORESCENCE LIFETIME ANALYSIS; SINGLE-MOLECULE FRET; NMDA RECEPTORS; PARTIAL AGONISM; AMPA RECEPTOR; STRUCTURAL DYNAMICS; PHOTON DISTRIBUTION; GLUTAMATE-RECEPTOR	The N-methyl-D-aspartate (NMDA) receptors are heteromeric non-selective cation channels that require the binding of glycine and glutamate for gating. Based on crystal structures, the mechanism of partial agonism at the glycine-binding site is thought to be mediated by a shift in the conformational equilibrium between an open clamshell and a closed clamshell-like structure of the bilobed ligand-binding domain (LBD). Using single-molecule Forster resonance energy transfer (smFRET) and multiparameter fluorescence detection, which allows us to study the conformational states and dynamics in the submillisecond time scale, we show that there are atleast three conformational states explored by the LBD: the low FRET, medium FRET, and high FRET states. The distance of the medium and low FRET states corresponds to what has been observed in crystallography structures. We show that the high FRET state, which would represent a more closed clamshell conformation than that observed in the crystal structure, is most likely the state initiating activation, as evidenced by the fact that the fraction of the protein in this state correlates well with the extent of activation. Furthermore, full agonist bound LBDs show faster dynamic motions between the medium and high FRET states, whereas they show slower dynamics when bound to weaker agonists or to antagonists.	[Dolino, Drew M.; Shaikh, Sana A.; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Adariani, Soheila Rezaei; Sanabria, Hugo] Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA	University of Texas System; University of Texas Health Science Center Houston; Clemson University	Jayaraman, V (corresponding author), MSB 6-528,6431 Fannin St, Houston, TX 77030 USA.; Sanabria, H (corresponding author), 214 Kinard Lab, Clemson, SC 29634 USA.	vasanthi.jayaraman@uth.tmc.edu; hsanabr@clemson.edu	Sanabria, Hugo/A-1231-2013	Sanabria, Hugo/0000-0001-7068-6827; Dolino, Drew/0000-0002-2690-7140	National Institutes of Health [R01 GM094246]; NIGMS [GM089657]; Clemson University; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089657, R01GM094246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Clemson University; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM094246 (to V. J.) and NIGMS Grant GM089657 (to D. M. D.), start-up funds from Clemson University (to H. S.), and a Schissler Foundation Fellowship for Translational Studies of Common Human Diseases (to D. M. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed AH, 2013, J BIOL CHEM, V288, P27658, DOI 10.1074/jbc.M113.495564; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Cai Q, 2007, BIOPHYS J, V93, P2110, DOI 10.1529/biophysj.107.109439; Cooper DR, 2015, BIOPHYS J, V109, P66, DOI 10.1016/j.bpj.2015.05.025; Dai J, 2015, STRUCTURE, V23, P228, DOI 10.1016/j.str.2014.11.012; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; Dolino DM, 2015, J BIOL CHEM, V290, P797, DOI 10.1074/jbc.M114.605436; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; Kalinin S, 2008, J PHYS CHEM B, V112, P8361, DOI 10.1021/jp711942q; Kalinin S, 2007, J PHYS CHEM B, V111, P10253, DOI 10.1021/jp072293p; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Kalinin S, 2010, J PHYS CHEM B, V114, P7983, DOI 10.1021/jp102156t; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kudryavtsev V, 2012, CHEMPHYSCHEM, V13, P1060, DOI 10.1002/cphc.201100822; Kuhnemuth R, 2001, SINGLE MOL, V2, P251, DOI 10.1002/1438-5171(200112)2:4<251::AID-SIMO251>3.0.CO;2-T; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maus M, 2001, ANAL CHEM, V73, P2078, DOI 10.1021/ac000877g; Muschielok A, 2008, NAT METHODS, V5, P965, DOI 10.1038/nmeth.1259; Ramaswamy S, 2012, J BIOL CHEM, V287, P43557, DOI 10.1074/jbc.M112.371815; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Sasmal DK, 2014, J AM CHEM SOC, V136, P12998, DOI 10.1021/ja506231j; Schaffer J, 1999, J PHYS CHEM A, V103, P331, DOI 10.1021/jp9833597; Sindbert S, 2011, J AM CHEM SOC, V133, P2463, DOI 10.1021/ja105725e; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wozniak AK, 2008, P NATL ACAD SCI USA, V105, P18337, DOI 10.1073/pnas.0800977105; Yao YN, 2013, STRUCTURE, V21, P1788, DOI 10.1016/j.str.2013.07.011	34	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16175	16185		10.1074/jbc.M116.721274	http://dx.doi.org/10.1074/jbc.M116.721274			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226581	Green Published, hybrid			2022-12-26	WOS:000380585400022
J	Zhao, LH; Yin, YT; Yang, DH; Liu, B; Hou, L; Wang, XX; Pal, K; Jiang, Y; Feng, Y; Cai, XQ; Dai, AT; Liu, MY; Wang, MW; Melcher, K; Xu, HE				Zhao, Li-Hua; Yin, Yanting; Yang, Dehua; Liu, Bo; Hou, Li; Wang, Xiaoxi; Pal, Kuntal; Jiang, Yi; Feng, Yang; Cai, Xiaoqing; Dai, Antao; Liu, Mingyao; Wang, Ming-Wei; Melcher, Karsten; Xu, H. Eric			Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; SMALL-MOLECULE AGONISTS; PEPTIDE-1 RECEPTOR; GLUCAGON RECEPTOR; PARATHYROID-HORMONE; DRUG DISCOVERY; GLP-1 RECEPTOR; RECOGNITION; LIGANDS; BINDING	G protein-coupled receptors (GPCRs) from the secretin-like (class B) family are key players in hormonal homeostasis and are important drug targets for the treatment of metabolic disorders and neuronal diseases. They consist of a large N-terminal extra cellular domain (ECD) and a transmembrane domain (TMD) with the GPCR signature of seven transmembrane helices. Class GPCRs are activated by peptide hormones with their C termini bound to the receptor ECD and their N termini bound to the TMD. It is thought that the ECD functions as an affinity trap to bind and localize the hormone to the receptor. This in turn would allow the hormone N terminus to insert into the TMD and induce conformational changes of the TMD to activate downstream signaling. In contrast to this prevailing model, we demonstrate that human class B GPCRs vary widely in their requirement of the ECD for activation. In one group, represented by corticotrophin-releasing factor receptor 1 (CRF1R), parathyroid hormone receptor (PTH1R), and pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1R), the ECD requirement for high affinity hormone binding can be bypassed by induced proximity and mass action effects, whereas in the other group, represented by glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), the LCD is required for signaling even when the hormone is covalently linked to the TMD. Furthermore, the activation of GLP-1R by small molecules that interact with the intracellular side of the receptor is dependent on the presence of its LCD, suggesting a direct role of the ECD in GLP-1R activation.	[Zhao, Li-Hua; Liu, Mingyao] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Zhao, Li-Hua; Liu, Mingyao] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Zhao, Li-Hua; Yin, Yanting; Liu, Bo; Hou, Li; Wang, Xiaoxi; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, VARI SIMM Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Zhao, Li-Hua; Yin, Yanting; Liu, Bo; Hou, Li; Wang, Xiaoxi; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Yin, Yanting; Pal, Kuntal; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Yang, Dehua; Feng, Yang; Cai, Xiaoqing; Dai, Antao; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Yang, Dehua; Feng, Yang; Cai, Xiaoqing; Dai, Antao; Wang, Ming-Wei] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China	East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Fudan University	Melcher, K; Xu, HE (corresponding author), Van Andel Res Inst, Ctr Canc & Cell Biol, Lab Struct Sci, Grand Rapids, MI 49503 USA.	Karsten.Melcher@vai.org; Eric.Xu@vai.org	Yang, Dehua/M-5789-2019; Yang, Dehua/S-6156-2017; sarkar, sabyasachi/A-9896-2010; Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021; Pal, Kuntal/W-6348-2019	sarkar, sabyasachi/0000-0002-8954-4375; Melcher, Karsten/0000-0002-9125-4027; PAL, KUNTAL/0000-0001-7094-2456; Liu, Mingyao/0000-0001-7339-5048; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, GM102545, GM104212]; National Natural Science Foundation of China [31300245, 31300607]; Van Andel Research Institute, Ministry of Science and Technology of China [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); National Health and Family Planning Commission [2012ZX09304-011, 2013ZX09401003-005, 2013ZX 09507001, 2013ZX09507-002]; Shanghai Science and Technology Development Fund [15DZ2291600]; Shanghai Science and Technology Committee [13ZR1447600]; Shanghai Rising-Star Program [14QA1404300]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104212, R01GM102545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Van Andel Research Institute, Ministry of Science and Technology of China; Amway (China); National Health and Family Planning Commission; Shanghai Science and Technology Development Fund; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Rising-Star Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662 (to H. E. X.) and GM102545 and GM104212 (to K. M.) This work was also supported by grants from the National Natural Science Foundation of China (31300245; to L.-H. Z.) and in part by the Van Andel Research Institute, Ministry of Science and Technology of China (2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001), Amway (China), the National Health and Family Planning Commission (2012ZX09304-011, 2013ZX09401003-005, 2013ZX 09507001, and 2013ZX09507-002; to M.-W. W.), Shanghai Science and Technology Development Fund (15DZ2291600; to M.-W. W.), National Natural Science Foundation of China (31300607; to Y. J.), Shanghai Science and Technology Committee (13ZR1447600; to Y. J.), Shanghai Rising-Star Program (14QA1404300; to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archbold JK, 2011, TRENDS PHARMACOL SCI, V32, P591, DOI 10.1016/j.tips.2011.05.007; Bortolato A, 2014, BRIT J PHARMACOL, V171, P3132, DOI 10.1111/bph.12689; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Eng H, 2013, DRUG METAB DISPOS, V41, P1470, DOI 10.1124/dmd.113.052183; Fan H, 2015, BRIT J PHARMACOL, V172, P64, DOI 10.1111/bph.12895; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Gravholt CH, 2001, J CLIN ENDOCR METAB, V86, P2085, DOI 10.1210/jc.86.5.2085; He M, 2012, ACTA PHARMACOL SIN, V33, P148, DOI 10.1038/aps.2011.169; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Liu Q, 2012, J MED CHEM, V55, P250, DOI 10.1021/jm201150j; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Ruiter M, 2003, DIABETES, V52, P1709, DOI 10.2337/diabetes.52.7.1709; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wang MW, 2010, ACTA PHARMACOL SIN, V31, P1026, DOI 10.1038/aps.2010.107; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	38	41	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15119	15130		10.1074/jbc.M116.726620	http://dx.doi.org/10.1074/jbc.M116.726620			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226600	Green Published, hybrid			2022-12-26	WOS:000380583200022
J	Yu, HQ; Gautam, AKS; Wilmington, SR; Wylie, D; Martinez-Fonts, K; Kago, G; Warburton, M; Chavali, S; Inobe, T; Finkelstein, IJ; Babu, MM; Matouschek, A				Yu, Houqing; Gautam, Amit K. Singh; Wilmington, Shameika R.; Wylie, Dennis; Martinez-Fonts, Kirby; Kago, Grace; Warburton, Marie; Chavali, Sreenivas; Inobe, Tomonao; Finkelstein, Ilya J.; Babu, M. Madan; Matouschek, Andreas			Conserved Sequence Preferences Contribute to Substrate Recognition by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; intrinsically disordered protein; proteasome; protein degradation; protein stability; protein targeting; protein turnover; ubiquitylation (ubiquitination); cellular protein abundance	PROTEIN HALF-LIFE; 26S PROTEASOME; ORNITHINE-DECARBOXYLASE; UBIQUITIN CHAINS; SACCHAROMYCES-CEREVISIAE; FLUORESCENT PROTEIN; PROTEOLYTIC MACHINE; DISORDERED SEGMENTS; REGULATORY PARTICLE; DEGRADATION SIGNAL	The proteasome has pronounced preferences for the amino acid sequence of its substrates at the site where it initiates degradation. Here, we report that modulating these sequences can tune the steady-state abundance of proteins over 2 orders of magnitude in cells. This is the same dynamic range as seen for inducing ubiquitination through a classic N-end rule degron. The stability and abundance of His3 constructs dictated by the initiation site affect survival of yeast cells and show that variation in proteasomal initiation can affect fitness. The proteasome's sequence preferences are linked directly to the affinity of the initiation sites to their receptor on the proteasome and are conserved between Saccharomyces cerevisiae, Schizosaccharomyces pombe, and human cells. These findings establish that the sequence composition of unstructured initiation sites influences protein abundance in vivo in an evolutionarily conserved manner and can affect phenotype and fitness.	[Yu, Houqing; Gautam, Amit K. Singh; Wilmington, Shameika R.; Martinez-Fonts, Kirby; Kago, Grace; Warburton, Marie; Finkelstein, Ilya J.; Matouschek, Andreas] Univ Texas Austin, Dept Mol Biosci, 2506 Speedway Stop A5000, Austin, TX 78712 USA; [Wylie, Dennis] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Yu, Houqing; Wilmington, Shameika R.; Martinez-Fonts, Kirby; Matouschek, Andreas] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Chavali, Sreenivas; Babu, M. Madan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Inobe, Tomonao] Toyama Univ, Frontier Res Core Life Sci, 3190 Gofuku, Toyama, Toyama 9308555, Japan	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Northwestern University; MRC Laboratory Molecular Biology; University of Toyama	Matouschek, A (corresponding author), Univ Texas Austin, Dept Mol Biosci, 2506 Speedway Stop A5000, Austin, TX 78712 USA.	matouschek@austin.utexas.edu	Mohan, Babu P./I-7362-2019; GAUTAM, AMIT KUMAR SINGH/AAN-6296-2020; Matouschek, Andreas/L-9379-2013	GAUTAM, AMIT KUMAR SINGH/0000-0001-9846-1945; Matouschek, Andreas/0000-0001-6016-2341	National Institutes of Health [U54GM105816, R21CA196456, R21CA191664]; Welch Foundation [F-1817, F-1808]; Cancer Prevention and Research Institute of Texas [RP140328]; Program to Disseminate Tenure Track System from the Ministry of Education, Culture, Sports, Science and Technology, Japan; United Kingdom Medical Research Council [MC_U105185859]; European Molecular Biology Organization; MRC [MC_U105185859] Funding Source: UKRI; Grants-in-Aid for Scientific Research [15H01531] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R21CA196456, T32CA080621, R21CA191664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004, U54GM105816] Funding Source: NIH RePORTER; Medical Research Council [MC_U105185859] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; Program to Disseminate Tenure Track System from the Ministry of Education, Culture, Sports, Science and Technology, Japan; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by National Institutes of Health Grants U54GM105816, R21CA196456, and R21CA191664 (to A. M.), Welch Foundation Grants F-1817 (to A. M.) and F-1808 (to I. J. F.), Cancer Prevention and Research Institute of Texas Grant RP140328 (to A. M.), the Program to Disseminate Tenure Track System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. I.), the United Kingdom Medical Research Council Grant MC_U105185859 (to M. M. B.), and the European Molecular Biology Organization Long-Term Fellowship (to S. C.) and Young Investigator Program (to M. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Cilia E, 2014, NUCLEIC ACIDS RES, V42, pW264, DOI 10.1093/nar/gku270; Cilia E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3741; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Fishbain S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1194; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fort P, 2015, GENOME BIOL EVOL, V7, P1363, DOI 10.1093/gbe/evv068; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; HAWKES TR, 1995, BIOCHEM J, V306, P385, DOI 10.1042/bj3060385; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Iosefson O, 2015, CELL REP, V12, P1032, DOI 10.1016/j.celrep.2015.07.007; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Koga N, 2009, P NATL ACAD SCI USA, V106, P18237, DOI 10.1073/pnas.0904756106; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Kraut DA, 2011, ACS CHEM BIOL, V6, P1087, DOI 10.1021/cb2002285; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Lu Y., 2015, SCIENCE, V348; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1248737; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martinez-Fonts K, 2016, BIOCHEMISTRY-US, V55, P1898, DOI 10.1021/acs.biochem.5b01310; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2011, METHODS MOL BIOL, V699, P355, DOI 10.1007/978-1-61737-950-5_17; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; VIHINEN M, 1994, PROTEINS, V19, P141, DOI 10.1002/prot.340190207; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Weatheritt RJ, 2012, NUCLEIC ACIDS RES, V40, P7123, DOI 10.1093/nar/gks442; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Wilmington SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152679; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wu HY, 2015, P NATL ACAD SCI USA, V112, P11229, DOI 10.1073/pnas.1508187112; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095	104	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14526	14539		10.1074/jbc.M116.727578	http://dx.doi.org/10.1074/jbc.M116.727578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226608	hybrid, Green Published			2022-12-26	WOS:000380366700010
J	Deng, H; Deng, S; Xu, HB; Deng, HX; Chen, YL; Yuan, LM; Deng, X; Yang, SB; Guan, LP; Zhang, JG; Yuan, H; Guo, Y				Deng, Hao; Deng, Sheng; Xu, Hongbo; Deng, Han-Xiang; Chen, Yulan; Yuan, Lamei; Deng, Xiong; Yang, Shengbo; Guan, Liping; Zhang, Jianguo; Yuan, Hong; Guo, Yi			Exome Sequencing of a Pedigree Reveals S339L Mutation in the TLN2 Gene as a Cause of Fifth Finger Camptodactyly	PLOS ONE			English	Article							TALIN; IDENTIFICATION	Camptodactyly is a digit deformity characterized by permanent flexion contracture of one or both fifth fingers at the proximal interphalangeal joints. Though over 60 distinct types of syndromic camptodactyly have been described, only one disease locus (3q11.2-q13.12) for nonsyndromic camptodactyly has been identified. To identify the genetic defect for camptodactyly in a four-generation Chinese Han family, exome and Sanger sequencings were conducted and a missense variant, c.1016C>T (p.S339L), in the talin 2 gene (TLN2) was identified. The variant co-segregated with disease in the family and was not observed in 12 unaffected family members or 1,000 normal controls, suggesting that p. S339L is a pathogenic mutation. Two asymptomatic carriers in the family indicated incomplete penetrance or more complicated compensated mechanism. Most of p. S339L carriers also have relatively benign cardiac phenotypes. Expression of wild and mutant TLN2 in HEK293 cells suggested the predominant localization in cytoplasm. Our data suggest a potential molecular link between TLN2 and camptodactyly pathogenesis.	[Deng, Hao; Deng, Sheng; Xu, Hongbo; Yuan, Lamei; Deng, Xiong; Yuan, Hong; Guo, Yi] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China; [Deng, Hao; Deng, Sheng; Xu, Hongbo; Yuan, Lamei; Deng, Xiong; Yuan, Hong; Guo, Yi] Cent S Univ, Xiangya Hosp 3, Dept Neurol, Changsha, Hunan, Peoples R China; [Deng, Sheng] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China; [Deng, Han-Xiang] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Div Neuromuscular Med, Chicago, IL 60611 USA; [Chen, Yulan; Guan, Liping; Zhang, Jianguo] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Yang, Shengbo] Cent S Univ, Xiangya Hosp 3, Dept Dermatol, Changsha, Hunan, Peoples R China; [Guo, Yi] Cent S Univ, Informat Secur & Big Data Res Inst, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Northwestern University; Feinberg School of Medicine; Beijing Genomics Institute (BGI); Central South University; Central South University	Deng, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China.; Deng, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Neurol, Changsha, Hunan, Peoples R China.	hdeng008@yahoo.com	GUO, YI/AAW-2801-2021; Yuan, Lamei/O-6331-2017; Deng, Hao/O-6340-2017	Yuan, Lamei/0000-0001-7558-0669; Deng, Hao/0000-0003-3240-4352; Deng, Sheng/0000-0002-8313-6522; Deng, Han-Xiang/0000-0002-0030-8465	National Natural Science Foundation of China [81101339, 81001476, 81441033]; Natural Science Foundation of Hunan Province, China [10JJ5029]; Construction Fund for Key Subjects of the Third Xiangya Hospital, Central South University, China; Postgraduates Innovative Pilot Scheme of Hunan Province, China [CX2014B109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Construction Fund for Key Subjects of the Third Xiangya Hospital, Central South University, China; Postgraduates Innovative Pilot Scheme of Hunan Province, China	This work was supported by National Natural Science Foundation of China (81101339, 81001476 and 81441033); Natural Science Foundation of Hunan Province, China (10JJ5029); Construction Fund for Key Subjects of the Third Xiangya Hospital, Central South University, China; and Postgraduates Innovative Pilot Scheme of Hunan Province, China (CX2014B109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bates Steven J, 2009, Plast Reconstr Surg, V124, p128e, DOI 10.1097/PRS.0b013e3181a80777; Brites MM, 1998, EUR J DERMATOL, V8, P355; Chen CP, 2004, PRENATAL DIAG, V24, P130, DOI 10.1002/pd.802; Conti FJ, 2008, DEVELOPMENT, V135, P2043, DOI 10.1242/dev.015818; Gurierrez-Franco MD, 2010, KOREAN J LAB MED, V30, P318, DOI 10.3343/kjlm.2010.30.3.318; Figuera LE, 2002, CLIN DYSMORPHOL, V11, P243, DOI 10.1097/00019605-200210000-00003; Flatt AE, 1994, THE CARE OF CONGENIT; Guo Y, 2013, NEUROSCI LETT, V555, P134, DOI 10.1016/j.neulet.2013.09.037; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larner AJ, 2011, EUR J DERMATOL, V21, P771, DOI 10.1684/ejd.2011.1464; Linder JA, 2009, J CRANIOFAC SURG, V20, P999, DOI 10.1097/SCS.0b013e3181ae21f9; LITTMAN A, 1968, J AMER MED ASSOC, V206, P1565; Malik S, 2008, EUR J HUM GENET, V16, P265, DOI 10.1038/sj.ejhg.5201957; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; O'Driscoll MC, 2008, CLIN DYSMORPHOL, V17, P157, DOI 10.1097/MCD.0b013e3283023d0c; Rajcan-Separovic E, 2007, J MED GENET, V44, P269, DOI 10.1136/jmg.2006.045013; Ravishanker R, 2004, Med J Armed Forces India, V60, P227, DOI 10.1016/S0377-1237(04)80051-0; Salazard B, 2008, CHIR MAIN, V27, pS157, DOI 10.1016/j.main.2008.07.018; SCHALLREUTER KU, 1993, HAUTARZT, V44, P157; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Spassov A, 2012, ARCH IMMUNOL THER EX, V60, P137, DOI 10.1007/s00005-012-0167-0; Toydemir RM, 2006, AM J HUM GENET, V79, P935, DOI 10.1086/508433; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289; Xia JH, 2000, J INVEST DERMATOL, V114, P1071, DOI 10.1046/j.1523-1747.2000.00978.x; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	30	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155180	10.1371/journal.pone.0155180	http://dx.doi.org/10.1371/journal.pone.0155180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223613	Green Submitted, gold, Green Published			2022-12-26	WOS:000376881700017
J	Filho, MAM; Dutra, JDL; Rocha, GB; Simas, AM; Freire, RO				Filho, Manoel A. M.; Dutra, Jose Diogo L.; Rocha, Gerd B.; Simas, Alfredo M.; Freire, Ricardo O.			Parameters for the RM1 Quantum Chemical Calculation of Complexes of the Trications of Thulium, Ytterbium and Lutetium	PLOS ONE			English	Article							CAMBRIDGE STRUCTURAL DATABASE; NEAR-INFRARED LUMINESCENCE; RARE-EARTH COMPLEXES; SPARKLE MODEL; LANTHANIDE COMPLEXES; AM1 CALCULATION; EUROPIUM(III) COMPLEXES; CRYSTAL-STRUCTURES; MESOPOROUS MCM-41; PREDICTION	The RM1 quantum chemical model for the calculation of complexes of Tm(III), Yb(III) and Lu(III) is advanced. Subsequently, we tested the models by fully optimizing the geometries of 126 complexes. We then compared the optimized structures with known crystallographic ones from the Cambridge Structural Database. Results indicate that, for thulium complexes, the accuracy in terms of the distances between the lanthanide ion and its directly coordinated atoms is about 2%. Corresponding results for ytterbium and lutetium are both 3%, levels of accuracy useful for the design of lanthanide complexes, targeting their countless applications.	[Filho, Manoel A. M.; Dutra, Jose Diogo L.; Freire, Ricardo O.] Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, Sao Cristovao, SE, Brazil; [Dutra, Jose Diogo L.; Simas, Alfredo M.] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil; [Rocha, Gerd B.] Univ Fed Paraiba, CCEN, Dept Quim, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade Federal de Sergipe; Universidade Federal de Pernambuco; Universidade Federal da Paraiba	Freire, RO (corresponding author), Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, Sao Cristovao, SE, Brazil.; Simas, AM (corresponding author), Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.	simas@ufpe.br; rfreire@ufs.br	DUTRA, JOSE DIOGO LISBOA/AAJ-9870-2021; Lisboa Dutra, José Diogo/I-7088-2013; Rocha, Gerd B/G-5115-2010; Freire, Ricardo/AGR-4537-2022; Freire, Ricardo O/B-7685-2008; Filho, Manoel Alves Machado/R-2505-2019	DUTRA, JOSE DIOGO LISBOA/0000-0003-2123-2209; Rocha, Gerd B/0000-0001-9805-9497; Freire, Ricardo/0000-0002-3603-3184; Freire, Ricardo O/0000-0002-3603-3184; 				Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Basalov IV, 2014, INORG CHEM, V53, P1654, DOI 10.1021/ic4027859; Borges AS, 2012, INORG CHEM, V51, P12867, DOI 10.1021/ic301776n; Bruno IJ, 2002, ACTA CRYSTALLOGR B, V58, P389, DOI 10.1107/S0108768102003324; Burdinski D, 2008, CHEM BIODIVERS, V5, P1505, DOI 10.1002/cbdv.200890139; Cantat T, 2006, ORGANOMETALLICS, V25, P1329, DOI 10.1021/om050877c; Ceyhan T, 2007, POLYHEDRON, V26, P73, DOI 10.1016/j.poly.2006.07.035; da Costa NB, 2001, J MOL STRUC-THEOCHEM, V545, P131, DOI 10.1016/S0166-1280(01)00407-9; da Costa NB, 2007, J PHYS CHEM A, V111, P5015, DOI 10.1021/jp0672104; Dang S, 2008, J PHYS CHEM C, V112, P13240, DOI 10.1021/jp8041632; de Mesquita ME, 2004, J ALLOY COMPD, V366, P124, DOI 10.1016/S0925-8388(03)00696-0; de Mesquita ME, 2002, INORG CHEM COMMUN, V5, P292, DOI 10.1016/S1387-7003(02)00382-9; de Sa GF, 2000, COORDIN CHEM REV, V196, P165, DOI 10.1016/S0010-8545(99)00054-5; DEANDRADE AVM, 1994, CHEM PHYS LETT, V227, P349, DOI 10.1016/0009-2614(94)00829-9; deAndrade AVM, 1996, J CHEM SOC FARADAY T, V92, P1835, DOI 10.1039/ft9969201835; DEANDRADE AVM, 1995, J ALLOY COMPD, V225, P55, DOI 10.1016/0925-8388(94)07009-1; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Dutra JDL, 2013, J CHEM THEORY COMPUT, V9, P3333, DOI 10.1021/ct301012h; Faustino WM, 2000, J MOL STRUC-THEOCHEM, V527, P245, DOI 10.1016/S0166-1280(00)00497-8; Feng J, 2009, J SOLID STATE CHEM, V182, P435, DOI 10.1016/j.jssc.2008.11.007; Feng J, 2009, MICROPOR MESOPOR MAT, V117, P278, DOI 10.1016/j.micromeso.2008.06.035; Filho MAM, 2014, J CHEM THEORY COMPUT, V10, P3031, DOI 10.1021/ct400909w; Filho MAM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086376, 10.1371/journal.pone.0107058]; Filho MAM, 2013, RSC ADV, V3, P16747, DOI 10.1039/c3ra41406j; Freire RO, 2007, CHEM PHYS LETT, V441, P354, DOI 10.1016/j.cplett.2007.05.036; Freire RO, 2006, CHEM PHYS LETT, V425, P138, DOI 10.1016/j.cplett.2006.04.103; Freire RO, 2006, J PHYS CHEM A, V110, P5897, DOI 10.1021/jp057286k; Freire RO, 2010, J CHEM THEORY COMPUT, V6, P2019, DOI 10.1021/ct100192c; Freire RO, 2005, J MOL MODEL, V12, P16, DOI 10.1007/s00894-005-0280-7; Freire RO, 2005, J COMPUT CHEM, V26, P1524, DOI 10.1002/jcc.20288; Freire RO, 2005, CHEM PHYS LETT, V411, P61, DOI 10.1016/j.cplett.2005.05.099; Freire RO, 2005, CHEM PHYS LETT, V405, P123, DOI 10.1016/j.cplett.2005.02.022; Freire RO, 2005, J LUMIN, V111, P81, DOI 10.1016/j.jlumin.2004.07.001; Jung J, 2014, EUR J INORG CHEM, P3888, DOI 10.1002/ejic.201400121; Kalinovskaya IV, 2014, RUSS J PHYS CHEM A+, V88, P1613, DOI 10.1134/S0036024414090180; Kaufman L., 2009, FINDING GROUPS DATA; Lei SB, 2008, NANO LETT, V8, P1836, DOI 10.1021/nl0803186; Li WZ, 2014, J LUMIN, V146, P205, DOI 10.1016/j.jlumin.2013.09.009; Lukesova L, 2007, DALTON T, P920, DOI 10.1039/b700269f; Meyer N, 2006, ORGANOMETALLICS, V25, P4179, DOI 10.1021/om060440k; Moodi A, 2013, J BIOMOL STRUCT DYN, V31, P937, DOI 10.1080/07391102.2012.718525; Otero A, 2012, ORGANOMETALLICS, V31, P2244, DOI 10.1021/om2011672; Panda TK, 2007, CHEM COMMUN, P5007, DOI 10.1039/b711669a; Pointillart F, 2013, INORG CHEM, V52, P5978, DOI 10.1021/ic400253m; Pushkarev AP, 2013, RUSS CHEM B+, V62, P392, DOI 10.1007/s11172-013-0051-z; Pushkarev VE, 2013, DALTON T, V42, P12083, DOI 10.1039/c3dt51357b; Rocha GB, 2004, INORG CHEM, V43, P2346, DOI 10.1021/ic034882p; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Wang JF, 2008, ORG LETT, V10, P445, DOI 10.1021/ol702739c; Yang S, 2014, INORG CHEM, V53, P105, DOI 10.1021/ic401747n; Yao CG, 2014, ORGANOMETALLICS, V33, P684, DOI 10.1021/om400925a; Zhang T, 2013, CHEM COMMUN, V49, P7252, DOI 10.1039/c3cc43469a	52	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0154500	10.1371/journal.pone.0154500	http://dx.doi.org/10.1371/journal.pone.0154500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223475	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700006
J	Goldstein, LD; Cao, Y; Pau, G; Lawrence, M; Wu, TD; Seshagiri, S; Gentleman, R				Goldstein, Leonard D.; Cao, Yi; Pau, Gregoire; Lawrence, Michael; Wu, Thomas D.; Seshagiri, Somasekar; Gentleman, Robert			Prediction and Quantification of Splice Events from RNA-Seq Data	PLOS ONE			English	Article							TRANSCRIPTOME; ALIGNMENT; BROWSER	Analysis of splice variants from short read RNA-seq data remains a challenging problem. Here we present a novel method for the genome-guided prediction and quantification of splice events from RNA-seq data, which enables the analysis of unannotated and complex splice events. Splice junctions and exons are predicted from reads mapped to a reference genome and are assembled into a genome-wide splice graph. Splice events are identified recursively from the graph and are quantified locally based on reads extending across the start or end of each splice variant. We assess prediction accuracy based on simulated and real RNA-seq data, and illustrate how different read aligners (GSNAP, HISAT2, STAR, TopHat2) affect prediction results. We validate our approach for quantification based on simulated data, and compare local estimates of relative splice variant usage with those from other methods (MISO, Cufflinks) based on simulated and real RNA-seq data. In a proof-of-concept study of splice variants in 16 normal human tissues (Illumina Body Map 2.0) we identify 249 internal exons that belong to known genes but are not related to annotated exons. Using independent RNA samples from 14 matched normal human tissues, we validate 9/9 of these exons by RT-PCR and 216/249 by paired-end RNA-seq (2 x 250 bp). These results indicate that de novo prediction of splice variants remains beneficial even in well-studied systems. An implementation of our method is freely available as an R/Bioconductor package SGSeq.	[Goldstein, Leonard D.; Cao, Yi; Pau, Gregoire; Lawrence, Michael; Wu, Thomas D.; Gentleman, Robert] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Goldstein, Leonard D.; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Gentleman, Robert] 23andMe Inc, Mountain View, CA USA	Roche Holding; Genentech; Roche Holding; Genentech	Goldstein, LD (corresponding author), Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA.; Goldstein, LD (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	goldstein.leonard@gene.com		Seshagiri, Somasekar/0000-0003-4272-6443	Genentech Inc.	Genentech Inc.(Roche HoldingGenentech)	The study was funded by Genentech Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamancos GP, 2014, METHODS MOL BIOL, V1126, P357, DOI 10.1007/978-1-62703-980-2_26; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heber Steffen, 2002, Bioinformatics, V18 Suppl 1, pS181; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	33	59	62	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156132	10.1371/journal.pone.0156132	http://dx.doi.org/10.1371/journal.pone.0156132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218464	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700044
J	Sarnelli, G; D'Alessandro, A; Iuvone, T; Capoccia, E; Gigli, S; Pesce, M; Seguella, L; Nobile, N; Aprea, G; Maione, F; de Palma, GD; Cuomo, R; Steardo, L; Esposito, G				Sarnelli, Giovanni; D'Alessandro, Alessandra; Iuvone, Teresa; Capoccia, Elena; Gigli, Stefano; Pesce, Marcella; Seguella, Luisa; Nobile, Nicola; Aprea, Giovanni; Maione, Francesco; de Palma, Giovanni Domenico; Cuomo, Rosario; Steardo, Luca; Esposito, Giuseppe			Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-alpha)-Dependent Manner	PLOS ONE			English	Article							FATTY-ACID AMIDE; BOWEL-DISEASE PATHOGENESIS; NITRIC-OXIDE; ULCERATIVE-COLITIS; CANCER CELLS; COLON-CANCER; PPAR-GAMMA; ANGIOGENESIS; HYPOXIA; MTOR	Background and Aim Angiogenesis is emerging as a pivotal process in chronic inflammatory pathologies, promoting immune infiltration and prompting carcinogenesis. Ulcerative Colitis (UC) and Crohn's Disease (CD) represent paradigmatic examples of intestinal chronic inflammatory conditions in which the process of neovascularization correlates with the severity and progression of the diseases. Molecules able to target the angiogenesis have thus the potential to synergistically affect the disease course. Beyond its anti-inflammatory effect, palmitoylethanolamide (PEA) is able to reduce angiogenesis in several chronic inflammatory conditions, but no data about its anti-angiogenic activity in colitis have been produced, yet. Methods The effects of PEA on inflammation-associated angiogenesis in mice with dextran sulphate sodium (DSS)-induced colitis and in patients with UC were assessed. The release of Vascular Endothelial Growth Factor (VEGF), the hemoglobin tissue content, the expression of CD31 and of phosphatidylinositol 3-kinase/Akt/mammalian-target-of-rapamycin (mTOR) signaling axis were all evaluated in the presence of different concentrations of PEA and concomitant administration of PPAR-alpha and -gamma antagonists. Results Our results demonstrated that PEA, in a selective peroxisome proliferator activated receptor (PPAR)-alpha dependent mechanism, inhibits colitis-associated angiogenesis, decreasing VEGF release and new vessels formation. Furthermore, we demonstrated that the mTOR/Akt axis regulates, at least partly, the angiogenic process in IBD and that PEA directly affects this pathway. Conclusions Our results suggest that PEA may improve inflammation-driven angiogenesis in colonic mucosa, thus reducing the mucosal damage and potentially affecting disease progression and the shift towards the carcinogenesis.	[Sarnelli, Giovanni; D'Alessandro, Alessandra; Pesce, Marcella; Aprea, Giovanni; Maione, Francesco; de Palma, Giovanni Domenico; Cuomo, Rosario] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Iuvone, Teresa] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Capoccia, Elena; Gigli, Stefano; Seguella, Luisa; Nobile, Nicola; Steardo, Luca; Esposito, Giuseppe] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Piazzale Aldo Moro 5, I-00185 Rome, Italy	University of Naples Federico II; University of Naples Federico II; Sapienza University Rome	Sarnelli, G (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy.; Esposito, G (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	sarnelli@unina.it; giuseppe.esposito@uniroma1.it	Pesce, Marcella/ABD-6001-2020; De Palma, Giovanni D/G-6895-2012; Steardo, Luca/H-9631-2017; Esposito, Giuseppe/AAA-7949-2019; aprea, giovanni/AAA-1983-2020; Sarnelli, Giovanni/AAB-4050-2019; Cuomo, Rosario/C-3446-2011	Pesce, Marcella/0000-0001-5996-4259; Steardo, Luca/0000-0002-7077-3506; Esposito, Giuseppe/0000-0001-8080-8218; Sarnelli, Giovanni/0000-0002-1467-1134; Cuomo, Rosario/0000-0003-0768-8381; SEGUELLA, LUISA/0000-0003-2346-9912; Maione, Francesco/0000-0001-7043-9295; APREA, Giovanni/0000-0003-2487-1006				Alkim C, 2015, INT J INFLAMM, V2015, DOI 10.1155/2015/970890; BHASKAR L, 1995, J GASTROEN HEPATOL, V10, P140, DOI 10.1111/j.1440-1746.1995.tb01068.x; Brown WH, 2012, P NATL ACAD SCI USA, V109, P14966, DOI 10.1073/pnas.1212887109; Capasso R, 2001, BRIT J PHARMACOL, V134, P945, DOI 10.1038/sj.bjp.0704339; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chidlow JH, 2006, AM J PATHOL, V169, P2014, DOI 10.2353/ajpath.2006.051021; Cipriano M, 2015, CNS NEUROL DISORD-DR, V14, P828, DOI 10.2174/1871527314666150317224155; Clottes T, 2005, B CANCER, V92, P119; Conti S, 2002, BRIT J PHARMACOL, V135, P181, DOI 10.1038/sj.bjp.0704466; Costa B, 2002, BRIT J PHARMACOL, V137, P413, DOI 10.1038/sj.bjp.0704900; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Cunliffe RN, 2002, APT, V66, P647; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; Davaatseren M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102975; De Filippis D, 2010, PHARMACOL RES, V61, P321, DOI 10.1016/j.phrs.2009.11.005; De Filippis D, 2007, J MOL MED, V85, P635, DOI 10.1007/s00109-007-0188-z; De Petrocellis L, 2002, FUND CLIN PHARMACOL, V16, P297, DOI 10.1046/j.1472-8206.2002.00094.x; Di Marzo V, 2001, BIOCHEM J, V358, P249, DOI 10.1042/0264-6021:3580249; Dormond-Meuwly A, 2011, BIOCHEM BIOPH RES CO, V407, P714, DOI 10.1016/j.bbrc.2011.03.086; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Esposito G, 2014, GUT, V63, P1300, DOI 10.1136/gutjnl-2013-305005; Farquhar-Smith WP, 2002, PAIN, V97, P11, DOI 10.1016/S0304-3959(01)00419-5; Ferrante M, 2006, INFLAMM BOWEL DIS, V12, P870, DOI 10.1097/01.mib.0000235095.01608.10; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; Goebel S, 2006, AM J PHYSIOL-GASTR L, V290, pG648, DOI 10.1152/ajpgi.00466.2005; Grevenitis P, 2015, SURG CLIN N AM, V95, P1159, DOI 10.1016/j.suc.2015.08.004; Hadjipanayi E, 2013, ORGANOGENESIS, V9, P261, DOI 10.4161/org.25970; Han S, 2007, ANTI-CANCER DRUG, V18, P237, DOI 10.1097/CAD.0b013e328011e67d; Hatoum OA, 2006, ANN NY ACAD SCI, V1072, P78, DOI 10.1196/annals.1326.003; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Martinez-Montiel MP, 2015, CLIN EXP GASTROENTER, V8, P257, DOI 10.2147/CEG.S58152; Montrose DC, 2015, PROSTAG OTH LIPID M, V116, P26, DOI 10.1016/j.prostaglandins.2014.10.002; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Orefice NS, 2016, NEUROTHERAPEUTICS, V13, P428, DOI 10.1007/s13311-016-0420-z; Paladini A, 2016, PAIN PHYSICIAN, V19, P11; Paleolog EM, 2002, ARTHRITIS RES THER, V4, pS81, DOI 10.1186/ar575; Ross RA, 2000, EUR J PHARMACOL, V401, P121, DOI 10.1016/S0014-2999(00)00437-4; Rubin DT, AMINOSALICYLATE THER; Sarnelli G, 2016, PHYTOTHERAPY RES, V2016; Scaldaferri F, 2009, GASTROENTEROLOGY, V136, P585, DOI 10.1053/j.gastro.2008.09.064; Scuderi C, 2011, J CELL MOL MED, V15, P2664, DOI 10.1111/j.1582-4934.2011.01267.x; Setia S, 2014, BIOMED PHARMACOTHER, V68, P721, DOI 10.1016/j.biopha.2014.07.006; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; Son MK, 2013, FOOD CHEM, V136, P26, DOI 10.1016/j.foodchem.2012.07.096; Tang J, 2010, DIGEST DIS SCI, V55, P1696, DOI 10.1007/s10620-009-0942-x; Tas SW, 2016, NAT REV RHEUMATOL, V12, P111, DOI 10.1038/nrrheum.2015.164; TSUJII M, 1995, J GASTROENTEROL, V30, P183, DOI 10.1007/BF02348663; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537	58	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156198	10.1371/journal.pone.0156198	http://dx.doi.org/10.1371/journal.pone.0156198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219328	Green Submitted, gold, Green Published			2022-12-26	WOS:000376880700050
J	Sterkowicz, S; Jaworski, J; Lech, G; Palka, T; Sterkowicz-Przybycien, K; Bujas, P; Pieta, P; Moscinski, Z				Sterkowicz, Stanislaw; Jaworski, Janusz; Lech, Grzegorz; Palka, Tomasz; Sterkowicz-Przybycien, Katarzyna; Bujas, Przemyslaw; Pieta, Pawel; Moscinski, Zenon			Effect of Acute Effort on Isometric Strength and Body Balance: Trained vs. Untrained Paradigm	PLOS ONE			English	Article							HANDGRIP STRENGTH; MUSCLE FATIGUE; POSTURAL BALANCE; JUDO; PERFORMANCE; ELITE; ENDURANCE; FITNESS; JUNIOR; LEVEL	Years of training in competitive sports leads to human body adaptation to a specific type of exercise. In judo bouts, maintaining hand grip on an opponent's clothes and postural balance is essential for the effective technical and tactical actions. This study compares changes after maximal anaerobic exercise among judo athletes and untrained subjects regarding 1) maximum isometric handgrip strength (HGSmax) and accuracy at the perceived 50% maximum handgrip force (1/2HGSmax) and 2) the balance of 13 judo athletes at national (n = 8) and international (n = 5) competitive levels and 19 untrained university students. The groups did not differ in age, body height, and weight. Body mass index (BMI) and body composition (JAWON) were evaluated. The Wingate Anaerobic Test (WAnT, Monark 875E) measured recommended anaerobic capacity indices. Hand grip strength (Takei dynamometer) and balance (biplate balance platform) were measured before warm-up (T1), before the WAnT test (T2), and after (T3). Parametric or non-parametric tests were performed after verifying the variable distribution assumption. Judoists had higher BMI and fat-free mass index (FFMI) than the students. The athletes also showed higher relative total work and relative peak power and lower levels of lactic acid. The difference in judoists between HGSmax at T1 and HGSmax at T3 was statistically significant. Before warm-up (T1), athletes showed higher strength (more divergent from the calculated 1/2HGSmax value) compared to students. Substantial fatigue after the WAnT test significantly deteriorated the body stability indices, which were significantly better in judo athletes at all time points. The findings suggest specific body adaptations in judoists, especially for body composition, anaerobic energy system efficiency, and postural balance. These characteristics could be trained for specifically by judo athletes to meet the time-motion and anaerobic demands of contemporary bouts.	[Sterkowicz, Stanislaw; Jaworski, Janusz; Lech, Grzegorz; Bujas, Przemyslaw] Univ Phys Educ, Dept Theory Sport & Kinesiol, Krakow, Poland; [Palka, Tomasz] Univ Phys Educ, Dept Physiol & Biochem, Krakow, Poland; [Sterkowicz-Przybycien, Katarzyna] Univ Phys Educ, Dept Gymnast & Dance, Krakow, Poland; [Pieta, Pawel] Univ Phys Educ, Dept Sports Med & Human Nutr, Krakow, Poland; [Moscinski, Zenon] Sport Club GKS Czarni, Dept Judo, Bytom, Poland		Sterkowicz, S (corresponding author), Univ Phys Educ, Dept Theory Sport & Kinesiol, Krakow, Poland.	stanislaw.sterkowicz@awf.krakow.pl	Bujas, Przemysław/U-1978-2017	Bujas, Przemysław/0000-0003-1047-8481; Jaworski, Janusz/0000-0002-2664-1012; Lech, Grzegorz/0000-0003-4987-9848	University of Physical Education, Cracow, Poland; American Manuscript Editors [977-190-363-427-326];  [60/BS/IS/2014]	University of Physical Education, Cracow, Poland; American Manuscript Editors; 	This work was supported by: 60/BS/IS/2014, Statutory research, URL: awf.krakow.pl; University of Physical Education, Cracow, Poland (JJ). The authors' institution funded travel and transportation of researcher and devices to sport club, supported data collection, and the cost of English editing by American Manuscript Editors (certificate No. 977-190-363-427-326).	Dias JA, 2012, SCI SPORT, V27, pE9, DOI 10.1016/j.scispo.2011.10.005; Adlerton AK, 1996, SCAND J MED SCI SPOR, V6, P211; Ageberg E, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-44; Almansba R, 2012, ARCH BUDO, V8, P153, DOI 10.12659/AOB.883365; American College of Sports Medicine, 2005, ACSMS HLTH REL PHYS; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Bizid R, 2009, EUR J APPL PHYSIOL, V106, P375, DOI 10.1007/s00421-009-1029-2; Bonitch-Gongora JG, 2013, ARCH BUDO, V9, P239; Bonitch-Gongora JG, 2012, J STRENGTH COND RES, V26, P1863, DOI 10.1519/JSC.0b013e318238ebac; Borkowski L, 2001, BIOL SPORT, V18, P107; Brown JP, 2002, BRIT J SPORT MED, V36, P310, DOI 10.1136/bjsm.36.4.310; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cortell-Tormo JM, 2013, ARCH BUDO, V9, P21, DOI 10.12659/AOB.883826; Crowell DH, 2001, J ATHL TRAIN S2, V36, P33; DOTAN R, 1983, EUR J APPL PHYSIOL O, V51, P409, DOI 10.1007/BF00429077; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Franchini E, 2005, BIOL SPORT, V22, P315; Franchini E, 2011, ARCH BUDO, V7, P1; Franchini E, 2011, INT J SPORT PHYSIOL, V6, P334, DOI 10.1123/ijspp.6.3.334; Franchini E, 2011, SPORTS MED, V41, P147, DOI 10.2165/11538580-000000000-00000; Golema M., 2003, THE RANGE OF TRANSPO; Gorski J, 2012, HUMAN PHYSL PHYS TRA, P79; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Hattori K, 1997, AM J HUM BIOL, V9, P573, DOI 10.1002/(SICI)1520-6300(1997)9:5<573::AID-AJHB5>3.0.CO;2-V; Heitkamp HC, 2001, INT J SPORTS MED, V22, P285, DOI 10.1055/s-2001-13819; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Hubner-Wozniak E, 2006, AWF WARSZAWA STUDIA, P100; Jagiello W, 2014, ARCH BUDO, V10; Jankowicz-Szymanska A, 2015, J PEDIATR ORTHOP B, V24, P456, DOI 10.1097/BPB.0000000000000202; Lech G, 2007, MED SPORT PRACTICA, V8, P81; Lech G, 2010, ARCH BUDO, V6, P1; LITTLE NG, 1991, J SPORT MED PHYS FIT, V31, P510; Maedessadat R, 2012, ANN BIOL RES, V3, P3716; Mala L, 2015, ARCH BUDO, V11, P217; Melnikov A. A., 2012, Human Physiology, V38, P176, DOI 10.1134/S0362119712020168; Miarka B, 2012, J SPORT SCI, V30, P899, DOI 10.1080/02640414.2012.679675; Moran-Navarro R, 2015, J SPORT HEALTH RES, V7, P19; Noakes TD, 2000, SCAND J MED SCI SPOR, V10, P123, DOI 10.1034/j.1600-0838.2000.010003123.x; NYLAND JA, 1994, J ORTHOP SPORT PHYS, V20, P132, DOI 10.2519/jospt.1994.20.3.132; Obminski Z, 2015, J MARTIAL ARTS ANTHR, V15, P52, DOI DOI 10.14589/ID0.15.2.8; Ohlenkamp N, 2006, BLACK BELT JUDO SKIL, P51; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Paillard T, 2002, BRIT J SPORT MED, V36, P304, DOI 10.1136/bjsm.36.4.304; Palka T, 2013, ARCH BUDO, V9; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Robertson P, 2009, J SPORTS THERAPY, V1, P1; Schwartz J., 2015, SPORT SCI HLTH, V11, P171, DOI [10.1007/s11332-015-0220-6, DOI 10.1007/S11332-015-0220-6]; Sogabe A, 2008, ARCH BUDO, V4, P70; Sterkowicz S, 2011, BIOL SPORT, V28, P271, DOI 10.5604/965486; Sterkowicz S, 2012, J COMBAT SPORTS MART, V1, P5, DOI DOI 10.5604/20815735.1047612; Sterkowicz S, 1999, J HUM KINET, V2, P115; Szmuchrowski LA, 2013, ARCH BUDO, V9, P175; Wojtys EM, 1996, AM J SPORT MED, V24, P615, DOI 10.1177/036354659602400509; Zemkowa E, 2007, MED SPORTIVA, V11, P70	54	14	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155985	10.1371/journal.pone.0155985	http://dx.doi.org/10.1371/journal.pone.0155985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218258	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700033
J	de Medeiros, RM; Valverde-Villegas, JM; Junqueira, DM; Graf, T; Lindenau, JD; de Mello, MG; Vianna, P; Almeida, SEM; Chies, JAB				de Medeiros, Rubia M.; valverde-Villegas, Jacqueline M.; Junqueira, Dennis M.; Graf, Tiago; Lindenau, Juliana D.; de Mello, Marineide G.; Vianna, Priscila; Almeida, Sabrina E. M.; Chies, Jose Artur B.			Rapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; DISEASE PROGRESSION; TYPE-1 INFECTION; VIRUS-INFECTION; PATHOGENESIS; CYTOKINES; INDUCTION; TH17	Cytokines are intrinsically related to disease progression in HIV infection. We evaluated the plasma levels of Th1/Th2/Th17 cytokines in extreme progressors, including slow (SPs) and rapid (RPs) progressors, who were thus classified based on clinical and laboratory follow-up covering a period of time before the initiation of HAART, ranging from 93-136.5 months for SPs and 7.5-16.5 months for RPs. Analyses were also performed based on the different stages of HIV infection (chronic, pre-HAART individuals-subjects sampled before initiating HAART but who initiated therapy from 12 to 24 months-and those receiving HAART). The plasma cytokine levels of 16 HIV-infected rapid progressors and 25 slow progressors were measured using a Human Th1/Th2/Th17 CBA kit. The IL-6 and IL-10 plasma levels differed significantly between the stages of HIV infection. The IL-6 levels were higher in slow progressors pre-HAART than in chronically infected SPs and HIV-seronegative individuals. The IL-10 levels were higher in slow progressors pre-HAART than in slow progressors receiving HAART and HIV-seronegative controls, and in rapid progressors, the IL-10 levels were higher in pre-HAART subjects than in HIV-seronegative controls. The results reflect the changes in the cytokine profile occurring during different clinical stages in HIV+ subjects. Our results suggest an association between increased IL-6 and IL-10 levels and pre-HAART stages independent of the slow or rapid progression status of the subjects. Thus, increased IL-6 and IL-10 levels could indicate a global inflammatory status and could be used as markers of the disease course in HIV-infected individuals.	[de Medeiros, Rubia M.; valverde-Villegas, Jacqueline M.; Junqueira, Dennis M.; Graf, Tiago; Almeida, Sabrina E. M.] State Fdn Prod & Hlth Res FEPPS, Technol & Sci Dev Ctr CDCT, Porto Alegre, RS, Brazil; [de Medeiros, Rubia M.; valverde-Villegas, Jacqueline M.; Lindenau, Juliana D.; Vianna, Priscila; Almeida, Sabrina E. M.; Chies, Jose Artur B.] Univ Fed Rio Grande do Sul, Post Grad Program Genet & Mol Biol, Porto Alegre, RS, Brazil; [Junqueira, Dennis M.] Uniritter Laureate Int Univ, Dept Hlth Sci, Porto Alegre, RS, Brazil; [Graf, Tiago] Univ Fed Santa Catarina, Post Grad Program Biotechnol & Biosci, Florianopolis, SC, Brazil; [de Mello, Marineide G.] Nossa Senhora da Conceicao Hosp, Infect Dis Serv, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Santa Catarina (UFSC)	Chies, JAB (corresponding author), Univ Fed Rio Grande do Sul, Post Grad Program Genet & Mol Biol, Porto Alegre, RS, Brazil.	jabchies@terra.com.br	Junqueira, Dennis/ABC-4378-2021; de Medeiros, Rúbia M/L-2761-2015; Lindenau, Juliana D/N-1683-2014; Gräf, Tiago/S-8535-2019; Chies, Jose/K-9664-2015	de Medeiros, Rúbia M/0000-0001-7403-5650; Lindenau, Juliana D/0000-0003-0538-9820; Gräf, Tiago/0000-0003-4921-7975; Chies, Jose/0000-0001-7025-0660; Esteves De Matos Almeida, Sabrina/0000-0003-3599-8520; Junqueira, Dennis/0000-0003-1576-484X; Valverde-Villegas, Jacqueline/0000-0001-9446-3521	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [190760/2010-9, 306349/2011-6]; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS) [12/2151-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [grant numbers 190760/2010-9 and 306349/2011-6]; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS) [Grant number 12/2151-2].	Ancuta P, 2010, CURR OPIN HIV AIDS, V5, P158, DOI 10.1097/COH.0b013e3283364733; Becker Y, 2004, VIRUS GENES, V28, P5, DOI 10.1023/B:VIRU.0000012260.32578.72; Breen EC, 2002, PHARMACOL THERAPEUT, V95, P295, DOI 10.1016/S0163-7258(02)00263-2; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Clerici M, 2010, CURR OPIN HIV AIDS, V5, P184, DOI 10.1097/COH.0b013e328335c23c; Douglas SD, 2003, CLIN VACCINE IMMUNOL; Gangwani MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135633; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Klein SA, 1997, AIDS, V11, P1111, DOI 10.1097/00002030-199709000-00005; Lafeuillade A, 1991, AIDS, P1139; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09867; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Nookala AR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0214-3; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Olson AD, 2014, JAIDS-J ACQ IMM DEF, V67, P15, DOI 10.1097/QAI.0000000000000240; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Reuter MA, 2012, CYTOKINE GROWTH F R, V23, P181, DOI 10.1016/j.cytogfr.2012.05.005; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sanders CM, 2008, EXP MOL PATHOL, V84, P31, DOI 10.1016/j.yexmp.2007.08.008; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; Williams A, 2013, CYTOKINE, V61, P521, DOI 10.1016/j.cyto.2012.11.006	31	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156163	10.1371/journal.pone.0156163	http://dx.doi.org/10.1371/journal.pone.0156163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214135	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880200063
J	Guo, TX; Chamoto, K; Nakatsugawa, M; Ochi, T; Yamashita, Y; Anczurowski, M; Butler, MO; Hirano, N				Guo, Tingxi; Chamoto, Kenji; Nakatsugawa, Munehide; Ochi, Toshiki; Yamashita, Yuki; Anczurowski, Mark; Butler, Marcus O.; Hirano, Naoto			Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELL; TCR GENE-THERAPY; NKT CELLS; ENDOGENOUS LIGANDS; STRUCTURAL BASIS; SELF-ANTIGENS; CUTTING EDGE; INKT CELLS; LYMPHOCYTES; SELECTION	Invariant natural killer T (iNKT) cells recognize self-lipids presented by CD1d through characteristic TCRs, which mainly consist of the invariant V alpha 14-J alpha 18 TCR alpha chain and V beta 8.2, 7 or 2 TCR beta chains with hypervariable CDR3 beta sequences in mice. The iNKT cell-CD1d axis is conserved between humans and mice, and human CD1d reactivity of murine iNKT cells have been described. However, the detailed differences between the recognition of human and mouse CD1d bound to various self-lipids by mouse iNKT TCRs are largely unknown. In this study, we generated a de novo murine iNKT TCR repertoire with a wider range of auto-reactivity compared with that of naturally occurring peripheral iNKT TCRs. V beta 8.2 mouse iNKT TCRs capable of recognizing the human CD1d-self-lipid tetramer were identified, although such clones were not detectable in the V beta 7 or V beta 2 iNKT TCR repertoire. In line with previously reports, clonotypic V beta 8.2 iNKT TCRs with unique CDR3 beta loops did not discriminate among lipids presented by mouse CD1d. Unexpectedly, however, these iNKT TCRs showed greater ligand selectivity toward human CD1d presenting the same lipids. Our findings demonstrated that the recognition of mouse and human CD1d-self-lipid complexes by murine iNKT TCRs is not conserved, thereby further elucidating the differences between cognate and cross-species reactivity of self-antigens by mouse iNKT TCRs.	[Guo, Tingxi; Chamoto, Kenji; Nakatsugawa, Munehide; Ochi, Toshiki; Yamashita, Yuki; Anczurowski, Mark; Butler, Marcus O.; Hirano, Naoto] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Campbell Family Canc Res Inst, Tumor Immunotherapy Program,Princess Margaret Can, Toronto, ON, Canada; [Guo, Tingxi; Anczurowski, Mark; Butler, Marcus O.; Hirano, Naoto] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Butler, Marcus O.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Hirano, N (corresponding author), Univ Hlth Network, Campbell Family Inst Breast Canc Res, Campbell Family Canc Res Inst, Tumor Immunotherapy Program,Princess Margaret Can, Toronto, ON, Canada.; Hirano, N (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	naoto.hirano@utoronto.ca		Butler, Marcus/0000-0002-9840-7057	National Institutes of Health [R01CA148673]; Ontario Institute for Cancer Research Clinical Investigator Award [IA-039]; Princess Margaret Cancer Foundation; Knudson Postdoctoral Fellowship; Canadian Institutes of Health Research Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship; Province of Ontario; Guglietti Fellowship Award; NATIONAL CANCER INSTITUTE [R01CA148673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Institute for Cancer Research Clinical Investigator Award; Princess Margaret Cancer Foundation(University of Toronto); Knudson Postdoctoral Fellowship; Canadian Institutes of Health Research Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Province of Ontario; Guglietti Fellowship Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (http://www.nih.gov) grant R01CA148673 (NH); the Ontario Institute for Cancer Research (http://oicr.on.ca) Clinical Investigator Award IA-039 (NH); The Princess Margaret Cancer Foundation (http://www.thepmcf.ca, MOB and NH); Knudson Postdoctoral Fellowship (http://www.uhn.ca, KC); Canadian Institutes of Health Research Canada Graduate Scholarship (http://www.cihr-irsc.gc.ca/e/193.html, TG); Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (http://www.nserc-crsng.gc.ca/index_eng. asp, TG); Province of Ontario (https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/PRDR013089.html, TG and MA); and Guglietti Fellowship Award (http://www.uhn.ca, TO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedel R, 2014, P NATL ACAD SCI USA, V111, pE119, DOI 10.1073/pnas.1320777110; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brennan PJ, 2014, P NATL ACAD SCI USA, V111, P13433, DOI 10.1073/pnas.1415357111; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Butler MO, 2007, CLIN CANCER RES, V13, P1857, DOI 10.1158/1078-0432.CCR-06-1905; Butler MO, 2014, IMMUNOL REV, V257, P191, DOI 10.1111/imr.12129; Butler MO, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002207; Butler MO, 2010, INT IMMUNOL, V22, P863, DOI 10.1093/intimm/dxq440; Cameron G, 2015, J IMMUNOL, V195, P4604, DOI 10.4049/jimmunol.1501222; Chamoto K, 2016, J AUTOIMMUN, V68, P39, DOI 10.1016/j.jaut.2015.12.005; Chong TW, 2015, J CLIN PATHOL, V68, P200, DOI 10.1136/jclinpath-2014-202735; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Gapin L, 2013, CURR OPIN IMMUNOL, V25, P168, DOI 10.1016/j.coi.2013.01.002; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Guo TX, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00247; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Kotsianidis I, 2011, AM J CLIN PATHOL, V136, P400, DOI 10.1309/AJCP2F2DOXOTXHZA; Liu DF, 2013, CLIN IMMUNOL, V149, P55, DOI 10.1016/j.clim.2013.06.005; Lopez-Sagaseta J, 2012, EMBO J, V31, P2047, DOI 10.1038/emboj.2012.54; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Nakatsugawa M, 2015, J IMMUNOL, V194, P3487, DOI 10.4049/jimmunol.1401717; Ochi T, 2015, CANCER IMMUNOL RES, V3, P1070, DOI 10.1158/2326-6066.CIR-14-0222; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Sanderson JP, 2013, EUR J IMMUNOL, V43, P815, DOI 10.1002/eji.201242952; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Tanaka M, 2011, CLIN CANCER RES, V17, P5392, DOI 10.1158/1078-0432.CCR-10-3083; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; Wang XH, 2012, J EXP MED, V209, P987, DOI 10.1084/jem.20111024; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636	50	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156114	10.1371/journal.pone.0156114	http://dx.doi.org/10.1371/journal.pone.0156114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213277	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200056
J	Kilale, AM; Ngadaya, E; Muhumuza, J; Kagaruki, GB; Lema, YL; Ngowi, BJ; Mfinanga, SG; Hinderaker, SG				Kilale, Andrew Martin; Ngadaya, Esther; Muhumuza, Julius; Kagaruki, Gibson Benard; Lema, Yakobo Leonard; Ngowi, Bernard James; Mfinanga, Sayoki Godfrey; Hinderaker, Sven Gudmund			Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania	PLOS ONE			English	Article							SMEAR-NEGATIVE TUBERCULOSIS; HIV-INFECTED PERSONS; PULMONARY TUBERCULOSIS; PREVALENCE; DETERMINANTS; BURDEN; ADULTS	Objective To determine and describe clinical symptoms, demographic characteristics and environmental exposures as determinants of pulmonary mycobacterial diseases among patients examined for tuberculosis in agropastoral communities in Northern Tanzania. Methods This was a cross sectional study. Sputum samples were collected from patients attending three hospitals in Tanzania, and were investigated for pulmonary tuberculosis by microscopy between November 2010 and June 2012. The patients were interviewed about background information, and potential exposure to mycobacteria. Results We examined 1,711 presumptive tuberculosis cases where 936 (54.2%) were males and 775 (45.3%) females. Of all the study participants, 277 (16%) were found to have sputum samples positive for mycobacteria; 228 (13%) were smear positive, 123 (7%) were culture positive and 74 (4%) were positive by both smear microscopy and culture. Of the 123 mycobacterial culture positive, 15 (12.2%) had non-tuberculous mycobacteria. Males were more likely than females to be positive for mycobacteria. Factors associated with mycobacterial disease were loss of appetite, age groups below 41 years, and being a male. Among HIV negative patients, loss of appetite, age below 20 years and being a male were associated with being mycobacterial positive. Among HIV positive patients, males and those patients with a persistently coughing family member were more likely to harbor mycobacteria. Conclusion The findings in this study show that both M. tuberculosis and non-tuberculous mycobacterial strains were prevalent in the study community. Some risk factors were identified. Although the reported predictors may improve screening for mycobacterial diseases, their use requires some precaution.	[Kilale, Andrew Martin; Ngadaya, Esther; Muhumuza, Julius; Lema, Yakobo Leonard; Mfinanga, Sayoki Godfrey] Natl Inst Med Res, Muhimbili Ctr, POB 3436, Dar Es Salaam, Tanzania; [Kagaruki, Gibson Benard; Ngowi, Bernard James] Natl Inst Med Res, Tukuyu Ctr, POB 538, Tukuyu, Tanzania; [Kilale, Andrew Martin; Muhumuza, Julius; Hinderaker, Sven Gudmund] Univ Bergen, CIH, Postbox 7804, N-5020 Bergen, Norway	National Institute of Medical Research; University of Bergen	Kilale, AM (corresponding author), Natl Inst Med Res, Muhimbili Ctr, POB 3436, Dar Es Salaam, Tanzania.; Kilale, AM (corresponding author), Univ Bergen, CIH, Postbox 7804, N-5020 Bergen, Norway.	kilale@yahoo.com		Ngadaya, Esther/0000-0003-4540-5637	Wellcome Trust through the Afrique One Consortium	Wellcome Trust through the Afrique One Consortium(Wellcome Trust)	The field work for this study was financially supported by the Wellcome Trust through the Afrique One Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; BECK K, 1991, J GEN INTERN MED, V6, pS19, DOI 10.1007/BF02599253; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Chheng R, 2008, INT J TUBERC LUNG D, V12, pS54; Chilima BZ, 2006, APPL ENVIRON MICROB, V72, P2343, DOI 10.1128/AEM.72.4.2343-2350.2006; Churchyard GJ, 2010, AIDS, V24, pS19, DOI 10.1097/01.aids.0000391018.72542.46; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; ELLIOTT AM, 1993, AIDS, V7, P981, DOI 10.1097/00002030-199307000-00012; Hema Madhav, 2015, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V4, P338; Horsburgh C R Jr, 1996, Semin Respir Infect, V11, P244; Kimerling ME, 2002, INT J TUBERC LUNG D, V6, P988; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lockwood DNJ, 2011, DERMATOL CLIN, V29, P125, DOI 10.1016/j.det.2010.08.016; Mawak Jd, 2006, Ghana Med J, V40, P132; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; National Tuberculosis and Leprosy Programme, 2013, MAN MAN TUB LEPR; National Tuberculosis and Leprosy Programme Ministry of Health and Social Welfare, 2013, ANN REPORT; Oloya J, 2008, EPIDEMIOL INFECT, V136, P636, DOI 10.1017/S0950268807009004; PALMER DL, 1981, SOUTHERN MED J, V74, P170, DOI 10.1097/00007611-198102000-00011; Porter JDH, 1996, J ANTIMICROB CHEMOTH, V37, P113, DOI 10.1093/jac/37.suppl_B.113; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Rewata Lidya, 2009, Acta Med Indones, V41 Suppl 1, P57; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Ssengooba S, 2012, TUBERCULOSIS RES TRE, V2012; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Taha M, 2009, ETHIOP J HEALTH DEV, V219, P131, DOI DOI 10.4314/EJHS.V21I2.69053; Tamhane A, 2009, INT J TUBERC LUNG D, V13, P347; Thomas DJ, 2006, J PHARM PRACT, V19, P10, DOI 10.1177/0897190005284100; Tortoli E, 2009, CLIN MICROBIOL INFEC, V15, P906, DOI 10.1111/j.1469-0691.2009.03014.x; van Ingen J, 2009, CLIN MICROBIOL INFEC, V15, P888, DOI 10.1111/j.1469-0691.2009.03013.x; Washington L, 1998, J THORAC IMAG, V13, P271, DOI 10.1097/00005382-199810000-00007; Were W, 2009, INT J TUBERC LUNG D, V13, P47; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; WHO, 2007, WHOHTMHIV200701; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2004, TB HIV CLIN MAN, V2nd	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0153711	10.1371/journal.pone.0153711	http://dx.doi.org/10.1371/journal.pone.0153711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213532	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200002
J	Scherer, D; Seyler, C; Xynogalos, P; Scholz, EP; Thomas, D; Backs, J; Andrassy, M; Volkers, M; Karle, CA; Katus, HA; Zitron, E				Scherer, Daniel; Seyler, Claudia; Xynogalos, Panagiotis; Scholz, Eberhard P.; Thomas, Dierk; Backs, Johannes; Andrassy, Martin; Voelkers, Mirko; Karle, Christoph A.; Katus, Hugo A.; Zitron, Edgar			Inhibition of Cardiac Kir Current (I-K1) by Protein Kinase C Critically Depends on PKC beta and Kir2.2	PLOS ONE			English	Article							RECTIFYING K+ CHANNEL; HEART-FAILURE; VENTRICULAR-ARRHYTHMIAS; POTASSIUM CHANNELS; SUDDEN-DEATH; ACTIVATION; MYOCYTES; ARRHYTHMOGENESIS; CARDIOMYOCYTES; ENDOTHELIN-1	Background Cardiac inwardly rectifying Kir current (I-K1) mediates terminal repolarisation and is critical for the stabilization of the diastolic membrane potential. Its predominant molecular basis in mammalian ventricle is heterotetrameric assembly of Kir2.1 and Kir2.2 channel subunits. It has been shown that PKC inhibition of I-K1 promotes focal ventricular ectopy. However, the underlying molecular mechanism has not been fully elucidated to date. Methods and Results In the Xenopus oocyte expression system, we observed a pronounced PKC-induced inhibition of Kir2.2 but not Kir2.1 currents. The PKC regulation of Kir2.2 could be reproduced by an activator of conventional PKC isoforms and antagonized by pharmacological inhibition of PKC beta. In isolated ventricular cardiomyocytes (rat, mouse), pharmacological activation of conventional PKC isoforms induced a pronounced inhibition of I-K1. The PKC effect in rat ventricular cardiomyocytes was markedly attenuated following co-application of a small molecule inhibitor of PKC beta. Underlining the critical role of PKC beta, the PKC-induced inhibition of I-K1 was absent in homozygous PKC beta knockout-mice. After heterologous expression of Kir2.1-Kir2.2 concatemers in Xenopus oocytes, heteromeric Kir2.1/Kir2.2 currents were also inhibited following activation of PKC. Conclusion We conclude that inhibition of cardiac I-K1 by PKC critically depends on the PKC beta isoform and Kir2.2 subunits. This regulation represents a potential novel target for the antiarrhythmic therapy of focal ventricular arrhythmias.	[Scherer, Daniel; Seyler, Claudia; Xynogalos, Panagiotis; Scholz, Eberhard P.; Thomas, Dierk; Backs, Johannes; Andrassy, Martin; Voelkers, Mirko; Karle, Christoph A.; Katus, Hugo A.; Zitron, Edgar] Med Univ Hosp Heidelberg, Dept Cardiol, Heidelberg, Germany; [Thomas, Dierk; Backs, Johannes; Voelkers, Mirko; Katus, Hugo A.; Zitron, Edgar] DZHK German Ctr Cardiovasc Res, Partner Site Heidelberg Mannheim, Heidelberg, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Scherer, D (corresponding author), Med Univ Hosp Heidelberg, Dept Cardiol, Heidelberg, Germany.	daniel.scherer@med.uni-heidelberg.de	Thomas, Dierk/V-3940-2017; Thomas, Dierk/ABA-4706-2021; Volkers, Mirko/E-7947-2010	Thomas, Dierk/0000-0002-5687-7843; Volkers, Mirko/0000-0003-2344-1856	Deutsche Forschungsgemeinschaft [ZI1177/1-1]; University of Heidelberg: Postdoc Fellowship Program of the Faculty of Medicine	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Heidelberg: Postdoc Fellowship Program of the Faculty of Medicine	This work was funded by Deutsche Forschungsgemeinschaft: project ZI1177/1-1 to EZ and University of Heidelberg: Postdoc Fellowship Program of the Faculty of Medicine to DS.	Adibhatla RM, 2012, NEUROCHEM RES, V37, P671, DOI 10.1007/s11064-011-0659-z; Becker R, 2000, CARDIOVASC RES, V45, P310, DOI 10.1016/S0008-6363(99)00362-4; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Bowman JC, 1997, J CLIN INVEST, V100, P2189, DOI 10.1172/JCI119755; Dhamoon AS, 2004, CIRC RES, V94, P1332, DOI 10.1161/01.RES.0000128408.66946.67; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; Henry P, 1996, J PHYSIOL-LONDON, V495, P681, DOI 10.1113/jphysiol.1996.sp021625; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262; Karle CA, 2002, CIRCULATION, V106, P1493, DOI 10.1161/01.CIR.0000029747.53262.5C; Kiesecker C, 2006, J MOL MED, V84, P46, DOI 10.1007/s00109-005-0707-8; Kong L, 2008, AM J PHYSIOL-HEART C, V294, pH1862, DOI 10.1152/ajpheart.01346.2007; Litosch I, 2009, BIOCHEM BIOPH RES CO, V390, P603, DOI 10.1016/j.bbrc.2009.10.013; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Ohoka Y, 1997, J IMMUNOL, V158, P5707; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Rajagopal S, 2008, BRAIN RES, V1210, P1, DOI 10.1016/j.brainres.2008.03.017; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; RYVES WJ, 1991, FEBS LETT, V288, P5, DOI 10.1016/0014-5793(91)80989-G; SATO R, 1995, J MEMBRANE BIOL, V148, P185; Schram G, 2003, CARDIOVASC RES, V59, P328, DOI 10.1016/S0008-6363(03)00366-3; Sosunov EA, 2004, CARDIOVASC RES, V61, P715, DOI 10.1016/j.cardiores.2003.12.025; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zhu GY, 1999, J BIOL CHEM, V274, P11643, DOI 10.1074/jbc.274.17.11643; Zitron E, 2004, CARDIOVASC RES, V63, P520, DOI 10.1016/j.cardiores.2004.02.015; Zitron E, 2008, J MOL CELL CARDIOL, V44, P84, DOI 10.1016/j.yjmcc.2007.10.008; Zobel C, 2003, J PHYSIOL-LONDON, V550, P365, DOI 10.1113/jphysiol.2002.036400	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156181	10.1371/journal.pone.0156181	http://dx.doi.org/10.1371/journal.pone.0156181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214373	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200066
J	Van Ness, LK; Jayaraman, D; Maeda, J; Barrett-Wilt, GA; Sussman, MR; Ane, JM				Van Ness, Lori K.; Jayaraman, Dhileepkumar; Maeda, Junko; Barrett-Wilt, Gregory A.; Sussman, Michael R.; Ane, Jean-Michel			Mass Spectrometric-Based Selected Reaction Monitoring of Protein Phosphorylation during Symbiotic Signaling in the Model Legume, Medicago truncatula	PLOS ONE			English	Article							ROOT HAIRS; ARABIDOPSIS-THALIANA; TARGETED PROTEOMICS; CARBON METABOLISM; FUNGAL SYMBIOSES; CALCIUM SPIKING; GENE FAMILY; KINASE; NODULATION; PLANT	Unlike the major cereal crops corn, rice, and wheat, leguminous plants such as soybean and alfalfa can meet their nitrogen requirement via endosymbiotic associations with soil bacteria. The establishment of this symbiosis is a complex process playing out over several weeks and is facilitated by the exchange of chemical signals between these partners from different kingdoms. Several plant components that are involved in this signaling pathway have been identified, but there is still a great deal of uncertainty regarding the early events in symbiotic signaling, i.e., within the first minutes and hours after the rhizobial signals (Nod factors) are perceived at the plant plasma membrane. The presence of several protein kinases in this pathway suggests a mechanism of signal transduction via posttranslational modification of proteins in which phosphate is added to the hydroxyl groups of serine, threonine and tyrosine amino acid side chains. To monitor the phosphorylation dynamics and complement our previous untargeted 'discovery' approach, we report here the results of experiments using a targeted mass spectrometric technique, Selected Reaction Monitoring (SRM) that enables the quantification of phosphorylation targets with great sensitivity and precision. Using this approach, we confirm a rapid change in the level of phosphorylation in 4 phosphosites of at least 4 plant phosphoproteins that have not been previously characterized. This detailed analysis reveals aspects of the symbiotic signaling mechanism in legumes that, in the long term, will inform efforts to engineer this nitrogen-fixing symbiosis in important non-legume crops such as rice, wheat and corn.	[Van Ness, Lori K.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Jayaraman, Dhileepkumar; Ane, Jean-Michel] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Maeda, Junko; Ane, Jean-Michel] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Barrett-Wilt, Gregory A.] Univ Wisconsin, Mass Spectrometry Prote Facil, Madison, WI 53706 USA; [Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ane, JM (corresponding author), Univ Wisconsin, Dept Agron, Madison, WI 53706 USA.; Ane, JM (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jeanmichel.ane@wisc.edu	Ané, Jean-Michel/G-5921-2010	Ané, Jean-Michel/0000-0002-3128-9439	National Science Foundation (NSF-PGRP) [IOS-0701846]; Division Of Integrative Organismal Systems [1546742] Funding Source: National Science Foundation	National Science Foundation (NSF-PGRP)(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a grant from the National Science Foundation (NSF-PGRP no. IOS-0701846) to MRS and JMA.	Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; [Anonymous], 2010, GATEWAY COMPUTING EN; Antolin-Llovera M, 2014, CURR BIOL, V24, P422, DOI 10.1016/j.cub.2013.12.053; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; Capoen W, 2011, P NATL ACAD SCI USA, V108, P14348, DOI 10.1073/pnas.1107912108; Cardenas L, 2000, PLANT PHYSIOL, V123, P443, DOI 10.1104/pp.123.2.443; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Chawade A, 2016, J PROTEOME RES, V15, P638, DOI 10.1021/acs.jproteome.5b01061; Colgrave ML, 2015, J PROTEOME RES, V14, P2659, DOI 10.1021/acs.jproteome.5b00187; Cullimore J, 2003, SCIENCE, V302, P575, DOI 10.1126/science.1091269; Delaux PM, 2013, TRENDS PLANT SCI, V18, P298, DOI 10.1016/j.tplants.2013.01.008; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; ES K, 2014, PLANT PHYSIOL, V165, P1171, DOI [10.1104/pp.114.238816, DOI 10.1104/PP.114.238816]; Esseling JJ, 2003, PLANT PHYSIOL, V132, P1982, DOI 10.1104/pp.103.021634; Farrah T, 2012, PROTEOMICS, V12, P1170, DOI 10.1002/pmic.201100515; Felle HH, 1998, PLANT J, V13, P455, DOI 10.1046/j.1365-313X.1998.00041.x; Fukao Y, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1017697; Glinski M, 2003, RAPID COMMUN MASS SP, V17, P1579, DOI 10.1002/rcm.1093; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Kevei Z, 2007, PLANT CELL, V19, P3974, DOI 10.1105/tpc.107.053975; Konert G, 2015, NEW PHYTOL, V205, P1250, DOI 10.1111/nph.13097; Kouchi H, 2010, PLANT CELL PHYSIOL, V51, P1381, DOI 10.1093/pcp/pcq107; Krajinski F, 2014, PLANT CELL, V26, P1808, DOI 10.1105/tpc.113.120436; Larrainzar E, 2015, PLANT PHYSIOL, V169, P233, DOI 10.1104/pp.15.00350; Larrainzar E, 2009, MOL PLANT MICROBE IN, V22, P1565, DOI 10.1094/MPMI-22-12-1565; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Messinese E, 2007, MOL PLANT MICROBE IN, V20, P912, DOI 10.1094/MPMI-20-8-0912; Miller DD, 2000, MOL PLANT MICROBE IN, V13, P1385, DOI 10.1094/MPMI.2000.13.12.1385; Miller JB, 2013, PLANT CELL, V25, P5053, DOI 10.1105/tpc.113.116921; Minkoff BB, 2015, MOL CELL PROTEOMICS, V14, P1169, DOI 10.1074/mcp.M114.043307; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Narumi R, 2012, J PROTEOME RES, V11, P5311, DOI 10.1021/pr3005474; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Peiter E, 2007, PLANT PHYSIOL, V145, P192, DOI 10.1104/pp.107.097261; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Rodrigues A, 2013, PLANT CELL, V25, P3871, DOI 10.1105/tpc.113.114066; Rose CM, 2012, MOL CELL PROTEOMICS, V11, P724, DOI 10.1074/mcp.M112.019208; Sieberer BJ, 2012, PLANT J, V69, P822, DOI 10.1111/j.1365-313X.2011.04834.x; Stevenson SE, 2015, J AGR FOOD CHEM, V63, P821, DOI 10.1021/jf504708u; Taylor NL, 2014, PLANT PHYSIOL, V164, P525, DOI 10.1104/pp.113.225524; Venkateshwaran M, 2015, P NATL ACAD SCI USA, V112, P9781, DOI 10.1073/pnas.1413762112; Venkateshwaran M, 2013, CURR OPIN PLANT BIOL, V16, P118, DOI 10.1016/j.pbi.2012.11.007; Volkening JD, 2012, MOL CELL PROTEOMICS, V11, P933, DOI 10.1074/mcp.M112.019471; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Wienkoop S, 2008, J EXP BOT, V59, P3307, DOI 10.1093/jxb/ern182; Zhang CQ, 2013, PLANT CELL REP, V32, P1543, DOI 10.1007/s00299-013-1466-6; Zhang YQ, 2012, ANALYST, V137, P2699, DOI 10.1039/c2an35383k	58	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155460	10.1371/journal.pone.0155460	http://dx.doi.org/10.1371/journal.pone.0155460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203723	Green Submitted, gold, Green Published			2022-12-26	WOS:000376291500014
J	Yao, RJ; Yang, JS; Wu, DH; Xie, WP; Gao, P; Jin, WH				Yao, Rongjiang; Yang, Jingsong; Wu, Danhua; Xie, Wenping; Gao, Peng; Jin, Wenhui			Digital Mapping of Soil Salinity and Crop Yield across a Coastal Agricultural Landscape Using Repeated Electromagnetic Induction (EMI) Surveys	PLOS ONE			English	Article							ELECTRICAL-CONDUCTIVITY; CALIBRATION MODEL; VARIABILITY; IRRIGATION; PREDICTION; ACCURACY; TREND	Reliable and real-time information on soil and crop properties is important for the development of management practices in accordance with the requirements of a specific soil and crop within individual field units. This is particularly the case in salt-affected agricultural landscape where managing the spatial variability of soil salinity is essential to minimize salinization and maximize crop output. The primary objectives were to use linear mixed-effects model for soil salinity and crop yield calibration with horizontal and vertical electromagnetic induction (EMI) measurements as ancillary data, to characterize the spatial distribution of soil salinity and crop yield and to verify the accuracy of spatial estimation. Horizontal and vertical EMI (type EM38) measurements at 252 locations were made during each survey, and root zone soil samples and crop samples at 64 sampling sites were collected. This work was periodically conducted on eight dates from June 2012 to May 2013 in a coastal salt-affected mud farmland. Multiple linear regression (MLR) and restricted maximum likelihood (REML) were applied to calibrate root zone soil salinity (ECe) and crop annual output (CAO) using ancillary data, and spatial distribution of soil ECe and CAO was generated using digital soil mapping (DSM) and the precision of spatial estimation was examined using the collected meteorological and groundwater data. Results indicated that a reduced model with EMh as a predictor was satisfactory for root zone ECe calibration, whereas a full model with both EMh and EMv as predictors met the requirement of CAO calibration. The obtained distribution maps of ECe showed consistency with those of EMI measurements at the corresponding time, and the spatial distribution of CAO generated from ancillary data showed agreement with that derived from raw crop data. Statistics of jackknifing procedure confirmed that the spatial estimation of ECe and CAO exhibited reliability and high accuracy. A general increasing trend of ECe was observed and moderately saline and very saline soils were predominant during the survey period. The temporal dynamics of root zone ECe coincided with those of daily rainfall, water table and groundwater data. Long-range EMI surveys and data collection are needed to capture the spatial and temporal variability of soil and crop parameters. Such results allowed us to conclude that, cost-effective and efficient EMI surveys, as one part of multi-source data for DSM, could be successfully used to characterize the spatial variability of soil salinity, to monitor the spatial and temporal dynamics of soil salinity, and to spatially estimate potential crop yield.	[Yao, Rongjiang; Yang, Jingsong; Xie, Wenping; Jin, Wenhui] Chinese Acad Sci, State Key Lab Soil & Sustainable Agr, Inst Soil Sci, Nanjing 210008, Jiangsu, Peoples R China; [Yao, Rongjiang; Yang, Jingsong; Wu, Danhua] Chinese Acad Sci, Nanjing Branch, Dongtai Inst Tidal Flat Res, Dongtai 224200, Peoples R China; [Gao, Peng] Univ S Carolina, Dept Geog, 709 Bull St, Columbia, SC 29208 USA	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Yang, JS (corresponding author), Chinese Acad Sci, State Key Lab Soil & Sustainable Agr, Inst Soil Sci, Nanjing 210008, Jiangsu, Peoples R China.; Yang, JS (corresponding author), Chinese Acad Sci, Nanjing Branch, Dongtai Inst Tidal Flat Res, Dongtai 224200, Peoples R China.	jsyang@issas.ac.cn			National Natural Science Foundation of China [41571223]; Innovation Project of Institute of Soil Science, CAS [ISSASIP1633]; Project of Science and Technology Service (STS) Network Initiative, Chinese Academy of Sciences [KFJ-SW-STS-141-2]; National Key Technology RD Program [2015BAD01B03]; Autonomous Innovation Project of Jiangsu Agricultural Science & Technology - China [CX(15) 1005]; Key R&D Project (Modern Agriculture) of Jiangsu Province [BE2015337]; Natural Science Foundation of Jiangsu Province - China [BK 20141266]; Key Technology R&D Program of Jiangsu Province China [BE2014678]; industries, universities and research institutes in Jiangsu Province - China [BY2010013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Institute of Soil Science, CAS; Project of Science and Technology Service (STS) Network Initiative, Chinese Academy of Sciences; National Key Technology RD Program(National Key Technology R&D Program); Autonomous Innovation Project of Jiangsu Agricultural Science & Technology - China; Key R&D Project (Modern Agriculture) of Jiangsu Province; Natural Science Foundation of Jiangsu Province - China(Natural Science Foundation of Jiangsu Province); Key Technology R&D Program of Jiangsu Province China; industries, universities and research institutes in Jiangsu Province - China	This study was funded by the financial support of the National Natural Science Foundation of China (41571223), the Innovation Project of Institute of Soil Science, CAS (ISSASIP1633), the Project of Science and Technology Service (STS) Network Initiative, Chinese Academy of Sciences (KFJ-SW-STS-141-2), the National Key Technology R&D Program (2015BAD01B03), the Autonomous Innovation Project of Jiangsu Agricultural Science & Technology - China (CX(15) 1005), the Key R&D Project (Modern Agriculture) of Jiangsu Province (BE2015337) and the Natural Science Foundation of Jiangsu Province - China (BK 20141266) the Key Technology R&D Program of Jiangsu Province China (BE2014678), and the major innovative construction project of cooperation between industries, universities and research institutes in Jiangsu Province - China (BY2010013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchuk VI, 2010, PROGR SOIL SCI, P15, DOI 10.1007/978-90-481-8859-8_2; Akramkhanov A., 2009, SUST MAN SAL WAT SAL, P19; Amakor XN, 2013, SOIL SCI SOC AM J, V77, P985, DOI 10.2136/sssaj2012.0320; Boettinger JL, 1997, ARID SOIL RES REHAB, V11, P375, DOI 10.1080/15324989709381490; Bourgault RR, 2012, SOIL SCI SOC AM J, V76, P2128, DOI 10.2136/sssaj2012.0091; Chuai XW, 2012, PEDOSPHERE, V22, P404, DOI 10.1016/S1002-0160(12)60026-5; Cordeiro MRC, 2011, ENVIRON TECHNOL, V33, P1; Corwin DL, 2014, GEODERMA, V230, P288, DOI 10.1016/j.geoderma.2014.03.019; Corwin DL, 2008, BOOKS SOIL PLANT ENV, P17; CORWIN DL, 1984, SOIL SCI SOC AM J, V48, P288, DOI 10.2136/sssaj1984.03615995004800020011x; Dang YP, 2011, SOIL RES, V49, P559, DOI 10.1071/SR11199; de Clercq WP, 2009, AGR WATER MANAGE, V96, P395, DOI 10.1016/j.agwat.2008.09.002; Doolittle JA, 2014, GEODERMA, V223, P33, DOI [10.1016/j.geoderma2014.01.027, 10.1016/j.geoderma.2014.01.027]; Dore T, 1998, EUR J AGRON, V8, P29, DOI 10.1016/S1161-0301(97)00006-3; ESRI, 2004, ARCGIS; Fu QL, 2000, STUDY PRACTICE AGR T, P102; Ganjegunte GK, 2012, LAND DEGRAD DEV, V25, P228; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Guo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127996; Guo Y, 2013, J INTEGR AGR, V12, P723, DOI 10.1016/S2095-3119(13)60290-7; Herrero J, 2011, J HYDROL, V405, P427, DOI 10.1016/j.jhydrol.2011.05.041; Herrero J, 2003, SOIL USE MANAGE, V19, P119, DOI 10.1079/SUM2002178; Huang J, 2014, SOIL USE MANAGE, V30, P394, DOI 10.1111/sum.12122; Huang XW, 2008, AGRON J, V100, P1463, DOI 10.2134/agronj2007.0325; Isidoro D, 2011, IRRIGATION SCI, V29, P197, DOI 10.1007/s00271-010-0223-7; Jaynes D. B., 1996, Applications of GIS to the modeling of non-point source pollutants in the vadose zone., P205; Johnson CK, 2003, AGRON J, V95, P303, DOI 10.2134/agronj2003.0303; Kerry R, 2008, PRECIS AGRIC, V9, P33, DOI 10.1007/s11119-008-9058-0; Lark RM, 2006, EUR J SOIL SCI, V57, P787, DOI 10.1111/j.1365-2389.2005.00768.x; Li HY, 2013, GEODERMA, V195, P31, DOI 10.1016/j.geoderma.2012.11.005; Li Y, 2007, COMPUT ELECTRON AGR, V56, P174, DOI 10.1016/j.compag.2007.01.013; Ma RJ, 2011, PRECIS AGRIC, V12, P55, DOI 10.1007/s11119-009-9156-7; Maas E.V., 1990, ASCE MANUALS REPORTS, P262; Madrigal LP, 2007, ADV ASSESSMENT MONIT, P14; McCulloch C. E., 2000, GEN LINEAR MIXED MOD; Minasny B, 2016, GEODERMA, V264, P301, DOI 10.1016/j.geoderma.2015.07.017; Mullen R.S., 2008, P 2008 INT SNOW SCI, P421; Qu CF, 2012, J IRRIGATION DRAINAG, V31, P23, DOI DOI 10.13522/J.CNKI.GGPS.2012.03.005; Rossel RAV, 2011, ADV AGRON, V113, P237, DOI 10.1016/B978-0-12-386473-4.00010-5; SLAVICH PG, 1993, AUST J SOIL RES, V31, P73, DOI 10.1071/SR9930073; Soil Survey Staff, 2014, SOIL SURV STAFF KEYS, P347; SPSS Inc., 2006, SPSS BAS 15 0 WIND U; Sudduth KA, 2001, COMPUT ELECTRON AGR, V31, P239, DOI 10.1016/S0168-1699(00)00185-X; Triantafilis J, 2010, J APPL GEOPHYS, V70, P144, DOI 10.1016/j.jappgeo.2009.12.003; Triantafilis J, 2009, AUST J SOIL RES, V47, P651, DOI 10.1071/SR08240; US Salinity Laboratory Staff, 1954, DIAGNOSIS IMPROVEMEN, P160; Verbeke G, 2000, LINEAR MIXED MODELS; Yao RJ, 2013, ENVIRON MONIT ASSESS, V185, P5151, DOI 10.1007/s10661-012-2932-2; Yao RJ, 2015, J SOIL SEDIMENT, V15, P902, DOI 10.1007/s11368-014-1055-5; Yao RJ, 2014, GEODERMA, V232, P381, DOI 10.1016/j.geoderma.2014.06.006; Zhu Q, 2010, SOIL SCI SOC AM J, V74, P1763, DOI 10.2136/sssaj2010.0056	51	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0153377	10.1371/journal.pone.0153377	http://dx.doi.org/10.1371/journal.pone.0153377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203697	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291500005
J	Kanzaki, N				Kanzaki, Natsumi			Stomatal Dimorphism of Neodiplogaster acaloleptae (Diplogastromorpha: Diplogastridae)	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; PHYLOGENETIC-RELATIONSHIPS; NEMATODA DIPLOGASTRIDAE; EVOLUTION; N.; XYLOPHILUS	Several genera belonging to the nematode family Diplogastridae show characteristic dimorphism in their feeding structures; specifically, they have microbial feeding stenostomatous and predatory eurystomatous morphs. A diplogastrid satellite model species, Pristionchus pacificus, and its close relatives have become a model system for studying this phenotypic plasticity, with intensive physiological and structural studies having been undertaken. However, the many other species that are morphologically and phylogenetically divergent from P. pacificus have not been examined to date. In the present study, the detailed stomatal structure and induction of dimorphism in Neodiplogaster acaloleptae were examined. N. acaloleptae has a fungal feeding stenostomatous morph and a predatory eurystomatous morph. The predatory morph was induced by starvation, high population density, and coculturing with its potential prey, Caenorhabditis elegans. The feeding behavior of the stenostomatous and eurystomatous morphs of N. acaloleptae was confirmed, demonstrating that 1) the stomatal and pharyngeal movements of the two morphs were basically identical, and 2) the stomatal elements were protracted to cut open the hyphae and/or prey to feed when a N. acaloleptae flips its dorsal movable tooth dorsally and tilts its subventral stegostomatal cylinder ventrally, forming a pair of scissors to cut the food source. The stoma morphology of N. acaloleptae with a single movable tooth and a long stoma is markedly different from that of Pristionchus, which has two movable teeth and a short stoma. It is, however, similar to that of Mononchoides, tentatively a sister to Neodiplogaster.	[Kanzaki, Natsumi] Forestry & Forest Prod Res Inst, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan	Forestry & Forest Products Research Institute - Japan	Kanzaki, N (corresponding author), Forestry & Forest Prod Res Inst, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	nkanzaki@affrc.go.jp			Japan Society for the Promotion of Science [26292083]; Environment Research and Technology Development Fund from the Ministry of the Environment, Japan [4-1401]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environment Research and Technology Development Fund from the Ministry of the Environment, Japan	This study was supported in part by the Grant-in-Aid for Scientific Research (B), 2014, No. 26292083, from the Japan Society for the Promotion of Science and Environment Research and Technology Development Fund (4-1401) from the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Bose N, 2012, ANGEW CHEM INT EDIT, V51, P12438, DOI 10.1002/anie.201206797; Braendle C, 2012, CURR BIOL, V22, pR294, DOI 10.1016/j.cub.2012.03.035; Bumbarger DJ, 2013, CELL, V152, P109, DOI 10.1016/j.cell.2012.12.013; Bumbarger DJ, 2013, PACIFICUS EATS C ELE; GIBLIN R N, 1984, Revue de Nematologie, V7, P189; HECHLER HC, 1971, J NEMATOL, V3, P341; Hooper D. J., 1986, Laboratory methods for work with plant and soil nematodes., P51; Hooper D. J., 1986, LAB METHODS WORK PLA, P59; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kanzaki N, 2008, NEMATOLOGY, V10, P545, DOI 10.1163/156854108784513833; Kanzaki N, 2016, NEMATOLOGY, V18, P221, DOI 10.1163/15685411-00002955; Kanzaki N, 2015, NEMATOLOGY, V17, P831, DOI 10.1163/15685411-00002908; Kanzaki N, 2010, NEMATOLOGY, V12, P49, DOI 10.1163/156854109X448339; Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Krenn HW, 2010, ANNU REV ENTOMOL, V55, P307, DOI 10.1146/annurev-ento-112408-085338; Maehara Noritoshi, 2013, Nematological Research, V43, P9, DOI 10.3725/jjn.43.9; Minagawa Nozomu, 1994, Japanese Journal of Nematology, V24, P75; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pfennig DW, 2002, EVOLUTION, V56, P1217; Ragsdale EJ, 2013, CELL, V155, P922, DOI 10.1016/j.cell.2013.09.054; Serobyan V, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1334; Serobyan V, 2013, EVOL DEV, V15, P161, DOI 10.1111/ede.12030; Steel H, 2011, NEMATOLOGY, V13, P347, DOI 10.1163/138855410X523023; Susoy V, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501031; Susoy V, 2015, ELIFE, V4, DOI 10.7554/eLife.05463; Tanahashi M, 2009, J INSECT PHYSIOL, V55, P983, DOI 10.1016/j.jinsphys.2009.07.002; Tanaka R, 2012, APPL ENTOMOL ZOOL, V47, P291, DOI 10.1007/s13355-012-0115-9; von Lieven AF, 2002, RUSS J NEMATOL, V10, P11; Wilecki M, 2015, J EXP BIOL, V218, P1306, DOI 10.1242/jeb.118620; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006; YEATES GW, 1993, J NEMATOL, V25, P315	34	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155715	10.1371/journal.pone.0155715	http://dx.doi.org/10.1371/journal.pone.0155715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196730	Green Submitted, Green Published, gold			2022-12-26	WOS:000376291100089
J	Rajan, MR; Nyman, E; Kjolhede, P; Cedersund, G; Stralfors, P				Rajan, Meenu Rohini; Nyman, Elin; Kjolhede, Preben; Cedersund, Gunnar; Stralfors, Peter			Systems-wide Experimental and Modeling Analysis of Insulin Signaling through Forkhead Box Protein O1 (FOXO1) in Human Adipocytes, Normally and in Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTION FACTOR; FAT-CELLS; DEPENDENT REGULATION; AKT PHOSPHORYLATION; ADIPOSE-TISSUE; OBESE-PATIENTS; RESISTANCE; RICTOR; DOWNSTREAM	Insulin resistance is a major aspect of type 2 diabetes (T2D), which results from impaired insulin signaling in target cells. Signaling to regulate forkhead box protein O1 (FOXO1) may be the most important mechanism for insulin to control transcription. Despite this, little is known about how insulin regulates FOXO1 and how FOXO1 may contribute to insulin resistance in adipocytes, which are the most critical cell type in the development of insulin resistance. We report a detailed mechanistic analysis of insulin control of FOXO1 in human adipocytes obtained from non-diabetic subjects and from patients with T2D. We show that FOXO1 is mainly phosphorylated through mTORC2-mediated phosphorylation of protein kinase B at Ser(473) and that this mechanism is unperturbed in T2D. We also demonstrate a cross-talk from the MAPK branch of insulin signaling to stimulate phosphorylation of FOXO1. The cellular abundance and consequently activity of FOXO1 are halved in T2D. Interestingly, inhibition of mTORC1 with rapamycin reduces the abundance of FOXO1 to the levels in T2D. This suggests that the reduction of the concentration of FOXO1 is a consequence of attenuation of mTORC1, which defines much of the diabetic state in human adipocytes. We integrate insulin control of FOXO1 in a network-wide mathematical model of insulin signaling dynamics based on compatible data from human adipocytes. The diabetic state is network-wide explained by attenuation of an mTORC1-to-insulin receptor substrate-1 (IRS1) feedback and reduced abundances of insulin receptor, GLUT4, AS160, ribosomal protein S6, and FOXO1. The model demonstrates that attenuation of the mTORC1-toIRS1 feedback is a major mechanism of insulin resistance in the diabetic state.	[Rajan, Meenu Rohini; Kjolhede, Preben; Cedersund, Gunnar; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Nyman, Elin; Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden; [Nyman, Elin] AstraZeneca Res & Dev, Cardiovasc & Metab Dis Innovat Med & Drug Metab &, S-43150 Gothenburg, Sweden	Linkoping University; Linkoping University; AstraZeneca	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	peter.stralfors@liu.se	Nyman, Elin/I-3363-2019	Nyman, Elin/0000-0002-4261-0291; Stralfors, Peter/0000-0002-1196-1806	Swedish Diabetes Fund, University of Linkoping; Swedish Research Council; AstraZeneca	Swedish Diabetes Fund, University of Linkoping; Swedish Research Council(Swedish Research CouncilEuropean Commission); AstraZeneca(AstraZeneca)	This work was supported by a 3-year program at the Swedish Diabetes Fund, University of Linkoping, and a 5-year program at the Swedish Research Council. The salary for E. N. was paid through a grant from AstraZeneca.	Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Barbato DL, 2014, BBA-MOL CELL BIOL L, V1841, P1555, DOI 10.1016/j.bbalip.2014.08.004; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Danielsson A, 2009, MOL MED, V15, P228, DOI 10.2119/molmed.2009.00037; de Vries GJ, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0032-z; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Filteau M, 2015, P NATL ACAD SCI USA, V112, P4501, DOI 10.1073/pnas.1409938112; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Laurencikiene J, 2011, J CLIN ENDOCR METAB, V96, pE2045, DOI 10.1210/jc.2011-1702; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; SALANS LB, 1971, J CLIN INVEST, V50, P1399, DOI 10.1172/JCI106623; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Tonks KT, 2013, DIABETOLOGIA, V56, P875, DOI 10.1007/s00125-012-2811-y; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Xu Y, 2014, EXP CLIN ENDOCR DIAB, V122, P287, DOI 10.1055/s-0034-1371830; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013	52	17	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15806	15819		10.1074/jbc.M116.715763	http://dx.doi.org/10.1074/jbc.M116.715763			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226562	Green Published, hybrid			2022-12-26	WOS:000380584200033
J	Chandra, G; Rangasamy, SB; Roy, A; Kordower, JH; Pahan, K				Chandra, Goutam; Rangasamy, Suresh B.; Roy, Avik; Kordower, Jeffrey H.; Pahan, Kalipada			Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PRIMED T-CELLS; NF-KAPPA-B; ACTIVATED RECEPTOR-ALPHA; MICROGLIAL CELLS; MULTIPLE-SCLEROSIS; UP-REGULATION; PROINFLAMMATORY CYTOKINES; CHRONIC NEURODEGENERATION; GENDER BIAS	Parkinson disease (PD) is second only to Alzheimer disease as the most common human neurodegenerative disorder, Despite intense investigation, no interdictive therapy is available for PD. Recent studies indicate that both innate and adaptive immune processes are active in PD. Accordingly, we found a rapid increase in RANTES (regulated on activation normal T cell expressed and secreted) and eotaxin, chemokines that are involved in T cell trafficking, in vivo in the substantia nigra pars compacta and the serum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. RANTES and eotaxin were also up-regulated in the substantia nigra pars compacta of post-mortem PD brains as compared with age -matched controls. Therefore, we investigated whether neutralization of RANTES and eotaxin could protect against nigrostriatal degeneration in MPTP -intoxicated mice, Interestingly, after peripheral administration, functional blocking antibodies against RANTES and eotaxin reduced the infiltration of CD4+ and CDS+ T cells into the nigra, attenuated nigral expression of proinflammatory molecules, and suppressed nigral activation of glial cells. These findings paralleled dopaminergic neuronal protection, normalized striatal neurotransmitters, and improved motor functions in MPTP -intoxicated mice. Therefore, we conclude that attenuation of the chemokine-dependent adaptive immune response may be of therapeutic benefit for P1) patients.	[Chandra, Goutam; Rangasamy, Suresh B.; Roy, Avik; Kordower, Jeffrey H.; Pahan, Kalipada] Rush Univ, Dept Neurol Sci, Med Ctr, 1735 West Harrison St,Suite Cohn 320, Chicago, IL 60612 USA	Rush University	Pahan, K (corresponding author), Rush Univ, Dept Neurol Sci, Med Ctr, 1735 West Harrison St,Suite Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			National Institutes of Health [NS083054, NS064564]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064564, R01NS083054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS083054 and NS064564. The authors do not have any conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Brahmachari S, 2010, J IMMUNOL, V184, P6103, DOI 10.4049/jimmunol.0804356; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Chabot S, 2001, J NEUROSCI METH, V105, P111, DOI 10.1016/S0165-0270(00)00346-0; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dasgupta S, 2005, J BIOL CHEM, V280, P32609, DOI 10.1074/jbc.M500299200; Dasgupta S, 2003, J BIOL CHEM, V278, P22424, DOI 10.1074/jbc.M301789200; Dasgupta S, 2002, J BIOL CHEM, V277, P39327, DOI 10.1074/jbc.M111841200; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Gendelman HE, 2015, J NEUROIMMUNE PHARM, V10, P645, DOI 10.1007/s11481-015-9639-4; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Hu SX, 1999, J LEUKOCYTE BIOL, V65, P815, DOI 10.1002/jlb.65.6.815; Jana M, 2002, J NEUROCHEM, V80, P197, DOI 10.1046/j.0022-3042.2001.00691.x; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P569, DOI 10.1007/s11481-014-9552-2; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P218, DOI 10.1007/s11481-013-9503-3; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Lee JK, 2011, J NEUROSCI, V31, P11879, DOI 10.1523/JNEUROSCI.1002-11.2011; Martin HL, 2016, GLIA, V64, P386, DOI 10.1002/glia.22935; Mondal S, 2012, J NEUROIMMUNE PHARM, V7, P544, DOI 10.1007/s11481-012-9377-9; Nitsch R, 2004, J NEUROSCI, V24, P2458, DOI 10.1523/JNEUROSCI.4703-03.2004; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Pahan P, 2015, NEURAL REGEN RES, V10, P30, DOI 10.4103/1673-5374.150647; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Roy A, 2015, NEUROSCIENCE, V302, P36, DOI 10.1016/j.neuroscience.2015.03.011; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Roy A, 2015, CELL METAB, V22, P253, DOI 10.1016/j.cmet.2015.05.022; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Roy A, 2011, NEUROSCIENTIST, V17, P244, DOI 10.1177/1073858410385006; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Wada T, 1999, NEPHROL DIAL TRANSPL, V14, P76, DOI 10.1093/ndt/14.1.76; Wei J, 2013, PARASITOL RES, V112, P207, DOI 10.1007/s00436-012-3127-z; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002	44	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15267	15281		10.1074/jbc.M116.714824	http://dx.doi.org/10.1074/jbc.M116.714824			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226559	Green Published, hybrid			2022-12-26	WOS:000380583200033
J	Ariki, NK; Munoz, LE; Armitage, EL; Goodstein, FR; George, KG; Smith, VL; Vetter, I; Herzig, V; King, GF; Loening, NM				Ariki, Nathanial K.; Munoz, Lisa E.; Armitage, Elizabeth L.; Goodstein, Francesca R.; George, Kathryn G.; Smith, Vanessa L.; Vetter, Irina; Herzig, Volker; King, Glenn F.; Loening, Nikolaus M.			Characterization of Three Venom Peptides from the Spitting Spider Scytodes thoracica	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; NMR CHEMICAL-SHIFTS; CYSTINE KNOT; TOXINS; ASSIGNMENT; PROTEINS; PROGRAMS; SEQUENCE; PORE	We present the solution-state NMR structures and preliminary functional characterizations of three venom peptides identified from the spitting spider Scytodes thoracica. Despite little sequence identity to other venom peptides, structural characterization reveals that these peptides contain an inhibitor cystine knot motif common to many venom peptides. These are the first structures for any peptide or protein from spiders of the Scytodidae family. Many venom peptides target neuronal ion channels or receptors. However, we have not been able to determine the target of these Scytodes peptides so we can only state with certainty the channels and receptors that they do not target.	[Ariki, Nathanial K.; Munoz, Lisa E.; Armitage, Elizabeth L.; Goodstein, Francesca R.; George, Kathryn G.; Smith, Vanessa L.; Loening, Nikolaus M.] Lewis & Clark Coll, Dept Chem, 0615 SW Palatine Hill Rd, Portland, OR 97219 USA; [Vetter, Irina; Herzig, Volker; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Loening, NM (corresponding author), Lewis & Clark Coll, Dept Chem, 0615 SW Palatine Hill Rd, Portland, OR 97219 USA.	loening@lclark.edu	King, Glenn F/J-5059-2012; Herzig, Volker/A-7177-2008; Vetter, Irina/A-6035-2010	King, Glenn F/0000-0002-2308-2200; Herzig, Volker/0000-0003-2514-3983; Vetter, Irina/0000-0002-3594-9588; Smith, Vanessa/0000-0002-0431-503X; Loening, Nikolaus/0000-0002-5074-6906	National Institute of General Medical Sciences [R15GM085733]; Australian National Health & Medical Research Council from the Australian Research Council [DP130103813]; John S. Rogers Science Research Program at Lewis Clark College; National Institute of Mental Health's Psychoactive Drug Screening Program (NIMH PDSP) [HHSN-271-2013-00017-C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085733] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian National Health & Medical Research Council from the Australian Research Council(Australian Research Council); John S. Rogers Science Research Program at Lewis Clark College; National Institute of Mental Health's Psychoactive Drug Screening Program (NIMH PDSP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.M.L. was supported by Award Number R15GM085733 from the National Institute of General Medical Sciences. G.F.K. is supported by a Principal Research Fellowship from the Australian National Health & Medical Research Council and Discovery Grant DP130103813 from the Australian Research Council. N.K.A., L.E.M., E.L.A., F.R.G, and K.G.G. acknowledge support from the John S. Rogers Science Research Program at Lewis & Clark College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Greta Binford and Dr. Pamela Zobel-Thropp (Department of Biology, Lewis & Clark College, Portland, Oregon, United States) for their work in discovering the venom peptide sequences characterized in this paper, and Dr. Geoff Brown (Department of Agriculture, Fisheries and Forestry, Brisbane, Australia) for supplying the blowflies used for the injection studies. Screening for binding to vertebrate receptors was generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract # HHSN-271-2013-00017-C (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bende NS, 2015, FEBS J, V282, P904, DOI 10.1111/febs.13189; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Binford GJ, 2008, MOL PHYLOGENET EVOL, V49, P538, DOI 10.1016/j.ympev.2008.08.003; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; Dutertre S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4521; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2007, TOXICON, V49, P513, DOI 10.1016/j.toxicon.2006.11.012; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liang SP, 1999, J PROTEIN CHEM, V18, P619, DOI 10.1023/A:1020693920990; Loening NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054401; Lucio AD, 2008, PROTEIN PEPTIDE LETT, V15, P700, DOI 10.2174/092986608785133708; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Nicholson GM, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P369, DOI 10.1016/B978-012369442-3/50057-X; Nicholson GM, 2007, TOXICON, V49, P490, DOI 10.1016/j.toxicon.2006.11.027; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pineda SS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-177; Platnick N. I., 1991, AM MUS NOVIT, V3016, P1; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Windley MJ, 2012, TOXINS, V4, P191, DOI 10.3390/toxins4030191; World Spider Catalog, 2016, WORLD SPID CAT VERS; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zobel-Thropp PA, 2014, J PROTEOME RES, V13, P817, DOI 10.1021/pr400875s	52	6	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156291	10.1371/journal.pone.0156291	http://dx.doi.org/10.1371/journal.pone.0156291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227898	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500104
J	Dai, XF; Zhang, H; Han, JJ; He, Y; Zhang, YY; Qi, Y; Pang, JJ				Dai, Xufeng; Zhang, Hua; Han, Juanjuan; He, Ying; Zhang, Yangyang; Qi, Yan; Pang, Ji-Jing			Effects of Subretinal Gene Transfer at Different Time Points in a Mouse Model of Retinal Degeneration	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; ACYLTRANSFERASE 1 LPCAT1; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; RETINITIS-PIGMENTOSA; PHOTORECEPTOR DEGENERATION; REPLACEMENT THERAPY; CONE FUNCTION; RD10 MOUSE; II CELLS; MICE	Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is necessary for photoreceptors to generate an important lipid component of their membranes. The absence of LPCAT1 results in early and rapid rod and cone degeneration. Retinal degeneration 11 (rd11) mice carry a mutation in the Lpcat1 gene, and are an excellent model of early-onset rapid retinal degeneration (RD). To date, no reports have documented gene therapy administration in the rd11 mouse model at different ages. In this study, the AAV8 (Y733F)-smCBA-Lpcat1 vector was subretinally injected at postnatal day (P) 10, 14, 18, or 22. Four months after injection, immunohistochemistry and analysis of retinal morphology showed that treatment at P10 rescued about 82% of the wild-type retinal thickness. However, the diffusion of the vector and the resulting rescue were limited to an area around the injection site that was only 31% of the total retinal area. Injection at P14 resulted in vector diffusion that covered approximately 84% of the retina, and we found that gene therapy was more effective against RD when exposure to light was limited before and after treatment. We observed long-term preservation of electroretinogram (ERG) responses, and preservation of retinal structure, indicating that early treatment followed by limited light exposure can improve gene therapy effectiveness for the eyes of rd11 mice. Importantly, delayed treatment still partially preserved M-cones, but not S-cones, and M-cones in the rd11 retina appeared to have a longer window of opportunity for effective preservation with gene therapy. These results provide important information regarding the effects of subretinal gene therapy in the mouse model of LPCAT1-deficiency.	[Dai, Xufeng; Zhang, Hua; Han, Juanjuan; He, Ying; Zhang, Yangyang; Qi, Yan; Pang, Ji-Jing] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Han, Juanjuan] Shanxi Med Univ, Fenyang Coll, Fenyang, Shanxi, Peoples R China	Wenzhou Medical University; Shanxi Medical University	Dai, XF; Pang, JJ (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.	daixufeng@sohu.com; jpangoph@hotmail.com	zhang, yangyang/GZG-7467-2022		Natural Science Foundation of Zhejiang Province of China [LY15H120002]; General Scientific Research Program from Zhejiang Provincial Education Commission of China [Y201431063]; Wenzhou Municipal Science and Technology Bureau of China [Y20140352, Y20140355]; National Natural Science Foundation of China [81371060]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); General Scientific Research Program from Zhejiang Provincial Education Commission of China; Wenzhou Municipal Science and Technology Bureau of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Zhejiang Province of China (LY15H120002, http://www.zjnsf.gov.cn/b/02/fundapply/fundapply_edit.aspx?appid=GUDA9222519E7379B345F01F2BE3C7B95B5, XD), General Scientific Research Program from Zhejiang Provincial Education Commission of China (Y201431063, http://www.zjkysz.cn/left_pthy.php, XD), grants from Wenzhou Municipal Science and Technology Bureau of China (Y20140352, http://kjxm.wzkj.gov.cn/Company/report/CR_apply.aspx?type=0&id=9408, XD and Y20140355, http://kjxm.wzkj.gov.cn/Company/report/CR_apply.aspx?type=0&id=9240, HZ), the National Natural Science Foundation of China (81371060, https://isisn.nsfc.gov.cn/egrantweb/contract/index?datetimestamp=1457056907909###, JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Allocca M, 2011, INVEST OPHTH VIS SCI, V52, P5713, DOI 10.1167/iovs.10-6269; Bennett J, 1996, NAT MED, V2, P649, DOI 10.1038/nm0696-649; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Campbell JP, 2016, DEV OPHTHALMOL, V55, P317, DOI 10.1159/000434698; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cho JH, 2007, MECH DEVELOP, V124, P543, DOI 10.1016/j.mod.2007.06.001; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Dalkara D, 2011, MOL THER, V19, P1602, DOI 10.1038/mt.2011.62; Ekesten B, 2005, VISUAL NEUROSCI, V22, P893, DOI 10.1017/S0952523805226172; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Han JJ, 2013, MOL VIS, V19, P2579; Hanif AM, 2015, INVEST OPHTH VIS SCI, V56, P6839, DOI 10.1167/iovs.15-16792; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Jacobs GH, 2007, DOC OPHTHALMOL, V115, P137, DOI 10.1007/s10633-007-9055-z; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Lewis GP, 2010, MOL VIS, V16, P1361; Li WS, 2009, MOL VIS, V15, P267; Li X, 2011, INVEST OPHTH VIS SCI, V52, P7, DOI 10.1167/iovs.10-6138; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; Maddox DM, 2015, INVEST OPHTH VIS SCI, V56, P3776, DOI 10.1167/iovs.14-16047; Marangoni D, 2015, INVEST OPHTH VIS SCI, V56, P6810, DOI 10.1167/iovs.15-16866; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Park TK, 2009, GENE THER, V16, P916, DOI 10.1038/gt.2009.61; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Qi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136523; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Sun X, 2010, GENE THER, V17, P117, DOI 10.1038/gt.2009.104; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Tsai TI, 2015, J NEUROPHYSIOL, V114, P2230, DOI 10.1152/jn.00188.2015; Tummala P, 2010, MOL VIS, V16, P252; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wilson-Ashworth HA, 2004, J MEMBRANE BIOL, V200, P25, DOI 10.1007/s00232-004-0691-x; Wu J, 2015, MOL MED REP, V12, P5983, DOI 10.3892/mmr.2015.4204; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Ye GJ, 2016, HUM GENE THER CL DEV, V27, P27, DOI 10.1089/humc.2015.163; Ye GJ, 2016, HUM GENE THER, V27, P72, DOI 10.1089/hum.2015.130; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241	46	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156542	10.1371/journal.pone.0156542	http://dx.doi.org/10.1371/journal.pone.0156542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228218	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500156
J	Li, JY; Tao, XY; Li, L; Mao, LC; Luo, ZS; Khan, ZU; Ying, TJ				Li, Jiayin; Tao, Xiaoya; Li, Li; Mao, Linchun; Luo, Zisheng; Khan, Zia Ullah; Ying, Tiejin			Comprehensive RNA-Seq Analysis on the Regulation of Tomato Ripening by Exogenous Auxin	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; NAC TRANSCRIPTION FACTORS; OXIDASE GENE FAMILY; VITIS-VINIFERA L.; ETHYLENE BIOSYNTHESIS; FRUIT-DEVELOPMENT; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; LYCOPERSICON-ESCULENTUM; DIFFERENTIAL EXPRESSION; SOLANUM-LYCOPERSICON	Auxin has been shown to modulate the fruit ripening process. However, the molecular mechanisms underlying auxin regulation of fruit ripening are still not clear. Illumina RNA sequencing was performed on mature green cherry tomato fruit 1 and 7 days after auxin treatment, with untreated fruit as a control. The results showed that exogenous auxin maintained system 1 ethylene synthesis and delayed the onset of system 2 ethylene synthesis and the ripening process. At the molecular level, genes associated with stress resistance were significantly up-regulated, but genes related to carotenoid metabolism, cell degradation and energy metabolism were strongly down-regulated by exogenous auxin. Furthermore, genes encoding DNA demethylases were inhibited by auxin, whereas genes encoding cytosine-5 DNA methyltransferases were induced, which contributed to the maintenance of high methylation levels in the nucleus and thus inhibited the ripening process. Additionally, exogenous auxin altered the expression patterns of ethylene and auxin signaling-related genes that were induced or repressed in the normal ripening process, suggesting significant crosstalk between these two hormones during tomato ripening. The present work is the first comprehensive transcriptome analysis of auxin-treated tomato fruit during ripening. Our results provide comprehensive insights into the effects of auxin on the tomato ripening process and the mechanism of crosstalk between auxin and ethylene.	[Li, Jiayin; Tao, Xiaoya; Li, Li; Mao, Linchun; Luo, Zisheng; Ying, Tiejin] Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Khan, Zia Ullah] Abdul Wali Khan Univ, Dept Agr, Mardan, Khyber Pakhtunk, Pakistan	Zhejiang University; Abdul Wali Khan University	Ying, TJ (corresponding author), Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	tjying@zju.edu.cn	Li, JiaYin/N-9516-2016	Li, Jiayin/0000-0002-6532-5485	National Basic Research Program of China [2013CB127101]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Basic Research Program of China (2013CB127101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Amoros A, 2004, SCI HORTIC-AMSTERDAM, V101, P387, DOI 10.1016/j.scienta.2003.11.010; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Barry CS, 1996, PLANT J, V9, P525, DOI 10.1046/j.1365-313X.1996.09040525.x; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bottcher C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-222; Bottcher C, 2012, FUNCT PLANT BIOL, V39, P745, DOI 10.1071/FP12132; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Bu JW, 2013, POSTHARVEST BIOL TEC, V86, P337, DOI 10.1016/j.postharvbio.2013.07.026; Cao DY, 2014, GENE, V550, P230, DOI 10.1016/j.gene.2014.08.034; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chaabouni S, 2009, J EXP BOT, V60, P1349, DOI 10.1093/jxb/erp009; Chen JX, 2016, PLANTA, V243, P183, DOI 10.1007/s00425-015-2402-5; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; CURRY EA, 1993, HORTSCIENCE, V28, P115, DOI 10.21273/HORTSCI.28.2.115; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Fagundes C, 2015, POSTHARVEST BIOL TEC, V109, P73, DOI 10.1016/j.postharvbio.2015.05.017; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; George S, 2010, J PLANT PHYSIOL, V167, P311, DOI 10.1016/j.jplph.2009.09.004; Giorio G, 2008, FEBS J, V275, P527, DOI 10.1111/j.1742-4658.2007.06219.x; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hao Y., 2014, THESIS U TOULOUSE; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Jafari Z, 2013, MOL BIOL REP, V40, P1341, DOI 10.1007/s11033-012-2178-7; Jones B, 2002, PLANT J, V32, P603, DOI 10.1046/j.1365-313X.2002.01450.x; Karavangeli M, 2005, BIOMOL ENG, V22, P121, DOI 10.1016/j.bioeng.2005.03.001; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondo S, 2000, J AM SOC HORTIC SCI, V125, P242, DOI 10.21273/JASHS.125.2.242; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Li JG, 2008, J PLANT GROWTH REGUL, V27, P283, DOI 10.1007/s00344-008-9055-6; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; LINCOLN JE, 1993, J BIOL CHEM, V268, P19422; Liu KD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2182-0; Liu KD, 2005, PLANT MOL BIOL, V58, P447, DOI 10.1007/s11103-005-6505-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma QL, 2014, J EXP BOT, V65, P61, DOI 10.1093/jxb/ert344; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Muday GK, 2012, TRENDS PLANT SCI, V17, P181, DOI 10.1016/j.tplants.2012.02.001; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; Oetiker JH, 1997, PLANT MOL BIOL, V34, P275, DOI 10.1023/A:1005800511372; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sell S, 2005, DNA SEQUENCE, V16, P80, DOI 10.1080/10425170500050817; Seymour GB, 2013, ANNU REV PLANT BIOL, V64, P219, DOI 10.1146/annurev-arplant-050312-120057; Seymour GB, 2013, PLANT BIOTECHNOL J, V11, P269, DOI 10.1111/j.1467-7652.2012.00738.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092900; Shi HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089926; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Stopar M, 2001, SCI HORTIC-AMSTERDAM, V87, P65, DOI 10.1016/S0304-4238(00)00169-2; Su LY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0495-4; Symons GM, 2012, J EXP BOT, V63, P4741, DOI 10.1093/jxb/ers147; Tatsuki M, 2013, J EXP BOT, V64, P1049, DOI 10.1093/jxb/ers381; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; WANG CY, 1987, HORTSCIENCE, V22, P276; Xiang CB, 1996, PLANT MOL BIOL, V32, P415, DOI 10.1007/BF00019093; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu T, 2003, J PLANT PHYSIOL, V160, P1305, DOI 10.1078/0176-1617-01205; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhang ZJ, 2009, PLANT PHYSIOL, V150, P365, DOI 10.1104/pp.109.135830; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; ZHOU JM, 1993, PLANT MOL BIOL, V22, P517, DOI 10.1007/BF00015980; Zouine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084203	74	35	36	12	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156453	10.1371/journal.pone.0156453	http://dx.doi.org/10.1371/journal.pone.0156453			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228127	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500140
J	Patel, SK; Prabhakar, P; Jain, AK; Saggurti, N; Adhikary, R				Patel, Sangram Kishor; Prabhakar, Parimi; Jain, Anrudh Kumar; Saggurti, Niranjan; Adhikary, Rajatashuvra			Relationship between Community Collectivization and Financial Vulnerability of Female Sex Workers in Southern India	PLOS ONE			English	Article							CONDOM USE; INTERVENTION; HIV; MOBILIZATION; PREVENTION; KARNATAKA; AVAHAN; RISK	Introduction Studies exploring the linkages between financial vulnerabilities and community collectivization of female sex workers (FSWs) are scarce in India despite having potential policy implications. To fill this gap in the literature, this study attempts to understand the financial vulnerabilities among FSWs and assess the relationship between community collectivization and financial vulnerabilities in southern India. Data and Methods Data were drawn from a cross-sectional, behavioral tracking survey (BTS)-2014, conducted among FSWs (N = 2400) in Andhra Pradesh, a southern state of India under the Avahan-India AIDS initiative program. Adjusted odds ratios (AOR) and their 95% confidence intervals (CI) were estimated through multivariate logistic regression, to assess the independent relationships of the degree of community collectivization indicators with financial vulnerability indicators, adjusting for socio-demographic characteristics. Results Most FSWs (87%) reported having either one or more financial vulnerability and nearly one-fifth had a high financial vulnerability. The risk of facing financial vulnerability was significantly lower among FSWs with a high degree of perceived collective efficacy (15% vs 31%; AOR: 0.4; 95% CI: 0.3-0.5) and collective agency (4% vs 21%; AOR: 0.2; 95% CI: 0.1-0.3) as compared to their respective counterparts, after controlling for their individual socio-demographic characteristics. FSWs with a high degree of collective efficacy are also less likely to report different components of financial vulnerability (e.g. income, saving, expenditure, and debt). Conclusion This study finding suggests that community-led interventions such as improving collectivization are promising strategies to address financial vulnerabilities and a path to a sustainable reduction of HIV risk. This study calls for further evidence-based research and measurement of the effects of community-led approaches in addressing the financial vulnerabilities of the key population at risk for HIV.	[Patel, Sangram Kishor; Adhikary, Rajatashuvra] Populat Council, HIV & AIDS Program, 142 Golf Links, New Delhi, India; [Prabhakar, Parimi] India HIV AIDS Alliance, Sarovar Ctr, Secretariat Rd, Hyderabad, Andhra Pradesh, India; [Jain, Anrudh Kumar] Populat Council, 1230 York Ave, New York, NY 10021 USA; [Saggurti, Niranjan] Bill & Melinda Gates Fdn, New Delhi, India	Population Council	Patel, SK (corresponding author), Populat Council, HIV & AIDS Program, 142 Golf Links, New Delhi, India.	sangramkishor@gmail.com		Saggurti, Niranjan/0000-0002-5267-8425	Knowledge Network project of the Population Council through Avahan, its India AIDS Initiative	Knowledge Network project of the Population Council through Avahan, its India AIDS Initiative	This paper was written as part of the Knowledge Network project of the Population Council, which is a grantee of the Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation and Avahan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avahan, 2008, AV IND AIDS IN BUS H; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Blanchard JF, 2005, J INFECT DIS, V191, pS139, DOI 10.1086/425273; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Chambers R., 1997, WHOSE REALITY COUNTS; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; Fin Mark Trust, 2009, CONS FIN VULN IND S; Ford K, 2002, SEX TRANSM DIS, V29, P50, DOI 10.1097/00007435-200201000-00009; Galavotti C, 2012, J EPIDEMIOL COMMUN H, V66, pII9, DOI 10.1136/jech-2011-200465; Ghose T, 2008, SOC SCI MED, V67, P311, DOI 10.1016/j.socscimed.2008.03.045; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; India HIV/AIDS Alliance, 2014, CBOS CBGS STAT REP; India HIV/AIDS Alliance and Population Council, 2014, AV DISS M BEST PRACT; Jana S, 1995, Indian J Public Health, V39, P125; Kothari U., 2001, Participation: the new tyranny?, P139; Kuhlmann AS, 2014, AIDS BEHAV, V18, P752, DOI 10.1007/s10461-013-0626-6; Parimi P, 2012, J EPIDEMIOL COMMUN H, V66, pII62, DOI 10.1136/jech-2011-200832; Pillai P., 2012, IMPACT 2 VULNERABILI; Prabhakar P, 2014, AIDS 2014 INT C MELB; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Saggurti N, 2013, AIDS CARE, V25, pS55, DOI 10.1080/09540121.2012.749334; Souverein D, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22943; Swarup P, 2012, J EPIDEMIOL COMMUNIT, V66, pii87, DOI [10.1136/jech-2011-200478, DOI 10.1136/JECH-2011-200478]; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; UNAIDS, 2010, COMB HIV PREV TAIL C; UNAIDS, 2012, UNAIDS GUID NOT HIV; Vejella S, 2016, AIDS BEHAV, V20, P776, DOI 10.1007/s10461-015-1171-2; Wheeler T, 2012, J EPIDEMIOL COMMUN H, V66, pII16, DOI 10.1136/jech-2012-201081; Whitney Moret ASPIRES FHI 360, 2014, EC STRENGTH FEM SEX	32	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156060	10.1371/journal.pone.0156060	http://dx.doi.org/10.1371/journal.pone.0156060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227998	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500061
J	Verroken, A; Defourny, L; de Waroux, OL; Belkhir, L; Laterre, PF; Delmee, M; Glupczynski, Y				Verroken, Alexia; Defourny, Lydwine; de Waroux, Olivier le Polain; Belkhir, Leila; Laterre, Pierre-Francois; Delmee, Michel; Glupczynski, Youri			Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; BETA-LACTA TEST; TIME; INFECTIONS; BACTEREMIA; RESISTANCE; SYSTEM	Shortening the turn-around time (TAT) of positive blood culture (BC) identification (ID) and susceptibility results is essential to optimize antimicrobial treatment in patients with sepsis. We aimed to evaluate the impact on antimicrobial prescription of a modified workflow of positive BCs providing ID and partial susceptibility results for Enterobacteriaceae (EB), Pseudomonas aeruginosa and Staphylococcus aureus on the day of BC positivity detection. This study was divided into a pre-intervention period (P0) with a standard BC workflow followed by 2 intervention periods (P1, P2) with an identical modified workflow. ID was performed with MALDI-TOF MS from blood, on early or on overnight subcultures. According to ID results, rapid phenotypic assays were realized to detect third generation cephalosporin resistant EB/P. aeruginosa or methicillin resistant S. aureus. Results were transmitted to the antimicrobial stewardship team for patient's treatment revision. Times to ID, to susceptibility results and to optimal antimicrobial treatment (OAT) were compared across the three study periods. Overall, 134, 112 and 154 positive BC episodes in P0, P1 and P2 respectively were included in the analysis. Mean time to ID (28.3 hours in P0) was reduced by 65.3% in P1 (10.2 hours) and 61.8% in P2 (10.8 hours). Mean time to complete susceptibility results was reduced by 27.5% in P1 and 27% in P2, with results obtained after 32.4 and 32.6 hours compared to 44.7 hours in P0. Rapid tests allowed partial susceptibility results to be obtained after a mean time of 11.8 hours in P1 and 11.7 hours in P2. Mean time to OAT was decreased to 21.6 hours in P1 and to 17.9 hours in P2 compared to 36.1 hours in P0. Reducing TAT of positive BC with MALDI-TOF MS ID and rapid susceptibility testing accelerated prescription of targeted antimicrobial treatment thereby potentially improving the patients' clinical outcome.	[Verroken, Alexia; Delmee, Michel] Catholic Univ Louvain, IREC, Pole Microbiol MBLG, B-1200 Brussels, Belgium; [Verroken, Alexia; Defourny, Lydwine; Delmee, Michel] Catholic Univ Louvain, Lab Microbiol, Clin Univ St Luc, B-1200 Brussels, Belgium; [de Waroux, Olivier le Polain] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Belkhir, Leila] Catholic Univ Louvain, Clin Univ St Luc, Dept Med Interne & Pathol Infect, B-1200 Brussels, Belgium; [Laterre, Pierre-Francois] Catholic Univ Louvain, Clin Univ St Luc, Dept Soins Intensifs, B-1200 Brussels, Belgium; [Glupczynski, Youri] CHU UCL Namur, Natl Reference Ctr Monitoring Antimicrobial Resis, Yvoir, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of London; London School of Hygiene & Tropical Medicine; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Verroken, A (corresponding author), Catholic Univ Louvain, IREC, Pole Microbiol MBLG, B-1200 Brussels, Belgium.; Verroken, A (corresponding author), Catholic Univ Louvain, Lab Microbiol, Clin Univ St Luc, B-1200 Brussels, Belgium.	alexia.verroken@uclouvain.be		le Polain de Waroux, Olivier/0000-0003-3458-2945; Verroken, Alexia/0000-0001-5486-964X				Beekmann SE, 2003, J CLIN MICROBIOL, V41, P3119, DOI 10.1128/JCM.41.7.3119-3125.2003; Beuving J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-156; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Bogaerts P, 2013, J ANTIMICROB CHEMOTH, V68, P1576, DOI 10.1093/jac/dkt065; Bogaerts P, 2007, J ANTIMICROB CHEMOTH, V59, P459, DOI 10.1093/jac/dkl527; Centers for Disease Control and Prevention, CS257671C CDCP NAT C; Centers for Disease Control and Prevention, NAT HEALTHC SAF NETW; Clerc O, 2013, CLIN INFECT DIS, V56, P1101, DOI 10.1093/cid/cis1204; Deresinski S, 2007, CLIN INFECT DIS, V45, pS177, DOI 10.1086/519472; Dortet L, 2014, CLIN MICROBIOL INFEC, V20, P340, DOI 10.1111/1469-0691.12318; Eigner U, 2009, CLIN LAB, V55, P289; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Eveillard M, 2010, CLIN MICROBIOL INFEC, V16, P1084, DOI 10.1111/j.1469-0691.2009.03044.x; Heraud S, 2015, ANN LAB MED, V35, P454, DOI 10.3343/alm.2015.35.4.454; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kohlmann R, 2015, INT J MED MICROBIOL, V305, P469, DOI 10.1016/j.ijmm.2015.04.004; Laurent T, 2013, J CLIN MICROBIOL, V51, P1951, DOI 10.1128/JCM.00524-13; Martiny D, 2013, CLIN MICROBIOL INFEC, V19, pE568, DOI 10.1111/1469-0691.12282; Morgenthaler Nils G, 2015, Int J Microbiol, V2015, P827416, DOI 10.1155/2015/827416; Renvoise A, 2013, J CLIN MICROBIOL, V51, P4012, DOI 10.1128/JCM.01936-13; Verroken A, 2015, EUR J CLIN MICROBIOL, V34, P405, DOI 10.1007/s10096-014-2242-4; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589; Walewski V, 2015, DIAGN MICR INFEC DIS, V83, P216, DOI 10.1016/j.diagmicrobio.2015.07.005	24	55	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156299	10.1371/journal.pone.0156299	http://dx.doi.org/10.1371/journal.pone.0156299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228001	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500106
J	Wu, YY; Kumar, R; Iida, R; Bagavant, H; Alarcon-Riquelme, ME				Wu, Ying-Yu; Kumar, Ramesh; Iida, Ryuji; Bagavant, Harini; Alarcon-Riquelme, Marta E.			BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; B-CELL RESPONSES; AUTOANTIBODY PRODUCTION; SYSTEMIC AUTOIMMUNITY; MURINE LUPUS; ERYTHEMATOSUS; DISEASE; MICE; TLR7; EXPRESSION	The purpose of our study was to investigate the effects of the adaptor Bank1 in TLR7 signaling using the B6.Sle1.yaa mouse, a lupus model that develops disease through exacerbated TLR7 expression. Crosses of B6.Sle1.yaa with Bank1(-/-) mice maintained several B and myeloid cell phenotypes close to normal wild-type levels. Most striking was the reduction in total serum IgG antibodies, but not of IgM, and reduced serum levels of autoantibodies, IL-6, and BAFF. Bank1 deficiency did modify numbers of MZ B cells and total B cell numbers, as well as expression of CXCR4 by follicular helper T cells. Other T cell changes were not observed. Bank1 deficiency did not modify numbers of germinal center B cells or plasma cells or clinical disease outcomes. Purified B cells from Bank1 deficient mice had strongly reduced Ifnb, Ifna4, Irf7, Aicda and Stat1 gene expression following TLR7 agonist stimulation. Interestingly, phosphorylation of Tyr701, but not of Ser727 of STAT1, was impaired in splenic B cells from B6.Sle1.yaa. Bank1(-/-) mice, as was the nuclear translocation of IRF7 in response to TLR7 agonist stimulation. Further, Bank1 deficiency in B6. Sle1. yaa mice reduced the production of IgG2c after in vitro TLR7 agonist stimulation. Our results demonstrate that Bank1 controls TLR7-mediated type I interferon production. Combined with the control of the nuclear translocation of IRF7, the modulation of STAT1 transcription and phosphorylation, Bank1 contributes to IgG production during development of autoimmune disease.	[Wu, Ying-Yu; Kumar, Ramesh; Iida, Ryuji; Bagavant, Harini; Alarcon-Riquelme, Marta E.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Alarcon-Riquelme, Marta E.] Univ Granada, Dept Med Genom, Andalusian Govt Ctr Genom & Oncol Res GENYO, Pfizer, Granada 18016, Spain; [Iida, Ryuji] Natl Inst Biomed Innovat, Hlth & Nutr Lab Cell Cultures, Osaka 5670085, Japan	Oklahoma Medical Research Foundation; Pfizer; University of Granada; National Institute of Health Sciences - Japan	Alarcon-Riquelme, ME (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	marta.alarcon@genyo.es	Bagavant, Harini/V-7735-2019; Alarcón-Riquelme, Marta E./ABF-8163-2020; Kumar, Ramesh/U-8358-2019; Kumar, Ramesh/A-8258-2019	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; 	Alliance for Lupus Research; National Institutes of Health COBRE [GM103456-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456] Funding Source: NIH RePORTER	Alliance for Lupus Research; National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Alliance for Lupus Research to MEAR (www.lupusresearch.org < http://www.lupusresearch.org >) and National Institutes of Health COBRE grant GM103456-09 to Pat Gaffney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Marta E. Alarcon-Riquelme works at the Pfizer/University of Granada/Andalusian Government Center for Genomics and Oncological Research (GENYO) as an employee of the Fundacion Publica Andaluza Progreso y Salud of the Andalusian Government. Pfizer/University of Granada/Andalusian Government Center for Genomics and Oncological Research (GENYO) did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Davidson A, 2012, CURR RHEUMATOL REP, V14, P295, DOI 10.1007/s11926-012-0258-2; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P3447, DOI 10.1002/art.24885; Elsner RA, 2012, J VIROL, V86, P7146, DOI 10.1128/JVI.06904-11; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Green NM, 2009, J IMMUNOL, V183, P1569, DOI 10.4049/jimmunol.0803899; Nguyen HV, 2012, BLOOD, V119, P4174, DOI 10.1182/blood-2011-09-378182; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Liu Z, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00306; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Maeda K, 2009, BLOOD, V113, P4534, DOI 10.1182/blood-2008-12-192559; Maier-Moore JS, 2014, ARTHRITIS RHEUMATOL, V66, P2521, DOI 10.1002/art.38716; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Pan ZJ, 2010, ANN RHEUM DIS, V69, P1195, DOI 10.1136/ard.2009.108282; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rozco G, 2009, ARTHRITIS RHEUM, V60, P372, DOI 10.1002/art.24244; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P339, DOI 10.1016/j.jaut.2009.11.001; Stohl W, 2005, ARTHRITIS RHEUM-US, V52, P2080, DOI 10.1002/art.21138; Suarez-Gestal M, 2009, ARTHRITIS RHEUM-US, V60, P2558, DOI 10.1002/art.24748; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tangye SG, 2015, CURR OPIN IMMUNOL, V34, P107, DOI 10.1016/j.coi.2015.02.010; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Walsh ER, 2012, P NATL ACAD SCI USA, V109, P16276, DOI 10.1073/pnas.1209372109; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Wu YY, 2013, J IMMUNOL, V191, P6110, DOI 10.4049/jimmunol.1301203; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83; Zhang ZP, 2012, MOL IMMUNOL, V50, P169, DOI 10.1016/j.molimm.2011.11.006	44	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156302	10.1371/journal.pone.0156302	http://dx.doi.org/10.1371/journal.pone.0156302			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228057	Green Submitted, gold, Green Published			2022-12-26	WOS:000376882500107
J	Sokol, B; Wasik, N; Jankowski, R; Holysz, M; Wieckowska, B; Jagodzinski, P				Sokol, Bartosz; Wasik, Norbert; Jankowski, Roman; Holysz, Marcin; Wieckowska, Barbara; Jagodzinski, Pawel			Soluble Toll-Like Receptors 2 and 4 in Cerebrospinal Fluid of Patients with Acute Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage	PLOS ONE			English	Article							EARLY BRAIN-INJURY; EXPRESSION; VASOSPASM; PROTEIN	Background Toll-like receptor (TLR) signalling begins early in subarachnoid haemorrhage (SAH), and plays a key role in inflammation following cerebral aneurysm rupture. Available studies suggest significance of endogenous first-line blockers of a TLR pathway-soluble TLR2 and 4. Methods Eighteen patients with SAH and acute hydrocephalus underwent endovascular coiling and ventriculostomy; sTLR2 and 4 levels were assayed in cerebrospinal fluid (CSF) collected on post-SAH days 0-3, 5, and 10-12. Release kinetics were defined. CSF levels of sTLR2 and 4 were compared with a control group and correlated with the clinical status on admission, the findings on imaging, the degree of systemic inflammation and the outcome following treatment. Results None of study group showed detectable levels of sTLR2 and 4 on post-SAH day 0-3. 13 patients showed increased levels in subsequent samples. In five SAH patients sTLR2 and 4 levels remained undetectable; no distinctive features of this group were found. On post-SAH day 5 the strongest correlation was found between sTLR2 level and haemoglobin level on admission (cc = -0.498, P = 0.037). On post-SAH day 10-12 the strongest correlation was revealed between sTLR2 and treatment outcome (cc = -0.501, P = 0.076). Remaining correlations with treatment outcome, status at admission, imaging findings and inflammatory markers on post-SAH day 5 and 10-12 were negligible or low (-0.5 <= cc <= 0.5). Conclusions In the majority of cases, rupture of a cerebral aneurysm leads to delayed release of soluble TLR forms into CSF. sTLR2 and 4 seem to have minor role in human post-SAH inflammation due to delayed release kinetics and low levels of these protein.	[Sokol, Bartosz; Wasik, Norbert; Jankowski, Roman] Poznan Univ Med Sci, Dept Neurosurg, Poznan, Poland; [Holysz, Marcin; Jagodzinski, Pawel] Poznan Univ Med Sci, Dept Biochem & Mol Biol, Poznan, Poland; [Wieckowska, Barbara] Poznan Univ Med Sci, Dept Comp Sci & Stat, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Wasik, N (corresponding author), Poznan Univ Med Sci, Dept Neurosurg, Poznan, Poland.	norbertwasik@gmail.com	Hołysz, Marcin/N-5411-2018	Hołysz, Marcin/0000-0003-2505-3582; Wasik, Norbert/0000-0003-4588-7787; Sokol, Bartosz/0000-0003-4814-2000; Jankowski, Roman/0000-0002-2368-4578; Wieckowska, Barbara/0000-0002-1811-2583; Jagodzinski, Pawel/0000-0002-9046-6802	Poznan University of Medical Sciences [502-01-011221178-03549]	Poznan University of Medical Sciences	This work was supported by the Poznan University of Medical Sciences grant (number 502-01-011221178-03549) received by Dr. Bartosz Sokol (URL: http://www.ump.edu.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrys C, 2013, J MATERN-FETAL NEO M, V26, P520, DOI 10.3109/14767058.2012.741634; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Galliera E, 2014, J CLIN MICROBIOL, V52, P620, DOI 10.1128/JCM.02727-13; Germano A, 2000, ACTA NEUROCHIR, V142, P575, DOI 10.1007/s007010050472; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Hopkins SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-255; Houssen ME, 2016, INT J RHEUM DIS, V19, P685, DOI 10.1111/1756-185X.12452; Johnson-Greene D, 2010, J HEAD TRAUMA REHAB, V25, P145, DOI 10.1097/HTR.0b013e3181d8287d; Kondelkova K, 2014, INT J DERMATOL, V53, pE512, DOI 10.1111/ijd.12381; Kurki MI, 2011, NEUROSURGERY, V68, P1667, DOI 10.1227/NEU.0b013e318210f001; Kuroishi T, 2007, MOL IMMUNOL, V44, P1969, DOI 10.1016/j.molimm.2006.09.028; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Ma CX, 2009, CHINESE MED J-PEKING, V122, P1575, DOI 10.3760/cma.j.issn.0366-6999.2009.13.019; Moraes L, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0970-2; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nakahara T, 2009, NEUROCRIT CARE, V11, P362, DOI 10.1007/s12028-009-9276-y; Pastorelli L, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/189341; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pluta RM, 1998, J NEUROSURG, V88, P557, DOI 10.3171/jns.1998.88.3.0557; Rabinstein AA, 2011, LANCET NEUROL, V10, P593, DOI 10.1016/S1474-4422(11)70122-3; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sarrafzadeh AS, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00134; Schneider U, 2015, ACTA NEUROPATHOL, V130, P215, DOI 10.1007/s00401-015-1440-1; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Sun Q, 2013, BRAIN RES, V1520, P134, DOI 10.1016/j.brainres.2013.05.010; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Ten Oever J, 2014, BMC IMMUNOL, V15, P55, DOI [10.1186/s12865-014-0055-y, DOI 10.1186/S12865-014-0055-Y]; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290; Zhang TT, 2014, INT IMMUNOPHARMACOL, V23, P585, DOI 10.1016/j.intimp.2014.10.009; Zhou ML, 2007, INFLAMM RES, V56, P93, DOI 10.1007/s00011-006-6035-9	34	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156171	10.1371/journal.pone.0156171	http://dx.doi.org/10.1371/journal.pone.0156171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223696	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700068
J	Cheung, KT; Fairley, CK; Read, TRH; Denham, I; Fehler, G; Bradshaw, CS; Chen, MY; Chow, EPF				Cheung, King T.; Fairley, Christopher K.; Read, Tim R. H.; Denham, Ian; Fehler, Glenda; Bradshaw, Catriona S.; Chen, Marcus Y.; Chow, Eric P. F.			HIV Incidence and Predictors of Incident HIV among Men Who Have Sex with Men Attending a Sexual Health Clinic in Melbourne, Australia	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; RISK-FACTORS; COST-EFFECTIVENESS; HOMOSEXUAL-MEN; UNITED-STATES; INFECTION; PREVALENCE; VALIDATION; DERIVATION; SCORE	Introduction The aim of this study was to determine the risk factors for HIV infection and the incidence in men who have sex with men (MSM). It is important to identify subgroups of MSM in which preventive interventions such as pre-exposure prophylaxis (PrEP) offered at the time of their last negative test would be considered cost-effective. Methods We conducted a retrospective cohort study of MSM attending Melbourne Sexual Health Centre (MSHC) during 2007-2013 with at least two HIV tests within 12 months of each other. Demographic characteristics, sexual and other behaviours, and bacterial sexually transmitted infection (STI) diagnoses were extracted from the date of the last negative HIV test. HIV incidence rate (IR) per 100 person-years for each risk factor was calculated. Results Of the 13907 MSM who attended MSHC, 5256 MSM had at least two HIV tests and were eligible, contributing 6391 person-years follow-up. 81 new HIV diagnoses were identified within 12 months of an HIV negative test with an incidence of 1.3 (95% CI: 1.0-1.6) per 100 person-years. Significant associations with subsequent HIV infection were: rectal gonorrhea (HIV IR: 3.4 95% CI: 2.1-5.2), rectal chlamydia (HIV IR: 2.6 95% CI: 1.7-3.7), inconsistent condom use (HIV IR: 2.1 95% CI: 1.6-2.7), use of post-exposure prophylaxis (HIV IR: 2.3 95% CI: 1.7-3.1), and injecting drug use (HIV IR: 8.5 95% CI: 3.4-17.5). Conclusion The incidence of HIV was above 2.0% in subgroups of MSM with specific characteristics at the last HIV negative test. PrEP is considered cost effective at this incidence and could potentially be used along with other preventive interventions for these individuals in more than half of the population.	[Cheung, King T.; Fairley, Christopher K.; Read, Tim R. H.; Denham, Ian; Fehler, Glenda; Bradshaw, Catriona S.; Chen, Marcus Y.; Chow, Eric P. F.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Cheung, King T.] Univ Melbourne, Melbourne Med Sch, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Fairley, Christopher K.; Read, Tim R. H.; Bradshaw, Catriona S.; Chen, Marcus Y.; Chow, Eric P. F.] Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia	University of Melbourne; Monash University	Chow, EPF (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Chow, EPF (corresponding author), Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia.	Echow@mshc.org.au	Chow, Eric P.F./W-6684-2019; Chow, Eric Pui Fung/H-3196-2013	Chow, Eric P.F./0000-0003-1766-0657; Chow, Eric Pui Fung/0000-0003-1766-0657; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678	Australian National Health and Medical Research Council (NHMRC) [568971]; NHMRC [1091226, 1091536]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) program grant (number 568971). The NHMRC also supports EPFC and TRHR with Early Career Fellowships (EPFC [number 1091226]; TRHR [number 1091536]).	Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Chow EPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103081; Giuliani M, 2014, EUROSURVEILLANCE, V19, P20969, DOI DOI 10.2807/1560-7917.ES2014.19.47.20969; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Haukoos JS, 2012, AM J EPIDEMIOL, V175, P838, DOI 10.1093/aje/kwr389; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Jia ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11205; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Katz D, 2014, 2014 STD PREV C ATL; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Meireles P, 2015, EURO SURVEILL, V20; Morin SF, 2012, BMJ, V345; Muraguri N, 2015, JAIDS-J ACQ IMM DEF, V68, P91, DOI 10.1097/QAI.0000000000000368; Ooi C, 2007, AUST PRESCR, V30, P8; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Prestage G, 2008, SEX HEALTH, V5, P97, DOI 10.1071/SH07080; Queensland Health Clinical Practice Improvement Centre, 2009, QUEENSL SEX HLTH CLI; Read TRH, 2007, SEX HEALTH, V4, P35, DOI 10.1071/SH06043; Rosenberg ES, 2012, AM J EPIDEMIOL, V176, P567, DOI 10.1093/aje/kws305; STI's in Gay Men Action Group (STIGMA), 2010, SEX TRANSM INF TEST; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; Xu JJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-3	25	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156160	10.1371/journal.pone.0156160	http://dx.doi.org/10.1371/journal.pone.0156160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219005	Green Published, gold			2022-12-26	WOS:000376880700047
J	Bali, V; Lazrak, A; Guroji, P; Matalon, S; Bebok, Z				Bali, Vedrana; Lazrak, Ahmed; Guroji, Purushotham; Matalon, Sadis; Bebok, Zsuzsanna			Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PHE508DEL CFTR; WILD-TYPE; PROTEIN; EXPRESSION; VX-809; DEFECT; GENE; IDENTIFICATION; DEGRADATION	The most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene leads to deletion of the phenylalanine at position 508 (Delta F508) in the CFTR protein and causes multiple folding and functional defects. Contrary to large-scale efforts by industry and academia, no significant therapeutic benefit has been achieved with a single "corrector". Therefore, investigations concentrate on drug combinations. Orkambi (Vertex Pharmaceuticals), the first FDA-approved drug for treatment of cystic fibrosis (CF) caused by this mutation, is a combination of a corrector (VX-809) that facilitates Delta F508 CFTR biogenesis and a potentiator (VX-770), which improves its function. Yet, clinical trials utilizing this combination showed only modest therapeutic benefit. The low efficacy Orkambi has been attributed to VX-770-mediated destabilization of VX-809-rescued Delta F508 CFTR. Here we report that the negative effects of VX-770 can be reversed by increasing the half-life of the endoplasmic reticulum (ER) form (band B) of Delta F508 CFTR with another corrector (Corr-4a.) Although Corr-4a alone has only minimal effects on Delta F508 CFTR rescue, it increases the half-life of Delta F508 CFTR band B when it is present during half-life measurements. Our data shows that stabilization of band B Delta F508 CFTR with Corr-4a and simultaneous rescue with VX-809, leads to a >2-fold increase in cAMP-activated, CFTRinh-172-inhibited currents compared to VX-809 alone, or VX-809+VX-770. The negative effects of VX-770 and the Corr-4a protection are specific to the native I507-ATT Delta F508 CFTR without affecting the inherently more stable, synonymous variant I507-ATC Delta F508 CFTR. Our studies emphasize that stabilization of Delta F508 CFTR band B in the ER might improve its functional rescue by Orkambi.	[Bali, Vedrana; Guroji, Purushotham; Bebok, Zsuzsanna] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Guroji, Purushotham; Matalon, Sadis; Bebok, Zsuzsanna] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL USA; [Lazrak, Ahmed; Matalon, Sadis; Bebok, Zsuzsanna] Univ Alabama Birmingham, Lung Injury & Repair Res Ctr, Birmingham, AL USA; [Bali, Vedrana] Michigan State Univ, Dept Physiol, Biomed Phys Sci Bldg E 567 Wilson Rd Rm 3115, E Lansing, MI 48824 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Michigan State University	Bebok, Z (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA.; Bebok, Z (corresponding author), Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL USA.; Bebok, Z (corresponding author), Univ Alabama Birmingham, Lung Injury & Repair Res Ctr, Birmingham, AL USA.	bebok@uab.edu		Guroji, Purushotham/0000-0001-9331-5711; Lazrak, Ahmed/0000-0002-4127-1937; , Vedrana/0000-0002-8881-8717	National Institutes of Health [2R01-HL076587, P30 DK072482]; Cystic Fibrosis Foundation [BEBOK14P0]; CounterACT Program; National Institute of Neurological Disorders and Stroke [5R21 ES024027 02, 1R21ES025423 01]; National Institute of Environmental Health Sciences [1UO1 ES026458, 5R21 ES025423]; National Institutes of Health (NIH) [2R01-HL076587, P30 DK072482, CFF BEBOK14P0]; NIH Office of the Director (NIH OD) from the National Institute of Environmental Health Sciences [5R21 ES024027 02, 1R21ES025423 01, 1UO1 ES026458, 5R21 ES025423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024027, U01ES026458, R21ES025423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); CounterACT Program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of the Director (NIH OD) from the National Institute of Environmental Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by 2R01-HL076587, National Institutes of Health ZsB; P30 DK072482, National Institutes of Health, PG; BEBOK14P0, Cystic Fibrosis Foundation, ZsB; the CounterACT Program; 5R21 ES024027 02, National Institute of Neurological Disorders and Stroke, SM; 1R21ES025423 01, National Institute of Neurological Disorders and Stroke, SM; 1UO1 ES026458, National Institute of Environmental Health Sciences, SM; and 5R21 ES025423, National Institute of Environmental Health Sciences, SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jim Collawn for the critical reading of the manuscript and Mrs. Nancy Brissie for her excellent technical assistance. Supported by: National Institutes of Health (NIH) 2R01-HL076587 (Bebok), P30 DK072482 (Guroji), and CFF BEBOK14P0 (Bebok), the CounterACT Program, NIH Office of the Director (NIH OD), (5R21 ES024027 02, 1R21ES025423 01, 1UO1 ES026458 and 5R21 ES025423 (Matalon) from the National Institute of Environmental Health Sciences,	Bali V, 2016, FASEB J, V30, P201, DOI 10.1096/fj.15-273714; Bali V, 2015, INT J BIOCHEM CELL B, V64, P58, DOI 10.1016/j.biocel.2015.03.011; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Brodsky JL, 2015, CELL, V163, P17, DOI 10.1016/j.cell.2015.09.003; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068001; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Clancy JP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009674; Farinha CM, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.152; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mayor Susan, 2015, BMJ, V350, ph2689, DOI 10.1136/bmj.h2689; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Pesce E, 2015, EUR J MED CHEM, V99, P14, DOI 10.1016/j.ejmech.2015.05.030; Phuan PW, 2015, MOL PHARMACOL, V88, P791, DOI 10.1124/mol.115.099689; Phuan PW, 2014, MOL PHARMACOL, V86, P42, DOI 10.1124/mol.114.092478; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roberts KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002477; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Shah K, 2015, J MOL BIOL, V427, P1464, DOI 10.1016/j.jmb.2015.02.003; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; WARD CL, 1994, J BIOL CHEM, V269, P25710; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Yang H, 2015, EXPERT OPIN THER PAT, V25, P991, DOI 10.1517/13543776.2015.1045878; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	38	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155882	10.1371/journal.pone.0155882	http://dx.doi.org/10.1371/journal.pone.0155882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214033	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200028
J	He, TX; Wang, QK; Wang, SL; Zhang, FY				He, Tongxin; Wang, Qingkui; Wang, Silong; Zhang, Fangyue			Nitrogen Addition Altered the Effect of Belowground C Allocation on Soil Respiration in a Subtropical Forest	PLOS ONE			English	Article							MICROBIAL COMMUNITY COMPOSITION; ORGANIC-CARBON MINERALIZATION; TEMPERATE FOREST; NUTRIENT ADDITIONS; ROOT RESPIRATION; LABILE CARBON; COMPONENTS; FERTILIZATION; TREES; BIOMASS	The availabilities of carbon (C) and nitrogen (N) in soil play an important role in soil carbon dioxide (CO2) emission. However, the variation in the soil respiration (R-s) and response of microbial community to the combined changes in belowground C and N inputs in forest ecosystems are not yet fully understood. Stem girdling and N addition were performed in this study to evaluate the effects of C supply and N availability on R-s and soil microbial community in a subtropical forest. The trees were girdled on 1 July 2012. R-s was monitored from July 2012 to November 2013, and soil microbial community composition was also examined by phospholipid fatty acids (PLFAs) 1 year after girdling. Results showed that R-s decreased by 40.5% with girdling alone, but N addition only did not change R-s. Interestingly, R-s decreased by 62.7% under the girdling with N addition treatment. The reducing effect of girdling and N addition on R-s differed between dormant and growing seasons. Girdling alone reduced R-s by 33.9% in the dormant season and 54.8% in the growing season compared with the control. By contrast, girdling with N addition decreased R-s by 59.5% in the dormant season and 65.4% in the growing season. Girdling and N addition significantly decreased the total and bacterial PLFAs. Moreover, the effect of N addition was greater than girdling. Both girdling and N addition treatments separated the microbial groups on the basis of the first principal component through principal component analysis compared with control. This indicated that girdling and N addition changed the soil microbial community composition. However, the effect of girdling with N addition treatment separated the microbial groups on the basis of the second principal component compared to N addition treatment, which suggested N addition altered the effect of girdling on soil microbial community composition. These results suggest that the increase in soil N availability by N deposition alters the effect of belowground C allocation on the decomposition of soil organic matter by altering the composition of the soil microbial community.	[He, Tongxin; Wang, Qingkui; Wang, Silong; Zhang, Fangyue] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [He, Tongxin; Zhang, Fangyue] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Qingkui; Wang, Silong] Huitong Natl Res Stn Forest Ecosyst, Huitong, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, QK (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China.; Wang, QK (corresponding author), Huitong Natl Res Stn Forest Ecosyst, Huitong, Peoples R China.	wqkui@163.com		Zhang, Fangyue/0000-0002-5479-6214	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB15010301]; National Natural Science Foundation of China [31570466]; National Basic Research Program of China [2012CB416905]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant no. XDB15010301), the National Natural Science Foundation of China (grant No. 31570466), and the National Basic Research Program of China (Grant no. 2012CB416905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102765; BhupinderpalSingh, 2003, PLANT CELL ENVIRON, V26, P1287, DOI 10.1046/j.1365-3040.2003.01053.x; Binkley D, 2006, OECOLOGIA, V148, P447, DOI 10.1007/s00442-006-0383-6; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Bradford MA, 2008, FUNCT ECOL, V22, P964, DOI 10.1111/j.1365-2435.2008.01404.x; Chen DM, 2012, APPL SOIL ECOL, V53, P108, DOI 10.1016/j.apsoil.2011.10.014; Chen DM, 2010, PLANT SOIL, V326, P123, DOI 10.1007/s11104-009-9986-0; Cleveland CC, 2007, BIOGEOCHEMISTRY, V82, P229, DOI 10.1007/s10533-006-9065-z; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Crow SE, 2009, GLOBAL CHANGE BIOL, V15, P2003, DOI 10.1111/j.1365-2486.2009.01850.x; Dannenmann M, 2009, SOIL BIOL BIOCHEM, V41, P1622, DOI 10.1016/j.soilbio.2009.04.024; Demoling F, 2008, SOIL BIOL BIOCHEM, V40, P370, DOI 10.1016/j.soilbio.2007.08.019; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; EDWARDS NT, 1979, OECOLOGIA, V40, P247, DOI 10.1007/BF00345322; Franklin O, 2003, ECOSYSTEMS, V6, P644, DOI 10.1007/s10021-002-0149-x; Frey B, 2006, FOREST ECOL MANAG, V225, P271, DOI 10.1016/j.foreco.2006.01.003; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gallo M, 2004, MICROB ECOL, V48, P218, DOI 10.1007/s00248-003-9001-x; Gao Q, 2014, SOIL BIOL BIOCHEM, V76, P297, DOI 10.1016/j.soilbio.2014.04.020; Garcia-Pausas J, 2011, SOIL BIOL BIOCHEM, V43, P1705, DOI 10.1016/j.soilbio.2011.04.016; Giardina CP, 2003, GLOBAL CHANGE BIOL, V9, P1438, DOI 10.1046/j.1365-2486.2003.00558.x; Hasselquist NJ, 2012, GLOBAL CHANGE BIOL, V18, P3596, DOI 10.1111/gcb.12001; Heath J, 2005, SCIENCE, V309, P1711, DOI 10.1126/science.1110700; Hogberg MN, 2003, NEW PHYTOL, V160, P225, DOI 10.1046/j.1469-8137.2003.00867.x; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 2002, OECOLOGIA, V132, P579, DOI 10.1007/s00442-002-0983-8; Hogberg P, 2009, FOREST ECOL MANAG, V257, P1764, DOI 10.1016/j.foreco.2009.01.036; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Jia SX, 2010, PLANT SOIL, V333, P325, DOI 10.1007/s11104-010-0348-8; Jordan MO, 1998, J PLANT NUTR, V21, P2441, DOI 10.1080/01904169809365576; Kaiser C, 2010, NEW PHYTOL, V187, P843, DOI 10.1111/j.1469-8137.2010.03321.x; Keeney DR., 1982, METHODS SOIL ANAL PA, DOI 10.2134/agronmonogr9.2.2ed.c33; Lee KH, 2003, FOREST ECOL MANAG, V185, P263, DOI 10.1016/S0378-1127(03)00164-6; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Luo Yand, 2006, SOIL RESP ENV; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Murugan R, 2014, SOIL BIOL BIOCHEM, V76, P257, DOI 10.1016/j.soilbio.2014.05.022; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Peacock AD, 2001, SOIL BIOL BIOCHEM, V33, P1011, DOI 10.1016/S0038-0717(01)00004-9; Phillips RP, 2007, NEW PHYTOL, V176, P655, DOI 10.1111/j.1469-8137.2007.02204.x; Rousk J, 2007, FEMS MICROBIOL ECOL, V62, P258, DOI 10.1111/j.1574-6941.2007.00398.x; Sampedro L, 2006, SOIL BIOL BIOCHEM, V38, P2188, DOI 10.1016/j.soilbio.2006.02.001; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Subke JA, 2004, OECOLOGIA, V139, P551, DOI 10.1007/s00442-004-1540-4; Subke JA, 2011, J ECOL, V99, P186, DOI 10.1111/j.1365-2745.2010.01740.x; Sun JF, 2016, SOIL SCI, V181, P29, DOI 10.1097/SS.0000000000000134; Sun ZZ, 2014, AGR FOREST METEOROL, V197, P103, DOI 10.1016/j.agrformet.2014.06.010; Treonis AM, 2004, SOIL BIOL BIOCHEM, V36, P533, DOI 10.1016/j.soilbio.2003.10.015; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9; Wan XH, 2015, PLANT SOIL, V387, P103, DOI 10.1007/s11104-014-2277-4; Wang QK, 2014, SOIL BIOL BIOCHEM, V72, P145, DOI 10.1016/j.soilbio.2014.01.020; Wang QK, 2014, SOIL BIOL BIOCHEM, V71, P13, DOI 10.1016/j.soilbio.2014.01.004; Wang QK, 2013, AGR FOREST METEOROL, V178, P152, DOI 10.1016/j.agrformet.2013.04.021; Weintraub MN, 2007, OECOLOGIA, V154, P327, DOI 10.1007/s00442-007-0804-1; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Yarwood SA, 2009, FEMS MICROBIOL ECOL, V70, P151, DOI 10.1111/j.1574-6941.2009.00733.x; Zhang CP, 2014, SOIL BIOL BIOCHEM, V75, P113, DOI 10.1016/j.soilbio.2014.04.013; Zhou LY, 2014, GLOBAL CHANGE BIOL, V20, P2332, DOI 10.1111/gcb.12490	68	6	7	6	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155881	10.1371/journal.pone.0155881	http://dx.doi.org/10.1371/journal.pone.0155881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213934	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200027
J	Lorenz, N; Reiger, M; Toro-Nahuelpan, M; Brachmann, A; Poettinger, L; Plener, L; Lassak, J; Jung, K				Lorenz, Nicola; Reiger, Matthias; Toro-Nahuelpan, Mauricio; Brachmann, Andreas; Poettinger, Lisa; Plener, Laure; Lassak, Juergen; Jung, Kirsten			Identification and Initial Characterization of Prophages in Vibrio campbellii	PLOS ONE			English	Article							ESCHERICHIA-COLI; REAL-TIME; MILKY SEA; HARVEYI; INDUCTION; BACTERIOPHAGE; CHOLERAE; GENOME; BIOLUMINESCENCE; CONSTRUCTION	Phages are bacteria targeting viruses and represent the most abundant biological entities on earth. Marine environments are exceptionally rich in bacteriophages, harboring a total of 4x10(30) viruses. Nevertheless, marine phages remain poorly characterized. Here we describe the identification of intact prophage sequences in the genome of the marine gamma-proteobacterium Vibrio campbellii ATCC BAA-1116 (formerly known as V. harveyi ATCC BAA-1116), which presumably belong to the family of Myoviridae. One prophage was found on chromosome I and shows significant similarities to the previously identified phage Phi HAP-1. The second prophage region is located on chromosome II and is related to Vibrio phage kappa. Exposure of V. campbellii to mitomycin C induced the lytic cycle of two morphologically distinct phages and, as expected, extracellular DNA from induced cultures was found to be specifically enriched for the sequences previously identified as prophage regions. Heat stress (50 degrees C, 30 min) was also found to induce phage release in V. campbellii. Notably, promoter activity of two representative phage genes indicated heterogeneous phage induction within the population.	[Lorenz, Nicola; Reiger, Matthias; Poettinger, Lisa; Plener, Laure; Lassak, Juergen; Jung, Kirsten] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, Dept Biol 1, Microbiol, Martinsried, Germany; [Toro-Nahuelpan, Mauricio] Univ Bayreuth, Dept Microbiol, Bayreuth, Germany; [Toro-Nahuelpan, Mauricio] Max Planck Inst Biochem, Dept Mol Struct Biol, Klopferspitz 18A, D-82152 Martinsried, Germany; [Brachmann, Andreas] Univ Munich, Dept Biol 1, Genet, Martinsried, Germany; [Reiger, Matthias] Tech Univ Munich, UNIKA T, Chair & Inst Environm Med, Augsburg, Germany; [Reiger, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Augsburg, Germany; [Plener, Laure] Gene & GreenTK, Fac Med, Marseille, France	University of Munich; University of Bayreuth; Max Planck Society; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; UDICE-French Research Universities; Aix-Marseille Universite	Jung, K (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, Dept Biol 1, Microbiol, Martinsried, Germany.	jung@lmu.de	Brachmann, Andreas/I-2241-2013; Lassak, Jürgen Michael/Q-2128-2019	Brachmann, Andreas/0000-0001-7980-8173; Lassak, Jürgen Michael/0000-0003-3936-3389; Toro-Nahuelpan, Mauricio/0000-0001-5333-3640	Deutsche Forschungsgemeinschaft (DFG) [SPP1617 (JU270/13-1), Exc114-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was financially supported by Deutsche Forschungsgemeinschaft (DFG) SPP1617 (JU270/13-1) and Exc114-2 to K. J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H., 1987, VIRUSES PROKARYOTES, V1; Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Anetzberger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048310; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bondy-Denomy J, 2014, J MICROBIOL, V52, P235, DOI 10.1007/s12275-014-4083-3; CAMPBELL NA, 2005, BIOLOGY; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Catap ES, 2003, DIS AQUAT ORGAN, V57, P11, DOI 10.3354/dao057011; Chang B, 2002, MICROBIOL IMMUNOL, V46, P565, DOI 10.1111/j.1348-0421.2002.tb02734.x; Crothers-Stomps C, 2010, J APPL MICROBIOL, V108, P1744, DOI 10.1111/j.1365-2672.2009.04578.x; Cui J, 2014, J VIROL, V88, P6403, DOI 10.1128/JVI.00362-14; Defoirdt T, 2012, ISME J, V6, P2314, DOI 10.1038/ismej.2012.58; Faruque SM, 2005, J BACTERIOL, V187, P4095, DOI 10.1128/JB.187.12.4095-4103.2005; Fried L, 2012, J MICROBIOL METH, V91, P537, DOI 10.1016/j.mimet.2012.09.023; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; GERDES JC, 1975, J VIROL, V15, P1231, DOI 10.1128/JVI.15.5.1231-1238.1975; Godeke J, 2011, ISME J, V5, P613, DOI 10.1038/ismej.2010.153; GREENBERG EP, 1979, ARCH MICROBIOL, V120, P87, DOI 10.1007/BF00409093; GUIDOLIN A, 1987, MICROBIOL REV, V51, P285, DOI 10.1128/MMBR.51.2.285-298.1987; Hershey AD, 1983, INTRO LAMBDA; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jiang SC, 1998, MICROBIAL ECOL, V35, P235, DOI 10.1007/s002489900079; Jiravanichpaisal P., 1994, Journal of Aquatic Animal Health, V6, P27, DOI 10.1577/1548-8667(1994)006&lt;0027:HBAPOV&gt;2.3.CO;2; LAPOTA D, 1988, J EXP MAR BIOL ECOL, V119, P55, DOI 10.1016/0022-0981(88)90152-9; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; MILLER HI, 1981, CELL, V25, P269, DOI 10.1016/0092-8674(81)90252-X; Miller SD, 2005, P NATL ACAD SCI USA, V102, P14181, DOI 10.1073/pnas.0507253102; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mobberley JM, 2008, J VIROL, V82, P6618, DOI 10.1128/JVI.00140-08; Nanda AM, 2015, J BACTERIOL, V197, P410, DOI 10.1128/JB.02230-14; Nanda AM, 2014, J BACTERIOL, V196, P180, DOI 10.1128/JB.01018-13; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; Plener L, 2015, J BACTERIOL, V197, P1747, DOI 10.1128/JB.02544-14; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Roberts JW, 1983, LYSOGENIC INDUCTION; Rossmann FS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004653; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	43	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156010	10.1371/journal.pone.0156010	http://dx.doi.org/10.1371/journal.pone.0156010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214518	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200044
J	Satterlee, T; Cary, JW; Calvo, AM				Satterlee, Timothy; Cary, Jeffrey W.; Calvo, Ana M.			RmtA, a Putative Arginine Methyltransferase, Regulates Secondary Metabolism and Development in Aspergillus flavus	PLOS ONE			English	Article							SCLEROTIAL PRODUCTION; CONIDIOPHORE DEVELOPMENT; MYCOTOXIN PRODUCTION; IN-VIVO; AFLATOXIN; GENE; COMPLEX; VEA; NIDULANS; BIOSYNTHESIS	Aspergillus flavus colonizes numerous oil seed crops such as corn, peanuts, treenuts and cotton worldwide, contaminating them with aflatoxin and other harmful potent toxins. In the phylogenetically related model fungus Aspergillus nidulans, the methyltransferase, RmtA, has been described to be involved in epigenetics regulation through histone modification. Epigenetics regulation affects a variety of cellular processes, including morphogenesis and secondary metabolism. Our study shows that deletion of rmtA in A. flavus results in hyperconidiating colonies, indicating that rmtA is a repressor of asexual development in this fungus. The increase in conidiation in the absence of rmtA coincides with greater expression of brlA, abaA, and wetA compared to that in the wild type. Additionally, the rmtA deletion mutant presents a drastic reduction or loss of sclerotial production, while forced expression of this gene increased the ability of this fungus to generate these resistant structures, revealing rmtA as a positive regulator of sclerotial formation. Importantly, rmtA is also required for the production of aflatoxin B-1 in A. flavus, affecting the expression of aflJ. Furthermore, biosynthesis of additional metabolites is also controlled by rmtA, indicating a broad regulatory output in the control of secondary metabolism. This study also revealed that rmtA positively regulates the expression of the global regulatory gene veA, which could contribute to mediate the effects of rmtA on development and secondary metabolism in this relevant opportunistic plant pathogen.	[Satterlee, Timothy; Calvo, Ana M.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Cary, Jeffrey W.] USDA ARS, So Reg Res Ctr, POB 19687, New Orleans, LA 70124 USA	Northern Illinois University; United States Department of Agriculture (USDA)	Calvo, AM (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	amcalvo@niu.edu			United States Department of Agriculture [58-6435-4-015 AMC]; Department of Biological Sciences at Northern Illinois University	United States Department of Agriculture(United States Department of Agriculture (USDA)); Department of Biological Sciences at Northern Illinois University	This work was supported by the United States Department of Agriculture grant 58-6435-4-015 AMC.; This work was supported by USDA grant 58-6435-4-015 and the Department of Biological Sciences at Northern Illinois University.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Aghcheh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112799; Aleta JM, 1998, TRENDS BIOCHEM SCI, V23, P89, DOI 10.1016/S0968-0004(98)01185-2; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Battilani P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24328; Bauer I, 2010, FUNGAL GENET BIOL, V47, P551, DOI 10.1016/j.fgb.2010.03.006; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002816; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Calvo AM, 2016, MYCOTA, V1, P475; Calvo AM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00062; Cary JW, 2006, APPL ENVIRON MICROB, V72, P1096, DOI 10.1128/AEM.72.2.1096-1101.2006; Chang PK, 2012, APPL ENVIRON MICROB, V78, P7557, DOI 10.1128/AEM.01241-12; CLEVELAND TE, 1987, APPL ENVIRON MICROB, V53, P2804, DOI 10.1128/AEM.53.12.2804-2807.1987; COLEYSMI.JR, 1971, ANNU REV PHYTOPATHOL, V9, P65, DOI 10.1146/annurev.py.09.090171.000433; Connolly LR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003916; Cotty PJ, 2007, INT J FOOD MICROBIOL, V119, P109, DOI 10.1016/j.ijfoodmicro.2007.07.060; COTTY PJ, 1988, PHYTOPATHOLOGY, V78, P1250, DOI 10.1094/Phyto-78-1250; Duran R. M., 2009, Open Mycology Journal, V3, P27, DOI 10.2174/1874437000903010027; Duran RM, 2007, APPL MICROBIOL BIOT, V73, P1158, DOI 10.1007/s00253-006-0581-5; Ehrlich KC, 2012, TOXINS, V4, P1582, DOI 10.3390/toxins4121582; Feldman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080756; Fink-Gremmels J, 1999, VET QUART, V21, P115, DOI 10.1080/01652176.1999.9695005; Fung F, 2004, J TOXICOL-CLIN TOXIC, V42, P217, DOI 10.1081/CLT-120030947; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gieseker K.E., 2004, MMWR MORB MORTAL WKL, V53, P790; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Horn BW, 2014, PHYTOPATHOLOGY, V104, P75, DOI 10.1094/PHYTO-05-13-0129-R; KAFER E, 1977, CAN J GENET CYTOL, V19, P723; Kale SP, 2008, FUNGAL GENET BIOL, V45, P1422, DOI 10.1016/j.fgb.2008.06.009; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Krijgsheld P, 2013, Stud Mycol, V74, P1, DOI 10.3114/sim0006; LANCASTER M, 1961, NATURE, V192, P1095, DOI 10.1038/1921095a0; Lewis L, 2005, ENVIRON HEALTH PERSP, V113, P1763, DOI 10.1289/ehp.7998; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; MAPLESTONE RA, 1992, GENE, V115, P151, DOI 10.1016/0378-1119(92)90553-2; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; McKean C, 2006, FOOD CHEM TOXICOL, V44, P868, DOI 10.1016/j.fct.2005.11.011; Medina A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00348; Myung K, 2009, J AGR FOOD CHEM, V57, P5089, DOI 10.1021/jf900783u; Nakazawa T, 2010, CURR GENET, V56, P361, DOI 10.1007/s00294-010-0307-1; Palmer JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003193; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Robens J, 2003, J TOXICOL-TOXIN REV, V22, P139, DOI 10.1081/TXR-120024089; Sarikaya-Bayram O, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00001; Sarikaya-Bayram O, 2014, DEV CELL, V29, P406, DOI 10.1016/j.devcel.2014.03.020; Soukup AA, 2012, MOL MICROBIOL, V86, P314, DOI 10.1111/j.1365-2958.2012.08195.x; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trojer P, 2004, BIOCHEMISTRY-US, V43, P10834, DOI 10.1021/bi049626i; Wang G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039700, 10.1371/journal.pone.0051764, 10.1371/journal.pone.0047051]	61	26	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155575	10.1371/journal.pone.0155575	http://dx.doi.org/10.1371/journal.pone.0155575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213959	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880200017
J	Bolger, CM; Sandbakk, O; Ettema, G; Federolf, P				Bolger, Conor M.; Sandbakk, Oyvind; Ettema, Gertjan; Federolf, Peter			How Hinge Positioning in Cross-Country Ski Bindings Affect Exercise Efficiency, Cycle Characteristics and Muscle Coordination during Submaximal Roller Skiing	PLOS ONE			English	Article							PUSH-OFF MECHANICS; TIME-FREQUENCY; POWER OUTPUT; PERFORMANCE; VARIABILITY; KLAPSKATES; RESPONSES; PATTERNS; ECONOMY; ENERGY	The purposes of the current study were to 1) test if the hinge position in the binding of skating skis has an effect on gross efficiency or cycle characteristics and 2) investigate whether hinge positioning affects synergistic components of the muscle activation in six lower leg muscles. Eleven male skiers performed three 4-min sessions at moderate intensity while cross-country ski-skating and using a klapskate binding. Three different positions were tested for the binding's hinge, ranging from the front of the first distal phalange to the metatarsal- phalangeal joint. Gross efficiency and cycle characteristics were determined, and the electromyographic (EMG) signals of six lower limb muscles were collected. EMG signals were wavelet transformed, normalized, joined into a multi-dimensional vector, and submitted to a principle component analysis (PCA). Our results did not reveal any changes to gross efficiency or cycle characteristics when altering the hinge position. However, our EMG analysis found small but significant effects of hinge positioning on muscle coordinative patterns (P < 0.05). The changed patterns in muscle activation are in alignment with previously described mechanisms that explain the effects of hinge positioning in speed-skating klapskates. Finally, the within-subject results of the EMG analysis suggested that in addition to the between-subject effects, further forms of muscle coordination patterns appear to be employed by some, but not all participants.	[Bolger, Conor M.; Sandbakk, Oyvind; Ettema, Gertjan; Federolf, Peter] Norwegian Univ Sci & Technol, Ctr Elite Sports Res, N-7034 Trondheim, Norway; [Federolf, Peter] Univ Innsbruck, Inst Sports Sci, A-6020 Innsbruck, Austria	Norwegian University of Science & Technology (NTNU); University of Innsbruck	Bolger, CM (corresponding author), Norwegian Univ Sci & Technol, Ctr Elite Sports Res, N-7034 Trondheim, Norway.	conor.bolger@ntnu.no	Ettema, Gertjan/C-2104-2018; Federolf, Peter/H-4481-2019	Federolf, Peter/0000-0002-0266-6813	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	PHD Student Conor Bolger is funded by the money from the Norwegian Research Council.	Ainegren M, 2008, ENGINEERING OF SPORT 7, VOL 2, P393, DOI 10.1007/978-2-287-09413-2_49; Boonstra TW, 2008, J ELECTROMYOGR KINES, V18, P717, DOI 10.1016/j.jelekin.2007.03.005; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; de Koning JJ, 2000, J BIOMECH, V33, P1225, DOI 10.1016/S0021-9290(00)00063-4; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Federolf P, 2012, SPORT BIOMECH, V11, P452, DOI 10.1080/14763141.2012.704933; Gray VL, 2015, J ELECTROMYOGR KINES, V25, P959, DOI 10.1016/j.jelekin.2015.09.003; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Houdijk H, 2003, MED SCI SPORT EXER, V35, P2077, DOI 10.1249/01.MSS.0000099085.84271.AB; Houdijk H, 2000, MED SCI SPORT EXER, V32, P635, DOI 10.1097/00005768-200003000-00013; Houdijk H, 2002, J APPL BIOMECH, V18, P292, DOI 10.1123/jab.18.4.292; Houdijk H, 2000, EUR J APPL PHYSIOL, V83, P283; Huber C, 2013, J BIOMECH, V46, P1262, DOI 10.1016/j.jbiomech.2013.02.017; Krishnamoorthy V, 2004, EXP BRAIN RES, V157, P18, DOI 10.1007/s00221-003-1812-y; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Roy JPR, 2006, MED SCI SPORT EXER, V38, P562, DOI 10.1249/01.mss.0000193562.22001.e8; Sandbakk O, 2014, SCAND J MED SCI SPOR, V24, P28, DOI 10.1111/j.1600-0838.2012.01482.x; Sandbakk O, 2010, EUR J APPL PHYSIOL, V109, P473, DOI 10.1007/s00421-010-1372-3; Schenau GJV, 1996, MED SCI SPORT EXER, V28, P531; Stefanyshyn DJ, 2000, SPORTVERLETZ SPORTSC, V14, P82, DOI 10.1055/s-2000-7867; Stoggl T, 2006, INT S BIOM SPORTS; Stoggl T, 2015, MED SCI SPORT EXER, V47, P1232, DOI 10.1249/MSS.0000000000000510; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Van Horne S, 2005, J APPL BIOMECH, V21, P211, DOI 10.1123/jab.21.3.211; Van Sickle JR, 2007, J BIOMECH, V40, P1262, DOI 10.1016/j.jbiomech.2006.05.026; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; von Tscharner V, 2002, J ELECTROMYOGR KINES, V12, P479, DOI 10.1016/S1050-6411(02)00005-6; Wakeling JM, 2010, J EXP BIOL, V213, P487, DOI 10.1242/jeb.036236	28	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0153078	10.1371/journal.pone.0153078	http://dx.doi.org/10.1371/journal.pone.0153078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203597	Green Submitted, gold, Green Published			2022-12-26	WOS:000376291500004
J	Bibiloni, MD; Salas, R; Nunez, GM; Villarreal, JZ; Sureda, A; Tur, JA				del Mar Bibiloni, Maria; Salas, Rogelio; Nunez, Georgina M.; Villarreal, Jesus Z.; Sureda, Antoni; Tur, Josep A.			Relation between Liver Transaminases and Dyslipidaemia among 2-10 y.o. Northern Mexican Children	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ALANINE AMINOTRANSFERASE; METABOLIC SYNDROME; FUNCTION TESTS; NORMAL-WEIGHT; ADOLESCENTS; PREVALENCE; RISK; ASSOCIATION; DISEASE	Background and Aims The increase in overweight and obese children may be linked to increased rates of liver damage and dyslipidaemia. This study aimed to explore the associations of liver biomarkers with overweight/obesity and dyslipidaemia in Mexican children. Methods The study was a population-based cross-sectional nutritional survey carried out in the State of Nuevo Leon, Mexico. The study included a 414 subjects aged between 2 and 10 years old (47.8% girls) who took part in the State Survey of Nutrition and Health-Nuevo Leon 2011/2012. Associations between alanine aminotransferase (ALT) and aspartate aminotransferase (AST), ALT/AST ratio, and major components of serum lipid profile were assessed. Results Children with high ALT (defined as >= P-75) showed higher prevalence of dyslipidaemia than their counterparts, with high prevalence of high TChol (P = 0.053), non-HDL-chol, TG, and low HDL-chol. Children with an AST/ALT >= T3 ratio were 0.43-times (95% CI: 0.25-0.74) and 0.27-times (95% CI: 0.17-0.44) low likely to be overweight/obese and to have dyslipidaemia than those with an AST/ALT <T1 ratio, respectively. The risk of high TChol, LDL-chol, non-HDL-chol and TG, and low HDL-chol levels also decreased in AST/ALT ratio groups. Conclusions Our results pose the need for further investigation on whether AST/ALT may be useful as screening test in the assessment of children with cardiometabolic risk.	[del Mar Bibiloni, Maria; Sureda, Antoni; Tur, Josep A.] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, E-07122 Palma De Mallorca, Spain; [del Mar Bibiloni, Maria; Sureda, Antoni; Tur, Josep A.] Inst Salud Carlos III, CIBEROBN Physiopathol Obes & Nutr, E-28029 Madrid, Spain; [Salas, Rogelio; Nunez, Georgina M.] Autonomous Univ Nuevo Leon, Fac Publ Hlth Nutr, Monterrey 64460, Mexico; [Villarreal, Jesus Z.] Dept Hlth State Nuevo Leon, Monterrey 64000, Mexico	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad Autonoma de Nuevo Leon	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, E-07122 Palma De Mallorca, Spain.; Tur, JA (corresponding author), Inst Salud Carlos III, CIBEROBN Physiopathol Obes & Nutr, E-28029 Madrid, Spain.	pep.tur@uib.es	del Mar Bibiloni, Maria/M-3123-2014; , Antoni/AAB-5250-2019; Gomila, Antonio Sureda/L-7191-2014; Sureda, Antoni/N-9588-2019; Tur, Josep/AAE-5748-2020	del Mar Bibiloni, Maria/0000-0001-8926-9206; , Antoni/0000-0001-8656-6838; Gomila, Antonio Sureda/0000-0003-2101-616X; Sureda, Antoni/0000-0001-8656-6838; Tur, Josep/0000-0002-6940-0761; /0000-0001-9835-1594	Department of Health, Government of the State of Nuevo Leon (Mexico), State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs [11/01791, 14/00636, RD06/0045/1004, CB12/03/30038]; Balearic Islands Gov. [35/2011]; EU FEDER funds; Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands under the Centre Catala de la Nutricio (IEC); Exernet Network	Department of Health, Government of the State of Nuevo Leon (Mexico), State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs(Spanish Government); Balearic Islands Gov.; EU FEDER funds(European Commission); Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands under the Centre Catala de la Nutricio (IEC); Exernet Network	This work was supported by the Department of Health, Government of the State of Nuevo Leon (Mexico), State Survey of Nutrition and Health-Nuevo Leon 2011/2012 (EESN-NL 2011/2012). It was also supported by the Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences, Projects 11/01791 and 14/00636, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038). Grant of support was given to research groups no. 35/2011 (Balearic Islands Gov.) and EU FEDER funds. This work was also supported by the Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands, coming under the Centre Catala de la Nutricio (IEC) and Exernet Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2015, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-407; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908; Botros Mona, 2013, Clin Biochem Rev, V34, P117; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Bibiloni MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119877; Elizondo-Montemayor L, 2014, OBES RES CLIN PRACT, V8, pE79, DOI 10.1016/j.orcp.2012.08.191; Escobedo-Melendez G, 2012, ANN HEPATOL, V11, P194, DOI 10.1016/S1665-2681(19)31024-5; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Kang KS, 2013, PEDIATR GASTROENTERO, V16, P225, DOI 10.5223/pghn.2013.16.4.225; Kwon OW, 2012, ALIMENT PHARM THER, V35, P1064, DOI 10.1111/j.1365-2036.2012.05061.x; Labayen I, 2015, PEDIATR OBES, V10, P361, DOI 10.1111/ijpo.273; Larrieta-Carrasco E, 2013, GENE, V520, P185, DOI 10.1016/j.gene.2013.03.038; Manco M, 2008, HEPATOLOGY, V48, P2087, DOI 10.1002/hep.22631; McCrindle BW, 2012, PEDIATRICS, V130, P353, DOI 10.1542/peds.2012-1137; National Heart Lung and Blood Institute, 2012, NIH PUBLICATION, V12-7486; Okada M, 2001, PREV MED, V32, P224, DOI 10.1006/pmed.2000.0805; Park HK, 2013, J PEDIATR GASTR NUTR, V56, P686, DOI 10.1097/MPG.0b013e31828b4e67; Purcell M, 2013, J DIGEST DIS, V14, P491, DOI 10.1111/1751-2980.12072; Purkins L, 2004, BRIT J CLIN PHARMACO, V57, P199, DOI 10.1046/j.1365-2125.2003.01969.x; Quispe R, 2015, ATHEROSCLEROSIS, V242, P243, DOI 10.1016/j.atherosclerosis.2015.06.057; Riggio S, 2010, EUR J CLIN INVEST, V40, P722, DOI 10.1111/j.1365-2362.2010.02323.x; Steinberger J, 2008, CIRCULATION, V117, P9, DOI 10.1161/CIRCULATIONAHA.107.743104; Sundvall J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-63; Thapa BR, 2007, INDIAN J PEDIATR, V74, P663, DOI 10.1007/s12098-007-0118-7; Tzima N, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-30; Wiegman A, 2015, EUR HEART J, V36, P2425, DOI 10.1093/eurheartj/ehv157	30	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155994	10.1371/journal.pone.0155994	http://dx.doi.org/10.1371/journal.pone.0155994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203747	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291500038
J	Feng, Z; Wen, H; Bi, R; Ju, XZ; Chen, XJ; Yang, WT; Wu, XH				Feng, Zheng; Wen, Hao; Bi, Rui; Ju, Xingzhu; Chen, Xiaojun; Yang, Wentao; Wu, Xiaohua			Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer	PLOS ONE			English	Article							PRETREATMENT NEUTROPHIL; SUPERIOR; PLATELET	Objective We aimed to demonstrate the clinical and prognostic significance of the preoperative neutrophil-to-lymphocyte ratio (NLR) in high-grade serous ovarian cancer (HGSC). Methods We retrospectively investigated 875 patients who underwent primary staging or debulking surgery for HGSC between April 2005 and June 2013 at our institution. None of these patients received neoadjuvant chemotherapy. NLR was defined as the absolute neutrophil count divided by the absolute lymphocyte count. Progression-free survival (PFS) and overall survival (OS) were analyzed with the Kaplan-Meier method and log-rank tests for univariate analyses. For multivariate analyses, Cox regression analysis was used to evaluate the effects of the prognostic factors, which were expressed as hazard ratios (HRs). Results The NLRs ranged from 0.30 to 24.0. The median value was 3.24 and used as the cutoff value to discriminate between the high-NLR (>= 3.24) and low-NLR (<3.24) groups. A high preoperative NLR level was associated with an advanced FIGO stage, increased CA125 level, more extensive ascites, worse cytoreduction outcome and chemoresistance. For univariate analyses, a high NLR was associated with reduced PFS (p<0.001) and OS (p<0.001). In multivariate analyses, a high NLR was still an independent predictor of PFS (p = 0.011), but not OS (p = 0.148). Conclusion Our study demonstrated that NLR could reflect tumor burden and clinical outcomes to a certain extent and should be regarded as a predictive and prognostic parameter for HGSC.	[Feng, Zheng; Wen, Hao; Ju, Xingzhu; Chen, Xiaojun; Wu, Xiaohua] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200032, Peoples R China; [Feng, Zheng; Wen, Hao; Bi, Rui; Ju, Xingzhu; Chen, Xiaojun; Yang, Wentao; Wu, Xiaohua] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Bi, Rui; Yang, Wentao] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, XH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200032, Peoples R China.; Wu, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.	docwuxh@hotmail.com			Science and Technology Commission of Shanghai Municipality [12411950300, 15411962000]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the key project of Science and Technology Commission of Shanghai Municipality (12411950300) and the leading project of Science and Technology Commission of Shanghai Municipality (15411962000) for XH Wu.	Asano Y, 2015, ANN SURG ONCOLOGY; Berek JS, 2012, INT J GYNECOL OBSTET, V119, pS118, DOI 10.1016/S0020-7292(12)60025-3; Bishara S, 2008, EUR J OBSTET GYN R B, V138, P71, DOI 10.1016/j.ejogrb.2007.05.012; Cho H, 2009, CANCER IMMUNOL IMMUN, V58, P15, DOI 10.1007/s00262-008-0516-3; Goh BK, 2015, SURGERY; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Han S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1629-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ishizuka M, 2015, ANN SURG ONCOLOGY; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Li MX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002133; Que Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1654-6; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; Suppan C, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2005-3; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wang Y, 2015, CANCER CHEMOTH PHARM, V75, P255, DOI 10.1007/s00280-014-2622-6; Williams KA, 2014, GYNECOL ONCOL, V132, P542, DOI 10.1016/j.ygyno.2014.01.026; Zhang GM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001473; Zhang WW, 2015, TUMOR BIOL, V36, P8831, DOI 10.1007/s13277-015-3533-9	20	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0156101	10.1371/journal.pone.0156101	http://dx.doi.org/10.1371/journal.pone.0156101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203425	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500043
J	Pani, G; Verslegers, M; Quintens, R; Samari, N; de Saint-Georges, L; van Oostveldt, P; Baatout, S; Benotmane, MA				Pani, Giuseppe; Verslegers, Mieke; Quintens, Roel; Samari, Nada; de Saint-Georges, Louis; van Oostveldt, Patrick; Baatout, Sarah; Benotmane, Mohammed Abderrafi			Combined Exposure to Simulated Microgravity and Acute or Chronic Radiation Reduces Neuronal Network Integrity and Survival	PLOS ONE			English	Article							SPACE RADIATION; SECONDARY NEUTRONS; PARTICLE RADIATION; PROTEOMIC ANALYSIS; MEMORY IMPAIRMENT; HUMAN-LYMPHOCYTES; RAT HYPOTHALAMUS; OXIDATIVE STRESS; CYTOSKELETON; APOPTOSIS	During orbital or interplanetary space flights, astronauts are exposed to cosmic radiations and microgravity. However, most earth-based studies on the potential health risks of space conditions have investigated the effects of these two conditions separately. This study aimed at assessing the combined effect of radiation exposure and microgravity on neuronal morphology and survival in vitro. In particular, we investigated the effects of simulated microgravity after acute (X-rays) or during chronic (Californium-252) exposure to ionizing radiation using mouse mature neuron cultures. Acute exposure to low (0.1 Gy) doses of Xrays caused a delay in neurite outgrowth and a reduction in soma size, while only the high dose impaired neuronal survival. Of interest, the strongest effect on neuronal morphology and survival was evident in cells exposed to microgravity and in particular in cells exposed to both microgravity and radiation. Removal of neurons from simulated microgravity for a period of 24 h was not sufficient to recover neurite length, whereas the soma size showed a clear re-adaptation to normal ground conditions. Genome-wide gene expression analysis confirmed a modulation of genes involved in neurite extension, cell survival and synaptic communication, suggesting that these changes might be responsible for the observed morphological effects. In general, the observed synergistic changes in neuronal network integrity and cell survival induced by simulated space conditions might help to better evaluate the astronaut's health risks and underline the importance of investigating the central nervous system and long-term cognition during and after a space flight.	[Pani, Giuseppe; Verslegers, Mieke; Quintens, Roel; Samari, Nada; de Saint-Georges, Louis; Baatout, Sarah; Benotmane, Mohammed Abderrafi] SCK CEN, Lab Mol & Cellular Biol, Inst Environm Hlth & Safety, Radiobiol Unit,Belgian Nucl Res Ctr, Mol, Belgium; [Pani, Giuseppe; van Oostveldt, Patrick] Univ Ghent, Dept Mol Biotechnol, Cell Syst & Imaging Res Grp CSI, B-9000 Ghent, Belgium; [Pani, Giuseppe] Univ Milan, Lab Membrane Biochem & Appl Nutr, Dept Pharmacol & Biomol Sci DiSFeB, Milan, Italy	Belgian Nuclear Research Centre (SCK-CEN); Ghent University; University of Milan	Benotmane, MA (corresponding author), SCK CEN, Lab Mol & Cellular Biol, Inst Environm Hlth & Safety, Radiobiol Unit,Belgian Nucl Res Ctr, Mol, Belgium.	abenotma@sckcen.be	Quintens, Roel/G-5339-2017	Quintens, Roel/0000-0002-4359-3403; Benotmane, Rafi/0000-0002-8985-1578; Baatout, Sarah/0000-0001-8110-751X; Verslegers, Mieke/0000-0001-8616-234X	PRODEX/ESA [C90-303, C90-391, C0-90-11-2801-02]; Sardinian government [EF-DR-A2008-67]	PRODEX/ESA(European Space Agency); Sardinian government(Regione Sardegna)	Funded by PRODEX/ESA: C90-303, C90-391, C0-90-11-2801-02, Sardinian government: EF-DR-A2008-67. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akleyev AV, 2012, RADIAT PROT DOSIM, V151, P689, DOI 10.1093/rpd/ncs183; Akleyev AV, 2014, CHRONIC RAD SYNDROME; Armstrong TW, 2001, RADIAT MEAS, V33, P229, DOI 10.1016/S1350-4487(00)00152-9; Battista N, 2012, FASEB J, V26, P1791, DOI 10.1096/fj.11-199406; Beck M, 2014, INT J MOL MED, V34, P606, DOI 10.3892/ijmm.2014.1785; Beck M, 2012, INT J MOL MED, V30, P309, DOI 10.3892/ijmm.2012.1001; BENES FM, 1992, J NEUROSCI, V12, P924; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benton ER, 2001, NUCL INSTRUM METH B, V184, P255, DOI 10.1016/S0168-583X(01)00748-0; Borst AG, 2009, MICROGRAVITY SCI TEC, V21, P287, DOI 10.1007/s12217-008-9043-2; Cao LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104279; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Cogoli A, 1993, NAGOYA U, V37, P107; Cucinotta FA, 2008, RADIAT RES, V170, P127, DOI 10.1667/RR1330.1; Cucinotta FA, 2014, LIFE SCI SPACE RES, V2, P54, DOI 10.1016/j.lssr.2014.06.003; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; DAMELIO FE, 1983, J HIRNFORSCH, V24, P479; Daniels RW, 2011, NEUROBIOL DIS, V41, P415, DOI 10.1016/j.nbd.2010.10.009; DAVIS JR, 1988, AVIAT SPACE ENVIR MD, V59, P1185; Demertzi A, 2016, BRAIN STRUCT FUNCT, V221, P2873, DOI 10.1007/s00429-015-1054-3; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dieriks B, 2009, RADIAT RES, V172, P423, DOI 10.1667/RR1682.1; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fuchs H S, 1980, Riv Med Aeronaut Spaz, V43, P332; Gal A, 2010, J NEUROSCI, V30, P16332, DOI 10.1523/JNEUROSCI.4859-10.2010; Gobbel GT, 1998, J NEUROSCI, V18, P147; Hada M, 2010, MUTAT RES-GEN TOX EN, V701, P67, DOI 10.1016/j.mrgentox.2010.03.009; Iqbal J, 2014, PROTEOMICS, V14, P1424, DOI 10.1002/pmic.201400019; Iqbal J, 2014, PROTEOMICS, V14, P262, DOI 10.1002/pmic.201300337; JOSEPH JA, 1992, RADIAT RES, V130, P88, DOI 10.2307/3578484; Lai PY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051906; Li HY, 2013, BIOMED ENVIRON SCI, V26, P726, DOI 10.3967/0895-3988.2013.09.003; Maalouf M, 2011, J RADIAT RES, V52, P126, DOI 10.1269/jrr.10128; Manda K, 2008, J PINEAL RES, V45, P430, DOI 10.1111/j.1600-079X.2008.00611.x; Manda K, 2008, BEHAV BRAIN RES, V187, P387, DOI 10.1016/j.bbr.2007.09.033; Manda K, 2007, BEHAV BRAIN RES, V177, P7, DOI 10.1016/j.bbr.2006.11.013; Mastroleo F, 2009, ISME J, V3, P1402, DOI 10.1038/ismej.2009.74; Maurer RH, 2001, IEEE T NUCL SCI, V48, P2029, DOI 10.1109/23.983167; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Meloni MA, 2006, PROTOPLASMA, V229, P243, DOI 10.1007/s00709-006-0210-2; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; Mognato M, 2009, MUTAT RES-FUND MOL M, V663, P32, DOI 10.1016/j.mrfmmm.2009.01.002; MOORE TP, 1987, AVIAT SPACE ENVIR MD, V58, pA91; Mundy WR, 2000, NEUROTOXICOLOGY, V21, P1135; NICOGOSSIAN A, 1988, ACTA ASTRONAUT, V17, P195, DOI 10.1016/0094-5765(88)90022-7; Okamoto M, 2009, RADIAT RES, V172, P718, DOI 10.1667/RR1741.1; Pani G, 2014, CYTOM PART A, V85, P188, DOI 10.1002/cyto.a.22408; Pani G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073857; Parihar VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400256; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHILPOTT DE, 1985, SCAN ELECTRON MICROS, P1177; RABIN BM, 1989, RADIAT RES, V119, P113, DOI 10.2307/3577371; Rapp D., 2006, MARS, V2, P46, DOI DOI 10.1555/MARS.2006.0004; REEVES GI, 1995, RADIAT RES, V142, P242, DOI 10.2307/3579035; Rizzo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032361; Rosner H, 2006, PROTOPLASMA, V229, P225, DOI 10.1007/s00709-006-0202-2; Samar N, 2013, INT J MOL MED, V31, P516, DOI 10.3892/ijmm.2013.1245; Santucci D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040112; Sanzari JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071757; Sarkar P, 2006, J PROTEOME RES, V5, P548, DOI 10.1021/pr050274r; Sarkar P, 2008, NEUROCHEM RES, V33, P2335, DOI 10.1007/s11064-008-9738-1; Sciola L, 1999, ADV SPACE RES, V24, P801, DOI 10.1016/S0273-1177(99)00078-2; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Um JW, 2014, CELL REP, V6, P1096, DOI 10.1016/j.celrep.2014.02.010; Uva BM, 2002, EUR J HISTOCHEM, V46, P209; Vanhavere F, 1998, RADIAT MEAS, V29, P573, DOI 10.1016/S1350-4487(98)00071-7; Veremeyeva G, 2010, HEALTH PHYS, V99, P337, DOI 10.1097/HP.0b013e3181d11303; Vernon PS, 2005, J VIROL, V79, P3438, DOI 10.1128/JVI.79.6.3438-3447.2005; Verreet T, 2015, J NEURODEV DISORD, V7, DOI 10.1186/1866-1955-7-3; Verslegers M, 2015, BRAIN STRUCT FUNCT, V220, P1601, DOI 10.1007/s00429-014-0747-3; Xu D, 2014, J RADIAT RES, V55, P720, DOI 10.1093/jrr/rru014; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	77	19	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155260	10.1371/journal.pone.0155260	http://dx.doi.org/10.1371/journal.pone.0155260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203085	Green Published, gold			2022-12-26	WOS:000376291500009
J	Yang, DQ; Li, Y; Shi, YH; Cui, ZY; Luo, YL; Zheng, MJ; Chen, J; Li, YX; Yin, YP; Wang, ZL				Yang, Dongqing; Li, Yong; Shi, Yuhua; Cui, Zhengyong; Luo, Yongli; Zheng, Mengjing; Chen, Jin; Li, Yanxia; Yin, Yanping; Wang, Zhenlin			Exogenous Cytokinins Increase Grain Yield of Winter Wheat Cultivars by Improving Stay-Green Characteristics under Heat Stress	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; LEAF SENESCENCE; ABSCISIC-ACID; WATER-STRESS; TOLERANCE; POSTANTHESIS; RICE; PHOTOSYNTHESIS; ACCUMULATION; INVOLVEMENT	Stay-green, a key trait of wheat, can not only increase the yield of wheat but also its resistance to heat stress during active photosynthesis. Cytokinins are the most potent general coordinator between the stay-green trait and senescence. The objectives of the present study were to identify and assess the effects of cytokinins on the photosynthetic organ and heat resistance in wheat. Two winter wheat cultivars, Wennong 6 (a stay-green cultivar) and Jimai 20 (a control cultivar), were subjected to heat stress treatment from 1 to 5 days after anthesis (DAA). The two cultivars were sprayed daily with 10 mg L-1 of 6-benzylaminopurine (6-BA) between 1 and 3 DAA under ambient and elevated temperature conditions. We found that the heat stress significantly decreased the number of kernels per spike and the grain yield (P < 0.05). Heat stress also decreased the zeatin riboside (ZR) content, but increased the gibberellin (GA3), indole-3-acetic acid (IAA), and abscisic acid (ABA) contents at 3 to 15 DAA. Application of 6-BA significantly (P < 0.05) increased the grain-filling rate, endosperm cell division rate, endosperm cell number, and 1,000-grain weight under heated condition. 6-BA application increased ZR and IAA contents at 3 to 28 DAA, but decreased GA3 and ABA contents. The contents of ZR, ABA, and IAA in kernels were positively and significantly correlated with the grain-filling rate (P < 0.05), whereas GA3 was counter-productive at 3 to 15 DAA. These results suggest that the decrease in grain yield under heat stress was due to a lower ZR content and a higher GA3 content compared to that at elevated temperature during the early development of the kernels, which resulted in less kernel number and lower grain-filling rate. The results also provide essential information for further utilization of the cytokinin substances in the cultivation of heat-resistant wheat.	[Yang, Dongqing; Li, Yong; Shi, Yuhua; Cui, Zhengyong; Luo, Yongli; Zheng, Mengjing; Chen, Jin; Li, Yanxia; Yin, Yanping; Wang, Zhenlin] Shandong Agr Univ, State Key Lab Crop Biol, Agron Coll, Tai An, Shandong, Peoples R China; [Shi, Yuhua] Agr Bur Yanzhou Dist, Jining, Shandong, Peoples R China	Shandong Agricultural University	Yin, YP; Wang, ZL (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Agron Coll, Tai An, Shandong, Peoples R China.	ypyin@126.com; zlwang@sdau.edu.cn			National Natural Science Foundation of China [31271661, 31271667, 30871477]; Shandong Modern Agriculture Technology and Industry System; Shandong Province Higher Educational Science and Technology Program [J14LF12]; National Basic Research Program of China [2015CB150404]; Special Fund for Agro-scientific Research in the Public Interest of China [201203100, 201203029]; National Science and Technology Support Program of China [2012BAD04B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Modern Agriculture Technology and Industry System; Shandong Province Higher Educational Science and Technology Program; National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest of China; National Science and Technology Support Program of China	The research was supported by the National Natural Science Foundation of China (No. 31271661, 31271667, 30871477), the Shandong Modern Agriculture Technology and Industry System. A Project of Shandong Province Higher Educational Science and Technology Program(J14LF12). The National Basic Research Program of China (973 Program, No. 2015CB150404), the Special Fund for Agro-scientific Research in the Public Interest of China (No. 201203100, 201203029) and the National Science and Technology Support Program of China (No. 2012BAD04B05).	Banowetz GM, 1999, PLANT CELL ENVIRON, V22, P309, DOI 10.1046/j.1365-3040.1999.00411.x; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Blum A, 1998, EUPHYTICA, V100, P77, DOI 10.1023/A:1018303922482; Calderini DF, 1999, AUST J PLANT PHYSIOL, V26, P453, DOI 10.1071/PP99015; Chen JB, 2010, ACTA PHYSIOL PLANT, V32, P875, DOI 10.1007/s11738-010-0475-0; [邓振镛 DENG Zhenyong], 2009, [地球科学进展, Advance in Earth Sciences], V24, P865; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Feng B, 2014, J AGRON CROP SCI, V200, P143, DOI 10.1111/jac.12045; Ferris R, 1998, ANN BOT-LONDON, V82, P631, DOI 10.1006/anbo.1998.0740; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hare PD, 1997, PLANT GROWTH REGUL, V23, P79, DOI 10.1023/A:1005954525087; Hays DB, 2007, PLANT SCI, V172, P1113, DOI 10.1016/j.plantsci.2007.03.004; He P, 1999, ACTA BOT SIN, V41, P1221; Labuschagne MT, 2009, J CEREAL SCI, V49, P184, DOI 10.1016/j.jcs.2008.09.001; Law RD, 1999, PLANT PHYSIOL, V120, P173, DOI 10.1104/pp.120.1.173; Liu XH, 2002, CROP SCI, V42, P466, DOI 10.2135/cropsci2002.0466; Cossani CM, 2012, PLANT PHYSIOL, V160, P1710, DOI 10.1104/pp.112.207753; Mondal S, 2013, FIELD CROP RES, V151, P19, DOI 10.1016/j.fcr.2013.06.015; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Salvucci ME, 2001, PLANT PHYSIOL, V127, P1053, DOI 10.1104/pp.010357; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Stone PJ, 1998, AUST J PLANT PHYSIOL, V25, P13, DOI 10.1071/PP96114; Stone PJ, 1995, AUST J PLANT PHYSIOL, V22, P927, DOI 10.1071/PP9950927; Thomas H, 2000, J EXP BOT, V51, P329, DOI 10.1093/jexbot/51.suppl_1.329; Thomas H, 2014, J EXP BOT, V65, P3889, DOI 10.1093/jxb/eru037; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang WQ, 2016, PLANT CELL REP, V35, P585, DOI 10.1007/s00299-015-1905-7; Wang X, 2012, J CEREAL SCI, V55, P331, DOI 10.1016/j.jcs.2012.01.004; Wheeler TR, 1996, J EXP BOT, V47, P623, DOI 10.1093/jxb/47.5.623; Xie ZJ, 2004, PLANT GROWTH REGUL, V44, P25, DOI 10.1007/s10725-004-1880-4; Xu F, 2012, J AGR FOOD CHEM, V60, P234, DOI 10.1021/jf2040884; Xu XL, 2004, PHOTOSYNTHETICA, V42, P317, DOI 10.1023/B:PHOT.0000040608.97976.a3; Xu YunJi, 2013, Acta Agronomica Sinica, V39, P1452, DOI 10.3724/SP.J.1006.2013.01452; [许智宏 Xu Zhihong], 2006, [植物学通报, Chinese Bulletin of Botany], V23, P433; Yan J., 2005, J SHIHEZI U, V23, P30; Yang JC, 2004, PLANT CELL ENVIRON, V27, P1055, DOI 10.1111/j.1365-3040.2004.01210.x; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2000, PLANT GROWTH REGUL, V30, P261, DOI 10.1023/A:1006356125418; Yang JC, 2002, PLANTA, V215, P645, DOI 10.1007/s00425-002-0789-2; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yaronskaya E, 2006, PLANTA, V224, P700, DOI 10.1007/s00425-006-0249-5; Yu S L, 1990, WHEAT SHANDONG PROVI; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zavaleta-Mancera HA, 2007, J PLANT PHYSIOL, V164, P1572, DOI 10.1016/j.jplph.2007.02.003; Zhang H, 2010, J EXP BOT, V61, P3719, DOI 10.1093/jxb/erq198; Zhao H, 2008, J AGRON CROP SCI, V194, P47, DOI 10.1111/j.1439-037X.2007.00283.x; Zhao MR, 2012, PLANT CELL REP, V31, P671, DOI 10.1007/s00299-011-1185-9	48	42	44	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155437	10.1371/journal.pone.0155437	http://dx.doi.org/10.1371/journal.pone.0155437			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203573	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500012
J	Fang, ZH; Marshall, CB; Yin, JNC; Mazhab-Jafari, MT; Gasmi-Seabrook, GMC; Smith, MJ; Nishikawa, T; Xu, Y; Neel, BG; Ikura, M				Fang, Zhenhao; Marshall, Christopher B.; Yin, Jiani C.; Mazhab-Jafari, Mohammad T.; Gasmi-Seabrook, Genevieve M. C.; Smith, Matthew J.; Nishikawa, Tadateru; Xu, Yang; Neel, Benjamin G.; Ikura, Mitsuhiko			Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSE NOONAN SYNDROME; REAL-TIME NMR; NEURONAL DIFFERENTIATION; KRAS MUTATIONS; SMALL GTPASES; DEVELOPMENTAL DISORDERS; SIGNALING PATHWAY; CANCER; ACTIVATION; GTP	RAS-like protein expressed in many tissues 1 (RIT1) is a disease-associated RAS subfamily small guanosine triphosphatase (GTPase). Recent studies revealed that germ-line and somatic RIT1 mutations can cause Noonan syndrome (NS), and drive proliferation of lung adenocarcinomas, respectively, akin to RAS mutations in these diseases. However, the locations of these RIT1 mutations differ significantly from those found in RAS, and do not affect the three mutational "hot spots" of RAS. Moreover, few studies have characterized the GTPase cycle of RIT1 and its disease-associated mutants. Here we developed a real-time NMR-based GTPase assay for RIT1 and investigated the effect of disease-associated mutations on GTPase cycle. RIT1 exhibits an intrinsic GTP hydrolysis rate similar to that of H-RAS, but its intrinsic nucleotide exchange rate is similar to 4-fold faster, likely as a result of divergent residues near the nucleotide binding site. All of the disease-associated mutations investigated increased the GTP-loaded, activated state of RIT1 in vitro, but they could be classified into two groups with different intrinsic GTPase properties. The S35T, A57G, and Y89H mutants exhibited more rapid nucleotide exchange, whereas F82V and T83P impaired GTP hydrolysis. A RAS-binding domain pulldown assay indicated that RIT1 A57G and Y89H were highly activated in HEK293T cells, whereas T83P and F82V exhibited more modest activation. All five mutations are associated with NS, whereas two (A57G and F82V) have also been identified in urinary tract cancers and myeloid malignancies. Characterization of the effects on the GTPase cycle of RIT1 disease-associated mutations should enable better understanding of their role in disease processes.	[Fang, Zhenhao; Marshall, Christopher B.; Yin, Jiani C.; Mazhab-Jafari, Mohammad T.; Gasmi-Seabrook, Genevieve M. C.; Smith, Matthew J.; Nishikawa, Tadateru; Xu, Yang; Neel, Benjamin G.; Ikura, Mitsuhiko] Univ Toronto, Campbell Family Inst Canc Res, Dept Med Biophys, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Yin, Jiani C.; Xu, Yang; Neel, Benjamin G.] NYU, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Mazhab-Jafari, Mohammad T.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Smith, Matthew J.] Univ Montreal, IRIC, 2900 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; New York University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal	Ikura, M (corresponding author), Univ Toronto, Campbell Family Inst Canc Res, Dept Med Biophys, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Marshall, CB (corresponding author), 101 Coll St, Toronto, ON M5G 2M9, Canada.	cmarshal@uhnres.utoronto.ca; mikura@uhnres.utoronto.ca	Marshall, Christopher/K-8943-2019; Xu, Yang/CAG-8877-2022; Smith, Matthew J/AAI-8060-2020	Marshall, Christopher/0000-0002-7571-5700; Xu, Yang/0000-0003-1670-6131; Smith, Matthew J/0000-0003-2896-9350; Fang, Zhenhao/0000-0002-1246-3665; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877; Yin, Jiani/0000-0002-9523-1930	Canada Foundation for Innovation	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	NMR spectrometers were funded by the Canada Foundation for Innovation.	Addissie YA, 2015, AM J MED GENET A, V167, P2657, DOI 10.1002/ajmg.a.37259; Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Berger AH, 2014, ONCOGENE, V33, P4418, DOI 10.1038/onc.2013.581; Bertola DR, 2014, AM J MED GENET A, V164, P2952, DOI 10.1002/ajmg.a.36722; BOS JL, 1989, CANCER RES, V49, P4682; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Calvert RJ, 2005, ANAL BIOCHEM, V343, P283, DOI 10.1016/j.ab.2005.06.008; Cave H, 2016, EUR J HUM GENET, V24, P1124, DOI 10.1038/ejhg.2015.273; Chen J, 2013, CANCER CHEMOTH PHARM, V71, P265, DOI 10.1007/s00280-012-2005-9; Chen PC, 2014, P NATL ACAD SCI USA, V111, P11473, DOI 10.1073/pnas.1324128111; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cirstea IC, 2013, HUM MOL GENET, V22, P262, DOI 10.1093/hmg/dds426; Cordeddu V, 2015, HUM MUTAT, V36, P1080, DOI 10.1002/humu.22834; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Ford B, 2009, BIOCHEMISTRY-US, V48, P11449, DOI 10.1021/bi901479b; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Gasper R, 2008, J MOL BIOL, V379, P51, DOI 10.1016/j.jmb.2008.03.011; Goddard D., 2008, SPARKY 3; Gomez-Segui I, 2013, LEUKEMIA, V27, P1943, DOI 10.1038/leu.2013.179; Gos M, 2014, AM J MED GENET A, V164, P2310, DOI 10.1002/ajmg.a.36646; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Huang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123918; Huang L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6410; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Janne PA, 2015, BRIT J CANCER, V113, P199, DOI 10.1038/bjc.2015.215; Kapoor A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108846; Koenighofer M, 2016, CLIN GENET, V89, P359, DOI 10.1111/cge.12608; Kouz K, 2016, GENET MED, V18, P1226, DOI 10.1038/gim.2016.32; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li Jin-tian, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P43; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Marshall CB, 2012, METHODS, V57, P473, DOI 10.1016/j.ymeth.2012.06.014; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; NUREKAMAL MSA, 1992, J BIOL CHEM, V267, P1415; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Romano AA, 2010, PEDIATRICS, V126, P746, DOI 10.1542/peds.2009-3207; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Sakabe K, 2002, FEBS LETT, V511, P15, DOI 10.1016/S0014-5793(01)03264-1; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shao HP, 1999, ARCH BIOCHEM BIOPHYS, V371, P207, DOI 10.1006/abbi.1999.1448; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Smith MJ, 2014, NAT CHEM BIOL, V10, P223, DOI [10.1038/NCHEMBIO.1435, 10.1038/nchembio.1435]; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; Stolze B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08535; STOUTEN PFW, 1993, FEBS LETT, V320, P1, DOI 10.1016/0014-5793(93)81644-F; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Yaoita M, 2016, HUM GENET, V135, P209, DOI 10.1007/s00439-015-1627-5; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	63	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15641	15652		10.1074/jbc.M116.714196	http://dx.doi.org/10.1074/jbc.M116.714196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226556	Green Published, hybrid			2022-12-26	WOS:000380584200019
J	Qin, L; Guimaraes, DSPSF; Melesse, M; Hall, MC				Qin, Liang; Guimaraes, Dimitrius Santiago P. S. F.; Melesse, Michael; Hall, Mark C.			Substrate Recognition by the Cdh1 Destruction Box Receptor Is a General Requirement for APC/C-Cdh1-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING-COMPLEX; CYCLE-DEPENDENT DEGRADATION; MITOTIC CHECKPOINT COMPLEX; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; KEN-BOX; PSEUDOSUBSTRATE INHIBITION; SPINDLE CHECKPOINT; UBIQUITIN LIGASE; MEDIATED PROTEOLYSIS	The anaphase-promoting complex, or cyclosome (APC/C), is a ubiquitin ligase that selectively targets proteins for degradation in mitosis and the G(1) phase and is an important component of the eukaryotic cell cycle control system. How the APC/C specifically recognizes its substrates is not fully understood. Although well characterized degron motifs such as the destruction box (D-box) and KEN-box are commonly found in APC/C substrates, many substrates apparently lack these motifs. A variety of alternative APC/C degrons have been reported, suggesting either that multiple modes of substrate recognition are possible or that our definitions of degron structure are incomplete. We used an in vivo yeast assay to compare the G1 degradation rate of 15 known substrates of the APC/C co-activator Cdh1 under normal conditions and conditions that impair binding of D-box, KEN-box, and the recently identified ABBA motif degrons to Cdh1. The D-box receptor was required for efficient proteolysis of all Cdh1 substrates, despite the absence of canonical D-boxes in many. In contrast, the KEN-box receptor was only required for normal proteolysis of a subset of substrates and the ABBA motif receptor for a single substrate in our system. Our results suggest that binding to the D-box receptor may be a shared requirement for recognition and processing of all Cdh1 substrates.	[Hall, Mark C.] Purdue Univ, Dept Biochem, 1203 West State St, W Lafayette, IN 47907 USA; Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, 1203 West State St, W Lafayette, IN 47907 USA.	mchall@purdue.edu	Melesse, Michael/AAA-9425-2019; Hall, Mark C./D-1698-2011	Melesse Vergara, Michael/0000-0002-3474-6981; Hall, Mark/0000-0001-6429-2506	National Institutes of Health [P30 CA02316]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the Purdue Center for Cancer Research shared resources, supported by National Institutes of Health Grant P30 CA02316, for DNA sequencing analysis. We thank Dr. Adam Rudner (University of Ottawa) for providing antibodies to APC subunits.	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Araki M, 2005, GENE DEV, V19, P2458, DOI 10.1101/gad.1361905; Arnold L, 2015, MOL BIOL CELL, V26, P843, DOI 10.1091/mbc.E14-09-1342; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Benanti JA, 2009, MOL CELL, V33, P581, DOI 10.1016/j.molcel.2009.01.032; Burton JL, 2011, EMBO J, V30, P1818, DOI 10.1038/emboj.2011.90; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Castro A, 2003, MOL CELL BIOL, V23, P4126, DOI 10.1128/MCB.23.12.4126-4138.2003; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Choi E, 2008, J BIOL CHEM, V283, P23701, DOI 10.1074/jbc.M803695200; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cotto-Rios XM, 2011, J CELL BIOL, V194, P177, DOI 10.1083/jcb.201101062; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Di Fiore B, 2015, DEV CELL, V32, P358, DOI 10.1016/j.devcel.2015.01.003; Diaz-Martinez LA, 2015, J BIOL CHEM, V290, P2431, DOI 10.1074/jbc.M114.616490; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Eshleman HD, 2014, J CELL SCI, V127, P4974, DOI 10.1242/jcs.161273; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gordon DM, 2001, P NATL ACAD SCI USA, V98, P12515, DOI 10.1073/pnas.231212498; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Ko N, 2007, MOL BIOL CELL, V18, P5139, DOI 10.1091/mbc.E07-05-0509; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lindon C, 2008, BIOCHEM SOC T, V36, P405, DOI 10.1042/BST0360405; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Martinez JS, 2012, CELL CYCLE, V11, P384, DOI 10.4161/cc.11.2.18944; McLean JR, 2011, CRIT REV BIOCHEM MOL, V46, P118, DOI 10.3109/10409238.2010.541420; Melesse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103517; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Ostapenko D, 2011, MOL BIOL CELL, V22, P2175, DOI 10.1091/mbc.E11-01-0031; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pfleger CM, 2000, GENE DEV, V14, P655; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Robbins JA, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-23; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shah R, 2001, GENETICS, V159, P965; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Sullivan M, 2007, J BIOL CHEM, V282, P19710, DOI 10.1074/jbc.M701507200; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Van Voorhis VA, 2014, CURR BIOL, V24, P1556, DOI 10.1016/j.cub.2014.05.052; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Zur A, 2002, EMBO J, V21, P4500, DOI 10.1093/emboj/cdf452	66	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15564	15574		10.1074/jbc.M116.731190	http://dx.doi.org/10.1074/jbc.M116.731190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226622	Green Published, hybrid			2022-12-26	WOS:000380584200013
J	Wei, QE; Ran, TT; Ma, CC; He, JH; Xu, DQ; Wang, WW				Wei, Qiaoe; Ran, Tingting; Ma, Chencui; He, Jianhua; Xu, Dongqing; Wang, Weiwu			Crystal Structure and Function of PqqF Protein in the Pyrroloquinoline Quinone Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-DEGRADING ENZYME; MITOCHONDRIAL PROCESSING PEPTIDASE; GLUCOSE-DEHYDROGENASE; SERRATIA-MARCESCENS; ACINETOBACTER-CALCOACETICUS; METHANOL DEHYDROGENASE; PRODIGIOSIN PRODUCTION; KLEBSIELLA-PNEUMONIAE; RESPIRATORY-CHAIN; MASS-SPECTROMETRY	Pyrroloquinoline quinone (PQQ) has received considerable attention due to its numerous important physiological functions. PqqA is a precursor peptide of PQQ with two conserved residues: glutamate and tyrosine. After linkage of the C gamma of glutamate and C epsilon of tyrosine by PqqE, these two residues are hypothesized to be cleaved from PqqA by PqqF. The linked glutamate and tyrosine residues are then used to synthesize PQQ. Here, we demonstrated that the pqqF gene is essential for PQQ biosynthesis as deletion of it eliminated the inhibition of prodigiosin production by glucose. We further determined the crystal structure of PqqF, which has a closed clamshell-like shape. The PqqF consists of two halves composed of an N-and a C-terminal lobe. The PqqF-N and PqqF-C lobes form a chamber with the volume of the cavity of similar to 9400 angstrom(3). The PqqF structure conforms to the general structure of inverzincins. Compared with the most thoroughly characterized inverzincin insulin-degrading enzyme, the size of PqqF chamber is markedly smaller, which may define the specificity for its substrate PqqA. Furthermore, the 14-amino acid-residue-long tag formed by the N-terminal tag from expression vector precisely protrudes into the counterpart active site; this N-terminal tag occupies the active site and stabilizes the closed, inactive conformation. His-48, His-52, Glu-129 and His-14 from the N-terminal tag coordinate with the zinc ion. Glu-51 acts as a base catalyst. The observed histidine residue-mediated inhibition may be applicable for the design of a peptide for the inhibition of M16 metalloproteases.	[Wei, Qiaoe; Ran, Tingting; Ma, Chencui; Xu, Dongqing; Wang, Weiwu] Nanjing Agr Univ, Dept Microbiol, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China; [He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China	Nanjing Agricultural University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Xu, DQ; Wang, WW (corresponding author), Nanjing Agr Univ, Dept Microbiol, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.	dqxu@njau.edu.cn; wwwang@njau.edu.cn	wang, weiwu/AAD-1490-2022	, Tingting/0000-0002-5541-3553; , weiwu/0000-0001-6922-9207; Xu, Dongqing/0000-0002-8388-2330	National Natural Science Foundation of Chain [31100028, 31170686, 31400055]; Natural Science Foundation of Jiangsu Province [BK20140690]; Youth Science and Technology Innovation Fund from Nanjing Agricultural University [KJ2013027]	National Natural Science Foundation of Chain(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Youth Science and Technology Innovation Fund from Nanjing Agricultural University	This work was supported by National Natural Science Foundation of Chain Grants 31100028, 31170686, and 31400055, Natural Science Foundation of Jiangsu Province Grant BK20140690, and a grant from the Youth Science and Technology Innovation Fund from Nanjing Agricultural University (KJ2013027). The authors declare that they have no conflicts of interest associated with the contents of this manuscript.	AIZENMAN E, 1992, J NEUROSCI, V12, P2362; Aleshin AE, 2009, STRUCTURE, V17, P1465, DOI 10.1016/j.str.2009.09.009; Anthony C, 2004, ARCH BIOCHEM BIOPHYS, V428, P2, DOI 10.1016/j.abb.2004.03.038; Bennett RG, 1997, DIABETES, V46, P197, DOI 10.2337/diabetes.46.2.197; BUNTING MI, 1949, J BACTERIOL, V58, P114, DOI 10.1128/JB.58.1.114-115.1949; Charton J, 2015, EUR J MED CHEM, V90, P547, DOI 10.1016/j.ejmech.2014.12.005; Charton J, 2014, EUR J MED CHEM, V79, P184, DOI 10.1016/j.ejmech.2014.04.009; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEMAIN AL, 1995, SYMP SOC GEN MICROBI, V53, P205; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; Duine JA, 2001, CHEM REC, V1, P74; DUINE JA, 1980, EUR J BIOCHEM, V108, P187, DOI 10.1111/j.1432-1033.1980.tb04711.x; Durham TB, 2015, J BIOL CHEM, V290, P20044, DOI 10.1074/jbc.M115.638205; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fender JE, 2012, APPL ENVIRON MICROB, V78, P6225, DOI 10.1128/AEM.01778-12; GERBER N N, 1975, Critical Reviews in Microbiology, V3, P469, DOI 10.3109/10408417509108758; GOOSEN N, 1989, A VAN LEEUW J MICROB, V56, P85, DOI 10.1007/BF00822588; GROEN BW, 1990, METHOD ENZYMOL, V188, P33; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Hao GF, 2012, J AM CHEM SOC, V134, P11168, DOI 10.1021/ja3001908; He K, 2003, BIOCHEM PHARMACOL, V65, P67, DOI 10.1016/S0006-2952(02)01453-3; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; Krishnaraj PU, 2001, FEMS MICROBIOL LETT, V205, P215, DOI 10.1111/j.1574-6968.2001.tb10950.x; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Magnusson OT, 2004, J AM CHEM SOC, V126, P5342, DOI 10.1021/ja0493852; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104851; MATSUSHITA K, 1987, J BACTERIOL, V169, P205, DOI 10.1128/jb.169.1.205-209.1987; McCord LA, 2013, P NATL ACAD SCI USA, V110, P13827, DOI 10.1073/pnas.1304575110; Metlitzky M, 2012, JBPC, V3, P206, DOI DOI 10.4236/JBPC.2012.32023; MEULENBERG JJM, 1990, FEMS MICROBIOL LETT, V71, P337, DOI 10.1016/0378-1097(90)90244-K; MEULENBERG JJM, 1992, MOL GEN GENET, V232, P284, DOI 10.1007/BF00280008; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Muhl D, 2014, METHODS MOL BIOL, V1149, P521, DOI 10.1007/978-1-4939-0473-0_40; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagao Y, 2000, J BIOL CHEM, V275, P34552, DOI 10.1074/jbc.M003110200; Nakano M, 2015, J NUTR SCI VITAMINOL, V61, P241, DOI 10.3177/jnsv.61.241; Noji N, 2007, J AGR FOOD CHEM, V55, P7258, DOI 10.1021/jf070483r; Ohtsuka J, 2009, PROTEINS, V75, P774, DOI 10.1002/prot.22365; Puehringer Sandra, 2008, BMC Biochemistry, V9, P8, DOI 10.1186/1471-2091-9-8; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Sarker MR, 1997, MOL MICROBIOL, V23, P410, DOI 10.1046/j.1365-2958.1997.t01-1-00190.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarzenbacher R, 2004, PROTEINS, V56, P401, DOI 10.1002/prot.20085; Shen YQ, 2012, BIOCHEMISTRY-US, V51, P2265, DOI 10.1021/bi201763d; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sole M, 1997, LETT APPL MICROBIOL, V25, P81, DOI 10.1046/j.1472-765X.1997.00171.x; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; Takeda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115722; Tao R, 2015, INFLAMMATION, V38, P1546, DOI 10.1007/s10753-015-0129-x; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Toyama H, 1997, MICROBIOL-SGM, V143, P595, DOI 10.1099/00221287-143-2-595; Tsai TY, 2009, PROTEINS, V76, P1042, DOI 10.1002/prot.22461; Umezawa K, 2015, J BACTERIOL, V197, P1322, DOI 10.1128/JB.02376-14; VANKLEEF MAG, 1988, ARCH MICROBIOL, V150, P32, DOI 10.1007/BF00409714; VANKLEEF MAG, 1988, FEBS LETT, V237, P91, DOI 10.1016/0014-5793(88)80178-9; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; WESTERLING J, 1979, BIOCHEM BIOPH RES CO, V87, P719, DOI 10.1016/0006-291X(79)92018-7; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Zhang CL, 2015, MOL MED REP, V12, P4382, DOI 10.3892/mmr.2015.3990	70	15	16	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15575	15587		10.1074/jbc.M115.711226	http://dx.doi.org/10.1074/jbc.M115.711226			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231346	hybrid, Green Published			2022-12-26	WOS:000380584200014
J	Wakabayashi, T; Hidaka, R; Fujimaki, S; Asashima, M; Kuwabara, T				Wakabayashi, Tamami; Hidaka, Ryo; Fujimaki, Shin; Asashima, Makoto; Kuwabara, Tomoko			Diabetes Impairs Wnt3 Protein-induced Neurogenesis in Olfactory Bulbs via Glutamate Transporter 1 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; POSTNATAL SUBVENTRICULAR ZONE; FIBROBLAST GROWTH FACTOR-2; PROGENITOR CELLS; IN-VITRO; NEUROTROPHIC FACTOR; DENTATE GYRUS; NEURONAL DIFFERENTIATION; ALZHEIMERS-DISEASE	Diabetes is associated with impaired cognitive function. Streptozotocin (STZ)-induced diabetic rats exhibit a loss of neurogenesis and deficits in behavioral tasks involving spatial learning and memory; thus, impaired adult hippocampal neurogenesis may contribute to diabetes-associated cognitive deficits. Recent studies have demonstrated that adult neurogenesis generally occurs in the dentate gyrus of the hippocampus, the sub ventricular zone, and the olfactory bulbs (OB) and is defective in patients with diabetes. We hypothesized that OB neurogenesis and associated behaviors would be affected in diabetes. In this study, we show that inhibition of Wnt3-induced neurogenesis in the OB causes several behavioral deficits in STZ-induced diabetic rats, including impaired odor discrimination, cognitive dysfunction, and increased anxiety. Notably, the sodium- and chloride-dependent GABA transporters and excitatory amino acid transporters that localize to GABAergic and glutamatergic terminals decreased in the OB of diabetic rats. Moreover, GAT1 inhibitor administration also hindered Wnt3-induced neurogenesis in vitro. Collectively, these data suggest that STZ-induced diabetes adversely affects OB neurogenesis via GABA and glutamate transporter systems, leading to functional impairments in olfactory performance.	[Wakabayashi, Tamami; Hidaka, Ryo; Fujimaki, Shin; Asashima, Makoto; Kuwabara, Tomoko] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Stem Cell Engn Res Grp, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan; [Fujimaki, Shin] Univ Tsukuba, Grad Sch Comprehens Human Sci, Phys Educ Hlth & Sport Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3038577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Wakabayashi, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Stem Cell Engn Res Grp, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	t.warashina@aist.go.jp	Kuwabara, Tomoko/M-1639-2018	Kuwabara, Tomoko/0000-0002-7668-0896	National Institute of Advanced Industrial Science and Technology; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Mitsubishi Foundation	National Institute of Advanced Industrial Science and Technology; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	Supported by the National Institute of Advanced Industrial Science and Technology.r Supported by a grant-in-aid for scientific research on innovative areas, a grant-in-aid for scientific research (B), the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Takeda Science Foundation, and the Mitsubishi Foundation. To whom correspondence should be addressed. Tel.: 81-29-861-2529; Fax: 81-29-861-2897; E-mail: t.warashina@aist.go.jp.	Anarkooli IJ, 2008, EXP DIABETES RES, DOI 10.1155/2008/638467; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bhutada P, 2012, PROG NEURO-PSYCHOPH, V37, P96, DOI 10.1016/j.pnpbp.2012.01.009; Biessels GJ, 2002, EUR J PHARMACOL, V441, P1, DOI 10.1016/S0014-2999(02)01486-3; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Carter BS, 2012, PHYSIOL GENOMICS, V44, P1188, DOI 10.1152/physiolgenomics.00097.2012; Coleman E, 2004, GLIA, V48, P166, DOI 10.1002/glia.20068; Coleman ES, 2010, BRAIN RES, V1306, P131, DOI 10.1016/j.brainres.2009.10.005; Dennis JC, 2005, J NEUROCYTOL, V34, P3, DOI 10.1007/s11068-005-5044-x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fujimaki S, 2014, J BIOL CHEM, V289, P7399, DOI 10.1074/jbc.M113.539247; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gandhi GK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090048; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Giachino C, 2009, EUR J NEUROSCI, V30, P9, DOI 10.1111/j.1460-9568.2009.06798.x; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gouveri E, 2014, ANGIOLOGY, V65, P869, DOI 10.1177/0003319714520956; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hidaka R, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt201; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Jabbarpour Z, 2014, BRAIN RES BULL, V101, P51, DOI 10.1016/j.brainresbull.2013.12.013; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin XT, 2012, EUR J NEUROSCI, V36, P2482, DOI 10.1111/j.1460-9568.2012.08147.x; Jolivalt CG, 2012, NEUROSCIENCE, V202, P405, DOI 10.1016/j.neuroscience.2011.11.032; Jurdak N, 2009, PHYSIOL BEHAV, V96, P1, DOI 10.1016/j.physbeh.2008.07.023; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Kumagai AK, 1999, DIABETES-METAB RES, V15, P261, DOI 10.1002/(SICI)1520-7560(199907/08)15:4<261::AID-DMRR43>3.0.CO;2-Z; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kuwabara T, 2011, EMBO MOL MED, V3, P742, DOI 10.1002/emmm.201100177; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lau WM, 2007, RESTOR NEUROL NEUROS, V25, P17; LEFLOCH JP, 1993, DIABETES CARE, V16, P934, DOI 10.2337/diacare.16.6.934; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Milanese M, 2010, J NEUROCHEM, V113, P489, DOI 10.1111/j.1471-4159.2010.06628.x; Moreno-Estelles M, 2012, STEM CELLS, V30, P2796, DOI 10.1002/stem.1243; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Muranyi M, 2006, DIABETES, V55, P349, DOI 10.2337/diabetes.55.02.06.db05-0654; Nguyen L, 2003, J NEUROSCI, V23, P3278; Nishimura M, 1997, MOL BRAIN RES, V45, P268, DOI 10.1016/S0169-328X(96)00259-8; Nitta A, 2002, NEUROTOXICOL TERATOL, V24, P695, DOI 10.1016/S0892-0362(02)00220-9; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Pallotto M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00166; Palmer TD, 1999, J NEUROSCI, V19, P8487; Piazza FV, 2011, BEHAV BRAIN RES, V217, P16, DOI 10.1016/j.bbr.2010.09.017; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3739, DOI 10.1113/jphysiol.2008.155325; Ramanathan M, 1998, PSYCHOPHARMACOLOGY, V135, P361, DOI 10.1007/s002130050523; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; RERUP C, 1969, EUR J PHARMACOL, V7, P89, DOI 10.1016/0014-2999(69)90169-1; Revsin Y, 2009, NEUROPSYCHOPHARMACOL, V34, P747, DOI 10.1038/npp.2008.136; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.0.CO;2-C; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Unemura K, 2012, J PHARMACOL SCI, V119, P30, DOI 10.1254/jphs.12047FP; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Verdile G, 2015, NEUROBIOL DIS, V84, P22, DOI 10.1016/j.nbd.2015.04.008; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; Zhou Yun, 2013, Front Endocrinol (Lausanne), V4, P165, DOI 10.3389/fendo.2013.00165	86	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15196	15211		10.1074/jbc.M115.672857	http://dx.doi.org/10.1074/jbc.M115.672857			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226528	Green Published, hybrid			2022-12-26	WOS:000380583200028
J	Wuttke, A; Yu, Q; Tengholm, A				Wuttke, Anne; Yu, Qian; Tengholm, Anders			Autocrine Signaling Underlies Fast Repetitive Plasma Membrane Translocation of Conventional and Novel Protein Kinase C Isoforms in beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; P2Y(1) RECEPTORS; TUMOR PROMOTER; CA2+ INFLUX; PKC-ALPHA; GLUCOSE; DYNAMICS; INVOLVEMENT; DELTA; ACTIVATION	PKC signaling has been implicated in the regulation of many cell functions, including metabolism, cell death, proliferation, and secretion. Activation of conventional and novel PKC isoforms is associated with their Ca2+- and/or diacylglycerol (DAG)-dependent translocation to the plasma membrane. In 13 cells, exocytosis of insulin granules evokes brief (<10 s) local DAG elevations ("spiking") at the plasma membrane because of autocrine activation of P2Y(1), purinoceptors by ATP co-released with insulin. Using total internal reflection microscopy, fluorescent protein -tagged PKCs, and signaling biosensors, we investigated whether DAG spiking causes membrane recruitment of PKCs and whether different classes of PKCs show characteristic responses. Glucose stimulation of MINE cells triggered DAG spiking with concomitant repetitive translocation of the novel isoforms PKCI, PKCE, and PKCirp The conventional PKCa, PKCI3I, and PKC beta II isoforms showed a more complex pattern with both rapid and slow translocation. K+ depolarization-induced PKCE translocation entirely mirrored DAG spiking, whereas PKC beta 1 translocation showed a sustained component, reflecting the subplasma membrane Ca2+ concentration ([Ca2+)pm), with additional effect during DAG spikes. Interference with DAG spiking by purinoceptor inhibition prevented intermittent translocation of PKCs and reduced insulin secretion but did not affect [Ca2+]{,1 elevation or sustained PKCAI translocation. The muscarinic agonist carbachol induced pronounced transient PKCi3I translocation and sustained recruitment of PKCE. When rise of [Ca2+](p), was prevented, the carbachol-induced DAG and PKCE responses were somewhat reduced, but PKCI3I translocation was completely abolished. We conclude that exocytosis-induced DAG spikes efficiently recruit both conventional and novel PKCs to the beta cell plasma membrane. PKC signaling is thus implicated in autocrine regulation of beta cell function.	[Wuttke, Anne; Yu, Qian; Tengholm, Anders] Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Box 571, S-75123 Uppsala, Sweden	Uppsala University	Tengholm, A (corresponding author), Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Box 571, S-75123 Uppsala, Sweden.	anders.tengholm@mcb.uu.se		YU, QIAN/0000-0003-4888-9446	Swedish Research Council; Novo Nordisk Foundation; Swedish Diabetes Foundation; European Foundation for the Study of Diabetes (EFSD)-MSD; Diabetes Research AMP; Wellness Foundation; Family Ernfors Foundation; Novo Nordisk Fonden [NNF14OC0010363] Funding Source: researchfish; European Foundation for the Study of Diabetes [MSD 2014_2] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Foundation; European Foundation for the Study of Diabetes (EFSD)-MSD; Diabetes Research AMP; Wellness Foundation; Family Ernfors Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	This work was supported by grants from the Swedish Research Council, the Novo Nordisk Foundation, the Swedish Diabetes Foundation, the European Foundation for the Study of Diabetes (EFSD)-MSD, the Diabetes Research & Wellness Foundation, and the Family Ernfors Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	ARKHAMMAR P, 1989, BIOCHEM J, V264, P207, DOI 10.1042/bj2640207; ARKHAMMAR P, 1994, J BIOL CHEM, V269, P2743; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; Biden TJ, 2008, BIOCHEM SOC T, V36, P916, DOI 10.1042/BST0360916; Carpenter L, 2004, DIABETES, V53, P53, DOI 10.2337/diabetes.53.1.53; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Duquesnes N, 2011, J MOL CELL CARDIOL, V51, P665, DOI 10.1016/j.yjmcc.2011.07.013; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Harris TE, 1996, BIOCHEM BIOPH RES CO, V227, P672, DOI 10.1006/bbrc.1996.1567; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; HII CST, 1987, BIOCHEM J, V246, P489, DOI 10.1042/bj2460489; Hui X, 2014, MOL CELL BIOL, V34, P2370, DOI 10.1128/MCB.00040-14; Ishikawa T, 2005, LIFE SCI, V77, P462, DOI 10.1016/j.lfs.2005.01.008; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; JONES PM, 1985, FEBS LETT, V191, P102, DOI 10.1016/0014-5793(85)81002-4; Kaneto H, 2002, J BIOL CHEM, V277, P3680, DOI 10.1074/jbc.M109647200; Khan S, 2014, DIABETOLOGIA, V57, P2535, DOI 10.1007/s00125-014-3368-8; KNUTSON KL, 1994, ENDOCRINOLOGY, V135, P881, DOI 10.1210/en.135.3.881; Knutson KL, 1996, J CELL BIOCHEM, V60, P130, DOI 10.1002/(SICI)1097-4644(19960101)60:1<130::AID-JCB15>3.0.CO;2-T; MALAISSE WJ, 1980, CANCER RES, V40, P3827; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marin-Vicente C, 2008, J MOL BIOL, V377, P1038, DOI 10.1016/j.jmb.2007.12.011; Mendez CF, 2003, J BIOL CHEM, V278, P44753, DOI 10.1074/jbc.M308664200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Petit P, 2009, EUR J PHARM SCI, V37, P67, DOI 10.1016/j.ejps.2009.01.007; Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200; Salehi A, 2005, DIABETES, V54, P2126, DOI 10.2337/diabetes.54.7.2126; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; TAMAGAWA T, 1985, FEBS LETT, V183, P433, DOI 10.1016/0014-5793(85)80825-5; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Tang SH, 1998, DIABETES, V47, P905, DOI 10.2337/diabetes.47.6.905; Tengholm A, 2014, DIABETOLOGIA, V57, P2436, DOI 10.1007/s00125-014-3392-8; Tewson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042791; Thore S, 2004, J BIOL CHEM, V279, P19396, DOI 10.1074/jbc.C400088200; Tian YM, 1996, MOL CELL ENDOCRINOL, V119, P185, DOI 10.1016/0303-7207(96)03811-7; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; VIRJI MAG, 1978, ENDOCRINOLOGY, V102, P706, DOI 10.1210/endo-102-3-706; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Wuttke A, 2013, FASEB J, V27, P1610, DOI 10.1096/fj.12-221499; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zawalich WS, 2001, MOL CELL ENDOCRINOL, V177, P95, DOI 10.1016/S0303-7207(01)00422-1; Zeng LL, 2012, ADV EXP MED BIOL, V740, P639, DOI 10.1007/978-94-007-2888-2_28; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	48	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14986	14995		10.1074/jbc.M115.698456	http://dx.doi.org/10.1074/jbc.M115.698456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226533	Green Published, hybrid			2022-12-26	WOS:000380583200011
J	Codding, SJ; Marty, N; Abdullah, N; Johnson, CP				Codding, Sara J.; Marty, Naomi; Abdullah, Nazish; Johnson, Colin P.			Dysferlin Binds SNAREs (Soluble N-Ethylmaleimide-sensitive Factor (NSF) Attachment Protein Receptors) and Stimulates Membrane Fusion in a Calcium-sensitive Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium-binding protein; exocytosis; membrane fusion; muscular dystrophy; SNARE proteins; dysferlin	GIRDLE MUSCULAR-DYSTROPHY; C2 DOMAINS REVEALS; VESICLE FUSION; CELL-MEMBRANE; MIYOSHI MYOPATHY; SKELETAL-MUSCLE; REPAIR; OTOFERLIN; SYNAPTOTAGMIN; COMPLEX	Resealing of tears in the sarcolemma of myofibers is a necessary step in the repair of muscle tissue. Recent work suggests a critical role for dysferlin in the membrane repair process and that mutations in dysferlin are responsible for limb girdle muscular dystrophy 2B and Miyoshi myopathy. Beyond membrane repair, dysferlin has been linked to SNARE-mediated exocytotic events including cytokine release and acid sphingomyelinase secretion. However, it is unclear whether dysferlin regulates SNARE-mediated membrane fusion. In this study we demonstrate a direct interaction between dysferlin and the SNARE proteins syntaxin 4 and SNAP-23. In addition, analysis of FRET and in vitro reconstituted lipid mixing assays indicate that dysferlin accelerates syntaxin 4/SNAP-23 heterodimer formation and SNARE-mediated lipid mixing in a calcium-sensitive manner. These results support a function for dysferlin as a calcium-sensing SNARE effector for membrane fusion events.	[Codding, Sara J.; Marty, Naomi; Abdullah, Nazish; Johnson, Colin P.] Oregon State Univ, Dept Biochem & Biophys, 2011 ALS, Corvallis, OR 97331 USA	Oregon State University	Johnson, CP (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 ALS, Corvallis, OR 97331 USA.	colin.johnson@oregonstate.edu	abdullah, nazish/M-9541-2016	abdullah, nazish/0000-0002-4776-7300; Codding, Sara/0000-0002-2519-0299; Johnson, Colin/0000-0002-6783-2835				Abdullah N, 2014, BIOPHYS J, V106, P382, DOI 10.1016/j.bpj.2013.11.4492; Achanzar WE, 1997, J CELL SCI, V110, P1073; Ampong Beryl N, 2005, Acta Myol, V24, P134; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Azakir BA, 2012, J BIOL CHEM, V287, P27629, DOI 10.1074/jbc.M112.391722; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Bushby KMD, 2000, ACTA NEUROL BELG, V100, P142; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Defour A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.272; Evesson FJ, 2010, J BIOL CHEM, V285, P28529, DOI 10.1074/jbc.M110.111120; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Han WQ, 2012, J CELL SCI, V125, P1225, DOI 10.1242/jcs.094565; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Humphrey GW, 2012, EXP CELL RES, V318, P127, DOI 10.1016/j.yexcr.2011.10.004; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; Kerr JP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00089; Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Lek A, 2012, TRAFFIC, V13, P185, DOI 10.1111/j.1600-0854.2011.01267.x; Lek A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-231; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lostal W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038036; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Marty NJ, 2013, BIOCHEMISTRY-US, V52, P5585, DOI 10.1021/bi400432f; Matsuda C, 1999, NEUROLOGY, V53, P1119, DOI 10.1212/WNL.53.5.1119; Matsuda C., 2012, PLOS CURR, V4, DOI DOI 10.1371/5035ADD8CAFF4; McDade JR, 2014, HUM MOL GENET, V23, P1677, DOI 10.1093/hmg/ddt557; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Padmanarayana M, 2014, BIOCHEMISTRY-US, V53, P5023, DOI 10.1021/bi5004469; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Redpath GMI, 2014, MOL BIOL CELL, V25, P3037, DOI 10.1091/mbc.E14-04-0947; Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Waddell LB, 2011, J NEUROPATH EXP NEUR, V70, P302, DOI 10.1097/NEN.0b013e31821350b0; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	51	14	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14575	14584		10.1074/jbc.M116.727016	http://dx.doi.org/10.1074/jbc.M116.727016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226605	hybrid, Green Published			2022-12-26	WOS:000380366700014
J	Sun, LW; Jiang, WJ; Sato, H; Kawachi, M; Lu, XW				Sun, Li-Wei; Jiang, Wen-Jing; Sato, Hiroaki; Kawachi, Masanobu; Lu, Xi-Wu			Rapid Classification and Identification of Microcystis aeruginosa Strains Using MALDI-TOF MS and Polygenetic Analysis	PLOS ONE			English	Article							RIBOSOMAL-RNA; INTACT MICROORGANISMS; GENUS MICROCYSTIS; MASS-SPECTROMETRY; CYANOBACTERIA; PHYCOCYANIN; PROTEINS; BACTERIA; GENES; 16S	Matrix-assisted laser desorption-ionization-time-of-flight mass spectrometry (MALDI-TOF MS) was used to establish a rapid, simple, and accurate method to differentiate among strains of Microcystis aeruginosa, one of the most prevalent types of bloom-forming cyanobacteria. M. aeruginosa NIES-843, for which a complete genome has been sequenced, was used to characterize ribosomal proteins as biomarkers and to optimize conditions for observing ribosomal proteins as major peaks in a given mass spectrum. Thirty-one of 52 ribosomal subunit proteins were detected and identified along the mass spectrum. Fifty-five strains of M. aeruginosa from different habitats were analyzed using MALDI-TOF MS; among these samples, different ribosomal protein types were observed. A polygenetic analysis was performed using an unweighted pair-group method with arithmetic means and different ribosomal protein types to classify the strains into five major clades. Two clades primarily contained toxic strains, and the other three clades contained exclusively non-toxic strains. This is the first study to differentiate cyanobacterial strains using MALDI-TOF MS.	[Sun, Li-Wei; Jiang, Wen-Jing; Lu, Xi-Wu] Southeast Univ, Sch Energy & Environm, Nanjing, Jiangsu, Peoples R China; [Sato, Hiroaki] Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, Environm Measurement Technol Grp, Tsukuba, Ibaraki, Japan; [Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Biodivers Resource Conservat Sect, Tsukuba, Ibaraki, Japan	Southeast University - China; National Institute of Advanced Industrial Science & Technology (AIST); National Institute for Environmental Studies - Japan	Sun, LW (corresponding author), Southeast Univ, Sch Energy & Environm, Nanjing, Jiangsu, Peoples R China.; Sato, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, Environm Measurement Technol Grp, Tsukuba, Ibaraki, Japan.	liwei-sun@seu.edu.cn; sato-hiroaki@aist.go.jp	Sato, Hiroaki/N-4160-2013; Sato, Hiroaki/AAC-3683-2019	Sato, Hiroaki/0000-0003-2558-9248; Sato, Hiroaki/0000-0003-2558-9248	Jiangsu Environmental Monitoring Foundation, China [1411]	Jiangsu Environmental Monitoring Foundation, China	The present study was supported by the Jiangsu Environmental Monitoring Foundation, China ( Project No. 1411), to LWS.	[Anonymous], 2008, DNA RES, DOI DOI 10.1093/dnares/dsm026; [Anonymous], 1999, TOXIC CYANOBACTERIA; Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077; Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584; Enora B, 2009, ISME J, V3, P419, DOI [10.1038/ismej.2008.121, DOI 10.1038/ISMEJ.2008.121]; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Francis G., 1878, NATURE, V18, P11, DOI [10.1038/018011d0, DOI 10.1038/018011D0]; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; Hettick JM, 2006, PROTEOMICS, V6, P6416, DOI 10.1002/pmic.200600335; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Kanae T, 2007, J PROTEOME RES, V6, P3899; Kanae T, 2007, ANAL CHEM, V79, P8712; Kardinaal WEA, 2005, AQUAT ECOL SER, V3, P41; Kasai F, 2004, NIES COLLECTION LIST, V7; Keys CJ, 2004, INFECT GENET EVOL, V4, P221, DOI 10.1016/j.meegid.2004.02.004; Krishnamurthy T, 1996, RAPID COMMUN MASS SP, V10, P1992, DOI 10.1002/(SICI)1097-0231(199612)10:15<1992::AID-RCM789>3.0.CO;2-V; Kuiper-Goodman T., 1999, TOXIC CYANOBACTERIA, P125; Kurmayer R, 2002, MICROB ECOL, V43, P107, DOI 10.1007/s00248-001-0039-3; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Linda E G, 2009, ALGAE, P96; Lyra C, 2001, INT J SYST EVOL MICR, V51, P513, DOI 10.1099/00207713-51-2-513; MOERSCHELL RP, 1990, J BIOL CHEM, V265, P19638; Neilan BA, 1997, INT J SYST BACTERIOL, V47, P693, DOI 10.1099/00207713-47-3-693; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P2286, DOI 10.1128/AEM.61.6.2286-2291.1995; Nishizawa T, 1999, J BIOCHEM-TOKYO, V126, P520, DOI 10.1093/oxfordjournals.jbchem.a022481; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Pineda FJ, 2003, ANAL CHEM, V75, P3817, DOI 10.1021/ac034069b; Randy JA, 1998, RAPID COMMUN MASS SP, V12, P630; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Ressom R., 1994, HLTH EFFECTS TOXIC C; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Simis SGH, 2005, LIMNOL OCEANOGR, V50, P237, DOI 10.4319/lo.2005.50.1.0237; Strickland J.D.H., 1968, BULLETIN, V167, P185; Sun LW, 2006, RAPID COMMUN MASS SP, V20, P3789, DOI 10.1002/rcm.2801; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tillett D, 2001, APPL ENVIRON MICROB, V67, P2810, DOI 10.1128/AEM.67.6.2810-2818.2001; World Health Organization (WHO), 1998, HLTH CRIT OTH SUPP I, V2; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9	38	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156275	10.1371/journal.pone.0156275	http://dx.doi.org/10.1371/journal.pone.0156275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227555	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500100
J	Brzezinski, M; Bury, K; Dabrowski, L; Holak, P; Sejda, A; Pawlak, M; Jagielak, D; Adamiak, Z; Rogowski, J				Brzezinski, M.; Bury, K.; Dabrowski, L.; Holak, P.; Sejda, A.; Pawlak, M.; Jagielak, D.; Adamiak, Z.; Rogowski, J.			The New 3D Printed Left Atrial Appendage Closure with a Novel Holdfast Device: A Pre-Clinical Feasibility Animal Study	PLOS ONE			English	Article							STROKE; FIBRILLATION; OCCLUSION; RISK; EXCLUSION; OBLITERATION; SURGERY; LAAOS	Introduction Many patients undergoing cardiac surgery have risk factors for both atrial fibrillation (AF) and stroke. The left atrial appendage (LAA) is the primary site for thrombi formation. The most severe complication of emboli derived from LAA is stroke, which is associated with a 12-month mortality rate of 38% and a 12-month recurrence rate of 17%. The most common form of treatment for atrial fibrillation and stroke prevention is the pharmacological therapy with anticoagulants. Nonetheless this form of therapy is associated with high risk of major bleeding. Therefore LAA occlusion devices should be tested for their ability to reduce future cerebral ischemic events in patients with high-risk of haemorrhage. Aim The aim of this study was to evaluate the safety and feasibility of a novel left atrial appendage exclusion device with a minimally invasive introducer in a swine model. Materials and Methods A completely novel LAA device, which is composed of two tubes connected together using a specially created bail, was designed using finite element modelling (FEM) to obtain an optimal support force of 36 N at the closure line. The monolithic form of the occluder was obtained by using additive manufacturing of granular PA2200 powder with the technology of selective laser sintering (SLS). Fifteen swine were included in the feasibility tests, with 10 animals undergoing fourteen days of follow-up and 5 animals undergoing long-term observation of 3 months. For one animal, the follow-up was further prolonged to 6 months. The device was placed via minithoracotomy. After the observation period, all of the animals were euthanized, and their hearts were tested for LAA closure and local inflammatory and tissue response. Results After the defined observation period, all fifteen hearts were explanted. In all cases the full closure of the LAA was achieved. The macroscopic and microscopic evaluation of the explanted hearts showed that all devices were securely integrated in the surrounding tissues. No pericarditis or macroscopic signs of inflammation at the site of the device were found. All pigs were in good condition with normal weight gain and no other clinical symptoms. Conclusion This novel 3D printed left atrial appendage closure technique with a novel holdfast device was proven to be safe and feasible in all pigs. A benign healing process without inflammation and damage to the surrounding structures or evidence of new thrombi formation was observed. Moreover, the uncomplicated survival and full LAA exclusion in all animals demonstrate the efficacy of this novel and relatively cheap device. Further clinical evaluation and implementation studies should be performed to introduce this new technology into clinical practice.	[Brzezinski, M.; Bury, K.; Pawlak, M.; Jagielak, D.; Rogowski, J.] Med Univ Gdansk, Dept Cardiac & Vasc Surg, Gdansk, Poland; [Dabrowski, L.] Gdansk Univ Technol, Fac Mech Engn, Gdansk, Poland; [Holak, P.; Adamiak, Z.] Univ Warmia & Mazury, Fac Vet Med, Dept Surg & Roentgenol, Olsztyn, Poland; [Sejda, A.] Med Univ Gdansk, Dept Pathomorphol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; University of Warmia & Mazury; Fahrenheit Universities; Medical University Gdansk	Bury, K (corresponding author), Med Univ Gdansk, Dept Cardiac & Vasc Surg, Gdansk, Poland.	kamilbury@me.com	Adamiak, Zbigniew/ABG-6173-2020; Dąbrowski, Leszek/AAF-6437-2019; adamiak, zbigniew/ABD-4580-2021	Adamiak, Zbigniew/0000-0001-8350-0198; Holak, Piotr/0000-0002-2050-1959; Sejda, Aleksandra/0000-0002-5498-5365; Bury, Kamil/0000-0002-4689-3516	JITMED LTD, JITSOLUTIONS SP ZOO [1/2013]	JITMED LTD, JITSOLUTIONS SP ZOO	This work was funded by JITMED LTD as a part of JITSOLUTIONS SP ZOO (www.jitsolutions.pl). The grant number was 1/2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2011, J THORAC CARDIOV SUR, V142, P1002, DOI 10.1016/j.jtcvs.2011.07.052; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; Block PC, 2009, JACC-CARDIOVASC INTE, V2, P594, DOI 10.1016/j.jcin.2009.05.005; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Crystal E, 2003, AM HEART J, V145, P174, DOI 10.1067/mhj.2003.44; Fumoto H, 2008, J THORAC CARDIOV SUR, V136, P1019, DOI 10.1016/j.jtcvs.2008.06.002; Garcia-Fernandez MA, 2003, J AM COLL CARDIOL, V42, P1253, DOI 10.1016/S0735-1097(03)00954-9; Healey JS, 2005, AM HEART J, V150, P288, DOI 10.1016/j.ahj.2004.09.054; International Organization for Standardization, 2007, 1099362007 ISO; Kanderian AS, 2008, J AM COLL CARDIOL, V52, P924, DOI 10.1016/j.jacc.2008.03.067; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Katz ES, 2000, J AM COLL CARDIOL, V36, P468, DOI 10.1016/S0735-1097(00)00765-8; Massumi A, 2013, AM J CARDIOL, V111, P869, DOI 10.1016/j.amjcard.2012.11.061; Park JW, 2011, CATHETER CARDIO INTE, V77, P700, DOI 10.1002/ccd.22764; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; PETERSEN P, 1988, EUR HEART J, V9, P291, DOI 10.1093/oxfordjournals.eurheartj.a062499; Price MJ, 2014, CIRCULATION, V130, P202, DOI 10.1161/CIRCULATIONAHA.114.009060; Reddy VY, 2011, CIRCULATION, V123, P417, DOI 10.1161/CIRCULATIONAHA.110.976449; Salzberg SP, 2010, J THORAC CARDIOV SUR, V139, P1269, DOI 10.1016/j.jtcvs.2009.06.033; Skaistis J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137444; Slater AD, 2012, ANN THORAC SURG, V93, P2035, DOI 10.1016/j.athoracsur.2011.12.077; Stollberger C, 2007, STROKE, V38, pE77, DOI 10.1161/STROKEAHA.107.489310; Viles-Gonzalez JF, 2012, J AM COLL CARDIOL, V59, P923, DOI 10.1016/j.jacc.2011.11.028; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	24	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0154559	10.1371/journal.pone.0154559	http://dx.doi.org/10.1371/journal.pone.0154559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219618	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700002
J	Khan, SA; Desclozeaux, M; Waugh, C; Hanger, J; Loader, J; Gerdts, V; Potter, A; Polkinghorne, A; Beagley, K; Timms, P				Khan, Shahneaz Ali; Desclozeaux, Marion; Waugh, Courtney; Hanger, Jon; Loader, Jo; Gerdts, Volker; Potter, Andrew; Polkinghorne, Adam; Beagley, Kenneth; Timms, Peter			Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants	PLOS ONE			English	Article							TH1/TH2 IMMUNE-RESPONSES; GENITAL-TRACT INFECTION; PROTECTIVE IMMUNITY; MURIDARUM INFECTION; GENE-EXPRESSION; TRACHOMATIS; POPULATION; PECORUM; DISEASE; MICE	Developing a vaccine against Chlamydia is key to combating widespread mortalities and morbidities associated with this infection in koalas (Phascolarctos cinereus). In previous studies, we have shown that two or three doses of a Recombinant Major Outer Membrane Protein (rMOMP) antigen-based vaccine, combined with immune stimulating complex (ISC) adjuvant, results in strong cellular and humoral immune responses in koalas. We have also separately evaluated a single dose vaccine, utilising a tri-adjuvant formula that comprises polyphosphazine based poly I:C and host defense peptides, with the same antigen. This formulation also produced strong cellular and humoral immune responses in captive koalas. In this current study, we directly compared the host immune responses of two sub-groups of wild Chlamydia negative koalas in one population vaccinated with the rMOMP protein antigen and adjuvanted with either the ISC or tri-adjuvant formula. Overall, both adjuvants produced strong Chlamydia-specific cellular (IFN-gamma and IL-17A) responses in circulating PBMCs as well as MOMP-specific and functional, in vitro neutralising antibodies. While the immune responses were similar, there were adjuvant-specific immune differences between the two adjuvants, particularly in relation to the specificity of the MOMP epitope antibody responses.	[Khan, Shahneaz Ali; Polkinghorne, Adam; Beagley, Kenneth; Timms, Peter] Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia; [Desclozeaux, Marion; Waugh, Courtney; Polkinghorne, Adam; Timms, Peter] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Ctr Anim Hlth Innovat, Locked Bag 4, Maroochydore, Qld 4558, Australia; [Hanger, Jon; Loader, Jo] Endeavour Vet Ecol Pty Ltd, 1695 Pumicestone Rd, Toorbul, Qld 4510, Australia; [Gerdts, Volker; Potter, Andrew] Univ Saskatchewan, Int Vaccine Ctr, Vaccine & Infect Dis Org, 120 Vet Rd, Saskatoon, SK, Canada; [Khan, Shahneaz Ali] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Khulshi 4202, Chittagong, Bangladesh	Queensland University of Technology (QUT); University of the Sunshine Coast; University of Saskatchewan	Timms, P (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.; Timms, P (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Ctr Anim Hlth Innovat, Locked Bag 4, Maroochydore, Qld 4558, Australia.	ptimms@usc.edu.au	; Beagley, Ken/J-1129-2012	Polkinghorne, Adam/0000-0002-6567-2962; Waugh, Courtney/0000-0001-5234-4137; Gerdts, Volker/0000-0001-8229-1611; Polkinghorne, Adam/0000-0002-6803-9222; Beagley, Ken/0000-0003-3112-6557; Timms, Peter/0000-0002-1682-0025	Australian Research Council (ARC) [LP1202000051]; Moreton Bay Rail Link project team; Department of Transport and Main Roads, Queensland Government; Queensland Department of Environment and Heritage Protection; Moreton Bay Regional Council; Endeavour Veterinary Ecology Pty Ltd; Australia Zoo Wildlife Hospital; Friends of the Koala; Lone Pine Koala Sanctuary; VIDO, Canada	Australian Research Council (ARC)(Australian Research Council); Moreton Bay Rail Link project team; Department of Transport and Main Roads, Queensland Government; Queensland Department of Environment and Heritage Protection; Moreton Bay Regional Council; Endeavour Veterinary Ecology Pty Ltd; Australia Zoo Wildlife Hospital; Friends of the Koala; Lone Pine Koala Sanctuary; VIDO, Canada	This project was financially supported by an Australian Research Council (ARC) Linkage grant (LP1202000051) awarded to PT, A. Polkinghorne and KB. The funding organization did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials. This work was significantly supported by the Moreton Bay Rail Link project team and the Department of Transport and Main Roads, Queensland Government. These groups provided support for the overall field work and sampling of the koalas. JH and JL are employed by Endeavour Veterinary Ecology Pty Ltd and were responsible for field work with the koalas and for collecting the samples for analysis. Special thanks to the authors' other collaborators including Queensland Department of Environment and Heritage Protection, Moreton Bay Regional Council, Endeavour Veterinary Ecology Pty Ltd, Australia Zoo Wildlife Hospital, Friends of the Koala, Lone Pine Koala Sanctuary and VIDO, Canada for their continued support of the authors' broader project to develop a chlamydial vaccine for the koala.	Agrawal T, 2009, CLIN IMMUNOL, V130, P347, DOI 10.1016/j.clim.2008.10.004; Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; Batteiger BE, 2010, J INFECT DIS, V201, pS178, DOI 10.1086/652400; Brown THT, 2012, VACCINE, V30, P350, DOI 10.1016/j.vaccine.2011.10.086; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; Cheng CM, 2011, VACCINE, V29, P3456, DOI 10.1016/j.vaccine.2011.02.057; Dar A, 2012, VET IMMUNOL IMMUNOP, V146, P289, DOI 10.1016/j.vetimm.2012.01.021; DARVILLE T, 1995, INFECT IMMUN, V63, P4675, DOI 10.1128/IAI.63.12.4675-4681.1995; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Gupta R, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-38; HOLLAND MJ, 1993, J INFECT DIS, V168, P1528, DOI 10.1093/infdis/168.6.1528; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Igietseme JU, 2000, J IMMUNOL, V164, P4212, DOI 10.4049/jimmunol.164.8.4212; Jha R, 2011, MICROBES INFECT, V13, P167, DOI 10.1016/j.micinf.2010.10.012; Jobbins SE, 2012, AUST J ZOOL, V60, P1, DOI 10.1071/ZO12013; Johansson M, 1997, INFECT IMMUN, V65, P1032, DOI 10.1128/IAI.65.3.1032-1044.1997; Kari L, 2009, J IMMUNOL, V182, P8063, DOI 10.4049/jimmunol.0804375; Khan SA, 2016, VACCINE, V34, P775, DOI 10.1016/j.vaccine.2015.12.050; Khan SA, 2014, VACCINE, V32, P5781, DOI 10.1016/j.vaccine.2014.08.037; Kollipara A, 2013, VACCINE, V31, P1217, DOI 10.1016/j.vaccine.2012.12.057; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Lau Q, 2014, HEREDITY, V113, P287, DOI 10.1038/hdy.2014.30; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomis WP, 2002, CURR OPIN MICROBIOL, V5, P87, DOI 10.1016/S1369-5274(02)00291-6; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Mathew M, 2014, DEV COMP IMMUNOL, V46, P423, DOI 10.1016/j.dci.2014.05.015; Mathew M, 2013, GENE, V527, P570, DOI 10.1016/j.gene.2013.06.019; Mathew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059958; Mozzato-Chamay N, 2000, J INFECT DIS, V182, P1545, DOI 10.1086/315891; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Mutwiri G, 2007, VACCINE, V25, P1204, DOI 10.1016/j.vaccine.2006.10.011; O'Meara CP, 2014, IMMUNOL CELL BIOL, V92, P287, DOI 10.1038/icb.2013.92; Ohman H, 2009, J INFECT DIS, V199, P1353, DOI 10.1086/597620; Olsen AW, 2015, J INFECT DIS; Polkinghorne A, 2013, VET MICROBIOLOGY; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Scurlock AM, 2011, INFECT IMMUN, V79, P1349, DOI 10.1128/IAI.00984-10; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Waugh CA, 2015, VACCINE; Waugh C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146934; WILMER JMW, 1993, WILDLIFE RES, V20, P177, DOI 10.1071/WR9930177; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Yang X, 1999, J IMMUNOL, V162, P1010; Yang X, 1998, Can J Infect Dis, V9, P99; Yu H, 2011, J IMMUNOL, V186, P3615, DOI 10.4049/jimmunol.1002952	49	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156094	10.1371/journal.pone.0156094	http://dx.doi.org/10.1371/journal.pone.0156094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219467	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700041
J	Luo, D; Wen, CX; Zhao, RC; Liu, XY; Liu, XX; Cui, JJ; Liang, JG; Liang, P				Luo, Dan; Wen, Caixia; Zhao, Rongchuan; Liu, Xinyu; Liu, Xinxin; Cui, Jingjing; Liang, Joshua G.; Liang, Peng			High Level Expression and Purification of Recombinant Proteins from Escherichia coli with AK-TAG	PLOS ONE			English	Article							ADENYLATE-KINASE; AFFINITY TAGS; FUSION PROTEINS; BINDING-PROTEIN; CLEAVAGE; EFFICIENT; TOXICITY; VECTORS; CLONING; MUTANT	Adenylate kinase (AK) from Escherichia coli was used as both solubility and affinity tag for recombinant protein production. When fused to the N-terminus of a target protein, an AK fusion protein could be expressed in soluble form and purified to near homogeneity in a single step from Blue-Sepherose via affinity elution with micromolar concentration of P1, P5- di (adenosine-5') pentaphosphate (Ap5A), a transition-state substrate analog of AK. Unlike any other affinity tags, the level of a recombinant protein expression in soluble form and its yield of recovery during each purification step could be readily assessed by AK enzyme activity in near real time. Coupled to a His-Tag installed at the N-terminus and a thrombin cleavage site at the C terminus of AK, the streamlined method, here we dubbed AK-TAG, could also allow convenient expression and retrieval of a cleaved recombinant protein in high yield and purity via dual affinity purification steps. Thus AK-TAG is a new addition to the arsenal of existing affinity tags for recombinant protein expression and purification, and is particularly useful where soluble expression and high degree of purification are at stake.	[Luo, Dan; Wen, Caixia; Zhao, Rongchuan; Liu, Xinyu; Liu, Xinxin; Cui, Jingjing; Liang, Peng] Sichuan Univ, Sch Life Sci, Dept Biochem & Mol Biol, Chengdu 610064, Peoples R China; [Liang, Joshua G.; Liang, Peng] Clover Biopharmaceut, Chengdu, Peoples R China; [Liang, Peng] GenHunter Corp, Grassmere Pk, Nashville, TN USA	Sichuan University	Liang, P (corresponding author), Sichuan Univ, Sch Life Sci, Dept Biochem & Mol Biol, Chengdu 610064, Peoples R China.; Liang, P (corresponding author), Clover Biopharmaceut, Chengdu, Peoples R China.; Liang, P (corresponding author), GenHunter Corp, Grassmere Pk, Nashville, TN USA.	liangpeng@scu.edu.cn	Zhao, Rongchuan/AAY-9881-2020	Zhao, Rongchuan/0000-0001-6198-8612	Chinese Ministry of Science and Technology [2012AA02A305, 2012ZX09103301]; 973 grant from the Chinese Ministry of Education	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); 973 grant from the Chinese Ministry of Education	This work was supported in part by a National 863 grant (2012AA02A305) (PL) and a grant (2012ZX09103301) from the Chinese Ministry of Science and Technology (PL), and a 973 grant (2012CB910700) from the Chinese Ministry of Education (PL). These authors (PL and JGL) are affiliated with commercial companies: Clover Biopharmaceuticals and GenHunter Corporation. The funders provided support in the form of salaries for authors PL and JGL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdelhamid MAA, 2014, APPL MICROBIOL BIOT, V98, P5677, DOI 10.1007/s00253-014-5754-z; BARZU O, 1983, FEBS LETT, V153, P280, DOI 10.1016/0014-5793(83)80624-3; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; CHANG JY, 1985, EUR J BIOCHEM, V151, P225, DOI 10.1111/j.1432-1033.1985.tb09092.x; Corti A., 2004, TUMOR NECROSIS FACTO; DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091; Eschenfeldt William H., 2010, Journal of Structural and Functional Genomics, V11, P31, DOI 10.1007/s10969-010-9082-y; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fong BA, 2010, TRENDS BIOTECHNOL, V28, P272, DOI 10.1016/j.tibtech.2010.02.003; Frey S, 2014, J CHROMATOGR A, V1337, P95, DOI 10.1016/j.chroma.2014.02.029; Goulas T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112643; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Hefti MH, 2001, ANAL BIOCHEM, V295, P180, DOI 10.1006/abio.2001.5214; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; HUSS RJ, 1983, J BIOL CHEM, V258, P3370; Hwang PM, 2014, FEBS LETT, V588, P247, DOI 10.1016/j.febslet.2013.09.028; KUPRIYANOV VV, 1986, BIOCHIM BIOPHYS ACTA, V869, P107, DOI 10.1016/0167-4838(86)90316-X; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lebendiker M, 2014, FEBS LETT, V588, P236, DOI 10.1016/j.febslet.2013.10.044; LIANG P, 1991, PROTEINS, V9, P28, DOI 10.1002/prot.340090105; LIANG P, 1989, GENE, V80, P21, DOI 10.1016/0378-1119(89)90246-1; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Liu XX, 2015, PROTEIN EXPRES PURIF, V109, P79, DOI 10.1016/j.pep.2015.02.010; Ma ZL, 2014, GENE, V544, P228, DOI 10.1016/j.gene.2014.04.037; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; McCluskey AJ, 2007, PROTEIN SCI, V16, P2726, DOI 10.1110/ps.072894407; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Nallamsetty S, 2007, NAT PROTOC, V2, P383, DOI 10.1038/nprot.2007.50; Shiau MY, 2001, MEDIAT INFLAMM, V10, P199, DOI 10.1080/09629350120080393; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; THOMPSON ST, 1975, P NATL ACAD SCI USA, V72, P669, DOI 10.1073/pnas.72.2.669; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155	34	5	5	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156106	10.1371/journal.pone.0156106	http://dx.doi.org/10.1371/journal.pone.0156106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214237	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200054
J	Mayen, AL; Bovet, P; Marti-Soler, H; Viswanathan, B; Gedeon, J; Paccaud, F; Marques-Vidal, P; Stringhini, S				Mayen, Ana-Lucia; Bovet, Pascal; Marti-Soler, Helena; Viswanathan, Bharathi; Gedeon, Jude; Paccaud, Fred; Marques-Vidal, Pedro; Stringhini, Silvia			Socioeconomic Differences in Dietary Patterns in an East African Country: Evidence from the Republic of Seychelles	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; RISK-FACTORS; CARDIOVASCULAR-DISEASE; VEGETABLE CONSUMPTION; NUTRITION TRANSITION; FOOD; ADULTS; ASSOCIATION; DETERMINANTS; OBESITY	Background In high income countries, low socioeconomic status (SES) is related to unhealthier dietary patterns, while evidence on the social patterning of diet in low and middle income countries is scarce. Objective In this study, we assess dietary patterns in the general population of a middle income country in the African region, the Republic of Seychelles, and examine their distribution according to educational level and income. Methods Data was drawn from two independent national surveys conducted in the Seychelles among adults aged 25-64 years in 2004 (n = 1236) and 2013 (n = 1240). Dietary patterns were assessed by principal component analysis (PCA). Educational level and income were used as SES indicators. Data from both surveys were combined as no interaction was found between SES and year. Results Three dietary patterns were identified: "snacks and drinks", "fruit and vegetables" and "fish and rice". No significant associations were found between SES and the "snacks and drinks" pattern. Low vs. high SES individuals had lower adherence to the "fruit and vegetables" pattern [prevalence ratio (95% CI) 0.71 (0.60-0.83)] but a higher adherence to the traditional "fish and rice" pattern [1.58 (1.32-1.88)]. Income modified the association between education and the "fish and rice" pattern (p = 0.02), whereby low income individuals had a higher adherence to this pattern in both educational groups. Conclusion Low SES individuals have a lower consumption of fruit and vegetables, but a higher consumption of traditional foods like fish and rice. The Seychelles may be at a degenerative diseases stage of the nutrition transition.	[Mayen, Ana-Lucia; Bovet, Pascal; Marti-Soler, Helena; Paccaud, Fred; Stringhini, Silvia] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Viswanathan, Bharathi; Gedeon, Jude] Minist Hlth, Victoria, Seychelles; [Marques-Vidal, Pedro] Univ Lausanne Hosp, Internal Med, Dept Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bovet, P (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Pascal.Bovet@chuv.ch	Mayen, Ana L/R-6521-2017; paccaud, fred/M-7516-2019; Marques-Vidal, Pedro M/C-9449-2009; Marti-Soler, Helena/AAA-7659-2019; Bovet, Pascal/F-4477-2011	Mayen, Ana L/0000-0001-9635-0416; Marques-Vidal, Pedro M/0000-0002-4548-8500; Marti-Soler, Helena/0000-0002-7127-205X; Bovet, Pascal/0000-0002-0242-4259	Swiss Excellence Government scholarship by the Swiss Confederation; Ambizione from the Swiss National Science Foundation (SNSF) [PZ00P3_147998]	Swiss Excellence Government scholarship by the Swiss Confederation; Ambizione from the Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	Ana-Lucia Mayen is supported by a Swiss Excellence Government scholarship awarded by the Swiss Confederation. Silvia Stringhini is supported by an Ambizione Grant (no PZ00P3_147998) from the Swiss National Science Foundation (SNSF).	Ag Bendech M, 1996, Sante, V6, P173; [Anonymous], 1994, EASY GUIDE FACTOR AN; Araujo MC, 2014, PUBLIC HEALTH NUTR, V17, P2740, DOI 10.1017/S1368980013003005; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Azizi H, 2015, HEALTH PROMOT PERSPE, V5, P72, DOI 10.15171/hpp.2015.009; Ball K, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0229-x; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Beaulac J, 2009, PREV CHRONIC DIS, V6; Becquey E, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-13; Bojorquez I, 2015, APPETITE, V92, P43, DOI 10.1016/j.appet.2015.05.003; Bovet P, 2008, OBES REV, V9, P511, DOI 10.1111/j.1467-789X.2008.00513.x; Bovet P, 2007, SEYCHELLES HEART STU; Bovet P., 2015, NATL SURVEY NONCOMMU; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Byers T, 2001, AM J EPIDEMIOL, V154, P1087, DOI 10.1093/aje/154.12.1087; Cardoso I, 2013, EUR J CLIN NUTR, V67, P135, DOI 10.1038/ejcn.2012.199; Chen Y, 2006, AM J CLIN NUTR, V84, P1224, DOI 10.1093/ajcn/84.5.1224; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Drewnowski A, 2005, J NUTR, V135, P900, DOI 10.1093/jn/135.4.900; El-Gilany AH, 2012, PAN AFR MED J, V13; Faber M, 2013, MATERN CHILD NUTR, V9, P409, DOI 10.1111/j.1740-8709.2011.00372.x; Faeh D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-163; Fallaize R, 2014, J MED INTERNET RES, V16, DOI [10.2196/jmir.3355, 10.2196/jmir.3105]; Fernandez-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78; Fuchs VR, 1982, TIME PREFERENCE HLTH; Hamilton LD., 2013, STAT STATA; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Hoffmann JF, 2013, CAD SAUDE PUBLICA, V29, P970, DOI 10.1590/S0102-311X2013000500014; Hopping BN, 2010, J HUM NUTR DIET, V23, P51, DOI 10.1111/j.1365-277X.2010.01100.x; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-912; International Fund for Agriculture Development (IFAD), 2013, EN POOR RUR PEOPL OV; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kesse-Guyot E, 2009, EUR J CLIN NUTR, V63, P521, DOI 10.1038/sj.ejcn.1602978; Landais E, 2015, PUBLIC HEALTH NUTR, V18, P809, DOI 10.1017/S1368980014001761; Lantz PM, 2005, J HEALTH SOC BEHAV, V46, P274, DOI 10.1177/002214650504600305; Layte R, 2009, EUR SOCIOL REV, V25, P399, DOI 10.1093/esr/jcn022; Link BG, 2008, J HEALTH SOC BEHAV, V49, P367, DOI 10.1177/002214650804900401; Link LB, 2013, AM J CLIN NUTR, V98, P1524, DOI 10.3945/ajcn.113.061184; Arruda SPM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-654; Marchioni Dirce Maria Lobo, 2005, Sao Paulo Med. J., V123, P124, DOI 10.1590/S1516-31802005000300007; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; McCartney DMA, 2013, BRIT J NUTR, V110, P2084, DOI 10.1017/S0007114513001463; MCLOYD VC, 1990, CHILD DEV, V61, P311, DOI 10.1111/j.1467-8624.1990.tb02781.x; Menchu M., 2002, CANASTA BASICA ALIME; Mishra G, 2002, EUR J CLIN NUTR, V56, P687, DOI 10.1038/sj.ejcn.1601391; Mohammadifard N, 2015, ARYA ATHEROSCLER, V11, P139; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2001, J NUTR, V131, p881S, DOI 10.1093/jn/131.3.881S; Njelekela M A, 2011, East Afr J Public Health, V8, P216; Olinto MTA, 2012, EUR J NUTR, V51, P281, DOI 10.1007/s00394-011-0213-4; Perrin AE, 2005, BRIT J NUTR, V93, P109, DOI 10.1079/BJN20041280; Phaswana-Mafuya N, 2013, SOCIODEMOGRAPHIC PRE, V2013, P6, DOI [10.3402/gha.v6i0.20680, DOI 10.3402/GHA.V6I0.20680]; Pisa PT, 2015, NUTRIENTS, V7, P3464, DOI 10.3390/nu7053464; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Safari A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-222; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; Singh Kishore, 2014, REP SPEC RAPP RIGHT; SMITH AM, 1992, J EPIDEMIOL COMMUN H, V46, P409, DOI 10.1136/jech.46.4.409; Sodjinou R, 2009, EUR J CLIN NUTR, V63, P222, DOI 10.1038/sj.ejcn.1602906; Statistics NBo, 2014, STAT NBO STAT B; Stringhini S, 2013, INT J EPIDEMIOL, V42, P1429, DOI 10.1093/ije/dyt084; Stringhini S, 2013, INT J CARDIOL, V168, P1201, DOI 10.1016/j.ijcard.2012.11.064; The World Bank, 2015, GNI PER CAP ATL METH; UNCTAD, 2015, COUNTR FACT SHEETS 2; Varraso R, 2012, AM J CLIN NUTR, V96, P1079, DOI 10.3945/ajcn.112.038109; World Health Organisation, 2015, NONC DIS FACT SHEET; World Health Organization, 2015, COUNTR SEYCH 2015; World Health Organization, 2014, GLOB ACT PLAN PREV C	74	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155617	10.1371/journal.pone.0155617	http://dx.doi.org/10.1371/journal.pone.0155617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2FT	27214139	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200019
J	Kalaghatgi, P; Sikorski, AM; Knops, E; Rupp, D; Sierra, S; Heger, E; Neumann-Fraune, M; Beggel, B; Walker, A; Timm, J; Walter, H; Obermeier, M; Kaiser, R; Bartenschlager, R; Lengauer, T				Kalaghatgi, Prabhav; Sikorski, Anna Maria; Knops, Elena; Rupp, Daniel; Sierra, Saleta; Heger, Eva; Neumann-Fraune, Maria; Beggel, Bastian; Walker, Andreas; Timm, Joerg; Walter, Hauke; Obermeier, Martin; Kaiser, Rolf; Bartenschlager, Ralf; Lengauer, Thomas			Geno2pheno([HCV]) - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents	PLOS ONE			English	Article							IN-VITRO RESISTANCE; SERINE-PROTEASE INHIBITORS; DAILY SIMEPREVIR TMC435; VIRUS GENOTYPE 1B; DRUG-RESISTANCE; NS5A INHIBITOR; VIROLOGICAL RESPONSE; NULL RESPONDERS; NAIVE PATIENTS; MUTATION-RATE	The face of hepatitis C virus (HCV) therapy is changing dramatically. Direct-acting antiviral agents (DAAs) specifically targeting HCV proteins have been developed and entered clinical practice in 2011. However, despite high sustained viral response (SVR) rates of more than 90%, a fraction of patients do not eliminate the virus and in these cases treatment failure has been associated with the selection of drug resistance mutations (RAMs). RAMs may be prevalent prior to the start of treatment, or can be selected under therapy, and furthermore they can persist after cessation of treatment. Additionally, certain DAAs have been approved only for distinct HCV genotypes and may even have subtype specificity. Thus, sequence analysis before start of therapy is instrumental for managing DAA-based treatment strategies. We have created the interpretation system geno2pheno([HCV]) (g2p([HCV])) to analyse HCV sequence data with respect to viral subtype and to predict drug resistance. Extensive reviewing and weighting of literature related to HCV drug resistance was performed to create a comprehensive list of drug resistance rules for inhibitors of the HCV protease in non-structural protein 3 (NS3-protease: Boceprevir, Paritaprevir, Simeprevir, Asunaprevir, Grazoprevir and Telaprevir), the NS5A replicase factor (Daclatasvir, Ledipasvir, Elbasvir and Ombitasvir), and the NS5B RNA-dependent RNA polymerase (Dasabuvir and Sofosbuvir). Upon submission of up to eight sequences, g2p([HCV]) aligns the input sequences, identifies the genomic region(s), predicts the HCV geno- and subtypes, and generates for each DAA a drug resistance prediction report. g2p([HCV]) offers easy-to-use and fast subtype and resistance analysis of HCV sequences, is continuously updated and freely accessible under http://hcv.geno2pheno.org/index.php. The system was partially validated with respect to the NS3-protease inhibitors Boceprevir, Telaprevir and Simeprevir by using data generated with recombinant, phenotypic cell culture assays obtained from patients' virus variants.	[Kalaghatgi, Prabhav; Beggel, Bastian; Lengauer, Thomas] Max Planck Inst Informat, German Ctr Infect Res DZIF Saarbrucken Partner Si, Dept Computat Biol & Appl Algorithm, D-66123 Saarbrucken, Germany; [Sikorski, Anna Maria; Knops, Elena; Sierra, Saleta; Heger, Eva; Neumann-Fraune, Maria; Kaiser, Rolf] Univ Cologne, Inst Virol, German Ctr Infect Res DZIF Cologne Bonn Partner S, D-50935 Cologne, Germany; [Sikorski, Anna Maria; Rupp, Daniel; Bartenschlager, Ralf] Heidelberg Univ, Mol Virol, Dept Infect Dis, German Ctr Infect Res DZIF Heidelberg Partner Sit, D-69120 Heidelberg, Germany; [Walker, Andreas; Timm, Joerg] Univ Dusseldorf, Inst Virol, Univ Hosp Dusseldorf, D-40225 Dusseldorf, Germany; [Walter, Hauke; Obermeier, Martin] MVZ Med Infektiol Zentrum Berlin MIB, D-13353 Berlin, Germany	German Center for Infection Research; Max Planck Society; German Center for Infection Research; University of Cologne; German Center for Infection Research; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Sierra, S (corresponding author), Univ Cologne, Inst Virol, German Ctr Infect Res DZIF Cologne Bonn Partner S, D-50935 Cologne, Germany.	saleta.sierra-aragon@uk-koeln.de	Timm, Jörg/P-7652-2019; Bartenschlager, Ralf/L-2582-2015	Timm, Jörg/0000-0001-7799-3045; Walker, Andreas/0000-0002-8736-0863; Bartenschlager, Ralf/0000-0001-5601-9307; Kalaghatgi, Prabhav/0000-0002-4742-6928; Lengauer, Thomas/0000-0003-3801-2640	German Center for Infection Research (DZIF) [8000 802-3]; German Center for Infection Research (DZIF-TTU Hepatitis) [05.805]; HIV-GRADE e.V; Resina HIV-HEP-MASTER [IIA5-2013-2514AUK375]; MSD-PEPSI Project	German Center for Infection Research (DZIF); German Center for Infection Research (DZIF-TTU Hepatitis); HIV-GRADE e.V; Resina HIV-HEP-MASTER; MSD-PEPSI Project	The development of geno2pheno[HCV] is funded by the German Center for Infection Research (DZIF, grant no. 8000 802-3; DZIF-TTU Hepatitis 05.805), HIV-GRADE e.V; Resina HIV-HEP-MASTER (IIA5-2013-2514AUK375); and the MSD-PEPSI Project.	Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Society of America (IDSA), 2015, HCV GUID REC TEST MA; [Anonymous], 2015, PRO; Bae A, 2010, ANTIMICROB AGENTS CH, V54, P5288, DOI 10.1128/AAC.00777-10; Barnard RJO, 2013, VIROLOGY, V444, P329, DOI 10.1016/j.virol.2013.06.029; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652; Chayama K, 2015, VIRUSES-BASEL, V7, P5328, DOI 10.3390/v7102876; Coburn CA, 2013, CHEMMEDCHEM, V8, P1930, DOI 10.1002/cmdc.201300343; De Luca A, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv043; Donaldson EF, 2015, HEPATOLOGY, V61, P56, DOI 10.1002/hep.27375; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Hernandez D, 2013, J CLIN VIROL, V57, P13, DOI 10.1016/j.jcv.2012.12.020; Holmes JA, 2015, HEPATIC MED-EVID RES, V7, P51, DOI 10.2147/HMER.S55864; Howe AYM, 2014, CLIN INFECT DIS, V59, P1657, DOI 10.1093/cid/ciu696; Itakura J, 2015, HEPATOL RES, V45, pE115, DOI 10.1111/hepr.12474; Jensen SB, 2015, ANTIMICROB AGENTS CH, V59, P7426, DOI 10.1128/AAC.01953-15; Karino Y, 2013, J HEPATOL, V58, P646, DOI 10.1016/j.jhep.2012.11.012; Kati W, 2015, ANTIMICROB AGENTS CH, V59, P1510, DOI 10.1128/AAC.04619-14; Kieffer TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034372; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lagace L, 2012, ANTIMICROB AGENTS CH, V56, P569, DOI 10.1128/AAC.05166-11; Lam JT, 2012, AM J HEALTH-SYST PH, V69, P2135, DOI 10.2146/ajhp110500; Lawitz E, 2014, J HEPATOL, V60, pS524, DOI 10.1016/S0168-8278(14)61460-4; Lawitz E, 2013, INCLUDING PATIENTS W; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lenz O, 2015, J HEPATOL, V62, P1008, DOI 10.1016/j.jhep.2014.11.032; Lenz O, 2013, J HEPATOL, V58, P445, DOI 10.1016/j.jhep.2012.10.028; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin C, 2005, J BIOL CHEM, V280, P36784, DOI 10.1074/jbc.M506462200; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Lutchman G, 2007, GASTROENTEROLOGY, V132, P1757, DOI 10.1053/j.gastro.2007.03.035; McCown MF, 2009, ANTIMICROB AGENTS CH, V53, P2129, DOI 10.1128/AAC.01598-08; McPhee F, 2015, ADV THER, V32, P637, DOI 10.1007/s12325-015-0221-5; McPhee F, 2014, ANTIVIR THER, V19, P479, DOI 10.3851/IMP2729; McPhee F, 2013, HEPATOLOGY, V58, P902, DOI 10.1002/hep.26388; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P5387, DOI 10.1128/AAC.01186-12; Murakami E, 2014, ANTIMICROB AGENTS CH, V58, P2105, DOI 10.1128/AAC.02068-13; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Neumann-Fraune M, 2014, INTERVIROLOGY, V57, P232, DOI 10.1159/000361076; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Osinusi A, 2015, JAMA-J AM MED ASSOC, V313, P1232, DOI 10.1001/jama.2015.1373; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Qi X, 2009, ANTIVIR RES, V81, P166, DOI 10.1016/j.antiviral.2008.11.002; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Schnell G, 2015, ANTIMICROB AGENTS CH, V59, P6807, DOI 10.1128/AAC.01229-15; Sierra S, 2011, JOVE-J VIS EXP, DOI 10.3791/3264; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sulkowski M, 2014, J HEPATOL, V60, pS4, DOI 10.1016/S0168-8278(14)60009-X; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Susser S, 2012, Z GASTROENTEROL, P50; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Tong X, 2008, ANTIVIR RES, V77, P177, DOI 10.1016/j.antiviral.2007.11.010; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; Toshikuni N, 2014, WORLD J GASTROENTERO, V20, P2876, DOI 10.3748/wjg.v20.i11.2876; Wang CF, 2013, ANTIMICROB AGENTS CH, V57, P2054, DOI 10.1128/AAC.02494-12; Wang CF, 2013, ANTIMICROB AGENTS CH, V57, P611, DOI 10.1128/AAC.01874-12; Wang CF, 2012, ANTIMICROB AGENTS CH, V56, P1350, DOI 10.1128/AAC.05977-11; Wong KA, 2013, ANTIMICROB AGENTS CH, V57, P6333, DOI 10.1128/AAC.02193-12; Wyles David L, 2012, Top Antivir Med, V20, P139; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zhou Y, 2008, ANTIMICROB AGENTS CH, V52, P110, DOI 10.1128/AAC.00863-07	79	81	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155869	10.1371/journal.pone.0155869	http://dx.doi.org/10.1371/journal.pone.0155869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196673	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291100121
J	Cao, H; Schroeder, B; Chen, J; Schott, MB; McNiven, MA				Cao, Hong; Schroeder, Barbara; Chen, Jing; Schott, Micah B.; McNiven, Mark A.			The Endocytic Fate of the Transferrin Receptor Is Regulated by c-Abl Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; TYROSINE KINASE; MAMMALIAN-CELLS; RETICULOCYTE MATURATION; CLATHRIN TRISKELIA; IRON-METABOLISM; DYNAMIN; DEGRADATION; CORTACTIN; BINDING	Clathrin-mediated endocytosis of transferrin (Tf) and its cognate receptor (TfR1) is a central pathway supporting the uptake of trophic iron. It has generally been assumed that this is a constitutive process. However, we have reported that the non-receptor tyrosine kinase, Src, is activated by Tf to facilitate the internalization of the Tf-TfR1 ligand-receptor complex. As an extension of these findings, we have tested whether subsequent trafficking steps might be regulated by additional kinase-dependent cascades, and we observed a significant endocytic block by inhibiting c-Abl kinase by a variety of methods. Importantly, Tf internalization was reduced significantly in all of these cell models and could be restored by re-expression of WTc-Abl. Surprisingly, this attenuated Tf-TfR1 endocytosis was due to a substantial drop in both the surface and total cellular receptor levels. Additional studies with the LDL receptor showed a similar effect. Surprisingly, immunofluorescence microscopy of imatinib-treated cells revealed a marked colocalization of internalized TfR1 with late endosomes/lysosomes, whereas attenuating the lysosome function with several inhibitors reduced this receptor loss. Importantly, inhibition of c-Abl resulted in a striking redistribution of the chaperone Hsc70 from a diffuse cytosolic localization to an association with the TfR1 at the late endosome-lysosome. Pharmacological inhibition of Hsc70 ATPase activity in cultured cells by the drug VER155008 prevents this chaperone-receptor interaction, resulting in an accumulation of the TfR1 in the early endosome. Thus, inhibition of c-Abl minimizes receptor recycling pathways and results in chaperone-dependent trafficking of the TfR1 to the lysosome for degradation. These findings implicate a novel role for c-Abl and Hsc70 as an unexpected regulator of Hsc70-mediated transport of trophic receptor cargo between the early and late endosomal compartments.	[Cao, Hong; Chen, Jing; Schott, Micah B.; McNiven, Mark A.] Mayo Clin, Ctr Basic Res Digest Dis, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Schroeder, Barbara] Mayo Clin, Dept Expt Pathol & Lab Med, Rochester, MN 55905 USA; [Schroeder, Barbara] Tech Munich, Chair Biol Imaging, Ismaninger Str 22, D-81675 Munich, Germany	Mayo Clinic; Mayo Clinic	McNiven, MA (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW,Guggenheim 1642D, Rochester, MN 55905 USA.	mmcniven@mayo.edu			National Institutes of Health [DK44650, T32DK007352, DK84567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044650, P30DK084567, T32DK007352, R01DK044650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK44650 (to M. A. M.), T32DK007352 (to M. B. S.), and DK84567 (to the Optical Microscopy Core of the Mayo Center for Cell Signaling in Gastroenterology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barisani D, 2002, BLOOD CELL MOL DIS, V29, P498, DOI 10.1006/bcmd.2002.0588; Beau I, 2010, MOL CELL, V39, P485, DOI 10.1016/j.molcel.2010.08.005; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Buchdunger E, 2002, EUR J CANCER, V38, pS28, DOI 10.1016/S0959-8049(02)80600-1; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Dores MR, 2012, MOL BIOL CELL, V23, P3612, DOI 10.1091/mbc.E12-03-0251; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HEUSER J, 1989, J CELL BIOL, V109, P1457, DOI 10.1083/jcb.109.4.1457; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Jacob M, 2009, CELL SIGNAL, V21, P1308, DOI 10.1016/j.cellsig.2009.03.016; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Lin YL, 2013, P NATL ACAD SCI USA, V110, P1664, DOI 10.1073/pnas.1214330110; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; MATHEW A, 1995, BIOCHEM J, V308, P823, DOI 10.1042/bj3080823; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; O'Dwyer ME, 2000, CURR OPIN ONCOL, V12, P594, DOI 10.1097/00001622-200011000-00013; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Shen SS, 2009, J CELL BIOL, V185, P629, DOI 10.1083/jcb.200810183; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Tachiyama R, 2011, GENES CELLS, V16, P448, DOI 10.1111/j.1365-2443.2011.01499.x; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Theis S, 1998, ONCOGENE, V17, P557, DOI 10.1038/sj.onc.1201973; Trinder D, 2003, INT J BIOCHEM CELL B, V35, P292, DOI 10.1016/S1357-2725(02)00258-3; UNGEWICKELL E, 1985, EMBO J, V4, P3385, DOI 10.1002/j.1460-2075.1985.tb04094.x; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Zhu JW, 2007, J BIOL CHEM, V282, P16086, DOI 10.1074/jbc.M701997200	58	20	20	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16424	16437		10.1074/jbc.M116.724997	http://dx.doi.org/10.1074/jbc.M116.724997			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27226592	Green Published, hybrid			2022-12-26	WOS:000380826700002
J	Burger, D; Stihle, M; Sharma, A; Di Lello, P; Benz, J; D'Arcy, B; Debulpaep, M; Fry, D; Huber, W; Kremer, T; Laeremans, T; Matile, H; Ross, A; Rufer, AC; Schoch, G; Steinmetz, MO; Steyaert, J; Rudolph, MG; Thoma, R; Ruf, A				Burger, Dominique; Stihle, Martine; Sharma, Ashwani; Di Lello, Paola; Benz, Jorg; D'Arcy, Brigitte; Debulpaep, Maja; Fry, David; Huber, Walter; Kremer, Thomas; Laeremans, Toon; Matile, Hugues; Ross, Alfred; Rufer, Arne C.; Schoch, Guillaume; Steinmetz, Michel O.; Steyaert, Jan; Rudolph, Markus G.; Thoma, Ralf; Ruf, Armin			Crystal Structures of the Human Doublecortin C- and N-terminal Domains in Complex with Specific Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL; ULTRACENTRIFUGATION; CRYSTALLOGRAPHY; STABILIZATION; RECOGNIZES; REFINEMENT; GENERATION; FRAGMENTS; TUBULIN; SYSTEM	Doublecortin is a microtubule-associated protein produced during neurogenesis. The protein stabilizes microtubules and stimulates their polymerization, which allows migration of immature neurons to their designated location in the brain. Mutations in the gene that impair doublecortin function and cause severe brain formation disorders are located on a tandem repeat of two doublecortin domains. The molecular mechanism of action of doublecortin is only incompletely understood. Anti-doublecortin antibodies, such as the rabbit polyclonal Abcam 18732, are widely used as neurogenesis markers. Here, we report the generation and characterization of antibodies that bind to single doublecortin domains. The antibodies were used as tools to obtain structures of both domains. Four independent crystal structures of the N-terminal domain reveal several distinct open and closed conformations of the peptide linking N- and C-terminal domains, which can be related to doublecortin function. An NMR assignment and a crystal structure in complex with a camelid antibody fragment show that the doublecortin C-terminal domain adopts the same well defined ubiquitin-like fold as the N-terminal domain, despite its reported aggregation and molten globule-like properties. The antibodies' unique domain specificity also renders them ideal research tools to better understand the role of individual domains in doublecortin function. A single chain camelid antibody fragment specific for the C-terminal doublecortin domain affected microtubule binding, whereas a monoclonal mouse antibody specific for the N-terminal domain did not. Together with steric considerations, this suggests that the microtubule-interacting doublecortin domain observed in cryoelectron micrographs is the C-terminal domain rather than the N-terminal one.	[Burger, Dominique; Stihle, Martine; Benz, Jorg; D'Arcy, Brigitte; Huber, Walter; Matile, Hugues; Ross, Alfred; Rufer, Arne C.; Rudolph, Markus G.; Thoma, Ralf; Ruf, Armin] F Hoffmann La Roche Ltd, Therapeut Modal, pRED Pharma Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Kremer, Thomas; Schoch, Guillaume] F Hoffmann La Roche Ltd, Roche Pharmaceut Res & Early Dev, NORD Discovery & Translat Area, Roche Innovat Ctr Basel, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Sharma, Ashwani] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Di Lello, Paola; Fry, David] Roche, Discovery Technol, Small Mol Res, pRED Pharma Res & Early Dev, Nutley, NJ 07110 USA; [Debulpaep, Maja; Laeremans, Toon; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Debulpaep, Maja; Laeremans, Toon; Steyaert, Jan] VIB, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium; [Di Lello, Paola] Genentech Inc, Dept Biol Struct, 1 DNA Way, San Francisco, CA 94080 USA; [Schoch, Guillaume] Fishawack Archimed AG, Elisabethenanlage 11, CH-4051 Basel, Switzerland	Roche Holding; Roche Holding; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Roche Holding; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Roche Holding; Genentech	Ruf, A (corresponding author), F Hoffmann La Roche Ltd, pRED Pharma Res & Early Dev, Therapeut Modal, Chem Biol, CH-4070 Basel, Switzerland.	armin.ruf@roche.com	Steinmetz, Michel O/AAA-3349-2022; steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011	Steinmetz, Michel O/0000-0001-6157-3687; Steyaert, Jan/0000-0002-3825-874X; Rudolph, Markus/0000-0003-0447-1101	EMBO Long Term Fellowship; Swiss National Science Foundation [310030B_138659]	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by an EMBO Long Term Fellowship (to A. S.) as well as Swiss National Science Foundation Grant 310030B_138659 (to M. O. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; Banner DW, 2013, ACTA CRYSTALLOGR D, V69, P1124, DOI 10.1107/S0907444913006574; Bechstedt S, 2014, CURR BIOL, V24, P2366, DOI 10.1016/j.cub.2014.08.039; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Campbell JN, 2011, METHODS MOL BIOL, V777, P87, DOI 10.1007/978-1-61779-252-6_6; Cierpicki T, 2006, PROTEINS, V64, P874, DOI 10.1002/prot.21068; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hausammann GJ, 2013, BIOCHEM BIOPH RES CO, V431, P70, DOI 10.1016/j.bbrc.2012.12.089; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kovari LC, 1995, STRUCTURE, V3, P1291, DOI 10.1016/S0969-2126(01)00266-0; Kremer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059269; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tereshko V, 2008, PROTEIN SCI, V17, P1175, DOI 10.1110/ps.034892.108; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISHART DS, 1994, J BIOMOL NMR, V4, P171	40	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16292	16306		10.1074/jbc.M116.726547	http://dx.doi.org/10.1074/jbc.M116.726547			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226599	Green Published, hybrid			2022-12-26	WOS:000380585400033
J	Lahiri, N; Shah, RR; Layre, E; Young, D; Ford, C; Murray, MB; Fortune, SM; Moody, DB				Lahiri, Nivedita; Shah, Rupal R.; Layre, Emilie; Young, David; Ford, Chris; Murray, Megan B.; Fortune, Sarah M.; Moody, D. Branch			Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; MS; Mycobacterium tuberculosis; siderophore; tuberculosis; lipidomics; multidrug resistance; rifampin	BACTERIAL RNA-POLYMERASE; SULFOLIPID-1 BIOSYNTHESIS; COMPENSATORY MUTATIONS; VIRULENCE; MACROPHAGES; DISCOVERY; IDENTIFICATION; ANTIGENS; REVEALS; PATHWAY	Global control of tuberculosis has become increasingly complicated with the emergence of multidrug-resistant strains of Mycobacterium tuberculosis. First-line treatments are anchored by two antibiotics, rifampin and isoniazid. Most rifampin resistance occurs through the acquisition of missense mutations in the rifampin resistance-determining region, an 81-base pair region encoding the rifampin binding site on the subunit of RNA polymerase (rpoB). Although these mutations confer a survival advantage in the presence of rifampin, they may alter the normal process of transcription, thereby imposing significant fitness costs. Because the downstream biochemical consequences of the rpoB mutations are unknown, we used an organism-wide screen to identify the number and types of lipids changed after rpoB mutation. A new mass spectrometry-based profiling platform systematically compared approximate to 10,000 cell wall lipids in a panel of rifampin-resistant mutants within two genetically distinct strains, CDC1551and W-Beijing. This unbiased lipidomic survey detected quantitative alterations (>2-fold, p < 0.05) in more than 100 lipids in each mutant. By focusing on molecular events that change among most mutants and in both genetic backgrounds, we found that rifampin resistance mutations lead to altered concentrations of mycobactin siderophores and acylated sulfoglycolipids. These findings validate a new organism-wide lipidomic analysis platform for drug-resistant mycobacteria and provide direct evidence for characteristic remodeling of cell wall lipids in rifampin-resistant strains of M. tuberculosis. The specific links between rifampin resistance and named lipid factors provide diagnostic and therapeutic targets that may be exploited to address the problem of drug resistance.	[Lahiri, Nivedita; Layre, Emilie; Young, David; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 514,1 Jimmy Fund Way, Boston, MA 02115 USA; [Lahiri, Nivedita; Layre, Emilie; Young, David; Moody, D. Branch] Harvard Med Sch, Smith Bldg,Rm 514,1 Jimmy Fund Way, Boston, MA 02115 USA; [Shah, Rupal R.; Ford, Chris; Fortune, Sarah M.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Murray, Megan B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 514,1 Jimmy Fund Way, Boston, MA 02115 USA.; Moody, DB (corresponding author), Harvard Med Sch, Smith Bldg,Rm 514,1 Jimmy Fund Way, Boston, MA 02115 USA.	bmoody@rics.bwh.harvard.edu		Fortune, Sarah/0000-0001-7565-9975; Layre, Emilie/0000-0003-3044-1299	National Institutes of Health [U19 AI076217, U19 AI111224, R01 AI049313, P30 AI060354]; Burroughs Wellcome Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313, P30AI060354, U19AI111224, U19AI076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants U19 AI076217, U19 AI111224, R01 AI049313, and P30 AI060354 and the Burroughs Wellcome Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisson GP, 2012, J BACTERIOL, V194, P6441, DOI 10.1128/JB.01013-12; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Coovadia YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077712; Cummings MP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-137; de Knegt GJ, 2013, TUBERCULOSIS, V93, P96, DOI 10.1016/j.tube.2012.10.013; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; EZEKIEL DH, 1968, NATURE, V220, P276, DOI 10.1038/220276a0; Favrot L, 2012, EXPERT REV ANTI-INFE, V10, P1023, DOI [10.1586/eri.12.91, 10.1586/ERI.12.91]; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Franke MF, 2013, CLIN INFECT DIS, V56, P770, DOI 10.1093/cid/cis1008; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gilmore SA, 2012, ACS CHEM BIOL, V7, P863, DOI 10.1021/cb200311s; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Layre E, 2013, BIOCHIMIE, V95, P109, DOI 10.1016/j.biochi.2012.08.012; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Madigan CA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004792; Madigan CA, 2012, P NATL ACAD SCI USA, V109, P1257, DOI 10.1073/pnas.1109958109; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Pang JM, 2012, J BACTERIOL, V194, P715, DOI 10.1128/JB.06304-11; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Sartain MJ, 2011, J LIPID RES, V52, P861, DOI 10.1194/jlr.M010363; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Strauss OJ, 2008, J CLIN MICROBIOL, V46, P1514, DOI 10.1128/JCM.01938-07; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; TOCCHINI.GP, 1968, NATURE, V220, P275, DOI 10.1038/220275a0; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Velayati AA, 2014, AM J TROP MED HYG, V90, P99, DOI 10.4269/ajtmh.13-0057	46	35	35	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14248	14256		10.1074/jbc.M116.716704	http://dx.doi.org/10.1074/jbc.M116.716704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226566	hybrid, Green Published			2022-12-26	WOS:000379975100029
J	Bertisch, B; Giudici, F; Negro, F; Moradpour, D; Mullhaupt, B; Moriggia, A; Estill, J; Keiser, O				Bertisch, Barbara; Giudici, Fabio; Negro, Francesco; Moradpour, Darius; Mullhaupt, Beat; Moriggia, Alberto; Estill, Janne; Keiser, Olivia		Swiss Hepatitis C Cohort Study	Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations	PLOS ONE			English	Article							VIRUS-INFECTION; GENERAL-POPULATION; HCV INFECTION; RISK-FACTORS; EPIDEMIOLOGY; PREVALENCE; SPAIN; NETHERLANDS; COUNTRIES; PATTERNS	Background Switzerland recommends individuals who originate from high-prevalence countries to be screened for hepatitis C virus (HCV) infection. However, not all these persons are equally at risk. We thus aimed to describe the number and characteristics of persons with HCV infection born outside of Switzerland. Methods We compared characteristics of anti-HCV-positive individuals in the Swiss Hepatitis C Cohort Study (SCCS) and of HCV cases reported to the Federal Office of Public Health (FOPH), with those of the general population in Switzerland. Persons who inject drugs (PWID) and persons who do not inject drugs (non-PWID) were compared by age groups for different countries of origin (represented by >= 1% of participants in the SCCS or FOPH). Results We included 4,199 persons from the SCCS and 26,610 cases from the FOPH. Both groups had similar characteristics. In both data sources non-PWID were more frequent in foreign-born than in Swiss-born persons (63% versus 34% in the SCCS). The only subgroup with a clearly higher proportion both in the SCCS and FOPH than in the general population were persons over 60 years from Italy and Spain, with a 3.7-and 2.8-fold increase in the SCCS. These persons were non-PWID (99%), less frequently HIV- and anti-HBc positive and more often female than PWID from Italy and Spain; cirrhosis at enrolment was frequent (31%). Their HCV genotypes were consistent with those observed in elderly non-PWID of their birth countries. In the FOPH a higher proportion than in the general population was also seen for cases from Georgia and Russia. Conclusion The identification of subgroups in which HCV infection is particularly frequent might allow for better targeting HCV screening among foreign-born persons in Switzerland and elsewhere.	[Bertisch, Barbara; Giudici, Fabio; Estill, Janne; Keiser, Olivia] Inst Social & Prevent Med, Bern, Switzerland; [Bertisch, Barbara] Checkpoint Zurich, Zurich, Switzerland; [Negro, Francesco] Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Negro, Francesco] Univ Hosp, Div Clin Pathol, Geneva, Switzerland; [Moradpour, Darius] Univ Lausanne, Ctr Hosp Univ Vaudois, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Mullhaupt, Beat] Univ Zurich Hosp, Swiss Hepatopancreatobiliary Ctr, CH-8091 Zurich, Switzerland; [Mullhaupt, Beat] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Moriggia, Alberto] Epatoctr Ticino Fdn, Lugano, Switzerland	University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Bertisch, B (corresponding author), Inst Social & Prevent Med, Bern, Switzerland.; Bertisch, B (corresponding author), Checkpoint Zurich, Zurich, Switzerland.	barbara.bertisch@ispm.unibe.ch	Dufour, Jean Francois Jacques/AAL-9866-2020; Negro, Francesco/E-2183-2012; Müllhaupt, Beat/O-3744-2016; Moradpour, Darius/G-7918-2017	Dufour, Jean Francois Jacques/0000-0002-8062-1346; Müllhaupt, Beat/0000-0002-9020-8192; Bertisch, Barbara/0000-0003-1725-4245; Moradpour, Darius/0000-0003-1977-6792	Swiss National Science Foundation [3347C0-108782/1, 33CS30-148417/1, 150934]; Gilead Sciences Switzerland; AbbVie; Gilead; Bristol Myers Squibb; Janssen-Cilag; MSD; Novartis; Roche Pharma Switzerland; Roche Diagnostics	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gilead Sciences Switzerland(Gilead Sciences); AbbVie(AbbVie); Gilead(Gilead Sciences); Bristol Myers Squibb(Bristol-Myers Squibb); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; Novartis(Novartis); Roche Pharma Switzerland; Roche Diagnostics	This work was supported by Swiss National Science Foundation grants 3347C0-108782/1 and 33CS30-148417/1 to the Swiss Hepatitis C Cohort Study, an unrestricted research grant by Gilead Sciences Switzerland (to BB) and unrestricted grants to the Swiss Hepatitis C Cohort Study Foundation by AbbVie, Gilead, Bristol Myers Squibb, Janssen-Cilag, MSD, Novartis, Roche Pharma Switzerland and Roche Diagnostics. OK and JE were funded by a PROSPER fellowship grant (150934) from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376; Bertisch B, 2010, SCHWEIZ MED FORUM, V10, P798; Bevilacqua P., 2002, STORIA EMIGRAZIONE I, VII; Bover O, 1999, MIGRATION SPAIN HIST; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Bruguera M, 2006, MED CLIN-BARCELONA, V127, P113, DOI 10.1157/13090276; Chiaramonte M, 1996, J HEPATOL, V24, P129, DOI 10.1016/S0168-8278(96)80020-1; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Cozzolongo R, 2009, AM J GASTROENTEROL, V104, P2740, DOI 10.1038/ajg.2009.428; DAmato Gianni, 2008, SCHWEIZERISCHES JB E, V27, P177; Delwaide J, 2006, EUR J GASTROEN HEPAT, V18, P707, DOI 10.1097/01.meg.0000219103.40435.8d; Dominguez A, 2001, J MED VIROL, V65, P688, DOI 10.1002/jmv.2091; Fabris P, 2008, J CLIN GASTROENTEROL, V42, P527, DOI 10.1097/MCG.0b013e318030e3ab; Fretz R, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13793; Gitto S, 2014, J CLIN TRANSL HEPATO, V2, P228, DOI 10.14218/JCTH.2014.00030; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Heidrich B, 2014, EUR J GASTROEN HEPAT, V26, P1090, DOI 10.1097/MEG.0000000000000164; Helsper CW, 2012, EPIDEMIOL INFECT, V140, P58, DOI 10.1017/S0950268811000112; Huppe D, 2008, Z GASTROENTEROL, V46, P34, DOI 10.1055/s-2007-963691; Miners AH, 2014, J VIRAL HEPATITIS, V21, P616, DOI 10.1111/jvh.12190; Modaresi Esfeh J, 2015, GASTROENTEROL REP, DOI [10.1093/gastro/gov040, DOI 10.1093/GASTR0/G0V040]; Mullhaupt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125214; Negro F, 2013, SCHWEIZERISCHE ARZTE, V94, P27; Negro F, 2014, DIGEST LIVER DIS, V46, pS158, DOI 10.1016/j.dld.2014.09.023; Prasad L, 2007, INT J EPIDEMIOL, V36, P731, DOI 10.1093/ije/dym096; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Riestra S, 2001, EUR J GASTROEN HEPAT, V13, P477, DOI 10.1097/00042737-200105000-00003; Sagmeister M, 2002, EUR J GASTROEN HEPAT, V14, P25, DOI 10.1097/00042737-200201000-00006; Sterling Richard K, 2015, Evid Based Med, V20, P23, DOI 10.1136/ebmed-2014-110103; Swiss Federal Office of Public Health, 2015, BULLETIN, V21, P376; Swiss Federal Office of Public Health, 2013, BULLETIN, V47, P850; Swiss Federal Office of Public Health, 2007, BULLETIN, V21, P371; Swiss Federal Statistical Office, INF FOR BORN PERS PO; Swiss Federal Statistical Office, FREQ PAT CONS GEN PR; Wedemeyer H, 2015, J VIRAL HEPATITIS, V22, P1, DOI 10.1111/jvh.12371; WHO, 2014, GUID SCREEN CAR TREA; Witteck A, 2011, SWISS MED WKLY; Zuure FR, 2013, LIVER INT, V33, P727, DOI 10.1111/liv.12131	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155464	10.1371/journal.pone.0155464	http://dx.doi.org/10.1371/journal.pone.0155464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227332	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000376882500022
J	Ivanova, NV; Kuzmina, ML; Braukmann, TWA; Borisenko, AV; Zakharov, EV				Ivanova, Natalia V.; Kuzmina, Maria L.; Braukmann, Thomas W. A.; Borisenko, Alex V.; Zakharov, Evgeny V.			Authentication of Herbal Supplements Using Next-Generation Sequencing	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; DNA-BASED AUTHENTICATION; ENDOPHYTIC FUNGI; BIOACTIVE COMPOUNDS; GINKGO-BILOBA; MARKET SUBSTITUTION; DIETARY-SUPPLEMENTS; GENOMIC DNA; ITS2 REGION; SEED SET	Background DNA-based testing has been gaining acceptance as a tool for authentication of a wide range of food products; however, its applicability for testing of herbal supplements remains contentious. Methods We utilized Sanger and Next-Generation Sequencing (NGS) for taxonomic authentication of fifteen herbal supplements representing three different producers from five medicinal plants: Echinacea purpurea, Valeriana officinalis, Ginkgo biloba, Hypericum perforatum and Trigonella foenum-graecum. Experimental design included three modifications of DNA extraction, two lysate dilutions, Internal Amplification Control, and multiple negative controls to exclude background contamination. Ginkgo supplements were also analyzed using HPLC-MS for the presence of active medicinal components. Results All supplements yielded DNA from multiple species, rendering Sanger sequencing results for rbcL and ITS2 regions either uninterpretable or non-reproducible between the experimental replicates. Overall, DNA from the manufacturer-listed medicinal plants was successfully detected in seven out of eight dry herb form supplements; however, low or poor DNA recovery due to degradation was observed in most plant extracts (none detected by Sanger; three out of seven-by NGS). NGS also revealed a diverse community of fungi, known to be associated with live plant material and/or the fermentation process used in the production of plant extracts. HPLC-MS testing demonstrated that Ginkgo supplements with degraded DNA contained ten key medicinal components. Conclusion Quality control of herbal supplements should utilize a synergetic approach targeting both DNA and bioactive components, especially for standardized extracts with degraded DNA. The NGS workflow developed in this study enables reliable detection of plant and fungal DNA and can be utilized by manufacturers for quality assurance of raw plant materials, contamination control during the production process, and the final product. Interpretation of results should involve an interdisciplinary approach taking into account the processes involved in production of herbal supplements, as well as biocomplexity of plant-plant and plant- fungal biological interactions.	[Ivanova, Natalia V.; Kuzmina, Maria L.; Braukmann, Thomas W. A.; Borisenko, Alex V.; Zakharov, Evgeny V.] Univ Guelph, Ctr Biodivers Gen, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Guelph	Ivanova, NV (corresponding author), Univ Guelph, Ctr Biodivers Gen, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	nivanova@uoguelph.ca	Borisenko, Alex/GQZ-9054-2022; Braukmann, Thomas/N-7333-2019	Braukmann, Thomas/0000-0002-2452-3776; Kuzmina, Maria/0000-0003-2725-9146	International Barcode of Life project - Ontario Ministry of Research and Innovation; Genome Canada through the Ontario Genomics Institute	International Barcode of Life project - Ontario Ministry of Research and Innovation; Genome Canada through the Ontario Genomics Institute(Genome Canada)	This work was supported by the International Barcode of Life project funded by the Ontario Ministry of Research and Innovation and by Genome Canada through the Ontario Genomics Institute.	Aly AH, 2013, PHARMAZIE, V68, P499, DOI 10.1691/ph.2013.6517; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; ARROYO J, 1992, ISRAEL J BOT, V41, P225; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Azmir J, 2013, J FOOD ENG, V117, P426, DOI 10.1016/j.jfoodeng.2013.01.014; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bansal Ankit, 2014, J Pharm Anal, V4, P223, DOI 10.1016/j.jpha.2013.12.001; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Bottero MT, 2011, VET J, V190, P34, DOI 10.1016/j.tvjl.2010.09.024; Brown BJ, 2001, OECOLOGIA, V129, P43, DOI 10.1007/s004420100700; Chandra S, 2012, APPL MICROBIOL BIOT, V95, P47, DOI 10.1007/s00253-012-4128-7; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Cui YN, 2012, FITOTERAPIA, V83, P913, DOI 10.1016/j.fitote.2012.04.009; de Boer HJ, 2015, DRUG SAFETY, V38, P611, DOI 10.1007/s40264-015-0306-8; DEBOER E, 1985, A VAN LEEUW J MICROB, V51, P435, DOI 10.1007/BF02275058; Deshmukh SK, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00715; Ding SJ, 2006, RAPID COMMUN MASS SP, V20, P2753, DOI 10.1002/rcm.2646; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; El-Nagerabi SAF, 2002, PHYTOPARASITICA, V30, P61, DOI 10.1007/BF02983971; Elshafie AE, 2002, MYCOPATHOLOGIA, V155, P155, DOI 10.1023/A:1020427527963; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Fazekas Aron J, 2012, Methods Mol Biol, V858, P223, DOI 10.1007/978-1-61779-591-6_11; FEINSINGER P, 1986, ECOLOGY, V67, P449, DOI 10.2307/1938589; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finlay RD, 2008, J EXP BOT, V59, P1115, DOI 10.1093/jxb/ern059; Focke F, 2011, J AGR FOOD CHEM, V59, P513, DOI 10.1021/jf103702s; GANDERS FR, 1979, NEW ZEAL J BOT, V17, P607, DOI 10.1080/0028825X.1979.10432574; Government of Canada HCHP and FBNHPD, 2013, QUAL NAT HLTH PROD G; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Handy SM, 2011, J AOAC INT, V94, P201; Hanner R, 2011, MITOCHONDR DNA, V22, P27, DOI 10.3109/19401736.2011.596833; Haouala R, 2008, J ENVIRON SCI, V20, P1453, DOI 10.1016/S1001-0742(08)62548-6; Hashem Mohamed, 2010, Saudi Journal of Biological Sciences, V17, P167, DOI 10.1016/j.sjbs.2010.02.011; Hawes MC, 2011, PLANT SCI, V180, P741, DOI 10.1016/j.plantsci.2011.02.007; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hidalgo O., 2010, Journal of Botany, V2010, P797246, DOI 10.1155/2010/797246; Hidalgo O, 2012, CARYOLOGIA, V65, P243, DOI 10.1080/00087114.2012.740193; Holker U, 2005, CURR OPIN MICROBIOL, V8, P301, DOI 10.1016/j.mib.2005.04.006; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Hoorfar J, 2003, J CLIN MICROBIOL, V41, P5835, DOI 10.1128/JCM.41.12.5835.2003; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JENNERSTEN O, 1988, J ECOL, V76, P1111, DOI 10.2307/2260638; Jiang Y, 2010, ANAL CHIM ACTA, V657, P9, DOI 10.1016/j.aca.2009.10.024; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068518; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kusari S, 2012, METABOLOMICS, P241; Kusari S, 2012, CHEM BIOL, V19, P792, DOI 10.1016/j.chembiol.2012.06.004; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Lazarowych NJ, 1998, DRUG INF J, V32, P497, DOI 10.1177/009286159803200222; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Li R, 2014, J NAT PROD, V77, P571, DOI 10.1021/np400821r; Lim SH, 1998, BIOL PLANTARUM, V41, P313, DOI 10.1023/A:1001863924917; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Mandeel QA, 2005, MYCOPATHOLOGIA, V159, P291, DOI 10.1007/s11046-004-5496-z; Martins S, 2013, APPL BIOCHEM BIOTECH, V171, P1227, DOI 10.1007/s12010-013-0222-2; Martins S, 2011, BIOTECHNOL ADV, V29, P365, DOI 10.1016/j.biotechadv.2011.01.008; Mohamed E, 2002, PAKISTAN J PLANT PAT; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Moraes DFC, 2015, PLANTA MED, V81, P687, DOI 10.1055/s-0035-1545843; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Novak J, 2007, FOOD RES INT, V40, P388, DOI 10.1016/j.foodres.2006.10.015; Nyren Pal, 2007, V373, P1; Oikonomou I, 2008, LETT APPL MICROBIOL, V46, P456, DOI 10.1111/j.1472-765X.2008.02340.x; Omezzine F, 2017, ARAB J CHEM, V10, pS3622, DOI 10.1016/j.arabjc.2014.03.013; Palhares RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127866; Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; POOLE SK, 1990, ANAL CHIM ACTA, V236, P3, DOI 10.1016/S0003-2670(00)83297-3; Posadzki P, 2013, EUR J CLIN PHARMACOL, V69, P295, DOI 10.1007/s00228-012-1353-z; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Radstrom P, 2003, PCR PRIMER LAB MANUA, P149; Rathcke B., 1983, P305; Rekosz-Burlaga H, 2014, ACTA SCI POL-HORTORU, V13, P117; Reynaud DTH, 2015, CAPABILITIES LIMITAT, P1; Rizzo I, 2004, MICROBIOL RES, V159, P113, DOI 10.1016/j.micres.2004.01.013; Rodriguez R.J., 2012, BIOCOMPLEXITY PLANT, V6, P155, DOI [10.1002/9781118314364.ch7, DOI 10.1002/9781118314364.CH7]; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; SCHEMSKE DW, 1981, ECOLOGY, V62, P946, DOI 10.2307/1936993; Schneiderman ET, 2015, CEASE DESIST NOTIFIC; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Skorska C, 2005, ANN AGR ENV MED, V12, P119; Southworth D, 2012, DEFINING COMPLEX INT, P205, DOI [10.1002/9781118314364.ch10, DOI 10.1002/9781118314364.CH10]; Steinmann D, 2011, J PHARMACEUT BIOMED, V55, P744, DOI 10.1016/j.jpba.2010.11.015; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Swetha VP, 2014, TURK J BIOL, V38, P151, DOI 10.3906/biy-1308-5; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Toju H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6273; Tournas V, 2006, INT J FOOD MICROBIOL, V108, P178, DOI 10.1016/j.ijfoodmicro.2005.11.009; Wallace LJ, 2012, FOOD RES INT, V49, P446, DOI 10.1016/j.foodres.2012.07.048; Waser N.M., 1983, P277; WASER NM, 1978, ECOLOGY, V59, P934, DOI 10.2307/1938545; Weiss S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0564-2; Wen FS, 2009, PLANT PHYSIOL, V151, P820, DOI 10.1104/pp.109.142067; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitlock R, 2008, MOL ECOL RESOUR, V8, P736, DOI 10.1111/j.1755-0998.2007.02074.x; WHO, 2011, WORLD MED SIT 2011 T; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Xin TY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08337; Ye YH, 2013, APPL MICROBIOL BIOT, V97, P7131, DOI 10.1007/s00253-013-5013-8; Zhang HW, 2014, PAK J PHARM SCI, V27, P1153; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492; Zhou H, 2015, EUR FOOD RES TECHNOL, V240, P379, DOI 10.1007/s00217-014-2337-2	123	79	83	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156426	10.1371/journal.pone.0156426	http://dx.doi.org/10.1371/journal.pone.0156426			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227830	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500133
J	Kohlmann, S; Gierk, B; Murray, AM; Scholl, A; Lehmann, M; Lowe, B				Kohlmann, Sebastian; Gierk, Benjamin; Murray, Alexandra M.; Scholl, Arne; Lehmann, Marco; Lowe, Bernd			Base Rates of Depressive Symptoms in Patients with Coronary Heart Disease: An Individual Symptom Analysis	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; MYOCARDIAL-INFARCTION; CARDIOVASCULAR PROGNOSIS; HEALTH QUESTIONNAIRE; ENHANCING RECOVERY; COGNITIVE SYMPTOMS; SOMATIC SYMPTOMS; ARTERY-DISEASE; VALIDITY; EVENTS	Background Major depression is common in coronary heart disease (CHD) but challenging to diagnose. Instead of focusing on the overall diagnosis of depression, base rates of depressive symptoms could facilitate screening and management of psychopathology in CHD. The present study investigates the frequency of individual depressive symptoms in CHD and their impact on cardiac and subjective health. Methods In total, 1337 in-and outpatients with CHD were screened for depressive symptoms with the Patient Health Questionnaire-9 (PHQ-9) at three different cardiac treatment sites. Tables stratified by age and gender were designed to illustrate base rates of depressive symptoms. Multiple regression analyses adjusted for sociodemographic and clinical data were conducted to test associations between individual depressive symptoms and quality of life as well impairment caused angina pectoris and dyspnea. Results During the last 14 days, more than half of patients reported a loss of energy (74.9%, 95% Confidence Interval (CI): 70.6-79.2), sleeping problems (69.4%, 95% CI: 64.9-74.0), loss of interest (55.7%, 95% CI: 50.8-60.7). In contrast, psychomotor change (25.6%, 95% CI: 21.3-30.0), feelings of failure (21.9%, 95% CI: 17.7-26.0), suicidal ideations (14.1%, 95% CI: 10.7-17.6) were less frequently reported. Depending on the outcome, only particular depressive symptoms were highly associated with low quality of life and impairment caused by angina pectoris and dyspnea. Loss of energy was the only depressive symptom that reliably predicted all three outcomes. Conclusions Depressive symptoms in CHD are frequent but vary widely in terms of frequency. Findings underline the differential effects of individual depressive symptoms on cardiac health. Presented base rates of depressive symptoms offer clinicians a new way to judge the severity of individual depressive symptoms and to communicate individual PHQ-9 profiles with patients with respect to gender, age, cardiac symptoms and quality of life.	[Kohlmann, Sebastian; Gierk, Benjamin; Murray, Alexandra M.; Scholl, Arne; Lehmann, Marco; Lowe, Bernd] Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany; [Kohlmann, Sebastian; Gierk, Benjamin; Murray, Alexandra M.; Scholl, Arne; Lehmann, Marco; Lowe, Bernd] Schon Clin Hamburg Eilbek, Hamburg, Germany; [Gierk, Benjamin] Asklepios Clin North Ochsenzoll, Dept Psychiat, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kohlmann, S (corresponding author), Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.; Kohlmann, S (corresponding author), Schon Clin Hamburg Eilbek, Hamburg, Germany.	s.kohlmann@uke.de	Löwe, Bernd/AAG-4038-2020	Lowe, Bernd/0000-0003-4220-3378; Kohlmann, Sebastian/0000-0003-1307-4618	German Federal Ministry of Education and Research, Germany; Asklepios Clinic North Ochsenzoll	German Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Asklepios Clinic North Ochsenzoll	The study DEPCSREEN-INFO was funded by the German Federal Ministry of Education and Research (https://www.bmbf.de/en/index.html), Germany (# 01GX1004; Principal Investigator: BL). Asklepios Clinic North Ochsenzoll provided support in the form of salaries for BG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Alderson SL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005146; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Azevedo RD, 2014, PSYCHOL MED, V44, P2689, DOI 10.1017/S0033291714000063; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Barley EA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-1; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481; Carney RM, 2012, PSYCHOSOM MED, V74, P33, DOI 10.1097/PSY.0b013e3182405ac4; Davidsen AS, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.24866; Davidson KW, 2013, JAMA INTERN MED, V173, P997, DOI 10.1001/jamainternmed.2013.915; Davidson KW, 2010, ARCH INTERN MED, V170, P600, DOI 10.1001/archinternmed.2010.29; de Jonge P, 2006, AM J PSYCHIAT, V163, P138, DOI 10.1176/appi.ajp.163.1.138; de Jonge P, 2012, BRIT J PSYCHIAT, V201, P337, DOI 10.1192/bjp.bp.112.110502; De Smedt D, 2013, INT J CARDIOL, V167, P2294, DOI 10.1016/j.ijcard.2012.06.025; Denollet J, 2013, PSYCHOSOM MED, V75, P701, DOI 10.1097/PSY.0b013e31829dbd36; Dowrick C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b663; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fried EI, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0325-4; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Gulliksson M, 2011, ARCH INTERN MED, V171, P134, DOI 10.1001/archinternmed.2010.510; Hemingway H, 2004, CAN J CARDIOL, V20, P305; Hoen PW, 2010, J AM COLL CARDIOL, V56, P838, DOI 10.1016/j.jacc.2010.03.080; Hoen PW, 2010, PSYCHOTHER PSYCHOSOM, V79, P319, DOI 10.1159/000319528; Holland R, 2010, J CARD FAIL, V16, P150, DOI 10.1016/j.cardfail.2009.08.010; Kessler RC, 2010, PSYCHOL MED, V40, P225, DOI 10.1017/S0033291709990213; Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634; Kohlmann S, 2013, JAMA INTERN MED, V173, P1469, DOI 10.1001/jamainternmed.2013.6835; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Malpass A, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X502119; Maxwell M, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-46; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Nowels D, 2005, QUAL LIFE RES, V14, P95, DOI 10.1007/s11136-004-0614-4; Ormel J, 2011, PSYCHOTHER PSYCHOSOM, V80, P264, DOI 10.1159/000323165; Pigeon WR, 2008, SLEEP, V31, P481, DOI 10.1093/sleep/31.4.481; Rief W, 2004, J AFFECT DISORDERS, V82, P271, DOI 10.1016/j.jad.2003.11.006; Roest AM, 2013, J AFFECT DISORDERS, V149, P335, DOI 10.1016/j.jad.2013.02.008; Roest AM, 2011, J AFFECT DISORDERS, V131, P158, DOI 10.1016/j.jad.2010.11.018; Schumann I, 2012, FAM PRACT, V29, P255, DOI 10.1093/fampra/cmr092; Shah A. J., 2014, AM HEART ASS, V3; Stewart JC, 2012, CIRCULATION, V126, P410, DOI 10.1161/CIRCULATIONAHA.112.094946; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Tully PJ, 2011, J HEALTH PSYCHOL, V16, P584, DOI 10.1177/1359105310383604; Uher R, 2012, PSYCHOL MED, V42, P967, DOI 10.1017/S0033291711001905; van der Feltz-Cornelis CM, 2014, NEUROPSYCH DIS TREAT, V10, P1057, DOI 10.2147/NDT.S59958; van Melle JP, 2005, EUR HEART J, V26, P2650, DOI 10.1093/eurheartj/ehi480; Warrings B, 2012, CIRCULATION SUPPLEME, V126; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	54	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156167	10.1371/journal.pone.0156167	http://dx.doi.org/10.1371/journal.pone.0156167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27228158	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500077
J	Kumar, N; Barua, S; Riyesh, T; Chaubey, KK; Rawat, KD; Khandelwal, N; Mishra, AK; Sharma, N; Chandel, SS; Sharma, S; Singh, MK; Sharma, DK; Singh, SV; Tripathi, BN				Kumar, Naveen; Barua, Sanjay; Riyesh, Thachamvally; Chaubey, Kundan K.; Rawat, Krishan Dutt; Khandelwal, Nitin; Mishra, Anil K.; Sharma, Nitika; Chandel, Surender S.; Sharma, Shalini; Singh, Manoj K.; Sharma, Dinesh K.; Singh, Shoor V.; Tripathi, Bhupendra N.			Complexities in Isolation and Purification of Multiple Viruses from Mixed Viral Infections: Viral Interference, Persistence and Exclusion	PLOS ONE			English	Article							DES PETITS RUMINANTS; MOUTH-DISEASE VIRUS; RESPIRATORY-TRACT INFECTIONS; DUAL INFECTION; DENGUE VIRUS; CELL-CULTURE; PESTE; PARTICLES; RISK; TRANSMISSION	Successful purification of multiple viruses from mixed infections remains a challenge. In this study, we investigated peste des petits ruminants virus (PPRV) and foot-and-mouth disease virus (FMDV) mixed infection in goats. Rather than in a single cell type, cytopathic effect (CPE) of the virus was observed in cocultured Vero/BHK-21 cells at 6th blind passage (BP). PPRV, but not FMDV could be purified from the virus mixture by plaque assay. Viral RNA (mixture) transfection in BHK-21 cells produced FMDV but not PPRV virions, a strategy which we have successfully employed for the first time to eliminate the negative-stranded RNA virus from the virus mixture. FMDV phenotypes, such as replication competent but noncytolytic, cytolytic but defective in plaque formation and, cytolytic but defective in both plaque formation and standard FMDV genome were observed respectively, at passage level BP8, BP15 and BP19 and hence complicated virus isolation in the cell culture system. Mixed infection was not found to induce any significant antigenic and genetic diversity in both PPRV and FMDV. Further, we for the first time demonstrated the viral interference between PPRV and FMDV. Prior transfection of PPRV RNA, but not Newcastle disease virus (NDV) and rotavirus RNA resulted in reduced FMDV replication in BHK-21 cells suggesting that the PPRV RNA-induced interference was specifically directed against FMDV. On long-term-coinfection of some acute pathogenic viruses (all possible combinations of PPRV, FMDV, NDV and buffalo-pox virus) in Vero cells, inmost cases, one of the coinfecting viruses was excluded at passage level 5 suggesting that the long-term coinfection may modify viral persistence. To the best of our knowledge, this is the first documented evidence describing a natural mixed infection of FMDV and PPRV. The study not only provides simple and reliable methodologies for isolation and purification of two epidemiologically and economically important groups of viruses, but could also help in establishing better guidelines for trading animals that could transmit further infections and epidemics in disease free nations.	[Kumar, Naveen; Chaubey, Kundan K.; Mishra, Anil K.; Sharma, Nitika; Singh, Manoj K.; Sharma, Dinesh K.; Singh, Shoor V.] ICAR Cent Inst Res Goats, Div Anim Hlth, Makhdoom, Mathura, India; [Kumar, Naveen; Barua, Sanjay; Riyesh, Thachamvally; Rawat, Krishan Dutt; Khandelwal, Nitin; Chandel, Surender S.; Tripathi, Bhupendra N.] ICAR Natl Res Ctr Equines, Natl Ctr Vet Type Culture Collect, Hisar, Haryana, India; [Sharma, Shalini] Lala Lajpat Rai Univ Vet & Anim Sci, Dept Vet Physiol & Biochem, Hisar, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute for Research on Goats; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Lala Lajpat Rai University of Veterinary & Animal Sciences	Kumar, N (corresponding author), ICAR Cent Inst Res Goats, Div Anim Hlth, Makhdoom, Mathura, India.; Kumar, N (corresponding author), ICAR Natl Res Ctr Equines, Natl Ctr Vet Type Culture Collect, Hisar, Haryana, India.	naveenkumar.icar@gmail.com	Kumar, Naveen/AAR-9084-2021	Chaubey, Kundan/0000-0002-5940-4638; Singh, Manoj Kumar/0000-0003-0118-3614	Indian Council of Agricultural Research (ICAR), India [IXX10113]; Science and Engineering Research Board, Department of Science and Technology, Government of India [SB/SO/AS-20/2014]	Indian Council of Agricultural Research (ICAR), India(Indian Council of Agricultural Research (ICAR)); Science and Engineering Research Board, Department of Science and Technology, Government of India	The project was partially funded through Indian Council of Agricultural Research (ICAR), India, to N. Kumar ( project code, IXX10113) as well as Science and Engineering Research Board, Department of Science and Technology, Government of India under project SB/SO/AS-20/2014 to N. Kumar. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; Balamurugan V, 2011, REV SCI TECH OIE, V30, P889; Bangham C R, 1993, Trends Microbiol, V1, P260, DOI 10.1016/0966-842X(93)90048-V; Bara Jeffrey J, 2014, Acta Trop, V130, P71, DOI 10.1016/j.actatropica.2013.10.016; Barnett PV, 1999, VET J, V158, P6, DOI 10.1053/tvjl.1998.0338; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Belsham GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014621; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; BRUMBACK BG, 1994, J CLIN MICROBIOL, V32, P2289, DOI 10.1128/JCM.32.9.2289-2290.1994; Calain P, 1999, VIROLOGY, V262, P114, DOI 10.1006/viro.1999.9915; Callens M, 1997, J VIROL METHODS, V67, P35, DOI 10.1016/S0166-0934(97)00074-8; Callis JJ, 1996, REV SCI TECH OIE, V15, P1075, DOI 10.20506/rst.15.3.974; Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10; Chang YY, 2009, ACTA BIOCH BIOPH SIN, V41, P998, DOI 10.1093/abbs/gmp093; Chua K B, 2004, Malays J Pathol, V26, P69; COONEY MK, 1976, AM J MED TECHNOL, V42, P158; DaPalma T, 2010, VIRUS RES, V149, P1, DOI 10.1016/j.virusres.2010.01.002; DITTMAR D, 1982, J GEN VIROL, V59, P273, DOI 10.1099/0022-1317-59-2-273; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; DOWNHAM MAP, 1975, BRIT MED J, V1, P235, DOI 10.1136/bmj.1.5952.235; Elnekave E, 2016, PREV VET MED, V125, P82, DOI 10.1016/j.prevetmed.2015.12.019; Escarmis C, 2008, J MOL BIOL, V376, P367, DOI 10.1016/j.jmb.2007.11.042; Ezeibe MCO, 2008, TROP ANIM HEALTH PRO, V40, P517, DOI 10.1007/s11250-008-9128-3; FRIEDMAN RM, 1964, NATURE, V201, P848, DOI 10.1038/201848a0; Garcia-Arriaza J, 2005, VIROLOGY, V335, P155, DOI 10.1016/j.virol.2005.02.012; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Garland AJM, 2011, REV SCI TECH OIE, V30, P189; Geale DW, 2015, TRANSBOUND EMERG DIS, V62, P388, DOI 10.1111/tbed.12165; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Haller O, 2015, J INTERF CYTOK RES, V35, P239, DOI 10.1089/jir.2015.1500; Heddini A, 2009, EUROSURVEILLANCE, V14; Hofmann MA, 2000, J VIROL METHODS, V87, P29, DOI 10.1016/S0166-0934(00)00154-3; Holmes Katherine, 2010, BMC Res Notes, V3, P53, DOI 10.1186/1756-0500-3-53; JANDA JM, 1979, J VIROL, V32, P697, DOI 10.1128/JVI.32.2.697-702.1979; Jorna T, 2003, TIJDSCHR DIERGENEESK, V128, P146; Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671; Kumar N, 2014, VIRUSES-BASEL, V6, P2287, DOI 10.3390/v6062287; Kumar N, 2013, J VIROL METHODS, V189, P388, DOI 10.1016/j.jviromet.2013.03.002; Kumar N, 2011, ANTIMICROB AGENTS CH, V55, P5553, DOI 10.1128/AAC.00725-11; Lefevre P C, 1990, Rev Sci Tech, V9, P935; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; LUNDQUIST RE, 1979, CELL, V18, P759, DOI 10.1016/0092-8674(79)90129-6; Malik YS, 2011, TRANSBOUND EMERG DIS, V58, P268, DOI 10.1111/j.1865-1682.2011.01201.x; MALIRAT V, 1994, VIRUS RES, V34, P31, DOI 10.1016/0168-1702(94)90117-1; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; MEISSNER HC, 1984, J PEDIATR-US, V104, P680, DOI 10.1016/S0022-3476(84)80943-9; Mondal B, 2009, TROP ANIM HEALTH PRO, V41, P1661, DOI 10.1007/s11250-009-9362-3; Moss A, 1999, J VIROL METHODS, V80, P59, DOI 10.1016/S0166-0934(99)00031-2; Nanda YP, 1996, VET MICROBIOL, V51, P207, DOI 10.1016/0378-1135(96)00025-9; NOMOTO A, 1979, J MOL BIOL, V128, P179, DOI 10.1016/0022-2836(79)90125-6; OLSON LC, 1973, AM J EPIDEMIOL, V97, P34, DOI 10.1093/oxfordjournals.aje.a121481; Padhi A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07040; Paton DJ, 2010, TRANSBOUND EMERG DIS, V57, P115, DOI 10.1111/j.1865-1682.2010.01137.x; Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28; Piccone ME, 2009, J VIROL, V83, P6681, DOI 10.1128/JVI.01729-08; RAHMAN M, 1990, REV INFECT DIS, V12, pS899; Reid SM, 2000, J VIROL METHODS, V89, P167, DOI 10.1016/S0166-0934(00)00213-5; Rodriguez-Calvo T, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-22; Rohani A, 2009, SE ASIAN J TROP MED, V40, P443; Saeed IK, 2015, TROP ANIM HEALTH PRO, V47, P995, DOI 10.1007/s11250-015-0798-3; Salas-Benito JS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/873404; Saravanan P, 2007, VET REC, V160, P410, DOI 10.1136/vr.160.12.410; Schultz-Cherry S, 2015, J INFECT DIS, V212, P1690, DOI 10.1093/infdis/jiv261; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Sharma S, 2014, J LEUKOCYTE BIOL, V95, P405, DOI 10.1189/jlb.0713386; Sivaram A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-95; SNOWDON WA, 1966, NATURE, V210, P1079, DOI 10.1038/2101079a0; STROHMAIER K, 1982, J GEN VIROL, V59, P295, DOI 10.1099/0022-1317-59-2-295; Subramaniam S, 2013, TRANSBOUND EMERG DIS, V60, P197, DOI 10.1111/j.1865-1682.2012.01332.x; Sutmoller P, 2003, VIRUS RES, V91, P101, DOI 10.1016/S0168-1702(02)00262-9; Tang MB, 2014, SE ASIAN J TROP MED, V45, P1326; Tekleghiorghis T., 2014, TRANSBOUND EMERG DIS; Toplu N, 2012, J COMP PATHOL, V146, P289, DOI 10.1016/j.jcpa.2011.07.004; Vagnozzi A, 2007, J VIROL, V81, P11669, DOI 10.1128/JVI.00557-07; van Engelenburg FAC, 2002, J HOSP INFECT, V51, P121, DOI 10.1053/jhin.2002.1211; Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706; Vento S, 2013, LANCET INFECT DIS, V13, P9, DOI 10.1016/S1473-3099(12)70312-2; WAGNER RR, 1960, BACTERIOL REV, V24, P151, DOI 10.1128/MMBR.24.1.151-166.1960; WANER JL, 1994, CLIN MICROBIOL REV, V7, P143, DOI 10.1128/CMR.7.2.143-151.1994; Wernery U, 2004, VET J, V168, P134, DOI 10.1016/j.tvjl.2003.10.005; WHITAKERDOWLING P, 1987, MICROBIOL REV, V51, P179, DOI 10.1128/MMBR.51.2.179-191.1987; Yeh JY, 2011, J CLIN MICROBIOL, V49, P1389, DOI 10.1128/JCM.00710-10	84	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156110	10.1371/journal.pone.0156110	http://dx.doi.org/10.1371/journal.pone.0156110			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227480	Green Published, gold			2022-12-26	WOS:000376882500069
J	Li, MM; Li, YH; Zhao, JY; Liu, H; Jia, SH; Li, J; Zhao, HP; Han, SC; Wang, YD				Li, Mengmeng; Li, Yihao; Zhao, Junyi; Liu, Hai; Jia, Shenghua; Li, Jie; Zhao, Heping; Han, Shengcheng; Wang, Yingdian			GpDSR7, a Novel E3 Ubiquitin Ligase Gene in Grimmia pilifera Is Involved in Tolerance to Drought Stress in Arabidopsis	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; ABIOTIC STRESS; 26S PROTEASOME; SALT; DESICCATION; MOSS; REHYDRATION; EXPRESSION; RESPONSES; ATAIRP1	The growth and development of plants under drought stress depends mainly on the expression levels of various genes and modification of proteins. To clarify the molecular mechanism of drought-tolerance of plants, suppression subtractive hybridisation cDNA libraries were screened to identify drought-stress-responsive unigenes in Grimmia pilifera, and a novel E3 ubiquitin ligase gene, GpDSR7, was identified among the 240 responsive unigenes. GpDSR7 expression was induced by various abiotic stresses, particularly by drought. GpDSR7 displayed E3 ubiquitin ligase activity in vitro and was exclusively localised on the ER membrane in Arabidopsis mesophyll protoplasts. GpDSR7-overexpressing transgenic Arabidopsis plants showed a high water content and survival ratio under drought stress. Moreover, the expression levels of some marker genes involved in drought stress were higher in the transgenic plants than in wild-type plants. These results suggest that GpDSR7, an E3 ubiquitin ligase, is involved in tolerance to drought stress at the protein modification level.	[Li, Mengmeng; Li, Yihao; Zhao, Junyi; Liu, Hai; Jia, Shenghua; Li, Jie; Zhao, Heping; Han, Shengcheng; Wang, Yingdian] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Coll Life Sci, Beijing 100875, Peoples R China	Beijing Normal University	Wang, YD (corresponding author), Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Coll Life Sci, Beijing 100875, Peoples R China.	ydwang@bnu.edu.cn			National High Technology Research and Development Program (863 Program) [2007AA02140]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program (863 Program, No. 2007AA02140). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazari A, 2014, CRYOBIOLOGY, V69, P511; Arya D, 2016, FEBS J, V283, P556, DOI 10.1111/febs.13611; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chen X, 2003, BIOL PLANTARUM, V46, P363, DOI 10.1023/A:1024369917715; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; DHINDSA RS, 1987, PLANT PHYSIOL, V83, P816, DOI 10.1104/pp.83.4.816; Fernandez CC, 2006, P NATL ACAD SCI USA, V103, P637, DOI 10.1073/pnas.0510267103; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Guerra D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00057; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; KEEVER C, 1957, ECOLOGY, V38, P422, DOI 10.2307/1929885; Kim JH, 2013, PLANT PHYSIOL, V162, P1733, DOI 10.1104/pp.113.220103; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Langridge P, 2015, CURR OPIN BIOTECH, V32, P130, DOI 10.1016/j.copbio.2014.11.027; Lee HK, 2009, PLANT CELL, V21, P622, DOI 10.1105/tpc.108.061994; Li YS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0653-8; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Liu HX, 2011, PLANT SIGNAL BEHAV, V6, P344, DOI 10.4161/psb.6.3.13914; McKAY ELIZABETH, 1935, PLANT PHYSIOL, V10, P803, DOI 10.1104/pp.10.4.803; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Munoz J, 1999, ANN MO BOT GARD, V86, P118, DOI 10.2307/2666219; OLIVER MJ, 1984, PLANT PHYSIOL, V74, P21, DOI 10.1104/pp.74.1.21; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Proctor MCF, 2004, PHYSIOL PLANTARUM, V122, P21, DOI 10.1111/j.1399-3054.2004.00348.x; Rochaix JD, 2014, ANNU REV PLANT BIOL, V65, P287, DOI 10.1146/annurev-arplant-050213-040226; Ryu MY, 2010, PLANT PHYSIOL, V154, P1983, DOI 10.1104/pp.110.164749; Sahu BB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-69; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Stone SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00135; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Verslues PE, 2014, PLANT PHYSIOL, V164, P144, DOI 10.1104/pp.113.224014; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Yang L, 2016, J INTEGR PLANT BIOL, V58, P67, DOI 10.1111/jipb.12364; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yu FF, 2016, MOL PLANT, V9, P21, DOI 10.1016/j.molp.2015.09.015; Yuan F, 2014, NATURE, V514, P367, DOI 10.1038/nature13593; Zhang HW, 2015, PLANT CELL, V27, P214, DOI 10.1105/tpc.114.134163; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	45	4	7	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155455	10.1371/journal.pone.0155455	http://dx.doi.org/10.1371/journal.pone.0155455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228205	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500021
J	Luna-Nacar, M; Navarrete-Perea, J; Moguel, B; Bobes, RJ; Laclette, JP; Carrero, JC				Luna-Nacar, Milka; Navarrete-Perea, Jose; Moguel, Barbara; Bobes, Raul J.; Laclette, Juan P.; Carrero, Julio C.			Proteomic Study of Entamoeba histolytica Trophozoites, Cysts, and Cyst-Like Structures	PLOS ONE			English	Article							PSEUDOCYST FORMATION; PROTEIN; ENCYSTATION; DIFFERENTIATION; PHAGOCYTOSIS; INVADENS; GENOME; CHITIN; STRESS; LECTIN	The cyst stage of Entamoeba histolytica is a promising therapeutic target against human amoebiasis. Our research team previously reported the production in vitro of Cyst-Like Structures (CLS) sharing structural features with cysts, including rounded shape, size reduction, multinucleation, and the formation of a chitin wall coupled to the overexpression of glucosamine 6-phosphate isomerase, the rate-limiting enzyme of the chitin synthesis pathway. A proteomic study of E. histolytica trophozoites, cysts, and in vitro-produced CLS is reported herein to determine the nature of CLS, widen our knowledge on the cyst stage, and identify possible proteins and pathways involved in the encystment process. Total protein extracts were obtained from E. histolytica trophozoites, CLS, and partially purified cysts recovered from the feces of amoebic human patients; extracts were trypsin-digested and analyzed by LC-MS/MS. In total, 1029 proteins were identified in trophozoites, 550 in CLS, and 411 in cysts, with 539, 299, and 84 proteins unique to each sample, respectively, and only 74 proteins shared by all three stages. About 70% of CLS proteins were shared with trophozoites, even though differences were observed in the relative protein abundance. While trophozoites showed a greater abundance of proteins associated to a metabolically active cell, CLS showed higher expression of proteins related to proteolysis, redox homeostasis, and stress response. In addition, the expression of genes encoding for the cyst wall proteins Jessie and Jacob was detected by RT-PCR and the Jacob protein identified by Western blotting and immunofluorescence in CLS. However, the proteomic profile of cysts as determined by LC-MS/MS was very dissimilar to that of trophozoites and CLS, with almost 40% of hypothetical proteins. Our global results suggest that CLS are more alike to trophozoites than to cysts, and they could be generated as a rapid survival response of trophozoites to a stressful condition, which allows the parasite to survive temporarily inside a chitin-like resistant cover containing Jacob protein. Our findings lead us to suggest that encystment and CLS formation could be distinct stress responses. In addition, we show that cysts express a high number of genes with unknown function, including four new, highly antigenic, possibly membrane-located proteins that could be targets of therapeutic and diagnostic usefulness.	[Luna-Nacar, Milka; Navarrete-Perea, Jose; Moguel, Barbara; Bobes, Raul J.; Laclette, Juan P.; Carrero, Julio C.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Immunol, Tercer Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Carrero, JC (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Immunol, Tercer Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	carrero@unam.mx		Carrero, Julio/0000-0003-1055-5774; Moguel, Barbara/0000-0002-4489-0055; Navarrete, Jose/0000-0002-6984-1495; Navarrete-Perea, Jose/0000-0001-6265-6214	Consejo Nacional de Ciencia y Tecnologia (CONACyT) de Mexico [167788]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico-UNAM [IN213611]; Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico; Conacyt [389536/255914]	Consejo Nacional de Ciencia y Tecnologia (CONACyT) de Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico-UNAM; Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT) de Mexico, Number 167788 granted to JCC and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico-UNAM, Number IN213611 granted to JCC. MLN gratefully acknowledges the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, and Conacyt for the scholarship PhD 389536/255914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was part of the doctoral thesis of Milka Azucena Luna Nacar, who gratefully acknowledges the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, and Conacyt for the scholarship PhD 389536/255914. We thank Mario Nequiz-Avendano for amoeba culturing, Salvador Rodriguez and CARPERMOR Laboratories for providing stool samples, Jeovanis Gil for bioinformatic assistance and Pavel Petrosyan for technical assistance.	Aguilar-Diaz H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/758341; Aguilar-Diaz H, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000607; Ali IKM, 2015, CLIN LAB MED, V35, P393, DOI 10.1016/j.cll.2015.02.009; Ali IKM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001643; AVRON B, 1986, J PROTOZOOL, V33, P522, DOI 10.1111/j.1550-7408.1986.tb05655.x; BAILEY GB, 1980, ARCH INVEST MED, V11, P11; Barron-Gonzalez MP, 2008, EXP PARASITOL, V118, P600, DOI 10.1016/j.exppara.2007.11.002; Biller L, 2014, MOL CELL PROTEOMICS, V13, P132, DOI 10.1074/mcp.M113.031393; Boettner DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buss SN, 2010, INT J PARASITOL, V40, P833, DOI 10.1016/j.ijpara.2009.12.007; Campos-Gongora E, 2000, ARCH MED RES, V31, P162, DOI 10.1016/S0188-4409(00)00054-0; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Davis PH, 2006, MOL MICROBIOL, V61, P1523, DOI 10.1111/j.1365-2958.2006.05344.x; Davis PH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000415; de la Cruz OH, 2014, J PROTEOMICS, V111, P46, DOI 10.1016/j.jprot.2014.03.041; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Eichinger D, 2001, J EUKARYOT MICROBIOL, V48, P17, DOI 10.1111/j.1550-7408.2001.tb00411.x; Falda M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S14; Fontana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004619; Ghosh SK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000750; Hamzah Z, 2006, J CLIN MICROBIOL, V44, P3196, DOI 10.1128/JCM.00778-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Husain A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001831; Kliescikova J, 2011, EXP PARASITOL, V127, P326, DOI 10.1016/j.exppara.2010.08.014; Kliescikova J, 2011, PROTIST, V162, P58, DOI 10.1016/j.protis.2010.03.006; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Leitsch D, 2005, EXP PARASITOL, V110, P191, DOI 10.1016/j.exppara.2005.02.016; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lopez-Rosas I, 2014, J PROTEOMICS, V111, P59, DOI 10.1016/j.jprot.2014.06.019; Lorenzi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000716; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; MacFarlane R, 2005, EXP PARASITOL, V110, P196, DOI 10.1016/j.exppara.2005.03.006; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; MacFarlane RC, 2005, INT J PARASITOL, V35, P533, DOI 10.1016/j.ijpara.2005.02.006; Marion S, 2005, CELL MICROBIOL, V7, P1504, DOI 10.1111/j.1462-5822.2005.00573.x; McCoy JJ, 2005, EXP PARASITOL, V110, P220, DOI 10.1016/j.exppara.2005.02.013; Mi H, 2013, NUCLEIC ACIDS RES, V4, P377; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Perdomo D, 2015, J PROTEOMICS, V112, P125, DOI 10.1016/j.jprot.2014.07.034; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; RENGPIEN S, 1975, J PARASITOL, V61, P24, DOI 10.2307/3279100; Said-Fernandez S, 2001, J PARASITOL, V87, P919, DOI 10.2307/3285156; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Tolstrup J, 2007, PARASITOLOGY, V134, P289, DOI 10.1017/S0031182006001442; Valdes J, 2014, J PROTEOMICS, V111, P30, DOI 10.1016/j.jprot.2014.07.027; Van Dellen KL, 2006, EUKARYOT CELL, V5, P836, DOI 10.1128/EC.5.5.836-848.2006; VAZQUEZDELARACISNEROS LG, 1984, J PARASITOL, V70, P629, DOI 10.2307/3281741; Walderich B, 1997, PARASITOL RES, V83, P719, DOI 10.1007/s004360050326; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Ximenez C, 2009, INFECT GENET EVOL, V9, P1023, DOI 10.1016/j.meegid.2009.06.008; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	59	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156018	10.1371/journal.pone.0156018	http://dx.doi.org/10.1371/journal.pone.0156018			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228164	Green Submitted, gold, Green Published			2022-12-26	WOS:000376882500051
J	Ortiz, AM; Carnathan, DG; Yu, J; Sheehan, KM; Kim, P; Reynaldi, A; Vanderford, TH; Klatt, NR; Brenchley, JM; Davenport, MP; Silvestri, G				Ortiz, Alexandra M.; Carnathan, Diane G.; Yu, Joana; Sheehan, Katherine M.; Kim, Peter; Reynaldi, Arnold; Vanderford, Thomas H.; Klatt, Nichole R.; Brenchley, Jason M.; Davenport, Miles P.; Silvestri, Guido			Analysis of the In Vivo Turnover of CD4+T-Cell Subsets in Chronically SIV-Infected Sooty Mangabeys	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; LYMPHOCYTE TURNOVER; HIV-1 INFECTION; MACAQUES; SUBPOPULATIONS; DYNAMICS; RATES	Aberrant turnover of memory CD4+ T-cells is central to Acquired Immunodeficiency Syndrome (AIDS) progression. Understanding the relationship between the turnover of CD4+ subsets and immunological homeostasis during simian immunodeficiency virus (SIV) infection in natural hosts may provide insight into mechanisms of immune regulation that may serve as models for therapeutic intervention in Human Immunodeficiency Virus (HIV)infected persons. Sooty mangabeys (SMs) have naturally evolved with SIV to avoid AIDS progression while maintaining healthy peripheral CD4+ T-cell counts and thus represent a model by which therapeutic interventions for AIDS progression might be elucidated. To assess the relationship between the turnover of CD4+ subsets and immunological homeostasis during SIV infection in non-progressive hosts, we treated 6 SIV-uninfected and 9 SIVinfected SMs with 2'-bromo-5'-deoxyuridine (BrdU) for 14 days and longitudinally assessed CD4+ T-cell subset turnover by polychromatic flow cytometry. We observed that, in SIVinfected SMs, turnover of CD4+ T-cell naive and central, transitional, and effector memory subsets is comparable to that in uninfected animals. Comparable turnover of CD4+ T-cell subsets irrespective of SIV-infection status likely contributes to the lack of aberrant immune activation and disease progression observed after infection in non-progressive hosts.	[Ortiz, Alexandra M.; Carnathan, Diane G.; Yu, Joana; Sheehan, Katherine M.; Vanderford, Thomas H.; Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Ortiz, Alexandra M.; Carnathan, Diane G.; Yu, Joana; Sheehan, Katherine M.; Vanderford, Thomas H.; Silvestri, Guido] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Kim, Peter; Reynaldi, Arnold; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Sydney, NSW 2052, Australia; [Ortiz, Alexandra M.; Klatt, Nichole R.; Brenchley, Jason M.] NIH, Mol Microbiol Lab, Bldg 10, Bethesda, MD 20892 USA; [Klatt, Nichole R.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	Emory University; Emory University; University of New South Wales Sydney; National Institutes of Health (NIH) - USA; University of Washington; University of Washington Seattle	Silvestri, G (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.; Silvestri, G (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	gsilves@emory.edu	Brenchley, Jason/AAC-5085-2019	Davenport, Miles/0000-0002-4751-1831; Reynaldi, Arnold/0000-0002-5529-5542; Kim, Peter/0000-0002-1492-4744; Brenchley, Jason/0000-0001-8357-2984	National Institutes of Health/National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs / OD [P51OD011132];  [R37-AI066998]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066998, ZIAAI001029] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs / OD; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by R37-AI066998 to GS (URL: www.grants.nih.gov). In addition, it was supported by the National Institutes of Health/National Center for Research Resources (P51RR000165) and is currently supported by the Office of Research Infrastructure Programs / OD P51OD011132 to the Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Cartwright EK, 2014, J IMMUNOL, V192, P4666, DOI 10.4049/jimmunol.1303193; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; De Boer RJ, 2003, J IMMUNOL, V170, P2479, DOI 10.4049/jimmunol.170.5.2479; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Kaur A, 2008, J VIROL, V82, P1084, DOI 10.1128/JVI.02197-07; Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Riddick NE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001064; Rosenzweig M, 1998, P NATL ACAD SCI USA, V95, P6388, DOI 10.1073/pnas.95.11.6388; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8	15	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156352	10.1371/journal.pone.0156352	http://dx.doi.org/10.1371/journal.pone.0156352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227993	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500121
J	Pian, C; Zhang, GL; Chen, Z; Chen, YY; Zhang, J; Yang, T; Zhang, LY				Pian, Cong; Zhang, Guangle; Chen, Zhi; Chen, Yuanyuan; Zhang, Jin; Yang, Tao; Zhang, Liangyun			LncRNApred: Classification of Long Non-Coding RNAs and Protein-Coding Transcripts by the Ensemble Algorithm with a New Hybrid Feature	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; PREDICTION; GENOME; DNA; GENES; IDENTIFICATION; EVOLUTION; ELEMENTS; DATABASE; REGIONS	As a novel class of noncoding RNAs, long noncoding RNAs (lncRNAs) have been verified to be associated with various diseases. As large scale transcripts are generated every year, it is significant to accurately and quickly identify lncRNAs from thousands of assembled transcripts. To accurately discover new lncRNAs, we develop a classification tool of random forest (RF) named LncRNApred based on a new hybrid feature. This hybrid feature set includes three new proposed features, which are MaxORF, RMaxORF and SNR. LncRNApred is effective for classifying lncRNAs and protein coding transcripts accurately and quickly. Moreover, our RF model only requests the training using data on human coding and non-coding transcripts. Other species can also be predicted by using LncRNApred. The result shows that our method is more effective compared with the Coding Potential Calculate (CPC). The web server of LncRNApred is available for free at http://mm20132014.wicp.net:57203/LncRNApred/home.jsp.	[Pian, Cong; Zhang, Guangle; Chen, Zhi; Chen, Yuanyuan; Zhang, Jin; Yang, Tao; Zhang, Liangyun] Nanjing Agr Univ, Coll Sci, Dept Math, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, LY (corresponding author), Nanjing Agr Univ, Coll Sci, Dept Math, Nanjing, Jiangsu, Peoples R China.	zlyun@njau.edu.cn	Chen, Yuanyuan/GXG-2130-2022	Pian, Cong/0000-0001-7401-2926	National Natural Science Foundation of China [11571173, 11401311, 31301229]; Natural Science Foundation of Jiangsu Province [BK20141358]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work is supported by the National Natural Science Foundation of China (11571173, 11401311, 31301229) and the Natural Science Foundation of Jiangsu Province (BK20141358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bao Michael, 2012, Genomics Proteomics & Bioinformatics, V10, P114, DOI 10.1016/j.gpb.2012.05.004; Bernhart Stephan H., 2009, Briefings in Functional Genomics & Proteomics, V8, P461, DOI 10.1093/bfgp/elp043; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cao JW, 2012, INFORM SCIENCES, V185, P66, DOI 10.1016/j.ins.2011.09.015; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; Coventry A, 2004, P NATL ACAD SCI USA, V101, P12102, DOI 10.1073/pnas.0404193101; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilebrecht S, 2011, NUCLEIC ACIDS RES, V39, P2057, DOI 10.1093/nar/gkq1153; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; FICKETT JW, 1992, NUCLEIC ACIDS RES, V20, P6441, DOI 10.1093/nar/20.24.6441; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guay C, 2012, DIABETES OBES METAB, V14, P12, DOI 10.1111/j.1463-1326.2012.01654.x; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lertampaiporn S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks878; Li DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077938; Li GB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780521; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu JF, 2006, PLOS GENET, V2, P529, DOI 10.1371/journal.pgen.0020029; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Moskalev EA, 2012, GENE CHROMOSOME CANC, V51, P105, DOI 10.1002/gcc.20943; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Raasch P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-491; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Saetrom P, 2005, NUCLEIC ACIDS RES, V33, P3263, DOI 10.1093/nar/gki644; Salari R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005433; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Sun K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S7; Sun L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139654; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; Tran TT, 2009, BIOINFORMATICS, V25, P2897, DOI 10.1093/bioinformatics/btp537; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Vucicevic D, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00048; Wang CL, 2006, BIOINFORMATICS, V22, P2590, DOI 10.1093/bioinformatics/btl441; Wang G, 2009, P NATL ACAD SCI USA, V106, P16794, DOI 10.1073/pnas.0909022106; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2011, RNA, V17, P578, DOI 10.1261/rna.2536111; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang F, 2012, RNA BIOL, V9, P110, DOI 10.4161/rna.9.1.18332; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Yoon W, 2010, AIDS, V24, P155, DOI 10.1097/QAD.0b013e32833202f5; Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12	79	38	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0154567	10.1371/journal.pone.0154567	http://dx.doi.org/10.1371/journal.pone.0154567			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228152	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500005
J	Quittner, AL; Cejas, I; Wang, NY; Niparko, JK; Barker, DH				Quittner, Alexandra L.; Cejas, Ivette; Wang, Nae-Yuh; Niparko, John K.; Barker, David H.		CDaCI Investigative Team	Symbolic Play and Novel Noun Learning in Deaf and Hearing Children: Longitudinal Effects of Access to Sound on Early Precursors of Language	PLOS ONE			English	Article							COCHLEAR IMPLANT USERS; ATTENTION; SPEECH; SKILLS; PRESCHOOLERS; ALGORITHM; ABILITIES; AUDITION; IMPACT	In the largest, longitudinal study of young, deaf children before and three years after cochlear implantation, we compared symbolic play and novel noun learning to age-matched hearing peers. Participants were 180 children from six cochlear implant centers and 96 hearing children. Symbolic play was measured during five minutes of videotaped, structured solitary play. Play was coded as "symbolic" if the child used substitution (e.g., a wooden block as a bed). Novel noun learning was measured in 10 trials using a novel object and a distractor. Cochlear implant vs. normal hearing children were delayed in their use of symbolic play, however, those implanted before vs. after age two performed significantly better. Children with cochlear implants were also delayed in novel noun learning (median delay 1.54 years), with minimal evidence of catch-up growth. Quality of parent-child interactions was positively related to performance on the novel noun learning, but not symbolic play task. Early implantation was beneficial for both achievement of symbolic play and novel noun learning. Further, maternal sensitivity and linguistic stimulation by parents positively affected noun learning skills, although children with cochlear implants still lagged in comparison to hearing peers.	[Quittner, Alexandra L.] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA; [Cejas, Ivette] Univ Miami, Miller Sch Med, Barton G Kids Hear Now Cochlear Implant Family Re, Dept Otolaryngol, Miami, FL 33136 USA; [Wang, Nae-Yuh] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Niparko, John K.] Univ So Calif, Dept Otolaryngol Head & Neck Surg, Los Angeles, CA USA; [Barker, David H.] Brown Univ, Dept Child & Adolescent Psychiat, Providence, RI 02912 USA	University of Miami; University of Miami; Johns Hopkins University; University of Southern California; Brown University	Quittner, AL (corresponding author), Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA.	aquittner@miami.edu		Wang, Nae-Yuh/0000-0001-6513-9730	National Institute on Deafness and Other Communication Disorders [R01 DC004797]; CityBridge Foundation; Sidgmore Family Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004797] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); CityBridge Foundation; Sidgmore Family Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The CDaCI Study was supported by grant R01 DC004797 from the National Institute on Deafness and Other Communication Disorders, the CityBridge Foundation, and the Sidgmore Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum M, 1999, DEV PSYCHOL, V35, P1399; Appelbaum M, 2000, CHILD DEV, V71, P960; Barker DH, 2009, DEV PSYCHOPATHOL, V21, P373, DOI 10.1017/S0954579409000212; Barnard JM, 2015, OTOL NEUROTOL, V36, P985, DOI 10.1097/MAO.0000000000000723; BELSKY J, 1981, DEV PSYCHOL, V17, P630, DOI 10.1037/0012-1649.17.5.630; Blamey PJ, 2011, OXFORD HDB DEAF STUD, V1, P241, DOI [10.1093/oxfordhb/9780199750986.013.0018, DOI 10.1093/OXFORDHB/9780199750986.013.0018]; Bornstein MH, 1999, CHILD DEV, V70, P833, DOI 10.1111/1467-8624.00060; Brown P M, 2001, J Deaf Stud Deaf Educ, V6, P15, DOI 10.1093/deafed/6.1.15; Cruz I, 2013, CHILD DEV, V84, P543, DOI 10.1111/j.1467-8624.2012.01863.x; Cruz I, 2012, OTOL NEUROTOL, V33, P751, DOI 10.1097/MAO.0b013e3182595309; Davidson Lisa S, 2014, Cochlear Implants Int, V15, P211, DOI 10.1179/1754762813Y.0000000051; DesJardin JL, 2009, J DEAF STUD DEAF EDU, V14, P22, DOI 10.1093/deafed/enn011; Dunn CC, 2014, EAR HEARING, V35, P148, DOI 10.1097/AUD.0b013e3182a4a8f0; FEIN GG, 1981, CHILD DEV, V52, P1095, DOI 10.1111/j.1467-8624.1981.tb03157.x; Fenson L, 1993, MACARTUR COMMUNICATI; Fink Nancy E, 2007, Cochlear Implants Int, V8, P92, DOI 10.1002/cii.333; Geers AE, 2003, EAR HEARING, V24, p46S, DOI 10.1097/01.AUD.0000051689.57380.1B; Gentleman R, 2008, ICENS NPMLE CENSORED; Gershkoff-Stowe L, 2004, CHILD DEV, V75, P1098, DOI 10.1111/j.1467-8624.2004.00728.x; GILBERTSON M, 1995, J SPEECH HEAR RES, V38, P630, DOI 10.1044/jshr.3803.630; Goldfield E. C., 1993, DYNAMIC APPROACHES D; Gomez G, 2009, STAT MODEL, V9, P259, DOI 10.1177/1471082X0900900402; Gregory S, 1983, ACQUISITION SYMBOLIC, P221; Henschel V, 2007, INTCOX COMPENDIUM AP; Holt RF, 2008, EAR HEARING, V29, P492, DOI 10.1097/AUD.0b013e31816c409f; Houston DM, 2012, DEVELOPMENTAL SCI, V15, P448, DOI 10.1111/j.1467-7687.2012.01140.x; Kirk KI, 2002, ANN OTO RHINOL LARYN, V111, P69, DOI 10.1177/00034894021110S515; Kluwin TN, 2000, AM ANN DEAF, V145, P26, DOI 10.1353/aad.2012.0247; Kral Andrej, 2006, Adv Otorhinolaryngol, V64, P89, DOI 10.1159/000094647; Laing GJ, 2002, BRIT MED J, V325, P1152, DOI 10.1136/bmj.325.7373.1152; Lederberg AR, 2009, J DEAF STUD DEAF EDU, V14, P44, DOI 10.1093/deafed/enn021; Lederberg AR, 2000, CHILD DEV, V71, P1571, DOI 10.1111/1467-8624.00249; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Mayne AM, 1998, VOLTA REV, V100, P29; MCCUNENICOLICH L, 1981, CHILD DEV, V52, P785, DOI 10.2307/1129078; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Pan W, 1999, J COMPUT GRAPH STAT, V8, P109, DOI 10.2307/1390923; Parmet Sharon, 2004, JAMA, V291, P2398, DOI 10.1001/jama.291.19.2398; Quittner A.L, 2007, AUDIOL MED, V5, P242, DOI DOI 10.1080/16513860701745401; Quittner AL, 2004, ARCH OTOLARYNGOL, V130, P547, DOI 10.1001/archotol.130.5.547; QUITTNER AL, 1994, PSYCHOL SCI, V5, P347, DOI 10.1111/j.1467-9280.1994.tb00284.x; Quittner AL, 2013, J PEDIATR-US, V162, P343, DOI 10.1016/j.jpeds.2012.08.003; Quittner AL, 2010, PARENT-SCI PRACT, V10, P136, DOI 10.1080/15295190903212851; Reynell J. K., 1990, REYNELL DEV LANGUAGE; Samuelson LK, 2005, DEVELOPMENTAL SCI, V8, P182, DOI 10.1111/j.1467-7687.2005.00405.x; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; Smith LB, 1998, DEV PSYCHOL, V34, P840, DOI 10.1037/0012-1649.34.5.840; Smith LB, 2002, PSYCHOL SCI, V13, P13, DOI 10.1111/1467-9280.00403; Spencer PE, 1996, CHILD DEV, V67, P867, DOI 10.1111/j.1467-8624.1996.tb01769.x; Stelmachowicz PG, 2004, EAR HEARING, V25, P47, DOI 10.1097/01.AUD.0000111258.98509.DE; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Thal DJ, 1999, J SPEECH LANG HEAR R, V42, P482, DOI 10.1044/jslhr.4202.482; VYGOTSKY LS, 1967, SOV PSYCHOL-USSR, V5, P6, DOI 10.2753/RPO1061-040505036; Walker EA, 2013, J SPEECH LANG HEAR R, V56, P375, DOI 10.1044/1092-4388(2012/11-0343); Wellner JA, 1997, J AM STAT ASSOC, V92, P945, DOI 10.2307/2965558	55	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155964	10.1371/journal.pone.0155964	http://dx.doi.org/10.1371/journal.pone.0155964			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27228032	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500047
J	Sampaio, VS; Gomes, AA; Silva, IM; Sachett, J; Ferreira, LCL; Oliveira, S; Sabido, M; Chalkidis, H; Guerra, MGVB; Salinas, JL; Wen, FH; Lacerda, MVG; Monteiro, WM				Sampaio, Vanderson Souza; Gomes, Andre Alexandre; Silva, Iran Mendonca; Sachett, Jacqueline; Lima Ferreira, Luiz Carlos; Oliveira, Samella; Sabido, Meritxell; Chalkidis, Hipocrates; Vale Barbosa Guerra, Maria Gracas; Salinas, Jorge Luis; Wen, Fan Hui; Guimaraes Lacerda, Marcus Vinicius; Monteiro, Wuelton Marcelo			Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon	PLOS ONE			English	Article							PHONEUTRIA-NIGRIVENTER; HEMOLYTIC-ANEMIA; BITE; ENVENOMATION; LOXOSCELISM; VENOM; LATRODECTISM; CTENIDAE; TOXINS	Background A better knowledge of the burden and risk factors associated with severity due to spider bites would lead to improved management with a reduction of sequelae usually seen for this neglected health problem, and would ensure proper use of antivenoms in remote localities in the Brazilian Amazon. The aim of this study was to analyze the profile of spider bites reported in the state of Amazonas in the Western Brazilian Amazon, and to investigate potential risk factors associated with severity of envenomation. Methodology/Principal Findings We used a case-control study in order to identify factors associated with spider bite severity in the Western Brazilian Amazon from 2007 to 2014. Patients evolving to any severity criteria were considered cases and those with non-severe bites were included in the control group. All variables were retrieved from the official Brazilian reporting systems. Socioeconomical and environmental components were also included in a multivariable analysis in order to identify ecological determinants of incidence and severity. A total of 1,181 spider bites were recorded, resulting in an incidence of 4 cases per 100,000 person/year. Most of the spider bites occurred in males (65.8%). Bites mostly occurred in rural areas (59.5%). The most affected age group was between 16 and 45 years old (50.9%). A proportion of 39.7% of the bites were related to work activities. Antivenom was prescribed to 39% of the patients. Envenomings recorded from urban areas [Odds ratio (OR) = 0.40 (95% CI = 0.30-0.71; p<0.001)] and living in a municipality with a mean health system performance index (MHSPI > median [OR = 0.64 (95% CI = 0.39-0.75; p<0.001)] were independently associated with decreased risk of severity. Work related accidents [OR = 2.09 (95% CI = 1.49-2.94; p<0.001)], Indigenous status [OR = 2.15 (95% CI = 1.19-3.86; p = 0.011)] and living in a municipality located > 300 km away from the state capital Manaus [OR = 1.90 (95% CI = 1.28-2.40; p<0.001)] were independently associated with a risk of severity. Living in a municipality located > 300 km away from the state capital Manaus [OR = 1.53 (95% CI = 1.15-2.02; p = 0.003)] and living in a municipality with a MHSPI <median [OR = 1.91 (95% CI = 1.28-2.47; p = 0.002)] increased the odds of antivenom underdosage. Conclusions Spider bites is prevalent across the study region with a higher incidence in the rainy season in rural areas. Spider bites can be painful and lead to local manifestations but rarely result in life-threatening envenoming. Major local complications were dermonecrosis and secondary infection in cases diagnosed as Loxosceles bites. Based on the correlations shown here, envenomings occurring in remote rural areas, Indigenous status and living in a municipality located >300 km away from the state capital Manaus could be contributing factors to higher severity of spider envenomings in this area, as well as to antivenom underdosage.	[Sampaio, Vanderson Souza; Gomes, Andre Alexandre; Silva, Iran Mendonca; Sachett, Jacqueline; Lima Ferreira, Luiz Carlos; Oliveira, Samella; Sabido, Meritxell; Vale Barbosa Guerra, Maria Gracas; Guimaraes Lacerda, Marcus Vinicius; Monteiro, Wuelton Marcelo] Fundacao Med Trop Dr Heitor Vieira Dourado, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil; [Sampaio, Vanderson Souza; Gomes, Andre Alexandre; Silva, Iran Mendonca; Sachett, Jacqueline; Lima Ferreira, Luiz Carlos; Oliveira, Samella; Vale Barbosa Guerra, Maria Gracas; Monteiro, Wuelton Marcelo] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil; [Sampaio, Vanderson Souza] Fundacao Vigilancia Saude Amazonas, Nucleo Sistemas Informacao, Manaus, Amazonas, Brazil; [Sabido, Meritxell] Univ Girona, Fac Med, Dept Med Sci, Catalunya, Spain; [Chalkidis, Hipocrates] Fac Integradas Tapajos, Curso Ciencias Biol, Santarem, Para, Brazil; [Salinas, Jorge Luis] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Wen, Fan Hui] Secretaria Estado Saude Sao Paulo, Inst Butantan, Sao Paulo, Brazil; [Guimaraes Lacerda, Marcus Vinicius] Fiocruz MS, Inst Pesquisas Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universitat de Girona; Emory University; Instituto Butantan; Fundacao Oswaldo Cruz	Monteiro, WM (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil.; Monteiro, WM (corresponding author), Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil.	wueltonmm@gmail.com	Sachett, Jacqueline/I-5642-2017; Fan, Hui Wen/C-3750-2019; Sampaio, Vanderson/M-4337-2015; Salinas, Jorge/ABC-7735-2021; Barbosa Guerra, Maria das Graças/AGZ-7397-2022; Sampaio, Vanderson/AAQ-1418-2020	Sachett, Jacqueline/0000-0001-5723-9977; Sampaio, Vanderson/0000-0001-7307-8851; Salinas, Jorge/0000-0002-9193-820X; Sampaio, Vanderson/0000-0001-7307-8851	PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq) [001/2013]	PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq)	This study was supported by the PPSUS Public Call (FAPEAM/SUSAM-SES-AM/MS/CNPq number 001/2013). JLS is a fellow from Fogarty Global Health [R25TW009337]. MVGL is a level 1 fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes E, 2003, ANIMAIS PECONHENTOS, P150; ARTAZA O, 1982, REV MED CHILE, V110, P1101; BARBARO KC, 1992, TOXICON, V30, P1117, DOI 10.1016/0041-0101(92)90057-C; Braitberg G, 2009, AUST FAM PHYSICIAN, V38, P862; Brazilian Ministry of Health, 2000, OB POR AR; Brazilian Ministry of Health, 2000, INC 100 000 HAB CAS; Brazilian Ministry of Health, 2000, CAS AC AR; Brazilian Ministry of Health, 2009, CAD 14 AC POR AN PEC, P23, DOI DOI 10.1016/J.SMRV.2014.10.006; Brazilian Ministry of Health, 2015, SUS SIST UN SAUD; Bucaretchi F, 2008, CLIN TOXICOL, V46, P885, DOI 10.1080/15563650802258524; Bucaretchi Fabio, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P17, DOI 10.1590/S0036-46652000000100003; CHAHL LA, 1975, PAIN, V1, P3, DOI 10.1016/0304-3959(75)90003-2; Chavez-Olortegui C, 2001, TOXICON, V39, P909, DOI 10.1016/S0041-0101(00)00218-X; CLARK RF, 1992, ANN EMERG MED, V21, P782, DOI 10.1016/S0196-0644(05)81021-2; de Roodt AR, 2011, ARCH ARGENT PEDIATR, V109, P62, DOI 10.1590/S0325-00752011000100014; de Roodt AR, J CLIN TOXICOL PHILA, V45, P678; de Souza AL, 2008, TOXICON, V51, P151, DOI 10.1016/j.toxicon.2007.08.011; de Souza A R, 1998, Rev Soc Bras Med Trop, V31, P95, DOI 10.1590/S0037-86821998000100012; Elbahlawan LM, 2005, PEDIATR EMERG CARE, V21, P177; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; Gasnier TR, 2001, J ARACHNOL, V29, P95, DOI 10.1636/0161-8202(2001)029[0095:POAOFS]2.0.CO;2; Gertsdi W. J., 1967, Bulletin of the American Museum of Natural History, V136, P117; Gewehr C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002198; Gomez HF, 1999, ACAD EMERG MED, V6, P1195, DOI 10.1111/j.1553-2712.1999.tb00133.x; Gomez MV, 2002, CELL MOL NEUROBIOL, V22, P579, DOI 10.1023/A:1021836403433; Instituto Brasileiro de Geografia e Estatistica, 2013, ATL 2010 POP CENS; Isbister GK, 2008, QJM-INT J MED, V101, P557, DOI 10.1093/qjmed/hcn048; Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1; Isbister GK, 2005, MED J AUSTRALIA, V182, P407, DOI 10.5694/j.1326-5377.2005.tb06760.x; Isbister GK, 2004, J TOXICOL-CLIN TOXIC, V42, P153, DOI 10.1081/CLT-120030941; Isbister GK, 2004, INTERN MED J, V34, P287, DOI 10.1111/j.1444-0903.2004.00562.x; Isbister GK, 2004, INTERN MED J, V34, P38, DOI 10.1111/j.1444-0903.2004.00506.x; Isbister GK, 2003, MED J AUSTRALIA, V179, P199, DOI 10.5694/j.1326-5377.2003.tb05499.x; Isbister GK, 2003, MED J AUSTRALIA, V179, P88, DOI 10.5694/j.1326-5377.2003.tb05442.x; Isbister GK, 2003, J TOXICOL-CLIN TOXIC, V41, P291, DOI 10.1081/CLT-120021114; Isbister GK, 2002, QJM-INT J MED, V95, P723, DOI 10.1093/qjmed/95.11.723; Isbister GK, 2002, J TOXICOL-CLIN TOXIC, V40, P231, DOI 10.1081/CLT-120005493; Lane DR, 2004, CUTIS, V74, P341; Lira-da-Silva R M, 1995, Rev Soc Bras Med Trop, V28, P205, DOI 10.1590/S0037-86821995000300007; LUCAS S, 1988, TOXICON, V26, P759, DOI 10.1016/0041-0101(88)90317-0; MÁLAQUE Ceila Maria Sant'Ana, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P139, DOI 10.1590/S0036-46652002000300005; MARETIC Z, 1983, TOXICON, V21, P457, DOI 10.1016/0041-0101(83)90123-X; McDade J, 2010, J PEDIATR-US, V156, P155, DOI 10.1016/j.jpeds.2009.07.021; McGlasson David L, 2009, Clin Lab Sci, V22, P216; MINTON SA, 1964, PEDIATRICS, V33, P283; Monte AA, 2011, ANN PHARMACOTHER, V45, P1491, DOI 10.1345/aph.1Q424; Mowry JB, 2014, CLIN TOXICOL, V52, P1032, DOI 10.3109/15563650.2014.987397; Pauli I, 2006, TOXICON, V48, P123, DOI 10.1016/j.toxicon.2006.05.005; Pauli I, 2009, TOXICON, V53, P660, DOI 10.1016/j.toxicon.2009.01.033; Pierini SV, 1996, TOXICON, V34, P225, DOI 10.1016/0041-0101(95)00125-5; Queiroz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128819; Robinson J., 2014, PRACTICE STANDARDS A; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; SCHENONE H, 1989, REV INST MED TROP SP, V31, P403, DOI 10.1590/S0036-46651989000600007; Sezerino UM, 1998, T ROY SOC TROP MED H, V92, P546, DOI 10.1016/S0035-9203(98)90909-9; Stoecker WV, 2006, J AM ACAD DERMATOL, V55, P888, DOI 10.1016/j.jaad.2006.04.065; Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Taylor EH, 1996, SOUTH MED J, V59, P1209; Torres-Sanchez MP, 2000, PADROES ESPACIAIS AB; VORSE H, 1972, J PEDIATR-US, V80, P1035, DOI 10.1016/S0022-3476(72)80023-4; WASSERMAN GS, 1984, J TOXICOL-CLIN TOXIC, V21, P451, DOI 10.3109/15563658308990434; Wen FH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003701; WILLIAMS ST, 1995, AM J CLIN PATHOL, V104, P463	64	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156386	10.1371/journal.pone.0156386	http://dx.doi.org/10.1371/journal.pone.0156386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227455	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500129
J	Sulatskaya, AI; Kuznetsova, IM; Belousov, MV; Bondarev, SA; Zhouravleva, GA; Turoverov, KK				Sulatskaya, Anna I.; Kuznetsova, Irina M.; Belousov, Mikhail V.; Bondarev, Stanislav A.; Zhouravleva, Galina A.; Turoverov, Konstantin K.			Stoichiometry and Affinity of Thioflavin T Binding to Sup35p Amyloid Fibrils	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION-PROTEIN; SPECTRAL PROPERTIES; FLUORESCENT DYE; PEPTIDE FIBRILS; QUANTUM YIELD; BOUND DYE; SCRAPIE; SITES; YEAST	In this work two modes of binding of the fluorescent probe thioflavin T to yeast prion protein Sup35p amyloid fibrils were revealed by absorption spectrometry of solutions prepared by equilibrium microdialysis. These binding modes exhibited significant differences in binding affinity and stoichiometry. Moreover, the absorption spectrum and the molar extinction coefficient of the dye bound in each mode were determined. The fluorescence quantum yield of the dye bound in each mode was determined via a spectrofluorimetric study of the same solutions in which the recorded fluorescence intensity was corrected for the primary inner filter effect. As previously predicted, the existence of one of the detected binding modes may be due to the incorporation of the dye into the grooves along the fiber axis perpendicular to the beta-sheets of the fibrils. It was assumed that the second type of binding with higher affinity may be due to the existence of ThT binding sites that are localized to areas where amyloid fibrils are clustered.	[Sulatskaya, Anna I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, Tikhoretsky Ave 4, St Petersburg 194064, Russia; [Turoverov, Konstantin K.] Peter Great St Petersburg Polytech Univ, Inst Phys Nanotechnol & Telecommun, Polytech Skaya 29, St Petersburg 195251, Russia; [Belousov, Mikhail V.; Bondarev, Stanislav A.; Zhouravleva, Galina A.] St Petersburg State Univ, Dept Genet & Biotechnol, Univ Skaya Emb 7-9, St Petersburg 199034, Russia; [Bondarev, Stanislav A.; Zhouravleva, Galina A.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Peter the Great St. Petersburg Polytechnic University; Saint Petersburg State University; Saint Petersburg State University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, Tikhoretsky Ave 4, St Petersburg 194064, Russia.; Turoverov, KK (corresponding author), Peter Great St Petersburg Polytech Univ, Inst Phys Nanotechnol & Telecommun, Polytech Skaya 29, St Petersburg 195251, Russia.	kkt@incras.ru	Bondarev, Stanislav/AAD-5124-2022; Zhouravleva, Galina/G-8651-2013; Belousov, Mikhail V./K-6017-2014; Kuznetsova, Irina M./R-9844-2017; Sulatskaya, Anna/I-6042-2014; Bondarev, Stanislav/F-7518-2014; Turoverov, Konstantin/S-2079-2016	Bondarev, Stanislav/0000-0003-3137-944X; Zhouravleva, Galina/0000-0002-3013-4662; Belousov, Mikhail V./0000-0002-7856-9075; Kuznetsova, Irina M./0000-0002-3336-4834; Sulatskaya, Anna/0000-0002-1207-3384; Bondarev, Stanislav/0000-0003-3137-944X; Turoverov, Konstantin/0000-0002-6977-1896	"Molecular and Cell Biology" Program of the Russian Academy of Sciences; Russian Foundation of Basic Research [16-54-00230 Bel, 16-04-01614]; RF President Fellowship [SP-1982.2015.4]; Research Resource Center "Molecular and Cell Technologies" of Saint-Petersburg State University; Saint-Petersburg State University [1.37.291.2015, 1.50.1041.2014]	"Molecular and Cell Biology" Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); RF President Fellowship; Research Resource Center "Molecular and Cell Technologies" of Saint-Petersburg State University; Saint-Petersburg State University	This work was supported in part by the "Molecular and Cell Biology" Program of the Russian Academy of Sciences, Russian Foundation of Basic Research, grants 16-54-00230 Bel (KKT) and 16-04-01614 (AIS), the RF President Fellowship SP-1982.2015.4 (AIS), and the Research Resource Center "Molecular and Cell Technologies" of Saint-Petersburg State University. The authors acknowledge Saint-Petersburg State University for the following research grants: 1.37.291.2015 (GAZ), 1.50.1041.2014 (GAZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Almstedt K, 2009, PRION, V3, P224, DOI 10.4161/pri.3.4.10112; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; De Ferrari GV, 2001, J BIOL CHEM, V276, P23282, DOI 10.1074/jbc.M009596200; DEARMOND SJ, 1993, BRIT MED BULL, V49, P725, DOI 10.1093/oxfordjournals.bmb.a072644; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DIENER TO, 1982, P NATL ACAD SCI-BIOL, V79, P5220, DOI 10.1073/pnas.79.17.5220; Fodera V, 2008, J PHYS CHEM B, V112, P15174, DOI 10.1021/jp805560c; Fonin AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103878; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; GIBBS CJ, 1978, P NATL ACAD SCI USA, V75, P6268, DOI 10.1073/pnas.75.12.6268; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; HADLOW WJ, 1959, LANCET, V2, P289; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; HSIAO K, 1990, NEUROLOGY, V40, P1820, DOI 10.1212/WNL.40.12.1820; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kitts CC, 2009, J PHYS CHEM B, V113, P12090, DOI 10.1021/jp903509u; KLATZO I, 1959, LAB INVEST, V8, P799; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; Kuznetsova IM, 2012, MOL NEUROBIOL, V45, P488, DOI 10.1007/s12035-012-8272-y; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030724; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Mao XB, 2011, ACS CHEM NEUROSCI, V2, P281, DOI 10.1021/cn200006h; Maskevich AA, 2007, J PROTEOME RES, V6, P1392, DOI 10.1021/pr0605567; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narayanan S, 2006, CHEMBIOCHEM, V7, P757, DOI 10.1002/cbic.200500382; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Serio TR, 1999, METHOD ENZYMOL, V309, P649; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Sulatskaya AI, 2010, SPECTROSC-INT J, V24, P169, DOI 10.1155/2010/620781; Sulatskaya A. I., 2015, P 7 EUR C BIOL MED S, P11; Sulatskaya Anna I, 2012, Methods Mol Biol, V895, P441, DOI 10.1007/978-1-61779-927-3_26; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Sulatskaya AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015385; Sutharsan J, 2010, CHEMMEDCHEM, V5, P56, DOI 10.1002/cmdc.200900440; Turoverov K. K., 2007, P SPIE, V6733; Ye L, 2005, J BIOL CHEM, V280, P23599, DOI 10.1074/jbc.M501285200; Ye L, 2008, J NEUROCHEM, V105, P1428, DOI 10.1111/j.1471-4159.2008.05245.x	52	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156314	10.1371/journal.pone.0156314	http://dx.doi.org/10.1371/journal.pone.0156314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228180	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500111
J	Zeng, WF; Li, Y; Sheng, CS; Huang, QF; Kang, YY; Zhang, L; Wang, S; Cheng, YB; Li, FK; Wang, JG				Zeng, Wei-Fang; Li, Yan; Sheng, Chang-Sheng; Huang, Qi-Fang; Kang, Yuan-Yuan; Zhang, Lu; Wang, Shuai; Cheng, Yi-Bang; Li, Fei-Ka; Wang, Ji-Guang			Association of Anthropometric and Bioelectrical Impedance Analysis Measures of Adiposity with High Molecular Weight Adiponectin Concentration	PLOS ONE			English	Article							METABOLIC SYNDROME; BODY-COMPOSITION; OBESITY; POPULATION; MEN; HYPOADIPONECTINEMIA; HYPERTENSION; DISEASE; CHINESE; HUMANS	Objective To investigate the relationship between adiposity measures and plasma concentration of high molecular weight (HMW) adiponectin. Methods In a Chinese sample (n = 1081), we performed measurements of anthropometry and bioelectrical impedance analysis (B broken vertical bar A). We defined overweight and obesity as a body mass index between 24 and 27.4 kg/m(2) and >= 27.5 kg/m(2), respectively, and central obesity as a waist circumference >= 90 cm in men and >= 80 cm in women. Plasma HMW adiponectin concentration was measured by the ELISA method. Results Plasma HMW adiponectin concentration was significantly (P < 0.0001) higher in women (n = 677, 2.47 mu g/mL) than men (n = 404, 1.58 mu g/mL) and correlated with advancing age in men (r = 0.28) and women (r = 0.29). In adjusted analyses, it was lower in the presence of overweight (n = 159, 1.26 mu g/mL in men and n = 227, 2.15 mu g/mL in women) and obesity (n = 60, 1.31 mu g/mL and n = 82, 2.10 mu g/mL, respectively) than normal weight subjects (n = 185, 2.07 mu g/mL and n = 368, 2.94 mu g/mL, respectively) and in the presence of central obesity (n = 106, 1.28 mu g/mL and n = 331, 2.12 mu g/mL, respectively) than subjects with a normal waist circumference (n = 298, 1.74 mu g/mL and n = 346, 2.74 mu g/mL, respectively). In multiple regression analyses stratified for gender, adjusted for confounders and considered separately each of the adiposity measures, all adiposity measures were significantly (r -0.18 to -0.31, P < 0.001) associated with plasma HMWadiponectin concentration. However, in further stratified and adjusted regression analyses considered stepwise all adiposity measures, only waist-to-hip ratio was significantly (P < 0.05) associated with plasma HMW adiponectin concentration inmen (r = -0.10) and women (r = -0.15). Conclusions Anthropometric measures of obesity, such as waist-to-hip ratio, but not BIA measures, are independently associated with plasma adiponectin concentration.	[Zeng, Wei-Fang; Li, Yan; Sheng, Chang-Sheng; Huang, Qi-Fang; Kang, Yuan-Yuan; Zhang, Lu; Wang, Shuai; Cheng, Yi-Bang; Li, Fei-Ka; Wang, Ji-Guang] Shanghai Jiao Tong Univ, Ctr Epidemiol Studies & Clin Trials, Shanghai Key Lab Hypertens,Ruijin Hosp, Shanghai Inst Hypertens,Dept Hypertens,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, JG (corresponding author), Shanghai Jiao Tong Univ, Ctr Epidemiol Studies & Clin Trials, Shanghai Key Lab Hypertens,Ruijin Hosp, Shanghai Inst Hypertens,Dept Hypertens,Sch Med, Shanghai 200030, Peoples R China.	jiguangwang@aim.com	Wang, Ji Guang/AAP-4045-2021	Wang, Ji Guang/0000-0001-8511-1524; Cheng, Yi-Bang/0000-0002-3822-3504	National Natural Science Foundation of China [81170245, 81270373, 81470533]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was financially supported by grants from the National Natural Science Foundation of China, grant number: 81170245, 81270373 and 81470533, http://www.nsfc.gov.cn/. JGW received the funding.	Araki S, 2006, J CLIN ENDOCR METAB, V91, P5113, DOI 10.1210/jc.2006-1051; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Bray M, 2013, OBESITY, V21, pE435, DOI 10.1002/oby.20125; Browning LM, 2010, OBESITY, V18, P2385, DOI 10.1038/oby.2010.71; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P4823, DOI 10.1210/jc.2003-030214; Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061; Hirose H, 2010, J ATHEROSCLER THROMB, V17, P1201, DOI 10.5551/jat.6106; Huang QF, 2013, AM J HYPERTENS, V26, P754, DOI 10.1093/ajh/hpt014; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Karmelic I, 2012, ARCH MED RES, V43, P145, DOI 10.1016/j.arcmed.2012.02.004; Koenig W, 2006, J AM COLL CARDIOL, V48, P1369, DOI 10.1016/j.jacc.2006.06.053; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Maruyama C, 2009, J ATHEROSCLER THROMB, V16, P207, DOI 10.5551/jat.E067; Poonawalla AH, 2013, J MAGN RESON IMAGING, V37, P707, DOI 10.1002/jmri.23846; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sheng CS, 2013, BLOOD PRESSURE, V22, P158, DOI 10.3109/08037051.2012.748998; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-6; Snijder MB, 2006, DIABETES CARE, V29, P2498, DOI 10.2337/dc06-0952; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Torigoe M, 2007, CLIN ENDOCRINOL, V67, P276, DOI 10.1111/j.1365-2265.2007.02876.x; Unno M, 2012, J ATHEROSCLER THROMB, V19, P462; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang JG, 2013, J STRENGTH COND RES, V27, P236, DOI 10.1519/JSC.0b013e31824f2040	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156041	10.1371/journal.pone.0156041	http://dx.doi.org/10.1371/journal.pone.0156041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227680	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500056
J	Abdelmagid, N; Bereczky-Veress, B; Atanur, S; Musilova, A; Zidek, V; Saba, L; Warnecke, A; Khademi, M; Studahl, M; Aurelius, E; Hjalmarsson, A; Garcia-Diaz, A; Denis, CV; Bergstrom, T; Skoldenberg, B; Kockum, I; Aitman, T; Hubner, N; Olsson, T; Pravenec, M; Diez, M				Abdelmagid, Nada; Bereczky-Veress, Biborka; Atanur, Santosh; Musilova, Alena; Zidek, Vaclav; Saba, Laura; Warnecke, Andreas; Khademi, Mohsen; Studahl, Marie; Aurelius, Elisabeth; Hjalmarsson, Anders; Garcia-Diaz, Ana; Denis, Cecile V.; Bergstrom, Tomas; Skoldenberg, Birgit; Kockum, Ingrid; Aitman, Timothy; Huebner, Norbert; Olsson, Tomas; Pravenec, Michal; Diez, Margarita			Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN-BARRIER PERMEABILITY; POLYMERASE-CHAIN-REACTION; VIRUS TYPE-1; EXPRESSION; LOCUS; RESISTANCE; SUSCEPTIBILITY; DEFICIENCY; PROTECTION	Herpes simplex encephalitis (HSE) is a rare complication of Herpes simplex virus type-1 infection. It results in severe parenchymal damage in the brain. Although viral latency in neurons is very common in the population, it remains unclear why certain individuals develop HSE. Here we explore potential host genetic variants predisposing to HSE. In order to investigate this we used a rat HSE model comparing the HSE susceptible SHR (Spontaneously Hypertensive Rats) with the asymptomatic infection of BN (Brown Norway). Notably, both strains have HSV-1 spread to the CNS at four days after infection. A genome wide linkage analysis of 29 infected HXB/BXH RILs (recombinant inbred lines-generated from the prior two strains), displayed variable susceptibility to HSE enabling the definition of a significant QTL (quantitative trait locus) named Hse6 towards the end of chromosome 4 (160.89-174Mb) containing the Vwf (von Willebrand factor) gene. This was the only gene in the QTL with both cis-regulation in the brain and included several non-synonymous SNPs (single nucleotide polymorphism). Intriguingly, in human chromosome 12 several SNPs within the intronic region between exon 43 and 44 of the VWF gene were associated with human HSE pathogenesis. In particular, rs917859 is nominally associated with an odds ratio of 1.5 (95% CI 1.11-2.02; p-value = 0.008) after genotyping in 115 HSE cases and 428 controls. Although there are possibly several genetic and environmental factors involved in development of HSE, our study identifies variants of the VWF gene as candidates for susceptibility in experimental and human HSE.	[Abdelmagid, Nada; Bereczky-Veress, Biborka; Warnecke, Andreas; Khademi, Mohsen; Kockum, Ingrid; Olsson, Tomas; Diez, Margarita] Karolinska Inst, Karolinska Univ Hosp, Neuroimmunol Unit, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Atanur, Santosh; Garcia-Diaz, Ana; Aitman, Timothy] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Musilova, Alena; Zidek, Vaclav; Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Saba, Laura] Univ Colorado, Denver Sch Med, Dept Pharmacol, Denver, CO 80202 USA; [Studahl, Marie] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Aurelius, Elisabeth; Hjalmarsson, Anders; Skoldenberg, Birgit] Karolinska Inst, Karolinska Univ Hosp, Infect Dis Unit, Dept Med, SE-17176 Stockholm, Sweden; [Denis, Cecile V.] Univ Paris Saclay, Univ Paris Sud, INSERM, UMR S 1176, F-94276 Le Kremlin Bicetre, France; [Bergstrom, Tomas] Univ Gothenburg, Dept Clin Virol, SE-41346 Gothenburg, Sweden; [Huebner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany	Karolinska Institutet; Karolinska University Hospital; Imperial College London; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Gothenburg; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Gothenburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Abdelmagid, N (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Neuroimmunol Unit, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	ada.abdelmagid@ki.se; margarita.diez@ki.se	Kockum, Ingrid/O-8781-2018; Pravenec, Michal/B-1666-2012; Saba, Laura/R-9533-2018; Denis, Cecile/A-7649-2011; Studahl, Marie/AAC-2045-2019	Kockum, Ingrid/0000-0002-0867-4726; Pravenec, Michal/0000-0001-9197-5871; Saba, Laura/0000-0001-9649-1294; Denis, Cecile/0000-0001-5152-9156; Olsson, Tomas/0000-0002-2938-1877; Khademi, Mohsen/0000-0003-0801-1444; Aitman, Timothy/0000-0002-7875-4502; Garcia Diaz, Ana Isabel/0000-0001-6941-6272	European Union; NeuroProMiSe; EURATrans; Swedish Brain Foundation; Swedish Society of Medicine; Magnus Bergvalls Foundation; Knut and Alice Wallenberg Foundation; Foundation for the Memory of Sigurd and Elsa Golje; Bjorklunds Foundation; Nils and Bibbi Jensens Foundation; Swedish Society for Medical Research; Swedish Research Council; Swedish Association of Persons with Neurological Disabilities; NIAAA, NIH [AA013162, AA016663]; Banbury Fund; Ministry of Health, Youth and Sports of the Czech Republic [LL1204]; Medical Research Council [MC_U120061454] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA013162] Funding Source: NIH RePORTER; MRC [MC_U120061454] Funding Source: UKRI	European Union(European Commission); NeuroProMiSe; EURATrans; Swedish Brain Foundation; Swedish Society of Medicine; Magnus Bergvalls Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Foundation for the Memory of Sigurd and Elsa Golje; Bjorklunds Foundation; Nils and Bibbi Jensens Foundation; Swedish Society for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Association of Persons with Neurological Disabilities; NIAAA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Banbury Fund; Ministry of Health, Youth and Sports of the Czech Republic; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported by grants from The 7th Framework Program of the European Union, NeuroProMiSe, the EURATrans, the Swedish Brain Foundation, Swedish Society of Medicine, Magnus Bergvalls Foundation, Knut and Alice Wallenberg Foundation, Foundation for the Memory of Sigurd and Elsa Golje, Bjorklunds Foundation, Nils and Bibbi Jensens Foundation, Swedish Society for Medical Research, Swedish Research Council, The Swedish Association of Persons with Neurological Disabilities; NIAAA, NIH (AA013162 and AA016663-INIA Project); The Banbury Fund and by the LL1204 grant (within the ERC CZ program) from the Ministry of Health, Youth and Sports of the Czech Republic. The funders did not have any role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Abdelmagid N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002753; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; AURELIUS E, 1993, J MED VIROL, V39, P179, DOI 10.1002/jmv.1890390302; AURELIUS E, 1991, LANCET, V337, P189, DOI 10.1016/0140-6736(91)92155-U; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bereczky-Veress B, 2008, J NEUROVIROL, V14, P102, DOI 10.1080/13550280701883832; Bereczky-Veress B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012350; Bhave SV, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-59; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chai QQ, 2014, J VIROL, V88, P4698, DOI 10.1128/JVI.03149-13; Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14; Davidson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051793; de Mast Q, 2007, J INFECT DIS, V196, P622, DOI 10.1086/519844; Ekelund E, 2006, AM J HUM GENET, V78, P1060, DOI 10.1086/504272; Halford WP, 2004, J VIROL, V78, P10086, DOI 10.1128/JVI.78.18.10086-10095.2004; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hjalmarsson A, 2009, J NEUROL, V256, P1243, DOI 10.1007/s00415-009-5106-6; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kastrukoff LF, 2015, IMMUNOL CELL BIOL, V93, P877, DOI 10.1038/icb.2015.54; Kastrukoff LF, 2010, VIROLOGY, V400, P248, DOI 10.1016/j.virol.2010.02.013; Kennedy PGE, 2002, J NEUROL NEUROSUR PS, V73, P237, DOI 10.1136/jnnp.73.3.237; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; Mueller M, 2006, BIOINFORMATICS, V22, P509, DOI 10.1093/bioinformatics/btk007; Noubade R, 2008, AM J PATHOL, V173, P892, DOI 10.2353/ajpath.2008.080001; Pasieka TJ, 2011, J VIROL, V85, P12972, DOI 10.1128/JVI.06032-11; Pereira RA, 2001, J IMMUNOL, V166, P5869, DOI 10.4049/jimmunol.166.10.5869; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sancho-Shimizu V, 2007, CURR OPIN ALLERGY CL, V7, P495, DOI 10.1097/ACI.0b013e3282f151d2; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sheridan BS, 2009, J VIROL, V83, P2237, DOI 10.1128/JVI.01699-08; Skoldenberg B, 2006, J NEUROL, V253, P163, DOI 10.1007/s00415-005-0941-6; SKOLDENBERG B, 1984, LANCET, V2, P707; Studahl M, 2013, DRUGS, V73, P131, DOI 10.1007/s40265-013-0007-5; Suidan GL, 2013, ARTERIOSCL THROM VAS, V33, P2112, DOI 10.1161/ATVBAHA.113.301362; Tabakoff B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-70; WHITLEY RJ, 1990, NEW ENGL J MED, V323, P242, DOI 10.1056/NEJM199007263230406; Wickham S, 2005, J NEUROIMMUNOL, V162, P51, DOI 10.1016/j.jneuroim.2005.01.001; Williams RW, 2001, GENOME BIOL, V2; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhou Y, 2010, NEUROL RES, V32, P801, DOI 10.1179/016164110X12644252260556	48	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155832	10.1371/journal.pone.0155832	http://dx.doi.org/10.1371/journal.pone.0155832			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224245	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000376881700032
J	de Bakker, DM; Meesters, EHWG; van Bleijswijk, JDL; Luttikhuizen, PC; Breeuwer, HJAJ; Becking, LE				de Bakker, Didier M.; Meesters, Erik H. W. G.; van Bleijswijk, Judith D. L.; Luttikhuizen, Pieternella C.; Breeuwer, Hans J. A. J.; Becking, Leontine E.			Population Genetic Structure, Abundance, and Health Status of Two Dominant Benthic Species in the Saba Bank National Park, Caribbean Netherlands: Montastraea cavernosa and Xestospongia muta	PLOS ONE			English	Article							GIANT BARREL SPONGE; REEF-BUILDING CORALS; PARTIAL MORTALITY; CONNECTIVITY; PRODUCTIVITY; RESOURCES; PATTERNS; BACTERIA; ISLANDS; ECOLOGY	Saba Bank, a submerged atoll in the Caribbean Sea with an area of 2,200 km2, has attained international conservation status due to the rich diversity of species that reside on the bank. In order to assess the role of Saba Bank as a potential reservoir of diversity for the surrounding reefs, we examined the population genetic structure, abundance and health status of two prominent benthic species, the coral Montastraea cavernosa and the sponge Xestospongia muta. Sequence data were collected from 34 colonies of M. cavernosa (nDNA ITS-15.8S-ITS2; 892 bp) and 68 X. muta sponges (mtDNA I3-M11 partition of COI; 544 bp) on Saba Bank and around Saba Island, and compared with published data across the wider Caribbean. Our data indicate that there is genetic connectivity between populations on Saba Bank and the nearby Saba Island as well as multiple locations in the wider Caribbean, ranging in distance from 100s-1000s km. The genetic diversity of Saba Bank populations of M. cavernosa (p = 0.055) and X. muta (p = 0.0010) was comparable to those in other regions in the western Atlantic. Densities and health status were determined along 11 transects of 50 m(2) along the south-eastern rim of Saba Bank. The densities of M. cavernosa (0.27 ind.m(-2), 95% CI: 0.12-0.52) were average, while the densities of X. muta (0.09 ind. m(-2), 95% CI: 0.02-0.32) were generally higher with respect to other Caribbean locations. No disease or bleaching was present in any of the specimens of the coral M. cavernosa, however, we did observe partial tissue loss (77.9% of samples) as well as overgrowth (48.1%), predominantly by cyanobacteria. In contrast, the majority of observed X. muta (83.5%) showed signs of presumed bleaching. The combined results of apparent gene flow among populations on Saba Bank and surrounding reefs, the high abundance and unique genetic diversity, indicate that Saba Bank could function as an important buffer for the region. Either as a natural source of larvae to replenish genetic diversity or as a storehouse of diversity that can be utilized if needed for restoration practices.	[de Bakker, Didier M.; Meesters, Erik H. W. G.; Becking, Leontine E.] Wageningen UR, Inst Marine Resources & Ecosyst Studies IMARES, POB 57, NL-1780 AB Den Helder, Netherlands; [de Bakker, Didier M.; van Bleijswijk, Judith D. L.; Luttikhuizen, Pieternella C.] Royal Netherlands Inst Sea Res, POB 59, NL-1790 AB Den Burg, Texel, Netherlands; [de Bakker, Didier M.; van Bleijswijk, Judith D. L.; Luttikhuizen, Pieternella C.] Univ Utrecht, Utrecht, Netherlands; [Breeuwer, Hans J. A. J.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, POB 94248, NL-1090 GE Amsterdam, Netherlands; [Becking, Leontine E.] Wageningen UR, Marine Anim Ecol, POB 338, NL-6700 AH Wageningen, Netherlands; [Becking, Leontine E.] Nat Biodivers Ctr, Darwinweg 2, NL-2300 RA Leiden, Netherlands	Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Amsterdam; Wageningen University & Research; Naturalis Biodiversity Center	de Bakker, DM; Becking, LE (corresponding author), Wageningen UR, Inst Marine Resources & Ecosyst Studies IMARES, POB 57, NL-1780 AB Den Helder, Netherlands.; de Bakker, DM (corresponding author), Royal Netherlands Inst Sea Res, POB 59, NL-1790 AB Den Burg, Texel, Netherlands.; de Bakker, DM (corresponding author), Univ Utrecht, Utrecht, Netherlands.; Becking, LE (corresponding author), Wageningen UR, Marine Anim Ecol, POB 338, NL-6700 AH Wageningen, Netherlands.; Becking, LE (corresponding author), Nat Biodivers Ctr, Darwinweg 2, NL-2300 RA Leiden, Netherlands.	didier.debakker@wur.nl; lisa.becking@wur.nl	de Bakker, Didier/P-3237-2019; Luttikhuizen, Pieternella/D-9078-2012; van bleijswijk, judith/F-7638-2017	de Bakker, Didier/0000-0003-2188-6827; Meesters, Erik/0000-0002-3877-1164	Ministry of Economic Affairs (EZ) BO (Beleidsondersteunend Onderzoek) program Caribbean Netherlands [BO-11-011.05-033]; WWF Netherlands; De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Rubicon [825.12.007]; De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VENI [863.14.020]	Ministry of Economic Affairs (EZ) BO (Beleidsondersteunend Onderzoek) program Caribbean Netherlands; WWF Netherlands; De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Rubicon(Netherlands Organization for Scientific Research (NWO)); De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VENI(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Ministry of Economic Affairs (EZ) BO (Beleidsondersteunend Onderzoek) program Caribbean Netherlands under project number BO-11-011.05-033 to EHWGM (http://www.dcnanature.org/resources/research-monitoring/bo-projects/; https://www.rijksoverheid.nl/ministeries/ministerie-van-economische-zaken); WWF Netherlands to EHWGM (http://www.wnf.nl/nl/wat_wnf_doet/projecten/details/?project=44); De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Rubicon; #825.12.007 to LEB (http://www.nwo.nl/onderzoek-en-resultaten/programmas/rubicon); De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VENI#863.14.020 to LEB (http://www.nwo.nl/en/funding/our-funding-instruments/nwo/innovational-research-incentives-scheme/veni/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeier H, 2011, FEMS MICROBIOL ECOL, V75, P218, DOI 10.1111/j.1574-6941.2010.01001.x; Armstrong RA, 2006, CONT SHELF RES, V26, P194, DOI 10.1016/j.csr.2005.10.004; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Bak RPM, 1998, MAR ECOL PROG SER, V175, P285, DOI 10.3354/meps175285; Bell JJ, 2008, MAR ECOL PROG SER, V368, P127, DOI 10.3354/meps07637; Bell JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091635; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Bruckner AW, 1997, B MAR SCI, V61, P919; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; Chiappone M, 1996, B MAR SCI, V58, P555; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cowart JD, 2006, CORAL REEFS, V25, P513, DOI 10.1007/s00338-006-0149-y; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cruz ICS, 2015, MAR BIOL, V162, P889, DOI 10.1007/s00227-015-2633-9; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; Diaz MC, 2001, B MAR SCI, V69, P535; DUFFY JE, 1992, MAR ECOL PROG SER, V90, P127, DOI 10.3354/meps090127; Dutra LXC, 2006, J COASTAL RES, P633; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Erwin PM, 2007, J MAR BIOL ASSOC UK, V87, P1683, DOI 10.1017/S0025315407058213; Etnoyer PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010668; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreira BP, 2013, CORAL REEFS, V32, P441, DOI 10.1007/s00338-012-0992-y; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; Goodbody-Gringley G, 2012, MAR ECOL-EVOL PERSP, V33, P32, DOI 10.1111/j.1439-0485.2011.00452.x; Henkel TP, 2005, MAR BIOL, V146, P301, DOI 10.1007/s00227-004-1448-x; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hoetjes PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010769; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Humman P, 1992, REEF CREATURE IDENTI; LASKER HR, 1984, CORAL REEFS, V3, P183, DOI 10.1007/BF00288253; Leaoa ZM, 2003, CORALS CORAL REEFS B; Loh TL, 2014, P NATL ACAD SCI USA, V111, P4151, DOI 10.1073/pnas.1321626111; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; Lopez-Legentil S, 2008, MOL ECOL, V17, P1840, DOI 10.1111/j.1365-294X.2008.03667.x; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; MACINTYRE I G, 1975, Caribbean Journal of Science, V15, P11; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; McKenna SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010749; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; McMurray SE, 2015, AQUAT BIOL, V23, P1, DOI 10.3354/ab00612; McMurray SE, 2011, LIMNOL OCEANOGR, V56, P2243, DOI 10.4319/lo.2011.56.6.2243; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Meesters EH, 1997, J SEA RES, V37, P131, DOI 10.1016/S1385-1101(96)00004-4; Meesters EH, 1996, B MAR SCI, V58, P838; Meesters HWG, 2010, BIODIVERSITY SABA BA; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Miranda RJ, 2013, LAT AM J AQUAT RES, V41, P351, DOI 10.3856/vol41-issue2-fulltext-14; Misof B, 2000, MOL PHYLOGENET EVOL, V17, P76, DOI 10.1006/mpev.2000.0817; Montalvo NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090517; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Montalvo NF, 2005, ANTON LEEUW INT J G, V87, P29, DOI 10.1007/s10482-004-6536-x; Mueller B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090152; Muller W, 2007, BIOGEOSCIENCES DISCU, V4, P385; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; Odorico DM, 1997, P ROY SOC B-BIOL SCI, V264, P77, DOI 10.1098/rspb.1997.0011; Porter JW, 1987, SPECIES PROFILES LIF; REISWIG H M, 1974, Journal of Experimental Marine Biology and Ecology, V14, P231, DOI 10.1016/0022-0981(74)90005-7; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; Rutzler K, 1983, PSZNI MAR ECOL, V4, P329, DOI DOI 10.1111/J.1439-0485.1983.TB00118.X; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Scheffers SR, 2004, CORAL REEFS, V23, P413, DOI 10.1007/s00338-004-0400-3; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; Swierts T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074396; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thacker RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009622; Toller W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009207; van Beek IJ, 2013, C01813 IMARES; van der Land J., 1977, FAO FISHERIES REPORT, V200, P469, DOI DOI 10.1371/JOURNAL.PONE.0009207; van Duyl FC, 2011, MAR BIOL, V158, P1653, DOI 10.1007/s00227-011-1681-z; VICENTE VP, 1990, CORAL REEFS, V8, P199, DOI 10.1007/BF00265011; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1990, MAR ECOL PROG SER, V67, P285, DOI 10.3354/meps067285; Williams JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010676; Wilson JR, 1998, MAR BIOL, V131, P339, DOI 10.1007/s002270050327; Wulff J., ADV MARINE BIOL, P273	87	13	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155969	10.1371/journal.pone.0155969	http://dx.doi.org/10.1371/journal.pone.0155969			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223808	gold, Green Published, Green Submitted			2022-12-26	WOS:000376881700048
J	Ding, XM; Lu, JH; Yu, RX; Wang, X; Wang, T; Dong, FY; Peng, B; Wu, WH; Liu, H; Geng, YJ; Zhang, RL; Ma, HW; Cheng, JQ; Yu, MH; Fang, SS				Ding, Xiaoman; Lu, Jiahai; Yu, Ruoxi; Wang, Xin; Wang, Ting; Dong, Fangyuan; Peng, Bo; Wu, Weihua; Liu, Hui; Geng, Yijie; Zhang, Renli; Ma, Hanwu; Cheng, Jinquan; Yu, Muhua; Fang, Shisong			Preliminary Proteomic Analysis of A549 Cells Infected with Avian Influenza Virus H7N9 and Influenza A Virus H1N1	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; ORNITHINE-DELTA-AMINOTRANSFERASE; FACTOR ACETYLHYDROLASE; POLY(RC)-BINDING PROTEIN-1; AMINO TRANSFERASE; A(H7N9) VIRUS; H5N1 VIRUS; IDENTIFICATION; MUTATIONS; PCBP1	A newly emerged H7N9 influenza virus poses high risk to human beings. However, the pathogenic mechanism of the virus remains unclear. The temporal response of primary human alveolar adenocarcinoma epithelial cells (A549) infected with H7N9 influenza virus and H1N1 influenza A virus (H1N1, pdm09) were evaluated using the proteomics approaches (2D-DIGE combined with MALDI-TOF-MS/MS) at 24, 48 and 72 hours post of the infection (hpi). There were 11, 12 and 33 proteins with significant different expressions (P<0.05) at 24, 48 and 72hpi, especially F-actin-capping protein subunit alpha-1 (CAPZA1), Ornithine aminotransferase (OAT), Poly(rC)-binding protein 1 (PCBP1), Eukaryotic translation initiation factor 5A-1 (EIF5A) and Platelet-activating factor acetylhydrolaseIb subunit beta (PAFAH1B2) were validated by western-blot analysis. The functional analysis revealed that the differential proteins in A549 cells involved in regulating cytopathic effect. Among them, the down-regulation of CAPZA1, OAT, PCBP1, EIF5A are related to the death of cells infected by H7N9 influenza virus. This is the first time show that the down-regulation of PAFAH1B2 is related to the later clinical symptoms of patients infected by H7N9 influenza virus. These findings may improve our understanding of pathogenic mechanism of H7N9 influenza virus in proteomics.	[Ding, Xiaoman; Lu, Jiahai] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Ruoxi] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Wang, Xin; Dong, Fangyuan; Peng, Bo; Wu, Weihua; Liu, Hui; Geng, Yijie; Zhang, Renli; Ma, Hanwu; Cheng, Jinquan; Fang, Shisong] Shenzhen Ctr Dis Control & Prevent, Key Reference Lab Pathogen & Biosafety, Major Infect Dis Control Key Lab, Shenzhen, Peoples R China; [Wang, Ting; Yu, Muhua] Nanshan Ctr Dis Control & Prevent, Shenzhen, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Shenzhen Center for Disease Control & Prevention (SZCDC)	Fang, SS (corresponding author), Shenzhen Ctr Dis Control & Prevent, Key Reference Lab Pathogen & Biosafety, Major Infect Dis Control Key Lab, Shenzhen, Peoples R China.; Yu, MH (corresponding author), Nanshan Ctr Dis Control & Prevent, Shenzhen, Peoples R China.	1175461964@qq.com; szcdcssf@aliyun.com			Shenzhen Science and Technology Innovation Project [JCYJ20140416095154398, JCYJ20140410164811662]	Shenzhen Science and Technology Innovation Project	This study was supported by a grant from Shenzhen Science and Technology Innovation Project (JCYJ20140416095154398 & JCYJ20140410164811662) to MHY and SSF. The funders of MHY had a role in study design and the funders of SSF had a role in preparation of the manuscript.	da Rocha IMA, 2012, J PLANT PHYSIOL, V169, P41, DOI 10.1016/j.jplph.2011.08.001; Arunachalam R, 2014, GENOMICS, V104, P545, DOI 10.1016/j.ygeno.2014.10.012; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Cheung CY, 2012, J INFECT DIS, V206, P640, DOI 10.1093/infdis/jis423; Cracchiolo BM, 2004, GYNECOL ONCOL, V94, P217, DOI 10.1016/j.ygyno.2004.03.018; Delalle I, 2005, GENETICS, V171, P1757, DOI 10.1534/genetics.105.049213; Doimo M, 2013, HUM MUTAT, V34, P229, DOI 10.1002/humu.22233; Fang SS, 2014, APPL MICROBIOL BIOT, V98, P9691, DOI 10.1007/s00253-014-5852-y; Funck D, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-40; Hai R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3854; Hampel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136914; Hopmann R, 1996, J CELL BIOL, V133, P1293, DOI 10.1083/jcb.133.6.1293; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Huo LR, 2008, BBA-PROTEINS PROTEOM, V1784, P1524, DOI 10.1016/j.bbapap.2008.06.017; Huo LR, 2012, NEUROSCI BULL, V28, P282, DOI 10.1007/s12264-012-1242-6; Huo LR, 2010, BBA-PROTEINS PROTEOM, V1804, P1954, DOI 10.1016/j.bbapap.2010.07.002; Hwang HH, 2011, MOL CELLS, V31, P239, DOI 10.1007/s10059-011-0026-6; Juncosa JI, 2013, ANAL BIOCHEM, V440, P145, DOI 10.1016/j.ab.2013.05.025; Lee SK, 2009, PROTEOMICS, V9, P4389, DOI 10.1002/pmic.200900165; Lee SB, 2009, BIOCHEM BIOPH RES CO, V383, P497, DOI 10.1016/j.bbrc.2009.04.049; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Livnat I, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00019; Lu ZJ, 2014, CELL PHYSIOL BIOCHEM, V33, P859, DOI 10.1159/000358658; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Manya H, 1998, J BIOL CHEM, V273, P18567, DOI 10.1074/jbc.273.29.18567; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Matsuo K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2085; Morrison J, 2014, J VIROL, V88, P10556, DOI 10.1128/JVI.00570-14; Riera J, 2007, FEBS LETT, V581, P3057, DOI 10.1016/j.febslet.2007.05.065; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Shafaghat F, 2015, ADV PHARM BULL, V5, P69, DOI 10.5681/apb.2015.009; Shi ZH, 2012, INT J GYNECOL CANCER, V22, P1125, DOI 10.1097/IGC.0b013e3182606ac3; Simon PF, 2015, J PROTEOME RES, V14, P4511, DOI 10.1021/acs.jproteome.5b00196; SNYDER F, 1995, BBA-LIPID LIPID MET, V1254, P231, DOI 10.1016/0005-2760(94)00192-2; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; Van Ranst M, 2013, LANCET, V381, P1883, DOI 10.1016/S0140-6736(13)60959-9; Vester D, 2009, PROTEOMICS, V9, P3316, DOI 10.1002/pmic.200800893; Wagemaker MJM, 2007, MYCOL RES, V111, P909, DOI 10.1016/j.mycres.2007.05.012; Wagener R, 2015, GENE CHROMOSOME CANC, V54, P555, DOI 10.1002/gcc.22268; Wang GL, 2007, P NATL ACAD SCI USA, V104, P2068, DOI 10.1073/pnas.0610832104; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Wodal W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113963; Wu YL, 2014, INT J BIOL SCI, V10, P109, DOI 10.7150/ijbs.8198; Yamayoshi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08039; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zeng H, 2015, J VIROL, V89, P4655, DOI 10.1128/JVI.03095-14; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	50	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156017	10.1371/journal.pone.0156017	http://dx.doi.org/10.1371/journal.pone.0156017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223893	Green Submitted, gold, Green Published			2022-12-26	WOS:000376881700049
J	Mellert, DJ; Williamson, WR; Shirangi, TR; Card, GM; Truman, JW				Mellert, David J.; Williamson, W. Ryan; Shirangi, Troy R.; Card, Gwyneth M.; Truman, James W.			Genetic and Environmental Control of Neurodevelopmental Robustness in Drosophila	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SENSORY NEURONS; COURTSHIP SONG; MELANOGASTER; PLASTICITY; NEUROBLASTS; PATTERNS; BRAIN; NEUROGENESIS; VARIABILITY	Interindividual differences in neuronal wiring may contribute to behavioral individuality and affect susceptibility to neurological disorders. To investigate the causes and potential consequences of wiring variation in Drosophila melanogaster, we focused on a hemilineage of ventral nerve cord interneurons that exhibits morphological variability. We find that late-born subclasses of the 12A hemilineage are highly sensitive to genetic and environmental variation. Neurons in the second thoracic segment are particularly variable with regard to two developmental decisions, whereas its segmental homologs are more robust. This variability "hotspot" depends on Ultrabithorax expression in the 12A neurons, indicating variability is cell-intrinsic and under genetic control. 12A development is more variable and sensitive to temperature in long-established laboratory strains than in strains recently derived from the wild. Strains with a high frequency of one of the 12A variants also showed a high frequency of animals with delayed spontaneous flight initiation, whereas other wing-related behaviors did not show such a correlation and were thus not overtly affected by 12A variation. These results show that neurodevelopmental robustness is variable and under genetic control in Drosophila and suggest that the fly may serve as a model for identifying conserved gene pathways that stabilize wiring in stressful developmental environments. Moreover, some neuronal lineages are variation hotspots and thus may be more amenable to evolutionary change.	[Mellert, David J.; Williamson, W. Ryan; Shirangi, Troy R.; Card, Gwyneth M.; Truman, James W.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Mellert, David J.] Jackson Lab Genom Med, Farmington, CT USA	Howard Hughes Medical Institute; Jackson Laboratory	Mellert, DJ (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA.; Mellert, DJ (corresponding author), Jackson Lab Genom Med, Farmington, CT USA.	Dave.Mellert@jax.org		Mellert, David/0000-0001-6606-0274; Williamson, Wallace/0000-0003-0010-8516	Howard Hughes Medical Institute (hhmi.org)	Howard Hughes Medical Institute (hhmi.org)	This work was funded by the Howard Hughes Medical Institute (hhmi.org). JWT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON H, 1979, DEV BIOL, V72, P364, DOI 10.1016/0012-1606(79)90125-8; Arthur BJ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-11; Barth M, 1997, J NEUROSCI, V17, P1493; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Chen J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004883; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; DOE CQ, 1985, DEV BIOL, V111, P193, DOI 10.1016/0012-1606(85)90445-2; DOE CQ, 1992, DEVELOPMENT, V116, P855; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Harris RM, 2012, THESIS U WASHINGTON; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Kuert PA, 2014, DEV BIOL, V390, P102, DOI 10.1016/j.ydbio.2014.03.021; Lack JB, 2016, P NATL ACAD SCI USA, V113, P1014, DOI 10.1073/pnas.1515964113; Langen M, 2013, ELIFE, V2, DOI 10.7554/eLife.00337; Li HH, 2014, CELL REP, V8, P897, DOI 10.1016/j.celrep.2014.06.065; Lin SW, 2013, CURR BIOL, V23, P1908, DOI 10.1016/j.cub.2013.07.074; Little GE, 2009, PLOS BIOL, V7, P756, DOI 10.1371/journal.pbio.1000098; Marin EC, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-31; Markow TA, 2005, ANNU REV GENET, V39, P263, DOI 10.1146/annurev.genet.39.073003.112454; Mellert DJ, 2012, GENETICS, V191, P1129, DOI 10.1534/genetics.112.140475; Miller DFB, 2001, MECH DEVELOP, V102, P3, DOI 10.1016/S0925-4773(01)00301-X; Mitchell KJ, 2014, GENETIC ARCHITECTURE, DOI [10.1101/009449, DOI 10.1101/009449]; MURPHEY RK, 1981, DEV BIOL, V88, P247, DOI 10.1016/0012-1606(81)90168-8; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; POWER ME, 1948, J COMP NEUROL, V88, P347, DOI 10.1002/cne.900880303; PROKOP A, 1991, DEVELOPMENT, V111, P79; Queitsch C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003041; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SATTERLIE RA, 1985, J EXP BIOL, V114, P691; Shirangi TR, 2013, CELL REP, V5, P678, DOI 10.1016/j.celrep.2013.09.039; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; SMITH JM, 1960, GENETICS, V45, P1039; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Suliman R, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00081; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Williams DW, 2002, DEVELOPMENT, V129, P617; Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345; Yuan Q, 2011, SCIENCE, V333, P1458, DOI 10.1126/science.1207121	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155957	10.1371/journal.pone.0155957	http://dx.doi.org/10.1371/journal.pone.0155957			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223118	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700045
J	Toth, A; Barna, T; Szabo, E; Elek, R; Hubert, A; Nagy, I; Nagy, I; Kriszt, B; Tancsics, A; Kukolya, J				Toth, Akos; Barna, Terezia; Szabo, Erna; Elek, Rita; Hubert, Agnes; Nagy, Istvan; Nagy, Istvan; Kriszt, Balazs; Tancsics, Andras; Kukolya, Jozsef			Cloning, Expression and Biochemical Characterization of Endomannanases from Thermobifida Species Isolated from Different Niches	PLOS ONE			English	Article							THERMOSTABLE BETA-MANNANASE; HETEROLOGOUS EXPRESSION; STREPTOMYCES-LIVIDANS; THERMOMONOSPORA-FUSCA; GENE CLONING; SP NOV.; BETA-1,4-MANNANASE; ENDOGLUCANASE; PURIFICATION; ENZYMES	Thermobifidas are thermotolerant, compost inhabiting actinomycetes which have complex polysaccharide hydrolyzing enzyme systems. The best characterized enzymes of these hydrolases are cellulases from T. fusca, while other important enzymes especially hemicellulases are not deeply explored. To fill this gap we cloned and investigated endomannanases from those reference strains of the Thermobifida genus, which have published data on other hydrolases (T. fusca TM51, T. alba CECT3323, T. cellulosilytica TB100(T) and T. halotolerans YIM90462(T)). Our phylogenetic analyses of 16S rDNA and endomannanase sequences revealed that T. alba CECT3323 is miss-classified; it belongs to the T. fusca species. The cloned and investigated endomannanases belong to the family of glycosyl hydrolases 5 (GH5), their size is around 50 kDa and they are modular enzymes. Their catalytic domains are extended by a C-terminal carbohydrate binding module (CBM) of type 2 with a 23-25 residues long interdomain linker region consisting of Pro, Thr and Glu/Asp rich repetitive tetrapeptide motifs. Their polypeptide chains exhibit high homology, interdomain sequence, which don't show homology to each other, but all of them are built up from 3-6 times repeated tetrapeptide motifs) (PTDP-Tc, TEEP-Tf, DPGT-Th). All of the heterologously expressed Man5A enzymes exhibited activity only on mannan. The pH optima of Man5A enzymes from T. halotolerans, T. cellulosilytica and T. fusca are slightly different (7.0, 7.5 and 8.0, respectively) while their temperature optima span within the range of 70-75 degrees C. The three endomannanases exhibited very similar kinetic performances on LBG-mannan substrate: 0.9-1.7mM of K-M and 80-120 1/sec of turnover number. We detected great variability in heat stability at 70 degrees C, which was influenced by the presence of Ca2+. The investigated endomannanases might be important subjects for studying the structure/function relation behind the heat stability and for industrial applications to hemicellulose degradation.	[Toth, Akos; Kukolya, Jozsef] Natl Agr Res & Innovat Ctr, Dept Appl & Environm Microbiol, Budapest, Hungary; [Barna, Terezia; Szabo, Erna; Elek, Rita] Univ Debrecen, Dept Genet & Appl Microbiol, Debrecen, Hungary; [Hubert, Agnes; Nagy, Istvan] Max Planck Inst Biochem, Dept Mol Struct Biol, Klopferspitz 18A, D-82152 Martinsried, Germany; [Nagy, Istvan] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Kriszt, Balazs] Szent Istvan Univ, Dept Environm Protect & Environm Safety, Godollo, Hungary; [Tancsics, Andras] Szent Istvan Univ, Reg Univ Ctr Excellence Environm Ind, Godollo, Hungary	University of Debrecen; Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Kukolya, J (corresponding author), Natl Agr Res & Innovat Ctr, Dept Appl & Environm Microbiol, Budapest, Hungary.	kukolya.jozsef@gmail.com	barna, terez/R-1357-2018; Hubert, Ágnes/O-6021-2017	Hubert, Ágnes/0000-0001-6452-299X; Nagy, Istvan/0000-0002-6740-1920; Tancsics, Andras/0000-0002-0927-1136; Kriszt, Balazs/0000-0002-9236-2820	Hungarian Academy of Sciences	Hungarian Academy of Sciences(Hungarian Academy of Sciences)	IN(4) was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MM, 2001, ENZYME MICROB TECH, V28, P8, DOI 10.1016/S0141-0229(00)00279-9; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P1490, DOI 10.1107/S0907444904014313; ARCAND N, 1993, BIOCHEM J, V290, P857, DOI 10.1042/bj2900857; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Beki E, 2003, APPL ENVIRON MICROB, V69, P1944, DOI 10.1128/AEM.69.4.1944-1952.2003; Blanco J, 1997, APPL MICROBIOL BIOT, V48, P208, DOI 10.1007/s002530051040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen CY, 2016, INT J BIOL MACROMOL, V82, P1, DOI 10.1016/j.ijbiomac.2015.10.008; Chen SL, 2007, J BACTERIOL, V189, P6260, DOI 10.1128/JB.00584-07; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Do BC, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-59; dos Santos CR, 2012, J STRUCT BIOL, V177, P469, DOI 10.1016/j.jsb.2011.11.021; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; HOPWOOD DA, 1983, J GEN MICROBIOL, V129, P2257; Hutchinson JB, 1929, GENETICS, V14, P519; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Kauppinen MS SM, 2003, United States, Patent No. 6566114; Kukolya J, 2002, INT J SYST EVOL MICR, V52, P1193, DOI [10.1099/ijs.0.01925-0, 10.1099/00207713-52-4-1193]; Kukolya J., 1997, Acta Phytopathologica et Entomologica Hungarica, V32, P97; Kumagai Y, 2012, BIOCHIMIE, V94, P2783, DOI 10.1016/j.biochi.2012.09.012; Kumagai Y, 2011, BBA-PROTEINS PROTEOM, V1814, P1127, DOI 10.1016/j.bbapap.2011.04.017; Lao GF, 1996, APPL ENVIRON MICROB, V62, P4256, DOI 10.1128/AEM.62.11.4256-4259.1996; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Liao HP, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/s12896-014-0090-z; Luo HY, 2009, APPL MICROBIOL BIOT, V82, P453, DOI 10.1007/s00253-008-1766-x; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; Madden TL, 1996, METHOD ENZYMOL, V266, P131; McCutchen CM, 1996, BIOTECHNOL BIOENG, V52, P332, DOI 10.1002/(SICI)1097-0290(19961020)52:2<332::AID-BIT13>3.0.CO;2-L; Meenakshi, 2010, BIORESOURCES, V5, P1689; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nelson N, 1944, J BIOL CHEM, V153, P375; Polari L, 2012, J AGR FOOD CHEM, V60, P11037, DOI 10.1021/jf303741h; Posta K, 2004, J BASIC MICROB, V44, P383, DOI 10.1002/jobm.200410422; Puchart V, 2004, BBA-GEN SUBJECTS, V1674, P239, DOI 10.1016/j.bbagen.2004.06.022; Puls J, 1997, MACROMOL SYMP, V120, P183, DOI 10.1002/masy.19971200119; Rainey FA, 1996, INT J SYST BACTERIOL, V46, P1088, DOI 10.1099/00207713-46-4-1088; Sachslehner A, 2000, J BIOTECHNOL, V80, P127, DOI 10.1016/S0168-1656(00)00253-4; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Shi PJ, 2011, ENZYME MICROB TECH, V49, P277, DOI 10.1016/j.enzmictec.2011.06.003; Shi PJ, 2011, J IND MICROBIOL BIOT, V38, P451, DOI 10.1007/s10295-010-0789-3; Song JM, 2008, COMP BIOCHEM PHYS B, V151, P32, DOI 10.1016/j.cbpb.2008.05.005; Songsiriritthigul C, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-20; Stoll D, 1999, APPL ENVIRON MICROB, V65, P2598; Sunna A, 2000, APPL ENVIRON MICROB, V66, P664, DOI 10.1128/AEM.66.2.664-670.2000; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; TALBOT G, 1990, APPL ENVIRON MICROB, V56, P3505, DOI 10.1128/AEM.56.11.3505-3510.1990; Tamaru Y, 2000, J BACTERIOL, V182, P244, DOI 10.1128/JB.182.1.244-247.2000; TAMARU Y, 1995, APPL ENVIRON MICROB, V61, P4454, DOI 10.1128/AEM.61.12.4454-4458.1995; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toth A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00482-13; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002; Yang LL, 2008, INT J SYST EVOL MICR, V58, P1821, DOI 10.1099/ijs.0.65732-0; Yin YR, 2015, BIOTECHNOL LETT, V37, P857, DOI 10.1007/s10529-014-1742-8; Zhang F, 2012, J IND MICROBIOL BIOT, V39, P1109, DOI 10.1007/s10295-012-1119-8; Zhang F, 2011, BIORESOURCE TECHNOL, V102, P10143, DOI 10.1016/j.biortech.2011.08.019; Zhang ZS, 1998, INT J SYST BACTERIOL, V48, P411, DOI 10.1099/00207713-48-2-411	61	13	13	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155769	10.1371/journal.pone.0155769	http://dx.doi.org/10.1371/journal.pone.0155769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223892	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700029
J	Vujic, N; Abate, JP; Schlager, S; David, T; Kratky, D; Koliwad, SK				Vujic, Nemanja; Abate, Jess Porter; Schlager, Stefanie; David, Tovo; Kratky, Dagmar; Koliwad, Suneil K.			Acyl-CoA: Diacylglycerol Acyltransferase 1 Expression Level in the Hematopoietic Compartment Impacts Inflammation in the Vascular Plaques of Atherosclerotic Mice	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; RECEPTOR KNOCKOUT MICE; APOE-DEFICIENT MICE; LESION DEVELOPMENT; CHOLESTEROL LEVELS; APOE(-/-) MICE; LDL RECEPTOR; TRIGLYCERIDE SYNTHESIS; HEPATIC STEATOSIS; COMBINED DELETION	The final step of triacylglycerol synthesis is catalyzed by acyl-CoA:diacylglycerol acyltransferases (DGATs). We have previously shown that ApoE(-/-) Dgat1(-/-) mice are protected from developing atherosclerosis in association with reduced foam cell formation. However, the role of DGAT1, specifically in myeloid and other hematopoietic cell types, in determining this protective phenotype is unknown. To address this question, we reconstituted the bone marrow of irradiated Ldlr(-/-) mice with that from wild-type (WT -> Ldlr(-/-)) and Dgat1(-/-)(Dgat1(-/-) -> Ldlr(-/-)) donor mice. We noted that DGAT1 in the hematopoietic compartment exerts a sex-specific effect on systemic cholesterol homeostasis. However, both male and female Dgat1(-/-) -> Ldlr(-/-) mice had higher circulating neutrophil and lower lymphocyte counts than control mice, suggestive of a classical inflammatory phenotype. Moreover, specifically examining the aortae of these mice revealed that Dgat1(-/-) -> Ldlr(-/-) mice have atherosclerotic plaques with increased macrophage content. This increase was coupled to a reduced plaque collagen content, leading to a reduced collagen-to-macrophage ratio. Together, these findings point to a difference in the inflammatory contribution to plaque composition between Dgat1(-/-) -> Ldlr(-/-) and control mice. By contrast, DGAT1 deficiency did not affect the transcriptional responses of cultured macrophages to lipoprotein treatment in vitro, suggesting that the alterations seen in the plaques of Dgat1(-/-) -> Ldlr(-/-) mice in vivo do not reflect a cell intrinsic effect of DGAT1 in macrophages. We conclude that although DGAT1 in the hematopoietic compartment does not impact the overall lipid content of atherosclerotic plaques, it exerts reciprocal effects on inflammation and fibrosis, two processes that control plaque vulnerability.	[Vujic, Nemanja; Schlager, Stefanie; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Abate, Jess Porter; Koliwad, Suneil K.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [David, Tovo] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Koliwad, Suneil K.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Medical University of Graz; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Koliwad, SK (corresponding author), Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria.	dagmar.kratky@medunigraz.at; skoliwad@diabetes.ucsf.edu	Kratky, Dagmar/ABF-5699-2021	Vujic, Nemanja/0000-0003-2977-7799; Kratky, Dagmar/0000-0003-1357-7573	Austrian Science Fund [W1226, P27070, F3004]; American Heart Association Beginning [13BGIA 14700057]; National Institute of Health Research Grant [R01DK103175]; Austrian Science Fund (FWF) [F 3004] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R03DK097433, R01DK103175, P30DK063720, P30DK098722] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); American Heart Association Beginning(American Heart Association); National Institute of Health Research Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Austrian Science Fund (W1226; DK); Austrian Science Fund (P27070; DK); Austrian Science Fund (F3004; DK); American Heart Association Beginning Grant-in-Aid (13BGIA 14700057; SKK) and the National Institute of Health Research Grant (R01DK103175; SKK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, J LIPID RES, V53, P2364, DOI 10.1194/jlr.M029041; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Caligiuri G, 1999, ATHEROSCLEROSIS, V145, P301, DOI 10.1016/S0021-9150(99)00081-7; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chandak PG, 2011, BBA-MOL CELL BIOL L, V1811, P1011, DOI 10.1016/j.bbalip.2011.08.010; Chen HC, 2004, DIABETES, V53, P1445, DOI 10.2337/diabetes.53.6.1445; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Gabriels K, 2014, RADIOTHER ONCOL, V110, P455, DOI 10.1016/j.radonc.2014.01.006; Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031; King AJ, 2009, J PHARMACOL EXP THER, V330, P526, DOI 10.1124/jpet.109.154047; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Lammers B, 2011, ARTERIOSCL THROM VAS, V31, P67, DOI 10.1161/ATVBAHA.110.215814; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Robblee MM, 2016, CELL REP, V14, P2611, DOI 10.1016/j.celrep.2016.02.053; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Streeper RS, 2012, AGING-US, V4, P13, DOI 10.18632/aging.100424; Tsuda N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112027; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Van Eck M, 2001, ATHEROSCLEROSIS, V154, P103, DOI 10.1016/S0021-9150(00)00471-8; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, P2600, DOI 10.1161/01.ATV.20.12.2600; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; VanEck M, 1997, ARTERIOSCL THROM VAS, V17, P3117, DOI 10.1161/01.ATV.17.11.3117; Vikstedt R, 2007, ARTERIOSCL THROM VAS, V27, P578, DOI 10.1161/01.ATV.0000254815.49414.be; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697; Zhao Y, 2011, AM J PATHOL, V179, P1522, DOI 10.1016/j.ajpath.2011.05.020; Zhao Y, 2010, CIRC RES, V107, pE20, DOI 10.1161/CIRCRESAHA.110.226282	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156364	10.1371/journal.pone.0156364	http://dx.doi.org/10.1371/journal.pone.0156364			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223895	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700089
J	Villar, VH; Vogler, O; Barcelo, F; Martin-Broto, J; Martinez-Serra, J; Ruiz-Gutierrez, V; Alemany, R				Hugo Villar, Victor; Vogler, Oliver; Barcelo, Francisca; Martin-Broto, Javier; Martinez-Serra, Jordi; Ruiz-Gutierrez, Valentina; Alemany, Regina			Down-Regulation of AKT Signalling by Ursolic Acid Induces Intrinsic Apoptosis and Sensitization to Doxorubicin in Soft Tissue Sarcoma	PLOS ONE			English	Article							BREAST-CANCER CELLS; N-TERMINAL KINASE; SYNOVIAL SARCOMA; BETA-CATENIN; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE-AKT; PI3K/AKT PATHWAY; MELANOMA-CELLS; CYCLIN D1; ACTIVATION	Several important biological activities have been attributed to the pentacyclic triterpene ursolic acid (UA), being its antitumoral effect extensively studied in human adenocarcinomas. In this work, we focused on the efficacy and molecular mechanisms involved in the antitumoral effects of UA, as single agent or combined with doxorubicin (DXR), in human soft tissue sarcoma cells. UA (5-50 mu M) strongly inhibited (up to 80%) the viability of STS cells at 24 h and its proliferation in soft agar, with higher concentrations increasing apoptotic death up to 30%. UA treatment (6-9 h) strongly blocked the survival AKT/GSK3 beta/beta-catenin signalling pathway, which led to a concomitant reduction of the anti-apoptotic proteins c-Myc and p21, altogether resulting in the activation of intrinsic apoptosis. Interestingly, UA at low concentrations (10-15 mu M) enhanced the antitumoral effects of DXR by up to 2-fold, while in parallel inhibiting DXR-induced AKT activation and p21 expression, two proteins implicated in antitumoral drug resistance and cell survival. In conclusion, UA is able to induce intrinsic apoptosis in human STS cells and also to sensitize these cells to DXR by blocking the AKT signalling pathway. Therefore, UA may have beneficial effects, if used as nutraceutical adjuvant during standard chemotherapy treatment of STS.	[Hugo Villar, Victor; Vogler, Oliver; Barcelo, Francisca; Martin-Broto, Javier; Martinez-Serra, Jordi; Alemany, Regina] Univ Balearic Isl, Inst Univ Invest Ciencies Salut IUNICS, Dept Biol, Grp Clin & Translat Res, Palma De Mallorca, Spain; [Martin-Broto, Javier] Univ Hosp Virgen del Rocio, Dept Oncol, Seville, Spain; [Martin-Broto, Javier] Biomed Inst Sevilla IBIS, Seville, Spain; [Martinez-Serra, Jordi] Univ Hosp Son Espases, Dept Hematol, Palma De Mallorca, Spain; [Ruiz-Gutierrez, Valentina] CSIC, Inst Grasa, E-41080 Seville, Spain; [Ruiz-Gutierrez, Valentina; Alemany, Regina] Inst Salud Carlos III ISCIII, CIBERobn, CIBER Fisiopatol Obesidad & Nutr CB06 03, Madrid, Spain; [Hugo Villar, Victor] Inst Europeen Chim & Biol, Pessac, France; [Hugo Villar, Victor] Inst Bergonie, INSERM, U916, VINCO, Bordeaux, France	Universitat de les Illes Balears; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Hospital Universitari Son Espases; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie	Alemany, R (corresponding author), Univ Balearic Isl, Inst Univ Invest Ciencies Salut IUNICS, Dept Biol, Grp Clin & Translat Res, Palma De Mallorca, Spain.; Alemany, R (corresponding author), Inst Salud Carlos III ISCIII, CIBERobn, CIBER Fisiopatol Obesidad & Nutr CB06 03, Madrid, Spain.	regina.alemany@uib.es	Villar, Victor H./GQA-6295-2022; Alemany, Regina/A-2314-2011; Villar, Victor H./GQR-0553-2022; Vögler, Oliver/D-7658-2011; IBIS, BIOMARCADORES/P-3515-2015; Martín-Broto, Javier/AAI-2313-2019; Barceló, Francisca/K-5288-2014; VILLAR, VICTOR H./AAD-2404-2020	Villar, Victor H./0000-0003-2837-5018; Villar, Victor H./0000-0003-2837-5018; Barceló, Francisca/0000-0002-9158-099X; Alemany, Regina/0000-0003-2180-1213; Martin-Broto, Javier/0000-0001-7350-6916	Institute of Health Carlos III through the subprogramme "CIBERobn (Centro de Investigacion Biomedica en Red de la Fisiopatologia de la Obesidad y Nutricion)"; Govern de les Illes Balears, Conselleria d'Educacio, Cultura i Universitats; European Social Fund	Institute of Health Carlos III through the subprogramme "CIBERobn (Centro de Investigacion Biomedica en Red de la Fisiopatologia de la Obesidad y Nutricion)"; Govern de les Illes Balears, Conselleria d'Educacio, Cultura i Universitats; European Social Fund(European Social Fund (ESF))	Research was supported by the Institute of Health Carlos III through the subprogramme "CIBERobn (Centro de Investigacion Biomedica en Red de la Fisiopatologia de la Obesidad y Nutricion)". VHV was supported by a predoctoral fellowship from 'Govern de les Illes Balears, Conselleria d'Educacio, Cultura i Universitats' under a program of joint financing with the European Social Fund.	Abdul-Ghani R, 2006, ONCOGENE, V25, P1743, DOI 10.1038/sj.onc.1209201; Achiwa Y, 2007, BIOSCI BIOTECH BIOCH, V71, P31, DOI 10.1271/bbb.60288; Bailey HH, 2006, CANCER-AM CANCER SOC, V107, P2462, DOI 10.1002/cncr.22308; Bonaccorsi I, 2008, CANCER LETT, V263, P130, DOI 10.1016/j.canlet.2007.12.026; Bozzi F, 2008, TRANSL ONCOL, V1, P95, DOI 10.1593/tlo.08121; Cha HJ, 1998, ONCOGENE, V16, P771, DOI 10.1038/sj.onc.1201587; Deng L, 2015, ONCOL LETT, V10, P3323, DOI 10.3892/ol.2015.3712; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fensterle J, 2014, ANTI-CANCER AGENT ME, V14, P629, DOI 10.2174/1871520614666140309225912; Friedrichs N, 2011, INT J CANCER, V129, P1564, DOI 10.1002/ijc.25829; Gao N, 2012, BRIT J PHARMACOL, V165, P1813, DOI 10.1111/j.1476-5381.2011.01684.x; Gartel AL, 2002, MOL CANCER THER, V1, P639; GREENE RF, 1983, CANCER RES, V43, P3417; Hernando E, 2007, NAT MED, V13, P748, DOI 10.1038/nm1560; Horvai AE, 2006, ARCH PATHOL LAB MED, V130, P792; Villar VH, 2014, J NUTR BIOCHEM, V25, P429, DOI 10.1016/j.jnutbio.2013.12.003; Kadioglu O, 2015, J NAT PROD, V78, P762, DOI 10.1021/np501007n; Kim DK, 2000, INT J CANCER, V87, P629, DOI 10.1002/1097-0215(20000901)87:5<629::AID-IJC2>3.0.CO;2-P; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Le Cesne A, 2000, J CLIN ONCOL, V18, P2676, DOI 10.1200/JCO.2000.18.14.2676; Li JJ, 2012, ONCOL REP, V28, P501, DOI 10.3892/or.2012.1827; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lu YJ, 2000, MOL CARCINOGEN, V29, P1; Manu KA, 2008, INT IMMUNOPHARMACOL, V8, P974, DOI 10.1016/j.intimp.2008.02.013; Marklein D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052898; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Owen RW, 2004, EUR J CANCER PREV, V13, P319, DOI 10.1097/01.cej.0000130221.19480.7e; Prasad S, 2011, J BIOL CHEM, V286, P5546, DOI 10.1074/jbc.M110.183699; Saito T, 2000, J PATHOL, V192, P342, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH705>3.0.CO;2-R; Saito T, 2002, J PATHOL, V196, P445, DOI 10.1002/path.1066; Shan JZ, 2011, CHIN J INTEGR MED, V17, P607, DOI 10.1007/s11655-011-0815-y; Shanmugam MK, 2013, BIOCHEM PHARMACOL, V85, P1579, DOI 10.1016/j.bcp.2013.03.006; Shishodia S, 2003, CANCER RES, V63, P4375; Tang C, 2009, ANTI-CANCER DRUG, V20, P249, DOI 10.1097/CAD.0b013e328327d476; Trautmann M, 2014, ONCOGENE, V33, P5006, DOI 10.1038/onc.2013.443; Trichopoulou A, 2000, CANCER EPIDEM BIOMAR, V9, P869; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yeh CT, 2010, MOL NUTR FOOD RES, V54, P1285, DOI 10.1002/mnfr.200900414; Zhang YX, 2009, BIOCHIMIE, V91, P1173, DOI 10.1016/j.biochi.2009.06.010; Zhang YX, 2010, MOL CARCINOGEN, V49, P374, DOI 10.1002/mc.20610; Zhu ZL, 2013, INT J NANOMED, V8, P129, DOI 10.2147/IJN.S38271	46	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155946	10.1371/journal.pone.0155946	http://dx.doi.org/10.1371/journal.pone.0155946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219337	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700030
J	Westover, M; Baxter, J; Baxter, R; Day, CC; Jensen, R; Petersen, S; Larsen, R				Westover, Matthew; Baxter, Jared; Baxter, Rick; Day, Casey C.; Jensen, Ryan; Petersen, Steve; Larsen, Randy			Assessing Greater Sage-Grouse Selection of Brood-Rearing Habitat Using Remotely-Sensed Imagery: Can Readily Available High-Resolution Imagery Be Used to Identify Brood-Rearing Habitat Across a Broad Landscape?	PLOS ONE			English	Article							SAGEBRUSH HABITATS; STRAWBERRY VALLEY; SURVIVAL; COVER; CONSERVATION; MANAGEMENT; POPULATIONS; PERSISTENCE; MOVEMENTS	Greater sage-grouse populations have decreased steadily since European settlement in western North America. Reduced availability of brood-rearing habitat has been identified as a limiting factor for many populations. We used radio-telemetry to acquire locations of sage-grouse broods from 1998 to 2012 in Strawberry Valley, Utah. Using these locations and remotely-sensed NAIP (National Agricultural Imagery Program) imagery, we 1) determined which characteristics of brood-rearing habitat could be used in widely available, high resolution imagery 2) assessed the spatial extent at which sage-grouse selected brood-rearing habitat, and 3) created a predictive habitat model to identify areas of preferred brood-rearing habitat. We used AIC model selection to evaluate support for a list of variables derived from remotely-sensed imagery. We examined the relationship of these explanatory variables at three spatial extents (45, 200, and 795 meter radii). Our top model included 10 variables (percent shrub, percent grass, percent tree, percent paved road, percent riparian, meters of sage/tree edge, meters of riparian/tree edge, distance to tree, distance to transmission lines, and distance to permanent structures). Variables from each spatial extent were represented in our top model with the majority being associated with the larger (795 meter) spatial extent. When applied to our study area, our top model predicted 75% of naive brood locations suggesting reasonable success using this method and widely available NAIP imagery. We encourage application of our methodology to other sage-grouse populations and species of conservation concern.	[Westover, Matthew; Baxter, Jared; Baxter, Rick; Petersen, Steve; Larsen, Randy] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Day, Casey C.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Jensen, Ryan] Brigham Young Univ, Dept Geog, Provo, UT 84602 USA; [Larsen, Randy] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Westover, Matthew] Ciruss Ecol Solut, Logan, UT USA	Brigham Young University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Brigham Young University; Brigham Young University	Baxter, R (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	rjb47rjb47@gmail.com	Day, Casey/AAY-1146-2021; Day, Casey C./H-3025-2013	Day, Casey C./0000-0001-6096-3448	Utah Reclamation Mitigation and Conservation Commission, Utah Division of Wildlife Resources, Brigham Young University, U.S. Forest Service, Sportsmen for Fish and Wildlife; Brigham Young University; U.S. Forest Service	Utah Reclamation Mitigation and Conservation Commission, Utah Division of Wildlife Resources, Brigham Young University, U.S. Forest Service, Sportsmen for Fish and Wildlife; Brigham Young University; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This work was supported by the Utah Reclamation Mitigation and Conservation Commission, Utah Division of Wildlife Resources, Brigham Young University, U.S. Forest Service, Sportsmen for Fish and Wildlife. The Utah Reclamation Mitigation and Conservation Commission provided the bulk of the funding and are interested in on-the-ground results in sage-grouse conservation. They had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Their URL is http://www.mitigationcommission.gov/. The Utah Division of Wildlife Resources have provided funding in terms of vehicle use and maintenance, equipment, flights, and on-the-ground help in the work. They had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Their URL is: http://wildlife.utah.gov/. Brigham Young University has provided support during the entire length of the project (1998 to present) in terms of funding for graduate students, vehicles, equipment, travel, etc. They played the pivotal role in study design, data collection and analysis, the decision to prepare and publish this manuscript. Their URL is: http://pws.byu.edu/. The U.S. Forest Service has provided funding and support via use of their facilities, bunkhouse and administration sites. They also completed NEPA for multiple portions of the project. They have been a supporter of the project from the beginning, but they have had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Their URL is: http://www.fs.usda.gov/uwcnf. Sportsmen for Fish and Wildlife have provided funding on an every other year basis for approximately a decade. They vigorously support research that provides information on conservation of sage grouse and their habitats. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Their URL is: http://sfw.net/.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Aldridge CL, 2002, J WILDLIFE MANAGE, V66, P433, DOI 10.2307/3803176; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Atamian MT, 2010, J WILDLIFE MANAGE, V74, P1533, DOI 10.2193/2009-226; Baxter R. J., 2003, THESIS; Baxter RJ, 2008, J WILDLIFE MANAGE, V72, P179, DOI 10.2193/2006-402; Baxter RJ, 2013, J WILDLIFE MANAGE, V77, P802, DOI 10.1002/jwmg.520; Beck JL, 2014, RANGELAND ECOL MANAG, V67, P328, DOI 10.2111/REM-D-12-00141.1; Bradley BA, 2011, WEST N AM NATURALIST, V71, P302, DOI 10.3398/064.071.0314; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CONGALTON RG, 1983, PHOTOGRAMM ENG REM S, V49, P69; Connelly J.W., 2004, CONSERVATION ASSESSM; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Crawford JA, 2004, J RANGE MANAGE, V57, P2, DOI 10.2307/4003949; Dahlgren DK, 2006, WILDLIFE SOC B, V34, P975, DOI 10.2193/0091-7648(2006)34[975:GSRTSM]2.0.CO;2; Dahlgren DK, 2010, J WILDLIFE MANAGE, V74, P1286, DOI 10.2193/2009-093; Davies KW, 2010, RANGELAND ECOL MANAG, V63, P630, DOI 10.2111/REM-D-09-00129.1; Dinkins JB, 2014, CONDOR, V116, P629, DOI 10.1650/CONDOR-13-163.1; DRUT MS, 1994, GREAT BASIN NAT, V54, P170; DRUT MS, 1994, J RANGE MANAGE, V47, P90, DOI 10.2307/4002848; Dzialak MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026273; Gregg MA, 2007, J WILDLIFE MANAGE, V71, P646, DOI 10.2193/2006-353; Hagen C. A., 1999, THESIS; Hausleitner D., 2003, THESIS; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Homer C. G., 2009, 20081027 US GEOL SUR; HOMER CG, 1993, J WILDLIFE MANAGE, V57, P78, DOI 10.2307/3809003; Homer CG, 2012, INT J APPL EARTH OBS, V14, P233, DOI 10.1016/j.jag.2011.09.012; HOSMER DW, 2000, WILEY PS TX, P1; Hulet A, 2014, RANGELAND ECOL MANAG, V67, P563, DOI 10.2111/REM-D-13-00044.1; Huwer S. L., 2004, THESIS; Irons J. R., 2012, LANDSAT TECHNICAL DE; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kirol CP, 2015, ECOL APPL, V25, P968, DOI 10.1890/13-1152.1; Kirol CP, 2012, CONDOR, V114, P75, DOI 10.1525/cond.2012.110024; KLEBENOW DA, 1969, J WILDLIFE MANAGE, V33, P649, DOI 10.2307/3799390; KLOTT JH, 1990, J WILDLIFE MANAGE, V54, P84, DOI 10.2307/3808905; Knapp PA, 1996, GLOBAL ENVIRON CHANG, V6, P37, DOI 10.1016/0959-3780(95)00112-3; Knick S.T., 2011, GREATER SAGE GROUSE, P664; Knick ST, 2011, STUD AVIAN BIOL, P13; Lahoz-Monfort JJ, 2010, J APPL ECOL, V47, P1094, DOI 10.1111/j.1365-2664.2010.01854.x; Leu M, 2011, STUD AVIAN BIOL, P253; Long RA, 2014, ECOL MONOGR, V84, P513, DOI 10.1890/13-1273.1; Long RA, 2009, J WILDLIFE MANAGE, V73, P294, DOI 10.2193/2008-052; Miller RF, 2011, STUD AVIAN BIOL, P145; Peck R. D., 2011, THESIS; Ramsey R. D., 2004, GEOCARTO INT, V19, P39, DOI DOI 10.1080/10106040408542305; Recio MR, 2013, METHODS ECOL EVOL, V4, P982, DOI 10.1111/2041-210X.12094; Santa ED, 2014, ECOL INDIC, V43, P297, DOI 10.1016/j.ecolind.2014.03.014; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Stickler CM, 2008, REMOTE SENS ENVIRON, V112, P2170, DOI 10.1016/j.rse.2007.10.013; Sveum CM, 1998, GREAT BASIN NAT, V58, P344; Thompson KM, 2006, WEST N AM NATURALIST, V66, P332, DOI 10.3398/1527-0904(2006)66[332:EBHUAP]2.0.CO;2; US Fish and Wildlife Service [USFWS], 2010, FED REGISTER, V75, P13910; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; Walker BL, 2016, J WILDLIFE MANAGE, V80, P63, DOI 10.1002/jwmg.962; WALLESTAD RO, 1971, J WILDLIFE MANAGE, V35, P129, DOI 10.2307/3799881; Wisdom MJ, 2011, STUD AVIAN BIOL, P451; Xian G, 2012, INT J REMOTE SENS, V33, P2034, DOI 10.1080/01431161.2011.605085	62	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156290	10.1371/journal.pone.0156290	http://dx.doi.org/10.1371/journal.pone.0156290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218829	gold, Green Submitted, Green Published			2022-12-26	WOS:000376880700056
J	Vogelin, M; Biedermann, L; Frei, P; Vavricka, SR; Scharl, S; Zeitz, J; Sulz, MC; Fried, M; Rogler, G; Scharl, M				Vogelin, Marius; Biedermann, Luc; Frei, Pascal; Vavricka, Stephan R.; Scharl, Sylvie; Zeitz, Jonas; Sulz, Michael C.; Fried, Michael; Rogler, Gerhard; Scharl, Michael			The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article							6-THIOGUANINE NUCLEOTIDE LEVELS; CD4+ T-LYMPHOCYTOPENIA; CROHNS-DISEASE; 6-MERCAPTOPURINE THERAPY; THIOPURINE METABOLITES; ULCERATIVE-COLITIS; PEDIATRIC-PATIENTS; METHYLTRANSFERASE; RISK; PHARMACOGENOMICS	Background Thiopurines are known to cause lymphopenia (< 1,500 lymphocytes/mu l). As severe lymphopenia (< 500C/mu l) is associated with opportunistic infections, we investigated severity of thiopurine-related lymphopenia and development of opportunistic infections in our tertiary referral centre. Methods We retrospectively screened medical records of 1,070 IBD patients and identified 100 individuals that developed a total of 161 episodes of lymphopenia during thiopurine treatment between 2002 and 2014. Occurrence of opportunistic infections was documented. A control group consisted of IBD patients receiving thiopurines but without developing lymphopenia. Results Of a total of 161 episodes of lymphopenia, 23% were severe (< 500C/mu l). In this subgroup, thiopurine dosing was modified in 64% (dosage reduction: 32%, medication discontinued: 32%). We identified 9 cases (5.5%) of opportunistic infections, of which only two occurred during severe lymphopenia. One opportunistic infection (4.5%) was identified in the control group. No association was found between opportunistic infections and severity of lymphopenia. All patients who suffered from opportunistic infections were receiving additional immunosuppressive medication. Conclusion Our patients treated with thiopurines rarely developed severe lymphopenia and opportunistic infections did not occur more often than in the control group. A careful monitoring of lymphocytes and prophylactic adjustment of thiopurine therapy might contribute to this low incidence.	[Vogelin, Marius; Biedermann, Luc; Frei, Pascal; Vavricka, Stephan R.; Scharl, Sylvie; Zeitz, Jonas; Sulz, Michael C.; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Stadtspital Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Vavricka, Stephan R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Sulz, Michael C.] Kantonsspital St Gallen, Div Gastroenterol & Hepatol, St Gallen, Switzerland	University of Zurich; University Zurich Hospital; Triemli Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Kantonsspital St. Gallen	Scharl, M (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland.; Scharl, M (corresponding author), Stadtspital Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland.	michael.scharl@usz.ch	Biedermann, Luc/J-2654-2017	Scharl, Michael/0000-0002-6729-1469	Swiss National Science Foundation [314730-146204, CRSII3 154488/1]; Swiss IBD Cohort Study [3347CO-108792]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort Study	This research was supported by research grants from the Swiss National Science Foundation to MS (Grant No. 314730-146204 and Grant No. CRSII3 154488/1) and to GR: the Swiss IBD Cohort Study (Grant No. 3347CO-108792).	Akbar AN, 2005, CURR OPIN IMMUNOL, V17, P480, DOI 10.1016/j.coi.2005.07.019; Al Rifai A, 2011, EUR J GASTROEN HEPAT, V23, P153, DOI 10.1097/MEG.0b013e32834233a2; Albrecht K, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000059; Amin J, 2015, INFLAMM BOWEL DIS, V21, P445, DOI 10.1097/MIB.0000000000000197; CANDY S, 1995, GUT, V37, P674, DOI 10.1136/gut.37.5.674; Casetta I, 2009, J NEUROL NEUROSUR PS, V80, P131, DOI 10.1136/jnnp.2008.144972; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Criscuoli V, 2006, WORLD J GASTROENTERO, V12, P4813; Cuffari C, 2000, ALIMENT PHARM THER, V14, P1009, DOI 10.1046/j.1365-2036.2000.00812.x; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; d'Halluin PN, 2005, GASTROEN CLIN BIOL, V29, P1264, DOI 10.1016/S0399-8320(05)82219-5; DEABREU R, 1995, ADV ENZYME REGUL, V35, P251, DOI 10.1016/0065-2571(94)00008-Q; Derijks LJJ, 2006, ALIMENT PHARM THER, V24, P715, DOI 10.1111/j.1365-2036.2006.02980.x; Dervieux T, 2001, CANCER RES, V61, P5810; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; do Carmo AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111574; Dubinsky MC, 2004, CLIN GASTROENTEROL H, V2, P731, DOI 10.1016/S1542-3565(04)00344-1; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Dubinsky MC, 2002, GASTROENTEROLOGY, V122, P904, DOI 10.1053/gast.2002.32420; DUNCAN RA, 1993, NEW ENGL J MED, V328, P393, DOI 10.1056/NEJM199302113280604; ELION GB, 1989, BIOSCIENCE REP, V9, P509, DOI 10.1007/BF01119794; FAIRCHILD CR, 1986, BIOCHEM PHARMACOL, V35, P3533, DOI 10.1016/0006-2952(86)90623-4; Frei P, 2013, WORLD J GASTROENTERO, V19, P1040, DOI 10.3748/wjg.v19.i7.1040; Friedman AB, 2014, INT J RHEUM DIS, V17, P132, DOI 10.1111/1756-185X.12204; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Gilissen LPL, 2012, J CROHNS COLITIS, V6, P698, DOI 10.1016/j.crohns.2011.12.003; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Gluck T, 2005, J RHEUMATOL, V32, P1473; Govani SM, 2010, J CROHNS COLITIS, V4, P444, DOI 10.1016/j.crohns.2010.02.009; Hanai H, 2010, INFLAMM BOWEL DIS, V16, P1376, DOI 10.1002/ibd.21190; Hequet O, 2002, ANN HEMATOL, V81, P340, DOI 10.1007/s00277-002-0458-3; Hussain Tahziba, 2015, J Immunoassay Immunochem, V36, P420, DOI 10.1080/15321819.2014.978082; Kochi S, 2010, SCAND J GASTROENTERO, V45, P608, DOI 10.3109/00365521003642559; Konidari Anastasia, 2014, World J Gastrointest Pharmacol Ther, V5, P63, DOI 10.4292/wjgpt.v5.i2.63; Kopylov U, 2014, J PEDIATR GASTR NUTR, V59, P511, DOI 10.1097/MPG.0000000000000455; Lennard L, 2004, BRIT J CLIN PHARMACO, V58, pS867, DOI 10.1111/j.1365-2125.2004.02314.x; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; Lennard L, 2002, GUT, V51, P143, DOI 10.1136/gut.51.2.143; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1051, DOI 10.1038/ajg.2012.89; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Mansharamani NG, 2000, CHEST, V118, P712, DOI 10.1378/chest.118.3.712; Merayo-Chalico J, 2013, QJM-INT J MED, V106, P451, DOI 10.1093/qjmed/hct046; Nguyen TMH, 2010, INT J CLIN PHARM TH, V48, P275; Nielsen OH, 2013, J CLIN PHARMACOL, V53, P575, DOI 10.1002/jcph.2; Okafor PN, 2013, INFLAMM BOWEL DIS, V19, P1764, DOI 10.1097/MIB.0b013e318281f562; Osterman MT, 2006, GASTROENTEROLOGY, V130, P1047, DOI 10.1053/j.gastro.2006.01.046; Ponchel F, 2011, CLIN CHIM ACTA, V412, P7, DOI 10.1016/j.cca.2010.09.002; Prefontaine E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000545.pub3; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Remuzzi G, 2007, J AM SOC NEPHROL, V18, P1973, DOI 10.1681/ASN.2006101153; Selik RM, 2014, MMWR RECOMM REP, V63; SMITH DK, 1993, NEW ENGL J MED, V328, P373, DOI 10.1056/NEJM199302113280601; Sood A, 2000, Indian J Gastroenterol, V19, P14; Stern A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005590.pub3; Stocco G, 2007, INFLAMM BOWEL DIS, V13, P57, DOI 10.1002/ibd.20004; Taxonera C, 2012, J CROHNS COLITIS, V6, P488, DOI 10.1016/j.crohns.2011.10.016; Nguyen TVA, 2013, INFLAMM BOWEL DIS, V19, P2404, DOI 10.1097/MIB.0b013e3182a508c6; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Timmer A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub3; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012; Van Assche G, 2010, J CROHNS COLITIS, V4, P63, DOI 10.1016/j.crohns.2009.09.009; Walker UA, 2006, CURR OPIN RHEUMATOL, V18, P389, DOI 10.1097/01.bor.0000231908.57913.2f; Weinshilboum RM, 2006, CELL MOL NEUROBIOL, V26, P539, DOI 10.1007/s10571-006-9095-z	64	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155218	10.1371/journal.pone.0155218	http://dx.doi.org/10.1371/journal.pone.0155218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214202	gold, Green Published			2022-12-26	WOS:000376880200009
J	Barros, MS; Gomes, E; Gueroni, DI; Ramos, AD; Mirotti, L; Florsheim, E; Bizzarro, B; Lino, CNR; Maciel, C; Lino-Dos-Santos-Franco, A; Tavares-de-Lima, W; Capurro, ML; Russo, M; Sa-Nunes, A				Barros, Michele S.; Gomes, Eliane; Gueroni, Daniele I.; Ramos, Anderson D.; Mirotti, Luciana; Florsheim, Esther; Bizzarro, Bruna; Lino, Ciro N. R.; Maciel, Ceres; Lino-Dos-Santos-Franco, Adriana; Tavares-de-Lima, Wothan; Capurro, Margareth L.; Russo, Momtchilo; Sa-Nunes, Anderson			Exposure to iBites Induces a Mixed-Type Allergic Response following Salivary Antigens Challenge in Mice	PLOS ONE			English	Article							MOSQUITO ALLERGY; AEDES-AEGYPTI; MOUSE MODEL; AIRWAY HYPERRESPONSIVENESS; LYMPHOCYTE-PROLIFERATION; EXPERIMENTAL ASTHMA; PASSIVE TRANSFER; MURINE MODEL; EOSINOPHIL; BITES	Classical studies have shown that Aedes aegypti salivary secretion is responsible for the sensitization to mosquito bites and many of the components present in saliva are immunogenic and capable of inducing an intense immune response. Therefore, we have characterized a murine model of adjuvant-free systemic allergy induced by natural exposure to mosquito bites. BALB/c mice were sensitized by exposure to A. aegypti mosquito bites and intranasally challenged with phosphate-buffered saline only or the mosquito's salivary gland extract (SGE). Blood, bronchoalveolar lavage (BAL) and lung were collected and evaluated for cellularity, histopathological analyses, cytokines and antibody determination. Respiratory pattern was analyzed by Penh measurements and tracheal segments were obtained to study in vitro reactivity to methacholine. BAL recovered from sensitized mice following challenge with SGE showed an increased number of eosinophils and Th2 cytokines such as IL-4, IL-5 and IL-13. Peribronchoalveolar eosinophil infiltration, mucus and collagen were also observed in lung parenchyma of sensitized mice, suggesting the development of a typical Th2 response. However, the antibody profile in serum of these mice evidenced a mixed-type response with presence of both, IgG1/IgE (Th2-related) and IgG2a (Th1-related) isotypes. In addition, changes in breathing pattern and tracheal reactivity to methacholine were not found. Taken together, our results show that A. aegypti bites trigger an atypical allergic reaction, with some classical cellular and soluble Th2 components in the lung, but also systemic Th1 and Th2 antibody isotypes and no change in either the respiratory pattern or the trachea responsiveness to agonist.	[Barros, Michele S.; Gomes, Eliane; Gueroni, Daniele I.; Ramos, Anderson D.; Mirotti, Luciana; Florsheim, Esther; Bizzarro, Bruna; Lino, Ciro N. R.; Maciel, Ceres; Russo, Momtchilo; Sa-Nunes, Anderson] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, SP, Brazil; [Lino, Ciro N. R.] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Lino-Dos-Santos-Franco, Adriana] Univ Nove de Julho UNINOVE, Grad Program Biophoton Appl Hlth Sci, Sao Paulo, SP, Brazil; [Tavares-de-Lima, Wothan] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, SP, Brazil; [Capurro, Margareth L.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, SP, Brazil; [Capurro, Margareth L.; Sa-Nunes, Anderson] Natl Council Sci & Technol Dev INCT EM CNPq, Natl Inst Sci & Technol Mol Entomol, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; Hannover Medical School; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade de Sao Paulo	Sa-Nunes, A (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, SP, Brazil.; Sa-Nunes, A (corresponding author), Natl Council Sci & Technol Dev INCT EM CNPq, Natl Inst Sci & Technol Mol Entomol, Rio De Janeiro, RJ, Brazil.	sanunes@usp.br	Capurro, Margareth/M-5286-2019; Sa-Nunes, Anderson/M-5654-2019; Capurro, Margareth L/F-8679-2012; Franco, Adriana Lino dos Santos/AAA-7081-2019; Lino-dos-Santos-Franco, Adriana/F-6336-2012; Sa-Nunes, Anderson/D-8667-2012; Tavares-de-Lima, Wothan/H-7486-2013; Bizzarro, Bruna/K-4778-2016; Florsheim, Esther Borges/G-5260-2015	Sa-Nunes, Anderson/0000-0002-1859-4973; Capurro, Margareth L/0000-0002-7480-2116; Franco, Adriana Lino dos Santos/0000-0002-7854-2833; Sa-Nunes, Anderson/0000-0002-1859-4973; Bizzarro, Bruna/0000-0001-6315-0549; Florsheim, Esther Borges/0000-0002-5889-7442	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/07208-0, 2009/09892-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302194/2009-6, 472536/2012-5]; Research Network on Bioactive Molecules from Arthropod Vectors from University of Sao Paulo [NAP-MOBIARVE 12.1.17661.1.7]; CNPq [134660/2010-2]; FAPESP [2011/06626-3, 2011/22669-4, 2009/12247-5, 2011/15569-3, 2010/18216-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Network on Bioactive Molecules from Arthropod Vectors from University of Sao Paulo; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2009/07208-0 and 2009/09892-6), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 302194/2009-6 and 472536/2012-5) and Research Network on Bioactive Molecules from Arthropod Vectors from University of Sao Paulo (NAP-MOBIARVE 12.1.17661.1.7). The following authors were recipients of fellowships: MSB (CNPq 134660/2010-2); DIG (FAPESP 2011/06626-3); ADR (FAPESP 2011/22669-4); BB (FAPESP 2009/12247-5); CNL (FAPESP 2011/15569-3); CM (FAPESP 2010/18216-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JR, 1966, EXP PARASITOL, V19, P132, DOI 10.1016/0014-4894(66)90061-0; Baqueiro T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-51; Becker E L, 1971, Adv Immunol, V13, P267, DOI 10.1016/S0065-2776(08)60186-8; Bizzarro B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-329; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Busse W, 1999, AM J RESP CRIT CARE, V160, P1035, DOI 10.1164/ajrccm.160.3.9902064; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Cantillo JF, 2014, INT ARCH ALLERGY IMM, V165, P271, DOI 10.1159/000371349; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955; Conrad ML, 2009, CLIN EXP ALLERGY, V39, P1246, DOI 10.1111/j.1365-2222.2009.03260.x; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Drazen JM, 1996, J EXP MED, V183, P1, DOI 10.1084/jem.183.1.1; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; Farraj AK, 2003, TOXICOL PATHOL, V31, P432, DOI 10.1080/01926230390213766; FEINGOLD BF, 1968, ANNU REV ENTOMOL, V13, P137, DOI 10.1146/annurev.en.13.010168.001033; Florsheim E, 2015, J IMMUNOL, V194, P4621, DOI 10.4049/jimmunol.1402493; Foster PS, 2002, PHARMACOL THERAPEUT, V94, P253, DOI 10.1016/S0163-7258(02)00220-6; Foster PS, 2001, IMMUNOL REV, V179, P173, DOI 10.1034/j.1600-065X.2001.790117.x; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Gonipeta B, 2009, J DAIRY SCI, V92, P4738, DOI 10.3168/jds.2008-1927; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; HECHT O, 1928, ARCH SCHIFFS TROP HY, V32, P15; Hernandez RG, 2006, PEDIATRICS, V118, pE189, DOI 10.1542/peds.2005-2550; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; HUDSON A, 1960, SCIENCE, V131, P1730, DOI 10.1126/science.131.3415.1730; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; LACK C, 1995, AM J RESP CRIT CARE, V152, P1765, DOI 10.1164/ajrccm.152.6.8520735; Lacy P, 2000, CHEM IMMUNOL, V76, P134; LARRIVEE DH, 1964, EXP PARASITOL, V15, P491, DOI 10.1016/0014-4894(64)90042-6; Maciel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110551; Mckiel J, 1959, CAN J ZOOL, V37, P11; MELLANBY K, 1946, NATURE, V158, P554, DOI 10.1038/158554c0; MOTA I, 1968, LIFE SCI PT 1 PHYSI, V7, P1289, DOI 10.1016/0024-3205(68)90258-0; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Parvataneni S, 2009, INT ARCH ALLERGY IMM, V149, P299, DOI 10.1159/000205575; Peng Z, 2006, ALLERGY, V61, P485, DOI 10.1111/j.1398-9995.2006.00985.x; Peng Z, 2015, ALLERGY; Peng ZK, 2007, CURR OPIN ALLERGY CL, V7, P350, DOI 10.1097/ACI.0b013e328259c313; Peng ZK, 1996, ANN ALLERG ASTHMA IM, V77, P238, DOI 10.1016/S1081-1206(10)63262-0; Peng ZK, 2004, J ALLERGY CLIN IMMUN, V114, P1189, DOI 10.1016/j.jaci.2004.08.014; Peng ZK, 2004, INT ARCH ALLERGY IMM, V133, P198, DOI 10.1159/000076787; Pope SM, 2005, J BIOL CHEM, V280, P13952, DOI 10.1074/jbc.M406037200; REUNALA T, 1990, CLIN EXP ALLERGY, V20, P19, DOI 10.1111/j.1365-2222.1990.tb02472.x; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; Ribeiro JMC, 2000, MED VET ENTOMOL, V14, P142, DOI 10.1046/j.1365-2915.2000.00227.x; RIBEIRO JMC, 1984, COMP BIOCHEM PHYS B, V79, P81, DOI 10.1016/0305-0491(84)90081-6; Rogerio AP, 2010, PHARMACOL RES, V62, P298, DOI 10.1016/j.phrs.2010.04.005; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Simons FER, 1999, J ALLERGY CLIN IMMUN, V104, P705, DOI 10.1016/S0091-6749(99)70348-9; Singh S, 2013, INDIAN J DERMATOL VE, V79, P151, DOI 10.4103/0378-6323.107629; Stumm CL, 2011, AM J PHYSIOL-LUNG C, V301, pL636, DOI 10.1152/ajplung.00158.2011; TOKURA Y, 1990, ARCH DERMATOL, V126, P362, DOI 10.1001/archderm.126.3.362; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; VANROSSUM JM, 1963, ARCH INT PHARMACOD T, V143, P240; Wang HS, 1999, INT ARCH ALLERGY IMM, V120, P135, DOI 10.1159/000024231; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Williams CMM, 2012, TOXICOL PATHOL, V40, P205, DOI 10.1177/0192623311430694; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zimmermann N, 2000, J IMMUNOL, V165, P5839, DOI 10.4049/jimmunol.165.10.5839; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	69	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155454	10.1371/journal.pone.0155454	http://dx.doi.org/10.1371/journal.pone.0155454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203689	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500013
J	Wickline, ED; Dale, IW; Merkel, CD; Heier, JA; Stolz, DB; Kwiatkowski, AV				Wickline, Emily D.; Dale, Ian W.; Merkel, Chelsea D.; Heier, Jonathon A.; Stolz, Donna B.; Kwiatkowski, Adam V.			alpha T-Catenin Is a Constitutive Actin-binding alpha-Catenin That Directly Couples the Cadherin center dot Catenin Complex to Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; BETA-CATENIN; AREA COMPOSITA; IN-VITRO; F-ACTIN; PROTEIN; VINCULIN; JUNCTIONS; TENSION; MECHANOTRANSDUCTION	alpha-Catenin is the primary link between the cadherin center dot catenin complex and the actin cytoskeleton. Mammalian alpha E-catenin is allosterically regulated: the monomer binds the beta-catenin center dot cadherin complex, whereas the homodimer does not bind beta-catenin but interacts with F-actin. As part of the cadherin center dot catenin complex, alpha E-catenin requires force to bind F-actin strongly. It is not known whether these properties are conserved across the mammalian alpha-catenin family. Here we show that alpha T (testes)-catenin, a protein unique to amniotes that is expressed predominantly in the heart, is a constitutive actin-binding alpha-catenin. We demonstrate that alpha T-catenin is primarily a monomer in solution and that alpha T-catenin monomer binds F-actin in cosedimentation assays as strongly as alpha E-catenin homodimer. The beta-catenin center dot alpha T-catenin heterocomplex also binds F-actin with high affinity unlike the beta-catenin center dot alpha E-catenin complex, indicating that alpha T-catenin can directly link the cadherin center dot catenin complex to the actin cytoskeleton. Finally, we show that a mutation in alpha T-catenin linked to arrhythmogenic right ventricular cardiomyopathy, V94D, promotes homodimerization, blocks beta-catenin binding, and in cardiomyocytes disrupts localization at cell-cell contacts. Together, our data demonstrate that alpha T-catenin is a constitutively active actin-binding protein that can physically couple the cadherin center dot catenin complex to F-actin in the absence of tension. We speculate that these properties are optimized to meet the demands of cardiomyocyte adhesion.	[Wickline, Emily D.; Dale, Ian W.; Merkel, Chelsea D.; Heier, Jonathon A.; Stolz, Donna B.; Kwiatkowski, Adam V.] Univ Pittsburgh, Sch Med, Dept Cell Biol, S324 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kwiatkowski, AV (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, S324 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15261 USA.	adamkwi@pitt.edu		Kwiatkowski, Adam/0000-0003-3997-7057	March of Dimes Basil O'Connor Starter Scholar Award; American Heart Association; National Institutes of Health [HL127711]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127711] Funding Source: NIH RePORTER	March of Dimes Basil O'Connor Starter Scholar Award(March of Dimes); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a March of Dimes Basil O'Connor Starter Scholar Award (to A. V. K.), an American Heart Association Grant-in-Aid (to A. V. K.), and National Institutes of Health Grant HL127711 (to A. V. K.). The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bianchini JM, 2015, J CELL BIOL, V210, P1065, DOI 10.1083/jcb.201411080; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Collinet C, 2013, PROG MOL BIOL TRANSL, V116, P25, DOI 10.1016/B978-0-12-394311-8.00002-9; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Ehler E, 2013, JOVE-J VIS EXP, DOI 10.3791/50154; Folmsbee SS, 2015, AM J PHYSIOL-LUNG C, V308, pL253, DOI 10.1152/ajplung.00331.2014; FOWLER VM, 1987, J BIOL CHEM, V262, P12792; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Goossens S, 2007, J CELL SCI, V120, P2126, DOI 10.1242/jcs.004713; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Janssens B, 2001, J CELL SCI, V114, P3177; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Li JF, 2015, CIRC RES, V116, P70, DOI 10.1161/CIRCRESAHA.116.304472; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Li J, 2015, J BIOL CHEM, V290, P18890, DOI 10.1074/jbc.M115.647941; Lyon RC, 2015, CIRC RES, V116, P1462, DOI 10.1161/CIRCRESAHA.116.304937; Maki K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24878; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Needham PG, 2006, YEAST, V23, P1151, DOI 10.1002/yea.1429; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nieset JE, 1997, J CELL SCI, V110, P1013; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; Vile A., 2014, CELL COMMUN ADHES, V21, P169; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	46	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15687	15699		10.1074/jbc.M116.735423	http://dx.doi.org/10.1074/jbc.M116.735423			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231342	Green Published, hybrid			2022-12-26	WOS:000380584200023
J	Yang, LW; Li, YT; Wang, XH; Mu, XJ; Qin, DZ; Huang, W; Alshahrani, S; Nieman, M; Peng, JT; Essandoh, K; Peng, TQ; Wang, YG; Lorenz, J; Soleimani, M; Zhao, ZQ; Fan, GC				Yang, Liwang; Li, Yutian; Wang, Xiaohong; Mu, Xingjiang; Qin, Dongze; Huang, Wei; Alshahrani, Saeed; Nieman, Michelle; Peng, Jiangtong; Essandoh, Kobina; Peng, Tianqing; Wang, Yigang; Lorenz, John; Soleimani, Manoocher; Zhao, Zhi-Qing; Fan, Guo-Chang			Overexpression of miR-223 Tips the Balance of Pro-and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CARDIOMYOCYTE HYPERTROPHY; PATHOLOGICAL HYPERTROPHY; C/EBP-BETA; GROWTH; MICRORNAS; PATHWAY; AKT; ACTIVATION; CELLS	MicroRNAs (miRNAs) have been extensively examined in pathological cardiac hypertrophy. However, few studies focused on profiling the miRNA alterations in physiological hypertrophic hearts. In this study we generated a transgenic mouse model with cardiac-specific overexpression of miR-223. Our results showed that elevation of miR-223 caused physiological cardiac hypertrophy with enhanced cardiac function but no fibrosis. Using the next generation RNA sequencing, we observed that most of dys-regulated genes (e.g. Atf3/5, Egr1/3, Sfrp2, Itgb1, Ndrg4, Akip1, Postn, Rxfp1, and Egln3) in miR-223-transgenic hearts were associated with cell growth, but they were not directly targeted by miR-223. Interestingly, these dys-regulated genes are known to regulate the Akt signaling pathway. Wefurther identified that miR-223 directly interacted with 3'-UTRs of FBXW7 and Acvr2a, two negative regulators of the Akt signaling. However, we also validated that miR-223 directly inhibited the expression of IGF-1R and beta 1-integrin, two positive regulators of the Akt signaling. Lastly, Western blotting did reveal that Akt was activated in miR-223-overexpressing hearts. Adenovirus-mediated overexpression of miR-223 in neonatal rat cardiomyocytes induced cell hypertrophy, which was blocked by the addition of MK2206, a specific inhibitor of Akt. Taken together, these data represent the first piece of work showing that miR-223 tips the balance of promotion and inactivation of Akt signaling cascades toward activation of Akt, a key regulator of physiological cardiac hypertrophy. Thus, our study suggests that the ultimate phenotype outcome of a miRNA may be decided by the secondary net effects of the whole target network rather than by several primary direct targets in an organ/tissue.	[Yang, Liwang; Qin, Dongze; Zhao, Zhi-Qing] Shanxi Med Univ, Taiyuan 030001, Peoples R China; [Yang, Liwang; Li, Yutian; Wang, Xiaohong; Mu, Xingjiang; Qin, Dongze; Alshahrani, Saeed; Peng, Jiangtong; Essandoh, Kobina; Fan, Guo-Chang] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Huang, Wei; Wang, Yigang] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Alshahrani, Saeed; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Res Serv, Vet Affairs Hosp, Cincinnati, OH 45267 USA; [Alshahrani, Saeed; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA; [Nieman, Michelle; Lorenz, John] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Peng, Jiangtong] Huazhong Univ Sci & Technol, Dept Cardiol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China; [Peng, Tianqing] Lawson Hlth Res Inst, Crit Illness Res, London, ON N6A 4G5, Canada	Shanxi Medical University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Huazhong University of Science & Technology; Western University (University of Western Ontario)	Fan, GC (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	fangg@ucmail.uc.edu	Fan, Guo-Chang/E-1153-2012; Alshahrani, Saeed/AAY-8319-2021; Peng, Tianqing/G-3340-2011	Fan, Guo-Chang/0000-0002-0439-8277; Huang, Wei/0000-0003-3046-4220; Li, Yutian/0000-0002-5118-0916	National Institutes of Health [R01 HL-087861, R01 GM-112930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL-087861 and R01 GM-112930 (to G.-C. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Cassavaugh JM, 2011, J CELL BIOCHEM, V112, P3882, DOI 10.1002/jcb.23321; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheong MW, 2015, J MOL MED, V93, P807, DOI 10.1007/s00109-015-1272-4; Chu WF, 2012, J CELL MOL MED, V16, P2022, DOI 10.1111/j.1582-4934.2011.01497.x; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639; Escribese MM, 2012, J IMMUNOL, V189, P1946, DOI 10.4049/jimmunol.1201064; Fan GC, 2004, AM J PHYSIOL-HEART C, V287, pH1705, DOI 10.1152/ajpheart.01211.2003; Fernandes T, 2015, AM J PHYSIOL-HEART C, V309, pH543, DOI 10.1152/ajpheart.00899.2014; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Ma ZC, 2013, EUR J APPL PHYSIOL, V113, P2473, DOI 10.1007/s00421-013-2685-9; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Martinelli NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093271; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Moc C, 2015, CARDIOVASC RES, V105, P160, DOI 10.1093/cvr/cvu243; Montano MM, 2013, CARDIOVASC RES, V99, P74, DOI 10.1093/cvr/cvt086; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Orenes-Pinero E, 2013, INT J CARDIOL, V167, P1651, DOI 10.1016/j.ijcard.2012.09.120; Ramasamy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121401; Ren J, 2015, BIOCHEM PHARMACOL, V93, P409, DOI 10.1016/j.bcp.2014.12.006; Riddle RC, 2011, J BIOL CHEM, V286, P44449, DOI 10.1074/jbc.M111.276683; Shettigar V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10794; Shi L, 2013, CIRC RES, V113, P1320, DOI 10.1161/CIRCRESAHA.113.301824; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P1001, DOI 10.1016/j.bbadis.2014.03.005; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Thackaberry E A, 2002, Cardiovasc Toxicol, V2, P263, DOI 10.1385/CT:2:4:263; Utispan K, 2012, INT J ONCOL, V41, P1110, DOI 10.3892/ijo.2012.1530; Velling T, 2004, EMBO REP, V5, P901, DOI 10.1038/sj.embor.7400234; Wang XH, 2014, BBA-MOL BASIS DIS, V1842, P701, DOI 10.1016/j.bbadis.2014.01.012; Wang XH, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/585709; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wang YS, 2015, CELL PHYSIOL BIOCHEM, V35, P1546, DOI 10.1159/000373970; Watanabe T, 2014, ARCH ORAL BIOL, V59, P595, DOI 10.1016/j.archoralbio.2014.03.003; Yang JJ, 2016, INT J BIOCHEM CELL B, V71, P62, DOI 10.1016/j.biocel.2015.12.004; Yeves AM, 2014, J MOL CELL CARDIOL, V76, P186, DOI 10.1016/j.yjmcc.2014.09.004; Yu HJ, 2013, INT J MOL SCI, V14, P21378, DOI 10.3390/ijms141121378; Zhou HB, 2015, CELL REP, V13, P1149, DOI 10.1016/j.celrep.2015.09.073; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291; Zolk O, 2008, BIOCHEM BIOPH RES CO, V376, P315, DOI 10.1016/j.bbrc.2008.08.152	47	32	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15700	15713		10.1074/jbc.M116.715805	http://dx.doi.org/10.1074/jbc.M116.715805			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226563	Green Published, hybrid			2022-12-26	WOS:000380584200024
J	Bazzone, A; Madej, MG; Kaback, HR; Fendler, K				Bazzone, Andre; Madej, M. Gregor; Kaback, H. Ronald; Fendler, Klaus			pH Regulation of Electrogenic Sugar/H+ Symport in MFS Sugar Permeases	PLOS ONE			English	Article							LAC CARRIER PROTEIN; MIX-AND-MATCH; ESCHERICHIA-COLI; ELECTROPHYSIOLOGICAL CHARACTERIZATION; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; BINDING; MECHANISM; PROTONATION; TRANSPORT	Bacterial sugar symporters in the Major Facilitator Superfamily (MFS) use the H+ (and in a few cases Na+) electrochemical gradients to achieve active transport of sugar into the cell. Because a number of structures of MFS sugar symporters have been solved recently, molecular insight into the transport mechanism is possible from detailed functional analysis. We present here a comparative electrophysiological study of the lactose permease (LacY), the fucose permease (FucP) and the xylose permease (XylE), which reveals common mechanistic principles and differences. In all three symporters energetically downhill electrogenic sugar/H+ symport is observed. Comparison of the pH dependence of symport at symmetrical pH exhibits broad bell-shaped pH profiles extending over 3 to 6 pH units and a decrease at extremely alkaline pH >= 9.4 and at acidic to neutral pH = 4.6-7.5. The pH dependence can be described by an acidic to neutral apparent pK (pK(app)) and an alkaline pK(app). Experimental evidence suggests that the alkaline pK(app) is due to H+ depletion at the protonation site, while the acidic pK(app) is due to inhibition of deprotonation. Since previous studies suggest that a single carboxyl group in LacY (Glu325) may be the only side chain directly involved in H+ translocation and a carboxyl side chain with similar properties has been identified in FucP (Asp46) and XylE (Asp27), the present results imply that the pK of this residue is switched during H+/sugar symport in all three symporters.	[Bazzone, Andre; Madej, M. Gregor; Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Madej, M. Gregor; Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Dept Physiol & Microbiol, Los Angeles, CA 90024 USA; [Madej, M. Gregor; Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Dept Immunol, Los Angeles, CA 90024 USA; [Madej, M. Gregor; Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Genet, Los Angeles, CA 90024 USA	Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Fendler, K (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	fendler@biophys.mpg.de		Bazzone, Andre/0000-0002-2419-3519; Fendler, Klaus/0000-0002-5699-7060; Madej, M. Gregor/0000-0001-9181-6387	Deutsche Forschungsgemeinschaft [SFB807]; NSF; Direct For Biological Sciences [1547801] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) SFB807 to KF and by an NSF Eager Grant (https://www.nsf.gov/about/transformative_research/submit.jsp) to HRK.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bazzone A, 2013, JOVE-J VIS EXP, P50230; Bazzone A, 2013, JOVE-J VIS EXP, DOI 10.3791/50230; CARRASCO N, 1989, BIOCHEMISTRY-US, V28, P2533, DOI 10.1021/bi00432a028; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Gaiko O, 2013, BIOCHEMISTRY-US, V52, P8261, DOI 10.1021/bi4013269; Garcia-Celma JJ, 2008, LANGMUIR, V24, P8119, DOI 10.1021/la800428h; Garcia-Celma JJ, 2010, BIOCHEMISTRY-US, V49, P6115, DOI 10.1021/bi100492p; Garcia-Celma JJ, 2009, P NATL ACAD SCI USA, V106, P7373, DOI 10.1073/pnas.0902471106; Guan L, 2004, P NATL ACAD SCI USA, V101, P12148, DOI 10.1073/pnas.0404936101; HERZLINGER D, 1984, BIOCHEMISTRY-US, V23, P3688, DOI 10.1021/bi00311a018; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Kumar H, 2015, P NATL ACAD SCI USA, V112, P9004, DOI 10.1073/pnas.1509854112; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; Madej MG, 2014, SPRINGER SER BIOPHYS, V17, P121, DOI 10.1007/978-3-642-53839-1_6; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Madej MG, 2013, P NATL ACAD SCI USA, V110, pE4831, DOI 10.1073/pnas.1319754110; Madej MG, 2013, P NATL ACAD SCI USA, V110, P5870, DOI 10.1073/pnas.1303538110; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Smirnova IN, 2008, P NATL ACAD SCI USA, V105, P8896, DOI 10.1073/pnas.0803577105; Sugihara J, 2012, P NATL ACAD SCI USA, V109, P14847, DOI 10.1073/pnas.1213445109; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; VIITANEN P, 1983, BIOCHEMISTRY-US, V22, P2531, DOI 10.1021/bi00279a034; Wisedchaisri G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5521; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003	36	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156392	10.1371/journal.pone.0156392	http://dx.doi.org/10.1371/journal.pone.0156392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227677	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500131
J	Gruninger, RJ; McAllister, TA; Forster, RJ				Gruninger, Robert J.; McAllister, Tim A.; Forster, Robert J.			Bacterial and Archaeal Diversity in the Gastrointestinal Tract of the North American Beaver (Castor canadensis)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MICROBIAL COMMUNITY; GUT MICROBIOTA; SEQUENCE; FOREGUT; RUMEN; METHANOGENS; EVOLUTION; WILD; PCR	The North American Beaver (Castor canadensis) is the second largest living rodent and an iconic symbol of Canada. The beaver is a semi-aquatic browser whose diet consists of lignocellulose from a variety of plants. The beaver is a hindgut fermenter and has an enlarged ceacum that houses a complex microbiome. There have been few studies examining the microbial diversity in gastrointestinal tract of hindgut fermenting herbivores. To examine the bacterial and archaeal communities inhabiting the gastrointestinal tract of the beaver, the microbiome of the ceacum and feaces was examined using culture-independent methods. DNA from the microbial community of the ceacum and feaces of 4 adult beavers was extracted, and the 16S rRNA gene was sequenced using either bacterial or archaeal specific primers. A total of 1447 and 1435 unique bacterial OTUs were sequenced from the ceacum and feaces, respectively. On average, the majority of OTUs within the ceacum were classified as Bacteroidetes (49.2%) and Firmicutes (47.6%). The feaces was also dominated by OTUs from Bacteroidetes (36.8%) and Firmicutes (58.9%). The composition of bacterial community was not significantly different among animals. The composition of the ceacal and feacal microbiome differed, but this difference is due to changes in the abundance of closely related OTUs, not because of major differences in the taxonomic composition of the communities. Within these communities, known degraders of lignocellulose were identified. In contrast, to the bacterial microbiome, the archaeal community was dominated by a single species of methanogen, Methanosphaera stadtmanae. The data presented here provide the first insight into the microbial community within the hindgut of the beaver.	[Gruninger, Robert J.; McAllister, Tim A.; Forster, Robert J.] Agr & Agri Food Canada, Lethbridge Res & Innovat Ctr, Lethbridge, AB, Canada	Agriculture & Agri Food Canada	Gruninger, RJ; Forster, RJ (corresponding author), Agr & Agri Food Canada, Lethbridge Res & Innovat Ctr, Lethbridge, AB, Canada.	Robert.Gruninger@agr.gc.ca; Robert.Forster@agr.gc.ca	McAllister, Tim A./R-9201-2017	McAllister, Tim A./0000-0002-8266-6513	Agriculture and Agri-food Canada	Agriculture and Agri-food Canada(Agriculture & Agri Food Canada)	This work was supported by funding from Agriculture and Agri-food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker CJ, 2013, VET MICROBIOL, V167, P554, DOI 10.1016/j.vetmic.2013.08.025; Ben David Y, 2015, ENVIRON MICROBIOL, V17, P3407, DOI 10.1111/1462-2920.12868; Bornscheuer U, 2014, ANGEW CHEM INT EDIT, V53, P10876, DOI 10.1002/anie.201309953; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chassard C, 2010, FEMS MICROBIOL ECOL, V74, P205, DOI 10.1111/j.1574-6941.2010.00941.x; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Facey HV, 2012, AM J PRIMATOL, V74, P408, DOI 10.1002/ajp.21992; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Garcia- Armado MA, 2014, MICROB ECOL, V63, P719; Godoy-Vitorino F, 2008, APPL ENVIRON MICROB, V74, P5905, DOI 10.1128/AEM.00574-08; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Godwin S, 2014, ISME J, V8, P1855, DOI 10.1038/ismej.2014.25; Gruninger RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089682; Gulino LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061463; Hackstein JHP, 1996, EVOLUTION, V50, P559, DOI [10.2307/2410831, 10.1111/j.1558-5646.1996.tb03868.x]; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ishaq SL, 2014, MICROB ECOL, V68, P185, DOI 10.1007/s00248-014-0399-0; Ishaq SL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-212; Kitts WD, 1957, CAN J ZOOL, V73, P967; Klieve AV, 2012, J APPL MICROBIOL, V113, P1065, DOI 10.1111/j.1365-2672.2012.05428.x; Kohl KD, 2014, ENVIRON MICROBIOL, V16, P2869, DOI 10.1111/1462-2920.12376; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mackenzie AK, 2015, APPL ENVIRON MICROB, V81, P187, DOI 10.1128/AEM.02858-14; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Naas AE, 2014, MBIO, V5, DOI 10.1128/mBio.01401-14; Nakamura N, 2011, AM J PRIMATOL, V73, P909, DOI 10.1002/ajp.20961; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ransom-Jones E, 2012, MICROB ECOL, V63, P267, DOI 10.1007/s00248-011-9998-1; Roggenbuck M, 2014, FEMS MICROBIOL ECOL, V90, P237, DOI 10.1111/1574-6941.12402; Rosell F, 2005, MAMMAL REV, V35, P248, DOI 10.1111/j.1365-2907.2005.00067.x; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; Stevens C. E., 2004, COMP PHYSL VERTEBRAT; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Upton BM, 2016, CHEM REV, V116, P2275, DOI 10.1021/acs.chemrev.5b00345; VISPO C, 1995, CAN J ZOOL, V73, P967, DOI 10.1139/z95-113; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Yuan ML, 2015, MOL ECOL, V24, P2521, DOI 10.1111/mec.13169; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	51	22	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156457	10.1371/journal.pone.0156457	http://dx.doi.org/10.1371/journal.pone.0156457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227334	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500142
J	Park, SR; Kim, S; Kim, YK; Kang, CK; Lee, KS				Park, Sang Rul; Kim, Sangil; Kim, Young Kyun; Kang, Chang-Keun; Lee, Kun-Seop			Photoacclimatory Responses of Zostera marina in the Intertidal and Subtidal Zones	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; SEAGRASS PHOTOSYNTHESIS; THALASSIA-TESTUDINUM; INORGANIC CARBON; HALOPHILA-OVALIS; LIGHT; GROWTH; DEPTH; DESICCATION; STRESS	Photoacclimatory responses of the seagrass Zostera marina in the intertidal and subtidal zones were investigated by measuring chlorophyll a fluorescence parameters, photosynthetic pigments, leaf delta C-13 values, and shoot morphology in two bay systems. Intertidal plants had higher carotenoid concentrations than subtidal plants to avoid photodamage under excess light conditions during the day. The maximum relative electron transport rate (rETR(max)) and minimum saturation irradiance (E-k) of the intertidal plants were higher than those of the subtidal plants, whereas photosynthetic efficiency (a) and maximum quantum yield (F-v/F-m) were higher in subtidal plants. The intertidal plants also had significantly greater Stern Volmer non-photochemical quenching (NPQ) than that of the subtidal plants. These results suggest that the subtidal plants photoacclimated to use limited light more efficiently, and the intertidal plants exhibited photosynthetic responses to minimize photodamage at excess irradiance. The delta C-13 values of leaf tissues were more negative in the intertidal plants than those in the subtidal plants, suggesting that the intertidal plants used atmospheric or dissolved CO2 for photosynthesis during emersion. Effective quantum yield (Delta F/F-m) in the intertidal plants decreased more slowly after emersion than that in the subtidal plants, indicating higher desiccation tolerance of the intertidal plants. The intertidal plants also recovered more rapidly from desiccation damage than the subtidal plants, suggesting photosynthetic adaptation to desiccation stress. The photosynthetic plasticity of Z. marina in response to variable environmental conditions most likely allows this species to occur in the intertidal and subtidal zones.	[Park, Sang Rul; Kim, Sangil] Jeju Natl Univ, Dept Marine Life Sci, Estuarine & Coastal Ecol Lab, Jeju, South Korea; [Kim, Young Kyun; Lee, Kun-Seop] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea; [Kang, Chang-Keun] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Gwangju, South Korea	Jeju National University; Pusan National University; Gwangju Institute of Science & Technology (GIST)	Lee, KS (corresponding author), Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea.	klee@pusan.ac.kr	Kang, Chang-Keun/GLR-8512-2022	Kim, Sangil/0000-0001-5009-8876	Ministry of Oceans and Fisheries, Korea; National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2015R1A2A2A01004850]	Ministry of Oceans and Fisheries, Korea; National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by the Ministry of Oceans and Fisheries, Korea (Project title: Long-term changes in structure and function in the marine ecosystems of Korea) to SRP, KSL, and CKK, and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST; NRF-2015R1A2A2A01004850) to KSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAL EG, 1994, J EXP MAR BIOL ECOL, V178, P113, DOI 10.1016/0022-0981(94)90228-3; [Anonymous], 2004, EUROPEAN SEAGRASSES; Apichanangkool P, 2014, BOT MAR, V57, P433, DOI 10.1515/bot-2014-0004; Armstrong GA, 1996, FASEB J, V10, P228, DOI 10.1096/fasebj.10.2.8641556; Beer S, 2002, FUNCT PLANT BIOL, V29, P349, DOI 10.1071/PP01185; Beer S, 1997, AQUAT BOT, V56, P277, DOI 10.1016/S0304-3770(96)01109-6; BEER S, 1989, AQUAT BOT, V34, P153, DOI 10.1016/0304-3770(89)90054-5; Bite JS, 2007, MAR BIOL, V152, P405, DOI 10.1007/s00227-007-0700-6; Bjork M, 1999, MAR ECOL PROG SER, V191, P121, DOI 10.3354/meps191121; Boese BL, 2005, BOT MAR, V48, P274, DOI 10.1515/BOT.2005.037; Boese BL, 2003, AQUAT BOT, V76, P329, DOI 10.1016/S0304-3770(03)00068-8; Campbell SJ, 2007, ESTUAR COAST SHELF S, V73, P551, DOI 10.1016/j.ecss.2007.02.014; CLOUGH BF, 1980, AQUAT BOT, V9, P1, DOI 10.1016/0304-3770(80)90002-9; Collier CJ, 2008, MAR ECOL PROG SER, V353, P65, DOI 10.3354/meps07171; Collin A, 2010, REMOTE SENS ENVIRON, V114, P520, DOI 10.1016/j.rse.2009.10.011; Demmig-Adams B, 1999, ADV PHOTOSYNTH, V8, P245; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; DUNTON KH, 1994, MAR ECOL PROG SER, V107, P281, DOI 10.3354/meps107281; Durako MJ, 2003, MAR BIOL, V142, P1219, DOI 10.1007/s00227-003-1038-3; Fry B., 1989, STABLE ISOTOPES ECOL, P196, DOI [DOI 10.1007/978-1-4612-3498-2, DOI 10.1007/978-1-4612-3498-2_12]; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hader DP, 1998, AQUAT BOT, V61, P225, DOI 10.1016/S0304-3770(98)00068-0; Hartel H, 1998, J EXP BOT, V49, P535, DOI 10.1093/jexbot/49.320.535; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hemminga MA, 1996, MAR ECOL PROG SER, V140, P285, DOI 10.3354/meps140285; Hirst A, 2008, 29 DEP PRIM IND; Invers O, 2001, J EXP MAR BIOL ECOL, V265, P203, DOI 10.1016/S0022-0981(01)00332-X; Kim MS, 2014, J EXP MAR BIOL ECOL, V461, P286, DOI 10.1016/j.jembe.2014.08.015; Kim YK, 2015, ESTUAR COAST, V38, P558, DOI 10.1007/s12237-014-9833-2; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Larkum AWD, 1996, SEAGRASS BIOL, P191; Lee KS, 2005, MAR BIOL, V147, P1091, DOI 10.1007/s00227-005-0011-8; Lee KS, 1997, J EXP MAR BIOL ECOL, V210, P53, DOI 10.1016/S0022-0981(96)02720-7; Lee KS., 2003, WORLD ATLAS SEAGRASS, P193; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Lee SY, 2006, MAR ECOL-EVOL PERSP, V27, P133, DOI 10.1111/j.1439-0485.2006.00089.x; LEUSCHNER C, 1993, AQUAT BOT, V45, P53, DOI 10.1016/0304-3770(93)90052-X; Longstaff BJ, 1999, AQUAT BOT, V65, P105, DOI 10.1016/S0304-3770(99)00035-2; MACAULEY JM, 1988, AQUAT BOT, V31, P277, DOI 10.1016/0304-3770(88)90017-4; Major KM, 2002, J EXP MAR BIOL ECOL, V275, P173, DOI 10.1016/S0022-0981(02)00212-5; MCPHERSON BF, 1987, ESTUAR COAST SHELF S, V25, P721, DOI 10.1016/0272-7714(87)90018-7; Micheli F, 2008, ECOL MONOGR, V78, P225, DOI 10.1890/06-1605.1; Nayar S, 2009, J EXP MAR BIOL ECOL, V373, P87, DOI 10.1016/j.jembe.2009.03.010; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Olive I, 2013, MAR BIOL, V160, P285, DOI 10.1007/s00227-012-2087-2; Park SR, 2011, J EXP MAR BIOL ECOL, V407, P275, DOI 10.1016/j.jembe.2011.06.023; Petrou K, 2013, MAR ECOL PROG SER, V482, P93, DOI 10.3354/meps10229; PLATT T, 1980, J MAR RES, V38, P687; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ralph PJ, 2002, MAR BIOL, V141, P639, DOI 10.1007/s00227-002-0866-x; Ralph PJ, 1998, MAR ECOL PROG SER, V171, P123, DOI 10.3354/meps171123; RALPH PJ, 1995, AQUAT BOT, V51, P55, DOI 10.1016/0304-3770(95)00456-A; Raven JA, 2002, FUNCT PLANT BIOL, V29, P355, DOI 10.1071/PP01201; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Schwarz AM, 2002, AQUAT BOT, V74, P263, DOI 10.1016/S0304-3770(02)00080-3; Schwarz AM, 2000, MAR BIOL, V137, P755, DOI 10.1007/s002270000433; Seddon S, 2001, MAR ECOL PROG SER, V220, P119, DOI 10.3354/meps220119; Silva J, 2005, J EXP MAR BIOL ECOL, V317, P87, DOI 10.1016/j.jembe.2004.11.010; Silva J, 2003, MAR ECOL PROG SER, V257, P37, DOI 10.3354/meps257037; Tanaka Y, 2004, MAR ECOL PROG SER, V284, P117, DOI 10.3354/meps284117; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Yabe T, 1996, ECOL RES, V11, P291, DOI 10.1007/BF02347786; Yakovleva IM, 2001, AQUAT BOT, V71, P47, DOI 10.1016/S0304-3770(01)00167-X; Yamamuro Masumi, 2001, Limnology, V2, P199, DOI 10.1007/s10201-001-8036-2	65	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156214	10.1371/journal.pone.0156214	http://dx.doi.org/10.1371/journal.pone.0156214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227327	Green Submitted, gold, Green Published			2022-12-26	WOS:000376882500082
J	Pelissie, B; Piou, C; Jourdan-Pineau, H; Pages, C; Blondin, L; Chapuis, MP				Pelissie, Benjamin; Piou, Cyril; Jourdan-Pineau, Helene; Pages, Christine; Blondin, Laurence; Chapuis, Marie-Pierre			Extra Molting and Selection on Nymphal Growth in the Desert Locust	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; SCHISTOCERCA-GREGARIA; LIFE-HISTORY; QUANTITATIVE GENETICS; CHORTHIPPUS-BRUNNEUS; MULTIMODEL INFERENCE; LARVAL DEVELOPMENT; PHASE POLYPHENISM; JUVENILE-HORMONE; TOBACCO HORNWORM	In insects, extra-molting has been viewed as a compensatory mechanism for nymphal growth that contributes to optimize body weight for successful reproduction. However, little is known on the capacity of extra-molting to evolve in natural populations, which limits our understanding of how selection acts on nymphal growth. We used a multi-generational pedigree, individual monitoring and quantitative genetics models to investigate the evolution of extra-molting and its impact on nymphal growth in a solitarious population of the desert locust, Schistocerca gregaria. Growth compensation via extra-molting was observed for 46% of the females, whose adult weight exceeded by 4% that of other females, at a cost of a 22% longer development time. We found a null heritability for body weight threshold only, and the highest and a strongly female-biased heritability for extra molting. Our genetic estimates show that (1) directional selection can act on growth rate, development time and extra-molting to optimize body weight threshold, the target of stabilizing selection, (2) extra-molting can evolve in natural populations, and (3) a genetic conflict, due to sexually antagonistic selection on extra-molting, might prevent its fixation. Finally, we discuss how antagonistic selection between solitarious and gregarious environments and/or genetic correlations between growth and phase traits might also impact the evolution of extra-molting in locusts.	[Pelissie, Benjamin; Piou, Cyril; Jourdan-Pineau, Helene; Chapuis, Marie-Pierre] CIRAD, UMR CBGP, F-34398 Montpellier, France; [Pages, Christine; Blondin, Laurence] CIRAD, UPR B AMR, F-34398 Montpellier, France; [Pelissie, Benjamin] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	CIRAD; Institut de Recherche pour le Developpement (IRD); CIRAD; University of Wisconsin System; University of Wisconsin Madison	Pelissie, B (corresponding author), CIRAD, UMR CBGP, F-34398 Montpellier, France.; Pelissie, B (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	benjamin.pelissie@icloud.com	Jourdan-Pineau, Hélène/AAR-3967-2021; Pélissié, Benjamin/AAL-5970-2021	Pélissié, Benjamin/0000-0001-8705-7023; Chapuis, Marie-Pierre/0000-0003-4405-7722	CIRAD (Agricultural Research for Development)	CIRAD (Agricultural Research for Development)	This work was funded by CIRAD (Agricultural Research for Development). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT F. O., 1955, Journal d'Agriculture Tropicale et de Botanique Appliquee, V2, P109; ALBRECHT FO, 1957, EVOLUTION, V11, P166, DOI 10.1111/j.1558-5646.1957.tb02886.x; Andersson Malte, 1994; Applebaum SW, 1997, ARCH INSECT BIOCHEM, V35, P375, DOI 10.1002/(SICI)1520-6327(1997)35:4<375::AID-ARCH3>3.0.CO;2-R; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Blondin L, 2013, J APPL ENTOMOL, V137, P673, DOI 10.1111/jen.12052; Bolund E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2002; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chapuis M- P, 2016, AFRICAN ENT IN PRESS, V24; Chapuis MP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-37; Clynen E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-201; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DEMPSTER ER, 1950, GENETICS, V35, P212; Dirsh VM, 1953, ANTILOCUST B, P1; Elston RC, 1977, JSTOR, P231; Esperk T, 2007, J ECON ENTOMOL, V100, P627, DOI 10.1603/0022-0493(2007)100[627:IVINOL]2.0.CO;2; Esperk T, 2007, ECOL ENTOMOL, V32, P243, DOI 10.1111/j.1365-2311.2007.00872.x; GANGWERE S. K., 1964, ANN ENTOMOL SOC AMER, V57, P662, DOI 10.1093/aesa/57.6.662; Gilmour A. R., 2014, ASREML USER GUIDE; GOTTHARD K, 2001, ANIMAL DEV ECOLOGY, P1; Greenlee KJ, 2005, J EXP BIOL, V208, P1385, DOI 10.1242/jeb.01521; Guttal V, 2012, ECOL LETT, V15, P1158, DOI 10.1111/j.1461-0248.2012.01840.x; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hagele BF, 2004, J INSECT PHYSIOL, V50, P621, DOI 10.1016/j.jinsphys.2004.04.008; Hammerschmidt K, 2012, HEREDITY, V108, P569, DOI 10.1038/hdy.2011.125; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; HASSALL M, 1987, J NAT HIST, V21, P329, DOI 10.1080/00222938700771051; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; HOULE D, 1992, GENETICS, V130, P195; HUGHES TD, 1980, PHYSIOL ENTOMOL, V5, P47, DOI 10.1111/j.1365-3032.1980.tb00210.x; Hunter-Jones P, 1958, ANTILOCUST B; INJEYAN HS, 1981, J INSECT PHYSIOL, V27, P97, DOI 10.1016/0022-1910(81)90115-3; JOLY L, 1954, CR SOC BIOL, V148, P579; Joly P, 1953, ANN SCI NAT, V11, P331; Joly P, 1962, ROLE JOUE CORPORA AL, P77; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kingsolver JG, 2007, P ROY SOC B-BIOL SCI, V274, P977, DOI 10.1098/rspb.2006.0036; Kvist J, 2013, MOL ECOL, V22, P602, DOI 10.1111/j.1365-294X.2012.05521.x; Maeno K, 2008, B ENTOMOL RES, V98, P527, DOI 10.1017/S0007485308006044; Maeno K, 2004, B ENTOMOL RES, V94, P349, DOI 10.1079/BER2004310; Maeno K, 2010, APPL ENTOMOL ZOOL, V45, P513, DOI 10.1303/aez.2010.513; Maeno K, 2009, J INSECT PHYSIOL, V55, P1013, DOI 10.1016/j.jinsphys.2009.07.005; Maeno K, 2009, J INSECT PHYSIOL, V55, P849, DOI 10.1016/j.jinsphys.2009.05.012; Mathur CB, 1938, AN EXTRA HOPPER STAG, P177; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Morrissey MB, 2014, QUANTITATIVE GENETICS IN THE WILD, P228; Mukerji S., 1938, Compte Rendu Conf int antiacrid Brussels, V5, P410; Nickerson B, 1956, ANTILOCUST B; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Popov GB, 1958, ANTILOCUST B, P70; Price T, 1991, LOW HERITABILITY LIF, V45, P853; Ramachandra Rao Y., 1939, Indian Journal of Agricultural Science, V9, P727; Reinhold K, 2013, EVOLUTION, V67, P3662, DOI 10.1111/evo.12224; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; ROFF DA, 1997, EVOLUTIONARY QUANTIT, P493; Rungs C., 1954, Compte Rendu Soc Sci nat Maroc Rabat, P130; Saastamoinen M, 2013, J ANIM ECOL, V82, P529, DOI 10.1111/1365-2656.12034; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Simons AM, 1998, J EVOLUTION BIOL, V11, P721, DOI 10.1007/s000360050115; Simpson SJ, 2008, CURR BIOL, V18, pR364, DOI 10.1016/j.cub.2008.02.029; Song Hojun, 2011, Psyche (Cambridge), V2011, P1, DOI 10.1155/2011/741769; Stearns SC, 1992, THE EVOLUTION OF LIF, P249; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; Telfer MG, 1999, OECOLOGIA, V121, P245, DOI 10.1007/s004420050926; Uvarov BP., 1966, GRASSHOPPERS LOCUSTS, V1; Volkonsky M, 1938, ARCH I PASTEUR ALGER, V4, P523; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wyman MJ, 2014, AM NAT, V184, P326, DOI 10.1086/677310; Zavodska R, 2003, J BIOL RHYTHM, V18, P106, DOI 10.1177/0748730403251711	77	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155736	10.1371/journal.pone.0155736	http://dx.doi.org/10.1371/journal.pone.0155736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227885	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500029
J	Placke, A; Kumar, A; Priya, S				Placke, Astrid; Kumar, Ashok; Priya, Shashank			Synthesis and Behavior of Cetyltrimethyl Ammonium Bromide Stabilized Zn1+xSnO3, (0 <= x <= 1) Nano-Crystallites	PLOS ONE			English	Article							HYDROTHERMAL SYNTHESIS; ZINC STANNATE; ZN2SNO4; NANOPARTICLES; EMISSION; PROPERTY	We report synthesis of cetyltrimethyl ammonium bromide (CTAB) stabilized Zn1+x SnO3 (0 <= x <= 1) nano-crystallites by facile cost-effective wet chemistry route. The X-ray diffraction patterns of as-synthesized powders at the Zn/Sn ratio of 1 exhibited formation of ZnSn (OH)(6). Increasing the Zn/Sn ratio further resulted in the precipitation of an additional phase corresponding to Zn(OH)(2). The decomposition of these powders at 650 degrees C for 3h led to the formation of the orthorhombic phase of ZnSnO3 and tetragonal SnO2-type phase of Zn2SnO4 at the Zn/Sn ratio of 1 and 2, respectively, with the formation of their mixed phases at intermediate compositions, i.e., at Zn/Sn ratio of 1.25, 1.50 and 1.75, respectively. The lattice parameters of orthorhombic and tetragonal phases were a - 3.6203 angstrom, b similar to 4.2646 A and c 12.8291A (for ZnSnO3) and a = b similar to 5.0136 A and c similar to 3.3055A (for Zn2SnO4). The transmission electron micrographs revealed the formation of nano-crystallites with aspect ratio - 2; the length and thickness being 24, 13 nm (for ZnSnO3) and 47, 22 nm (for Zn2Sn04), respectively. The estimated direct bandgap values for the ZnSnO3 and Zn2SnO4 were found to be 4.21 eV and 4.12 eV, respectively. The ac conductivity values at room temperature (at 10 kHz) for the ZnSnO3 and Zn2SnO4 samples were 8.02 x 10(-8) Omega(-1) cm-land 6.77 x 10(-8) Omega(-1) cm(-1), respectively. The relative permittivity was found to increase with increase in temperature, the room temperature values being 14.24 and 25.22 for the samples ZnSnO3 and Zn2SnO4, respectively. Both the samples, i.e., ZnSnO3 and Zn2SnO4, exhibited low values of loss tangent up to 300 K, the room temperature values being 0.89 and 0.72, respectively. A dye-sensitized solar cell has been fabricated using the optimized sample of zinc stannate photo-anode, i.e., Zn2SnO4. The cyclic voltammetry revealed oxidation and reduction around 0.40 V (current density similar to 11.1 mA/cm2) and 0.57 V (current density- 11.7 mA/cm(2)) for Zn2SnO4 photo -anode in presence of light.	[Placke, Astrid; Kumar, Ashok] Natl Inst Technol Kurukshetra, Dept Phys, Kurukshetra 136119, Haryana, India; [Placke, Astrid] Univ Appl Sci & Art, Dept Phys Technol, D-37083 Gottingen, Germany; [Priya, Shashank] Virginia Tech, CEHMS, Blacksburg, VA 24061 USA	National Institute of Technology (NIT System); National Institute of Technology Kurukshetra; HAWK University of Applied Sciences & Arts Hildesheim Holzminden Gottingen; Virginia Polytechnic Institute & State University	Kumar, A (corresponding author), Natl Inst Technol Kurukshetra, Dept Phys, Kurukshetra 136119, Haryana, India.	ashokku@nitkkr.ac.in	Priya, S/GQH-7176-2022	Kumar, Ashok/0000-0001-9152-9062; Priya, Shashank/0000-0003-1367-3434	SERB-DST, Government of India [SERB/F/1769/2013-2014]; DAAD	SERB-DST, Government of India; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by SERB-DST, Government of India (SERB/F/1769/2013-2014), and a DAAD fellowship to AP.	Alpuche-Aviles MA, 2009, J AM CHEM SOC, V131, P3216, DOI 10.1021/ja806719x; Baruah S, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/1/013004; Cai P, 2013, J MATER CHEM A, V1, P5217, DOI 10.1039/c3ta10228a; Chen YC, 2004, MATER TRANS, V45, P1684, DOI 10.2320/matertrans.45.1684; Errandonea D, 2008, PROG MATER SCI, V53, P711, DOI 10.1016/j.pmatsci.2008.02.001; Hu LH, 2008, J AM CHEM SOC, V130, P16136, DOI 10.1021/ja806400e; Hwang D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07353; Jia TK, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/197824; Kumar A, 2015, ADV CHEM LETT, V2, P3; Kumar A, 2013, J SOL-GEL SCI TECHN, V68, P46, DOI 10.1007/s10971-013-3132-4; Kumar AA, 2015, RSC ADV, V5, P17202, DOI 10.1039/c4ra16775a; Kumar V, 2016, PHYSICA B, V480, P36, DOI 10.1016/j.physb.2015.07.020; Kumar V, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/13/135701; Lan JL, 2010, CURR APPL PHYS, V10, pS168, DOI 10.1016/j.cap.2009.11.064; Lupan O, 2016, SENSOR ACTUAT B-CHEM, V224, P434, DOI 10.1016/j.snb.2015.10.042; Mali SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11424; Minami T, 2000, MRS BULL, V25, P38, DOI 10.1557/mrs2000.149; Miyauchi M, 2010, CHEM COMMUN, V46, P1529, DOI 10.1039/b921010e; Najim M, 2015, PHYS CHEM CHEM PHYS, V17, P22923, DOI 10.1039/c5cp03488d; Ong KP, 2015, APL MATER, V3, DOI 10.1063/1.4919564; Paulowicz I, 2015, ADV ELECTRON MATER, V1, DOI 10.1002/aelm.201500081; Sevik C, 2006, PHYS REV B, V74, P193; Singh R., 2011, J SENS TECHNOL, V01, P116, DOI DOI 10.4236/JST.2011.14016; Som S, 2016, ULTRASON SONOCHEM, V28, P79, DOI 10.1016/j.ultsonch.2015.07.003; Som S, 2014, DALTON T, V43, P9860, DOI 10.1039/c4dt00349g; Som S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4876316; Som S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/41/415102; Suhaimi S, 2015, INT J ELECTROCHEM SC, V10, P2859; Suzuki Y, 2015, J PHYS C SER, V4, P596; Tan B, 2007, J AM CHEM SOC, V129, P4162, DOI 10.1021/ja070804f; Wu Y, 2011, CHEM NANOSTRUCTURED, P127; Xu JQ, 2006, SOLID STATE ELECTRON, V50, P504, DOI 10.1016/j.sse.2006.02.001; Yang HG, 2008, NATURE, V453, P638, DOI 10.1038/nature06964; Young DL, 2002, J APPL PHYS, V92, P310, DOI 10.1063/1.1483104; Zeng J, 2008, J PHYS CHEM C, V112, P4159, DOI 10.1021/jp7113797; Zhao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06847; Zhao Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4745034; Zhu HL, 2006, J PHYS CHEM B, V110, P7631, DOI 10.1021/jp060304t; Zou ZG, 2001, NATURE, V414, P625, DOI 10.1038/414625a	39	10	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156246	10.1371/journal.pone.0156246	http://dx.doi.org/10.1371/journal.pone.0156246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228102	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500093
J	Barashkov, NA; Pshennikova, VG; Posukh, OL; Teryutin, FM; Solovyev, AV; Klarov, LA; Romanov, GP; Gotovtsev, NN; Kozhevnikov, AA; Kirillina, EV; Sidorova, OG; Vasilyev, LM; Fedotova, EE; Morozov, IV; Bondar, AA; Solovyeva, NA; Kononova, SK; Rafailov, AM; Sazonov, NN; Alekseev, AN; Tomsky, MI; Dzhemileva, LU; Khusnutdinova, EK; Fedorova, SA				Barashkov, Nikolay A.; Pshennikova, Vera G.; Posukh, Olga L.; Teryutin, Fedor M.; Solovyev, Aisen V.; Klarov, Leonid A.; Romanov, Georgii P.; Gotovtsev, Nyurgun N.; Kozhevnikov, Andrey A.; Kirillina, Elena V.; Sidorova, Oksana G.; Vasilyev, Lena M.; Fedotova, Elvira E.; Morozov, Igor V.; Bondar, Alexander A.; Solovyeva, Natalya A.; Kononova, Sardana K.; Rafailov, Adyum M.; Sazonov, Nikolay N.; Alekseev, Anatoliy N.; Tomsky, Mikhail I.; Dzhemileva, Lilya U.; Khusnutdinova, Elza K.; Fedorova, Sardana A.			Spectrum and Frequency of the GJB2 Gene Pathogenic Variants in a Large Cohort of Patients with Hearing Impairment Living in a Subarctic Region of Russia (the Sakha Republic)	PLOS ONE			English	Article							CONNEXIN 26 GENE; MUTATIONS CAUSING DEAFNESS; HIGH PREVALENCE; CHILDHOOD DEAFNESS; CARRIER FREQUENCY; DFNB1 MUTATIONS; CX26 GENE; POPULATION; FOUNDER; ALLELES	Pathogenic variants in the GJB2 gene, encoding connexin 26, are known to be a major cause of hearing impairment (HI). More than 300 allelic variants have been identified in the GJB2 gene. Spectrum and allelic frequencies of the GJB2 gene vary significantly among different ethnic groups worldwide. Until now, the spectrum and frequency of the pathogenic variants in exon 1, exon 2 and the flanking intronic regions of the GJB2 gene have not been described thoroughly in the Sakha Republic (Yakutia), which is located in a subarctic region in Russia. The complete sequencing of the non-coding and coding regions of the GJB2 gene was performed in 393 patients with HI (Yakuts-296, Russians-51, mixed and other ethnicities-46) and in 187 normal hearing individuals of Yakut (n = 107) and Russian (n = 80) populations. In the total sample (n = 580), we revealed 12 allelic variants of the GJB2 gene, 8 of which were recessive pathogenic variants. Ten genotypes with biallelic recessive pathogenic variants in the GJB2 gene (in a homozygous or a compound heterozygous state) were found in 192 out of 393 patients (48.85%). We found that the most frequent GJB2 pathogenic variant in the Yakut patients was c.-23+1G>A (51.82%) and that the second most frequent was c.109G>A (2.37%), followed by c.35delG (1.64%). Pathogenic variants c.35delG (22.34%), c.-23+1G>A (5.31%), and c.313_326del14 (2.12%) were found to be the most frequent among the Russian patients. The carrier frequencies of the c.-23+1G>A and c.109G>A pathogenic variants in the Yakut control group were 10.20% and 2.80%, respectively. The carrier frequencies of c.35delG and c.101T>C were identical (2.5%) in the Russian control group. We found that the contribution of the GJB2 gene pathogenic variants in HI in the population of the Sakha Republic (48.85%) was the highest among all of the previously studied regions of Asia. We suggest that extensive accumulation of the c.-23+1G>A pathogenic variant in the indigenous Yakut population (92.20% of all mutant chromosomes in patients) and an extremely high (10.20%) carrier frequency in the control group may indicate a possible selective advantage for the c.-23+1G>A carriers living in subarctic climate.	[Barashkov, Nikolay A.; Pshennikova, Vera G.; Teryutin, Fedor M.; Solovyev, Aisen V.; Klarov, Leonid A.; Romanov, Georgii P.; Gotovtsev, Nyurgun N.; Sidorova, Oksana G.; Solovyeva, Natalya A.; Kononova, Sardana K.; Tomsky, Mikhail I.; Fedorova, Sardana A.] Yakut Sci Ctr Complex Med Problems, Fed State Budgetary Sci Inst, Dept Mol Genet, Yakutsk, Russia; [Barashkov, Nikolay A.; Pshennikova, Vera G.; Teryutin, Fedor M.; Solovyev, Aisen V.; Romanov, Georgii P.; Gotovtsev, Nyurgun N.; Solovyeva, Natalya A.; Kononova, Sardana K.; Rafailov, Adyum M.; Fedorova, Sardana A.] MK Ammosov North Eastern Fed Univ, Inst Nat Sci, Mol Biol Lab, Yakutsk, Russia; [Posukh, Olga L.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Lab Human Mol Genet,Fed Res Ctr, Novosibirsk 630090, Russia; [Posukh, Olga L.; Morozov, Igor V.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Klarov, Leonid A.] Minist Publ Hlth Sakha Republ, Republican Hosp 2, Ctr Emergency Med, Dept Radiol, Yakutsk, Russia; [Kozhevnikov, Andrey A.] Minist Publ Hlth Sakha Republ, Republican Hosp 2, Ctr Emergency Med, Republican Ctr Profess Pathol, Yakutsk, Russia; [Kirillina, Elena V.] MK Ammosov North Eastern Fed Univ, Inst Foreign Philol & Reg Studies, Yakutsk, Russia; [Vasilyev, Lena M.; Fedotova, Elvira E.] Minist Publ Hlth Sakha Republ, Natl Med Ctr, Republican Hosp 1, Audiol Logopaed Ctr, Yakutsk, Russia; [Morozov, Igor V.; Bondar, Alexander A.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, SB RAS Genom Core Facil, Novosibirsk, Russia; [Sazonov, Nikolay N.] MK Ammosov North Eastern Fed Univ, Inst Nat Sci, Dept Biochem & Biotechnol, Yakutsk, Russia; [Alekseev, Anatoliy N.] Russian Acad Sci, Siberian Branch, Inst Humanitarian Res & Indigenous Peoples North, Yakutsk, Russia; [Dzhemileva, Lilya U.; Khusnutdinova, Elza K.] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Lab Human Mol Genet, Ufa 450001, Russia; [Dzhemileva, Lilya U.] Bashkir State Med Univ, Dept Immunol & Human Reprod Hlth, Ufa, Russia; [Khusnutdinova, Elza K.] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Russia	Yakut Science Centre of Complex Medical Problems; North-Eastern Federal University in Yakutsk; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; North-Eastern Federal University in Yakutsk; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; North-Eastern Federal University in Yakutsk; Institute for Humanities Research & Indigenous Studies of the North; Russian Academy of Sciences; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State Medical University; Bashkir State University	Barashkov, NA (corresponding author), Yakut Sci Ctr Complex Med Problems, Fed State Budgetary Sci Inst, Dept Mol Genet, Yakutsk, Russia.; Barashkov, NA (corresponding author), MK Ammosov North Eastern Fed Univ, Inst Nat Sci, Mol Biol Lab, Yakutsk, Russia.	barashkov2004@mail.ru	Teryutin, Fedor/K-5104-2017; Solovyeva, Natalya/Q-9965-2018; Morozov, Igor/AAH-5352-2021; Dzhemileva, Lilya U/K-8636-2013; Готовцев, Ньургун/K-8020-2017; Solovyeva, Natalya/L-4470-2017; Sidorova, Oksana/ABA-1042-2020; Solovyev, Aisen/F-4012-2017; Posukh, Olga L/Q-6065-2016; Pshennikova, Vera/F-4031-2017; Fedorova, Sardana/K-5445-2017; Dzhemilev, Usein M./O-5155-2015; Klarov, Leonid/L-4463-2017; Alekseev, Anatoliy Nickolaevich/O-1096-2015; Bondar, Alexander/AAA-7087-2020; Barashkov, Nikolay/F-1499-2017; Kononova, Sardana/K-7096-2017; Romanov, Georgii P/E-6367-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Kirillina, Elena/A-5581-2017	Teryutin, Fedor/0000-0002-8659-0886; Solovyeva, Natalya/0000-0002-3570-2585; Morozov, Igor/0000-0002-0307-4203; Dzhemileva, Lilya U/0000-0003-3315-4746; Готовцев, Ньургун/0000-0002-4710-1592; Posukh, Olga L/0000-0003-1352-3591; Pshennikova, Vera/0000-0001-6866-9462; Dzhemilev, Usein M./0000-0002-7992-6337; Klarov, Leonid/0000-0003-1588-0971; Alekseev, Anatoliy Nickolaevich/0000-0002-9488-573X; Bondar, Alexander/0000-0001-9181-0487; Barashkov, Nikolay/0000-0002-6984-7934; Kononova, Sardana/0000-0002-2143-0021; Romanov, Georgii P/0000-0002-2936-5818; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Fedorova, Sardana/0000-0002-6952-3868; Kirillina, Elena/0000-0002-5583-0250	Russian Foundation for Basic Research [14-04-01741_a, 16-34-00564_mol_a, 16-34-00234_mol_a]; Project of the Ministry of Education and Science of the Russian Federation [6.656.2014/K]; SB RAS Integration Project [92]; SB RAS grant [0324-2015-0031]; Sakha Republic Government project "Yakutian history"; NOFMU grants [2013020100612]; grants of the Head of the Sakha Republic (Yakutia) for young scientists, experts and students [76, 105]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Project of the Ministry of Education and Science of the Russian Federation; SB RAS Integration Project; SB RAS grant; Sakha Republic Government project "Yakutian history"; NOFMU grants; grants of the Head of the Sakha Republic (Yakutia) for young scientists, experts and students	This work was supported by the grants of the Russian Foundation for Basic Research (#14-04-01741_a, #16-34-00564_mol_a, #16-34-00234_mol_a), by the Project of the Ministry of Education and Science of the Russian Federation (#6.656.2014/K), by the SB RAS Integration Project #92, by the SB RAS grant #0324-2015-0031, by Sakha Republic Government project "Yakutian history", by NOFMU grants 2013020100612, and by grants of the Head of the Sakha Republic (Yakutia) for young scientists, experts and students for 2015 (RG#76 from 02.06.2015) and for 2016 (RG#105 from 08.02.2016).	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Abidi O, 2007, INT J PEDIATR OTORHI, V71, P1239, DOI 10.1016/j.ijporl.2007.04.019; Al-Qahtani MH, 2010, GENET TEST MOL BIOMA, V14, P79, DOI 10.1089/gtmb.2009.0111; Amorini M, 2015, ANN HUM GENET, V79, P341, DOI 10.1111/ahg.12120; Antoniadi T, 2000, HUM MUTAT, V16, P7, DOI 10.1002/1098-1004(200007)16:1<7::AID-HUMU2>3.0.CO;2-A; Bajaj Y, 2008, CLIN OTOLARYNGOL, V33, P313, DOI 10.1111/j.1749-4486.2008.01754.x; Barashkov N. A., 2008, Vestnik Otorinolaringologii, P23; Barashkov NA, 2014, J GENET GENOME RES, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100848; Barashkov NA, 2011, J HUM GENET, V56, P631, DOI 10.1038/jhg.2011.72; Bazazzadegan N, 2012, INT J PEDIATR OTORHI, V76, P1164, DOI 10.1016/j.ijporl.2012.04.026; Bliznets E A, 2012, Genetika, V48, P112; Bonyadi MJ, 2014, INT J PEDIATR OTORHI, V78, P637, DOI 10.1016/j.ijporl.2014.01.022; Bosch J, 2014, OMICS, V18, P481, DOI 10.1089/omi.2013.0166; Carlsson PI, 2012, ACTA OTO-LARYNGOL, V132, P1301, DOI 10.3109/00016489.2012.701018; Carranza C, 2016, CLIN GENET, V89, P461, DOI 10.1111/cge.12676; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Chen TB, 2014, ANN HUM GENET, V78, P235, DOI 10.1111/ahg.12062; Cifuentes L, 2013, BIOL RES, V46, P239, DOI 10.4067/S0716-97602013000300003; Common JEA, 2004, J MED GENET, V41, P573, DOI 10.1136/jmg.2003.017632; Cordeiro-Silva MD, 2011, MOL BIOL REP, V38, P1309, DOI 10.1007/s11033-010-0231-y; D'Adamo P, 2009, EUR J HUM GENET, V17, P284, DOI 10.1038/ejhg.2008.225; Dahl HHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059624; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Dalamon V, 2010, AUDIOL NEURO-OTOL, V15, P194, DOI 10.1159/000254487; Danilenko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036354; Davarnia B, 2012, INT J PEDIATR OTORHI, V76, P268, DOI 10.1016/j.ijporl.2011.11.019; Arenas-Sordo MD, 2012, INT J PEDIATR OTORHI, V76, P1678, DOI 10.1016/j.ijporl.2012.08.005; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Dzhemileva LU, 2010, J HUM GENET, V55, P749, DOI 10.1038/jhg.2010.101; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Frei K, 2002, EUR J HUM GENET, V10, P427, DOI 10.1038/sj.ejhg.5200826; Gallant E, 2013, AM J MED GENET A, V161, P2148, DOI 10.1002/ajmg.a.36042; Gasmelseed Nagla M A, 2004, Hum Mutat, V23, P206, DOI 10.1002/humu.9216; Green GE, 2002, AM J MED GENET, V109, P167, DOI 10.1002/ajmg.10330; Gronskov K, 2004, GENET TEST, V8, P181, DOI 10.1089/1090657041797419; Hamelmann C., 2001, HUM MUTAT, V18, P84, DOI [10.1002/humu.1156, DOI 10.1002/HUMU.1156]; Homoe P, 2012, INT J AUDIOL, V51, P433, DOI 10.3109/14992027.2012.660575; Janecke AR, 2002, HUM GENET, V111, P145, DOI 10.1007/s00439-002-0762-y; Kabahuma RI, 2011, INT J PEDIATR OTORHI, V75, P611, DOI 10.1016/j.ijporl.2011.01.029; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125416; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; Kupka Susan, 2002, Hum Mutat, V20, P77, DOI 10.1002/humu.9044; Lalayants M. R., 2011, Vestnik Otorinolaringologii, P31; Lasisi AO, 2014, INT J PEDIATR OTORHI, V78, P1870, DOI 10.1016/j.ijporl.2014.08.014; Lazar C, 2010, INT J PEDIATR OTORHI, V74, P351, DOI 10.1016/j.ijporl.2009.12.015; Liu XZ, 2002, HUM GENET, V111, P394, DOI 10.1007/s00439-002-0811-6; Lopponen T, 2003, LARYNGOSCOPE, V113, P1758; Man YKS, 2007, J MEMBRANE BIOL, V218, P29, DOI 10.1007/s00232-007-9025-0; Mani RS, 2009, EUR J HUM GENET, V17, P502, DOI 10.1038/ejhg.2008.179; Matos TD, 2013, INT J AUDIOL, V52, P466, DOI 10.3109/14992027.2013.783719; Meyer CG, 2002, NAT MED, V8, P1332, DOI 10.1038/nm1202-1332; Minarik G, 2012, INT J PEDIATR OTORHI, V76, P400, DOI 10.1016/j.ijporl.2011.12.020; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Najmabadi Hossein, 2002, Hum Mutat, V19, P572, DOI 10.1002/humu.9033; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Oliveira CA, 2002, CLIN GENET, V61, P354, DOI 10.1034/j.1399-0004.2002.610506.x; Gravina LP, 2010, INT J PEDIATR OTORHI, V74, P250, DOI 10.1016/j.ijporl.2009.11.014; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Paz-y-Mino C, 2014, INT J PEDIATR OTORHI, V78, P1648, DOI 10.1016/j.ijporl.2014.07.014; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Popova DP, 2012, EUR ARCH OTO-RHINO-L, V269, P1589, DOI 10.1007/s00405-011-1817-2; Posukh O, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-12; Rabionet R, 2000, HUM GENET, V106, P40, DOI 10.1007/s004390051007; RamShankar M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e68; Riahi Z, 2013, GENE, V525, P1, DOI 10.1016/j.gene.2013.04.078; Roux Anne-Francoise, 2004, BMC Med Genet, V5, P5; Sansovic I, 2009, GENET TEST MOL BIOMA, V13, P693, DOI 10.1089/gtmb.2009.0073; Seeman P, 2006, CLIN GENET, V69, P410, DOI 10.1111/j.1399-0004.2006.00602.x; Seeman P, 2004, CLIN GENET, V66, P152, DOI 10.1111/j.1399-0004.2004.00283.x; Shahin H, 2002, HUM GENET, V110, P284, DOI 10.1007/s00439-001-0674-2; Shan JD, 2010, INT J PEDIATR OTORHI, V74, P611, DOI 10.1016/j.ijporl.2010.03.004; Siem G, 2010, INT J AUDIOL, V49, P596, DOI 10.3109/14992021003743269; Simpson C, 2013, CELL TISSUE RES, V351, P107, DOI 10.1007/s00441-012-1502-9; Sirmaci A, 2006, J GENET, V85, P213, DOI 10.1007/BF02935334; Snoeckx Rikkert L, 2005, Hum Mutat, V26, P60, DOI 10.1002/humu.9350; Snoeckx RL, 2005, AM J MED GENET A, V135A, P126, DOI 10.1002/ajmg.a.30726; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Sterna O, 2009, P LATVIAN ACAD SCI B, V63, P198; Tamayo ML, 2009, INT J PEDIATR OTORHI, V73, P97, DOI 10.1016/j.ijporl.2008.10.001; Teek R, 2010, INT J PEDIATR OTORHI, V74, P1007, DOI 10.1016/j.ijporl.2010.05.026; Tekin M, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9137; Tekin M, 2010, ANN HUM GENET, V74, P155, DOI 10.1111/j.1469-1809.2010.00564.x; Toth T, 2007, INT J MOL MED, V20, P315; Trotta L, 2011, INT J AUDIOL, V50, P133, DOI 10.3109/14992027.2010.537377; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Tsukada K, 2015, ANN OTO RHINOL LARYN, V124, p61S, DOI 10.1177/0003489415575060; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Vuckovic D, 2015, EUR J HUM GENET, V23, P563, DOI 10.1038/ejhg.2014.151; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Zainal SA, 2012, INT J PEDIATR OTORHI, V76, P1175, DOI 10.1016/j.ijporl.2012.04.027; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	96	23	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156300	10.1371/journal.pone.0156300	http://dx.doi.org/10.1371/journal.pone.0156300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224056	Green Submitted, gold, Green Published			2022-12-26	WOS:000376881700081
J	Dong, JF; Cui, XY; Wang, SP; Wang, F; Pang, Z; Xu, N; Zhao, GQ; Wang, SP				Dong, Junfu; Cui, Xiaoyong; Wang, Shuping; Wang, Fang; Pang, Zhe; Xu, Ning; Zhao, Guoqiang; Wang, Shiping			Changes in Biomass and Quality of Alpine Steppe in Response to N & P Fertilization in the Tibetan Plateau	PLOS ONE			English	Article							SOIL-MOISTURE; NITROGEN; GRASSLAND; COMMUNITIES; MEADOW; DEGRADATION; LIMITATION; MANAGEMENT; EFFICIENCY; GRADIENT	In the alpine steppe zone on the Central Tibetan Plateau, a large amount of area has been degraded due to natural and artificial factors. N & P fertilization is widely accepted to recover degraded pastures in other regions all over the world. However, it is not clear how alpine steppe communities respond to N & P fertilization, and what is the optimal application rate, in the perspective of forage production. To attempt to explore these questions, in July 2013, two fencing sites were designed in Baingoin County with 12 treatments of different levels of nitrogen (N-0: 0; N-1: 7.5 g m(-2) yr(-1); N-2: 15 g m(-2) yr(-1)) & phosphate (P-0: 0; P-1: 7.5 gP(2)O(5) m(-2) yr(-1); P-2: 15 gP(2)O(5) m(-2) yr(-1); P-3: 30 gP(2)O(5) m(-2) yr(-1)). The results indicated N&P addition was capable to ameliorate the quality of the two sites in the Tibetan Plateau steppe. Increasing N application level resulted in significant increment in Gramineae and total biomass in the two sites. P addition significantly improved the quantity of Compositae, total biomass and the biomasss of other species in site II, while it only significantly improved the total biomass in site I. Gramineae was much more sensitive to N-induced changes than P-induced changes, and this indicated N addition was better to ameliorate the quality of plateau steppe than P-induced changes. No strong evidence was found for critical threshold within 15 g N m(-2) yr(-1), and there was decreasing tendency when P addition rate was above 15 g m(-2) yr(-1). N&P has the potential to accelerate soil acidification, which improved the content of available K, likely as a result of nonsignificant correlation between biomass and soil moisture. This work highlights the the tradeoffs that exist in N and P addition in recovering degraded steppe.	[Dong, Junfu; Wang, Shuping; Wang, Fang; Xu, Ning; Zhao, Guoqiang] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China; [Dong, Junfu; Cui, Xiaoyong; Pang, Zhe] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Wang, Shiping] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Wang, SP (corresponding author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.	wshuping@ucas.ac.cn	Cui, Xiaoyong/B-3669-2016	Cui, Xiaoyong/0000-0001-7592-5866	Natural Science Foundation of China (NSFC) [41230750]; National Program on Key Basic Research Project (973 Program) [SQ2012CC067288]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China)	The work was supported by Natural Science Foundation of China (NSFC) 41230750, and National Program on Key Basic Research Project (973 Program) SQ2012CC067288.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Baumann F, 2009, GLOBAL CHANGE BIOL, V15, P3001, DOI 10.1111/j.1365-2486.2009.01953.x; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; Cao GM, 2004, SOIL BIOL BIOCHEM, V36, P237, DOI 10.1016/j.soilbio.2003.09.010; Chen H, 2014, QUATERNARY SCI REV, V95, P151, DOI 10.1016/j.quascirev.2014.05.003; [高清竹 Gao Qingzhu], 2010, [中国农业气象, Chinese Journal of Agrometeorology], V31, P582; Goebel MO, 2011, GLOBAL CHANGE BIOL, V17, P2640, DOI 10.1111/j.1365-2486.2011.02414.x; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Jalali M, 2006, GEODERMA, V135, P63, DOI 10.1016/j.geoderma.2005.11.006; Jiang J, 2013, EUROPEAN J SOIL BIOL, P6; Kudernatsch T, 2008, BASIC APPL ECOL, V9, P263, DOI 10.1016/j.baae.2007.02.005; Lamarque JF, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005825; Li Kai-hui, 2008, Yingyong Shengtai Xuebao, V19, P2364; Li X.X., 2011, ACTA ECOL SIN, V31, P174, DOI [10.1016/j.chnaes.2011.03.009, DOI 10.1016/J.CHNAES.2011.03.009]; Liu Xiao-Dong, 2011, Chinese Journal of Plant Ecology, V35, P1209, DOI 10.3724/SP.J.1258.2011.01209; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Liu YW, 2013, PLANT SOIL, V373, P515, DOI 10.1007/s11104-013-1814-x; Ma Y, 2001, CANYE KEXUE, V19, P1; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Meng Fandong, 2013, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V33, P1923; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Niu K, 2005, ACTA PHYTOECOLOGICAL, V30, P817; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; OAKS A, 1994, PLANT PHYSIOL, V106, P407, DOI 10.1104/pp.106.2.407; Page J. R., 1982, METHODS SOIL ANAL 2; Piao ShiLong, 2004, Acta Phytoecologica Sinica, V28, P491; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Ren GH, 2013, ECOL ENG, V61, P110, DOI 10.1016/j.ecoleng.2013.09.017; Smith RS, 2000, J APPL ECOL, V37, P1029, DOI 10.1046/j.1365-2664.2000.00566.x; Song CJ, 2010, J ARID ENVIRON, V74, P1003, DOI 10.1016/j.jaridenv.2010.02.003; Tian Zixuan C, 2012, CHINESE AGR SCI B, V2; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wang CT, 2010, PLANT SOIL, V331, P377, DOI 10.1007/s11104-009-0259-8; Wang Jian-lin, 2013, Yingyong Shengtai Xuebao, V24, P3399; [王建林 WANG Jianlin], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P1478; Wang JS, 2015, MT RES DEV, V35, P78, DOI 10.1659/MRD-JOURNAL-D-11-00104.1; Wang JingSheng, 2013, Journal of Resources and Ecology, V4, P43; Wang KC, 2005, BOUND-LAY METEOROL, V116, P117, DOI 10.1007/s10546-004-7403-z; Whitehead D.C., 1995, GRASSLAND NITROGEN; Wu FZ, 2008, ENVIRON EXP BOT, V63, P248, DOI 10.1016/j.envexpbot.2007.11.002; Wu GL, 2009, PLANT SOIL, V319, P115, DOI 10.1007/s11104-008-9854-3; [谢高地 Xie Gaodi], 2003, [自然资源学报, Journal of Natural Resources], V18, P189; Yang YF, 2014, ISME J, V8, P430, DOI 10.1038/ismej.2013.146; Yang ZL, 2011, PLANT SOIL, V345, P315, DOI 10.1007/s11104-011-0784-0; Zeng DH, 2010, BIOGEOCHEMISTRY, V98, P185, DOI 10.1007/s10533-009-9385-x; Zhang XM, 2014, SOIL BIOL BIOCHEM, V72, P26, DOI 10.1016/j.soilbio.2014.01.034; [宗宁 Zong Ning], 2012, [自然资源学报, Journal of Natural Resources], V27, P1696	49	16	22	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156146	10.1371/journal.pone.0156146	http://dx.doi.org/10.1371/journal.pone.0156146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223104	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700065
J	He, XH; Landman, S; Bauland, SCG; van den Dolder, J; Koenen, HJPM; Joosten, I				He, Xuehui; Landman, Sija; Bauland, Stijn C. G.; van den Dolder, Juliette; Koenen, Hans J. P. M.; Joosten, Irma			A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VIVO; CUTTING EDGE; RAPAMYCIN; EXPRESSION; INDUCTION; STABILITY; PHENOTYPE; PRESERVES; MECHANISM	Regulatory T cells (Treg) are important for immune homeostasis and are considered of great interest for immunotherapy. The paucity of Treg numbers requires the need for ex vivo expansion. Although therapeutic Treg flow-sorting is feasible, most centers aiming at Treg-based therapy focus on magnetic bead isolation of CD4+CD25+ Treg using a good manufacturing practice compliant closed system that achieves lower levels of cell purity. Polyclonal Treg expansion protocols commonly use anti-CD3 plus anti-CD28 monoclonal antibody (mAb) stimulation in the presence of rhIL-2, with or without rapamycin. However, the resultant Treg population is often heterogeneous and pro-inflammatory cytokines like IFN gamma and IL-17A can be produced. Hence, it is crucial to search for expansion protocols that not only maximize ex vivo Treg proliferative rates, but also maintain Treg stability and preserve their suppressive function. Here, we show that ex vivo expansion of low purity magnetic bead isolated Treg in the presence of a TNFR2 agonist mAb (TNFR2-agonist) together with rapamycin, results in a homogenous stable suppressive Treg population that expresses FOXP3 and Helios, shows low expression of CD127 and hypo-methylation of the FOXP3 gene. These cells reveal a low IL-17A and IFN gamma producing potential and hardly express the chemokine receptors CCR6, CCR7 and CXCR3. Restimulation of cells in a pro-inflammatory environment did not break the stability of this Treg population. In a preclinical humanized mouse model, the TNFR2-agonist plus rapamycin expanded Treg suppressed inflammation in vivo. Importantly, this Treg expansion protocol enables the use of less pure, but more easily obtainable cell fractions, as similar outcomes were observed using either FACS-sorted or MACS-isolated Treg. Therefore, this protocol is of great interest for the ex vivo expansion of Treg for clinical immunotherapy.	[He, Xuehui; Landman, Sija; Koenen, Hans J. P. M.; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands; [Bauland, Stijn C. G.] Sanavisie Bodyclin, Mill, Netherlands; [van den Dolder, Juliette] Hycult Biotech, Uden, Netherlands	Radboud University Nijmegen	Joosten, I (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands.	Irma.Joosten@radboudumc.nl	Koenen, Hans J.P.M./A-2852-2014; He, Xuehui/Q-1562-2015; Joosten, Irma/N-4418-2013	He, Xuehui/0000-0002-3801-4091; Joosten, Irma/0000-0003-2950-4977	Sanavisie Bodyclinic; Hycult Biotech;  [NSFC61263039];  [NSFC11101321]	Sanavisie Bodyclinic; Hycult Biotech; ; 	The funders (Sanavisie Bodyclinic and Hycult Biotech) provided support in the form of offering research materials e.g. human skins or TNFR2-agonist for authors (XH, SL, HJPM, and IJ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The scientific roles of these authors are articulated in the "Author Contributions" section. XH is also supported by NSFC61263039 and NSFC11101321.	Annunziato F, 2002, J EXP MED, V196, P379, DOI 10.1084/jem.20020110; Ashley CW, 2009, J IMMUNOL, V183, P4843, DOI 10.4049/jimmunol.0900845; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Battaglia M, 2012, METHODS MOL BIOL, V821, P279, DOI 10.1007/978-1-61779-430-8_17; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Chen X, 2010, EUR J IMMUNOL, V40, P1099, DOI 10.1002/eji.200940022; Coenen JJA, 2006, BLOOD, V107, P1018, DOI 10.1182/blood-2005-07-3032; de Oliveira VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045509; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; He XH, 2014, J INVEST DERMATOL, V134, P975, DOI 10.1038/jid.2013.459; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Koenen HJPM, 2005, J IMMUNOL, V174, P7573, DOI 10.4049/jimmunol.174.12.7573; Kreijveld E, 2007, BLOOD, V109, P244, DOI 10.1182/blood-2006-05-021931; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Miller PG, 2015, J IMMUNOL, V195, P2633, DOI 10.4049/jimmunol.1500286; Mougiakakos D, 2011, BLOOD, V117, P857, DOI 10.1182/blood-2010-09-307041; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; Nagar M, 2010, J IMMUNOL, V184, P3570, DOI 10.4049/jimmunol.0902070; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Okubo Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03153; Pahwa R, 2010, J IMMUNOL METHODS, V363, P67, DOI 10.1016/j.jim.2010.10.006; Peters JH, 2013, BLOOD, V122, P2213, DOI 10.1182/blood-2013-03-489443; Peters JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003161; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Scotta C, 2013, HAEMATOLOGICA, V98, P1291, DOI 10.3324/haematol.2012.074088; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Singer BD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00046; Singh K, 2012, AM J TRANSPLANT, V12, P1441, DOI 10.1111/j.1600-6143.2011.03963.x; Tresoldi E, 2011, HAEMATOL-HEMATOL J, V96, P1357, DOI 10.3324/haematol.2011.041483; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	38	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156311	10.1371/journal.pone.0156311	http://dx.doi.org/10.1371/journal.pone.0156311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224512	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700084
J	Rodriguez-Gamir, J; Primo-Millo, E; Forner-Giner, MA				Rodriguez-Gamir, Juan; Primo-Millo, Eduardo; Angeles Forner-Giner, Maria			An Integrated View of Whole-Tree Hydraulic Architecture. Does Stomatal or Hydraulic Conductance Determine Whole Tree Transpiration?	PLOS ONE			English	Article							VAPOR-PRESSURE DEFICIT; LEAF GAS-EXCHANGE; WATER RELATIONS; AQUAPORIN EXPRESSION; MINERAL-NUTRITION; LOBLOLLY-PINE; ROOT PRESSURE; CITRUS TREES; APPLE-TREES; GROWTH	Hydraulic conductance exerts a strong influence on many aspects of plant physiology, namely: transpiration, CO2 assimilation, growth, productivity or stress response. However we lack full understanding of the contribution of root or shoot water transport capacity to the total water balance, something which is difficult to study in trees. Here we tested the hypothesis that whole plant hydraulic conductance modulates plant transpiration using two different seedlings of citrus rootstocks, Poncirus trifoliata (L.) Raf. and Cleopatra mandarin (Citrus reshni Hort ex Tan.). The two genotypes presented important differences in their root or shoot hydraulic conductance contribution to whole plant hydraulic conductance but, even so, water balance proved highly dependent on whole plant conductance. Further, we propose there is a possible equilibrium between root and shoot hydraulic conductance, similar to that between shoot and root biomass production, which could be related with xylem anatomy.	[Rodriguez-Gamir, Juan; Primo-Millo, Eduardo; Angeles Forner-Giner, Maria] Valencian Inst Agr Res, Dept Citriculture & Vegetal Prod, Valencia, Spain		Forner-Giner, MA (corresponding author), Valencian Inst Agr Res, Dept Citriculture & Vegetal Prod, Valencia, Spain.	former_margin@gva.es	Forner-Giner, Angeles/D-5306-2014; Primo-Millo, Eduardo/D-8584-2014	Forner-Giner, Angeles/0000-0003-3237-0893; Primo-Millo, Eduardo/0000-0002-2146-0175; Rodriguez Gamir, Juan/0000-0002-0874-0463	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria [RTA2014-00059]; Generalitat Valenciana; FEDER funds	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA)); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); FEDER funds(European Commission)	This work was funded by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (RTA2014-00059), Generalitat Valenciana and FEDER funds.	Forner-Giner MA, 2009, J AM POMOL SOC, V63, P72; BRISSON N, 1993, PLANT SOIL, V154, P227, DOI 10.1007/BF00012528; Brodribb TJ, 2008, PLANT CELL ENVIRON, V31, P1557, DOI 10.1111/j.1365-3040.2008.01865.x; Brodribb TJ, 2000, PLANT CELL ENVIRON, V23, P1381, DOI 10.1046/j.1365-3040.2000.00647.x; Brodribb TJ, 2005, NEW PHYTOL, V165, P839, DOI 10.1111/j.1469-8137.2004.01259.x; Brodribb TJ, 2002, PLANT CELL ENVIRON, V25, P1435, DOI 10.1046/j.1365-3040.2002.00919.x; Buckley TN, 2005, NEW PHYTOL, V168, P275, DOI 10.1111/j.1469-8137.2005.01543.x; Bunce JA, 2006, PLANT CELL ENVIRON, V29, P1644, DOI 10.1111/j.1365-3040.2006.01541.x; CASTLE WS, 1977, J AM SOC HORTIC SCI, V102, P403; Clearwater MJ, 2007, J EXP BOT, V58, P1741, DOI 10.1093/jxb/erm029; Cochard H, 1996, ANN SCI FOREST, V53, P197, DOI 10.1051/forest:19960203; Cohen S, 2002, PLANT CELL ENVIRON, V25, P17, DOI 10.1046/j.1365-3040.2002.00795.x; Cohen S, 2007, J EXP BOT, V58, P4213, DOI 10.1093/jxb/erm281; Dewar RC, 2002, PLANT CELL ENVIRON, V25, P1383, DOI 10.1046/j.1365-3040.2002.00909.x; Domec JC, 2006, PLANT CELL ENVIRON, V29, P26, DOI 10.1111/j.1365-3040.2005.01397.x; Domec JC, 2009, PLANT CELL ENVIRON, V32, P1500, DOI 10.1111/j.1365-3040.2009.02014.x; Domec JC, 2009, PLANT CELL ENVIRON, V32, P980, DOI 10.1111/j.1365-3040.2009.01981.x; Fichot R, 2011, J EXP BOT, V62, P2093, DOI 10.1093/jxb/erq415; Fletcher AL, 2007, ENVIRON EXP BOT, V61, P145, DOI 10.1016/j.envexpbot.2007.05.004; Goncalves B, 2007, TREES-STRUCT FUNCT, V21, P121, DOI 10.1007/s00468-006-0102-2; Hacke UG, 2010, TREE PHYSIOL, V30, P1016, DOI 10.1093/treephys/tpq058; Henzler T, 1999, PLANTA, V210, P50, DOI 10.1007/s004250050653; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hubbard RM, 2001, PLANT CELL ENVIRON, V24, P113, DOI 10.1046/j.1365-3040.2001.00660.x; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Laur J, 2013, J EXP BOT, V64, P2283, DOI 10.1093/jxb/ert096; Lo Gullo MA, 2003, PLANT SOIL, V250, P259, DOI 10.1023/A:1022840103573; Maherali H, 2003, PLANT CELL ENVIRON, V26, P1297, DOI 10.1046/j.1365-3040.2003.01054.x; Manzoni S, 2013, NEW PHYTOL, V198, P169, DOI 10.1111/nph.12126; Martinez-Alcantara B, 2012, TREES-STRUCT FUNCT, V27, P629; Martorell S, 2014, PLANT CELL ENVIRON, V37, P617, DOI 10.1111/pce.12182; Marykate ZB, 2013, TREE PHYSIOL, V31, P508; Medina Camilo Lazaro, 1998, Bragantia, V57, P15; MEINZER FC, 1990, PLANT CELL ENVIRON, V13, P383, DOI 10.1111/j.1365-3040.1990.tb02142.x; Meinzer FC, 2010, OECOLOGIA, V164, P287, DOI 10.1007/s00442-010-1734-x; Mencuccini M, 2003, PLANT CELL ENVIRON, V26, P163, DOI 10.1046/j.1365-3040.2003.00991.x; MONTEITH JL, 1995, PLANT CELL ENVIRON, V18, P357, DOI 10.1111/j.1365-3040.1995.tb00371.x; Nardini A, 2000, TREES-STRUCT FUNCT, V15, P14, DOI 10.1007/s004680000071; Nardini A, 2006, TREE PHYSIOL, V26, P1137, DOI 10.1093/treephys/26.9.1137; Olmstead MA, 2006, J AM SOC HORTIC SCI, V131, P577, DOI 10.21273/JASHS.131.5.577; Ounapuu E, 2013, PLANT PHYSIOL BIOCH, V68, P104, DOI 10.1016/j.plaphy.2013.04.011; Pearcy R. W., 1989, Plant physiological ecology: field methods and instrumentation., P137; Perrone I, 2012, PLANT PHYSIOL, V160, P965, DOI 10.1104/pp.112.203455; Pratt RB, 2010, FUNCT ECOL, V24, P70, DOI 10.1111/j.1365-2435.2009.01613.x; Quentin AG, 2012, TREE PHYSIOL, V32, P958, DOI 10.1093/treephys/tps066; Rodriguez-Gamir J, 2012, ENVIRON EXP BOT, V78, P163, DOI 10.1016/j.envexpbot.2011.12.027; Rodriguez-Gamir J, 2011, PLANT SOIL, V347, P91, DOI 10.1007/s11104-011-0826-7; Rodriguez-Gamir J, 2010, PHYSIOL PLANTARUM, V139, P159, DOI 10.1111/j.1399-3054.2010.01351.x; Romero P, 2006, TREE PHYSIOL, V26, P1537, DOI 10.1093/treephys/26.12.1537; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2005, NEW PHYTOL, V167, P403, DOI 10.1111/j.1469-8137.2005.01432.x; Sadok W, 2010, J EXP BOT, V61, P821, DOI 10.1093/jxb/erp350; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Sinclair TR, 2008, PHYSIOL PLANTARUM, V132, P446, DOI 10.1111/j.1399-3054.2007.01028.x; Solari LI, 2006, TREE PHYSIOL, V26, P1343, DOI 10.1093/treephys/26.10.1343; SPERRY JS, 1993, J EXP BOT, V44, P1075, DOI 10.1093/jxb/44.6.1075; Steudle E, 2000, J EXP BOT, V51, P1531, DOI 10.1093/jexbot/51.350.1531; Steudle E, 2001, ANNU REV PLANT PHYS, V52, P847, DOI 10.1146/annurev.arplant.52.1.847; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Syvertsen J.P., 1994, HDB ENV PHYSL FRUIT, P65; SYVERTSEN JP, 1985, J AM SOC HORTIC SCI, V110, P865; SYVERTSEN JP, 1988, J AM SOC HORTIC SCI, V113, P889; Tadeo FR, 1997, PLANTA, V202, P370, DOI 10.1007/s004250050139; Tombesi S, 2010, ANN BOT-LONDON, V105, P327, DOI 10.1093/aob/mcp281; Tsuda M, 2000, J EXP BOT, V51, P823, DOI 10.1093/jexbot/51.345.823; Tsuda M, 1997, TREE PHYSIOL, V17, P351; TYREE MT, 1994, IAWA J, V15, P335, DOI 10.1163/22941932-90001369; Tyree MT, 2003, TREES-STRUCT FUNCT, V17, P95, DOI 10.1007/s00468-002-0227-x; TYREE MT, 1995, J EXP BOT, V46, P83, DOI 10.1093/jxb/46.1.83; Tyree MT, 1998, OECOLOGIA, V114, P293, DOI 10.1007/s004420050450; Weatherley P.E., 1982, ENCY PLANT PHYSL N B, P79; YAMADA S, 1995, PLANT CELL, V7, P1129, DOI 10.1105/tpc.7.8.1129; YANG SD, 1993, TREE PHYSIOL, V12, P231, DOI 10.1093/treephys/12.3.231; ZEKRI M, 1989, PHYSIOL PLANTARUM, V77, P99, DOI 10.1111/j.1399-3054.1989.tb05984.x	75	13	13	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155246	10.1371/journal.pone.0155246	http://dx.doi.org/10.1371/journal.pone.0155246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223695	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700018
J	Masoompour, SM; Lankarani, KB; Honarvar, B; Tabatabaee, SH; Moghadami, M; Khosravizadegan, Z				Masoompour, Seyed Masoom; Lankarani, Kamran B.; Honarvar, Behnam; Tabatabaee, Seyed Hamidreza; Moghadami, Mohsen; Khosravizadegan, Zahra			Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study	PLOS ONE			English	Article							BLADDER-CANCER; REGISTRY; MORTALITY; TUMORS; RISK	We have evaluated the ever changing epidemiology of cancers in Fars province, Iran since the re-establishment of Fars cancer registry. Based on the collected data from all related sources in Fars province from 2007-2010 we calculated the cancer age-standardized rates per 100,000 person-years (ASRs). The results are presented as incidence rates of cases by site according to the International Classification of Diseases for Oncology (ICD-O), sex, age, crude rate, and ASRs. In women the total ASR was 41.70 per 100,000 from 1985-1989 which had increased to 55.50 and 95.46 during 1998-2002 and 2007-2010. The incidence of breast cancer in women during 2007-2010 was about two and four times higher than 1998-2002 and 1985-1989. The incidence of colorectal cancer in women during 2007-2010 was about three and five times higher than 1998-2002 and 1985-1989. In men the total ASR was 62.9 per 100,000 in 1985-1989 that increased to 64.50 and 101.48 during 1998-2002 and 2007-2010. Although stomach cancer was the most common cancer among men during 1985-1989 and 1998-2002, but in recent study bladder cancer was the most common cancer among men in Fars province. The incidence of colorectal cancer in men during 2007-2010 was about three times higher than 1998-2002 and 1985-1989. This study shows growing incidence of cancer in southern Iran. The colorectal cancer in both genders had increased and its pattern is similar to western countries. In men, bladder and prostate cancers had a growing rate and the incidences of these cancers in the present study were greater than stomach cancer.	[Masoompour, Seyed Masoom] Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz 7134845794, Iran; [Lankarani, Kamran B.; Honarvar, Behnam] Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz 7134845794, Iran; [Tabatabaee, Seyed Hamidreza] Shiraz Univ Med Sci, Sch Hlth, Dept Epidemiol, Shiraz 7134845794, Iran; [Moghadami, Mohsen] Shiraz Univ Med Sci, HIV AIDS Res Ctr, Shiraz 7134845794, Iran; [Khosravizadegan, Zahra] Shiraz Univ Med Sci, Dept Canc Surveillance, Deputy Hlth, Shiraz 7134845794, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Lankarani, KB (corresponding author), Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz 7134845794, Iran.	lankaran@sums.ac.ir	Lankarani, Kamran B/P-5336-2019; Honarvar, Behnam/K-1623-2013; lankarani, kamran b/D-5901-2012; moghadami, mohsen/T-6539-2018; Masoompour, Seyed Masoom/B-8165-2018; Lankarani, Kamran Bagheri/P-2066-2017	Lankarani, Kamran B/0000-0002-7524-9017; Honarvar, Behnam/0000-0002-1081-5778; moghadami, mohsen/0000-0001-8015-0313; Masoompour, Seyed Masoom/0000-0002-0129-7155; Lankarani, Kamran Bagheri/0000-0002-7524-9017; Khosravizadegan, Zahra/0000-0001-6768-2585	Shiraz University of Medical Sciences [93-01-62-9098]	Shiraz University of Medical Sciences	We would like to thank all cancer registry data providers in Fars province, especially the staff of the Cancer Surveillance Department of the Deputy of Health at Shiraz University of Medical Sciences. The authors wish to thank the deputy chancellor of Shiraz University of Medical Sciences for approving the proposal of project (number 93-01-62-9098, Shiraz University of Medical Sciences). The authors would like to thank the Research Consultation Center (RCC) for their invaluable assistance in editing this article.	Aliasgari M A, 2004, Urol J, V1, P253; [Anonymous], 2010, GLOBOCAN 2008 CANC I; Babaei M, 2009, IRAN J PUBLIC HEALTH, V38, P35; Belpomme D, 2007, INT J ONCOL, V30, P1037; BOFFETTA P, 1994, CA-CANCER J CLIN, V44, P81, DOI 10.3322/canjclin.44.2.81; Etemadi Arash, 2008, Arch Iran Med, V11, P577; Farshad S., 2010, Iranian Journal of Clinical Infectious Diseases, V5, P65; Fritz PA, 2000, INT CLASSIFICATION D; Groves F D, 1994, Curr Opin Hematol, V1, P321; Islami F, 2014, EUR UROL, V66, P1054, DOI 10.1016/j.eururo.2014.08.059; Izquierdo JN, 2000, AM J PUBLIC HEALTH, V90, P695, DOI 10.2105/AJPH.90.5.695; Jakszyn P, 2006, WORLD J GASTROENTERO, V12, P4296, DOI 10.3748/wjg.v12.i27.4296; Jazayeri SB, 2013, ASIAN PAC J CANCER P, V14, P3979, DOI 10.7314/APJCP.2013.14.6.3979; Jemal Ahmedin, 2009, V471, P3, DOI 10.1007/978-1-59745-416-2_1; Jensen OM, 1991, CANC REGISTRATION PR; Kuipers EJ, 1999, ALIMENT PHARM THERAP, V13, P3, DOI 10.1046/j.1365-2036.1999.00002.x; Lankarani KB, 2002, IRAN J MED SCI, V1, P10; Madeb R, 2004, UROL ONCOL-SEMIN ORI, V22, P86, DOI 10.1016/S1078-1439(03)00139-X; Maryam Zakerinia, 2015, Asian Pac J Cancer Prev, V16, P239; Masoompour SM, 2011, CANCER EPIDEMIOL, V35, pE42, DOI 10.1016/j.canep.2011.05.018; McKinney PA, 2005, BIOELECTROMAGNETICS, pS60, DOI 10.1002/bem.20149; Mousavi SM, 2009, ASIAN PAC J CANCER P, V10, P413; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Peterson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029177; Pishdad GR, 1996, INT J OBESITY, V20, P963; Pourhoseingholi Asma, 2012, Gastroenterol Hepatol Bed Bench, V5, P54; Roshandel G, 2012, ARCH IRAN MED, V15, P196, DOI 012154/AIM.004; Saalabian MJ, 1990, REGISTRY NEOPLASTIC; Salehi A, 2011, ASIAN PAC J CANCER P, V12, P1323; Somi MH, 2008, ASIAN PAC J CANCER P, V9, P327; Statistical Center of Iran, 1999, STAT CTR IR IR STAT; Statistical Center of Iran, 2009, STAT CTR IR IR STAT; Talaiezadeh A, 2013, ASIAN PAC J CANCER P, V14, P7517, DOI 10.7314/APJCP.2013.14.12.7517; da Costa LAV, 2008, EINSTEIN-SAO PAULO, V6, P507; Yavari P, 2009, ASIAN PAC J CANCER P, V10, P681	35	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155669	10.1371/journal.pone.0155669	http://dx.doi.org/10.1371/journal.pone.0155669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219458	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700011
J	Anderson, K; Burford, O; Emmerton, L				Anderson, Kevin; Burford, Oksana; Emmerton, Lynne			Mobile Health Apps to Facilitate Self-Care: A Qualitative Study of User Experiences	PLOS ONE			English	Article							TECHNOLOGY ACCEPTANCE; YOUNG-PEOPLE; MANAGEMENT; ASTHMA; LITERACY; INTERVENTION; PROTOCOL; PROGRAM; MODEL; RISK	Objective Consumers are living longer, creating more pressure on the health system and increasing their requirement for self-care of chronic conditions. Despite rapidly-increasing numbers of mobile health applications ('apps') for consumers' self-care, there is a paucity of research into consumer engagement with electronic self-monitoring. This paper presents a qualitative exploration of how health consumers use apps for health monitoring, their perceived benefits from use of health apps, and suggestions for improvement of health apps. Materials and Methods 'Health app' was defined as any commercially-available health or fitness app with capacity for self-monitoring. English-speaking consumers aged 18 years and older using any health app for self-monitoring were recruited for interview from the metropolitan area of Perth, Australia. The semi-structured interview guide comprised questions based on the Technology Acceptance Model, Health Information Technology Acceptance Model, and the Mobile Application Rating Scale, and is the only study to do so. These models also facilitated deductive thematic analysis of interview transcripts. Implicit and explicit responses not aligned to these models were analyzed inductively. Results Twenty-two consumers (15 female, seven male) participated, 13 of whom were aged 26-35 years. Eighteen participants reported on apps used on iPhones. Apps were used to monitor diabetes, asthma, depression, celiac disease, blood pressure, chronic migraine, pain management, menstrual cycle irregularity, and fitness. Most were used approximately weekly for several minutes per session, and prior to meeting initial milestones, with significantly decreased usage thereafter. Deductive and inductive thematic analysis reduced the data to four dominant themes: engagement in use of the app; technical functionality of the app; ease of use and design features; and management of consumers' data. Conclusions The semi-structured interviews provided insight into usage, benefits and challenges of health monitoring using apps. Understanding the range of consumer experiences and expectations can inform design of health apps to encourage persistence in self-monitoring.	[Anderson, Kevin; Burford, Oksana; Emmerton, Lynne] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia	Curtin University	Emmerton, L (corresponding author), Curtin Univ, Sch Pharm, Perth, WA 6845, Australia.	lynne.emmerton@curtin.edu.au		Anderson, Kevin/0000-0001-7324-491X				Anderson K, 2016, AUST HEALTH REV, V40, P591, DOI 10.1071/AH15162; Android, 2016, LAUNCH CHECKL; Antezana G, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4098; Apple, 2015, APP STOR REV GUID; Baker DW, 1998, J GEN INTERN MED, V13, P791, DOI 10.1046/j.1525-1497.1998.00242.x; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; BECKER MH, 1978, PUBLIC HEALTH REP, V93, P268; Blodt S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-490; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Briz-Ponce L, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0352-x; Burt RS, 2005, BROKERAGE CLOSURE IN; Chiang LC, 2004, J ASTHMA, V41, P205, DOI 10.1081/JAS-120026078; Cho J, 2014, AM J HEALTH BEHAV, V38, P860, DOI 10.5993/AJHB.38.6.8; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Cooper S, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0546-4; Cormier DJ, 2006, J CARDIOPULM REHABIL, V26, P250, DOI [10.1097/00008483-200607000-00015, DOI 10.1097/00008483-200607000-00015]; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Doherty G, 2010, INTERACT COMPUT, V22, P243, DOI 10.1016/j.intcom.2010.02.006; Dolan B, 2014, RISE SEEMINGLY SERIO; Dumas RA, 2014, HLTH APP COMPLETELY; Elias Pierre, 2013, Med 2 0, V2, pe1, DOI 10.2196/med20.2014; Eyles H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-950; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Finkelstein EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099572; Fishbein M, 2007, PREDICTION CHANGE HL; Gill PS, 2012, RISK MANAG HEALTHC P, V5, P105, DOI 10.2147/RMHP.S34813; Green J, 2009, QUALITATIVE METHODS; Green L, 2014, PRECEDE PROCEED MODE; Hasford J, 2010, ALLERGY, V65, P347, DOI 10.1111/j.1398-9995.2009.02161.x; Haug S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1140; Hebly P, 2012, THESIS ERASMUS U ROT; Hesse-Biber S. N., 2010, PRACTICE QUALITATIVE; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; Holman H, 2004, PUBLIC HEALTH REP, V119, P239, DOI 10.1016/j.phr.2004.04.002; Host T, 2014, HLTH MARKET VALIDATI; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jeon E, 2015, HEALTHC INFORM RES, V21, P10, DOI 10.4258/hir.2015.21.1.10; Jin BS, 2010, COMPUT IND, V61, P350, DOI 10.1016/j.compind.2009.12.006; Kenny R, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.4370; Kim J, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2143; Kirwan M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2588; Korhonen I, 2003, IEEE ENG MED BIOL, V22, P66, DOI 10.1109/MEMB.2003.1213628; Krebs P, 2015, JMIR MHEALTH UHEALTH, V3, P107, DOI 10.2196/mhealth.4924; Licskai CJ, 2013, CAN RESPIR J, V20, P301, DOI 10.1155/2013/906710; Lister C, 2014, JMIR SERIOUS GAMES, V2, P51, DOI 10.2196/games.3413; Liu WT, 2011, EUR RESPIR J, V37, P310, DOI 10.1183/09031936.00000810; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; MADDEN TJ, 1992, PERS SOC PSYCHOL B, V18, P3, DOI 10.1177/0146167292181001; McCarroll ML, 2015, GYNECOL ONCOL, V137, P508, DOI 10.1016/j.ygyno.2014.12.025; Miller KM, 2013, DIABETES CARE, V36, P2009, DOI 10.2337/dc12-1770; Morrison LG, 2014, J MED INTERNET RES, V16, P43, DOI 10.2196/jmir.3579; Nilges P, 2007, SCHMERZ, V21, P57, DOI 10.1007/s00482-006-0508-1; OptumHealth, 2010, OPTUMHEALTH DEB OPTU; Pan D, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3956; Pandey A, 2013, J CANCER EDUC, V28, P138, DOI 10.1007/s13187-012-0446-9; Phillips D.N., 2000, POSTPOSITIVISM ED RE; Proudfoot J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-312; Radcliffe C, 2003, MED EDUC, V37, P32, DOI 10.1046/j.1365-2923.2003.01405.x; Ryan D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1756; Scheibe Madlen, 2015, Med 2 0, V4, pe1, DOI 10.2196/med20.3912; Stoyanov SR, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3422; Thomas O., 2014, APPLES HLTH APP IS E; Underwood B, 2015, BR DENT J, V219, P7; Velsor-Friedrich Barbara, 2005, J Pediatr Health Care, V19, P163, DOI 10.1016/j.pedhc.2004.12.002; Wiederhold BK, 2013, CYBERPSYCH BEH SOC N, V16, P411, DOI 10.1089/cyber.2013.1520; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Williams MV, 1998, CHEST, V114, P1008, DOI 10.1378/chest.114.4.1008; Yarbrough AK, 2007, MED CARE RES REV, V64, P650, DOI 10.1177/1077558707305942; Zichermann G., 2011, GAMIFICATION DESIGN	69	146	147	7	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156164	10.1371/journal.pone.0156164	http://dx.doi.org/10.1371/journal.pone.0156164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2FT	27214203	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200064
J	Kweon, SM; Chi, F; Higashiyama, R; Lai, K; Tsukamoto, H				Kweon, Soo-Mi; Chi, Feng; Higashiyama, Reiichi; Lai, Keane; Tsukamoto, Hidekazu			Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-gamma in Activation of Hepatic Stellate Cells	PLOS ONE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; LIVER FIBROSIS; CRUCIAL ROLE; PROLIFERATION; INHIBITION; GROWTH; PLAYS	PPAR-gamma is essential for differentiation of hepatic stellate cells (HSC), and its loss due to epigenetic repression by methyl-CpG binding protein 2 (MeCP2) causes HSC myofibroblastic activation mediated in part via Wnt pathway, the key cellular event in liver fibrosis. Decreased miR-132 was previously proposed to promote MeCP2 protein translation for Ppar-gamma repression in activated HSC (aHSC). The present study aimed to test this notion and to better understand the mechanisms of MeCP2 upregulation in aHSC. MeCP2 protein is increased on day 3 to 7 as HSC become activated in primary culture on plastic, but this is accompanied by increased but not reduced miR-132 or miR-212 which is also expected to target MeCP2 due to its similar sequence with miR-132. The levels of these mRNAs are decreased 40 similar to 50% in aHSCs isolated from experimental cholestatic liver fibrosis but increased 6-8 fold in aHSC from hepatotoxic liver fibrosis in rats. Suppression of either or both of miR132 and miR212 with specific anti-miRNA oligonucleotides (anti-oligo), does not affect MeCP2 protein levels in aHSCs. The Wnt antagonist FJ9 which inhibits HSC activation, increases miR-132/miR-212, reduces MeCP2 and its enrichment at 5' Ppar-gamma promoter, and restores Ppar-gamma expression but the anti-oligo do not prevent Ppar-gamma upregulation. The pan-NADPH oxidase (NOX) inhibitor diphenyleneiodonium (DPI) also reduces both MeCP2 and stabilized non-(S33/S37/Thr41)-phospho beta-catenin and reverts aHSC to quiescent cells but do not affect miR-132/miR-212 levels. Wnt antagonism with FJ9 increases MeCP2 protein degradation in cultured HSC, and FJ9-mediated loss of MeCP2 is rescued by leupeptin but not by proteasome and lysozome inhibitors. In conclusion, canonical Wnt pathway increases MeCP2 protein due to protein stability which in turn represses Ppar-gamma and activates HSC.	[Kweon, Soo-Mi; Chi, Feng; Higashiyama, Reiichi; Lai, Keane; Tsukamoto, Hidekazu] Univ So Calif, Dept Pathol, Southern Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90089 USA; [Tsukamoto, Hidekazu] Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA USA	University of Southern California	Tsukamoto, H (corresponding author), Univ So Calif, Dept Pathol, Southern Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90089 USA.; Tsukamoto, H (corresponding author), Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA USA.	htsukamo@usc.edu			National Institute on Alcohol Abuse and Alcoholism [P50AA011999, U01AA018663, R24AA12885]; Medical Research Service of Department of Veterans Affairs [5I01BX001991]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885, U01AA018663, P50AA011999] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001991] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Service of Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by National Institute on Alcohol Abuse and Alcoholism, http://www.niaaa.nih.gov (P50AA011999 to HT); National Institute on Alcohol Abuse and Alcoholism, http://www.niaaa.nih.gov (U01AA018663 to HT); National Institute on Alcohol Abuse and Alcoholism, http://www.niaaa.nih.gov (R24AA12885 to HT); Medical Research Service of Department of Veterans Affairs, http://www.va.gov/ (5I01BX001991 to HT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2005, HEPATOLOGY, V41, P1272, DOI 10.1002/hep.20719; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bellini E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00236; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Cui WH, 2011, HEPATOLOGY, V54, P949, DOI 10.1002/hep.24465; De Minicis S, 2008, HEPATOLOGY, V48, P2016, DOI 10.1002/hep.22560; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; Hellerbrand C, 1998, HEPATOLOGY, V27, P1285, DOI 10.1002/hep.510270514; Hoshiko S, 2013, CANCER RES, V73, P2659, DOI 10.1158/0008-5472.CAN-12-3337; Jiang JX, 2010, GASTROENTEROLOGY, V139, P1375, DOI 10.1053/j.gastro.2010.05.074; Kajla S, 2012, FASEB J, V26, P2049, DOI 10.1096/fj.11-196360; Lan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129743; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Sun J, 2015, J NEURO-ONCOL, V122, P481, DOI 10.1007/s11060-015-1753-x; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Thambirajah AA, 2009, BIOESSAYS, V31, P561, DOI 10.1002/bies.200800220; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105; Zhu NL, 2010, J BIOL CHEM, V285, P30463, DOI 10.1074/jbc.M110.156703; Zhu NL, 2012, JBIOLCHEM	27	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156111	10.1371/journal.pone.0156111	http://dx.doi.org/10.1371/journal.pone.0156111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214381	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200055
J	Leesombun, A; Boonmasawai, S; Shimoda, N; Nishikawa, Y				Leesombun, Arpron; Boonmasawai, Sookruetai; Shimoda, Naomi; Nishikawa, Yoshifumi			Effects of Extracts from Thai Piperaceae Plants against Infection with Toxoplasma gondii	PLOS ONE			English	Article							EURYCOMA-LONGIFOLIA JACK; IN-VITRO; ANTIMALARIAL ACTIVITIES; BETLE; PARASITE; PROTEIN; ROOT; VIVO; L.	Herbal medicines and natural herb extracts are widely used as alternative treatments for various parasitic diseases, and such extracts may also have potential to decrease the side effects of the standard regimen drugs used to treat toxoplasmosis (sulfadiazine-pyrimethamine combination). We evaluated how effective the Thai piperaceae plants Piper betle, P. nigrum and P. sarmentosum are against Toxoplasma gondii infection in vitro and in vivo. Individually, we extracted the piperaceae plants with ethanol, passed them through a rotary evaporator and then lyophilized them to obtain crude extracts for each one. The in vitro study indicated that the P. betle extract was the most effective extract at inhibiting parasite growth in HFF cells (IC50 on RH-GFP: 23.2 mu g/mL, IC50 on PLK-GFP: 21.4 mu g/mL). Further-more, treatment of experimental mice with the P. betle extract for 7 days after infection with 1,000 tachyzoites of the T. gondii PLK strain increased their survival (survival rates: 100% in 400 mg/kg-treated, 83.3% in 100 mg/kg-treated, 33.3% in 25 mg/kg-treated, 33.3% in untreated mice). Furthermore, treatment with 400 mg/kg of the P. betle extract resulted in 100% mouse survival following infection with 100,000 tachyzoites. The present study shows that P. betle extract has the potential to act as a medical plant for the treatment of toxoplasmosis.	[Leesombun, Arpron; Shimoda, Naomi; Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 0808555, Japan; [Boonmasawai, Sookruetai] Mahidol Univ, Fac Vet Sci, Dept Preclin & Appl Anim Sci, 999 Phutthamonthon Sai 4 Rd Salaya, Phutthamonthon Nakhonpat 73170, Thailand	Obihiro University of Agriculture & Veterinary Medicine; Mahidol University	Nishikawa, Y (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 0808555, Japan.	nisikawa@obihiro.ac.jp						Al-Adhroey AH, 2011, MOLECULES, V16, P107, DOI 10.3390/molecules16010107; Al-Zanbagi NA, 2009, J FAM COMMUNITY MED, V16, P59; Ali I, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-7; Arambewela LSR, 2005, J ETHNOPHARMACOL, V102, P239, DOI 10.1016/j.jep.2005.06.016; Atjanasuppat K, 2009, J ETHNOPHARMACOL, V123, P475, DOI 10.1016/j.jep.2009.03.010; Bagatela BS, 2013, NAT PROD RES, V27, P2202, DOI 10.1080/14786419.2013.821123; Bhalerao S. A., 2013, J PHARMACOGNOSY PHYT, V1, P10; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; Chaveerach A., 2006, Ethnobotany Research and Applications, V4, P223; Choochote Wej, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P33, DOI 10.1590/S0036-46652006000100007; de Oliveira TC, 2009, EXP PARASITOL, V122, P233, DOI 10.1016/j.exppara.2009.04.010; Dwivedi V., 2014, J PHARMACOGNOSY PHYT, V3, P93; El-Zawawy Lobna A., 2008, Journal of the Egyptian Society of Parasitology, V38, P185; Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009; EVANS PH, 1984, J AGR FOOD CHEM, V32, P1254, DOI 10.1021/jf00126a011; Fazal Farhan, 2014, Chin J Integr Med; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Jain V, 2015, STRUCTURE, V23, P819, DOI 10.1016/j.str.2015.02.011; Kavitha N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-91; Khanam Zakia, 2015, Journal of King Saud University Science, V27, P23, DOI 10.1016/j.jksus.2014.04.006; Koch A, 2005, J ETHNOPHARMACOL, V101, P95, DOI 10.1016/j.jep.2005.03.011; Maisuthisakul P, 2007, FOOD CHEM, V100, P1409, DOI 10.1016/j.foodchem.2005.11.032; McLeod R., 2014, CURR PEDIAT REP, V2, P166; Misra P, 2009, J MED MICROBIOL, V58, P1058, DOI 10.1099/jmm.0.009290-0; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nishikawa Y, 2003, INT J PARASITOL, V33, P1525, DOI 10.1016/S0020-7519(03)00204-2; Nishikawa Y, 2008, PARASITOL INT, V57, P219, DOI 10.1016/j.parint.2007.10.004; Pillai S, 2012, APCBEE PROC, V2, P92, DOI 10.1016/j.apcbee.2012.06.017; Rekha VPB, 2014, AM J ETHNOMED, V1, P276; Ruangnoo S., 2012, Journal of the Medical Association of Thailand, V95, P127; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; SCHOONDERMARKVANDEVEN E, 1995, ANTIMICROB AGENTS CH, V39, P763, DOI 10.1128/AAC.39.3.763; Scott Ian M., 2008, Phytochemistry Reviews, V7, P65, DOI 10.1007/s11101-006-9058-5; Sepulveda-Arias Juan C, 2014, Recent Pat Antiinfect Drug Discov, V9, P186; Sudmoon R, 2012, J MED PLANTS RES, V6, P1168, DOI DOI 10.5897/JMPR11.807; Suthanurak M., 2010, THAI PHARM, V32, P160; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; Thiengsusuk A, 2013, PARASITOL RES, V112, P1475, DOI 10.1007/s00436-013-3294-6; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004; Youn HJ, 2003, VET PARASITOL, V116, P7, DOI 10.1016/S0304-4017(03)00154-7	43	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156116	10.1371/journal.pone.0156116	http://dx.doi.org/10.1371/journal.pone.0156116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213575	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880200058
J	Cutting, KA; Cross, WF; Anderson, ML; Reese, EG				Cutting, Kyle A.; Cross, Wyatt F.; Anderson, Michelle L.; Reese, Elizabeth G.			Seasonal Change in Trophic Niche of Adfluvial Arctic Grayling (Thymallus arcticus) and Coexisting Fishes in a High-Elevation Lake System	PLOS ONE			English	Article							FRESH-WATER FISH; BIOLOGICAL INVASIONS; INTERSPECIFIC COMPETITION; HABITAT COMPRESSION; DISSOLVED-OXYGEN; STABLE-ISOTOPES; CLIMATE-CHANGE; RESOURCE USE; POPULATION; NITROGEN	Introduction of non-native species is a leading threat to global aquatic biodiversity. Competition between native and non-native species is often influenced by changes in suitable habitat or food availability. We investigated diet breadth and degree of trophic niche overlap for a fish assemblage of native and non-native species inhabiting a shallow, high elevation lake system. This assemblage includes one of the last remaining post-glacial endemic populations of adfluvial Arctic grayling (Thymallus arcticus) in the contiguous United States. We examined gut contents and stable isotope values of fish taxa in fall and spring to assess both short-(days) and long-term (few months) changes in trophic niches. We incorporate these short-term (gut contents) data into a secondary isotope analysis using a Bayesian statistical framework to estimate long-term trophic niche. Our data suggest that in this system, Arctic grayling share both a short-and long-term common food base with non-native trout of cutthroat x rainbow hybrid species (Oncorhynchus clarkia bouvieri x Oncorhynchus mykiss) and brook trout (Salvelinus fontinalis). In addition, trophic niche overlap among Arctic grayling, hybrid trout, and brook trout appeared to be stronger during spring than fall. In contrast, the native species of Arctic grayling, burbot (Lota lota), and suckers (Catostomus spp.) largely consumed different prey items. Our results suggest strong seasonal differences in trophic niche overlap among Arctic grayling and non-native trout, with a potential for greatest competition for food during spring. We suggest that conservation of endemic Arctic grayling in high-elevation lakes will require recognition of the potential for coexisting non-native taxa to impede well-intentioned recovery efforts.	[Cutting, Kyle A.] US Fish & Wildlife Serv, Red Rock Lakes Natl Wildlife Refuge, Lima, MT USA; [Cross, Wyatt F.; Reese, Elizabeth G.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Anderson, Michelle L.] Univ Montana, Dept Biol, Dillon, MT USA	United States Department of the Interior; US Fish & Wildlife Service; Montana State University System; Montana State University Bozeman; University of Montana System; University of Montana	Cutting, KA (corresponding author), US Fish & Wildlife Serv, Red Rock Lakes Natl Wildlife Refuge, Lima, MT USA.	kyle_cutting@fws.gov			U.S. Fish and Wildlife Service Inventory and Monitoring Program	U.S. Fish and Wildlife Service Inventory and Monitoring Program	The U.S. Fish and Wildlife Service Inventory and Monitoring Program provided financial support for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 2009, AQUAT ECOL, V43, P765, DOI 10.1007/s10452-009-9261-8; BARBOUR CD, 1974, AM NAT, V108, P473, DOI 10.1086/282927; Behnke RJ, 1992, AM FISH SOC MONO, V6; Behnke RJ, 2002, TROUT SALMON N AM; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; Buzby KM, 2004, CAN J FISH AQUAT SCI, V61, P1954, DOI 10.1139/F04-126; Catalan J, 2002, J PALEOLIMNOL, V28, P25, DOI 10.1023/A:1020315817235; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Clavero M, 2006, ECOL APPL, V16, P2313, DOI 10.1890/1051-0761(2006)016[2313:HDAIRO]2.0.CO;2; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Copp GH, 2005, J APPL ICHTHYOL, V21, P242, DOI 10.1111/j.1439-0426.2005.00690.x; Cote J, 2010, P ROY SOC LOND B BIO; Cross WF, 2013, ECOL MONOGR, V83, P311, DOI 10.1890/12-1727.1; Cucherousset J, 2011, FISHERIES, V36, P215, DOI 10.1080/03632415.2011.574578; CUNJAK RA, 1988, CAN J FISH AQUAT SCI, V45, P443, DOI 10.1139/f88-053; DAVIS JC, 1975, J FISH RES BOARD CAN, V32, P2295, DOI 10.1139/f75-268; Eby LA, 2002, CAN J FISH AQUAT SCI, V59, P952, DOI 10.1139/F02-067; Fausch KD, 2008, BIOL INVASIONS, V10, P685, DOI 10.1007/s10530-007-9162-5; Foley B, 2012, FRESHWATER BIOL, V57, P278, DOI 10.1111/j.1365-2427.2011.02662.x; Gido KB, 1999, FRESHWATER BIOL, V42, P387, DOI 10.1046/j.1365-2427.1999.444490.x; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Hanson P. C., 1997, WISCUT97001 U WISC S; Hayden B, 2015, FRESHWATER BIOL, V60, P1000, DOI 10.1111/fwb.12564; Helland IP, 2011, J ANIM ECOL, V80, P539, DOI 10.1111/j.1365-2656.2010.01793.x; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Huryn AD, 1998, OECOLOGIA, V115, P173, DOI 10.1007/s004420050505; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jeppesen E, 2012, HYDROBIOLOGIA, V694, P1, DOI 10.1007/s10750-012-1182-1; Katzman LM, 1998, THESIS; Kaya C.M., 1992, P MONT ACAD SCI, V52, P43; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; LEWIS WM, 1983, CAN J FISH AQUAT SCI, V40, P1779, DOI 10.1139/f83-207; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Macchi PJ, 2007, LIMNOLOGICA, V37, P76, DOI 10.1016/j.limno.2006.09.004; Manly B. F, 2006, RANDOMIZATION BOOTST, P70; MEEHAN WR, 1978, J FISH RES BOARD CAN, V35, P1359, DOI 10.1139/f78-212; MOGEN JT, 1996, THESIS MONTANA STATE; MORIN A, 1994, J N AM BENTHOL SOC, V13, P357, DOI 10.2307/1467365; Moyle P.B., 1986, Ecological Studies, P27; NELSON PH, 1954, J WILDLIFE MANAGE, V18, P324, DOI 10.2307/3797019; NORTHCOTE TG, 1995, REV FISH BIOL FISHER, V5, P141; Nowak GM, 2004, N AM J FISH MANAGE, V24, P624, DOI 10.1577/M03-033.1; Nykanen M, 2004, ARCH HYDROBIOL, V161, P417, DOI 10.1127/0003-9136/2004/0161-0417; Nykanen M., 2004, HABITAT SELECTION RI; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Peterson DP, 2009, CAN J FISH AQUAT SCI, V66, P1758, DOI 10.1139/F09-113; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Power M., 2008, POLAR LAKES RIVERS L, P249; PRAGER J, 1982, J COMP PHYSIOL, V148, P323, DOI 10.1007/BF00679017; PREJS A, 1987, OECOLOGIA, V71, P397, DOI 10.1007/BF00378713; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; R Core Development Team, R LANG ENV STAT COMP; RAJASILTA M, 1992, CAN J FISH AQUAT SCI, V49, P644, DOI 10.1139/f92-073; Ricca MA, 2007, CAN J ZOOL, V85, P40, DOI 10.1139/Z06-187; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; Sanchez-Hernandez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143016; SCHOENER TW, 1982, AM SCI, V70, P586; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Schreck C.B., 1997, P145; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Vitule JRS, 2009, FISH FISH, V10, P98, DOI 10.1111/j.1467-2979.2008.00312.x; Solomon CT, 2011, ECOLOGY, V92, P1115, DOI 10.1890/i0012-9658-92-5-1115; Stendera S, 2012, HYDROBIOLOGIA, V696, P1, DOI 10.1007/s10750-012-1183-0; Svensson E, 2014, J EXP MAR BIOL ECOL, V457, P173, DOI 10.1016/j.jembe.2014.04.014; United States Fish and Wildlife Service, 2009, COMPR CONS PLAN; Vincent RE, 1962, THESIS U MICHIGAN; Vitousek PM, 1996, AM SCI, V84, P468; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wright TF, 2010, ETHOL ECOL EVOL, V22, P393, DOI 10.1080/03949370.2010.505580; Xie S, 2000, J FISH BIOL, V57, P867, DOI 10.1006/jfbi.2000.1354	84	11	11	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0156187	10.1371/journal.pone.0156187	http://dx.doi.org/10.1371/journal.pone.0156187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27205901	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291500048
J	Park, B; Roy, B; Woo, MA; Palomares, JA; Fonarow, GC; Harper, RM; Kumar, R				Park, Bumhee; Roy, Bhaswati; Woo, Mary A.; Palomares, Jose A.; Fonarow, Gregg C.; Harper, Ronald M.; Kumar, Rajesh			Lateralized Resting-State Functional Brain Network Organization Changes in Heart Failure	PLOS ONE			English	Article							SMALL-WORLD; INSULAR CORTEX; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; ANATOMICAL NETWORKS; CONNECTIVITY; ARCHITECTURE; RESPONSES; LESIONS; HEALTH	Heart failure (HF) patients show brain injury in autonomic, affective, and cognitive sites, which can change resting-state functional connectivity (FC), potentially altering overall functional brain network organization. However, the status of such connectivity or functional organization is unknown in HF. Determination of that status was the aim here, and we examined region-to-region FC and brain network topological properties across the whole-brain in 27 HF patients compared to 53 controls with resting-state functional MRI procedures. Decreased FC in HF appeared between the caudate and cerebellar regions, olfactory and cerebellar sites, vermis and medial frontal regions, and precentral gyri and cerebellar areas. However, increased FC emerged between the middle frontal gyrus and sensorimotor areas, superior parietal gyrus and orbito/medial frontal regions, inferior temporal gyrus and lingual gyrus/cerebellar lobe/pallidum, fusiform gyrus and superior orbitofrontal gyrus and cerebellar sites, and within vermis and cerebellar areas; these connections were largely in the right hemisphere (p<0.005; 10,000 permutations). The topology of functional integration and specialized characteristics in HF are significantly changed in regions showing altered FC, an outcome which would interfere with brain network organization (p<0.05; 10,000 permutations). Brain dysfunction in HF extends to resting conditions, and autonomic, cognitive, and affective deficits may stem from altered FC and brain network organization that may contribute to higher morbidity and mortality in the condition. Our findings likely result from the prominent axonal and nuclear structural changes reported earlier in HF; protecting neural tissue may improve FC integrity, and thus, increase quality of life and reduce morbidity and mortality.	[Park, Bumhee; Palomares, Jose A.; Kumar, Rajesh] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90024 USA; [Roy, Bhaswati; Woo, Mary A.] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA; [Harper, Ronald M.; Kumar, Rajesh] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Harper, Ronald M.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Kumar, Rajesh] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Kumar, Rajesh] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kumar, R (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90024 USA.; Kumar, R (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.; Kumar, R (corresponding author), Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA.; Kumar, R (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA.	rkumar@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093; Roy, Bhaswati/0000-0001-6886-8349	National Institutes of Health [R01 NR-013625, R01 NR-014669]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014669, R01NR013625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by National Institutes of Health R01 NR-013625 and R01 NR-014669.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aggleton JP, 2005, EUR J NEUROSCI, V22, P2519, DOI 10.1111/j.1460-9568.2005.04450.x; Almeida OP, 2001, INTERN MED J, V31, P290, DOI 10.1046/j.1445-5994.2001.00067.x; Banzett RB, 2000, NEUROREPORT, V11, P2117, DOI 10.1097/00001756-200007140-00012; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; CECHETTO DF, 1990, AM J PHYSIOL, V258, pR245, DOI 10.1152/ajpregu.1990.258.1.R245; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cohen R.A., 2008, AM PSYCHIAT PUBLISHI, P405; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dubbelink KTEO, 2014, BRAIN, V137, P197, DOI 10.1093/brain/awt316; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Ferrier K, 2005, CHEST, V128, P2116, DOI 10.1378/chest.128.4.2116; Floras JS, 2003, ACTA PHYSIOL SCAND, V177, P391, DOI 10.1046/j.1365-201X.2003.01087.x; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Frick A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.85; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Henderson LA, 2004, J APPL PHYSIOL, V96, P693, DOI 10.1152/japplphysiol.00852.2003; Holmes MJ, 2002, BRAIN RES, V938, P62, DOI 10.1016/S0006-8993(02)02495-2; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Jiang W, 2007, AM HEART J, V154, P102, DOI 10.1016/j.ahj.2007.03.043; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kumar R, 2011, J NEUROL SCI, V307, P106, DOI 10.1016/j.jns.2011.04.028; Laird AR, 2013, NEUROIMAGE, V80, P505, DOI 10.1016/j.neuroimage.2013.04.073; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li JJ, 2013, CEREB CORTEX, V23, P542, DOI [10.1093/cercor/bhs034, 10.1093/cercor/bhs410]; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; LUTHERER LO, 1986, AM J PHYSIOL, V250, pR418, DOI 10.1152/ajpregu.1986.250.3.R418; Mann D., 2008, BRAUNWALDS HEART DIS, P541; Monti RP, 2014, NEUROIMAGE, V103, P427, DOI 10.1016/j.neuroimage.2014.07.033; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Notarius CF, 2007, J CARD FAIL, V13, P470, DOI 10.1016/j.cardfail.2007.03.014; Ogren Jennifer A, 2014, Curr Heart Fail Rep, V11, P321, DOI 10.1007/s11897-014-0211-y; Ogren JA, 2012, CEREBELLUM, V11, P931, DOI 10.1007/s12311-012-0361-y; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Pazo JH, 2002, CELL MOL NEUROBIOL, V22, P645, DOI 10.1023/A:1021844605250; Petrucci RJ, 2006, ANN THORAC SURG, V81, P1738, DOI 10.1016/j.athoracsur.2005.12.010; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Pressler SJ, 2010, J CARD FAIL, V16, P750, DOI 10.1016/j.cardfail.2010.04.007; Radford MJ, 2005, J AM COLL CARDIOL, V46, P1179, DOI [10.1016/j.jacc.2005.07.013, 10.1161/CIRCULATIONAHA.105.170073]; Redeker NS, 2010, SLEEP, V33, P551, DOI 10.1093/sleep/33.4.551; Reekie YL, 2008, P NATL ACAD SCI USA, V105, P9787, DOI 10.1073/pnas.0800417105; Riegel B, 2002, AM J CRIT CARE, V11, P520, DOI 10.4037/ajcc2002.11.6.520; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rumsfeld JS, 2003, J AM COLL CARDIOL, V42, P1811, DOI 10.1016/j.jacc.2003.07.013; Sadaghiani S, 2013, NEUROIMAGE, V80, P379, DOI 10.1016/j.neuroimage.2013.04.100; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; Trojano L, 2003, J NEUROL, V250, P1456, DOI 10.1007/s00415-003-0249-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang JH, 2015, HUM BRAIN MAPP, V36, P1828, DOI 10.1002/hbm.22740; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Woo MA, 2005, J CARD FAIL, V11, P437, DOI 10.1016/j.cardfail.2005.02.003; Woo MA, 2003, J APPL PHYSIOL, V95, P677, DOI 10.1152/japplphysiol.00101.2003; Woo Mary A, 2007, Congest Heart Fail, V13, P29, DOI 10.1111/j.1527-5299.2007.05856.x; Woo Mary A., 2003, Curr Treat Options Cardiovasc Med, V5, P459, DOI 10.1007/s11936-003-0035-7; Woo MA, 2015, EUR J HEART FAIL, V17, P494, DOI 10.1002/ejhf.241; Woo MA, 2015, J NEUROSCI RES, V93, P678, DOI 10.1002/jnr.23525; Woo MA, 2014, J NEUROL SCI, V346, P271, DOI 10.1016/j.jns.2014.09.006; Woo MA, 2009, J CARD FAIL, V15, P214, DOI 10.1016/j.cardfail.2008.10.020; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yin DZ, 2014, HUM BRAIN MAPP, V35, P3343, DOI 10.1002/hbm.22406; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	100	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155894	10.1371/journal.pone.0155894	http://dx.doi.org/10.1371/journal.pone.0155894			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203600	Green Submitted, gold, Green Published			2022-12-26	WOS:000376291500028
J	Sun, Y; Muller-Scharer, H; Schaffner, U				Sun, Yan; Muller-Scharer, Heinz; Schaffner, Urs			Neighbour Origin and Ploidy Level Drive Impact of an Alien Invasive Plant Species in a Competitive Environment	PLOS ONE			English	Article							CENTAUREA-STOEBE; CYTOTYPE; KNAPWEED; AMERICA; WEAPONS; COMMUNITIES; ASTERACEAE; RELEASE; SPACE; SHIFT	Our understanding of the potential mechanisms driving the spread and naturalization of alien plant species has increased over the past decades, but specific knowledge on the factors contributing to their increased impact in the introduced range is still urgently needed. The native European plant Centaurea stoebe occurs as two cytotypes with different life histories (monocarpic diploids, allo-polycarpic tetraploids). However, only tetraploids have been found in its introduced range in North America, where C. stoebe has become a most prominent plant invader. Here, we focus on the ploidy level of C. stoebe and origin of neighbouring community in explaining the high impact during the invasion of new sites in the introduced range. We conducted a mesocosm experiment under open-field conditions with the diploid (EU2x) and tetraploid (EU4x) cytotype of Centaurea stoebe from its native European (EU) range, and with the invasive tetraploid (NA4x) cytotype from the introduced North American (NA) range in competition with EU (old) or NA (new) neighbouring plant communities. In the presence of competition, the biomass of EU neighbouring community was reduced to a comparable level by all three geo-cytotypes of C. stoebe. In contrast, the biomass of the NA neighbouring community was reduced beyond when competing with tetraploid, but not with diploid C. stoebe. The fact that the biomass of all three geo-cytotypes of C. stoebe was correlated with the biomass of the EU neighbouring community, but not with that of the NA neighbouring community suggests that different mechanisms underlie the competitive interactions between C. stoebe and its old vs. new neighbouring communities, such as competition for the same limiting resources at home vs competition through novel allelo-chemicals or differential resource uptake strategies in the introduced range. We therefore caution to simply use the ecosystem impact assessed at home to predict impact in the introduced range.	[Sun, Yan; Muller-Scharer, Heinz] Univ Fribourg, Dept Biol Ecol & Evolut, Chemin Musee 10, CH-1700 Fribourg, Switzerland; [Sun, Yan; Schaffner, Urs] CABI, Rue Grillons 1, CH-2800 Delemont, Switzerland	University of Fribourg	Sun, Y (corresponding author), Univ Fribourg, Dept Biol Ecol & Evolut, Chemin Musee 10, CH-1700 Fribourg, Switzerland.; Sun, Y (corresponding author), CABI, Rue Grillons 1, CH-2800 Delemont, Switzerland.	yansun.ecology@gmail.com	Mueller-Schaerer, Heinz/H-5277-2011	Sun, Yan/0000-0002-6439-266X; Muller-Scharer, heinz/0000-0003-0936-1470	Swiss National Science Foundation (SNSF) [31003A_125314]; National Centre of Competence in Research (SNSF-NCCR)	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Centre of Competence in Research (SNSF-NCCR)	This work was supported by the Swiss National Science Foundation (SNSF grant number 31003A_125314 to HMS) and the National Centre of Competence in Research (SNSF-NCCR) 'Plant Survival' (to US and HMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Blumenthal D, 2009, P NATL ACAD SCI USA, V106, P7899, DOI 10.1073/pnas.0812607106; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broz AK, 2009, BMC PLANT BIOL, P9; Callaway R, 2011, ECOLOGY; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2012, BIOL INVASIONS, V14, P1143, DOI 10.1007/s10530-011-0145-1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Cleland EE, 2011, NEW PHYTOL, V189, P649, DOI 10.1111/j.1469-8137.2010.03607.x; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Enloe SF, 2004, WEED SCI, V52, P929, DOI 10.1614/WS-03-156R; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Hahn MA, 2012, ECOLOGY LETT; Hahn MA, 2013, AM J BOT, V100, P1555, DOI 10.3732/ajb.1200540; Hahn MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050284; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Henery ML, 2010, J ECOL, V98, P800, DOI 10.1111/j.1365-2745.2010.01672.x; Hoopes M.F., 2013, INVASION ECOLOGY, V2nd; Hulme PE, 2013, TRENDS ECOL EVOL, V28, P212, DOI 10.1016/j.tree.2012.10.010; Kaur R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044966; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Marrs RA, 2008, MOL ECOL, V17, P4197, DOI 10.1111/j.1365-294X.2008.03903.x; Mraz P, 2014, ANN BOT-LONDON, V114, P289, DOI 10.1093/aob/mcu105; Mraz P, 2012, ANN BOT-LONDON, V110, P615, DOI 10.1093/aob/mcs120; Mraz P, 2012, MOL PHYLOGENET EVOL, V62, P612, DOI 10.1016/j.ympev.2011.11.006; Mraz P, 2011, INT J PLANT SCI, V172, P386, DOI 10.1086/658151; Ordonez A, 2014, GLOBAL ECOL BIOGEOGR, V23, P264, DOI 10.1111/geb.12123; Ortega YK, 2012, ECOLOGY, V93, P783, DOI 10.1890/11-0750.1; Pattison RR, 1998, OECOLOGIA, V117, P449, DOI 10.1007/s004420050680; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Qin RM, 2013, NEW PHYTOL, V197, P979, DOI 10.1111/nph.12071; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Richardson DM, 2013, DIVERS DISTRIB, V19, P1461, DOI 10.1111/ddi.12150; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; ROCHE CT, 1991, NORTHWEST SCI, V65, P53; Rohlf FJ., 2011, BIOMETRY PRINCIPLES; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Sun Y, 2013, ECOLOGY, V94, P2124, DOI 10.1890/12-1910.1; Tharayil N, 2009, NEW PHYTOL, V181, P424, DOI 10.1111/j.1469-8137.2008.02647.x; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Vitousek P.M., 1996, ECOSYSTEM MANAGEMENT, P183; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	50	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155712	10.1371/journal.pone.0155712	http://dx.doi.org/10.1371/journal.pone.0155712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203687	Green Published, gold			2022-12-26	WOS:000376291500021
J	Becattini, B; Zani, F; Breasson, L; Sardi, C; D'Agostino, VG; Choo, MK; Provenzani, A; Park, JM; Solinas, G				Becattini, Barbara; Zani, Fabio; Breasson, Ludovic; Sardi, Claudia; D'Agostino, Vito Giuseppe; Choo, Min-Kyung; Provenzani, Alessandro; Park, Jin Mo; Solinas, Giovanni			JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damage	FASEB JOURNAL			English	Article						type-2 diabetes; insulin resistance; metabolic inflammation; antioxidants; oxidative stress tolerance	EXTENDS LIFE-SPAN; INSULIN-RECEPTOR SUBSTRATE-1; HEME OXYGENASE-1 GENE; PROMOTES OBESITY; PROTEIN-KINASE; IN-VIVO; RESISTANCE; INFLAMMATION; PHOSPHORYLATION; ACTIVATION	Obesity and insulin resistance are associated with oxidative stress, which may be implicated in the progression of obesity-related diseases. The kinase JNK1 has emerged as a promising drug target for the treatment of obesity and type 2 diabetes. JNK1 is also a key mediator of the oxidative stress response, which can promote cell death or survival, depending on the magnitude and context of its activation. In this article, we describe a study in which the long-term effects of JNK1 inactivation on glucose homeostasis and oxidative stress in obese mice were investigated for the first time. Mice lacking JNK1 (JNK1(-/-)) were fed an obesogenic high-fat diet (HFD) for a long period. JNK1(-/-) mice fed an HFD for the long term had reduced expression of antioxidant genes in their skin, more skin oxidative damage, and increased epidermal thickness and inflammation compared with the effects in control wild-type mice. However, we also observed that the protection from obesity, adipose tissue inflammation, steatosis, and insulin resistance, conferred by JNK1 ablation, was sustained over a long period and was paralleled by decreased oxidative damage in fat and liver. We conclude that compounds targeting JNK1 activity in brain and adipose tissue, which do not accumulate in the skin, may be safer and most effective.Becattini, B., Zani, F., Breasson, L., Sardi, C., D'Agostino, V. G., Choo, M.-K., Provenzani, A., Park, J. M., Solinas, G. JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damage.	[Becattini, Barbara; Zani, Fabio; Breasson, Ludovic; Sardi, Claudia; Solinas, Giovanni] Univ Fribourg, Dept Med, Lab Metab Stress Biol, Fribourg, Switzerland; [D'Agostino, Vito Giuseppe; Provenzani, Alessandro] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Choo, Min-Kyung; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Choo, Min-Kyung; Park, Jin Mo] Harvard Med Sch, Charlestown, MA USA; [Becattini, Barbara; Breasson, Ludovic; Sardi, Claudia; Solinas, Giovanni] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, S-41345 Gothenburg, Sweden	University of Fribourg; University of Trento; Harvard University; Massachusetts General Hospital; University of Gothenburg	Solinas, G (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, S-41345 Gothenburg, Sweden.	giovanni.solinas@wlab.gu.se	Solinas, Giovanni/P-6596-2017; Solinas, Giovanni/R-4777-2019; D'Agostino, Vito/AAS-4260-2020	Solinas, Giovanni/0000-0002-0140-2621; Solinas, Giovanni/0000-0002-0140-2621; D'Agostino, Vito/0000-0003-3379-2254; Becattini, Barbara/0000-0002-1002-6891; Breasson, Ludovic/0000-0003-2168-976X; Provenzani, Alessandro/0000-0003-1652-3415	Swiss National Science Foundation; Swedish Diabetes Foundation; Swedish Research Council; University of Gothenburg; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Diabetes Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Gothenburg; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the Swiss National Science Foundation, the Swedish Diabetes Foundation, the Swedish Research Council, and a startup package from the University of Gothenburg (to G.S.). Author contributions: B. Becattini and F. Zani performed most of the experiments, analyzed data, and contributed to the discussion; L. Breasson and C. Sardi performed experiments; V. G. D'Agostino and A. Provenzani performed the DNA microarray analysis; M.-K. Choo and J. M. Park performed the skin histopathological analysis and discussed the skin data; G. Solinas conceived the project, the experimental design, and wrote the manuscript; B. Becattini, F. Zani, A. Provenzani, M.-K. Choo and J. M. Park, significantly contributed to the writing of the manuscript with their comments; and all authors approved the paper. The authors declare no conflicts of interest.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kauser S, 2011, J INVEST DERMATOL, V131, P979, DOI 10.1038/jid.2010.397; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; Lao Y, 2014, CELL BIOL TOXICOL, V30, P147, DOI 10.1007/s10565-014-9276-3; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Maresca V, 2008, PIGM CELL MELANOMA R, V21, P200, DOI 10.1111/j.1755-148X.2007.00432.x; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Patel SA, 2014, ANTIOXID REDOX SIGN, V20, P2997, DOI 10.1089/ars.2013.5671; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Ray PD, 2015, BBA-GENE REGUL MECH, V1849, P1277, DOI 10.1016/j.bbagrm.2015.08.004; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Shaukat Z, 2016, CURR DRUG TARGETS, V17, P154, DOI 10.2174/1389450116666150126111055; Solinas G, 2012, OBES REV, V13, P69, DOI 10.1111/j.1467-789X.2012.01047.x; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Son YO, 2011, TOXICOL SCI, V119, P335, DOI 10.1093/toxsci/kfq335; Tsaousidou E, 2014, CELL REP, V9, P1495, DOI 10.1016/j.celrep.2014.10.045; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Vernia S, 2016, CELL REP, V14, P2273, DOI 10.1016/j.celrep.2016.02.026; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Zhang XY, 2013, CELL SIGNAL, V25, P150, DOI 10.1016/j.cellsig.2012.09.004; Zheng RJ, 2014, TOXICOL APPL PHARM, V275, P113, DOI 10.1016/j.taap.2014.01.001; Zheng RJ, 2014, FREE RADICAL BIO MED, V67, P1, DOI 10.1016/j.freeradbiomed.2013.10.011	44	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3124	3132		10.1096/fj.201600393R	http://dx.doi.org/10.1096/fj.201600393R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27230858	Green Submitted, Green Published			2022-12-26	WOS:000382816300013
J	Hall, G; Cullen, E; Sawmynaden, K; Arnold, J; Fox, S; Cowan, R; Muskett, FW; Matthews, D; Merritt, A; Kettleborough, C; Cruikshank, W; Taylor, D; Bayliss, R; Carr, MD				Hall, Gareth; Cullen, Eilish; Sawmynaden, Kovilen; Arnold, Joanne; Fox, Simon; Cowan, Richard; Muskett, Frederick W.; Matthews, David; Merritt, Andrew; Kettleborough, Catherine; Cruikshank, William; Taylor, Debra; Bayliss, Richard; Carr, Mark D.			Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16) MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE CHEMOATTRACTANT FACTOR; PDZ DOMAIN; BINDING; RECOGNITION; MIGRATION; CELLS; IDENTIFICATION; TRANSFORMATION; ASSOCIATION; ACTIVATION	Interleukin-16 (IL-16) is reported to be a chemoattractant cytokine and modulator of T-cell activation, and has been proposed as a ligand for the co-receptor CD4. The secreted active form of IL-16 has been detected at sites of T(H)1-mediated inflammation, such as those seen in autoimmune diseases, ischemic reperfusion injury (IRI), and tissue transplant rejection. Neutralization of IL-16 recruitment to its receptor, using an anti-IL16 antibody, has been shown to significantly attenuate inflammation and disease pathology in IRI, as well as in some autoimmune diseases. The 14.1 antibody is a monoclonal anti-IL-16 antibody, which when incubated with CD4(+) cells is reported to cause a reduction in the T(H)1-type inflammatory response. Secreted IL-16 contains a characteristic PDZ domain. PDZ domains are typically characterized by a defined globular structure, along with a peptide-binding site located in a groove between the alpha B and beta B structural elements and a highly conserved carboxylate-binding loop. In contrast to other reported PDZ domains, the solution structure previously reported for IL-16 reveals a tryptophan residue obscuring the recognition groove. We have solved the structure of the 14.1Fab fragment in complex with IL-16, revealing that binding of the antibody requires a conformational change in the IL-16 PDZ domain. This involves the rotation of the alpha B-helix, accompanied movement of the peptide groove obscuring tryptophan residue, and consequent opening up of the binding site for interaction. Our study reveals a surprising mechanism of action for the antibody and identifies new opportunities for the development of IL-16-targeted therapeutics, including small molecules that mimic the interaction of the antibody.	[Hall, Gareth; Cowan, Richard; Muskett, Frederick W.; Bayliss, Richard; Carr, Mark D.] Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England; [Cullen, Eilish; Sawmynaden, Kovilen; Arnold, Joanne; Fox, Simon; Matthews, David; Merritt, Andrew; Kettleborough, Catherine; Taylor, Debra] Ctr Therapeut Discovery, MRC Technol, 1-3 Burtonhole Lane,Mill Hill, London NW7 1AD, England; [Cruikshank, William] Boston Univ, Sch Med, Boston, MA 02118 USA	University of Leicester; Boston University	Hall, G; Carr, MD (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.; Matthews, D (corresponding author), Ctr Therapeut Discovery, MRC Technol, 1-3 Burtonhole Lane,Mill Hill, London NW7 1AD, England.	gh126@le.ac.uk; david.matthews@tech.mrc.ac.uk; mdc12@le.ac.uk		Cowan, Richard/0000-0003-0311-9739; Bayliss, Richard/0000-0003-0604-2773; Carr, Mark/0000-0002-3939-0996	MRC [MC_G1000806] Funding Source: UKRI; Medical Research Council [MC_G1000806] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Addis PW, 2014, J BIOL CHEM, V289, P7200, DOI 10.1074/jbc.M113.492215; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Center DM, 1996, IMMUNOL TODAY, V17, P476, DOI 10.1016/0167-5699(96)10052-I; Conti P, 2002, ALLERGY ASTHMA PROC, V23, P103; CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; CRUIKSHANK WW, 1994, P NATL ACAD SCI USA, V91, P5109, DOI 10.1073/pnas.91.11.5109; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glass WG, 2006, J INTERF CYTOK RES, V26, P511, DOI 10.1089/jir.2006.26.511; Harris BZ, 2001, J CELL SCI, V114, P3219; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Ivanova ME, 2015, ACTA CRYSTALLOGR D, V71, P555, DOI 10.1107/S139900471402776X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Keane J, 1998, J IMMUNOL, V160, P5945; LABERGE S, 1995, J IMMUNOL, V155, P2902; Larsen NA, 2001, J MOL BIOL, V311, P9, DOI 10.1006/jmbi.2001.4839; Lawson ADG, 2012, NAT REV DRUG DISCOV, V11, P519, DOI 10.1038/nrd3756; Lim KG, 1996, J IMMUNOL, V156, P2566; Little FF, 2004, EXPERT OPIN BIOL TH, V4, P837, DOI 10.1517/14712598.4.6.837; Liu Y, 1999, J BIOL CHEM, V274, P23387, DOI 10.1074/jbc.274.33.23387; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lynch EA, 2003, J IMMUNOL, V171, P4965, DOI 10.4049/jimmunol.171.10.4965; Ma JC, 2012, J BIOL CHEM, V287, P33123, DOI 10.1074/jbc.M112.381756; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muhlhahn P, 1998, NAT STRUCT BIOL, V5, P682, DOI 10.1038/1376; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicoll J, 1999, J IMMUNOL, V163, P1827; Richmond J, 2014, J CELL PHYSIOL, V229, P139, DOI 10.1002/jcp.24441; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rumsaeng V, 1997, J IMMUNOL, V159, P2904; Santamaria P, 2003, ADV EXP MED BIOL, V520, P1; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Stoitzner P, 2001, J INVEST DERMATOL, V116, P641, DOI 10.1046/j.1523-1747.2001.01328.x; Wang S, 2008, KIDNEY INT, V73, P318, DOI 10.1038/sj.ki.5002692; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Wilson KC, 2002, BIOCHEMISTRY-US, V41, P14306, DOI 10.1021/bi020163v; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144	46	4	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16840	16848		10.1074/jbc.M115.709303	http://dx.doi.org/10.1074/jbc.M115.709303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27231345	Green Published, hybrid			2022-12-26	WOS:000380826700039
J	Popov-Celeketic, D; Bianchi, F; Ruiz, SJ; Meutiawati, F; Poolman, B				Popov-Celeketic, Dusan; Bianchi, Frans; Ruiz, Stephanie J.; Meutiawati, Febrina; Poolman, Bert			A Plasma Membrane Association Module in Yeast Amino Acid Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; NUCLEAR-PORE COMPLEX; KINASE-A PATHWAY; SACCHAROMYCES-CEREVISIAE; PHEROMONE RESPONSE; MASTER REGULATOR; GENE-EXPRESSION; CELL-SURFACE; CORTICAL ER; PERMEASE	Amino acid permeases (AAPs) in the plasma membrane (PM) of Saccharomyces cerevisiae are responsible for the uptake of amino acids and involved in regulation of their cellular levels. Here, we report on a strong and complex module for PM association found in the C-terminal tail of AAPs. Using in silico analyses and mutational studies we found that the C-terminal sequences of Gap1, Bap2, Hip1, Tat1, Tat2, Mmp1, Sam3, Agp1, and Gnp1 are about 50 residues long, associate with the PM, and have features that discriminate them from the termini of organellar amino acid transporters. We show that this sequence (named PMasseq) contains an amphipathic alpha-helix and the FWC signature, which is palmitoylated by palmitoyltransferase Pfa4. Variations of PMasseq, found in different AAPs, lead to different mobilities and localization patterns, whereas the disruption of the sequence has an adverse effect on cell viability. We propose that PMasseq modulates the function and localization of AAPs along the PM. PMasseq is one of the most complex protein signals for plasma membrane association across species and can be used as a delivery vehicle for the PM.	[Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 4, NL-9747 AG Groningen, Netherlands; [Popov-Celeketic, Dusan] Univ Utrecht, Fac Sci, Dept Biol, Div Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands	University of Groningen; University of Groningen; Utrecht University	Poolman, B (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Popov-Celeketic, Dusan/O-2371-2016; Bianchi, Frans/E-8796-2018; Institute, Zernike/W-7033-2019; Meutiawati, Febrina/H-3419-2016	Popov-Celeketic, Dusan/0000-0002-0512-6900; Bianchi, Frans/0000-0002-9385-9695; Ruiz, Stephanie/0000-0003-1522-3760	Fonds Economische Structuurversterking from the Dutch Ministry of Economic Affairs, Agriculture and Innovation (ELI); Netherlands Organisation for Scientific Research (NWO) TOP-GO Program [700.10.53]	Fonds Economische Structuurversterking from the Dutch Ministry of Economic Affairs, Agriculture and Innovation (ELI); Netherlands Organisation for Scientific Research (NWO) TOP-GO Program(Netherlands Organization for Scientific Research (NWO))	This work was carried out within the Biotechnology-based Ecologically Balanced Sustainable Industrial Consortium (BE-Basic) Research and Development Program, which was granted a Fonds Economische Structuurversterking subsidy from the Dutch Ministry of Economic Affairs, Agriculture and Innovation (EL&I), and was also supported in part by Netherlands Organisation for Scientific Research (NWO) TOP-GO Program Project 700.10.53. The authors declare that they have no conflicts of interest with the contents of this article.	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bitinaite Jurate, 2009, Curr Protoc Mol Biol, VChapter 3, DOI 10.1002/0471142727.mb0321s86; BLOBEL G, 1981, HARVEY LECT, V76, P125; Brachmann CB, 1998, YEAST, V14, P115; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gatto GJ, 2003, GENOME RES, V13, P617, DOI 10.1101/gr.667603; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Hennerdal A, 2011, BIOINFORMATICS, V27, P1322, DOI 10.1093/bioinformatics/btr119; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kralt A, 2015, TRAFFIC, V16, P135, DOI 10.1111/tra.12243; Lee CC, 2005, PLASMID, V54, P80, DOI 10.1016/j.plasmid.2004.12.001; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Meinema AC, 2013, TRAFFIC, V14, P487, DOI 10.1111/tra.12048; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Neiman AM, 2000, GENETICS, V155, P1643; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Omura F, 2001, FEMS MICROBIOL LETT, V194, P207, DOI 10.1016/S0378-1097(00)00532-2; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Phillips R., 2013, PHYS BIOL CELL, P525; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Vivero-Pol L, 2005, J AM CHEM SOC, V127, P12770, DOI 10.1021/ja0533850; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020	68	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16024	16037		10.1074/jbc.M115.706770	http://dx.doi.org/10.1074/jbc.M115.706770			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226538	Green Published, hybrid			2022-12-26	WOS:000380585400009
J	Lafaye, C; Van Molle, I; Dufe, VT; Wahni, K; Boudier, A; Leroy, P; Collet, JF; Messens, J				Lafaye, Celine; Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Boudier, Ariane; Leroy, Pierre; Collet, Jean-Francois; Messens, Joris			Sulfur Denitrosylation by an Engineered Trx-like DsbG Enzyme Identifies Nucleophilic Cysteine Hydrogen Bonds as Key Functional Determinant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-NITROSYLATION; ESCHERICHIA-COLI; DISULFIDE-ISOMERASE; ACTIVE-SITE; REDOX PROPERTIES; IN-VIVO; THIOREDOXIN; SYSTEM; NITROSOTHIOLS; REFINEMENT	Exposure of bacteria to NO results in the nitrosylation of cysteine thiols in proteins and low molecular weight thiols such as GSH. The cells possess enzymatic systems that catalyze the denitrosylation of these modified sulfurs. An important player in these systems is thioredoxin (Trx), a ubiquitous, cytoplasmic oxidoreductase that can denitrosylate proteins in vivo and S-nitrosoglutathione (GSNO) in vitro. However, a periplasmic or extracellular denitrosylase has not been identified, raising the question of how extracytoplasmic proteins are repaired after nitrosative damage. In this study, we tested whether DsbG and DsbC, two Trx family proteins that function in reducing pathways in the Escherichia coli periplasm, also possess denitrosylating activity. Both DsbG and DsbC are poorly reactive toward GSNO. Moreover, DsbG is unable to denitrosylate its specific substrate protein, YbiS. Remarkably, by borrowing the CGPC active site of E. coli Trx-1 in combination with a T200M point mutation, we transformed DsbG into an enzyme highly reactive toward GSNO and YbiS. Thepk, of the nucleophilic cysteine, as well as the redox and thermodynamic properties of the engineered DsbG are dramatically changed and become similar to those of E. coli Trx-1. X-ray structural insights suggest that this results from a loss of two direct hydrogen bonds to the nucleophilic cysteine sulfur in the DsbG mutant. Our results highlight the plasticity of the Trx structural fold and reveal that the subtle change of the number of hydrogen bonds in the active site of Trx-like proteins is the key factor that thermodynamically controls reactivity toward nitrosylated compounds.	[Lafaye, Celine; Dufe, Veronica Tamu; Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, 75-39 Ave Hippocrate, B-1200 Brussels, Belgium; [Lafaye, Celine; Dufe, Veronica Tamu; Collet, Jean-Francois] WELBIO, B-1200 Brussels, Belgium; [Lafaye, Celine; Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Collet, Jean-Francois; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Messens, Joris] Vlaams Inst Biotechnol, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Boudier, Ariane; Leroy, Pierre] Univ Lorraine, Fac Pharm, F-54000 Nancy, France; [Collet, Jean-Francois] FRS, Maitre Rech, Brussels, Belgium; [Collet, Jean-Francois] WELBIO, FRFS, Brussels, Belgium; [Messens, Joris] Vlaams Inst Biotechnol, Brussels, Belgium; [Messens, Joris] Vrije Univ Brussel, Brussels, Belgium	Universite Catholique Louvain; WELBIO; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite de Lorraine; Fonds de la Recherche Scientifique - FNRS; WELBIO; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Collet, JF (corresponding author), Catholic Univ Louvain, de Duve Inst, 75-39 Ave Hippocrate, B-1200 Brussels, Belgium.; Messens, J (corresponding author), Vrije Univ Brussel, Struct Biol Res Ctr, Oxidat Stress Signaling Lab, Vlaams Inst Biotechnol, Pl Laan 2, B-1050 Brussels, Belgium.	joris.messens@vib-vub.be	Messens, Joris/AAH-3008-2020	Messens, Joris/0000-0002-2128-8264; Collet, Jean-Francois/0000-0001-8069-7036; Van Molle, Inge/0000-0003-0114-9379	OMICS@VIB Marie Curie COFUND fellowship; Vlaams Instituut voor Biotechnologie; Research Foundation Flanders Research Program [G.0305.12]; Flanders Hercules Foundation [HERC16, UABR/09/005]; WELBIO; FRS-Fonds de la Recherche Scientifique	OMICS@VIB Marie Curie COFUND fellowship; Vlaams Instituut voor Biotechnologie; Research Foundation Flanders Research Program; Flanders Hercules Foundation; WELBIO(WELBIO); FRS-Fonds de la Recherche Scientifique	This work was supported by OMICS@VIB Marie Curie COFUND fellowship (to I. V. M.); funds from the Vlaams Instituut voor Biotechnologie; Research Foundation Flanders Research Program G.0305.12; Flanders Hercules Foundation Grants HERC16 and UABR/09/005 for the purification and in house x-ray crystallography platform, respectively; funds from WELBIO; and a Credit de Recherche grant from the FRS-Fonds de la Recherche Scientifique. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Cook JA, 1996, ANAL BIOCHEM, V238, P150, DOI 10.1006/abio.1996.0268; Denoncin K, 2014, J BIOL CHEM, V289, P12356, DOI 10.1074/jbc.M114.554055; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Laver JR, 2013, ANTIOXID REDOX SIGN, V18, P309, DOI 10.1089/ars.2012.4767; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messens J, 2004, J MOL BIOL, V339, P527, DOI 10.1016/j.jmb.2004.04.016; Moore KP, 2002, METHOD ENZYMOL, V359, P256; Mossner E, 1998, PROTEIN SCI, V7, P1233; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; SHEVCHIK VE, 1994, EMBO J, V13, P2007, DOI 10.1002/j.1460-2075.1994.tb06470.x; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Zander T, 1998, METHOD ENZYMOL, V290, P59, DOI 10.1016/S0076-6879(98)90007-6; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	43	3	3	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15020	15028		10.1074/jbc.M116.729426	http://dx.doi.org/10.1074/jbc.M116.729426			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226614	hybrid, Green Published			2022-12-26	WOS:000380583200014
J	Yang, XX; Zhang, WW; Chen, YL; Li, Y; Sun, L; Liu, Y; Liu, MY; Yu, M; Li, XJ; Han, JH; Duan, YJ				Yang, Xiaoxiao; Zhang, Wenwen; Chen, Yuanli; Li, Yan; Sun, Lei; Liu, Ying; Liu, Mengyang; Yu, Miao; Li, Xiaoju; Han, Jihong; Duan, Yajun			Activation of Peroxisome Proliferator-activated Receptor (PPAR gamma) and CD36 Protein Expression THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY ATHEROSCLEROSIS; ESTROGEN PLUS PROGESTIN; LOW-DENSITY-LIPOPROTEIN; B SCAVENGER RECEPTOR; RANDOMIZED CONTROLLED-TRIAL; DEFECTIVE FATTY-ACID; INSULIN-RESISTANCE; POSTMENOPAUSAL WOMEN; GENE-EXPRESSION; OXIDIZED LDL	Progesterone or its analog, one of components of hormone replacement therapy, may attenuate the cardioprotective effects of estrogen. However, the underlying mechanisms have not been fully elucidated. Expression of CD36, a receptor for oxidized LDL (oxLDL) that enhances macrophage/foam cell formation, is activated by the transcription factor peroxisome proliferator-activated receptor gamma (PPARy). CD36 also functions as a fatty acid transporter to influence fatty acid metabolism and the pathophysiological status of several diseases. In this study, we determined that progesterone induced macrophage CD36 expression, which is related to progesterone receptor (PR) activity. Progesterone enhanced cellular oxLDL uptake in a CD36dependent manner. Mechanistically, progesterone increased PPARy expression and PPARy promoter activity in a PR dependent manner and the binding of PR with the progesterone response element in the PPARy promoter. Specific deletion of macrophage PPARy (MOPPARy KO) expression in mice abolished progesterone -induced macrophage CD36 expression and cellular oxLDL accumulation. We also determined that, associated with gestation and increased serum progesterone levels, CD36 and PPARy expression in mouse adipose tissue, skeletal muscle, and peritoneal macrophages were substantially activated. Taken together, our study demonstrates that progesterone can play dual pathophysiological roles by activating PPARy expression, in which progesterone increases macrophage CD36 expression and oxLDL accumulation, a negative effect on atherosclerosis, and enhances the PPAR gamma-CD36 pathway in adipose tissue and skeletal muscle, a protective effect on pregnancy.	[Yang, Xiaoxiao; Zhang, Wenwen; Li, Yan; Sun, Lei; Liu, Ying; Liu, Mengyang; Yu, Miao; Li, Xiaoju] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Yuanli] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Han, Jihong; Duan, Yajun] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Collaborat Innovat Ctr Biotherapy, Tianjin 300071, Peoples R China; [Chen, Yuanli; Han, Jihong; Duan, Yajun] Hefei Univ Technol, Coll Biomed Engn, 193 Tongxi Rd, Hefei 230000, Peoples R China	Nankai University; Nankai University; Nankai University; Hefei University of Technology	Han, JH; Duan, YJ (corresponding author), Hefei Univ Technol, Coll Biomed Engn, 193 Tongxi Rd, Hefei 230000, Peoples R China.	jihonghan2008@nankai.edu.cn; yduan@hfut.edu.cn	Liu, Mengyang/AAA-6289-2019	Liu, Mengyang/0000-0002-3790-923X	National Science Foundation of China [81473204, 81573427, 31400694]; Program for Changjiang Scholars and Innovative Research Team in University Grant [IRT13023]; 111 Project [B08011]; International Science and Technology Cooperation Program of China [2015DFA30430]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); International Science and Technology Cooperation Program of China	This work was supported by National Science Foundation of China Grants 81473204 (to J. H.), 81573427 (to V. D.), and 31400694 (to Y. C.); Program for Changjiang Scholars and Innovative Research Team in University Grant IRT13023 and 111 Project Grant B08011 (to J. H.); and International Science and Technology Cooperation Program of China Grant 2015DFA30430 (to J. H., Y. D., and Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams MR, 1997, ARTERIOSCL THROM VAS, V17, P217, DOI 10.1161/01.ATV.17.1.217; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Allred KF, 2006, J BIOL CHEM, V281, P1419, DOI 10.1074/jbc.M506046200; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Corpeleijn E, 2006, DIABETIC MED, V23, P907, DOI 10.1111/j.1464-5491.2006.01888.x; Diep CH, 2015, J MOL ENDOCRINOL, V54, pR31, DOI 10.1530/JME-14-0252; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Feng JW, 2000, J LIPID RES, V41, P688; Froment P, 2006, J ENDOCRINOL, V189, P199, DOI 10.1677/joe.1.06667; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Han JH, 2004, CIRCULATION, V109, P790, DOI 10.1161/01.CIR.0000112576.40815.13; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Hanke H, 1996, ATHEROSCLEROSIS, V121, P129, DOI 10.1016/0021-9150(95)05710-2; Hanke H, 1996, CIRCULATION, V94, P175, DOI 10.1161/01.CIR.94.2.175; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Hsia J, 2004, CIRCULATION, V109, P620, DOI 10.1161/01.CIR.0000115309.63979.92; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kim JY, 2008, MOL CELL BIOL, V28, P1770, DOI 10.1128/MCB.01556-07; Koh KK, 2004, ARTERIOSCL THROM VAS, V24, P1171, DOI 10.1161/01.ATV.0000131262.98040.65; Komar CM, 2001, ENDOCRINOLOGY, V142, P4831, DOI 10.1210/en.142.11.4831; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; LIEBERMAN BA, 1993, MOL ENDOCRINOL, V7, P515, DOI 10.1210/me.7.4.515; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nickenig G, 2000, CIRCULATION, V102, P1828; Oz HS, 2011, INFLAMM RES, V60, P93, DOI 10.1007/s00011-010-0241-1; PADWICK ML, 1986, NEW ENGL J MED, V315, P930, DOI 10.1056/NEJM198610093151504; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SMITH DC, 1975, NEW ENGL J MED, V293, P1164, DOI 10.1056/NEJM197512042932302; STURDEE DW, 1978, BRIT MED J, V1, P1575, DOI 10.1136/bmj.1.6127.1575; Sun L, 2003, J LIPID RES, V44, P1877, DOI 10.1194/jlr.M300084-JLR200; Sun YJ, 2010, DIABETES CARE, V33, P2065, DOI 10.2337/dc10-0460; Wassmann K, 2005, CIRC RES, V97, P1046, DOI 10.1161/01.RES.0000188212.57180.55; Yang XX, 2015, J BIOL CHEM, V290, P21788, DOI 10.1074/jbc.M115.654582	46	20	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15108	15118		10.1074/jbc.M116.726737	http://dx.doi.org/10.1074/jbc.M116.726737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226602	Green Published, hybrid			2022-12-26	WOS:000380583200021
J	Kaster, BC; Knippa, KC; Kaplan, CD; Peterson, DO				Kaster, Benjamin C.; Knippa, Kevin C.; Kaplan, Craig D.; Peterson, David O.			RNA Polymerase II Trigger Loop Mobility: INDIRECT EFFECTS OF Rpb9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; RNA polymerase II; Saccharomyces cerevisiae; transcription; yeast genetics; Rpb1; Rpb9; trigger loop	SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; STRUCTURAL BASIS; SUBUNIT RPB9; ALPHA-AMANITIN; IN-VIVO; CLEAVAGE ACTIVITY; 3'-END FORMATION; FACTOR TFIIS; DNA-DAMAGE	Rpb9 is a conserved RNA polymerase II (pol II) subunit, the absence of which confers alterations to pol II enzymatic properties and transcription fidelity. It has been suggested previously that Rpb9 affects mobility of the trigger loop (TL), a structural element of Rpb1 that moves in and out of the active site with each elongation cycle. However, a biochemical mechanism for this effect has not been defined. We find that the mushroom toxin -amanitin, which inhibits TL mobility, suppresses the effect of Rpb9 on NTP misincorporation, consistent with a role for Rpb9 in this process. Furthermore, we have identified missense alleles of RPB9 in yeast that suppress the severe growth defect caused by rpb1-G730D, a substitution within Rpb1 -helix 21 (21). These alleles suggest a model in which Rpb9 indirectly affects TL mobility by anchoring the position of 21, with which the TL directly interacts during opening and closing. Amino acid substitutions in Rpb9 or Rpb1 that disrupt proposed anchoring interactions resulted in phenotypes shared by rpb9 strains, including increased elongation rate in vitro. Combinations of rpb9 with the fast rpb1 alleles that we identified did not result in significantly faster in vitro misincorporation rates than those resulting from rpb9 alone, and this epistasis is consistent with the idea that defects caused by the rpb1 alleles are related mechanistically to the defects caused by rpb9. We conclude that Rpb9 supports intra-pol II interactions that modulate TL function and thus pol II enzymatic properties.	[Kaster, Benjamin C.; Knippa, Kevin C.; Kaplan, Craig D.; Peterson, David O.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Peterson, DO (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	dopeterson@tamu.edu	Kaplan, Craig/AAO-4500-2021	Kaplan, Craig/0000-0002-7518-695X	Texas A&M AgriLife Research; NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097260, P41GM103311] Funding Source: NIH RePORTER	Texas A&M AgriLife Research; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mikhail Kashlev for providing yeast strain BJ5464 His-Bio; Mary Bryk for sharing reagents, equipment, and advice; Diane Hawley and Amber Wadle for valuable discussions; Guillermo Calero for communication of results prior to publication; and Adam Peterson and undergraduate students Jerritt Nunneley, Lauren Rinando Nelson, Jessica Wald, Julianna Hudnall Baker, and J. Colin Klingemann for technical assistance. The support of Texas A&M AgriLife Research is also acknowledged. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, National Institutes of Health, Grant P41-GM103311).	ACKER J, 1993, NUCLEIC ACIDS RES, V21, P5345, DOI 10.1093/nar/21.23.5345; ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Braberg H, 2013, CELL, V154, P775, DOI 10.1016/j.cell.2013.07.033; Brachmann CB, 1998, YEAST, V14, P115; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Bucheli ME, 2005, EMBO J, V24, P2150, DOI 10.1038/sj.emboj.7600687; Bucheli ME, 2007, RNA, V13, P1756, DOI 10.1261/rna.607207; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; Costa G L, 1996, Methods Mol Biol, V57, P239; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Hemming SA, 2000, J BIOL CHEM, V275, P2288, DOI 10.1074/jbc.275.4.2288; HULL MW, 1995, GENE DEV, V9, P481, DOI 10.1101/gad.9.4.481; Hyle JW, 2003, J BIOL CHEM, V278, P28470, DOI 10.1074/jbc.M303736200; Jenks MH, 2008, MOL CELL BIOL, V28, P3883, DOI 10.1128/MCB.00380-08; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kaplan CD, 2013, BBA-GENE REGUL MECH, V1829, P39, DOI 10.1016/j.bbagrm.2012.09.007; Kaplan CD, 2012, PLOS GENET, V8, P172, DOI 10.1371/journal.pgen.1002627; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Knippa K, 2013, BIOCHEMISTRY-US, V52, P7807, DOI 10.1021/bi4009566; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; Koyama H, 2010, GENES CELLS, V15, P151, DOI 10.1111/j.1365-2443.2009.01372.x; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Li SS, 2006, MOL CELL BIOL, V26, P9430, DOI 10.1128/MCB.01656-06; Liu X, 2013, BBA-GENE REGUL MECH, V1829, P2, DOI 10.1016/j.bbagrm.2012.09.003; Malagon F, 2004, GENETICS, V166, P1215, DOI 10.1534/genetics.166.3.1215; Martinez-Rucobo FW, 2013, BBA-GENE REGUL MECH, V1829, P9, DOI 10.1016/j.bbagrm.2012.09.002; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roghanian M, 2011, NUCLEIC ACIDS RES, V39, P4352, DOI 10.1093/nar/gkq1359; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Shaw RJ, 2001, J BIOL CHEM, V276, P32905, DOI 10.1074/jbc.M105075200; SIKORSKI RS, 1989, GENETICS, V122, P19; Spencer J.F.T., 1989, YEAST GENETICS MANUA; Sun ZW, 1996, NUCLEIC ACIDS RES, V24, P2560, DOI 10.1093/nar/24.13.2560; Svetlov V, 2013, BBA-GENE REGUL MECH, V1829, P20, DOI 10.1016/j.bbagrm.2012.08.009; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Van Mullem V, 2002, J BIOL CHEM, V277, P10220, DOI 10.1074/jbc.M107207200; Walmacq C, 2012, MOL CELL, V46, P18, DOI 10.1016/j.molcel.2012.02.006; Walmacq C, 2009, J BIOL CHEM, V284, P19601, DOI 10.1074/jbc.M109.006908; Wang BB, 2013, BIOPHYS J, V105, P767, DOI 10.1016/j.bpj.2013.05.060; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; WIELAND T, 1991, EXPERIENTIA, V47, P1186, DOI 10.1007/BF01918382	60	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14883	14895		10.1074/jbc.M116.714394	http://dx.doi.org/10.1074/jbc.M116.714394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226557	Green Published, hybrid			2022-12-26	WOS:000380366700039
J	He, ZF; Riva, M; Bjork, P; Sward, K; Morgelin, M; Leanderson, T; Ivars, F				He, Zhifei; Riva, Matteo; Bjork, Per; Sward, Karl; Morgelin, Matthias; Leanderson, Tomas; Ivars, Fredrik			CD14 Is a Co-Receptor for TLR4 in the S100A9-Induced Pro-Inflammatory Response in Monocytes	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; FACTOR-KAPPA-B; LIPID RAFTS; BACTERIAL LIPOPOLYSACCHARIDE; SIGNALING PATHWAYS; BINDING-PROTEINS; S100A9 PROTEIN; RECEPTOR; LPS; ENDOCYTOSIS	The cytosolic Ca2+-binding S100A9 and S100A8 proteins form heterodimers that are primarily expressed in human neutrophils and monocytes. We have recently shown that S100A9 binds to TLR4 in vitro and induces TLR4-dependent NF-kappa B activation and a proinflammatory cytokine response in monocytes. In the present report we have further investigated the S100A9-mediated stimulation of TLR4 in monocytes. Using transmission immunoelectron microscopy, we detected focal binding of S100A9 to monocyte membrane subdomains containing the caveolin-1 protein and TLR4. Furthermore, the S100A9 protein was detected in early endosomes of the stimulated cells, indicating that the protein could be internalized by endocytosis. Although stimulation of monocytes with S100A9 was strictly TLR4-dependent, binding of S100A9 to the plasma membrane and endocytosis of S100A9 was still detectable and coincided with CD14 expression in TLR4-deficient cells. We therefore investigated whether CD14 would be involved in the TLR4-dependent stimulation and could show that the S100A9-induced cytokine response was inhibited both in CD14-deficient cells and in cells exposed to CD14 blocking antibodies. Further, S100A9 was not internalized into CD14-deficient cells suggesting a direct role of CD14 in endocytosis of S100A9. Finally, we could detect satiable binding of S100A9 to CD14 in surface plasmon resonance experiments. Taken together, these results indicate that CD14 is a co-receptor of TLR4 in the S100A9-induced cytokine response.	[He, Zhifei; Riva, Matteo; Leanderson, Tomas; Ivars, Fredrik] Lund Univ, Dept Expt Med Sci, Immunol Sect, Immunol Grp, Lund, Sweden; [Riva, Matteo; Bjork, Per; Leanderson, Tomas] Act Biotech AB, Lund, Sweden; [Sward, Karl] Lund Univ, Dept Expt Med Sci, Sect Cell & Tissue Biol, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Sect Infect Biol, Lund, Sweden	Lund University; Lund University; Lund University	Ivars, F (corresponding author), Lund Univ, Dept Expt Med Sci, Immunol Sect, Immunol Grp, Lund, Sweden.	fredrik.ivars@med.lu.se		Riva, Matteo/0000-0003-2697-6717	Swedish Cancer Society [100591]; Swedish Research Council [7480]; Swedish Strategic Research Foundation; Alfred Osterlunds Stiftelse; Greta and Johan Kocks Stiftelser; King Gustav V Memorial Fund; Inga Britt och Arne Lundbergs Forskningsstiftelse; Active Biotech AB	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Alfred Osterlunds Stiftelse; Greta and Johan Kocks Stiftelser; King Gustav V Memorial Fund; Inga Britt och Arne Lundbergs Forskningsstiftelse; Active Biotech AB	This work was funded by Swedish Cancer Society grant #100591; https://www.cancerfonden.se/forskning (TL); Swedish Research Council project #7480; http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html (TL); The Swedish Strategic Research Foundation; http://www.stratresearch.se (MM); Alfred Osterlunds Stiftelse; http://www.alfredosterlundsstiftelse.se (FI and MM); Greta and Johan Kocks Stiftelser; http://www.kockskastiftelsen.se (FI and MM); King Gustav V Memorial Fund; http://www.kungahuset.se/monarkinhovstaterna/kungligastiftelser/forskning/konunggustafvs80arsfond/english.4.67e94750148caf4ad27d21.html (MM); Inga Britt och Arne Lundbergs Forskningsstiftelse; http://www.lundbergsstiftelsen.se/index_en.html (Institutional grant). Active Biotech AB provided support in the form of salaries for authors MR, PB and TL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Arakawa R, 2000, J LIPID RES, V41, P1952; Arnold V, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-122; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Borzecka K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/824919; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Feng H, 2013, LIFE SCI, V93, P1, DOI 10.1016/j.lfs.2013.05.016; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Gaus K, 2005, J LIPID RES, V46, P1526, DOI 10.1194/jlr.M500103-JLR200; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hibino T, 2013, CANCER RES, V73, P172, DOI 10.1158/0008-5472.CAN-11-3843; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Ling GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4039; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Matveev S, 1999, J LIPID RES, V40, P1647; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Rammes A, 1997, J BIOL CHEM, V272, P9496; Razani B, 2001, J BIOL CHEM, V276, P38121; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Saitoh S, 2004, J ENDOTOXIN RES, V10, P257, DOI 10.1179/096805104225005904; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Shuto T, 2005, BIOCHEM BIOPH RES CO, V338, P1402, DOI 10.1016/j.bbrc.2005.10.102; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Thieblemont N, 1998, IMMUNITY, V8, P771, DOI 10.1016/S1074-7613(00)80582-8; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/186093; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Wang PY, 1996, J INFLAMM, V47, P126; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	73	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156377	10.1371/journal.pone.0156377	http://dx.doi.org/10.1371/journal.pone.0156377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228163	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500125
J	Schaal, C; Chellappan, S				Schaal, Courtney; Chellappan, Srikumar			Nicotine-Mediated Regulation of Nicotinic Acetylcholine Receptors in Non-Small Cell Lung Adenocarcinoma by E2F1 and STAT1 Transcription Factors	PLOS ONE			English	Article							PROMOTES TUMOR-GROWTH; SUSCEPTIBILITY LOCUS; MICROARRAY DATA; TARGET GENES; CANCER CELLS; PROLIFERATION; METASTASIS; ACTIVATION; INVASION; SMOKING	Cigarette smoking is the major risk factor for non-small cell lung cancer (NSCLC), which accounts for 80% of all lung cancers. Nicotine, the addictive component of tobacco smoke, can induce proliferation, migration, invasion, epithelial-mesenchymal transition (EMT), angiogenesis, and survival in NSCLC cell lines, as well as growth and metastasis of NSCLC in mice. This nicotine-mediated tumor progression is facilitated through activation of nicotinic acetylcholine receptors (nAChRs), specifically the alpha 7 subunit; however, how the alpha 7 nAChR gene is regulated in lung adenocarcinoma is not fully clear. Here we demonstrate that the alpha 7 nAChR gene promoter is differentially regulated by E2F and STAT transcription factors through a competitive interplay; E2F1 induces the promoter, while STAT transcription factors repress it by binding to an overlapping site at a region -294 through -463bp upstream of the transcription start site. Treatment of cells with nicotine induced the mRNA and protein levels of alpha 7 nAChR; this could be abrogated by treatment with inhibitors targeting Src, PI3K, MEK, alpha 7 nAChR, CDK4/6 or a disruptor of the Rb-Raf-1 interaction. Further, nicotine-mediated induction of alpha 7 nAChR was reduced when E2F1 was depleted and in contrast elevated when STAT1 was depleted by siRNAs. Interestingly, extracts from e-cigarettes, which have recently emerged as healthier alternatives to traditional cigarette smoking, can also induce alpha 7 nAChR expression in a manner similar to nicotine. These results suggest an autoregulatory feed-forward loop that induces the levels of alpha 7 nAChR upon exposure to nicotine, which enhances the strength of the signal. It can be imagined that such an induction of alpha 7 nAChR contributes to the tumor-promoting functions of nicotine.	[Schaal, Courtney; Chellappan, Srikumar] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Schaal, Courtney] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Canc Biol PhD Program, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Chellappan, S (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.	srikumar.chellappan@moffitt.org			NCI [CA127725]; Lung Cancer Center of Excellence at Moffitt; Lung Cancer Center of Excellence at the Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA127725] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Center of Excellence at Moffitt; Lung Cancer Center of Excellence at the Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the grant CA127725 from the NCI as well as internal funds form the Lung Cancer Center of Excellence at Moffitt. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors thank Drs. Uwe Rix and Eric Haura for helpful discussions, as well as the Moffitt Cancer Center Microscopy Core Facility for their assistance. These studies were supported by the grant CA127725 from the NCI to SPC as well as the Lung Cancer Center of Excellence at the Moffitt Cancer Center.	Aali N, 2015, CELL MOL BIOL LETT, V20, P948, DOI 10.1515/cmble-2015-0056; Abrams DB, 2014, JAMA-J AM MED ASSOC, V311, P135, DOI 10.1001/jama.2013.285347; Al-Wadei HAN, 2012, CURR CANCER DRUG TAR, V12, P97; Al-Wadei HAN, 2009, CARCINOGENESIS, V30, P506, DOI 10.1093/carcin/bgp010; Al-Wadei MH, 2016, EUR J CANCER, V52, P188, DOI 10.1016/j.ejca.2015.10.003; Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Auf R, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i425; Beregovyi S M, 2015, Ukr Biochem J, V87, P70; Brown KC, 2013, J BIOL CHEM, V288, P33049, DOI 10.1074/jbc.M113.501601; Calderon LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143277; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Davis R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007524; Furrukh Muhammad, 2013, Sultan Qaboos Univ Med J, V13, P345; Grando SA, 2015, INT IMMUNOPHARMACOL, V29, P1, DOI 10.1016/j.intimp.2015.08.023; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Guha P, 2014, BREAST CANCER RES TR, V145, P5, DOI 10.1007/s10549-014-2912-z; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Improgo MR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00251; Itier V, 2001, FEBS LETT, V504, P118, DOI 10.1016/S0014-5793(01)02702-8; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; Khalil AA, 2013, BRAIN TUMOR PATHOL, V30, P73, DOI 10.1007/s10014-012-0101-5; Kunigal S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-24; Lee CH, 2011, J ONCOL, V2011, DOI 10.1155/2011/693424; Lee J, 2012, LIFE SCI, V91, P1058, DOI 10.1016/j.lfs.2012.06.032; Lee SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18146; Leventhal AM, 2015, JAMA-J AM MED ASSOC, V314, P700, DOI 10.1001/jama.2015.8950; Ma XL, 2014, TOXICOL APPL PHARM, V278, P172, DOI 10.1016/j.taap.2014.04.023; Medjber K, 2015, LUNG CANCER, V87, P258, DOI 10.1016/j.lungcan.2015.01.001; Momi N, 2013, ONCOGENE, V32, P1384, DOI 10.1038/onc.2012.163; Muxel SM, 2016, J PINEAL RES, V60, P394, DOI 10.1111/jpi.12321; Nair S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-173; Nieh S, 2015, HEAD NECK-J SCI SPEC, V37, P1712, DOI 10.1002/hed.23820; Phillips DH, 2002, CARCINOGENESIS, V23, P1979, DOI 10.1093/carcin/23.12.1979; Pillai S, 2015, METHODS MOL BIOL, V1288, P429, DOI 10.1007/978-1-4939-2474-5_25; Pillai S, 2015, CANCER RES, V75, P1009, DOI 10.1158/0008-5472.CAN-14-0681; Pillai S, 2011, MOL CELL BIOL, V31, P3052, DOI 10.1128/MCB.01311-10; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 1998, BIOCHEM PHARMACOL, V55, P1377, DOI 10.1016/S0006-2952(97)00651-5; Shah M, 2015, CELL CYCLE, V14, P323, DOI 10.4161/15384101.2014.980643; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh T, 2016, MMWR-MORBID MORTAL W, V64, P1403, DOI 10.15585/mmwr.mm6452a3; Singhal S, 2011, J NANOTECHNOL, V2011, DOI [10.1155/2011/930243, 10.1155/2011/456743]; Sun HJ, 2015, EXP TOXICOL PATHOL, V67, P477, DOI 10.1016/j.etp.2015.07.001; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Togashi Y, 2015, LUNG CANCER, V88, P16, DOI 10.1016/j.lungcan.2015.01.027; Trevino JG, 2012, NEOPLASIA, V14, P1102, DOI 10.1593/neo.121044; Vuong LM, 2015, MOL CELL BIOL, V35, P3471, DOI 10.1128/MCB.00030-15; Walton KM, 2015, NICOTINE TOB RES, V17, P259, DOI 10.1093/ntr/ntu214; Yoo SS, 2014, LUNG CANCER, V86, P85, DOI 10.1016/j.lungcan.2014.08.002; Yuge K, 2015, MOL CANCER THER, V14, P2112, DOI 10.1158/1535-7163.MCT-15-0140	62	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156451	10.1371/journal.pone.0156451	http://dx.doi.org/10.1371/journal.pone.0156451			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228072	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500138
J	Blennow, K; Persson, J; Persson, E; Hanewinkel, M				Blennow, Kristina; Persson, Johannes; Persson, Erik; Hanewinkel, Marc			Forest Owners' Response to Climate Change: University Education Trumps Value Profile	PLOS ONE			English	Article							R PACKAGE; SCIENCE; RISK	Do forest owners' levels of education or value profiles explain their responses to climate change? The cultural cognition thesis (CCT) has cast serious doubt on the familiar and often criticized "knowledge deficit" model, which says that laypeople are less concerned about climate change because they lack scientific knowledge. Advocates of CCT maintain that citizens with the highest degrees of scientific literacy and numeracy are not the most concerned about climate change. Rather, this is the group in which cultural polarization is greatest, and thus individuals with more limited scientific literacy and numeracy are more concerned about climate change under certain circumstances than those with higher scientific literacy and numeracy. The CCT predicts that cultural and other values will trump the positive effects of education on some forest owners' attitudes to climate change. Here, using survey data collected in 2010 from 766 private forest owners in Sweden and Germany, we provide the first evidence that perceptions of climate change risk are uncorrelated with, or sometimes positively correlated with, education level and can be explained without reference to cultural or other values. We conclude that the recent claim that advanced scientific literacy and numeracy polarizes perceptions of climate change risk is unsupported by the forest owner data. In neither of the two countries was university education found to reduce the perception of risk from climate change. Indeed in most cases university education increased the perception of risk. Even more importantly, the effect of university education was not dependent on the individuals' value profile.	[Blennow, Kristina; Persson, Erik] Swedish Univ Agr Sci, Dept Landscape Architecture Planning & Management, Alnarp, Sweden; [Persson, Johannes] Lund Univ, Dept Philosophy, Lund, Sweden; [Hanewinkel, Marc] Univ Freiburg, Chair Forestry Econ & Forest Planning, Hugstetter Str 55, D-79106 Freiburg, Germany	Swedish University of Agricultural Sciences; Lund University; University of Freiburg	Blennow, K (corresponding author), Swedish Univ Agr Sci, Dept Landscape Architecture Planning & Management, Alnarp, Sweden.	kristina.blennow@slu.se	hanewinkel, marc/E-5639-2011; Persson, Erik/J-8155-2019; Blennow, Kristina/D-7388-2016	hanewinkel, marc/0000-0003-4081-6621; Persson, Erik/0000-0002-5000-948X; Blennow, Kristina/0000-0002-7602-5322; Persson, Johannes/0000-0003-4568-1850	EU [226544]; foundation for strategic environmental research programme Mistra-SWECIA; Bank of Sweden Tercentenary Foundation [M14-0138:1]; Linnaeus programme LUCID ("Lund University Centre of Excellence for Integration of Social and Natural Dimensions of Sustainability", FORMAS)	EU(European Commission); foundation for strategic environmental research programme Mistra-SWECIA; Bank of Sweden Tercentenary Foundation; Linnaeus programme LUCID ("Lund University Centre of Excellence for Integration of Social and Natural Dimensions of Sustainability", FORMAS)	This study was supported by the EU project MOTIVE ("Models for adaptive forest management", grant 226544) (Motive-project.net) to KB, EP and MH and the foundation for strategic environmental research programme Mistra-SWECIA to KB. (www.mistra-swecia.se/en). JP was supported by the Bank of Sweden Tercentenary Foundation programme VBE ("Vetenskap och beprovad erfarenhet" (www.vbe.lu.se), M14-0138:1) and the Linnaeus programme LUCID ("Lund University Centre of Excellence for Integration of Social and Natural Dimensions of Sustainability" (www.lucid.lu.se/), FORMAS, 2008-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, 1401 NSB NAT SCI FDN; [Anonymous], 2014, R LANG ENV STAT COMP; Blennow K, 2014, FORESTRY, V87, P219, DOI 10.1093/forestry/cpt032; Blennow K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050182; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; de Leeuw Jan., 2006, MULTIPLE CORRES ANAL; Douglas Mary, 1983, RISK CULTURE; DURANT JR, 1989, NATURE, V340, P11, DOI 10.1038/340011a0; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Hansen J, 2003, APPETITE, V41, P111, DOI 10.1016/S0195-6663(03)00079-5; Honaker J, 2011, J STAT SOFTW, V45, P1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Imai K, 2011, ZELIG EVERYONES STAT; Kahan DM, 2015, ANN AM ACAD POLIT SS, V658, P192, DOI 10.1177/0002716214559002; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Mair P, 2010, J STAT SOFTW, V32, P1; Meyer D, 2006, J STAT SOFTW, V17, P1, DOI [DOI 10.18637/JSS.V017.I03, 10.18637/jss.v017.i03]; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Persson E, 2011, REPORT STAKEHOLDER A; POULTON EC, 1968, PSYCHOL BULL, V69, P1, DOI 10.1037/h0025267; van de Vijver F, 1997, EUR REV APPL PSYCHOL, V47, P263; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weber EU, 2010, WIRES CLIM CHANGE, V1, P332, DOI 10.1002/wcc.41; Zetlaoui M, 2011, BIOMETRICS, V67, P1647, DOI 10.1111/j.1541-0420.2011.01588.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	29	11	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155137	10.1371/journal.pone.0155137	http://dx.doi.org/10.1371/journal.pone.0155137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GI	27223473	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000376881700016
J	Brunelle, BW; O'Grady, AM; Nicholson, EM; Seabury, CM				Brunelle, Brian W.; O'Grady, Allison M.; Nicholson, Eric M.; Seabury, Christopher M.			Disparate Modes of Evolution Shaped Modern Prion (PRNP) and Prion-Related Doppel (PRND) Variation in Domestic Cattle	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; STRONG PURIFYING SELECTION; STATISTICAL-METHOD; SIMPLE DEPENDENCE; DEATH EVOLUTION; GENE; KNOCKOUT; MICE; PRP; FAMILY	Previous investigations aimed at determining whether the mammalian prion protein actually facilitates tangible molecular aspects of either a discrete or pleiotropic functional niche have been debated, especially given the apparent absence of overt behavioral or physiological phenotypes associated with several mammalian prion gene (PRNP) knockout experiments. Moreover, a previous evaluation of PRNP knockout cattle concluded that they were normal, suggesting that the bovine prion protein is physiologically dispensable. Herein, we examined the frequency and distribution of nucleotide sequence variation within the coding regions of bovine PRNP and the adjacent Doppel (PRND) gene, a proximal paralogue to PRNP on BTA13. Evaluation of PRND variation demonstrated that the gene does not depart from a strictly neutral model of molecular evolution, and would therefore not be expected to influence tests of selection within PRNP. Collectively, our analyses confirm that intense purifying selection is indeed occurring directly on bovine PRNP, which is indicative of a protein with an important role. These results suggest that the lack of observed fitness effects may not manifest in the controlled environmental conditions used to care for and raise PRNP knockout animals.	[Brunelle, Brian W.; O'Grady, Allison M.; Nicholson, Eric M.] ARS, Virus & Pr Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [Seabury, Christopher M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Brunelle, Brian W.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA	United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA)	Nicholson, EM (corresponding author), ARS, Virus & Pr Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.; Seabury, CM (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	Eric.Nicholson@ars.usda.gov; CSeabury@cvm.tamu.edu			USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded in its entirety by congressional appropriation to the USDA-ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais-Bonnet A, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00056; Black SAG, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00045; Brunelle BW, 2008, J DAIRY SCI, V91, P338, DOI 10.3168/jds.2007-0423; Brunelle BW, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-36; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Cai JJ, 2009, GENOME BIOL EVOL, V1, P131, DOI 10.1093/gbe/evp013; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Fisher CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027744; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; FU YX, 1993, GENETICS, V133, P693; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Halliez S, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00058; HATEBOER G, 1995, EMBO J, V14, P3159, DOI 10.1002/j.1460-2075.1995.tb07318.x; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Karatayev O, 2010, ALCOHOL CLIN EXP RES, V34, P72, DOI 10.1111/j.1530-0277.2009.01068.x; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Makzhami S, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00035; Mastrangelo P, 2001, GENE, V275, P1, DOI 10.1016/S0378-1119(01)00627-8; Mehrabian M, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00053; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nakamura BN, 2010, FREE RADICAL BIO MED, V49, P1368, DOI 10.1016/j.freeradbiomed.2010.07.019; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M, 2000, P NATL ACAD SCI USA, V97, P10866, DOI 10.1073/pnas.97.20.10866; Nicholson EM, 2015, BIOANALYSIS, V7, P253, DOI 10.4155/bio.14.301; Ochs K, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00063; Piontkivska H, 2002, MOL BIOL EVOL, V19, P689, DOI 10.1093/oxfordjournals.molbev.a004127; Plackett TP, 2010, J AM COLL SURGEONS, V210, P73, DOI 10.1016/j.jamcollsurg.2009.09.019; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Premzl M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Rondena M, 2005, THERIOGENOLOGY, V63, P1195, DOI 10.1016/j.theriogenology.2004.06.009; Roucou X, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00057; Sakudo A, 2015, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00075; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Seabury CM, 2010, P NATL ACAD SCI USA, V107, P151, DOI 10.1073/pnas.0913006107; Seabury CM, 2004, P NATL ACAD SCI USA, V101, P15142, DOI 10.1073/pnas.0406403101; Seabury CM, 2004, MAMM GENOME, V15, P828, DOI 10.1007/s00335-004-2400-6; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Tobler I, 1997, J NEUROSCI, V17, P1869; Tsangaras K, 2014, J MOL EVOL, V79, P12, DOI 10.1007/s00239-014-9632-1; Watt NT, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00041; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Yi XW, 2010, ATHEROSCLEROSIS, V211, P424, DOI 10.1016/j.atherosclerosis.2010.03.009; Yu GH, 2006, J GEN VIROL, V87, P1019, DOI 10.1099/vir.0.81384-0	60	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155924	10.1371/journal.pone.0155924	http://dx.doi.org/10.1371/journal.pone.0155924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224046	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700041
J	Jordan-Williams, KL; Ramanujam, N; Farr, AG; Ruddell, A				Jordan-Williams, Kimberly L.; Ramanujam, Neela; Farr, Andrew G.; Ruddell, Alanna			The Lymphatic Endothelial mCLCA1 Antibody Induces Proliferation and Growth of Lymph Node Lymphatic Sinuses	PLOS ONE			English	Article							FIBROBLASTIC RETICULAR CELLS; VASCULAR-STROMAL GROWTH; CHLORIDE CHANNEL; TUMOR-METASTASIS; CD11C(+) CELLS; LYMPHANGIOGENESIS; INFLAMMATION; EXPANSION; GLYCOPROTEIN; HYALURONAN	Lymphocyte-and leukocyte-mediated lymph node (LN) lymphatic sinus growth (lymphangiogenesis) is involved in immune responses and in diseases including cancer and arthritis. We previously discovered a 10.1.1 Ab that recognizes the lymphatic endothelial cell (LEC) surface protein mCLCA1, which is an interacting partner for LFA1 and Mac-1 that mediates lymphocyte adhesion to LECs. Here, we show that 10.1.1 Ab treatment specifically induces LEC proliferation, and influences migration and adhesion in vitro. Functional testing by injection of mice with 10.1.1 Ab but not control hamster Abs identified rapid induction of LN LEC proliferation and extensive lymphangiogenesis within 23 h. BrdU pulse-chase analysis demonstrated incorporation of proliferating LYVE-1-positive LEC into the growing medullary lymphatic sinuses. The 10.1.1 Ab-induced LN remodeling involved coordinate increases in LECs and also blood endothelial cells, fibroblastic reticular cells, and double negative stroma, as is observed during the LN response to inflammation. 10.1.1 Ab-induced lymphangiogenesis was restricted to LNs, as mCLCA1-expressing lymphatic vessels of the jejunum and dermis were unaffected by 23 h 10.1.1 Ab treatment. These findings demonstrate that 10.1.1 Ab rapidly and specifically induces proliferation and growth of LN lymphatic sinuses and stroma, suggesting a key role of mCLCA1 in coordinating LN remodeling during immune responses.	[Jordan-Williams, Kimberly L.; Ruddell, Alanna] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Ramanujam, Neela; Ruddell, Alanna] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Farr, Andrew G.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Ruddell, A (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.; Ruddell, A (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	ruddella@uw.edu		Ruddell, Alanna/0000-0002-0195-5576	NIH-NCI [R01 CA68328]; Edson Foundation; NIH [T32CA080416]; Mary Gates Research Scholarship; NATIONAL CANCER INSTITUTE [T32CA080416, R01CA068328] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Edson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Gates Research Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NIH-NCI R01 CA68328 and the Edson Foundation (AR), NIH T32CA080416 (KLJ), and Mary Gates Research Scholarship (NR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Benahmed F, 2014, J IMMUNOL, V192, P4153, DOI 10.4049/jimmunol.1301765; Benahmed F, 2012, CLIN IMMUNOL, V144, P109, DOI 10.1016/j.clim.2012.05.004; Bouta EM, 2015, SEMIN CELL DEV BIOL, V38, P90, DOI 10.1016/j.semcdb.2015.01.001; Card CM, 2014, J CLIN INVEST, V124, P943, DOI 10.1172/JCI73316; Chang JE, 2015, TRENDS IMMUNOL, V36, P30, DOI 10.1016/j.it.2014.11.003; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; FARR A, 1992, J HISTOCHEM CYTOCHEM, V40, P651, DOI 10.1177/40.5.1374092; FARR A, 1993, J IMMUNOL, V150, P1160; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Furuya M, 2010, J IMMUNOL, V185, P5769, DOI 10.4049/jimmunol.1002226; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Guo RL, 2009, ARTHRITIS RHEUM-US, V60, P2666, DOI 10.1002/art.24764; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Hall KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031794; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Ji RC, 2009, HISTOL HISTOPATHOL, V24, P377, DOI 10.14670/HH-24.377; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Jordan-Williams KL, 2014, LYMPHAT RES BIOL, V12, P144, DOI 10.1089/lrb.2013.0053; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118; Lee JY, 2010, CIRCULATION, V122, P1413, DOI 10.1161/CIRCULATIONAHA.110.941468; Li J, 2010, J IMMUNOL, V184, P6142, DOI 10.4049/jimmunol.0903489; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Onder L, 2012, BLOOD, V120, P4675, DOI 10.1182/blood-2012-03-416859; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Ruddell A, 2008, ONCOGENE, V27, P3145, DOI 10.1038/sj.onc.1210973; Ruddell A, 2003, AM J PATHOL, V163, P2233, DOI 10.1016/S0002-9440(10)63581-X; Ruddell A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-354; Ruddell A, 2011, NEOPLASIA, V13, P748, DOI 10.1593/neo.11756; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Swartz MA, 2014, CANCER IMMUNOL RES, V2, P701, DOI 10.1158/2326-6066.CIR-14-0115; Tan KW, 2012, J IMMUNOL, V188, P4065, DOI 10.4049/jimmunol.1101854; Tewalt EF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00305; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156079	10.1371/journal.pone.0156079	http://dx.doi.org/10.1371/journal.pone.0156079			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224029	gold, Green Published, Green Submitted			2022-12-26	WOS:000376881700060
J	Wen, X; Pickens, J; Mousa, JJ; Leser, GP; Lamb, RA; Crowe, JE; Jardetzky, TS				Wen, Xiaolin; Pickens, Jennifer; Mousa, Jarrod J.; Leser, George P.; Lamb, Robert A.; Crowe, James E., Jr.; Jardetzky, Theodore S.			A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; F-PROTEIN; MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; GLYCOPROTEIN; INFECTION; VACCINE; MOTAVIZUMAB; PREFUSION	Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are paramyxoviruses that are responsible for substantial human health burden, particularly in children and the elderly. The fusion (F) glycoproteins are major targets of the neutralizing antibody response and studies have mapped dominant antigenic sites in F. Here we grafted a major neutralizing site of RSV F, recognized by the prophylactic monoclonal antibody palivizumab, onto HMPV F, generating a chimeric protein displaying epitopes of both viruses. We demonstrate that the resulting chimeric protein (RPM-1) is recognized by both anti-RSV and anti-HMPV F neutralizing antibodies indicating that it can be used to map the epitope specificity of antibodies raised against both viruses. Mice immunized with the RPM-1 chimeric antigen generate robust neutralizing antibody responses to MPV but weak or no cross-reactive recognition of RSV F, suggesting that grafting of the single palivizumab epitope stimulates a comparatively limited antibody response. The RPM-1 protein provides a new tool for characterizing the immune responses resulting from RSV and HMPV infections and provides insights into the requirements for developing a chimeric subunit vaccine that could induce robust and balanced immunity to both virus infections.	[Wen, Xiaolin; Jardetzky, Theodore S.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Pickens, Jennifer; Mousa, Jarrod J.; Crowe, James E., Jr.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Pickens, Jennifer; Mousa, Jarrod J.; Crowe, James E., Jr.] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, 221 Kirkland Hall, Nashville, TN 37235 USA; [Leser, George P.; Lamb, Robert A.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA; [Leser, George P.; Lamb, Robert A.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Crowe, James E., Jr.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	Stanford University; Vanderbilt University; Vanderbilt University; Howard Hughes Medical Institute; Northwestern University; Northwestern University; Vanderbilt University	Jardetzky, TS (corresponding author), Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA.	tjardetz@stanford.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079; Mousa, Jarrod/0000-0003-4709-2478	National Institutes of Health [AI-23173, GM-61050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by National Institutes of Health (http://www.nih.gov/) Research Grants AI-23173 (to R.A.L.) and GM-61050 (to T.S.J.). R.A.L. is an Investigator of the Howard Hughes Medical Institute (https://www.hhmi.org/).	Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; [Anonymous], 2013, FIELDS VIROLOGY; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Connolly SA, 2006, P NATL ACAD SCI USA, V103, P17903, DOI 10.1073/pnas.0608678103; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fenton Caroline, 2004, Paediatr Drugs, V6, P177, DOI 10.2165/00148581-200406030-00004; Gill MA, 2009, EXPERT OPIN BIOL TH, V9, P1335, DOI 10.1517/14712590903287499; Gilman MSA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005035; Graham BS, 2015, CURR OPIN IMMUNOL, V35, P30, DOI 10.1016/j.coi.2015.04.005; Graham BS, 2013, CURR TOP MICROBIOL, V372, P391, DOI 10.1007/978-3-642-38919-1_20; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; Hall Caroline Breese, 2012, Infectious Disorders - Drug Targets, V12, P92; Hamelin ME, 2010, ANTIVIR RES, V88, P31, DOI 10.1016/j.antiviral.2010.07.001; Jardetzky TS, 2014, CURR OPIN VIROL, V5, P24, DOI 10.1016/j.coviro.2014.01.005; Luo XZ, 2015, ANGEW CHEM INT EDIT, V54, P14531, DOI 10.1002/anie.201507928; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Schickli JH, 2009, HUM VACCINES, V5, P582, DOI 10.4161/hv.9131; Schuster JE, 2015, J INFECT DIS, V211, P216, DOI 10.1093/infdis/jiu307; Stewart-Jones GBE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128779; Swanson K, 2010, VIROLOGY, V402, P372, DOI 10.1016/j.virol.2010.03.050; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Ulbrandt ND, 2006, J VIROL, V80, P7799, DOI 10.1128/JVI.00318-06; Ulbrandt ND, 2008, J GEN VIROL, V89, P3113, DOI 10.1099/vir.0.2008/005199-0; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Weisman LE, 2009, CURR OPIN MOL THER, V11, P208; Wen XL, 2012, NAT STRUCT MOL BIOL, V19, P461, DOI 10.1038/nsmb.2250; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155917	10.1371/journal.pone.0155917	http://dx.doi.org/10.1371/journal.pone.0155917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224013	gold, Green Published			2022-12-26	WOS:000376881700040
J	Barington, L; Rummel, PC; Luckmann, M; Pihl, H; Larsen, O; Daugvilaite, V; Johnsen, AH; Frimurer, TM; Karlshoj, S; Rosenkilde, MM				Barington, Line; Rummel, Pia C.; Luckmann, Michael; Pihl, Heidi; Larsen, Olav; Daugvilaite, Viktorija; Johnsen, Anders H.; Frimurer, Thomas M.; Karlshoj, Stefanie; Rosenkilde, Mette M.			Role of Conserved Disulfide Bridges and Aromatic Residues in Extracellular Loop 2 of Chemokine Receptor CCR8 for Chemokine and Small Molecule Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; T-CELLS; PROTEIN; ACTIVATION; IDENTIFICATION; RECOGNITION; MODULATION; INHIBITOR; SEQUENCE	Chemokine receptors play important roles in the immune system and are linked to several human diseases. The initial contact of chemokines with their receptors depends on highly specified extracellular receptor features. Here we investigate the importance of conserved extracellular disulfide bridges and aromatic residues in extracellular loop 2 (ECL-2) for ligand binding and activation in the chemokine receptor CCR8. We used inositol 1,4,5-trisphosphate accumulation and radioligand binding experiments to determine the impact of receptor mutagenesis on both chemokine and small molecule agonist and antagonist binding and action in CCR8. We find that the seven-transmembrane (TM) receptor conserved disulfide bridge (7TM bridge) linking transmembrane helix III (TMIII) and ECL-2 is crucial for chemokine and small molecule action, whereas the chemokine receptor conserved disulfide bridge between the N terminus and TMVII is needed only for chemokines. Furthermore, we find that two distinct aromatic residues in ECL-2, Tyr(184) (Cys + 1) and Tyr(187) (Cys + 4), are crucial for binding of the CC chemokines CCL1 (agonist) and MC148 (antagonist), respectively, but not for small molecule binding. Finally, using in silico modeling, we predict an aromatic cluster of interaction partners for Tyr(187) in TMIV (Phe(171)) and TMV (Trp(194)). We show in vitro that these residues are crucial for the binding and action of MC148, thus supporting their participation in an aromatic cluster with Tyr(187). This aromatic cluster appears to be present in a large number of CC chemokine receptors and thereby could play a more general role to be exploited in future drug development targeting these receptors.	[Barington, Line; Rummel, Pia C.; Luckmann, Michael; Pihl, Heidi; Larsen, Olav; Daugvilaite, Viktorija; Karlshoj, Stefanie; Rosenkilde, Mette M.] Univ Copenhagen, Dept Neurosci & Pharmacol, Panum Inst Bldg 18-5,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Luckmann, Michael; Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Johnsen, Anders H.] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Rosenkilde, MM (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Panum Inst Bldg 18-5,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	DAUGVILAITE, VIKTORIJA/E-2573-2017; Daugvilaite, Viktorija/AAI-1490-2019	DAUGVILAITE, VIKTORIJA/0000-0001-8786-348X; Daugvilaite, Viktorija/0000-0001-8786-348X; Barington, Line/0000-0003-4282-6970; Frimruer, Thomas/0000-0002-9682-8245; Karlshoj, Stefanie/0000-0001-6505-0883; Luckmann, Michael/0000-0002-6294-1768; Rosenkilde, Mette Marie/0000-0001-9600-3254	Det Frie Forskningsrad; Horslev-Fonden; Lundbeckfonden; Novo Nordisk; Novo Nordisk Foundation Center for Basic Metabolic Research; NovoNordisk Foundation Center for Protein Research; Novo Nordisk Fonden [NNF12OC0001900] Funding Source: researchfish	Det Frie Forskningsrad(Det Frie Forskningsrad (DFF)); Horslev-Fonden; Lundbeckfonden(Lundbeckfonden); Novo Nordisk(Novo Nordisk); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); NovoNordisk Foundation Center for Protein Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Det Frie Forskningsrad, Horslev-Fonden, Lundbeckfonden, Novo Nordisk, Novo Nordisk Foundation Center for Basic Metabolic Research, and NovoNordisk Foundation Center for Protein Research. The authors declare that they have no conflicts of interest with the contents of this article.	Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Ai LS, 2002, BIOCHEMISTRY-US, V41, P8332, DOI 10.1021/bi025855y; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Chalikiopoulos A, 2013, J CHEM INF MODEL, V53, P2863, DOI 10.1021/ci4003848; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Damon I, 1998, P NATL ACAD SCI USA, V95, P6403, DOI 10.1073/pnas.95.11.6403; Gadhe CG, 2015, J BIOMOL STRUCT DYN, V33, P2491, DOI 10.1080/07391102.2014.1002006; GAO JL, 1994, J BIOL CHEM, V269, P28539; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Heydorn A, 2004, MOL PHARMACOL, V66, P250, DOI 10.1124/mol.66.2.250; Islam SA, 2013, J EXP MED, V210, P1889, DOI 10.1084/jem.20130240; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jenkins TJ, 2007, J MED CHEM, V50, P566, DOI 10.1021/jm061118e; Jensen PC, 2012, BRIT J PHARMACOL, V166, P258, DOI 10.1111/j.1476-5381.2011.01771.x; Jensen PC, 2008, J BIOL CHEM, V283, P23121, DOI 10.1074/jbc.M803458200; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Jin J, 2007, BIOORG MED CHEM LETT, V17, P1722, DOI 10.1016/j.bmcl.2006.12.076; Karlsson AKC, 2011, BIOCHEM BIOPH RES CO, V407, P764, DOI 10.1016/j.bbrc.2011.03.097; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Limatola C, 2005, EXP CELL RES, V307, P65, DOI 10.1016/j.yexcr.2005.02.020; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; McLean KA, 2004, VIROLOGY, V325, P241, DOI 10.1016/j.virol.2004.04.027; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Pease JE, 2010, CLIN EXP ALLERGY, V40, P1110, DOI 10.1111/j.1365-2222.2010.03552.x; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Rummel PC, 2012, BRIT J PHARMACOL, V167, P1206, DOI 10.1111/j.1476-5381.2012.02076.x; Rummel PC, 2013, MOL PHARMACOL, V84, P335, DOI 10.1124/mol.113.086702; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwarz MK, 2002, NAT REV DRUG DISCOV, V1, P347, DOI 10.1038/nrd795; Soler D, 2006, J IMMUNOL, V177, P6940, DOI 10.4049/jimmunol.177.10.6940; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2014, CURR MED CHEM, V21, P3594, DOI 10.2174/0929867321666140716093155; Thiele S, 2012, J MED CHEM, V55, P8164, DOI 10.1021/jm301121j; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	64	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16208	16220		10.1074/jbc.M115.706747	http://dx.doi.org/10.1074/jbc.M115.706747			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226537	hybrid, Green Published			2022-12-26	WOS:000380585400025
J	Guthrie, LN; Abiraman, K; Plyler, ES; Sprenkle, NT; Gibson, SA; McFarland, BC; Rajbhandari, R; Rowse, AL; Benveniste, EN; Meares, GP				Guthrie, Lauren N.; Abiraman, Kavitha; Plyler, Emily S.; Sprenkle, Neil T.; Gibson, Sara A.; McFarland, Braden C.; Rajbhandari, Rajani; Rowse, Amber L.; Benveniste, Etty N.; Meares, Gordon P.			Attenuation of PKR-like ER Kinase (PERK) Signaling Selectively Controls Endoplasmic Reticulum Stress-induced Inflammation Without Compromising Immunological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; NEURODEGENERATIVE DISEASES; INNATE IMMUNITY; CELLS; ACTIVATION; ASTROCYTES; EXPRESSION; SYSTEM; GROWTH; DAMAGE	Inflammation and endoplasmic reticulum (ER) stress are associated with many neurological diseases. ER stress is brought on by the accumulation of misfolded proteins in the ER, which leads to activation of the unfolded protein response (UPR), a conserved pathway that transmits signals to restore homeostasis or eliminate the irreparably damaged cell. We provide evidence that inhibition or genetic haploinsufficiency of protein kinase R-like endoplasmic reticulum kinase (PERK) can selectively control inflammation brought on by ER stress without impinging on UPR-dependent survival and adaptive responses or normal immune responses. Using astrocytes lacking one or both alleles of PERK or the PERK inhibitor GSK2606414, we demonstrate that PERK haploinsufficiency or partial inhibition led to reduced ER stress-induced inflammation (IL-6, CCL2, and CCL20 expression) without compromising prosurvival responses. In contrast, complete loss of PERK blocked canonical PERK-dependent UPR genes and promoted apoptosis. Reversal of eIF2 alpha-mediated translational repression using ISRIB potently suppressed PERK-dependent inflammatory gene expression, indicating that the selective modulation of inflammatory gene expression by PERK inhibition may be linked to attenuation of eIF2 alpha phosphorylation and reveals a previously unknown link between translational repression and transcription of inflammatory genes. Additionally, ER-stressed astrocytes can drive an inflammatory M1-like phenotype in microglia, and this can be attenuated with inhibition of PERK. Importantly, targeting PERK neither disrupted normal cytokine signaling in astrocytes or microglia nor impaired macrophage phagocytosis or T cell polarization. Collectively, this work suggests that targeting PERK may provide a means for selective immunoregulation in the context of ER stress without disrupting normal immune function.	[Guthrie, Lauren N.; Plyler, Emily S.; Sprenkle, Neil T.; Meares, Gordon P.] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, 1 Med Ctr Dr,BMRC 311, Morgantown, WV 26505 USA; [Abiraman, Kavitha; Gibson, Sara A.; McFarland, Braden C.; Rajbhandari, Rajani; Rowse, Amber L.; Benveniste, Etty N.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	West Virginia University; University of Alabama System; University of Alabama Birmingham	Meares, GP (corresponding author), West Virginia Univ, Dept Microbiol Immunol & Cell Biol, 1 Med Ctr Dr,BMRC 311, Morgantown, WV 26505 USA.	gpmeares@hsc.wvu.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155; McFarland, Braden C./0000-0002-7517-9688	National Multiple Sclerosis Society [TA3050-A-1, CA-1059-A-13]; National Institutes of Health [NS57563, CA158534]; West Virginia Clinical and Translational Science Institute; NIGMS, National Institutes of Health [U54GM104942]; NATIONAL CANCER INSTITUTE [R01CA158534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057563] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia Clinical and Translational Science Institute; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Multiple Sclerosis Society Career Transition Award TA3050-A-1 (to G. P. M.), National Multiple Sclerosis Society Collaborative Award CA-1059-A-13 (to E. N. B.), and National Institutes of Health Grants NS57563 and CA158534 (to E. N. B.). Support was also provided by the West Virginia Clinical and Translational Science Institute and NIGMS, National Institutes of Health Grant U54GM104942. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; Halliday M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.49; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14; Meares GP, 2013, J IMMUNOL, V190, P372, DOI 10.4049/jimmunol.1202390; Meares GP, 2004, FEBS LETT, V574, P181, DOI 10.1016/j.febslet.2004.08.026; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Verkhratsky A, 2014, BIOCHEM SOC T, V42, P1291, DOI 10.1042/BST20140107; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	41	58	58	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15830	15840		10.1074/jbc.M116.738021	http://dx.doi.org/10.1074/jbc.M116.738021			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226638	hybrid, Green Published			2022-12-26	WOS:000380584200035
J	Ishikura, S; Iwaihara, Y; Tanaka, Y; Luo, H; Nishi, K; Doi, K; Koyanagi, M; Okamura, T; Tsunoda, T; Shirasawa, S				Ishikura, Shuhei; Iwaihara, Yuri; Tanaka, Yoko; Luo, Hao; Nishi, Kensuke; Doi, Keiko; Koyanagi, Midori; Okamura, Tadashi; Tsunoda, Toshiyuki; Shirasawa, Senji			The Nuclear Zinc Finger Protein Zfat Maintains Fox01 Protein Levels in Peripheral T Cells by Regulating the Activities of Autophagy and the Akt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE THYROID-DISEASE; TRANSCRIPTION FACTORS; PROTEASOMAL DEGRADATION; CULTURED-CELLS; BETA-SECRETASE; H+-ATPASE; FOXO1; HOMEOSTASIS; INHIBITION; SURVIVAL	Forkhead box O1 (FoxO1) is a key molecule for the development and functions of peripheral 'I' cells. However, the precise mechanisms regulating FoxO1 expression in peripheral T cells remain elusive. We previously reported that Zfat"-CD4Cre mice showed a marked decline in FoxO1 protein levels in peripheral T cells, partially through proteasomal degradation. Here we have identified the precise mechanisms, apart from proteasorne-mediated degradation, of the decreased FoxO1 levels in Zfat-deficient T cells. First, we confirmed that tamoxifeninducible deletion of Zfat in Zfat ff-CreERT2 mice coincidently decreases FoxO1 protein levels in peripheral T cells, indicating that Zfat is essential for maintaining FoxO1 levels in these cells. Although the proteasome-specific inhibitors lactacystin and epoxomicin only moderately increase FoxO1 protein levels, the inhibitors of lysosomal proteolysis bafilomycin A1 and chloroquine restore the decreased FoxO1 levels in Zfat-deficient T cells to levels comparable with those in control cells. Furthermore, Zfat-deficient 'I' cells show increased numbers of autophagosomes and decreased levels of p62 protein, together indicating that Zfat deficiency promotes lysosomal FoxO1 degradation through autophagy. In addition, Zfat deficiency increases the phosphorylation levels of Thr-308 and Ser-473 of Akt and the relative amounts of cytoplasmic to nuclear FoxO1 protein levels, indicating that Zfat deficiency causes Akt activation, leading to nuclear exclusion of FoxOl. Our findings have demonstrated a novel role of Zfat in maintaining FoxO1 protein levels in peripheral T cells by regulating the activities of autophagy and the Akt signaling pathway.	[Ishikura, Shuhei; Iwaihara, Yuri; Tanaka, Yoko; Luo, Hao; Nishi, Kensuke; Doi, Keiko; Koyanagi, Midori; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Fukuoka 8140180, Japan; [Ishikura, Shuhei; Iwaihara, Yuri; Tanaka, Yoko; Doi, Keiko; Koyanagi, Midori; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Cent Res Inst Adv Mol Med, Fukuoka 8140180, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Lab Anim Med, Tokyo 1628655, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Sect Anim Models, Dept Infect Dis, Tokyo 1628655, Japan	Fukuoka University; Fukuoka University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Shirasawa, S (corresponding author), Fukuoka Univ, Dept Cell Biol, Fac Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	sshirasa@fukuoka-u.ac.jp			JSPS; MEXT-supported Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research [15K08166] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research B (to S. S.) from the JSPS and a Grant-in-Aid for the FOAM from the MEXT-supported Program for the Strategic Research Foundation at Private Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Abbenante G, 2000, BIOCHEM BIOPH RES CO, V268, P133, DOI 10.1006/bbrc.2000.2098; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Arden KC, 2002, ARCH BIOCHEM BIOPHYS, V403, P292, DOI 10.1016/S0003-9861(02)00207-2; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Comabella M, 2009, ARCH NEUROL-CHICAGO, V66, P972, DOI 10.1001/archneurol.2009.150; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Doi K, 2014, ANTICANCER RES, V34, P4489; Doi K, 2012, BIOCHEM BIOPH RES CO, V425, P107, DOI 10.1016/j.bbrc.2012.07.065; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fujimoto T, 2009, FEBS LETT, V583, P568, DOI 10.1016/j.febslet.2008.12.063; HASHIDA S, 1980, J BIOCHEM-TOKYO, V88, P1805, DOI 10.1093/oxfordjournals.jbchem.a133155; Hawse WF, 2015, J IMMUNOL, V194, P4615, DOI 10.4049/jimmunol.1402554; HAYASHI M, 1992, BIOCHEM BIOPH RES CO, V182, P939, DOI 10.1016/0006-291X(92)91822-8; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Inoue N, 2012, J CLIN IMMUNOL, V32, P1243, DOI 10.1007/s10875-012-9721-0; Ishikura S, 2015, J CELL BIOCHEM, V116, P149, DOI 10.1002/jcb.24954; Ito H, 2009, J ENZYM INHIB MED CH, V24, P279, DOI [10.1080/14756360802166921, 10.1080/14756360802166921 ]; Iwaihara Y, 2015, ANTICANCER RES, V35, P4419; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Koyanagi M, 2008, GENOMICS, V91, P451, DOI 10.1016/j.ygeno.2008.01.009; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Laine A, 2015, J IMMUNOL, V195, P1791, DOI 10.4049/jimmunol.1500849; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Luo CT, 2013, TRENDS IMMUNOL, V34, P531, DOI 10.1016/j.it.2013.08.003; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; McLeod IX, 2011, J IMMUNOL, V187, P5051, DOI 10.4049/jimmunol.1100710; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Newton RH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00151; Ogawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076254; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Tsunoda T, 2013, ANTICANCER RES, V33, P2833; Tsunoda T, 2010, P NATL ACAD SCI USA, V107, P14199, DOI 10.1073/pnas.1002494107; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	60	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15282	15291		10.1074/jbc.M116.723734	http://dx.doi.org/10.1074/jbc.M116.723734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226588	hybrid, Green Published			2022-12-26	WOS:000380583200034
J	Mitzelfelt, KA; Limphong, P; Choi, MJ; Kondrat, FDL; Lai, SP; Kolander, KD; Kwok, WM; Dai, Q; Grzybowski, MN; Zhang, HL; Taylor, GM; Lui, Q; Thao, MT; Hudson, JA; Barresi, R; Bushby, K; Jungbluth, H; Wraige, E; Geurts, AM; Benesch, JLP; Riedel, M; Christians, ES; Minella, AC; Benjamina, IJ				Mitzelfelt, Katie A.; Limphong, Pattraranee; Choi, Melinda J.; Kondrat, Frances D. L.; Lai, Shuping; Kolander, Kurt D.; Kwok, Wai-Meng; Dai, Qiang; Grzybowski, Michael N.; Zhang, Huali; Taylor, Graydon M.; Lui, Qiang; Thao, Mai T.; Hudson, Judith A.; Barresi, Rita; Bushby, Kate; Jungbluth, Heinz; Wraige, Elizabeth; Geurts, Aron M.; Benesch, Justin L. P.; Riedel, Michael; Christians, Elisabeth S.; Minella, Alex C.; Benjamina, Ivor J.			The Human 343delT HSPB5 Chaperone Associated with Early-onset Skeletal Myopathy Causes Defects in Protein Solubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; PLURIPOTENT STEM-CELLS; FILAMENT INTERACTIONS; MUSCLE; DESMIN; GENE; EXPRESSION; AGGREGATION; DEGRADATION	Mutations of HSP B 5 (also known as CRYAB or all-crystallin), a bona fide heat shock protein and molecular chaperone encoded by the HSPB5 (crystallin, alpha B) gene, are linked to multisystem disorders featuring variable combinations of cataracts, cardiomyopathy, and skeletal myopathy. This study aimed to investigate the pathological mechanisms involved in an early onset myofibrillar myopathy manifesting in a child harboring a homozygous recessive mutation in HSPB5, 343delT. To study HSPB5 343delT protein dynamics, we utilize model cell culture systems including induced pluripotent stein cells derived from the 343delT patient (343delT/343delT) along with isogenic, heterozygous, gene -corrected control cells (WT Kit 343delT) and BHK21 cells, a cell line lacking endogenous HSPB5 expression. 343delT/343delT and WT KI/343delT-induced pluripotent stem cell-derived skeletal myotubes and cardiomyocytes did not express detectable levels of 343delT protein, contributable to the extreme insolubility of the mutant protein. Overexpression of HSPB5 343delT resulted in insoluble mutant protein aggregates and induction of a cellular stress response. Co-expression of 343delT with WT prevented visible aggregation of 343delT and improved its solubility. Additionally, in vitro refolding of 343delT in the presence of WT rescued its solubility. We demonstrate an interaction between WT and 343delT both in vitro and within cells. These data support a loss-of-function model for the myopathy observed in the patient because the insoluble mutant would be unavailable to perform normal functions of HSPB5, although additional gain-of-function effects of the mutant protein cannot be excluded. Additionally, our data highlight the solubilization of 343delT by WT, concordant with the recessive inheritance of the disease and absence of symptoms in carrier individuals.	[Mitzelfelt, Katie A.; Benjamina, Ivor J.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Limphong, Pattraranee] Arcturus Therapeut, San Diego, CA 92121 USA; [Choi, Melinda J.; Lai, Shuping; Kolander, Kurt D.; Dai, Qiang; Grzybowski, Michael N.; Thao, Mai T.; Geurts, Aron M.; Benjamina, Ivor J.] Med Coll Wisconsin, Ctr Cardiovasc, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Kwok, Wai-Meng] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Kwok, Wai-Meng] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Kondrat, Frances D. L.; Benesch, Justin L. P.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England; [Zhang, Huali] Cent S Univ, Xiangya Sch Med, Dept Pathophysiol, Changsha 410078, Hunan, Peoples R China; [Taylor, Graydon M.; Lui, Qiang] Univ Utah, Dept Med, Div Cardiol, Salt Lake City, UT 84132 USA; [Hudson, Judith A.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northem Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Barresi, Rita] Dent Hosp, Muscle Immunoanalysis Unit, Natl Hlth Serv, England Hlth Sci Serv Rare Neuromuscular Dis, Newcastle Upon Tyne NE2 4AZ, Tyne & Wear, England; [Bushby, Kate] Newcastle Univ, Inst Med Genet, Med Res Council Ctr Neuromuscular Dis,Neuromuscul, John Walton Ctr Muscular Dystrophy Res,Int Ctr Li, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Jungbluth, Heinz; Wraige, Elizabeth] Guys & St Thomas Natl Hlth Serv Fdn Trust, Evelina Childrens Hosp, Neuromuscular Serv, Dept Paediat Neurol, London SE1 7EH, England; [Jungbluth, Heinz] Kings Coll London, Muscle Signalling Sect, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Jungbluth, Heinz] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London SE5 9RX, England; [Riedel, Michael] PharmaCell, NL-6229 EV Maastricht, Netherlands; [Christians, Elisabeth S.] Univ Paris 06, Sorbonne Univ, CNRS, LBDV,UMR 7009, 181 Chemin Lazaret, F-06230 Villefranche Sur Mer, France; [Minella, Alex C.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA	Utah System of Higher Education; University of Utah; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Oxford; Central South University; Utah System of Higher Education; University of Utah; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; NHS Blood & Transplant (NHSBT); Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Versiti Blood Center of Wisconsin	Benjamina, IJ (corresponding author), Med Coll Wisconsin, Ctr Cardiovasc, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	ibenjamin@mcw.edu	Barresi, Rita/AAB-9569-2022	Barresi, Rita/0000-0001-7351-959X; Jungbluth, Heinz/0000-0002-7159-3427; Minella, Alex/0000-0001-6693-3362	National Institute of Health [8DP1HL17650-04]; Royal Society; Ruth L. Kirschstein National Research Service Award F31 Individual Fellowship [1F31AR067618-01A1]; Biotechnology and Biological Sciences Research Council [BB/J018082/1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR067618] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008396] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0512-10036] Funding Source: researchfish; BBSRC [BB/J018082/1] Funding Source: UKRI	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Ruth L. Kirschstein National Research Service Award F31 Individual Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Institute of Health Director's Pioneer Award Grant 8DP1HL17650-04 (to I. J. B.) and a Royal Society University Research Fellowship (to J. L. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Ruth L. Kirschstein National Research Service Award F31 Individual Fellowship 1F31AR067618-01A1.r Supported by the Biotechnology and Biological Sciences Research Council (BB/J018082/1).	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bekes M, 2011, J BIOL CHEM, V286, P10238, DOI 10.1074/jbc.M110.205153; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Christians ES, 2014, CURR PROTEIN PEPT SC, V15, P189, DOI 10.2174/1389203715666140331111518; Christians ES, 2012, INT J BIOCHEM CELL B, V44, P1632, DOI 10.1016/j.biocel.2012.06.006; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Elliott JL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0375; Flores-Jasso CF, 2009, ACTA PHARMACOL SIN, V30, P1177, DOI 10.1038/aps.2009.108; Forrest KML, 2011, NEUROMUSCULAR DISORD, V21, P37, DOI 10.1016/j.nmd.2010.11.003; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; GOPALSRIVASTAVA R, 1993, MOL CELL BIOL, V13, P7144, DOI 10.1128/MCB.13.11.7144; GOPALSRIVASTAVA R, 1995, MOL CELL BIOL, V15, P7081; Hochberg GKA, 2014, PROG BIOPHYS MOL BIO, V115, P11, DOI 10.1016/j.pbiomolbio.2014.03.003; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Houck SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025859; Jackstadt R, 2015, BBA-GENE REGUL MECH, V1849, P544, DOI 10.1016/j.bbagrm.2014.04.003; Kotter S, 2014, J CELL BIOL, V204, P187, DOI 10.1083/jcb.201306077; Kondrat F. L., 2015, STRUCTURAL PROTEOMIC, P349; Kumarapeli ARK, 2008, CIRC RES, V103, P1473, DOI 10.1161/CIRCRESAHA.108.180117; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Mitzelfelt K. A., 2015, BIG BOOK SMALL HEAT, P269; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Neppl RL, 2014, J BIOL CHEM, V289, P17240, DOI 10.1074/jbc.M114.549584; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Perng MD, 1999, J CELL SCI, V112, P2099; Peroutka RJ, 2008, PROTEIN SCI, V17, P1586, DOI 10.1110/ps.035576.108; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Rajagopal P, 2015, ELIFE, V4, DOI 10.7554/eLife.07304; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang HL, 2010, J MOL CELL CARDIOL, V49, P918, DOI 10.1016/j.yjmcc.2010.09.004	48	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14939	14953		10.1074/jbc.M116.730481	http://dx.doi.org/10.1074/jbc.M116.730481			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226619	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000380583200007
J	Liu, YZ; Cheng, XY; Zhang, T; Lee, S; Yamauchi, J; Xiao, X; Gittes, G; Qu, S; Jiang, CL; Dong, HH				Liu, Yun-Zi; Cheng, Xiaoyun; Zhang, Ting; Lee, Sojin; Yamauchi, Jun; Xiao, Xiangwei; Gittes, George; Qu, Shen; Jiang, Chun-Lei; Dong, H. Henry			Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell ( cell); dyslipidemia; lipid metabolism; obesity; type 2 diabetes; ApoC3; apolipoprotein c	APOLIPOPROTEIN-C-III; TRIGLYCERIDE-RICH LIPOPROTEIN; CYTOKINE-INDUCED APOPTOSIS; LOW-DENSITY LIPOPROTEINS; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; PLASMA-LIPOPROTEINS; OXIDATIVE STRESS; LIPASE ACTIVITY	Hypertriglyceridemia results from increased production and decreased clearance of triglyceride-rich very low-density lipoproteins, a pathological condition that accounts for heightened risk of ischemic vascular diseases in obesity and type 2 diabetes. Despite its intimate association with insulin resistance, whether hypertriglyceridemia constitutes an independent risk for beta cell dysfunction in diabetes is unknown. Answering this fundamental question is stymied by the fact that hypertriglyceridemia is intertwined with hyperglycemia and insulin resistance in obese and diabetic subjects. To circumvent this limitation, we took advantage of apolipoprotein C3 (ApoC3)-transgenic mice, a model with genetic predisposition to hypertriglyceridemia. We showed that ApoC3-transgenic mice, as opposed to age/sex-matched wild-type littermates, develop hypertriglyceridemia with concomitant elevations in plasma cholesterol and non-esterified fatty acid levels. Anti-insulin and anti-glucagon dual immunohistochemistry in combination with morphometric analysis revealed that ApoC3-transgenic and wild-type littermates had similar beta cell and alpha cell masses as well as islet size and architecture. These effects correlated with similar amplitudes of glucose-stimulated insulin secretion and similar degrees of postprandial glucose excursion in ApoC3-transgenic versus wild-type littermates. Oil Red O histology did not visualize lipid infiltration into islets, correlating with the lack of ectopic triglyceride and cholesterol depositions in the pancreata of ApoC3-transgenic versus wild-type littermates. ApoC3-transgenic mice, despite persistent hypertriglyceridemia, maintained euglycemia under both fed and fasting conditions without manifestation of insulin resistance and fasting hyperinsulinemia. Thus, hypertriglyceridemia per se is not an independent risk factor for beta cell dysfunction in ApoC3 transgenic mice.	[Liu, Yun-Zi; Cheng, Xiaoyun; Zhang, Ting; Lee, Sojin; Yamauchi, Jun; Dong, H. Henry] Univ Pittsburgh, Sch Med, Dept Pediat,UPMC, Div Pediat Endocrinol,Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Xiao, Xiangwei; Gittes, George] Univ Pittsburgh, Sch Med, Dept Surg, Div Pediat Surg,Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15224 USA; [Liu, Yun-Zi; Jiang, Chun-Lei] Second Mil Med Univ, Fac Psychol & Mental Hlth, Shanghai 200433, Peoples R China; [Cheng, Xiaoyun; Qu, Shen] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Endocrinol & Metab, Shanghai 200072, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Naval Medical University; Tongji University	Dong, HH (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	dongh@pitt.edu	Cheng, Xiaoyun/HDM-5535-2022	Xiao, Xiangwei/0000-0003-0890-9203; Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01 DK098437]; Chinese Natural Science Foundation [201306580015]; Chinese College and Education Interdisciplinary Research Fund in Tongji University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese College and Education Interdisciplinary Research Fund in Tongji University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK098437. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no conflicts of interest to declare with the contents of this article.; Recipient of Fellowship 201306580015 from the Chinese Natural Science Foundation.; Supported in part by the Chinese College and Education Interdisciplinary Research Fund in Tongji University.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Avall K, 2015, P NATL ACAD SCI USA, V112, pE2611, DOI 10.1073/pnas.1423849112; Bard JM, 2001, ARTERIOSCL THROM VAS, V21, P407, DOI 10.1161/01.ATV.21.3.407; Brewer HB, 1999, AM J CARDIOL, V83, p3F; Chan DC, 2006, ARTERIOSCL THROM VAS, V26, P590, DOI 10.1161/01.ATV.0000203519.25116.54; Chan DC, 2002, CLIN CHEM, V48, P278; CHEN M, 1994, J LIPID RES, V35, P1918; Cohn JS, 2004, J CLIN ENDOCR METAB, V89, P3949, DOI 10.1210/jc.2003-032056; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dallinga-Thie GM, 2001, J LIPID RES, V42, P1450; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; Gerritsen G, 2005, J LIPID RES, V46, P1466, DOI 10.1194/jlr.M400479-JLR200; Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P2753, DOI 10.1161/01.ATV.17.11.2753; HERBERT PN, 1983, METABOLIC BASIS INHE, P589; Hopkins PN, 2003, CIRCULATION, V108, P519, DOI 10.1161/01.CIR.0000081777.17879.85; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Jong MC, 2001, J LIPID RES, V42, P1578; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; KINNUNEN PKJ, 1976, FEBS LETT, V65, P354, DOI 10.1016/0014-5793(76)80145-7; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Krauss RM, 1998, AM J CARDIOL, V81, p13B, DOI 10.1016/S0002-9149(98)00032-0; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCCONATHY WJ, 1992, J LIPID RES, V33, P995; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Nieves DJ, 2003, DIABETES, V52, P172, DOI 10.2337/diabetes.52.1.172; Norata GD, 2015, TRENDS PHARMACOL SCI, V36, P675, DOI 10.1016/j.tips.2015.07.001; Olivieri O, 2002, J LIPID RES, V43, P1450, DOI 10.1194/jlr.M200145-JLR200; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Qu S, 2007, J LIPID RES, V48, P1476, DOI 10.1194/jlr.M600498-JLR200; QUARFORDT SH, 1982, J BIOL CHEM, V257, P4642; REAVEN GM, 1994, J LIPID RES, V35, P820; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; STEWART MW, 1994, J INTERN MED, V236, P41; Storling J, 2011, ENDOCRINOLOGY, V152, P3040, DOI 10.1210/en.2010-1422; Su DM, 2007, DIABETES, V56, P2274, DOI 10.2337/db07-0371; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talmud PJ, 1997, CURR OPIN LIPIDOL, V8, P154, DOI 10.1097/00041433-199706000-00005; Taskinen MR, 2011, ARTERIOSCL THROM VAS, V31, P2144, DOI 10.1161/ATVBAHA.111.224808; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Waterworth DM, 2000, J LIPID RES, V41, P1103; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zhang T, 2016, ENDOCRINOLOGY, V157, P1055, DOI 10.1210/en.2015-1852	56	9	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14695	14705		10.1074/jbc.M115.707885	http://dx.doi.org/10.1074/jbc.M115.707885			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226540	Green Published, hybrid			2022-12-26	WOS:000380366700023
J	Patra, A; Su, Y; Zhang, QQ; Johnson, KM; Guengerich, FP; Egli, M				Patra, Amritraj; Su, Yan; Zhang, Qianqian; Johnson, Kevin M.; Guengerich, F. Peter; Egli, Martin			Structural and Kinetic Analysis of Miscoding Opposite the DNA Adduct 1,N-6-Ethenodeoxyadenosine by Human Translesion DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA enzyme; DNA polymerase; enzyme kinetics; X-ray crystallography	VINYL-CHLORIDE; 1,N(6)-ETHENODEOXYADENOSINE ADDUCT; ETHENO ADDUCTS; IN-VITRO; 1,N-6-ETHENOADENINE; N2,3-ETHENOGUANINE; FLUORESCENCE; REPLICATION; BYPASS; LESION	1,N-6-Ethenodeoxyadenosine (1,N-6-EdA) is the major etheno lesion formed in the reaction of DNA with epoxides substituted with good leaving groups (e.g. vinyl chloride epoxide). This lesion is also formed endogenously in DNA from lipid oxidation. Recombinant human DNA polymerase (hpol ) can replicate oligonucleotide templates containing 1,N-6-EdA. In steady-state kinetic analysis, hpol preferred to incorporate dATP and dGTP, compared with dTTP. Mass spectral analysis of incorporation products also showed preferred purine (A, G) incorporation and extensive -1 frameshifts, suggesting pairing of the inserted purine and slippage before further replication. Five x-ray crystal structures of hpol ternary complexes were determined, three at the insertion and two at the extension stage. Two insertion complexes revealed incoming non-hydrolyzable dATP or dGTP analogs not pairing with but instead in a staggered configuration relative to 1,N-6-EdA in the anti conformation, thus opposite the 5-T in the template, explaining the proclivity for frameshift misincorporation. In another insertion complex, dTTP was positioned opposite 1,N-6-EdA, and the adduct base was in the syn conformation, with formation of two hydrogen bonds. At the extension stage, with either an incorporated dA or dT opposite 1,N-6-EdA and 2-deoxythymidine-5-[(,)-imido]triphosphate opposite the 5-A, the 3-terminal nucleoside of the primer was disordered, consistent with the tendency not to incorporate dTTP opposite 1,N-6-EdA. Collectively, the results show a preference for purine pairing opposite 1,N-6-EdA and for -1 frameshifts.	[Patra, Amritraj; Su, Yan; Zhang, Qianqian; Johnson, Kevin M.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Zhang, Qianqian] Shanghai CP Guojian Pharmaceut Co, 399 Libing Rd,Zhangjiang High Tech Pk, Shanghai 201203, Peoples R China	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.; Egli, M (corresponding author), Dept Biochem, 868A Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu; martin.egli@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [T32CA009582, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010546, P30ES000267, R01ES010375] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Lei for help with protein expression and K. Trisler for assistance in the preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team at sector 21 of the Advanced Photon Source, Argonne, IL. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBIN A, 1975, BIOCHEM BIOPH RES CO, V67, P596, DOI 10.1016/0006-291X(75)90854-2; BASU AK, 1987, BIOCHEMISTRY-US, V26, P5626, DOI 10.1021/bi00392a007; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Calabretta A, 2013, BIOCHEMISTRY-US, V52, P1990, DOI 10.1021/bi400116y; Carvalho VM, 2000, CHEM RES TOXICOL, V13, P397, DOI 10.1021/tx9901682; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Chowdhury G., 2011, CURR PROTOC NUCL ACI, P1; Chowdhury G., 2016, ENCY ANAL CHEM; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; DeMott M. S., 2010, CHEM BIOL DNA DAMAGE, P21; DUDOCK BS, 1969, P NATL ACAD SCI USA, V62, P941, DOI 10.1073/pnas.62.3.941; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; FEDTKE N, 1990, CARCINOGENESIS, V11, P1287, DOI 10.1093/carcin/11.8.1287; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; GUENGERICH FP, 1992, J AM CHEM SOC, V114, P1074, DOI 10.1021/ja00029a041; INOUE Y, 1979, BIOPOLYMERS, V18, P2175, DOI 10.1002/bip.1979.360180908; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1820, DOI 10.1021/bi00221a014; LAIB RJ, 1981, CHEM-BIOL INTERACT, V37, P219, DOI 10.1016/0009-2797(81)90179-4; LEONARD GA, 1994, BIOCHEMISTRY-US, V33, P4755, DOI 10.1021/bi00182a002; LEONARD NJ, 1984, CRC CR REV BIOCH MOL, V15, P125, DOI 10.3109/10409238409102299; LEONARD NJ, 1993, CHEMTRACTS BIOCH MOL, V4, P251; LEONARD NJ, 1992, CHEMTRACTS BIOCH MOL, V3, P273; Levine RL, 2000, CANCER RES, V60, P4098; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; MALAVEILLE C, 1975, BIOCHEM BIOPH RES CO, V63, P363, DOI 10.1016/0006-291X(75)90697-X; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; Moriya M, 1999, IARC SCI PUBL, P263; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandya GA, 1996, BIOCHEMISTRY-US, V35, P11487, DOI 10.1021/bi960170h; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; SANTOS CD, 1991, BIOCHEMISTRY-US, V30, P1828, DOI 10.1021/bi00221a015; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SATTSANGI PD, 1977, J ORG CHEM, V42, P3292, DOI 10.1021/jo00440a020; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SINGER B, 1984, CARCINOGENESIS, V5, P1165, DOI 10.1093/carcin/5.9.1165; SINGER B, 1992, P NATL ACAD SCI USA, V89, P9386, DOI 10.1073/pnas.89.20.9386; SPENCER RD, 1974, EUR J BIOCHEM, V45, P425, DOI 10.1111/j.1432-1033.1974.tb03566.x; SWENBERG JA, 1992, CARCINOGENESIS, V13, P727, DOI 10.1093/carcin/13.4.727; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Tolentino JH, 2008, NUCLEIC ACIDS RES, V36, P1300, DOI 10.1093/nar/gkm1157; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Weismann CG, 2007, CURR OPIN CARDIOL, V22, P200, DOI 10.1097/HCO.0b013e3280f629c7; Wessels MW, 2010, CLIN GENET, V78, P103, DOI 10.1111/j.1399-0004.2010.01435.x; Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao LL, 2012, ANGEW CHEM INT EDIT, V51, P5466, DOI 10.1002/anie.201109004	56	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14134	14145		10.1074/jbc.M116.732487	http://dx.doi.org/10.1074/jbc.M116.732487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226627	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000379975100021
J	Wang, T; Xu, WC; Qin, ML; Yang, Y; Bao, PH; Shen, FX; Zhang, ZL; Xu, J				Wang, Tao; Xu, Wangchao; Qin, Meiling; Yang, Yi; Bao, Puhua; Shen, Fuxiao; Zhang, Zhenlin; Xu, Jin			Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); endoplasmic reticulum-associated protein degradation (ERAD); post-translational modification (PTM); stress granule; stress response; sumoylation; hexamer; valosin-containing protein; p97 (VCP)	NEURODEGENERATIVE DISEASES; AAA-ATPASE; OXIDATIVE STRESS; QUALITY-CONTROL; PROTEIN VCP; SUMO; COMPLEX; DEGRADATION; PROTEOSTASIS; MECHANISMS	Valosin-containing protein/p97(VCP) is a hexameric ATPase vital to protein degradation during endoplasmic reticulum stress. It regulates diverse cellular functions including autophagy, chromatin remodeling, and DNA repair. In addition, mutations in VCP cause inclusion body myopathy, Paget disease of the bone, and frontotemporal dementia (IBMPFD), as well as amyotrophic lateral sclerosis. Nevertheless, how the VCP activities were regulated and how the pathogenic mutations affect the function of VCP during stress are not unclear. Here we show that the small ubiquitin-like modifier (SUMO)-ylation of VCP is a normal stress response inhibited by the disease-causing mutations in the N-domain. Under oxidative and endoplasmic reticulum stress conditions, the SUMOylation of VCP facilitates the distribution of VCP to stress granules and nucleus, and promotes the VCP hexamer assembly. In contrast, pathogenic mutations in the VCP N-domain lead to reduced SUMOylation and weakened VCP hexamer formation upon stress. Defective SUMOylation of VCP also causes altered co-factor binding and attenuated endoplasmic reticulum-associated protein degradation. Furthermore, SUMO-defective VCP fails to protect against stress-induced toxicity in Drosophila. Therefore, our results have revealed SUMOylation as a molecular signaling switch to regulate the distribution and functions of VCP during stress response, and suggest that deficiency in VCP SUMOylation caused by pathogenic mutations will render cells vulnerable to stress insults.	[Wang, Tao; Xu, Wangchao; Qin, Meiling; Yang, Yi; Bao, Puhua; Shen, Fuxiao; Xu, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Xu, Wangchao; Yang, Yi] Univ Chinese Acad Sci, Shanghai 200031, Peoples R China; [Zhang, Zhenlin] Shanghai Jiao Tong Univ, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University	Xu, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China.	Jin.Xu@ion.ac.cn		Xu, Jin/0000-0001-6617-5311; Wang, Tao/0000-0002-8177-0298	Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience, Shanghai Pujiang Talent Program Grant [12PJ1410000]; National Science Foundation of China [81371402]	Hundreds of Talents Program, Chinese Academy of Sciences; State Key Laboratory of Neuroscience, Shanghai Pujiang Talent Program Grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Hundreds of Talents Program, Chinese Academy of Sciences, the State Key Laboratory of Neuroscience, Shanghai Pujiang Talent Program Grant 12PJ1410000, and National Science Foundation of China Grant 81371402 (to J. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchberger A, 2015, FEBS LETT, V589, P2578, DOI 10.1016/j.febslet.2015.08.028; Chang YC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001288; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Eifler K, 2015, FEBS J, V282, P3669, DOI 10.1111/febs.13378; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Fessart D, 2013, CANCER LETT, V337, P26, DOI 10.1016/j.canlet.2013.05.030; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gu JM, 2013, BONE, V52, P9, DOI 10.1016/j.bone.2012.09.012; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Landgrave-Gomez J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00058; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Mathias RA, 2015, MOL CELL PROTEOMICS, V14, P456, DOI 10.1074/mcp.O114.046565; Matsuzaki S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10730; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Sahin U, 2014, J CELL BIOL, V204, P931, DOI 10.1083/jcb.201305148; Seguin SJ, 2014, CELL DEATH DIFFER, V21, P1838, DOI 10.1038/cdd.2014.103; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Song CC, 2015, BBA-MOL CELL RES, V1853, P222, DOI 10.1016/j.bbamcr.2014.10.019; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Tong L, 2015, MOL NEUROBIOL, V51, P1221, DOI 10.1007/s12035-014-8797-3; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zhang Z, 2013, DEV CELL, V25, P636, DOI 10.1016/j.devcel.2013.05.006; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115	65	36	37	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14373	14384		10.1074/jbc.M116.729343	http://dx.doi.org/10.1074/jbc.M116.729343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226613	hybrid, Green Published			2022-12-26	WOS:000379975100039
J	Bierowiec, K; Ploneczka-Janeczko, K; Rypula, K				Bierowiec, Karolina; Ploneczka-Janeczko, Katarzyna; Rypula, Krzysztof			Is the Colonisation of Staphylococcus aureus in Pets Associated with Their Close Contact with Owners?	PLOS ONE			English	Article							COAGULASE-POSITIVE STAPHYLOCOCCI; RISK-FACTORS; ANTIBIOTIC-RESISTANCE; COMPANION ANIMALS; FUSIDIC ACID; FELINE STAPHYLOCOCCI; MRSA INFECTION; HEALTHY CATS; FERAL CATS; SPA TYPES	In human beings and animals, staphylococci constitute part of the normal microbial population. Staphylococcus aureus could be classified as an opportunistic pathogen because the bacteria are noted in clinically healthy individuals, but when the immune system becomes compromised, they can also cause a wide range of infections. The objective of this study was to test the hypothesis that cats who are in close contact with their owners are at the greatest risk of being colonised with S. aureus. Two groups of cats were investigated: single, pet (domestic) cats that do not have outdoor access; and a local population of feral cats living in urban areas. The prevalence of S. aureus in domestic cats was 19.17%, while it's prevalence in the feral cat population was only 8.3%; which was statistically significant. Analysis of antibiotic resistance, at the genotypic as well as phenotypic level, showed that S. aureus isolates from pet cats were more likely to harbour antibiotic resistant determinants. The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in households was 10.21%, while in feral cats it was only 1.4%. In conclusion, this study has revealed a correlation between close contact with humans and a higher risk of the cats being colonised with S. aureus and harbouring the antibiotic resistant determinants.	[Bierowiec, Karolina; Ploneczka-Janeczko, Katarzyna; Rypula, Krzysztof] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Epizootiol, Div Infect Dis & Vet Adm,Clin Birds & Exot Anim, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences	Bierowiec, K (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Epizootiol, Div Infect Dis & Vet Adm,Clin Birds & Exot Anim, Wroclaw, Poland.	karolina.bierowiec@up.wroc.pl	Płoneczka-Janeczko, Katarzyna/I-6274-2013; Bierowiec, Karolina/A-6805-2017; Bierowiec, Karolina/K-3064-2019	Płoneczka-Janeczko, Katarzyna/0000-0002-7621-4449; Bierowiec, Karolina/0000-0002-7663-4312; Rypula, Krzysztof/0000-0003-3884-4834	Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences [B030/0024/15]; European Union as part of the European Social Fund - Grant Plus edition; Centre of Biotechnology's Leading National Research Centre (KNOW)	Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences; European Union as part of the European Social Fund - Grant Plus edition; Centre of Biotechnology's Leading National Research Centre (KNOW)	This work was supported by the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences ( B030/0024/15), co-financed by the European Union as part of the European Social Fund - Grant Plus edition 2013/2014 and by the Centre of Biotechnology's Leading National Research Centre (KNOW) for the years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JL, 2007, VET DERMATOL, V18, P252, DOI 10.1111/j.1365-3164.2007.00604.x; Bania J, 2006, INT J FOOD MICROBIOL, V108, P36, DOI 10.1016/j.ijfoodmicro.2005.10.013; Bradley SF, 2007, CLIN INFECT DIS, V44, P186, DOI 10.1086/510395; Brink AJ, 2012, S AFR J SURG, V50, P20; Chen HJ, 2010, ANTIMICROB AGENTS CH, V54, P4985, DOI 10.1128/AAC.00523-10; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI WAYN PA; Cohn LA, 2010, J VET EMERG CRIT CAR, V20, P31, DOI 10.1111/j.1476-4431.2009.00497.x; Porrero MC, 2014, APPL ENVIRON MICROB, V80, P4865, DOI 10.1128/AEM.00647-14; Coughlan K, 2010, ZOONOSES PUBLIC HLTH, V57, P220, DOI 10.1111/j.1863-2378.2009.01302.x; Coutant C, 1996, DIAGN MICR INFEC DIS, V25, P9, DOI 10.1016/0732-8893(96)00070-3; Couto N, 2015, J ANTIMICROB CHEMOTH, V70, P2483, DOI 10.1093/jac/dkv141; Cuny C, 2013, INT J MED MICROBIOL, V303, P331, DOI 10.1016/j.ijmm.2013.02.010; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Eckholm NG, 2013, VET DERMATOL, V24, P154, DOI 10.1111/j.1365-3164.2012.01051.x; Emaneini M, 2013, Ann Burns Fire Disasters, V26, P76; Gandolfi-Decristophoris P, 2013, J VET SCI, V14, P449, DOI 10.4142/jvs.2013.14.4.449; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Glaser P, 2016, MBIO, V7, DOI 10.1128/mBio.02183-15; Guardabassi L, 2009, GUIDE TO ANTIMICROBI; Hamilton E, 2013, JAVMA-J AM VET MED A, V243, P990, DOI 10.2460/javma.243.7.990; Hariharan H, 2011, COMP IMMUNOL MICROB, V34, P129, DOI 10.1016/j.cimid.2010.05.001; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Iverson SA, 2015, VET MICROBIOL, V176, P202, DOI 10.1016/j.vetmic.2015.01.003; Jeremiah CJ, 2016, J HOSP INFECT, V92, P183, DOI 10.1016/j.jhin.2015.10.023; Johnson RC, 2015, INFECT IMMUN, V83, P802, DOI 10.1128/IAI.02664-14; Kasprzyk Joanna, 2015, Medycyna Doswiadczalna i Mikrobiologia, V67, P79; Kottler S, 2010, J VET INTERN MED, V24, P132, DOI 10.1111/j.1939-1676.2009.0424.x; Krupa P, 2014, POULTRY SCI, V93, P3179, DOI 10.3382/ps.2014-04321; Krupa P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141475; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Larsen J, 2014, J GLOB ANTIMICROB RE, V2, P260, DOI 10.1016/j.jgar.2014.09.003; Leibler JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148789; Lilenbaum W, 1998, LETT APPL MICROBIOL, V27, P224, DOI 10.1046/j.1472-765X.1998.00406.x; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Loeffler A, 2008, J ANTIMICROB CHEMOTH, V62, P1301, DOI 10.1093/jac/dkn398; Loeffler A, 2011, EPIDEMIOL INFECT, V139, P1019, DOI 10.1017/S095026881000227X; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Luczak-Kadlubowska A, 2008, J CLIN MICROBIOL, V46, P2930, DOI 10.1128/JCM.00869-08; Luria BJ, 2004, J FELINE MED SURG, V6, P287, DOI 10.1016/j.jfms.2003.11.005; Magalhaes RJS, 2010, VET RES, V41, DOI 10.1051/vetres/2010028; Almeida GCM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-328; Malaviolle X, 2008, J ANTIMICROB CHEMOTH, V62, P1018, DOI 10.1093/jac/dkn345; Manian FA, 2003, CLIN INFECT DIS, V36, pE26, DOI 10.1086/344772; Martin MC, 2003, FOOD MICROBIOL, V20, P605, DOI 10.1016/S0740-0020(02)00180-6; McCarthy AJ, 2012, VET DERMATOL, V23, P267, DOI 10.1111/j.1365-3164.2012.01072.x; McKinnell JA, 2013, INFECT CONT HOSP EP, V34, P1077, DOI 10.1086/673157; Morris DO, 2012, ZOONOSES PUBLIC HLTH, V59, P286, DOI 10.1111/j.1863-2378.2011.01448.x; Muniz IM, 2013, ZOONOSES PUBLIC HLTH, V60, P504, DOI 10.1111/zph.12027; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otto Michael, 2010, Expert Rev Dermatol, V5, P183, DOI 10.1586/edm.10.6; Patel A, 2002, ADV VET DERMATOL, V4, P85; Patel A, 1999, VET DERMATOL, V10, P257, DOI 10.1046/j.1365-3164.1999.00178.x; Petinaki E, 2012, CLIN MICROBIOL INFEC, V18, P626, DOI 10.1111/j.1469-0691.2012.03881.x; Peton V, 2014, INFECT GENET EVOL, V21, P602, DOI 10.1016/j.meegid.2013.08.011; Qureshi Adnan I, 2009, J Vasc Interv Neurol, V2, P132; Resch M, 2008, INT J FOOD MICROBIOL, V127, P99, DOI 10.1016/j.ijfoodmicro.2008.06.013; Rizzotti L, 2005, J FOOD PROTECT, V68, P955, DOI 10.4315/0362-028X-68.5.955; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Seah C, 2012, ANTIMICROB AGENTS CH, V56, P1916, DOI 10.1128/AAC.05325-11; Sharma-Kuinkel BK, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv093; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Sing A, 2008, NEW ENGL J MED, V358, P1200, DOI 10.1056/NEJMc0706805; Skramm I, 2014, J BONE JOINT SURG AM, V96A, P882, DOI 10.2106/JBJS.M.00919; Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121; Coutinho VDS, 2010, BRAZ J INFECT DIS, V14, P564, DOI 10.1016/S1413-8670(10)70113-6; Tilahun B, 2015, AM J CRIT CARE, V24, P8, DOI 10.4037/ajcc2015102; Vincze S, 2014, PLOS ONE, V9; Vincze S, 2014, INT J MED MICROBIOL, V304, P787, DOI 10.1016/j.ijmm.2014.07.007; Walther B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035197; Wan MT, 2012, J APPL MICROBIOL, V112, P205, DOI 10.1111/j.1365-2672.2011.05179.x; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Weiss S, 2013, VET MICROBIOL, V167, P680, DOI 10.1016/j.vetmic.2013.07.036; Wendlandt S, 2015, TRENDS MICROBIOL, V23, P44, DOI 10.1016/j.tim.2014.10.002; Wisniewska Katarzyna, 2013, Medycyna Doswiadczalna i Mikrobiologia, V65, P139	77	34	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156052	10.1371/journal.pone.0156052	http://dx.doi.org/10.1371/journal.pone.0156052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227897	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500059
J	Bourne, A; Holness, S; Holden, P; Scorgie, S; Donatti, CI; Midgley, G				Bourne, Amanda; Holness, Stephen; Holden, Petra; Scorgie, Sarshen; Donatti, Camila I.; Midgley, Guy			A Socio-Ecological Approach for Identifying and Contextualising Spatial Ecosystem-Based Adaptation Priorities at the Sub-National Level	PLOS ONE			English	Article							GLOBAL CHANGE IMPACTS; CLIMATE-CHANGE; SOUTH-AFRICA; LAND-USE; LOCAL-GOVERNMENT; BIODIVERSITY; CONSERVATION; RESILIENCE; VEGETATION; BENEFITS	Climate change adds an additional layer of complexity to existing sustainable development and biodiversity conservation challenges. The impacts of global climate change are felt locally, and thus local governance structures will increasingly be responsible for preparedness and local responses. Ecosystem-based adaptation (EbA) options are gaining prominence as relevant climate change solutions. Local government officials seldom have an appropriate understanding of the role of ecosystem functioning in sustainable development goals, or access to relevant climate information. Thus the use of ecosystems in helping people adapt to climate change is limited partially by the lack of information on where ecosystems have the highest potential to do so. To begin overcoming this barrier, Conservation South Africa in partnership with local government developed a socio-ecological approach for identifying spatial EbA priorities at the sub-national level. Using GIS-based multi-criteria analysis and vegetation distribution models, the authors have spatially integrated relevant ecological and social information at a scale appropriate to inform local level political, administrative, and operational decision makers. This is the first systematic approach of which we are aware that highlights spatial priority areas for EbA implementation. Nodes of socio-ecological vulnerability are identified, and the inclusion of areas that provide ecosystem services and ecological resilience to future climate change is innovative. The purpose of this paper is to present and demonstrate a methodology for combining complex information into user-friendly spatial products for local level decision making on EbA. The authors focus on illustrating the kinds of products that can be generated from combining information in the suggested ways, and do not discuss the nuance of climate models nor present specific technical details of the model outputs here. Two representative case studies from rural South Africa demonstrate the replicability of this approach in rural and peri-urban areas of other developing and least developed countries around the world.	[Bourne, Amanda] Conservat South Africa, Springbok, South Africa; [Holness, Stephen] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Holden, Petra; Scorgie, Sarshen] Conservat South Africa, Cape Town, South Africa; [Holden, Petra] Univ Cape Town, Plant Conservat Unit, ZA-7925 Cape Town, South Africa; [Donatti, Camila I.] Conservat Int, Gordon & Betty Moore Ctr Sci, Arlington, VA USA; [Midgley, Guy] Univ Stellenbosch, Global Change Biol Unit, ZA-7600 Stellenbosch, South Africa	Nelson Mandela University; University of Cape Town; Conservation International; Stellenbosch University	Bourne, A (corresponding author), Conservat South Africa, Springbok, South Africa.	abourne@conservation.org	Donatti, Camila I./AAV-2324-2020; Donatti, Camila/AAF-3605-2020; Bourne, Amanda/AAO-6825-2020; Holden, Petra/AAQ-3951-2021	Bourne, Amanda/0000-0001-6078-0676; Holden, Petra/0000-0002-3047-1407	International Climate Initiative, an initiative of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety by the German Bundestag [11_II_084_Global_A_EbA solutions]; International Climate Initiative; Critical Ecosystem Partnership Fund [61486]	International Climate Initiative, an initiative of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety by the German Bundestag; International Climate Initiative; Critical Ecosystem Partnership Fund	The methodology for defining spatial ecosystem-based adaptation priorities was developed in the Namakwa District with funding from the International Climate Initiative, an initiative of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety adopted on the basis of a decision by the German Bundestag, grant number 11_II_084_Global_A_EbA solutions. The International Climate Initiative paid the full-time salary for corresponding author Amanda Bourne from Sept 2011 to June 2015. The same project also funded time for Stephen Holness, Camila Donatti, and Sarshen Scorgie to develop the methodology, conduct the spatial analysis and contribute to technical reporting. The methodology was refined and replicated in the Alfred Nzo District with funding from the Critical Ecosystem Partnership Fund, grant number 61486. The Critical Ecosystem Partnership Fund is a joint initiative of l'Agence Francaise de Developpement, Conservation International, the European Union, the Global Environment Facility, the Government of Japan, the MacArthur Foundation and the World Bank. This project funded time for Stephen Holness and Petra Holden to undertake the spatial analysis, and the stakeholder engagement and report writing processes respectively. Although the authors received funding to conduct the original analyses, as above, the authors received no specific funding to produce this manuscript and all volunteered their time to convert the methodology from technical report into manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessa L, 2008, LANDSCAPE URBAN PLAN, V85, P27, DOI 10.1016/j.landurbplan.2007.09.007; [Anonymous], 2014, NAMAKWA DISTRICT MUN; [Anonymous], 2008, NAMAKWA BIODIVERSITY; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bourne A, 2015, CLIMATE CHANGE VULNE; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; CARE International, 2009, CLIMATE VULNERABILIT; Carrick PJ, 2015, ECOL MANAG RESTOR, V16, P86, DOI 10.1111/emr.12169; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Conservation South Africa, 2015, ALFRED NZO DISTRICT; Conservation South Africa, 2015, CLIMATE CHANGE VULNE; Cousins B, 2007, J ARID ENVIRON, V70, P834, DOI 10.1016/j.jaridenv.2007.04.002; Cowling R. M., 1999, Diversity and Distributions, V5, P51, DOI 10.1046/j.1472-4642.1999.00038.x; Cumming GS, 2014, NATURE, V515, P50, DOI 10.1038/nature13945; Davis C, 2016, S AFR J SCI IN PRESS; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; de Sherbinin A, 2014, CLIMATIC CHANGE, V123, P23, DOI 10.1007/s10584-013-0900-7; DEA, 2013, LONG TERM ADAPTATION; DEDEAT (Department of Economic Development Environmental Affairs and Tourism), 2013, THE EASTERN CAPE SOC; Department of Environmental Affairs Department of Cooperative Governance the South African Local Government Association, 2012, LETS RESPOND INTEGRA; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Doswald N, 2014, CLIM DEV, V6, P185, DOI 10.1080/17565529.2013.867247; Doswald N., 2015, PROMOTING ECOSYSTEMS; Edenhofer O., 2014, CONTRIBUTION WORKING; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Engelbrecht FA, 2009, INT J CLIMATOL, V29, P1013, DOI 10.1002/joc.1742; Engelbrecht FA, 2005, CLIMATE CHANGE WATER, P57; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Field C.B., 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Godfree R, 2011, GLOBAL CHANGE BIOL, V17, P943, DOI 10.1111/j.1365-2486.2010.02292.x; Gordon H.B., 2010, 21 CTR AUSTR WEATH C; Government of South Africa, 2008, NATIONAL PROTECTED A; Hamann M, 2015, GLOBAL ENVIRON CHANG, V34, P218, DOI 10.1016/j.gloenvcha.2015.07.008; Hannah L, 2002, CONSERV BIOL, V16, P264, DOI 10.1046/j.1523-1739.2002.00465.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hoffman MT, 2009, S AFR J SCI, V105, P54; Hoffman MT, 1999, THE KAROO ECOLOGICAL; Holness SD, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1029; Huq S, 2007, ENVIRON URBAN, V19, P3, DOI 10.1177/0956247807078058; Jones HP, 2012, NAT CLIM CHANGE, V2, P504, DOI 10.1038/NCLIMATE1463; Kelso C, 2007, CLIMATIC CHANGE, V83, P357, DOI 10.1007/s10584-007-9264-1; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Klein RJT, 2001, J COASTAL RES, V17, P531; Kotze D, 2009, WATER RESEARCH COMMI; Lavorel S, 2015, GLOBAL CHANGE BIOL, V21, P12, DOI 10.1111/gcb.12689; Leichenko R. M., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P1, DOI 10.1023/A:1015860421954; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Ludi E, 2014, COMMUNITY-BASED ADAPTATION TO CLIMATE CHANGE: SCALING IT UP, P36; Magadlela D, 2004, S AFR J SCI, V100, P94; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Measham TG, 2011, MITIG ADAPT STRAT GL, V16, P889, DOI 10.1007/s11027-011-9301-2; Metzger MJ, 2008, REG ENVIRON CHANGE, V8, P91, DOI 10.1007/s10113-008-0044-x; Moncrieff GR, 2015, S AFR J BOT, V101, P16, DOI 10.1016/j.sajb.2015.02.004; Moncrieff GR, 2014, NEW PHYTOL, V201, P908, DOI 10.1111/nph.12551; Mucina L, 2006, THE VEGETATION OF SO; Munroe R, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-13; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nel JL, 2012, NATIONAL BIODIVERSIT, V2; Nel JL, 2011, WRC REPORT NO TT 500; Nozawa T., 2007, CGER SUPERCOMPUTER M, V12; Oettle N, 2014, PARTICIPATORY ADAPTA; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Pasquini L, 2013, HABITAT INT, V40, P225, DOI 10.1016/j.habitatint.2013.05.003; Pasquini L, 2015, ENVIRON DEV SUSTAIN, V17, P1121, DOI 10.1007/s10668-014-9594-x; Petersen C, 2008, WORLD RESOURCES REPO; Pramova E, 2012, WIRES CLIM CHANGE, V3, P581, DOI 10.1002/wcc.195; Rannow S, 2010, LANDSCAPE URBAN PLAN, V98, P160, DOI 10.1016/j.landurbplan.2010.08.017; Reid H, 2015, CLIM DEV, DOI [10.1080/17565529.2015.1034233, DOI 10.1080/17565529.2015.1034233]; Roberts D, 2012, ENVIRON URBAN, V24, P167, DOI 10.1177/0956247811431412; Roeckner E, 2003, MAX PLANCK INSTITUTE; Ruckelshaus M, 2013, MAR POLICY, V40, P154, DOI 10.1016/j.marpol.2013.01.009; Samuels MI, 2013, THESIS; SANBI (South African National Biodiversity Institute), 2009, UPDATING NATIONAL LA; Schulze RE, 2010, ATLAS OF CLIMATE CHA; Schulze RE, 2005, CLIMATE CHANGE WATER, P141; Schulze RE, 2011, WATER RESEARCH COMMI; Seavy NE, 2015, ECOL RESTOR, V27, P330; Secretariat of the Convention on Biological Diversity, 2009, TECHNICAL SERIES, V41; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; StatsSA (Statistics South Africa), 2012, CENSUS 2011 STATISTI; Stevens B, 2013, J ADV MODEL EARTH SY, V5, P146, DOI 10.1002/jame.20015; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Travers A, 2012, UNEP WORKING DOCUMEN; Turpie JK, 2011, REPORT PRODUCED FOR; Van Wyk A, 2001, REGIONS OF FLORISTIC; Vetter S, 2009, S AFR J SCI, V105, P29, DOI 10.1590/s0038-23532009000100017; Walker B., 2004, Ecology and Society, V9, P5; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wamsler C, 2014, GLOBAL ENVIRON CHANG, V29, P189, DOI 10.1016/j.gloenvcha.2014.09.008; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wigley BJ, 2009, AFR J ECOL, V47, P62, DOI 10.1111/j.1365-2028.2008.01051.x; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	101	22	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155235	10.1371/journal.pone.0155235	http://dx.doi.org/10.1371/journal.pone.0155235			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227671	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500011
J	Ding, FR; Tan, AD; Ju, WJ; Li, XJ; Li, S; Ding, J				Ding, Fangrui; Tan, Aidi; Ju, Wenjun; Li, Xuejuan; Li, Shao; Ding, Jie			The Prediction of Key Cytoskeleton Components Involved in Glomerular Diseases Based on a Protein-Protein Interaction Network	PLOS ONE			English	Article							GENE-EXPRESSION; ACTIN; IDENTIFICATION; TRANSCRIPTOME; MUTATIONS; EVOLUTION	Maintenance of the physiological morphologies of different types of cells and tissues is essential for the normal functioning of each system in the human body. Dynamic variations in cell and tissue morphologies depend on accurate adjustments of the cytoskeletal system. The cytoskeletal system in the glomerulus plays a key role in the normal process of kidney filtration. To enhance the understanding of the possible roles of the cytoskeleton in glomerular diseases, we constructed the Glomerular Cytoskeleton Network (GCNet), which shows the protein-protein interaction network in the glomerulus, and identified several possible key cytoskeletal components involved in glomerular diseases. In this study, genes/proteins annotated to the cytoskeleton were detected by Gene Ontology analysis, and glomerulus-enriched genes were selected from nine available glomerular expression datasets. Then, the GCNet was generated by combining these two sets of information. To predict the possible key cytoskeleton components in glomerular diseases, we then examined the common regulation of the genes in GCNet in the context of five glomerular diseases based on their transcriptomic data. As a result, twenty-one cytoskeleton components as potential candidate were highlighted for consistently down-or up-regulating in all five glomerular diseases. And then, these candidates were examined in relation to existing known glomerular diseases and genes to determine their possible functions and interactions. In addition, the mRNA levels of these candidates were also validated in a puromycin aminonucleoside (PAN) induced rat nephropathy model and were also matched with existing Diabetic Nephropathy (DN) transcriptomic data. As a result, there are 15 of 21 candidates in PAN induced nephropathy model were consistent with our predication and also 12 of 21 candidates were matched with differentially expressed genes in the DN transcriptomic data. By providing a novel interaction network and prediction, GCNet contributes to improving the understanding of normal glomerular function and will be useful for detecting target cytoskeleton molecules of interest that may be involved in glomerular diseases in future studies.	[Ding, Fangrui; Li, Xuejuan; Ding, Jie] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Tan, Aidi; Li, Shao] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Tan, Aidi; Li, Shao] Tsinghua Univ, Dept Automat, Bioinformat Div, TNLIST, Beijing 100084, Peoples R China; [Ju, Wenjun] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Peking University; Tsinghua University; Tsinghua University; University of Michigan System; University of Michigan	Ding, J (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.; Li, S (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.; Li, S (corresponding author), Tsinghua Univ, Dept Automat, Bioinformat Div, TNLIST, Beijing 100084, Peoples R China.	shaoli@mail.tsinghua.edu.cn; djnc_5855@126.com	Li, Shao/GPX-5473-2022	Li, Shao/0000-0002-8709-9167; Tan, Aidi/0000-0002-4793-9846; Ju, Wenjun/0000-0002-9136-8454	National Basic Research Program of China (973 Program) [2012CB517700]; National Nature Science Foundation of China [30830105, 81170657, 81225025, 91229201]; Nature Science Foundation of Beijing [7072080]; Beijing Key Laboratory of Molecular Diagnosis and Study of Pediatric Genetic Diseases	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Beijing; Beijing Key Laboratory of Molecular Diagnosis and Study of Pediatric Genetic Diseases	This work was supported by the following organizations: the National Basic Research Program of China (973 Program, No. 2012CB517700 www.nsfc.gov.cn), the National Nature Science Foundation of China (Nos. 30830105, 81170657, 81225025 and 91229201 www.nsfc.gov.cn), and the Nature Science Foundation of Beijing (No. 7072080 www.bjnsf.org) and the Beijing Key Laboratory of Molecular Diagnosis and Study of Pediatric Genetic Diseases (www.bjkw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Cuellar LM, 2009, NEPHROLOGY, V14, P94, DOI 10.1111/j.1440-1797.2008.01009.x; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Garg P, 2011, ADV CHRONIC KIDNEY D, V18, P233, DOI 10.1053/j.ackd.2011.06.001; Gunning PW, 2015, J CELL SCI, V128, P2009, DOI 10.1242/jcs.165563; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; He L, 2007, KIDNEY INT, V71, P889, DOI 10.1038/sj.ki.5002158; He L, 2008, J AM SOC NEPHROL, V19, P260, DOI 10.1681/ASN.2007050588; Higgins JPT, 2004, MOL BIOL CELL, V15, P649, DOI 10.1091/mbc.E03-06-0432; Jha V, 2012, NEPHROL DIAL TRANSPL, V27, P32, DOI 10.1093/ndt/gfs113; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Li XY, 2014, EXP BIOL MED, V239, P922, DOI 10.1177/1535370214530365; Lindenmeyer MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011545; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Miao J, 2009, NEPHROL DIAL TRANSPL, V24, P3297, DOI 10.1093/ndt/gfp338; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; New LA, 2013, J BIOL CHEM, V288, P1500, DOI 10.1074/jbc.M112.439463; Nystrom J, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-13; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Warsow G, 2013, KIDNEY INT, V84, P104, DOI 10.1038/ki.2013.64; Wasik AA, 2014, AM J PATHOL, V184, P1727, DOI 10.1016/j.ajpath.2014.03.002; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wickstead B, 2011, J CELL BIOL, V194, P513, DOI 10.1083/jcb.201102065; WOLOSEWICK JJ, 1979, J CELL BIOL, V82, P114, DOI 10.1083/jcb.82.1.114; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27	38	4	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156024	10.1371/journal.pone.0156024	http://dx.doi.org/10.1371/journal.pone.0156024			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227331	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500052
J	El Allaoui, N; Serra, T; Colomer, J; Soler, M; Casamitjana, X; Oldham, C				El Allaoui, Nazha; Serra, Teresa; Colomer, Jordi; Soler, Marianna; Casamitjana, Xavier; Oldham, Carolyn			Interactions between Fragmented Seagrass Canopies and the Local Hydrodynamics	PLOS ONE			English	Article							POSIDONIA-OCEANICA; FLOW; MEADOWS; GAPS; BEDS; WAVE; COMMUNITIES; TURBULENCE; ADVANTAGE; RETENTION	The systematic creation of gaps within canopies results in fragmentation and the architecture of fragmented canopies differs substantially from non-fragmented canopies. Canopy fragmentation leads to spatial heterogeneity in hydrodynamics and therefore heterogeneity in the sheltering of canopy communities. Identifying the level of instability due to canopy fragmentation is important for canopies in coastal areas impacted by human activities and indeed, climate change. The gap orientation relative to the wave direction is expected to play an important role in determining wave attenuation and sheltering. Initially we investigated the effect of a single transversal gap within a canopy (i.e. a gap oriented perpendicular to the wave direction) on hydrodynamics, which was compared to fully vegetated canopies (i.e. no gaps) and also to bare sediment. The wave velocity increased with gap width for the two canopy densities studied (2.5% and 10% solid plant fraction) reaching wave velocities found over bare sediments. The turbulent kinetic energy (TKE) within the gap also increased, but was more attenuated by the adjacent vegetation than the wave velocity. As expected, denser canopies produced a greater attenuation of both the wave velocity and the turbulent kinetic energy within an adjacent gap, compared to sparse canopies. Using non-dimensional analysis and our experimental data, a parameterization for predicting TKE in a canopy gap was formulated, as a function of easily measured variables. Based on the experimental results, a fragmented canopy model was then developed to determine the overall mixing level in such canopies. The model revealed that canopies with large gaps present more mixing than canopies with small gaps despite having the same total gap area in the canopy. Furthermore, for the same total gap area, dense fragmented canopies provide more shelter than sparse fragmented canopies.	[El Allaoui, Nazha; Serra, Teresa; Colomer, Jordi; Soler, Marianna; Casamitjana, Xavier] Univ Girona, Dept Phys, Girona 17071, Spain; [Oldham, Carolyn] Univ Western Australia, Sch Civil Environm & Min Engn, Perth, WA 6009, Australia	Universitat de Girona; University of Western Australia	Serra, T (corresponding author), Univ Girona, Dept Phys, Girona 17071, Spain.	teresa.serra@udg.edu	Serra, Teresa/L-9279-2014; Colomer, Jordi/Y-5386-2018	Serra, Teresa/0000-0002-6075-5849; Colomer, Jordi/0000-0002-9330-0269; Oldham, Carolyn/0000-0003-2968-6889; casamitjana, xavier/0000-0003-1662-9076; Soler, Marianna/0000-0001-8422-1609	Ministerio de Ciencia e Innovacion of the Spanish Government [CGL2010-17289]; University of Western Australia	Ministerio de Ciencia e Innovacion of the Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Western Australia	This work was supported by Ministerio de Ciencia e Innovacion of the Spanish Government through grant CGL2010-17289. Oldham was supported by a Study Leave Grant from The University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson ME, 2014, COAST ENG, V83, P82, DOI 10.1016/j.coastaleng.2013.10.004; Bianchi CN, 2008, SEAGRASS MEADOWS FLO; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V239, P299, DOI 10.1016/S0022-0981(99)00039-8; Bologna PAX, 2002, ESTUARIES, V25, P1033, DOI 10.1007/BF02691350; Boudouresque C.F., 2012, RAMOGE PUBLICATION, P1, DOI DOI 10.1007/S10750-015-2333-Y; BOUDOURESQUE CF, 1985, ANN I OCEANOGR PARIS, V61, P27; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; Bouma TJ, 2007, CONT SHELF RES, V27, P1020, DOI 10.1016/j.csr.2005.12.019; Bouma TJ, 2014, COAST ENG, V87, P147, DOI 10.1016/j.coastaleng.2013.11.014; Bradley K, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2007JF000951; Coulombier T, 2012, ESTUAR COAST SHELF S, V101, P64, DOI 10.1016/j.ecss.2012.02.014; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; El Allaoui N, 2015, J HYDROL, V531, P840, DOI 10.1016/j.jhydrol.2015.10.041; EVANS JH, 1972, AM J PHYS, V40, P1815, DOI 10.1119/1.1987069; Feller IC, 1999, BIOTROPICA, V31, P607, DOI 10.1111/j.1744-7429.1999.tb00408.x; Folkard AM, 2011, ENVIRON FLUID MECH, V11, P289, DOI 10.1007/s10652-010-9197-5; Fredriksen S, 2010, MAR BIOL RES, V6, P189, DOI 10.1080/17451000903042461; Gacia E, 2001, ESTUAR COAST SHELF S, V52, P505, DOI 10.1006/ecss.2000.0753; Gera A, 2013, J ECOL, V101, P1053, DOI 10.1111/1365-2745.12109; Ghisalberti M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000871; Ghisalberti M, 2014, CURR BIOL, V24, P305, DOI 10.1016/j.cub.2013.12.017; Granata TC, 2001, MAR ECOL PROG SER, V218, P95, DOI 10.3354/meps218095; Hansen JCR, 2012, MAR ECOL PROG SER, V448, P271, DOI 10.3354/meps09225; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; Hendriks IE, 2011, ESTUAR COAST, V34, P60, DOI 10.1007/s12237-010-9309-y; Infantes E, 2009, BOT MAR, V52, P419, DOI 10.1515/BOT.2009.050; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; Koch EW, 1999, MAR ECOL PROG SER, V184, P63, DOI 10.3354/meps184063; Lara M, 2012, MAR POLLUT BULL, V64, P2471, DOI 10.1016/j.marpolbul.2012.07.044; Lasagna R, 2011, ESTUAR COAST SHELF S, V94, P255, DOI 10.1016/j.ecss.2011.07.003; Lefebvre A, 2010, CONT SHELF RES, V30, P1783, DOI 10.1016/j.csr.2010.08.006; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002789; Luhar M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006345; Macreadie PI, 2009, CONSERV BIOL, V23, P644, DOI 10.1111/j.1523-1739.2008.01130.x; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Montefalcone M, 2009, ECOL INDIC, V9, P595, DOI 10.1016/j.ecolind.2008.09.013; Moore KA, 2000, ESTUARIES, V23, P115, DOI 10.2307/1353229; Neumeier U, 2004, J COASTAL RES, V20, P435, DOI 10.2112/1551-5036(2004)020[0435:FRAASP]2.0.CO;2; Neumeier U, 2006, J COASTAL RES, P433; Orth RJ, 2009, AQUAT BOT, V90, P204, DOI 10.1016/j.aquabot.2008.07.004; Paul M, 2012, MAR ECOL PROG SER, V444, P31, DOI 10.3354/meps09489; Paul M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006797; Pergent G, 2014, MEDITERR MAR SCI, V15, P462, DOI 10.12681/mms.621; Pujol D, 2013, CONT SHELF RES, V66, P9, DOI 10.1016/j.csr.2013.06.012; Pujol D, 2013, J HYDROL, V486, P281, DOI 10.1016/j.jhydrol.2013.01.024; Pujol D, 2010, CONT SHELF RES, V30, P1019, DOI 10.1016/j.csr.2010.02.014; Recio M, 2013, ESTUAR COAST, V36, P997, DOI 10.1007/s12237-013-9607-2; REUSCH TBH, 1995, J EXP MAR BIOL ECOL, V192, P257, DOI 10.1016/0022-0981(95)00074-2; Reusch TBH, 1999, OIKOS, V84, P398, DOI 10.2307/3546420; Ricart AM, 2015, MAR ECOL PROG SER, V532, P89, DOI 10.3354/meps11384; Ros A, 2014, CONT SHELF RES, V91, P220, DOI 10.1016/j.csr.2014.10.004; Tanner JE, 2005, AUSTRAL ECOL, V30, P210, DOI 10.1111/j.1442-9993.2005.01438.x; Vacchi M, 2012, ESTUAR COAST SHELF S, V97, P58, DOI 10.1016/j.ecss.2011.11.024; Vinther HF, 2008, ESTUAR COAST SHELF S, V77, P91, DOI 10.1016/j.ecss.2007.09.007; WALKER DI, 1992, MAR POLLUT BULL, V25, P191, DOI 10.1016/0025-326X(92)90224-T; Williams SL, 2007, J EXP MAR BIOL ECOL, V350, P89, DOI 10.1016/j.jembe.2007.05.032	57	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156264	10.1371/journal.pone.0156264	http://dx.doi.org/10.1371/journal.pone.0156264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227321	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500097
J	Li, L; Li, XY; Hu, HJ; Shin, H; Zhou, P				Li, Le; Li, Xiaoyan; Hu, Huijing; Shin, Henry; Zhou, Ping			The Effect of Subcutaneous Fat on Electrical Impedance Myography: Electrode Configuration and Multi-Frequency Analyses	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NEUROMUSCULAR DISEASE; SKELETAL-MUSCLE; INITIAL ASSESSMENT; ATROPHY; RESISTIVITY; ANISOTROPY; ARRAY; AGE	This study investigates the impact of the subcutaneous fat layer (SFL) thickness on localized electrical impedance myography (EIM), as well as the effects of different current electrodes, varying in distance and direction, on EIM output. Twenty-three healthy subjects underwent localized multi-frequency EIM on their biceps brachii muscles with a hand-held electrode array. The EIM measurements were recorded under three different configurations: wide (or outer) longitudinal configuration 6.8 cm, narrow (or inner) longitudinal configuration 4.5 cm, and narrow transverse configuration 4.5 cm. Ultrasound was applied to measure the SFL thickness. Coefficients of determination (R-2) of three EIM variables (resistance, reactance, and phase) and SFL thickness were calculated. For the longitudinal configuration, the wide distance could reduce the effects of the subcutaneous fat when compared with the narrow distance, but a significant correlation still remained for all three EIM parameters. However, there was no significant correlation between SFL thickness and reactance in the transverse configuration (R-2 = 0.0294, p = 0.434). Utilizing a ratio of 50kHz/100kHz phase was found to be able to help reduce the correlation with SFL thickness for all the three configurations. The findings indicate that the appropriate selection of the current electrode distance, direction and the multi-frequency phase ratio can reduce the impact of subcutaneous fat on EIM. These settings should be evaluated for future clinical studies using hand-held localized arrays to perform EIM.	[Li, Le] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rehabil Med, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Huijing; Zhou, Ping] Guangdong Prov Work Injury Rehabil Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Le; Li, Xiaoyan; Hu, Huijing; Shin, Henry; Zhou, Ping] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Li, Le; Li, Xiaoyan; Hu, Huijing; Shin, Henry; Zhou, Ping] TIRR Mem Hermann Res Ctr, Houston, TX USA	Sun Yat Sen University; University of Texas System; University of Texas Health Science Center Houston	Zhou, P (corresponding author), Guangdong Prov Work Injury Rehabil Ctr, Guangzhou, Guangdong, Peoples R China.; Zhou, P (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA.; Zhou, P (corresponding author), TIRR Mem Hermann Res Ctr, Houston, TX USA.	ping.zhou.1@uth.tmc.edu	Li, Le/N-1841-2019	Li, Le/0000-0002-9340-9061	Science and Technology Planning Project of Guangdong Province [2015A050502022, 2014A050503052]; China Scholarship Council; National Institutes of Health of the U.S. Department of Health and Human Services [R01NS080839]; Memorial Hermann Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080839] Funding Source: NIH RePORTER	Science and Technology Planning Project of Guangdong Province; China Scholarship Council(China Scholarship Council); National Institutes of Health of the U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Hermann Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Science and Technology Planning Project of Guangdong Province under grants 2015A050502022 and 2014A050503052, the China Scholarship Council, the National Institutes of Health of the U.S. Department of Health and Human Services under grant R01NS080839, and the Memorial Hermann Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron R, 2002, SKELETAL MUSCLE PATO; Aaron R, 2006, PHYSIOL MEAS, V27, P953, DOI 10.1088/0967-3334/27/10/002; Baumgartner RN, 1998, J APPL PHYSIOL, V84, P257, DOI 10.1152/jappl.1998.84.1.257; Chin AB, 2008, MUSCLE NERVE, V37, P560, DOI 10.1002/mus.20981; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Elia M, 2000, ANN NY ACAD SCI, V904, P298; Esper GJ, 2006, MUSCLE NERVE, V34, P595, DOI 10.1002/mus.20626; Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201; Garmirian LP, 2009, MUSCLE NERVE, V39, P16, DOI 10.1002/mus.21115; Jafarpoor M, 2013, IEEE T BIO-MED ENG, V60, P1446, DOI 10.1109/TBME.2012.2237030; Kortman HGJ, 2013, PHYSIOL MEAS, V34, P1611, DOI 10.1088/0967-3334/34/12/1611; Narayanaswami P, 2012, MUSCLE NERVE, V46, P257, DOI 10.1002/mus.23307; Rutkove SB, 2002, MUSCLE NERVE, V25, P390, DOI 10.1002/mus.10048; Rutkove SB, 2014, MUSCLE NERVE, V49, P441, DOI 10.1002/mus.24128; Rutkove SB, 2012, MUSCLE NERVE, V45, P642, DOI 10.1002/mus.23233; Rutkove SB, 2010, MUSCLE NERVE, V42, P915, DOI 10.1002/mus.21784; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Ryan AS, 2002, ARCH PHYS MED REHAB, V83, P1703, DOI 10.1053/apmr.2002.36399; Sanchez B., 2014, IEEE T BIOMED ENG; Schwartz S, 2015, CLIN NEUROPHYSIOL, V126, P202, DOI 10.1016/j.clinph.2014.05.007; Shiffman CA, 1999, PHYS MED BIOL, V44, P2409, DOI 10.1088/0031-9155/44/10/304; Shklyar I, 2015, PEDIATR NEUROL, V52, P202, DOI 10.1016/j.pediatrneurol.2014.09.014; Sung M, 2013, CLIN NEUROPHYSIOL, V124, P400, DOI 10.1016/j.clinph.2012.07.013; Tarulli AW, 2007, CLIN NEUROPHYSIOL, V118, P2393, DOI 10.1016/j.clinph.2007.07.016; Tarulli AW, 2006, PHYSIOL MEAS, V27, P1269, DOI 10.1088/0967-3334/27/12/002; VALDIOSERA R, 1974, J GEN PHYSIOL, V63, P432, DOI 10.1085/jgp.63.4.432	26	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156154	10.1371/journal.pone.0156154	http://dx.doi.org/10.1371/journal.pone.0156154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227876	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500073
J	Mitchell, JT; Sweitzer, MM; Tunno, AM; Kollins, SH; McClernon, FJ				Mitchell, John T.; Sweitzer, Maggie M.; Tunno, Angela M.; Kollins, Scott H.; McClernon, F. Joseph			"I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SUBSTANCE USE; HEALTH INFORMATION; INTERNET; WEB; EXPECTANCY; STRATEGIES; CHILDHOOD; POSTINGS; IMPACT	Background Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for problematic cannabis use. However, clinical and anecdotal evidence suggest an increasingly popular perception that cannabis is therapeutic for ADHD, including via online resources. Given that the Internet is increasingly utilized as a source of healthcare information and may influence perceptions, we conducted a qualitative analysis of online forum discussions, also referred to as threads, on the effects of cannabis on ADHD to systematically characterize the content patients and caregivers may encounter about ADHD and cannabis. Methods A total of 268 separate forum threads were identified. Twenty percent (20%) were randomly selected, which yielded 55 separate forum threads (mean number of individual posts per forum thread = 17.53) scored by three raters (Cohen's kappa = 0.74). A final sample of 401 posts in these forum threads received at least one endorsement on predetermined topics following qualitative coding procedures. Results Twenty-five (25%) percent of individual posts indicated that cannabis is therapeutic for ADHD, as opposed to 8% that it is harmful, 5% that it is both therapeutic and harmful, and 2% that it has no effect on ADHD. This pattern was generally consistent when the year of each post was considered. The greater endorsement of therapeutic versus harmful effects of cannabis did not generalize to mood, other (non-ADHD) psychiatric conditions, or overall domains of daily life. Additional themes emerged (e.g., cannabis being considered sanctioned by healthcare providers). Conclusions Despite that there are no clinical recommendations or systematic research supporting the beneficial effects of cannabis use for ADHD, online discussions indicate that cannabis is considered therapeutic for ADHD-this is the first study to identify such a trend. This type of online information could shape ADHD patient and caregiver perceptions, and influence cannabis use and clinical care.	[Mitchell, John T.; Sweitzer, Maggie M.; Tunno, Angela M.; Kollins, Scott H.; McClernon, F. Joseph] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Mitchell, John T.; Sweitzer, Maggie M.; Kollins, Scott H.; McClernon, F. Joseph] Duke Ctr Addict Sci & Technol, Durham, NC USA	Duke University	Mitchell, JT (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA.; Mitchell, JT (corresponding author), Duke Ctr Addict Sci & Technol, Durham, NC USA.	john.mitchell@duke.edu	Kollins, Scott/AAD-6291-2020; Sweitzer, Maggie/GPK-2525-2022	Kollins, Scott/0000-0001-6847-6935; Sweitzer, Maggie/0000-0002-5085-3752	National Institute on Drug Abuse [K23 DA032577, K24 DA023464]; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA032577, K24DA023464] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institute on Drug Abuse (K23 DA032577 to JTM and K24 DA023464 to SHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsop DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044864; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2004, MAR MED NEED SCI BAS; Barkley RA, 2007, J SAFETY RES, V38, P113, DOI 10.1016/j.jsr.2006.09.004; Bidwell LC, 2014, DRUG ALCOHOL DEPEN, V135, P88, DOI 10.1016/j.drugalcdep.2013.11.013; Blakely G, 2014, NURS HEALTH SCI, V16, P387, DOI 10.1111/nhs.12122; Blume A, 2009, NEUROPSYCHIATRIE, V23, P42; Boyer Celia, 2004, Stud Health Technol Inform, V100, P159; Boyer EW, 2007, CYBERPSYCHOL BEHAV, V10, P1, DOI 10.1089/cpb.2006.9999; Boyer EW, 2005, PEDIATRICS, V115, P302, DOI 10.1542/peds.2004-1199; Boyer EW, 2001, NEW ENGL J MED, V345, P469, DOI 10.1056/NEJM200108093450619; Burri M, 2006, NICOTINE TOB RES, V8, pS13, DOI 10.1080/14622200601042513; Bylund CL, 2007, PATIENT EDUC COUNS, V66, P346, DOI 10.1016/j.pec.2007.01.009; Crane NA, 2013, NEUROPSYCHOL REV, V23, P117, DOI 10.1007/s11065-012-9222-1; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Daniulaityte R, 2013, DRUG ALCOHOL DEPEN, V130, P241, DOI 10.1016/j.drugalcdep.2012.11.003; De Alwis D, 2014, ADDICT BEHAV, V39, P1278, DOI 10.1016/j.addbeh.2014.04.003; Del Boca FK, 2002, ALCOHOL CLIN EXP RES, V26, P926, DOI 10.1097/00000374-200206000-00024; Falck RS, 2004, DRUG ALCOHOL DEPEN, V74, P45, DOI 10.1016/j.drugalcdep.2003.11.009; Flower A, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-162; Fox S, 2013, HLTH ONLINE 2013, DOI DOI 10.1186/1471-244X-10-113; Goldman MS, 2002, ALCOHOL CLIN EXP RES, V26, P737, DOI 10.1097/00000374-200205000-00021; Griffiths P, 2000, SUBST USE MISUSE, V35, P811, DOI 10.3109/10826080009148423; Hadland SE, 2015, J DEV BEHAV PEDIATR, V36, P115, DOI 10.1097/DBP.0000000000000129; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hall W, 2009, INT J DRUG POLICY, V20, P458, DOI 10.1016/j.drugpo.2009.02.013; Harty SC, 2015, SUBST USE MISUSE, V50, P1470, DOI 10.3109/10826084.2015.1018545; Hechtman L, FUNCTIONAL ADU UNPUB; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Johnston L. D., 2014, MONITORING FUTURE NA; Kummervold PE, 2002, NORD J PSYCHIAT, V56, P59, DOI 10.1080/08039480252803945; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange JE, 2010, DRUG ALCOHOL DEPEN, V108, P138, DOI 10.1016/j.drugalcdep.2009.11.010; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Lipsman A, 2015, US DIGITAL FUTURE FO; Lisdahl KM, 2016, DRUG ALCOHOL DEPEN, V161, P135, DOI 10.1016/j.drugalcdep.2016.01.032; Lisdahl Krista M, 2014, Curr Addict Rep, V1, P144; McMullan M, 2006, PATIENT EDUC COUNS, V63, P24, DOI 10.1016/j.pec.2005.10.006; Miller PG, 2010, ADDICTION, V105, P1557, DOI 10.1111/j.1360-0443.2010.02992.x; Molina BSG, 2013, J AM ACAD CHILD PSY, V52, P250, DOI 10.1016/j.jaac.2012.12.014; Mounteney J, 2010, SUBST USE MISUSE, V45, P266, DOI 10.3109/10826080903368598; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Poole R, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.4123; Rasmussen J, 2016, BRAIN IMAGING BEHAV, V10, P761, DOI 10.1007/s11682-015-9438-9; Saloner B, 2015, PEDIATRICS, V135, P955, DOI 10.1542/peds.2015-0436; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Schifano F, 2006, PROG NEURO-PSYCHOPH, V30, P640, DOI 10.1016/j.pnpbp.2005.11.035; Strohbeck-Kuehner P, 2008, CANNABINOIDS, V3, P1; Tamm L, 2013, DRUG ALCOHOL DEPEN, V133, P607, DOI 10.1016/j.drugalcdep.2013.08.001; Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Wald HS, 2007, PATIENT EDUC COUNS, V68, P218, DOI 10.1016/j.pec.2007.05.016; Wartella E, 2015, TEENS HLTH TECHNOLOG; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Zaman T, 2015, J ADDICT MED, V9, P317, DOI 10.1097/ADM.0000000000000138	55	49	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156614	10.1371/journal.pone.0156614	http://dx.doi.org/10.1371/journal.pone.0156614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227537	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500160
J	Ono, NN; Qin, XQ; Wilson, AE; Li, G; Tian, L				Ono, Nadia N.; Qin, Xiaoqiong; Wilson, Alexander E.; Li, Gang; Tian, Li			Two UGT84 Family Glycosyltransferases Catalyze a Critical Reaction of Hydrolyzable Tannin Biosynthesis in Pomegranate (Punica granatum)	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; SHIKIMATE-PATHWAY; GENE-EXPRESSION; UDP-GLUCOSE; GALLIC ACID; PLANT; IDENTIFICATION; PURIFICATION; PROTEINS	Hydrolyzable tannins (HTs) play important roles in plant herbivore deterrence and promotion of human health. A critical step in HT production is the formation of 1-O-galloyl-beta-D-glucopyranoside (beta-glucogallin, ester-linked gallic acid and glucose) by a UDP-glucosyltransferase (UGT) activity. We cloned and biochemically characterized four candidate UGTs from pomegranate (Punica granatum), of which only UGT84A23 and UGT84A24 exhibited beta-glucogallin forming activities in enzyme assays. Although overexpression and single RNAi knockdown pomegranate hairy root lines of UGT84A23 or UGT84A24 did not lead to obvious alterations in punicalagin (the prevalent HT in pomegranate) accumulation, double knockdown lines of the two UGTs resulted in largely reduced levels of punicalagins and bis-hexahydroxydiphenyl glucose isomers. An unexpected accumulation of galloyl glucosides (ether-linked gallic acid and glucose) was also detected in the double knockdown lines, suggesting that gallic acid was utilized by an unidentified UGT activity for glucoside formation. Transient expression in Nicotiana benthamiana leaves and immunogold labeling in roots of pomegranate seedlings collectively indicated cytosolic localization of UGT84A23 and UGT84A24. Overall, functional characterization and localization of UGT84A23 and UGT84A24 open up opportunities for further understanding the regulatory control of HT metabolism in plants and its coordination with other biochemical pathways in the metabolic network.	[Ono, Nadia N.; Qin, Xiaoqiong; Wilson, Alexander E.; Li, Gang; Tian, Li] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Tian, Li] Shanghai Chenshan Bot Garden, Shanghai Key Lab Plant Funct Genom & Resources, Shanghai, Peoples R China; [Tian, Li] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Li, Gang] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of California System; University of California Davis; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Nebraska System; University of Nebraska Lincoln	Tian, L (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Tian, L (corresponding author), Shanghai Chenshan Bot Garden, Shanghai Key Lab Plant Funct Genom & Resources, Shanghai, Peoples R China.; Tian, L (corresponding author), Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China.	ltian@ucdavis.edu	li, gang/N-5749-2016	Tian, Li/0000-0001-6461-6072	National Science Foundation [MCB1120323]; National Science Foundation; UC Davis, Department of Plant Sciences; Henry A. Jastro Research Fellowship	National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); UC Davis, Department of Plant Sciences; Henry A. Jastro Research Fellowship	This work was supported by the National Science Foundation (MCB1120323 to LT), the National Science Foundation Graduate Research Fellowship (NNO), the UC Davis, Department of Plant Sciences Graduate Research Fellowship (NNO and AEW) and the Henry A. Jastro Research Fellowship (NNO and AEW).	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Alanen HI, 2006, J BIOL CHEM, V281, P33727, DOI 10.1074/jbc.M604314200; Bandaranayake PCG, 2010, PLANT CELL, V22, P1404, DOI 10.1105/tpc.110.074831; Broun Pierre, 2006, Phytochemistry Reviews, V5, P27, DOI 10.1007/s11101-006-9000-x; Buzzini P, 2008, MINI-REV MED CHEM, V8, P1179, DOI 10.2174/138955708786140990; Cui LL, 2016, J EXP BOT, V67, P2285, DOI 10.1093/jxb/erw053; DAMATO TA, 1984, PLANTA, V162, P104, DOI 10.1007/BF00410205; Dhaubhadel S, 2008, J EXP BOT, V59, P981, DOI 10.1093/jxb/ern046; Ding L, 2007, J EXP BOT, V58, P2053, DOI 10.1093/jxb/erm059; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GANSON RJ, 1986, PLANT PHYSIOL, V82, P203, DOI 10.1104/pp.82.1.203; GROSS GG, 1992, RECENT ADV PHYTOCHEM, V26, P297; GROSS GG, 1983, PHYTOCHEMISTRY, V22, P2179, DOI 10.1016/S0031-9422(00)80141-7; GROSS GG, 1982, FEBS LETT, V148, P67, DOI 10.1016/0014-5793(82)81244-1; Grundhofer P, 2001, PHYTOCHEMISTRY, V57, P915, DOI 10.1016/S0031-9422(01)00099-1; Grundhofer P, 2001, PLANT SCI, V160, P987, DOI 10.1016/S0168-9452(01)00341-7; HASLAM E, 1988, J CHEM ECOL, V14, P1789, DOI 10.1007/BF01013477; Haslam E., 1979, RECENT ADV PHYTOCHEM, P475; Heber D, 2008, CANCER LETT, V269, P262, DOI 10.1016/j.canlet.2008.03.043; Hunter PR, 2007, PLANT PHYSIOL, V145, P1371, DOI 10.1104/pp.107.103945; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Khater F, 2012, J EXP BOT, V63, P1201, DOI 10.1093/jxb/err340; Koleckar V, 2008, MINI-REV MED CHEM, V8, P436, DOI 10.2174/138955708784223486; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Liu YJ, 2012, J BIOL CHEM, V287, P44406, DOI 10.1074/jbc.M112.403071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunkenbein S, 2006, PLANT PHYSIOL, V140, P1047, DOI 10.1104/pp.105.074955; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Mayhew TM, 2011, J EXP BOT, V62, P4101, DOI 10.1093/jxb/err176; MCMANUS JP, 1985, J CHEM SOC PERK T 2, P1429, DOI 10.1039/p29850001429; Mena P, 2012, MOLECULES, V17, P14821, DOI 10.3390/molecules171214821; Meyers KJ, 2006, J AGR FOOD CHEM, V54, P7686, DOI 10.1021/jf061264t; Mittasch J, 2014, PHYTOCHEMISTRY, V99, P44, DOI 10.1016/j.phytochem.2013.11.023; MOUSDALE DM, 1985, PLANTA, V163, P241, DOI 10.1007/BF00393514; Mugford ST, 2013, PLANT CELL, V25, P1078, DOI 10.1105/tpc.113.110551; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ono NN, 2012, PLANTA, V236, P931, DOI 10.1007/s00425-012-1706-y; Ono NN, 2011, PLANT SCI, V180, P439, DOI 10.1016/j.plantsci.2010.11.012; Ono NN, 2011, J INTEGR PLANT BIOL, V53, P800, DOI 10.1111/j.1744-7909.2011.01073.x; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Russin WA, 2001, MICROWAVE TECHNIQUES AND PROTOCOLS, P25, DOI 10.1007/978-1-59259-128-2_3; Seeram N, 2005, SEP PURIF TECHNOL, V41, P49, DOI 10.1016/j.seppur.2004.04.003; Shanks JV, 1999, CURR OPIN BIOTECH, V10, P151, DOI 10.1016/S0958-1669(99)80026-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taoka K, 2007, PLANT CELL, V19, P1866, DOI 10.1105/tpc.107.052522; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; WEISEMANN S, 1988, BIOORG CHEM, V16, P29, DOI 10.1016/0045-2068(88)90035-1; Werner RA, 2004, PHYTOCHEMISTRY, V65, P2809, DOI 10.1016/j.phytochem.2004.08.020; YAZAKI K, 1995, PHYTOCHEMISTRY, V38, P1127, DOI 10.1016/0031-9422(94)00821-A	52	33	36	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156319	10.1371/journal.pone.0156319	http://dx.doi.org/10.1371/journal.pone.0156319			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227328	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500112
J	Peng, J; Zhang, L; Liu, JR; Luo, JY; Zhao, XH; Dong, HL; Ma, Y; Sui, N; Zhou, ZG; Meng, YL				Peng, Jun; Zhang, Lei; Liu, Jingran; Luo, Junyu; Zhao, Xinhua; Dong, Helin; Ma, Yan; Sui, Ning; Zhou, Zhiguo; Meng, Yali			Effects of Soil Salinity on Sucrose Metabolism in Cotton Fiber	PLOS ONE			English	Article							BOLL CHARACTERISTICS; CELLULOSE; SYNTHASE; ELONGATION; EXPRESSION; INVERTASE; QUALITY; LEAVES; PLANTS; YIELDS	Cotton (Gosspium hirsutum L.) is classified as a salt tolerant crop. However, its yield and fiber quality are negatively affected by soil salinity. Studies on the enzymatic differences in sucrose metabolism under different soil salinity levels are lacking. Therefore, field experiments, using two cotton cultivars, CCRI-79 (salt-tolerant) and Simian 3 (salt-sensitive), were conducted in 2013 and 2014 at three different salinity levels (1.15 dS m(-1) [low soil salinity], 6.00 dS m(-1) [medium soil salinity], and 11.46 dS m(-1) [high soil salinity]). The objective was to elucidate the effects of soil salinity on sucrose content and the activity of key enzymes that are related to sucrose metabolism in cotton fiber. Results showed that as the soil salinity increased, cellulose content, sucrose content, and sucrose transformation rate declined; the decreases in cellulose content and sucrose transformation rate caused by the increase in soil salinity were more in Simian 3 than those in CCRI-79. With increase in soil salinity, activities of sucrose metabolism enzymes sucrose phophate synthase (SPS), acidic invertase, and alkaline invertase were decreased, whereas sucrose synthase (SuSy) activity increased. However, the changes displayed in the SuSy and SPS activities in response to increase in soil salinity were different and the differences were large between the two cotton cultivars. These results illustrated that suppressed cellulose synthesis and sucrose metabolism under high soil salinity were mainly due to the change in SPS, SuSy, and invertase activities, and the difference in cellulose synthesis and sucrose metabolism in fiber for the two cotton cultivars in response to soil salinity was determined mainly by both SuSy and SPS activities.	[Peng, Jun; Zhou, Zhiguo; Meng, Yali] Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol & Ecol Southern China, Nanjing, Jiangsu, Peoples R China; [Peng, Jun; Zhang, Lei; Liu, Jingran; Luo, Junyu; Zhao, Xinhua; Dong, Helin; Ma, Yan] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Sui, Ning] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Zhejiang Chinese Medical University	Zhou, ZG; Meng, YL (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol & Ecol Southern China, Nanjing, Jiangsu, Peoples R China.	giscott@njau.edu.cn; mengyl@njau.edu.cn		Ma, Yan/0000-0001-6897-5064	National Natural Science Foundation of China [31301262, 31501257]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest [201503109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest	The authors are grateful for financial support from the National Natural Science Foundation of China (31301262, 31501257), the Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP), and the Special Fund for Agro-scientific Research in the Public Interest (201503109).	Abdullah Z., 1986, PROSPECTS BIOSALINE, P125; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Ashraf M, 2002, CRIT REV PLANT SCI, V21, P1, DOI 10.1016/S0735-2689(02)80036-3; Ashraf M, 2000, AGRONOMIE, V20, P917, DOI 10.1051/agro:2000168; Balibrea ME, 2000, PHYSIOL PLANTARUM, V110, P503, DOI 10.1111/j.1399-3054.2000.1100412.x; Banks S. W., 1997, 1997 Proceedings Beltwide Cotton Conferences, New Orleans, LA, USA, January 6-10, 1997: Volume 2., P1422; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; But SY, 2015, ARCH MICROBIOL, V197, P471, DOI 10.1007/s00203-015-1080-9; Chao DY, 2005, CELL RES, V15, P796, DOI 10.1038/sj.cr.7290349; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105088; Chowdhry TM, 1972, COTTON SOILS PAKISTA, P275; d'Avo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068289; Delmer D, 2002, METAB ENG, V20, P22, DOI DOI 10.1006/MBEN.2001.0206; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; DELMER DP, 1995, PLANT CELL, V7, P987, DOI 10.1105/tpc.7.7.987; Dong H., 2012, AUST J CROP SCI, V6, P333, DOI DOI 10.3316/INFORMIT.054789177704118; Dong He-zhong, 2012, Yingyong Shengtai Xuebao, V23, P566; Dong HZ, 2010, EUR J AGRON, V33, P285, DOI 10.1016/j.eja.2010.08.002; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Fernandes FM, 2004, BIOL PLANTARUM, V48, P317, DOI 10.1023/B:BIOP.0000033465.59361.d2; Haigler CH, 2007, PLANT MOL BIOL, V63, P815, DOI 10.1007/s11103-006-9127-6; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; HUBER SC, 1986, PLANT PHYSIOL, V81, P1008, DOI 10.1104/pp.81.4.1008; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; LONGENECKER DE, 1973, SOIL SCI, V115, P294, DOI 10.1097/00010694-197304000-00005; LONGENECKER DE, 1974, SOIL SCI, V118, P387, DOI 10.1097/00010694-197412000-00007; Lu SW, 2010, AFR J BIOTECHNOL, V9, P842; Ma Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089476; Park AY, 2008, TRANSGENIC RES, V17, P181, DOI 10.1007/s11248-007-9090-2; Pettigrew WT, 2008, CROP SCI, V48, P278, DOI 10.2135/cropsci2007.05.0261; Pettigrew WT, 2001, CROP SCI, V41, P1108, DOI 10.2135/cropsci2001.4141108x; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Shu HM, 2009, EUR J AGRON, V31, P61, DOI 10.1016/j.eja.2009.03.004; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; WAFLER U, 1994, PLANT PHYSIOL BIOCH, V32, P697; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wang YH, 2009, PLANT GROWTH REGUL, V57, P203, DOI 10.1007/s10725-008-9337-9; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Zhang Guo-wei, 2011, Yingyong Shengtai Xuebao, V22, P2045; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3	41	15	15	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156398	10.1371/journal.pone.0156398	http://dx.doi.org/10.1371/journal.pone.0156398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227773	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500132
J	Zhou, YQ; Xu, XY; Lv, HB; Wen, QR; Li, J; Tan, LY; Li, JQ; Sheng, XJ				Zhou, Yanqing; Xu, Xiaying; Lv, Huabing; Wen, Qirong; Li, Juan; Tan, Linyu; Li, Jianqi; Sheng, Xiujie			The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-13 EXPRESSION; ADENOCARCINOMA TRANSCRIPT 1; LUNG-CANCER; METASTASIS; CARCINOMA; ADAMTS1; INHIBITION; PROGNOSIS; GENES	Background Metastasis associated in lung adenocarcinoma transcript-1 (MALAT-1) is overexpressed during cancer progression and promotes cell migration and invasion in many solid tumors. However, its role in ovarian cancer remains poorly understood. Methods Expressions of MALAT-1 were detected in 37 normal ovarian tissues and 45 ovarian cancer tissues by reverse transcription polymerase chain reaction (RT-PCR). Cell proliferation was observed by CCK-8 assay; Flow cytometry was used to measure cell cycle and apoptosis; Cell migration was detected by transwell migration and invasion assay. In order to evaluate the function of MALAT-1, shRNA combined with DNA microarray and Functional enrichment analysis were performed to determine the transcriptional effects of MALAT-1 silencing in OVCAR3 cells. RNA and protein expression were measured by qRT-PCR and Western blotting, respectively. Results We found that upregulation of MALAT-1 mRNA in ovarian cancer tissues and enhanced MALAT-1 expression was associated with FIGO stage. Knockdown of MALAT-1 expression in OVCAR3 cells inhibited cell proliferation, migration, and invasion, leading to G0/G1 cell cycle arrest and apoptosis. Overexpressed MALAT-1 expression in SKOV3 cells promoted cell proliferation, migration and invasion. Downregulation of MALAT-1 resulted in significant change of gene expression (at least 2-fold) in 449 genes, which regulate proliferation, cell cycle, and adhesion. As a consequence of MALAT-1 knockdown, MMP13 protein expression decreased, while the expression of MMP19 and ADAMTS1 was increased. Conclusions The present study found that MALAT-1 is highly expressed in ovarian tumors. MALAT-1 promotes the growth and migration of ovarian cancer cells, suggesting that MALAT-1 may be an important contributor to ovarian cancer development.	[Sheng, Xiujie] Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; Guangzhou Med Univ, Key Lab Major Obstetr Dis Guangdong Prov, Key Lab Reprod & Genet, Guangdong Higher Educ Inst Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Sheng, XJ (corresponding author), Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.	xjsheng@gzemail.cn			Science and Information Technology Agency of Guangzhou [2010GNE00221]; Mechanism Study of MALAT1 Promote Invasion and Metastasis of Ovarian Cancer by Targeted Regulating STAT3 Signaling Pathway [2014A020212517]	Science and Information Technology Agency of Guangzhou; Mechanism Study of MALAT1 Promote Invasion and Metastasis of Ovarian Cancer by Targeted Regulating STAT3 Signaling Pathway	This study was supported by grants from the Science and Information Technology Agency of Guangzhou (No. 2010GNE00221) and the Mechanism Study of MALAT1 Promote Invasion and Metastasis of Ovarian Cancer by Targeted Regulating STAT3 Signaling Pathway (No. 2014A020212517).	Ahmed FY, 1996, J CLIN ONCOL, V14, P2968, DOI 10.1200/JCO.1996.14.11.2968; Chen J, 2013, DIGEST DIS SCI, V58, P405, DOI 10.1007/s10620-012-2379-x; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fehrmann RSN, 2007, ONCOLOGIST, V12, P960, DOI 10.1634/theoncologist.12-8-960; Foda AM, 2014, TUMOR BIOL, V35, P5653, DOI 10.1007/s13277-014-1748-9; Freitas VM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-2; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Guo FJ, 2010, ACTA BIOCH BIOPH SIN, V42, P224, DOI 10.1093/abbs/gmq008; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hantke B, 2003, BIOL CHEM, V384, P1247, DOI 10.1515/BC.2003.137; Horak S, 1992, Ginekol Pol, V63, P619; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Inagaki J, 2014, EXP CELL RES, V323, P263, DOI 10.1016/j.yexcr.2014.03.002; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; NAKAJIMA M, 1990, J NATL CANCER I, V82, P1890, DOI 10.1093/jnci/82.24.1890; Obika M, 2012, CANCER SCI, V103, P1889, DOI 10.1111/j.1349-7006.2012.02381.x; Ochi K, 1997, MOL GEN GENET, V256, P488; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ren SC, 2013, EUR J CANCER, V49, P2949, DOI 10.1016/j.ejca.2013.04.026; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang JR, 2013, EUR REV MED PHARMACO, V17, P427; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583	29	53	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155250	10.1371/journal.pone.0155250	http://dx.doi.org/10.1371/journal.pone.0155250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227769	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500012
J	Ding, XL; Ye, JR; Lin, SX; Wu, XQ; Li, DW; Nian, B				Ding, Xiaolei; Ye, Jianren; Lin, Sixi; Wu, Xiaoqin; Li, Dewei; Nian, Bo			Deciphering the Molecular Variations of Pine Wood Nematode Bursaphelenchus xylophilus with Different Virulence	PLOS ONE			English	Article							PCR-RFLP; RNA-SEQ; EXPRESSION ANALYSIS; WILT DISEASE; FAMILIES; GENOMICS; DNA; APHELENCHOIDIDAE; MICRORNAS; MECHANISM	Bursaphelenchus xylophilus is the causative agent of pine wilt disease which has caused huge economic losses in many countries. It has been reported that two forms of pine wood nematodes existed in its native region, i.e., with strong virulence and weak virulence. However, little is known about the molecular differences between the two forms. To better understand their molecular variations, transcriptome and genome sequences of three strongly virulent and one weakly virulent strains were analyzed. We found 238 transcripts and 84 exons which showed notable changes between the two virulent forms. Functional analyses of both differentially expressed transcripts and exons indicated that different virulence strains showed dissimilar nematode growth, reproduction, and oxidoreductase activities. In addition, we also detected a small number of exon-skipping events in B. xylophilus. Meanwhile, 117 SNPs were identified as potential genetic markers in distinguishing the two forms. Four of them were further proved to have undergone allele specific expressions and possibly interrupted the target site of evolutionary conserved B. xylophilus miR-47. These particular SNPs were experimentally verified by including eight additional strains to ensure the validity of our sequencing results. These results could help researchers to better diagnose nematode species with different virulence and facilitate the control of pine wilt disease.	[Ding, Xiaolei; Ye, Jianren; Lin, Sixi; Wu, Xiaoqin; Li, Dewei; Nian, Bo] Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Ding, Xiaolei; Ye, Jianren; Lin, Sixi; Wu, Xiaoqin; Nian, Bo] Jiangsu Key Lab Prevent & Management Invas Specie, Nanjing, Jiangsu, Peoples R China; [Li, Dewei] Connecticut Agr Expt Stn, Valley Lab, Windsor, CT 06095 USA	Nanjing Forestry University; Connecticut Agricultural Experiment Station	Ye, JR (corresponding author), Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.; Ye, JR (corresponding author), Jiangsu Key Lab Prevent & Management Invas Specie, Nanjing, Jiangsu, Peoples R China.	njfu_jrye@163.com	ye, jian/GQH-3702-2022		National key Technology RD Program [2012BAD19B0703]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Doctorate Fellowship Foundation of Nanjing Forestry University [2011YB019]	National key Technology RD Program(National Key Technology R&D Program); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Doctorate Fellowship Foundation of Nanjing Forestry University	This work was supported by the National key Technology R&D Program (2012BAD19B0703), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Doctorate Fellowship Foundation of Nanjing Forestry University (2011YB019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2003, APPL ENTOMOL ZOOL, V38, P565, DOI 10.1303/aez.2003.565; Aikawa T, 2007, NEMATOLOGY, V9, P371, DOI 10.1163/156854107781352007; Akiba M, 2012, PLANT DIS, V96, P249, DOI 10.1094/PDIS-12-10-0910; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Asai E, 2005, FOREST PATHOL, V35, P135, DOI 10.1111/j.1439-0329.2004.00396.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell GDM, 2013, GENOME BIOL EVOL, V5, P1309, DOI 10.1093/gbe/evt072; BOLLA RI, 1993, J NEMATOL, V25, P227; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa V, 2013, EUR J HUM GENET, V21, P134, DOI 10.1038/ejhg.2012.129; Cutter AD, 2013, MOL ECOL, V22, P2074, DOI 10.1111/mec.12281; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Ding XL, 2015, GENE, V555, P346, DOI 10.1016/j.gene.2014.11.030; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Espada M, 2016, MOL PLANT PATHOL, V17, P286, DOI 10.1111/mpp.12280; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Henkle-Duhrsen K, 2001, MOL BIOCHEM PARASIT, V114, P129, DOI 10.1016/S0166-6851(01)00252-3; Iwahori H, 1998, FUND APPL NEMATOL, V21, P655; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Palomares-Rius JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2085-0; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; SHAHJAHAN RM, 1995, BIOTECHNIQUES, V19, P332; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Takemoto S, 2005, APPL ENTOMOL ZOOL, V40, P529, DOI 10.1303/aez.2005.529; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Utsuzawa S, 2005, PHYTOPATHOLOGY, V95, P737, DOI 10.1094/PHYTO-95-0737; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Vicente CSL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123839; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P444; Wan L, 2012, IEEE ACM T COMPUT BI, V9, P1281, DOI 10.1109/TCBB.2012.83; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; Yan X, 2012, GENE, V505, P81, DOI 10.1016/j.gene.2012.05.041; Ye ZQ, 2014, NUCLEIC ACIDS RES, V42, P2856, DOI 10.1093/nar/gkt1338; Zhang Q, 2006, BIOSCI BIOTECH BIOCH, V70, P2727, DOI 10.1271/bbb.60330; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Zhu LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038095	54	26	28	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156040	10.1371/journal.pone.0156040	http://dx.doi.org/10.1371/journal.pone.0156040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224277	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700052
J	Hu, JK; Crampton, JC; Locci, M; Crotty, S				Hu, Joyce K.; Crampton, Jordan C.; Locci, Michela; Crotty, Shane			CRISPR-Mediated Slamf1(Delta/Delta) Slamf5(Delta/Delta) Slamf6(Delta/Delta) Triple Gene Disruption Reveals NKT Cell Defects but Not T Follicular Helper Cell Defects	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE DISEASE; MEMORY B-CELLS; HUMORAL IMMUNITY; ADAPTER SAP; MICE; RECEPTORS; DIFFERENTIATION; ACTIVATION; GENERATION; DEFICIENT	SAP (SH2D1A) is required intrinsically in CD4 T cells to generate germinal center responses and long-term humoral immunity. SAP binds to SLAM family receptors, including SLAM, CD84, and Ly108 to enhance cytokine secretion and sustained T cell: B cell adhesion, which both improve T follicular helper (Tfh) cell aid to germinal center (GC) B cells. To understand the overlapping roles of multiple SLAM family receptors in germinal center responses, Slamf1(Delta/Delta) Slamf5(Delta/Delta) Slamf6(Delta/Delta) triple gene disruption (Slamf1,5,6(Delta/Delta)) mice were generated using CRISPR-Cas9 gene editing to eliminate expression of SLAM (CD150), CD84, and Ly108, respectively. Gene targeting was highly efficient, with 6 of 6 alleles disrupted in 14 of 23 pups and the majority of alleles disrupted in the remaining pups. NKT cell differentiation in Slamf1,5,6(Delta/Delta) mice was defective, but not completely absent. The remaining NKT cells exhibited substantially increased 2B4 (SLAMF4) expression. Surprisingly, there were no overt defects in germinal center responses to acute viral infections or protein immunizations in Slamf1,5,6(Delta/Delta) mice, unlike Sh2d1a(-/-) mice. Similarly, in the context of a competitive environment, SLAM family receptor expressing GC Tfh cell, GC B cell, and plasma cell responses exhibited no advantages over Slamf1,5,6(Delta/Delta) cells.	[Hu, Joyce K.; Crampton, Jordan C.; Locci, Michela; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Crotty, Shane] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.; Crotty, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	shane@lji.org	Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262	National Institutes of Health [AI63107, AI72543]; La Jolla Institute for Allergy and Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Jolla Institute for Allergy and Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health (http://www.nih.gov/) grants AI63107 and AI72543 and La Jolla Institute for Allergy and Immunology (http://www.liai.org/) institutional funds.	Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; De Calisto J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00186; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hu JK, 2015, J VIROL, V89, P10383, DOI 10.1128/JVI.01653-15; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Ma CS, 2006, J CLIN INVEST, V116, P322, DOI 10.1172/JCI25720; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; Malbran A, 2004, BLOOD, V103, P1625, DOI 10.1182/blood-2003-07-2525; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Palendira U, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001187; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tangye SG, 2015, CELL, V162, DOI 10.1016/j.cell.2015.07.055; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang NH, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00158; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	38	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156074	10.1371/journal.pone.0156074	http://dx.doi.org/10.1371/journal.pone.0156074			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223891	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700059
J	Jacobsen, A; Heijmans, N; Verkaar, F; Smit, MJ; Heringa, J; van Amerongen, R; Feenstra, KA				Jacobsen, Annika; Heijmans, Nika; Verkaar, Folkert; Smit, Martine J.; Heringa, Jaap; van Amerongen, Renee; Feenstra, K. Anton			Construction and Experimental Validation of a Petri Net Model of Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							BETA-CATENIN; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; COLORECTAL-CANCER; NUCLEAR TRANSPORT; AXIS FORMATION; WNT PATHWAY; IN-VIVO; ACTIVATION; TRANSCRIPTION	The Wnt/beta-catenin signaling pathway is important for multiple developmental processes and tissue maintenance in adults. Consequently, deregulated signaling is involved in a range of human diseases including cancer and developmental defects. A better understanding of the intricate regulatory mechanism and effect of physiological (active) and pathophysiological (hyperactive) WNT signaling is important for predicting treatment response and developing novel therapies. The constitutively expressed CTNNB1 (commonly and hereafter referred to as beta-catenin) is degraded by a destruction complex, composed of amongst others AXIN1 and GSK3. The destruction complex is inhibited during active WNT signaling, leading to beta-catenin stabilization and induction of beta-catenin/TCF target genes. In this study we investigated the mechanism and effect of beta-catenin stabilization during active and hyperactive WNT signaling in a combined in silico and in vitro approach. We constructed a Petri net model of Wnt/beta-catenin signaling including main players from the plasma membrane (WNT ligands and receptors), cytoplasmic effectors and the downstream negative feedback target gene AXIN2. We validated that our model can be used to simulate both active (WNT stimulation) and hyperactive (GSK3 inhibition) signaling by comparing our simulation and experimental data. We used this experimentally validated model to get further insights into the effect of the negative feedback regulator AXIN2 upon WNT stimulation and observed an attenuated beta-catenin stabilization. We furthermore simulated the effect of APC inactivating mutations, yielding a stabilization of beta-catenin levels comparable to the Wnt-pathway activities observed in colorectal and breast cancer. Our model can be used for further investigation and viable predictions of the role of Wnt/beta-catenin signaling in oncogenesis and development.	[Jacobsen, Annika; Heringa, Jaap; Feenstra, K. Anton] Vrije Univ Amsterdam, Ctr Integrat Bioinformat IBIVU, Amsterdam, Netherlands; [Jacobsen, Annika; Heringa, Jaap; Feenstra, K. Anton] Vrije Univ Amsterdam, Dept Comp Sci, Amsterdam, Netherlands; [Jacobsen, Annika; Verkaar, Folkert; Smit, Martine J.; Heringa, Jaap; Feenstra, K. Anton] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, Amsterdam, Netherlands; [Heijmans, Nika; van Amerongen, Renee] Univ Amsterdam, Sect Mol Cytol, Amsterdam, Netherlands; [Heijmans, Nika; van Amerongen, Renee] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Verkaar, Folkert; Smit, Martine J.] Vrije Univ Amsterdam, Div Med Chem, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Jacobsen, A (corresponding author), Vrije Univ Amsterdam, Ctr Integrat Bioinformat IBIVU, Amsterdam, Netherlands.; Jacobsen, A (corresponding author), Vrije Univ Amsterdam, Dept Comp Sci, Amsterdam, Netherlands.; Jacobsen, A (corresponding author), Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, Amsterdam, Netherlands.	annika.jacobsen.86@gmail.com	van Amerongen, Renee/G-2945-2017; Feenstra, Anton/H-9195-2019; van Amerongen, Renee/N-6645-2019	van Amerongen, Renee/0000-0002-8808-2092; Feenstra, Anton/0000-0001-6755-9667; van Amerongen, Renee/0000-0002-8808-2092; Jacobsen, Annika/0000-0003-4818-2360; Heijmans, Nika/0000-0002-5639-9407; Smit, Martine/0000-0003-2713-0238	Netherlands Organisation for Scientific Research (NWO) [612.001.203]; NWO-Vici grant [918.14.657]; University of Amsterdam; Dutch Cancer Society (KWF) [ANW 2013-6057]; NWO ALW, VIDI grant [864.13.002]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO-Vici grant(Netherlands Organization for Scientific Research (NWO)); University of Amsterdam; Dutch Cancer Society (KWF)(KWF Kankerbestrijding); NWO ALW, VIDI grant	This work was in part funded by the Netherlands Organisation for Scientific Research (NWO) (http://www.nwo.nl/) grant 612.001.203 to KAF, the NWO-Vici grant 918.14.657 to MJS, University of Amsterdam (a MacGillavry fellowship to RvA), the Dutch Cancer Society (KWF, career development award ANW 2013-6057 to RvA) and the NWO ALW, VIDI grant 864.13.002 to RvA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Albuquerque C, 2011, BBA-REV CANCER, V1816, P219, DOI 10.1016/j.bbcan.2011.07.005; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Benary U, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00021; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bonzanni N, 2013, BIOINFORMATICS, V29, P80, DOI 10.1093/bioinformatics/btt243; Bonzanni N, 2009, BIOINFORMATICS, V25, P2049, DOI 10.1093/bioinformatics/btp355; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gonzalez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053323; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jamieson C, 2014, SEMIN CANCER BIOL, V27, P20, DOI 10.1016/j.semcancer.2014.04.012; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kofahl B, 2010, BIOCHEM SOC T, V38, P1281, DOI 10.1042/BST0381281; Kogan Y, 2012, BIOCHEM J, V444, P115, DOI 10.1042/BJ20111887; Krepska E, 2008, LECT N BIOINFORMAT, V5054, P48, DOI 10.1007/978-3-540-68413-8_4; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Lloyd-Lewis B, 2013, WIRES SYST BIOL MED, V5, P391, DOI 10.1002/wsbm.1221; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazzoni SM, 2014, CANCER LETT, V355, P1, DOI 10.1016/j.canlet.2014.09.018; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Petri CA., 1962, THESIS TU DARMSTADT; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Reisig CAR, 1998, LNCS, V1491; Reisig CAR G, 1998, LNCS, V1492; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Ruths D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000005; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Suriben R, 2006, DEV DYNAM, V235, P3177, DOI 10.1002/dvdy.20968; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031882; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Verkaar Folkert, 2012, Sci Signal, V5, pmr2, DOI 10.1126/scisignal.2003714; Verkaar F, 2010, FASEB J, V24, P1205, DOI 10.1096/fj.09-141671; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	67	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155743	10.1371/journal.pone.0155743	http://dx.doi.org/10.1371/journal.pone.0155743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218469	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700014
J	Kunz, HH; Park, J; Mevers, E; Garcia, AV; Highhouse, S; Gerwick, WH; Parker, JE; Schroeder, JI				Kunz, Hans-Henning; Park, Jiyoung; Mevers, Emily; Garcia, Ana V.; Highhouse, Samantha; Gerwick, William H.; Parker, Jane E.; Schroeder, Julian I.			Small Molecule DFPM Derivative-Activated Plant Resistance Protein Signaling in Roots Is Unaffected by EDS1 Subcellular Targeting Signal and Chemical Genetic Isolation of victr R-Protein Mutants	PLOS ONE			English	Article							GREEN PEACH APHID; NB-ARC DOMAIN; DISEASE RESISTANCE; INNATE IMMUNITY; NUCLEAR ACCUMULATION; NATURAL VARIATION; ARABIDOPSIS EDS1; STRUCTURAL BASIS; DEFENSE; PAD4	The small molecule DFPM ([5-(3,4-dichlorophenyl)furan-2-yl]-piperidine-1-ylmethanethione) was recently shown to trigger signal transduction via early effector-triggered immunity signaling genes including EDS1 and PAD4 in Arabidopsis thaliana accession Col-0. Chemical genetic analyses of A. thaliana natural variants identified the plant Resistance protein-like Toll/Interleukin1 Receptor (TIR)-Nucleotide Binding (NB)-Leucine-Rich Repeat (LRR) protein VICTR as required for DFPM-mediated root growth arrest. Here a chemical genetic screen for mutants which disrupt DFPM-mediated root growth arrest in the Col-0 accession identified new mutant alleles of the TIR-NB-LRR gene VICTR. One allele, victr-6, carries a Gly216-to-Asp mutation in the Walker A domain supporting an important function of the VICTR nucleotide binding domain in DFPM responses consistent with VICTR acting as a canonical Resistance protein. The essential nucleo-cytoplasmic regulator of TIR-NBLRR-mediated effector-triggered immunity, EDS1, was reported to have both nuclear and cytoplasmic actions in pathogen resistance. DFPM was used to investigate the requirements for subcellular EDS1 localization in DFPM-mediated root growth arrest. EDS1-YFP fusions engineered to localize mainly in the cytoplasm or the nucleus by tagging with a nuclear export signal (NES) or a nuclear localization signal (NLS), respectively, were tested. We found that wild-type EDS1-YFP and both the NES and NLS-tagged EDS1 variants were induced by DFPM treatments and fully complemented eds1 mutant plants in root responses to DFPM, suggesting that enrichment of EDS1 in either compartment could confer DFPM-mediated root growth arrest. We further found that a light and O-2-dependent modification of DFPM is necessary to mediate DFPM signaling in roots. Chemical analyses including Liquid Chromatography-Mass Spectrometry and High-Resolution Atmospheric Pressure Chemical Ionization Mass Spectrometry identified a DFPM modification product that is likely responsible for bioactivity mediating root growth arrest. We propose a chemical structure of this product and a possible reaction mechanism for DFPM modification.	[Kunz, Hans-Henning; Park, Jiyoung; Highhouse, Samantha; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Mevers, Emily; Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol Biomed, La Jolla, CA 92093 USA; [Garcia, Ana V.; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kunz, Hans-Henning] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; Max Planck Society; University of California System; University of California San Diego; Washington State University	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu		Schroeder, Julian/0000-0002-3283-5972	National Institutes of Health [R01GM060396]; Human Frontier Science Program Long-Term fellowships [LT-000226/2013]; Alexander von Humboldt Feodor Lynen fellowship; Growth Regulation & Oncogenesis Training Grant from the National Institutes of Health/National Cancer Institute [T32A009523-24]; International Max-Planck Research School (IMPRS); Deutsche Forschungsgemeinschaft [SPP 1212]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Long-Term fellowships; Alexander von Humboldt Feodor Lynen fellowship; Growth Regulation & Oncogenesis Training Grant from the National Institutes of Health/National Cancer Institute; International Max-Planck Research School (IMPRS); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health (R01GM060396 to JIS, http://grantome.com/grant/NIH/R01-GM060396-13A1), Human Frontier Science Program Long-Term fellowships (to H-HK and LT-000226/2013 to JP, http://www.hfsp.org/), an Alexander von Humboldt Feodor Lynen fellowship (to H-HK, https://www.humboldt-foundation.de/web/lynen-fellowship.html), a Growth Regulation & Oncogenesis Training Grant from the National Institutes of Health/National Cancer Institute (T32A009523-24 to EM, http://www.cancer.gov/), an International Max-Planck Research School (IMPRS) PhD fellowship (AG, https://www.mpg.de/en/imprs) and Deutsche Forschungsgemeinschaft SPP 1212 (Plant-Microbe) grant (to JEP, http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakin KV, 2006, CURR MED CHEM, V13, P223, DOI 10.2174/092986706775197917; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Garcia AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000970; Geletneky C, 1998, EUR J ORG CHEM, V1998, P1625; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 1996, GENETICS, V143, P973; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; IESCE MR, 1995, J ORG CHEM, V60, P5324, DOI 10.1021/jo00121a063; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim TH, 2012, PLANT CELL, V24, P5177, DOI 10.1105/tpc.112.107235; Kim TH, 2011, CURR BIOL, V21, P990, DOI 10.1016/j.cub.2011.04.045; Louis J, 2012, PLANT PHYSIOL, V158, P1860, DOI 10.1104/pp.112.193417; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Pegadaraju V, 2007, PLANT J, V52, P332, DOI 10.1111/j.1365-313X.2007.03241.x; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Roberts M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003465; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schreiber SL, 2005, NAT CHEM BIOL, V1, P64, DOI 10.1038/nchembio0705-64; Stuttmann J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005990; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wagner S, 2013, CELL HOST MICROBE, V14, P619, DOI 10.1016/j.chom.2013.11.006; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845; WIDHOLM JM, 1972, STAIN TECHNOL, V47, P189, DOI 10.3109/10520297209116483; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042	36	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155937	10.1371/journal.pone.0155937	http://dx.doi.org/10.1371/journal.pone.0155937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219122	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700029
J	Kuo, HF; Liu, PL; Chong, IW; Liu, YP; Chen, YH; Ku, PM; Li, CY; Chen, HH; Chiang, HC; Wang, CL; Chen, HJ; Chen, YC; Hsieh, CC				Kuo, Hsuan-Fu; Liu, Po-Len; Chong, Inn-Wen; Liu, Yu-Peng; Chen, Yung-Hsiang; Ku, Po-Ming; Li, Chia-Yang; Chen, Hsiu-Hua; Chiang, Hui-Ching; Wang, Chiao-Lin; Chen, Huang-Jen; Chen, Yen-Chieh; Hsieh, Chong-Chao			Pigment Epithelium-Derived Factor Mediates Autophagy and Apoptosis in Myocardial Hypoxia/Reoxygenation Injury	PLOS ONE			English	Article							HYPOXIA-INDUCED APOPTOSIS; ISCHEMIA/REPERFUSION INJURY; H9C2 CELLS; STRESS; DEATH; PEDF; INFARCTION; CANCER; CARDIOMYOCYTES; TRANSLOCATION	Pigment epithelium-derived factor (PEDF) is a multifunctional protein that exhibits antiangiogenic, antitumor, anti-inflammatory, antioxidative, anti-atherogenic, and cardioprotective properties. While it was recently shown that PEDF expression is inhibited under low oxygen conditions, the functional role of PEDF in response to hypoxia/reoxygenation (H/R) remains unclear. The goal of this study was to therefore investigate the influence of PEDF on myocardial H/R injury. For these analyses, PEDF-specific small interfering RNA-expressing and PEDF-expressing lentivirus (PEDF-LV) vectors were utilized to knockdown or stably overexpress PEDF, respectively, within human cardiomyocytes (HCM) in vitro. We noted that reactive oxygen species (ROS) play important roles in the induction of cell death pathways, including apoptosis and autophagy in ischemic hearts. Our findings demonstrate that overexpression of PEDF resulted in a significant reduction in ROS production and attenuation of mitochondrial membrane potential depletion under H/R conditions. Furthermore, PEDF inhibited the activation of a two-step apoptotic pathway in which caspase-dependent (caspase-9 and caspase-3) and caspase-independent (apoptosis inducing factor and endonuclease G), which in turn cleaves several crucial substrates including the DNA repair enzyme poly (ADP-ribose) polymerase. Meanwhile, overexpression of PEDF also promoted autophagy, a process that is typically activated in response to H/R. Therefore, these findings suggest that PEDF plays a critical role in preventing H/R injury by modulating anti-oxidant and anti-apoptotic factors and promoting autophagy.	[Kuo, Hsuan-Fu; Chen, Hsiu-Hua; Chiang, Hui-Ching; Wang, Chiao-Lin; Chen, Huang-Jen; Chen, Yen-Chieh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung 801, Taiwan; [Liu, Po-Len; Chong, Inn-Wen] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung 807, Taiwan; [Liu, Yu-Peng; Li, Chia-Yang] Kaohsiung Med Univ, Dept Genome Med, Kaohsiung 801, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung 404, Taiwan; [Chen, Yung-Hsiang] Asia Univ, Coll Med & Hlth Sci, Dept Psychol, Taichung 413, Taiwan; [Ku, Po-Ming] Chi Mei Hosp, Cardiovasc Ctr, Tainan 736, Taiwan; [Ku, Po-Ming] Chia Nan Univ Pharm & Sci, Tainan 717, Taiwan; [Hsieh, Chong-Chao] Kaohsiung Med Univ Hosp, Dept Surg, Div Cardiovasc Surg, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; China Medical University Taiwan; Asia University Taiwan; Chia Nan University of Pharmacy & Science; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Hsieh, CC (corresponding author), Kaohsiung Med Univ Hosp, Dept Surg, Div Cardiovasc Surg, Kaohsiung 807, Taiwan.	chchhs@cc.kmu.edu.tw	Kuo, Hsuan-Fu/GVS-2875-2022; Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; LI, CHIA-YANG/0000-0001-5689-9850	Kaohsiung Medical University [KMUH102-2M18, KMUH104-4M32]; Kaohsiung Municipal Ta-Tung Hospital [KMTTH-103-10]; China Medical University [CMU104-S-37]; Taiwan Ministry of Science and Technology [MOST 104-2314-B-037-081-MY2, MOST 104-2314-B-037-087, MOST 104-2320-B-039-016-MY3]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; China Medical University(China Medical University); Taiwan Ministry of Science and Technology; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported in part by grants from the Kaohsiung Medical University (KMUH102-2M18 and KMUH104-4M32), Kaohsiung Municipal Ta-Tung Hospital (KMTTH-103-10), China Medical University (CMU104-S-37), Taiwan Ministry of Science and Technology (MOST 104-2314-B-037-081-MY2, MOST 104-2314-B-037-087, and MOST 104-2320-B-039-016-MY3), and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Chen WT, 2014, BIOMEDICINE-TAIWAN, V4, P24, DOI 10.7603/s40681-014-0005-2; Das G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008813; Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020; Gao X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05637; Guan XJ, 2015, CELL PHYSIOL BIOCHEM, V36, P285, DOI 10.1159/000374071; Guo Z, 2015, EUR J PHARMACOL, V761, P245, DOI 10.1016/j.ejphar.2015.05.056; Hunot S, 2001, SCIENCE, V292, P865, DOI 10.1126/science.1060885; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Kostin S, 2005, ADV CLIN CHEM, V40, P37, DOI 10.1016/S0065-2423(05)40002-5; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Le Page S, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0467-8; Lim CY, 2015, PHARMACOGN MAG, V11, P311, DOI 10.4103/0973-1296.153084; Liu H, 2013, SEMIN CANCER BIOL, V23, P352, DOI 10.1016/j.semcancer.2013.06.008; Liu PL, 2010, AM J RESP CELL MOL, V43, P530, DOI 10.1165/rcmb.2009-0269OC; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; Ma XC, 2015, MOL CELL BIOL, V35, P956, DOI 10.1128/MCB.01091-14; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; Park M, 2015, J CELL PHYSIOL, V230, P630, DOI 10.1002/jcp.24781; Sanchez A, 2012, NEUROSCI RES, V72, P1, DOI 10.1016/j.neures.2011.09.003; Sheng Y, 2014, BRIT J PHARMACOL, V171, P4970, DOI 10.1111/bph.12821; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tsai JR, 2014, ARCH PHARM RES, V37, P548, DOI 10.1007/s12272-013-0232-1; Viventi J, 2012, IEEE ENG MED BIO, P1394, DOI 10.1109/EMBC.2012.6346199; Wang XY, 2015, BIOCHEM BIOPH RES CO, V465, P394, DOI 10.1016/j.bbrc.2015.08.015; Xuan HQ, 2015, BIOCHEMISTRY-MOSCOW+, V80, P276, DOI 10.1134/S0006297915030037; Yu CC, 2016, BIOMEDICINE-TAIWAN, V6, P29, DOI 10.7603/s40681-016-0005-5; Zeng M, 2013, BIOCHEM BIOPH RES CO, V436, P180, DOI 10.1016/j.bbrc.2013.05.070; Zhang H, 2015, INT J MOL SCI, V16, P5618, DOI 10.3390/ijms16035618	30	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156059	10.1371/journal.pone.0156059	http://dx.doi.org/10.1371/journal.pone.0156059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219009	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700037
J	Richards, JS; Vasquez, AA; Franke, B; Hoekstra, PJ; Heslenfeld, DJ; Oosterlaan, J; Faraone, SV; Buitelaar, JK; Hartman, CA				Richards, Jennifer S.; Vasquez, Alejandro Arias; Franke, Barbara; Hoekstra, Pieter J.; Heslenfeld, Dirk J.; Oosterlaan, Jaap; Faraone, Stephen V.; Buitelaar, Jan K.; Hartman, Catharina A.			Developmentally Sensitive Interaction Effects of Genes and the Social Environment on Total and Subcortical Brain Volumes	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MATERNAL EXPRESSED EMOTION; DEFICIT HYPERACTIVITY DISORDER; DEVIANT PEER AFFILIATION; EARLY-LIFE STRESS; HIPPOCAMPAL VOLUMES; GRAY-MATTER; DIFFERENTIAL SUSCEPTIBILITY; EXTERNALIZING BEHAVIORS	Smaller total brain and subcortical volumes have been linked to psychopathology including attention-deficit/hyperactivity disorder (ADHD). Identifying mechanisms underlying these alterations, therefore, is of great importance. We investigated the role of gene-environment interactions (GxE) in interindividual variability of total gray matter (GM), caudate, and putamen volumes. Brain volumes were derived from structural magnetic resonance imaging scans in participants with (N = 312) and without ADHD (N = 437) from N = 402 families (age M = 17.00, SD = 3.60). GxE effects between DAT1, 5-HTT, and DRD4 and social environments (maternal expressed warmth and criticism; positive and deviant peer affiliation) as well as the possible moderating effect of age were examined using linear mixed modeling. We also tested whether findings depended on ADHD severity. Deviant peer affiliation was associated with lower caudate volume. Participants with low deviant peer affiliations had larger total GM volumes with increasing age. Likewise, developmentally sensitive GxE effects were found on total GM and putamen volume. For total GM, differential age effects were found for DAT1 9-repeat and HTTLPR L/L genotypes, depending on the amount of positive peer affiliation. For putamen volume, DRD4 7-repeat carriers and DAT1 10/10 homozygotes showed opposite age relations depending on positive peer affiliation and maternal criticism, respectively. All results were independent of ADHD severity. The presence of differential age-dependent GxE effects might explain the diverse and sometimes opposing results of environmental and genetic effects on brain volumes observed so far.	[Richards, Jennifer S.; Vasquez, Alejandro Arias; Buitelaar, Jan K.] Radboud Univ Nijmegen, Donders Inst Brain, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Richards, Jennifer S.; Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands; [Vasquez, Alejandro Arias; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Vasquez, Alejandro Arias; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Hoekstra, Pieter J.; Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Heslenfeld, Dirk J.; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Faraone, Stephen V.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiatr Disorders, Bergen, Norway	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Vrije Universiteit Amsterdam; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Bergen	Richards, JS (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.; Richards, JS (corresponding author), Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands.	Jennifer.Richards@radboudumc.nl	Faraone, Stephen/AAE-7334-2019; Franke, Barbara/D-4836-2009; Richards, Jennifer/V-3715-2019; Buitelaar, J.K./AAY-7522-2020; Faraone, Stephen V/O-7239-2018	Faraone, Stephen/0000-0002-9217-3982; Franke, Barbara/0000-0003-4375-6572; Faraone, Stephen V/0000-0002-9217-3982	NIH [R01MH62873, R01MH081803]; NWO Large Investment Grant [1750102007010]; NWO Brain & Cognition an Integrative Approach grant [433-09-242]; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; VU University Amsterdam; European Community's Seventh Framework Programme (FP7) [278948, 602450, 602805]; European Community's Horizon 2020 Programme [643051]; Vici grant from NWO [016-130-669]; National Institutes of Health (NIH) Consortium grant [U54 EB020403]; cross-NIH alliance; K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway; NIMH [R13MH059126, R01MH094469]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081803, R01MH094469, R13MH059126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO Large Investment Grant; NWO Brain & Cognition an Integrative Approach grant; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; VU University Amsterdam; European Community's Seventh Framework Programme (FP7); European Community's Horizon 2020 Programme; Vici grant from NWO; National Institutes of Health (NIH) Consortium grant; cross-NIH alliance; K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The International Multisite ADHD Genetics (IMAGE) project is a multi-site, international effort. Funding support for the IMAGE project was provided by NIH grants R01MH62873 and R01MH081803 to Dr. Faraone and the genotyping of samples was provided through the Genetic Association Information Network (GAIN). The dataset used for the analyses described in this manuscript was obtained from the database of Genotypes and Phenotypes (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number #20726-2. This work was further supported by an NWO Large Investment Grant 1750102007010 and NWO Brain & Cognition an Integrative Approach grant (433-09-242) (to Dr. Buitelaar), and grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and VU University Amsterdam. The research leading to these results also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 278948 (TACTICS) and number 602450 (IMAGEMEND) as well as from the European Community's Horizon 2020 Programme under grant agreement no 643051 (MiND). Dr. Franke is supported by a Vici grant from NWO (grant number 016-130-669), and she and Dr. Buitelaar received funding from the National Institutes of Health (NIH) Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centers of Excellence. Dr. Faraone is supported by the K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway, the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 602805 and NIMH grants R13MH059126 and R01MH094469.	Arnold LE, 2013, CHILD ADOL PSYCH CL, V22, P381, DOI 10.1016/j.chc.2013.03.001; ASARNOW JR, 1994, J ABNORM CHILD PSYCH, V22, P129, DOI 10.1007/BF02167896; Atmaca M, 2011, J ANXIETY DISORD, V25, P680, DOI 10.1016/j.janxdis.2011.03.002; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Belsky J, 1997, PSYCHOL INQ, V8, P182, DOI 10.1207/s15327965pli0803_3; Belsky J., 2005, ORIGINS SOCIAL MIND, P139; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P409, DOI 10.1111/j.1469-7610.2010.02281.x; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Bjornebekk A, 2013, NEUROIMAGE, V65, P194, DOI 10.1016/j.neuroimage.2012.10.009; Blumenthal JD, 2002, NEUROIMAGE, V16, P89, DOI 10.1006/nimg.2002.1076; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Brookes KJ, 2006, ARCH GEN PSYCHIAT, V63, P74, DOI 10.1001/archpsyc.63.1.74; BROWN GW, 1966, HUM RELAT, V19, P241, DOI 10.1177/001872676601900301; Burt SA, 2014, PSYCHOL MED, V44, P821, DOI 10.1017/S0033291713000974; Burt SA, 2009, DEV PSYCHOL, V45, P1752, DOI 10.1037/a0016687; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Carballedo A, 2013, AM J MED GENET B, V162B, P183, DOI 10.1002/ajmg.b.32130; Cartwright KL, 2011, J AM ACAD CHILD PSY, V50, P1042, DOI 10.1016/j.jaac.2011.07.006; Caylak E, 2012, AM J MED GENET B, V159B, P613, DOI 10.1002/ajmg.b.32077; Chang Z, 2013, JAMA PSYCHIAT, V70, P311, DOI 10.1001/jamapsychiatry.2013.287; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Chen W., 2006, AM PSYCHOL ASS, P3; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Congdon E, 2008, J PERS, V76, P1447, DOI 10.1111/j.1467-6494.2008.00528.x; Conners C. K., 1999, CONNERSADULT ADHD RA; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Cremers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028421; Dawson JF, 2014, J BUS PSYCHOL, V29, P1, DOI 10.1007/s10869-013-9308-7; den Braber A, 2013, NEUROIMAGE, V83, P98, DOI 10.1016/j.neuroimage.2013.06.027; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649; Elia Josephine, 2007, Curr Psychiatry Rep, V9, P434, DOI 10.1007/s11920-007-0057-z; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Everaerd D, 2012, NEUROPSYCHOPHARMACOL, V37, P1848, DOI 10.1038/npp.2012.32; Faraone SV, 2014, MOL PSYCHIATR, V19, P880, DOI 10.1038/mp.2013.126; Frodl T, 2008, MOL PSYCHIATR, V13, P1093, DOI 10.1038/mp.2008.62; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Frodl T, 2010, NEUROPSYCHOPHARMACOL, V35, P1383, DOI 10.1038/npp.2010.8; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gerritsen L, 2012, MOL PSYCHIATR, V17, P597, DOI 10.1038/mp.2011.51; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Greven CU, 2015, JAMA PSYCHIAT, V72, P490, DOI 10.1001/jamapsychiatry.2014.3162; Gu J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00262; Hale WW, 2011, J CHILD PSYCHOL PSYC, V52, P1174, DOI 10.1111/j.1469-7610.2011.02400.x; Hall FS, 2012, PHYSIOL BEHAV, V107, P623, DOI 10.1016/j.physbeh.2012.05.014; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Hernaus D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092722; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Hickie IB, 2007, J AFFECT DISORDERS, V98, P137, DOI 10.1016/j.jad.2006.07.010; Hicks BM, 2009, ARCH GEN PSYCHIAT, V66, P640, DOI 10.1001/archgenpsychiatry.2008.554; Hirshfeld DR, 1997, J AM ACAD CHILD PSY, V36, P205, DOI 10.1097/00004583-199702000-00011; Hou JQ, 2013, TWIN RES HUM GENET, V16, P698, DOI 10.1017/thg.2013.24; Hoza B, 2007, J PEDIATR PSYCHOL, V32, P655, DOI 10.1093/jpepsy/jsm024; Hyde LW, 2011, TRENDS COGN SCI, V15, P417, DOI 10.1016/j.tics.2011.07.001; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Knafo A, 2013, DEV PSYCHOPATHOL, V25, P1, DOI 10.1017/S0954579412000855; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li SC, 2013, NEUROSCI BIOBEHAV R, V37, P2201, DOI 10.1016/j.neubiorev.2013.07.019; Luby JL, 2012, P NATL ACAD SCI USA, V109, P2854, DOI 10.1073/pnas.1118003109; Miguel-Hidalgo Jose Javier, 2013, Int J Adolesc Med Health, V25, P245, DOI 10.1515/ijamh-2013-0058; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Pingault JB, 2015, JAMA PSYCHIAT, V72, P651, DOI 10.1001/jamapsychiatry.2015.0469; Price JS, 2013, BEHAV BRAIN RES, V242, P158, DOI 10.1016/j.bbr.2012.11.013; Rabl U, 2014, J NEUROSCI, V34, P9917, DOI 10.1523/JNEUROSCI.3113-13.2014; Raznahan A, 2014, P NATL ACAD SCI USA, V111, P1592, DOI 10.1073/pnas.1316911111; Richards JS, 2014, J AM ACAD CHILD PSY, V53, P311, DOI 10.1016/j.jaac.2013.11.011; Ring HA, 2002, J NEUROL NEUROSUR PS, V72, P12, DOI 10.1136/jnnp.72.1.12; Rommel Anna Sophie, 2015, PLoS One, V10, pe0124357, DOI 10.1371/journal.pone.0124357; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; SCHACHAR R, 1987, J AM ACAD CHILD PSY, V26, P728, DOI 10.1097/00004583-198709000-00019; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2007, ARCH GEN PSYCHIAT, V64, P921, DOI 10.1001/archpsyc.64.8.921; Shaw P, 2013, BIOL PSYCHIAT, V74, P599, DOI 10.1016/j.biopsych.2013.04.007; Shook D, 2011, AM J MED GENET B, V156B, P28, DOI 10.1002/ajmg.b.31132; Sonuga-Barke EJS, 2009, J CHILD PSYCHOL PSYC, V50, P1052, DOI 10.1111/j.1469-7610.2009.02095.x; Stein JL, 2011, MOL PSYCHIATR, V16, P927, DOI 10.1038/mp.2011.32; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Taki Y, 2013, HUM BRAIN MAPP, V34, P3347, DOI 10.1002/hbm.22145; Tarantino N, 2014, DEV PSYCHOL, V50, P663, DOI 10.1037/a0034345; Taylor WD, 2005, ARCH GEN PSYCHIAT, V62, P537, DOI 10.1001/archpsyc.62.5.537; Teicher MH, 2006, ANN NY ACAD SCI, V1071, P313, DOI 10.1196/annals.1364.024; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Teicher MH, 2010, AM J PSYCHIAT, V167, P1464, DOI 10.1176/appi.ajp.2010.10010030; Thissen AJAM, 2015, AM J MED GENET B, V168, P471, DOI 10.1002/ajmg.b.32290; Thompson BL, 2009, J AUTISM DEV DISORD, V39, P260, DOI 10.1007/s10803-008-0624-0; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Meer DD, 2015, AM J PSYCHIAT, V172, P768, DOI 10.1176/appi.ajp.2015.14081035; von Rhein D, 2015, EUR CHILD ADOLES PSY, V24, P265, DOI 10.1007/s00787-014-0573-4; Walden B, 2004, J ABNORM PSYCHOL, V113, P440, DOI 10.1037/0021-843x.113.3.440; Wechsler D., 2002, WISC III HANDLEIDING; Wechsler D, 2000, WAIS III NEDERLANDST; Weigard A, 2014, DEVELOPMENTAL SCI, V17, P71, DOI 10.1111/desc.12099; Whittle S, 2014, DEV COGN NEUROS-NETH, V8, P7, DOI 10.1016/j.dcn.2013.10.006; Wierenga L, 2014, NEUROIMAGE, V96, P67, DOI 10.1016/j.neuroimage.2014.03.072; Xu X, 2008, AM J MED GENET B, V147B, P1306, DOI 10.1002/ajmg.b.30737; ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037/0021-843X.86.2.103	101	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155755	10.1371/journal.pone.0155755	http://dx.doi.org/10.1371/journal.pone.0155755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218681	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880700015
J	Hajek, A; Konig, HH				Hajek, Andre; Koenig, Hans-Helmut			Effect of Health Comparisons on Functional Health and Depressive Symptoms - Results of a Population-Based Longitudinal Study of Older Adults in Germany	PLOS ONE			English	Article							QUALITY-OF-LIFE; COMPARISON INCOME; SELF-EFFICACY; MENTAL-HEALTH; SATISFACTION; HAPPINESS; VALIDATION; MORTALITY; WILL; HOPE	Objective To investigate the effect of health comparisons on functional health and depressive symptoms in a longitudinal approach. Gender differences were examined. Methods The German Ageing Survey (DEAS) is a nationwide, representative longitudinal study of community dwelling individuals living in Germany aged 40 and older. The surveys in 2008 and 2011 were used, with n = 3,983 respondents taking part in both waves. Health comparisons were quantified by the question "How would you rate your health compared with other people your age" (Much better; somewhat better; the same; somewhat worse, much worse). Functional health was assessed by the subscale "physical functioning" of the 36-Item Short Form Health Survey (SF-36) and depressive symptoms were measured by the Center for Epidemiologic Studies Depression Scale (CES-D). Results Adjusting for sociodemographic factors, self-assessed health, social network, self-efficacy and optimism, and morbidity, fixed effects regressions revealed that functional health decreased significantly and considerably with negative health comparisons in the total sample (transitions from 'the same' to 'much worse': beta = -11.8), predominantly in men. The effects of negative health comparisons (transitions from 'the same' to 'much worse': beta = 4.8) on depressive symptoms were comparable (in terms of significance) to the effects on functional health, with stronger effects in women. Positive comparisons did not affect functional health and depressive symptoms. Conclusion Our findings underline the relevance of negative health comparisons on functional health (men) and depressive symptoms (women). Comparison effects are asymmetric and mostly upwards.	[Hajek, Andre; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	a.hajek@uke.de	König, Hans-Helmut/P-1211-2018	König, Hans-Helmut/0000-0001-5711-6862; Hajek, Andre/0000-0002-6886-2745				Arigo D, 2014, HEALTH PSYCHOL REV, V8, P154, DOI 10.1080/17437199.2011.634572; Binder M, 2013, METROECONOMICA, V64, P361, DOI 10.1111/meca.12011; Blanchflower DG, 2004, J PUBLIC ECON, V88, P1359, DOI 10.1016/S0047-2727(02)00168-8; Boyce CJ, 2011, J ECON BEHAV ORGAN, V78, P183, DOI 10.1016/j.jebo.2011.01.004; Boyce CJ, 2010, PSYCHOL SCI, V21, P471, DOI 10.1177/0956797610362671; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; BUUNK BP, 1990, J PERS SOC PSYCHOL, V59, P1238, DOI 10.1037/0022-3514.59.6.1238; Cameron C., 2005, MICROECONOMETRICS US, P1056; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chiu HC, 2005, INT J GERIATR PSYCH, V20, P635, DOI 10.1002/gps.1292; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; Clark AE, 2010, ECON J, V120, P573, DOI 10.1111/j.1468-0297.2010.02359.x; Duesenberry J.S., 1949, INCOME SAVING THEORY, DOI 10.2307/2226615; Easterlin R. A., 1974, NATIONS HOUSEHOLDS E, P89, DOI [DOI 10.1016/B978-0-12-205050-3.50008-7, 10.1016/b978-0-12-205050-3.50008-7]; Easterlin RA, 2001, ECON J, V111, P465, DOI 10.1111/1468-0297.00646; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Engstler H., 2010, ALTERN WANDEL BEFUND, P34; Falomir-Pichastor JM, 2013, HEALTH PSYCHOL REV, V7, P202, DOI 10.1080/17437199.2011.570516; Ferrer-i-Carbonell A, 2005, J PUBLIC ECON, V89, P997, DOI 10.1016/j.jpubeco.2004.06.003; Ferrer-i-Carbonell A., 2008, DO PEOPLE ADAPT CHAN; Frijters P, 2011, SCAND J ECON, V113, P190, DOI 10.1111/j.1467-9442.2010.01638.x; Gallagher MW, 2009, J POSIT PSYCHOL, V4, P548, DOI 10.1080/17439760903157166; Gangl M, 2010, ANNU REV SOCIOL, V36, P21, DOI 10.1146/annurev.soc.012809.102702; Grun C, 2010, J LABOR RES, V31, P285, DOI 10.1007/s12122-010-9093-2; Hagedoorn M, 2002, J CLIN EPIDEMIOL, V55, P176, DOI 10.1016/S0895-4356(01)00438-3; Hajek A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146967; Hajek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144203; Hajek A, 2015, QUAL LIFE RES, V24, P2713, DOI 10.1007/s11136-015-1005-8; Hollander H, 2001, J ECON BEHAV ORGAN, V45, P227, DOI 10.1016/S0167-2681(01)00144-5; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Maennig W, 2012, APPL ECON LETT, V19, P1719, DOI 10.1080/13504851.2011.652775; Mayraz G., 2009, LIFE SATISFACTION RE; McBride M, 2001, J ECON BEHAV ORGAN, V45, P251, DOI 10.1016/S0167-2681(01)00145-7; Muris P, 2002, PERS INDIV DIFFER, V32, P337, DOI 10.1016/S0191-8869(01)00027-7; Oswald AJ, 2008, J PUBLIC ECON, V92, P1061; Pagan-Rodriguez R, 2012, SOC INDIC RES, V108, P365, DOI 10.1007/s11205-011-9889-3; Powdthavee N, 2009, SOC SCI MED, V69, P1834, DOI 10.1016/j.socscimed.2009.09.023; Proto E, 2015, J ECON PSYCHOL, V48, P17, DOI 10.1016/j.joep.2015.02.001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roberts G, 1999, J GERONTOL B-PSYCHOL, V54, pS24, DOI 10.1093/geronb/54B.1.S24; Schiel S., 2011, METHODENBERICHT DTSC; Senik C, 2009, J ECON BEHAV ORGAN, V72, P408, DOI 10.1016/j.jebo.2009.04.019; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Sullivan MD, 1998, PSYCHOSOM MED, V60, P473, DOI 10.1097/00006842-199807000-00014; United Nations Educational Scientific and Cultural Organization, 1997, INT STAND CLASS ED I; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245	51	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156235	10.1371/journal.pone.0156235	http://dx.doi.org/10.1371/journal.pone.0156235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2FT	27213731	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200070
J	Swartzwelder, HS; Risher, ML; Miller, KM; Colbran, RJ; Winder, DG; Wills, TA				Swartzwelder, H. Scott; Risher, Mary-Louise; Miller, Kelsey M.; Colbran, Roger J.; Winder, Danny G.; Wills, Tiffany A.			Changes in the Adult GluN2B Associated Proteome following Adolescent Intermittent Ethanol Exposure	PLOS ONE			English	Article							METHYL-D-ASPARTATE; NMDA RECEPTOR SUBUNITS; MESSENGER-RNA EXPRESSION; LONG-TERM POTENTIATION; DENDRITIC SPINES; MATURE HIPPOCAMPUS; CEREBRAL-CORTEX; ALPHA-ACTININ; RAT-BRAIN; CAMKII	Adolescent alcohol use is the strongest predictor for alcohol use disorders. In rodents, adolescents have distinct responses to acute ethanol, and prolonged alcohol exposure during adolescence can maintain these phenotypes into adulthood. One brain region that is particularly sensitive to the effects of both acute and chronic ethanol exposure is the hippocampus. Adolescent intermittent ethanol exposure (AIE) produces long lasting changes in hippocampal synaptic plasticity and dendritic morphology, as well as in the susceptibility to acute ethanol-induced spatial memory impairment. Given the pattern of changes in hippocampal structure and function, one potential target for these effects is the ethanol sensitive GluN2B subunit of the NMDA receptor, which is known to be involved in synaptic plasticity and dendritic morphology. Thus we sought to determine if there were persistent changes in hippocampal GluN2B signaling cascades following AIE. We employed a previously validated GluN2B-targeted proteomic strategy that was used to identify novel signaling mechanisms altered by chronic ethanol exposure in the adult hippocampus. We collected adult hippocampal tissue (P70) from rats that had been given 2 weeks of AIE from P30-45. Tissue extracts were fractionated into synaptic and non-synaptic pools, immuno-precipitated for GluN2B, and then analyzed using proteomic methods. We detected a large number of proteins associated with GluN2B. AIE produced significant changes in the association of many proteins with GluN2B in both synaptic and non-synaptic fractions. Intriguingly the number of proteins changed in the non-synaptic fraction was double that found in the synaptic fraction. Some of these proteins include those involved in glutamate signaling cytoskeleton rearrangement, calcium signaling, and plasticity. Disruptions in these pathways may contribute to the persistent cellular and behavioral changes found in the adult hippocampus following AIE. Further, the robust change in non-synaptic proteins suggests that AIE may prime this signaling pathway for future ethanol exposures in adulthood.	[Swartzwelder, H. Scott; Risher, Mary-Louise; Miller, Kelsey M.] Duke Univ, Med Ctr, Durham VA Med Ctr, Durham, NC USA; [Swartzwelder, H. Scott; Risher, Mary-Louise; Miller, Kelsey M.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Swartzwelder, H. Scott] Duke Univ, Med Ctr, Dept Psychol & Neurosci, Durham, NC USA; [Colbran, Roger J.; Winder, Danny G.; Wills, Tiffany A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Colbran, Roger J.; Winder, Danny G.] Vanderbilt Univ, Vanderbilt Brain Inst, 221 Kirkland Hall, Nashville, TN 37235 USA; [Colbran, Roger J.; Winder, Danny G.] Vanderbilt Univ, JF Kennedy Ctr Res Human Dev, 221 Kirkland Hall, Nashville, TN 37235 USA; [Wills, Tiffany A.] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wills, TA (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.; Wills, TA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA.	twills@lsuhsc.edu	Risher, Louise/AAP-2646-2020; Winder, Danny G./H-4857-2013; Colbran, Roger/AAU-7708-2021	Risher, Louise/0000-0002-3139-4378; Colbran, Roger/0000-0001-7401-8244	National Institute of Mental Health [R01-MH063232]; National Institute on Alcohol Abuse and Alcoholism [R01-AA019455, K99-AA22651, 2U01AA019925]; U.S. Department of Veteran Affairs [1IK2BX002505]; VA Senior Research Career Scientist award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019925, R00AA022651, K99AA022651] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002505] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); U.S. Department of Veteran Affairs(US Department of Veterans Affairs); VA Senior Research Career Scientist award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	R.C. was supported by R01-MH063232, National Institute of Mental Health (https://www.nimh.nih.gov/). D.G.W. was supported by R01-AA019455, National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/). T.A.W. was supported by K99-AA22651, National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/). M.L.R was supported by 1IK2BX002505, U.S. Department of Veteran Affairs (http://www.research.va.gov/). H.S.S was supported by 2U01AA019925, National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/) and a VA Senior Research Career Scientist award.	Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2004, NEUROPSYCHOPHARMACOL, V29, P1988, DOI 10.1038/sj.npp.1300528; Baucum AJ, 2013, J NEUROCHEM, V124, P490, DOI 10.1111/jnc.12101; Baucum AJ, 2010, MOL CELL PROTEOMICS, V9, P1243, DOI 10.1074/mcp.M900387-MCP200; Blevins T, 1995, NEUROSCI LETT, V200, P214, DOI 10.1016/0304-3940(95)12086-J; Blevins T, 1997, J NEUROCHEM, V69, P2345; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Carpenter-Hyland EP, 2006, EUR J NEUROSCI, V24, P3496, DOI 10.1111/j.1460-9568.2006.05247.x; Clapp P, 2010, J PHARMACOL EXP THER, V332, P720, DOI 10.1124/jpet.109.158741; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; FOLLESA P, 1995, MOL BRAIN RES, V29, P99, DOI 10.1016/0169-328X(94)00235-7; Giedd JN, 1999, BIOL PSYCHIAT, V46, P892, DOI 10.1016/S0006-3223(99)00072-4; Gladding CM, 2011, MOL CELL NEUROSCI; Grant BF, 1998, ALCOHOL HEALTH RES W, V22, P144; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hardy PA, 1999, BRAIN RES, V819, P33, DOI 10.1016/S0006-8993(98)01340-7; Hendricson AW, 2007, J PHARMACOL EXP THER, V321, P60, DOI 10.1124/jpet.106.111419; Henniger MSH, 2003, EUR J PHARMACOL, V470, P33, DOI 10.1016/S0014-2999(03)01787-4; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; Jalan-Sakrikar N, 2012, J BIOL CHEM, V287, P15275, DOI 10.1074/jbc.M112.351817; Kalluri HSG, 1998, MOL BRAIN RES, V58, P221, DOI 10.1016/S0169-328X(98)00112-0; Kash TL, 2009, NEUROPSYCHOPHARMACOL, V34, P2420, DOI 10.1038/npp.2009.69; Kim K, 2015, NEURON, V87, P813, DOI 10.1016/j.neuron.2015.07.023; McQueeny T, 2009, ALCOHOL CLIN EXP RES, V33, P1278, DOI 10.1111/j.1530-0277.2009.00953.x; Nagy J, 2003, NEUROCHEM INT, V42, P35, DOI 10.1016/S0197-0186(02)00062-1; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P2403, DOI 10.1111/acer.12913; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P989, DOI 10.1111/acer.12725; Risher ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062940; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Swartzwelder HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140042; Swartzwelder HS, 1995, ALCOHOL CLIN EXP RES, V19, P1480, DOI 10.1111/j.1530-0277.1995.tb01011.x; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vargas WM, 2014, J NEUROSCI, V34, P14777, DOI 10.1523/JNEUROSCI.3189-13.2014; White AM, 2000, ALCOHOL CLIN EXP RES, V24, P1251, DOI 10.1111/j.1530-0277.2000.tb02091.x; Wills TA, 2017, ADDICT BIOL, V22, P275, DOI 10.1111/adb.12319; Wills TA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012161; Wills TA, 2012, P NATL ACAD SCI USA, V109, pE278, DOI 10.1073/pnas.1113820109; ZECEVIC N, 1989, DEV BRAIN RES, V50, P11, DOI 10.1016/0165-3806(89)90124-7	43	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155951	10.1371/journal.pone.0155951	http://dx.doi.org/10.1371/journal.pone.0155951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213757	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200037
J	Zaidi, SSEA; Shafiq, M; Amin, I; Scheffler, BE; Scheffler, JA; Briddon, RW; Mansoor, S				Zaidi, Syed Shan-e-Ali; Shafiq, Muhammad; Amin, Imran; Scheffler, Brian E.; Scheffler, Jodi A.; Briddon, Rob W.; Mansoor, Shahid			Frequent Occurrence of Tomato Leaf Curl New Delhi Virus in Cotton Leaf Curl Disease Affected Cotton in Pakistan	PLOS ONE			English	Article							PCR-MEDIATED AMPLIFICATION; YELLOW VEIN DISEASE; DNA-BETA SATELLITE; BIPARTITE BEGOMOVIRUS; UNIVERSAL PRIMERS; DISTINCT STRAIN; 1ST REPORT; GEMINIVIRUS; IDENTIFICATION; COMPONENTS	Cotton leaf curl disease (CLCuD) is the major biotic constraint to cotton production on the Indian subcontinent, and is caused by monopartite begomoviruses accompanied by a specific DNA satellite, Cotton leaf curl Multan betasatellite (CLCuMB). Since the breakdown of resistance against CLCuD in 2001/2002, only one virus, the "Burewala" strain of Cotton leaf curl Kokhran virus (CLCuKoV-Bur), and a recombinant form of CLCuMB have consistently been identified in cotton across the major cotton growing areas of Pakistan. Unusually a bipartite isolate of the begomovirus Tomato leaf curl virus was identified in CLCuD-affected cotton recently. In the study described here we isolated the bipartite begomovirus Tomato leaf curl New Delhi virus (ToLCNDV) from CLCuD-affected cotton. To assess the frequency and geographic occurrence of ToLCNDV in cotton, CLCuD-symptomatic cotton plants were collected from across the Punjab and Sindh provinces between 2013 and 2015. Analysis of the plants by diagnostic PCR showed the presence of CLCuKoV-Bur in all 31 plants examined and ToLCNDV in 20 of the samples. Additionally, a quantitative real-time PCR analysis of the levels of the two viruses in co-infected plants suggests that coinfection of ToLCNDV with the CLCuKoV-Bur/CLCuMB complex leads to an increase in the levels of CLCuMB, which encodes the major pathogenicity (symptom) determinant of the complex. The significance of these results are discussed.	[Zaidi, Syed Shan-e-Ali; Shafiq, Muhammad; Amin, Imran; Briddon, Rob W.; Mansoor, Shahid] Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, POB 577,Jhang Rd, Faisalabad, Pakistan; [Zaidi, Syed Shan-e-Ali; Shafiq, Muhammad] PIEAS, Islamabad, Pakistan; [Scheffler, Brian E.] Genom & Bioinformat Res Unit, 141 Expt Stn Rd, Stoneville, MS 38776 USA; [Scheffler, Jodi A.] USDA ARS, Crop Genet Res Unit, Stoneville, MS 38776 USA	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; United States Department of Agriculture (USDA)	Mansoor, S (corresponding author), Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, POB 577,Jhang Rd, Faisalabad, Pakistan.	shahidmansoor7@gmail.com	Briddon, Rob W./I-5921-2012; Zaidi, Syed Shan-e-Ali/M-3084-2016	Briddon, Rob W./0000-0001-8738-0365; Zaidi, Syed Shan-e-Ali/0000-0002-2976-4624; Shafiq, Muhammad/0000-0002-1308-1538; Mansoor, Shahid/0000-0001-7418-1826; Scheffler, Brian/0000-0003-1968-8952	Higher Education Commission (HEC), Govt. of Pakistan; International Center for Agricultural Research in the Dry Areas (ICARDA) - United States Department of Agriculture (USDA), Agricultural Research Service (ARS) [58-6402-0-178F]; ARS [ARS-0426343, ARS-0425248] Funding Source: Federal RePORTER	Higher Education Commission (HEC), Govt. of Pakistan(Higher Education Commission of Pakistan); International Center for Agricultural Research in the Dry Areas (ICARDA) - United States Department of Agriculture (USDA), Agricultural Research Service (ARS); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	SSZ is supported by Ph.D scholarship from Higher Education Commission (HEC), Govt. of Pakistan under "Indigenous 5000 Ph.D Fellowship Program". This research was funded in part through the "Pak-US cotton productivity enhancement program'' of the International Center for Agricultural Research in the Dry Areas (ICARDA) funded by United States Department of Agriculture (USDA), Agricultural Research Service (ARS), under Agreement No. 58-6402-0-178F. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the USDA or ICARDA.	Amin I, 2006, ARCH VIROL, V151, P2055, DOI 10.1007/s00705-006-0773-4; Amrao L, 2010, VIRUS RES, V152, P153, DOI 10.1016/j.virusres.2010.06.019; Briddon RW, 2014, VIRUS RES, V186, P114, DOI 10.1016/j.virusres.2013.12.008; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; Briddon RW, 2004, VIROLOGY, V324, P462, DOI 10.1016/j.virol.2004.03.041; Briddon RW, 2002, MOL BIOTECHNOL, V20, P315, DOI 10.1385/MB:20:3:315; Briddon RW, 2000, VIRUS RES, V71, P151, DOI 10.1016/S0168-1702(00)00195-7; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Brown JK, 2015, ARCH VIROL, V160, P1593, DOI 10.1007/s00705-015-2398-y; Bull SE, 2003, MOL BIOTECHNOL, V23, P83, DOI 10.1385/MB:23:1:83; Cui XF, 2005, J VIROL, V79, P10764, DOI 10.1128/JVI.79.16.10764-10775.2005; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Haider MS, 2006, PLANT PATHOL, V55, P285, DOI 10.1111/j.1365-3059.2005.01278.x; Hameed U, 2014, PLANT DIS, V98, P1447, DOI 10.1094/PDIS-04-14-0345-PDN; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Hussain M, 2003, PLANT PATHOL, V52, P809, DOI 10.1111/j.1365-3059.2003.00931.x; Jyothsna P, 2013, APPL MICROBIOL BIOT, V97, P5457, DOI 10.1007/s00253-012-4685-9; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Kumar J, 2015, ARCH VIROL, V160, P1219, DOI 10.1007/s00705-015-2384-4; Kumar J, 2014, J VIROL, V88, P7093, DOI 10.1128/JVI.02911-13; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Malik AH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-173; Mansoor S, 2003, PLANT PATHOL, V52, P784, DOI 10.1111/j.1365-3059.2003.00893.x; Mansoor S, 2003, ARCH VIROL, V148, P1969, DOI 10.1007/s00705-003-0149-y; Mansoor S, 1999, VIROLOGY, V259, P190, DOI 10.1006/viro.1999.9766; Manzoor MT, 2014, ARCH VIROL, V159, P1217, DOI 10.1007/s00705-013-1911-4; Melgarejo TA, 2013, J VIROL, V87, P5397, DOI 10.1128/JVI.00234-13; Mubin M, 2012, VIRUS GENES, V44, P112, DOI 10.1007/s11262-011-0662-0; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nawaz-ul-Rehman MS, 2010, VIROLOGY, V405, P300, DOI 10.1016/j.virol.2010.06.024; PADIDAM M, 1995, J GEN VIROL, V76, P25, DOI 10.1099/0022-1317-76-1-25; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paprotka T, 2010, VIROLOGY, V404, P148, DOI 10.1016/j.virol.2010.05.003; Phaneendra C, 2012, INDIAN J VIROL, V23, P42, DOI 10.1007/s13337-011-0054-z; Qazi J, 2007, VIRUS RES, V128, P135, DOI 10.1016/j.virusres.2007.04.002; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Romay G, 2010, ARCH VIROL, V155, P1843, DOI 10.1007/s00705-010-0760-7; Saeed M, 2005, MOL PLANT MICROBE IN, V18, P7, DOI 10.1094/MPMI-18-0007; Saeed M, 2007, J GEN VIROL, V88, P2881, DOI 10.1099/vir.0.83049-0; Sanchez-Campos S, 2013, VIRUS RES, V173, P286, DOI 10.1016/j.virusres.2013.02.002; Sanderfoot AA, 1996, TRENDS CELL BIOL, V6, P353, DOI 10.1016/0962-8924(96)10031-3; Sattar MN, 2013, J GEN VIROL, V94, P695, DOI 10.1099/vir.0.049627-0; Saunders K, 1999, VIROLOGY, V264, P142, DOI 10.1006/viro.1999.9948; Saunders K, 2004, VIROLOGY, V324, P37, DOI 10.1016/j.virol.2004.03.018; Shafiq M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-367; Shahid MS, 2007, ARCH VIROL, V152, P2131, DOI 10.1007/s00705-007-1043-9; Shuja MN, 2014, ARCH VIROL, V159, P2787, DOI 10.1007/s00705-014-2097-0; Tahir M, 2005, PLANT PATHOL, V54, P807, DOI 10.1111/j.1365-3059.2005.01215.x; Tamura K., 2013, MOL BIOL EVOL; Venkataravanappa V, 2012, VIRUS GENES, V44, P522, DOI 10.1007/s11262-012-0732-y; Yang XL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002329; Zaidi SSA, 2015, PLANT DIS, V99, P1655, DOI 10.1094/PDIS-02-15-0195-PDN; Zhou XP, 1998, J GEN VIROL, V79, P915, DOI 10.1099/0022-1317-79-4-915; Zhou XP, 2013, ANNU REV PHYTOPATHOL, V51, P357, DOI 10.1146/annurev-phyto-082712-102234	55	44	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155520	10.1371/journal.pone.0155520	http://dx.doi.org/10.1371/journal.pone.0155520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213535	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200013
J	[Anonymous]				[Anonymous]			Solving the Riddle of the Role of Sphingolipids in Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material																			0	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11460	11461		10.1074/jbc.O116.000003	http://dx.doi.org/10.1074/jbc.O116.000003			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27226641	Green Published, hybrid			2022-12-26	WOS:000377042100042
J	Sun, YM; Cote, JF; Du, KY				Sun, Yingmin; Cote, Jean-Francois; Du, Keyong			Elmo2 Is a Regulator of Insulin-dependent Glut4 Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOBLAST FUSION; GLUCOSE TRANSPORTERS; SIGNAL-TRANSDUCTION; EXCHANGE FACTORS; APOPTOTIC CELLS; RAC ACTIVATION; RHO FAMILIES; PROTEIN; ENGULFMENT; ASSOCIATION	Elmo2, a member of the Elmo protein family, has been implicated in the regulation of Rac1 and Akt activation. Recently, we found that Elmo2 specifically interacts with ClipR-59. Because Akt and Rac1 have been implicated in insulin dependent Glut4 membrane translocation, we hypothesize here that Elmo2 may play a role in insulin-dependent Glut4 membrane translocation. Accordingly, we found that overexpression of Elmo2 enhanced, whereas its knockdown suppressed, insulin-dependent Glut4 membrane translocation in both 3T3-L1 adipocytes and L6 skeletal muscle cells. We also examined whether Elmo2 contributes to the insulin-mediated activation of Rac1 and Akt. We found that Elmo2 is required for insulin-induced Rac1 GTP loading, but not AKT activation, in L6 cells induced by insulin. Instead, Elmo2 is required to promote the insulin-induced membrane association of Akt. Together, our studies demonstrate that Elmo2 is a new regulator of insulin-dependent Glut4 membrane translocation through modulating Rac1 activity and Akt membrane compartmentalization.	[Sun, Yingmin; Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA; [Cote, Jean-Francois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Tufts Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Du, KY (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org			National Institutes of Health [RO1 DK084319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	his work was supported by National Institutes of Health Grant RO1 DK084319 (to K. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Thuraia A, 2015, MOL CELL BIOL, V35, P76, DOI 10.1128/MCB.00764-14; Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel Manishha, 2011, Small GTPases, V2, P268; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ren WY, 2012, J BIOL CHEM, V287, P26890, DOI 10.1074/jbc.M112.357699; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Schaker K, 2015, J BIOL CHEM, V290, P6408, DOI 10.1074/jbc.M114.633701; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sun L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002785; Sun YM, 2015, J BIOL CHEM, V290, P6130, DOI 10.1074/jbc.M114.616680; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009	33	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16150	16161		10.1074/jbc.M116.731521	http://dx.doi.org/10.1074/jbc.M116.731521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226625	hybrid, Green Published			2022-12-26	WOS:000380585400020
J	Gu, MG; Rice, CM				Gu, Meigang; Rice, Charles M.			The Spring -Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; hepatitis C virus (HCV); RNA helicase; RNA virus; structure-function; viral replication	VIRAL DIARRHEA VIRUS; STRAND RNA-SYNTHESIS; CELL-CULTURE; EFFICIENT REPLICATION; PRIMASE INHIBITORS; HEPATOMA-CELLS; IN-VIVO; PROTEIN; DNA; MECHANISM	Genomic DNA replication requires helicases to processively unwind duplexes. Although helicases encoded by positive-strand RNA viruses are necessary for RNA genome replication, their functions are not well understood. We determined structures of the hepatitis C virus helicase (NS3h) in complex with the transition state ATP mimic ADP.AlF4- and compared them with the previous nucleic acid-associated ternary complexes. The results suggested that nucleic acid binding promotes a structural change of the spring helix at the transition state, optimizing the interaction network centered on the nucleophilic water. Analysis of ATP hydrolysis with and without conformational restraints on the spring helix further supported the importance of its action for both nucleic acid-stimulated and basal catalysis. We further found that an F238P substitution, predicted to destabilize the helix, diminished viral RNA replication without significantly affecting ATP-dependent duplex unwinding. The stability of the secondary structure, thus, seems critical for additional functions of NS3h. Taken together, the results suggest that the spring helix may be central to the coordination of multiple modes of NS3h action. Further characterization centered on this element may help understand the molecular details of how the viral helicase facilitates RNA replication. This new structural information may also aid efforts to develop specific inhibitors targeting this essential viral enzyme.	[Gu, Meigang; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA	Rockefeller University	Gu, MG; Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.	mgu@rockefeller.edu; ricec@rockefeller.edu			Marie-Josee and Henry R. Kravis Fellowship at The Rockefeller University; National Institutes of Health (NIH) [CA057973]; Center for Synchrotron Biosciences [P30-EB-009998]; National Center for Research Resources of the National Institutes of Health [1S10RR022321-01]; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Marie-Josee and Henry R. Kravis Fellowship at The Rockefeller University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Synchrotron Biosciences; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in part, by National Institutes of Health (NIH) Grant CA057973 and Center for Synchrotron Biosciences Grant P30-EB-009998 (National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH). This work was also supported by generous gifts from the Greenberg Medical Research Institute, the Starr Foundation, the Richard Salomon Family Foundation, the Ronald A. Shellow, M.D. Memorial Fund, Paul Nash and the MGM Mirage Voice Foundation, and Gregory F. Lloyd Memorial contributions. The use of the Rigaku/MSC microMax 007HF in the Rockefeller University Structural Biology Resource Center was made possible by Grant 1S10RR022321-01 from the National Center for Research Resources of the National Institutes of Health. The authors declare that they have no conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by funds from a Marie-Josee and Henry R. Kravis Fellowship at The Rockefeller University. To whom correspondence may be addressed. E-mail: mgu@rockefeller.edu.	Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Barton DJ, 1997, J VIROL, V71, P8482, DOI 10.1128/JVI.71.11.8482-8489.1997; Belon CA, 2008, BIOTECHNIQUES, V45, P433, DOI 10.2144/000112834; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; Chono K, 2010, J ANTIMICROB CHEMOTH, V65, P1733, DOI 10.1093/jac/dkq198; Chung HY, 2014, J VIROL, V88, P11022, DOI 10.1128/JVI.01582-14; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Crute JJ, 2002, NAT MED, V8, P386, DOI 10.1038/nm0402-386; De I, 1996, J VIROL, V70, P2706; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Grassmann CW, 1999, J VIROL, V73, P9196, DOI 10.1128/JVI.73.11.9196-9205.1999; Gu BH, 2000, J VIROL, V74, P1794, DOI 10.1128/JVI.74.4.1794-1800.2000; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadare G, 1997, J VIROL, V71, P2583; KALLNER A, 1975, CLIN CHIM ACTA, V59, P35, DOI 10.1016/0009-8981(75)90215-6; Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Salam KA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/467869; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tortorici MA, 2015, J VIROL, V89, P4356, DOI 10.1128/JVI.03165-14; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0	47	12	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14499	14509		10.1074/jbc.M115.704379	http://dx.doi.org/10.1074/jbc.M115.704379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226535	Green Published, hybrid			2022-12-26	WOS:000380366700008
J	Dadinova, LA; Shtykova, EV; Konarev, PV; Rodina, EV; Snalina, NE; Vorobyeva, NN; Kurilova, SA; Nazarova, TI; Jeffries, CM; Svergun, DI				Dadinova, Liubov A.; Shtykova, Eleonora V.; Konarev, Petr V.; Rodina, Elena V.; Snalina, Natalia E.; Vorobyeva, Natalia N.; Kurilova, Svetlana A.; Nazarova, Tatyana I.; Jeffries, Cy M.; Svergun, Dmitri I.			X-Ray Solution Scattering Study of Four Escherichia coli Enzymes Involved in Stationary-Phase Metabolism	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; GLUTAMATE-DECARBOXYLASE; BIOLOGICAL MACROMOLECULES; INORGANIC PYROPHOSPHATASE; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; SCHIFF-BASE; MECHANISM	The structural analyses of four metabolic enzymes that maintain and regulate the stationary growth phase of Escherichia coli have been performed primarily drawing on the results obtained from solution small angle X-ray scattering (SAXS) and other structural techniques. The proteins are (i) class I fructose-1,6-bisphosphate aldolase (FbaB); (ii) inorganic pyrophosphatase (PPase); (iii) 5-keto-4-deoxyuronate isomerase (KduI); and (iv) glutamate decarboxylase (GadA). The enzyme FbaB, that until now had an unknown structure, is predicted to fold into a TIM-barrel motif that form globular protomers which SAXS experiments show associate into decameric assemblies. In agreement with previously reported crystal structures, PPase forms hexamers in solution that are similar to the previously reported Xray crystal structure. Both KduI and GadA that are responsible for carbohydrate (pectin) metabolism and acid stress responses, respectively, form polydisperse mixtures consisting of different oligomeric states. Overall the SAXS experiments yield additional insights into shape and organization of these metabolic enzymes and further demonstrate the utility of hybrid methods, i.e., solution SAXS combined with X-ray crystallography, bioinformatics and predictive 3D-structural modeling, as tools to enrich structural studies. The results highlight the structural complexity that the protein components of metabolic networks may adopt which cannot be fully captured using individual structural biology techniques.	[Dadinova, Liubov A.; Shtykova, Eleonora V.; Konarev, Petr V.] Russian Acad Sci, AV Shubnikov Inst Crystallog, Fed Sci Res Ctr Crystallog & Photon, Moscow, Russia; [Dadinova, Liubov A.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Shtykova, Eleonora V.; Vorobyeva, Natalia N.; Kurilova, Svetlana A.; Nazarova, Tatyana I.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Rodina, Elena V.; Snalina, Natalia E.; Vorobyeva, Natalia N.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Jeffries, Cy M.; Svergun, Dmitri I.] DESY, EMBL, Hamburg Outstn, Notkestr 85, Hamburg, Germany	Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Jeffries, CM; Svergun, DI (corresponding author), DESY, EMBL, Hamburg Outstn, Notkestr 85, Hamburg, Germany.	cy.jeffries@embl-hamburg.de; svergun@embl-hamburg.de	Kurilova, Svetlana/AAD-7256-2019; Shtykova, Eleonora V./G-6241-2013; Dadinova, Liubov/F-2058-2014; Konarev, Petr V/W-1380-2017	Shtykova, Eleonora V./0000-0003-4347-7266; Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696; /0000-0002-8718-7343	Bundesministerium fur Bildung und Forschung (BMBF; German Ministry of Education and Science) project BIOSCAT [05K12YE1]; German Ministry of Education and Science (BMBF) project BIOSCAT [05K20912]	Bundesministerium fur Bildung und Forschung (BMBF; German Ministry of Education and Science) project BIOSCAT; German Ministry of Education and Science (BMBF) project BIOSCAT	This work was supported in part by the Bundesministerium fur Bildung und Forschung (BMBF; German Ministry of Education and Science) project BIOSCAT, Grant 05K12YE1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by German Ministry of Education and Science (BMBF) project BIOSCAT, Grant 05K20912. We are grateful to the staff members of EMBL SAXS beam line P12 at the Petra III storage ring, DESY, Hamburg, Germany for technical support. Special thanks go to Maxim Petoukhov for valuable advice on SAXS data processing.	Allen AE, 2012, MOL BIOL EVOL, V29, P367, DOI 10.1093/molbev/msr223; Bacun-Druzina V, 2011, FOOD TECHNOL BIOTECH, V49, P13; BAI NJ, 1981, J BIOSCIENCE, V3, P323, DOI 10.1007/BF02702620; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; BRUNNGRABER EG, 1963, BIOCHEM J, V87, P624, DOI 10.1042/bj0870624; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; Choi KH, 2001, BIOCHEMISTRY-US, V40, P13868, DOI 10.1021/bi0114877; CONDEMINE G, 1991, MOL MICROBIOL, V5, P2191, DOI 10.1111/j.1365-2958.1991.tb02149.x; Crowther RL, 2005, PROTEINS, V61, P680, DOI 10.1002/prot.20598; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Galperin MY, 2000, FEMS MICROBIOL LETT, V183, P259, DOI 10.1016/S0378-1097(99)00612-6; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOPHER A, 1990, P NATL ACAD SCI USA, V87, P5449, DOI 10.1073/pnas.87.14.5449; GOTZ F, 1980, EUR J BIOCHEM, V108, P295, DOI 10.1111/j.1432-1033.1980.tb04723.x; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Heinonen J. K., 2001, BIOL ROLE INORGANIC; Jeffries CM, 2015, J SYNCHROTRON RADIAT, V22, P273, DOI 10.1107/S1600577515000375; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; Lorentzen E, 2013, J BIOL CHEM, V278, P47235; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rodina E, 2011, BIOCHIMIE, V93, P1576, DOI 10.1016/j.biochi.2011.05.023; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Samygina VR, 2007, J MOL BIOL, V366, P1305, DOI 10.1016/j.jmb.2006.11.082; SCAMUFFA MD, 1980, BIOCHIM BIOPHYS ACTA, V614, P583, DOI 10.1016/0005-2744(80)90247-8; Shams F, 2014, BIOCHEM SOC T, V42, P1792, DOI 10.1042/BST20140203; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; STRAUSBA.PH, 1970, BIOCHEMISTRY-US, V9, P226, DOI 10.1021/bi00804a006; STRIBLING D, 1973, BIOCHEM J, V131, P833, DOI 10.1042/bj1310833; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2013, INT UNION CRYSTALLOG, V19; Thomson GJ, 1998, BIOCHEM J, V331, P437, DOI 10.1042/bj3310437; TIKHONEN.AS, 1968, BIOCHIM BIOPHYS ACTA, V167, P476, DOI 10.1016/0005-2744(68)90232-5; TO CM, 1971, J MOL BIOL, V59, P215, DOI 10.1016/0022-2836(71)90424-4; TRAUT TW, 1994, CRIT REV BIOCHEM MOL, V29, P125, DOI 10.3109/10409239409086799; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Uberto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074477; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yu SM, 1999, PLANT PHYSIOL, V121, P687, DOI 10.1104/pp.121.3.687; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	60	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156105	10.1371/journal.pone.0156105	http://dx.doi.org/10.1371/journal.pone.0156105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227414	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500068
J	Li, Q; Meng, J; Wang, YQ				Li, Qian; Meng, Jin; Wang, Yuanqing			New Cricetid Rodents from Strata near the Eocene-Oligocene Boundary in Erden Obo Section (Nei Mongol, China)	PLOS ONE			English	Article							MAMMALIA; YUNNAN	New cricetids (Eucricetodon wangae sp. nov., Eucricetodon sp. and Pappocricetodon sizi-wangqiensis sp. nov.) are reported from the lower and middle parts of the "Upper Red" beds of the Erden Obo section in Nei Mongol, China. Eucricetodon wangae is more primitive than other known species of the genus from lower Oligocene of Asia and Europe in having a single anterocone on M1, a single connection between the protocone and the paracone, the anterior metalophule connection in M1-2 and weaker anteroconid and ectomesolophid in lower molars. Pappocricetodon siziwangqiensis is more advanced than other species of the genus in permanently missing P4 and having posterior protolophule connection. These fossils suggest that the age of the "Upper Red" of the Erden Obo section is younger than the age of the Upper Eocene Houldjin and Caijiachong formations, but older than those containing the Shandgolian faunas; the "Upper Red" is most closely correlative to the Ergilian beds in age, and probably close to the Eocene/Oligocene boundary. Given the age estimate, Eucricetodon wangae provides the new evidence to support that cricetid dispersal from Asia to Europe occurred prior to the Eocene-Oligocene boundary.	[Li, Qian; Meng, Jin; Wang, Yuanqing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Li, Q (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	liqian@ivpp.ac.cn			Major Basic Research Projects of MST of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [41572013]; Chinese Academy of Sciences [KZCX2-EW-106]; Special Fund for Fossil Excavation and Preparation, CAS; Geological Survey of China [1212011120115, 1212011120142]	Major Basic Research Projects of MST of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Special Fund for Fossil Excavation and Preparation, CAS; Geological Survey of China(China Geological Survey)	This research was supported by the Major Basic Research Projects of MST of China (973 Program) ( 2012CB821900), the National Natural Science Foundation of China ( 41572013), the Chinese Academy of Sciences ( KZCX2-EW-106), the Special Fund for Fossil Excavation and Preparation, CAS, and the Geological Survey of China ( Nos. 1212011120115 and 1212011120142).	Baciu C, 2001, CR ACAD SCI II A, V333, P441, DOI 10.1016/S1251-8050(01)01659-7; Dashzeveg Demberelyin, 1993, Tertiary Research, V14, P141; Dawson Mary R., 1998, Bulletin of Carnegie Museum of Natural History, V34, P278; Daxner-Hock G., 2007, ANN NATURHISTORISC A, V108, P1; Daxner-Hock Gudrun, 2000, Palaeontologische Zeitschrift, V74, P215; de Bruijn Hans, 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P47; Emry RJ, 1998, J VERTEBR PALEONTOL, V18, P218, DOI 10.1080/02724634.1998.10011045; Emry RJ, 1998, B CARNEGIE MUSEUM NA, V34, P298; Engesser B., 1985, Eclogae Geologicae Helvetiae, V78, P669; Freudenthal M., 1994, Scripta Geologica, V104, P1; Freudenthal M., 1992, Revista Espanola de Paleontologia, P49; Freudenthal M., 1996, Scripta Geologica, V112, P1; Gomes Rodrigues Helder, 2013, Spanish Journal of Palaeontology, V28, P17; Gudrun DAXNER-HCK, 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P348; Hugueney Marguerite, 1999, P347; Jiang H. X, 1983, GEOLOGY NEI MONGOL, V2, P18; Kowalski K., 1974, Palaeontologia Polonica, VNo. 30, P147; Li Qian, 2012, Vertebrata Palasiatica, V50, P237; LINDSAY EH, 1978, J PALEONTOL, V52, P590; Maridet O, 2013, J VERTEBR PALEONTOL, V33, P185, DOI 10.1080/02724634.2012.710283; Maridet O, 2009, AM MUS NOVIT, P1, DOI 10.1206/676.1; Matthew W. D., 1923, American Museum Novitates, VNo. 102, P1; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Misonne X., 1957, Bull Inst roy Sci nat Belg, V33, P1; Osborn H.F., 1929, AM MUS NOVIT, V353, P1; Qi Tao, 1990, Vertebrata Palasiatica, V28, P25; Qiu Z-X., 2007, PALAEONT SIN C, V29, P1; Rodrigues HG, 2012, J ASIAN EARTH SCI, V56, P160, DOI 10.1016/j.jseaes.2012.05.007; Schaub S., 1925, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V45, P1; Shevyreva N. S, 1967, PALEONTOLOGICHESKIA, V2, P90; Tong Y.S., 1997, PALEONT SIN NEW SER, V26, P1; Tong Yongsheng, 1992, Vertebrata Palasiatica, V30, P1; Vianey-Liaud M., 1972, Palaeovertebrata, V5, P1; Wang Ban-Yue, 2007, Vertebrata Palasiatica, V45, P195; Wang Ban-Yue, 1994, Annals of Carnegie Museum, V63, P239; WANG BY, 1987, VERTEBRAT PALASIATIC, V25, P187; WANG BY, 1986, VERTEBRAT PALASIATIC, V24, P110; Wang BY, 2003, VERTEBRAT PALASIATIC, V45, P195; [王元青 Wang Yuanqing], 2012, [古脊椎动物学报, Vertebrata Palasiatica], V50, P181; Ye Jie, 2005, Vertebrata Palasiatica, V43, P49; Zdansky O., 1930, Palaeontologia Sinica, V6C, P1	41	8	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156233	10.1371/journal.pone.0156233	http://dx.doi.org/10.1371/journal.pone.0156233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227833	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500088
J	Pandey, D; Kaur, S; Kamath, A				Pandey, Deeksha; Kaur, Simar; Kamath, Asha			Banking Umbilical Cord Blood (UCB) Stem Cells: Awareness, Attitude and Expectations of Potential Donors from One of the Largest Potential Repository (India)	PLOS ONE			English	Article							PREGNANT-WOMEN; COLLECTION; KNOWLEDGE; OBSTETRICIANS	Background The concept of Umbilical Cord blood (UCB) stem cells is emerging as a non-invasive, efficacious alternative source of hematopoietic stem cells to treat a variety of blood and bone marrow diseases, blood cancers, metabolic disorders and immune deficiencies. Aim of the present study was to determine the level of awareness about banking UCB among pregnant women in India. We also assessed patient perception for banking of UCB and explored the patient expectations of banking UCB in future. This is the first study to assess current attitudes, in a sample population of potential donors from one of the largest potential UCB repository (India). Obtaining this information may help optimize recruitment efforts and improve patient education. Material and Method Present explorative questionnaire based survey included 254 pregnant women in the final analysis. Results We established only 26.5% pregnant women in our study population knew what exactly is meant by UCB. A large proportion (55.1%) was undecided on whether they want to bank UCB or not. Women were more aware of the more advertised private cord blood banking compared to public banking. More than half of the pregnant women expected their obstetrician to inform them regarding UCB. One-third of the women in our population had undue expectations from banking of the UCB. Conclusion Obstetricians should play a more active role in explaining the patients regarding pros and cons of UCB banking.	[Pandey, Deeksha; Kamath, Asha] Manipal Univ, KMC Manipal, Dept Obstet & Gynaecol, Manipal, Karnataka, India; [Kamath, Asha] Manipal Univ, KMC Manipal, Dept Community Med, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Pandey, D (corresponding author), Manipal Univ, KMC Manipal, Dept Obstet & Gynaecol, Manipal, Karnataka, India.	deekshiiiobg@gmail.com		Kamath, Asha/0000-0003-0727-8067				[Anonymous], 2015, OBSTET GYNECOL, V126, pe127, DOI [10.1097/AOG.0000000000001212, DOI 10.1097/A0G.0000000000001212]; Ballen KK, 2008, BIOL BLOOD MARROW TR, V14, P356, DOI 10.1016/j.bbmt.2007.11.005; Baron F, 2015, EXPERT REV HEMATOL; Cairo MS, 2007, PEDIATRICS, V119, P165, DOI 10.1542/peds.2006-2901; Committee on Obstetric Practice, 2008, Obstet Gynecol, V111, P475, DOI 10.1097/AOG.0b013e318166603c; Fernandez CV, 2003, CAN MED ASSOC J, V168, P695; Fox NS, 2007, J PERINAT MED, V35, P314, DOI 10.1515/JPM.2007.084; Haw J, 2015, MONASH BIOETH REV; Herlihy MM, 2013, OBSTET GYNECOL, V121, P851, DOI 10.1097/AOG.0b013e31828882aa; Katz G, 2011, TRANSFUSION, V51, P578, DOI 10.1111/j.1537-2995.2010.02954.x; Kurtzberg J, 2005, J CLIN INVEST, V115, P2592, DOI 10.1172/JCI26690; Lu HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144001; Magalon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143440; Martin PL, 2011, AM FAM PHYSICIAN, V84, P661; Sullivan MJ, 2008, NAT REV CANCER, V8, P554, DOI 10.1038/nrc2418; Tuteja M, 2016, INDIAN J PEDIATR, V83, P238, DOI 10.1007/s12098-015-1909-x; Viswanathan C, 2009, INDIAN J HEMATOL BLO, V25, P111, DOI 10.1007/s12288-009-0023-5; Walker T, 2012, TRANSFUSION, V52, P787, DOI 10.1111/j.1537-2995.2011.03383.x	18	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155782	10.1371/journal.pone.0155782	http://dx.doi.org/10.1371/journal.pone.0155782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228155	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500034
J	Tribollet, V; Barenton, B; Kroiss, A; Vincent, S; Zhang, L; Forcet, C; Cerutti, C; Perian, S; Allioli, N; Samarut, J; Vanacker, JM				Tribollet, Violaine; Barenton, Bruno; Kroiss, Auriane; Vincent, Severine; Zhang, Ling; Forcet, Christelle; Cerutti, Catherine; Perian, Severine; Allioli, Nathalie; Samarut, Jacques; Vanacker, Jean-Marc			miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERR alpha	PLOS ONE			English	Article							ESTROGEN-RELATED-RECEPTOR; BREAST-CANCER; EXPRESSION; PROLIFERATION; MICRORNA; TARGET; BIOMARKERS; CARCINOMA; MIGRATION; GROWTH	MicroRNA-135a (miR-135a) down-modulates parameters of cancer progression and its expression is decreased in metastatic breast cancers (as compared to non-metastatic tumors) as well as in prostate tumors relative to normal tissue. These expression and activity patterns are opposite to those of the Estrogen-Related Receptor alpha (ERR alpha), an orphan member of the nuclear receptor family. Indeed high expression of ERR alpha correlates with poor prognosis in breast and prostate cancers, and the receptor promotes various traits of cancer aggressiveness including cell invasion. Here we show that miR-135a down-regulates the expression of ERR alpha through specific sequences of its 3'UTR. As a consequence miR-135a also reduces the expression of downstream targets of ERR alpha. miR-135a also decreases cell invasive potential in an ERR alpha-dependent manner. Our results suggest that the decreased expression of miR-135a in metastatic tumors leads to elevated ERR alpha expression, resulting in increased cell invasion capacities.	[Tribollet, Violaine; Barenton, Bruno; Kroiss, Auriane; Vincent, Severine; Zhang, Ling; Forcet, Christelle; Cerutti, Catherine; Perian, Severine; Allioli, Nathalie; Samarut, Jacques; Vanacker, Jean-Marc] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, UMR5242,Ecole Normale Super Lyon, F-69365 Lyon, France; [Allioli, Nathalie] Univ Lyon, Fac Pharm, Inst Sci Pharmaceut & Biol, Lyon, France; [Samarut, Jacques] Univ Lyon, Fac Med Lyon Sud, Lyon, France; [Samarut, Jacques] Hosp Civils Lyon, Ctr Hosp Lyon Sud, UMOMT, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Vanacker, JM (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, UMR5242,Ecole Normale Super Lyon, F-69365 Lyon, France.	jean-marc.vanacker@ens-lyon.fr	Samarut, Jacques/AAD-2587-2019	PERIAN, Severine/0000-0003-0942-7302	Ligue contre le Cancer	Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was funded by Ligue contre le Cancer (comites Puy-de-Dome https://www.liguecancer.net/cd63/journal and Drome https://www.liguecancer.net/cd26/journal) to JS and JMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2002, CANCER RES, V62, P6510; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernatchez G, 2013, CARCINOGENESIS, V34, P2253, DOI 10.1093/carcin/bgt180; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Cai Q, 2013, ONCOGENE, V32, P2079, DOI 10.1038/onc.2012.221; Carnesecchi J, 2016, MOL CELL ENDOCRINOL, V432, P47, DOI 10.1016/j.mce.2015.07.019; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Chang CY, 2012, CLIN CANCER RES, V18, P6089, DOI 10.1158/1078-0432.CCR-11-3221; Chen YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-111; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Gallet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054837; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Golubovskaya VM, 2014, ANTI-CANCER AGENT ME, V14, P18, DOI 10.2174/187152061401140108113435; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kammerer M, 2013, MOL CELL ENDOCRINOL, V369, P150, DOI 10.1016/j.mce.2013.01.024; Kroiss A, 2015, ONCOGENE, V34, P2846, DOI 10.1038/onc.2014.222; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Ren JW, 2015, INT J CLIN EXP PATHO, V8, P6356; Sailland J, 2014, P NATL ACAD SCI USA, V111, P15108, DOI 10.1073/pnas.1402094111; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Teyssier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007942; Tiwari A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17621; Tiwari A, 2014, J BIOL CHEM, V289, P32276, DOI 10.1074/jbc.M114.584136; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wu YM, 2015, ONCOTARGET, V6, P25588, DOI 10.18632/oncotarget.4436; Xi Jianzhong Jeff, 2013, Cancer Treat Res, V158, P119, DOI 10.1007/978-3-642-31659-3_5; Yuk JM, 2015, IMMUNITY, V43, P80, DOI 10.1016/j.immuni.2015.07.003; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; Zhou WW, 2012, ACTA BIOCH BIOPH SIN, V44, P838, DOI 10.1093/abbs/gms071; Zou C, 2014, J PATHOL, V233, P61, DOI 10.1002/path.4329	45	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156445	10.1371/journal.pone.0156445	http://dx.doi.org/10.1371/journal.pone.0156445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227989	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500136
J	Tsuji, S; Ohbayashi, T; Yamakage, K; Oshimura, M; Tada, M				Tsuji, Saori; Ohbayashi, Tetsuya; Yamakage, Kohji; Oshimura, Mitsuo; Tada, Masako			A Cytoplasmic Form of Gaussia luciferase Provides a Highly Sensitive Test for Cytotoxicity	PLOS ONE			English	Article							GENE-EXPRESSION; CELL LINE; IN-VIVO; BIOLUMINESCENCE; HYBRIDIZATION; TOXICITY; REPORTER; CULTURE; ASSAY; CDNA	The elimination of unfavorable chemicals from our environment and commercial products requires a sensitive and high-throughput in vitro assay system for drug-induced hepatotoxicity. Some previous methods for evaluating hepatotoxicity measure the amounts of cytoplasmic enzymes secreted from damaged cells into the peripheral blood or culture medium. However, most of these enzymes are proteolytically digested in the extracellular milieu, dramatically reducing the sensitivity and reliability of such assays. Other methods measure the decrease in cell viability following exposure to a compound, but such end-point assays are often confounded by proliferation of surviving cells that replace dead or damaged cells. In this study, with the goal of preventing false-negative diagnoses, we developed a sensitive luminometric cytotoxicity test using a stable form of luciferase. Specifically, we converted Gaussia luciferase (G-Luc) from an actively secreted form to a cytoplasmic form by adding an ER-retention signal composed of the four amino acids KDEL. The bioluminescent signal was >30-fold higher in transgenic HepG2 human hepatoblastoma cells expressing G-Luc+KDEL than in cells expressing wild-type G-Luc. Moreover, G-Luc+KDEL secreted from damaged cells was stable in culture medium after 24 hr at 37 degrees C. We evaluated the accuracy of our cytotoxicity test by subjecting identical samples obtained from chemically treated transgenic HepG2 cells to the G-Luc+KDEL assay and luminometric analyses based on secretion of endogenous adenylate kinase or cellular ATP level. Time-dependent accumulation of G-Luc+KDEL in the medium increased the sensitivity of our assay above those of existing tests. Our findings demonstrate that strong and stable luminescence of G-Luc+KDEL in human hepatocyte-like cells, which have high levels of metabolic activity, make it suitable for use in a high-throughput screening system for monitoring time-dependent cytotoxicity in a limited number of cells.	[Tsuji, Saori] Org Tottori Ind Promot, Bio Frontier Project Promot Sect, Nishi Cho 86, Yonago, Tottori 6838503, Japan; [Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Nishi Cho 86, Yonago, Tottori 6838503, Japan; [Yamakage, Kohji] Food & Drug Safety Ctr FDSC, Hatano Res Inst, 729-5 Ochiai, Hatano, Kanagawa 2578523, Japan; [Oshimura, Mitsuo; Tada, Masako] Tottori Univ, Chromosome Engn Res Ctr, Nishi Cho 86, Yonago, Tottori 6838503, Japan	Tottori University; Tottori University	Tada, M (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Nishi Cho 86, Yonago, Tottori 6838503, Japan.	matada@med.tottori-u.ac.jp			Ministry of Economy, Trade and Industry (METI) of Japan [20150317]	Ministry of Economy, Trade and Industry (METI) of Japan	This work was supported solely by a National Grant [The Japanese Financial Support number 20150317] from The Ministry of Economy, Trade and Industry (METI) of Japan.	Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Cho MH, 2008, TOXICOL IN VITRO, V22, P1099, DOI 10.1016/j.tiv.2008.02.013; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Mersch-Sundermann V, 2004, TOXICOLOGY, V198, P329, DOI 10.1016/j.tox.2004.02.009; MIYAZAKI J, 1989, GENE, V79, P269; Moghadam AR, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0773-6; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; OECD, 2011, WORKSH US MECH INF F; OECD, 2008, TEST NO 407 REP DOS; Olsson T, 1983, J Appl Biochem, V5, P437; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tsuji S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104123; Verhaegen M, 2002, ANAL BIOCHEM, V306, P314, DOI 10.1006/abio.2002.5724; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243; Westmoreland C, 2014, NAT BIOTECHNOL, V32, P541, DOI 10.1038/nbt.2922; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031; Yuan BZ, 2008, TRANSL ONCOL, V1, P129, DOI 10.1593/tlo.08133	23	5	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156202	10.1371/journal.pone.0156202	http://dx.doi.org/10.1371/journal.pone.0156202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228203	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500079
J	Upadhyaya, JD; Chakraborty, R; Shaik, FA; Jaggupilli, A; Bhullar, RP; Chelikani, P				Upadhyaya, Jasbir D.; Chakraborty, Raja; Shaik, Feroz A.; Jaggupilli, Appalaraju; Bhullar, Rajinder P.; Chelikani, Prashen			The Pharmacochaperone Activity of Quinine on Bitter Taste Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; DELTA-OPIOID RECEPTOR; ENDOPLASMIC-RETICULUM; FUNCTIONAL-CHARACTERIZATION; DESENSITIZATION; ACTIVATION; PHOSPHORYLATION; INTERNALIZATION; TERMINUS; LIGANDS	Bitter taste is one of the five basic taste sensations which is mediated by 25 bitter taste receptors (T2Rs) in humans. The mechanism of bitter taste signal transduction is not yet elucidated. The cellular processes underlying T2R desensitization including receptor internalization, trafficking and degradation are yet to be studied. Here, using a combination of molecular and pharmacological techniques we show that T2R4 is not internalized upon agonist treatment. Pretreatment with bitter agonist quinine led to a reduction in subsequent quinine-mediated calcium responses to 35 +/- 5% compared to the control untreated cells. Interestingly, treatment with different bitter agonists did not cause internalization of T2R4. Instead, quinine treatment led to a 2-fold increase in T2R4 cell surface expression which was sensitive to Brefeldin A, suggesting a novel pharmacochaperone activity of quinine. This phenomenon of chaperone activity of quinine was also observed for T2R7, T2R10, T2R39 and T2R46. Our results suggest that the observed action of quinine for these T2Rs is independent of its agonist activity. This study provides novel insights into the pharmacochaperone activity of quinine and possible mechanism of T2R desensitization, which is of fundamental importance in understanding the mechanism of bitter taste signal transduction.	[Upadhyaya, Jasbir D.; Chakraborty, Raja; Shaik, Feroz A.; Jaggupilli, Appalaraju; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB R3E 0W2, Canada; [Upadhyaya, Jasbir D.; Chakraborty, Raja; Shaik, Feroz A.; Jaggupilli, Appalaraju; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Manitoba Chemosensory Biol MCSB Res Grp, Winnipeg, MB R3E 0W2, Canada; [Upadhyaya, Jasbir D.; Chakraborty, Raja; Shaik, Feroz A.; Jaggupilli, Appalaraju; Chelikani, Prashen] Childrens Hosp Res Inst Manitoba, Winnipeg, MB R3E 3P4, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB R3E 0W2, Canada.; Chelikani, P (corresponding author), Univ Manitoba, Manitoba Chemosensory Biol MCSB Res Grp, Winnipeg, MB R3E 0W2, Canada.; Chelikani, P (corresponding author), Childrens Hosp Res Inst Manitoba, Winnipeg, MB R3E 3P4, Canada.	Prashen.Chelikani@umanitoba.ca	Upadhyaya, Jasbir/L-4724-2019; Jaggupilli, Appalaraju/L-2808-2019; Chakraborty, Raja/L-6316-2017	Upadhyaya, Jasbir/0000-0003-0815-2108; Shaik, Feroz Ahmed/0000-0002-9747-2594; Jaggupilli, Appalaraju/0000-0002-1718-8551; Chelikani, Prashen/0000-0003-1129-7957	discovery grant from the Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04099]; peer-reviewed research and development program grant from Alberta Livestock and Meat Agency Ltd [2015P002R]; Manitoba Medical Service Foundation Allen Rouse Career Award; Research Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba Graduate Fellowships	discovery grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); peer-reviewed research and development program grant from Alberta Livestock and Meat Agency Ltd; Manitoba Medical Service Foundation Allen Rouse Career Award; Research Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba Graduate Fellowships	This work was supported by a discovery grant (RGPIN-2014-04099) from the Natural Sciences and Engineering Research Council of Canada, a peer-reviewed research and development program grant (2015P002R) from Alberta Livestock and Meat Agency Ltd, and a Manitoba Medical Service Foundation Allen Rouse Career Award to PC. JDU and RC were supported by graduate studentships from Research Manitoba and the Children's Hospital Research Institute of Manitoba. FAS and AJ were supported by University of Manitoba Graduate Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Blake AD, 1997, J BIOL CHEM, V272, P782, DOI 10.1074/jbc.272.2.782; Bray L, 2014, J BIOL CHEM, V289, P33754, DOI 10.1074/jbc.M114.612614; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Chakraborty R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029996; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen Y, 2006, J PHARMACOL EXP THER, V319, P765, DOI 10.1124/jpet.106.107987; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Maehashi K, 2008, BIOCHEM BIOPH RES CO, V365, P851, DOI 10.1016/j.bbrc.2007.11.070; Makhija L, 2014, AM J RESP CELL MOL, V50, P923, DOI 10.1165/rcmb.2013-0320OC; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mostafapour S, 1996, RECEPT SIGNAL TRANS, V6, P151; Mottram PL, 2003, IMMUNOL CELL BIOL, V81, P350, DOI 10.1046/j.1440-1711.2003.01184.x; Ouedraogo M, 2008, TRAFFIC, V9, P305, DOI 10.1111/j.1600-0854.2007.00691.x; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Pydi SP, 2015, BIOCHEMISTRY-US, V54, P2622, DOI 10.1021/acs.biochem.5b00265; Pydi SP, 2014, J BIOL CHEM, V289, P25054, DOI 10.1074/jbc.M114.576975; Pydi SP, 2014, BBA-BIOMEMBRANES, V1838, P231, DOI 10.1016/j.bbamem.2013.08.009; Pydi SP, 2013, BIOCHEM BIOPH RES CO, V430, P179, DOI 10.1016/j.bbrc.2012.11.029; Pydi SP, 2012, J NEUROCHEM, V122, P537, DOI 10.1111/j.1471-4159.2012.07808.x; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; ROETTGER BF, 1995, J CELL BIOL, V130, P579, DOI 10.1083/jcb.130.3.579; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Singh N, 2014, BIOCHEM BIOPH RES CO, V446, P499, DOI 10.1016/j.bbrc.2014.02.140; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; Upadhyaya J, 2015, BBA-BIOMEMBRANES, V1848, P1502, DOI 10.1016/j.bbamem.2015.03.035; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Upadhyaya JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110373; vanHooft JA, 1996, BRIT J PHARMACOL, V117, P839; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zubare-Samuelov M, 2005, AM J PHYSIOL-CELL PH, V289, pC483, DOI 10.1152/ajpcell.00547.2004	45	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156347	10.1371/journal.pone.0156347	http://dx.doi.org/10.1371/journal.pone.0156347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223611	gold, Green Published, Green Submitted			2022-12-26	WOS:000376881700087
J	Yamaji, Y; Yasui, Y; Nakayama, T				Yamaji, Yoshiaki; Yasui, Yosuke; Nakayama, Tetsuo			Development of Acquired Immunity following Repeated Respiratory Syncytial Virus Infections in Cotton Rats	PLOS ONE			English	Article							T-CELLS; MEMORY; RESPONSES; PROTEINS; DISEASE; ADULTS; LUNG	Respiratory syncytial virus (RSV) infections occur every year worldwide. Most infants are infected with RSV by one year of age and are reinfected because immune responses after the first infection are too weak to protect against subsequent infections. In the present study, immune responses against RSV were investigated in order to obtain a better understanding of repetitive RSV infections in cotton rats. No detectable neutralizing antibody (NT) was developed after the first infection, and the second infection was not prevented. The results of histological examinations revealed severe inflammation, viral antigens were detected around bronchial epithelial cells, and infectious viruses were recovered from lung homogenates. Following the second infection neutralizing antibodies were significantly elevated, and CD8(+) cells were activated in response to RSV-F253-265. No viral antigens was detected thereafter in lung tissues and infectious viruses were not recovered. Similar results were obtained in the present study using the subgroups A and B. These results support the induction of humoral and cellular immune responses following repetitive infections with RSV; however, these responses were insufficient to eliminate viruses in the first and second infections.	[Yamaji, Yoshiaki; Nakayama, Tetsuo] Kitasato Univ, Kitasato Inst Life Sci, Lab Viral Infect 1, Minato Ku, Shirokane 5-9-1, Tokyo 1088641, Japan; [Yasui, Yosuke] Keio Univ, Ctr Hlth, Yokohama, Kanagawa 2238521, Japan	Kitasato University; Keio University	Nakayama, T (corresponding author), Kitasato Univ, Kitasato Inst Life Sci, Lab Viral Infect 1, Minato Ku, Shirokane 5-9-1, Tokyo 1088641, Japan.	tetsuo-n@lisci.kitasato-u.ac.jp			Daiichi Sankyo Pharmaceutical company	Daiichi Sankyo Pharmaceutical company	This study was supported by the Daiichi Sankyo Pharmaceutical company in the form of a research grant to Tetsuo Nakayama. The specific roles of this author are articulated in the Author Contributions section. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bueno SM, 2008, P NATL ACAD SCI USA, V105, P20822, DOI 10.1073/pnas.0806244105; Chang J, 2002, NAT MED, V8, P54, DOI 10.1038/nm0102-54; Cherukuri A, 2013, CLIN VACCINE IMMUNOL, V20, P239, DOI 10.1128/CVI.00580-12; Curtis SJ, 2002, EXP BIOL MED, V227, P799, DOI 10.1177/153537020222700912; ELANGO N, 1986, P NATL ACAD SCI USA, V83, P1906, DOI 10.1073/pnas.83.6.1906; Evans JE, 1996, VIRUS RES, V43, P155, DOI 10.1016/0168-1702(96)01327-5; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Glenn GM, 2015, VACCINE, V33, P6488, DOI 10.1016/j.vaccine.2015.08.039; Gonzalez PA, 2008, P NATL ACAD SCI USA, V105, P14999, DOI 10.1073/pnas.0802555105; Heidema J, 2004, J GEN VIROL, V85, P2365, DOI 10.1099/vir.0.80131-0; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Martinez-Sobrido L, 2006, J VIROL, V80, P1130, DOI 10.1128/JVI.80.3.1130-1139.2006; McKimm-Breschkin JL, 2004, J VIROL METHODS, V120, P113, DOI 10.1016/j.jviromet.2004.02.020; MURPHY BR, 1986, J CLIN MICROBIOL, V23, P1009, DOI 10.1128/JCM.23.6.1009-1014.1986; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; PRINCE GA, 1985, J VIROL, V55, P517, DOI 10.1128/JVI.55.3.517-520.1985; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Sawada A, 2011, VACCINE, V29, P1481, DOI 10.1016/j.vaccine.2010.12.028; Senft AP, 2010, AM J RESP CELL MOL, V42, P404, DOI 10.1165/rcmb.2008-0229OC; Shaw CA, 2013, VACCINE, V31, P306, DOI 10.1016/j.vaccine.2012.11.006; Smith G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050852; Yamaji Y, 2014, VACCINE, V32, P4529, DOI 10.1016/j.vaccine.2014.06.024; Zeng RH, 2008, BIOCHEM BIOPH RES CO, V377, P495, DOI 10.1016/j.bbrc.2008.10.002; Zomer-Kooijker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087162	25	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155777	10.1371/journal.pone.0155777	http://dx.doi.org/10.1371/journal.pone.0155777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224021	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700030
J	Mackenzie, BDE; Auld, TD; Keith, DA; Hui, FKC; Ooi, MKJ				Mackenzie, Berin D. E.; Auld, Tony D.; Keith, David A.; Hui, Francis K. C.; Ooi, Mark K. J.			The Effect of Seasonal Ambient Temperatures on Fire-Stimulated Germination of Species with Physiological Dormancy: A Case Study Using Boronia (Rutaceae)	PLOS ONE			English	Article							POSTFIRE SEEDLING EMERGENCE; HEAT-SHOCK; INCREASES GERMINATION; SOIL TEMPERATURES; CAPE PROTEACEAE; PARTNER CUES; SMOKE; RECRUITMENT; INTENSITY; ESTABLISHMENT	Dormancy and germination requirements determine the timing and magnitude of seedling emergence, with important consequences for seedling survival and growth. Physiological dormancy is the most widespread form of dormancy in flowering plants, yet the seed ecology of species with this dormancy type is poorly understood in fire-prone vegetation. The role of seasonal temperatures as germination cues in these habitats is often overlooked due to a focus on direct fire cues such as heat shock and smoke, and little is known about the combined effects of multiple fire-related cues and environmental cues as these are seldom assessed in combination. We aimed to improve understanding of the germination requirements of species with physiological dormancy in fire-prone floras by investigating germination responses across members of the Rutaceae from south eastern Australia. We used a fully factorial experimental design to quantify the individual and combined effects of heat shock, smoke and seasonal ambient temperatures on germination of freshly dispersed seeds of seven species of Boronia, a large and difficult-to-germinate genus. Germination syndromes were highly variable but correlated with broad patterns in seed morphology and phylogenetic relationships between species. Seasonal temperatures influenced the rate and/or magnitude of germination responses in six species, and interacted with fire cues in complex ways. The combined effects of heat shock and smoke ranged from neutral to additive, synergistic, unitive or negative and varied with species, seasonal temperatures and duration of incubation. These responses could not be reliably predicted from the effect of the application of single cues. Based on these findings, fire season and fire intensity are predicted to affect both the magnitude and timing of seedling emergence in wild populations of species with physiological dormancy, with important implications for current fire management practices and for population persistence under climate change.	[Mackenzie, Berin D. E.; Auld, Tony D.; Keith, David A.; Ooi, Mark K. J.] Univ New S Wales, Ctr Ecosyst Sci, Kensington, NSW 2052, Australia; [Mackenzie, Berin D. E.; Auld, Tony D.; Keith, David A.] Off Environm & Heritage NSW, Ecosyst Management Sci, POB 1967, Hurstville, NSW 2220, Australia; [Hui, Francis K. C.] Australian Natl Univ, Inst Math Sci, GPO Box 4, Canberra, ACT 2601, Australia; [Auld, Tony D.; Ooi, Mark K. J.] Univ Wollongong, Inst Conservat Biol, Wollongong, NSW 2522, Australia	University of New South Wales Sydney; Office of Environment & Heritage - New South Wales; Australian National University; University of Wollongong	Mackenzie, BDE (corresponding author), Univ New S Wales, Ctr Ecosyst Sci, Kensington, NSW 2052, Australia.; Mackenzie, BDE (corresponding author), Off Environm & Heritage NSW, Ecosyst Management Sci, POB 1967, Hurstville, NSW 2220, Australia.	berin.mackenzie@environment.nsw.gov.au	Ooi, Mark K J/A-4779-2012	Ooi, Mark K J/0000-0002-3046-0417; Auld, Tony/0000-0002-8766-2829; Hui, Francis/0000-0003-0765-3533; Keith, David/0000-0002-7627-4150; Mackenzie, Berin/0000-0001-6898-9925	Valette Williams Scholarship in Botany by the North Shore Group of the Australian Native Plant Society; Australia Flora Foundation; Australian Research Council [LP110100527]	Valette Williams Scholarship in Botany by the North Shore Group of the Australian Native Plant Society; Australia Flora Foundation; Australian Research Council(Australian Research Council)	This study was supported in part by: 1) a Valette Williams Scholarship in Botany awarded to BM in 2013 by the North Shore Group of the Australian Native Plant Society (http://www.blandfordia.org.au/); 2) an Australia Flora Foundation research grant awarded to MO and BM (http://www.aff.org.au/); and 3) an Australian Research Council Linkage Project grant [grant number LP110100527] awarded to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld TD, 2000, AUST J BOT, V48, P539, DOI 10.1071/BT99046; AULD TD, 1991, AUST J ECOL, V16, P53, DOI 10.1111/j.1442-9993.1991.tb01481.x; AULD TD, 2008, WEB ECOLOGY, V8, P47, DOI DOI 10.5194/WE-8-47-2008; Auld Tony D., 2001, Cunninghamia, V7, P213; Auld TD, 2009, PLANT ECOL, V200, P117, DOI 10.1007/s11258-008-9437-7; Australian Government Bureau of Meteorology, 2012, CLIM DAT ONL; Baker KS, 2005, SEED SCI RES, V15, P339, DOI 10.1079/SSR2005222; Baker KS, 2005, ANN BOT-LONDON, V96, P1225, DOI 10.1093/aob/mci274; Baker KS, 2005, PLANT SOIL, V277, P345, DOI 10.1007/s11104-005-7971-9; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; BELL DT, 1994, AUST J BOT, V42, P501, DOI 10.1071/BT9940501; BELL DT, 1993, BOT REV, V59, P24, DOI 10.1007/BF02856612; Benson Doug, 2001, Cunninghamia, V7, P241; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; BOND WJ, 1984, VEGETATIO, V56, P65; BOND WJ, 1984, J ECOL, V72, P209, DOI 10.2307/2260014; Bradstock RA, 2003, J VEG SCI, V14, P345, DOI 10.1658/1100-9233(2003)014[0345:AAOPFT]2.0.CO;2; BRADSTOCK RA, 1992, AUST J BOT, V40, P75, DOI 10.1071/BT9920075; BRADSTOCK RA, 1995, J APPL ECOL, V32, P76, DOI 10.2307/2404417; Brown NAC, 2004, S AFR J BOT, V70, P559, DOI 10.1016/S0254-6299(15)30194-0; Carrington ME, 1999, J ECOL, V87, P1025, DOI 10.1046/j.1365-2745.1999.00419.x; Castro J, 2006, ANN BOT-LONDON, V98, P1233, DOI 10.1093/aob/mcl208; Chiwocha SDS, 2009, PLANT SCI, V177, P252, DOI 10.1016/j.plantsci.2009.06.007; COWLING RM, 1987, J APPL ECOL, V24, P645, DOI 10.2307/2403899; DELANGE JH, 1993, S AFR J BOT, V59, P188; DIXON KW, 1995, OECOLOGIA, V101, P185, DOI 10.1007/BF00317282; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; Duretto M.F., 2013, FLORA AUSTR, P124; ENRIGHT NJ, 1989, J ECOL, V77, P1111, DOI 10.2307/2260826; Fenner M., 2005, ECOLOGY SEEDS; Flematti GR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1356; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; Gilmour CA, 2000, AUST J BOT, V48, P603, DOI 10.1071/BT99029; JEFFERY DJ, 1988, S AFR J BOT, V54, P28, DOI 10.1016/S0254-6299(16)31358-8; Jones RH, 1997, AM J BOT, V84, P1714, DOI 10.2307/2446470; Keeley JE, 1998, ECOLOGY, V79, P2320, DOI 10.1890/0012-9658(1998)079[2320:SISGIC]2.0.CO;2; Keeley JE, 1997, SCIENCE, V276, P1248, DOI 10.1126/science.276.5316.1248; KEELEY JE, 1991, BOT REV, V57, P81, DOI 10.1007/BF02858766; Keith DA, 1997, OECOLOGIA, V112, P340, DOI 10.1007/s004420050318; Kenny BJ, 2000, AUSTRAL ECOL, V25, P664, DOI 10.1111/j.1442-9993.2000.tb00072.x; Kenny BJ, 2003, FIRE RELATED GERMINA; Kery M., 2010, INTRO WINBUGS ECOLOG; Knox KJE, 2006, OECOLOGIA, V149, P730, DOI 10.1007/s00442-006-0480-6; Kruger F. J., 1984, Ecological effects of fire in South African ecosystems, P219; Kruger F.J., 1984, Ecological Studies, V48, P67; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; LEMAITRE DC, 1988, S AFR J BOT, V54, P575, DOI 10.1016/S0254-6299(16)31256-X; Lucas C, 2007, BUSHFIRE WEATHER SE, P1; Martyn Amelia J., 2009, Cunninghamia, V11, P203; McIntyre DK, 1972, AUST PLANTS, V6, P260; McLoughlin LC, 1998, AUST J ECOL, V23, P393, DOI 10.1111/j.1442-9993.1998.tb00744.x; Menges ES, 2000, TRENDS ECOL EVOL, V15, P51, DOI 10.1016/S0169-5347(99)01763-2; Merritt DJ, 2007, AUST J BOT, V55, P336, DOI 10.1071/BT06106; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; MORENO JM, 1991, ECOLOGY, V72, P1993, DOI 10.2307/1941554; Morris EC, 2000, AUST J BOT, V48, P179, DOI 10.1071/BT98051; Morrison DA, 2000, AUSTRAL ECOL, V25, P292, DOI 10.1111/j.1442-9993.2000.tb00031.x; Nelson DC, 2012, ANNU REV PLANT BIOL, V63, P107, DOI 10.1146/annurev-arplant-042811-105545; Ooi MKJ, 2007, SEEDS: BIOLOGY, DEVELOPMENT AND ECOLOGY, P205, DOI 10.1079/9781845931971.0205; Ooi Mark, 2004, Ecological Management & Restoration, V5, P141, DOI 10.1111/j.1442-8903.2004.201-6.x; Ooi MKJ, 2006, ANN BOT-LONDON, V98, P421, DOI 10.1093/aob/mcl118; Ooi MKJ, 2014, ECOL EVOL, V4, P656, DOI 10.1002/ece3.973; Ooi MKJ, 2010, AUST J BOT, V58, P248, DOI 10.1071/BT09228; Ooi MKJ, 2006, INT J WILDLAND FIRE, V15, P261, DOI 10.1071/WF05024; Ooi MKJ, 2004, PLANT ECOL, V174, P183, DOI 10.1023/B:VEGE.0000046171.97671.e6; Parker V.T., 1989, ECOLOGY SOIL SEED BA, P231, DOI [10.1016/b978-0-12-440405-2.50016-6, DOI 10.1016/B978-0-12-440405-2.50016-6]; PAYNTER BH, 1991, AUST J AGR RES, V42, P901, DOI 10.1071/AR9910901; Penman TD, 2008, INT J WILDLAND FIRE, V17, P572, DOI 10.1071/WF07092; Plummer M, 2003, JAGS PROGRAM ANAL BA; Quintana JR, 2004, J BIOGEOGR, V31, P241, DOI 10.1111/j.1365-2699.2004.00955.x; R Core Team, 2013, R LANG ENV STAT COMP; Reyes O, 2009, PLANT ECOL, V202, P113, DOI 10.1007/s11258-008-9532-9; Roche S, 1997, AUST J BOT, V45, P783, DOI 10.1071/BT96099; Roche S, 1998, AUST J ECOL, V23, P111, DOI 10.1111/j.1442-9993.1998.tb00709.x; Scott J, 1994, 297 MCDOUGALL PORTN; SKORDILIS A, 1995, SEED SCI RES, V5, P151, DOI 10.1017/S0960258500002774; Stern H, 2000, AUST METEOROL MAG, V49, P87; Su YS., 2015, R2JAGS USING R RUN J; Therneau T.M., 2015, SURVIVAL SURVIVAL AN; Thomas PB, 2007, AUSTRAL ECOL, V32, P605, DOI 10.1111/j.1442-9993.2007.01730.x; Thomas PB, 2010, OECOLOGIA, V162, P293, DOI 10.1007/s00442-009-1456-0; Thomas PB, 2003, AUSTRAL ECOL, V28, P674, DOI 10.1046/j.1442-9993.2003.1330.doc.x; Thompson K, 2003, SEED SCI RES, V13, P97, DOI 10.1079/SSR2003128; Thompson K, 2013, SEED SCI RES, V23, P1, DOI 10.1017/S0960258512000190; Thompson K, 2010, SEED SCI RES, V20, P209, DOI 10.1017/S0960258510000267; Tieu A, 2001, SEED SCI RES, V11, P69, DOI 10.1079/SSR200061; Tormo J, 2014, J VEG SCI, V25, P771, DOI 10.1111/jvs.12120; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Vigilante T., 1998, SMOKE GERMINATION AU; Vleeshouwers LM, 1995, J ECOL, V83, P1031, DOI 10.2307/2261184; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; WESTOBY M, 1990, ECOLOGY, V71, P1307, DOI 10.2307/1938268; Whelan R.J.., 1995, ECOLOGY FIRE; Whitehorne GJ, 1975, INT PLANT PROPAGATOR, V25, P291; Willatt RC, 2010, IEEE T GEOSCI REMOTE, V48, P365, DOI 10.1109/TGRS.2009.2028237	95	32	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156142	10.1371/journal.pone.0156142	http://dx.doi.org/10.1371/journal.pone.0156142			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218652	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700045
J	Sousa, T; Direito, B; Lima, J; Ferreira, C; Nunes, U; Castelo-Branco, M				Sousa, Teresa; Direito, Bruno; Lima, Joao; Ferreira, Carlos; Nunes, Urbano; Castelo-Branco, Miguel			Control of Brain Activity in hMT+/V5 at Three Response Levels Using fMRI-Based Neurofeedback/BCI	PLOS ONE			English	Article							REAL-TIME FMRI; CORTEX ACTIVITY; FUNCTIONAL-ANALYSIS; SELF-REGULATION; VISUAL-CORTEX; MOTION; PERCEPTION; INTERFACE; IMPAIRMENT; ACTIVATION	A major challenge in brain-computer interface (BCI) research is to increase the number of command classes and levels of control. BCI studies often use binary control level approaches (level 0 and 1 of brain activation for each class of control). Different classes may often be achieved but not different levels of activation for the same class. The increase in the number of levels of control in BCI applications may allow for larger efficiency in neuro-feedback applications. In this work we test the hypothesis whether more than two modulation levels can be achieved in a single brain region, the hMT+/V5 complex. Participants performed three distinct imagery tasks during neurofeedback training: imagery of a stationary dot, imagery of a dot with two opposing motions in the vertical axis and imagery of a dot with four opposing motions in vertical or horizontal axes (imagery of 2 or 4 motion directions). The larger the number of motion alternations, the higher the expected hMT+/V5 response. A substantial number (17 of 20) of participants achieved successful binary level of control and 12 were able to reach even 3 significant levels of control within the same session, confirming the whole group effects at the individual level. With this simple approach we suggest that it is possible to design a parametric system of control based on activity modulation of a specific brain region with at least 3 different levels. Furthermore, we show that particular imagery task instructions, based on different number of motion alternations, provide feasible achievement of different control levels in BCI and/or neurofeedback applications.	[Sousa, Teresa; Direito, Bruno; Lima, Joao; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci CNC IBILI, Coimbra, Portugal; [Sousa, Teresa; Ferreira, Carlos; Castelo-Branco, Miguel] Univ Coimbra, Inst Nucl Sci Appl Hlth ICNAS, Coimbra, Portugal; [Sousa, Teresa; Nunes, Urbano] Univ Coimbra, Dept Elect & Comp Engn, Inst Syst & Robot ISR UC, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci CNC IBILI, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), Univ Coimbra, Inst Nucl Sci Appl Hlth ICNAS, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Sousa, Teresa/GRJ-2027-2022; Castelo-Branco, Miguel/F-3866-2019; Cipriano Ferreira, Carlos Daniel/K-6094-2014; Nunes, Urbano J/G-1187-2011; Direito, Bruno/Y-6099-2018	Sousa, Teresa/0000-0003-2652-3152; Castelo-Branco, Miguel/0000-0003-4364-6373; Cipriano Ferreira, Carlos Daniel/0000-0002-0629-7146; Nunes, Urbano J/0000-0002-7750-5221; Direito, Bruno/0000-0002-3259-8815	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/80735/2011]; BRAINTRAIN project [FP7-HEALTH-INNOVATION-1-602186]; COMPETE [FCT-UID/NEU/04539/2013]; AMS HMI12 [RECI/EEIAUT/0181/2012];  [POCI-01-0145-FEDER-007440]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); BRAINTRAIN project; COMPETE; AMS HMI12; 	This work was supported by the Portuguese Foundation for Science and Technology (FCT) concerning Ph.D. fellowship SFRH/BD/80735/2011 (TS), the BRAINTRAIN project FP7-HEALTH-2013-INNOVATION-1-602186, FCT-UID/NEU/04539/2013,-COMPETE, POCI-01-0145-FEDER-007440 and AMS HMI12: RECI/EEIAUT/0181/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020; Castelo-Branco M, 2002, P NATL ACAD SCI USA, V99, P13914, DOI 10.1073/pnas.202049999; Castelo-Branco M, 2009, J NEUROPHYSIOL, V102, P3016, DOI 10.1152/jn.90812.2008; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Goebel R, 2012, NEUROIMAGE, V62, P748, DOI 10.1016/j.neuroimage.2012.01.083; Graewe B, 2013, CEREB CORTEX, V23, P2489, DOI 10.1093/cercor/bhs246; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Huk AC, 2002, NAT NEUROSCI, V5, P72, DOI 10.1038/nn774; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Kaas A, 2010, NEUROIMAGE, V49, P794, DOI 10.1016/j.neuroimage.2009.07.055; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Kutner MH, 1996, J ROYAL TISTICAL SOC; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Larsson J, 2006, J NEUROPHYSIOLOGY; Lee JH, 2009, NEUROSCI LETT, V450, P1, DOI 10.1016/j.neulet.2008.11.024; Lenoski B, 2008, IEEE J-STSP, V2, P828, DOI 10.1109/JSTSP.2008.2007819; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Scharnowski F, 2012, J NEUROSCI, V32, P17830, DOI 10.1523/JNEUROSCI.6334-11.2012; Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345; Sorger B., 2010, BRAIN SPEAKS ITSELF; Sorger B, 2012, CURR BIOL, V22, P1333, DOI 10.1016/j.cub.2012.05.022; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Talairach J., 1988, COPLANAR STEREOTAXIS; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Weiskopf N, 2004, J PHYSIOL-PARIS, V98, P357, DOI 10.1016/j.jphysparis.2005.09.019; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; Yoo SS, 2007, NEUROREPORT, V18, P1915, DOI 10.1097/WNR.0b013e3282f202ac; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe	46	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155961	10.1371/journal.pone.0155961	http://dx.doi.org/10.1371/journal.pone.0155961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214131	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200040
J	Zhang, Y; Huang, HY; Dong, XQ; Fang, YL; Wang, KJ; Zhu, LJ; Wang, K; Huang, T; Yang, JL				Zhang, Yi; Huang, Haiyun; Dong, Xiaoqing; Fang, Yiliang; Wang, Kejing; Zhu, Lijuan; Wang, Ke; Huang, Tao; Yang, Jialiang			A Dynamic 3D Graphical Representation for RNA Structure Analysis and Its Application in Non-Coding RNA Classification	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; CHAOS GAME REPRESENTATION; P RNA; DATABASE; SIMILARITY; ALIGNMENT; PROBABILITIES; PSEUDOKNOTS; MICRORNAS	With the development of new technologies in transcriptome and epigenetics, RNAs have been identified to play more and more important roles in life processes. Consequently, various methods have been proposed to assess the biological functions of RNAs and thus classify them functionally, among which comparative study of RNA structures is perhaps the most important one. To measure the structural similarity of RNAs and classify them, we propose a novel three dimensional (3D) graphical representation of RNA secondary structure, in which an RNA secondary structure is first transformed into a characteristic sequence based on chemical property of nucleic acids; a dynamic 3D graph is then constructed for the characteristic sequence; and lastly a numerical characterization of the 3D graph is used to represent the RNA secondary structure. We tested our algorithm on three datasets: (1) Dataset I consisting of nine RNA secondary structures of viruses, (2) Dataset II consisting of complex RNA secondary structures including pseudo-knots, and (3) Dataset III consisting of 18 non-coding RNA families. We also compare our method with other nine existing methods using Dataset II and III. The results demonstrate that our method is better than other methods in similarity measurement and classification of RNA secondary structures.	[Zhang, Yi; Dong, Xiaoqing; Wang, Kejing; Zhu, Lijuan; Wang, Ke; Yang, Jialiang] Hebei Univ Sci & Technol, Dept Math, Shijiazhuang 050018, Hebei, Peoples R China; [Zhang, Yi] Hebei Lab Pharmaceut Mol Chem, Shijiazhuang 050018, Hebei, Peoples R China; [Huang, Haiyun] Hebei Univ Sci & Technol, Dept Informat Retrieval Lib, Shijiazhuang 050018, Hebei, Peoples R China; [Fang, Yiliang] Int Travel Healthcare Ctr, Fuzhou 350001, Fujian, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Yang, Jialiang] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Hebei University of Science & Technology; Hebei University of Science & Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Icahn School of Medicine at Mount Sinai	Zhang, Y; Yang, JL (corresponding author), Hebei Univ Sci & Technol, Dept Math, Shijiazhuang 050018, Hebei, Peoples R China.; Zhang, Y (corresponding author), Hebei Lab Pharmaceut Mol Chem, Shijiazhuang 050018, Hebei, Peoples R China.; Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China.; Yang, JL (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	zhaqi1972@163.com; tohuangtao@126.com; Jialiang.yang@mssm.edu	zhang, Yi/HGC-9092-2022	zhang, Yi/0000-0002-4057-678X; Yang, Jialiang/0000-0003-4689-8672	National Science Foundation of China [11171088]; Science and technology project of Hebei Province [A2015208108, 1520341]; Science Fund of the Hebei University of Science and Technology Foundation [2014PT67]; Hebei Province Foundation for Advanced Talents [A201400121]; Educational Commission of Hebei Province on of Humanities and Social Sciences [SZ16180]; National Science and Technology Support Program [2012BAK11B05]; Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) Support Program [2015IK037]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology project of Hebei Province; Science Fund of the Hebei University of Science and Technology Foundation; Hebei Province Foundation for Advanced Talents; Educational Commission of Hebei Province on of Humanities and Social Sciences; National Science and Technology Support Program; Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) Support Program	This work was partially supported by the National Science Foundation of China (No 11171088 to YZ), the Science and technology project of Hebei Province (No A2015208108 to YZ, No 1520341 to HH), the Science Fund of the Hebei University of Science and Technology Foundation (No 2014PT67 to YZ), the Hebei Province Foundation for Advanced Talents (No A201400121 to YZ), the Educational Commission of Hebei Province on of Humanities and Social Sciences (No SZ16180 to HH), the National Science and Technology Support Program (No 2012BAK11B05 to YF), and Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) Support Program (No 2015IK037 to YF).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Bafna V, 1996, DIMACS TECHNICAL REP, V96, P30; Bai FL, 2005, CHEM PHYS LETT, V408, P258, DOI 10.1016/j.cplett.2005.04.052; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Brown JW, 1998, NUCLEIC ACIDS RES, V26, P351, DOI 10.1093/nar/26.1.351; D Dowell R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-400; Feng J, 2008, CHEM PHYS LETT, V454, P355, DOI 10.1016/j.cplett.2008.01.041; Frank DN, 2000, RNA, V6, P1895, DOI 10.1017/S1355838200001461; Harris JK, 2001, RNA, V7, P220, DOI 10.1017/S1355838201001777; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Jiang R, 2015, J MOL CELL BIOL, V7, P214, DOI 10.1093/jmcb/mjv008; Li C, 2008, CHEM PHYS LETT, V458, P249, DOI 10.1016/j.cplett.2008.04.112; Li Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-280; Liao B, 2005, J BIOMOL STRUCT DYN, V22, P455, DOI 10.1080/07391102.2005.10507016; Liao B, 2004, J BIOMOL STRUCT DYN, V21, P827, DOI 10.1080/07391102.2004.10506972; Liao B, 2007, J MATH CHEM, V42, P1015, DOI 10.1007/s10910-006-9156-z; Lindgreen S, 2007, BIOINFORMATICS, V23, P3304, DOI 10.1093/bioinformatics/btm525; Liu LW, 2007, J MATH CHEM, V42, P595, DOI 10.1007/s10910-006-9135-4; Liu LW, 2012, PHYSCS PROC, V33, P96, DOI 10.1016/j.phpro.2012.05.035; Luo JW, 2006, J MATH CHEM, V39, P629, DOI 10.1007/s10910-005-9053-x; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Puton T, 2013, NUCLEIC ACIDS RES, V41, P4307, DOI 10.1093/nar/gkt101; Reusken CBEM, 1996, NUCLEIC ACIDS RES, V24, P2660, DOI 10.1093/nar/24.14.2660; Sato K, 2011, BIOINFORMATICS, V27, pI85, DOI 10.1093/bioinformatics/btr215; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; TENDAM E, 1992, BIOCHEMISTRY-US, V31, P11665, DOI 10.1021/bi00162a001; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; van Batenburg FHD, 2000, NUCLEIC ACIDS RES, V28, P201, DOI 10.1093/nar/28.1.201; Wang CY, 2013, CURR GENOMICS, V14, P371, DOI 10.2174/13892029113149990005; Wang QC, 2014, BBA-PROTEINS PROTEOM, V1844, P191, DOI 10.1016/j.bbapap.2013.08.002; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Xu X, 2007, BIOINFORMATICS, V23, P1883, DOI 10.1093/bioinformatics/btm272; Yang JL, 2008, J COMPUT BIOL, V15, P1295, DOI 10.1089/cmb.2007.0209; Yao YH, 2005, J COMPUT CHEM, V26, P1339, DOI 10.1002/jcc.20271; Yao YH, 2005, J MOL STRUC-THEOCHEM, V755, P131, DOI 10.1016/j.theochem.2005.08.009; Zhu W, 2005, J MOL STRUC-THEOCHEM, V757, P193, DOI 10.1016/j.theochem.2005.04.042; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9	43	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0152238	10.1371/journal.pone.0152238	http://dx.doi.org/10.1371/journal.pone.0152238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213271	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200001
J	Lee, NK; Yang, J; Chang, EH; Park, SE; Lee, J; Choi, SJ; Oh, W; Chang, JW; Na, DL				Lee, Na Kyung; Yang, Jehoon; Chang, Eun Hyuk; Park, Sang Eon; Lee, Jeongmin; Choi, Soo Jin; Oh, Wonil; Chang, Jong Wook; Na, Duk L.			Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model	PLOS ONE			English	Article							MARROW MONONUCLEAR-CELLS; TRANSGENIC MOUSE; BLOOD; BARRIER; RATS; INFUSION; TRANSPLANTATION; MANNITOL; ISCHEMIA; STROKE	Mesenchymal stem cells (MSCs) have a promising role as a therapeutic agent for neurodegenerative diseases such as Alzheimer's disease (AD). Prior studies suggested that intraarterially administered MSCs are engrafted into the brain in stroke or traumatic brain injury (TBI) animal models. However, a controversial standpoint exists in terms of the integrity of the blood brain barrier (BBB) in transgenic AD mice. The primary goal of this study was to explore the feasibility of delivering human umbilical cord-blood derived mesenchymal stem cells (hUCB-MSCs) into the brains of non-transgenic WT (C3H/C57) and transgenic AD (APP/PS1) mice through the intra-arterial (IA) route. Through two experiments, mice were infused with hUCB-MSCs via the right internal carotid artery and were sacrificed at two different time points: 6 hours (experiment 1) or 5 minutes (experiment 2) after infusion. In both experiments, no cells were detected in the brain parenchyma while MSCs were detected in the cerebrovasculature in experiment 2. The results from this study highlight that intra-arterial delivery of MSCs is not the most favorable route to be implemented as a potential therapeutic approach for AD.	[Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Chang, Jong Wook] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Chang, Jong Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea; [Yang, Jehoon] Samsung Biomed Res Inst, Lab Anim Res Ctr, Seoul, South Korea; [Chang, Eun Hyuk] Samsung Elect Co Ltd, Samsung Adv Inst Technol SAIT, Samsung Biomed Res Inst, Seoul 135710, South Korea; [Choi, Soo Jin; Oh, Wonil] MEDIPOST Co Ltd, Biomed Res Inst, Gyeonggi Do 463400, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; MEDIPOST	Chang, JW (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Na, DL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.; Na, DL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea.; Chang, JW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea.	kjistlife@hanmail.net; dukna@naver.com		Lee, Na Kyung/0000-0001-6116-2562	Korean Health Technology R&D Project, Ministry of Health and Welfare [HI12C1821]; Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C3484]	Korean Health Technology R&D Project, Ministry of Health and Welfare; Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants received from the Korean Health Technology R&D Project, Ministry of Health and Welfare (HI12C1821), and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, (HI14C3484), Republic of Korea. Three of the co-authors, EHC, SJC, and WIO, are currently employed by the following commercial companies: Samsung Electronics Co., Ltd and MEDIPOST Co., Ltd, respectively. The funders provided support in the form of salaries for authors [EHC, SJC, and WIO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Casey David A, 2010, P T, V35, P208; Chhabra Lovely, 2012, Indian Pacing Electrophysiol J, V12, P32; Choi JJ, 2008, ULTRASONIC IMAGING, V30, P189, DOI 10.1177/016173460803000304; COSOLO WC, 1989, AM J PHYSIOL, V256, pR443, DOI 10.1152/ajpregu.1989.256.2.R443; Cui LL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt544; Do TM, 2014, NEUROPHARMACOLOGY, V81, P311, DOI 10.1016/j.neuropharm.2014.02.010; Guo L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt327; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Khabbal J, 2015, CELL TRANSPLANT, V24, P819, DOI 10.3727/096368914X679336; Kim DH, 2015, STEM CELLS DEV, V24, P2378, DOI 10.1089/scd.2014.0487; Kim Hee Jin, 2015, Alzheimers Dement (N Y), V1, P95, DOI 10.1016/j.trci.2015.06.007; Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140; Kim Ju-Yeon, 2012, World J Stem Cells, V4, P110, DOI 10.4252/wjsc.v4.i11.110; Kim JS, 2012, NANOMEDICINE-UK, V7, P219, DOI [10.2217/NNM.11.94, 10.2217/nnm.11.94]; Kristen D, 2008, MULTISCALE MODEL SIM, V7, P888; Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045; Lee PH, 2012, ANN NEUROL, V72, P32, DOI 10.1002/ana.23612; Lin H, 2011, CELL MOL IMMUNOL, V8, P19, DOI 10.1038/cmi.2010.57; Mitkari B, 2013, EXP NEUROL, V239, P158, DOI 10.1016/j.expneurol.2012.09.018; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Okuma Y, 2013, NEUROSCI LETT, V554, P156, DOI 10.1016/j.neulet.2013.08.058; Park HJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0180-4; Park KS, 2010, NANOMED-NANOTECHNOL, V6, P263, DOI 10.1016/j.nano.2009.07.005; Park SE, 2016, NEUROREPORT, V27, P235, DOI 10.1097/WNR.0000000000000526; Poduslo JF, 2001, NEUROBIOL DIS, V8, P555, DOI 10.1006/nbdi.2001.0402; Rosado-de-Castro PH, 2013, REGEN MED, V8, P145, DOI [10.2217/RME.13.2, 10.2217/rme.13.2]; Song SK, 2011, NEUROBIOL AGING, V32, P2183, DOI 10.1016/j.neurobiolaging.2009.12.017; Toyoshima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127302; Wagner B, 2013, ADV BIOCHEM ENG BIOT, V130, P19, DOI 10.1007/10_2012_155; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Yamamoto R, 1985, J JAPANESE SOC CLIN, V24, P150; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yavagal DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093735	35	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155912	10.1371/journal.pone.0155912	http://dx.doi.org/10.1371/journal.pone.0155912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203695	Green Submitted, gold, Green Published			2022-12-26	WOS:000376291500029
J	Sun, QY; Qi, X; Zhang, Y; Wu, XD; Liang, MF; Li, C; Li, DX; Cardona, CJ; Xing, Z				Sun, Qiyu; Qi, Xian; Zhang, Yan; Wu, Xiaodong; Liang, Mifang; Li, Chuan; Li, Dexin; Cardona, Carol J.; Xing, Zheng			Synaptogyrin-2 Promotes Replication of a Novel Tick-borne Bunyavirus through Interacting with Viral Nonstructural Protein NSs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOCYTOPENIA SYNDROME VIRUS; INTRACELLULAR LIPID DROPLETS; SEVERE FEVER; INCLUSION-BODIES; ANIMAL-CELLS; PC12 CELLS; NUCLEOPROTEIN; CHINA; INTERFERON; CELLUGYRIN	Synaptogyrin-2 is a non-neuronal member of the synaptogyrin family involved in synaptic vesicle biogenesis and trafficking. Little is known about the function of synaptogyrin-2. Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease characterized by high fever, thrombocytopenia, and leukocytopenia with high mortality, caused by a novel tick-borne phlebovirus in the family Bunyaviridae. Our previous studies have shown that the viral nonstructural protein NSs forms inclusion bodies (IBs) that are involved in viral immune evasion, as well as viral RNA replication. In this study, we sought to elucidate the mechanism by which NSs formed the IBs, a lipid droplet-based structure confirmed by NSs co-localization with perilipin A and adipose differentiation-related protein (ADRP). Through a high throughput screening, we identified synaptogyrin-2 to be highly up-regulated in response to SFTS bunyavirus (SFTSV) infection and to be a promoter of viral replication. We demonstrated that synaptogyrin-2 interacted with NSs and was translocated into the IBs, which were reconstructed from lipid droplets into large structures in infection. Viral RNA replication decreased, and infectious virus titers were lowered significantly when synaptogyrin-2 was silenced in specific shRNA-expressing cells, which correlated with the reduced number of the large IBs restructured from regular lipid droplets. We hypothesize that synaptogyrin-2 is essential to promoting the formation of the IBs to become virus factories for viral RNA replication through its interaction with NSs. These findings unveil the function of synaptogyrin-2 as an enhancer in viral infection.	[Sun, Qiyu; Zhang, Yan; Wu, Xiaodong; Xing, Zheng] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Sun, Qiyu; Zhang, Yan; Wu, Xiaodong; Xing, Zheng] Nanjing Univ, Sch Med, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China; [Qi, Xian] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Liang, Mifang; Li, Chuan; Li, Dexin] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota, Coll Vet Med, Vet & Biomed Sci, St Paul, MN 55108 USA	Nanjing University; Nanjing University; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Minnesota System; University of Minnesota Twin Cities	Xing, Z (corresponding author), Nanjing Univ, Sch Med, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.; Xing, Z (corresponding author), Univ Minnesota, 300D Vet Sci Bldg,1971 Commonwealth Ave, St Paul, MN 55108 USA.	zxing@umn.edu	Xing, Zheng/O-3137-2015	Xing, Zheng/0000-0002-7288-0268	National Natural Science Foundation of China [81571993]; Mega Infectious Diseases Program from the Ministry of Science and Technology of China [2014ZX10004001-002]; 973 Grant from the Ministry of Science and Technology of China [2011CB504705]; Natural Science Foundation of Jiangsu Province [BK20131450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega Infectious Diseases Program from the Ministry of Science and Technology of China; 973 Grant from the Ministry of Science and Technology of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China Grant 81571993, Grant 2014ZX10004001-002 from the Mega Infectious Diseases Program from the Ministry of Science and Technology of China (to ZX), 973 Grant (2011CB504705 from the Ministry of Science and Technology of China (to M. L. and D. L.), and Grant BK20131450 from the Natural Science Foundation of Jiangsu Province (to X. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham C, 2011, NEUROSCIENCE, V190, P75, DOI 10.1016/j.neuroscience.2011.05.069; Belfort GM, 2005, J BIOL CHEM, V280, P7262, DOI 10.1074/jbc.M404851200; Belfort GM, 2003, J BIOL CHEM, V278, P47971, DOI 10.1074/jbc.M304174200; Bragina L, 2010, NEUROSCIENCE, V165, P934, DOI 10.1016/j.neuroscience.2009.11.009; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Carromeu C, 2007, ARCH VIROL, V152, P2259, DOI 10.1007/s00705-007-1048-4; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Derdowski A, 2008, J GEN VIROL, V89, P2698, DOI 10.1099/vir.0.2008/004051-0; Elliott RM, 2014, CURR OPIN VIROL, V5, P50, DOI 10.1016/j.coviro.2014.01.011; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030328; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hubner K, 2002, INT REV CYTOL, V214, P103; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; Kedra D, 1998, HUM GENET, V103, P131, DOI 10.1007/s004390050795; Khor VK, 2013, CURR OPIN CLIN NUTR, V16, P632, DOI 10.1097/MCO.0b013e3283651106; Kim WY, 2015, CLIN INFECT DIS, V60, P1681, DOI 10.1093/cid/civ128; KONDRUP J, 1984, DAN MED BULL, V31, P109; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Lifland AW, 2012, J VIROL, V86, P8245, DOI 10.1128/JVI.00215-12; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; LONDOS C, 1995, BIOCHEM SOC T, V23, P611, DOI 10.1042/bst0230611; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; MATUMOTO M., 1949, JAP JOUR EXPTL MED, V20, P175; McIntosh AL, 2010, LIPIDS, V45, P465, DOI 10.1007/s11745-010-3424-1; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Netherton C, 2007, ADV VIRUS RES, V70, P101, DOI 10.1016/S0065-3527(07)70004-0; Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Ning YJ, 2014, J MOL CELL BIOL, V6, DOI 10.1093/jmcb/mju015; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Park SW, 2014, TICKS TICK-BORNE DIS, V5, P975, DOI 10.1016/j.ttbdis.2014.07.020; Ploen D, 2013, EUR J CELL BIOL, V92, P374, DOI 10.1016/j.ejcb.2013.12.003; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; Santiago FW, 2014, J VIROL, V88, P4572, DOI 10.1128/JVI.03021-13; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Shimojima Masayuki, 2013, Uirusu, V63, P7; SPEHNER D, 1991, J VIROL, V65, P6296, DOI 10.1128/JVI.65.11.6296-6300.1991; Stevens RJ, 2012, J NEUROSCI, V32, P18054, DOI 10.1523/JNEUROSCI.2668-12.2012; Storey SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE991, DOI 10.1152/ajpendo.00109.2011; Stubbs AM, 2014, ANN EMERG MED, V64, P314, DOI [10.1016/j.annemergmed.2014.06.011, 10.1016/j.annemergmed.2014.06.012]; Sun QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11816; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; VALTORTA F, 1989, CELL BIOL INT REP, V13, P1023, DOI 10.1016/0309-1651(89)90017-9; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Wu XD, 2014, FASEB J, V28, P2504, DOI 10.1096/fj.13-243857; Wu XD, 2014, J VIROL, V88, P3067, DOI 10.1128/JVI.03510-13; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	59	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16138	16149		10.1074/jbc.M116.715599	http://dx.doi.org/10.1074/jbc.M116.715599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226560	hybrid, Green Published			2022-12-26	WOS:000380585400019
J	Beyrakhova, KA; van Straaten, K; Li, L; Boniecki, MT; Anderson, DH; Cygler, M				Beyrakhova, Ksenia A.; van Straaten, Karin; Li, Lei; Boniecki, Michal T.; Anderson, Deborah H.; Cygler, Miroslaw			Structural and Functional Investigations of the Effector Protein LpiR1 from Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERVER; MODEL; ENVIRONMENT; PREDICTION; SECRETION; SEQUENCE	Legionella pneumophila is a causative agent of a severe pneumonia, known as Legionnaires' disease. Legionella pathogenicity is mediated by specific virulence factors, called bacterial effectors, which are injected into the invaded host cell by the bacterial type IV secretion system. Bacterial effectors are involved in complex interactions with the components of the host cell immune and signaling pathways, which eventually lead to bacterial survival and replication inside the mammalian cell. Structural and functional studies of bacterial effectors are, therefore, crucial for elucidating the mechanisms of Legionella virulence. Here we describe the crystal structure of the LpiR1 (Lpg0634) effector protein and investigate the effects of its overexpression in mammalian cells. LpiR1 is an alpha-helical protein that consists of two similar domains aligned in an antiparallel fashion. The hydrophilic cleft between the domains might serve as a binding site for a potential host cell interaction partner. LpiR1 binds the phosphate group at a conserved site and is stabilized by Mn2+, Ca2+, or Mg2+ ions. When overexpressed in mammalian cells, a GFP-LpiR1 fusion protein is localized in the cytoplasm. Intracellular signaling antibody array analysis revealed small changes in the phosphorylation state of several components of the Akt signaling pathway in HEK293T cells overexpressing LpiR1.	[Beyrakhova, Ksenia A.; van Straaten, Karin; Li, Lei; Boniecki, Michal T.; Cygler, Miroslaw] Univ Saskatchewan, Saskatchewan Canc Agcy, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Anderson, Deborah H.] Univ Saskatchewan, Saskatchewan Canc Agcy, Canc Res, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan; University of Saskatchewan	Cygler, M (corresponding author), Univ Saskatchewan, Saskatchewan Canc Agcy, Dept Biochem, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca		Boniecki, Michal/0000-0002-0854-0891	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We acknowledge the Protein Characterization and Crystallization Facility, College of Medicine, University of Saskatchewan for access to the crystallization robot and the 08ID-1 beamline at the Canadian Light Source (CLS) for diffraction data collection. Canadian Light Source is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research. We thank Dr. Wei Xiao and Dr. Zhaojia Wu (Department of Microbiology and Immunology, University of Saskatchewan) for providing pcDNA4/TO-HA and pEGF-N1 plasmids and mammalian cells used in this work. We also thank Dr. Alla Gagarinova for helpful discussions and Dr. Alexander Grigoryan (College of Agriculture and Bioresources, University of Saskatchewan) for help with the phylogenetic analysis.	Abraham AL, 2009, J MOL BIOL, V394, P522, DOI 10.1016/j.jmb.2009.09.031; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hayashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011718; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Ko KS, 2002, J CLIN MICROBIOL, V40, P2653, DOI 10.1128/JCM.40.7.2653-2658.2002; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Qin ZS, 2013, NUCLEIC ACIDS RES, V41, P7356, DOI 10.1093/nar/gkt542; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vincent CD, 2006, MOL MICROBIOL, V62, P1278, DOI 10.1111/j.1365-2958.2006.05446.x; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	31	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15767	15777		10.1074/jbc.M115.708701	http://dx.doi.org/10.1074/jbc.M115.708701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226543	hybrid, Green Published			2022-12-26	WOS:000380584200029
J	Offermann, LR; Schlachter, CR; Perdue, ML; Majorek, KA; He, JZ; Booth, WT; Garrett, J; Kowal, K; Chruszcz, M				Offermann, Lesa R.; Schlachter, Caleb R.; Perdue, Makenzie L.; Majorek, Karolina A.; He, John Z.; Booth, William T.; Garrett, Jessica; Kowal, Krzysztof; Chruszcz, Maksymilian			Structural, Functional, and Immunological Characterization of Profilin Panallergens Amb a 8, Art v 4, and Bet v 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CROSS-REACTIVITY; PROTEIN FAMILIES; ALLERGENIC REACTIVITY; IMMUNOGLOBULIN-E; MAJOR ALLERGEN; IGE EPITOPES; POLLEN; SENSITIZATION; IDENTIFICATION	Ragweed allergens affect several million people in the United States and Canada. To date, only two ragweed allergens, Ambt 5 and Amb a 11, have their structures determined and deposited to the Protein Data Bank. Here, we present structures of methylated ragweed allergen Amb a 8, Amb a 8 in the presence of poly(L-proline), and Art v 4 (mugwort allergen). Amb a 8 and Art v 4 are panallergens belonging to the profilin family of proteins. They share significant sequence and structural similarities, which results in cross-recognition by IgE antibodies. Molecular and immunological properties of Amb a 8 and Art v 4 are compared with those of Bet v 2 (birch pollen allergen) as well as with other allergenic profilins. We purified recombinant allergens that are recognized by patient IgE and are highly cross-reactive. It was determined that the analyzed allergens are relatively unstable. Structures of Amb a 8 in complex with poly(L-proline) 10 or poly(L-proline) 14 are the first structures of the plant profilin in complex with proline-rich peptides. Amb a 8 binds the poly(L-proline) in a mode similar to that observed in human, mouse, and P. falciparum profilin.peptide complexes. However, only some of the residues that form the peptide binding site are conserved.	[Offermann, Lesa R.; Schlachter, Caleb R.; Perdue, Makenzie L.; He, John Z.; Booth, William T.; Garrett, Jessica; Chruszcz, Maksymilian] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Offermann, Lesa R.] Davidson Coll, Dept Chem, Davidson, NC 28035 USA; [Majorek, Karolina A.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Kowal, Krzysztof] Med Univ Bialystok, Dept Allergol & Internal Med, PL-15276 Bialystok, Poland; [Kowal, Krzysztof] Med Univ Bialystok, Dept Expt Allergol & Immunol, PL-15276 Bialystok, Poland	University of South Carolina System; University of South Carolina Columbia; Davidson College; University of Virginia; Medical University of Bialystok; Medical University of Bialystok	Chruszcz, M (corresponding author), Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.	chruszcz@mailbox.sc.edu	Chruszcz, Maksymilian/E-6407-2011	Chruszcz, Maksymilian/0000-0001-7521-5485; Offermann, Lesa/0000-0002-0365-7978; /0000-0002-0910-1292	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The structural results shown here are derived from work performed at Argonne National Laboratory, at the Southeast Regional Collaborative Access Team (SER-CAT) and the Life Sciences Collaborative Access Team (LS-CAT) of the Advanced Photon Source. Supporting institutions for SER-CAT may be found on the SER-CAT website. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado MI, 2014, ALLERGY, V69, P1610, DOI 10.1111/all.12509; Asero R, 2008, CLIN EXP ALLERGY, V38, P1033, DOI 10.1111/j.1365-2222.2008.02980.x; Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Asero R, 2003, J ALLERGY CLIN IMMUN, V112, P427, DOI 10.1067/mai.2003.1611; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Asturias JA, 2002, INT IMMUNOL, V14, P993, DOI 10.1093/intimm/dxf070; Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Barderas R, 2004, J ALLERGY CLIN IMMUN, V113, P1192, DOI 10.1016/j.jaci.2003.12.587; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behnen M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-34; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Bonura A, 2014, MOL IMMUNOL, V57, P220, DOI 10.1016/j.molimm.2013.09.004; Boopathy S, 2015, P NATL ACAD SCI USA, V112, P7984, DOI 10.1073/pnas.1424108112; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Cases B, 2010, INT ARCH ALLERGY IMM, V153, P215, DOI 10.1159/000314361; Crespo JF, 2006, MOL NUTR FOOD RES, V50, P282, DOI 10.1002/mnfr.200500200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gadermaier G, 2004, CURR ALLERGY ASTHM R, V4, P391, DOI 10.1007/s11882-004-0090-5; Gadermaier G, 2014, METHODS, V66, P55, DOI 10.1016/j.ymeth.2013.06.014; Ganglberger E, 2001, INT ARCH ALLERGY IMM, V125, P216, DOI 10.1159/000053819; Ghosh D, 2014, J BIOL CHEM, V289, P21374, DOI 10.1074/jbc.M114.559971; HANSSON A, 1988, BIOCHEM BIOPH RES CO, V150, P526, DOI 10.1016/0006-291X(88)90425-1; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; LINDBERG U, 1988, BIOCHIM BIOPHYS ACTA, V967, P391, DOI 10.1016/0304-4165(88)90102-X; Lopez-Torrejon G, 2005, ALLERGY, V60, P1424, DOI 10.1111/j.1398-9995.2005.00903.x; Lopez-Torrejon G, 2005, CLIN EXP ALLERGY, V35, P1065, DOI 10.1111/j.1365-2222.2005.02303.x; Lopez-Torrejon G, 2007, J ALLERGY CLIN IMMUN, V119, P1481, DOI 10.1016/j.jaci.2007.02.004; MACHESKY LM, 1990, CELL REGUL, V1, P937, DOI 10.1091/mbc.1.12.937; Mari A, 2001, INT ARCH ALLERGY IMM, V125, P57, DOI 10.1159/000053797; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mondal AK, 1998, ANN AGR ENV MED, V5, P17; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oberhuber C, 2008, INT ARCH ALLERGY IMM, V145, P94, DOI 10.1159/000108134; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polet D, 2007, FEBS LETT, V581, P211, DOI 10.1016/j.febslet.2006.12.013; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Rossi RE, 1996, ALLERGY, V51, P940; Scheurer S, 2001, J CHROMATOGR B, V756, P315, DOI 10.1016/S0378-4347(01)00090-1; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; Tawde P, 2006, J ALLERGY CLIN IMMUN, V118, P915, DOI 10.1016/j.jaci.2006.05.028; Tinghino R, 2002, J ALLERGY CLIN IMMUN, V109, P314, DOI 10.1067/mai.2002.121528; Tordesillas L, 2010, CLIN EXP ALLERGY, V40, P174, DOI 10.1111/j.1365-2222.2009.03401.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Vallverdu A, 1998, J ALLERGY CLIN IMMUN, V101, P363, DOI 10.1016/S0091-6749(98)70249-0; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Villalta D, 2010, J INVEST ALLERG CLIN, V20, P591; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Westphal S, 2004, ALLERGY, V59, P526, DOI 10.1046/j.1398-9995.2003.00413.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wopfner N, 2008, ALLERGY, V63, P872, DOI 10.1111/j.1398-9995.2008.01635.x; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419	74	25	27	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15447	15459		10.1074/jbc.M116.733659	http://dx.doi.org/10.1074/jbc.M116.733659			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231348	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000380584200003
J	Li, XM; Ortega, B; Kim, B; Welling, PA				Li, Xiangming; Ortega, Bernardo; Kim, Boyoung; Welling, Paul A.			A Common Signal Patch Drives AP-1 Protein-dependent Golgi Export of Inwardly Rectifying Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN ADAPTER COMPLEXES; DISTAL CONVOLUTED TUBULE; RECTIFIER K+ CHANNEL; ENDOPLASMIC-RETICULUM; STRUCTURAL EXPLANATION; BASOLATERAL POLARITY; ANGSTROM RESOLUTION; ATP CHANNELS; KIR2.1; RECOGNITION	Nearly all members of the inwardly rectifying potassium (Kir) channel family share a cytoplasmic domain structure that serves as an unusual AP-1 clathrin adaptor-dependent Golgi export signal in one Kir channel, Kir2.1 (KCNJ2), raising the question whether Kir channels share a common Golgi export mechanism. Here we explore this idea, focusing on two structurally and functionally divergent Kir family members, Kir2.3 (KCNJ4) and Kir4.1/5.1 (KCNJ10/16), which have similar to 50% amino identity. We found that Golgi export of both channels is blocked upon siRNA-mediated knockdown of the AP-1 gamma subunit, as predicted for the common AP-1-dependent trafficking process. A comprehensive mutagenic analysis, guided by homology mapping in atomic resolution models of Kir2.1, Kir2.3, and Kir4.1/5.1, identified a common structure that serves as a recognition site for AP-1 binding and governs Golgi export. Larger than realized from previous studies with Kir2.1, the signal is created by a patch of residues distributed at the confluence of cytoplasmic N and C termini. The signal involves a stretch of hydrophobic residues from the C-terminal region that form a hydrophobic cleft, an adjacent cluster of basic residues within the N terminus, and a potential network of salt bridges that join the N-and C-terminal poles together. Because patch formation and AP-1 binding are dependent on proper folding of the cytoplasmic domains, the signal provides a common quality control mechanism at the Golgi for Kir channels. These findings identify a new proteostatic mechanism that couples protein folding of channels to forward trafficking in the secretory pathway.	[Li, Xiangming; Kim, Boyoung; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ortega, Bernardo] SUNY Coll Brockport, Dept Biol, Brockport, NY 14420 USA	University System of Maryland; University of Maryland Baltimore; State University of New York (SUNY) System	Welling, PA (corresponding author), Univ Maryland, Sch Med, Rm 5029 Bressler,655 W Baltimore St, Baltimore, MD 21201 USA.	pwelling@som.umaryland.edu			NIDDK, National Institutes of Health [DK063049, DK054231]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054231, R01DK063049] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by funds from the NIDDK, National Institutes of Health (DK063049, DK054231, and DK063049 to P. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arakel EC, 2014, J CELL SCI, V127, P2106, DOI 10.1242/jcs.141440; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; de la Fuente-Ortega E, 2015, MOL BIOL CELL, V26, P1728, DOI 10.1091/mbc.E15-01-0047; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Jain S, 2015, MOL BIOL CELL, V26, P218, DOI 10.1091/mbc.E14-07-1177; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang CB, 2014, P NATL ACAD SCI USA, V111, P11864, DOI 10.1073/pnas.1411705111	46	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14963	14972		10.1074/jbc.M116.729822	http://dx.doi.org/10.1074/jbc.M116.729822			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226616	hybrid, Green Published			2022-12-26	WOS:000380583200009
J	Wang, H; Lu, B; Castillo, J; Zhang, Y; Yang, ZE; McAllister, G; Lindeman, A; Reece-Hoyes, J; Tallarico, J; Russ, C; Hoffman, G; Xu, WQ; Schirle, M; Cong, F				Wang, Hui; Lu, Bo; Castillo, Johnny; Zhang, Yue; Yang, Zinger; McAllister, Gregory; Lindeman, Alicia; Reece-Hoyes, John; Tallarico, John; Russ, Carsten; Hoffman, Greg; Xu, Wenqing; Schirle, Markus; Cong, Feng			Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO PATHWAY; TISSUE HOMEOSTASIS; TUMOR-SUPPRESSOR; ADP-RIBOSYLATION; FAMILY PROTEINS; BREAST-CANCER; DEGRADATION; TARGET; KRAS; AXIN	YAP signaling pathway plays critical roles in tissue homeostasis, and aberrant activation of YAP signaling has been implicated in cancers. To identify tractable targets of YAP pathway, we have performed a pathway-based pooled CRISPR screen and identified tankyrase and its associated E3 ligase RNF146 as positive regulators of YAP signaling. Genetic ablation or pharmacological inhibition of tankyrase prominently suppresses YAP activity and YAP target gene expression. Using a proteomic approach, we have identified angiomotin family proteins, which are known negative regulators of YAP signaling, as novel tankyrase substrates. Inhibition of tankyrase or depletion of RNF146 stabilizes angiomotins. Angiomotins physically interact with tankyrase through a highly conserved motif at their N terminus, and mutation of this motif leads to their stabilization. Tankyrase inhibitor -induced stabilization of angiomotins reduces YAP nuclear translocation and decreases downstream YAP signaling. We have further shown that knock -out of YAP sensitizes non-small cell lung cancer to EGER inhibitor Erlotinib. Tankyrase inhibitor, but not porcupine inhibitor, which blocks Wnt secretion, enhances growth inhibitory activity of Erlotinib. This activity is mediated by YAP inhibition and not Wnt/O-catenin inhibition. Our data suggest that tankyrase inhibition could serve as a novel strategy to suppress YAP signaling for combinatorial targeted therapy.	[Wang, Hui; Lu, Bo; Castillo, Johnny; Zhang, Yue; Yang, Zinger; McAllister, Gregory; Lindeman, Alicia; Reece-Hoyes, John; Tallarico, John; Russ, Carsten; Hoffman, Greg; Schirle, Markus; Cong, Feng] Novartis Inst Biomed Res, Dept Dev & Mol Pathways, Cambridge, MA 02139 USA; [Xu, Wenqing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Novartis; University of Washington; University of Washington Seattle	Cong, F (corresponding author), Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA.	feng.cong@novartis.com		Castillo, Johnny/0000-0003-2009-7519; Reece-Hoyes, John/0000-0001-5251-5813; Yang Loureiro, Zinger/0000-0001-8543-4841				Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; DaRosa PA, 2015, NATURE, V517, P223, DOI 10.1038/nature13826; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Irvine KD, 2012, SEMIN CELL DEV BIOL, V23, P812, DOI 10.1016/j.semcdb.2012.04.006; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Li N, 2015, GENE DEV, V29, P157, DOI 10.1101/gad.251785.114; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Nishimura M, 2002, J BIOL CHEM, V277, P5583, DOI 10.1074/jbc.M110154200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Patrie KM, 2005, BBA-MOL CELL RES, V1745, P131, DOI 10.1016/j.bbamcr.2005.05.011; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Schoumacher M, 2014, CANCER RES, V74, P3294, DOI 10.1158/0008-5472.CAN-14-0138-T; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; Shultz MD, 2013, J MED CHEM, V56, P6495, DOI 10.1021/jm400807n; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wang WQ, 2015, CELL REP, V13, P524, DOI 10.1016/j.celrep.2015.09.014; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhou X, 2015, J CLIN INVEST, V125, P2123, DOI 10.1172/JCI79573; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	51	52	52	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15256	15266		10.1074/jbc.M116.722967	http://dx.doi.org/10.1074/jbc.M116.722967			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27231341	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000380583200032
J	LoRicco, JG; Xu, CS; Neidleman, J; Bergkvist, M; Greene, WC; Roan, NR; Makhatadze, GI				LoRicco, Josephine G.; Xu, Changmingzi Sherry; Neidleman, Jason; Bergkvist, Magnus; Greene, Warner C.; Roan, Nadia R.; Makhatadze, George I.			Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; atomic force microscopy (AFM); biophysics; confocal microscopy; fluorescence; HIV-1; SEVI; Semen; Semenogelin	NF-KAPPA-B; MEDIATED ENHANCEMENT; SEMINAL PLASMA; THIOFLAVIN T; EPITHELIAL-CELLS; ALPHA-SYNUCLEIN; SEVI; EXPRESSION; CYTOKINE; PEPTIDE	Recent in vitro studies have demonstrated that amyloid fibrils found in semen from healthy and HIV-infected men, as well as semen itself, can markedly enhance HIV infection rates. Semen fibrils are made up of multiple naturally occurring peptide fragments derived from semen. The best characterized of these fibrils are SEVI (semen-derived enhancer of viral infection), made up of residues 248-286 of prostatic acidic phosphatase, and the SEM1 fibrils, made up of residues 86-107 of semenogelin 1. A small molecule screen for antagonists of semen fibrils identified four compounds that lowered semen-mediated enhancement of HIV-1 infectivity. One of the four, gallic acid, was previously reported to antagonize other amyloids and to exert anti-inflammatory effects. To better understand the mechanism by which gallic acid modifies the properties of semen amyloids, we performed biophysical measurements (atomic force microscopy, electron microscopy, confocal microscopy, thioflavin T and Congo Red fluorescence assays, zeta potential measurements) and quantitative assays on the effects of gallic acid on semen-mediated enhancement of HIV infection and inflammation. Our results demonstrate that gallic acid binds to both SEVI and SEM1 fibrils and modifies their surface electrostatics to render them less cationic. In addition, gallic acid decreased semen-mediated enhancement of HIV infection but did not decrease the inflammatory response induced by semen. Together, these observations identify gallic acid as a non-polyanionic compound that inhibits semen-mediated enhancement of HIV infection and suggest the potential utility of incorporating gallic acid into a multicomponent microbicide targeting both the HIV virus and host components that promote viral infection.	[LoRicco, Josephine G.; Xu, Changmingzi Sherry; Makhatadze, George I.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Rm 3244A,110 8th St, Troy, NY 12180 USA; [LoRicco, Josephine G.; Xu, Changmingzi Sherry; Makhatadze, George I.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Neidleman, Jason; Greene, Warner C.; Roan, Nadia R.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Bergkvist, Magnus] SUNY Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA; [Bergkvist, Magnus] SUNY Polytech Inst, Coll Engn, Albany, NY 12203 USA; [Roan, Nadia R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; SUNY Polytechnic Institute; SUNY Polytechnic Institute; University of California System; University of California San Francisco	Makhatadze, GI (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Rm 3244A,110 8th St, Troy, NY 12180 USA.; Roan, NR (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.; Roan, NR (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA.	nadia.roan@ucsf.edu; makhag@rpi.edu		LoRicco, Josephine/0000-0002-1550-2463	National Institutes of Health (NIH) [R21GM101134, R00AI104262, R21AI120774]; NIH; University of California; San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research [P30-AI027763]; Department of Defense [W81XWH-11-1-0562]; NIH [5T32GM067545-10]; NATIONAL CANCER INSTITUTE [R21CA120774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R00AI104262, R21AI116252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM101134, T32GM067545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Grants R21GM101134 (to G. I. M.) and R00AI104262 and R21AI120774 (to N. R. R.). Grant funding for this project was also received from NIH, University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research, Grant P30-AI027763 (to N. R. R.). In addition, funding was provided from Department of Defense Grant W81XWH-11-1-0562 (to W. C. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIH Training Grant 5T32GM067545-10.	Ardah MT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00197; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; Capule CC, 2012, J AM CHEM SOC, V134, P905, DOI 10.1021/ja210931b; Castellano LM, 2015, BIOL OPEN, V4, P1206, DOI 10.1242/bio.010215; Chen JC, 2014, HUM REPROD, V29, P1255, DOI 10.1093/humrep/deu047; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Di Giovanni S, 2010, J BIOL CHEM, V285, P14941, DOI 10.1074/jbc.M109.080390; Doane TL, 2012, ACCOUNTS CHEM RES, V45, P317, DOI 10.1021/ar200113c; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; French KC, 2014, BIOCHEMISTRY-US, V53, P3267, DOI 10.1021/bi500427r; French KC, 2012, BIOCHEMISTRY-US, V51, P10127, DOI 10.1021/bi301406d; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Jayamani J, 2014, EUR J MED CHEM, V85, P352, DOI 10.1016/j.ejmech.2014.07.111; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; Kim SH, 2006, TOXICOL SCI, V91, P123, DOI 10.1093/toxsci/kfj063; Krainer G, 2015, METHODS, V76, P116, DOI 10.1016/j.ymeth.2014.10.034; KROES BH, 1992, PLANTA MED, V58, P499, DOI 10.1055/s-2006-961535; Liu YQ, 2014, BBA-PROTEINS PROTEOM, V1844, P1481, DOI 10.1016/j.bbapap.2014.04.013; Liu YQ, 2013, BIOORG MED CHEM LETT, V23, P6336, DOI 10.1016/j.bmcl.2013.09.071; McCrate OA, 2013, CHEM COMMUN, V49, P4193, DOI 10.1039/c2cc37792f; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Olsen JS, 2010, J BIOL CHEM, V285, P35488, DOI 10.1074/jbc.M110.163659; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Picken MM, 2010, ARCH PATHOL LAB MED, V134, P545, DOI 10.1043/1543-2165-134.4.545; Popovych N, 2012, J PHYS CHEM B, V116, P3650, DOI 10.1021/jp2121577; Roan NR, 2014, J VIROL, V88, P7221, DOI 10.1128/JVI.00269-14; Roan NR, 2012, M S-MED SCI, V28, P358, DOI 10.1051/medsci/2012284008; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2010, J BIOL CHEM, V285, P1861, DOI 10.1074/jbc.M109.066167; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Robbins KJ, 2012, LANGMUIR, V28, P16490, DOI 10.1021/la303677t; Rollenhagen C, 2011, MUCOSAL IMMUNOL, V4, P671, DOI 10.1038/mi.2011.34; Shanmuganathan A, 2013, PROTEIN EXPRES PURIF, V88, P196, DOI 10.1016/j.pep.2013.01.003; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; Tang QY, 2013, J VIROL, V87, P12583, DOI 10.1128/JVI.02083-13; Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; Ye ZQ, 2009, BIOCHEMISTRY-US, V48, P11582, DOI 10.1021/bi901709j; Yoon CH, 2013, JOINT BONE SPINE, V80, P274, DOI 10.1016/j.jbspin.2012.08.010; Zirafi O, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009634	48	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14045	14055		10.1074/jbc.M116.718684	http://dx.doi.org/10.1074/jbc.M116.718684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226574	Green Published, hybrid			2022-12-26	WOS:000379975100013
J	Schutz, I; Lopez-Hernandez, T; Gao, Q; Puchkov, D; Jabs, S; Nordmeyer, D; Schmudde, M; Ruhl, E; Graf, CM; Haucke, V				Schuetz, Irene; Lopez-Hernandez, Tania; Gao, Qi; Puchkov, Dmytro; Jabs, Sabrina; Nordmeyer, Daniel; Schmudde, Madlen; Ruehl, Eckart; Graf, Christina M.; Haucke, Volker			Lysosomal Dysfunction Caused by Cellular Accumulation of Silica Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; caveolae; endocytosis; endosome; lysosome; silica nanoparticles	SURFACE FUNCTIONALIZATION; MEMBRANE; INTERNALIZATION; MECHANISMS; AUTOPHAGY; DELIVERY; CELLS; SIZE	Nanoparticles (NPs) are widely used as components of drugs or cosmetics and hold great promise for biomedicine, yet their effects on cell physiology remain poorly understood. Here we demonstrate that clathrin-independent dynamin 2-mediated caveolar uptake of surface-functionalized silica nanoparticles (SiNPs) impairs cell viability due to lysosomal dysfunction. We show that internalized SiNPs accumulate in lysosomes resulting in inhibition of autophagy-mediated protein turnover and impaired degradation of internalized epidermal growth factor, whereas endosomal recycling proceeds unperturbed. This phenotype is caused by perturbed delivery of cargo via autophagosomes and late endosomes to SiNP-filled cathepsin B/L-containing lysosomes rather than elevated lysosomal pH or altered mTOR activity. Given the importance of autophagy and lysosomal protein degradation for cellular proteostasis and clearance of aggregated proteins, these results raise the question of beneficial use of NPs in biomedicine and beyond.	[Schuetz, Irene; Lopez-Hernandez, Tania; Puchkov, Dmytro; Jabs, Sabrina; Haucke, Volker] Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany; [Gao, Qi; Nordmeyer, Daniel; Schmudde, Madlen; Ruehl, Eckart; Graf, Christina M.; Haucke, Volker] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Jabs, Sabrina] Max Delbruck Ctr Mol Med MDC, Robert Rossle Str 10, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Haucke, V (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany.	haucke@fmp-berlin.de	Hernandez, Tania Lopez/AAH-8754-2019; Jabs, Sabrina/F-9026-2019	Jabs, Sabrina/0000-0001-8065-8002; Puchkov, Dmytro/0000-0001-8341-4847; Lopez-Hernandez, Tania/0000-0002-0814-2850	Deutsche Forschungsgemeinschaft (DFG) [SFB 765/TP B04, C04, SPP1313/NANO-SELECT]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB 765/TP B04, C05, SPP1313/NANO-SELECT). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Rawi M, 2011, ARCH TOXICOL, V85, P813, DOI 10.1007/s00204-010-0642-5; Arriagada FJ, 1999, J COLLOID INTERF SCI, V211, P210, DOI 10.1006/jcis.1998.5985; Chaudhary N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001832; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Cleal K, 2013, CURR PHARM DESIGN, V19, P2878; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fisichella M, 2010, J NANOSCI NANOTECHNO, V10, P2314, DOI 10.1166/jnn.2010.1917; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Graf C, 2012, LANGMUIR, V28, P7598, DOI 10.1021/la204913t; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Kenzaoui BH, 2012, BIOCHEM J, V441, P813, DOI 10.1042/BJ20111252; Liang H, 2014, J APPL TOXICOL, V34, P367, DOI 10.1002/jat.2953; Luzio JP, 2010, BIOCHEM SOC T, V38, P1413, DOI 10.1042/BST0381413; Ma NN, 2013, J NANOSCI NANOTECHNO, V13, P6485, DOI 10.1166/jnn.2013.7525; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moreau K, 2013, TRENDS BIOCHEM SCI, V38, P57, DOI 10.1016/j.tibs.2012.11.004; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sandhoff K, 2013, J NEUROSCI, V33, P10195, DOI 10.1523/JNEUROSCI.0822-13.2013; Santra S, 2001, ANAL CHEM, V73, P4988, DOI 10.1021/ac010406+; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Treuel L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0939; von Kleist L, 2012, TRAFFIC, V13, P495, DOI 10.1111/j.1600-0854.2011.01292.x; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Zhang FF, 2004, ANAL BIOANAL CHEM, V380, P637, DOI 10.1007/s00216-004-2804-x	35	67	68	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14170	14184		10.1074/jbc.M115.710947	http://dx.doi.org/10.1074/jbc.M115.710947			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226546	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000379975100024
J	Nedelkovska, H; Rosenberg, AF; Hilchey, SP; Hyrien, O; Burack, WR; Quataert, SA; Baker, CM; Azadniv, M; Welle, SL; Ansell, SM; Kim, M; Bernstein, SH				Nedelkovska, Hristina; Rosenberg, Alexander F.; Hilchey, Shannon P.; Hyrien, Ollivier; Burack, W. Richard; Quataert, Sally A.; Baker, Christina M.; Azadniv, Mitra; Welle, Stephen L.; Ansell, Stephen M.; Kim, Minsoo; Bernstein, Steven H.			Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR MICROENVIRONMENT; HIGH NUMBERS; MEDIATED SUPPRESSION; HODGKINS-LYMPHOMA; MESSENGER-RNA; IMMUNE CELLS; ANTIGEN 4	We have previously shown that regulatory T cells (Tregs) infiltrating follicular lymphoma lymph nodes are quantitatively and qualitatively different than those infiltrating normal and reactive nodes. To gain insight into how such Treg populations differ, we performed RNA sequence (RNAseq) analyses on flow sorted Tregs from all three sources. We identify several molecules that could contribute to the observed increased suppressive capacity of follicular lymphoma nodal tregs, including upregulation of CTLA-4, IL-10, and GITR, all confirmed by protein expression. In addition, we identify, and confirm functionally, a novel mechanism by which Tregs target to and accumulate within a human tumor microenvironment, through the down regulation of S1PR1, SELL (L-selectin) and CCR7, potentially resulting in greater lymph node retention. In addition we identify and confirm functionally the upregulation of the chemokine receptor CXCR5 as well as the secretion of the chemokines CXCL13 and IL-16 demonstrating the unique ability of the follicular derived Tregs to localize and accumulate within not only the malignant lymph node, but also localize and accumulate within the malignant B cell follicle itself. Such findings offer significant new insights into how follicular lymphoma nodal Tregs may contribute to the biology of follicular lymphoma and identify several novel therapeutic targets.	[Nedelkovska, Hristina; Hilchey, Shannon P.; Burack, W. Richard; Azadniv, Mitra; Bernstein, Steven H.] Univ Rochester, Med Ctr, Dept Med, James P Wilmot Canc Ctr,Lymphoma Biol Program, Rochester, NY 14642 USA; [Rosenberg, Alexander F.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Hyrien, Ollivier] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Quataert, Sally A.; Baker, Christina M.; Kim, Minsoo] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol,Aab Inst, Rochester, NY 14642 USA; [Welle, Stephen L.] Univ Rochester, Med Ctr, Genom Res Ctr, Rochester, NY 14642 USA; [Ansell, Stephen M.] Mayo Clin, Div Hematol, Rochester, MN USA; [Nedelkovska, Hristina] SUNY Coll Geneseo, Dept Biol, Geneseo, NY 14454 USA; [Bernstein, Steven H.] Bristol Myers Squibb Co, Immunooncol Translat Res & Dev, Princeton, NJ USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Mayo Clinic; State University of New York (SUNY) System; SUNY Geneseo; Bristol-Myers Squibb	Bernstein, SH (corresponding author), Univ Rochester, Med Ctr, Dept Med, James P Wilmot Canc Ctr,Lymphoma Biol Program, Rochester, NY 14642 USA.; Bernstein, SH (corresponding author), Bristol Myers Squibb Co, Immunooncol Translat Res & Dev, Princeton, NJ USA.	steven.bernstein@bms.com			National Institute for Allergy and Infectious Disease [5-29712, R24 AI054953]; Leukemia and Lymphoma Society Translational Grant [6344-11]; U.S. Public Health Service Grant [R01-CA122645]; U.S. Public Health Service Specialized Programs of Research Excellence (SPORE) [P50-CA130805]; National Institutes for Health [T32 CA09363]; NATIONAL CANCER INSTITUTE [R01CA122645, P50CA130805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI054953] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Leukemia and Lymphoma Society Translational Grant; U.S. Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); U.S. Public Health Service Specialized Programs of Research Excellence (SPORE); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Internal Pilot Project Grant 5-29712 from National Institute for Allergy and Infectious Disease R24 AI054953 awarded to SHB and SPH. Leukemia and Lymphoma Society Translational Grant 6344-11 awarded to SHB. U.S. Public Health Service Grant R01-CA122645 awarded to SHB. U.S. Public Health Service Specialized Programs of Research Excellence (SPORE) P50-CA130805 awarded to SHB. HN was supported by National Institutes for Health Grant T32 CA09363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2006, J CLIN ONCOL, V24, P5350, DOI 10.1200/JCO.2006.06.4766; Ame-Thomas P, 2012, LEUKEMIA, V26, P1053, DOI 10.1038/leu.2011.301; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Brady MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097597; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Carreras J, 2009, J CLIN ONCOL, V27, P1470, DOI 10.1200/JCO.2008.18.0513; Cha ZS, 2013, TUMOR BIOL, V34, P3579, DOI 10.1007/s13277-013-0937-2; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Farinha P, 2010, BLOOD, V115, P289, DOI 10.1182/blood-2009-07-235598; Friedberg JW, 2009, J CLIN ONCOL, V27, P1202, DOI 10.1200/JCO.2008.18.1495; Gribben JG, 2010, CURR OPIN ONCOL, V22, P424, DOI 10.1097/CCO.0b013e32833d5938; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hilchey Shannon P, 2007, Immunol Invest, V36, P629, DOI 10.1080/08820130701674463; Hilchey SP, 2007, J IMMUNOL, V178, P4051, DOI 10.4049/jimmunol.178.7.4051; Hilchey SP, 2011, BLOOD, V118, P3591, DOI 10.1182/blood-2011-03-340646; Hilchey SP, 2009, J IMMUNOL, V183, P6157, DOI 10.4049/jimmunol.0900475; Jia YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117458; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; McFadden C, 2007, J IMMUNOL, V179, P6439, DOI 10.4049/jimmunol.179.10.6439; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Priceman SJ, 2014, CELL REP, V6, P992, DOI 10.1016/j.celrep.2014.02.016; Rawal S, 2013, J IMMUNOL, V190, P6681, DOI 10.4049/jimmunol.1201363; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sarro SM, 2010, LEUKEMIA RES, V34, P1670, DOI 10.1016/j.leukres.2010.06.031; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Shi WW, 2014, DNA CELL BIOL, V33, P355, DOI 10.1089/dna.2013.2332; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Sun L, 2010, IMMUNOL CELL BIOL, V88, P477, DOI 10.1038/icb.2009.117; Sweetenham JW, 2010, ANN ONCOL, V21, P1196, DOI 10.1093/annonc/mdp460; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Taquet N, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/285812; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Wahlin BE, 2010, CLIN CANCER RES, V16, P637, DOI 10.1158/1078-0432.CCR-09-2487; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144; Zhang YJ, 2001, J BIOL CHEM, V276, P1299, DOI 10.1074/jbc.M008513200	51	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155347	10.1371/journal.pone.0155347	http://dx.doi.org/10.1371/journal.pone.0155347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228053	Green Submitted, gold, Green Published			2022-12-26	WOS:000376882500016
J	Van der Straeten, C; Byttebier, P; Eeckhoudt, A; Victor, J				Van der Straeten, Catherine; Byttebier, Paul; Eeckhoudt, Annelies; Victor, Jan			Meniscal Allograft Transplantation Does Not Prevent or Delay Progression of Knee Osteoarthritis	PLOS ONE			English	Article							FOLLOW-UP; DEGENERATIVE TEARS; MENISCECTOMY; JOINT; SURGERY; ARTHROPLASTY; ARTHROSCOPY; OUTCOMES; PATIENT	Background Meniscal tears are common knee injuries. Meniscal allograft transplantation (MAT) has been advocated to alleviate symptoms and delay osteoarthritis (OA) after meniscectomy. We investigated (1) the long-term outcome of MAT as a treatment of symptomatic meniscectomy, (2) most important factors affecting survivorship and (3) OA progression. Methods From 1989 till 2013, 329 MAT were performed in 313 patients. Clinical and radiographic results and MAT survival were evaluated retrospectively. Failure was defined as conversion to knee arthroplasty (KA) or total removal of the MAT. Results Mean age at surgery was 33 years (15-57); 60% were males. No-to-mild cartilage damage was found in 156 cases, moderate-to-severe damage in 130. Simultaneous procedures in 118 patients included cartilage procedures, osteotomy or ACL-reconstruction. At a mean follow-up of 6.8 years (0.2-24.3 years), 5 patients were deceased and 48 lost (14.6%), 186 MAT were in situ (56.5%) whilst 90 (27.4%) had been removed, including 63 converted to a KA (19.2%). Cumulative allograft survivorship was 15.1%(95% CI: 13.9-16.3) at 24.0 years. In patients <35 years at surgery, survival was significantly better (24.1%) compared to >= 35 years (8.0%) (p = 0.017). In knees with no-to-mild cartilage damage more allografts survived (43.0%) compared to moderate-to-severe damage (6.6%) (p = 0.003). Simultaneous osteotomy significantly deteriorated survival (0% at 24.0 years) (p = 0.010). 61% of patients underwent at least one additional surgery (1-11) for clinical symptoms after MAT. Consecutive radiographs showed significant OA progression at a mean of 3.8 years (p<0.0001). Incremental Kellgren-Lawrence grade was +1,1 grade per 1000 days (2,7yrs). Conclusions MAT did not delay or prevent tibiofemoral OA progression. 19.2% were converted to a knee prosthesis at a mean of 10.3 years. Patients younger than 35 with no-to-mild cartilage damage may benefit from MAT for relief of symptoms (survivorship 51.9% at 20.2 years), but patients and healthcare payers and providers should be aware of the high number of surgical re-interventions.	[Van der Straeten, Catherine] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Musculoskeletal Sci & Technol, London, England; [Byttebier, Paul; Eeckhoudt, Annelies; Victor, Jan] Ghent Univ Hosp, Dept Orthopaed & Traumatol, Ghent, Belgium	Imperial College London; Ghent University; Ghent University Hospital	Van der Straeten, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Musculoskeletal Sci & Technol, London, England.	c.van-der-straeten@imperial.ac.uk	Van Der Straeten, Catherine/E-2625-2016	Van Der Straeten, Catherine/0000-0001-5659-0853; Victor, Jan/0000-0003-3988-9014				BAKER BE, 1985, AM J SPORT MED, V13, P1, DOI 10.1177/036354658501300101; Bozic KJ, 2005, J ARTHROPLASTY, V20, P17, DOI 10.1016/j.arth.2005.04.021; Carr AJ, 2015, NAT REV RHEUMATOL, V11, P77, DOI 10.1038/nrrheum.2014.174; Cohen SB, 2012, PHYSICIAN SPORTSMED, V40, P66, DOI 10.3810/psm.2012.09.1983; Debeer P, 2000, ARTHROSCOPY, V16, P71, DOI 10.1016/S0749-8063(00)90131-2; Dye SF, 1996, CLIN ORTHOP RELAT R, P10; Edd SN, 2015, J BIOMECH, V48, P1420, DOI 10.1016/j.jbiomech.2015.02.035; ElAttar M, 2011, KNEE SURG SPORT TR A, V19, P147, DOI 10.1007/s00167-010-1351-6; Englund M, 2003, ARTHRITIS RHEUM-US, V48, P2178, DOI 10.1002/art.11088; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664, DOI 10.1302/0301-620X.30B4.664; FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887; Hall MJ, 2006, NATL HLTH STAT REPOR, V0; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Katz JN, 2014, OSTEOARTHR CARTILAGE, V22, P1749, DOI 10.1016/j.joca.2014.07.016; Katz JN, 2013, NEW ENGL J MED, V369, P677, DOI 10.1056/NEJMc1307177; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Khetia EA, 2007, SPORTS MED ARTHROSC, V15, P114, DOI 10.1097/JSA.0b013e3180dca217; Kim S, 2011, J BONE JOINT SURG AM, V93A, P994, DOI 10.2106/JBJS.I.01618; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Lyons MC, 2012, CLIN ORTHOP RELAT R, V470, P84, DOI 10.1007/s11999-011-2144-z; MacConaill MA, 1932, J ANAT, V66, P210; McNulty AL, 2007, ARTHRITIS RHEUM-US, V56, P3033, DOI 10.1002/art.22839; Messner K, 1998, J ANAT, V193, P161, DOI 10.1046/j.1469-7580.1998.19320161.x; Moens K, 2014, ACTA ORTHOP BELG, V80, P403; Monllau JC, 2014, J TRANSPLANT TECH RE, V4, P127, DOI DOI 10.4172/2161-0991.1000127; Pengas IP, 2012, J BONE JOINT SURG BR, V94B, P1649, DOI 10.1302/0301-620X.94B12.30562; Petty CA, 2011, ARTHROSCOPY, V27, P419, DOI 10.1016/j.arthro.2010.08.016; Poulsen MR, 2011, PHYSICIAN SPORTSMED, V39, P123, DOI 10.3810/psm.2011.02.1870; Rai MF, 2013, ARTHRITIS RHEUM, V65, P1; Rai MF, 2014, ARTHRITIS RHEUMATOL, V66, P2152, DOI 10.1002/art.38643; Rancel MMS, 2001, COMMUN STAT-THEOR M, V30, P799, DOI 10.1081/STA-100002258; Reed ME, 2013, ORTHOPEDICS, V36, pE1060, DOI 10.3928/01477447-20130724-24; Roemer FW, 2015, OSTEOARTHR CARTILAGE, V23, P2184, DOI 10.1016/j.joca.2015.07.002; Rosso F, 2015, AM J SPORT MED, V43, P998, DOI 10.1177/0363546514536021; Samitier G, 2015, KNEE SURG SPORT TR A, V23, P323, DOI 10.1007/s00167-014-3344-3; Seedholm B, 1971, ARCH ENG MED, V8, P220; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; SMILLIE I. S., 1967, CLIN ORTHOP RELATED RES, V51., P117; Smith NA, 2015, KNEE SURG SPORTS TRA; Stone AV, 2014, OSTEOARTHR CARTILAGE, V22, P264, DOI 10.1016/j.joca.2013.11.002; Verdonk R, 2002, Acta Orthop Belg, V68, P118; Vundelinckx B, 2014, AM J SPORT MED, V42, P1592, DOI 10.1177/0363546514530092; Warren R F, 1985, Arthroscopy, V1, P170, DOI 10.1016/S0749-8063(85)80005-0; Zaffagnini S, 2011, AM J SPORT MED, V39, P977, DOI 10.1177/0363546510391179	46	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156183	10.1371/journal.pone.0156183	http://dx.doi.org/10.1371/journal.pone.0156183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228174	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500078
J	Prabowo, WE; Darras, K; Clough, Y; Toledo-Hernandez, M; Arlettaz, R; Mulyani, YA; Tscharntke, T				Prabowo, Walesa Edho; Darras, Kevin; Clough, Yann; Toledo-Hernandez, Manuel; Arlettaz, Raphael; Mulyani, Yeni A.; Tscharntke, Teja			Bird Responses to Lowland Rainforest Conversion in Sumatran Smallholder Landscapes, Indonesia	PLOS ONE			English	Article							OIL PALM; RUBBER PLANTATIONS; ECOSYSTEM SERVICES; CONSERVATION; BIODIVERSITY; DIVERSITY; COMMUNITIES; AGROFORESTS; UNDERSTORY; SULAWESI	Rapid land-use change in the tropics causes dramatic losses in biodiversity and associated functions. In Sumatra, Indonesia, lowland rainforest has mainly been transformed by smallholders into oil palm (Elaeis guineensis) and rubber (Hevea brasiliensis) monocultures, interspersed with jungle rubber (rubber agroforests) and a few forest remnants. In two regions of the Jambi province, we conducted point counts in 32 plots of four different land-use types (lowland rainforest, jungle rubber, rubber plantation and oil palm plantation) as well as in 16 nearby homegardens, representing a small-scale, traditional agricultural system. We analysed total bird abundance and bird abundance in feeding guilds, as well as species richness per point count visit, per plot, and per land-use system, to unveil the conservation importance and functional responses of birds in the different land-use types. In total, we identified 71 species from 24 families. Across the different land-use types, abundance did not significantly differ, but both species richness per visit and per plot were reduced in plantations. Feeding guild abundances between land-use types were variable, but homegardens were dominated by omnivores and granivores, and frugivorous birds were absent from monoculture rubber and oil palm. Jungle rubber played an important role in harbouring forest bird species and frugivores. Homegardens turned out to be of minor importance for conserving birds due to their low sizes, although collectively, they are used by many bird species. Changes in functional composition with land-use conversion may affect important ecosystem functions such as biological pest control, pollination, and seed dispersal. In conclusion, maintaining forest cover, including degraded forest and jungle rubber, is of utmost importance to the conservation of functional and taxonomic bird diversity.	[Prabowo, Walesa Edho; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Darras, Kevin; Clough, Yann; Toledo-Hernandez, Manuel; Tscharntke, Teja] Univ Gottingen, Dept Crop Sci, Div Agroecol, D-37073 Gottingen, Germany; [Mulyani, Yeni A.] Bogor Agr Univ, Fac Forestry, Dept Forest Resources Conservat & Ecotourism, Bogor, Indonesia	University of Bern; University of Gottingen; Bogor Agricultural University	Darras, K (corresponding author), Univ Gottingen, Dept Crop Sci, Div Agroecol, D-37073 Gottingen, Germany.	kdarras@gwdg.de	Arlettaz, Raphaël/O-2182-2016; Tscharntke, Teja/N-5123-2014; Darras, Kevin Felix Arno/B-9672-2014	Arlettaz, Raphaël/0000-0001-6360-5339; Darras, Kevin Felix Arno/0000-0002-9013-3784	Deutsche Forschungsgemeinschaft (DFG) [CRC990 EFForTS]; Swiss Government; Swiss National Science Foundation [31003A_125398, 31003A_149656]; Georg-August University of Gottingen; German research foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Swiss Government; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Georg-August University of Gottingen; German research foundation(German Research Foundation (DFG))	This study was financed by the Deutsche Forschungsgemeinschaft (DFG) in the framework of the collaborative German-Indonesian research project CRC990 EFForTS. W. E. Prabowo was supported by a Swiss Government MSc scholarship. The authors are grateful to the Swiss National Science Foundation for its financial support (grant no. 31003A_125398 and 31003A_149656 to R. Arlettaz. The authors acknowledge support from the open access publication funds of the Georg-August University of Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the field team of B09 sub-group, B.P.H. Hamonangan and Patrick M. Diaz, for the kind field assistance. We thank the following persons and organizations for granting us access to and use of their properties: village leaders, local plot owners, PT Humusindo, PT REKI, PT Perkebunan Nusantara VI, Bukit Duabelas National Park. We are grateful to Louis-Felix Bersier, Pamela Lagrange, and an anonymous reviewer for stimulating us to improve our manuscript. We acknowledge support by the German research foundation and the open access publication funds of the Georg-August University of Gottingen.	Abrahamczyk S, 2008, BIRD CONSERV INT, V18, P349, DOI 10.1017/S0959270908007570; AMOAH FM, 1995, AGROFOREST SYST, V30, P289, DOI 10.1007/BF00705215; Anderson D, 2004, MODEL SELECTION MULT, V2nd; Aratrakorn S, 2006, BIRD CONSERV INT, V16, P71, DOI 10.1017/S0959270906000062; Azhar B, 2015, BIODIVERS CONSERV, V24, P3125, DOI 10.1007/s10531-015-1005-6; Azhar B, 2014, BASIC APPL ECOL, V15, P336, DOI 10.1016/j.baae.2014.06.001; Azhar B, 2013, IBIS, V155, P297, DOI 10.1111/ibi.12025; Azhar B, 2011, FOREST ECOL MANAG, V262, P2306, DOI 10.1016/j.foreco.2011.08.026; Bas Y, 2008, BIODIVERS CONSERV, V17, P3403, DOI 10.1007/s10531-008-9420-6; Beukema H, 2007, AGROFOREST SYST, V70, P217, DOI 10.1007/s10457-007-9037-x; BirdLife International, BIRDL DAT ZON; Cheke R, HDB BIRDS WORLD ALIV; Clough Y, NAT COMMUN IN PRESS; De Chenon R., 2006, J OIL PALM RES, P122; del Hoyo J., 2015, HDB BIRDS WORLD ALIV; Dinas Komunikasi dan Informatika Prov, 2013, DIN KOM INF PROV; Drescher J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0275; Feintrenie L., 2009, Small-scale Forestry, V8, P323, DOI 10.1007/s11842-009-9086-2; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; GIBBS JP, 1993, BIOTROPICA, V25, P236, DOI 10.2307/2389188; Goulart FF, 2011, AGROFOREST SYST, V82, P239, DOI 10.1007/s10457-011-9398-z; GOUYON A, 1993, AGROFOREST SYST, V22, P181, DOI 10.1007/BF00705233; Gouyon A, 2003, 20031 ICRAF; Harvey CA, 1998, AGROFOREST SYST, V44, P37, DOI 10.1023/A:1006122211692; Hothorn T, 2008, BIOMETRICAL J, V50, P346; Jambari A, 2012, J OIL PALM RES, V24, P1277; Kehlenbeck K, 2004, AGROFOREST SYST, V63, P53, DOI 10.1023/B:AGFO.0000049433.95038.25; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Koh LP, 2010, P NATL ACAD SCI USA, V107, P11140, DOI 10.1073/pnas.1000530107; Kopp T, 2015, MOVING RUBBER BETTER; Kumar B.M., 2006, TROPICAL HOMEGARDENS, V3; Kumar BM, 2004, AGROFOREST SYST, V61-2, P135, DOI 10.1023/B:AGFO.0000028995.13227.ca; LAMBERT FR, 1992, PHILOS T R SOC B, V335, P443, DOI 10.1098/rstb.1992.0036; Lee JSH, 2014, CONSERV LETT, V7, P25, DOI 10.1111/conl.12039; Leimona B, 2015, ECOSYST SERV, V12, P16, DOI 10.1016/j.ecoser.2014.12.012; Li SN, 2013, AGROFOREST SYST, V87, P1117, DOI 10.1007/s10457-013-9624-y; Maas B, 2016, BIOL REV, V91, P1081, DOI 10.1111/brv.12211; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; MACKINNON J., 1993, FIELD GUIDE BIRDS BO; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; Marsh R., 1998, Food, Nutrition and Agriculture, P4; Mohri H, 2013, ECOSYST SERV, V5, pE124, DOI 10.1016/j.ecoser.2013.07.006; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Powell LL, 2015, BIOL CONSERV, V188, P1, DOI 10.1016/j.biocon.2015.03.025; R Core Team, 2021, R LANGUAGE ENV STAT; RALPH CJ, 1995, MONITORING BIRD POPU, P161; Robbins CS, 1981, BIRD ACTIVITY LEVELS, P301; Schroth G., 2013, AGROFORESTRY BIODIVE; Sekercioglu CH, 2012, J ORNITHOL, V153, pS153, DOI 10.1007/s10336-012-0869-4; Snoeck D, 2013, IND CROP PROD, V43, P578, DOI 10.1016/j.indcrop.2012.07.053; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sutherland W. J., 2004, BIRD ECOLOGY CONSERV; Terborgh J., 1986, Tasks for Vegetation Science, V15, P371; The IUCN Species Survival Commission, 2004, IUCN RED LIST THREAT; THIOLLAY JM, 1995, CONSERV BIOL, V9, P335, DOI 10.1046/j.1523-1739.1995.9020335.x; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; USDA, 2007, IND PALM OIL PROD; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilman H, 2014, ECOLOGY, V95, P2027, DOI DOI 10.1890/13-1917.1; Yamamoto Y., 1991, Japanese Journal of Tropical Agriculture, V35, P104	64	26	26	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0154876	10.1371/journal.pone.0154876	http://dx.doi.org/10.1371/journal.pone.0154876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224063	Green Published, gold			2022-12-26	WOS:000376881700011
J	Auray, G; Lachance, C; Wang, YC; Gagnon, CA; Segura, M; Gottschalk, M				Auray, Gael; Lachance, Claude; Wang, Yingchao; Gagnon, Carl A.; Segura, Mariela; Gottschalk, Marcelo			Transcriptional Analysis of PRRSV-Infected Porcine Dendritic Cell Response to Streptococcus suis Infection Reveals Up-Regulation of Inflammatory-Related Genes Expression	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; ALVEOLAR MACROPHAGES; HAEMOPHILUS-PARASUIS; BACTERIAL-ENDOTOXIN; I INTERFERONS; SWINE; SEROTYPE-2; PATHOGEN; PIGS; SUSCEPTIBILITY	The porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most important swine pathogens and often serves as an entry door for other viral or bacterial pathogens, of which Streptococcus suis is one of the most common. Pre-infection with PRRSV leads to exacerbated disease caused by S. suis infection. Very few studies have assessed the immunological mechanisms underlying this higher susceptibility. Since antigen presenting cells play a major role in the initiation of the immune response, the in vitro transcriptional response of bone marrow-derived dendritic cells (BMDCs) and monocytes in the context of PRRSV and S. suis co-infection was investigated. BMDCs were found to be more permissive than monocytes to PRRSV infection; S. suis phagocytosis by PRRSV-infected BMDCs was found to be impaired, whereas no effect was found on bacterial intracellular survival. Transcription profile analysis, with a major focus on inflammatory genes, following S. suis infection, with and without pre-infection with PRRSV, was then performed. While PRRSV pre-infection had little effect on monocytes response to S. suis infection, a significant expression of several pro-inflammatory molecules was observed in BMDCs pre-infected with PRRSV after a subsequent infection with S. suis. While an additive effect could be observed for CCL4, CCL14, CCL20, and IL-15, a distinct synergistic up-regulatory effect was observed for IL-6, CCL5 and TNF-alpha after co-infection. This increased pro-inflammatory response by DCs could participate in the exacerbation of the disease observed during PRRSV and S. suis co-infection.	[Auray, Gael; Lachance, Claude; Wang, Yingchao; Gagnon, Carl A.; Segura, Mariela; Gottschalk, Marcelo] Univ Montreal, Fac Vet Med, Grp Rech Malad Infect Prod Anim GREMIP, 3200 Sicotte, St Hyacinthe, PQ J2S 2M2, Canada	Universite de Montreal	Gottschalk, M (corresponding author), Univ Montreal, Fac Vet Med, Grp Rech Malad Infect Prod Anim GREMIP, 3200 Sicotte, St Hyacinthe, PQ J2S 2M2, Canada.	marcelo.gottschalk@umontreal.ca	wang, yan/GSE-6489-2022; Segura, Mariela/AAG-5708-2020; wang, yingying/GRS-3058-2022; Gottschalk, Marcelo/I-8116-2012; Gagnon, Carl A/A-9239-2015	Gagnon, Carl A./0000-0003-4528-541X	Natural Science and Engineering Research Council of Canada [04435]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Science and Engineering Research Council of Canada grant number 04435 (http://www.nserc-crsng.gc.ca).	Auray G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059629; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bonifait L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-47; Brockmeier SL, 2000, AM J VET RES, V61, P892, DOI 10.2460/ajvr.2000.61.892; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Dang Y, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-86; De Baere MI, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-47; de Greeff A, 2010, VET MICROBIOL, V141, P59, DOI 10.1016/j.vetmic.2009.07.031; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dea S, 1996, J CLIN MICROBIOL, V34, P1488, DOI 10.1128/JCM.34.6.1488-1493.1996; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Feng WH, 2001, J VIROL, V75, P4889, DOI 10.1128/JVI.75.10.4889-4895.2001; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Gagnon CA, 2008, J VET DIAGN INVEST, V20, P545, DOI 10.1177/104063870802000503; GALINA L, 1994, VET REC, V134, P60, DOI 10.1136/vr.134.3.60; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gomez-Laguna J, 2013, VET J, V195, P148, DOI 10.1016/j.tvjl.2012.11.012; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Halbur P, 2000, J CLIN MICROBIOL, V38, P1156, DOI 10.1128/JCM.38.3.1156-1160.2000; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Jobin MC, 2006, MICROB PATHOGENESIS, V40, P29, DOI 10.1016/j.micpath.2005.10.003; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kearney SJ, 2013, J IMMUNOL, V191, P3384, DOI 10.4049/jimmunol.1203510; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Lachance C, 2013, INFECT IMMUN, V81, P1928, DOI 10.1128/IAI.01317-12; Lecours MP, 2012, MICROBES INFECT, V14, P941, DOI 10.1016/j.micinf.2012.03.008; Lecours MP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-72; Lee SM, 2004, VET IMMUNOL IMMUNOP, V102, P217, DOI 10.1016/j.vetimm.2004.09.009; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li B, 2015, VIRUS RES, V196, P60, DOI 10.1016/j.virusres.2014.11.006; Lin X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124086; Liu ML, 2011, VET MICROBIOL, V150, P126, DOI 10.1016/j.vetmic.2010.12.014; Lunney JK, 2010, VIRUS RES, V154, P1, DOI 10.1016/j.virusres.2010.10.009; MacInnes JI, 2008, CAN J VET RES, V72, P242; Madsen LW, 2002, J VET MED B, V49, P211, DOI 10.1046/j.1439-0450.2002.00491.x; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Segales J, 1998, J COMP PATHOL, V118, P231, DOI 10.1016/S0021-9975(05)80129-X; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Shi KC, 2010, VET MICROBIOL, V140, P155, DOI 10.1016/j.vetmic.2009.07.021; Smith HE, 1999, IDENTIFICATION CHARA; Solano GI, 1998, CAN J VET RES, V62, P251; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Thanawongnuwech R, 2000, VET PATHOL, V37, P143, DOI 10.1354/vp.37-2-143; Tohno M, 2008, MOL IMMUNOL, V45, P194, DOI 10.1016/j.molimm.2007.04.019; Tsai YC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-174; Van Gucht S, 2004, VET IMMUNOL IMMUNOP, V102, P165, DOI 10.1016/j.vetimm.2004.09.006; Van Gucht S, 2003, J CLIN MICROBIOL, V41, P960, DOI 10.1128/JCM.41.3.960-966.2003; VanReeth K, 1996, VET MICROBIOL, V48, P325, DOI 10.1016/0378-1135(95)00145-X; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; WILLIAMS AE, 1990, MICROB PATHOGENESIS, V8, P189, DOI 10.1016/0882-4010(90)90046-S; Xu M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-184; Yu J, 2012, VET MICROBIOL, V158, P316, DOI 10.1016/j.vetmic.2012.03.001; Zhang HM, 2012, VET MICROBIOL, V159, P494, DOI 10.1016/j.vetmic.2012.04.025; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947	68	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156019	10.1371/journal.pone.0156019	http://dx.doi.org/10.1371/journal.pone.0156019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213692	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200048
J	Sharma, S; van Teijlingen, E; Belizan, JM; Hundley, V; Simkhada, P; Sicuri, E				Sharma, Sheetal; van Teijlingen, Edwin; Belizan, Jose M.; Hundley, Vanora; Simkhada, Padam; Sicuri, Elisa			Measuring What Works: An Impact Evaluation of Women's Groups on Maternal Health Uptake in Rural Nepal	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; INSTITUTIONAL DELIVERY; ANTENATAL CARE; INTERVENTIONS; MORTALITY; SERVICES; CHILD; DETERMINANTS; DIFFERENCE	Background There is a need for studies evaluating maternal health interventions in low-income countries. This paper evaluates one such intervention designed to promote maternal health among rural women in Nepal. Methods and Results This was a five-year controlled, non-randomised, repeated cross-sectional study (2007, 2010, 2012) of a participatory community-based maternal health promotion intervention focusing on women's groups to improve maternal health services uptake. In total 1,236 women of childbearing age, who had their last child <= two years ago, were interviewed. Difference-in-Difference estimation assessed the effects of the intervention on selected outcome variables while controlling for a constructed wealth index and women's characteristics. In the first three years (from 2007 to the 2010), the intervention increased women's likelihood of attending for antenatal care at least once during pregnancy by seven times [OR = 7.0, 95% CI (2.3; 21.4)], of taking iron and folic acid by three times [OR = 3.0, 95% CI (1.2; 7.8)], and of seeking four or more antenatal care visits of two times, although not significantly [OR = 2.2, 95% CI (1.0; 4.7)]. Over five years, women were more likely to seek antenatal care at least once [OR = 3.0, 95% CI (1.5; 5.2)], to take iron/ folic acid [OR = 1.9, [95% CI (1.1; 3.2)], and to attend postnatal care [OR = 1.5, [95% CI (1.1; 2.2)]. No improvement was found on attending antenatal care in the first trimester, birthing at an institution or with a skilled birth attendant. Conclusion Community-based health promotion has a much stronger effect on the uptake of antenatal care and less on delivery care. Other factors not easily resolved through health promotion interventions may influence these outcomes, such as costs or geographical constraints. The evaluation has implications for policy and practice in public health, especially maternal health promotion.	[Sharma, Sheetal; van Teijlingen, Edwin; Hundley, Vanora] Bournemouth Univ, Fac Hlth & Social Sci, Poole BH12 5BB, Dorset, England; [Belizan, Jose M.] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Simkhada, Padam] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Sicuri, Elisa] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Sicuri, Elisa] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, Hlth Econ Grp, London, England	Bournemouth University; Liverpool John Moores University; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Imperial College London	Sharma, S (corresponding author), Bournemouth Univ, Fac Hlth & Social Sci, Poole BH12 5BB, Dorset, England.	ssharma@bournemouth.ac.uk	van Teijlingen, Edwin R/A-3727-2010; Sicuri, Elisa/L-8012-2014	van Teijlingen, Edwin R/0000-0001-5523-8583; Sicuri, Elisa/0000-0002-2499-2732; Belizan, Jose/0000-0002-8412-3010; Simkhada, Padam/0000-0002-5706-6479; Sharma, Sheetal/0000-0003-2149-0806	Green Tara Trust (UK); Bournemouth University (UK)	Green Tara Trust (UK); Bournemouth University (UK)	This work was supported by Green Tara Trust (UK) and Bournemouth University (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2012, HEALTH POLICY PLANN, V27, P9, DOI 10.1093/heapol/czs086; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Alderman H, 2009, PUBLIC HEALTH NUTR, V12, P667, DOI 10.1017/S1368980008002619; Asefa A, 2013, LANCET, V382, P9; Bennett L.., 2008, CASTE ETHNIC REGIONA; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bonell CP, 2011, J EPIDEMIOL COMMUN H, V65, P582, DOI 10.1136/jech.2008.082602; Borghi J, 2006, TROP MED INT HEALTH, V11, P228, DOI 10.1111/j.1365-3156.2005.01546.x; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Central Bureau of Statistics, 2001, STAT YB NEP; Choulagai B, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-49; Christiansen G., 1999, EVALUATION QUALITY A; Coast E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108130; Datta J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-568; Davies M, 2005, HLTH PROMOTION THEOR; de Heer HD, 2011, AM J PUBLIC HEALTH, V101, P1907, DOI 10.2105/AJPH.2011.300177; Donnay F, 2000, INT J GYNECOL OBSTET, V70, P89, DOI 10.1016/S0020-7292(00)00236-8; Duflo Esther, 2012, Science, V336, P1398, DOI 10.1126/science.1224965; Ensor T, 2014, HLTH POL, V90, P247; Ensor T, 2014, B WORLD HEALTH ORGAN, V92, P51, DOI 10.2471/BLT.13.122721; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Gibbon D, CLASS NOTES; Godin Gaston, 2007, Promot Educ, V14, P138; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Irwin A, 2006, PLOS MED, V3, P749, DOI 10.1371/journal.pmed.0030106; J-PAL, 2015, IMP EV; Judd J, 2001, HEALTH PROMOT INT, V16, P367, DOI 10.1093/heapro/16.4.367; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Kestler E, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-73; Khanal V, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-4; Khanal V, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-19; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Lee RB, 2012, ASIA PACIFIC E J HLT, V1; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Liu XN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-566; Malenga G, 2012, LANCET, V379, P2131, DOI 10.1016/S0140-6736(12)60369-9; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Middleberg MI, 2003, PROMOTING REPRODUCTI; Milne L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0564-6; Ministry of Health and Population, 2012, NEP ANN REP 2009 201; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; NICE, 2007, BEH CHANG PRINC EFF; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Osrin D, 2009, B WORLD HEALTH ORGAN, V87, P772, DOI 10.2471/BLT.08.051060; Oxford Poverty and Human Development Initiative, 2013, NEP COUNTR BRIEF; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Puri M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-29; Rauniar G P, 2012, Kathmandu Univ Med J (KUMJ), V10, P30; Reynolds HW, 2006, INT FAM PLAN PERSPEC, V32, P6, DOI 10.1363/3200606; Rosato M, 2012, INT HEALTH, V4, P176, DOI 10.1016/j.inhe.2012.03.007; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Schlotter M, 2010, 4725 U MUN IZA IF I; Shrestha BP, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-136; Simkhada B, 2006, Kathmandu Univ Med J (KUMJ), V4, P258; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Simkhada B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-34; Simkhada P., 2009, Asian Journal of Epidemiology, V2, P44, DOI 10.3923/aje.2009.44.48; Subba N, 2014, J NOBEL MED COLL, V3, P10, DOI DOI 10.3126/jonmc.v3i1.10047; Teijlingen E. van, 2012, Health Renaissance, V10, P229; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The World Bank, 2006, EXP IND EV GROUP WOR; Transparency International, 2014, 2014 ANTIC PUBL PROC; Tuntiseranee P, 1999, J EPIDEMIOL COMMUN H, V53, P624, DOI 10.1136/jech.53.10.624; United Nations Population Fund (UNFPA), 1995, INT C POP DEV GEND E; Vanderweele TJ, 2013, J AM STAT ASSOC, V108, P469, DOI 10.1080/01621459.2013.779832; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Waldinger F., 2010, DIFFERENCE IN DIFFER, V3; Warren C, 2006, OPPORTUNITIES FOR AF; Witter S, 2011, HLTH POLICY PLAN S2, V26, pii84; World Health Organization, 2012, DAIL IR FOL AC SUPPL; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; World Health Organization UNICEF, 2003, ANT CAR DEV COUNTR P; World Health Organization (WHO), 2001, WHO EUR SER; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	80	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155144	10.1371/journal.pone.0155144	http://dx.doi.org/10.1371/journal.pone.0155144			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2FT	27214032	Green Published, Green Accepted, gold			2022-12-26	WOS:000376880200007
J	Chen, CC; Dienhart, JA; Bolton, EC				Chen, Congcong; Dienhart, Jason A.; Bolton, Eric C.			Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells	PLOS ONE			English	Article							CANCER CELLS; HYDROGEN-PEROXIDE; RECEPTOR ACTIVATION; SIGNALING PATHWAYS; DOWN-REGULATION; PROTEIN-KINASE; DEATH PATHWAY; BASAL-CELLS; STEM-CELLS; GENE	Androgen receptor (AR) signaling is crucial to the development and homeostasis of the prostate gland, and its dysregulation mediates common prostate pathologies. The mechanisms whereby AR regulates growth suppression and differentiation of luminal epithelial cells in the prostate gland and proliferation of malignant versions of these cells have been investigated in human and rodent adult prostate. However, the cellular stress response of human prostate epithelial cells is not well understood, though it is central to prostate health and pathology. Here, we report that androgen sensitizes HPr-1AR and RWPE-AR human prostate epithelial cells to cell stress agents and apoptotic cell death. Although 5 alpha-dihydrotestosterone (DHT) treatment alone did not induce cell death, co-treatment of HPr-1AR cells with DHT and an apoptosis inducer, such as staurosporine (STS), TNFt, or hydrogen peroxide, synergistically increased cell death in comparison to treatment with each apoptosis inducer by itself. We found that the synergy between DHT and apoptosis inducer led to activation of the intrinsic/mitochondrial apoptotic pathway, which is supported by robust cleavage activation of caspase-9 and caspase-3. Further, the dramatic depolarization of the mitochondrial membrane potential that we observed upon co-treatment with DHT and STS is consistent with increased mitochondrial outer membrane permeabilization (MOMP) in the pro-apoptotic mechanism. Interestingly, the synergy between DHT and apoptosis inducer was abolished by AR antagonists and inhibitors of transcription and protein synthesis, suggesting that AR mediates pro-apoptotic synergy through transcriptional regulation of MOMP genes. Expression analysis revealed that pro-apoptotic genes (BCL2L11/BIM and AIFM2) were DHT-induced, whereas pro-survival genes (BCL2L1/BCL-XL and MCL1) were DHT-repressed. Hence, we propose that the net effect of these AR-mediated expression changes shifts the balance of BCL2-family proteins, such that androgen signaling sensitizes mitochondria to apoptotic signaling, thus rendering HPr-1AR more vulnerable to cell death signals. Our study offers insight into AR-mediated regulation of prostate epithelial cell death signaling.	[Chen, Congcong; Dienhart, Jason A.; Bolton, Eric C.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Bolton, EC (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.	boltonec@life.illinois.edu			University of Illinois at Urbana-Champaign	University of Illinois at Urbana-Champaign	This work was supported by University of Illinois at Urbana-Champaign startup funds to ECB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; BONKHOFF H, 1993, VIRCHOWS ARCH A, V422, P35, DOI 10.1007/BF01605130; Bonkhoff H, 1998, PROSTATE, V34, P251, DOI 10.1002/(SICI)1097-0045(19980301)34:4<251::AID-PROS2>3.0.CO;2-K; Borgne Annie, 2003, Prog Cell Cycle Res, V5, P453; Boutros PC, 2015, NAT GENET, V47, P736, DOI 10.1038/ng.3315; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Chaigne-Delalande B, 2008, ARCH IMMUNOL THER EX, V56, P9, DOI 10.1007/s00005-008-0002-9; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Claessens F, 2001, J STEROID BIOCHEM, V76, P23, DOI 10.1016/S0960-0760(00)00154-0; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COMPERE SJ, 1981, J BIOL CHEM, V256, P6341; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dobashi Y, 2004, INT J CANCER, V110, P532, DOI 10.1002/ijc.20167; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Friedlander TW, 2012, UROL CLIN N AM, V39, P453, DOI 10.1016/j.ucl.2012.07.003; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; Giansanti V, 2011, APOPTOSIS, V16, P321, DOI 10.1007/s10495-011-0589-x; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Godfrey B, 2010, CELL RES, V20, P1138, DOI 10.1038/cr.2010.65; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Heisler LE, 1997, MOL CELL ENDOCRINOL, V126, P59, DOI 10.1016/S0303-7207(96)03970-6; HEYTLER PG, 1962, BIOCHEM BIOPH RES CO, V7, P272, DOI 10.1016/0006-291X(62)90189-4; Higgins J, 2015, HORM CANCER-US, V6, P67, DOI 10.1007/s12672-014-0215-9; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; ISAACS JT, 1994, SEMIN CANCER BIOL, V5, P391; Kennedy BA, 2010, NUCLEIC ACIDS RES, V38, pD676, DOI 10.1093/nar/gkp734; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138286; Kurita T, 2001, CELL DEATH DIFFER, V8, P192, DOI 10.1038/sj.cdd.4400797; Lafevre-Bernt MA, 2003, J BIOL CHEM, V278, P34918, DOI 10.1074/jbc.M302841200; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lee SO, 2012, J ENDOCRINOL, V213, P173, DOI 10.1530/JOE-11-0474; Li PF, 1997, CIRCULATION, V96, P3602; Lin YT, 2006, MOL CELL BIOL, V26, P1908, DOI 10.1128/MCB.26.5.1908-1916.2006; Lin YT, 2013, BIOCHEM BIOPH RES CO, V430, P289, DOI 10.1016/j.bbrc.2012.10.135; Ling MT, 2001, J ENDOCRINOL, V170, P287, DOI 10.1677/joe.0.1700287; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Liu AY, 2004, AM J PATHOL, V165, P1543, DOI 10.1016/S0002-9440(10)63412-8; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Lu S, 1997, CANCER RES, V57, P4511; Ma ZF, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0042-9; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Michalides R, 2002, BREAST CANCER RES TR, V74, P55, DOI 10.1023/A:1016074309582; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Nguyen TVV, 2005, J NEUROCHEM, V94, P1639, DOI 10.1111/j.1471-4159.2005.03318.x; Papadopoulou N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-88; Perlmutter Mark A, 2007, Rev Urol, V9 Suppl 1, pS3; Rokhlin OW, 2005, ONCOGENE, V24, P6773, DOI 10.1038/sj.onc.1208833; Ruan S, 1998, CANCER RES, V58, P1538; RUSHMERE NK, 1987, MOL CELL ENDOCRINOL, V51, P259, DOI 10.1016/0303-7207(87)90036-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Simoes VL, 2013, J STEROID BIOCHEM, V135, P15, DOI 10.1016/j.jsbmb.2012.11.019; SOEFFING WJ, 1995, J ANDROL, V16, P197; Stoyanova T, 2013, P NATL ACAD SCI USA, V110, P20111, DOI 10.1073/pnas.1320565110; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TERADA H, 1981, BIOCHIM BIOPHYS ACTA, V639, P225, DOI 10.1016/0304-4173(81)90011-2; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang XT, 2004, CANCER RES, V64, P1377, DOI 10.1158/0008-5472.CAN-03-2428; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Wei H, 2010, J CELL BIOCHEM, V111, P967, DOI 10.1002/jcb.22785; Wen SM, 2014, CANCER TREAT REV, V40, P31, DOI 10.1016/j.ctrv.2013.07.008; Whitacre DC, 2002, CELL GROWTH DIFFER, V13, P1; Wong WWL, 2008, IUBMB LIFE, V60, P390, DOI 10.1002/iub.51; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203	94	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0156145	10.1371/journal.pone.0156145	http://dx.doi.org/10.1371/journal.pone.0156145			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203692	Green Submitted, Green Published, gold			2022-12-26	WOS:000376291500045
J	Iltzsche, F; Simon, K; Stopp, S; Pattschull, G; Francke, S; Wolter, P; Hauser, S; Murphy, DJ; Garcia, P; Rosenwald, A; Gaubatz, S				Iltzsche, F.; Simon, K.; Stopp, S.; Pattschull, G.; Francke, S.; Wolter, P.; Hauser, S.; Murphy, D. J.; Garcia, P.; Rosenwald, A.; Gaubatz, S.			An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma	ONCOGENE			English	Article							B-MYB; IN-VIVO; K-RAS; CHROMOSOMAL INSTABILITY; EXPRESSION PROFILES; MOTOR PROTEINS; G(2)/M GENES; CANCER; COMPLEX; TRANSCRIPTION	The conserved Myb-MuvB (MMB) multiprotein complex has an important role in transcriptional activation of mitotic genes. MMB target genes are overexpressed in several different cancer types and their elevated expression is associated with an advanced tumor state and a poor prognosis. This suggests that MMB could contribute to tumorigenesis by mediating overexpression of mitotic genes. However, although MMB has been extensively characterized biochemically, the requirement for MMB in tumorigenesis in vivo has not been investigated. Here we demonstrate.that MMB is required for tumor formation in a mouse model of lung cancer driven by oncogenic K-RAS. We also identify a requirement for the mitotic kinesin KIF23, a key target gene of MMB, in tumorigenesis. RNA interference-mediated depletion of KIF23 inhibited lung tumor formation in vivo and induced apoptosis in lung cancer cell lines. Our results suggest that inhibition of KIF23 could be a strategy for treatment of lung cancer.	[Iltzsche, F.; Simon, K.; Stopp, S.; Pattschull, G.; Francke, S.; Wolter, P.; Hauser, S.; Gaubatz, S.] Univ Wurzburg, Theodor Boveri Inst, Dept Physiol Chem, Bioctr, Wurzburg, Germany; [Murphy, D. J.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Murphy, D. J.] CRUK Beatson Inst, Glasgow, Lanark, Scotland; [Garcia, P.] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Rosenwald, A.; Gaubatz, S.] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Rosenwald, A.] Univ Wurzburg, Inst Pathol, Wurzburg, Germany	University of Wurzburg; University of Glasgow; Beatson Institute; University of Birmingham; University of Wurzburg; University of Wurzburg	Gaubatz, S (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Bioctr, Hubland, D-97074 Wurzburg, Bavaria, Germany.	stefan.gaubatz@biozentrum.uni-wuerzburg.de	Garcia, Paloma/AFO-2595-2022; Murphy, Daniel/V-1079-2019	Murphy, Daniel/0000-0002-5538-5468; Gaubatz, Stefan/0000-0001-8751-4191; Garcia, Paloma/0000-0001-5582-8575	Deutsche Krebshilfe [110928]; Sander Stiftung [2015.038.1]; DFG [GA 575/5-2]	Deutsche Krebshilfe(Deutsche Krebshilfe); Sander Stiftung; DFG(German Research Foundation (DFG))	We thank Tyler Jacks, Anton Berns, Roger Watson, Geert Carmeliet, Thorsten Stiewe and Andras Nagy for reagents, and Sabine Roth and Susi Spahr for excellent technical help. We thank all members of the laboratory for their suggestions and critical reading of the manuscript. This work was supported by grants from the Deutsche Krebshilfe (110928), Sander Stiftung (2015.038.1) and DFG (GA 575/5-2) towards SG.	Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Bowman BM, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005607; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cellurale C, 2011, MOL CELL BIOL, V31, P1565, DOI 10.1128/MCB.01122-10; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Esterlechner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062882; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P164, DOI 10.1093/nar/gkv927; Fischer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063187; Garcia P, 2005, GENESIS, V43, P189, DOI 10.1002/gene.20170; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Marino S, 2000, GENE DEV, V14, P994; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Takahashi S, 2012, J NEURO-ONCOL, V106, P519, DOI 10.1007/s11060-011-0706-2; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tavner F, 2007, ONCOGENE, V26, P2727, DOI 10.1038/sj.onc.1210087; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433	48	31	33	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					110	121		10.1038/onc.2016.181	http://dx.doi.org/10.1038/onc.2016.181			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27212033	Green Published, Green Accepted			2022-12-26	WOS:000394069100010
J	Martinelli, GB; Olivari, D; Cecconi, ADR; Talamini, L; Ottoboni, L; Lecker, SH; Stretch, C; Baracos, VE; Bathe, OF; Resovi, A; Giavazzi, R; Cervo, L; Piccirillo, R				Martinelli, G. B.; Olivari, D.; Cecconi, A. D. Re; Talamini, L.; Ottoboni, L.; Lecker, S. H.; Stretch, C.; Baracos, V. E.; Bathe, O. F.; Resovi, A.; Giavazzi, R.; Cervo, L.; Piccirillo, R.			Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia	ONCOGENE			English	Article							PROTEIN-COUPLED RECEPTOR; SKELETAL-MUSCLE; CHEMOKINE RECEPTOR; PROGENITOR CELLS; WEIGHT-LOSS; CXCR4; INTERLEUKIN-6; DEGRADATION; REGENERATION; EXPRESSION	Cancer cachexia is a life-threatening syndrome that affects most patients with advanced cancers and causes severe body weight loss, with rapid depletion of skeletal muscle. No treatment is available. We analyzed microarray data sets to identify a subset of genes whose expression is specifically altered in cachectic muscles of Yoshida hepatoma-bearing rodents but not in those with diabetes, disuse, uremia or fasting. Ingenuity Pathways Analysis indicated that three genes belonging to the C-X-C motif chemokine receptor 4 (CXCR4) pathway were downregulated only in muscles atrophying because of cancer: stromal cell-derived factor 1 (SDF1), adenylate cyclase 7 (ADCY7), and p21 protein-activated kinase 1 (PAK1). Notably, we found that, in the Rectus Abdominis muscle of cancer patients, the expression of SDF1 and CXCR4 was inversely correlated with that of two ubiquitin ligases induced in muscle wasting, atrogin-1 and MuRF1, suggesting a possible clinical relevance of this pathway. The expression of all main SDF1 isoforms (alpha, beta, gamma) also declined in Tibialis Anterior muscle from cachectic mice bearing murine colon adenocarcinoma or human renal cancer and drugs with anticachexia properties restored their expression. Overexpressing genes of this pathway (that is, SDF1 or CXCR4) in cachectic muscles increased the fiber area by 20%, protecting them from wasting. Similarly, atrophying myotubes treated with either SDF1 alpha or SDF1 beta had greater total protein content, resulting from reduced degradation of overall long-lived proteins. However, inhibiting CXCR4 signaling with the antagonist AMD3100 did not affect protein homeostasis in atrophying myotubes, whereas normal myotubes treated with AMD3100 showed time-and dose-dependent reductions in diameter, until a plateau, and lower total protein content. This further confirms the involvement of a saturable pathway (that is, CXCR4). Overall, these findings support the idea that activating the CXCR4 pathway in muscle suppresses the deleterious wasting associated with cancer.	[Martinelli, G. B.; Olivari, D.; Cecconi, A. D. Re; Talamini, L.; Giavazzi, R.; Piccirillo, R.] IRCCS Mario Negri Inst Pharmacol Res, Dept Oncol, Via G La Masa 19, I-20156 Milan, Italy; [Ottoboni, L.] INSpe, San Raffaele Sci Inst, Milan, Italy; [Lecker, S. H.] Beth Israel Deaconess Med Ctr, Boston, MA USA; [Stretch, C.; Baracos, V. E.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Bathe, O. F.] Univ Calgary, Dept Surg & Oncol, Calgary, AB, Canada; [Resovi, A.] IRCCS Mario Negri Inst Pharmacol Res, Tumor Angiogenesis Unit, Dept Oncol, Bergamo, Italy; [Cervo, L.] IRCCS Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Beth Israel Deaconess Medical Center; University of Alberta; University of Calgary; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Piccirillo, R (corresponding author), IRCCS Mario Negri Inst Pharmacol Res, Dept Oncol, Via G La Masa 19, I-20156 Milan, Italy.	rosanna.piccirillo@marionegri.it	RE CECCONI, ANDREA DAVID/AAG-4949-2021; Giavazzi, Raffaella/ABB-9768-2020; Cervo, Luigi/AAA-8081-2020; Resovi, Andrea/ABG-7483-2021; Piccirillo, Rosanna/K-6619-2016; Piccirillo, Rosanna/AAQ-3653-2020; Giavazzi, Raffaella/J-7424-2018; Olivari, Davide/AAC-4733-2022	RE CECCONI, ANDREA DAVID/0000-0003-1502-9108; Giavazzi, Raffaella/0000-0001-5249-8208; Cervo, Luigi/0000-0003-1314-1876; Resovi, Andrea/0000-0001-9560-0815; Piccirillo, Rosanna/0000-0002-1613-9352; Piccirillo, Rosanna/0000-0002-1613-9352; Olivari, Davide/0000-0003-0802-6603; Talamini, Laura/0000-0001-6010-2947; Stretch, Cynthia/0000-0002-5152-2728	Italian Association for Cancer Research [AIRC Start-UP 11423, AIRC-IG 14532, AIRC 12182]; Union under the Marie Curie International Reintegration Grant [PIRG08-GA-2010-277008]; Fondazione Veronesi; FISM [2012/B/10]; Fondazione Eugenio Morandi	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Union under the Marie Curie International Reintegration Grant; Fondazione Veronesi(Fondazione Umberto Veronesi); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Fondazione Eugenio Morandi	We are grateful to the Italian Association for Cancer Research (AIRC Start-UP 11423 to RP and AIRC-IG 14532 and AIRC 12182 to RG) and the Union under the Marie Curie International Reintegration Grant (PIRG08-GA-2010-277008 to RP). LO is the recipient of a training research fellowship from 'Fondazione Veronesi' and of a grant from FISM (2012/B/10). AR is the recipient of a fellowship from 'Fondazione Eugenio Morandi'. We thank JD Baggott for help with the editing.	Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Bedard N, 2015, FASEB J, V29, P3889, DOI 10.1096/fj.15-270579; Bennani-Baiti N, 2011, SUPPORT CARE CANCER, V19, P1451, DOI 10.1007/s00520-010-0972-0; Bobadilla M, 2014, STEM CELLS DEV, V23, P1417, DOI 10.1089/scd.2013.0491; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chong SW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-54; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; FEARON KCH, 1991, ANN SURG, V213, P26, DOI 10.1097/00000658-199101000-00005; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Jatoi A, 2007, CANCER, V110, P1396, DOI 10.1002/cncr.22944; Kuroda K, 2007, UROLOGY, V69, P113, DOI 10.1016/j.urology.2006.09.039; Leal MA, 2014, DEV DYNAM, V243, P509, DOI 10.1002/dvdy.24092; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Melchonna R, 2010, MUSCLE NERVE, V41, P828, DOI 10.1002/mus.21611; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Navegantes LCC, 2002, CURR OPIN CLIN NUTR, V5, P281, DOI 10.1097/00075197-200205000-00007; Oka M, 1996, CANCER RES, V56, P2776; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; OVESEN L, 1993, J CLIN ONCOL, V11, P2043, DOI 10.1200/JCO.1993.11.10.2043; Perez AL, 2009, MUSCLE NERVE, V40, P562, DOI 10.1002/mus.21317; Piccirillo R, 2012, EMBO J, V31, P3334, DOI 10.1038/emboj.2012.178; Pillarisetti K, 2001, INFLAMMATION, V25, P293, DOI 10.1023/A:1012808525370; Porporato PE, 2013, J CLIN INVEST, V123, P611, DOI 10.1172/JCI39920; Pretto F, 2015, ONCOTARGET, V6, P3043, DOI 10.18632/oncotarget.2812; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scott HR, 1996, BRIT J CANCER, V73, P1560, DOI 10.1038/bjc.1996.294; Steen A, 2009, MINI-REV MED CHEM, V9, P1605, DOI 10.2174/138955709791012265; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Toledo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113931; Toschi A, 2011, MOL ENDOCRINOL, V25, P1661, DOI 10.1210/me.2011-1049; Wang H, 2010, CELL SIGNAL, V22, P1022, DOI 10.1016/j.cellsig.2010.02.005; White JP, 2014, P NATL ACAD SCI USA, V111, P15756, DOI 10.1073/pnas.1417898111; WHITE ME, 1988, J ANIM SCI, V66, P34, DOI 10.2527/jas1988.66134x; Wiedenmann Bertram, 2008, J Support Oncol, V6, P18; Wiegant J, 2002, CANCER GENET CYTOGEN, V139, P126, DOI 10.1016/S0165-4608(02)00623-4; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f	50	24	25	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 1	2016	35	48					6212	6222		10.1038/onc.2016.153	http://dx.doi.org/10.1038/onc.2016.153			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED4YH	27212031				2022-12-26	WOS:000388857700006
J	Bhattacharjee, A; Yang, HJ; Duffy, M; Robinson, E; Conrad-Antoville, A; Lu, YW; Capps, T; Braiterman, L; Wolfgang, M; Murphy, MP; Yi, L; Kaler, SG; Lutsenko, S; Ralle, M				Bhattacharjee, Ashima; Yang, Haojun; Duffy, Megan; Robinson, Emily; Conrad-Antoville, Arianrhod; Lu, Ya-Wen; Capps, Tony; Braiterman, Lelita; Wolfgang, Michael; Murphy, Michael P.; Yi, Ling; Kaler, Stephen G.; Lutsenko, Svetlana; Ralle, Martina			The Activity of Menkes Disease Protein ATP7A Is Essential for Redox Balance in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY COPPER THERAPY; TX-J MOUSE; WILSON-DISEASE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MURINE HOMOLOG; IN-VIVO; MODEL; CELLS; MICE	Copper-transporting ATPase ATP7A is essential for mammalian copper homeostasis. Loss of ATP7A activity is associated with fatal Menkes disease and various other pathologies. In cells, ATP7A inactivation disrupts copper transport from the cytosol into the secretory pathway. Using fibroblasts from Menkes disease patients and mouse 3T3-L1 cells with a CRISPR/Cas9-inactivated ATP7A, we demonstrate that ATP7A dysfunction is also damaging to mitochondrial redox balance. In these cells, copper accumulates in nuclei, cytosol, and mitochondria, causing distinct changes in their redox environment. Quantitative imaging of live cells using GRX1-roGFP2 and HyPer sensors reveals highest glutathione oxidation and elevation of H2O2 in mitochondria, whereas the redox environment of nuclei and the cytosol is much less affected. Decreasing the H2O2 levels in mitochondria with MitoQ does not prevent glutathione oxidation; i.e. elevated copper and not H2O2 is a primary cause of glutathione oxidation. Redox misbalance does not significantly affect mitochondrion morphology or the activity of respiratory complex IV but markedly increases cell sensitivity to even mild glutathione depletion, resulting in loss of cell viability. Thus, ATP7A activity protects mitochondria from excessive copper entry, which is deleterious to redox buffers. Mitochondrial redox misbalance could significantly contribute to pathologies associated with ATP7A inactivation in tissues with paradoxical accumulation of copper (i.e. renal epithelia).	[Bhattacharjee, Ashima; Yang, Haojun; Lu, Ya-Wen; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Braiterman, Lelita] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Wolfgang, Michael] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Duffy, Megan; Robinson, Emily; Conrad-Antoville, Arianrhod; Capps, Tony; Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Yi, Ling; Kaler, Stephen G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Translat Neurosci, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lutsenko, S (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.; Ralle, M (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	Lutsenko@jhmi.edu; rallem@ohsu.edu	Ralle, Martina/H-2936-2019; Kaler, Stephen/GPT-3845-2022; Murphy, Michael/C-2120-2009	Duffy, Megan/0000-0002-3212-4927; Murphy, Michael/0000-0003-1115-9618	Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008768] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090016, R01GM101502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Ann Hubbard (Johns Hopkins University School of Medicine) for XS and YS cells, Dr. Tobias P. Dick (German Cancer Research Center (DKFZ), Heidelberg, Germany) for the GRX1-roGFP2 construct, and Dr. Vadim Gladyshev (Brigham and Women's Hospital, Harvard Medical School) for the HyPer constructs. The Elemental Analysis Core at Oregon Health and Science University performed ICP-MS measurements. We acknowledge use of the Advanced Photon Source at Argonne National Laboratory, supported by the Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. We thank the staff of Johns Hopkins School of Medicine MicFac facility for help with EM sample sectioning and staining.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Burkhead JL, 2011, J MOL BIOL, V406, P44, DOI 10.1016/j.jmb.2010.12.001; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Du T, 2008, PROTEOMICS, V8, P1819, DOI 10.1002/pmic.200700895; GOKA TJ, 1976, P NATL ACAD SCI USA, V73, P604, DOI 10.1073/pnas.73.2.604; Grimes A, 1997, HUM MOL GENET, V6, P1037, DOI 10.1093/hmg/6.7.1037; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hamilton JP, 2016, HEPATOLOGY, V63, P1828, DOI 10.1002/hep.28406; Hodgkinson VL, 2015, J PATHOL, V236, P241, DOI 10.1002/path.4511; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Jones DP, 2006, CHEM-BIOL INTERACT, V163, P38, DOI 10.1016/j.cbi.2006.07.008; Kaler SG, 1995, ANN NEUROL, V38, P921, DOI 10.1002/ana.410380613; Kaler SG, 1996, BIOCHEM MOL MED, V57, P37, DOI 10.1006/bmme.1996.0007; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kodama H, 2005, J INHERIT METAB DIS, V28, P971, DOI 10.1007/s10545-005-0150-6; La Fontaine S, 2001, HUM MOL GENET, V10, P361, DOI 10.1093/hmg/10.4.361; La Fontaine S, 2010, INT J BIOCHEM CELL B, V42, P206, DOI 10.1016/j.biocel.2009.11.007; Leary SC, 2013, MOL BIOL CELL, V24, P683, DOI 10.1091/mbc.E12-09-0705; Lenartowicz M, 2001, FOLIA HISTOCHEM CYTO, V39, P275; Lenartowicz M, 2010, BIOL TRACE ELEM RES, V136, P204, DOI 10.1007/s12011-009-8533-4; Liu PC, 2005, MOL GENET METAB, V85, P291, DOI 10.1016/j.ymgme.2005.04.007; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Marthandan S, 2011, FREE RADICAL RES, V45, P351, DOI 10.3109/10715762.2010.532497; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; Medici V, 2014, EPIGENETICS-US, V9, P286, DOI 10.4161/epi.27110; MENKES JH, 1962, PEDIATRICS, V29, P764; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Nomura S, 2014, J NUCL MED, V55, P845, DOI 10.2967/jnumed.113.131797; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Pletjushkina OY, 2006, BIOCHEMISTRY-MOSCOW+, V71, P60, DOI 10.1134/S0006297906010093; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Roberts EA, 2008, MOL GENET METAB, V93, P54, DOI 10.1016/j.ymgme.2007.08.127; Rodriguez S, 2012, CHEM BIOL, V19, P391, DOI 10.1016/j.chembiol.2011.12.022; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; ROYCE PM, 1980, BIOCHEM J, V192, P579, DOI 10.1042/bj1920579; Schushan M, 2012, METALLOMICS, V4, P669, DOI 10.1039/c2mt20025b; Sheline CT, 2004, ANN NEUROL, V55, P645, DOI 10.1002/ana.20047; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Williams TD, 2008, AQUAT TOXICOL, V90, P83, DOI 10.1016/j.aquatox.2008.07.019; Wilmarth PA, 2012, METALLOMICS, V4, P660, DOI 10.1039/c2mt20017a; Wooton-Kee CR, 2015, J CLIN INVEST, V125, P3449, DOI 10.1172/JCI78991; Zischka H, 2011, J CLIN INVEST, V121, P1508, DOI 10.1172/JCI45401	52	41	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16644	16658		10.1074/jbc.M116.727248	http://dx.doi.org/10.1074/jbc.M116.727248			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27226607	hybrid, Green Published			2022-12-26	WOS:000380826700023
J	Chan, CY; Dominguez, D; Parra, KJ				Chan, Chun-Yuan; Dominguez, Dennis; Parra, Karlett J.			Regulation of Vacuolar H plus -ATPase (V-ATPase) Reassembly by Glycolysis Flow in 6-Phosphofructo-1-kinase (PFK-1)-deficient Yeast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; SACCHAROMYCES-CEREVISIAE; MUTATIONAL ANALYSIS; CYTOSOLIC PH; IN-VIVO; ESCHERICHIA-COLI; V-0 SUBUNIT; GLUCOSE; PATHWAY; PUMP	Yeast 6-phosphofructo-1-kinase (PFK-1) has two subunits, Pfk1p and Pfk2p. Deletion of Pfk2p alters glucose-dependent V-ATPase reassembly and vacuolar acidification (Chan, C. Y., and Parra, K. J. (2014) Yeast phosphofructokinase-1 subunit Pfk2p is necessary for pH homeostasis and glucose-dependent vacuolar ATPase reassembly. J. Biol. Chem. 289, 19448-19457). This study capitalized on the mechanisms suppressing vacuolar H(+)-ATPase (V-ATPase) in pfk2 Delta to gain new knowledge of the mechanisms underlying glucose-dependent V-ATPase regulation. Because V-ATPase is fully assembled in pfk2 Delta, and glycolysis partially suppressed at steady state, we manipulated glycolysis and assessed its direct involvement on V-ATPase function. At steady state, the ratio of proton transport to ATP hydrolysis increased 24% after increasing the glucose concentration from 2% to 4% to enhance the glycolysis flow in pfk2 Delta. Tighter coupling restored vacuolar pH when glucose was abundant and glycolysis operated below capacity. After readdition of glucose to glucose-deprived cells, glucose-dependent V1Vo reassembly was proportional to the glycolysis flow. Readdition of 2% glucose to pfk2 Delta cells, which restored 62% of ethanol concentration, led to equivalent 60% V1Vo reassembly levels. Steady-state level of assembly (100% reassembly) was reached at 4% glucose when glycolysis reached a threshold in pfk2 Delta (=40% the wild-type flow). At 4% glucose, the level of Pfk1p co-immunoprecipitated with V-ATPase decreased 58% in pfk2 Delta, suggesting that Pfk1p binding to V-ATPase may be inhibitory in the mutant. We concluded that V-ATPase activity at steady state and V-ATPase reassembly after readdition of glucose to glucose-deprived cells are controlled by the glycolysis flow. We propose a new mechanism by which glucose regulates V-ATPase catalytic activity that occurs at steady state without changing V1Vo assembly	[Chan, Chun-Yuan; Dominguez, Dennis; Parra, Karlett J.] Univ New Mexico, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Chan, Chun-Yuan] Van Andel Inst, Grand Rapids, MI 49503 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Van Andel Institute	Parra, KJ (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, MSC08 4670, Albuquerque, NM 87131 USA.	kjparra@salud.unm.edu	Chan, Chun Yuan/F-5811-2010		National Institutes of Health [R01GM086495]; American Heart Association [14PRE19020015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM086495 (to K. J. P.) and American Heart Association Grant 14PRE19020015 (to C. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Banaszak K, 2011, J MOL BIOL, V407, P284, DOI 10.1016/j.jmb.2011.01.019; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Chan CY, 2014, J BIOL CHEM, V289, P19448, DOI 10.1074/jbc.M114.569855; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Dechant R, 2014, MOL CELL, V55, P409, DOI 10.1016/j.molcel.2014.06.002; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Fogarty FM, 2014, ONCOGENE, V33, P4653, DOI 10.1038/onc.2013.403; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; HEINISCH J, 1986, MOL GEN GENET, V202, P75, DOI 10.1007/BF00330520; HEINISCH J, 1986, CURR GENET, V11, P227, DOI 10.1007/BF00420611; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; HO MN, 1993, J BIOL CHEM, V268, P18286; Ibanez AJ, 2013, P NATL ACAD SCI USA, V110, P8790, DOI 10.1073/pnas.1209302110; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2016, ADV EXP MED BIOL, V892, P33, DOI 10.1007/978-3-319-25304-6_3; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Lenzen S, 2014, J BIOL CHEM, V289, P12189, DOI 10.1074/jbc.R114.557314; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4128, DOI 10.1021/bi00313a018; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muller ML, 1999, J BIOL CHEM, V274, P10706, DOI 10.1074/jbc.274.16.10706; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Poulsen AK, 2008, BIOCHEMISTRY-US, V47, P7477, DOI 10.1021/bi800396e; Rienmuller F, 2012, J BIOL CHEM, V287, P8986, DOI 10.1074/jbc.M111.310367; Schroder TD, 2013, FEBS J, V280, P6033, DOI 10.1111/febs.12522; Sennoune SR, 2012, CURR PROTEIN PEPT SC, V13, P152; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Smardon AM, 2014, J BIOL CHEM, V289, P32316, DOI 10.1074/jbc.M114.574442; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	63	11	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15820	15829		10.1074/jbc.M116.717488	http://dx.doi.org/10.1074/jbc.M116.717488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226568	Green Published, hybrid			2022-12-26	WOS:000380584200034
J	Stachler, AE; Marchfelder, A				Stachler, Aris-Edda; Marchfelder, Anita			Gene Repression in Haloarchaea Using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas I-B System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON HALOFERAX-VOLCANII; IMMUNE-SYSTEM; CAS SYSTEMS; RNA; DNA; DEGRADATION; DEFENSE; REQUIREMENTS; BIOGENESIS; NUCLEASE	The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system is used by bacteria and archaea to fend off foreign genetic elements. Since its discovery it has been developed into numerous applications like genome editing and regulation of transcription in eukaryotes and bacteria. For archaea currently no tools for transcriptional repression exist. Because molecular biology analyses in archaea become more and more widespread such a tool is vital for investigating the biological function of essential genes in archaea. Here we use the model archaeon Haloferax volcanii to demonstrate that its endogenous CRISPR-Cas system I-B can be harnessed to repress gene expression in archaea. Deletion of cas3 and cas6b genes results in efficient repression of transcription. crRNAs targeting the promoter region reduced transcript levels down to 8%. crRNAs targeting the reading frame have only slight impact on transcription. crRNAs that target the coding strand repress expression only down to 88%, whereas crRNAs targeting the template strand repress expression down to 8%. Repression of an essential gene results in reduction of transcription levels down to 22%. Targeting efficiencies can be enhanced by expressing a catalytically inactive Cas3 mutant. Genes can be targeted on plasmids or on the chromosome, they can be monocistronic or part of a polycistronic operon.	[Stachler, Aris-Edda; Marchfelder, Anita] Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany	Ulm University	Marchfelder, A (corresponding author), Univ Ulm, Biol 2, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de		Marchfelder, Anita/0000-0002-1382-1794	Deutsche Forschungsgemeinschaft in the frame of the Deutsche Forschungsgemeinschaft Forschergruppe FOR1680 [MA1538/16-2]	Deutsche Forschungsgemeinschaft in the frame of the Deutsche Forschungsgemeinschaft Forschergruppe FOR1680(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MA1538/16-2 in the frame of the Deutsche Forschungsgemeinschaft Forschergruppe FOR1680. The authors declare that they have no conflicts of interest with the contents of this article.	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Alstetter M., 2012, BIOLOGY, VII; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Brendel J, 2014, J BIOL CHEM, V289, P7164, DOI 10.1074/jbc.M113.508184; Cass SDB, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150043; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Dierolf J., 2010, BIOLOGY, VII; Fineran PC, 2014, CURR OPIN MICROBIOL, V18, P83, DOI 10.1016/j.mib.2014.02.007; Gasiunas G, 2014, CELL MOL LIFE SCI, V71, P449, DOI 10.1007/s00018-013-1438-6; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hawkins M, 2013, NATURE, V503, P544, DOI 10.1038/nature12650; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Maier LK, 2015, BIOCHIMIE, V117, P129, DOI 10.1016/j.biochi.2015.02.023; Maier Lisa-Katharina, 2015, Life-Basel, V5, P521, DOI 10.3390/life5010521; Maier LK, 2015, J BIOL CHEM, V290, P4192, DOI 10.1074/jbc.M114.617506; Maier Lisa-Katharina, 2012, Mob Genet Elements, V2, P228; Maier LK, 2013, RNA BIOL, V10, P865, DOI 10.4161/rna.24282; Maier LK, 2013, BIOCHEM SOC T, V41, P374, DOI 10.1042/BST20120263; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Schwarz T., 2015, BIOLOGY, VII; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Staals R. H., 2013, CRISPR CAS SYSTEMS, P145; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Stoll B, 2013, BIOCHEM SOC T, V41, P1444, DOI 10.1042/BST20130098; Terns RM, 2014, TRENDS GENET, V30, P111, DOI 10.1016/j.tig.2014.01.003; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Zebec Z, 2014, NUCLEIC ACIDS RES, V42, P5280, DOI 10.1093/nar/gku161	48	41	43	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15226	15242		10.1074/jbc.M116.724062	http://dx.doi.org/10.1074/jbc.M116.724062			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226589	Green Published, hybrid			2022-12-26	WOS:000380583200030
J	Aldinucci, A; Bonechi, E; Manuelli, C; Nosi, D; Masini, E; Passani, MB; Ballerini, C				Aldinucci, Alessandra; Bonechi, Elena; Manuelli, Cinzia; Nosi, Daniele; Masini, Emanuela; Passani, Maria Beatrice; Ballerini, Clara			Histamine Regulates Actin Cytoskeleton in Human Toll-like Receptor 4-activated Monocyte-derived Dendritic Cells Tuning CD4(+) T Lymphocyte Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; cytoskeleton; dendritic cell; histamine; immunology; innate immunity	IMMUNE REGULATION; PERIPHERAL-BLOOD; EXPRESSION; DIFFERENTIATION; ACTIVATION; INNATE; ANTIHISTAMINES; INFLAMMATION; POLARIZATION; MODULATION	Histamine, a major mediator in allergic diseases, differentially regulates the polarizing ability of dendritic cells after Toll-like receptor (TLR) stimulation, by not completely explained mechanisms. In this study we investigated the effects of histamine on innate immune reaction during the response of human monocyte-derived DCs (mDCs) to different TLR stimuli: LPS, specific for TLR4, and Pam3Cys, specific for heterodimer molecule TLR1/TLR2. We investigated actin remodeling induced by histamine together with mDCs phenotype, cytokine production, and the stimulatory and polarizing ability of Th0. By confocal microscopy and RT-PCR expression of Rac1/CdC42 Rho GTPases, responsible for actin remodeling, we show that histamine selectively modifies actin cytoskeleton organization induced by TLR4, but not TLR2 and this correlates with increased IL4 production and decreased IFN by primed T cells. We also demonstrate that histamine-induced cytoskeleton organization is at least in part mediated by down-regulation of small Rho GTPase CdC42 and the protein target PAK1, but not by down-regulation of Rac1. The presence and relative expression of histamine receptors HR1-4 and TLRs were determined as well. Independently of actin remodeling, histamine down-regulates IL12p70 and CXCL10 production in mDCs after TLR2 and TLR4 stimulation. We also observed a trend of IL10 up-regulation that, despite previous reports, did not reach statistical significance.	[Aldinucci, Alessandra; Bonechi, Elena; Masini, Emanuela; Ballerini, Clara] Univ Florence, Dept Neurosci Psychol Drugs & Child Hlth, I-50137 Florence, Italy; [Manuelli, Cinzia; Nosi, Daniele] Univ Florence, Dept Clin & Expt Med, I-50137 Florence, Italy; [Passani, Maria Beatrice] Univ Florence, Dept Hlth Sci, I-50137 Florence, Italy	University of Florence; University of Florence; University of Florence	Ballerini, C (corresponding author), Univ Florence, Dept Neurosci Psychol Drugs & Child Hlth, I-50137 Florence, Italy.	clara.ballerini@unifi.it		ballerini, clara/0000-0002-7812-9029; Aldinucci, Alessandra/0000-0003-4556-913X; passani, beatrice/0000-0002-7729-9069; Nosi, Daniele/0000-0002-1903-5145; Bonechi, Elena/0000-0001-6406-5776	Ente Cassa di Risparmio Project [MASI-CRF13]	Ente Cassa di Risparmio Project	This work was supported in part by Ente Cassa di Risparmio Project MASI-CRF13. The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Aldinucci A, 2010, J IMMUNOL, V185, P5102, DOI 10.4049/jimmunol.1001332; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Beghdadi W, 2008, J EXP MED, V205, P395, DOI 10.1084/jem.20071548; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Carroll-Portillo A, 2015, J CELL BIOL, V210, P851, DOI 10.1083/jcb.201412074; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Deifl S, 2014, ALLERGY, V69, P1602, DOI 10.1111/all.12501; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Ferstl R, 2012, FRONT BIOSCI-LANDMRK, V17, P40, DOI 10.2741/3914; Frei R, 2013, J ALLERGY CLIN IMMUN, V132, P194, DOI 10.1016/j.jaci.2013.01.013; Glatzer F, 2014, INT ARCH ALLERGY IMM, V163, P11, DOI 10.1159/000355960; Gutzmer R, 2002, J ALLERGY CLIN IMMUN, V109, P524, DOI 10.1067/mai.2002.121944; Gutzmer R, 2005, J IMMUNOL, V174, P5224, DOI 10.4049/jimmunol.174.9.5224; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Idzko M, 2002, J ALLERGY CLIN IMMUN, V109, P839, DOI 10.1067/mai.2002.124044; Jang Sujeong, 2012, Chonnam Med J, V48, P7, DOI 10.4068/cmj.2012.48.1.7; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Kucuksezer UC, 2013, J ALLERGY CLIN IMMUN, V131, P875, DOI 10.1016/j.jaci.2012.10.051; Mazzoni A, 2001, J CLIN INVEST, V108, P1865, DOI 10.1172/JCI13930; Metz M, 2011, INT ARCH ALLERGY IMM, V155, P355, DOI 10.1159/000321614; Morrison VL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6359; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Reuter S, 2012, J IMMUNOL, V188, P5123, DOI 10.4049/jimmunol.1101618; Shao L, 2015, INT J CLIN EXP PATHO, V8, P5263; Simon T, 2012, INT IMMUNOL, V24, P107, DOI 10.1093/intimm/dxr107; Smolinska S, 2014, ALLERGY, V69, P273, DOI 10.1111/all.12330; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yang CB, 2012, EXP PHYSIOL, V97, P1315, DOI 10.1113/expphysiol.2012.065854; Zhai RR, 2013, VIROLOGY, V442, P163, DOI 10.1016/j.virol.2013.04.009; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	39	8	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14803	14814		10.1074/jbc.M116.720680	http://dx.doi.org/10.1074/jbc.M116.720680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226579	Green Published, hybrid			2022-12-26	WOS:000380366700032
J	Togao, O; Hiwatashi, A; Keupp, J; Yamashita, K; Kikuchi, K; Yoshiura, T; Yoneyama, M; Kruiskamp, MJ; Sagiyama, K; Takahashi, M; Honda, H				Togao, Osamu; Hiwatashi, Akio; Keupp, Jochen; Yamashita, Koji; Kikuchi, Kazufumi; Yoshiura, Takashi; Yoneyama, Masami; Kruiskamp, Marijn J.; Sagiyama, Koji; Takahashi, Masaya; Honda, Hiroshi			Amide Proton Transfer Imaging of Diffuse Gliomas: Effect of Saturation Pulse Length in Parallel Transmission-Based Technique	PLOS ONE			English	Article							BRAIN-TUMORS; PARACEST AGENTS; EXCHANGE; CONTRAST; GLIOBLASTOMA; COMPLEXES; PEPTIDES; PROTEINS; MRI	In this study, we evaluated the dependence of saturation pulse length on APT imaging of diffuse gliomas using a parallel transmission-based technique. Twenty-two patients with diffuse gliomas (9 low-grade gliomas, LGGs, and 13 high-grade gliomas, HGGs) were included in the study. APT imaging was conducted at 3T with a 2-channel parallel transmission scheme using three different saturation pulse lengths (0.5 s, 1.0 s, 2.0 s). The 2D fast spin-echo sequence was used for imaging. Z-spectrum was obtained at 25 frequency offsets from -6 to +6 ppm (step 0.5 ppm). A point-by-point B0 correction was performed with a B0 map. Magnetization transfer ratio (MTRasym) and Delta MTRasym (contrast between tumor and normal white matter) at 3.5 ppm were compared among different saturation lengths. A significant increase in MTRasym (3.5 ppm) of HGG was found when the length of saturation pulse became longer (3.09 +/- 0.54% at 0.5 s, 3.83 +/- 0.67% at 1 s, 4.12 +/- 0.97% at 2 s), but MTRasym (3.5 ppm) was not different among the saturation lengths in LGG Delta MTRasym (3.5 ppm) increased with the length of saturation pulse in both LGG (0.48 +/- 0.56% at 0.5 s, 1.28 +/- 0.56% at 1 s, 1.88 +/- 0.56% at 2 s and HGG (1.72 +/- 0.54% at 0.5 s, 2.90 +/- 0.49% at 1 s, 3.83 +/- 0.88% at 2 s). In both LGG and HGG, APT-weighted contrast was enhanced with the use of longer saturation pulses.	[Togao, Osamu; Hiwatashi, Akio; Yamashita, Koji; Kikuchi, Kazufumi; Yoshiura, Takashi; Sagiyama, Koji; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, 3-1-1 Maidashi Higashi Ku, Fukuoka 8128582, Japan; [Keupp, Jochen; Kruiskamp, Marijn J.] Philips Res Europe, Rontgenstr 24-26, D-22335 Hamburg, Germany; [Yoneyama, Masami] Philips Elect Japan, 2-13-37 Konan Minato Ku, Tokyo 1088507, Japan; [Takahashi, Masaya] UT Southwestern Med Ctr, Adv Imaging Res Ctr, 2201 Inwood Rd, Dallas, TX 75235 USA	Kyushu University; Philips; Philips Research; Philips; University of Texas System; University of Texas Southwestern Medical Center Dallas	Togao, O (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, 3-1-1 Maidashi Higashi Ku, Fukuoka 8128582, Japan.	togao@radiol.med.kyushu-u.ac.jp	Togao, Osamu/AAE-4702-2022; Kikuchi, Kazufumi/AAP-4286-2021	Kikuchi, Kazufumi/0000-0003-1292-1846; Togao, Osamu/0000-0002-5910-7852; Yamashita, Koji/0000-0002-7417-739X; Sagiyama, Koji/0000-0001-7253-0703	Japan Society for the Promotion of Science (JSPS) [26461827, 26293278, 26670564, 26461826, 26461828]; Philips Research Europe and Philips Electronics Japan; JSPS KAKENHI Grant [26461827, 26293278, 26670564, 26461826, 26461828]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Philips Research Europe and Philips Electronics Japan; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research KAKENHI, grant numbers: 26461827 (OT), 26293278 (TY), 26670564 (TY), 26461826 (AH), 26461828 (KY), http://www.jsps.go.jp/english/e-grants/index.html. This work was also supported by Philips Research Europe and Philips Electronics Japan. The funders provided support in the form of salaries for authors [JK and MY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by JSPS KAKENHI Grant Number: 26461827, 26293278, 26670564, 26461826, and 26461828.	KEUPP J, 2011, P INT SOC MAGN RESON, V19, P710; Keupp J, 2012, P INT SOC MAGN RESON, V20, P4258; Mani T, 2009, CONTRAST MEDIA MOL I, V4, P183, DOI 10.1002/cmmi.279; Sagiyama K, 2014, P NATL ACAD SCI USA, V111, P4542, DOI 10.1073/pnas.1323855111; Salhotra A, 2008, NMR BIOMED, V21, P489, DOI 10.1002/nbm.1216; Togao O, 2015, J MAGN RESON IMAGING, V42, P1346, DOI 10.1002/jmri.24895; Togao O, 2014, NEURO-ONCOLOGY, V16, P441, DOI 10.1093/neuonc/not158; Togao O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077019; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Wada T, 2016, RADIOL PHYS TECHNOL, V9, P15, DOI 10.1007/s12194-015-0326-1; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wen ZB, 2010, NEUROIMAGE, V51, P616, DOI 10.1016/j.neuroimage.2010.02.050; Woods M, 2006, CHEM SOC REV, V35, P500, DOI 10.1039/b509907m; Zhao XN, 2011, MAGN RESON MED, V66, P1033, DOI 10.1002/mrm.22891; Zhou JY, 2013, MAGN RESON MED, V70, P320, DOI 10.1002/mrm.24784; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	18	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155925	10.1371/journal.pone.0155925	http://dx.doi.org/10.1371/journal.pone.0155925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227746	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500042
J	Zhang, XM; Wojtkowiak, JW; Martinez, GV; Cornnell, HH; Hart, CP; Baker, AF; Gillies, R				Zhang, Xiaomeng; Wojtkowiak, Jonathan W.; Martinez, Gary V.; Cornnell, Heather H.; Hart, Charles P.; Baker, Amanda F.; Gillies, Robert			MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR HYPOXIA; NAB-PACLITAXEL; R1 RESECTIONS; CELLS; THERAPY; ANGIOGENESIS; CARCINOGENESIS; GEMCITABINE; PROGRESSION	TH-302 is a hypoxia-activated prodrug known to activate selectively under the hypoxic conditions commonly found in solid tumors. It is currently being evaluated in clinical trials, including two trials in Pancreatic Ductal Adenocarcinomas (PDAC). The current study was undertaken to evaluate imaging biomarkers for prediction and response monitoring of TH-302 efficacy in xenograft models of PDAC. Dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) were used to monitor acute effects on tumor vasculature and cellularity, respectively. Three human PDAC xenografts with known differential responses to TH-302 were imaged prior to, and at 24 h and 48 hours following a single dose of TH-302 or vehicle to determine if imaging changes presaged changes in tumor volumes. DW-MRI was performed at five b-values to generate apparent diffusion coefficient of water (ADC) maps. For DCE-MRI, a standard clinically available contrast reagent, Gd-DTPA, was used to determine blood flow into the tumor region of interest. TH-302 induced a dramatic decrease in the DCE transfer constant (K-trans) within 48 hours after treatment in the sensitive tumors, Hs766t and Mia PaCa-2, whereas TH-302 had no effect on the perfusion behavior of resistant SU. 86.86 tumors. Tumor cellularity, estimated from ADC, was significantly increased 24 and 48 hours after treatment in Hs766t, but was not observed in the Mia PaCa-2 and SU. 86.86 groups. Notably, growth inhibition of Hs766t was observed immediately (day 3) following initiation of treatment, but was not observed in Mia-PaCa-2 tumors until 8 days after initiation of treatment. Based on these preclinical findings, DCE-MRI measures of vascular perfusion dynamics and ADC measures of cell density are suggested as potential TH-302 response biomarkers in clinical trials.	[Zhang, Xiaomeng; Wojtkowiak, Jonathan W.; Martinez, Gary V.; Cornnell, Heather H.; Gillies, Robert] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Hart, Charles P.] Threshold Pharmaceut, San Francisco, CA USA; [Baker, Amanda F.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Arizona Center Cancer Care; University of Arizona	Zhang, XM (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA.	xmzhang@gmail.com		Gillies, Robert/0000-0002-8888-7747; Hart, Charles/0000-0003-4440-726X	US National Institutes of Health [R01CA125627, R01CA077575, U54CA143970]; Moffitt Cancer Center Small Animal Imaging Laboratory, a CCSG [P30-CA76292]; NATIONAL CANCER INSTITUTE [R01CA125627, U54CA143970, R01CA077575] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Cancer Center Small Animal Imaging Laboratory, a CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: US National Institutes of Health: R01CA125627, R01CA077575 and U54CA143970; www.nih.gov; the funding above was used in the study design, data collection and analysis; Moffitt Cancer Center Small Animal Imaging Laboratory, a CCSG funded core facility, CCSG Grant number: P30-CA76292; www.moffitt.org; the funding above was used for part of small animal imaging.	Akakura N, 2001, CANCER RES, V61, P6548; Angst E, 2012, J GASTROINTEST SURG, V16, P673, DOI 10.1007/s11605-011-1791-4; BROWN JM, 1994, INT J RADIAT BIOL, V65, P95, DOI 10.1080/09553009414550131; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Campbell F, 2009, HISTOPATHOLOGY, V55, P277, DOI 10.1111/j.1365-2559.2009.03376.x; Cardenas-Rodriguez J, 2012, MAGN RESON IMAGING, V30, P1002, DOI 10.1016/j.mri.2012.02.015; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Esposito I, 2008, ANN SURG ONCOL, V15, P1651, DOI 10.1245/s10434-008-9839-8; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Ferrone CR, 2008, J GASTROINTEST SURG, V12, P701, DOI 10.1007/s11605-007-0384-8; Galban S, 2010, CURR PHARM BIOTECHNO, V11, P701, DOI 10.2174/138920110792246627; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Guo N, 2012, MOL IMAGING BIOL, V14, P743, DOI 10.1007/s11307-012-0541-7; Hart CP, 2009, CLIN EXP METASTAS, V26, P851; Hashim AI, 2011, NMR BIOMED, V24, P582, DOI 10.1002/nbm.1644; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Howard TJ, 2006, J GASTROINTEST SURG, V10, P1338, DOI 10.1016/j.gassur.2006.09.008; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Ide T, 2007, ANN SURG ONCOL, V14, P2600, DOI 10.1245/s10434-007-9435-3; Jessica D, 2011, AM ASS CANC RES ANN; Jessica D, 2010, AMERICAN ASSOCIATION; Kling J, 2012, NAT BIOTECHNOL, V30, P381, DOI 10.1038/nbt0512-381; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Liu Q, 2012, CANCER CHEMOTH PHARM, V69, P1487, DOI 10.1007/s00280-012-1852-8; Masamune A, 2008, AM J PHYSIOL-GASTR L, V295, pG709, DOI 10.1152/ajpgi.90356.2008; Pizzi S, 2009, HISTOL HISTOPATHOL, V24, P175, DOI 10.14670/HH-24.175; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Sun JD, 2012, CLIN CANCER RES, V18, P758, DOI 10.1158/1078-0432.CCR-11-1980; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Vaupel P, ONCOLOGIST S5, V9, P4; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wojtkowiak JW, 2015, CANCER METAB, V3, DOI 10.1186/s40170-014-0026-z; Yankeelov TE, 2007, MAGN RESON IMAGING, V25, P1, DOI 10.1016/j.mri.2006.09.006; Zafar SF, 2012, AM J CLIN ONCOLOGY; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]	42	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155289	10.1371/journal.pone.0155289	http://dx.doi.org/10.1371/journal.pone.0155289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227903	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500014
J	Chen, MS; Liu, SZ; Wang, HY; Cheng, XY; El Bouhssini, M; Whitworth, RJ				Chen, Ming-Shun; Liu, Sanzhen; Wang, Haiyan; Cheng, Xiaoyan; El Bouhssini, Mustapha; Whitworth, R. Jeff			Massive Shift in Gene Expression during Transitions between Developmental Stages of the Gall Midge, Mayetiola Destructor	PLOS ONE			English	Article							HESSIAN FLY DIPTERA; WINTER-WHEAT; CECIDOMYIIDAE POPULATIONS; VIRULENCE; CLONING; TRANSCRIPTOME; REVEALS; CDNAS; PROTEINS; MOSQUITO	Mayetiola destructor is a destructive pest of wheat and has six developmental stages. Molecular mechanisms controlling the transition between developmental stages remain unknown. Here we analyzed genes that were expressed differentially between two successive developmental stages, including larvae at 1, 3, 5, and 7 days, pupae, and adults. A total of 17,344 genes were expressed during one or more of these studied stages. Among the expressed genes, 38-68% were differently expressed between two successive stages, with roughly equal percentages of up-and down-regulated genes. Analysis of the functions of the differentially expressed genes revealed that each developmental stage had some unique types of expressed genes that are characteristic of the physiology at that stage. This is the first genome-wide analysis of genes differentially expressed in different stages in a gall midge. The large dataset of up-and down-regulated genes in each stage of the insect shall be very useful for future research to elucidate mechanisms regulating insect development and other biological processes.	[Chen, Ming-Shun] Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Chen, Ming-Shun; Cheng, Xiaoyan; Whitworth, R. Jeff] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Liu, Sanzhen] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Wang, Haiyan] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA; [El Bouhssini, Mustapha] Int Ctr Agr Res Dry Area, Rabat, Morocco	Kansas State University; United States Department of Agriculture (USDA); Kansas State University; Kansas State University; Kansas State University	Chen, MS (corresponding author), Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA.; Chen, MS (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	mchen@ksu.edu	Cheng, Xiaoyan/K-6041-2017	Cheng, Xiaoyan/0000-0001-9494-9441	U.S. Department of Agriculture [USDA NIFA 2010-03741]; Agricultural Research Service, the U.S. Department of Agriculture; ARS [ARS-0424855] Funding Source: Federal RePORTER	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Agricultural Research Service, the U.S. Department of Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research was supported by a grant from the U.S. Department of Agriculture (USDA NIFA 2010-03741) and by annual base funds to MSC from the Agricultural Research Service, the U.S. Department of Agriculture.	Aggarwal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100958; Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742; Allen Margaret Louise, 2015, J Genomics, V3, P20, DOI 10.7150/jgen.10385; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentur JS, 2008, ENTOMOL EXP APPL, V129, P96, DOI 10.1111/j.1570-7458.2008.00756.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buntin GD, 1999, J ECON ENTOMOL, V92, P1190, DOI 10.1093/jee/92.5.1190; BYERS RA, 1972, J ECON ENTOMOL, V65, P955, DOI 10.1093/jee/65.4.955; Censier F, 2013, Commun Agric Appl Biol Sci, V78, P287; Chavalle S, 2015, PEST MANAG SCI, V71, P783, DOI 10.1002/ps.3855; Chen H, 2013, INSECT BIOCHEM MOLEC, V43, P701, DOI 10.1016/j.ibmb.2013.05.006; Chen MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-296; Chen MS, 2009, J ECON ENTOMOL, V102, P1663, DOI 10.1603/029.102.0434; Chen MS, 2009, J ECON ENTOMOL, V102, P774, DOI 10.1603/029.102.0239; Chu YJ, 2012, NUCLEIC ACID THER, V22, P271, DOI 10.1089/nat.2012.0367; DeAngelis J., 1989, ORNAMENT NW ARCH, V13, P15; GAGNE RJ, 1989, ANN ENTOMOL SOC AM, V82, P73, DOI 10.1093/aesa/82.1.73; Gagne RJ, 2004, CATALOG CECIDOMYIIDA, P25; Garces-Carrera S, 2014, J ECON ENTOMOL, V107, P417, DOI 10.1603/EC13372; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Harris MO, 2008, ANNU REV ENTOMOL, V48, P549; Hernandez LM, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0987-6; Khajuria C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-187; Liu X, 2006, INSECT BIOCHEM MOLEC, V36, P665, DOI 10.1016/j.ibmb.2006.05.008; Liu XY, 2010, PLANT PHYSIOL, V154, P1588, DOI 10.1104/pp.110.164111; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maddur AA, 2006, INSECT MOL BIOL, V15, P485, DOI 10.1111/j.1365-2583.2006.00660.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mezghani-Khemakhem M, 2012, INT J MOL SCI, V13, P14446, DOI 10.3390/ijms131114446; Mittapalli O, 2005, INSECT MOL BIOL, V14, P309, DOI 10.1111/j.1365-2583.2005.00561.x; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Poelchau MF, 2013, J EXP BIOL, V216, P4082, DOI 10.1242/jeb.089508; Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143; Ratcliffe RH, 2000, J ECON ENTOMOL, V93, P1319, DOI 10.1603/0022-0493-93.4.1319; Roubos CR, 2010, FLA ENTOMOL, V93, P283, DOI 10.1653/024.093.0220; Sanchez L, 2014, SEX DEV, V8, P83, DOI 10.1159/000356709; Skuhrava Marcela, 2009, Acta Societatis Zoologicae Bohemicae, V73, P87; Stuart JJ, 2012, ANNU REV PHYTOPATHOL, V50, P339, DOI 10.1146/annurev-phyto-072910-095255; Stuart Jeffrey J., 2008, V1, P93, DOI 10.1007/978-3-540-73833-6_7; Tarrant AM, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0091-8; Tian CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11042; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Zhao CY, 2016, J INSECT PHYSIOL, V84, P22, DOI 10.1016/j.jinsphys.2015.10.001; Zhao CY, 2015, CURR BIOL, V25, P613, DOI 10.1016/j.cub.2014.12.057; Zhu YC, 2005, INSECT BIOCHEM MOLEC, V35, P23, DOI 10.1016/j.ibmb.2004.09.006	50	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155616	10.1371/journal.pone.0155616	http://dx.doi.org/10.1371/journal.pone.0155616			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224654	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700024
J	Li, B; Sankaran, JS; Judex, S				Li, Bing; Sankaran, Jeyantt Srinivas; Judex, Stefan			Trabecular and Cortical Bone of Growing C3H Mice Is Highly Responsive to the Removal of Weightbearing	PLOS ONE			English	Article							SUSPENSION-INDUCED OSTEOPENIA; MESENCHYMAL STEM-CELLS; MOUSE LONG BONES; 2 INBRED STRAINS; COMPUTED-TOMOGRAPHY; WEIGHT-BEARING; C57BL/6J MICE; GENETIC-LOCI; C3H/HEJ; DENSITY	Genetic make-up strongly influences the skeleton's susceptibility to the loss of weight bearing with some inbred mouse strains experiencing great amounts of bone loss while others lose bone at much smaller rates. At young adulthood, female inbred C3H/HeJ (C3H) mice are largely resistant to catabolic pressure induced by unloading. Here, we tested whether the depressed responsivity to unloading is inherent to the C3H genetic make-up or whether a younger age facilitates a robust skeletal response to unloading. Nine-week-old, skeletally immature, female C3H mice were subjected to 3wk of hindlimb unloading (HLU, n = 12) or served as normal baseline controls (BC, n = 10) or age-matched controls (AC, n = 12). In all mice, cortical and trabecular architecture of the femur, as well as levels of bone formation and resorption, were assessed with mu CT, histomorphometry, and histology. Changes in bone marrow progenitor cell populations were determined with flow cytometry. Following 21d of unloading, HLU mice had 52% less trabecular bone in the distal femur than normal age-matched controls. Reflecting a loss of trabecular tissue compared to baseline controls, trabecular bone formation rates (BFR/BS) in HLU mice were 40% lower than in age-matched controls. Surfaces undergoing osteoclastic resorption were not significantly different between groups. In the mid-diaphysis, HLU inhibited cortical bone growth leading to 14% less bone area compared to age-matched controls. Compared to AC, BFR/BS of HLU mice were 53% lower at the endo-cortical surface and 49% lower at the periosteal surface of the mid-diaphysis. The enriched osteoprogenitor cell population (OPC) comprised 2% of the bone marrow stem cells in HLU mice, significantly different from 3% OPC in the AC group. These data show that bone tissue in actively growing C3H mice is lost rapidly, or fails to grow, during the removal of functional weight bearing-in contrast to the insignificant response previously demonstrated in female young adult C3H mice. Thus, the attributed low sensitivity of the C3H mouse strain to the loss of mechanical signals is not apparent at a young age and this trait therefore does not reflect a genetic regulation throughout the life span of this strain. These results highlight the significance of age in modulating the contribution of genetics in orchestrating bone's response to unloading and that the skeletal unresponsiveness of young adult C3H mice to the loss of weight bearing is not genetically hard-wired.	[Li, Bing] Tianjin Hosp, Dept Orthoped, Tianjin 300211, Peoples R China; [Li, Bing; Sankaran, Jeyantt Srinivas; Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Judex, S (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	stefan.judex@stonybrook.edu	Sankaran, Jeyantt Srinivas/K-1203-2019; Li, Bing/AAR-9714-2021	Sankaran, Jeyantt Srinivas/0000-0002-8613-9219; Li, Bing/0000-0002-4689-8480; Li, Bing/0000-0002-7896-7903	National Aeronautics and Space Administration [NNX12AL25G]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Aeronautics and Space Administration (NNX12AL25G). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter MP, 1998, CALCIFIED TISSUE INT, V63, P442, DOI 10.1007/s002239900554; Akhter MP, 2002, J CLIN DENSITOM, V5, P207, DOI 10.1385/JCD:5:2:207; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chen C, 1999, BONE, V25, P413, DOI 10.1016/S8756-3282(99)00185-4; Chen XD, 1999, J BONE MINER RES, V14, P362, DOI 10.1359/jbmr.1999.14.3.362; Ellman R, 2014, CALCIFIED TISSUE INT, V94, P327, DOI 10.1007/s00223-013-9814-7; Ensrud KE, 2003, J AM GERIATR SOC, V51, P1740, DOI 10.1046/j.1532-5415.2003.51558.x; Frey-Rindova P, 2000, SPINAL CORD, V38, P26, DOI 10.1038/sj.sc.3100905; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6; Gupta S, 2012, AM J PHYSIOL-REG I, V303, pR159, DOI 10.1152/ajpregu.00499.2011; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Judex S, 2004, J BONE MINER RES, V19, P607, DOI 10.1359/JBMR.040110; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Judex S, 2013, J BONE MINER RES, V28, P1537, DOI 10.1002/jbmr.1883; Kesavan C, 2006, BONE, V39, P634, DOI 10.1016/j.bone.2006.03.005; Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133; Lian J B, 1995, Iowa Orthop J, V15, P118; Lin CS, 2013, HISTOL HISTOPATHOL, V28, P1109, DOI 10.14670/HH-28.1109; Lublinsky S, 2007, CALCIFIED TISSUE INT, V81, P285, DOI 10.1007/s00223-007-9063-8; MINAIRE P, 1989, Clinical Rheumatology, V8, P95, DOI 10.1007/BF02207242; Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; Pan Z, 2008, STEM CELLS DEV, V17, P795, DOI 10.1089/scd.2008.0254; Poliachik SL, 2008, BONE, V42, P653, DOI 10.1016/j.bone.2007.12.222; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Rosen CJ, 1997, BONE, V21, P217, DOI 10.1016/S8756-3282(97)00143-9; Rucci N, 2007, J CELL BIOCHEM, V100, P464, DOI 10.1002/jcb.21059; Sakata T, 1999, J BONE MINER RES, V14, P1596, DOI 10.1359/jbmr.1999.14.9.1596; Sankaran JS, 2016, MAMM GENOME, V27, P47, DOI 10.1007/s00335-015-9611-x; Sheng MHC, 2006, CALCIFIED TISSUE INT, V78, P293, DOI 10.1007/s00223-005-0303-5; Sheng MHC, 1999, BONE, V25, P421, DOI 10.1016/S8756-3282(99)00184-2; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; SIMSKE SJ, 1992, J BIOMECH, V25, P489, DOI 10.1016/0021-9290(92)90089-J; SIMSKE SJ, 1991, J MATER SCI-MATER M, V2, P43, DOI 10.1007/BF00701686; Squire M, 2004, BONE, V35, P1353, DOI 10.1016/j.bone.2004.08.010; VANVLASSELAER P, 1994, BLOOD, V84, P753, DOI 10.1182/blood.V84.3.753.bloodjournal843753; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; ZHANG RW, 1995, J BONE MINER RES, V10, P415; Zhong N, 2005, AVIAT SPACE ENVIR MD, V76, P530	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156222	10.1371/journal.pone.0156222	http://dx.doi.org/10.1371/journal.pone.0156222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223115	gold, Green Submitted, Green Published			2022-12-26	WOS:000376881700075
J	Roy, A; Femel, J; Huijbers, EJM; Spillmann, D; Larsson, E; Ringvall, M; Olsson, AK; Abrink, M				Roy, Ananya; Femel, Julia; Huijbers, Elisabeth J. M.; Spillmann, Dorothe; Larsson, Erik; Ringvall, Maria; Olsson, Anna-Karin; Abrink, Magnus			Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma	PLOS ONE			English	Article							MAST-CELL PROTEASES; LARGE GENE LISTS; BREAST-CANCER; MOLECULAR SIGNATURE; SECRETORY GRANULE; DEFICIENT MICE; IMMUNE CELLS; SOLID TUMORS; STEM-CELLS; PROTEOGLYCAN	In hematopoietic cells, serglycin proteoglycans mainly contribute to proper storage and secretion of inflammatory mediators via their negatively charged glycosaminoglycans. Serglycin proteoglycans are also expressed in cancer cells where increased expression has been linked to poor prognosis. However, the serglycin-dependent mediators promoting cancer progression remain to be determined. In the present study we report that genetic ablation of serglycin proteoglycan completely blocks lung metastasis in the MMTV-PyMT-driven mouse breast cancer model, while serglycin-deficiency did not affect primary tumour growth or number of mammary tumours. Although E-cadherin expression was higher in the serglycin-deficient primary tumour tissue, indicating reduced invasiveness, serglycin-deficient tumour cells were still detected in the circulation. These data suggest that serglycin proteoglycans play a role in extravasation as well as colonization and growth of metastatic cells. A microarray expression analysis and functional annotation of differentially expressed genes identified several biological pathways where serglycin may be important. Our results suggest that serglycin and serglycin-dependent mediators are potential drug targets to prevent metastatic disease/dissemination of cancer.	[Roy, Ananya; Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Box 7028, S-75007 Uppsala, Sweden; [Roy, Ananya; Femel, Julia; Spillmann, Dorothe; Ringvall, Maria; Olsson, Anna-Karin] Uppsala Univ, Dept Med Biochem & Microbiol, Box 582, S-75123 Uppsala, Sweden; [Huijbers, Elisabeth J. M.] VUMC Canc Ctr Amsterdam, Dept Med Oncol, Angiogenesis Lab, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Larsson, Erik] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Uppsala University	Abrink, M (corresponding author), Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Box 7028, S-75007 Uppsala, Sweden.	magnus.abrink@slu.se	Åbrink, Magnus/AAK-8346-2020; Huijbers, Elisabeth J.M./K-7764-2013	Huijbers, Elisabeth J.M./0000-0002-7742-9839; Abrink, Magnus/0000-0002-1335-3927	Vetenskapradet [2011-3533]	Vetenskapradet	This work was funded by Vetenskapradet, 2011-3533, to M.A., http://www.vr.se/inenglish/researchfunding/supportedresearchdatabase.4.64ab6081125e0044d4b8000526.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Alderton GK, 2013, NAT REV CANCER, V13, P3, DOI 10.1038/nrc3428; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Daves MH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-56; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Grujic M, 2008, J IMMUNOL, V181, P1043, DOI 10.4049/jimmunol.181.2.1043; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hamilton A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126688; He L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0707-4; Ho HCK, 2001, BIOL REPROD, V64, P1667, DOI 10.1095/biolreprod64.6.1667; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072287; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter K, 2003, NAT GENET, V34, P23, DOI 10.1038/ng0503-23b; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Korpetinou A, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00327; Korpetinou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078157; Le Voyer T, 2001, GENOMICS, V74, P253, DOI 10.1006/geno.2001.6562; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lundequist A, 2006, BIOL CHEM, V387, P1513, DOI 10.1515/BC.2006.189; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Purushothaman A, 2014, J BIOL CHEM, V289, P5499, DOI 10.1074/jbc.M113.532143; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Sawesi O, 2010, J BIOL CHEM, V285, P38005, DOI 10.1074/jbc.M110.118471; Schick BP, 2003, BBA-MOL CELL RES, V1593, P259, DOI 10.1016/S0167-4889(02)00396-8; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Skliris A, 2013, FEBS J, V280, P2342, DOI 10.1111/febs.12179; Skliris A, 2011, EUR J IMMUNOL, V41, P437, DOI 10.1002/eji.201040429; Smith HA, 2013, J MOL MED, V91, P411, DOI 10.1007/s00109-013-1021-5; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Wernersson S, 2009, J LEUKOCYTE BIOL, V85, P401, DOI 10.1189/jlb.1008670; Woelfle U, 2003, CANCER RES, V63, P5679; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	58	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156151	10.1371/journal.pone.0156151	http://dx.doi.org/10.1371/journal.pone.0156151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223472	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700066
J	Wang, YL; Shen, HH; Cheng, PY; Chu, YJ; Hwang, HR; Lam, KK; Lee, YM				Wang, Yi-Li; Shen, Hsin-Hsueh; Cheng, Pao-Yun; Chu, Yen-Ju; Hwang, Hwong-Ru; Lam, Kwok-Keung; Lee, Yen-Mei			17-DMAG, an HSP90 Inhibitor, Ameliorates Multiple Organ Dysfunction Syndrome via Induction of HSP70 in Endotoxemic Rats	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; SHOCK-PROTEIN 90; INFLAMMATORY RESPONSES; GELDANAMYCIN ANALOG; OXIDATIVE STRESS; HEME OXYGENASE-1; SEPSIS; HEAT-SHOCK-PROTEIN-70; ACTIVATION; EXPRESSION	Sepsis is a systemic inflammatory disorder, accompanied with elevated oxidative stress, leading to multiple organ dysfunction syndrome (MODS), and disseminated intravascular coagulation. 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein (HSP) 90 inhibitor, has been reported to possess anti-inflammatory effects. In this study, the beneficial effects of 17-DMAG on lipopolysaccharide (LPS) induced MODS and DIC was evaluated in anesthetized rats. 17-DMAG (5 mg/kg, i.p.) was significantly increased survival rate, and prevented hypotension in LPS (30 mg/kg i.v. infused for 4 h) induced endotoxemia. The elevated levels of alanine aminotransferase (ALT), creatine phosphokinase (CPK), lactate dehydrogenase, creatinine, nitric oxide (NO) metabolites, IL-6, and TNF-alpha in LPS-exposed rat plasma were significantly reduced by 17-DMAG. Moreover, 17-DMAG suppressed LPS-induced superoxide anion production and caspase 3 activation in heart tissues. LPS induced the prolongation of prothrombin time, and a pronounced decrease in platelet count, which were improved by 17-DMAG. 17-DMAG markedly induced HSP70 and heme oxygenase (HO)-1, and suppressed inducible nitric oxide synthase (iNOS) and phosphorylated NF-kappa B p65 protein expression in organs 6 h after LPS initiation. Pretreatment with high dose of quercetin (300 mg/kg, i.p.), as an HSP70 inhibitor, reversed the beneficial effects of 17-DMAG on survival rate, plasma levels of ALT, CPK, creatinine, IL-6, and NO metabolites, iNOS induction, and caspase-3 activation in LPS-treated rats. In conclusion, 17-DMAG possesses the anti-inflammatory and antioxidant effects that were proved through LPS-induced acute inflammation, which is associated with induction of HSP70 and HO-1, leading to prevent MODS in sepsis.	[Wang, Yi-Li; Lee, Yen-Mei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Shen, Hsin-Hsueh; Chu, Yen-Ju; Lee, Yen-Mei] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Cheng, Pao-Yun] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan; [Hwang, Hwong-Ru] Kaohsiung Vet Gen Hosp, Dept Med, Div Cardiol, Kaohsiung, Taiwan; [Lam, Kwok-Keung] Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan; [Lam, Kwok-Keung] Catholic Mercy Hosp, Dept Anesthesiol, Hsinchu, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Kaohsiung Veterans General Hospital; Taipei Medical University	Lee, YM (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Lee, YM (corresponding author), Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.; Lam, KK (corresponding author), Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan.; Lam, KK (corresponding author), Catholic Mercy Hosp, Dept Anesthesiol, Hsinchu, Taiwan.	lamkkmi@hotmail.com; ymlee@mail.ndmctsgh.edu.tw		Lee, Yen Mei/0000-0002-5855-5346	Ministry of Science and Technology [NSC104-2320-B-016-010]; Ministry of National Defense [103-M052]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of National Defense	This work was supported by the Ministry of Science and Technology (NSC104-2320-B-016-010, YML), & The Ministry of National Defense (103-M052, YML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambade A, 2012, HEPATOLOGY, V55, P1585, DOI 10.1002/hep.24802; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Asakura H, 2002, CRIT CARE MED, V30, P161, DOI 10.1097/00003246-200201000-00023; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; ELIA G, 1994, BIOCHEM J, V300, P201, DOI 10.1042/bj3000201; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Glaze ER, 2005, CANCER CHEMOTH PHARM, V56, P637, DOI 10.1007/s00280-005-1000-9; GREGORY SA, 1989, MOL CELL BIOL, V9, P2752, DOI 10.1128/MCB.9.6.2752; Hardaway RM, 2001, SEMIN THROMB HEMOST, V27, P577, DOI 10.1055/s-2001-18863; Harrison EM, 2008, AM J PHYSIOL-RENAL, V295, pF397, DOI 10.1152/ajprenal.00361.2007; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Horn KD, 1998, QJM-MON J ASSOC PHYS, V91, P265, DOI 10.1093/qjmed/91.4.265; HOSOKAWA N, 1990, CELL STRUCT FUNCT, V15, P393, DOI 10.1247/csf.15.393; ITO T, 1990, THROMB RES, V59, P735, DOI 10.1016/0049-3848(90)90055-H; Kiang JG, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-21; Kiang JG, 2009, RADIAT RES, V172, P321, DOI 10.1667/RR1585.1; Kung CW, 2011, THROMB RES, V127, P582, DOI 10.1016/j.thromres.2011.01.017; Lam KK, 2013, EUR J PHARMACOL, V699, P67, DOI 10.1016/j.ejphar.2012.11.044; Lee YM, 2011, J ETHNOPHARMACOL, V135, P179, DOI 10.1016/j.jep.2011.03.009; Luo SX, 2011, AM J PHYSIOL-CELL PH, V301, pC227, DOI 10.1152/ajpcell.00493.2010; Madrigal-Matute J, 2012, CARDIOVASC RES, V95, P116, DOI 10.1093/cvr/cvs158; Madrigal-Matute J, 2010, CARDIOVASC RES, V86, P330, DOI 10.1093/cvr/cvq046; McConnell KW, 2011, J IMMUNOL, V186, P3718, DOI 10.4049/jimmunol.1003652; Neviere R, 2001, AM J RESP CRIT CARE, V163, P218, DOI 10.1164/ajrccm.163.1.2003109; O'Neill S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12958; Opal SM, 2003, SCAND J INFECT DIS, V35, P545, DOI 10.1080/00365540310015638; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Qi J, 2014, BIOL PHARM BULL, V37, P1713, DOI 10.1248/bpb.b14-00208; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shimp SK, 2012, INFLAMM RES, V61, P521, DOI 10.1007/s00011-012-0442-x; Singleton KD, 2005, NUTRITION, V21, P214, DOI 10.1016/j.nut.2004.05.023; Stouthard JML, 1996, THROMB HAEMOSTASIS, V76, P738; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; VANDERPOLL T, 1994, J EXP MED, V179, P1253, DOI 10.1084/jem.179.4.1253; VANDEVENTER SJH, 1990, BLOOD, V76, P2520; Vega VL, 2003, MOL BIOL CELL, V14, P764, DOI 10.1091/mbc.E02-08-0498; Vinokurov M, 2012, CELL STRESS CHAPERON, V17, P89, DOI 10.1007/s12192-011-0288-0; Wang YL, 2015, J ETHNOPHARMACOL, V162, P168, DOI 10.1016/j.jep.2014.12.062; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200	47	29	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155583	10.1371/journal.pone.0155583	http://dx.doi.org/10.1371/journal.pone.0155583			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224288	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700022
J	Papageorgiou, KV; Suarez, NM; Wilkie, GS; McDonald, M; Graham, EM; Davison, AJ				Papageorgiou, Konstantinos V.; Suarez, Nicolas M.; Wilkie, Gavin S.; McDonald, Michael; Graham, Elizabeth M.; Davison, Andrew J.			Genome Sequence of Canine Herpesvirus	PLOS ONE			English	Article							THYMIDINE KINASE GENE; COMPLETE DNA-SEQUENCE; NUCLEOTIDE-SEQUENCE; VIRUS-1 INFECTION; IDENTIFICATION; PROTEIN; DOGS; ALPHAHERPESVIRUSES; SEROPREVALENCE; REPLICATION	Canine herpesvirus is a widespread alphaherpesvirus that causes a fatal haemorrhagic disease of neonatal puppies. We have used high-throughput methods to determine the genome sequences of three viral strains (0194, V777 and V1154) isolated in the United Kingdom between 1985 and 2000. The sequences are very closely related to each other. The canine herpesvirus genome is estimated to be 125 kbp in size and consists of a unique long sequence (97.5 kbp) and a unique short sequence (7.7 kbp) that are each flanked by terminal and internal inverted repeats (38 bp and 10.0 kbp, respectively). The overall nucleotide composition is 31.6% G+C, which is the lowest among the completely sequenced alphaherpesviruses. The genome contains 76 open reading frames predicted to encode functional proteins, all of which have counterparts in other alphaherpesviruses. The availability of the sequences will facilitate future research on the diagnosis and treatment of canine herpesvirus-associated disease.	[Papageorgiou, Konstantinos V.; Suarez, Nicolas M.; Wilkie, Gavin S.; Davison, Andrew J.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland; [McDonald, Michael; Graham, Elizabeth M.] Univ Glasgow, Div Vet Pathol Publ Hlth & Dis Surveillance, Glasgow, Lanark, Scotland; [Papageorgiou, Konstantinos V.] Aristotle Univ Thessaloniki, Fac Vet, Sch Hlth Sci, Dept Microbiol & Infect Dis, GR-54006 Thessaloniki, Greece	University of Glasgow; University of Glasgow; Aristotle University of Thessaloniki	Davison, AJ (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland.	andrew.davison@glasgow.ac.uk		McDonald, Michael/0000-0002-6636-4283	Department of Microbiology and Infectious Diseases, Veterinary Faculty, Aristotle University of Thessaloniki; Greek Ministry of Defence; Medical Research Council [MC_UU_12014/3]; MRC [MC_UU_12014/3, MC_UU_12014/12, G0801822] Funding Source: UKRI; Medical Research Council [MC_UU_12014/12, G0801822] Funding Source: researchfish	Department of Microbiology and Infectious Diseases, Veterinary Faculty, Aristotle University of Thessaloniki; Greek Ministry of Defence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Department of Microbiology and Infectious Diseases, Veterinary Faculty, Aristotle University of Thessaloniki (to KP; www.auth.gr/en), the Greek Ministry of Defence (to KP; http://www.mod.mil.gr/mod/en/), and the Medical Research Council (grant number MC_UU_12014/3 to AD; http://www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arii J, 2006, MICROBES INFECT, V8, P1054, DOI 10.1016/j.micinf.2005.11.004; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Babaei H, 2010, TRANSBOUND EMERG DIS, V57, P348, DOI 10.1111/j.1865-1682.2010.01155.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benson KAS, 2006, J VIROL METHODS, V136, P261, DOI 10.1016/j.jviromet.2006.03.033; Burr PD, 1996, VET MICROBIOL, V53, P227, DOI 10.1016/S0378-1135(96)01227-8; CARMICHA.LE, 1965, AM J VET RES, V26, P803; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Delhon G, 2003, J VIROL, V77, P10339, DOI 10.1128/JVI.77.19.10339-10347.2003; Erles K, 2004, J CLIN MICROBIOL, V42, P4524, DOI 10.1128/JCM.42.10.4524-4529.2004; FULTON RW, 1974, AM J VET RES, V35, P853; Gandar F, 2015, J VIROL, V89, P11438, DOI 10.1128/JVI.01794-15; GOODHEART CR, 1975, PROG MED VIROL, V19, P324; Haanes EJ, 1998, VIRUS RES, V53, P151, DOI 10.1016/S0168-1702(97)00152-4; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Krogenaes A, 2012, THERIOGENOLOGY, V78, P153, DOI 10.1016/j.theriogenology.2012.01.031; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lembo D, 2004, J VIROL, V78, P4278, DOI 10.1128/JVI.78.8.4278-4288.2004; LIMBACH KJ, 1994, J GEN VIROL, V75, P2029, DOI 10.1099/0022-1317-75-8-2029; LUST G, 1971, J INFECT DIS, V124, P572, DOI 10.1093/infdis/124.6.572; MANNING A, 1988, J GEN VIROL, V69, P1601, DOI 10.1099/0022-1317-69-7-1601; Martina BEE, 2003, J GEN VIROL, V84, P1427, DOI 10.1099/vir.0.19005-0; MCGEOCH DJ, 1986, NUCLEIC ACIDS RES, V14, P1727, DOI 10.1093/nar/14.4.1727; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Miyoshi M, 1999, ARCH VIROL, V144, P407, DOI 10.1007/s007050050514; Miyoshi M, 2000, ARCH VIROL, V145, P1715, DOI 10.1007/s007050070086; Nishikawa Y, 1998, VIRUS RES, V56, P77, DOI 10.1016/S0168-1702(98)00062-8; OKUDA Y, 1993, AM J VET RES, V54, P551; Pellett PE, 2012, VIRUS TAXONOMY, P111, DOI DOI 10.1016/B978-0-12-384684-6.00007-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reading MJ, 1998, ARCH VIROL, V143, P1477, DOI 10.1007/s007050050391; Remond M, 1996, J GEN VIROL, V77, P37, DOI 10.1099/0022-1317-77-1-37; Remond M, 1995, VIRUS RES, V39, P341, DOI 10.1016/0168-1702(95)00089-5; Reubel GH, 2002, VIRUS GENES, V25, P195, DOI 10.1023/A:1020118003743; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Rijsewijk FAM, 1999, VET MICROBIOL, V65, P1, DOI 10.1016/S0378-1135(98)00285-5; Ronsse V, 2002, REPROD DOMEST ANIM, V37, P299, DOI 10.1046/j.1439-0531.2002.00363.x; ROTA PA, 1990, ARCH VIROL, V115, P139, DOI 10.1007/BF01310631; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyack SG, 2006, VIRUS GENES, V33, P299, DOI 10.1007/s11262-006-0069-5; Tyack SG, 1997, DNA SEQUENCE, V7, P365, DOI 10.3109/10425179709034057; Wilkie GS, 2014, SCI REP-UK, V4, DOI 10.1038/srep06299; Xuan XN, 1996, VIRUS GENES, V12, P185, DOI 10.1007/BF00572957; Yesilbag K, 2012, RES VET SCI, V92, P36, DOI 10.1016/j.rvsc.2010.10.016	46	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156015	10.1371/journal.pone.0156015	http://dx.doi.org/10.1371/journal.pone.0156015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213534	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000376880200046
J	Edwards, MO; Kotecha, SJ; Lowe, J; Richards, L; Watkins, WJ; Kotecha, S				Edwards, Martin O.; Kotecha, Sarah J.; Lowe, John; Richards, Louise; Watkins, W. John; Kotecha, Sailesh			Management of Prematurity-Associated Wheeze and Its Association with Atopy	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; CHRONIC LUNG-DISEASE; SCHOOL-CHILDREN BORN; PRETERM BIRTH; RESPIRATORY SYMPTOMS; GESTATIONAL-AGE; EARLY-CHILDHOOD; INFANTS; ASTHMA; TERM	Introduction Although preterm birth is associated with respiratory morbidity in childhood, the role of family history of atopy and whether appropriate treatment has been instituted is unclear. Thus we assessed (i) the prevalence of respiratory symptoms, particularly wheezing, in childhood; (ii) evaluated the role of family history of atopy and mode of delivery, and (iii) documented the drug usage, all in preterm-born children compared to term-born control children. Methods We conducted a cross-sectional population-based questionnaire study of 1-10 year-old preterm-born children (n = 13,361) and matched term-born controls (13,361). Data (n = 7,149) was analysed by gestational groups (24-32 weeks, 33-34 weeks, 35-36 weeks and 37-43 weeks) and by age, <5 years old or >= 5 years. Main Results Preterm born children aged <5 years (n = 2,111, term n = 1,402) had higher rates of wheeze-ever[ odds ratio: 2.7 (95% confidence intervals 2.2, 3.3); 1.8 (1.5, 2.2); 1.5 (1.3, 1.8) respectively for the 24-32 weeks, 33-34 weeks, 35-36 weeks groups compared to term]. Similarly for the = 5 year age group (n = 2,083, term n = 1,456) wheezing increased with increasing prematurity [odds ratios 3.3 (2.7, 4.1), 1.8 (1.5, 2.3) and 1.6 (1.3, 1.9) for the three preterm groups compared to term]. At both age groups, inhaler usage was greater in the lowest preterm group but prematurity-associated wheeze was independent of a family history of atopy. Conclusions Increasing prematurity was associated with increased respiratory symptoms, which were independent of a family history of atopy. Use of bronchodilators was also increased in the preterm groups but its efficacy needs careful evaluation.	[Edwards, Martin O.; Kotecha, Sarah J.; Lowe, John; Richards, Louise; Watkins, W. John; Kotecha, Sailesh] Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff, S Glam, Wales	Cardiff University	Kotecha, S (corresponding author), Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff, S Glam, Wales.	kotechas@cardiff.ac.uk		Kotecha, Sailesh/0000-0003-3535-7627	MRC Experimental Medicine Challenge Grant [MR/M022552/1]; Mason Medical Research Foundation; Children and Young Peoples Research Network Wales (CYPRN); MRC [MR/M022552/1] Funding Source: UKRI; Medical Research Council [MR/M022552/1] Funding Source: researchfish	MRC Experimental Medicine Challenge Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mason Medical Research Foundation; Children and Young Peoples Research Network Wales (CYPRN); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by MRC Experimental Medicine Challenge Grant (ref: MR/M022552/1), Mason Medical Research Foundation grant, and Children and Young Peoples Research Network Wales (CYPRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Astle V, 2015, J ASTHMA, V52, P40, DOI 10.3109/02770903.2014.952436; Been JV, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001596; Blanken MO, 2013, NEW ENGL J MED, V369, P782, DOI 10.1056/NEJMc1307429; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Burr ML, 2006, THORAX, V61, P296, DOI 10.1136/thx.2005.045682; CHAN KN, 1993, ARCH DIS CHILD, V69, P120, DOI 10.1136/adc.69.1.120; D'Souza-Vazirani D, 2005, ARCH PEDIAT ADOL MED, V159, P167, DOI 10.1001/archpedi.159.2.167; Damgaard AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117253; Edwards MO, 2015, J ALLERGY CLIN IMMUN, V136, P581, DOI 10.1016/j.jaci.2015.05.005; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Filippone M, 2013, EUR RESPIR J, V42, P1430, DOI 10.1183/09031936.00055913; Filippone M, 2012, EUR RESPIR J, V40, P1253, DOI 10.1183/09031936.00185511; Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011; Government W, 2015, WELSH IND MULT DEPR; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; John N, 2014, ALL WALES PERINATAL; Joshi S, 2007, EARLY HUM DEV, V83, P789, DOI 10.1016/j.earlhumdev.2007.09.007; Joshi S, 2013, J PEDIATR-US, V162, P813, DOI 10.1016/j.jpeds.2012.09.040; Kallen B, 2013, EUR RESPIR J, V41, P671, DOI 10.1183/09031936.00041912; Kotecha S, 2002, ARCH DIS CHILD-FETAL, V87, pF11, DOI 10.1136/fn.87.1.F11; Kotecha SJ, 2015, NEONATOLOGY, V107, P231, DOI 10.1159/000371539; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Kotecha SJ, 2012, SEMIN FETAL NEONAT M, V17, P77, DOI 10.1016/j.siny.2012.01.004; Kotecha SJ, 2012, THORAX, V67, P54, DOI 10.1136/thoraxjnl-2011-200329; Kotecha SJ, 2010, AM J RESP CRIT CARE, V181, P969, DOI 10.1164/rccm.200906-0897OC; Lal MK, 2003, PEDIATRICS, V111, P483, DOI 10.1542/peds.111.3.483; Martin RJ, 2013, J PEDIATR-US, V162, P443, DOI 10.1016/j.jpeds.2012.11.028; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Pan H, LMSGROWTH MICROSOFT; Paranjothy S, 2013, PEDIATRICS, V132, pE1562, DOI 10.1542/peds.2013-1737; Pelkonen AS, 1997, AM J RESP CRIT CARE, V156, P1178, DOI 10.1164/ajrccm.156.4.9610028; Pelkonen AS, 2001, RESP MED, V95, P565, DOI 10.1053/rmed.2001.1104; Powell CVE, 2002, ARCH DIS CHILD, V87, P376, DOI 10.1136/adc.87.5.376; Pruteanu AI, 2014, COCHRANE DB SYST REV, DOI [10.1002/ebch.1989, 10.1002/14651858.CD009878.pub2]; Rosas-Salazar C, 2014, J ALLERGY CLIN IMMUN, V133, P357, DOI 10.1016/j.jaci.2013.09.003; Sheikh S, 2001, CHEST, V120, P1190, DOI 10.1378/chest.120.4.1190; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Teig N, 2012, J PEDIATR-US, V161, P1085, DOI 10.1016/j.jpeds.2012.06.007; Trinick R, 2012, EUR RESPIR J, V39, P899, DOI 10.1183/09031936.00070311; Vernacchio L, 2007, J AM BOARD FAM MED, V20, P160, DOI 10.3122/jabfm.2007.02.060125; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Vrijlandt EJLE, 2013, AM J RESP CRIT CARE, V187, P1234, DOI 10.1164/rccm.201211-2070OC; Wong PM, 2008, EUR RESPIR J, V32, P321, DOI 10.1183/09031936.00127107; Yuan W, 2003, EUR J EPIDEMIOL, V18, P763, DOI 10.1023/A:1025390420122	46	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155695	10.1371/journal.pone.0155695	http://dx.doi.org/10.1371/journal.pone.0155695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203564	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000376291500020
J	Hulsegge, G; Spijkerman, AMW; van der Schouw, YT; Bakker, SJL; Gansevoort, RT; Smit, HA; Verschuren, WMM				Hulsegge, Gerben; Spijkerman, Annemieke M. W.; van der Schouw, Yvonne T.; Bakker, Stephan J. L.; Gansevoort, Ron T.; Smit, Henriette A.; Verschuren, W. M. Monique			Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease - The Doetinchem Cohort Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; C-REACTIVE PROTEIN; AMERICAN-HEART-ASSOCIATION; NECROSIS-FACTOR-ALPHA; FATTY LIVER-DISEASE; BODY-MASS INDEX; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; 52 COUNTRIES; FOLLOW-UP	Risk factors often develop at young age and are maintained over time, but it is not fully understood how risk factors develop over time preceding cardiovascular disease (CVD). Our objective was to examine how levels and trajectories of metabolic risk factors and biochemical markers prior to diagnosis differ between people with and without CVD over a period of up to 15-20 years. A total of 449 incident non-fatal and fatal CVD cases and 1,347 age-and sex-matched controls were identified in a prospective cohort between 1993 and 2011. Metabolic risk factors and biochemical markers were measured at five-year intervals prior to diagnosis. Trajectories of metabolic risk factors and biochemical markers were analysed using random coefficient analyses. Although not always statistically significant, participants with CVD had slightly more unfavourable levels for most metabolic risk factors and biochemical markers 15-20 years before diagnosis than controls. Subsequent trajectories until diagnosis were similar in participants with incident CVD and controls for body mass index, diastolic blood pressure, total cholesterol, HDL cholesterol, random glucose, triglycerides, gamma glutamyltransferase, C-reactive protein and uric acid. Trajectories were more unfavourable in participants with CVD than controls for systolic blood pressure, waist circumference and estimated glomerular filtration rate (p <= 0.05). For example, among participants with CVD, systolic blood pressure increased on average by 9 mmHg over the 18-year period preceding diagnosis, whereas the increase among controls was 4 mmHg. In conclusion, unfavourable levels of metabolic risk factors and biochemical markers are present long before CVD, which indicates that the risk of CVD is already partly determined in young adulthood. This underscores the need for early prevention to reduce the burden of CVD.	[Hulsegge, Gerben; Spijkerman, Annemieke M. W.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv Natl, NL-3720 BA Bilthoven, Netherlands; [Hulsegge, Gerben; van der Schouw, Yvonne T.; Smit, Henriette A.; Verschuren, W. M. Monique] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bakker, Stephan J. L.; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 AV Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Groningen	Hulsegge, G (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv Natl, NL-3720 BA Bilthoven, Netherlands.; Hulsegge, G (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	gerben.hulsegge@rivm.nl	van der Schouw, Yvonne T./F-8327-2014	van der Schouw, Yvonne T./0000-0002-4605-435X; Hulsegge, Gerben/0000-0003-4649-9436	Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health and the Environment [S/260236/01/LC]; Biobanking and Biomolecular Resources Research Infrastructure Grant [CP2011-27]	Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health and the Environment; Biobanking and Biomolecular Resources Research Infrastructure Grant	This work was supported by the Ministry of Health, Welfare and Sport of the Netherlands and the National Institute for Public Health and the Environment (Grant number: S/260236/01/LC), and the Biobanking and Biomolecular Resources Research Infrastructure (Grant number: CP2011-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN LB, 1993, J INTERN MED, V234, P309, DOI 10.1111/j.1365-2796.1993.tb00748.x; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Chirovsky DR, 2009, EUR J CARDIOV PREV R, V16, P404, DOI 10.1097/HJR.0b013e32832c8891; Church TS, 2006, GASTROENTEROLOGY, V130, P2023, DOI 10.1053/j.gastro.2006.03.019; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; de Bruin A, 2003, KOPPELING VAN LMR EN; DeClercq Vanessa, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P228, DOI 10.2174/187152908785849080; Eckel RH, 1997, CIRCULATION, V96, P3248, DOI 10.1161/01.CIR.96.9.3248; Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Goldstein BA, 2015, BIOMETRICS, V71, P478, DOI 10.1111/biom.12283; Guerra Sandra, 2003, Rev Port Cardiol, V22, P167; Hirokawa J, 1998, J BIOCHEM, V123, P733; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hulsegge G, 2016, EUR J PUBLIC HEALTH, V26, P135, DOI 10.1093/eurpub/ckv125; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; KEMPER HCG, 1990, PREV MED, V19, P642, DOI 10.1016/0091-7435(90)90061-N; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Nguyen S, 2007, CURR OPIN NEPHROL HY, V16, P71, DOI 10.1097/MNH.0b013e32802ef4b6; PAGNAN A, 1982, PREV MED, V11, P381, DOI 10.1016/0091-7435(82)90042-1; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Siani A, 2002, AM J HYPERTENS, V15, P780, DOI 10.1016/S0895-7061(02)02976-X; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; STOKES J, 1987, CIRCULATION, V75, P65; Tabak AG, 2010, EUR J ENDOCRINOL, V163, P89, DOI 10.1530/EJE-10-0277; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thapa BR, 2007, INDIAN J PEDIATR, V74, P663, DOI 10.1007/s12098-007-0118-7; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Twisk JWR, 1997, AM J EPIDEMIOL, V145, P888, DOI 10.1093/oxfordjournals.aje.a009048; Vaartjes I, 2013, HART VAATZIEKTEN NED; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; WILLIAMS KM, 1987, TRANSFUSION, V27, P431, DOI 10.1046/j.1537-2995.1987.27587320539.x; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Yu X, 2008, J GERIATR CARDIOL, V5, P223; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	45	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155978	10.1371/journal.pone.0155978	http://dx.doi.org/10.1371/journal.pone.0155978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203599	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291500036
J	Moghal, A; Hwang, L; Faull, K; Ibba, M				Moghal, Adil; Hwang, Lin; Faull, Kym; Ibba, Michael			Multiple Quality Control Pathways Limit Non-protein Amino Acid Use by Yeast Cytoplasmic Phenylalanyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; GENETIC-CODE; PROTEIN-BIOSYNTHESIS; MISTRANSLATION; TRANSLATION; TYROSINE; SPECIFICITY; FREQUENCY; ERRORS; CELLS	Non-protein amino acids, particularly isomers of the proteinogenic amino acids, present a threat to proteome integrity if they are mistakenly inserted into proteins. Quality control during aminoacyl-tRNA synthesis reduces non-protein amino acid incorporation by both substrate discrimination and proofreading. For example phenylalanyl-tRNA synthetase (PheRS) proofreads the non-protein hydroxylated phenylalanine derivative m-Tyr after its attachment to tRNAPhe. We now show in Saccharomyces cerevisiae that PheRS misacylation of tRNAPhe with the more abundant Phe oxidation product o-Tyr is limited by kinetic discrimination against o-Tyr-AMP in the transfer step followed by o-Tyr-AMP release from the synthetic active site. This selective rejection of a non-protein aminoacyl-adenylate is in addition to known kinetic discrimination against certain non-cognates in the activation step as well as catalytic hydrolysis of mispaired aminoacyl-tRNAPhe species. We also report an unexpected resistance to cytotoxicity by a S. cerevisiae mutant with ablated post-transfer editing activity when supplemented with o-Tyr, cognate Phe, or Ala, the latter of which is not a substrate for activation by this enzyme. Our phenotypic, metabolomic, and kinetic analyses indicate at least three modes of discrimination against non-protein amino acids by S. cerevisiae PheRS and support a non-canonical role for SccytoPheRS post-transfer editing in response to amino acid stress.	[Moghal, Adil; Ibba, Michael] Ohio State Univ, Dept Microbiol, Ohio State Biochem Program, Columbus, OH 43210 USA; [Hwang, Lin; Faull, Kym] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	Ohio State University; University of California System; University of California Los Angeles	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 West 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu		Moghal, Adil/0000-0003-4097-331X	National Institutes of Health [T32 GM008512, GM086252]; National Science Foundation [MCB-1412611, MCB 1412773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM086252, T32GM008512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Training Grants T32 GM008512 and GM086252 (to A. M.). This work was also supported by National Science Foundation Grants MCB-1412611 and MCB 1412773. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Bullwinkle T, 2014, ANNU REV GENET, V48, P149, DOI 10.1146/annurev-genet-120213-092101; Bullwinkle TJ, 2016, P NATL ACAD SCI USA, V113, P2252, DOI 10.1073/pnas.1525206113; Bullwinkle TJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02501; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; FAULL KF, 1977, PEDIATR RES, V11, P631, DOI 10.1203/00006450-197705000-00002; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Ling JQ, 2012, J BIOL CHEM, V287, P28518, DOI 10.1074/jbc.M112.372920; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; LOFTFIELD RB, 1963, BIOCHEM J, V89, P82, DOI 10.1042/bj0890082; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Poljak A, 2003, REDOX REP, V8, P371, DOI 10.1179/135100003225003401; Popp O, 2015, BIOTECHNOL BIOENG, V112, P1187, DOI 10.1002/bit.25528; Raina M, 2014, J BIOL CHEM, V289, P17780, DOI 10.1074/jbc.M114.564609; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Yadavalli SS, 2013, NUCLEIC ACIDS RES, V41, P1104, DOI 10.1093/nar/gks1240	28	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15796	15805		10.1074/jbc.M116.726828	http://dx.doi.org/10.1074/jbc.M116.726828			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226603	Green Published, hybrid			2022-12-26	WOS:000380584200032
J	Oikawa, T; Nonaka, T; Terada, M; Tamaoka, A; Hisanaga, S; Hasegawa, M				Oikawa, Takayuki; Nonaka, Takashi; Terada, Makoto; Tamaoka, Akira; Hisanaga, Shin-ichi; Hasegawa, Masato			alpha-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SYSTEM ATROPHY; LEWY BODY DISEASE; NEURODEGENERATIVE-DISEASES; PARKINSONS-DISEASE; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; IN-VITRO; FILAMENTS; PROTEIN; MUTATION	alpha-synuclein is the major component of Lewy bodies and Lewy neurites in Parkinson disease and dementia with Lewy bodies and of glial cytoplasmic inclusions in multiple system atrophy. It has been suggested that alpha-synuclein fibrils or intermediate protofibrils in the process of fibril formation may have a toxic effect on neuronal cells. In this study, we investigated the ability of soluble monomeric alpha-synuclein to promote microtubule assembly and the effects of conformational changes of alpha-synuclein on Tau -promoted microtubule assembly. In marked contrast to previous findings, monomeric alpha-synuclein had no effect on microtubule polymerization. However, both alpha-synuclein fibrils and protofibrils inhibited Tau-promoted micro tubule assembly. The inhibitory effect of alpha-synuclein fibrils was greater than that of the protofibrils. Dot blot overlay assay and spin -down techniques revealed that alpha-synuclein fibrils bind to Tau and inhibit microtubule assembly by depleting the Tau available for microtubule polymerization. Using various deletion mutants of a.-synuclein and Tau, the acidic C-terminal region of alpha-synuclein and the basic central region of Tau were identified as regions involved in the binding. Furthermore, introduction of alpha-synuclein fibrils into cultured cells overexpressing Tau protein induced Tau aggregation. These results raise the possibility that alpha-synuclein fibrils interact with Tau, inhibit its function to stabilize microtubules, and also promote Tau aggregation, leading to dysfunction of neuronal cells.	[Oikawa, Takayuki; Nonaka, Takashi; Terada, Makoto; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 1568506, Japan; [Oikawa, Takayuki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; [Terada, Makoto; Tamaoka, Akira] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Neurol, Tsukuba, Ibaraki 3058576, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University; University of Tsukuba	Hasegawa, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan.	hasegawa-ms@igakuken.or.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403	Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants [26117005, 15H02356, 26111730]; Japan Society for the Promotion of Science KAKENHI Grant [23228004]; Ministry of Health, Labor, and Welfare of Japan [13800916]; Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED	Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants; Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants 26117005 and 15H02356 (to M. H.) and 26111730 (to T. N.),Japan Society for the Promotion of Science KAKENHI Grant 23228004 (to M. H.), Ministry of Health, Labor, and Welfare of Japan Grant 13800916 (to M. H.), grant-in-aid for research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis,and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Castillo P. E., 2000, NEURON, V25, P239; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Colom-Cadena M, 2013, J NEUROPATH EXP NEUR, V72, P1203, DOI 10.1097/NEN.0000000000000018; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Feany MB, 2003, NEURON, V40, P1, DOI 10.1016/S0896-6273(03)00600-7; Fujishiro H, 2008, ACTA NEUROPATHOL, V116, P17, DOI 10.1007/s00401-008-0383-1; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hinckelmann MV, 2013, TRENDS CELL BIOL, V23, P634, DOI 10.1016/j.tcb.2013.08.007; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lindersson EK, 2004, NEUROREPORT, V15, P2735; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Merrick SE, 1997, J NEUROSCI, V17, P5726; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WEISENBERG RC, 1984, J CELL BIOL, V99, P1527, DOI 10.1083/jcb.99.4.1527; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	58	48	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15046	15056		10.1074/jbc.M116.736355	http://dx.doi.org/10.1074/jbc.M116.736355			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226637	Green Published, hybrid			2022-12-26	WOS:000380583200016
J	Das, F; Dey, N; Bera, A; Kasinath, BS; Ghosh-Choudhury, N; Choudhury, GG				Das, Falguni; Dey, Nirmalya; Bera, Amit; Kasinath, Balakuntalam S.; Ghosh-Choudhury, Nandini; Choudhury, Goutam Ghosh			MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; cancer; cell signaling; microRNA (miRNA); mTOR complex (mTORC)	PHASE-III TRIAL; MAMMALIAN TARGET; CLEAR-CELL; MESSENGER-RNA; TRANSLATION INITIATION; TUMOR PROGRESSION; PROMOTER ACTIVITY; MESANGIAL CELLS; CANCER; RAPAMYCIN	Elevated IGF-1/insulin-like growth factor-1 receptor (IGF-1R) autocrine/paracrine signaling in patients with renal cell carcinoma is associated with poor prognosis of the disease independent of their von Hippel-Lindau (VHL) status. Increased expression of IGF-1R in renal cancer cells correlates with their potency of tumor development and progression. The mechanism by which expression of IGF-1R is increased in renal carcinoma is not known. We report that VHL-deficient and VHL-positive renal cancer cells possess significantly decreased levels of mature, pre-, and pri-miR-214 than normal proximal tubular epithelial cells. We identified an miR-214 recognition element in the 3UTR of IGF-1R mRNA and confirmed its responsiveness to miR-214. Overexpression of miR-214 decreased the IGF-1R protein levels, resulting in the inhibition of Akt kinase activity in both types of renal cancer cells. IGF-1 provoked phosphorylation and inactivation of PRAS40 in an Akt-dependent manner, leading to the activation of mTORC1 signal transduction to increase phosphorylation of S6 kinase and 4EBP-1. Phosphorylation-deficient mutants of PRAS40 and 4EBP-1 significantly inhibited IGF-1R-driven proliferation of renal cancer cells. Expression of miR-214 suppressed IGF-1R-induced phosphorylation of PRAS40, S6 kinase, and 4EBP-1, indicating inhibition of mTORC1 activity. Finally, miR-214 significantly blocked IGF-1R-forced renal cancer cell proliferation, which was reversed by expression of 3UTR-less IGF-1R and constitutively active mTORC1. Together, our results identify a reciprocal regulation of IGF-1R levels and miR-214 expression in renal cancer cells independent of VHL status. Our data provide evidence for a novel mechanism for IGF-1R-driven renal cancer cell proliferation involving miR-214 and mTORC1.	[Kasinath, Balakuntalam S.; Ghosh-Choudhury, Nandini; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Vet Affairs Res & Geriatr Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Educ & Clin Ctr, San Antonio, TX 78229 USA; [Das, Falguni; Dey, Nirmalya; Bera, Amit; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Choudhury, GG (corresponding author), South Texas Vet Hlth Care Syst, Vet Affairs Res & Geriatr Res, San Antonio, TX 78229 USA.; Choudhury, GG (corresponding author), South Texas Vet Hlth Care Syst, Educ & Clin Ctr, San Antonio, TX 78229 USA.; Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			Veterans Affairs Research Service Merit Review Grant [2 I01 BX000926]; National Institutes of Health [RO1 DK50190]; Veterans Affairs Merit Review Grant [5I01BX001340, 5I01BX000150]; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000926] Funding Source: NIH RePORTER	Veterans Affairs Research Service Merit Review Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Veterans Affairs Research Service Merit Review Grant 2 I01 BX000926 and National Institutes of Health Grant RO1 DK50190 (to G. G. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Veterans Affairs Merit Review Grant 5I01BX001340.; Supported by Veterans Affairs Merit Review Grant 5I01BX000150.; Recipient of a Veterans Affairs Senior Research Career Scientist Award. To whom correspondence should be addressed. E-mail: choudhuryg@uthscsa.edu.	Abou Youssif T, 2011, CANCER-AM CANCER SOC, V117, P290, DOI 10.1002/cncr.25402; ALMEIDA A, 1994, GENE CHROMOSOME CANC, V11, P63, DOI 10.1002/gcc.2870110110; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BASERGA R, 1995, CANCER RES, V55, P249; Bera A, 2014, EXP CELL RES, V328, P99, DOI 10.1016/j.yexcr.2014.06.022; Bera A, 2013, CELL SIGNAL, V25, P2575, DOI 10.1016/j.cellsig.2013.08.005; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Burgos SA, 2010, DOMEST ANIM ENDOCRIN, V38, P211, DOI 10.1016/j.domaniend.2009.10.005; Cheung C, 2005, INT J UROL, V12, P17, DOI 10.1111/j.1442-2042.2004.00993.x; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cho D, 2007, CLIN GENITOURIN CANC, V5, P379, DOI 10.3816/CGC.2007.n.020; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109608; Das F, 2012, J BIOL CHEM, V287, P3808, DOI 10.1074/jbc.M111.246397; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037366; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Grosshans H, 2010, CANCER CELL, V18, P295, DOI 10.1016/j.ccr.2010.10.005; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; KALEKO M, 1990, MOL CELL BIOL, V10, P464, DOI 10.1128/MCB.10.2.464; Karumanchi SA, 2002, CURR OPIN NEPHROL HY, V11, P37, DOI 10.1097/00041552-200201000-00006; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Mahimainathan L, 2009, J BIOL CHEM, V284, P27790, DOI 10.1074/jbc.M109.028860; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maor SB, 2000, MOL GENET METAB, V69, P130, DOI 10.1006/mgme.1999.2958; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Meng Z, 2008, J CELL PHYSIOL, V217, P172, DOI 10.1002/jcp.21486; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Neal CS, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-64; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Parker AS, 2004, CANCER-AM CANCER SOC, V100, P2577, DOI 10.1002/cncr.20322; Parker AS, 2003, J UROLOGY, V170, P420, DOI 10.1097/01.ju.0000071474.70103.92; Parker AS, 2002, HUM PATHOL, V33, P801, DOI 10.1053/hupa.2002.126186; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Qian CN, 2009, CANCER RES, V69, P8256, DOI 10.1158/0008-5472.CAN-09-1689; Rasmuson T, 2004, ACTA ONCOL, V43, P744, DOI 10.1080/02841860410017260; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Rosendahl A, 2004, INT J ONCOL, V25, P1327; Rosendahl AH, 2008, INT J CANCER, V123, P1286, DOI 10.1002/ijc.23642; Rouviere O, 2006, NAT CLIN PRACT ONCOL, V3, P200, DOI 10.1038/ncponc0479; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Schips L, 2004, AM J CLIN PATHOL, V122, P931, DOI 10.1309/G7PY0RE7T86HQYV; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Traynor K, 2009, AM J HEALTH-SYST PH, V66, P788, DOI 10.2146/news090037; Venkatesan B, 2008, FASEB J, V22, P3469, DOI 10.1096/fj.08-109488; Wang YH, 2009, MECH DEVELOP, V126, P781, DOI 10.1016/j.mod.2009.08.005; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yakar S, 2005, J Endocrinol Invest, V28, P19; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Yu ZW, 2010, ORAL ONCOL, V46, P317, DOI 10.1016/j.oraloncology.2010.02.002; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	91	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14662	14676		10.1074/jbc.M115.694331	http://dx.doi.org/10.1074/jbc.M115.694331			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226530	Green Published, hybrid			2022-12-26	WOS:000380366700021
J	Valencia-Sanchez, MI; Rodriguez-Hernandez, A; Ferreira, R; Santamaria-Suarez, HA; Arciniega, M; Dock-Bregeon, AC; Moras, D; Beinsteiner, B; Mertens, H; Svergun, D; Brieba, LG; Grotli, M; Torres-Larios, A				Igor Valencia-Sanchez, Marco; Rodriguez-Hernandez, Annia; Ferreira, Ruben; Anibal Santamaria-Suarez, Hugo; Arciniega, Marcelino; Dock-Bregeon, Anne-Catherine; Moras, Dino; Beinsteiner, Brice; Mertens, Haydyn; Svergun, Dmitri; Brieba, Luis G.; Grotli, Morten; Torres-Larios, Alfredo			Structural Insights into the Polyphyletic Origins of Glycyl tRNA Synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; crystal structure; molecular evolution; structure-function; substrate specificity	HORIZONTAL GENE-TRANSFER; ESCHERICHIA-COLI; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; BETA-SUBUNIT; AMINO-ACIDS; PROTEIN; EVOLUTION; CODE	Glycyl tRNA synthetase (GlyRS) provides a unique case among class II aminoacyl tRNA synthetases, with two clearly widespread types of enzymes: a dimeric ((2)) species present in some bacteria, archaea, and eukaryotes; and a heterotetrameric form ((22)) present in most bacteria. Although the differences between both types of GlyRS at the anticodon binding domain level are evident, the extent and implications of the variations in the catalytic domain have not been described, and it is unclear whether the mechanism of amino acid recognition is also dissimilar. Here, we show that the -subunit of the (22) GlyRS from the bacterium Aquifex aeolicus is able to perform the first step of the aminoacylation reaction, which involves the activation of the amino acid with ATP. The crystal structure of the -subunit in the complex with an analog of glycyl adenylate at 2.8 angstrom resolution presents a conformational arrangement that properly positions the cognate amino acid. This work shows that glycine is recognized by a subset of different residues in the two types of GlyRS. A structural and sequence analysis of class II catalytic domains shows that bacterial GlyRS is closely related to alanyl tRNA synthetase, which led us to define a new subclassification of these ancient enzymes and to propose an evolutionary path of (22) GlyRS, convergent with (2) GlyRS and divergent from AlaRS, thus providing a possible explanation for the puzzling existence of two proteins sharing the same fold and function but not a common ancestor.	[Igor Valencia-Sanchez, Marco; Rodriguez-Hernandez, Annia; Anibal Santamaria-Suarez, Hugo; Arciniega, Marcelino; Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estructural, Inst Fisiol Celular, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico; [Rodriguez-Hernandez, Annia; Brieba, Luis G.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Irapuato 04510, Guanajuato, Mexico; [Ferreira, Ruben; Grotli, Morten] Univ Gothenburg, Dept Chem & Mol Biol, SE-41296 Gothenburg, Sweden; [Dock-Bregeon, Anne-Catherine] CNRS, Lab Biol Integrat Milieux Marins, F-29680 Roscoff, France; [Moras, Dino; Beinsteiner, Brice] CNRS, Ctr Integrat Biol, Dept Integrated Struct Biol, Inst Genet & Mol & Cellular Biol,UMR 7104, 1 Rue Laurent Fries, Illkirch Graffenstaden, France; [Mertens, Haydyn; Svergun, Dmitri] DESY, Hamburg Outstat, European Mol Biol Lab, Notkestr 85, D-22603 Hamburg, Germany	Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Torres-Larios, A (corresponding author), Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	torres@ifc.unam.mx	Grötli, Morten/A-8735-2010; Rodriguez-Hernandez, Annia/AAF-2479-2020; Brieba, Luis/I-8447-2016	Grötli, Morten/0000-0003-3621-4222; Rodriguez-Hernandez, Annia/0000-0002-6206-3766; Brieba, Luis/0000-0002-6073-5207; Dock-Bregeon, Anne-Catherine/0000-0002-6913-4061; Svergun, Dmitri/0000-0003-0830-5696; Mertens, Haydyn/0000-0002-5664-744X; Arciniega, Marcelino/0000-0002-7526-6941; Torres-Larios, Alfredo/0000-0002-0702-350X; Valencia, Marco/0000-0002-7199-4546	United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant [085P1000817]	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor Grant	We thank Elizabeth Nallely Cabrera Gonzalez and Nevena Cvetesic for scientific and technical guidance, Prof. John J. Perona for the gift of gene coding for the tRNA nucleotidyltransferase, and Martha Contreras and Beatriz Aguirre Lopez for technical support. The critical reading by Jonathan Ipsaro and Rajan Sankaranarayanan is greatly acknowledged. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science at Argonne National Laboratory, was supported by the United States Department of Energy under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnez JG, 1999, J MOL BIOL, V286, P1449, DOI 10.1006/jmbi.1999.2562; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; BERG P, 1956, J BIOL CHEM, V222, P1015; BERG P, 1958, P NATL ACAD SCI USA, V44, P78, DOI 10.1073/pnas.44.2.78; BERGMANN F, 1961, J BIOL CHEM, V236, P1735; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Blanchet CE, 2015, J SYNCHROTRON RADIAT, V22, P461, DOI 10.1107/S160057751402829X; BURBAUM JJ, 1990, PROTEINS, V7, P99, DOI 10.1002/prot.340070202; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Caetano-Anolles G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072225; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chien CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094659; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englert M, 2013, FEBS LETT, V587, P3360, DOI 10.1016/j.febslet.2013.08.037; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Finarov I, 2010, STRUCTURE, V18, P343, DOI 10.1016/j.str.2010.01.002; Fournier GP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0350-0; Fournier GP, 2009, PHILOS T R SOC B, V364, P2229, DOI 10.1098/rstb.2009.0033; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Freist W, 1996, BIOL CHEM H-S, V377, P343; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Giege R., 2013, ECOSAL PLUS, DOI [10.1128/ecosalplus.ESP-0002-201, DOI 10.1128/ECOSALPLUS.ESP-0002-201]; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P935, DOI 10.1107/S090744490703315X; Klipcan L, 2013, TRENDS BIOCHEM SCI, V38, P229, DOI 10.1016/j.tibs.2012.11.002; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Lichtarge O, 2001, NAT STRUCT BIOL, V8, P918, DOI 10.1038/nsb1101-918; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Majorek KA, 2014, NUCLEIC ACIDS RES, V42, P4160, DOI 10.1093/nar/gkt1414; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; Mazauric MH, 1998, EUR J BIOCHEM, V251, P744, DOI 10.1046/j.1432-1327.1998.2510744.x; MCDONALD T, 1980, BIOCHEMISTRY-US, V19, P1402, DOI 10.1021/bi00548a022; NAGEL GM, 1984, NUCLEIC ACIDS RES, V12, P4377, DOI 10.1093/nar/12.10.4377; Nawaz M., 2008, WILEY ENCY CHEM BIOL, DOI [10.1002/9780470048672.wecb008, DOI 10.1002/9780470048672.WECB008]; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Donoghue P, 2005, J MOL BIOL, V346, P875, DOI 10.1016/j.jmb.2004.11.053; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Okamoto Koji, 2005, Nucleic Acids Symp Ser (Oxf), P299, DOI 10.1093/nass/49.1.299; OSTREM DL, 1970, P NATL ACAD SCI USA, V67, P1967, DOI 10.1073/pnas.67.4.1967; OSTREM DL, 1974, BIOCHEMISTRY-US, V13, P1338, DOI 10.1021/bi00704a006; Pang YLJ, 2014, WIRES RNA, V5, P461, DOI 10.1002/wrna.1224; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PREISS J, 1959, P NATL ACAD SCI USA, V45, P319, DOI 10.1073/pnas.45.3.319; Redwan IN, 2012, EUR J ORG CHEM, V2012, P3665, DOI 10.1002/ejoc.201200329; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Rodriguez-Hernandez A, 2011, STRUCTURE, V19, P386, DOI 10.1016/j.str.2010.12.017; Rodriguez-Hernandez A, 2010, BIOCHEMISTRY-US, V49, P6727, DOI 10.1021/bi100886z; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; Schimmel P, 2011, PHILOS T R SOC B, V366, P2965, DOI 10.1098/rstb.2011.0158; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Smith TF, 2015, FEBS LETT, V589, P3499, DOI 10.1016/j.febslet.2015.10.006; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Tan Kemin, 2012, Journal of Structural and Functional Genomics, V13, P233, DOI 10.1007/s10969-012-9142-6; Tang SN, 2005, FEBS LETT, V579, P1441, DOI 10.1016/j.febslet.2005.01.045; TOTH MJ, 1990, J BIOL CHEM, V265, P1000; TOTH MJ, 1990, J BIOL CHEM, V265, P1005; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, GENOME RES, V9, P689; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045	84	9	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14430	14446		10.1074/jbc.M116.730382	http://dx.doi.org/10.1074/jbc.M116.730382			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226617	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000380366700003
J	Cao, GC; Jia, M; Zhao, X; Wang, LB; Tu, XB; Wang, GJ; Nong, XQ; Zhang, ZH				Cao, Guangchun; Jia, Miao; Zhao, Xia; Wang, Lei; Tu, Xiongbing; Wang, Guangjun; Nong, Xiangqun; Zhang, Zehua			Different Effects of Metarhizium anisopliae Strains IMI330189 and IBC200614 on Enzymes Activities and Hemocytes of Locusta migratoria L.	PLOS ONE			English	Article							PROPHENOLOXIDASE-ACTIVATING SYSTEM; BEAUVERIA-BASSIANA; ENTOMOPATHOGENIC FUNGUS; OXIDATIVE STRESS; IMMUNE-RESPONSE; INSECTICIDE-RESISTANCE; PHENOLOXIDASE ACTIVITY; ACETYLCHOLINESTERASE; EXPRESSION; DESTRUXINS	Background Metarhizium is an important class of entomopathogenic fungi in the biocontrol of insects, but its virulence is affected by insect immunity. To clarify the mechanism in virulence of Metarhizium, we compared the immunological differences in Locusta migratoria L. when exposed to two strains of Metarhizium anisopliae (Ma). Results The virulence of Ma IMI330189 was significantly higher than that of Ma IBC200614 to locust, and IMI330189 overcame the hemocytes and began destroying the hemocytes of locust at 72 h after spray, while locust is immune to IBC200614. IMI330189 could overcome the humoral immunity of locust by inhibiting the activities of phenol oxidase (PO), esterases, multi-function oxidases (MFOs) and acetylcholinesterases in locust while increasing the activities of glutathione-S-transferases (GSTs), catalase and aryl-acylamidase (AA). However IBC200614 inhibit the activities of GSTs and AA in locust and increase the activities of MFOs, PO, superoxide dismutase, peroxidase and chitinase in locust. The changes of enzymes activities in period of infection showed that the time period between the 2nd and the 5th day after spray is critical in the pathogenic process. Conclusion These results found the phenomenon that Ma initiatively broke host hemocytes, revealed the correlation between the virulence of Ma and the changes of enzymes activities in host induced by Ma, and clarified the critical period in the infection of Ma. So, these results should provide guidance for the construction of efficient biocontrol Ma strains.	[Cao, Guangchun; Jia, Miao; Zhao, Xia; Wang, Lei; Tu, Xiongbing; Wang, Guangjun; Nong, Xiangqun; Zhang, Zehua] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, ZH (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	zhangzehua@caas.cn		Zehua, Zhang/0000-0002-0648-8954	National Natural Science Foundation of China [31471823]; Special Fund for Agro-scientific Research in the Public Interest [201003079]; earmarked fund for China Agriculture Research System [CARS-35-07]; Innovation Project of Chinese Academy of Agricultural Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System; Innovation Project of Chinese Academy of Agricultural Sciences	This study was supported by the "National Natural Science Foundation of China, 31471823", "The Special Fund for Agro-scientific Research in the Public Interest, 201003079", "The earmarked fund for China Agriculture Research System, CARS-35-07" and Innovation Project of Chinese Academy of Agricultural Sciences.	AHMAD S, 1992, BIOCHEM SYST ECOL, V20, P269, DOI 10.1016/0305-1978(92)90040-K; Anggraeni T, 2011, ENTOMOL RES, V41, P1, DOI 10.1111/j.1748-5967.2010.00311.x; Barata C, 2004, AQUAT TOXICOL, V66, P125, DOI 10.1016/j.aquatox.2003.07.004; Bartholomay LC, 2004, INSECT MOL BIOL, V13, P125, DOI 10.1111/j.0962-1075.2004.00467.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chang CC, 2013, AQUAT TOXICOL, V130, P18, DOI 10.1016/j.aquatox.2012.12.024; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; Chaurasia A, 2016, PESTIC BIOCHEM PHYS, V127, P28, DOI 10.1016/j.pestbp.2015.09.002; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Dubovskiy I.M., 2012, ENTOMOL REV, V92, P27, DOI DOI 10.1134/S0013873812010022; El-Demerdash FM, 2013, J ENVIRON SCI HEAL B, V48, P593, DOI 10.1080/03601234.2013.774998; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Felton G.W., 1995, OXIDATIVE STRESS ANT, P356, DOI DOI 10.1007/978-1-4615-9689-9_10; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Feyereisen R, 2005, COMPREHENSIVE MOL IN, V4, P1; Finney DJ, 1971, PROBIT ANAL; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; Gillespie JP, 2000, J INSECT PHYSIOL, V46, P429, DOI 10.1016/S0022-1910(99)00128-6; Glupov VV, 2001, INSECT PATHOGENS STR, P475; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gopalakrishnan S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/824962; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; GUPTA S, 1989, J LIQ CHROMATOGR, V12, P383, DOI 10.1080/01483918908051742; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; HANSEN LG, 1971, BIOCHEM PHARMACOL, V20, P1569, DOI 10.1016/0006-2952(71)90285-1; Hicks BJ, 2001, FOREST ECOL MANAG, V149, P275, DOI 10.1016/S0378-1127(00)00561-2; Hillyer JF, 2005, CELL MICROBIOL, V7, P39, DOI 10.1111/j.1462-5822.2004.00430.x; HSU SC, 1975, APPL MICROBIOL, V29, P422, DOI 10.1128/AEM.29.3.422-426.1975; Hung SY, 1996, J INVERTEBR PATHOL, V67, P35, DOI 10.1006/jipa.1996.0006; James PJ, 1994, IOBC WPRS B, V17, P218; JEGOROV A, 1990, Microbios Letters, V45, P65; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LeOra Software, 1987, POLO PC US PROB AN L; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li XW, 2010, J NW A F U NATURAL S, V38, P151; Liu Shouzhu, 2009, Open Biochem J, V3, P9, DOI 10.2174/1874091X00903010009; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Matsuda D, 2004, J ANTIBIOT, V57, P1; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moores GD, 1998, PESTIC BIOCHEM PHYS, V62, P164, DOI 10.1006/pest.1998.2373; Moreno-Garcia M, 2014, INFECT GENET EVOL, V24, P25, DOI 10.1016/j.meegid.2014.02.010; Mullen LM, 2006, J INSECT PHYSIOL, V52, P389, DOI 10.1016/j.jinsphys.2005.10.008; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Oppenoorth F. J., 1976, INSECTICIDE BIOCH PH, P507; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; ROSLAVTSEVA SA, 1993, IZV AKAD NAUK BIOL+, P368; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Samson RA, 1988, ATLAS ENTOMOPATHOGIE; Sandhu SS, 2012, J PATHOG, V2012, DOI 10.1155/2012/126819; Serebrov V.V., 2001, Izvestiya Rossiiskoi Akademii Nauk Seriya Biologicheskaya, V5, P588; Serebrov VV, 2003, MIKOL FITOPATOL, V37, P76; Serebrov VV, 2006, IMZV RAN SER BIOL, V6, P581; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Soderlund D. M., 1990, PESTICIDE RESISTANCE, P58; Sree KS, 2008, J APPL ENTOMOL, V132, P68, DOI 10.1111/j.1439-0418.2007.01239.x; STLEGER RJ, 1988, J INVERTEBR PATHOL, V52, P459, DOI 10.1016/0022-2011(88)90059-6; SUZUKI A, 1970, AGR BIOL CHEM TOKYO, V34, P813, DOI 10.1080/00021369.1970.10859690; Tang BZ, 2011, PESTIC BIOCHEM PHYS, V101, P80, DOI 10.1016/j.pestbp.2011.08.003; Tartar A, 2005, MYCOPATHOLOGIA, V160, P303, DOI 10.1007/s11046-005-0134-y; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; Vilcinskas A, 1999, COMP BIOCHEM PHYS C, V122, P83, DOI 10.1016/S0742-8413(98)10082-8; Vioque-Fernandez A, 2009, BIOMARKERS, V14, P299, DOI 10.1080/13547500902913211; WAHLMAN M, 1993, J NAT PROD, V56, P643, DOI 10.1021/np50094a034; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; WEISER J, 1988, J INVERTEBR PATHOL, V51, P92, DOI 10.1016/0022-2011(88)90092-4; Wu Qing-Jun, 2011, Chinese Journal of Applied Entomology, V48, P291; Xing Jing, 2011, Chinese Journal of Pesticide Science, V13, P464, DOI 10.3969/j.issn.1008-7303.2011.05.05; Xue CB, 2007, APPL BIOCHEM BIOTECH, V143, P101, DOI 10.1007/s12010-007-8007-0; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029; Zibaee A, 2009, BIOCONTROL SCI TECHN, V19, P485, DOI 10.1080/09583150902847127	74	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155257	10.1371/journal.pone.0155257	http://dx.doi.org/10.1371/journal.pone.0155257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227835	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500013
J	Li, L; Lei, QS; Zhang, SJ; Kong, LN; Qin, B				Li, Lin; Lei, Qing-song; Zhang, Shu-Jun; Kong, Ling-na; Qin, Bo			Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ISOPEPTIDASE ACTIVITY; ANTIVIRAL ACTIVITY; CHRONIC INFECTION; STIMULATED GENE; PROTEASE UBP43; IFN-ALPHA; ISG15; EXPRESSION; PROTEINS	Ubiquitin-specific protease 18 (USP18, also known as UBP43) has both interferon stimulated gene 15 (ISG15) dependent and ISG15-independent functions. By silencing the expression of USP18 in HepG2.2.15 cells, we studied the effect of USP18 on the anti-HBV activity of IFN-F and demonstrated that knockdown of USP18 significantly Inhibited the HBV expression and increased the expression of ISGs. Levels of hepatitis B virus surface antigen (HBsAg), hepatitis B virus e antigen (HBeAg), HBV DNA and intracellular hepatitis B virus core antigen (HBcAg) were dramatically decreased with or without treatment of indicated dose of IFN-F. Suppression of USP18 activated the JAK/STAT signaling pathway as shown by the increased and prolonged expression of phosphorylated signal transducer and activator of transcription 1 (p-STAT1) in combination with enhanced expression of several interferon stimulated genes (ISGs). Our results indicated that USP18 modulates the anti-HBV activity of IFN-F via activation of the JAK/STAT signaling pathway in Hepg2.2.15 cells.	[Li, Lin; Lei, Qing-song; Zhang, Shu-Jun; Kong, Ling-na; Qin, Bo] Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Kong, Ling-na] Chongqing Med Univ, Coll Nursing, Chongqing 400016, Peoples R China	Chongqing Medical University; Chongqing Medical University	Qin, B (corresponding author), Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	cqqino@126.com			National Science Foundation of China [81271838]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants (81271838) from the National Science Foundation of China, http://www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Burkart C, 2012, J BIOL CHEM, V287, P4883, DOI 10.1074/jbc.M111.255570; Chen LM, 2010, J GEN VIROL, V91, P382, DOI 10.1099/vir.0.015388-0; Colonne PM, 2011, BIOCHEM BIOPH RES CO, V416, P153, DOI 10.1016/j.bbrc.2011.11.015; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Guo YL, 2012, MOL CANCER THER, V11, P1968, DOI 10.1158/1535-7163.MCT-12-0248; Hong BX, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-132; Honke N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003650; Ketscher L, 2015, P NATL ACAD SCI USA, V112, P1577, DOI 10.1073/pnas.1412881112; Kim JH, 2008, J IMMUNOL, V181, P6467, DOI 10.4049/jimmunol.181.9.6467; Kim KI, 2005, J IMMUNOL, V175, P847, DOI 10.4049/jimmunol.175.2.847; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Li YJ, 2014, REV MED VIROL, V24, P332, DOI 10.1002/rmv.1795; Liu XX, 2013, SPRINGERBRIEF COMPUT, P1, DOI 10.1007/978-1-4614-9074-6_1; MacParland SA, 2016, J VIROLOGY; Makki MS, 2013, EXP CELL RES, V319, P612, DOI 10.1016/j.yexcr.2012.12.021; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Malhotra S, 2013, EUR J NEUROL, V20, P1390, DOI 10.1111/ene.12193; Murray EJ, 2011, ANTIMICROB AGENTS CH, V55, P4311, DOI 10.1128/AAC.00644-11; Pang YJ, 2013, LIVER INT, V33, P1230, DOI 10.1111/liv.12185; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Salaiegheh M, 2010, ANN NEUROL, V67, P53, DOI 10.1002/ana.21805; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Xiao C, 2012, J VIRAL HEPATITIS, V19, pE1, DOI 10.1111/j.1365-2893.2011.01471.x; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801	32	25	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156496	10.1371/journal.pone.0156496	http://dx.doi.org/10.1371/journal.pone.0156496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227879	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500149
J	Quaranta, MT; Spinello, I; Paolillo, R; Macchia, G; Boe, A; Ceccarini, M; Labbaye, C; Macioce, P				Quaranta, Maria Teresa; Spinello, Isabella; Paolillo, Rosa; Macchia, Gianfranco; Boe, Alessandra; Ceccarini, Marina; Labbaye, Catherine; Macioce, Pompeo			Identification of beta-Dystrobrevin as a Direct Target of miR-143: Involvement in Early Stages of Neural Differentiation	PLOS ONE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; NEURONAL DIFFERENTIATION; ALPHA-DYSTROBREVIN; GENOMIC ORGANIZATION; CELL-LINES; EXPRESSION; HYPOXIA; PROTEIN; MICRORNAS	Duchenne Muscular Dystrophy, a genetic disorder that results in a gradual breakdown of muscle, is associated to mild to severe cognitive impairment in about one-third of dystrophic patients. The brain dysfunction is independent of the muscular pathology, occurs early, and is most likely due to defects in the assembly of the Dystrophin-associated Protein Complex (DPC) during embryogenesis. We have recently described the interaction of the DPC component beta-dystrobrevin with members of complexes that regulate chromatin dynamics, and suggested that beta-dystrobrevin may play a role in the initiation of neuronal differentiation. Since oxygen concentrations and miRNAs appear as well to be involved in the cellular processes related to neuronal development, we have studied how these factors act on beta-dystrobrevin and investigated the possibility of their functional interplay using the NTera-2 cell line, a well-established model for studying neurogenesis. We followed the pattern of expression and regulation of beta-dystrobrevin during the early stages of neuronal differentiation induced by exposure to retinoic acid (RA) under hypoxia as compared with normoxia, and found that beta-dystrobrevin expression is regulated during RA-induced differentiation of NTera-2 cells. We also found that beta-dystrobrevin pattern is delayed under hypoxic conditions, together with a delay in the differentiation and an increase in the proliferation rate of cells. We identified miRNA-143 as a direct regulator of beta-dystrobrevin expression, demonstrated that beta-dystrobrevin is expressed in the nucleus and showed that, in line with our previous in vitro results, beta-dystrobrevin is a repressor of synapsin I in live cells. Altogether the newly identified regulatory pathway miR-143/beta-dystrobrevin/synapsin I provides novel insights into the functions of beta-dystrobrevin and opens up new perspectives for elucidating the molecular mechanisms underlying the neuronal involvement in muscular dystrophy.	[Quaranta, Maria Teresa; Spinello, Isabella; Paolillo, Rosa; Boe, Alessandra; Labbaye, Catherine] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Macchia, Gianfranco; Macioce, Pompeo] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Ceccarini, Marina] Ist Super Sanita, Natl Ctr Rare Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Macioce, P (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	pompeo.macioce@iss.it	SPINELLO, ISABELLA/J-8779-2016; Boe, Alessandra/AAA-2653-2019; Macioce, Pompeo/H-2142-2016; Labbaye, Catherine/J-9930-2016; Quaranta, Maria Teresa/AAC-2134-2019; Ceccarini, Marina/A-6637-2015	Boe, Alessandra/0000-0002-8888-7501; Macioce, Pompeo/0000-0002-1829-9448; Quaranta, Maria Teresa/0000-0002-5886-507X; Labbaye, Catherine/0000-0003-1255-4396; Ceccarini, Marina/0000-0002-7021-4499	Italian Ministry of Health [RF-2010-2312222]; Italy-USA Collaborative Programme [7DR1]	Italian Ministry of Health(Ministry of Health, Italy); Italy-USA Collaborative Programme	This study was partially supported by the Italian Ministry of Health to C.L. (Grant RF-2010-2312222) and by the Italy-USA Collaborative Programme to P.M. (Grant Rare Diseases, 7DR1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DE, 2004, J BIOL CHEM, V279, P7014, DOI 10.1074/jbc.M312205200; Ambrose HJ, 1997, GENOMICS, V39, P359, DOI 10.1006/geno.1996.4515; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Artegiani B, 2010, J BIOL CHEM, V285, P24740, DOI 10.1074/jbc.M109.090654; Baldassarre G, 2000, CELL GROWTH DIFFER, V11, P517; Batliner J, 2012, LEUKEMIA RES, V36, P237, DOI 10.1016/j.leukres.2011.10.006; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Braunschweig L, 2015, MOL CELL NEUROSCI; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Ceballos-Chavez M, 2012, P NATL ACAD SCI USA, V109, P8085, DOI 10.1073/pnas.1121522109; Ceccarini M, 2007, J MOL BIOL, V371, P1174, DOI 10.1016/j.jmb.2007.06.019; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chen Y, 2015, EXP CELL RES, V330, P442, DOI 10.1016/j.yexcr.2014.10.022; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Crosby ME, 2009, CURR PHARM DESIGN, V15, P3861, DOI 10.2174/138161209789649367; Daoud F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006574; De Arcangelis V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012098; De Filippis L, 2011, CELL MOL LIFE SCI, V68, P2831, DOI 10.1007/s00018-011-0723-5; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Fukuda Yoko, 2005, Nucleic Acids Symp Ser (Oxf), P341; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Grady RM, 2006, J NEUROSCI, V26, P2841, DOI 10.1523/JNEUROSCI.4823-05.2006; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Haile Y, 2014, J NEUROSCI RES, V92, P1187, DOI 10.1002/jnr.23399; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hamada N, 2012, NEUROCHEM INT, V60, P743, DOI 10.1016/j.neuint.2012.03.010; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Leypoldt F, 2002, NEUROSCI LETT, V324, P37, DOI 10.1016/S0304-3940(02)00170-2; Loh NY, 2001, MOL CELL BIOL, V21, P7442, DOI 10.1128/MCB.21.21.7442-7448.2001; Loh NY, 1998, MAMM GENOME, V9, P857, DOI 10.1007/s003359900883; Macioce P, 2003, J CELL SCI, V116, P4847, DOI 10.1242/jcs.00805; Marrone AK, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-26; Meza-Sosa KF, 2012, J NEUROSCI RES, V90, P1, DOI 10.1002/jnr.22701; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Paonessa F, 2013, J BIOL CHEM, V288, P3227, DOI 10.1074/jbc.M112.399782; Pelosi L, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00069; Petronelli A, 2011, LEUKEMIA RES, V35, P534, DOI 10.1016/j.leukres.2010.09.013; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; Rees MLJ, 2007, NEUROMUSCULAR DISORD, V17, P123, DOI 10.1016/j.nmd.2006.11.003; Rodriguez-Munoz R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137328; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sheridan KM, 1998, J MOL NEUROSCI, V10, P121, DOI 10.1007/BF02737123; Smith B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011109; Spinello I, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.24; Tadayoni R, 2012, MOL NEUROBIOL, V45, P43, DOI 10.1007/s12035-011-8218-9; Tonge PD, 2010, DIFFERENTIATION, V80, P20, DOI 10.1016/j.diff.2010.04.001; Valtorta F, 2011, SEMIN CELL DEV BIOL, V22, P378, DOI 10.1016/j.semcdb.2011.07.008; Veroni C, 2007, J NEUROSCI RES, V85, P2631, DOI 10.1002/jnr.21186; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Villarreal-Silva M, 2010, NEUROCHEM RES, V35, P366, DOI 10.1007/s11064-009-0064-z; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xiong L, 2012, FEBS J, V279, P4318, DOI 10.1111/febs.12021; Yamagata T, 2010, PEDIATR SURG INT, V26, P1179, DOI 10.1007/s00383-010-2700-8; Yao MY, 2014, AM J PHYSIOL-LUNG C, V307, pL829, DOI 10.1152/ajplung.00081.2014; Yatsenko AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5906	68	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156325	10.1371/journal.pone.0156325	http://dx.doi.org/10.1371/journal.pone.0156325			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223470	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700086
J	Fujikura, K				Fujikura, Kohei			Global Carrier Rates of Rare Inherited Disorders Using Population Exome Sequences	PLOS ONE			English	Article							PATHOGENIC VARIANTS; COMPLEX TRAITS; EPIDEMIOLOGY; MUTATIONS; HEMOGLOBIN; MAP	Exome sequencing has revealed the causative mutations behind numerous rare, inherited disorders, but it is challenging to find reliable epidemiological values for rare disorders. Here, I provide a genetic epidemiology method to identify the causative mutations behind rare, inherited disorders using two population exome sequences (1000 Genomes and NHLBI). I created global maps of carrier rate distribution for 18 recessive disorders in 16 diverse ethnic populations. Out of a total of 161 mutations associated with 18 recessive disorders, I detected 24 mutations in either or both exome studies. The genetic mapping revealed strong international spatial heterogeneities in the carrier patterns of the inherited disorders. I next validated this methodology by statistically evaluating the carrier rate of one well-understood disorder, sickle cell anemia (SCA). The population exome-based epidemiology of SCA [ African ( allele frequency (AF) = 0.0454, N = 2447), Asian (AF = 0, N = 286), European (AF = 0.000214, N = 4677), and Hispanic (AF = 0.0111, N = 362)] was not significantly different from that obtained from a clinical prevalence survey. A pair-wise proportion test revealed no significant differences between the two exome projects in terms of AF (46/48 cases; P > 0.05). I conclude that population exome-based carrier rates can form the foundation for a prospectively maintained database of use to clinical geneticists. Similar modeling methods can be applied to many inherited disorders.	[Fujikura, Kohei] Kobe Univ, Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan	Kobe University	Fujikura, K (corresponding author), Kobe Univ, Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kofujikura@gmail.com		Brusgaard, Klaus/0000-0002-2096-4988				Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Becker F, 2011, EUR J HUM GENET, V19, pS6, DOI 10.1038/ejhg.2010.249; Bornstein MH, 2013, SOC SCI MED, V97, P307, DOI 10.1016/j.socscimed.2012.09.049; Casey JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16022; Docherty S, 2012, BIOMEDICAL SCI ESSEN, P116; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Fujikura K, 2015, MOL GENET GENOM MED, V3, P272, DOI 10.1002/mgg3.140; Gazal S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17453; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Hunter JM, 2015, MOL GENET GENOM MED, V3, P283, DOI 10.1002/mgg3.142; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; Jordan L, 2013, J PEDIAT HEMATOL ONC, V35, P165, DOI 10.1097/MPH.0b013e3182847483; Joshi R, 2015, MOL GENET GENOM MED, V3, P221, DOI 10.1002/mgg3.136; Katsanis SH, 2013, NAT REV GENET, V14, P415, DOI 10.1038/nrg3493; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kisioglu AN, 2010, J BIOSOC SCI, V42, P161, DOI 10.1017/S0021932009990472; Krickeberg K, 2005, HANDBOOK OF EPIDEMIOLOGY, P1545; Ku CS, 2012, ANN NEUROL, V71, P5, DOI 10.1002/ana.22647; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; Lee WC, 2003, ANN HUM GENET, V67, P618, DOI 10.1046/j.1529-8817.2003.00063.x; Lek M, ANAL PROTEIN CODING; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Modell B, 2002, NAT REV GENET, V3, P225, DOI 10.1038/nrg754; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Morton DA, 2013, MED ISSUES SOCIAL SE; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; de la Paz MP, 2010, ADV EXP MED BIOL, V686, P17, DOI 10.1007/978-90-481-9485-8_2; Scriver C.R., 1995, METABOLIC MOL BASES; Siemiatkowska AM, 2014, JAMA OPHTHALMOL, V132, P1002, DOI 10.1001/jamaophthalmol.2014.983; Steinberg KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09124; Stern HJ, 2014, J CLIN MED, V3, P280, DOI 10.3390/jcm3010280; Tabor HK, 2014, AM J HUM GENET, V95, P183, DOI 10.1016/j.ajhg.2014.07.006; Tabor HK, 2012, AM J MED GENET A, V158A, P2382, DOI 10.1002/ajmg.a.35545; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van Rheenen W, 2014, BRAIN, V137, DOI 10.1093/brain/awu299; WHO, SCREEN THE GEN	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155552	10.1371/journal.pone.0155552	http://dx.doi.org/10.1371/journal.pone.0155552			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219052	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880700008
J	Vongsuvanh, R; van der Poorten, D; Iseli, T; Strasser, SI; McCaughan, GW; George, J				Vongsuvanh, Roslyn; van der Poorten, David; Iseli, Tristan; Strasser, Simone I.; McCaughan, Geoffrey W.; George, Jacob			Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							UNITED-STATES; ALPHA-FETOPROTEIN; BIOMARKER; OSTEOPONTIN; CANCER; MORTALITY; DISEASE	Robust biomarkers for population-level hepatocellular carcinoma (HCC) surveillance are lacking. We compared serum midkine (MDK), dickkopf-1 (DKK1), osteopontin (OPN) and AFP for HCC diagnosis in 86 HCC patients matched to 86 cirrhotics, 86 with chronic liver disease (CLD) and 86 healthy controls (HC). Based on the performance of each biomarker, we assessed a separate longitudinal cohort of 28 HCC patients, at and before cancer diagnosis. Serum levels of MDK and OPN were higher in HCC patients compared to cirrhosis, CLD and HC groups. DKK1 was not different between cases and controls. More than half of HCC patients had normal AFP. In this AFP-negative HCC cohort, 59.18% (n = 29/49) had elevated MDK, applying the optimal cut-off of 0.44 ng/ml. Using AFP >= 20 IU/ml or MDK >= 0.44 ng/ml, a significantly greater number (76.7%; n = 66/86) of HCC cases were detected. The area under the receiver operating curve for MDK was superior to AFP and OPN in NASH-HCC diagnosis. In the longitudinal cohort, MDK was elevated in 15/28 (54%) of HCC patients at diagnosis, of whom 67% had elevated MDK 6 months prior. Conclusion: AFP and MDK have a complementary role in HCC detection. MDK increases the diagnostic yield in AFP-negative HCC and has greater diagnostic performance than AFP, OPN and DKK-1 in the diagnosis of NASH-HCC. Additionally, MDK has a promising role in the pre-clinical diagnosis of HCC.	[Vongsuvanh, Roslyn; van der Poorten, David; Iseli, Tristan; George, Jacob] Westmead Hosp, Univ Sydney, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia; [Strasser, Simone I.; McCaughan, Geoffrey W.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Vongsuvanh, R (corresponding author), Westmead Hosp, Univ Sydney, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia.	rvongsuv@med.usyd.edu.au	George, jacob/P-1496-2014	MCCAUGHAN, GEOFFREY/0000-0002-1483-1636	Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; National Health and Medical Research Council of Australia (NHMRC) [1053206]; Cancer Institute Translational Cancer Research Centre grant;  [1006759];  [1047417];  [1049857]	Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute Translational Cancer Research Centre grant; ; ; 	Jacob George, David van der Poorten and Roslyn Vongsuvanh are supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; Jacob George is also supported by a National Health and Medical Research Council of Australia (NHMRC) Program Grant (1053206), Project grants 1006759, 1047417 and 1049857, and a Cancer Institute Translational Cancer Research Centre grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; Fan NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088299; Fong ZV, 2014, CANCER-AM CANCER SOC, V120, P2824, DOI 10.1002/cncr.28730; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Giannelli G, 2014, GUT, V63, P1668, DOI 10.1136/gutjnl-2014-307323; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hung YJ, 2011, AM J CLIN PATHOL, V136, P594, DOI 10.1309/AJCPWT70XOVXSVGE; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Kadomatsu K, 2014, BRIT J PHARMACOL, V171, P936, DOI 10.1111/bph.12537; Kim J, 2006, AM J GASTROENTEROL, V101, P2051, DOI 10.1111/j.1572-0241.2006.00679.x; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Muramatsu T, 2014, BRIT J PHARMACOL, V171, P811, DOI 10.1111/bph.12571; NAULT J-C, 2014, TRANSLATIONAL GASTRO, V3, P100; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; Shang SF, 2012, HEPATOLOGY, V55, P483, DOI 10.1002/hep.24703; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Sherman M, 2014, BEST PRACT RES CL GA, V28, P783, DOI 10.1016/j.bpg.2014.08.008; Sterling RK, 2012, AM J GASTROENTEROL, V107, P64, DOI 10.1038/ajg.2011.312; Takada T, 1997, BIOCHEM BIOPH RES CO, V241, P756, DOI 10.1006/bbrc.1997.7873; Vongsuvanh R, 2013, HEPATOL INT, V7, pS823, DOI 10.1007/s12072-013-9453-0; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Zhang CH, 2012, INT J CANCER, V130, P2685, DOI 10.1002/ijc.26301; Zhu WW, 2013, CLIN CANCER RES, V19, P3944, DOI 10.1158/1078-0432.CCR-12-3363	31	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155800	10.1371/journal.pone.0155800	http://dx.doi.org/10.1371/journal.pone.0155800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219517	Green Published, gold			2022-12-26	WOS:000376880700021
J	Ahn, CH; Yoon, JW; Hahn, S; Moon, MK; Park, KS; Cho, YM				Ahn, Chang Ho; Yoon, Ji Won; Hahn, Seokyung; Moon, Min Kyong; Park, Kyong Soo; Cho, Young Min			Evaluation of Non-Laboratory and Laboratory Prediction Models for Current and Future Diabetes Mellitus: A Cross-Sectional and Retrospective Cohort Study	PLOS ONE			English	Article							RISK SCORE; EXTERNAL VALIDATION; SCREENING SCORE; LIFE-STYLE; TYPE-2; PREVENTION; TOOL	Background Various diabetes risk scores composed of non-laboratory parameters have been developed, but only a few studies performed cross-validation of these scores and a comparison with laboratory parameters. We evaluated the performance of diabetes risk scores composed of non-laboratory parameters, including a recently published Korean risk score (KRS), and compared them with laboratory parameters. Methods The data of 26,675 individuals who visited the Seoul National University Hospital Healthcare System Gangnam Center for a health screening program were reviewed for cross-sectional validation. The data of 3,029 individuals with a mean of 6.2 years of follow-up were reviewed for longitudinal validation. The KRS and 16 other risk scores were evaluated and compared with a laboratory prediction model developed by logistic regression analysis. Results For the screening of undiagnosed diabetes, the KRS exhibited a sensitivity of 81%, a specificity of 58%, and an area under the receiver operating characteristic curve (AROC) of 0.754. Other scores showed AROCs that ranged from 0.697 to 0.782. For the prediction of future diabetes, the KRS exhibited a sensitivity of 74%, a specificity of 54%, and an AROC of 0.696. Other scores had AROCs ranging from 0.630 to 0.721. The laboratory prediction model composed of fasting plasma glucose and hemoglobin A1c levels showed a significantly higher AROC (0.838, P < 0.001) than the KRS. The addition of the KRS to the laboratory prediction model increased the AROC (0.849, P = 0.016) without a significant improvement in the risk classification (net reclassification index: 4.6%, P = 0.264). Conclusions The non-laboratory risk scores, including KRS, are useful to estimate the risk of undiagnosed diabetes but are inferior to the laboratory parameters for predicting future diabetes.	[Ahn, Chang Ho; Yoon, Ji Won; Moon, Min Kyong; Park, Kyong Soo; Cho, Young Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Yoon, Ji Won] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea; [Hahn, Seokyung] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Moon, Min Kyong] Seoul Natl Univ, Coll Med, Dept Internal Med, Boramae Med Ctr, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Cho, YM (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	ymchomd@snu.ac.kr	Moon, Min Kyong/AAE-7663-2020; Park, Kyong Soo/C-2265-2008	Moon, Min Kyong/0000-0002-5460-2846; Park, Kyong Soo/0000-0003-3597-342X; Hahn, Seokyung/0000-0002-4684-4917				Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Akash MSH, 2013, CURR DIABETES REV, V9, P286, DOI 10.2174/15733998113099990062; Akash MSH, 2013, J CELL BIOCHEM, V114, P525, DOI 10.1002/jcb.24402; Al Khalaf M. M., 2010, Eastern Mediterranean Health Journal, V16, P725; Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013; Alssema M, 2011, DIABETOLOGIA, V54, P1004, DOI 10.1007/s00125-010-1990-7; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2014, NATL DIABETES STAT R; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Chatterton H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4624; Chaturvedi V., 2008, CVD PREV CONTROL, V3, P141, DOI [DOI 10.1016/j.cvdpc.2008.07.002, DOI 10.1016/J.CVDPC.2008.07.002]; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Echouffo-Tcheugui JB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-136; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Heianza Y, 2013, J CLIN ENDOCR METAB, V98, P1051, DOI 10.1210/jc.2012-3092; Korean Diabetes Association, 2013, TREATING TOBACCO USE; Korean Ministry of Health and Welfare, 2012, KOR HLTH STAT 2012 K; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Phillips LS, 2014, DIABETES CARE, V37, P2668, DOI 10.2337/dc14-0817; de Sousa AGP, 2009, EUR J EPIDEMIOL, V24, P101, DOI 10.1007/s10654-009-9314-2; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wannamethee SG, 2011, DIABETIC MED, V28, P23, DOI 10.1111/j.1464-5491.2010.03171.x	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156155	10.1371/journal.pone.0156155	http://dx.doi.org/10.1371/journal.pone.0156155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214034	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880200062
J	Palazzo, A; Lovero, D; D'Addabbo, P; Caizzi, R; Marsano, RM				Palazzo, Antonio; Lovero, Domenica; D'Addabbo, Pietro; Caizzi, Ruggiero; Marsano, Rene Massimiliano			Identification of Bari Transposons in 23 Sequenced Drosophila Genomes Reveals Novel Structural Variants, MITEs and Horizontal Transfer	PLOS ONE			English	Article							HETEROCHROMATIC H39 REGION; TARGET SITE SELECTION; REPBASE UPDATE; ELEMENTS; EVOLUTION; FAMILY; DNA; MELANOGASTER; DIVERSITY; ORGANIZATION	Bari elements are members of the Tc1-mariner superfamily of DNA transposons, originally discovered in Drosophila melanogaster, and subsequently identified in silico in 11 sequenced Drosophila genomes and as experimentally isolated in four non-sequenced Drosophila species. Bari-like elements have been also studied for their mobility both in vivo and in vitro. We analyzed 23 Drosophila genomes and carried out a detailed characterization of the Bari elements identified, including those from the heterochromatic Bari1 cluster in D. melanogaster. We have annotated 401 copies of Bari elements classified either as putatively autonomous or inactive according to the structure of the terminal sequences and the presence of a complete transposase-coding region. Analyses of the integration sites revealed that Bari transposase prefers AT-rich sequences in which the TA target is cleaved and duplicated. Furthermore evaluation of transposon's co-occurrence near the integration sites of Bari elements showed a non-random distribution of other transposable elements. We also unveil the existence of a putatively autonomous Bari1 variant characterized by two identical long Terminal Inverted Repeats, in D. rhopaloa. In addition, we detected MITEs related to Bari transposons in 9 species. Phylogenetic analyses based on transposase gene and the terminal sequences confirmed that Bari-like elements are distributed into three subfamilies. A few inconsistencies in Bari phylogenetic tree with respect to the Drosophila species tree could be explained by the occurrence of horizontal transfer events as also suggested by the results of dS analyses. This study further clarifies the Bari transposon's evolutionary dynamics and increases our understanding on the Tc1-mariner elements' biology.	[Palazzo, Antonio; D'Addabbo, Pietro; Caizzi, Ruggiero; Marsano, Rene Massimiliano] Univ Bari Aldo Moro, Dipartimento Biol, Via Orabona 4, I-70125 Bari, Italy; [Lovero, Domenica] CNR, Ist Biomembrane & Bioenerget, Via Amendola 165-A, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR)	Marsano, RM (corresponding author), Univ Bari Aldo Moro, Dipartimento Biol, Via Orabona 4, I-70125 Bari, Italy.	renemassimiliano.marsano@uniba.it	Lovero, Domenica/I-7849-2018; D'Addabbo, Pietro/AAC-7731-2020; Palazzo, Antonio/AAH-1352-2020; Palazzo, Antonio/AAW-2480-2021; Marsano, René Massimiliano/B-9640-2012; D'Addabbo, Pietro/D-8551-2016	Lovero, Domenica/0000-0002-7883-8896; Palazzo, Antonio/0000-0003-0961-6832; Marsano, René Massimiliano/0000-0001-8450-1010; D'Addabbo, Pietro/0000-0003-3325-4931				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CAGGESE C, 1995, GENETICA, V96, P269, DOI 10.1007/BF01439581; CAIZZI R, 1993, GENETICS, V133, P335; Capy P, 1998, MOL B INT U, P1; Chen Jiongjiong, 2012, Mob Genet Elements, V2, P127; Chen ZX, 2014, GENOME RES, V24, P1209, DOI 10.1101/gr.159384.113; Chiu JC, 2013, G3-GENES GENOM GENET, V3, P2257, DOI 10.1534/g3.113.008185; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Craig NL, 1997, ANNU REV BIOCHEM, V66, P437, DOI 10.1146/annurev.biochem.66.1.437; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dias ES, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-119; Dias ES, 2011, GENET RES, V93, P381, DOI 10.1017/S0016672311000371; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupeyron M, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-4; Fernandez-Medina RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-272; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Goriaux C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00257; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; He B, 2012, GENOME RES, V22, P2507, DOI 10.1101/gr.137406.112; Hoskins RA, 2015, GENOME RES, V25, P445, DOI 10.1101/gr.185579.114; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lonnig WE, 2002, ANNU REV GENET, V36, P389, DOI 10.1146/annurev.genet.36.040202.092802; Loreto ELS, 2008, HEREDITY, V100, P545, DOI 10.1038/sj.hdy.6801094; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Ludwig A, 2008, INSECT MOL BIOL, V17, P113, DOI 10.1111/j.1365-2583.2007.00787.x; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; Marsano RM, 2004, MOL GENET GENOMICS, V270, P477, DOI 10.1007/s00438-003-0947-7; Marsano RM, 2003, GENETICA, V117, P281; Marsano RM, 2003, GENE, V307, P167, DOI 10.1016/S0378-1119(03)00458-X; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MERRIMAN PJ, 1995, GENETICS, V141, P1425; Moschetti R, 1998, GENETICS, V150, P239; Moschetti R, 2008, MOL GENET GENOMICS, V279, P451, DOI 10.1007/s00438-008-0324-7; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oliveira SG, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-14; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Palazzo A, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-21; Palazzo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079385; Pardue Mary-Lou, 2000, Trends in Genetics, V16, P155, DOI 10.1016/S0168-9525(00)01979-X; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Robertson HM, 1998, MARINER TRANSPOSONS, P268; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rubin E, 1997, MOL CELL BIOL, V17, P6294, DOI 10.1128/MCB.17.11.6294; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Vos JC, 1996, GENE DEV, V10, P755, DOI 10.1101/gad.10.6.755; Wallau GL, 2016, MOL BIOL EVOL, V33, P1094, DOI 10.1093/molbev/msv341; Wallau GL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-727; Wallau GL, 2012, GENOME BIOL EVOL, V4, P801, DOI 10.1093/gbe/evs055; Wallau GL, 2011, GENETICA, V139, P1487, DOI 10.1007/s10709-012-9648-7; WU CI, 1988, CELL, V54, P179, DOI 10.1016/0092-8674(88)90550-8; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zanni V, 2013, P NATL ACAD SCI USA, V110, P19842, DOI 10.1073/pnas.1313677110; Zhou Q, 2012, SCIENCE, V337, P341, DOI 10.1126/science.1225385; Zhou Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-109	72	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156014	10.1371/journal.pone.0156014	http://dx.doi.org/10.1371/journal.pone.0156014			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213270	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200045
J	Jones, PD; Kaiser, MA; Najafabadi, MG; Mcvey, DG; Beveridge, AJ; Schofield, CL; Samani, NJ; Webb, TR				Jones, Peter D.; Kaiser, Michael A.; Najafabadi, Maryam Ghaderi; Mcvey, David G.; Beveridge, Allan J.; Schofield, Christine L.; Samani, Nilesh J.; Webb, Tom R.			The Coronary Artery Disease-associated Coding Variant in Zinc Finger C3HC-type Containing 1 (ZC3HC1) Affects Cell Cycle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-INTERACTION PARTNER; PLURIPOTENT STEM-CELLS; SMOOTH-MUSCLE-CELLS; MOLECULAR-DYNAMICS; CANDIDATE GENES; INACTIVATION; ATHEROSCLEROSIS; PHOSPHORYLATION; LOCALIZATION; LOCI	Genome-wide association studies have to date identified multiple coronary artery disease (CAD)-associated loci; however, for most of these loci the mechanism by which they affect CAD risk is unclear. The CAD-associated locus 7q32.2 is unusual in that the lead variant, rs11556924, is not in strong linkage disequilibrium with any other variant and introduces a coding change in ZC3HC1, which encodes NIPA. In this study, we show that rs11556924 polymorphism is associated with lower regulatory phosphorylation of NIPA in the risk variant, resulting in NIPA with higher activity. Using a genome-editing approach we show that this causes an effective decrease in cyclin-B1 stability in the nucleus, thereby slowing its nuclear accumulation. By perturbing the rate of nuclear cyclin-B1 accumulation, rs11556924 alters the regulation of mitotic progression resulting in an extended mitosis. This study shows that the CAD-associated coding polymorphism in ZC3HC1 alters the dynamics of cell-cycle regulation by NIPA.	[Jones, Peter D.; Kaiser, Michael A.; Najafabadi, Maryam Ghaderi; Mcvey, David G.; Beveridge, Allan J.; Samani, Nilesh J.; Webb, Tom R.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Jones, Peter D.; Kaiser, Michael A.; Najafabadi, Maryam Ghaderi; Mcvey, David G.; Beveridge, Allan J.; Samani, Nilesh J.; Webb, Tom R.] Univ Leicester, Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Schofield, Christine L.] Horizon Discovery Ltd, 7100 Cambridge Res Pk, Cambridge CB25 9TL, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Webb, TR (corresponding author), Univ Leicester, Glenfield Hosp, Cardiovasc Res Ctr, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England.	tw126@le.ac.uk	Webb, Tom/GMW-5311-2022; Webb, Tom/C-6237-2011	Webb, Tom/0000-0001-5998-8226; McVey, David Graham/0000-0002-6402-2546; Jones, Peter/0000-0002-6667-7562	Leducq Foundation [12CVD02]; European Union [261123]; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish	Leducq Foundation(Leducq Foundation); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Transatlantic Networks of Excellence Award (12CVD02) from The Leducq Foundation and the FP7 European Union funded project CVgenes@target (261123). The authors declare that they have no conflicts of interest with the contents of this article.	Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Bassermann F, 2007, J BIOL CHEM, V282, P15965, DOI 10.1074/jbc.M610819200; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Boehm Manfred, 2003, Prog Cell Cycle Res, V5, P19; Braenne I, 2015, ARTERIOSCL THROM VAS, V35, P2207, DOI 10.1161/ATVBAHA.115.306108; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Erbilgin A, 2013, J LIPID RES, V54, P1894, DOI 10.1194/jlr.M037085; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Herring BP, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-21; Hurley PJ, 2007, ONCOGENE, V26, P2535, DOI 10.1038/sj.onc.1210049; Illert AL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.373464; Illert AL, 2012, DEVELOPMENT, V139, P2523, DOI 10.1242/dev.073072; Kan YN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004251; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim HS, 2014, STEM CELLS DEV, V23, P2673, DOI 10.1089/scd.2014.0167; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lopez-Mejias R, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4335; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca; MORISHITA R, 1994, GENE, V149, P13, DOI 10.1016/0378-1119(94)90406-5; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Silvestre-Roig C, 2013, ARTERIOSCL THROM VAS, V33, P1036, DOI 10.1161/ATVBAHA.112.300580; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Team RC, 2014, R LANG ENV STAT COMP; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Yamase Y, 2016, BIOMED REP, V4, P178, DOI 10.3892/br.2015.551; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	49	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16318	16327		10.1074/jbc.M116.734020	http://dx.doi.org/10.1074/jbc.M116.734020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226629	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000380585400035
J	Dubey, JP; Ferreira, LR; Alsaad, M; Verma, SK; Alves, DA; Holland, GN; McConkey, GA				Dubey, Jitender P.; Ferreira, Leandra R.; Alsaad, Mohammad; Verma, Shiv K.; Alves, Derron A.; Holland, Gary N.; McConkey, Glenn A.			Experimental Toxoplasmosis in Rats Induced Orally with Eleven Strains of Toxoplasma gondii of Seven Genotypes: Tissue Tropism, Tissue Cyst Size, Neural Lesions, Tissue Cyst Rupture without Reactivation, and Ocular Lesions	PLOS ONE			English	Article							CONGENITAL TRANSMISSION; PARASITIC INFECTION; GENETIC DIVERSITY; SANTA ISABEL; MICE; OOCYSTS; CATS; BRAZIL; SCHIZOPHRENIA; PATHOGENICITY	Background The protozoan parasite Toxoplasma gondii is one of the most widely distributed and successful parasites. Toxoplasma gondii alters rodent behavior such that infected rodents reverse their fear of cat odor, and indeed are attracted rather than repelled by feline urine. The location of the parasite encysted in the brain may influence this behavior. However, most studies are based on the highly susceptible rodent, the mouse. Methodology/Principal Findings Latent toxoplasmosis was induced in rats (10 rats per T. gondii strains) of the same age, strain, and sex, after oral inoculation with oocysts (natural route and natural stage of infection) of 11 T. gondii strains of seven genotypes. Rats were euthanized at two months post inoculation (p.i.) to investigate whether the parasite genotype affects the distribution, location, tissue cyst size, or lesions. Tissue cysts were enumerated in different regions of the brains, both in histological sections as well in saline homogenates. Tissue cysts were found in all regions of the brain. The tissue cyst density in different brain regions varied extensively between rats with many regions highly infected in some animals. Overall, the colliculus was most highly infected although there was a large amount of variability. The cerebral cortex, thalamus, and cerebellum had higher tissue cyst densities and two strains exhibited tropism for the colliculus and olfactory bulb. Histologically, lesions were confined to the brain and eyes. Tissue cyst rupture was frequent with no clear evidence for reactivation of tachyzoites. Ocular lesions were found in 23 (25%) of 92 rat eyes at two months p.i. The predominant lesion was focal inflammation in the retina. Tissue cysts were seen in the sclera of one and in the optic nerve of two rats. The choroid was not affected. Only tissue cysts, not active tachyzoite infections, were detected. Tissue cysts were seen in histological sections of tongue of 20 rats but not in myocardium and leg muscle. Conclusion/Significance This study reevaluated in depth the rat model of toxoplasmosis visualizing cyst rupture and clarified many aspects of the biology of the parasite useful for future investigations.	[Dubey, Jitender P.; Ferreira, Leandra R.; Verma, Shiv K.] ARS, USDA, Beltsville Agr Res Ctr, Anim Parasit Dis Lab, Beltsville, MD USA; [Alsaad, Mohammad; McConkey, Glenn A.] Univ Leeds, Fac Biol Sci, Miall Bldg,Clarendon Way, Leeds, W Yorkshire, England; [Alves, Derron A.] Vet Pathol Serv Joint Pathol Ctr, 606 Stephen Sitter Ave, Silver Spring, MD USA; [Holland, Gary N.] Univ Calif Los Angeles, Stein Eye Inst, Ocular Inflammatory Dis Ctr, Los Angeles, CA USA; [Holland, Gary N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA	United States Department of Agriculture (USDA); University of Leeds; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dubey, JP (corresponding author), ARS, USDA, Beltsville Agr Res Ctr, Anim Parasit Dis Lab, Beltsville, MD USA.	Jitender.Dubey@ars.usda.gov	Alsaad, Dr Mohammad/GZM-9598-2022; McConkey, Glenn A./I-4062-2019	McConkey, Glenn/0000-0001-6529-794X				Afonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032489; Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Arantes TEF, 2015, AM J OPHTHALMOL, V159, P1002, DOI 10.1016/j.ajo.2015.02.015; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; BEVERLEY J K, 1958, Trans Ophthalmol Soc U K, V78, P109; BEVERLEY JKA, 1959, NATURE, V183, P1348, DOI 10.1038/1831348a0; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Burnett AJ, 1998, OPHTHALMOLOGY, V105, P1032, DOI 10.1016/S0161-6420(98)96004-3; Demar M, 2007, CLIN INFECT DIS, V45, pE88, DOI 10.1086/521246; Di CM, 2008, INFECT IMMUN, V76, P3491, DOI [10.1128/IAI.00254-08, DOI 10.1128/IAI.00254-08]; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP, 2006, VET PARASITOL, V141, P42, DOI 10.1016/j.vetpar.2006.04.037; Dubey JP, 2011, J PARASITOL, V97, P842, DOI 10.1645/GE-2728.1; Dubey JP, 2011, INT J PARASITOL, V41, P827, DOI 10.1016/j.ijpara.2011.03.006; Dubey JP, 2010, J PARASITOL, V96, P713, DOI 10.1645/GE-2429.1; DUBEY JP, 1976, J PROTOZOOL, V23, P537, DOI 10.1111/j.1550-7408.1976.tb03836.x; DUBEY JP, 1995, J PARASITOL, V81, P410, DOI 10.2307/3283823; Dubey JP, 1996, J PARASITOL, V82, P951, DOI 10.2307/3284205; Dubey JP, 1996, J PARASITOL, V82, P438, DOI 10.2307/3284082; Dubey JP, 1998, VET PARASITOL, V77, P1, DOI 10.1016/S0304-4017(97)00227-6; DUBEY JP, 1988, VET PARASITOL, V30, P97, DOI 10.1016/0304-4017(88)90156-2; DUBEY JP, 1980, AM J VET RES, V41, P427; DUBEY JP, 1992, J PARASITOL, V78, P151, DOI 10.2307/3283705; Dubey JP, 1997, J PARASITOL, V83, P870, DOI 10.2307/3284282; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; DUBEY JP, 1995, J PARASITOL, V81, P48, DOI 10.2307/3284004; DUBEY JP, 1993, J VET DIAGN INVEST, V5, P472, DOI 10.1177/104063879300500334; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; ESCAJADILLO A, 1991, AM J TROP MED HYG, V44, P382, DOI 10.4269/ajtmh.1991.44.382; FERGUSON DJP, 1987, PARASITOL RES, V73, P483, DOI 10.1007/BF00535321; FERGUSON DJP, 1991, INT J EXP PATHOL, V72, P463; FERGUSON DJP, 1989, PARASITOL RES, V75, P599, DOI 10.1007/BF00930955; FRENKEL JK, 1987, AM J TROP MED HYG, V36, P517, DOI 10.4269/ajtmh.1987.36.517; Gatkowska J, 2012, PARASITOL RES, V111, P53, DOI 10.1007/s00436-011-2800-y; Gonzalez LE, 2007, BEHAV BRAIN RES, V177, P70, DOI 10.1016/j.bbr.2006.11.012; Grigg ME, 2009, INT J PARASITOL, V39, P925, DOI 10.1016/j.ijpara.2009.02.005; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Holland GN, 1999, AM J OPHTHALMOL, V128, P413, DOI 10.1016/S0002-9394(99)00300-1; HOLLAND GN, 1988, AM J OPHTHALMOL, V106, P653, DOI 10.1016/0002-9394(88)90697-6; HOLLAND GN, 1996, OCULAR INFECT IMMUNI, P1183; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; Luder CGK, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P217, DOI 10.1016/B978-0-12-396481-6.00007-6; LUNDE MN, 1983, J PARASITOL, V69, P806, DOI 10.2307/3281034; Martin HL, 2015, NEUROSCIENCE, V306, P50, DOI 10.1016/j.neuroscience.2015.08.005; McAllister MM, 1996, J PARASITOL, V82, P354, DOI 10.2307/3284181; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; Melzer T C, 2010, J Neuroparasitology, V1, DOI 10.4303/jnp/N100505; NICHOLSON DH, 1976, ARCH OPHTHALMOL-CHIC, V94, P248, DOI 10.1001/archopht.1976.03910030120009; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; REMINGTON J, 1961, J INFECT DIS, V108, P163, DOI 10.1093/infdis/108.2.163; REMINGTON J, 1961, J IMMUNOL, V87, P578; Remington J. S., 2006, INFECT DIS FETUS NEW, P947, DOI DOI 10.1016/B0-72-160537-0/50033-5; Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; Silveira C, 2015, AM J OPHTHALMOL, V159, P1013, DOI 10.1016/j.ajo.2015.02.017; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Su E, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P161, DOI 10.1016/B978-0-12-396481-6.00005-2; Sullivan AM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003283; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P727, DOI 10.1093/schbul/sbm026; VAN DER WAAIJ D., 1959, Tropical and Geographical Medicine, V11, P345; Vaudaux JD, 2010, J INFECT DIS, V202, P1226, DOI 10.1086/656397; Velmurugan GV, 2009, J PARASITOL, V95, P95, DOI 10.1645/GE-1746.1; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Watson C, 2006, RAT BRAIN STEREOTAXI; Watts E, 2015, MBIO, V6, DOI 10.1128/mBio.01155-15; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9	76	46	51	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156255	10.1371/journal.pone.0156255	http://dx.doi.org/10.1371/journal.pone.0156255			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228262	Green Published, gold			2022-12-26	WOS:000376882500095
J	Oka, T; Lu, ZY; Phan, T; Delwart, EL; Saif, LJ; Wang, QH				Oka, Tomoichiro; Lu, Zhongyan; Phan, Tung; Delwart, Eric L.; Saif, Linda J.; Wang, Qiuhong			Genetic Characterization and Classification of Human and Animal Sapoviruses	PLOS ONE			English	Article							PORCINE ENTERIC CALICIVIRUSES; MOLECULAR CHARACTERIZATION; IDENTIFICATION; NOROVIRUSES; PREVALENCE; DIVERSITY; SWINE; KOBUVIRUSES; ROTAVIRUSES; DIARRHEA	Sapoviruses (SaVs) are enteric caliciviruses that have been detected in multiple mammalian species, including humans, pigs, mink, dogs, sea lions, chimpanzees, and rats. They show a high level of diversity. A SaV genome commonly encodes seven nonstructural proteins (NSs), including the RNA polymerase protein NS7, and two structural proteins (VP1 and VP2). We classified human and animal SaVs into 15 genogroups (G) based on available VP1 sequences, including three newly characterized genomes from this study. We sequenced the full length genomes of one new genogroup V (GV), one GVII and one GVIII porcine SaV using long range RT-PCR including newly designed forward primers located in the conserved motifs of the putative NS3, and also 5' RACE methods. We also determined the 5'-and 3'-ends of sea lion GV SaV and canine GXIII SaV. Although the complete genomic sequences of GIX-GXII, and GXV SaVs are unavailable, common features of SaV genomes include: 1) "GTG" at the 50-end of the genome, and a short (9 similar to 14 nt) 50-untranslated region; and 2) the first five amino acids (M [A/V] S [K/R] P) of the putative NS1 and the five amino acids (FEMEG) surrounding the putative cleavage site between NS7 and VP1 were conserved among the chimpanzee, two of five genogroups of pig (GV and GVIII), sea lion, canine, and human SaVs. In contrast, these two amino acid motifs were clearly different in three genogroups of porcine (GIII, GVI and GVII), and bat SaVs. Our results suggest that several animal SaVs have genetic similarities to human SaVs. However, the ability of SaVs to be transmitted between humans and animals is uncertain.	[Oka, Tomoichiro; Lu, Zhongyan; Saif, Linda J.; Wang, Qiuhong] Ohio State Univ, Ohio Agr Res & Dev Ctr, Coll Food Agr & Environm Sci, Food Anim Hlth Res Program,Dept Vet Prevent Med, Wooster, OH 44691 USA; [Oka, Tomoichiro] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Phan, Tung; Delwart, Eric L.] Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA USA; [Phan, Tung; Delwart, Eric L.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University System of Ohio; Ohio State University; National Institute of Infectious Diseases (NIID); Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Saif, LJ; Wang, QH (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Coll Food Agr & Environm Sci, Food Anim Hlth Res Program,Dept Vet Prevent Med, Wooster, OH 44691 USA.	saif.2@osu.edu; wang.655@osu.edu	Saif, Linda/E-4005-2011	Phan, Tung/0000-0003-3517-3078	Ohio State University; USDA, National Institute of Food and Agriculture [2011-68003-30395]; Blood Systems Research Institute; NIH [R01-HL-105770]; Ohio Agricultural Research and Development Center (OARDC), The Ohio State University	Ohio State University(Ohio State University); USDA, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Blood Systems Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research and Development Center (OARDC), The Ohio State University(Ohio State University)	This research was supported by The Ohio State University (www.osu.edu) through start-up funding for Q. Wang. This research was also supported by the USDA, National Institute of Food and Agriculture, grant 2011-68003-30395 (to L.J. Saif and Q. Wang; subaward co-PIs)(https://nifa.usda.gov/). E.L. Delwart (PI) and T. Phan were supported by Blood Systems Research Institute and NIH (R01-HL-105770) (http://www.nih.gov/). Salaries and research support were provided by state and federal funds provided to the Ohio Agricultural Research and Development Center (OARDC), The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amimo JO, 2013, VET MICROBIOL, V164, P27, DOI 10.1016/j.vetmic.2013.01.039; Amimo JO, 2013, J CLIN MICROBIOL, V51, P1142, DOI 10.1128/JCM.03193-12; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Guo M, 2001, ARCH VIROL, V146, P479, DOI 10.1007/s007050170157; Guo M, 1999, J VIROL, V73, P9625, DOI 10.1128/JVI.73.11.9625-9631.1999; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Liu W, 2014, VIRUS GENES, V49, P100, DOI 10.1007/s11262-014-1078-4; Martella V, 2008, J CLIN MICROBIOL, V46, P1907, DOI 10.1128/JCM.00341-08; Mombo IM, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00680-14; Nakamura K, 2010, J CLIN MICROBIOL, V48, P1215, DOI 10.1128/JCM.02130-09; Oka T, 2006, J GEN VIROL, V87, P3329, DOI 10.1099/vir.0.81799-0; Oka T, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00349-13; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; SAIF LJ, 1980, J CLIN MICROBIOL, V12, P105, DOI 10.1128/JCM.12.1.105-111.1980; Scheuer KA, 2013, J CLIN MICROBIOL, V51, P2344, DOI 10.1128/JCM.00865-13; Shibata S., 2015, Genome Announcements, V3, pe01553; Sisay Z, 2013, ARCH VIROL, V158, P1583, DOI 10.1007/s00705-013-1619-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034987; Wang QH, 2006, J VIROL METHODS, V132, P135, DOI 10.1016/j.jviromet.2005.10.003; Wang QH, 2005, J CLIN MICROBIOL, V43, P5963, DOI 10.1128/JCM.43.12.5963-5972.2005; Wang QH, 2007, VACCINE, V25, P5453, DOI 10.1016/j.vaccine.2006.12.032	23	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156373	10.1371/journal.pone.0156373	http://dx.doi.org/10.1371/journal.pone.0156373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228126	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500124
J	Pyo, JH; Lee, H; Min, BH; Lee, JH; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, KM; Ahn, HS; Jung, SH; Kim, S; Kim, JJ				Pyo, Jeung Hui; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Choi, Min Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Kyoung-Mee; Ahn, Hyeon Seon; Jung, Sin-Ho; Kim, Sung; Kim, Jae J.			A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer	PLOS ONE			English	Article							ENDOSCOPIC SUBMUCOSAL DISSECTION; RING CELL-CARCINOMA; MUCOSAL RESECTION; CLINICAL-SIGNIFICANCE; ESOPHAGEAL CANCER; HISTOLOGICAL TYPE; ADENOCARCINOMA; SURGERY; MICROMETASTASIS; FEASIBILITY	Background and Aim Endoscopic submucosal dissection (ESD) for undifferentiated type early gastric cancer is regarded as an investigational treatment. Few studies have tried to identify the risk factors that predict lymph-node metastasis (LNM) in intramucosal poorly differentiated adenocarcinomas (PDC). This study was designed to develop a risk scoring system (RSS) for predicting LNM in intramucosal PDC. Methods From January 2002 to July 2015, patients diagnosed with mucosa-confined PDC, among those who underwent curative gastrectomy with lymph node dissection were reviewed. A risk model based on independent predicting factors of LNM was developed, and its performance was internally validated using a split sample approach. Results Overall, LNM was observed in 5.2% (61) of 1169 patients. Four risk factors [Female sex, tumor size >= 3.2 cm, muscularis mucosa (M3) invasion, and lymphatic-vascular involvement] were significantly associated with LNM, which were incorporated into the RSS. The area under the receiver operating characteristic curve for predicting LNM after internal validation was 0.69 [95% confidence interval (CI), 0.59-0.79]. A total score of 2 points corresponded to the optimal RSS threshold with a discrimination of 0.75 (95% CI 0.69-0.81). The LNM rates were 1.6% for low risk (<2 points) and 8.9% for high-risk (>= 2 points) patients, with a negative predictive value of 98.6%(95% CI 0.98-1.00). Conclusions A RSS could be useful in clinical practice to determine which patients with intramucosal PDC have low risk of LNM.	[Pyo, Jeung Hui; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Kim, Jae J.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Choi, Min Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Ahn, Hyeon Seon; Jung, Sin-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Jung, Sin-Ho] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Duke University	Lee, H; Lee, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	leehyuk@skku.edu; stomachlee@gmail.com	Kim, Sung/G-4114-2014; Pyo, Jh/HHD-0876-2022	Lee, Hyuk/0000-0003-4271-7205				Abe N, 2004, GASTROINTEST ENDOSC, V60, P242, DOI 10.1016/S0016-5107(04)01682-7; Abe N, 2002, AM J SURG, V183, P168, DOI 10.1016/S0002-9610(01)00860-1; Abe N, 2004, AM J SURG, V188, P181, DOI 10.1016/j.amjsurg.2003.12.060; [Anonymous], 2000, WHO CLASSIFICATION T; Arigami T, 2013, ANN SURG ONCOL, V20, P515, DOI 10.1245/s10434-012-2355-x; Asakawa Y, 2015, WORLD J GASTROENTERO, V21, P2683, DOI 10.3748/wjg.v21.i9.2683; Cho JW, 2014, CLIN ENDOSC, V47, P523, DOI 10.5946/ce.2014.47.6.523; Edge SB, 2010, AJCC CANC STAGING MA; Gotoda T, 2000, CANCER, V3, P219; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Gotoda T, 2013, DIGEST ENDOSC, V25, P55, DOI 10.1111/den.12003; Ha TK, 2008, ANN SURG ONCOL, V15, P508, DOI 10.1245/s10434-007-9660-9; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Huo ZB, 2012, WORLD J GASTROENTERO, V18, P6489, DOI 10.3748/wjg.v18.i44.6489; Ishida K, 1997, CANCER, V79, P1069, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1069::AID-CNCR3>3.0.CO;2-B; Ishikawa S, 2007, GASTRIC CANCER, V10, P35, DOI 10.1007/s10120-006-0407-2; Kang HY, 2010, SURG ENDOSC, V24, P509, DOI 10.1007/s00464-009-0614-0; Kim HM, 2011, SURG ENDOSC, V25, P3087, DOI 10.1007/s00464-011-1674-5; Kim JH, 2009, GASTROINTEST ENDOSC, V69, pE1, DOI 10.1016/j.gie.2008.10.040; Kitamura K, 1997, J SURG ONCOL, V64, P42, DOI 10.1002/(SICI)1096-9098(199701)64:1<42::AID-JSO9>3.0.CO;2-P; Kunisaki C, 2009, ENDOSCOPY, V41, P498, DOI 10.1055/s-0029-1214758; Lee JH, 2012, BRIT J SURG, V99, P1688, DOI 10.1002/bjs.8934; Lee SH, 2015, EUR J GASTROEN HEPAT, V27, P170, DOI 10.1097/MEG.0000000000000258; Li C, 2008, ANN SURG ONCOL, V15, P764, DOI 10.1245/s10434-007-9707-y; Maehara Y, 1996, SURGERY, V119, P397, DOI 10.1016/S0039-6060(96)80138-3; Park JM, 2009, EUR J GASTROEN HEPAT, V21, P1132, DOI 10.1097/MEG.0b013e32832a21d8; Park YD, 2008, ENDOSCOPY, V40, P7, DOI 10.1055/s-2007-966750; Pyo JH, 2016, AM J GASTROENTEROL, V111, P240, DOI 10.1038/ajg.2015.427; Pyo JH, 2016, ANN SURG; Shim CN, 2014, SURG ENDOSC, V28, P2199, DOI 10.1007/s00464-014-3453-6; Shim CN, 2014, WORLD J GASTROENTERO, V20, P3938, DOI 10.3748/wjg.v20.i14.3938; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Stein HJ, 2005, ANN SURG, V242, P566, DOI 10.1097/01.sla.0000184211.75970.85; Takizawa K, 2013, GASTRIC CANCER, V16, P531, DOI 10.1007/s10120-012-0220-z; Tsuruta O, 2000, Diagn Ther Endosc, V6, P101, DOI 10.1155/DTE.6.101; Ye BD, 2008, J GASTROEN HEPATOL, V23, P46, DOI 10.1111/j.1440-1746.2006.04791.x	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156207	10.1371/journal.pone.0156207	http://dx.doi.org/10.1371/journal.pone.0156207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228258	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500080
J	Araujo, BF; Ferreira, ML; de Campos, PA; Royer, S; Batistao, DWD; Dantas, RCC; Goncalves, IR; Faria, ALS; de Brito, CS; Yokosawa, J; Gontijo, PP; Ribas, RM				Araujo, Bruna Fuga; Ferreira, Melina Lorraine; de Campos, Paola Amaral; Royer, Sabrina; da Fonseca Batistao, Deivid William; Cavalcanti Dantas, Raquel Cristina; Goncalves, Iara Rossi; Souza Faria, Ana Luiza; de Brito, Cristiane Silveira; Yokosawa, Jonny; Gontijo-Filho, Paulo Pinto; Ribas, Rosineide Marques			Clinical and Molecular Epidemiology of Multidrug-Resistant P. aeruginosa Carrying aac(6)'-Ib-cr, qnrS1 and bla(SPM) Genes in Brazil	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL RESISTANCE; ACINETOBACTER-BAUMANNII; PREVALENCE; QUINOLONE; SURVEILLANCE; BACTEREMIA; MUTATIONS; MORTALITY	We described a comprehensive analysis of the molecular epidemiology of multidrug-resistant (MDR) P. aeruginosa. Molecular analysis included typing by Pulsed Field Gel Electrophoresis, identification of genes of interest through PCR-based assays and sequencing of target genes. Case-control study was conducted to better understand the prognostic of patients and the impact of inappropriate therapy in patients with bacteremia, as well as the risk factors of MDR infections. We observed a high rate of MDR isolates (40.7%), and 51.0% of them was independently associated with inappropriate antibiotic therapy. Bacteremia was detected in 66.9% of patients, and prolonged hospital stay was expressive in those resistant to fluoroquinolone. Plasmid-mediated quinolone resistance genes (PMQR), qnrS(1) and aac(6')Ib-cr, were detected in two different nosocomial isolates (5.3%), and the aac(6')-Ib(7) variant was detected at a high frequency (87.5%) in those negative to PMQR. The presence of mutations in gyrA and parC genes was observed in 100% and 85% of selected isolates, respectively. Isolates harboring PMQR genes or mutations in gyrA and parC were not closely related, except in those containing SPM (Sao Paulo metallo-beta-lactamase) clone. In addition, there is no study published in Brazil to date reporting the presence of Pseudomonas aeruginosa isolates harboring both qnrS(1) and aac(6')Ib-cr genes, with alarming frequency of patients with inappropriate therapy.	[Araujo, Bruna Fuga; Ferreira, Melina Lorraine; de Campos, Paola Amaral; Royer, Sabrina; da Fonseca Batistao, Deivid William; Cavalcanti Dantas, Raquel Cristina; Goncalves, Iara Rossi; Souza Faria, Ana Luiza; de Brito, Cristiane Silveira; Gontijo-Filho, Paulo Pinto; Ribas, Rosineide Marques] Univ Fed Uberlandia, Mol Microbiol Lab, Inst Ciencias Biomed ICBIM, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil; [Yokosawa, Jonny] Univ Fed Uberlandia, Virol Lab, Inst Ciencias Biomed ICBIM, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Araujo, BF (corresponding author), Univ Fed Uberlandia, Mol Microbiol Lab, Inst Ciencias Biomed ICBIM, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	bruna.fuga@hotmail.com	Goncalves, Iara/GRO-4035-2022; Gonçalves, Iara Rossi/AAJ-6326-2020; ribas, Rosineide m/D-2461-2018; Batistão, Deivid William da Fonseca/V-7770-2018	Gonçalves, Iara Rossi/0000-0001-5594-7099; ribas, Rosineide m/0000-0001-9295-6832; Batistão, Deivid William da Fonseca/0000-0002-4928-3473; Campos, Paola Amaral de/0000-0001-9384-7582; Dantas, Raquel/0000-0002-4605-1773; Faria, Ana Maria/0000-0002-0604-8510	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) provided financial support and scholarships.	Agnello Melissa, 2012, PLoS One, V7, pe42973, DOI 10.1371/journal.pone.0042973; Akya A, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.20980v2; Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006; Andrade LN, 2014, INT J ANTIMICROB AG, V43, P196, DOI 10.1016/j.ijantimicag.2013.10.006; Andrade SS, 2003, J ANTIMICROB CHEMOTH, V52, P140, DOI 10.1093/jac/dkg270; Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12; Bennett PM, 1999, J ANTIMICROB CHEMOTH, V43, P1, DOI 10.1093/jac/43.1.1; Borges Lizandra Ferreira de Almeida E, 2012, Interdiscip Perspect Infect Dis, V2012, P579681, DOI 10.1155/2012/579681; Bouchillon Sam, 2012, Open Microbiol J, V6, P74; Burgos J, 2015, EUR RESPIR J, V46, P561, DOI 10.1183/09031936.00034415; Capuano VSC, 2012, THESIS U SAO PAULO S; Cezario RC, 2009, ENFERM INFEC MICR CL, V27, P269, DOI 10.1016/j.eimc.2008.09.009; Clinical and Laboratory Standards Institute (CLSI), 2016, M100 PERFORMANCE STA, V26th; CLSI, 2012, M02A11 CLSI; da Fonseca EL, 2010, ANTIMICROB AGENTS CH, V54, P2743, DOI 10.1128/AAC.00012-10; Dantas RC, 2014, J MED MICROBIOLOGY, P63; Dantas RC, 2015, THESIS U FEDERAL UBE; Conterno Lucieni de Oliveira, 2002, Braz J Infect Dis, V6, P288, DOI 10.1590/S1413-86702002000600004; De Oliveira RA, 2014, PERSPECTIVAS MED, V25, P11; Costa LMD, 2015, REV SOC BRAS MED TRO, V48, P212, DOI 10.1590/0037-8682-0198-2014; El Salabi A, 2010, ANTIMICROB AGENTS CH, V54, P582, DOI 10.1128/AAC.00719-09; Ferreira ML, 2015, J MED MICROBIOL, V64, P262, DOI 10.1099/jmm.0.000023; Fonseca EL, 2015, J ANTIMICROB CHEMOTH, V70, P2547, DOI 10.1093/jac/dkv152; Gales AC, 2003, J ANTIMICROB CHEMOTH, V52, P699, DOI 10.1093/jac/dkg416; Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007; Galetti R, 2010, THESIS U SAO PAULO R, P49; Galetti R, 2015, DIAGN MICR INFEC DIS, V82, P179, DOI 10.1016/j.diagmicrobio.2015.02.011; Gilbert DN, 2007, SANFORD GUIDE ANTIMI, P37; Goel N, 2011, J ANTIMICROB CHEMOTH; Franco MRG, 2010, CLINICS, V65, P825, DOI 10.1590/S1807-59322010000900002; Gontijo-Filho PP, 2006, J BASIC APPL PHARM S, V27, P97; Gootz TD, 2009, ANTIMICROB AGENTS CH, V53, P1998, DOI 10.1128/AAC.01355-08; Gross U, 2011, EMERG INFECT DIS, V17, P1879, DOI [10.3201/edi1710.110327, 10.3201/eid1710.110327]; Gulmez D, 2008, INT J ANTIMICROB AG, V31, P523, DOI 10.1016/j.ijantimicag.2008.01.017; Gulen TA, 2015, INT J INFECT DIS, V38, P32, DOI [10.1016/j.ijid.2015.06.014, 10.1016/j.ijid.2015.06.01]; Higgins PG, 2003, INT J ANTIMICROB AG, V21, P409, DOI 10.1016/S0924-8579(03)00009-8; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Jiang XB, 2014, DIAGN MICR INFEC DIS, V79, P381, DOI 10.1016/j.diagmicrobio.2014.03.025; Baumgart AMK, 2010, BRAZ J INFECT DIS, V14, P433, DOI 10.1590/S1413-86702010000500002; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; Koutsogiannou M, 2013, J CLIN MICROBIOL, V51, P665, DOI 10.1128/JCM.03071-12; Lee JK, 2005, INT J ANTIMICROB AG, V25, P290, DOI 10.1016/j.ijantimicag.2004.11.012; Liu Yang, 2014, Zhonghua Shao Shang Za Zhi, V30, P15; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Rodriguez-Martinez JM, 2011, J INFECT CHEMOTHER, V17, P149, DOI 10.1007/s10156-010-0120-2; McClaran J, 1996, CAN FAM PHYSICIAN, V42, P449; Moreira MR, 2013, REV SOC BRAS MED TRO, V46, P39, DOI 10.1590/0037-868216722013; Mouneimne H, 1999, ANTIMICROB AGENTS CH, V43, P62, DOI 10.1128/AAC.43.1.62; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Padoveze MC, 2016, AM J INFECT CONTROL, V44, P74, DOI 10.1016/j.ajic.2015.08.004; Piekarska K, 2015, INT J ANTIMICROB AG, V45, P238, DOI 10.1016/j.ijantimicag.2014.09.019; Porto JP, 2013, REV SOC BRAS MED TRO, V46, P713, DOI 10.1590/0037-8682-0199-2013; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Sader HS, 2005, CLIN MICROBIOL INFEC, V11, P73, DOI 10.1111/j.1469-0691.2004.01031.x; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; Scheffer MC, 2010, BRAZ J INFECT DIS, V14, P508, DOI 10.1590/S1413-86702010000500014; Scheffer MC, 2010, REV SOC BRAS MED TRO, V43, P367, DOI 10.1590/S0037-86822010000400006; Schwarz S, 2010, J ANTIMICROB CHEMOTH; Silva LV, 2014, INT J MED MICROBIOL, V304, P990, DOI 10.1016/j.ijmm.2014.07.001; Sligl WI, 2015, INT J INFECT DIS, V37, P129, DOI 10.1016/j.ijid.2015.06.024; van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711; Woodford N, 2010, METHODS MOL BIOL, V642, P181, DOI 10.1007/978-1-60327-279-7_14; Wright LL, 2015, J ANTIMICROB CHEMOTH, V70, P103, DOI 10.1093/jac/dku339; Xavier DE, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-217; Yang H, 2008, ANTIMICROB AGENTS CH, V52, P4268, DOI 10.1128/AAC.00830-08; Yang XY, 2015, INT J CLIN EXP MED, V8, P1386; Zavascki AP, 2005, J ANTIMICROB CHEMOTH, V56, P1148, DOI 10.1093/jac/dki390	69	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155914	10.1371/journal.pone.0155914	http://dx.doi.org/10.1371/journal.pone.0155914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219003	Green Submitted, gold, Green Published			2022-12-26	WOS:000376880700027
J	Kim, MS; Yu, JH; Lee, MY; Kim, AL; Jo, MH; Kim, M; Cho, SR; Kim, YH				Kim, Myung-Sun; Yu, Ji Hea; Lee, Min-Young; Kim, Ah Leum; Jo, Mi Hyun; Kim, MinGi; Cho, Sung-Rae; Kim, Young-Han			Differential Expression of Extracellular Matrix and Adhesion Molecules in Fetal-Origin Amniotic Epithelial Cells of Preeclamptic Pregnancy	PLOS ONE			English	Article							TISSUE INHIBITORS; METALLOPROTEINASES; TRANSCRIPTOME; WOMEN; GENE	Preeclampsia is a common disease that can occur during human pregnancy and is a leading cause of both maternal and neonatal morbidity and mortality. Inadequate trophoblast invasion and deficient remodeling of uterine spiral arteries are associated with preeclampsia (PE). The development of this syndrome is thought to be related to multiple factors. Recently, we isolated patient-specific human amniotic epithelial cells (AECs) from the placentas of 3 women with normal pregnancy and 3 with preeclamptic pregnancy. Since the characteristics of human AECs in PE are different from those in normal pregnancy, we sought to confirm the genes differentially expressed between preeclamptic pregnancy and normal pregnancy. Therefore, we performed transcriptome analysis to investigate the candidate genes associated with the possible pathophysiology of preeclampsia. Pathway analysis was performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) and Kyoto Encyclopedia of Genes and Genomes (KEGG) online resource. In this study, we selected a total of 12 pathways and focused on extracellular matrix-related and biological adhesion molecules. Using RT-PCR array and real-time PCR, we confirmed that COL16A1, ITGB2, and LAMA3 were significantly up-regulated, but ITGA1, ITGA3, ITGA6, MMP1, MMP3, MMP10 and MMP11 were significantly down-regulated in preeclamptic fetal origin cells. Taken together, we suggest that the genes and pathways identified here may be responsible for the occurrence and development of PE, and controlling their expression may play a role in communication with fetal-maternal placenta to keep normal pregnancy.	[Kim, Myung-Sun; Jo, Mi Hyun; Kim, Young-Han] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seoul, South Korea; [Kim, Myung-Sun; Yu, Ji Hea; Lee, Min-Young; Kim, MinGi; Cho, Sung-Rae] Severance Hosp, Dept & Res Inst Rehabil Med, Seoul, South Korea; [Kim, Ah Leum; Jo, Mi Hyun; Kim, Young-Han] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea; [Kim, Myung-Sun; Yu, Ji Hea; Lee, Min-Young; Kim, MinGi; Cho, Sung-Rae] Avison Biomed Res Ctr, Yonsei Stem Cell Res Ctr, Seoul, South Korea; [Yu, Ji Hea; Kim, MinGi; Cho, Sung-Rae] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, YH (corresponding author), Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seoul, South Korea.; Cho, SR (corresponding author), Severance Hosp, Dept & Res Inst Rehabil Med, Seoul, South Korea.; Kim, YH (corresponding author), Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea.; Cho, SR (corresponding author), Avison Biomed Res Ctr, Yonsei Stem Cell Res Ctr, Seoul, South Korea.; Cho, SR (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	SRCHO918@yuhs.ac; YHKIM522@yuhs.ac		Cho, Sung-Rae/0000-0003-1429-2684; Kim, Young-Han/0000-0003-0645-6028	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2005083]; Ministry of Science, ICT & Future Planning [NRF-2014R1A2A1A11052042, NRF-2015M3A9B4067068]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2005083) and the Ministry of Science, ICT & Future Planning (NRF-2014R1A2A1A11052042, and NRF-2015M3A9B4067068), http://www.nrf.re.kr/nrf_eng_cms/.	Ai B, 2015, MOL ECOL RESOUR, V15, P619, DOI 10.1111/1755-0998.12333; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Anton L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100148; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Diaz-Prado S, 2011, DIFFERENTIATION, V81, P162, DOI 10.1016/j.diff.2011.01.005; Estrada-Gutierrez G, 2011, AM J PATHOL, V178, P451, DOI 10.1016/j.ajpath.2010.11.003; Evron Ayelet, 2011, Int J Stem Cells, V4, P123; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; He P, 2014, J OBSTET GYNAECOL, DOI [10.3109/01443615.2014.990430:1-7, DOI 10.3109/01443615.2014.990430:1-7.]; Huisman MA, 2004, PLACENTA, V25, P253, DOI 10.1016/j.placenta.2003.10.006; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Kim JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102893; Kim YH, 2008, REPROD SCI, V15, P939, DOI 10.1177/1933719108322431; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Konttinen YT, 1999, ANN RHEUM DIS, V58, P691, DOI 10.1136/ard.58.11.691; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084201; Lin JQ, 2013, FUNGAL GENET BIOL, V56, P78, DOI 10.1016/j.fgb.2013.04.007; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Molvarec A, 2010, HYPERTENS RES, V33, P892, DOI 10.1038/hr.2010.92; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Shan N, 2015, REPROD SCI, V22, P969, DOI 10.1177/1933719115570913; Song JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061231; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Woo Jin K, 2013, INT J IND ENTOMOLOGY, p[27, 271]; Zhao HX, 2010, DIFFERENTIATION, V80, P123, DOI 10.1016/j.diff.2010.03.002	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156038	10.1371/journal.pone.0156038	http://dx.doi.org/10.1371/journal.pone.0156038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218821	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700036
J	Valdez, DJ; Benitez-Vieyra, SM				Javier Valdez, Diego; Miguel Benitez-Vieyra, Santiago			A Spectrophotometric Study of Plumage Color in the Eared Dove (Zenaida auriculata), the Most Abundant South American Columbiforme	PLOS ONE			English	Article							FEMALE MATE CHOICE; ULTRAVIOLET VISION; SEXUAL SELECTION; VISUAL PIGMENTS; RECEPTOR NOISE; OIL DROPLETS; SWS1 OPSIN; BIRDS; EVOLUTION; PIGEONS	For birds, plumage color perception is critical in social interactions such as courtship, in both monochromatic and dichromatic species. In the Eared Dove (Zenaida auriculata), perhaps the most abundant South American Columbiforme, the plumage of males and females looks alike and both sexes share the same melanistic coloration with gray and pink tones. The aim of this study was therefore to determine whether evident sexual dichromatism exists in the plumage of the Eared Dove using a spectrophotometry technique in the avianvisible range (300-700 nm). The results of the classic colorimetric variables analysis (hue, chroma and brightness) show that males are in general brighter and have higher UV chroma values than females. The avian visual model points to differences in achromatic and chromatic levels between males and females in body regions possibly involved in sexual selection (e. g. the crown). The model also indicates chromatic or achromatic differences in body regions not subject to sexual selection such as the black spots on the wing coverts and white tail bands, both of which may be involved in intra-or inter-gender-specific communication.	[Javier Valdez, Diego] Univ Nacl Cordoba, Ctr Zool Aplicada, IDEA, CONICET, RA-5000 Cordoba, Argentina; [Miguel Benitez-Vieyra, Santiago] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Inst Multidisciplinario Biol Vegetal IMBIV, CONICET, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Valdez, DJ (corresponding author), Univ Nacl Cordoba, Ctr Zool Aplicada, IDEA, CONICET, RA-5000 Cordoba, Argentina.	dvaldez@unc.edu.ar	Benitez-Vieyra, Santiago/AAT-3076-2020	Benitez-Vieyra, Santiago/0000-0003-4116-7969; Valdez, Diego Javier/0000-0002-4467-6761	zoo of Cordoba	zoo of Cordoba	The authors received no specific funding for this work. The writer (Diego Javier Valdez) had no funding to cover publication costs. This work was made possible by the generous support of the zoo of Cordoba, who provided all the elements to catch the animals. PhDs Alicia Sercic and Andrea Cocucci from Multidisciplinary Institute of Plant Biology (IMBIV-CONICET-UNC) selflessly lent the spectrophotometer. PhD. Santiago Benitez collaborated in analyzing the data and writing the manuscript. None of these persons and institutions mentioned above had grants to cover publication costs.	Andersson S, 1996, P ROY SOC B-BIOL SCI, V263, P843, DOI 10.1098/rspb.1996.0124; Ballentine B, 2003, CONDOR, V105, P593, DOI 10.1650/7234; Baptista L. F., 1997, HDB BIRDS WORLD, V4, P60; Bennett ATD, 2007, AM NAT, V169, pS1, DOI 10.1086/510163; Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Bucher E., 1977, ECOSUR, V4, P47; BUCHER E H, 1976, Physis Seccion C los Continentes y los Organismos Terrestres, V35, P17; BUCHER EH, 1982, BIOTROPICA, V14, P255, DOI 10.2307/2388083; Bucher EH, 1970, SERIE CIENCIA TECNIC; Butcher G.S., 1989, Current Ornithology, V6, P51; Delhey K, 2006, BEHAV ECOL, V17, P790, DOI 10.1093/beheco/arl012; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; EMMERTON J, 1980, J COMP PHYSIOL, V141, P47, DOI 10.1007/BF00611877; EMMERTON J, 1983, EXPERIENTIA, V39, P1161, DOI 10.1007/BF01943162; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; GOODWIN D, 1966, AUK, V83, P117, DOI 10.2307/4082982; Greenewalt CH, 1960, P AM PHILOS SOC, V104, P249, DOI DOI 10.1364/JOSA.50; Hill G.E., 2006, BIRD COLOURATION FUN; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; HILL GE, 1993, EVOLUTION, V47, P1515, DOI 10.1111/j.1558-5646.1993.tb02172.x; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Johnson KP, 2000, CONDOR, V102, P864, DOI 10.1650/0010-5422(2000)102[0864:AMPOTD]2.0.CO;2; Kang SW, 2010, NEUROSCIENCE, V170, P200, DOI 10.1016/j.neuroscience.2010.06.082; Mahler BA, 2002, CONDOR, V104, P248, DOI 10.1650/0010-5422(2002)104[0248:OAOSPD]2.0.CO;2; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; McGraw KJ, 2004, NATURWISSENSCHAFTEN, V91, P125, DOI 10.1007/s00114-003-0498-0; Meadows MG, 2011, BEHAV ECOL SOCIOBIOL, V65, P1317, DOI 10.1007/s00265-010-1135-5; Narosky T, 2010, AVES ARGENINA URUGUA; Navarro J.L., 1986, Vida Silvestre Neotropical, V1, P79; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Odeen A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-36; Odeen A, 2009, J COMP PHYSIOL A, V195, P167, DOI 10.1007/s00359-008-0395-2; Pearn SM, 2001, P ROY SOC B-BIOL SCI, V268, P2273, DOI 10.1098/rspb.2001.1813; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ranvaud R., 2001, Brazilian Journal of Biology, V61, P651; Remy A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1839, DOI 10.1007/s00265-010-0995-z; Savalli Udo M., 1995, Current Ornithology, V12, P141; Senar JC, 2003, NATURWISSENSCHAFTEN, V90, P234, DOI 10.1007/s00114-003-0414-7; Siefferman L, 2005, EVOLUTION, V59, P1819, DOI 10.1111/j.0014-3820.2005.tb01828.x; Siitari H, 2002, ANIM BEHAV, V63, P97, DOI 10.1006/anbe.2001.1870; Team RC, 2014, R LANG ENV STAT COMP; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Valdez DJ, 2009, FASEB J, V23, P1186, DOI 10.1096/fj.08-117085; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; Yin HW, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051916; Yoshioka S., 2002, FORMA, V17, P169	51	5	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155501	10.1371/journal.pone.0155501	http://dx.doi.org/10.1371/journal.pone.0155501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213273	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200012
J	Schertz, M; Mehdaoui, H; Hamlat, A; Piotin, M; Banydeen, R; Mejdoubi, M				Schertz, Mathieu; Mehdaoui, Hossein; Hamlat, Abderrahmane; Piotin, Michel; Banydeen, Rishika; Mejdoubi, Mehdi			Incidence and Mortality of Spontaneous Subarachnoid Hemorrhage in Martinique	PLOS ONE			English	Article							INTRACRANIAL ANEURYSMS; RISK-FACTORS; POPULATION; PREVALENCE; REGION; GENDER; TRENDS; AGE	Background Incidence of spontaneous subarachnoid hemorrhages (SAH) varies wildly across the world and seems to be low in Central and South America (4.2 per 100 000 person-years; CI 95%; 3.1-5.7). The objective of our study was to describe the characteristics of SAH and to estimate its incidence and severity in Martinique, a small French island located in the Caribbean Sea. Methods Due to its insular nature and small captive population, Martinique is ideal for the setting up of population-based epidemiological studies with good exhaustiveness. Our study, spanning a 7 year period (2007-2013), consisted of retrospective case ascertainment with multiple overlapping methods. Crude incidence and 30 day case-fatality rates for SAH among the Martinican population were computed for the study period. Incidence and disease severity was also analyzed according to age, gender and aneurysm presence. World age-standardized incidence rates were also calculated. Results A total of 121 patients had a SAH during the study period, with a higher frequency of female cases (71.1% versus 28.9%, p< 0.001). Patient mean age was 57.1 years (median = 55 [46-66]). An aneurysmal origin was found in 96 SAH cases (79.3%). Crude annual incidence was 4.36 per 100 000 person-years (CI 95% 2.30-6.42). World age-standardized incidence was 3.29 per 100 000 person-years (CI 95% 1.74-4.84). During the 30 days following SAH diagnosis, 29 patients died (case fatality rate: 24% (CI 95% 16.4-31.6)). Conclusions The incidence of spontaneous subarachnoid hemorrhage in Martinique is much lower than in other parts of the world and similar to countries in Central and South America. These results are possibly related to environmental factors and most particularly to a low rate of smoking in the Martinican population. Thirty-day case-fatality rate is similar to what is observed in developed countries.	[Schertz, Mathieu; Mejdoubi, Mehdi] Univ Hosp Martinique, Dept Neuroradiol, Fort De France, Martinique, France; [Mehdaoui, Hossein] Univ Hosp Martinique, Dept Crit Care & Emergency, Fort De France, Martinique, France; [Hamlat, Abderrahmane] Univ Hosp Martinique, Dept Neurosurg, Fort De France, Martinique, France; [Piotin, Michel] Rothschild Fdn, Dept Intervent Neuroradiol, Paris, France; [Banydeen, Rishika] Univ Hosp Martinique, Dept Clin Res, Fort De France, Martinique, France	CHU Martinique; CHU Martinique; CHU Martinique; CHU Martinique	Schertz, M (corresponding author), Univ Hosp Martinique, Dept Neuroradiol, Fort De France, Martinique, France.	schertzmathieu@hotmail.fr	Mehdaoui, Hossein/A-2466-2019	Mehdaoui, Hossein/0000-0001-8647-5215; mejdoubi, mehdi/0000-0001-9422-9356; Piotin, Michel/0000-0002-1354-4328; Schertz, Mathieu/0000-0002-2183-2426				Ahmad OB., 2001, AGE STANDARDIZATION; [Anonymous], 2015, QUALITY LIFE BALANCE; [Anonymous], 2015, POP; Corbin DO, STROKE, V35, P1254; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Donnan GA, 2010, LANCET NEUROL, V9, P133, DOI 10.1016/S1474-4422(10)70001-6; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Flaherty ML, 2005, J STROKE CEREBROVASC, P267; Inamo J, 2005, J HYPERTENS, V23, P1341, DOI 10.1097/01.hjh.0000173515.83481.d4; Kaminogo M, 2003, STROKE, V34, P16, DOI 10.1161/01.STR.0000046763.48330.AD; Kissela BM, 2002, STROKE, V33, P1321, DOI 10.1161/01.STR.0000014773.57733.3E; Kongable GL, 1996, J NEUROSURG, V84, P43, DOI 10.3171/jns.1996.84.1.0043; Labovitz DL, 2006, NEUROEPIDEMIOLOGY, V26, P147, DOI 10.1159/000091655; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; MONPLAISIR N, 1985, TISSUE ANTIGENS, V26, P1; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Olindo S, 2014, STROKE, V45, P3367, DOI 10.1161/STROKEAHA.114.005930; Ruigrok YM, 2001, STROKE, V32, P1173, DOI 10.1161/01.STR.32.5.1173; Smeeton NC, 2007, STROKE, V38, P3133, DOI 10.1161/STROKEAHA.107.487082; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vlak MHM, 2013, STROKE, V44, P984, DOI 10.1161/STROKEAHA.111.000329	21	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155945	10.1371/journal.pone.0155945	http://dx.doi.org/10.1371/journal.pone.0155945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213614	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880200036
J	Giffin, MM; Shi, LB; Gennaro, ML; Sohaskey, CD				Giffin, Michelle M.; Shi, Lanbo; Gennaro, Maria L.; Sohaskey, Charles D.			Role of Alanine Dehydrogenase of Mycobacterium tuberculosis during Recovery from Hypoxic Nonreplicating Persistence	PLOS ONE			English	Article							GIARDIA-LAMBLIA; GUINEA-PIGS; METABOLISM; GLYCINE; PURIFICATION; GLYOXYLATE; GRANULOMA; GROWTH; ALD; TRANSCRIPTION	Mycobacterium tuberculosis can maintain a nonreplicating persistent state in the host for decades, but must maintain the ability to efficiently reactivate and produce active disease to survive and spread in a population. Among the enzymes expressed during this dormancy is alanine dehydrogenase, which converts pyruvate to alanine, and glyoxylate to glycine concurrent with the oxidation of NADH to NAD. It is involved in the metabolic remodeling of M. tuberculosis through its possible interactions with both the glyoxylate and methylcitrate cycle. Both mRNA levels and enzymatic activities of isocitrate lyase, the first enzyme of the glyoxylate cycle, and alanine dehydrogenase increased during entry into nonreplicating persistence, while the gene and activity for the second enzyme of the glyoxylate cycle, malate synthase were not. This could suggest a shift in carbon flow away from the glyoxylate cycle and instead through alanine dehydrogenase. Expression of ald was also induced in vitro by other persistence-inducing stresses such as nitric oxide, and was expressed at high levels in vivo during the initial lung infection in mice. Enzyme activity was maintained during extended hypoxia even after transcription levels decreased. An ald knockout mutant of M. tuberculosis showed no reduction in anaerobic survival in vitro, but resulted in a significant lag in the resumption of growth after reoxygenation. During reactivation the ald mutant had an altered NADH/NAD ratio, and alanine dehydrogenase is proposed to maintain the optimal NADH/NAD ratio during anaerobiosis in preparation of eventual regrowth, and during the initial response during reoxygenation.	[Giffin, Michelle M.; Sohaskey, Charles D.] Dept Vet Affairs Med Ctr, Long Beach, CA USA; [Shi, Lanbo; Gennaro, Maria L.] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Sohaskey, CD (corresponding author), Dept Vet Affairs Med Ctr, Long Beach, CA USA.	Chuck@Sohaskey.com		Gennaro, Maria Laura/0000-0003-4801-3567	Medical Research Services of the U.S. Department of Veterans Affairs; NIAID [AI104615]; NHLBI [HL 106788]	Medical Research Services of the U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the Medical Research Services of the U.S. Department of Veterans Affairs (CDS) and from the NIAID (AI104615) and NHLBI (HL 106788) (MLG).	Aitken A., 2002, PROTEIN PROTOCOLS HD, P595, DOI DOI 10.1385/1-59259-169-8:595; Archuleta RJ, 2005, TUBERCULOSIS, V85, P147, DOI 10.1016/j.tube.2004.09.002; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; CABALLERO FJ, 1989, J BACTERIOL, V171, P3205, DOI 10.1128/jb.171.6.3205-3210.1989; CASTRIC PA, 1983, CAN J MICROBIOL, V29, P1344, DOI 10.1139/m83-209; Chen JM, 2003, INFECT IMMUN, V71, P708, DOI 10.1128/IAI.71.2.708-716.2003; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; Desjardin LE, 2001, J BACTERIOL, V183, P5311, DOI 10.1128/JB.183.18.5311-5316.2001; Desjardins CA, 2016, NAT GENET, V48, P544, DOI 10.1038/ng.3548; Deters M, 1997, RES COMMUN MOL PATH, V97, P199; EDWARDS MR, 1989, MOL BIOCHEM PARASIT, V37, P19, DOI 10.1016/0166-6851(89)90098-4; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; FEAVERS IM, 1990, MOL MICROBIOL, V4, P275, DOI 10.1111/j.1365-2958.1990.tb00594.x; Feng ZY, 2002, J BACTERIOL, V184, P5001, DOI 10.1128/JB.184.18.5001-5010.2002; FOURNEAU JP, 1974, ARZNEIMITTELFORSCH, V24, P27; Giffin MM, 2012, J BACTERIOL, V194, P1045, DOI 10.1128/JB.05914-11; GOLDMAN DS, 1959, BIOCHIM BIOPHYS ACTA, V34, P527, DOI 10.1016/0006-3002(59)90305-1; GOPINATHAN KP, 1963, BIOCHEM J, V87, P444, DOI 10.1042/bj0870444; Gould TA, 2006, MOL MICROBIOL, V61, P940, DOI 10.1111/j.1365-2958.2006.05297.x; HAAPANEN JH, 1959, AM REV RESPIR DIS, V80, P1; Hartman T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004510; Hinc K, 2006, J BACTERIOL, V188, P4373, DOI 10.1128/JB.01877-05; HOYT JC, 1991, J BACTERIOL, V173, P6844, DOI 10.1128/jb.173.21.6844-6848.1991; Jung JY, 2013, INFECT IMMUN, V81, P3198, DOI 10.1128/IAI.00611-13; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; LONDON J, 1966, J GEN MICROBIOL, V44, P241, DOI 10.1099/00221287-44-2-241; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miyashita Y, 2008, PLANT CELL PHYSIOL, V49, P92, DOI 10.1093/pcp/pcm171; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; PAGET TA, 1990, MOL BIOCHEM PARASIT, V42, P63, DOI 10.1016/0166-6851(90)90113-Z; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rocha M, 2010, AMINO ACIDS, V39, P1043, DOI 10.1007/s00726-010-0596-1; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; Saxena S, 2015, EUR J MED CHEM, V92, P401, DOI 10.1016/j.ejmech.2014.12.046; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Sohaskey Charles D, 2015, Methods Mol Biol, V1285, P201, DOI 10.1007/978-1-4939-2450-9_11; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; van Schaik EJ, 2009, INFECT IMMUN, V77, P4275, DOI 10.1128/IAI.00609-09; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yin M, 2002, AM J PHYSIOL-RENAL, V282, pF417, DOI 10.1152/ajprenal.00011.2001; Zabalza A, 2009, PLANT PHYSIOL, V149, P1087, DOI 10.1104/pp.108.129288; Zhang K, 2003, NEUROCHEM RES, V28, P893, DOI 10.1023/A:1023275426637; Zhang X, 2007, APPL MICROBIOL BIOT, V77, P355, DOI 10.1007/s00253-007-1170-y	60	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155522	10.1371/journal.pone.0155522	http://dx.doi.org/10.1371/journal.pone.0155522			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203084	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500017
J	Kristbjornsdottir, A; Aspelund, T; Rafnsson, V				Kristbjornsdottir, Adalbjorg; Aspelund, Thor; Rafnsson, Vilhjalmur			Association of Cancer Incidence and Duration of Residence in Geothermal Heating Area in Iceland: An Extended Follow-Up	PLOS ONE			English	Article							GROUND GAS EMISSIONS; AIR-POLLUTION; HEALTH-HAZARDS; BREAST-CANCER; VOLCANIC AREA; NEW-ZEALAND; HOT-WATER; MORTALITY; ROTORUA; EXPOSURE	Background Residents of geothermal areas have higher incidence of non-Hodgkin's lymphoma, breast cancer, prostate cancer, and kidney cancers than others. These populations are exposed to chronic low-level ground gas emissions and various pollutants from geothermal water. The aim was to assess whether habitation in geothermal areas and utilisation of geothermal water is associated with risk of cancer according to duration of residence. Methods The cohort obtained from the census 1981 was followed to the end of 2013. Personal identifier was used in record linkage with nation-wide emigration, death, and cancer registries. The exposed population, defined by community codes, was located on young bedrock and had utilised geothermal water supply systems since 1972. Two reference populations were located by community codes on older bedrock or had not utilised geothermal water supply systems for as long a period as had the exposed population. Adjusted hazard ratio (HR), 95% confidence intervals (CI) non-stratified and stratified on cumulative years of residence were estimated in Cox-model. Results The HR for all cancer was 1.21 (95% CI 1.12-1.30) as compared with the first reference area. The HR for pancreatic cancer was 1.93 (1.22-3.06), breast cancer, 1.48 (1.23-1.80), prostate cancer 1.47 (1.22-1.77), kidney cancer 1.46 (1.03-2.05), lymphoid and haematopoietic tissue 1.54 (1.21-1.97), non-Hodgkin's lymphoma 2.08 (1.38-3.15) and basal cell carcinoma of the skin 1.62 (1.35-1.94). Positive dose-response relationship was observed between incidence of cancers and duration of residence, and between incidence of cancer and degree of geothermal/volcanic activity in the comparison areas. Conclusions The higher cancer incidence in geothermal areas than in reference areas is consistent with previous findings. As the dose-response relationships were positive between incidence of cancers and duration of residence, it is now more urgent than before to investigate the chemical and physical content of the geothermal water and of the ambient air of the areas to detect recognized or new carcinogens.	[Kristbjornsdottir, Adalbjorg; Aspelund, Thor] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Rafnsson, Vilhjalmur] Univ Iceland, Fac Med, Dept Prevent Med, Reykjavik, Iceland	University of Iceland; University of Iceland	Rafnsson, V (corresponding author), Univ Iceland, Fac Med, Dept Prevent Med, Reykjavik, Iceland.	vilraf@hi.is	Aspelund, Thor/C-5983-2008; Aspelund, Thor/K-7022-2019	Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433	University of Iceland Research Fund [123368]; RANNIs-the Icelandic research fund [141746-052]	University of Iceland Research Fund; RANNIs-the Icelandic research fund	This study was supported by grants from the University of Iceland Research Fund, Grant number: 123368, and RANNIs-the Icelandic research fund, Grant number: 141746-052.	Amaral A, 2006, SCI TOTAL ENVIRON, V367, P123, DOI 10.1016/j.scitotenv.2006.01.024; [Anonymous], 2012, KRABBAMEIN ISLANDI U; ARMANNSSON H, 1982, GEOCHIM COSMOCHIM AC, V46, P167, DOI 10.1016/0016-7037(82)90244-7; Armitage P, 1991, STAT METHODS MED RES; AXELSON O, 1988, AM J IND MED, V13, P105, DOI 10.1002/ajim.4700130107; Bates MN, 1997, AUST NZ J PUBL HEAL, V21, P581, DOI 10.1111/j.1467-842X.1997.tb01759.x; Bates MN, 1998, INT J EPIDEMIOL, V27, P10, DOI 10.1093/ije/27.1.10; Baxter PJ, 1999, J VOLCANOL GEOTH RES, V92, P95, DOI 10.1016/S0377-0273(99)00070-0; Beaubien SE, 2003, J VOLCANOL GEOTH RES, V123, P63, DOI 10.1016/S0377-0273(03)00028-3; Carlsen HK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000343; Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483; COX DR, 1972, J R STAT SOC B, V34, P187; D'Ippoliti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138182; DOLL R, 1991, INT J CANCER, V47, P803, DOI 10.1002/ijc.2910470602; Durand M, 2005, SCI TOTAL ENVIRON, V345, P69, DOI 10.1016/j.scitotenv.2004.10.023; Einarsson P, 2008, PURE APPL GEOPHYS, V165, P63, DOI 10.1007/s00024-007-0292-6; Fridleifsson IB, 1979, JOKULL, V29, P47; Goldin LR, 2012, J CLIN ONCOL, V30, P179, DOI 10.1200/JCO.2011.37.1203; Halldorsson O, 2014, 1401 IRSA GR; Hansell A, 2004, ARCH ENVIRON HEALTH, V59, P628, DOI 10.1080/00039890409602947; Haraldsdottir S, 2016, THESIS U ICELAND; Haraldsson IG, 2010, OS201003; Hartge P, 2006, NONHODGKIN LYMPHOMA; Iwanaga M, 2011, J CLIN ONCOL, V29, P428, DOI 10.1200/JCO.2010.31.3080; Keller NS, 2014, GEOCHIM COSMOCHIM AC, V142, P15, DOI 10.1016/j.gca.2014.08.007; Kristbjornsdottir A, 2015, ACTA ONCOL, V54, P115, DOI 10.3109/0284186X.2014.923113; Kristbjornsdottir A, 2013, INT J CANCER, V133, P2944, DOI 10.1002/ijc.28298; Kristbjornsdottir A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-73; Kristmannsdottir H, 2005, HK0503 U AK; Kristmannsdottir H, 2004, HK0401 U AK; Leonardi G, 2012, ENVIRON HEALTH PERSP, V120, P721, DOI 10.1289/ehp.1103534; Moran A, 2012, FAM CANCER, V11, P235, DOI 10.1007/s10689-011-9506-2; Nriagu J., 2011, ENCY ENV HLTH, P681, DOI [10.1016/B978-0-444-52272-6.00391-3, DOI 10.1016/B978-0-444-52272-6.00391-3]; Pellegriti G, 2009, JNCI-J NATL CANCER I, V101, P1575, DOI 10.1093/jnci/djp354; Public Health Institute of Iceland, 2005, UMF REYK SAM 2005; Rafnsson V, 2015, LAEKNABLADID, V101, P328; Rodrigues AS, 2012, ENVIRON INT, V49, P51, DOI 10.1016/j.envint.2012.08.008; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Russo M, 2015, ANTICANCER RES, V35, P3995; Saemundsson K., 1979, JOKULL, V29, P7; Schnatter AR, 2012, J NATL CANCER I, V104, P1724, DOI 10.1093/jnci/djs411; Schubauer-Berigan MK, 2015, AM J IND MED, V58, P252, DOI 10.1002/ajim.22419; Sigurdsson T, 2015, TENORM GEOTHERMAL AP; Sigurosson H, 2015, LAEKNABLADID, V101, P276; SMALL C, 2001, GLOBAL ENV CHANGE B, V3, P93, DOI DOI 10.1016/S1464-2867(02)00002-5; Sun LM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000737; 't Mannetje A, 2016, ENVIRON HEALTH PERSP, V124, P396, DOI 10.1289/ehp.1409294; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Thorlacius S, 1997, AM J HUM GENET, V60; Wang SS, 2015, AM J EPIDEMIOL, V181, P406, DOI 10.1093/aje/kwu290; Witham CS, 2004, B VOLCANOL, V67, P15, DOI 10.1007/s00445-004-0357-7; Yang L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001729	53	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155922	10.1371/journal.pone.0155922	http://dx.doi.org/10.1371/journal.pone.0155922			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27205903	gold, Green Published, Green Submitted			2022-12-26	WOS:000376291500032
J	Lucas, CGDO; Matassoli, FL; Pecanha, LMT; Santillo, BT; Oliveira, LMD; Oshiro, TM; Marques, ETDA; Oxenius, A; de Arruda, LB				Lucas, Carolina G. D. O.; Matassoli, Flavio L.; Pecanha, Ligia M. T.; Santillo, Bruna Tereso; da Silva Oliveira, Luanda Mara; Oshiro, Telma Miyuki; Marques, Ernesto T. D. A., Jr.; Oxenius, Annette; de Arruda, Luciana B.			Dendritic cells primed with a chimeric plasmid containing HIV-1-gag associated with lysosomal-associated protein-1 (LAMP/gag) is a potential therapeutic vaccine against HIV	FASEB JOURNAL			English	Article						HIV immunotherapy; T-cell activation; dendritic cell vaccine	HUMAN-IMMUNODEFICIENCY-VIRUS; REGULATORY T-CELLS; 1-INFECTED INDIVIDUALS; VIROLOGICAL RESPONSES; MEMBRANE PROTEIN-1; II COMPARTMENT; GAG; INFECTION; ELICITS; CD4(+)	The decline in number and function of T cells is a hallmark of HIV infection, and preservation or restoration of HIV-specific cellular immune response is a major goal of AIDS treatment. Dendritic cells (DCs) play a key role in the initiation and maintenance of the immune response, and their use as a vaccine vehicle is a promising strategy for enhancing vaccine efficacy. We evaluated the potential of DC-mediated immunization with a DNA vaccine consisting of HIV-1-p55gag (gag, group-specific antigen) associated to lysosomal associated protein (LAMP) sequence (LAMP/gag vaccine). Immunization of mice with mouse DCs transfected with LAMP/gag (Lg-mDCs) stimulated more potent B-and T-cell responses than naked DNA or DCs pulsed with inactivated HIV. Anti-Gag antibody levels were sustained for at least 3 mo after immunization, and recall T-cell responses were also strongly detected at this time point. Human DCs transfected with LAMP/gag (Lg-hDCs) were also activated and able to stimulate greater T-cell response than native gag-transfected DCs. Coculture between Lg-hDCs and T lymphocytes obtained from patients with HIV resulted in upregulation of CD38, CD69, HLA-DR, and granzyme B by CD4(+) and CD8(+) T cells, and increased IFN-gamma and TNF-alpha production. These results indicate that the use of LAMP/gag-DC may be an efficient strategy for enhancing immune function in patients with HIV.	[Lucas, Carolina G. D. O.; Matassoli, Flavio L.; de Arruda, Luciana B.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, Rio De Janeiro, Brazil; [Pecanha, Ligia M. T.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Imunol, Rio De Janeiro, Brazil; [Santillo, Bruna Tereso; da Silva Oliveira, Luanda Mara; Oshiro, Telma Miyuki] Univ Sao Paulo, Escola Med, Dept Dermatol, Lab Dermatol & Imunodeficiencias LIM 56, Sao Paulo, Brazil; [Santillo, Bruna Tereso; Oxenius, Annette] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Marques, Ernesto T. D. A., Jr.] Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Marques, Ernesto T. D. A., Jr.] Fundacao Oswaldo Cruz Fiocruz Pernambuco, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Virol, Recife, PE, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; ETH Zurich; Fundacao Oswaldo Cruz	de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, CCS, Lab I SS 048, Bloco 1,Av Carlos Chagas Filho,377 Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	arruda@micro.ufrj.br	Oshiro, Telma M/C-7152-2012; Arruda, Luciana B/N-9086-2013; da Silva Oliveira, Luanda Mara/E-7273-2013; Tereso Santillo, Bruna/P-6047-2016; Marques, Ernesto T. A/L-4967-2013	Oshiro, Telma M/0000-0002-8791-9233; da Silva Oliveira, Luanda Mara/0000-0003-0903-8219; Tereso Santillo, Bruna/0000-0003-2851-1657; Marques, Ernesto T. A/0000-0003-3826-9358; Lucas, Carolina/0000-0003-4590-2756	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Coordination for the Improvement of Higher Education Personnel); CAPES/Programa Professor Visitante do Exterior-Ciencias sem Fronteiras (CAPES-Special Visiting Researcher, Science Without Borders program); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Scientific and Technological Development); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Research Support Foundation of the State of Rio de Janeiro); Swiss National Science Foundation [310030-113947]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/Programa Professor Visitante do Exterior-Ciencias sem Fronteiras (CAPES-Special Visiting Researcher, Science Without Borders program); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Research Support Foundation of the State of Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. James K. Hildreth (University of California-Davis, Davis, CA, USA) and Dr. J. Thomas August (The Johns Hopkins School of Medicine, Baltimore, MD, USA) for kindly providing the anti-Gag M1 and anti-LAMP-2 antibodies, respectively; Dr. Helio Dutra [Instituto de Ciencias Biomedicas, Universidade Federal do Rio de Janeiro (UFRJ)] for helpful assistance with flow cytometry; and Joao Baltazar (Instituto de Microbiologia Paulo de Goes, UFRJ) for technical support. This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Coordination for the Improvement of Higher Education Personnel), CAPES/Programa Professor Visitante do Exterior-Ciencias sem Fronteiras (CAPES-Special Visiting Researcher, Science Without Borders program), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Scientific and Technological Development), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Research Support Foundation of the State of Rio de Janeiro), and the Swiss National Science Foundation Grant 310030-113947 (to A.O.). C.G.D.O.L. and F.L.M. were the recipients of FAPERJ and CAPES fellowships. The authors declare no conflicts of interest.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Andres C, 2015, J VIROL, V89, P9189, DOI 10.1128/JVI.01062-15; Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; Ayinde D, 2015, J VIROL, V89, P6994, DOI 10.1128/JVI.00069-15; Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Buisson S, 2009, J INFECT DIS, V199, P1862, DOI 10.1086/599122; Chen Wei-Ti, 2013, J AIDS Clin Res, V4, P218; Chikhlikar P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000135; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Connolly NC, 2008, CLIN VACCINE IMMUNOL, V15, P284, DOI 10.1128/CVI.00221-07; Costiniuk CT, 2013, AIDS RES HUM RETROV, V29, P266, DOI [10.1089/aid.2011.0343, 10.1089/AID.2011.0343]; Godinho RMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099887; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DCV2/MANON07-ORVACS Study Group, 2013, SCI TRANSL MED, V5; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Erikstrup C, 2010, JAIDS-J ACQ IMM DEF, V53, P303, DOI 10.1097/QAI.0b013e3181ca3f7c; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; French MA, 2013, AIDS, V27, P519, DOI 10.1097/QAD.0b013e32835cb720; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kaushik S, 2013, AIDS RES HUM RETROV, V29, P501, DOI [10.1089/aid.2012.0200, 10.1089/AID.2012.0200]; Kim CJ, 2013, J IMMUNOL, V191, P2164, DOI 10.4049/jimmunol.1300829; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Kovari H, 2013, CLIN INFECT DIS, V56, P870, DOI 10.1093/cid/cis919; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Kulkarni V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111085; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Levy Y, 2006, AIDS, V20, P405, DOI 10.1097/01.aids.0000206504.09159.d3; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mishra S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104606, 10.1371/journal.pone.0097881]; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Presicce P, 2012, AIDS, V26, P263, DOI 10.1097/QAD.0b013e32834ed8df; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Schenal M, 2005, AIDS, V19, P653, DOI 10.1097/01.aids.0000166088.85951.25; Sciaranghella G, 2013, AIDS, V27, P175, DOI 10.1097/QAD.0b013e32835bd1f0; Selvaraj A, 2013, PATHOG DIS, V69, P184, DOI 10.1111/2049-632X.12067; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Simon GG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008574; Smed-Sorensen A, 2011, CURR OPIN HIV AIDS, V6, P405, DOI 10.1097/COH.0b013e328349b06b; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Turk G, 2013, J VIROL, V87, P7445, DOI 10.1128/JVI.00865-13; Van Gulck E, 2012, AIDS, V26, pF1, DOI 10.1097/QAD.0b013e32834f33e8; Wilgenhof S, 2011, J IMMUNOTHER, V34, P448, DOI 10.1097/CJI.0b013e31821dcb31; Yonkers NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023884	55	1	1	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2970	2984		10.1096/fj.201500059	http://dx.doi.org/10.1096/fj.201500059			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27199296				2022-12-26	WOS:000380994000029
J	Knights, AJ; Yik, JJ; Jusoh, HM; Norton, LJ; Funnell, APW; Pearson, RCM; Bell-Anderson, KS; Crossley, M; Quinlan, KGR				Knights, Alexander J.; Yik, Jinfen J.; Jusoh, Hanapi Mat; Norton, Laura J.; Funnell, Alister P. W.; Pearson, Richard C. M.; Bell-Anderson, Kim S.; Crossley, Merlin; Quinlan, Kate G. R.			Kruppel-like Factor 3 (KLF3/BKLF) Is Required for Widespread Repression of the Inflammatory Modulator Galectin-3 (Lgals3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL BINDING-PROTEIN; ADIPOSE-TISSUE; CO-REPRESSOR; IN-VIVO; HEART-FAILURE; DNA-BINDING; FACTOR GENE; ACTIVATION; EXPRESSION; CELLS	The Lgals3 gene encodes a multifunctional beta-galactoside-binding protein, galectin-3. Galectin-3 has been implicated in a broad range of biological processes from chemotaxis and inflammation to fibrosis and apoptosis. The role of galectin-3 as a modulator of inflammation has been studied intensively, and recent evidence suggests that it may serve as a protective factor in obesity and other metabolic disorders. Despite considerable interest in galectin-3, little is known about its physiological regulation at the transcriptional level. Here, using knockout mice, chromatin immunoprecipitations, and cellular and molecular analyses, we show that the zinc finger transcription factor Kruppel-like factor 3 (KLF3) directly represses galectin-3 transcription. We find that galectin-3 is broadly up-regulated in KLF3-deficient mouse tissues, that KLF3 occupies regulatory regions of the Lgals3 gene, and that KLF3 directly binds its cognate elements (CACCC boxes) in the galectin-3 promoter and represses its activation in cellular assays. We also provide mechanistic insights into the regulation of Lgals3, demonstrating that C-terminal binding protein (CtBP) is required to drive optimal KLF3-mediated silencing. These findings help to enhance our understanding of how expression of the inflammatory modulator galectin-3 is controlled, opening up avenues for potential therapeutic interventions in the future.	[Knights, Alexander J.; Yik, Jinfen J.; Norton, Laura J.; Funnell, Alister P. W.; Pearson, Richard C. M.; Crossley, Merlin; Quinlan, Kate G. R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Jusoh, Hanapi Mat] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Bell-Anderson, Kim S.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Quinlan, KGR (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	kate.quinlan@unsw.edu.au	Bell-Anderson, Kim/A-5588-2009; Knights, Alexander/AAL-1769-2021; Crossley, Merlin/D-7888-2011	Quinlan, Kate/0000-0002-5722-8183; Crossley, Merlin/0000-0003-2057-3642; Norton, Laura/0000-0002-7950-381X; Knights, Alexander/0000-0001-8402-2212	National Health and Medical Research Council [APP1025877]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Grant APP1025877. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad T, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.004374; Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Burdach J, 2014, NUCLEIC ACIDS RES, V42, P276, DOI 10.1093/nar/gkt895; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Crossley M, 1996, MOL CELL BIOL, V16, P1695; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Dewi V, 2015, J BIOL CHEM, V290, P8591, DOI 10.1074/jbc.M115.638338; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Funnell APW, 2012, MOL CELL BIOL, V32, P3281, DOI 10.1128/MCB.00173-12; Hancock D, 2010, BIOCHEM MOL BIOL EDU, V38, P309, DOI 10.1002/bmb.20414; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; HO MK, 1982, J IMMUNOL, V128, P1221; Iacobini C, 2004, FASEB J, V18, P1773, DOI 10.1096/fj.04-2031fje; Jack BHA, 2011, INT J BIOCHEM CELL B, V43, P693, DOI 10.1016/j.biocel.2011.01.017; Karlsen AE, 2006, BIOCHEM BIOPH RES CO, V344, P406, DOI 10.1016/j.bbrc.2006.03.105; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kelsey L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003612; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MacKinnon AC, 2013, GLYCOBIOLOGY, V23, P654, DOI 10.1093/glycob/cwt006; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Pang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057915; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Pearson RCM, 2011, IUBMB LIFE, V63, P86, DOI 10.1002/iub.422; Pejnovic NN, 2013, ADIPOCYTE, V2, P266, DOI 10.4161/adip.24881; Pejnovic NN, 2013, DIABETES, V62, P1932, DOI 10.2337/db12-0222; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Srivatsan V, 2015, EUR J PREV CARDIOL, V22, P1096, DOI 10.1177/2047487314552797; Stock M, 2003, J BIOL CHEM, V278, P17360, DOI 10.1074/jbc.M207631200; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Vu TT, 2011, J IMMUNOL, V187, P5032, DOI 10.4049/jimmunol.1101450; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; Vladimirova V, 2008, J NEUROSCI RES, V86, P2450, DOI 10.1002/jnr.21686; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhang HY, 2009, ENDOCRINE, V35, P101, DOI 10.1007/s12020-008-9129-z; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	50	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16048	16058		10.1074/jbc.M116.715748	http://dx.doi.org/10.1074/jbc.M116.715748			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226561	Green Published, hybrid			2022-12-26	WOS:000380585400011
J	Mashiko, T; Sakashita, E; Kasashima, K; Tominaga, K; Kuroiwa, K; Nozaki, Y; Matsuura, T; Hamamoto, T; Endo, H				Mashiko, Takafumi; Sakashita, Eiji; Kasashima, Katsumi; Tominaga, Kaoru; Kuroiwa, Kenji; Nozaki, Yasuyuki; Matsuura, Tohru; Hamamoto, Toshiro; Endo, Hitoshi			Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; LINKED MUTATIONS; EXPORT SIGNAL; IN-VIVO; TDP-43; LOCALIZATION; ALS; TRANSPORT; FUS	Cytoplasmic protein aggregates are one of the pathological hallmarks of neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FT LD). Several RNA-binding proteins have been identified as components of inclusion bodies. Developmentally regulated RNA-binding protein 1 (Drbl)/RNA-binding motif protein 45 is an RNA-binding protein that was recently described as a component in ALS- and FTLD-related inclusion bodies. However, the molecular mechanism underlying cytoplasmic Drbl aggregation remains unclear. Here, using an in vitro cellular model, we demonstrated that Drbl co-localizes with cytoplasmic aggregates mediated by TAR DNA-binding protein 43, a major component of ALS and FTLD-related inclusion bodies. We also defined the domains involved in the subcellular localization of Drbl to clarify the role of Drbl in the formation of cytoplasmic aggregates in ALS and FTLD. Drbl predominantly localized in the nucleus via a classical nuclear localization signal in its carboxyl terminus and is a shuttling protein between the nucleus and cytoplasm. Furthermore, we identify a double leucine motif serving as a nuclear export signal. The Drbl mutant, presenting mutations in both nuclear localization signal and nuclear export signal, is prone to aggregate in the cytoplasm. The mutant Drb 1-induced cytoplasmic aggregates not only recruit TAR DNA-binding protein 43 but also decrease the mitochondrial membrane potential. Taken together, these results indicate that perturbation of Drbl nuclear cytoplasmic trafficking induces toxic cytoplasmic aggregates, suggesting that mislocalization of Drbl is involved in the cause of cytotoxicity in neuronal cells.	[Mashiko, Takafumi; Sakashita, Eiji; Kasashima, Katsumi; Tominaga, Kaoru; Kuroiwa, Kenji; Hamamoto, Toshiro; Endo, Hitoshi] Jichi Med Univ, Sch Med, Dept Biochem, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Nozaki, Yasuyuki] Jichi Med Univ, Sch Med, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Matsuura, Tohru] Jichi Med Univ, Sch Med, Div Neurol, Dept Internal Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan	Jichi Medical University; Jichi Medical University; Jichi Medical University	Endo, H (corresponding author), Jichi Med Univ, Sch Med, Dept Biochem, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	hendo@jichi.ac.jp	Tominaga, Kaoru/AAL-4250-2020	Tominaga, Kaoru/0000-0001-8799-528X	Jichi Medical University; MEXT	Jichi Medical University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Jichi Medical University graduate student start-up grants for young investigators, a Jichi Medical University graduate student research award, a Jichi Medical University young investigator award, and the MEXT-Supported Program for Strategic Research Foundation at Private Universities 2011-2015 and 2013-2017. The authors declare that they have no conflicts of interest with the contents of this article.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bakkar N, 2015, MOL CELL BIOL, V35, P2385, DOI 10.1128/MCB.00087-15; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Carri MT, 1997, FEBS LETT, V414, P365, DOI 10.1016/S0014-5793(97)01051-X; Collins M, 2012, ACTA NEUROPATHOL, V124, P717, DOI 10.1007/s00401-012-1045-x; Cozzolino M, 2012, PROG NEUROBIOL, V97, P54, DOI 10.1016/j.pneurobio.2011.06.003; Hans F, 2014, J BIOL CHEM, V289, P19164, DOI 10.1074/jbc.M114.561704; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kasashima K, 1999, GENES CELLS, V4, P667, DOI 10.1046/j.1365-2443.1999.00292.x; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kinoshita Y, 2009, J NEUROPATH EXP NEUR, V68, P1184, DOI 10.1097/NEN.0b013e3181bc3bec; Konno T, 2014, NEUROPATH APPL NEURO, V40, P783, DOI 10.1111/nan.12157; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14262; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; MICHAEL WM, 1995, CELL, V83, P415; Nagara Y, 2013, BRAIN PATHOL, V23, P534, DOI 10.1111/bpa.12040; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Tamada H, 2002, BIOCHEM BIOPH RES CO, V297, P96, DOI 10.1016/S0006-291X(02)02132-0; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zinszner H, 1997, J CELL SCI, V110, P1741	45	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14996	15007		10.1074/jbc.M115.712232	http://dx.doi.org/10.1074/jbc.M115.712232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226551	Green Published, hybrid			2022-12-26	WOS:000380583200012
J	Guerra-Moreno, A; Hanna, J				Guerra-Moreno, Angel; Hanna, John			Tmc1 Is a Dynamically Regulated Effector of the Rpn4 Proteotoxic Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; protein degradation; proteostasis; stress response; yeast; Rpn4; Tmc1; arsenite	SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; PROTEASOMAL DEGRADATION; POLYUBIQUITIN GENE; PROTEIN; RESISTANCE; BINDING; CELLS; YEAST; PROTEOSTASIS	The ubiquitin-proteasome system represents the major pathway of selective intracellular protein degradation in eukaryotes. Misfolded proteins represent an important class of substrates for this pathway, and the failure to destroy misfolded proteins is associated with a number of human diseases. The transcription factor Rpn4 mediates a key proteotoxic stress response whose best known function is to control proteasome abundance by a homeostatic feedback mechanism. Here we identify the uncharacterized zinc finger protein Tmc1 as a dynamically regulated stress-responsive protein. Rpn4 induces TMC1 transcription in response to misfolded proteins. However, this response is counteracted by rapid proteasome-dependent degradation of Tmc1, which serves to normalize Tmc1 protein levels after induction. Precise control of Tmc1 levels is needed in vivo to survive multiple stressors related to proteostasis. Thus, Tmc1 represents a novel effector and substrate of the Rpn4 proteotoxic stress response.	[Hanna, John] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Hanna, John] Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hanna, J (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Hanna, J (corresponding author), Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA.	jwhanna@partners.org	Angel, Guerra-Moreno/AAF-7135-2021; Guerra-Moreno, Angel/K-6258-2015	Angel, Guerra-Moreno/0000-0003-2321-1129; Guerra-Moreno, Angel/0000-0003-2321-1129	National Institutes of Health [DP5-OD019800]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD019800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant DP5-OD019800 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Guerra-Moreno A, 2015, J BIOL CHEM, V290, P29695, DOI 10.1074/jbc.M115.684969; Hanna J, 2014, J BIOL CHEM, V289, P1876, DOI 10.1074/jbc.M113.534032; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hwang GW, 2006, FEBS LETT, V580, P6813, DOI 10.1016/j.febslet.2006.11.045; Ilina Y, 2008, BIOCHEM J, V415, P467, DOI 10.1042/BJ20080713; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Ju DH, 2008, MOL CELL BIOL, V28, P1404, DOI 10.1128/MCB.01787-07; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kim MN, 2015, BBA-MOL CELL RES, V1853, P996, DOI 10.1016/j.bbamcr.2015.02.010; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; Pan XW, 2010, GENETICS, V186, P725, DOI 10.1534/genetics.110.117655; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Sa-Moura B, 2013, J BIOL CHEM, V288, P33682, DOI 10.1074/jbc.M113.521088; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Valasek L, 2001, J BIOL CHEM, V276, P43351, DOI 10.1074/jbc.M106887200; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	30	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14788	14795		10.1074/jbc.M116.726398	http://dx.doi.org/10.1074/jbc.M116.726398			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226598	Green Published, hybrid			2022-12-26	WOS:000380366700030
J	Liu, TT; Grubisha, MJ; Frahm, KA; Wendell, SG; Liu, JY; Ricke, WA; Auchus, RJ; DeFranco, DB				Liu, Teresa T.; Grubisha, Melanie J.; Frahm, Krystle A.; Wendell, Stacy G.; Liu, Jiayan; Ricke, William A.; Auchus, Richard J.; DeFranco, Donald B.			Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor (ER) Response to 5-Reductase Inhibition in Prostate Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclooxygenase (COX); prostaglandin; prostate; steroidogenesis; transforming growth factor (TGF-)	DUAL 5-ALPHA-REDUCTASE INHIBITOR; ANTIINFLAMMATORY DRUG-USE; RIBONUCLEIC-ACID LEVELS; SIDE-CHAIN CLEAVAGE; COMBINATION THERAPY; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; REDUCTASE INHIBITOR; ANDROGEN RECEPTOR; GENE-EXPRESSION; CANCER CELLS	Current pharmacotherapies for symptomatic benign prostatic hyperplasia (BPH), an androgen receptor-driven, inflammatory disorder affecting elderly men, include 5-reductase (5AR) inhibitors (i.e. dutasteride and finasteride) to block the conversion of testosterone to the more potent androgen receptor ligand dihydrotestosterone. Because dihydrotestosterone is the precursor for estrogen receptor (ER) ligands, 5AR inhibitors could potentially limit ER activation, which maintains prostate tissue homeostasis. We have uncovered signaling pathways in BPH-derived prostate epithelial cells (BPH-1) that are impacted by 5AR inhibition. The induction of apoptosis and repression of the cell adhesion protein E-cadherin by the 5AR inhibitor dutasteride requires both ER and TGF. Dutasteride also induces cyclooxygenase type 2 (COX-2), which functions in a negative feedback loop in TGF and ER signaling pathways as evidenced by the potentiation of apoptosis induced by dutasteride or finasteride upon pharmacological inhibition or shRNA-mediated ablation of COX-2. Concurrently, COX-2 positively impacts ER action through its effect on the expression of a number of steroidogenic enzymes in the ER ligand metabolic pathway. Therefore, effective combination pharmacotherapies, which have included non-steroidal anti-inflammatory drugs, must take into account biochemical pathways affected by 5AR inhibition and opposing effects of COX-2 on the tissue-protective action of ER.	[Liu, Teresa T.; Grubisha, Melanie J.; Frahm, Krystle A.; Wendell, Stacy G.; DeFranco, Donald B.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 7041 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA; [Liu, Jiayan; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Liu, Jiayan; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Pharmacol, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Ricke, William A.] Univ Wisconsin, Dept Urol, Madison, WI 53705 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	DeFranco, DB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 7041 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	dod1@pitt.edu	Gelhaus, Stacy/AAF-2570-2019		National Institutes of Health [5T32DK007774-15, R01GM086596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310, K12DK100022, T32DK007052, T32DK007774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 5T32DK007774-15 (to T. T. L.) and R01GM086596 (to R. J. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Baltaci S, 2001, BJU INT, V88, P100, DOI 10.1046/j.1464-410x.2001.02231.x; Barkin J, 2003, EUR UROL, V44, P461, DOI 10.1016/S0302-2838(03)00367-1; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Beaudoin C, 1997, MOL CELL ENDOCRINOL, V133, P63, DOI 10.1016/S0303-7207(97)00143-3; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; CHUTE CG, 1993, J UROLOGY, V150, P85, DOI 10.1016/S0022-5347(17)35405-8; Cunha GR, 1996, PROSTATE, P22; Di Silverio F, 2005, EUR UROL, V47, P72, DOI 10.1016/j.eururo.2004.08.024; Fiandalo MV, 2014, INT J BIOL SCI, V10, P596, DOI 10.7150/ijbs.8780; Grubisha MJ, 2012, MOL ENDOCRINOL, V26, P940, DOI 10.1210/me.2011-1371; Guerini V, 2005, CANCER RES, V65, P5445, DOI 10.1158/0008-5472.CAN-04-1941; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; ISAACS JT, 1989, PROSTATE, P33; Ishizaki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01528; Jiang M, 2010, STEM CELLS, V28, P344, DOI 10.1002/stem.284; Kim HK, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/783287; Kirby RS, 2000, UROLOGY, V56, P3, DOI 10.1016/S0090-4295(00)00747-0; Konig JE, 2004, PROSTATE, V58, P121, DOI 10.1002/pros.10317; Kramer G, 2006, CURR OPIN UROL, V16, P25; Kramer G, 2002, PROSTATE, V52, P43, DOI 10.1002/pros.10084; Lau KM, 2000, CANCER RES, V60, P3175; Lazier CB, 2004, PROSTATE, V58, P130, DOI 10.1002/pros.10340; LEPOR H, 1990, PROSTATE, P75; Liu TT, 2015, RNA, V21, P1159, DOI 10.1261/rna.045559.114; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; McPherson S. J., 2006, E SCHERING FDN S P, V1,, P131; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Nickel JC, 1999, BJU INT, V84, P976; Oliveira AG, 2007, STEROIDS, V72, P914, DOI 10.1016/j.steroids.2007.08.001; Parsons JK, 2012, EUR UROL, V62, P234, DOI 10.1016/j.eururo.2012.03.007; PAYNE AH, 1991, ENDOCRINOLOGY, V129, P1429, DOI 10.1210/endo-129-3-1429; Pelletier G, 2008, BEST PRACT RES CL EN, V22, P223, DOI 10.1016/j.beem.2008.02.004; Ren RQ, 2007, BLOOD, V109, P2847, DOI 10.1182/blood-2006-08-039743; Roehrborn CG, 2015, PROSTATE CANCER P D, V18, P43, DOI 10.1038/pcan.2014.43; Roehrborn CG, 2002, UROLOGY, V60, P434, DOI 10.1016/S0090-4295(02)01905-2; Roehrborn CG, 2011, UROLOGY, V78, P641, DOI 10.1016/j.urology.2011.03.063; Samarasinghe RA, 2011, P NATL ACAD SCI USA, V108, P16657, DOI 10.1073/pnas.1102821108; Schenk JM, 2012, AM J EPIDEMIOL, V176, P156, DOI 10.1093/aje/kwr524; Schmidt LJ, 2004, J ANDROL, V25, P944; Sewer MB, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290163; Simanainen U, 2007, ENDOCRINOLOGY, V148, P2264, DOI 10.1210/en.2006-1223; St Sauver JL, 2006, AM J EPIDEMIOL, V164, P760, DOI 10.1093/aje/kwj258; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Susperregui ARG, 2011, MOL ENDOCRINOL, V25, P1006, DOI 10.1210/me.2010-0515; Sutcliffe S, 2012, BJU INT, V110, P1050, DOI 10.1111/j.1464-410X.2011.10867.x; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TREMBLAY Y, 1993, MOL ENDOCRINOL, V7, P355, DOI 10.1210/me.7.3.355; Wang WZ, 2004, PROSTATE, V61, P60, DOI 10.1002/pros.20061; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wilson JD, 2003, ENDOCRINOLOGY, V144, P575, DOI 10.1210/en.2002-220721; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104	60	6	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14747	14760		10.1074/jbc.M115.711515	http://dx.doi.org/10.1074/jbc.M115.711515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226548	Green Published, hybrid			2022-12-26	WOS:000380366700027
J	McDaniel, SL; Fligor, JE; Ruan, C; Cui, HC; Bridgers, JB; DiFiore, JV; Guo, AH; Li, B; Strahl, BD				McDaniel, Stephen L.; Fligor, Jennifer E.; Ruan, Chun; Cui, Haochen; Bridgers, Joseph B.; DiFiore, Julia V.; Guo, Angela H.; Li, Bing; Strahl, Brian D.			Combinatorial Histone Readout by the Dual Plant Homeodomain (PHD) Fingers of Rco1 Mediates Rpd3S Chromatin Recruitment and the Maintenance of Transcriptional Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; gene transcription; histone acetylation; histone deacetylase (HDAC); PHD finger; Rco1; Rpd3S	DEACETYLASE COMPLEX; SET2 METHYLATION; CODING REGIONS; BUR1 KINASE; H3; ELONGATION; RECOGNITION; LYSINE-36; PROMOTER; EXCHANGE	The plant homeodomain (PHD) finger is found in many chromatin-associated proteins and functions to recruit effector proteins to chromatin through its ability to bind both methylated and unmethylated histone residues. Here, we show that the dual PHD fingers of Rco1, a member of the Rpd3S histone deacetylase complex recruited to transcribing genes, operate in a combinatorial manner in targeting the Rpd3S complex to histone H3 in chromatin. Although mutations in either the first or second PHD finger allow for Rpd3S complex formation, the assembled complexes from these mutants cannot recognize nucleosomes or function to maintain chromatin structure and prevent cryptic transcriptional initiation from within transcribed regions. Taken together, our findings establish a critical role of combinatorial readout in maintaining chromatin organization and in enforcing the transcriptional fidelity of genes.	[McDaniel, Stephen L.; DiFiore, Julia V.; Strahl, Brian D.] Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Bridgers, Joseph B.; Guo, Angela H.; Strahl, Brian D.] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Fligor, Jennifer E.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Ruan, Chun; Cui, Haochen; Li, Bing] Univ Texas Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Strahl, BD (corresponding author), UNC Sch Med, 3060 Genet Med CB 7260, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259; Guo, Angela/0000-0001-5265-7205; Bridgers, Joseph/0000-0002-0585-4131	NIGMS, National Institutes of Health [GM110058]; National Institutes of Health [T32 GM007092, GM090077]; Welch Foundation [I-1713]; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110058, T32GM007092, R01GM090077] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM110058 (to B. D. S.), National Institutes of Health Grants T32 GM007092 (to S. L. M. and J. V. D.) and GM090077 (to B. L.), and Welch Foundation Grant I-1713 (to B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Gilbert TM, 2014, MOL CELL PROTEOMICS, V13, P2883, DOI 10.1074/mcp.M114.038224; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Huh JW, 2012, EMBO J, V31, P3564, DOI 10.1038/emboj.2012.221; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kumar GS, 2012, J MOL BIOL, V422, P519, DOI 10.1016/j.jmb.2012.06.013; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lee CH, 2013, MOL CELL, V52, P255, DOI 10.1016/j.molcel.2013.08.024; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lickwar CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004886; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ruan C, 2016, J BIOL CHEM, V291, P5428, DOI 10.1074/jbc.M115.703637; Ruan C, 2015, CELL REP, V10, P204, DOI 10.1016/j.celrep.2014.12.027; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Silva AC, 2012, J BIOL CHEM, V287, P1709, DOI 10.1074/jbc.M111.316489; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang SS, 2011, MOL CELL BIOL, V31, P3171, DOI 10.1128/MCB.05017-11; Yun M, 2012, METHODS MOL BIOL, V833, P237, DOI 10.1007/978-1-61779-477-3_15; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	31	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14796	14802		10.1074/jbc.M116.720193	http://dx.doi.org/10.1074/jbc.M116.720193			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226578	Green Published, hybrid			2022-12-26	WOS:000380366700031
J	Persson, A; Tykesson, E; Westergren-Thorsson, G; Malmstrom, A; Ellervik, U; Mani, K				Persson, Andrea; Tykesson, Emil; Westergren-Thorsson, Gunilla; Malmstrom, Anders; Ellervik, Ulf; Mani, Katrin			Xyloside-primed Chondroitin Sulfate/Dermatan Sulfate from Breast Carcinoma Cells with a Defined Disaccharide Composition Has Cytotoxic Effects in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; chondroitin sulfate; dermatan sulfate; glycosaminoglycan; heparan sulfate; high-performance liquid chromatography (HPLC); structure-function; disaccharide fingerprint; xyloside	BETA-D-XYLOSIDES; HEPARAN-SULFATE; TUMOR-GROWTH; GLYCOSAMINOGLYCANS; BIOSYNTHESIS; FIBROBLASTS; PROLIFERATION; PROTEOGLYCAN; CANCER; ATTENUATION	We previously reported that the xyloside 2-(6-hydroxynaphthyl) -d-xylopyranoside (XylNapOH), in contrast to 2-naphthyl -d-xylopyranoside (XylNap), specifically reduces tumor growth both in vitro and in vivo. Although there are indications that this could be mediated by the xyloside-primed glycosaminoglycans (GAGs) and that these differ in composition depending on xyloside and cell type, detailed knowledge regarding a structure-function relationship is lacking. In this study we isolated XylNapOH- and XylNap-primed GAGs from a breast carcinoma cell line, HCC70, and a breast fibroblast cell line, CCD-1095Sk, and demonstrated that both XylNapOH- and XylNap-primed chondroitin sulfate/dermatan sulfate GAGs derived from HCC70 cells had a cytotoxic effect on HCC70 cells and CCD-1095Sk cells. The cytotoxic effect appeared to be mediated by induction of apoptosis and was inhibited in a concentration-dependent manner by the XylNap-primed heparan sulfate GAGs. In contrast, neither the chondroitin sulfate/dermatan sulfate nor the heparan sulfate derived from CCD-1095Sk cells primed on XylNapOH or XylNap had any effect on the growth of HCC70 cells or CCD-105Sk cells. These observations were related to the disaccharide composition of the XylNapOH- and XylNap-primed GAGs, which differed between the two cell lines but was similar when the GAGs were derived from the same cell line. To our knowledge this is the first report on cytotoxic effects mediated by chondroitin sulfate/dermatan sulfate.	[Persson, Andrea; Tykesson, Emil; Westergren-Thorsson, Gunilla; Malmstrom, Anders; Mani, Katrin] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Ellervik, Ulf] Lund Univ, Ctr Anal & Synth, Ctr Chem & Chem Engn, SE-22184 Lund, Sweden	Lund University; Lund University	Persson, A (corresponding author), Biomed Ctr A13, SE-22184 Lund, Sweden.	andrea.persson@med.lu.se	Tykesson, Emil/F-9879-2014	Tykesson, Emil/0000-0002-0511-9831; Mani, Katrin/0000-0002-1821-0634; Malmstrom, Anders/0000-0002-6691-146X	Alfred Osterlund Foundation; Crafoord Foundation; Foundation of the Hedda and John Forssman Fund; Lund University; Medical Faculty at Lund University; Swedish Cancer Society; Swedish Foundation for Strategic Research; Swedish Research Council	Alfred Osterlund Foundation; Crafoord Foundation; Foundation of the Hedda and John Forssman Fund; Lund University; Medical Faculty at Lund University; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Alfred Osterlund Foundation, the Crafoord Foundation, the Foundation of the Hedda and John Forssman Fund, Lund University, the Medical Faculty at Lund University, the Swedish Cancer Society, the Swedish Foundation for Strategic Research, and the Swedish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; FARACH MC, 1988, BIOL REPROD, V39, P443, DOI 10.1095/biolreprod39.2.443; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; FRANSSON LA, 1992, BIOCHIM BIOPHYS ACTA, V1137, P287, DOI 10.1016/0167-4889(92)90149-6; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Jacobsson M, 2006, J MED CHEM, V49, P1932, DOI 10.1021/jm0512488; Joo EJ, 2014, OMICS, V18, P231, DOI 10.1089/omi.2013.0128; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; Mani K, 1998, CANCER RES, V58, P1099; MARGOLIS RK, 1991, J CELL SCI, V99, P237; MATUOKA K, 1984, CELL STRUCT FUNCT, V9, P357, DOI 10.1247/csf.9.357; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mizumoto S, 2015, CURR OPIN STRUC BIOL, V34, P35, DOI 10.1016/j.sbi.2015.06.004; Muto J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025480; Nilsson U, 2010, CANCER RES, V70, P3771, DOI 10.1158/0008-5472.CAN-09-4331; Raman K, 2011, BIOCHEM BIOPH RES CO, V404, P86, DOI 10.1016/j.bbrc.2010.11.069; Smetsers TFCM, 2003, CANCER RES, V63, P2965; Stachtea XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140279; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Syrokou A, 1999, CELL PROLIFERAT, V32, P85, DOI 10.1046/j.1365-2184.1999.32230085.x; Toomey JR, 2006, J THROMB HAEMOST, V4, P1989, DOI 10.1111/j.1538-7836.2006.02064.x; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Victor XV, 2009, J BIOL CHEM, V284, P25842, DOI 10.1074/jbc.M109.043208; WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319; WESTERGRENTHORSSON G, 1993, EXP CELL RES, V206, P93, DOI 10.1006/excr.1993.1124; Weyers A, 2012, OMICS, V16, P79, DOI 10.1089/omi.2011.0102; Willis CM, 2012, J BIOL CHEM, V287, P37042, DOI 10.1074/jbc.M112.391490	33	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14871	14882		10.1074/jbc.M116.716829	http://dx.doi.org/10.1074/jbc.M116.716829			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226567	Green Published, hybrid			2022-12-26	WOS:000380366700038
J	Yun, BL; Guan, XL; Liu, YZ; Zhang, Y; Wang, YQ; Qi, XL; Cui, HY; Liu, CJ; Zhang, YP; Gao, HL; Gao, L; Li, K; Gao, YL; Wang, XM				Yun, Bing-Ling; Guan, Xiao-Lu; Liu, Yong-Zhen; Zhang, Yao; Wang, Yong-Qiang; Qi, Xiao-Le; Cui, Hong-Yu; Liu, Chang-Jun; Zhang, Yan-Ping; Gao, Hong-Lei; Gao, Li; Li, Kai; Gao, Yu-Long; Wang, Xiao-Mei			Integrin v1 Modulation Affects Subtype B Avian Metapneumovirus Fusion Protein-mediated Cell-Cell Fusion and Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fusion protein; infection; integrin; membrane fusion; viral replication; aMPV; B; fusogenicity	NEWCASTLE-DISEASE VIRUS; RESPIRATORY SYNCYTIAL VIRUS; PARAMYXOVIRUS MEMBRANE-FUSION; LOW-PH; F-PROTEIN; HEMAGGLUTININ-NEURAMINIDASE; ATTACHMENT PROTEIN; IN-VITRO; ENTRY; ACTIVATION	Avian metapneumovirus (aMPV) fusion (F) protein mediates virus-cell membrane fusion to initiate viral infection, which requires F protein binding to its receptor(s) on the host cell surface. However, the receptor(s) for aMPV F protein is still not identified. All known subtype B aMPV (aMPV/B) F proteins contain a conserved Arg-Asp-Asp (RDD) motif, suggesting that the aMPV/B F protein may mediate membrane fusion via the binding of RDD to integrin. When blocked with integrin-specific peptides, aMPV/B F protein fusogenicity and viral replication were significantly reduced. Specifically we identified integrin v and/or 1-mediated F protein fusogenicity and viral replication using antibody blocking, small interfering RNAs (siRNAs) knockdown, and overexpression. Additionally, overexpression of integrin v and 1 in aMPV/B non-permissive cells conferred aMPV/B F protein binding and aMPV/B infection. When RDD was altered to RAE (Arg-Ala-Glu), aMPV/B F protein binding and fusogenic activity were profoundly impaired. These results suggest that integrin v1 is a functional receptor for aMPV/B F protein-mediated membrane fusion and virus infection, which will provide new insights on the fusogenic mechanism and pathogenesis of aMPV.	[Yun, Bing-Ling; Guan, Xiao-Lu; Liu, Yong-Zhen; Zhang, Yao; Wang, Yong-Qiang; Qi, Xiao-Le; Cui, Hong-Yu; Liu, Chang-Jun; Zhang, Yan-Ping; Gao, Hong-Lei; Gao, Li; Li, Kai; Gao, Yu-Long; Wang, Xiao-Mei] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Heilongjiang, Peoples R China; [Wang, Xiao-Mei] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Gao, YL; Wang, XM (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, 427 Maduan St, Harbin 150001, Heilongjiang, Peoples R China.	ylg@hvri.ac.cn; xmw@hvri.ac.cn			fund for the Modern Agro-industry Technology Research System [nycytx-42-G3-01]	fund for the Modern Agro-industry Technology Research System	This work was supported by the fund for the Modern Agro-industry Technology Research System number nycytx-42-G3-01. The authors declare that they have no conflicts of interest with the contents of this article.	Aung YH, 2008, AVIAN PATHOL, V37, P65, DOI 10.1080/03079450701802222; Avitabile E, 2004, J VIROL, V78, P8015, DOI 10.1128/JVI.78.15.8015-8025.2004; BAGAI S, 1995, J VIROL, V69, P6712, DOI 10.1128/JVI.69.11.6712-6719.1995; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Bose S, 2014, J VIROL, V88, P3925, DOI 10.1128/JVI.03741-13; Bose S, 2013, J VIROL, V87, P13520, DOI 10.1128/JVI.02123-13; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200; Cook JKA, 2000, VET J, V160, P118, DOI 10.1053/tvjl.2000.0486; Cox RG, 2012, J VIROL, V86, P12148, DOI 10.1128/JVI.01133-12; Cseke G, 2009, P NATL ACAD SCI USA, V106, P1566, DOI 10.1073/pnas.0801433106; de Graaf M, 2009, J GEN VIROL, V90, P1408, DOI 10.1099/vir.0.009688-0; Dutch RE, 1998, J VIROL, V72, P7745, DOI 10.1128/JVI.72.10.7745-7753.1998; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Gallo SA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-90; GOUGH RE, 2003, DIS POULTRY, P92; Gout E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541939; Guionie O, 2007, J VIROL METHODS, V139, P150, DOI 10.1016/j.jviromet.2006.09.022; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Heikkila O, 2009, J GEN VIROL, V90, P197, DOI 10.1099/vir.0.004838-0; Herfst S, 2008, J VIROL, V82, P8891, DOI 10.1128/JVI.00472-08; Jardetzky TS, 2014, CURR OPIN VIROL, V5, P24, DOI 10.1016/j.coviro.2014.01.005; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Kinzler ER, 2005, J VIROL, V79, P7827, DOI 10.1128/JVI.79.12.7827-7837.2005; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Li PH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-154; Ling R, 2008, J GEN VIROL, V89, P525, DOI 10.1099/vir.0.83309-0; Liu Q, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003770; Mase M, 2003, AVIAN DIS, V47, P481, DOI 10.1637/0005-2086(2003)047[0481:POAPSA]2.0.CO;2; Mirza AM, 2011, J BIOL CHEM, V286, P17851, DOI 10.1074/jbc.M111.233965; MOORE JP, 1993, VIRAL FUSION MECHANI, P233; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Pebworth MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110453; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Rothwangl KB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-12; Schowalter RM, 2006, J VIROL, V80, P10931, DOI 10.1128/JVI.01287-06; Schowalter RM, 2009, J VIROL, V83, P1511, DOI 10.1128/JVI.01381-08; Smith EC, 2013, J BIOL CHEM, V288, P35726, DOI 10.1074/jbc.M113.514554; StoneHulslander J, 1997, J VIROL, V71, P6287, DOI 10.1128/JVI.71.9.6287-6295.1997; Talekar A, 2013, J VIROL, V87, P10980, DOI 10.1128/JVI.01646-13; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Van de Walle GR, 2008, J VIROL, V82, P11859, DOI 10.1128/JVI.00868-08; Wei YW, 2014, J VIROL, V88, P4338, DOI 10.1128/JVI.03491-13; Wei YW, 2012, J VIROL, V86, P11800, DOI 10.1128/JVI.00232-12; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Xu R, 2013, MBIO, V4, DOI 10.1128/mBio.00803-13; Yun BL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15584; Yun BL, 2015, ARCH VIROL, V160, P2445, DOI 10.1007/s00705-015-2524-x; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zhang BS, 2008, J VIROL, V82, P1204, DOI 10.1128/JVI.01393-07	52	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14815	14825		10.1074/jbc.M115.711382	http://dx.doi.org/10.1074/jbc.M115.711382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226547	Green Published, hybrid			2022-12-26	WOS:000380366700033
J	Biscarini, F; Cozzi, P; Casella, L; Riccardi, P; Vattari, A; Orasen, G; Perrini, R; Tacconi, G; Tondelli, A; Biselli, C; Cattivelli, L; Spindel, J; McCouch, S; Abbruscato, P; Vale, G; Piffanelli, P; Greco, R				Biscarini, Filippo; Cozzi, Paolo; Casella, Laura; Riccardi, Paolo; Vattari, Alessandra; Orasen, Gabriele; Perrini, Rosaria; Tacconi, Gianni; Tondelli, Alessandro; Biselli, Chiara; Cattivelli, Luigi; Spindel, Jennifer; McCouch, Susan; Abbruscato, Pamela; Vale, Giampiero; Piffanelli, Pietro; Greco, Raffaella			Genome-Wide Association Study for Traits Related to Plant and Grain Morphology, and Root Architecture in Temperate Rice Accessions	PLOS ONE			English	Article							ORYZA-SATIVA L.; NORTHERN LIMIT REGION; LINKAGE DISEQUILIBRIUM; COMPLEX TRAITS; POPULATION-STRUCTURE; GREEN-REVOLUTION; COMMON DISEASES; GENE; GROWTH; YIELD	Background In this study we carried out a genome-wide association analysis for plant and grain morphology and root architecture in a unique panel of temperate rice accessions adapted to European pedo-climatic conditions. This is the first study to assess the association of selected phenotypic traits to specific genomic regions in the narrow genetic pool of temperate japonica. A set of 391 rice accessions were GBS-genotyped yielding-after data editing-57000 polymorphic and informative SNPS, among which 54% were in genic regions. Results In total, 42 significant genotype-phenotype associations were detected: 21 for plant morphology traits, 11 for grain quality traits, 10 for root architecture traits. The FDR of detected associations ranged from 3.10(-7) to 0.92 (median: 0.25). In most cases, the significant detected associations co-localised with QTLs and candidate genes controlling the phenotypic variation of single or multiple traits. The most significant associations were those for flag leaf width on chromosome 4 (FDR = 3.10(-7)) and for plant height on chromosome 6 (FDR = 0.011). Conclusions We demonstrate the effectiveness and resolution of the developed platform for high-throughput phenotyping, genotyping and GWAS in detecting major QTLs for relevant traits in rice. We identified strong associations that may be used for selection in temperate irrigated rice breeding: e.g. associations for flag leaf width, plant height, root volume and length, grain length, grain width and their ratio. Our findings pave the way to successfully exploit the narrow genetic pool of European temperate rice and to pinpoint the most relevant genetic components contributing to the adaptability and high yield of this germplasm. The generated data could be of direct use in genomic-assisted breeding strategies.	[Biscarini, Filippo; Casella, Laura; Riccardi, Paolo; Vattari, Alessandra; Abbruscato, Pamela; Piffanelli, Pietro; Greco, Raffaella] PTP Sci Pk, I-26900 Lodi, Italy; [Cozzi, Paolo] IBBA CNR, Lodi, Italy; [Orasen, Gabriele; Perrini, Rosaria; Biselli, Chiara; Vale, Giampiero] CREA Council Agr Res & Econ, Rice Res Unit, I-13100 Vercelli, Italy; [Tacconi, Gianni; Tondelli, Alessandro; Cattivelli, Luigi; Vale, Giampiero] CREA Council Agr Res & Econ, Genom Res Ctr, I-29017 Fiorenzuola Darda, Piacenza, Italy; [Spindel, Jennifer; McCouch, Susan] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Biotecnologia Agraria (IBBA-CNR); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Cornell University	Biscarini, F (corresponding author), PTP Sci Pk, I-26900 Lodi, Italy.	filippo.biscarini@ptp.it	Cozzi, Paolo/AFM-1008-2022; Biscarini, Filippo/H-3334-2019; Spindel, Jennifer/F-1373-2017; Tondelli, Alessandro/AAJ-1720-2020; cattivelli, luigi/AAE-7046-2020; Valè, Giampiero/ABF-1492-2020; Tondelli, Alessandro/I-7433-2015	Biscarini, Filippo/0000-0002-3901-2354; Tondelli, Alessandro/0000-0001-9299-7773; cattivelli, luigi/0000-0002-6067-4600; Valè, Giampiero/0000-0003-2158-9726; Tondelli, Alessandro/0000-0001-9299-7773; Cozzi, Paolo/0000-0003-0388-6874	European research project "GS-Ruse"; European research project "Eurigen"; Italian national research project "Risinnova"; Division Of Integrative Organismal Systems [1026555] Funding Source: National Science Foundation	European research project "GS-Ruse"; European research project "Eurigen"; Italian national research project "Risinnova"; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research leading to these results has received funding from the European research projects "GS-Ruse" (http://www.first-gsruse.net/) and "Eurigen" (Action of the AGRI GEN RES PROGRAM) and from the Italian national research project "Risinnova" (http://risinnova.entecra.it/).; The research leading to these results has received funding from the European research projects "GS-Ruse" (http://www.first-gsruse.net/) and "Eurigen" (Action 49 of the AGRI GEN RES PROGRAM) and from the Italian national research project "Risinnova" (http://risinnova.entecra.it/).	Ahmadi N, 2014, RICE, V7, DOI 10.1186/s12284-014-0029-y; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amarawathi Y, 2008, MOL BREEDING, V21, P49, DOI 10.1007/s11032-007-9108-8; [Anonymous], 2014, TEMPERATE RICE GLOBA; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bacciu N, 2012, P 16 QTL MAS WORKSH, P24; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biselli C, 2014, RICE, V7, DOI 10.1186/1939-8433-7-1; Bohmanova J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-421; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P969, DOI 10.1007/BF00222910; Chen YL, 2015, PLANT MOL BIOL REP, V33, P69, DOI 10.1007/s11105-014-0731-3; Chung PJ, 2009, PLANT J, V59, P764, DOI 10.1111/j.1365-313X.2009.03908.x; Comas LH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00442; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; El Nahry AH, 2011, AGR WATER MANAGE, V98, P517, DOI 10.1016/j.agwat.2010.09.012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Faivre-Rampant O, 2011, MOL BREEDING, V27, P233, DOI 10.1007/s11032-010-9426-0; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Hu YF, 2009, BIOCHEM BIOPH RES CO, V388, P266, DOI 10.1016/j.bbrc.2009.07.162; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102448; Ichitani K, 1997, BREEDING SCI, V47, P145; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Jiang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118169; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kaur S, 2013, CRITICAL RE IN PRESS; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li N, 2015, ADV SEED BIOL, V11, P78; Liang YS, 2011, RICE SCI, V18, P265, DOI 10.1016/S1672-6308(12)60004-3; Lim JH, 2014, MOL CELLS, V37, P149, DOI 10.14348/molcells.2014.2336; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Matusmoto T, 2016, RICE SCI, V23, P51, DOI 10.1016/j.rsci.2016.01.006; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nagasawa N, 2013, PLANT J, V75, P592, DOI 10.1111/tpj.12223; O'Brien AMP, 2014, LIVEST SCI, V166, P121, DOI 10.1016/j.livsci.2014.05.007; Okumoto Y, 1996, EUPHYTICA, V92, P63, DOI 10.1007/BF00022829; Perrier X, 2003, GENETIC DIVERSITY CU; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Serraj R, 2011, PLANT PROD SCI, V14, P1, DOI 10.1626/pps.14.1; Shen GJ, 2014, PLANT SCI, V215, P11, DOI 10.1016/j.plantsci.2013.10.004; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Tonini, 2011, OPPORTUNITIES GLOBAL; VanLiere JM, 2008, THEOR POPUL BIOL, V74, P130, DOI 10.1016/j.tpb.2008.05.006; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Werck-Reichhart Daniele, 2002, Arabidopsis Book, V1, pe0028, DOI 10.1199/tab.0028; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yue Bing, 2006, Acta Genetica Sinica, V33, P824, DOI 10.1016/S0379-4172(06)60116-9; Zhang GH, 2014, MOL PLANT; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093017; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zuo JR, 2014, ANNU REV GENET, V48, P99, DOI 10.1146/annurev-genet-120213-092138	78	50	54	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155425	10.1371/journal.pone.0155425	http://dx.doi.org/10.1371/journal.pone.0155425			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228161	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500019
J	Freitas, C; Deschenes, S; Au, BN; Smith, K; Schmitz, N				Freitas, Cassandra; Deschenes, Sonya; Au, Bonnie; Smith, Kimberley; Schmitz, Norbert			Risk of Diabetes in Older Adults with Co-Occurring Depressive Symptoms and Cardiometabolic Abnormalities: Prospective Analysis from the English Longitudinal Study of Ageing	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; TYPE-2; METAANALYSIS; ASSOCIATION; PREVALENCE; OBESITY; HYPERTENSION; INFLAMMATION; AGREEMENT	High depressive symptoms and cardiometabolic abnormalities are independently associated with an increased risk of diabetes. The purpose of this study was to assess the association of co-occurring depressive symptoms and cardiometabolic abnormalities on risk of diabetes in a representative sample of the English population aged 50 years and older. Data were from the English Longitudinal Study of Ageing. The sample comprised of 4454 participants without diabetes at baseline. High depressive symptoms were based on a score of 4 or more on the 8-item binary Centre for Epidemiologic Studies-Depression scale. Cardiometabolic abnormalities were defined as 3 or more cardiometabolic risk factors (hypertension, impaired glycemic control, systemic inflammation, low high-density lipoprotein cholesterol, high triglycerides, and central obesity). Cox proportional hazards regressions assessed the association between co-occurring depressive symptoms and cardiometabolic abnormalities with incidence of diabetes. Multiple imputation by chained equations was performed to account for missing data. Covariates included age, sex, education, income, smoking status, physical activity, alcohol consumption, and cardiovascular comorbidity. The follow-up period consisted of 106 months, during which 193 participants reported a diagnosis of diabetes. Diabetes incidence rates were compared across the following four groups: 1) no or low depressive symptoms and no cardiometabolic abnormalities (reference group, n = 2717); 2) high depressive symptoms only (n = 338); 3) cardiometabolic abnormalities only (n = 1180); and 4) high depressive symptoms and cardiometabolic abnormalities (n = 219). Compared to the reference group, the hazard ratio for diabetes was 1.29 (95% CI 0.63, 2.64) for those with high depressive symptoms only, 3.88 (95% CI 2.77, 5.44) for those with cardiometabolic abnormalities only, and 5.56 (95% CI 3.45, 8.94) for those with both high depressive symptoms and cardiometabolic abnormalities, after adjusting for socio-demographic, lifestyle and clinical variables. These findings suggest that those with high depressive symptoms and cardiometabolic abnormalities are at a particularly increased risk of type 2 diabetes.	[Freitas, Cassandra; Schmitz, Norbert] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Freitas, Cassandra; Deschenes, Sonya; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Deschenes, Sonya; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Au, Bonnie] Sunnybrook Hlth Sci Ctr, Primary Care Res Unit, Toronto, ON M4N 3M5, Canada; [Smith, Kimberley] Brunel Univ London, Dept Life Sci, Uxbridge, Middx, England	McGill University; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Brunel University	Freitas, C (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Freitas, C (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	cassandra.freitas@mail.mcgill.ca	Deschenes, Sonya/G-6341-2017; Schmitz, Norbert/AAH-3624-2020; Schmitz, Norbert/A-5177-2010	Schmitz, Norbert/0000-0001-7777-6323; Smith, Kimberley/0000-0002-1323-627X				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 2015, MY COMM AW PROGR OLD; [Anonymous], 2014, DIAB PUBL HLTH RES M; Assmann SF, 1996, EPIDEMIOLOGY, V7, P286, DOI 10.1097/00001648-199605000-00012; Au B, 2014, J PSYCHOSOM RES, V77, P180, DOI 10.1016/j.jpsychores.2014.07.012; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Council S, 1992, ALLIED DUNBAR NATL F; Cracknell R, 2010, HOUSE COMMONS LIB RE, V2010, P44; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Demakakos P, 2010, DIABETES CARE, V33, P792, DOI 10.2337/dc09-1663; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004; Ford ES, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-35; Freitas C, 2015, INT J GERIATR PSYCHI; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Hamer M, 2009, PSYCHONEUROENDOCRINO, V34, P1050, DOI 10.1016/j.psyneuen.2009.02.004; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; International Diabetes Federation, 2014, IDF DIAB ATL UPD POS; Jacoby R, 2002, PSYCHIAT ELDERLY; Jokela M, 2014, MOL PSYCHIATR, V19, P910, DOI 10.1038/mp.2013.162; Jones GRD, 2011, MED J AUSTRALIA, V195, P45, DOI 10.5694/j.1326-5377.2011.tb03190.x; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Saad MAN, 2014, ARQ BRAS CARDIOL, V102, P263, DOI 10.5935/abc.20140013; Office for National Statistics, 2013, POP EST UK ENGL WAL; Okura Y, J CLIN EPIDEMIOLOGY, V57, P1096; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Patel SB, 2008, CURR HYPERTENS REP, V10, P131, DOI 10.1007/s11906-008-0025-y; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raghunathan TE, 2004, ANNU REV PUBL HEALTH, V25, P99, DOI 10.1146/annurev.publhealth.25.102802.124410; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Schmitz N, 2007, PSYCHOSOM MED, V69, P332, DOI 10.1097/PSY.0b013e31804259e0; Steffick DE, 2000, DOCUMENTION AFFECTIV; Steptoe A., 2012, INT J EPIDEMIOLOGY; The University of Wisconsin-Madison Social Science Computing Cooperative, 2013, MULT IMP STAT; Turvey C L, 1999, Int Psychogeriatr, V11, P139, DOI 10.1017/S1041610299005694; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Vogelzangs N, 2011, J CLIN PSYCHIAT, V72, P598, DOI 10.4088/JCP.10m06559; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	53	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155741	10.1371/journal.pone.0155741	http://dx.doi.org/10.1371/journal.pone.0155741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227974	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500030
J	Kang, TY; Hong, JM; Jung, JW; Kang, HW; Cho, DW				Kang, Tae-Yun; Hong, Jung Min; Jung, Jin Woo; Kang, Hyun-Wook; Cho, Dong-Woo			Construction of Large-Volume Tissue Mimics with 3D Functional Vascular Networks	PLOS ONE			English	Article							PERFUSION CULTURE; OXYGEN-TRANSPORT; SCAFFOLD; FABRICATION; TRANSPLANTATION; ANGIOGENESIS; JUNCTIONS; SURFACE; REPAIR	We used indirect stereolithography (SL) to form inner-layered fluidic networks in a porous scaffold by introducing a hydrogel barrier on the luminal surface, then seeded the networks separately with human umbilical vein endothelial cells and human lung fibroblasts to form a tissue mimic containing vascular networks. The artificial vascular networks provided channels for oxygen transport, thus reducing the hypoxic volume and preventing cell death. The endothelium of the vascular networks significantly retarded the occlusion of channels during whole-blood circulation. The tissue mimics have the potential to be used as an in vitro platform to examine the physiologic and pathologic phenomena through vascular architecture.	[Kang, Tae-Yun] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Hong, Jung Min; Jung, Jin Woo; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyungbuk, South Korea; [Kang, Hyun-Wook] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Dept Biomed Engn, Ulsan, South Korea	Yale University; Pohang University of Science & Technology (POSTECH); Ulsan National Institute of Science & Technology (UNIST)	Cho, DW (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyungbuk, South Korea.	dwcho@postech.ac.kr	Kang, Hyun-Wook/AAY-1766-2021		National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2012-0001235]	National Research Foundation of Korea (NRF) grant - Korean government (MEST)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST), No. 2012-0001235, (http://www.nrf.re.kr/nrf_eng_cms/).	Araujo JV, 2008, J BIOMAT SCI-POLYM E, V19, P1261, DOI 10.1163/156856208786052335; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688; Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327; Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109; Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Dunn JCY, 2006, TISSUE ENG, V12, P705, DOI 10.1089/ten.2006.12.705; El-Sabbagh AM, 2013, ASAIO J, V59, P474, DOI 10.1097/MAT.0b013e31829f0e6e; Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017; Hoganson DM, 2011, LAB CHIP, V11, P700, DOI 10.1039/c0lc00158a; Huang H, 2007, BIOMATERIALS, V28, P3815, DOI 10.1016/j.biomaterials.2007.05.004; Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105; Jung JW, 2012, INT J PRECIS ENG MAN, V13, P445, DOI 10.1007/s12541-012-0057-8; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kang HW, 2012, TISSUE ENG PART C-ME, V18, P719, DOI [10.1089/ten.tec.2011.0621, 10.1089/ten.TEC.2011.0621]; Kang TY, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015007; Kang TY, 2013, LANGMUIR, V29, P701, DOI 10.1021/la303552m; Kang TY, 2013, ACTA BIOMATER, V9, P4716, DOI 10.1016/j.actbio.2012.08.042; Kang TY, 2011, ACTA BIOMATER, V7, P3345, DOI 10.1016/j.actbio.2011.05.015; Le Guelte A, 2011, METHODS MOL BIOL, V763, P265, DOI 10.1007/978-1-61779-191-8_18; Liska R, 2005, J APPL POLYM SCI, V97, P2286, DOI 10.1002/app.22025; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Morgan JP, 2013, NAT PROTOC, V8, P1820, DOI 10.1038/nprot.2013.110; Murray CD, 1926, P NATL ACAD SCI USA, V12, P299, DOI 10.1073/pnas.12.5.299; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318; Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316; Sakai Y, 2004, MAT SCI ENG C-BIO S, V24, P379, DOI 10.1016/j.msec.2003.12.007; Seol YJ, 2012, SOFT MATTER, V8, P1730, DOI 10.1039/c1sm06863f; Solchaga LA, 2006, TISSUE ENG, V12, P1851, DOI 10.1089/ten.2006.12.1851; STEIN PD, 1974, CIRC RES, V35, P608, DOI 10.1161/01.RES.35.4.608; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Verseijden F, 2012, J TISSUE ENG REGEN M, V6, P169, DOI 10.1002/term.410; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	40	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156529	10.1371/journal.pone.0156529	http://dx.doi.org/10.1371/journal.pone.0156529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228079	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500153
J	Lauro, F; Giancotti, LA; Ilari, S; Dagostino, C; Gliozzi, M; Morabito, C; Malafoglia, V; Raffaeli, W; Muraca, M; Goffredo, BM; Mollace, V; Muscoli, C				Lauro, Filomena; Giancotti, Luigino Antonio; Ilari, Sara; Dagostino, Concetta; Gliozzi, Micaela; Morabito, Chiara; Malafoglia, Valentina; Raffaeli, William; Muraca, Maurizio; Goffredo, Bianca M.; Mollace, Vincenzo; Muscoli, Carolina			Inhibition of Spinal Oxidative Stress by Bergamot Polyphenolic Fraction Attenuates the Development of Morphine Induced Tolerance and Hyperalgesia in Mice	PLOS ONE			English	Article							NITRIC-OXIDE; ANTINOCICEPTIVE TOLERANCE; SUPEROXIDE-DISMUTASE; GLUTAMINE-SYNTHETASE; THERMAL HYPERALGESIA; NEUROPATHIC PAIN; REACTIVE OXYGEN; ESSENTIAL OIL; MODEL; PEROXYNITRITE	Citrus Bergamia Risso, commonly known as Bergamot, is a fruit whose Essential Oil and Bergamot Polyphenolic Fraction have numerous medicinal properties. It is also an excellent antioxidant and in this study, for the first time, its potential effect on morphine induced tolerance in mice has been investigated. Our studies revealed that development of antinociceptive tolerance to repeated doses of morphine in mice is consistently associated with increased formation of superoxide, malondialdehyde and tyrosine-nitrated proteins in the dorsal horn of the spinal cord such as the enzyme glutamine synthase. Nitration of this protein is intimately linked to inactivation of its biological function and resulting increase of glutamate levels in the spinal cord. Administration of Bergamot Polyphenolic Fraction (5-50 mg/kg) attenuated tolerance development. This effect was accompanied by reduction of superoxide and malondialdehyde production, prevention of GS nitration, re-establishment of its activity and of glutamate levels. Our studies confirmed the main role of free radicals during the cascade of events induced by prolonged morphine treatment and the co-administration of natural derivatives antioxidant such as Bergamot Polyphenolic Fraction can be an important therapeutic approach to restore opioids analgesic efficacy.	[Lauro, Filomena; Giancotti, Luigino Antonio; Ilari, Sara] San Raffaele Roma Srl, Catanzaro, Italy; [Dagostino, Concetta] Univ Parma, Dept Surg Sci, I-43100 Parma, Italy; [Dagostino, Concetta] YAP Young Pain Collaborat, Parma, Italy; [Gliozzi, Micaela; Mollace, Vincenzo; Muscoli, Carolina] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Inst Res Food Safety & Hlth IRC FSH, Catanzaro, Italy; [Morabito, Chiara] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Malafoglia, Valentina; Raffaeli, William] ISAL Fdn, Inst Res Pain, Torre Pedrera, RN, Italy; [Muraca, Maurizio; Goffredo, Bianca M.] Childrens Hosp Bambino Gesu, Res Inst, Res Labs, Rome, Italy	University of Parma; Magna Graecia University of Catanzaro; Sapienza University Rome; IRCCS Bambino Gesu	Muscoli, C (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Inst Res Food Safety & Hlth IRC FSH, Catanzaro, Italy.	muscoli@unicz.it	ilari, sara/C-2628-2017; Dagostino, Concetta/K-2815-2016; Gliozzi, Micaela/D-4405-2015; Malafoglia, Valentina/K-6495-2016; Muraca, Maurizio/G-3063-2012; Giancotti, Luigi/P-3450-2019	Dagostino, Concetta/0000-0002-6746-6716; Malafoglia, Valentina/0000-0002-1533-704X; Giancotti, Luigi/0000-0003-1837-9891; Goffredo, Bianca/0000-0001-9933-3240; ilari, sara/0000-0002-6756-6530; GIANCOTTI, ALDO/0000-0003-2117-8062; Raffaeli, William/0000-0003-0240-8993; Lauro, Filomena/0000-0001-8212-8603	Programma Operativo Nazionale "Ricerca e Competitivita" (PON "RC") [PON03PE_00078_1, PON03PE_00078_2]; Giovani Ricercatori [GR-2010-2318370]	Programma Operativo Nazionale "Ricerca e Competitivita" (PON "RC"); Giovani Ricercatori	This work was supported by grants from: Programma Operativo Nazionale "Ricerca e Competitivita" 2007-2013 (PON "R&C") PON03PE_00078_1 to Vincenzo Mollace; Programma Operativo Nazionale "Ricerca e Competitivita" 2007-2013 (PON "R&C") PON03PE_00078_2 to Vincenzo Mollace; Giovani Ricercatori GR-2010-2318370 to Carolina Muscoli. The funder provided support in the form of salaries for authors [FL, LAG, SI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Zaher AO, 2010, NEUROCHEM RES, V35, P1557, DOI 10.1007/s11064-010-0215-2; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Batista PA, 2010, J PAIN, V11, P1222, DOI 10.1016/j.jpain.2010.02.022; Espin JC, 2007, PHYTOCHEMISTRY, V68, P2986, DOI 10.1016/j.phytochem.2007.09.014; Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; DAO DN, 1991, STROKE, V22, P1312, DOI 10.1161/01.STR.22.10.1312; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Fairbanks CA, 1997, J PHARMACOL EXP THER, V282, P1408; FOLEY KM, 1995, ANTI-CANCER DRUG, V6, P4, DOI 10.1097/00001813-199504003-00002; KITTO KF, 1992, NEUROSCI LETT, V148, P1, DOI 10.1016/0304-3940(92)90790-E; KOLESNIKOV YA, 1992, EUR J PHARMACOL, V221, P399, DOI 10.1016/0014-2999(92)90732-J; Kuhad A, 2008, INDIAN J EXP BIOL, V46, P108; Laird K, 2012, LETT APPL MICROBIOL, V54, P169, DOI 10.1111/j.1472-765X.2011.03190.x; LEVINE RL, 1983, J BIOL CHEM, V258, P1828; Li T, 2012, BRAIN RES, V1433, P80, DOI 10.1016/j.brainres.2011.11.045; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mandalari G, 2007, J APPL MICROBIOL, V103, P2056, DOI 10.1111/j.1365-2672.2007.03456.x; Mattson MP, 2002, METHOD ENZYMOL, V352, P455; McInnis J, 2002, J PHARMACOL EXP THER, V301, P478, DOI 10.1124/jpet.301.2.478; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Meotti FC, 2006, BIOCHEM PHARMACOL, V72, P1707, DOI 10.1016/j.bcp.2006.08.028; Mollace V, 2008, J CARDIOVASC PHARM T, V13, P120, DOI 10.1177/1074248407313821; Mollace V, 2011, FITOTERAPIA, V82, P309, DOI 10.1016/j.fitote.2010.10.014; Muscoli C, 2004, PAIN, V111, P96, DOI 10.1016/j.pain.2004.06.004; Muscoli C, 2013, J BIOL REGULATORS HO, V28, P105; Muscoli C, 2007, J CLIN INVEST, V117, P3530, DOI 10.1172/JCI32420; Muscoli C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/950947; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; Raygude Kiran S., 2012, Inflammopharmacology, V20, P331, DOI 10.1007/s10787-012-0122-z; Salerno Raffaele, 2016, PharmaNutrition, V4, pS1, DOI 10.1016/j.phanu.2015.10.001; Salvemini D, 2002, PULM PHARMACOL THER, V15, P439, DOI 10.1006/pupt.2002.0374; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; Salvemini D, 2009, ARCH BIOCHEM BIOPHYS, V484, P238, DOI 10.1016/j.abb.2008.11.005; Shao HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100938; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Valsecchi AE, 2008, J NEUROCHEM, V107, P230, DOI 10.1111/j.1471-4159.2008.05614.x; Wang Y, 2012, NAT MED, V18, P385, DOI 10.1038/nm.2633; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Warleta F, 2011, NUTRIENTS, V3, P839, DOI 10.3390/nu3100839; Wei A, 2010, J AGR FOOD CHEM, V58, P7218, DOI 10.1021/jf101077s	41	22	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156039	10.1371/journal.pone.0156039	http://dx.doi.org/10.1371/journal.pone.0156039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227548	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500055
J	Peng, J; Liu, JR; Zhang, L; Luo, JY; Dong, HL; Ma, Y; Zhao, XH; Chen, BL; Sui, N; Zhou, ZG; Meng, YL				Peng, Jun; Liu, Jingran; Zhang, Lei; Luo, Junyu; Dong, Helin; Ma, Yan; Zhao, Xinhua; Chen, Binglin; Sui, Ning; Zhou, Zhiguo; Meng, Yali			Effects of Soil Salinity on Sucrose Metabolism in Cotton Leaves	PLOS ONE			English	Article							CARBOHYDRATE-METABOLISM; PHOSPHATE SYNTHASE; FUNCTIONAL LEAVES; CARBON PRODUCTION; SALT; PHOTOSYNTHESIS; GROWTH; PIGMENTS; TOLERANT; ENZYMES	This study investigated sucrose metabolism of the youngest fully expanded main-stem leaf (MSL) and the subtending leaf of cotton (Gossypium hirsutum L.) boll (LSCB) of salt-tolerant (CCRI-79) and salt-sensitive (Simian 3) cultivars and its relationship to boll weight under low, medium and high soil salinity stress in Dafeng, China, in 2013 and 2014. The results showed that with increased soil salinity, 1) both the chlorophyll content and net photosynthetic rate (Pn) decreased, while the internal CO2 concentration firstly declined, and then increased in the MSL and LSCB; 2) carbohydrate contents in the MSL reduced significantly, while sucrose and starch contents in the LSCB increased, as did the activities of sucrose phosphate synthase (SPS) and sucrose synthase (SuSy) in both the MSL and LSCB; 3) but invertase activity in both the MSL and LSCB did not change significantly. Our study also showed that the LSCB was more sensitive to soil salinity than was the MSL. Of the measured physiological indices, higher SPS activity, mainly controlled by sps3, may contribute to adaption of the LSCB to soil salinity stress because SPS is beneficial for efficiently sucrose synthesis, reduction of cellular osmotic potential and combined actions of Pn, and sucrose transformation rate and SPS may contribute to the reduction in boll weight under soil salinity stress.	[Peng, Jun; Chen, Binglin; Zhou, Zhiguo; Meng, Yali] Nanjing Agr Univ, Key Lab Crop Physiol & Ecol Southern China, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Peng, Jun; Liu, Jingran; Zhang, Lei; Luo, Junyu; Dong, Helin; Ma, Yan; Zhao, Xinhua] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Liu, Jingran] Jiangsu Normal Univ, Sch Life Sci, Inst Integrat Plant Biol, Xuzhou, Peoples R China; [Sui, Ning] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Jiangsu Normal University; Zhejiang Chinese Medical University	Meng, YL (corresponding author), Nanjing Agr Univ, Key Lab Crop Physiol & Ecol Southern China, Minist Agr, Nanjing, Jiangsu, Peoples R China.	giscott@njau.edu.cn; mengyl@njau.edu.cn		Ma, Yan/0000-0001-6897-5064	National Natural Science Foundation of China [31301262, 31501257]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest [201503109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest	The authors are grateful for financial support from the National Natural Science Foundation of China ( 31301262 and 31501257), Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP), and the Special Fund for Agro-scientific Research in the Public Interest ( 201503109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirjani Mohammad Reza, 2011, International Journal of Botany, V7, P73, DOI 10.3923/ijb.2011.73.81; ASHLEY DA, 1972, CROP SCI, V12, P69, DOI 10.2135/cropsci1972.0011183X001200010023x; Balibrea ME, 2000, PHYSIOL PLANTARUM, V110, P503, DOI 10.1111/j.1399-3054.2000.1100412.x; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; CONSTABLE GA, 1980, AUST J PLANT PHYSIOL, V7, P539, DOI 10.1071/PP9800539; Desingh R., 2007, General and Applied Plant Physiology, V33, P221; Dong He-zhong, 2012, Yingyong Shengtai Xuebao, V23, P566; Fu JM, 2010, J AM SOC HORTIC SCI, V135, P506, DOI 10.21273/JASHS.135.6.506; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; HENDRIX DL, 1994, AGR FOREST METEOROL, V70, P153, DOI 10.1016/0168-1923(94)90054-X; HUBER SC, 1992, PLANT PHYSIOL, V99, P1275, DOI 10.1104/pp.99.4.1275; Huber SC, 1996, ANNU REV PLANT PHYS, V47, P431, DOI 10.1146/annurev.arplant.47.1.431; HUBER SC, 1982, PLANT PHYSIOL, V69, P691, DOI 10.1104/pp.69.3.691; Khan HA, 2015, J PLANT PHYSIOL, V182, P1, DOI 10.1016/j.jplph.2015.05.002; Khelil A, 2007, PLANT PHYSIOL BIOCH, V45, P551, DOI 10.1016/j.plaphy.2007.05.003; Kreuzwieser J, 2002, PLANT CELL ENVIRON, V25, P1039, DOI 10.1046/j.1365-3040.2002.00886.x; LAFTA AM, 1995, PLANT PHYSIOL, V109, P637, DOI 10.1104/pp.109.2.637; Li CR, 2002, PLANT SCI, V163, P313, DOI 10.1016/S0168-9452(02)00100-0; Li NY, 2008, AQUAT BOT, V88, P303, DOI 10.1016/j.aquabot.2007.12.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [鲁少尉 Lu Shaowei], 2012, [华北农学报, Acta Agriculturae Boreali-Sinica], V27, P136; LUNN JE, 1995, PLANTA, V197, P385, DOI 10.1007/BF00202661; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Pattanagul W, 2008, INDIAN J EXP BIOL, V46, P736; Poljakoff-Mayber A., 1999, HDB PLANT CROP STRES, P125; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Shu HM, 2009, EUR J AGRON, V31, P61, DOI 10.1016/j.eja.2009.03.004; WULLSCHLEGER SD, 1990, CROP SCI, V30, P1259, DOI 10.2135/cropsci1990.0011183X003000060021x; Yang XH, 2005, PHYSIOL PLANTARUM, V124, P343, DOI 10.1111/j.1399-3054.2005.00518.x; Zhang Guo-wei, 2011, Yingyong Shengtai Xuebao, V22, P1771; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112807; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; 胡根海, 2007, [棉花学报, Cotton Science], V19, P69	35	28	28	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156241	10.1371/journal.pone.0156241	http://dx.doi.org/10.1371/journal.pone.0156241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228029	Green Submitted, gold, Green Published			2022-12-26	WOS:000376882500091
J	Koenders, L; Cousijn, J; Vingerhoets, WAM; van den Brink, W; Wiers, RW; Meijer, CJ; Machielsen, MWJ; Veltman, DJ; Goudriaan, AE; de Haan, L				Koenders, Laura; Cousijn, Janna; Vingerhoets, Wilhelmina A. M.; van den Brink, Wim; Wiers, Reinout W.; Meijer, Carin J.; Machielsen, Marise W. J.; Veltman, Dick J.; Goudriaan, Anneke E.; de Haan, Lieuwe			Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study	PLOS ONE			English	Article							MENTAL-HEALTH; USE DISORDERS; MARIJUANA USE; BRAIN; ABNORMALITIES; AMYGDALA; VOLUME; ADOLESCENTS; DEPENDENCE; ADDICTION	Cannabis is the most frequently used illicit drug worldwide. Cross-sectional neuroimaging studies suggest that chronic cannabis exposure and the development of cannabis use disorders may affect brain morphology. However, cross-sectional studies cannot make a conclusive distinction between cause and consequence and longitudinal neuroimaging studies are lacking. In this prospective study we investigate whether continued cannabis use and higher levels of cannabis exposure in young adults are associated with grey matter reductions. Heavy cannabis users (N = 20, age baseline M = 20.5, SD = 2.1) and non-cannabis using healthy controls (N = 22, age baseline M = 21.6, SD = 2.45) underwent a comprehensive psychological assessment and a T1-structural MRI scan at baseline and 3 years follow- up. Grey matter volumes (orbitofrontal cortex, anterior cingulate cortex, insula, striatum, thalamus, amygdala, hippocampus and cerebellum) were estimated using the software package SPM (VBM-8 module). Continued cannabis use did not have an effect on GM volume change at follow-up. Cross-sectional analyses at baseline and follow-up revealed consistent negative correlations between cannabis related problems and cannabis use (in grams) and regional GM volume of the left hippocampus, amygdala and superior temporal gyrus. These results suggests that small GM volumes in the medial temporal lobe are a risk factor for heavy cannabis use or that the effect of cannabis on GM reductions is limited to adolescence with no further damage of continued use after early adulthood. Long-term prospective studies starting in early adolescence are needed to reach final conclusions.	[Koenders, Laura; Cousijn, Janna; van den Brink, Wim; Meijer, Carin J.; Machielsen, Marise W. J.; Goudriaan, Anneke E.; de Haan, Lieuwe] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Vingerhoets, Wilhelmina A. M.] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Vingerhoets, Wilhelmina A. M.] Maastricht Univ, Dept Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands; [Cousijn, Janna; Wiers, Reinout W.] Univ Amsterdam, Dept Dev Psychol, Addict Dev & Psychopathol ADAPT Lab, Amsterdam, Netherlands; [Wiers, Reinout W.] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Cousijn, Janna] Univ Utrecht, Dept Dev Psychol & Psychon, Utrecht, Netherlands; [Goudriaan, Anneke E.] Arkin Mental Hlth Care, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Univ Med Ctr, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; University of Amsterdam; University of Amsterdam; Utrecht University; Vrije Universiteit Amsterdam	Koenders, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	l.koenders@amc.uva.nl	Wiers, Reinout/AAB-4008-2021	Wiers, Reinout/0000-0002-4312-9766; Cousijn, Janna/0000-0002-7699-2582	Academic Medical Center of the University of Amsterdam; Netherlands Organization for Scientific research - Health Research and Development, ZonMW [31180002, 31160007]; Vici by the Dutch Organization for Scientific Research (NWO) [453.008.001]	Academic Medical Center of the University of Amsterdam; Netherlands Organization for Scientific research - Health Research and Development, ZonMW; Vici by the Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This paper is supported through funding received from the Academic Medical Center of the University of Amsterdam and the Netherlands Organization for Scientific research - Health Research and Development, ZonMW grant #31180002 awarded to A.E. Goudriaan and W. van den Brink and grant #31160007 awarded to L. de Haan. Additional funding was obtained from Vici grant #453.008.001 awarded to R.W. Wiers by the Dutch Organization for Scientific Research (NWO) and from the Amsterdam Brain Imaging Center (BIC) for MRI scans.	Adamson SJ, 2003, DRUG ALCOHOL REV, V22, P309, DOI 10.1080/0959523031000154454; Arseneault L, 2002, BMJ, V325; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashtari M, 2011, J PSYCHIATR RES, V45, P1055, DOI 10.1016/j.jpsychires.2011.01.004; Ashtari M, 2008, J PSYCHIATR RES, V43, P189, DOI 10.1016/j.jpsychires.2008.12.002; Babor TF., 2001, AUDIT ALCOHOL USE DI; Batalla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055821; Battistella G, 2014, NEUROPSYCHOPHARMACOL; Benegal V, 2007, ADDICT BIOL, V12, P122, DOI 10.1111/j.1369-1600.2006.00043.x; Block RI, 2000, NEUROREPORT, V11, P491, DOI 10.1097/00001756-200002280-00013; Cheetham A, 2012, BIOL PSYCHIAT, V71, P684, DOI 10.1016/j.biopsych.2011.10.029; Churchwell JC, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00225; Copeland J, 2013, CURR OPIN PSYCHIATR, V26, P325, DOI 10.1097/YCO.0b013e328361eae5; Cousijn J, 2014, ADDICT BIOL, V19, P282, DOI 10.1111/adb.12111; Cousijn J, 2012, NEUROIMAGE, V59, P3845, DOI 10.1016/j.neuroimage.2011.09.046; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Delisi LE, 2006, HARM REDUCT J, V3, P1; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Filbey FM, 2009, P NATL ACAD SCI USA, V106, P13016, DOI 10.1073/pnas.0903863106; Gilman JM, 2014, J NEUROSCI, V34, P5529, DOI 10.1523/JNEUROSCI.4745-13.2014; Hall WD, 2006, AUST NZ J PSYCHIAT, V40, P105, DOI 10.1111/j.1440-1614.2006.01756.x; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Jacobus J, 2014, CURRENT PHARM DESIGN, V20, P1; Jager G, 2007, EUR NEUROPSYCHOPHARM, V17, P289, DOI 10.1016/j.euroneuro.2006.10.003; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lorenzetti V, 2013, CURR PHARM DES, V20; Lorenzetti V, 2010, SUBST USE MISUSE, V45, P1787, DOI 10.3109/10826084.2010.482443; Matochik JA, 2005, DRUG ALCOHOL DEPEN, V77, P23, DOI 10.1016/j.drugalcdep.2004.06.011; Medina KL, 2009, ADDICT BIOL, V14, P457, DOI 10.1111/j.1369-1600.2009.00166.x; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nielsen F. A., 2002, AUTOMATIC ANATOMICAL; Osborne JW., 2010, PRACT ASSESS RES EVA, V15; Ramikie TS, 2014, NEURON, V81, P1111, DOI 10.1016/j.neuron.2014.01.012; Rocchetti M, 2013, PSYCHIAT CLIN NEUROS, V67, P483, DOI 10.1111/pcn.12085; ROESE NJ, 1993, PSYCHOL BULL, V114, P363, DOI 10.1037/0033-2909.114.2.363; Schmand B, 1991, Tijdschr Gerontol Geriatr, V22, P15; Schoenbaum G, 2008, BIOL PSYCHIAT, V63, P256, DOI 10.1016/j.biopsych.2007.06.003; Scholes-Balog KE, 2013, J ADOLESCENCE, V36, P519, DOI 10.1016/j.adolescence.2013.03.001; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sjoerds Z, 2013, WORLD J BIOL PSYCHIA, V14, P565, DOI 10.3109/15622975.2011.640942; Tzilos GK, 2005, AM J ADDICTION, V14, P64, DOI 10.1080/10550490590899862; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Weiland BJ, 2015, J NEUROSCI, V35, P1505, DOI 10.1523/JNEUROSCI.2946-14.2015; Wierenga L, 2014, NEUROIMAGE, V96, P67, DOI 10.1016/j.neuroimage.2014.03.072; Wittchen HU, 2007, DRUG ALCOHOL DEPEN, V88, pS60, DOI 10.1016/j.drugalcdep.2006.12.013; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694	51	43	43	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0152482	10.1371/journal.pone.0152482	http://dx.doi.org/10.1371/journal.pone.0152482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224247	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700002
J	Park, G; Yaden, DB; Schwartz, HA; Kern, ML; Eichstaedt, JC; Kosinski, M; Stillwell, D; Ungar, LH; Seligman, MEP				Park, Gregory; Yaden, David Bryce; Schwartz, H. Andrew; Kern, Margaret L.; Eichstaedt, Johannes C.; Kosinski, Michael; Stillwell, David; Ungar, Lyle H.; Seligman, Martin E. P.			Women are Warmer but No Less Assertive than Men: Gender and Language on Facebook	PLOS ONE			English	Article							INTERPERSONAL CIRCUMPLEX; SEX-DIFFERENCES; METAANALYSIS; PERSONALITY; TRAITS; MODEL	Using a large social media dataset and open-vocabulary methods from computational linguistics, we explored differences in language use across gender, affiliation, and assertiveness. In Study 1, we analyzed topics (groups of semantically similar words) across 10 million messages from over 52,000 Facebook users. Most language differed little across gender. However, topics most associated with self-identified female participants included friends, family, and social life, whereas topics most associated with self-identified male participants included swearing, anger, discussion of objects instead of people, and the use of argumentative language. In Study 2, we plotted male-and female-linked language topics along two interpersonal dimensions prevalent in gender research: affiliation and assertiveness. In a sample of over 15,000 Facebook users, we found substantial gender differences in the use of affiliative language and slight differences in assertive language. Language used more by self-identified females was interpersonally warmer, more compassionate, polite, and-contrary to previous findings-slightly more assertive in their language use, whereas language used more by self-identified males was colder, more hostile, and impersonal. Computational linguistic analysis combined with methods to automatically label topics offer means for testing psychological theories unobtrusively at large scale.	[Park, Gregory; Yaden, David Bryce; Eichstaedt, Johannes C.; Seligman, Martin E. P.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Schwartz, H. Andrew] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Kern, Margaret L.] Univ Melbourne, Grad Sch Educ, Melbourne, Vic 3010, Australia; [Kosinski, Michael; Stillwell, David] Univ Cambridge, Psychometr Ctr, Cambridge, England; [Ungar, Lyle H.] Univ Penn, Dept Comp & Informat Sci, 200 S 33Rd St, Philadelphia, PA 19104 USA	University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Melbourne; University of Cambridge; University of Pennsylvania	Yaden, DB (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	dyaden@sas.upenn.edu	Kern, Margaret L./T-3661-2018; Schwartz, H. Andrew/AAE-7276-2021; Kosinski, Michal/AAH-7375-2019	Kern, Margaret L./0000-0003-4300-598X; Kosinski, Michal/0000-0003-2936-4775; Yaden, David/0000-0002-9604-6227; Eichstaedt, Johannes/0000-0002-3220-2972	Templeton Religion Trust [0048]	Templeton Religion Trust	This work was supported by the Templeton Religion Trust, 0048, https://www.templeton.org, to MEPS LHU HAS JCE GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PA, 2006, SEX DIFFERENCES SIMI, P117; Atkins DC, 2012, J FAM PSYCHOL, V26, P816, DOI 10.1037/a0029607; Back MD, 2010, PSYCHOL SCI, V21, P372, DOI 10.1177/0956797609360756; Bakan D., 1966, THE DUALITY OF HUMAN; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; BRODY LR, 2008, HDB EMOTIONS, P395, DOI DOI 10.1007/978-1-4419-1465-1_21; BURKE RJ, 1976, PSYCHOL REP, V38, P531, DOI 10.2466/pr0.1976.38.2.531; Canary D.J., 2009, SEX DIFFERENCES SIMI; CARLI LL, 1989, J PERS SOC PSYCHOL, V56, P565, DOI 10.1037/0022-3514.56.4.565; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; Crawford M., 1995, TALKING DIFFERENCE G; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; DeYoung CG, 2013, J PERS, V81, P465, DOI 10.1111/jopy.12020; Duggan M, 2014, SOCIAL MEDIA UPDATE; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; Eagly AH, 2000, DEVELOPMENTAL SOCIAL PSYCHOLOGY OF GENDER, P123; Fast LA, 2010, J PERS, V78, P313, DOI 10.1111/j.1467-6494.2009.00617.x; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Gurtman M.B., 2003, HDB PSYCHOL; Gurtman MB, 2009, SOC PERSONAL PSYCHOL, V3, P601, DOI 10.1111/j.1751-9004.2009.00172.x; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Koenig A.M., 2006, SOCIAL ROLE THEORY S; Kosinski M, 2015, AM PSYCHOL, V70, P543, DOI 10.1037/a0039210; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; Leaper C, 2007, PERS SOC PSYCHOL REV, V11, P328, DOI 10.1177/1088868307302221; Leaper C, 2011, PSYCHOL WOMEN QUART, V35, P129, DOI 10.1177/0361684310392728; Leary T., 1957, INTERPERSONAL DIAGNO; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Lippa RA, 2010, SOC PERSONAL PSYCHOL, V4, P1098, DOI 10.1111/j.1751-9004.2010.00320.x; MacCallum A. K., 2002, MALLET MACHINE LEARN; MCCRAE RR, 1989, J PERS SOC PSYCHOL, V56, P586, DOI 10.1037/0022-3514.56.4.586; Mehl MR, 2007, SCIENCE, V317, P82, DOI 10.1126/science.1139940; MOSKOWITZ DS, 1994, J PERS SOC PSYCHOL, V66, P753, DOI 10.1037/0022-3514.66.4.753; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Mulac A, 2001, HUM COMMUN RES, V27, P121, DOI 10.1093/hcr/27.1.121; MULAC A, 1985, J PERS SOC PSYCHOL, V49, P1098, DOI 10.1037/0022-3514.49.4.1098; Mulac A., 2006, GENDER LINKED LANGUA; Newman ML, 2008, DISCOURSE PROCESS, V45, P211, DOI 10.1080/01638530802073712; OConnor B, 2011, COMPUTATIONAL TEXT A, V41, P43; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pennebaker J. W., DEV PSYCHOMETRIC PRO; Potts C., 2011, HAPPYFUNTOKENIZER VE; Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Ruths D, 2014, SCIENCE, V346, P1063, DOI 10.1126/science.346.6213.1063; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Su R, 2009, PSYCHOL BULL, V135, P859, DOI 10.1037/a0017364; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Wiggins J.S., 1995, INTERPERSONAL ADJECT; Wiggins JS, 1996, J PERS ASSESS, V66, P217, DOI 10.1207/s15327752jpa6602_2; Wiggins JS., 1991, AGENCY COMMUNION CON; Williams WM, 2015, P NATL ACAD SCI USA, V112, P5360, DOI 10.1073/pnas.1418878112; Wood JT, 1998, SEX DIFFERENCES AND SIMILARITIES IN COMMUNICATIONS, P19; Yaden DB, 2015, J RELIG SPIRITU 0727	60	48	48	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155885	10.1371/journal.pone.0155885	http://dx.doi.org/10.1371/journal.pone.0155885			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GI	27223607	Green Published, gold			2022-12-26	WOS:000376881700037
J	Hayat, T; Qayyum, S; Imtiaz, M; Alsaedi, A				Hayat, Tasawar; Qayyum, Sumaira; Imtiaz, Maria; Alsaedi, Ahmed			MHD Flow and Heat Transfer between Coaxial Rotating Stretchable Disks in a Thermally Stratified Medium	PLOS ONE			English	Article							POROUS-MEDIA; FLUID-FLOW; MIXED CONVECTION; NANOFLUID FLOW; UNSTEADY-FLOW; SHEET; MAGNETOHYDRODYNAMICS; RADIATION; BOUNDARY; SURFACE	This paper investigates the unsteady MHD flow of viscous fluid between two parallel rotating disks. Fluid fills the porous space. Energy equation has been constructed by taking Joule heating, thermal stratification and radiation effects into consideration. We convert system of partial differential equations into system of highly nonlinear ordinary differential equations after employing the suitable transformations. Convergent series solutions are obtained. Behavior of different involved parameters on velocity and temperature profiles is examined graphically. Numerical values of skin friction coefficient and Nusselt number are computed and inspected. It is found that tangential velocity profile is increasing function of rotational parameter. Fluid temperature reduces for increasing values of thermal stratification parameter. At upper disk heat transfer rate enhances for larger values of Eckert and Prandtl numbers.	[Hayat, Tasawar; Qayyum, Sumaira; Imtiaz, Maria] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Fac Sci, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Imtiaz, M (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan.	mi_qau@yahoo.com	Qayyum, Sumaira/AAA-7476-2019; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019; Imtiaz, Maria/AAE-2547-2021	Alsaedi, Ahmed/0000-0003-3452-8922; 				Ahmad R, 2016, J MAGN MAGN MATER, V407, P69, DOI 10.1016/j.jmmm.2016.01.038; [Anonymous], 2013, J EGYPTIAN MATH SOC, DOI DOI 10.1016/j.joems.2013.02.006; ARORA RC, 1972, INT J HEAT MASS TRAN, V15, P2119, DOI 10.1016/0017-9310(72)90036-1; Bhattacharyya K, 2012, INT J HEAT MASS TRAN, V55, P2945, DOI 10.1016/j.ijheatmasstransfer.2012.01.051; Chapple P. J., 1962, 8 FLD PRINC U DEP ME; Cochran WG, 1934, P CAMB PHILOS SOC, V30, P365, DOI 10.1017/S0305004100012561; Ellahi R, 2014, J POROUS MEDIA, V17, P143, DOI 10.1615/JPorMedia.v17.i2.50; Ellahi R., 2015, Z NATURFORSCH, V70, P115, DOI DOI 10.1515/ZNA-2014-0258; Ganji DD, 2014, POWDER TECHNOL, V263, P50, DOI 10.1016/j.powtec.2014.04.089; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Hatami M, 2014, J MOL LIQ, V195, P230, DOI 10.1016/j.molliq.2014.02.024; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107858; Hayat T, 2016, J AEROSPACE ENG, V29, DOI 10.1061/(ASCE)AS.1943-5525.0000533; Hayat T, 2016, AIP ADV, V6, DOI 10.1063/1.4942091; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148662; Hayat T, 2015, J MOL LIQ, V212, P203, DOI 10.1016/j.molliq.2015.09.012; Hayat T, 2016, INT J HEAT MASS TRAN, V92, P100, DOI 10.1016/j.ijheatmasstransfer.2015.08.013; Hsiao KL, 2016, APPL THERM ENG, V98, P850, DOI 10.1016/j.applthermaleng.2015.12.138; Hsiao KL, 2015, COMMUN NONLINEAR SCI, V28, P232, DOI 10.1016/j.cnsns.2015.04.004; Hsiao KL, 2011, INT J NONLIN MECH, V46, P1, DOI 10.1016/j.ijnonlinmec.2010.06.005; Jamal-Abad MT, 2016, RENEW ENERG, V91, P147, DOI 10.1016/j.renene.2016.01.050; Karman T.V., 1921, J APPL MATH COMP MEC, V1, P233, DOI DOI 10.1002/ZAMM.19210010401; KUMAR SK, 1989, APPL MATH MODEL, V13, P494, DOI 10.1016/0307-904X(89)90098-X; Lin YH, 2015, POWDER TECHNOL, V274, P324, DOI 10.1016/j.powtec.2015.01.039; MELLOR GL, 1968, J FLUID MECH, V31, P95, DOI 10.1017/S0022112068000054; Moniem A.A., 2013, APPL MATH-US, V4, P694, DOI [10.4236/am.2013.44096, DOI 10.4236/AM.2013.44096]; Mukhopadhyay S, 2013, ALEX ENG J, V52, P259, DOI 10.1016/j.aej.2013.02.003; Rashidi S, 2015, J MAGN MAGN MATER, V378, P128, DOI 10.1016/j.jmmm.2014.11.020; Shehzad SA, 2015, J MOL LIQ, V209, P723, DOI 10.1016/j.molliq.2015.05.058; Sheikholeslami M, 2013, ADV POWDER TECHNOL, V24, P980, DOI 10.1016/j.apt.2013.01.012; Sheikholeslami M, 2014, COMMUN NUMBER ANAL; Soong CY, 2003, EXP THERM FLUID SCI, V27, P295, DOI 10.1016/S0894-1777(02)00310-2; STEWARTSON K, 1953, P CAMB PHILOS SOC, V49, P333, DOI 10.1017/S0305004100028437; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V90, P51, DOI 10.1016/j.compfluid.2013.11.005; Yan WM, 1997, INT J HEAT MASS TRAN, V40, P773, DOI 10.1016/0017-9310(96)00183-4; Yang LH, 2015, APPL THERM ENG, V86, P301, DOI 10.1016/j.applthermaleng.2015.04.035; Zhang CL, 2015, APPL MATH MODEL, V39, P165, DOI 10.1016/j.apm.2014.05.023; Zhang Y, 2016, ANN NUCL ENERGY, V90, P212, DOI 10.1016/j.anucene.2015.12.006; Zhao Y, 2016, INT J HEAT MASS TRAN, V92, P1061, DOI 10.1016/j.ijheatmasstransfer.2015.08.105	42	34	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155899	10.1371/journal.pone.0155899	http://dx.doi.org/10.1371/journal.pone.0155899			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218651	Green Submitted, gold, Green Published			2022-12-26	WOS:000376880700025
J	Meegahakumbura, MK; Wambulwa, MC; Thapa, KK; Li, MM; Moller, M; Xu, JC; Yang, JB; Liu, BY; Ranjitkar, S; Liu, J; Li, DZ; Gao, LM				Meegahakumbura, M. K.; Wambulwa, M. C.; Thapa, K. K.; Li, M. M.; Moller, M.; Xu, J. C.; Yang, J. B.; Liu, B. Y.; Ranjitkar, S.; Liu, J.; Li, D. Z.; Gao, L. M.			Indications for Three Independent Domestication Events for the Tea Plant (Camellia sinensis (L.) O. Kuntze) and New Insights into the Origin of Tea Germplasm in China and India Revealed by Nuclear Microsatellites	PLOS ONE			English	Article							GENETIC DIVERSITY; RICE DOMESTICATION; SINGLE DOMESTICATION; SSR MARKERS; RAPD MARKERS; AFLP MARKERS; CULTIVARS; SELECTION; ASSAMICA; DIFFERENTIATION	Background Tea is the world's most popular non-alcoholic beverage. China and India are known to be the largest tea producing countries and recognized as the centers for the domestication of the tea plant (Camellia sinensis (L.) O. Kuntze). However, molecular studies on the origin, domestication and relationships of the main teas, China type, Assam type and Cambod type are lacking. Methodology/Principal Findings Twenty-three nuclear microsatellite markers were used to investigate the genetic diversity, relatedness, and domestication history of cultivated tea in both China and India. Based on a total of 392 samples, high levels of genetic diversity were observed for all tea types in both countries. The cultivars clustered into three distinct genetic groups (i.e. China tea, Chinese Assam tea and Indian Assam tea) based on STRUCTURE, PCoA and UPGMA analyses with significant pairwise genetic differentiation, corresponding well with their geographical distribution. A high proportion (30%) of the studied tea samples were shown to possess genetic admixtures of different tea types suggesting a hybrid origin for these samples, including the Cambod type. Conclusions We demonstrate that Chinese Assam tea is a distinct genetic lineage from Indian Assam tea, and that China tea sampled from India was likely introduced from China directly. Our results further indicate that China type tea, Chinese Assam type tea and Indian Assam type tea are likely the result of three independent domestication events from three separate regions across China and India. Our findings have important implications for the conservation of genetic stocks, as well as future breeding programs.	[Meegahakumbura, M. K.; Wambulwa, M. C.; Li, M. M.; Liu, J.; Li, D. Z.; Gao, L. M.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650201, Peoples R China; [Meegahakumbura, M. K.; Wambulwa, M. C.; Yang, J. B.; Li, D. Z.] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species Southwest China, Kunming 650201, Peoples R China; [Meegahakumbura, M. K.; Wambulwa, M. C.; Li, M. M.; Li, D. Z.] Univ Chinese Acad Sci, Beijing 10049, Peoples R China; [Meegahakumbura, M. K.] Coconut Res Inst, Lunuwila, Sri Lanka; [Wambulwa, M. C.] World Agroforestry Ctr, Nairobi, Kenya; [Thapa, K. K.] Dinhata Coll, Dept Bot, Dinhata 736135, W Bengal, India; [Moller, M.] Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland; [Xu, J. C.; Ranjitkar, S.] Chinese Acad Sci, Ctr Mt Ecosyst Studies, Kunming 650201, Peoples R China; [Xu, J. C.; Ranjitkar, S.] Chinese Acad Sci, World Agroforestry Ctr, East & Cent Asia Reg Off, Kunming Inst Bot, Kunming 650201, Peoples R China; [Liu, B. Y.] Yunnan Acad Agr Sci, Tea Res Inst, Menghai 666201, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; CGIAR; World Agroforestry (ICRAF); Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Academy of Agricultural Sciences	Li, DZ; Gao, LM (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650201, Peoples R China.; Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species Southwest China, Kunming 650201, Peoples R China.; Li, DZ (corresponding author), Univ Chinese Acad Sci, Beijing 10049, Peoples R China.	dzl@mail.kib.ac.cn; gaolm@mail.kib.ac.cn	Gao, Lianming/H-4527-2011; Ranjitkar, Sailesh/I-9307-2014; Xu, Jianchu/Y-2890-2019; Gao, Lian-Ming/AAU-2613-2021; Li, De-Zhu/G-8203-2011	Gao, Lianming/0000-0001-9047-2658; Ranjitkar, Sailesh/0000-0002-4741-3975; Gao, Lian-Ming/0000-0001-9047-2658; Li, De-Zhu/0000-0002-4990-724X; Wambulwa, Moses/0000-0002-6373-5915	National Natural Science Foundation of China [31161140350, 31160175]; Ministry of Science and Technology of the People's Republic of China [2012FY110800]; Applied Fundamental Research Foundation of Yunnan Province [2014GA003]; CGIAR research programs on 'Forests, Trees and Agroforestry' [CRP6.2]; Rural and Environment Science and Analytical Services division (RESAS) in the Scottish Government	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Applied Fundamental Research Foundation of Yunnan Province; CGIAR research programs on 'Forests, Trees and Agroforestry'(CGIAR); Rural and Environment Science and Analytical Services division (RESAS) in the Scottish Government	This work was funded by the National Natural Science Foundation of China (grant number: 31161140350 to LMG, grant number: 31160175 to BYL, http://www.nsfc.gov.cn), the Ministry of Science and Technology of the People's Republic of China (grant number: 2012FY110800 to LMG, http://www.most.gov.cn), and the Applied Fundamental Research Foundation of Yunnan Province (grant number: 2014GA003 to DZL, http://www.ynstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Tea Research Institute of Yunnan and the Tea Board of India and Tea Research Association are thanked for providing their tea germplasm for our research work. We are grateful to R. Barthakur and S. S. Sikand of TATA group of plantations in India, for providing accesses of their tea germplasm collections. We also thank C.N. Fu, S.X. Yang, Q. Wei, X.J. Ge, X. Hong, Y.X. Qiu, Y.X. Zhang, L.N. Zhang, J.Y. Zhou, D. Wu, L. Fang, F. Luo and P.H. Fu for their kind help in the collection of tea germplasm in China. We further thank J. Yang and all the members of the molecular biology laboratory of KIB for their valuable support for the lab work. We express our gratitude to Drs. KS Burgess for editing and improving the manuscript, and C. Jost and L. Perera for their constructive comments on an earlier version of the manuscript. We acknowledge support from the CGIAR research programs on 'Forests, Trees and Agroforestry' (CRP6.2) for collecting the tea samples from various location. The Royal Botanic Garden Edinburgh is supported by the Rural and Environment Science and Analytical Services division (RESAS) in the Scottish Government. The authors further thank the Editor Prof. Kenneth M. Olsen and two anonymous reviewers for their valuable comments on this manuscript.	Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Balasaravanan T, 2003, PLANT SCI, V165, P365, DOI 10.1016/S0168-9452(03)00196-1; Benerjee B, 1992, TEA CULTIVATION CONS; Blackman BK, 2011, P NATL ACAD SCI USA, V108, P14360, DOI 10.1073/pnas.1104853108; Borthakur D, 2012, TOKLAI NEWS, V18, P1; Castillo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-266; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Charles HBJ, 1981, SEED CULTIVATION STO; Chen L, 2005, PLANT BREEDING, V124, P404, DOI 10.1111/j.1439-0523.2005.01100.x; Chen L, 2005, BIODIVERS CONSERV, V14, P1433, DOI 10.1007/s10531-004-9787-y; Das S.C., 2012, GLOBAL TEA BREEDING, P69, DOI DOI 10.1007/978-3-642-31878-8_3; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Diez CM, 2015, NEW PHYTOL, V206, P436, DOI 10.1111/nph.13181; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellis RT., 1995, EVOLUTION CROP PLANT; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Fang W, 2012, PLANT SYST EVOL, V298, P469, DOI 10.1007/s00606-011-0559-3; Fang WP, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.35; FAO, 2020, CLIMWAT 2 0 DAT; Felsenstein J., 2004, INFERRING PHYLOGENIE; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gunn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021143; Guns Diamond J., 1997, GUNS GERMS STEEL FAT; HARA Y, 1995, FOOD REV INT, V11, P371, DOI [10.1080/87559129509541054, 10.1080/87559129509541053, 10.1080/87559129509541056, 10.1080/87559129509541052]; Hasimoto M., 1972, JAP J TROP AGR, V16, P297; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ji PZ, 2011, PAK J BOT, V43, P281; Jin C, 2005, GENET RESOUR CROP EV, V52, P41; Karthigeyan S, 2008, BIOCHEM GENET, V46, P810, DOI 10.1007/s10528-008-9195-1; Katoh Y, 2003, EUPHYTICA, V134, P287, DOI 10.1023/B:EUPH.0000004970.39267.02; KINGDONWARD F, 1950, NATURE, V165, P297, DOI 10.1038/165297a0; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li Miao-miao, 2015, Plant Diversity and Resources, V37, P29, DOI 10.7677/ynzwyj201514048; Liu BenYing, 2010, Acta Agronomica Sinica, V36, P391, DOI 10.3724/SP.J.1006.2010.00391; Lu Y, 1974, THE CLASSIC OF TEA; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Ming T. L., 2000, MONOGRAPH GENUS CAME; Ming T.L., 2007, FLORA CHINA, V12, P366; Mondal TK, 2004, PLANT CELL TISS ORG, V76, P195, DOI 10.1023/B:TICU.0000009254.87882.71; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Paul S, 1997, THEOR APPL GENET, V94, P255, DOI 10.1007/s001220050408; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Raina SN, 2012, GENET RESOUR CROP EV, V59, P1527, DOI 10.1007/s10722-011-9782-6; Rambaut A., 2012, FIGTREE VERSION 1 4; Rodgers S, 1975, TEA Q, V45, P91; Roy SC, 2009, INDIAN J BIOTECHNOL, V8, P370; Sealy J. R., 1958, REVISION GENUS CAMEL; Sharma RK, 2010, BIOCHEM GENET, V48, P549, DOI 10.1007/s10528-010-9338-z; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Stuart C. P, 1919, B JARDIN BOT BUITENZ, V1, P193; Takeo T., 1992, Journal of Tea Science, V12, P81; Tan LQ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0914-6; Taniguchi F, 2014, TREE GENET GENOMES, V10, P1555, DOI 10.1007/s11295-014-0779-0; Ukers William H, 1935, ALL ABOUT TEA, V1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wambulwa MC, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-015-0963-x; WICKRAMARATNE MRT, 1985, TROP AGR, V62, P243; WIGHT W, 1957, NATURE, V179, P506, DOI 10.1038/179506a0; WIGHT W, 1962, CURR SCI INDIA, V31, P298; WIGHT W, 1959, NATURE, V183, P1726, DOI 10.1038/1831726a0; Wikramaratne MR, 1981, TEA Q, V50, P183; Yao MZ, 2008, PLANT BREEDING, V127, P166, DOI 10.1111/j.1439-0523.2007.01448.x; Yao MZ, 2012, TREE GENET GENOMES, V8, P205, DOI 10.1007/s11295-011-0433-z; Yu F., 1986, J TEA SCI, V6, P1; Zhao DW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-14; Zhao FR, 2008, J SIMAO TEACHERS COL, V24, P28; Zhu ZF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3200	78	33	38	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155369	10.1371/journal.pone.0155369	http://dx.doi.org/10.1371/journal.pone.0155369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218820	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880700006
J	Gatto, KP; Busin, CS; Lourenco, LB				Gatto, Kaleb Pretto; Busin, Carmen Silvia; Lourenco, Luciana Bolsoni			Unraveling the Sex Chromosome Heteromorphism of the Paradoxical Frog Pseudis tocantins	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; SATELLITE DNA; CYTOGENETIC ANALYSIS; RANA-RUGOSA; ANURA; AMPHIBIA; EVOLUTION; SEQUENCE; RECOMBINATION; REPEATS	The paradoxical frog Pseudis tocantins is the only species in the Hylidae family with known heteromorphic Z and W sex chromosomes. The Z chromosome is metacentric and presents an interstitial nucleolar organizer region (NOR) on the long arm that is adjacent to a pericentromeric heterochromatic band. In contrast, the submetacentric W chromosome carries a pericentromeric NOR on the long arm, which is adjacent to a clearly evident heterochromatic band that is larger than the band found on the Z chromosome and justify the size difference observed between these chromosomes. Here, we provide evidence that the non-centromeric heterochromatic bands in Zq and Wq differ not only in size and location but also in composition, based on comparative genomic hybridization (CGH) and an analysis of the anuran PcP190 satellite DNA. The finding of PcP190 sequences in P. tocantins extends the presence of this satellite DNA, which was previously detected among Leptodactylidae and Hylodidae, suggesting that this family of repetitive DNA is even older than it was formerly considered. Seven groups of PcP190 sequences were recognized in the genome of P. tocantins. PcP190 probes mapped to the heterochromatic band in Wq, and a Southern blot analysis indicated the accumulation of PcP190 in the female genome of P. tocantins, which suggests the involvement of this satellite DNA in the evolution of the sex chromosomes of this species.	[Gatto, Kaleb Pretto; Lourenco, Luciana Bolsoni] Univ Estadual Campinas, Inst Biol, Dept Biol Estrutural & Func, BR-13083863 Sao Paulo, Brazil; [Busin, Carmen Silvia] Univ Passo Fundo, Inst Ciencias Biol, Lab Citogenet, BR-99001970 Passo Fundo, RS, Brazil	Universidade Estadual de Campinas; Universidade de Passo Fundo	Lourenco, LB (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Estrutural & Func, BR-13083863 Sao Paulo, Brazil.	bolsoni@unicamp.br	Lourenço, Luciana Bolsoni/AAD-4667-2021; Lourenço, Luciana B/B-5971-2013; Gatto, Kaleb Pretto/ABH-1420-2021	Lourenço, Luciana B/0000-0001-6602-6850; Busin, Carmen Silvia/0000-0002-5724-735X; Pretto Gatto, Kaleb/0000-0002-2261-229X	Sao Paulo Research Foundation (FAPESP) [2014/23542-6, 2011/05416-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP, #2014/23542-6 and studentship #2011/05416-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Sao Paulo Research Foundation (FAPESP) for financial support (#2014/23542-6) and studentship (#2011/05416-5) and Stenio Eder Vittorazzi for help in the isolation of some of the repetitive sequences of PcP190EcoRI. Additionally, the authors would like to thank Joao Vitor Mattos for help in FISH assays, and Patricia P. Parise Maltempi, Ana Paula Z. Silva de Pietri, Daniel Pacheco Bruschi, Juliana Nascimento and Stenio Eder Vittorazzi for reading the first draft of the manuscript and for valuable comments and discussion.	Abramyan J, 2009, CHROMOSOME RES, V17, P1015, DOI 10.1007/s10577-009-9095-1; Acosta MJ, 2010, GENETICA, V138, P1085, DOI 10.1007/s10709-010-9496-2; Amor N, 2009, CYTOGENET GENOME RES, V127, P33, DOI 10.1159/000279444; Ananias F, 2007, HEREDITAS, V144, P206, DOI 10.1111/j.2007.0018-0661.02026.x; AYARES D, 1986, P NATL ACAD SCI USA, V83, P5199, DOI 10.1073/pnas.83.14.5199; Ayling LJ, 2002, CYTOGENET GENOME RES, V99, P125, DOI 10.1159/000071584; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BECAK W, 1964, CHROMOSOMA, V15, P606, DOI 10.1007/BF00319994; Busin CS, 2008, GENETICA, V133, P119, DOI 10.1007/s10709-007-9189-7; Caramaschi Ulisses, 1998, Revista Brasileira de Zoologia, V15, P929; Craves JAM, 2008, ANNU REV GENET, V42, P565, DOI 10.1146/annurev.genet.42.110807.091714; Cuevas CC, 1996, CHROMOSOME RES, V4, P467, DOI 10.1007/BF02265054; da Silva EL, 2013, CYTOGENET GENOME RES, V139, P22, DOI 10.1159/000342957; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Fouquet A, 2013, MOL PHYLOGENET EVOL, V67, P445, DOI 10.1016/j.ympev.2013.02.009; GREEN DM, 1988, CHROMOSOMA, V97, P55, DOI 10.1007/BF00331795; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPER ME, 1983, NUCLEIC ACIDS RES, V11, P2313, DOI 10.1093/nar/11.8.2313; HILLIS DM, 1990, J EVOLUTION BIOL, V3, P49, DOI 10.1046/j.1420-9101.1990.3010049.x; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Itoh Y, 2002, CHROMOSOME RES, V10, P499, DOI 10.1023/A:1020944414750; ITURRA P, 1989, GENETICA, V78, P25; Koubova M, 2014, CHROMOSOME RES, V22, P441, DOI 10.1007/s10577-014-9430-z; Kuhn GCS, 2009, HEREDITY, V102, P453, DOI 10.1038/hdy.2009.9; Kuhn GCS, 2008, CHROMOSOME RES, V16, P307, DOI 10.1007/s10577-007-1195-1; Lepesant JMJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r14; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mariotti B, 2009, MOL GENET GENOMICS, V281, P249, DOI 10.1007/s00438-008-0405-7; Matsubara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095226; Medeiros LR, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-59; Miura I, 1997, CHROMOSOMA, V106, P178, DOI 10.1007/s004120050237; Miura I, 2009, GEN-RES ISSUES, P123; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; NAKAYAMA I, 1994, CHROMOSOMA, V103, P31, DOI 10.1007/BF00364723; Nishioka Midori, 1994, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V13, P1; Nishioka Midori, 1993, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V12, P55; Odierna G, 2004, CHROMOSOME RES, V12, P671, DOI 10.1023/B:CHRO.0000045746.59805.58; Ohno S., 1967, SEX CHROMOSOMES SEX; OKUMURA K, 1987, NUCLEIC ACIDS RES, V15, P7477, DOI 10.1093/nar/15.18.7477; Opperman R, 2004, GENETICS, V168, P2207, DOI 10.1534/genetics.104.032896; Parise-Maltempi PP, 2007, CYTOGENET GENOME RES, V116, P218, DOI 10.1159/000098190; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; Plohl M, 2012, GENOME DYNAM, V7, P126, DOI 10.1159/000337122; Plohl M, 2010, HEREDITY, V104, P543, DOI 10.1038/hdy.2009.141; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; RAGGHIANTI M, 1995, CHROMOSOME RES, V3, P497, DOI 10.1007/BF00713965; Robles F, 2004, GENE, V338, P133, DOI 10.1016/j.gene.2004.06.001; Rodrigues DS, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-17; RUBNITZ J, 1984, MOL CELL BIOL, V4, P2253, DOI 10.1128/MCB.4.11.2253; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMID M, 1983, CHROMOSOMA, V88, P69, DOI 10.1007/BF00329505; SCHMID M, 1987, CHROMOSOMA, V95, P271, DOI 10.1007/BF00294784; Schmid M, 2002, CYTOGENET GENOME RES, V99, P330, DOI 10.1159/000071612; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; Schmid M, 2002, CYTOGENET GENOME RES, V97, P81, DOI 10.1159/000064055; SCHMID M, 1993, CYTOGENET CELL GENET, V62, P238, DOI 10.1159/000133486; SCHMID M, 1980, CHROMOSOMA, V80, P69, DOI 10.1007/BF00327567; Schmid M, 2012, CYTOGENET GENOME RES, V138, P68; Schmid M, 2014, CYTOGENET GENOME RES, V142, P268, DOI 10.1159/000362216; SINGH L, 1980, CHROMOSOMA, V79, P137, DOI 10.1007/BF01175181; SINGH L, 1976, CHROMOSOMA, V59, P43, DOI 10.1007/BF00327708; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsoumani KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079393; Uno Y, 2008, CHROMOSOME RES, V16, P637, DOI 10.1007/s10577-008-1217-7; Uno Y, 2015, CYTOGENET GENOME RES, V145, P218, DOI 10.1159/000431211; Valenzuela N, 2008, SEX DEV, V2, P64, DOI 10.1159/000129691; Viegas-Pequignot E, 1992, IN SITU HYBRIDIZATIO, P137; VITELLI L, 1982, CHROMOSOMA, V84, P475, DOI 10.1007/BF00292849; Vitkova M, 2007, CHROMOSOME RES, V15, P917, DOI 10.1007/s10577-007-1173-7; Vittorazzi SE, 2011, CYTOGENET GENOME RES, V134, P101, DOI 10.1159/000325540; Vittorazzi SE, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0111-x	73	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156176	10.1371/journal.pone.0156176	http://dx.doi.org/10.1371/journal.pone.0156176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214234	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200065
J	Yamaguchi, T; Devassy, JG; Monirujjaman, M; Gabbs, M; Aukema, HM				Yamaguchi, Tamio; Devassy, Jessay G.; Monirujjaman, Md; Gabbs, Melissa; Aukema, Harold M.			Lack of Benefit of Early Intervention with Dietary Flax and Fish Oil and Soy Protein in Orthologous Rodent Models of Human Hereditary Polycystic Kidney Disease	PLOS ONE			English	Article							FATTY-ACID COMPOSITION; RENAL INJURY; RAT MODEL; PROGRESSION; MICE; NEPHRONOPHTHISIS; THERAPY; ISOLATE	Rationale for dietary advice in polycystic kidney disease (PKD) is based in part on animal studies that have examined non-orthologous models with progressive development of cystic disease. Since no model completely mimics human PKD, the purpose of the current studies was to examine the effects of dietary soy protein (compared to casein) or oils enriched in omega-3 fatty acids (fish or flax oil compared to soy oil) on early disease progression in two orthologous models of PKD. The models studied were Pkd2WS25/-mice as a model of autosomal dominant PKD, and PCK rats as a model of autosomal recessive PKD. After 13 weeks of feeding, dietary fish (but not flax) oil resulted in larger kidneys and greater kidney water content in female Pkd2WS25/-compared to control mice. After 12 weeks of feeding male PCK compared to control rats, both fish and flax compared to soy oil resulted in enlarged kidneys and livers, greater kidney water content and higher kidney cyst area in diseased rats. Dietary soy protein compared to casein had no effects in Pkd2WS25/-compared to control mice. In PCK rats, kidney and liver histology were not improved, but lower proteinuria and higher urine pH suggest that soy protein could be beneficial in the long term. Therefore, in contrast to studies in non-orthologous models during the progressive development phase, these studies in orthologous PKD models do not support dietary advice to increase soy protein or oils enriched in omega-3 oils in early PKD.	[Yamaguchi, Tamio; Devassy, Jessay G.; Monirujjaman, Md; Gabbs, Melissa; Aukema, Harold M.] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada; [Yamaguchi, Tamio; Devassy, Jessay G.; Monirujjaman, Md; Gabbs, Melissa; Aukema, Harold M.] St Boniface Hosp Res Ctr, Canadian Ctr Agrifood Res Hlth & Med, Winnipeg, MB, Canada; [Yamaguchi, Tamio] Suzuka Univ Med Sci, Dept Clin Nutr, Suzuka, Mie, Japan; [Aukema, Harold M.] Childrens Hosp, Res Inst Manitoba, 840 Sherbrook St, Winnipeg, MB R3A 1S1, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Aukema, HM (corresponding author), Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada.; Aukema, HM (corresponding author), St Boniface Hosp Res Ctr, Canadian Ctr Agrifood Res Hlth & Med, Winnipeg, MB, Canada.; Aukema, HM (corresponding author), Childrens Hosp, Res Inst Manitoba, 840 Sherbrook St, Winnipeg, MB R3A 1S1, Canada.	Harold.Aukema@UManitoba.CA		Aukema, Harold/0000-0002-6982-7239; Monirujjaman, Md./0000-0003-2773-3530	Canadian Institutes of Health Research [MOP110956]; Natural Sciences and Engineering Research Council of Canada; Research Manitoba; Manitoba Graduate Scholarship program; University of Manitoba	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research Manitoba; Manitoba Graduate Scholarship program; University of Manitoba	These studies were supported by a grant (MOP110956) to HMA and TY from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/), a training fellowship to JGD from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) CREATE program, scholarships from Research Manitoba (http://researchmanitoba.ca/) and the Manitoba Graduate Scholarship program to MM, and a University of Manitoba (http://umanitoba.ca/) studentship to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukema HM, 1999, J AM SOC NEPHROL, V10, P300; Aukema HM, 2001, KIDNEY INT, V59, P52, DOI 10.1046/j.1523-1755.2001.00465.x; AUKEMA HM, 1992, NUTR RES, V12, P1383, DOI 10.1016/S0271-5317(05)80537-8; AUKEMA HM, 1992, KIDNEY INT, V42, P837, DOI 10.1038/ki.1992.358; Baur BP, 2014, PHARMACOTHERAPY, V34, P605, DOI 10.1002/phar.1421; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cahill LE, 2007, BRIT J NUTR, V97, P77, DOI 10.1017/S0007114507250470; Cipolla MJ, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000196948.15019.28; Fair DE, 2004, J NUTR, V134, P1504, DOI 10.1093/jn/134.6.1504; Happe H, 2014, NAT REV NEPHROL, V10, P587, DOI 10.1038/nrneph.2014.137; Hartung EA, 2014, PEDIATRICS, V134, pE833, DOI 10.1542/peds.2013-3646; Higashihara E, 2008, NEPHROL DIAL TRANSPL, V23, P2847, DOI 10.1093/ndt/gfn144; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Ibrahim NHM, 2014, MOL NUTR FOOD RES, V58, P768, DOI 10.1002/mnfr.201300332; Lu J, 2003, J NUTR, V133, P180, DOI 10.1093/jn/133.1.180; Maditz KH, 2015, J PEDIATR GASTR NUTR, V60, P467, DOI 10.1097/MPG.0000000000000649; Maditz KH, 2014, NUTR RES, V34, P526, DOI 10.1016/j.nutres.2014.05.001; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Ogborn MR, 2006, LIPIDS, V41, P1141, DOI 10.1007/s11745-006-5064-z; Ogborn MR, 2002, LIPIDS, V37, P1059, DOI 10.1007/s11745-002-1001-4; Ogborn MR, 1998, AM J PHYSIOL-RENAL, V274, pF541, DOI 10.1152/ajprenal.1998.274.3.F541; OGBORN MR, 2005, J AM NUTR ASS, V8, P26; Omran H, 2001, J AM SOC NEPHROL, V12, P107, DOI 10.1681/ASN.V121107; Ong ACM, 2015, LANCET, V385, P1993, DOI 10.1016/S0140-6736(15)60907-2; Perrone RD, DIET POTENTIAL TREAT; PKD Charity, 2016, LIV PKD DIET LIF; PKD Foundation of Canada, 2016, LIV PKD COMM NUTR QU; PKD Foundation (USA), 2016, LIV PKD COMM NUTR QU; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sankaran D, 2004, LIPIDS, V39, P207, DOI 10.1007/s11745-004-1221-7; Sankaran D, 2007, NEPHRON EXP NEPHROL, V106, pE122, DOI 10.1159/000104836; Spithoven EM, 2014, KIDNEY INT, V86, P1244, DOI 10.1038/ki.2014.120; Sullivan D., NEW DIET PATIENTS AU; Tanner GA, 2000, KIDNEY INT, V58, P1859, DOI 10.1046/j.1523-1755.2000.00357.x; Tomobe K, 1998, AM J KIDNEY DIS, V31, P55, DOI 10.1053/ajkd.1998.v31.pm9428452; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; YAMAGUCHI T, 1990, RES COMMUN CHEM PATH, V69, P335; Yamaguchi T, 2015, PROSTAG LEUKOTR ESS, V94, P83, DOI 10.1016/j.plefa.2014.11.009	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155790	10.1371/journal.pone.0155790	http://dx.doi.org/10.1371/journal.pone.0155790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213553	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880200024
J	Mondal, B; Patil, V; Shwetha, SD; Sravani, K; Hegde, AS; Arivazhagan, A; Santosh, V; Kanduri, M; Somasundaram, K				Mondal, B.; Patil, V.; Shwetha, S. D.; Sravani, K.; Hegde, A. S.; Arivazhagan, A.; Santosh, V.; Kanduri, M.; Somasundaram, K.			Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration	ONCOGENE			English	Article							TGF-BETA; DNA METHYLATION; BINDING-PROTEIN; GLIOBLASTOMA; TEMOZOLOMIDE; ACTIVATION; EXPRESSION; PROTEOGLYCANS; RADIOTHERAPY; SURVIVAL	An integrative functional genomics study of multiple forms of data are vital for discovering molecular drivers of cancer development and progression. Here, we present an integrated genomic strategy utilizing DNA methylation and transcriptome profile data to discover epigenetically regulated genes implicated in cancer development and invasive progression. More specifically, this analysis identified fibromodulin (FMOD) as a glioblastoma (GBM) upregulated gene because of the loss of promoter methylation. Secreted FMOD promotes glioma cell migration through its ability to induce filamentous actin stress fiber formation. Treatment with cytochalasin D, an actin polymerization inhibitor, significantly reduced the FMOD-induced glioma cell migration. Small interfering RNA and small molecule inhibitor-based studies identified that FMOD-induced glioma cell migration is dependent on integrin-FAK-Src-Rho-ROCK signaling pathway. FMOD lacking C-terminus LRR11 domain (Delta FMOD), which does not bind collagen type I, failed to induce integrin and promote glioma cell migration. Further, FMOD-induced integrin activation and migration was abrogated by a 9-mer wild-type peptide from the FMOD C-terminus. However, the same peptide with mutation in two residues essential for FMOD interaction with collagen type I failed to compete with FMOD, thus signifying the importance of collagen type IFMOD interaction in integrin activation. Chromatin immunoprecipitation-PCR experiments revealed that transforming growth factor beta-1 (TGF-beta 1) regulates FMOD expression through epigenetic remodeling of FMOD promoter that involved demethylation and gain of active histone marks with a simultaneous loss of DNMT3A and EZH2 occupancy, but enrichment of Sma- and Mad related protein-2 (SMAD2) and CBP. FMOD silencing inhibited the TGF-beta 1-mediated glioma cell migration significantly. In univariate and multivariate Cox regression analysis, both FMOD promoter methylation and transcript levels predicted prognosis in GBM. Thus, this study identified several epigenetically regulated alterations responsible for cancer development and progression. Specifically, we found that secreted FMOD as an important regulator of glioma cell migration downstream of TGF-beta 1 pathway and forms a potential basis for therapeutic intervention in GBM.	[Mondal, B.; Patil, V.; Somasundaram, K.] Indian Inst Sci, Dept Microbiol & Cell Biol, CV Raman Ave, Bangalore 560012, Karnataka, India; [Shwetha, S. D.; Sravani, K.; Santosh, V.] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore, Karnataka, India; [Hegde, A. S.] Sri Satya Sai Inst Higher Med Sci, Dept Neurosurg, Bangalore, Karnataka, India; [Arivazhagan, A.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Kanduri, M.] Sahlgrens Univ Hosp, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden	Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Sahlgrenska University Hospital	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, CV Raman Ave, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in	kanduri, meena/AAG-1813-2019; KANDURI, MEENA/AAI-6169-2021	KANDURI, MEENA/0000-0003-2781-4779; Mondal, Baisakhi/0000-0002-8171-4333	DBT, Government of India; IISc	DBT, Government of India(Department of Biotechnology (DBT) India); IISc	The results published here are in whole or part based upon data generated by The Cancer Genome Atlas (TCGA) pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions, which constitute the TCGA research network, can be found at http://cancergenome.nih.gov/. The use of data sets from Institute NC and GSE22866 is acknowledged. IISc NGS facility is acknowledged for methylation and microarray experiments. KS thanks DBT, Government of India for financial support. KS is a JC Bose Fellow of the Department of Science and Technology. BM acknowledges IISc for the fellowship.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Au SLK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068226; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Beiko J, 2014, NEURO-ONCOLOGY, V16, P81, DOI 10.1093/neuonc/not159; Bevilacqua MA, 2005, J BIOL CHEM, V280, P31809, DOI 10.1074/jbc.M414677200; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Chopra S, 2015, EXP CELL RES, V334, P246, DOI 10.1016/j.yexcr.2015.03.001; Choudhury A, 2010, BRIT J HAEMATOL, V151, P327, DOI 10.1111/j.1365-2141.2010.08362.x; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Fernandez AF, 2012, TRENDS GENET, V28, P474, DOI 10.1016/j.tig.2012.05.006; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Lin LC, 2014, CLIN EXP METASTAS, V31, P881, DOI 10.1007/s10585-014-9677-y; Lu Y, 2011, ONCOL REP, V25, P1329, DOI 10.3892/or.2011.1195; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Mayr C, 2005, BLOOD, V105, P1566, DOI 10.1182/blood-2004-04-1233; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Ridley AJ, 2001, J CELL SCI, V114, P2713; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Scherer HJ, 1940, J NEUROL PSYCHIATRY, V3, P147, DOI 10.1136/jnnp.3.2.147; Shukla S, 2014, CURR SCI INDIA, V107, P815; Shukla S, 2013, CANCER RES, V73, P6563, DOI 10.1158/0008-5472.CAN-13-0298; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Zheng Z, 2011, J INVEST DERMATOL, V131, P769, DOI 10.1038/jid.2010.381	49	24	25	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					71	83		10.1038/onc.2016.176	http://dx.doi.org/10.1038/onc.2016.176			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27212030				2022-12-26	WOS:000394069100007
J	Huang, XP; Ludke, A; Dhingra, S; Guo, J; Sun, Z; Zhang, L; Weisel, RD; Li, RK				Huang, Xi-Ping; Ludke, Ana; Dhingra, Sanjiv; Guo, Jian; Sun, Zhuo; Zhang, Li; Weisel, Richard D.; Li, Ren-Ke			Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart	FASEB JOURNAL			English	Article						myocardial infarction; cell therapy; immune privilege	POSEIDON RANDOMIZED-TRIAL; INTERFERON-GAMMA; TRANSENDOCARDIAL INJECTION; CARDIAC REPAIR; THERAPY; CIITA; ENGRAFTMENT; CHALLENGES; DELIVERY; DISEASE	This study was performed to investigate how to overcome immunorejection associated with allogeneic stem cell therapy in the infarcted heart. Allogeneic bone marrow mesenchymal stem cell (MSC) differentiation increases major histocompatibility complex II (MHC II) expression, inducing transition from immunoprivileged to immunogenic phenotype. MHC II expression is regulated by the class II transactivator (CIITA). We isolated and characterized mouse and human MSCs and knocked down CIITA expression. Wild-type (WT) or CIITA-knockout (CIITA(-)) mouse MSCs were implanted into infarcted mouse myocardia, and recipient allo-antibody formation, cell survival, and cardiac function were measured. WT mouse and human MSCs that were myogenically differentiated showed increased MHC II and CIITA expression. Differentiated CIITA(-) MSCs lacked MHC II induction and showed reduced cytotoxicity in allogeneic leukocyte coculture. Differentiation of human MSCs increased MHC II expression, which resulted in cytotoxicity in allogeneic leukocyte coculture and was prevented by CIITA small interfering RNA. In contrast to WT MSCs, CIITA(-) MSCs did not initiate recipient allo-antibody formation and instead survived in the injured myocardium and significantly improved ventricular function. Decreasing CIITA expression in allogeneic MSCs abolished MHC II induction during myogenic differentiation and prevented immunorejection of these cells from the infarcted myocardium, which enhanced beneficial functional effects of MSC implantation on myocardial repair.Huang, X.-P., Ludke, A., Dhingra, S., Guo, J., Sun, Z., Zhang, L., Weisel, R. D., Li, R.-K. Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart.	[Huang, Xi-Ping; Ludke, Ana; Guo, Jian; Sun, Zhuo; Weisel, Richard D.; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada; [Dhingra, Sanjiv] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Zhang, Li] Univ Toronto, Dept Pathobiol & Immunol, Toronto, ON, Canada; [Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Dept Surg, Div Cardiac Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Manitoba; University of Toronto; University of Toronto	Li, RK (corresponding author), MaRS Ctr, Toronto Med Discovery Tower,Room 3-702, Toronto, ON M5G 1L7, Canada.	renkeli@uhnres.utoronto.ca	Dhingra, Sanjiv/D-8766-2014	Dhingra, Sanjiv/0000-0002-2664-7633; Li, Ren-Ke/0000-0002-2584-060X	Canadian Institutes of Health Research [332652]; Heart and Stroke Foundation of Canada Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada Fellowship Award(Heart & Stroke Foundation of Canada)	The authors thank Dr. Leigh Botly (Department of Cardiovascular Surgery, Toronto General Research Institute, University Health Network) for help with manuscript preparation and editing. This study was supported by the Canadian Institutes of Health Research (Foundation Grant 332652 to R.-K.L.). A.L. is supported by a Heart and Stroke Foundation of Canada Fellowship Award. R.-K.L. holds a Canada Research Chair in Cardiac Regeneration. Author contributions: X.-P. Huang and A. Ludke designed and performed research, analyzed data and wrote the paper; S. Dhingra, J. Guo and Z. Sun performed research; L. Zhang contributed to data analysis and interpretation; and R. D. Weisel and R.-K. Li designed research and wrote the paper. The authors declare no conflicts of interest.	Alagesan S, 2014, CURR OPIN ORGAN TRAN, V19, P65, DOI 10.1097/MOT.0000000000000043; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Brickey WJ, 2002, TRANSPLANTATION, V74, P1341, DOI 10.1097/00007890-200211150-00024; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; Cimini M, 2007, CIRCULATION, V116, pI77, DOI 10.1161/CIRCULATIONAHA.107.708107; Dhingra S, 2010, TRENDS CARDIOVAS MED, V20, P263, DOI 10.1016/j.tcm.2011.12.002; Grinnemo KH, 2004, J THORAC CARDIOV SUR, V127, P1293, DOI 10.1016/j.jtcvs.2003.07.037; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Karantalis V, 2015, CIRC RES, V116, P1413, DOI 10.1161/CIRCRESAHA.116.303614; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Li SH, 2009, J THORAC CARDIOV SUR, V137, P1225, DOI 10.1016/j.jtcvs.2008.11.001; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; McDevitt HO, 1998, CURR OPIN IMMUNOL, V10, P677, DOI 10.1016/S0952-7915(98)80088-5; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Pearl JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005090; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Satoh A, 2004, ONCOGENE, V23, P8876, DOI 10.1038/sj.onc.1208144; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Suncion VY, 2014, CIRC RES, V114, P1292, DOI 10.1161/CIRCRESAHA.114.302854; VADDI K, 1994, CIRCULATION, V90, P694, DOI 10.1161/01.CIR.90.2.694; Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005	26	21	22	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3069	3082		10.1096/fj.201600331R	http://dx.doi.org/10.1096/fj.201600331R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27221978				2022-12-26	WOS:000382816300007
J	Hayes, JB; Sircy, LM; Heusinkveld, LE; Ding, WD; Leander, RN; McClelland, EE; Nelson, DE				Hayes, James B.; Sircy, Linda M.; Heusinkveld, Lauren E.; Ding, Wandi; Leander, Rachel N.; McClelland, Erin E.; Nelson, David E.			Modulation of Macrophage Inflammatory Nuclear Factor kappa B (NF-kappa B) Signaling by Intracellular Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; DEPENDENT TRANSCRIPTION; PULMONARY INFECTION; INDUCED DEGRADATION; POLYSACCHARIDE; CAPSULE; GLUCURONOXYLOMANNAN; MITOCHONDRIAL	Cryptococcus neoformans (Cn) is a common facultative intracellular pathogen that can cause life-threatening fungal meningitis in immunocompromised individuals. Shortly after infection, Cn is detectable as both extra-and intracellular yeast particles, with Cn being capable of establishing long-lasting latent infections within host macrophages. Although recent studies have shown that shed capsular polysaccharides and intact extracellular Cn can compromise macrophage function through modulation of NF-kappa B signaling, it is currently unclear whether intracellular Cn also affects NF-kappa B signaling. Utilizing live cell imaging and computational modeling, we find that extra-and intracellular Cn support distinct modes of NF-kappa B signaling in cultured murine macrophages. Specifically, in RAW 264.7 murine macrophages treated with extracellular glucuronoxylomannan (GXM), the major Cn capsular polysaccharide, LPS-induced nuclear translocation of p65 is inhibited, whereas in cells with intracellular Cn, LPS-induced nuclear translocation of p65 is both amplified and sustained. Mathematical simulations and quantification of nascent protein expression indicate that this is a possible consequence of Cn-induced "translational interference," impeding I kappa B alpha resynthesis. We also show that long term Cn infection induces stable nuclear localization of p65 and I kappa B alpha proteins in the absence of additional proinflammatory stimuli. In this case, nuclear localization of p65 is not accompanied by TNF alpha or inducible NOS (iNOS) expression. These results demonstrate that capsular polysaccharides and intact intracellular yeast manipulate NF-kappa B via multiple distinct mechanisms and provide new insights into how Cn might modulate cellular signaling at different stages of an infection.	[Hayes, James B.; Sircy, Linda M.; Heusinkveld, Lauren E.; McClelland, Erin E.; Nelson, David E.] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37130 USA; [Ding, Wandi; Leander, Rachel N.] Middle Tennessee State Univ, Dept Math Sci, Murfreesboro, TN 37130 USA	Middle Tennessee State University; Middle Tennessee State University	McClelland, EE; Nelson, DE (corresponding author), Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37130 USA.	erin.mcclelland@mtsu.edu; david.e.nelson@mtsu.edu		Sircy, Linda/0000-0003-3335-9258; Ding, Wandi/0000-0002-2031-9700; Nelson, David/0000-0002-5034-0885	Middle Tennessee State University; Middle Tennessee State University Faculty Research and Creative Committee (FRCAC); Middle Tennessee State University Foundation; Middle Tennessee State University Undergraduate Research Center (URECA); Sigma Xi Grants-in-Aid of Research Program (GIAR)	Middle Tennessee State University; Middle Tennessee State University Faculty Research and Creative Committee (FRCAC); Middle Tennessee State University Foundation; Middle Tennessee State University Undergraduate Research Center (URECA); Sigma Xi Grants-in-Aid of Research Program (GIAR)	This work was supported by start-up funds from Middle Tennessee State University (to D. E. N. and E. E. M.), by Middle Tennessee State University Faculty Research and Creative Committee (FRCAC) and the Middle Tennessee State University Foundation (Special Projects) funds (to D. E. N.), and scholarships from Middle Tennessee State University Undergraduate Research Center (URECA) and Sigma Xi Grants-in-Aid of Research Program (GIAR) (to L. E. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Ben-Abdallah M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002555; Bergqvist S, 2009, P NATL ACAD SCI USA, V106, P19328, DOI 10.1073/pnas.0908797106; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; CHERNIAK R, 1982, CARBOHYD RES, V103, P239, DOI 10.1016/S0008-6215(00)80686-2; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; Coelho C, 2015, J IMMUNOL, V194, P2345, DOI 10.4049/jimmunol.1402350; Coelho C, 2014, ANNU REV PATHOL-MECH, V9, P219, DOI 10.1146/annurev-pathol-012513-104653; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Dalloneau E, 2011, J IMMUNOL, V187, P4826, DOI 10.4049/jimmunol.1101087; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; FROMTLING RA, 1982, MYCOPATHOLOGIA, V79, P23, DOI 10.1007/BF00636177; Ganesh L, 2006, MOL CELL BIOL, V26, P3864, DOI 10.1128/MCB.26.10.3864-3874.2006; Garcia-Rivera J, 2004, EUKARYOT CELL, V3, P385, DOI 10.1128/EC.3.2.385-392.2004; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Monari C, 2005, J INFECT DIS, V191, P127, DOI 10.1086/426511; Moreira D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004684; Morris KR, 2003, INFECT IMMUN, V71, P1442, DOI 10.1128/IAI.71.3.1442-1452.2003; Moyrand F, 2008, EUKARYOT CELL, V7, P2069, DOI 10.1128/EC.00189-08; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Nelson DE, 2004, BIOCHEM SOC T, V32, P1090; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ohshima D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046911; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Piccioni M, 2013, INFECT IMMUN, V81, P90, DOI 10.1128/IAI.00553-12; POWDERLY WG, 1994, CLIN INFECT DIS, V18, P789, DOI 10.1093/clinids/18.5.789; Rajasingham R, 2014, EMERG INFECT DIS, V20, P722, DOI 10.3201/eid2004.131277; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Sung MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004764; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Vecchiarelli A, 2013, FUTURE MICROBIOL, V8, P1107, DOI 10.2217/fmb.13.84; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; Williams RA, 2014, COMPUTATION, V2, P131, DOI 10.3390/computation2040131; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	59	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15614	15627		10.1074/jbc.M116.738187	http://dx.doi.org/10.1074/jbc.M116.738187			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231343	Green Published, hybrid			2022-12-26	WOS:000380584200017
J	Ou, Y; Chan, G; Zuo, J; Rattner, JB; van der Hoorn, FA				Ou, Young; Chan, Gordon; Zuo, Jeremy; Rattner, Jerome B.; van der Hoorn, Frans A.			Purinergic A2b Receptor Activation by Extracellular Cues Affects Positioning of the Centrosome and Nucleus and Causes Reduced Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A(2B) ADENOSINE RECEPTORS; ACUTE LUNG INJURY; NEURONAL MIGRATION; EXCHANGE FACTOR; DROSOPHILA EYE; SUBCELLULAR-LOCALIZATION; NERVOUS-SYSTEM; CYCLIC-AMP; DYNEIN; RAP1B	The tight, relative positioning of the nucleus and centrosome in mammalian cells is important for the regulation of cell migration. Under pathophysiological conditions, the purinergic A2b receptor can regulate cell motility, but the underlying mechanism remains unknown. Expression of A2b, normally low, is increased in tissues experiencing adverse physiological conditions, including hypoxia and inflammation. ATP is released from such cells. We investigated whether extracellular cues can regulate centrosome-nucleus positioning and cell migration. We discovered that hypoxia as well as extracellular ATP cause a reversible increase in the distance between the centrosome and nucleus and reduced cell motility. We uncovered the underlying pathway: both treatments act through the A2b receptor and specifically activate the Epac1/RapGef3 pathway. We show that cells lacking A2b do not respond in this manner to hypoxia or ATP but transfection of A2b restores this response, that Epac1 is critically involved, and that Rap1B is important for the relative positioning of the centrosome and nucleus. Our results represent, to our knowledge, the first report demonstrating that pathophysiological conditions can impact the distance between the centrosome and nucleus. Furthermore, we identify the A2b receptor as a central player in this process.	[Ou, Young; Zuo, Jeremy; van der Hoorn, Frans A.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Rattner, Jerome B.] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Chan, Gordon] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Chan, Gordon] Univ Alberta, Canc Res Inst Northern Alberta, Edmonton, AB T6G 1Z2, Canada	University of Calgary; University of Calgary; University of Alberta; University of Alberta	van der Hoorn, FA (corresponding author), Cumming Sch Med, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	fvdhoorn@ucalgary.ca	Chan, Gordon/AAN-7784-2020	Chan, Gordon/0000-0003-0497-9407	Canadian Institutes of Health Research Grant [MOP 111008]; Alberta Innovates - Health Solutions	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions	This work was supported by Canadian Institutes of Health Research Grant MOP 111008 (to F. A. V. D. H.) and a summer studentship from Alberta Innovates - Health Solutions (to J. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Agircan FG, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0461; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Archambault V, 2012, CELL CYCLE, V11, P1490, DOI 10.4161/cc.19724; Awasthi A, 2010, J EXP MED, V207, P1923, DOI 10.1084/jem.20100040; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brock TG, 2008, EXP CELL RES, V314, P255, DOI 10.1016/j.yexcr.2007.10.011; Brugerolle G, 2003, PROTOPLASMA, V222, P13, DOI 10.1007/s00709-003-0016-4; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Burakov AV, 2013, CELL BIOL INT, V37, P95, DOI 10.1002/cbin.10016; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Chouker A, 2012, TRANSPLANTATION, V94, P894, DOI 10.1097/TP.0b013e31826a9a46; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dobyns W B, 1987, Birth Defects Orig Artic Ser, V23, P225; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Edwards HV, 2012, SEMIN CELL DEV BIOL, V23, P181, DOI 10.1016/j.semcdb.2011.09.005; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fitzgerald C, 2006, J BIOL CHEM, V281, P38172, DOI 10.1074/jbc.M606010200; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Gloerich M, 2011, J CELL BIOL, V193, P1009, DOI 10.1083/jcb.201011126; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; Gupta M, 2005, J BIOL CHEM, V280, P8109, DOI 10.1074/jbc.M413697200; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jodoin JN, 2012, MOL BIOL CELL, V23, P4713, DOI 10.1091/mbc.E12-07-0558; Kim YC, 2000, J MED CHEM, V43, P1165, DOI 10.1021/jm990421v; KLINZ FJ, 1992, EUR J BIOCHEM, V207, P207, DOI 10.1111/j.1432-1033.1992.tb17039.x; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Li AH, 1998, J MED CHEM, V41, P3186, DOI 10.1021/jm980093j; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin KT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6917; Luxton GWG, 2011, CURR OPIN CELL BIOL, V23, P579, DOI 10.1016/j.ceb.2011.08.001; Luxton GWG, 2011, NUCLEUS-PHILA, V2, P173, DOI [10.4161/nucl.2.3.16243, 10.1073/pnas.1000824108]; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; Melani A, 2012, EXP NEUROL, V233, P193, DOI 10.1016/j.expneurol.2011.09.036; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Muller CE, 1998, BIOORGAN MED CHEM, V6, P707, DOI 10.1016/S0968-0896(98)00025-X; Nakagawa S, 2014, AM J PHYSIOL-RENAL, V307, pF1404, DOI 10.1152/ajprenal.00196.2014; Ntantie E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003374; Ou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048773; Ou YY, 2002, J CELL SCI, V115, P1825; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; SNYDER M, 1994, CHROMOSOMA, V103, P369, DOI 10.1007/BF00362281; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Steininger TS, 2011, BRAIN RES, V1407, P1, DOI 10.1016/j.brainres.2011.06.050; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; TOMLINSON A, 1986, SCIENCE, V231, P400, DOI 10.1126/science.231.4736.400; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; van Hooren KWEM, 2012, J BIOL CHEM, V287, P24713, DOI 10.1074/jbc.M111.321976; Wakai A, 2001, SHOCK, V15, P297, DOI 10.1097/00024382-200115040-00008; Weyler S, 2006, CHEMMEDCHEM, V1, P891, DOI 10.1002/200600066; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wittchen Erika S, 2011, Small GTPases, V2, P65; Xaus J, 1999, J IMMUNOL, V162, P3607; Yamada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3033; Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Yang Y, 2015, ONCOL REP, V34, P2385, DOI 10.3892/or.2015.4234; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhu J, 2010, MOL BIOL CELL, V21, P4418, DOI 10.1091/mbc.E10-07-0627; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398	90	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15388	15403		10.1074/jbc.M116.721241	http://dx.doi.org/10.1074/jbc.M116.721241			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226580	Green Published, hybrid			2022-12-26	WOS:000380583200042
J	Gross, SM; Rotwein, P				Gross, Sean M.; Rotwein, Peter			Unraveling Growth Factor Signaling and Cell Cycle Progression in Individual Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; cell proliferation; cell signaling; growth factor; signal transduction	RESTRICTION POINT; NEGATIVE REGULATORS; DNA-SYNTHESIS; PROLIFERATION; DYNAMICS; RECEPTOR; DISTINCT; INSULIN; PROTEIN; PHASES	Cultured cells require the actions of growth factors to enter the cell cycle, but how individual members of a population respond to the same stimulus remains unknown. Here we have employed continuous monitoring by live cell imaging in a dual-reporter cell model to investigate the regulation of short-term growth factor signaling (protein kinase B (PKB/Akt) activity) and longer-term progression through the cell cycle (cyclin-dependent kinase 2 activity). In the total population, insulin-like growth factor-I (IGF-I)-enhanced cell cycle entry by >5-fold compared with serum-free medium (from 13.5 to 78%), but at the single cell level we observed a broad distribution in the timing of G1 exit (4-24 h, mean approximate to 12 h) that did not vary with either the amount or duration of IGF-I treatment. Cells that failed to re-enter the cell cycle exhibited similar responses to IGF-I in terms of integrated Akt activity and migration distance compared with those that did. We made similar observations with EGF, PDGF-AA, and PDGF-BB. As potential thresholds of growth factor-mediated cell cycle progression appeared to be heterogeneous within the population, the longer-term proliferative outcomes of individual cells to growth factor stimulation could not be predicted based solely on acute Akt signaling responses, no matter how robust these might be. Thus, although we could define a relationship at the population level between growth factor-induced Akt signaling dynamics and cell cycle progression, we could not predict the fate of individual cells.	[Gross, Sean M.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Rotwein, Peter] Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [R01 DK042748-26]; NATIONAL CANCER INSTITUTE [T32CA106195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health research grant, R01 DK042748-26 (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barr AR, 2016, CELL SYST, V2, P27, DOI 10.1016/j.cels.2016.01.001; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gross SM, 2016, J CELL SCI, V129, P2052, DOI 10.1242/jcs.183764; Gross SM, 2015, J CELL SCI, V128, P2509, DOI 10.1242/jcs.168773; Gross SM, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-10; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Jones SM, 2001, FEBS LETT, V490, P110, DOI 10.1016/S0014-5793(01)02113-5; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; PLEDGER WJ, 1978, P NATL ACAD SCI USA, V75, P2839, DOI 10.1073/pnas.75.6.2839; PLEDGER WJ, 1977, P NATL ACAD SCI USA, V74, P4481, DOI 10.1073/pnas.74.10.4481; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yuan X, 2014, MOL BIOL CELL, V25, P441, DOI 10.1091/mbc.E13-08-0480; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	30	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14628	14638		10.1074/jbc.M116.734194	http://dx.doi.org/10.1074/jbc.M116.734194			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226630	Green Published, hybrid			2022-12-26	WOS:000380366700019
J	Knyphausen, P; de Boor, S; Kuhlmann, N; Scislowski, L; Extra, A; Baldus, L; Schacherl, M; Baumann, U; Neundorf, I; Lammers, M				Knyphausen, Philipp; de Boor, Susanne; Kuhlmann, Nora; Scislowski, Lukas; Extra, Antje; Baldus, Linda; Schacherl, Magdalena; Baumann, Ulrich; Neundorf, Ines; Lammers, Michael			Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; GTPase; p53; sirtuin; synthetic biology	STRUCTURAL BASIS; SIRT3-MEDIATED DEACETYLATION; HISTONE DEACETYLASES; STRUCTURE VALIDATION; COREPRESSOR COMPLEX; DIFFRACTION DATA; TRANSGENIC MICE; DRUG TARGET; DNA-BINDING; ADP-RIBOSE	Sirtuins are NAD(+)-dependent lysine deacylases, regulating a variety of cellular processes. The nuclear Sirt1, the cytosolic Sirt2, and the mitochondrial Sirt3 are robust deacetylases, whereas the other sirtuins have preferences for longer acyl chains. Most previous studies investigated sirtuin-catalyzed deacylation on peptide substrates only. We used the genetic code expansion concept to produce natively folded, site-specific, and lysine-acetylated Sirt1-3 substrate proteins, namely Ras-related nuclear, p53, PEPCK1, superoxide dismutase, cyclophilin D, and Hsp10, and analyzed the deacetylation reaction. Some acetylated proteins such as Ras-related nuclear, p53, and Hsp10 were robustly deacetylated by Sirt1-3. However, other reported sirtuin substrate proteins such as cyclophilin D, superoxide dismutase, and PEPCK1 were not deacetylated. Using a structural and functional approach, we describe the ability of Sirt1-3 to deacetylate two adjacent acetylated lysine residues. The dynamics of this process have implications for the lifetime of acetyl modifications on di-lysine acetylation sites and thus constitute a new mechanism for the regulation of proteins by acetylation. Our studies support that, besides the primary sequence context, the protein structure is a major determinant of sirtuin substrate specificity.	[Knyphausen, Philipp; de Boor, Susanne; Kuhlmann, Nora; Scislowski, Lukas; Extra, Antje; Baldus, Linda; Lammers, Michael] Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Knyphausen, Philipp; de Boor, Susanne; Kuhlmann, Nora; Scislowski, Lukas; Extra, Antje; Baldus, Linda; Lammers, Michael] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Schacherl, Magdalena; Baumann, Ulrich; Neundorf, Ines] Univ Cologne, Inst Biochem, Zulpicher Str 47b, D-50674 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Lammers, M (corresponding author), Univ Cologne, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Lammers, M (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.	michael.lammers@uni-koeln.de	Baumann, Ulrich/B-1220-2013; Schacherl, Magdalena/AAT-6362-2021; Schacherl, Magdalena/M-1590-2014; Lammers, Michael/AAX-1164-2020	Schacherl, Magdalena/0000-0002-5478-2509; Schacherl, Magdalena/0000-0002-5478-2509; Lammers, Michael/0000-0003-4168-4640; Neundorf, Ines/0000-0001-6450-3991	Emmy Noether Programme of the German Research Foundation (Deutsche Forschungsgemeinschaft) [LA2984-1/1]; European Community [283570]; International Graduate School in Development Health and Disease	Emmy Noether Programme of the German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); European Community(European Commission); International Graduate School in Development Health and Disease	This work was supported in part by Emmy Noether Programme of the German Research Foundation (Deutsche Forschungsgemeinschaft) Grant LA2984-1/1 and by European Community's Seventh Framework Programme FP7/2007-2013b by Grant 283570 (BioStruct-X). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the International Graduate School in Development Health and Disease.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Anderson G, 2014, MOL NEUROBIOL, V49, P771, DOI 10.1007/s12035-013-8554-z; Arbely E, 2011, P NATL ACAD SCI USA, V108, P8251, DOI 10.1073/pnas.1105028108; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baur JA, 2010, SCIENCE, V329, P1012, DOI 10.1126/science.329.5995.1012; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Braidy N, 2012, CURR OPIN PSYCHIATR, V25, P226, DOI 10.1097/YCO.0b013e32835112c1; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Case CL, 2007, BBA-GEN SUBJECTS, V1770, P1576, DOI 10.1016/j.bbagen.2007.07.012; Chakraborty C, 2013, CURR DRUG TARGETS, V14, P666, DOI 10.2174/1389450111314060008; Chalkiadaki A, 2015, NAT REV CANCER, V15, DOI 10.1038/nrc3985; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Boor S, 2015, P NATL ACAD SCI USA, V112, pE3679, DOI 10.1073/pnas.1505995112; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denu JM, 2012, J BIOL CHEM, V287, P42417, DOI 10.1074/jbc.R112.428862; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Dittenhafer-Reed KE, 2011, CHEMBIOCHEM, V12, P281, DOI 10.1002/cbic.201000434; Donadini A, 2013, CURR DRUG TARGETS, V14, P653, DOI 10.2174/1389450111314060006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Frazzi R, 2013, INT J CANCER, V132, P1013, DOI 10.1002/ijc.27748; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Nguyen GTT, 2013, ACTA CRYSTALLOGR D, V69, P1423, DOI 10.1107/S0907444913015448; Gnad F, 2010, BIOINFORMATICS, V26, P1666, DOI 10.1093/bioinformatics/btq260; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2012, NAT REV MOL CELL BIO, V13, P207, DOI 10.1038/nrm3308; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hirsch BM, 2011, MOL BIOSYST, V7, P16, DOI 10.1039/c0mb00033g; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; IVY JM, 1986, MOL CELL BIOL, V6, P688, DOI 10.1128/MCB.6.2.688; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Khan AN, 2005, J BIOL CHEM, V280, P36073, DOI 10.1074/jbc.M508247200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Knyphausen Philipp, 2015, Small GTPases, V6, P189, DOI 10.1080/21541248.2015.1103399; Kuhlmann N, 2016, J BIOL CHEM, V291, P5484, DOI 10.1074/jbc.M115.707091; Kuhlmann N, 2016, BIOCHEMISTRY-US, V55, P304, DOI 10.1021/acs.biochem.5b01242; Landry SJ, 1997, BIOCHEMISTRY-US, V36, P10975, DOI 10.1021/bi971141p; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lu ZP, 2015, J BIOL CHEM, V290, P2466, DOI 10.1074/jbc.M114.606228; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Montgomery DC, 2014, J AM CHEM SOC, V136, P8669, DOI 10.1021/ja502372j; Morimoto J, 2012, ANGEW CHEM INT EDIT, V51, P3423, DOI 10.1002/anie.201108118; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakagawa Takashi, 2014, Cell Metab, V20, P192, DOI 10.1016/j.cmet.2014.06.001; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Reed SM, 2015, CANCERS, V7, P30, DOI 10.3390/cancers7010030; RINE J, 1987, GENETICS, V116, P9; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Simic Z, 2015, CHEMBIOCHEM, V16, P2337, DOI 10.1002/cbic.201500364; Sinclair DA, 2014, ANNU REV PHARMACOL, V54, P363, DOI 10.1146/annurev-pharmtox-010611-134657; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Smith BC, 2006, STRUCTURE, V14, P1207, DOI 10.1016/j.str.2006.07.004; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Suzuki T, 2009, BIOORG MED CHEM LETT, V19, P5670, DOI 10.1016/j.bmcl.2009.08.028; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Winnik S, 2015, EUR HEART J, V36, P3404, DOI 10.1093/eurheartj/ehv290; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yang T, 2012, J BIOL CHEM, V287, P40279, DOI 10.1074/jbc.M112.349704; Yuan H, 2012, J BIOL CHEM, V287, P42428, DOI 10.1074/jbc.R112.372300; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang ZN, 2014, STEM CELLS, V32, P157, DOI 10.1002/stem.1532; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016	110	31	33	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14677	14694		10.1074/jbc.M116.726307	http://dx.doi.org/10.1074/jbc.M116.726307			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226597	Green Published, hybrid			2022-12-26	WOS:000380366700022
J	Linde, M; Peterhoff, D; Sterner, R; Babinger, P				Linde, Mona; Peterhoff, David; Sterner, Reinhard; Babinger, Patrick			Identification and Characterization of Heptaprenylglyceryl Phosphate Processing Enzymes in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetyltransferase; enzyme; lipid ether; phosphatase; maltose	ESCHERICHIA-COLI; ACYL MIGRATION; SUBSTRATE-SPECIFICITY; BIOSYNTHESIS; ARCHAEA; BACTERIA; MALTOSE; ACETYLTRANSFERASE; ACYLTRANSFERASES; TRANSACETYLASE	In Archaea, ether lipids play an essential role as the main building blocks of the cellular membrane. Recently, ether lipids have also been discovered in the domain of Bacteria, and the key enzymes that catalyze their synthesis, glycerol-1-phosphate dehydrogenase and heptaprenylglyceryl phosphate synthase, have been described. In Bacillales, heptaprenylglyceryl phosphate does not become linked to a second polyprenyl moiety like ether lipids in Archaea but is dephosphorylated and acetylated. Here, we report on the enzymes that catalyze these reactions. We enriched the phosphatase activity from a B. subtilis cell extract and suppose that dephosphorylation is catalyzed by the phosphatase PhoB or by any other phosphatase in an unspecific manner. By screening a B. subtilis knock-out library for deficiency in acetylation, the yvoF gene product was identified to be the acetyltransferase. The acetyl-CoA-dependent enzyme YvoF is a close relative of maltose O-acetyltransferase (MAT). Its catalytic properties were analyzed and compared with MAT. YvoF and MAT partially overlap in substrate and product range in vitro, but MAT is not able to complement the yvoF knock-out in vivo.	[Linde, Mona; Peterhoff, David; Sterner, Reinhard; Babinger, Patrick] Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany; [Peterhoff, David] Univ Regensburg, Inst Med Microbiol & Hyg, D-93042 Regensburg, Germany	University of Regensburg; University of Regensburg	Babinger, P (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.	patrick.babinger@ur.de	Sterner, Reinhard/ABI-6781-2020; Peterhoff, David/ABD-6746-2020	Sterner, Reinhard/0000-0001-8177-8460; Babinger, Patrick/0000-0002-7490-6732	Deutsche Forschungsgemeinschaft [BA 3943/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Research Grant BA 3943/2-1 from the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Fattah WR, 2005, J BACTERIOL, V187, P5166, DOI 10.1128/JB.187.15.5166-5178.2005; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOOS W, 1981, J BACTERIOL, V146, P725, DOI 10.1128/JB.146.2.725-732.1981; BRAND B, 1991, J BIOL CHEM, V266, P14113; Doud EH, 2011, J AM CHEM SOC, V133, P1270, DOI 10.1021/ja109578b; Fischer E, 1920, BER DTSCH CHEM GES, V53, P1621, DOI 10.1002/cber.19200530904; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Guldan H, 2011, ANGEW CHEM INT EDIT, V50, P8188, DOI 10.1002/anie.201101832; HULETT FM, 1991, J BIOL CHEM, V266, P1077; Jain S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00641; Kates M., 1986, TECHNIQUES LIPIDOLOG, V2nd; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KODALI DR, 1990, CHEM PHYS LIPIDS, V52, P163, DOI 10.1016/0009-3084(90)90111-4; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Koga Y, 2011, J MOL EVOL, V72, P274, DOI 10.1007/s00239-011-9428-5; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Lo Leggio L, 2003, BIOCHEMISTRY-US, V42, P5225, DOI 10.1021/bi0271446; Lombard J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/630910; Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815; Lyubachevskaya G, 2000, LIPIDS, V35, P1353, DOI 10.1007/s11745-000-0652-5; Payandeh J, 2007, J MOL EVOL, V64, P364, DOI 10.1007/s00239-006-0141-8; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Peterhoff D, 2014, MOL MICROBIOL, V92, P885, DOI 10.1111/mmi.12596; Peterhoff D, 2012, CHEMBIOCHEM, V13, P1297, DOI 10.1002/cbic.201200127; Ren FF, 2013, CHEMBIOCHEM, V14, P195, DOI 10.1002/cbic.201200748; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Roderick SL, 2005, CR BIOL, V328, P568, DOI 10.1016/j.crvi.2005.03.005; STECK T L, 1973, Journal of Supramolecular Structure, V1, P220, DOI 10.1002/jss.400010307; Turon F, 2003, CHEM PHYS LIPIDS, V125, P41, DOI 10.1016/S0009-3084(03)00069-0; VUORIO R, 1994, FEBS LETT, V337, P289, DOI 10.1016/0014-5793(94)80211-4; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; ZABIN I, 1962, J BIOL CHEM, V237, P253; ZHANG DL, 1993, J AM CHEM SOC, V115, P1270, DOI 10.1021/ja00057a008	36	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14861	14870		10.1074/jbc.M115.711994	http://dx.doi.org/10.1074/jbc.M115.711994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226549	Green Published, hybrid			2022-12-26	WOS:000380366700037
J	Levy, S; Dedeoglu, F; Gaffin, JM; Garvey, KC; Harstad, E; MacGinnitie, A; Rufo, PA; Huang, Q; Ziemnik, RE; Wisk, LE; Weitzman, ER				Levy, Sharon; Dedeoglu, Fatma; Gaffin, Jonathan M.; Garvey, Katharine C.; Harstad, Elizabeth; MacGinnitie, Andrew; Rufo, Paul A.; Huang, Qian; Ziemnik, Rosemary E.; Wisk, Lauren E.; Weitzman, Elissa R.			A Screening Tool for Assessing Alcohol Use Risk among Medically Vulnerable Youth	PLOS ONE			English	Article							ADOLESCENT SUBSTANCE USE; MOTIVATIONAL INTERVENTION; SOCIOECONOMIC-STATUS; COLLEGE-STUDENTS; UNITED-STATES; MARIJUANA USE; DRINKING; HEALTH; PREVALENCE; CHILDREN	Background In an effort to reduce barriers to screening for alcohol use in pediatric primary care, the National Institute on Alcoholism and Alcohol Abuse (NIAAA) developed a two -question Youth Alcohol Screening Tool derived from population-based survey data. It is unknown whether this screening tool, designed for use with general populations, accurately identifies risk among youth with chronic medical conditions (YCMC). This growing population, which comprises nearly one in four youth in the US, faces a unique constellation of drinking-related risks. Method To validate the NIAAA Youth Alcohol Screening Tool in a population of YCMC, we performed a cross-sectional validation study with a sample of 388 youth ages 9-18 years presenting for routine subspecialty care at a large children's hospital for type 1 diabetes, persistent asthma, cystic fibrosis, inflammatory bowel disease, or juvenile idiopathic arthritis. Participants self-administered the NIAAA Youth Alcohol Screening Tool and the Diagnostic Interview Schedule for Children as a criterion standard measure of alcohol use disorders (AUD). Receiver operating curve analysis was used to determine cut points for identifying youth at moderate and highest risk for an AUD. Results Nearly one third of participants (n = 118; 30.4%) reported alcohol use in the past year; 86.4% (106) of past year drinkers did not endorse any AUD criteria, 6.8% (n = 8) of drinkers endorsed a single criterion, and 6.8% of drinkers met criteria for an AUD. Using the NIAAA tool, optimal cut points found to identify youth at moderate and highest risk for an AUD were >= 6 and >= 12 drinking days in the past year, respectively. Conclusions The NIAAA Youth Alcohol Screening Tool is highly efficient for detecting alcohol use and discriminating disordered use among YCMC. This brief screen appears feasible for use in specialty care to ascertain alcohol-related risk that may impact adversely on health status and disease management.	[Levy, Sharon; Huang, Qian; Ziemnik, Rosemary E.] Boston Childrens Hosp, Adolescent Subst Abuse Program, Div Dev Behav Pediat, Boston, MA USA; [Levy, Sharon; Harstad, Elizabeth; Wisk, Lauren E.; Weitzman, Elissa R.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Dedeoglu, Fatma] Boston Childrens Hosp, Rheumatol Program, Div Immunol, Boston, MA USA; [Gaffin, Jonathan M.] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA; [Garvey, Katharine C.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Harstad, Elizabeth] Boston Childrens Hosp, Div Dev Med, Boston, MA USA; [MacGinnitie, Andrew] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Rufo, Paul A.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Wisk, Lauren E.; Weitzman, Elissa R.] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Levy, S (corresponding author), Boston Childrens Hosp, Adolescent Subst Abuse Program, Div Dev Behav Pediat, Boston, MA USA.	Sharon.Levy@childrens.harvard.edu	Wisk, Lauren/H-7392-2019; Rufo, Paul/F-6458-2019; Milford, Bethany/C-4389-2018	GAFFIN, JONATHAN/0000-0003-2213-4504	National Institute on Alcohol Abuse and Alcoholism [1R01AA021913-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI106945] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant #1R01AA021913-01 from The National Institute on Alcohol Abuse and Alcoholism.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson P., 2005, ALCOHOL PRIMARY HLTH; Baer JS, 2001, AM J PUBLIC HEALTH, V91, P1310, DOI 10.2105/AJPH.91.8.1310; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Borsari B, 2000, J CONSULT CLIN PSYCH, V68, P728, DOI 10.1037//0022-006X.68.4.728; BRADY KT, 1993, AM J PSYCHIAT, V150, P1707; Britto MT, 2000, ARCH PEDIAT ADOL MED, V154, P478, DOI 10.1001/archpedi.154.5.478; Chung T, 2012, PEDIATRICS, V129, P205, DOI 10.1542/peds.2011-1828; Crosnoe R, 2006, SOCIOL EDUC, V79, P44, DOI 10.1177/003804070607900103; Gilbert AL, 2014, J ADOLESCENT HEALTH, V55, P672, DOI 10.1016/j.jadohealth.2014.05.016; Goodman E, 2002, ARCH PEDIAT ADOL MED, V156, P448, DOI 10.1001/archpedi.156.5.448; Haller DM, 2014, CAN MED ASS J; Hingson Ralph W, 2004, Traffic Inj Prev, V5, P228, DOI 10.1080/15389580490465256; Kelly SM, 2014, PEDIATRICS, V133, P819, DOI 10.1542/peds.2013-2346; Levy S, 2013, ASS MED ED RES SUBST; Levy S, 2014, JAMA PEDIATR, V168, P822, DOI 10.1001/jamapediatrics.2014.774; Levy S, 2014, CAN MED ASSOC J, V186, P565, DOI 10.1503/cmaj.140303; Miller PM, 2006, ALCOHOL ALCOHOLISM, V41, P306, DOI 10.1093/alcalc/agl022; Miller-Hagan RS, 2002, DIABETES EDUCATOR, V28, P233, DOI 10.1177/014572170202800209; Monti PM, 2007, ADDICTION, V102, P1234, DOI 10.1111/j.1360-0443.2007.01878.x; Murphy DA, 2012, AIDS PATIENT CARE ST, V26, P95, DOI 10.1089/apc.2011.0157; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Institute on Alcohol Abuse and Alcoholism, 2011, RFA AA 12 008 EV NIA; National Institute on Alcohol Abuse and Alcoholism, 2011, NIH PUBLICATION; Neighbors CJ, 2010, J STUD ALCOHOL DRUGS, V71, P384, DOI 10.15288/jsad.2010.71.384; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Perrin JM, 2014, HEALTH AFFAIR, V33, P2099, DOI 10.1377/hlthaff.2014.0832; Rodriguez RN, 2011, WIRES COMPUT STAT, V3, P1, DOI 10.1002/wics.131; Sawyer SM, 2007, LANCET, V369, P1481, DOI 10.1016/S0140-6736(07)60370-5; Schilling EA, 2009, J ADOLESCENT HEALTH, V44, P335, DOI 10.1016/j.jadohealth.2008.08.006; Shaffer D, 2007, DIAGNOSTIC INTERVIEW; Shrier LA, 2014, ADDICT BEHAV, V39, P173, DOI 10.1016/j.addbeh.2013.09.028; Stern SA, 2007, J SUBST ABUSE TREAT, V32, P153, DOI 10.1016/j.jsat.2006.07.009; Tait RJ, 2004, DRUG ALCOHOL DEPEN, V74, P289, DOI 10.1016/j.drugalcdep.2004.01.003; Van Cleave J, 2010, JAMA-J AM MED ASSOC, V303, P623, DOI 10.1001/jama.2010.104; Weitzman ER, 2015, PEDIATRICS, V136, P450, DOI 10.1542/peds.2015-0722; Williams JF, 2011, PEDIATRICS, V128, pE1330, DOI 10.1542/peds.2011-1754; Wilson CR, 2004, PEDIATRICS, V114, pE536, DOI 10.1542/peds.2004-0098; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Winters KC, 2007, PSYCHOL ADDICT BEHAV, V21, P249, DOI 10.1037/0893-164X.21.2.249; Young A, 2008, J STUD ALCOHOL DRUGS, V69, P39, DOI 10.15288/jsad.2008.69.39	43	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156240	10.1371/journal.pone.0156240	http://dx.doi.org/10.1371/journal.pone.0156240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227975	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500090
J	Priviero, FBM; Toque, HAF; Nunes, KP; Priolli, DG; Teixeira, CE; Webb, RC				Priviero, Fernanda B. M.; Toque, Haroldo A. F.; Nunes, Kenia Pedrosa; Priolli, Denise G.; Teixeira, Cleber E.; Webb, R. Clinton			Impaired Corpus Cavernosum Relaxation Is Accompanied by Increased Oxidative Stress and Up-Regulation of the Rho-Kinase Pathway in Diabetic (Db/Db) Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; NITRIC-OXIDE SYNTHASE; ERECTILE DYSFUNCTION; PENILE ERECTION; RHOA/RHO-KINASE; RAT MODEL; NAD(P)H OXIDASE; NERVE INJURY; SUPEROXIDE; INHIBITION	Basal release of nitric oxide from endothelial cells modulates contractile activity in the corpus cavernosum via inhibition of the RhoA/Rho-kinase signaling pathway. We aimed to investigate nitric oxide bioavailability, oxidative stress and the Rho-kinase pathway in the relaxation of the corpus cavernosum of an obese and diabetic model of mice (db/db mice). We hypothesized that in db/db mice impaired relaxation induced by Rho-kinase inhibitor is accompanied by diminished NO bioavailability, increased oxidative stress and upregulation of the RhoA/Rho-kinase signalling pathway. Cavernosal strips from male lean and non-diabetic db/+ and db/db mice were mounted in myographs and isometric force in response to Rho-kinase inhibitor Y-27632 was recorded. Enzyme activity and protein expression of oxidative stress markers and key molecules of the RhoA/Rho-kinase pathway were analyzed. The Rho-kinase inhibitor Y-27632 concentration-dependently caused corpus cavernosum relaxation and inhibited cavernosal contractions. Nonetheless, a rightward shift in the curves obtained in corpus cavernosum of db/db mice was observed. Compared to db/+, this strain presented increased active RhoA, higher MYPT-1 phosphorylation stimulated by phenylephrine, and increased expression of ROK alpha and Rho-GEFs. Further, we observed normal expression of endothelial and neuronal NOS in corpus cavernosum of db/db mice. However, nitrate/nitrate (NOx) levels were diminished, suggesting decreased NO bioavailability. We measured the oxidant status and observed increased lipid peroxidation, with decreased SOD activity and expression. In conclusion, our data demonstrate that in db/db mice, upregulation of the RhoA/Rho-kinase signalling pathway was accompanied by decreased NO bioavailability and increased oxidative stress contributing to impaired relaxation of the corpus cavermosum of db/db mice.	[Priviero, Fernanda B. M.; Priolli, Denise G.] Univ Sao Francisco, Lab Multidisciplinary Res, Sao Paulo, Brazil; [Toque, Haroldo A. F.] Augusta Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Nunes, Kenia Pedrosa] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Teixeira, Cleber E.; Webb, R. Clinton] Augusta Univ, Dept Physiol, Augusta, GA USA	Universidade Sao Francisco; University System of Georgia; Augusta University; Florida Institute of Technology; University System of Georgia; Augusta University	Priviero, FBM (corresponding author), Univ Sao Francisco, Lab Multidisciplinary Res, Sao Paulo, Brazil.	fernanda.bmp@gmail.com	Priolli, Denise/C-4490-2012; Priviero, Fernanda/E-2193-2012	Priolli, Denise/0000-0003-3190-4013; Priviero, Fernanda/0000-0002-6022-2081; Nunes, Kenia/0000-0002-4838-7617	National Institutes of Health [HL-71138, HL-74167]; American Heart Association - National Scientific Development Grant [SDG12080023]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association - National Scientific Development Grant	This study was supported by grants from the National Institutes of Health (HL-71138, HL-74167). Dr. Nunes is funded by American Heart Association - National Scientific Development Grant SDG12080023.	Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Andersson KE, 2001, PHARMACOL REV, V53, P417; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Carneiro FS, 2010, J SEX MED, V7, P3620, DOI 10.1111/j.1743-6109.2010.02000.x; Cellek S, 2000, DRUG TODAY, V36, P135, DOI 10.1358/dot.2000.36.2-3.568787; Claudino MA, 2011, LIFE SCI, V88, P272, DOI 10.1016/j.lfs.2010.11.018; Claudino MA, 2010, UROLOGY, V75, P961, DOI 10.1016/j.urology.2009.05.098; Dovinova I, 2013, PPAR RES, V2013, DOI 10.1155/2013/541871; Gratzke C, 2010, J UROLOGY, V184, P2197, DOI 10.1016/j.juro.2010.06.094; Hannan JL, 2013, J UROLOGY, V189, P1155, DOI 10.1016/j.juro.2012.09.104; Hilgers RHP, 2005, EXP BIOL MED, V230, P829, DOI 10.1177/153537020523001107; Hutcheson R, 2012, EXP DIABETES RES, DOI 10.1155/2012/271028; Jin LM, 2006, FASEB J, V20, P536, DOI 10.1096/fj.05-4232fje; Jin LM, 2004, AM J PHYSIOL-HEART C, V287, pH1495, DOI 10.1152/ajpheart.01006.2003; KOLODNY RC, 1974, DIABETES, V23, P306, DOI 10.2337/diab.23.4.306; Kovanecz I, 2006, BJU INT, V98, P116, DOI 10.1111/j.1464-410X.2006.06268.x; Liu K, 2012, J ANDROL, V33, P1186, DOI 10.2164/jandrol.112.016642; Lu QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140762; Luttrell IP, 2008, AM J PHYSIOL-HEART C, V294, pH2204, DOI 10.1152/ajpheart.00027.2008; Martinez-Salamanca Juan I., 2010, Archivos Espanoles de Urologia, V63, P581; Musicki B, 2010, J SEX MED, V7, P3023, DOI 10.1111/j.1743-6109.2010.01880.x; Nangle MR, 2003, DIABETES, V52, P2396, DOI 10.2337/diabetes.52.9.2396; Nunes KP, 2015, J PHARMACOL EXP THER, V353, P330, DOI 10.1124/jpet.114.220970; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Priviero FBM, 2007, ACTA PHARMACOL SIN, V28, P751, DOI 10.1111/j.1745-7254.2007.00584.x; Priviero FBM, 2010, J PHARMACOL EXP THER, V333, P184, DOI 10.1124/jpet.109.160606; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Rodrigues FL, 2015, LIFE SCI; Saito M, 2012, PHARMACOL RES, V66, P325, DOI 10.1016/j.phrs.2012.06.005; Sanchez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036027; SARAN M, 1990, FREE RADICAL RES COM, V10, P221, DOI 10.3109/10715769009149890; Shukla N, 2005, EUR J PHARMACOL, V517, P224, DOI 10.1016/j.ejphar.2005.05.012; Silva FH, 2015, UROLOGY, V86, DOI 10.1016/j.urology.2015.04.035; Silva FH, 2013, J SEX MED, V10, P960, DOI 10.1111/jsm.12063; Toque HA, 2013, J SEX MED, V10, P1502, DOI 10.1111/jsm.12134; Toque HA, 2011, BJU INT, V107, P1628, DOI 10.1111/j.1464-410X.2010.09704.x; Tostes RC, 2008, J SEX MED, V5, P1284, DOI 10.1111/j.1743-6109.2008.00804.x; Ushiyama M, 2004, HYPERTENS RES, V27, P253, DOI 10.1291/hypres.27.253; Vicari E, 2010, J SEX MED, V7, P1247, DOI 10.1111/j.1743-6109.2009.01420.x; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Zhang W, 2011, J BIOSCI BIOENG, V112, P215, DOI 10.1016/j.jbiosc.2011.05.013; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156030	10.1371/journal.pone.0156030	http://dx.doi.org/10.1371/journal.pone.0156030			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227463	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500054
J	Coetzee, LM; Moodley, K; Glencross, DK				Coetzee, Lindi-Marie; Moodley, Keshendree; Glencross, Deborah Kim			Performance Evaluation of the Becton Dickinson FACSPresto (TM) Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa	PLOS ONE			English	Article							POINT-OF-CARE; EXTERNAL QUALITY ASSESSMENT; HIV-INFECTED PATIENTS; T-CELL ENUMERATION; ANTIRETROVIRAL TREATMENT; MULTICENTER EVALUATION; ANALYZER; INITIATION; BLOOD; MANAGEMENT	Background The BD-FACSPresto (TM) CD4 is a new, point-of-care (POC) instrument utilising finger-stick capillary blood sampling. This study evaluated its performance against predicate CD4 testing in South Africa. Methods Phase-I testing: HIV+ patient samples (n = 214) were analysed on the Presto (TM) under ideal laboratory conditions using venous blood. During Phase-II, 135 patients were capillary-bled for CD4 testing on FACSPresto (TM), performed according to manufacturer instruction. Comparative statistical analyses against predicate PLG/CD4 method and industry standards were done using GraphPad Prism 6. It included Bland-Altman with 95% limits of agreement (LOA) and percentage similarity with coefficient of variation (% CV) analyses for absolute CD4 count (cells/mu l) and CD4 percentage of lymphocytes (CD4%). Results In Phase-I, 179/217 samples yielded reportable results with Presto (TM) using venous blood filled cartridges. Compared to predicate, a mean bias of 40.4+/-45.8 (LOA of -49.2 to 130.2) and % similarity (% CV) of 106.1%+/-7.75 (7.3%) was noted for CD4 absolute counts. In Phase-2 field study, 118/135 capillary-bled Presto T samples resulted CD4 parameters. Compared to predicate, a mean bias of 50.2+/-92.8 (LOA of -131.7 to 232) with % similarity (% CV) 105%+/-10.8 (10.3%), and 2.87+/-2.7 (LOA of -8.2 to 2.5) with similarity of 94.7+/-6.5% (6.83%) noted for absolute CD4 and CD4% respectively. No significant clinical differences were indicated for either parameter using two sampling methods. Conclusion The Presto (TM) produced remarkable precision to predicate methods, irrespective of venous or capillary blood sampling. A consistent, clinically insignificant over-estimation (5-7%) of counts against PLG/CD4 and equivalency to FACSCount (TM) was noted. Further field studies are awaited to confirm longer-term use.	[Coetzee, Lindi-Marie; Glencross, Deborah Kim] Charlotte Maxeke Hosp, Lab CD4, Natl Hlth Lab Serv South Africa NHLS, Johannesburg, South Africa; [Coetzee, Lindi-Marie; Moodley, Keshendree; Glencross, Deborah Kim] Univ Witwatersrand, Dept Mol Med & Haematol, Fac Hlth Sci, 7 York Rd, ZA-2198 Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand	Coetzee, LM (corresponding author), Charlotte Maxeke Hosp, Lab CD4, Natl Hlth Lab Serv South Africa NHLS, Johannesburg, South Africa.; Coetzee, LM (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Fac Hlth Sci, 7 York Rd, ZA-2198 Johannesburg, South Africa.	lindi.coetzee@nhls.ac.za		Glencross, Deborah/0000-0001-7106-769X				Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; Biosciences B, 2014, BD FACSPRESTO SYST N; Boyle DS, 2012, TRENDS BIOTECHNOL, V30, P45, DOI 10.1016/j.tibtech.2011.06.015; Centers for Disease Control and Prevention, 2003, MORBIDITY MORTALITY; Ciaranello AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117751; Daktari, 2015, DAKT CD4 SYST DAKT D; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Denny TN, 2008, CYTOM PART B-CLIN CY, V74B, pS52, DOI 10.1002/cyto.b.20417; Department of Health SA, 2011, NAT STRAT PLAN HIV T; Department of Health SA, 2008, POL GUID IMPL PMTCT; Department of Health SA, HIV COUNS TEST HCT C; Department of Health SA, 2015, NAT CONS GUID PREV M; Department of Health SA, 2013, S AFR ANT TREATM GUI; Department of Health SA, 2014, NAT CONS GUID PREV M; Department of Health SA, 2003, OP PLAN COMPR HIV AI; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Fajardo E, 2015, B WORLD HEALTH ORGAN, V93, P623, DOI 10.2471/BLT.14.146480; Fryland M, 2006, T ROY SOC TROP MED H, V100, P980, DOI 10.1016/j.trstmh.2005.11.014; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS40, DOI 10.1002/cyto.b.20384; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS69, DOI 10.1002/cyto.b.20397; Glencross DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114727; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; GURLEY RJ, 1989, P NATL ACAD SCI USA, V86, P1993, DOI 10.1073/pnas.86.6.1993; Haleyur Giri Setty Mohan Kumar, 2014, AIDS Res Treat, V2014, P497046, DOI 10.1155/2014/497046; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kaplan JE, 2015, JAIDS-J ACQ IMM DEF, V68, pS331, DOI 10.1097/QAI.0000000000000484; Koyalta Donato, 2013, BMC Res Notes, V6, P169, DOI 10.1186/1756-0500-6-169; Larson BA, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/941493; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Lawrie D, 2010, CYTOM PART B-CLIN CY, V78B, P201, DOI 10.1002/cyto.b.20520; Liang J, 2015, CHINESE MED J-PEKING, V128, P890, DOI 10.4103/0366-6999.154283; LIFSON JD, 1989, IMMUNOL REV, V109, P93, DOI 10.1111/j.1600-065X.1989.tb00021.x; Logan C, 2013, J IMMUNOL METHODS, V387, P107, DOI 10.1016/j.jim.2012.10.002; Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y; Mandy FF, 1997, CYTOMETRY, V30, P157, DOI 10.1002/(SICI)1097-0320(19970815)30:4&lt;157::AID-CYTO1&gt;3.0.CO;2-H; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mangwiro AZ, 2014, JAIDS-J ACQ IMM DEF, V67, pS139, DOI 10.1097/QAI.0000000000000326; Massambu C, 2009, AM J CLIN PATHOL, V131, P861, DOI 10.1309/AJCP3ZAAFUPCIXIG; Mbopi-Keou FX, 2012, CLIN VACCINE IMMUNOL, V19, P609, DOI 10.1128/CVI.00023-12; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107410; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Myer L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18649; Pattanapanyasat K, 2005, CYTOM PART B-CLIN CY, V65B, P29, DOI 10.1002/cyto.b.20052; Pattanapanyasat K, 2008, CYTOM PART B-CLIN CY, V74B, pS98, DOI 10.1002/cyto.b.20415; Patten GEM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18518; Peeling RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115019; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Scott LE, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0396-2; Shafiee H, 2015, ANNU REV MED, V66, P387, DOI 10.1146/annurev-med-092112-143017; Stevens W, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0173-7; Strauss K, 1996, CYTOMETRY, V26, P52; Wade D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116663; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; WHO, 2014, SUMM STUD PROT MULT; World Health Organization, 2014, WHO PREQ DIAGN PROGR; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; ZAUNDERS J, 1995, AIDS, V9, P561, DOI 10.1097/00002030-199506000-00005	64	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156266	10.1371/journal.pone.0156266	http://dx.doi.org/10.1371/journal.pone.0156266			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224025	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700080
J	Marzullo, A; Ambrosi, F; Inchingolo, M; Manca, F; Devito, F; Angiletta, D; Zito, A; Scicchitano, P; Ciccone, MM				Marzullo, Andrea; Ambrosi, Francesca; Inchingolo, Mirjam; Manca, Fabio; Devito, Fiorella; Angiletta, Domenico; Zito, Annapaola; Scicchitano, Pietro; Ciccone, Marco Matteo			ST2L Transmembrane Receptor Expression: An Immunochemical Study on Endarterectomy Samples	PLOS ONE			English	Article							SOLUBLE ST2; HISTOLOGICAL CLASSIFICATION; ATHEROSCLEROTIC LESIONS; VULNERABLE PLAQUE; ENDOTHELIAL-CELLS; VASCULAR-SURGERY; ARTERY-DISEASE; IL-33; INTERLEUKIN-33; ACTIVATION	Background ST2 (suppression of tumorigenity) has been described as a receptor for the interleukin-33, a member of the IL-1 family of cytokines. It is associated to coronary artery disease, all-causes mortality and cardiovascular mortality. Aims The present study was designed to assess the immunohistochemical expression of the ST2 receptor (ST2L/II-1R) in atherosclerotic plaques of formalin fixed paraffin-embedded internal carotid arteries of patients with and without cerebro-vascular symptoms. Methods and Results The study involved 41 cases (23 asymptomatic and 18 symptomatic). All the clinical and morphological parameters examined were uniformly distributed between the two groups, with a mild predominance of degree of calcification in asymptomatic cases (p = 0.01). ST2L expression was found to be more evident as a membrane pattern in macrophages when observing carotid atherosclerotic plaques of symptomatic patients, rather than in asymptomatic patients' plaques (77.7% vs 39.1%; p = 0.015), and its expression was particularly remarkable in VI type plaque (AHA). Significantly, ST2L was marked by the endothelium of neoangiogenetic vessels on the shoulder region of the plaque, but not (apart from a few cases) in the endothelium covering the residual lumen of the vessel. Conclusions The ST2L immunohistochemical expression was for the first time investigated in a large number of human carotid atherosclerotic plaques, as for its pattern of distribution in the different plaque cell populations. Furthermore, ST2L was particularly remarkable on macrophages, as a membrane pattern, of symptomatic patients' plaque. Considering our data, we hypothesize that ST2L/IL33 axis could drive the mechanism of plaque development and eventually rupture.	[Marzullo, Andrea; Ambrosi, Francesca] Univ Bari, Sch Med, Pathol Sect, Dept Emergency & Organ Transplantat DETO, Bari, Italy; [Inchingolo, Mirjam; Angiletta, Domenico] Univ Bari, Sch Med, Vasc Surg Sect, Dept Emergency & Organ Transplantat DETO, Bari, Italy; [Manca, Fabio] Univ Bari, Dept Sci Educ Psychol & Commun, Bari, Italy; [Devito, Fiorella; Zito, Annapaola; Scicchitano, Pietro; Ciccone, Marco Matteo] Univ Bari, Dept Emergency & Organ Transplantat DETO, Cardiovasc Dis Sect, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Ciccone, MM (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat DETO, Cardiovasc Dis Sect, Bari, Italy.	marcomatteo.ciccone@uniba.it	Ciccone, Marco M/C-5271-2013; Scicchitano, Pietro/K-8870-2016; MANCA, FABIO/AAK-1260-2020	Ciccone, Marco M/0000-0002-5710-4228; Scicchitano, Pietro/0000-0003-0471-0053; zito, paola cosma/0000-0003-3198-3655; Marzullo, Andrea/0000-0003-1265-3685	University of Bari; Assut Europe S.p.A. [12 - 00173]	University of Bari; Assut Europe S.p.A.	This work was partly supported by a grant of University of Bari (2010) which came from the financial fund of the Pathology Section of the Department of Emergency and Organ Transplantation (DETO), Medical School, University of Bari, Bari, Italy. This work was also partially supported by Assut Europe S.p.A. (Via G. Gregoraci, 12 - 00173 Rome - Italy). The funds from Assut Europe S.p.A were used to cover the costs of publication. No other additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2010, MOL CELL BIOCHEM, V335, P75, DOI 10.1007/s11010-009-0244-9; Chen LQ, 2013, CLIN CHEM, V59, P536, DOI 10.1373/clinchem.2012.191106; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Ciccone MM, 2013, MOLECULES, V18, P15314, DOI 10.3390/molecules181215314; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Hobson RW, 2008, J VASC SURG, V48, P480, DOI 10.1016/j.jvs.2008.05.036; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Kunes Pavel, 2010, Acta Medica (Hradec Kralove), V53, P125; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Nighoghossian N, 2005, STROKE, V36, P2764, DOI 10.1161/01.STR.0000190895.51934.43; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Pollheimer J, 2013, ARTERIOSCL THROM VAS, V33, pE47, DOI 10.1161/ATVBAHA.112.253427; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Rao DS, 2005, CARDIOVASC PATHOL, V14, P285, DOI 10.1016/j.carpath.2005.07.003; Ribatti D, 2008, ANN MED, V40, P606, DOI 10.1080/07853890802186913; Ricotta JJ, 2011, J VASC SURG, V54, pE1, DOI 10.1016/j.jvs.2011.07.031; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Shen JY, 2015, SEMIN ARTHRITIS RHEU, V45, P18, DOI 10.1016/j.semarthrit.2015.02.001; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Tu X, 2013, AM J HUM GENET, V93, P652, DOI 10.1016/j.ajhg.2013.08.009; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wasserman A, 2012, ISR MED ASSOC J, V14, P620; Weinberg EO, 2009, BIOMARK MED, V3, P495, DOI 10.2217/BMM.09.56; Willems S, 2013, ATHEROSCLEROSIS, V231, P48, DOI 10.1016/j.atherosclerosis.2013.08.024	36	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156315	10.1371/journal.pone.0156315	http://dx.doi.org/10.1371/journal.pone.0156315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223112	gold, Green Submitted, Green Published			2022-12-26	WOS:000376881700085
J	Goebel, J; Seifert, I; Nensa, F; Schemuth, HP; Maderwald, S; Quick, HH; Schlosser, T; Jensen, C; Bruder, O; Nassenstein, K				Goebel, Juliane; Seifert, Ingmar; Nensa, Felix; Schemuth, Haemi P.; Maderwald, Stefan; Quick, Harald H.; Schlosser, Thomas; Jensen, Christoph; Bruder, Oliver; Nassenstein, Kai			Can Native T1 Mapping Differentiate between Healthy and Diffuse Diseased Myocardium in Clinical Routine Cardiac MR Imaging?	PLOS ONE			English	Article							EUROPEAN-SOCIETY; DIAGNOSIS; MANAGEMENT; RESOLUTION	Objectives T1 mapping allows quantitative myocardial assessment, but its value in clinical routine remains unclear. We investigated, whether the average native myocardial T1 value can be used as a diagnostic classifier between healthy and diffuse diseased myocardium. Methods Native T1 mapping was performed in 54 persons with healthy hearts and in 150 patients with diffuse myocardial pathologies (coronary artery disease (CAD): n = 76, acute myocarditis: n = 19, convalescent myocarditis: n = 26, hypertrophic cardiomyopathy (HCM): n = 12, dilated cardiomyopathy (DCM): n = 17) at 1.5 Tesla in a mid-ventricular short axis slice using a modified Look-Locker inversion recovery (MOLLI) sequence. The average native myocardial T1 value was measured using dedicated software for each patient. The mean as well as the range of the observed average T1 values were calculated for each group, and compared using t-test. The ability of T1 mapping to differentiate between healthy and diffuse diseased myocardium was assessed using receiver operating characteristic analysis (ROC). Results The mean T1 value of the group "healthy hearts" (955 +/- 34ms) differed significantly from that of the groups DCM (992 +/- 37ms, p<0.001), HCM (980 +/- 44ms, p = 0.035), and acute myocarditis (974 +/- 36ms, p = 0.044). No significant difference was observed between the groups "healthy hearts" and CAD (951 +/- 37ms, p = 0.453) or convalescent myocarditis (965 +/- 40ms, p = 0.240). The average native T1 value varied considerably within all groups (range: healthy hearts, 838-1018ms; DCM, 882-1034ms; HCM, 897-1043ms; acute myocarditis, 925-1025ms; CAD, 867-1082ms; convalescent myocarditis, 890-1071ms) and overlapped broadly between all groups. ROC analysis showed, that the average native T1 value does not allow for differentiating between healthy and diffuse diseased myocardium, except for the subgroup of DCM. Conclusions The average native T1 value in cardiac MR imaging does not allow differentiating between healthy and diffusely diseased myocardium in individual cases.	[Goebel, Juliane; Nensa, Felix; Schemuth, Haemi P.; Schlosser, Thomas; Nassenstein, Kai] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Seifert, Ingmar; Jensen, Christoph; Bruder, Oliver] Elisabeth Hosp, Clin Cardiol & Angiol, Essen, Germany; [Maderwald, Stefan; Quick, Harald H.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Quick, Harald H.] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Goebel, J (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Juliane.Goebel@uk-essen.de	Jensen, Christoph/AAF-4589-2019; Maderwald, Stefan/B-4241-2011	Jensen, Christoph/0000-0001-9808-8191; Nensa, Felix/0000-0002-5811-7100	Siemens Healthcare GmbH, Erlangen, Germany; University Hospital Essen, Essen	Siemens Healthcare GmbH, Erlangen, Germany; University Hospital Essen, Essen	This work was supported by a research agreement between Siemens Healthcare GmbH, Erlangen, Germany, and the University Hospital Essen, Essen. The works-in-progress (WIP) investigational T1 quantitative mapping sequence was provided by Siemens Healthcare GmbH, Erlangen, Germany.	Breuckmann F, 2009, JACC-CARDIOVASC IMAG, V2, P121, DOI 10.1016/j.jcmg.2008.10.011; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Dass S, 2012, CIRC-CARDIOVASC IMAG, V5, P726, DOI 10.1161/CIRCIMAGING.112.976738; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Ferreira VM, 2012, J CARDIOVASCULAR MAG, V14; Hinojar R, 2015, JACC-CARDIOVASC IMAG, V8, P38; Jellis CL, 2014, CARDIOVASC DIAGN THE, V4, P126, DOI 10.3978/j.issn.2223-3652.2013.09.03; Karamitsos TD, 2013, JACC-CARDIOVASC IMAG, V6, P488, DOI 10.1016/j.jcmg.2012.11.013; Kawel N, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-27; Kellman P, 2014, J CARDIOVASCULAR MAG, V16; Kellman P, 2014, MAGN RESON MED, V71, P1428, DOI 10.1002/mrm.24793; Kellman P, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-63; Messroghli DR, 2007, MAGN RESON MED, V58, P34, DOI 10.1002/mrm.21272; Messroghli DR, 2006, RADIOLOGY, V238, P1004, DOI 10.1148/radiol.2382041903; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Moon JC, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-92; Nassenstein K, 2010, EUR RADIOL, V20, P2341, DOI 10.1007/s00330-010-1827-2; Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69; Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019; Sado DM, 2013, CIRC-CARDIOVASC IMAG, V6, P392, DOI 10.1161/CIRCIMAGING.112.000070; Schultheiss HP, 2001, CARDIOLOGY; Thomas DE, 2009, EUR J ECHOCARDIOGR, V10, piii15, DOI 10.1093/ejechocard/jep158	22	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155591	10.1371/journal.pone.0155591	http://dx.doi.org/10.1371/journal.pone.0155591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219329	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700010
J	Son, DJ; Jung, JC; Hong, JT				Son, Dong Ju; Jung, Jae Chul; Hong, Jin Tae			Epothilones Suppress Neointimal Thickening in the Rat Carotid Balloon-Injury Model by Inducing Vascular Smooth Muscle Cell Apoptosis through p53-Dependent Signaling Pathway	PLOS ONE			English	Article							DRUG-COATED BALLOONS; CANCER-CELLS; ELUTING STENTS; GROWTH ARREST; P53; PROLIFERATION; RESTENOSIS; ATHEROSCLEROSIS; PACLITAXEL; MIGRATION	Microtubule stabilizing agents (MTSA) are known to inhibit vascular smooth muscle cell (VSMC) proliferation and migration, and effectively reduce neointimal hyperplasia and restenosis. Epothilones (EPOs), non-taxane MTSA, have been found to be effective in the inhibition of VSMC proliferation and neointimal formation by cell cycle arrest. However, effect of EPOs on apoptosis in hyper-proliferated VSMCs as a possible way to reduce neointimal formation and its action mechanism related to VSMC viability has not been suited yet. Thus, the purposes of the present study was to investigate whether EPOs are able to inhibit neointimal formation by inducing apoptosis within the region of neointimal hyperplasia in balloon-injured rat carotid artery, as well as underlying action mechanism. Treatment of EPO-B and EPO-D significantly induced apoptotic cell death and mitotic catastrophe in hyper-proliferated VSMCs, resulting in cell growth inhibition. Further, EPOs significantly suppressed VSMC proliferation and induced apoptosis by activation of p53-dependent apoptotic signaling pathway, Bax/cytochrome c/caspase-3. We further demonstrated that the local treatment of carotid arteries with EPOs potently inhibited neointimal lesion formation by induction of apoptosis in rat carotid injury model. Our findings demonstrate a potent anti-neointimal hyperplasia property of EPOs by inducing p53-depedent apoptosis in hyper-proliferated VSMCs.	[Son, Dong Ju; Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Son, Dong Ju; Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Cheongju, Chungbuk, South Korea; [Jung, Jae Chul] Rexgene Biotech Co, Life Sci Res Inst, Cheongju, Chungbuk, South Korea	Chungbuk National University; Chungbuk National University	Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea.; Hong, JT (corresponding author), Chungbuk Natl Univ, Med Res Ctr, Cheongju, Chungbuk, South Korea.	jinthong@chungbuk.ac.kr	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Research Foundation of Korea [NRF] - Korea Government (MSIP: Ministry of Science, ICT and Future Planning) [MRC, 2008-0062275]	National Research Foundation of Korea [NRF] - Korea Government (MSIP: Ministry of Science, ICT and Future Planning)	This work was supported by the National Research Foundation of Korea [NRF] grant funded by the Korea Government (MSIP: Ministry of Science, ICT and Future Planning) (no. MRC, 2008-0062275). Dr. Jae Chul Jung is employed by Rexgene Biotech Co. and received funding in the form of a salary. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzori F, 2008, EXPERT REV ANTICANC, V8, P1299, DOI 10.1586/14737140.8.8.1299; Axel DI, 1997, CIRCULATION, V96, P636; Baumgart T, 2015, CANCER INVEST, V33, P213, DOI 10.3109/07357907.2015.1020115; Blagosklonny MV, 2006, CELL CYCLE, V5, P1574, DOI 10.4161/cc.5.14.3113; Byrne RA, 2014, NAT REV CARDIOL, V11, P13, DOI 10.1038/nrcardio.2013.165; Carney BK, 2012, CYTOSKELETON, V69, P278, DOI 10.1002/cm.21024; Chen YY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05651; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Dasari B, 2015, EUR J MED CHEM, V94, P497, DOI 10.1016/j.ejmech.2014.10.062; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Forli S, 2014, CURR TOP MED CHEM, V14, P2312, DOI 10.2174/1568026614666141130095855; Geng Y, 2010, J HISTOCHEM CYTOCHEM, V58, P265, DOI 10.1369/jhc.2009.954024; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Giannakakou P, 2002, P NATL ACAD SCI USA, V99, P10855, DOI 10.1073/pnas.132275599; HAUST MD, 1960, AM J PATHOL, V37, P377; Jung JC, 2004, J ORG CHEM, V69, P9269, DOI 10.1021/jo048742o; Kim JH, 2013, APOPTOSIS, V18, P110, DOI 10.1007/s10495-012-0772-8; Kim JY, 2013, INT J MOL MED, V31, P1388, DOI 10.3892/ijmm.2013.1333; Kim TJ, 2007, VASC PHARMACOL, V47, P229, DOI 10.1016/j.vph.2007.06.009; Kleber FX, 2013, CLIN RES CARDIOL, V102, P785, DOI 10.1007/s00392-013-0609-7; Lim S, 2006, ARTERIOSCL THROM VAS, V26, P808, DOI 10.1161/01.ATV.0000204634.26163.a7; Lim Y, 2007, J PHARMACOL EXP THER, V321, P648, DOI 10.1124/jpet.106.117622; Loh JP, 2012, JACC-CARDIOVASC INTE, V5, P1001, DOI 10.1016/j.jcin.2012.08.005; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Quick Q. A., 2008, Experimental Oncology, V30, P195; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Rogalska A, 2015, ENVIRON TOXICOL PHAR, V39, P700, DOI 10.1016/j.etap.2015.01.023; Rogalska A, 2014, TOXICOL IN VITRO, V28, P675, DOI 10.1016/j.tiv.2014.02.007; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; SCHWARTZ SM, 1995, THROMB HAEMOSTASIS, V74, P541; Silverman-Gavrila R, 2013, AM J PATHOL, V182, P628, DOI 10.1016/j.ajpath.2012.11.007; SOLLOTT SJ, 1995, J CLIN INVEST, V95, P1869, DOI 10.1172/JCI117867; Son DJ, 2006, J PHARMACOL EXP THER, V317, P627, DOI 10.1124/jpet.105.095901; Son DJ, 2012, BIOCHEM BIOPH RES CO, V427, P349, DOI 10.1016/j.bbrc.2012.09.061; Stanelle J, 2003, CARDIOVASC RES, V59, P512, DOI 10.1016/S0008-6363(03)00392-4; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; Toutouzas K, 2004, EUR HEART J, V25, P1679, DOI 10.1016/j.ehj.2004.06.011; TRAVO P, 1980, BLOOD VESSELS, V17, P110; Venghateri JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075182; Waksman R, 2009, CIRC-CARDIOVASC INTE, V2, P352, DOI 10.1161/CIRCINTERVENTIONS.109.873703; Walsh K, 2000, CIRC RES, V87, P184, DOI 10.1161/01.RES.87.3.184; Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341; Wan J, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-101; Wang XF, 2007, J CARDIOVASC PHARM, V49, P253, DOI 10.1097/FJC.0b013e318033dfb3; Woods TC, 2004, ANNU REV MED, V55, P169, DOI 10.1146/annurev.med.55.091902.105243; Zheng H, 2014, GENET MOL RES, V13, P1993, DOI 10.4238/2014.March.24.4; Zheng H, 2011, MED HYPOTHESES, V77, P278, DOI 10.1016/j.mehy.2011.04.035; Zhu Y, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28672	52	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155859	10.1371/journal.pone.0155859	http://dx.doi.org/10.1371/journal.pone.0155859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218463	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700024
J	Hoogeveen, HR; Jolij, J; ter Horst, GJ; Lorist, MM				Hoogeveen, Heleen R.; Jolij, Jacob; ter Horst, Gert J.; Lorist, Monicque M.			Brain Potentials Highlight Stronger Implicit Food Memory for Taste than Health and Context Associations	PLOS ONE			English	Article							SEMANTIC RELATEDNESS; CONSUMER ACCEPTANCE; CHOICE; WORDS; RECOGNITION; CONGRUENT; ATTITUDES; EXPLICIT; LANGUAGE; RATINGS	Increasingly consumption of healthy foods is advised to improve population health. Reasons people give for choosing one food over another suggest that non-sensory features like health aspects are appreciated as of lower importance than taste. However, many food choices are made in the absence of the actual perception of a food's sensory properties, and therefore highly rely on previous experiences of similar consumptions stored in memory. In this study we assessed the differential strength of food associations implicitly stored in memory, using an associative priming paradigm. Participants (N = 30) were exposed to a forced-choice picture-categorization task, in which the food or non-food target images were primed with either non-sensory or sensory related words. We observed a smaller N400 amplitude at the parietal electrodes when categorizing food as compared to non-food images. While this effect was enhanced by the presentation of a food-related word prime during food trials, the primes had no effect in the non-food trials. More specifically, we found that sensory associations are stronger implicitly represented in memory as compared to non-sensory associations. Thus, this study highlights the neuronal mechanisms underlying previous observations that sensory associations are important features of food memory, and therefore a primary motive in food choice.	[Hoogeveen, Heleen R.; ter Horst, Gert J.] Top Inst Food & Nutr, POB 557, NL-6700 AN Wageningen, Netherlands; [Hoogeveen, Heleen R.; ter Horst, Gert J.; Lorist, Monicque M.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, Antonius Deusinglaan 2, NL-9713 AW Groningen, Netherlands; [Jolij, Jacob; Lorist, Monicque M.] Univ Groningen, Dept Expt Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; University of Groningen	Hoogeveen, HR (corresponding author), Top Inst Food & Nutr, POB 557, NL-6700 AN Wageningen, Netherlands.; Hoogeveen, HR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, Antonius Deusinglaan 2, NL-9713 AW Groningen, Netherlands.	h.r.hoogeveen@umcg.nl	Jolij, Jacob/A-9560-2009	Jolij, Jacob/0000-0002-9137-052X; Lorist, Monicque M./0000-0002-7361-093X	TI Food and Nutrition	TI Food and Nutrition	Funding for this work was realized by TI Food and Nutrition (http://www.tifn.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunabeitia JA, 2008, Q J EXP PSYCHOL, V61, P1861, DOI 10.1080/17470210701774283; Ansorge U, 2014, CONSCIOUS COGN, V27, P268, DOI 10.1016/j.concog.2014.05.009; Bates D., 2014, LINEAR MIXED EFFECTS; BIRCH LL, 1984, APPETITE, V5, P109, DOI 10.1016/S0195-6663(84)80030-6; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carretie L, 2000, MOTIV EMOTION, V24, P1, DOI 10.1023/A:1005520224700; Coates SL, 2006, APPL COGNITIVE PSYCH, V20, P1101, DOI 10.1002/acp.1262; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Contento IR, 2006, J ADOLESCENT HEALTH, V38, P575, DOI 10.1016/j.jadohealth.2005.05.025; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dell'Acqua R, 1999, COGNITION, V73, pB1, DOI 10.1016/S0010-0277(99)00049-9; Drieghe D, 2002, J EXP PSYCHOL LEARN, V28, P951, DOI 10.1037//0278-7393.28.5.951; Eertmans A, 2001, HEALTH EDUC RES, V16, P443, DOI 10.1093/her/16.4.443; Forwood SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077500; Friese M, 2008, BRIT J SOC PSYCHOL, V47, P397, DOI 10.1348/014466607X241540; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green MF, 2005, J COGNITIVE NEUROSCI, V17, P13, DOI 10.1162/0898929052880011; Grunert KG, 2000, INT DAIRY J, V10, P575, DOI 10.1016/S0958-6946(00)00085-6; Gutjar S, 2014, APPETITE, V80, P109, DOI 10.1016/j.appet.2014.05.006; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; Hollands GJ, 2011, HEALTH PSYCHOL, V30, P195, DOI 10.1037/a0022261; Issanchou S, 2002, OLFACTION, TASTE, AND COGNITION, P211, DOI 10.1017/CBO9780511546389.020; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jackson AF, 2014, PSYCHOPHYSIOLOGY, V51, P1061, DOI 10.1111/psyp.12283; Jaeger SR, 2008, FOOD QUAL PREFER, V19, P539, DOI 10.1016/j.foodqual.2008.02.005; Kiefer M, 2001, MEM COGNITION, V29, P100, DOI 10.3758/BF03195745; Koster MA, 2004, CHEM SENSES, V29, P441, DOI 10.1093/chemse/bjh047; KRAMER FM, 1992, APPETITE, V18, P1, DOI 10.1016/0195-6663(92)90206-L; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Laurent JP, 2006, BRAIN RES, V1068, P151, DOI 10.1016/j.brainres.2005.10.076; McRae K, 2005, BEHAV RES METHODS, V37, P547, DOI 10.3758/BF03192726; McRae K, 1998, J EXP PSYCHOL LEARN, V24, P558, DOI 10.1037/0278-7393.24.3.558; McRae K, 1997, J EXP PSYCHOL GEN, V126, P99, DOI 10.1037/0096-3445.126.2.99; Miller LMS, 2012, APPETITE, V59, P129, DOI 10.1016/j.appet.2012.04.009; Nijs Ilse M T, 2008, Eat Behav, V9, P462, DOI 10.1016/j.eatbeh.2008.07.009; Oeusoonthornwattana O, 2010, JUDGM DECIS MAK, V5, P310; Ortells JJ, 2013, J EXP PSYCHOL LEARN, V39, P394, DOI 10.1037/a0028876; Ortu D, 2013, NEUROPSYCHOLOGIA, V51, P1742, DOI 10.1016/j.neuropsychologia.2013.05.003; Piech RM, 2010, APPETITE, V54, P579, DOI 10.1016/j.appet.2009.11.003; Race EA, 2009, J COGNITIVE NEUROSCI, V21, P1766, DOI 10.1162/jocn.2009.21132; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Rhodes SM, 2008, PSYCHOPHYSIOLOGY, V45, P50, DOI 10.1111/j.1469-8986.2007.00598.x; RICHARDSON NJ, 1994, MEAT SCI, V36, P57, DOI 10.1016/0309-1740(94)90033-7; Richetin J, 2007, INT J PSYCHOL, V42, P166, DOI 10.1080/00207590601067078; Ryan L, 2007, CEREB CORTEX, V17, P982, DOI 10.1093/cercor/bhl009; Sanchez-Casas R, 2012, SPAN J PSYCHOL, V15, P891, DOI 10.5209/rev_SJOP.2012.v15.n3.39382; Stockburger J, 2008, BEHAV NEUROSCI, V122, P936, DOI 10.1037/a0012517; Tepper BJ, 1998, FOOD QUAL PREFER, V9, P267, DOI 10.1016/S0950-3293(98)00006-8; Thoma V, 2013, JUDGM DECIS MAK, V8, P34; Urala N., 2003, Nutrition & Food Science, V33, P148, DOI 10.1108/00346650310488499; Van den Bussche E, 2012, PSYCHOL BELG, V52, P59, DOI 10.5334/pb-52-1-59; Veldhuizen MG, 2010, APPETITE, V54, P71, DOI 10.1016/j.appet.2009.09.008; Verbeke W, 2005, FOOD QUAL PREFER, V16, P45, DOI 10.1016/j.foodqual.2004.01.001; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Von Essen E, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23000; Weibel S, 2013, CONSCIOUS COGN, V22, P517, DOI 10.1016/j.concog.2013.02.010; Wheatley T, 2005, J COGNITIVE NEUROSCI, V17, P1871, DOI 10.1162/089892905775008689; Yoon C, 2012, MARKET LETT, V23, P473, DOI 10.1007/s11002-012-9188-z	60	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0154128	10.1371/journal.pone.0154128	http://dx.doi.org/10.1371/journal.pone.0154128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2FT	27213567	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200003
J	Rajabi, H; Tagde, A; Alam, M; Bouillez, A; Pitroda, S; Suzuki, Y; Kufe, D				Rajabi, H.; Tagde, A.; Alam, M.; Bouillez, A.; Pitroda, S.; Suzuki, Y.; Kufe, D.			DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ZINC-FINGER PROTEINS; BREAST-CANCER CELLS; TRANSCRIPTIONAL REGULATION; MAINTENANCE METHYLATION; LUNG-CANCER; DE-NOVO; EXPRESSION; GENE; 3B	Aberrant expression of the DNA methyltransferases (DNMTs) and disruption of DNA methylation patterns are associated with carcinogenesis and cancer cell survival. The oncogenic MUC1-C protein is aberrantly overexpressed in diverse carcinomas; however, there is no known link between MUC1-C and DNA methylation. Our results demonstrate that MUC1-C induces the expression of DNMT1 and DNMT3b, but not DNMT3a, in breast and other carcinoma cell types. We show that MUC1-C occupies the DNMT1 and DNMT3b promoters in complexes with NF-kappa B p65 and drives DNMT1 and DNMT3b transcription. In this way, MUC1-C controls global DNA methylation as determined by analysis of LINE-1 repeat elements. The results further demonstrate that targeting MUC1-C downregulates DNA methylation of the CDH1 tumor suppressor gene in association with induction of E-cadherin expression. These findings provide compelling evidence that MUC1-C is of functional importance to induction of DNMT1 and DNMT3b and, in turn, changes in DNA methylation patterns in cancer cells.	[Rajabi, H.; Tagde, A.; Alam, M.; Bouillez, A.; Suzuki, Y.; Kufe, D.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Pitroda, S.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Suzuki, Y.] Osaka Police Hosp, Dept Surg Gastroenterol, Osaka, Osaka 5430035, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Chicago; Osaka Police Hospital	Kufe, D (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu			National Cancer Institute of the National Institutes of Health [CA97098, CA166480]; Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA166480, R01CA097098] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this paper was supported by the National Cancer Institute of the National Institutes of Health under award numbers CA97098 and CA166480, and by the Lung Cancer Research Foundation.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Ahuja N, 2014, J CLIN INVEST, V124, P56, DOI 10.1172/JCI69736; Alam M, 2014, ONCOTARGET, V5, P2622, DOI 10.18632/oncotarget.1848; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Berger N, 2007, EXP HEMATOL, V35, P1495, DOI 10.1016/j.exphem.2007.07.006; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Gnemmi V, 2014, CANCER LETT, V346, P225, DOI 10.1016/j.canlet.2013.12.029; Hasegawa M, 2016, ONCOTARGET, V7, P11756, DOI 10.18632/oncotarget.7598; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jinawath A, 2005, BIOCHEM J, V385, P557, DOI 10.1042/BJ20040684; Kishikawa S, 2002, EUR J BIOCHEM, V269, P2961, DOI 10.1046/j.1432-1033.2002.02972.x; Ko YG, 2005, J BIOL CHEM, V280, P9627, DOI 10.1074/jbc.M413822200; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lin RK, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-46; Lisanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079044; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Qu Y, 2010, AM J CLIN PATHOL, V134, P826, DOI 10.1309/AJCPHGQ69FXDFWII; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Rajabi H, 2014, ONCOGENE, V33, P1680, DOI 10.1038/onc.2013.114; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rodic N, 2014, AM J PATHOL, V184, P1280, DOI 10.1016/j.ajpath.2014.01.007; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shen N, 2014, ONCOTARGET, V5, P5494, DOI 10.18632/oncotarget.2131; Takahashi H, 2015, ONCOGENE, V34, P5187, DOI 10.1038/onc.2014.442; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yamada N, 2008, CANCER RES, V68, P2708, DOI 10.1158/0008-5472.CAN-07-6844; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; ZRIHANLICHT S, 1995, INT J CANCER, V62, P245, DOI 10.1002/ijc.2910620303	41	59	62	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 15	2016	35	50					6439	6445		10.1038/onc.2016.180	http://dx.doi.org/10.1038/onc.2016.180			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TP	27212035	Green Accepted, Green Submitted			2022-12-26	WOS:000390247600008
J	Choi, SY; Park, SK; Yoo, HW; Pi, JH; Kang, CJ				Choi, Seung-Young; Park, Sung-Kyun; Yoo, Han-Woong; Pi, Joo-Hyun; Kang, Chang-Joong			Charged Amino Acid-rich Leucine Zipper-1 (Crlz-1) as a Target of Wnt Signaling Pathway Controls Pre -B Cell Proliferation by Affecting Runx/CBFj3-targeted VpreB and lambda 5 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; ENHANCER ACTIVITY; DIFFERENTIATION; SITES; INHIBITION; ACTIVATION; EXPRESSION; MECHANISM; PROMOTER; RECEPTOR	The proliferation of pre-B cells is known to further increase the clonal diversity of B cells at the stage of pre-B cells by allowing the same rearranged heavy chains to combine with differently rearranged light chains in a subsequent developmental stage, Crlz-1 (charged amino acid -rich leucine zipper-1) was found to control this proliferation of pre-B cells by working as a Wnt (wingless -related mouse mammary tumor virus integration site) target gene in these cells. Mechanistically, Crlz-1 protein functioned by mobilizing cytoplasmic CBF13 (core binding factor (1) into the nucleus to allow Runx (runt -related transcription factor)/CBF/3 heterodimerization. Runx/CBF13 then turned on its target genes such as EBF (early B cell factor), VpreB, and A5 and thereby pre -B cell receptor signaling, leading to the expression of cyclins D2 and D3. Actually, the proliferative function of Crlz-1 was demonstrated by not only Crlz-1 or beta-catenin knockdown but also Crlz-1 overexpression. Furthermore, the mechanistic view that the proliferative function of Crlz-1 is caused by relaying Wnt/(3-catenin to pre-B cell receptor signaling pathways through the regulation of Runx/CBIT heterodimerization was also verified by employing niclosamide, XAV939, and Lid as Wnt inhibitors and activator, respectively.	[Choi, Seung-Young; Park, Sung-Kyun; Yoo, Han-Woong; Pi, Joo-Hyun; Kang, Chang-Joong] Kyung Hee Univ, Dept Genet Engn, Coll Life Sci, 1 Seocheon, Yongin 17104, Gyeonggi Do, South Korea	Kyung Hee University	Kang, CJ (corresponding author), Kyung Hee Univ, Dept Genet Engn, Coll Life Sci, 1 Seocheon, Yongin 17104, Gyeonggi Do, South Korea.	cjkang@khu.ac.kr	Kang, ChangJoong/AAG-1171-2021	Kang, Chang Joong/0000-0002-2696-4508	National Research Foundation of Korea [NRF-2013R1A1A2006609]; BK21-plus Program of the Ministry of Education of Korea	National Research Foundation of Korea(National Research Foundation of Korea); BK21-plus Program of the Ministry of Education of Korea	This work was supported by Grant NRF-2013R1A1A2006609 from the National Research Foundation of Korea and also in part by the BK21-plus Program of the Ministry of Education of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Huang H, 2012, GENE DEV, V26, P1587, DOI 10.1101/gad.192054.112; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kuo YH, 2008, BLOOD, V111, P1543, DOI 10.1182/blood-2007-07-104422; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lim JH, 2006, J IMMUNOL, V177, P5420, DOI 10.4049/jimmunol.177.8.5420; Lim JH, 2013, J HISTOCHEM CYTOCHEM, V61, P522, DOI 10.1369/0022155413486159; Lim JH, 2009, J MOL BIOL, V390, P339, DOI 10.1016/j.jmb.2009.05.040; Martensson A, 2001, EUR J IMMUNOL, V31, P3165, DOI 10.1002/1521-4141(200111)31:11<3165::AID-IMMU3165>3.0.CO;2-N; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Neel BG, 2012, GENE DEV, V26, P1520, DOI 10.1101/gad.198051.112; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Park SK, 2011, MOL CELLS, V32, P67, DOI 10.1007/s10059-011-1031-5; Park SK, 2009, BBA-GENE REGUL MECH, V1789, P702, DOI 10.1016/j.bbagrm.2009.08.011; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sakuma T, 2001, MECH DEVELOP, V104, P151, DOI 10.1016/S0925-4773(01)00366-5; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013	26	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15008	15019		10.1074/jbc.M115.712901	http://dx.doi.org/10.1074/jbc.M115.712901			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226553	Green Published, hybrid			2022-12-26	WOS:000380583200013
J	Mohl, BP; Roy, P				Mohl, Bjorn-Patrick; Roy, Polly			Cellular Casein Kinase 2 and Protein Phosphatase 2A Modulate Replication Site Assembly of Bluetongue Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; protein phosphatase 2 (PP2A); viral protein; viral replication; virus assembly; bluetongue virus; CK2; VIBs; virus inclusion bodies	SINGLE-STRANDED RNA; NONSTRUCTURAL PROTEIN-2; INCLUSION-BODIES; PHOSPHORYLATION; PHOSPHOPROTEIN; INHIBITOR; RELEASE; GROWTH; CELLS; NS2	A number of cytoplasmic replicating viruses produce cytoplasmic inclusion bodies or protein aggregates; however, a hallmark of viruses of the Reoviridae family is that they utilize these sites for purposes of replication and capsid assembly, functioning as viral assembly factories. Here we have used bluetongue virus (BTV) as a model system for this broad family of important viruses to understand the mechanisms regulating inclusion body assembly. Newly synthesized viral proteins interact with sequestered viral RNA molecules prior to capsid assembly and double-stranded RNA synthesis within viral inclusion bodies (VIBs). VIBs are predominantly comprised of a BTV-encoded non-structural protein 2 (NS2). Previous in vitro studies indicated that casein kinase 2 (CK2) mediated the phosphorylation of NS2, which regulated the propensity of NS2 to form larger aggregates. Using targeted pharmacological reagents, specific mutation in the viral genome by reverse genetics and confocal microscopy, here we demonstrate that CK2 activity is important for BTV replication. Furthermore, we show that a novel host cell factor, protein phosphatase 2A, is involved in NS2 dephosphorylation and that, together with CK2, it regulates VIB morphology and virus replication. Thus, these two host enzymes influence the dynamic nature of VIB assembly/disassembly, and these concerted activities may be relevant to the assembly and the release of these cores from VIBs.	[Mohl, Bjorn-Patrick; Roy, Polly] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roy, P (corresponding author), London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England.	polly.roy@lshtm.ac.uk		Roy, Polly/0000-0001-6535-6911	Wellcome Trust [100218/Z/12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust Senior Investigator Award 100218/Z/12/Z (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Butan C, 2004, J BIOL CHEM, V279, P37613, DOI 10.1074/jbc.M400502200; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Das SC, 2004, J VIROL, V78, P6420, DOI 10.1128/JVI.78.12.6420-6430.2004; Eichwald C, 2002, J VIROL, V76, P3461, DOI 10.1128/JVI.76.7.3461-3470.2002; Hemonnot B, 2004, J BIOL CHEM, V279, P32426, DOI 10.1074/jbc.M313137200; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; HUISMANS H, 1987, J VIROL, V61, P3589, DOI 10.1128/JVI.61.11.3589-3595.1987; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; HYATT AD, 1989, VIROLOGY, V173, P21, DOI 10.1016/0042-6822(89)90218-3; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; Law LMJ, 2003, J VIROL, V77, P1764, DOI 10.1128/JVI.77.3.1764-1771.2003; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuo E, 2013, J VIROL, V87, P882, DOI 10.1128/JVI.02363-12; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Modrof J, 2005, J VIROL, V79, P10023, DOI 10.1128/JVI.79.15.10023-10031.2005; Modrof J, 2002, J BIOL CHEM, V277, P33099, DOI 10.1074/jbc.M203775200; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Ross-Thriepland D, 2015, J VIROL, V89, P3123, DOI 10.1128/JVI.02995-14; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Strack S., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/398751; Taraporewala ZF, 2001, VIROLOGY, V280, P221, DOI 10.1006/viro.2000.0764; THOMAS CP, 1990, J GEN VIROL, V71, P2073, DOI 10.1099/0022-1317-71-9-2073; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203	29	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14566	14574		10.1074/jbc.M116.714766	http://dx.doi.org/10.1074/jbc.M116.714766			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226558	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000380366700013
J	Morozov, YI; Temiakov, D				Morozov, Yaroslav I.; Temiakov, Dmitry			Human Mitochondrial Transcription Initiation Complexes Have Similar Topology on the Light and Heavy Strand Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial DNA (mtDNA); promoter; protein cross-linking; RNA polymerase; transcription; transcription factor; LSP; TFAM; TFB2M; mtRNAP	RNA-POLYMERASE; REGULATORY ELEMENTS; DNA	Transcription is a highly regulated process in all domains of life. In human mitochondria, transcription of the circular genome involves only two promoters, called light strand promoter (LSP) and heavy strand promoter (HSP), located in the opposite DNA strands. Initiation of transcription occurs upon sequential assembly of an initiation complex that includes mitochondrial RNA polymerase (mtRNAP) and the initiation factors mitochondrial transcription factor A (TFAM) and TFB2M. It has been recently suggested that the transcription initiation factor TFAM binds to HSP and LSP in opposite directions, implying that the mechanisms of transcription initiation are drastically dissimilar at these promoters. In contrast, we found that binding of TFAM to HSP and the subsequent recruitment of mtRNAP results in a pre-initiation complex that is remarkably similar in topology and properties to that formed at the LSP promoter. Our data suggest that assembly of the pre-initiation complexes on LSP and HSP brings these transcription units in close proximity, providing an opportunity for regulatory proteins to simultaneously control transcription initiation in both mtDNA strands.	[Morozov, Yaroslav I.; Temiakov, Dmitry] Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Temiakov, D (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA.	d.temiakov@rowan.edu			National Institutes of Health [RO1GM104231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant RO1GM104231 (to D. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Morozov YI, 2015, NUCLEIC ACIDS RES, V43, P3726, DOI 10.1093/nar/gkv235; Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356; Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Posse V, 2014, NUCLEIC ACIDS RES, V42, P3638, DOI 10.1093/nar/gkt1397; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; TOPPER JN, 1989, MOL CELL BIOL, V9, P1200, DOI 10.1128/MCB.9.3.1200; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955	14	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13432	13435		10.1074/jbc.C116.727966	http://dx.doi.org/10.1074/jbc.C116.727966			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27226527	Green Published, hybrid			2022-12-26	WOS:000379771100003
J	Foster, GM; Coleman, M; Thomsen, E; Ranson, H; Yangalbe-Kalnone, E; Moundai, T; Kodindo, ID; Nakebang, A; Mahamat, A; Peka, M; Kerah-Hinzoumbe, C				Foster, Geraldine Marie; Coleman, Michael; Thomsen, Edward; Ranson, Hilary; Yangalbe-Kalnone, Elise; Moundai, Tchomfienet; Kodindo, Israel Demba; Nakebang, Amen; Mahamat, Adoum; Peka, Mallaye; Kerah-Hinzoumbe, Clement			Spatial and Temporal Trends in Insecticide Resistance among Malaria Vectors in Chad Highlight the Importance of Continual Monitoring	PLOS ONE			English	Article							ANOPHELES-ARABIENSIS; AREA; IMPLEMENTATION; IDENTIFICATION; TRANSMISSION; MUTATION; KDR	Background A longitudinal Anopheles gambiae s.l. insecticide resistance monitoring programme was established in four sentinel sites in Chad 2008-2010. When this programme ended, only sporadic bioassays were performed in a small number of sites. Methods WHO diagnostic dose assays were used to measure the prevalence of insecticide resistance to 0.1% bendiocarb, 4% DDT, 0.05% deltamethrin, 1% fenitrothion, and 0.75% permethrin in the main malaria vectors at the beginning and end of the malaria transmission season for three years 2008-2010, with subsequent collections in 2011 and 2014. Species and molecular identification of An. gambiae M and S forms and kdr genotyping was performed using PCR-RLFP; circumsporozoite status was assessed using ELISA. Results Between 2008 and 2010, significant changes in insecticide resistance profiles to deltamethrin and permethrin were seen in 2 of the sites. No significant changes were seen in resistance to DDT in any site during the study period. Testing performed after the period of routine monitoring had ended showed dramatic increases to DDT and pyrethroid resistance in 3 sites. No resistance to organophosphate or carbamate insecticides was detected. An. arabiensis was the predominate member of the An. gambiae complex in all 4 sites; adult collections showed temporal variation in species composition in only 1 site. Kdr analysis identified both 1014F and 1014S alleles in An. gambiae S only. Circumsporozoite analysis showed the highest vector infection rates were present in Donia, a site with extensive use of agricultural insecticides. Conclusions During the monitoring gap of four years, significant changes occurred in resistance prevalence in 3 of the 4 sites (p = <0.001), endangering the efficacy of currently implemented malaria control interventions. Significant changes in insecticide resistance profiles and a lack of kdr resistance alleles in adult populations highlight the urgent need for comprehensive entomological monitoring to be implemented and sustained in country.	[Foster, Geraldine Marie; Coleman, Michael; Thomsen, Edward; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Yangalbe-Kalnone, Elise; Moundai, Tchomfienet; Kodindo, Israel Demba; Nakebang, Amen; Kerah-Hinzoumbe, Clement] Programme Natl Lutte Paludisme, Ndjamena, Chad; [Mahamat, Adoum] Minist Sante Publ, Programme Natl Lutte Onchocercose, Ndjamena, Chad; [Peka, Mallaye] Minist Sante Publ, Programme Natl Lutte Trypanosomiase Humaine Afric, Ndjamena, Chad	Liverpool School of Tropical Medicine; University of Liverpool	Ranson, H (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England.	hilary.ranson@lstmed.ac.uk	Thomsen, Edward/AAH-3299-2020	Thomsen, Edward/0000-0003-1136-6430; Coleman, Michael/0000-0003-4186-3526; Ranson, Hilary/0000-0003-2332-8247	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR) [AY0588]	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR)(World Health Organization)	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR) (Grant AY0588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PLAN NAT DEV SAN 2 P; BROWN A W, 1958, Bull World Health Organ, V18, P309; Churcher TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7054; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; HAMON J, 1968, Medecine Tropicale, V28, P521; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Jones CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-24; Kerah-Hinzoumbe C., 2009, BMC INFECT DIS, V9, P71, DOI DOI 10.1186/1471-2334-9-71; Kerah-Hinzoumbe C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-192; Labbo R, 2012, MED VET ENTOMOL, V26, P386, DOI 10.1111/j.1365-2915.2012.01011.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4; PASKEWITZ SM, 1990, MED VET ENTOMOL, V4, P367, DOI 10.1111/j.1365-2915.1990.tb00453.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Thomsen EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099822; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; Tuschman M, 2013, GLOBAL MALARIA PROGR; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2013, TEST PROC INS RES MA; WIRTZ RA, 1987, J MED ENTOMOL, V24, P433, DOI 10.1093/jmedent/24.4.433; Witzig C, 2013, HEREDITY, V110, P389, DOI 10.1038/hdy.2012.112; Wondji C, 2005, MOL ECOL, V14, P3683, DOI 10.1111/j.1365-294X.2005.02699.x; World Health Organization, 2012, WHO GLOB MAL PROGR G	32	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155746	10.1371/journal.pone.0155746	http://dx.doi.org/10.1371/journal.pone.0155746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228026	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000376882500031
J	Higuchi, T; Endo, M; Hanamura, T; Gohno, T; Niwa, T; Yamaguchi, Y; Horiguchi, J; Hayashi, S				Higuchi, Toru; Endo, Megumi; Hanamura, Toru; Gohno, Tatsuyuki; Niwa, Toshifumi; Yamaguchi, Yuri; Horiguchi, Jun; Hayashi, Shin-ichi			Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer	PLOS ONE			English	Article							ANION-TRANSPORTING POLYPEPTIDES; OVARIAN SUPPRESSION; DEPENDENT GROWTH; MCF-7 CELLS; EXPRESSION; TAMOXIFEN; ANASTROZOLE; RECURRENCE; EXEMESTANE; ADAPTATION	Aromatase inhibitors (AIs) effectively treat hormone receptor-positive postmenopausal breast cancer, but some patients do not respond to treatment or experience recurrence. Mechanisms of AI resistance include ligand-independent activation of the estrogen receptor (ER) and signaling via other growth factor receptors; however, these do not account for all forms of resistance. Here we present an alternative mechanism of AI resistance. We ectopically expressed aromatase in MCF-7 cells expressing green fluorescent protein as an index of ER activity. Aromatase-overexpressing MCF-7 cells were cultured in estrogen-depleted medium supplemented with testosterone and the AI, letrozole, to establish letrozole-resistant (LR) cell lines. Compared with parental cells, LR cells had higher mRNA levels of steroid sulfatase (STS), which converts estrone sulfate (E1S) to estrone, and the organic anion transporter peptides (OATPs), which mediate the uptake of E1S into cells. LR cells proliferated more in E1S-supplemented medium than did parental cells, and LR proliferation was effectively inhibited by an STS inhibitor in combination with letrozole and by ER-targeting drugs. Analysis of ER-positive primary breast cancer tissues showed a significant correlation between the increases in the mRNA levels of STS and the OATPs in the LR cell lines, which supports the validity of this AI-resistant model. This is the first study to demonstrate the contribution of STS and OATPs in E1S metabolism to the proliferation of AI-resistant breast cancer cells. We suggest that E1S metabolism represents a new target in AI-resistant breast cancer treatment.	[Higuchi, Toru; Endo, Megumi; Hanamura, Toru; Gohno, Tatsuyuki; Niwa, Toshifumi; Hayashi, Shin-ichi] Tohoku Univ, Grad Sch Med, Dept Mol & Funct Dynam, Sendai, Miyagi 980, Japan; [Higuchi, Toru; Horiguchi, Jun] Gunma Univ, Grad Sch Med, Dept Visceral & Thorac Organ Surg, Maebashi, Gunma 371, Japan; [Hanamura, Toru] Shinshu Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg, Matsumoto, Nagano 390, Japan; [Yamaguchi, Yuri] Saitama Canc Ctr, Res Inst Clin Oncol, 818 Komuro, Ina, Saitama 3620806, Japan; [Hayashi, Shin-ichi] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epi Genome & Dis, Sendai, Niyagi 980, Japan	Tohoku University; Gunma University; Shinshu University; Tohoku University	Hayashi, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Mol & Funct Dynam, Sendai, Miyagi 980, Japan.; Hayashi, S (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Regulatory Epi Genome & Dis, Sendai, Niyagi 980, Japan.	shin@med.tohoku.ac.jp	Hanamura, Toru/AAE-5184-2020	Hanamura, Toru/0000-0002-6934-8588; Niwa, Toshifumi/0000-0002-9580-9042	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591344]; Ministry of Health, Labor and Welfare, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (23591344, https://kaken.nii.ac.jp); a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare, Japan (http://www.mhlw.go.jp); and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (http://www.nibio.go.jp/information/).	Al Sarakbi W, 2006, ANTICANCER RES, V26, P4985; Amir E, 2012, CANCER TREAT REV, V38, P708, DOI 10.1016/j.ctrv.2011.11.006; Banerjee M, 2015, DRUG DISCOV TODAY, V20, P618, DOI 10.1016/j.drudis.2014.11.011; Banerjee N, 2014, BREAST CANCER RES TR, V145, P647, DOI 10.1007/s10549-014-2990-y; Banerjee N, 2012, J PHARMACOL EXP THER, V342, P510, DOI 10.1124/jpet.112.192344; Barone I, 2009, CANCER RES, V69, P4724, DOI 10.1158/0008-5472.CAN-08-4194; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Becker MA, 2011, MOL ENDOCRINOL, V25, P516, DOI 10.1210/me.2010-0373; Bogina G, 2011, VIRCHOWS ARCH, V459, P1, DOI 10.1007/s00428-011-1097-7; Coombes RC, 2013, BREAST CANC RES TREA; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; De Amicis F, 2010, BREAST CANCER RES TR, V121, P1, DOI 10.1007/s10549-009-0436-8; Doyle LA, 1999, P NATL ACAD SCI USA, V96, P2569; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Fujii R, 2014, J STEROID BIOCHEM, V144, P513, DOI 10.1016/j.jsbmb.2014.08.019; Fujiki N, 2014, J STEROID BIOCHEM, V139, P61, DOI 10.1016/j.jsbmb.2013.08.012; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hamidovic Alma, 2010, J Oncol Pharm Pract, V16, P39, DOI 10.1177/1078155209104380; Hanamura T, 2013, BREAST CANCER RES TR, V139, P731, DOI 10.1007/s10549-013-2595-x; Ishida H, 2007, BREAST CANCER RES TR, V106, P215, DOI 10.1007/s10549-007-9495-x; Jelovac D, 2005, CANCER RES, V65, P5380, DOI 10.1158/0008-5472.CAN-04-4502; Johnston SRD, 2006, CLIN CANCER RES, V12, p1061S, DOI 10.1158/1078-0432.CCR-05-2125; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Matsumoto M, 2008, ENDOCR-RELAT CANCER, V15, P451, DOI 10.1677/ERC-07-0227; Miki Y, 2006, CANCER RES, V66, P535, DOI 10.1158/0008-5472.CAN-05-1070; Miyoshi Y, 2003, CLIN CANCER RES, V9, P2288; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; O'Hara J, 2012, CLIN CANCER RES, V18, P3305, DOI 10.1158/1078-0432.CCR-11-3300; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Pasqualini JR, 1980, BREAST CANC RES TREA, V8, P233; Poirier D, 2011, J STEROID BIOCHEM, V125, P83, DOI 10.1016/j.jsbmb.2010.12.007; PROST O, 1984, CANCER RES, V44, P661; Purohit A, 2000, CANCER RES, V60, P3394; Rasmussen LM, 2007, BREAST CANCER RES TR, V106, P191, DOI 10.1007/s10549-007-9494-y; Sabnis GJ, 2013, BREAST CANCER RES TR, V138, P699, DOI 10.1007/s10549-013-2474-5; Santen RJ, 2008, ADV EXP MED BIOL, V630, P19; SANTNER SJ, 1984, J CLIN ENDOCR METAB, V59, P29, DOI 10.1210/jcem-59-1-29; Stanway SJ, 2006, CLIN CANCER RES, V12, P1585, DOI 10.1158/1078-0432.CCR-05-1996; Takagi K, 2010, ENDOCR-RELAT CANCER, V17, P415, DOI 10.1677/ERC-09-0257; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Utsumi T, 1999, CANCER RES, V59, P377; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4; VIGNON F, 1980, ENDOCRINOLOGY, V106, P1079, DOI 10.1210/endo-106-4-1079; Wlcek K, 2008, CANCER BIOL THER, V7, P1452, DOI 10.4161/cbt.7.9.6282; Yamaguchi Y, 2005, CANCER RES, V65, P4653, DOI 10.1158/0008-5472.CAN-04-3236	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155844	10.1371/journal.pone.0155844	http://dx.doi.org/10.1371/journal.pone.0155844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228187	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500036
J	Keskinov, AA; Tapias, V; Watkins, SC; Ma, Y; Shurin, MR; Shurin, GV				Keskinov, Anton A.; Tapias, Victor; Watkins, Simon C.; Ma, Yang; Shurin, Michael R.; Shurin, Galina V.			Impact of the Sensory Neurons on Melanoma Growth In Vivo	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; SUPPRESSOR-CELLS; PANCREATIC-CANCER; PERINEURAL INVASION; PROSTATE-CANCER; NERVE-FIBERS; TUMOR-GROWTH; CARCINOMA; MARKER; VITRO	Nerve endings are often identified within solid tumors, but their impact on the tumor growth and progression remains poorly understood. Emerging data suggests that the central nervous system may affect cancer development and spreading via the hypothalamic-pituitaryadrenal axis and autonomous nervous system. However, the role of the afferent sensory neurons in tumor growth is unclear, except some reports on perineural invasion in prostate and pancreatic cancer and cancer-related pain syndrome. Here, we provide the results of primary testing of the concept that the interaction between melanoma cells and sensory neurons may induce the formation of tumor-supporting microenvironment via attraction of immune regulatory cells by the tumor-activated dorsal root ganglion (DRG) neurons. We report that despite DRG cells not directly up-regulating proliferation of melanoma cells in vitro, presence of DRG neurons allows tumors to grow significantly faster in vivo. This effect has been associated with increased production of chemokines by tumor-activated DRG neurons and attraction of myeloid-derived suppressor cells both in vitro and in vivo. These initial proof-of-concept results justify further investigations of the sensory (afferent) nervous system in the context of tumorigenesis and the local protumorigenic immunoenvironment.	[Keskinov, Anton A.; Ma, Yang; Shurin, Michael R.; Shurin, Galina V.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; [Tapias, Victor] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Watkins, Simon C.] Univ Pittsburgh, Dept Cell Biol & Physiol, Med Ctr, Pittsburgh, PA USA; [Shurin, Michael R.] Univ Pittsburgh, Dept Immunol, Med Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Keskinov, AA (corresponding author), Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA.	ank142@pitt.edu	Watkins, Simon/ABG-2590-2021; Tapias, Victor/GOJ-7231-2022; Tapias, Victor/ABG-1539-2021	Watkins, Simon/0000-0003-4092-1552; Tapias, Victor/0000-0002-1783-7320; Shurin, Michael/0000-0002-6570-7395	National Institutes of Health, National Cancer Institute [RO1 CA154369]; NATIONAL CANCER INSTITUTE [R01CA154369] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health, National Cancer Institute grant RO1 CA154369.	Ahsberg K, 2009, SCAND J GASTROENTERO, V44, P947, DOI 10.1080/00365520903039945; Albo D, 2011, CANCER-AM CANCER SOC, V117, P4834, DOI 10.1002/cncr.26117; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Averbeck B, 2000, NEUROSCIENCE, V98, P135, DOI 10.1016/S0306-4522(00)00095-6; Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Campbell LK, 2003, MODERN PATHOL, V16, P963, DOI 10.1097/01.MP.0000087088.88280.B0; Caygill C P, 1991, Eur J Cancer Prev, V1, P35; Ceyhan GO, 2008, BIOCHEM BIOPH RES CO, V374, P442, DOI 10.1016/j.bbrc.2008.07.035; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Dai H, 2007, HUM PATHOL, V38, P299, DOI 10.1016/j.humpath.2006.08.002; Devor M, 1999, PAIN, pS27, DOI 10.1016/S0304-3959(99)00135-9; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; Golan H, 2009, J NUCL MED, V50, P1072, DOI 10.2967/jnumed.108.061085; Khaled YS, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/879897; Leo M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124942; Li JH, 2008, CELL BIOL INT, V32, P1530, DOI 10.1016/j.cellbi.2008.08.022; Liu CY, 2010, J CANCER RES CLIN, V136, P35, DOI 10.1007/s00432-009-0634-0; Lu SH, 2003, WORLD J GASTROENTERO, V9, P399; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; McDonald PG, 2013, BRAIN BEHAV IMMUN, V30, pS1, DOI 10.1016/j.bbi.2013.01.003; MITCHELL BS, 1994, EUR J CANCER, V30A, P1100, DOI 10.1016/0959-8049(94)90465-0; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; Parker KH, 2015, ADV CANCER RES, V128, P95, DOI 10.1016/bs.acr.2015.04.002; Raju B, 2009, EUR J ORAL SCI, V117, P351, DOI 10.1111/j.1600-0722.2009.00646.x; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Rosa AC, 2013, BRIT J PHARMACOL, V170, P38, DOI 10.1111/bph.12266; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Schuller HM, 2008, ANTI-CANCER DRUG, V19, P655, DOI 10.1097/CAD.0b013e3283025b58; Seifert P, 2002, VIRCHOWS ARCH, V440, P291, DOI 10.1007/s004280100496; Seifert P, 2002, AM J OPHTHALMOL, V133, P711, DOI 10.1016/S0002-9394(02)01329-6; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Tapias Victor, 2014, Curr Protoc Cytom, V68, DOI 10.1002/0471142956.cy1233s68; Tashiro M, 1999, PSYCHO-ONCOL, V8, P283, DOI 10.1002/(SICI)1099-1611(199907/08)8:4<283::AID-PON384>3.3.CO;2-1; TATSUTA M, 1992, INT J CANCER, V50, P298, DOI 10.1002/ijc.2910500221; Terada T, 2001, PATHOL INT, V51, P89, DOI 10.1046/j.1440-1827.2001.01172.x; Tomita T, 2012, DIGEST DIS SCI, V57, P364, DOI 10.1007/s10620-011-1876-7; Ustinova EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056886; Vachkov IH, 2007, CANCER SCI, V98, P1192, DOI 10.1111/j.1349-7006.2007.00508.x; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhou M, 2001, AM J CLIN PATHOL, V115, P39, DOI 10.1309/2APJ-YKBD-97EH-67GW	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156095	10.1371/journal.pone.0156095	http://dx.doi.org/10.1371/journal.pone.0156095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227315	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000376882500067
J	Challa, AK; Boitet, ER; Turner, AN; Johnson, LW; Kennedy, D; Downs, ER; Hymel, KM; Gross, AK; Kesterson, RA				Challa, Anil K.; Boitet, Evan R.; Turner, Ashley N.; Johnson, Larry W.; Kennedy, Daniel; Downs, Ethan R.; Hymel, Katherine M.; Gross, Alecia K.; Kesterson, Robert A.			Novel Hypomorphic Alleles of the Mouse Tyrosinase Gene Induced by CRISPR-Cas9 Nucleases Cause Non-Albino Pigmentation Phenotypes	PLOS ONE			English	Article							GENOME; ZEBRAFISH; MUTATION; SYSTEM; TALEN	Tyrosinase is a key enzyme in melanin biosynthesis. Mutations in the gene encoding tyrosinase (Tyr) cause oculocutaneous albinism (OCA1) in humans. Alleles of the Tyr gene have been useful in studying pigment biology and coat color formation. Over 100 different Tyr alleles have been reported in mice, of which approximate to 24% are spontaneous mutations, approximate to 60% are radiation-induced, and the remaining alleles were obtained by chemical mutagenesis and gene targeting. Therefore, most mutations were random and could not be predicted a priori. Using the CRISPR-Cas9 system, we targeted two distinct regions of exon 1 to induce pigmentation changes and used an in vivo visual phenotype along with heteroduplex mobility assays (HMA) as readouts of CRISPR-Cas9 activity. Most of the mutant alleles result in complete loss of tyrosinase activity leading to an albino phenotype. In this study, we describe two novel in-frame deletion alleles of Tyr, dhoosara (Sanskrit for gray) and chandana (Sanskrit for sandalwood). These alleles are hypomorphic and show lighter pigmentation phenotypes of the body and eyes. This study demonstrates the utility of CRISPR-Cas9 system in generating domain-specific in-frame deletions and helps gain further insights into structure-function of Tyr gene.	[Challa, Anil K.; Turner, Ashley N.; Johnson, Larry W.; Kennedy, Daniel; Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Boitet, Evan R.; Gross, Alecia K.] Univ Alabama Birmingham, Dept Optometry & Vis Sci, Birmingham, AL USA; [Downs, Ethan R.; Hymel, Katherine M.] Univ Alabama Birmingham, Sci & Technol Honors Program, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Challa, AK (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA.	akchalla@uab.edu	Gross, Alecia K./AAJ-1792-2021; Challa, Anil Kumar/AAQ-3306-2021; Turner, Ashley Nicole/M-9413-2019; Challa, Anil Kumar/A-5819-2009	Gross, Alecia K./0000-0003-1857-6633; Turner, Ashley Nicole/0000-0001-7796-1975; Challa, Anil Kumar/0000-0002-3633-3304	NIH [P30CA13148, P30AR048311, P30DK074038, P30DK05336, P60DK079626]; NEI [R01EY019311]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, P30DK074038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	RAK is supported by awards NIH P30CA13148, P30AR048311, P30DK074038, P30DK05336, and P60DK079626. AKG is supported by NEI R01EY019311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORDERS CL, 1994, PROTEIN SCI, V3, P541; Claybon A, 2011, JOVE-J VIS EXP, DOI 10.3791/2563; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; KWON BS, 1989, BIOCHEM BIOPH RES CO, V161, P252, DOI 10.1016/0006-291X(89)91588-X; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Menke DB, 2013, GENESIS, V51, P605, DOI 10.1002/dvg.22422; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Parikh BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116484; RIORDAN JF, 1977, SCIENCE, V195, P884, DOI 10.1126/science.190679; Seruggia D, 2015, NUCLEIC ACIDS RES, V43, P4855, DOI 10.1093/nar/gkv375; TOWNSEND D, 1981, J EXP ZOOL, V216, P113, DOI 10.1002/jez.1402160112; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	17	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155812	10.1371/journal.pone.0155812	http://dx.doi.org/10.1371/journal.pone.0155812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224051	gold, Green Published, Green Submitted			2022-12-26	WOS:000376881700031
J	Delben, JA; Zago, CE; Tyhovych, N; Duarte, S; Vergani, CE				Delben, Juliana Aparecida; Zago, Chaiene Evelin; Tyhovych, Natalia; Duarte, Simone; Vergani, Carlos Eduardo			Effect of Atmospheric-Pressure Cold Plasma on Pathogenic Oral Biofilms and In Vitro Reconstituted Oral Epithelium	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NONTHERMAL PLASMA; CANDIDA-ALBICANS; BACTERIAL BIOFILMS; DISCHARGE PLASMA; STERILIZATION; INACTIVATION; SURVIVAL; EFFICACY; ECOLOGY	Considering the ability of atmospheric-pressure cold plasma (ACP) to disrupt the biofilm matrix and rupture cell structure, it can be an efficient tool against virulent oral biofilms. However, it is fundamental that ACP does not cause damage to oral tissue. So, this study evaluated (1) the antimicrobial effect of ACP on single-and dual-species biofilms of Candida albicans and Staphylococcus aureus as well as (2) the biological safety of ACP on in vitro reconstituted oral epithelium. Standardized cell suspensions of each microorganism were prepared for biofilm culture on acrylic resin discs at 37 degrees C for 48 hours. The biofilms were submitted to ACP treatment at 10 mm of plasma tip-to-sample distance during 60 seconds. Positive controls were penicillin G and fluconazole for S. aureus and C. albicans, respectively. The biofilms were analyzed through counting of viable colonies, confocal laser scanning microscopy, scanning electron microscopy and fluorescence microscopy for detection of reactive oxygen species. The in vitro reconstituted oral epithelium was submitted to similar ACP treatment and analyzed through histology, cytotoxocity test (LDH release), viability test (MTT assay) and imunnohistochemistry (Ki67 expression). All plasma-treated biofilms presented significant log10 CFU/mL reduction, alteration in microorganism/biofilm morphology, and reduced viability in comparison to negative and positive controls. In addition, fluorescence microscopy revealed presence of reactive oxygen species in all plasma-treated biofilms. Low cytotoxicity and high viability were observed in oral epithelium of negative control and plasma group. Histology showed neither sign of necrosis nor significant alteration in plasma-treated epithelium. Ki67-positive cells revealed maintenance of cell proliferation in plasma-treated epithelium. Atmospheric-pressure cold plasma is a promissing approach to eliminate single- nd dual-species biofilms of C. albicans and S. aureus without having toxic effects in oral epithelium.	[Delben, Juliana Aparecida; Zago, Chaiene Evelin; Vergani, Carlos Eduardo] Sao Paulo State Univ, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil; [Tyhovych, Natalia; Duarte, Simone] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA	Universidade Estadual Paulista; New York University	Vergani, CE (corresponding author), Sao Paulo State Univ, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil.	vergani@foar.unesp.br	Duarte, Simone/Y-2496-2019; Zago, Chaiene Evelin/D-9530-2013; Delben, Juliana A/L-5469-2016; Vergani, Carlos E/A-3043-2008; FAPESP, CDMF/J-3591-2015	Duarte, Simone/0000-0002-4744-4026; Vergani, Carlos E/0000-0002-7375-4714; Delben, Juliana/0000-0002-6510-3727; FAPESP, CDMF/0000-0002-4464-0937	Sao Paulo Research Foundation [2012/20699-6, 2013/21388-7]; GSK/IADR Innovation in Oral Care Award	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); GSK/IADR Innovation in Oral Care Award	This work was supported by grant 2012/20699-6-Sao Paulo Research Foundation (http://www.fapesp.br/en/) (JAD), grant 2013/21388-7-Sao Paulo Research Foundation (http://www.fapesp.br/en/) (JAD), and grant 2012 GSK/IADR Innovation in Oral Care Award (http://www.iadr.com/i4a/pages/index.cfm?pageid=3426#.Vfcgnc6hsfo) (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawareek MY, 2012, FEMS IMMUNOL MED MIC, V65, P381, DOI 10.1111/j.1574-695X.2012.00942.x; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Bayliss DL, 2013, INT J ANTIMICROB AG, V41, P398, DOI 10.1016/j.ijantimicag.2012.12.005; Black CE, 2010, SURG CLIN N AM, V90, P1147, DOI 10.1016/j.suc.2010.08.009; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; De Geyter N, 2012, ANNU REV BIOMED ENG, V14, P255, DOI 10.1146/annurev-bioeng-071811-150110; Delben J.A., 2014, PLASMA MED, V4, P231, DOI [10.1615/PlasmaMed.2014012361, DOI 10.1615/PLASMAMED.2014012361]; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Ferrell JR, 2013, BIOFOULING, V29, P585, DOI 10.1080/08927014.2013.795554; Fricke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042539; Glass R. Thomas, 2001, Journal of the American Osteopathic Association, V101, P92; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Hoffmann C, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-21; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kaloriti D, 2014, MBIO, V5, DOI 10.1128/mBio.01334-14; Koban I, 2011, J CLIN PERIODONTOL, V38, P956, DOI 10.1111/j.1600-051X.2011.01740.x; Koban I, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073039; Liu DX, 2011, J HUAZHONG U SCI-MED, V31, P852, DOI 10.1007/s11596-011-0690-y; Mai-Prochnow A, 2014, INT J ANTIMICROB AG, V43, P508, DOI 10.1016/j.ijantimicag.2014.01.025; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pappas D, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3559547; Parahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P46, DOI 10.1128/CMR.00028-08; Pereira-Cenci T, 2008, J APPL ORAL SCI, V16, P86, DOI 10.1590/S1678-77572008000200002; Peters BM, 2010, FEMS IMMUNOL MED MIC, V59, P493, DOI 10.1111/j.1574-695X.2010.00710.x; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1491, DOI 10.1111/j.1751-1097.2009.00589.x; Pulimood S, 2002, DIAGN MICR INFEC DIS, V44, P353, DOI 10.1016/S0732-8893(02)00460-1; Ribeiro DG, 2012, GERODONTOLOGY, V29, P203, DOI 10.1111/j.1741-2358.2011.00578.x; Ribeiro DG, 2009, J DENT, V37, P666, DOI 10.1016/j.jdent.2009.04.009; Ristic BZ, 2014, BIOMATERIALS, V35, P4428, DOI 10.1016/j.biomaterials.2014.02.014; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Silva S, 2011, J ORAL PATHOL MED, V40, P421, DOI 10.1111/j.1600-0714.2010.00981.x; Smith AJ, 2001, J MED MICROBIOL, V50, P940, DOI 10.1099/0022-1317-50-11-940; Thein ZM, 2006, ARCH ORAL BIOL, V51, P672, DOI 10.1016/j.archoralbio.2006.02.005; Traba C, 2011, BIOFOULING, V27, P763, DOI 10.1080/08927014.2011.602188; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Yadev NR, 2011, MICROB PATHOGENESIS, V50, P278, DOI 10.1016/j.micpath.2010.11.009; Yamazaki H, 2011, DENT MATER J, V30, P384, DOI 10.4012/dmj.2010-190; Zago CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123206; Zissis AJ, 2000, INT J PROSTHODONT, V13, P136	50	52	54	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155427	10.1371/journal.pone.0155427	http://dx.doi.org/10.1371/journal.pone.0155427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224027	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700020
J	Li, CY; Chaung, W; Mozayan, C; Chabra, R; Wang, P; Narayan, RK				Li, Chunyan; Chaung, Wayne; Mozayan, Cameron; Chabra, Ranjeev; Wang, Ping; Narayan, Raj K.			A New Approach for On-Demand Generation of Various Oxygen Tensions for In Vitro Hypoxia Models	PLOS ONE			English	Article							CELL-CULTURE; MICROFLUIDIC DEVICES; HYDROGEN-PEROXIDE; STEM-CELLS; GRADIENTS; INJURY; ALPHA; MICROENVIRONMENT; MACROPHAGES; ISCHEMIA	The development of in vitro disease models closely mimicking the functions of human disease has captured increasing attention in recent years. Oxygen tensions and gradients play essential roles in modulating biological systems in both physiologic and pathologic events. Thus, controlling oxygen tension is critical for mimicking physiologically relevant in vivo environments for cell, tissue and organ research. We present a new approach for on-demand generation of various oxygen tensions for in vitro hypoxia models. Proof-of-concept prototypes have been developed for conventional cell culture microplate by immobilizing a novel oxygen-consuming biomaterial on the 3D-printed insert. For the first time, rapid (similar to 3.8 minutes to reach 0.5% O-2 from 20.9% O-2) and precisely controlled oxygen tensions/gradients (2.68 mmHg per 50 mu m distance) were generated by exposing the biocompatible biomaterial to the different depth of cell culture media. In addition, changing the position of 3D-printed inserts with immobilized biomaterials relative to the cultured cells resulted in controllable and rapid changes in oxygen tensions (<130 seconds). Compared to the current technologies, our approach allows enhanced spatiotemporal resolution and accuracy of the oxygen tensions. Additionally, it does not interfere with the testing environment while maintaining ease of use. The elegance of oxygen tension manipulation introduced by our new approach will drastically improve control and lower the technological barrier of entry for hypoxia studies. Since the biomaterials can be immobilized in any devices, including microfluidic devices and 3D-printed tissues or organs, it will serve as the basis for a new generation of experimental models previously impossible or very difficult to implement.	[Li, Chunyan; Chabra, Ranjeev; Narayan, Raj K.] Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY USA; [Li, Chunyan; Mozayan, Cameron; Narayan, Raj K.] Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY USA; [Chaung, Wayne; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA	Northwell Health; Northwell Health; Northwell Health	Li, CY (corresponding author), Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY USA.; Li, CY (corresponding author), Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY USA.	cli11@nshs.edu		Wang, Ping/0000-0002-1557-0394	Department of Neurosurgery at Northwell Health; U.S. Department of Defense [W81XWH-10-1-0978]	Department of Neurosurgery at Northwell Health; U.S. Department of Defense(United States Department of Defense)	This work was supported in part by the Department of Neurosurgery at Northwell Health and U.S. Department of Defense (W81XWH-10-1-0978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2010, LAB CHIP, V10, P388, DOI 10.1039/b920401f; Allen CB, 2001, AM J PHYSIOL-LUNG C, V281, pL1021, DOI 10.1152/ajplung.2001.281.4.L1021; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Benam KH, 2015, ANNU REV PATHOL-MECH, V10, P195, DOI 10.1146/annurev-pathol-012414-040418; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bickler PE, 2015, NEUROSCIENCE, V310, P306, DOI 10.1016/j.neuroscience.2015.09.021; Brennan MD, 2014, LAB CHIP, V14, P4305, DOI 10.1039/c4lc00853g; Byrne MB, 2014, TRENDS BIOTECHNOL, V32, P556, DOI 10.1016/j.tibtech.2014.09.006; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chang CW, 2014, LAB CHIP, V14, P3762, DOI 10.1039/c4lc00732h; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r; Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003; Huang QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061345; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Hung SP, 2012, J ORTHOP RES, V30, P260, DOI 10.1002/jor.21517; Lee WH, 2009, ARCH PHARM RES, V32, P421, DOI 10.1007/s12272-009-1316-9; Lo JF, 2010, LAB CHIP, V10, P2394, DOI 10.1039/c004660d; Martou G, 2006, J APPL PHYSIOL, V101, P1335, DOI 10.1152/japplphysiol.00278.2006; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mueller S, 2009, ADV MED SCI-POLAND, V54, P121, DOI 10.2478/v10039-009-0042-3; Nistico R, 2008, BRIT J PHARMACOL, V153, P1022, DOI 10.1038/sj.bjp.0707587; Peng CC, 2013, LAB CHIP, V13, P3239, DOI 10.1039/c3lc50388g; Polinkovsky M, 2009, LAB CHIP, V9, P1073, DOI 10.1039/b816191g; SCANNELL G, 1993, J SURG RES, V54, P281, DOI 10.1006/jsre.1993.1044; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Skolimowski M, 2010, LAB CHIP, V10, P2162, DOI 10.1039/c003558k; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Waldbaur A, 2011, ANAL METHODS-UK, V3, P2681, DOI 10.1039/c1ay05253e; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]; Yu X, 2012, J MOL CELL CARDIOL, V53, P848, DOI 10.1016/j.yjmcc.2012.10.002	36	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155921	10.1371/journal.pone.0155921	http://dx.doi.org/10.1371/journal.pone.0155921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219067	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880700028
J	Yu, Y; Zhou, YF; Chen, MR; Li, X; Qiao, GL; Sun, J; Liao, XP; Liu, YH				Yu, Yang; Zhou, Yu-Feng; Chen, Mei-Ren; Li, Xiao; Qiao, Gui-Lin; Sun, Jian; Liao, Xiao-Ping; Liu, Ya-Hong			In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion	PLOS ONE			English	Article							BOVINE MASTITIS; BROAD-SPECTRUM; PHARMACOKINETICS; PHARMACODYNAMICS; INFECTION; COWS; BIOAVAILABILITY; IDENTIFICATION; EFFICACY; HEALTHY	Staphylococcus aureus remains the major cause of morbidity of bovine mastitis worldwide leading to massive economic losses. Cefquinome is a fourth generation cephalosporin, which preserves susceptibility and antibacterial activity against S. aureus. This work aims to study the pharmacokinetic (PK) and pharmacodynamic (PD) modeling following intramammary administration of cefquinome against S. aureus mastitis. The mouse model of S. aureus mastitis was developed for the PK/PD experiments. The plasma PK characteristics after intramammary injection of cefquinome at various single doses of 25, 50, 100, 200, 400 mu g per gland (both fourth pairs of glands: L4 and R4) were calculated using one-compartment and first-order absorption model. PD study was investigated based on twenty-one intermittent dosing regimens, of which total daily dose ranged from 25 to 4800 mu g per mouse and dosage intervals included 8, 12 or 24 h. The sigmoid E-max model of inhibitory effect was employed for PK/PD modeling. The results of PK/PD integration of cefquinome against S. aureus suggested that the percentage of duration that drug concentration exceeded the minimal inhibitory concentration (% T>MIC) and the ratio of area under time-concentration curve over MIC (AUC/MIC) are important indexes to evaluate the antibacterial activity. The PK/PD parameters of % T>MIC and AUC(0-24)/MIC were 35.98% and 137.43 h to obtain a 1.8 logCFU/gland reduction of bacterial colony counts in vivo, against S. aureus strains with cefquinome MIC of 0.5 mu g/ml.	[Yu, Yang; Zhou, Yu-Feng; Chen, Mei-Ren; Li, Xiao; Sun, Jian; Liao, Xiao-Ping; Liu, Ya-Hong] South China Agr Univ, Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou, Guangdong, Peoples R China; [Yu, Yang; Zhou, Yu-Feng; Chen, Mei-Ren; Li, Xiao; Sun, Jian; Liao, Xiao-Ping; Liu, Ya-Hong] South China Agr Univ, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China; [Qiao, Gui-Lin] Def Threat Reduct Agcy, 8725 John J Kingman Rd,MS 6201, Ft Belvoir, VA 22060 USA	South China Agricultural University; South China Agricultural University; United States Department of Defense; Defense Threat Reduction Agency	Liu, YH (corresponding author), South China Agr Univ, Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou, Guangdong, Peoples R China.; Liu, YH (corresponding author), South China Agr Univ, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China.	lyh@scau.edu.cn		Zhou, Yu-Feng/0000-0001-6882-5058	Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT13063]; Natural Science Foundation of Guangdong Province [S2012030006590]; Science and Technology Planning Project of Guangdong Province, China [2012A020800004]	Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (Grant No. IRT13063), the Natural Science Foundation of Guangdong Province (Grant No. S2012030006590), Science and Technology Planning Project of Guangdong Province, China (Grant No. 2012A020800004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taher AY, 2010, J ANIM VET ADV, V9, P848, DOI 10.3923/javaa.2010.848.852; Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; Andes D, 2002, ANTIMICROB AGENTS CH, V46, P1665, DOI 10.1128/AAC.46.6.1665-1670.2002; Baranski Wojciech, 2008, Medycyna Weterynaryjna, V64, P301; Bradley AJ, 2011, J DAIRY SCI, V94, P692, DOI 10.3168/jds.2010-3192; Brouillette E, 2005, MICROBES INFECT, V7, P560, DOI 10.1016/j.micinf.2004.11.008; Brouillette E, 2004, VET MICROBIOL, V101, P253, DOI 10.1016/j.vetmic.2004.04.008; Cagnardi P, 2009, J VET PHARMACOL THER, V32, P145; CLSI (Clinical and Laboratory Standards Institute), 2013, VET01A4E CLSI; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Dinakaran V, 2013, TROP ANIM HEALTH PRO, V45, P1509, DOI 10.1007/s11250-013-0390-7; Dumka VK, 2013, SMALL RUMINANT RES, V113, P273, DOI 10.1016/j.smallrumres.2013.02.010; Ehinger AM, 2005, J VET PHARMACOL THER, V26, P93; Gruet P, 2001, ADV DRUG DELIVER REV, V50, P245, DOI 10.1016/S0169-409X(01)00160-0; Hobarth G, 2004, TIERAERZTL UMSCHAU, V59, P718; Hwang YH, 2011, J VET PHARMACOL THER, V34, P618, DOI 10.1111/j.1365-2885.2011.01289.x; Institute of Laboratory Animal Resources. Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A; Intorre L, 2013, LARGE ANIM REV, V19, P287; Kirkan S, 2005, TURK J VET ANIM SCI, V29, P791; LIMBERT M, 1991, ANTIMICROB AGENTS CH, V35, P14, DOI 10.1128/AAC.35.1.14; Malouin F, 2005, FEMS IMMUNOL MED MIC, V45, P245, DOI 10.1016/j.femsim.2005.04.003; NEWBOULD FH, 1974, CAN J COMP MED, V38, P411; Schwarz S, 2010, J ANTIMICROB CHEMOTH; Shan Q, 2014, J VET PHARMACOL THER, V37, P178, DOI 10.1111/jvp.12076; Uney K, 2011, ANTIMICROB AGENTS CH, V55, P854, DOI 10.1128/AAC.01126-10; Wang J, 2014, ANTIMICROB AGENTS CH, V58, P3008, DOI 10.1128/AAC.01666-13; Zhao DH, 2014, VET J, V201, P109, DOI 10.1016/j.tvjl.2014.05.010; Zhou YF, 2015, J VET PHARMACOL THER, V38, P543, DOI 10.1111/jvp.12225; Zonca A, 2011, J DAIRY SCI, V94, P3455, DOI 10.3168/jds.2010-4109	29	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156273	10.1371/journal.pone.0156273	http://dx.doi.org/10.1371/journal.pone.0156273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218674	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880700055
J	An, M; Colarelli, SM; O'Brien, K; Boyajian, ME				An, Mihyang; Colarelli, Stephen M.; O'Brien, Kimberly; Boyajian, Melanie E.			Why We Need More Nature at Work: Effects of Natural Elements and Sunlight on Employee Mental Health and Work Attitudes	PLOS ONE			English	Article							METHOD VARIANCE; OUTDOOR ENVIRONMENT; STRESS RECOVERY; LIGHT EXPOSURE; BENEFITS; WINDOW; SELF; RESTORATION; GREEN; VIEW	This study investigated the effects of natural elements and direct and indirect sunlight exposure on employee mental health and work attitudes. We recruited participants via an online panel from the United States and India, and analyzed data from 444 employees. Natural elements and sunlight exposure related positively to job satisfaction and organizational commitment, and negatively to depressed mood and anxiety. Direct sunlight was a dominant predictor of anxiety; indirect sunlight was a dominant predictor of depressed mood, job satisfaction, and organizational commitment. Natural elements buffered the relationship between role stressors and job satisfaction, depressed mood, and anxiety. We also found that depressed mood partially mediated the relationship between natural elements and job satisfaction. We discuss scientific and policy implications of these findings.	[An, Mihyang] Cent Michigan Univ, Sch Publ Serv & Global Citizenship, Mt Pleasant, MI 48859 USA; [Colarelli, Stephen M.] Hong Kong Baptist Univ, Sch Business, Dept Management, Hong Kong, Hong Kong, Peoples R China; [Colarelli, Stephen M.; O'Brien, Kimberly; Boyajian, Melanie E.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA	Central Michigan University; Hong Kong Baptist University; Central Michigan University	Colarelli, SM (corresponding author), Hong Kong Baptist Univ, Sch Business, Dept Management, Hong Kong, Hong Kong, Peoples R China.; Colarelli, SM (corresponding author), Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA.	scolarelli@gmail.com						Barger P., 2011, IND ORGAN PSYCHOL-US, V49, P11, DOI [DOI 10.1145/1809400.1809422, https://doi.org/10.3389/fpsyg.2017.01359, DOI 10.3389/FPSYG.2017.01359]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berman MG, 2008, PSYCHOL SCI, V19, P1207, DOI 10.1111/j.1467-9280.2008.02225.x; Beukeboom CJ, 2012, J ALTERN COMPLEM MED, V18, P329, DOI 10.1089/acm.2011.0488; Beute F, 2014, APPL PSYCHOL-HLTH WE, V6, P67, DOI 10.1111/aphw.12019; Blau P., 1964, EXCHANGE POWER SOCIA; Bodin M, 2003, PSYCHOL SPORT EXERC, V4, P141, DOI 10.1016/S1469-0292(01)00038-3; BOUBEKRI M, 1991, ENVIRON BEHAV, V23, P474, DOI 10.1177/0013916591234004; Bringslimark T, 2009, J ENVIRON PSYCHOL, V29, P422, DOI 10.1016/j.jenvp.2009.05.001; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Brosschot JF, 2005, PSYCHONEUROENDOCRINO, V30, P1043, DOI 10.1016/j.psyneuen.2005.04.008; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; BUDESCU DV, 1993, PSYCHOL BULL, V114, P542, DOI 10.1037/0033-2909.114.3.542; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cammann C., 1983, ASSESSING ORG CHANGE, P71, DOI DOI 10.1177/017084068400500420; Carlopio JR, 1996, J OCCUP HEALTH, V24, P579; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cohen LM, 2007, J ARCHIT PLAN RES, V24, P289; Colarelli SM, 2015, BIOL FDN ORG BEHAV, P1; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Doty DH, 1998, ORGAN RES METHODS, V1, P374, DOI 10.1177/109442819814002; Dravigne A, 2008, HORTSCIENCE, V43, P183, DOI 10.21273/HORTSCI.43.1.183; Dumont M, 2007, SLEEP MED, V8, P557, DOI 10.1016/j.sleep.2006.11.008; EISENBERGER R, 1986, J APPL PSYCHOL, V71, P500, DOI 10.1037/0021-9010.75.1.51; EMERSON RM, 1976, ANNU REV SOCIOL, V2, P335, DOI 10.1146/annurev.so.02.080176.002003; Faragher EB, 2005, OCCUP ENVIRON MED, V62, P105, DOI 10.1136/oem.2002.006734; Felsten G, 2009, J ENVIRON PSYCHOL, V29, P160, DOI 10.1016/j.jenvp.2008.11.006; Ganster DC, 2013, J MANAGE, V39, P1085, DOI 10.1177/0149206313475815; Hansmann Ralf, 2007, Urban Forestry & Urban Greening, V6, P213, DOI 10.1016/j.ufug.2007.08.004; Harris C, 2006, DEV LEAN WORKFORCE G; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kaida K, 2006, SLEEP, V29, P462, DOI 10.1093/sleep/29.4.462; Kaplan R., 1989, EXPERIENCE NATURE PS, DOI DOI 10.1097/00005053-199111000-00012; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kaplan S., 1995, URBAN FOREST LANDSCA, P100; Kim TH, 2010, SCI TOTAL ENVIRON, V408, P2600, DOI 10.1016/j.scitotenv.2010.02.025; Knight C, 2010, J EXP PSYCHOL-APPL, V16, P158, DOI 10.1037/a0019292; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; LAMBERT SJ, 1990, HUM RELAT, V43, P239, DOI 10.1177/001872679004300303; Leather P, 1998, ENVIRON BEHAV, V30, P739, DOI 10.1177/001391659803000601; Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114; Locke EA, 1977, HDB IND ORG PSYCHOL; Lottrup L, 2013, LANDSCAPE URBAN PLAN, V110, P5, DOI 10.1016/j.landurbplan.2012.09.002; Mayer FS, 2009, ENVIRON BEHAV, V41, P607, DOI 10.1177/0013916508319745; MOWDAY RT, 1979, J VOCAT BEHAV, V14, P224, DOI 10.1016/0001-8791(79)90072-1; Nieuwenhuis M, 2014, J EXP PSYCHOL-APPL, V20, P199, DOI 10.1037/xap0000024; Parsons R, 1998, J ENVIRON PSYCHOL, V18, P113, DOI 10.1006/jevp.1998.0086; Partonen T, 2000, J AFFECT DISORDERS, V57, P55, DOI 10.1016/S0165-0327(99)00063-4; Pettit JW, 2011, J FAM PSYCHOL, V25, P127, DOI 10.1037/a0022320; Podsakoff NP, 2007, J APPL PSYCHOL, V92, P438, DOI 10.1037/0021-9010.92.2.438; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RIZZO JR, 1970, ADMIN SCI QUART, V15, P150, DOI 10.2307/2391486; S?rbom, 2006, LISREL 8 8 COMPUTER; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; SPECTOR PE, 1994, J ORGAN BEHAV, V15, P385, DOI 10.1002/job.4030150503; SPECTOR PE, 1987, J APPL PSYCHOL, V72, P438, DOI 10.1037/0021-9010.72.3.438; Stegmeier D, 2008, INNOVATIONS OFFICE D; Taylor AF, 2002, J ENVIRON PSYCHOL, V22, P49, DOI 10.1006/jevp.2001.0241; U.S. Census Bureau, 2010, US HOURS WORK 12 MON; Ulrich R.S., 1993, BIOPHILIA HYPOTHESIS, P73, DOI DOI 10.3389/FPSYG.2020.00511; ULRICH RS, 1981, ENVIRON BEHAV, V13, P523, DOI 10.1177/0013916581135001; ULRICH RS, 1986, LANDSCAPE URBAN PLAN, V13, P29, DOI 10.1016/0169-2046(86)90005-8; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; van der Klink JJL, 2001, AM J PUBLIC HEALTH, V91, P270, DOI 10.2105/AJPH.91.2.270; van der Wal AJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2295; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Velarde M. D., 2007, Urban Forestry & Urban Greening, V6, P199, DOI 10.1016/j.ufug.2007.07.001; VERDERBER S, 1986, ENVIRON BEHAV, V18, P450, DOI 10.1177/0013916586184002; Verhoeven V, 2012, J NUTR HEALTH AGING, V16, P417, DOI 10.1007/s12603-011-0361-5; Vischer JC, 2007, STRESS HEALTH, V23, P175, DOI 10.1002/smi.1134; Wohlwill JF, 1976, ADV THEORY RES, P37; Wood RA, 2006, WATER AIR SOIL POLL, V175, P163, DOI 10.1007/s11270-006-9124-z; WURTMAN RJ, 1989, SCI AM, V260, P68, DOI 10.1038/scientificamerican0189-68; Zhang Z, 2015, BIOL FDN ORG BEHAV, P139	80	31	31	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155614	10.1371/journal.pone.0155614	http://dx.doi.org/10.1371/journal.pone.0155614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2FT	27214041	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200018
J	Meyer, CG; Reiling, N; Ehmen, C; Ruge, G; Owusu-Dabo, E; Horstmann, RD; Thye, T				Meyer, Christian G.; Reiling, Norbert; Ehmen, Christa; Ruge, Gerd; Owusu-Dabo, Ellis; Horstmann, Rolf D.; Thye, Thorsten			TLR1 Variant H305L Associated with Protection from Pulmonary Tuberculosis	PLOS ONE			English	Article							HUMAN GENETIC SUSCEPTIBILITY; MYCOBACTERIUM-TUBERCULOSIS; TOLL; LIPOPROTEINS; RECOGNITION; INFECTION; RESPONSES; MICE	Toll like receptors (TLR) are key elements of the innate immune response and involved in the recognition of pathogens. To test common and rare TLR variants involved in susceptibility or resistance to infection with Mycobacterium tuberculosis we screened the exons of the genes encoding TLR 1, 2, 4, and the adaptor molecule TIRAP in more than 4500 tuberculosis (TB) cases and controls from Ghana. The analysis yielded 109 variants with possible functional impact, including 101 non-synonymous variants, three stop-variants, and five indels. Association analyses yielded a significant result for the TLR1 variant rs3923647, conferring strong protection against TB (Odds ratio [OR] 0.21, CI confidence interval [CI] 0.05-0.6, P-nominal 1 x 10(-3)) when applying a recessive model of inheritance. Replication analyses with an additional 3370 Ghanaian cases and control samples, and with data from a recent TB study of 533 African-Americans confirmed the protective effect and resulted in a combined OR of 0.19, with a nominal P value of 2.2 x 10(-5), and a corrected P value of 4.1 x 10(-4). The SNP is located near the binding pocket of TLR1 and causes an amino acid exchange from histidine to leucine at position 305. The observed effect may, therefore, be attributable to structural changes in the recognition site of the TLR1 molecule, allowing to bind those mycobacterial ligands which preferentially may induce a protective immune response. This is supported by the analysis of BCG-stimulated peripheral blood mononuclear cells, showing increased induction of the proinflammatory cytokine IFN-gamma in carriers of the mutant TLR1 rs3923647 TT genotype, compared to the IFN-gamma levels of individuals with the AT and AA genotypes.	[Meyer, Christian G.; Ehmen, Christa; Ruge, Gerd; Horstmann, Rolf D.; Thye, Thorsten] Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Meyer, Christian G.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Reiling, Norbert] Res Ctr Borstel, Div Microbial Interface Biol, Borstel, Germany; [Owusu-Dabo, Ellis] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Dept Community Hlth, Sch Med Sci, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Eberhard Karls University of Tubingen; Forschungszentrum Borstel; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology	Thye, T (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	thye@bnitm.de	Reiling, Norbert/D-6796-2013	Reiling, Norbert/0000-0001-6673-4291	German Federal Ministry of Education and Research, German National Genome Research Network [01GS0162, NIE-S17T20, 73.240]	German Federal Ministry of Education and Research, German National Genome Research Network	This work was supported by the German Federal Ministry of Education and Research, German National Genome Research Network (NGFN1, Project 01GS0162; NGFN2, NIE-S17T20, NGFN Plus 73.240). All authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bellamy R, 2000, LANCET, V355, P588, DOI 10.1016/S0140-6736(99)00426-2; Bellamy RJ, 1998, NOVART FDN SYMP, V217, P3, DOI 10.1002/0470846526.ch2; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Heffelfinger C, 2014, EUR J HUM GENET, V22, P551, DOI 10.1038/ejhg.2013.194; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020908; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tian T, 2013, INFECT GENET EVOL, V14, P156, DOI 10.1016/j.meegid.2012.11.009; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063357	30	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156046	10.1371/journal.pone.0156046	http://dx.doi.org/10.1371/journal.pone.0156046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214039	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200051
J	Pan, L; Ren, LL; Chen, F; Feng, YQ; Luo, YQ				Pan, Long; Ren, Lili; Chen, Fang; Feng, Yuqian; Luo, Youqing			Antifeedant Activity of Ginkgo biloba Secondary Metabolites against Hyphantria cunea Larvae: Mechanisms and Applications	PLOS ONE			English	Article							SUSCEPTIBILITY; EXTRACTS; ENZYMES	Ginkgo biloba is a typical relic plant that rarely suffers from pest hazards. This study analyzed the pattern of G. biloba pest hazards in Beijing; tested the antifeedant activity of G. biloba extracts, including ginkgo flavonoids, ginkgolide, and bilobalide, against Hyphantria cunea larvae; determined the activities of glutathione transferase (GSTs), acetylcholinesterase (AChE), carboxylesterase (CarE) and mixed-functional oxidase (MFO), in larvae after feeding on these G. biloba secondary metabolites; and screened for effective botanical anti-feedants in the field. In this study, no indicators of insect infestation were found for any of the examined leaves of G. biloba; all tested secondary metabolites showed significant antifeedant activity and affected the activity of the four larval detoxifying enzymes. Ginkgolide had the highest antifeedant activity and the most significant effect on the detoxifying enzymes (P< 0.05). Spraying leaves with G. biloba extracts or ginkgolide both significantly repelled H. cunea larvae in the field (P< 0.05), although the former is more economical and practical. This study investigated the antifeedant activity of G. biloba secondary metabolites against H. cunea larvae, and the results provide new insights into the mechanism of G. biloba pest resistance. This study also developed new applications of G. biloba secondary metabolites for effective pest control.	[Pan, Long; Ren, Lili; Chen, Fang; Feng, Yuqian; Luo, Youqing] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing 100083, Peoples R China	Beijing Forestry University	Luo, YQ (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing 100083, Peoples R China.	Youqingluo@126.com			Special Project for Scientific Research of Forestry Commonweal Industry of National Forestry Bureau [201404401]	Special Project for Scientific Research of Forestry Commonweal Industry of National Forestry Bureau	This study was supported by Special Project for Scientific Research of Forestry Commonweal Industry of National Forestry Bureau (201404401).	Akhtar Y, 2004, J APPL ENTOMOL, V128, P32, DOI 10.1046/j.1439-0418.2003.00806.x; Batala E., 2009, International Journal of Sustainable Development and Planning, V4, P344, DOI 10.2495/SDP-V4-N4-345-356; [戴宇婷 Dai Yuting], 2012, [植物保护, Plant Protection], V38, P79; Dong Jun-Feng, 2002, Acta Entomologica Sinica, V45, P296; Fuentes-Contreras E, 2007, J ECON ENTOMOL, V100, P551, DOI 10.1603/0022-0493(2007)100[551:EOARAA]2.0.CO;2; Hu Xiao, 2011, Journal of Beijing Forestry University, V33, P151; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Jimenez AA, 2013, REV COLOMB ENTOMOL, V39, P113; Kamila D, 2013, PLOS ONE, V8; Leng Ping-sheng, 2001, Journal of Plant Resources and Environment, V10, P15; Li J, 2009, J CHROMATOGR A, V1216, P8759, DOI 10.1016/j.chroma.2009.03.002; Li Ling, 2011, Shengtaixue Zazhi, V30, P53; Li Shui-Qing, 2005, Chinese Bulletin of Entomology, V42, P491; Liang HL, 2008, ACTA AGR JIANGXI, V20, P49; Mohanta TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032822; Morimoto M, 2003, J AGR FOOD CHEM, V51, P389, DOI 10.1021/jf025627a; Namountougou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048412; Pan Ya-Fei, 2006, Chinese Bulletin of Entomology, V43, P496; Peng Lu, 2010, Acta Entomologica Sinica, V53, P572; Prisila M, 2015, PLOS ONE, V10; Pszczolkowski MA, 2011, J AGR FOOD CHEM, V59, P10879, DOI 10.1021/jf202386c; Rong J., 2003, ENTOMOL KNOWLEDG, V40, P13; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; So SS, 2012, ENTOMOL RES, V42, P158, DOI 10.1111/j.1748-5967.2012.00449.x; Tang RB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045597, 10.1371/journal.pone.0049256]; van Beek TA, 2009, J CHROMATOGR A, V1216, P2002, DOI 10.1016/j.chroma.2009.01.013; Van Leeuwen T, 2005, PEST MANAG SCI, V61, P499, DOI 10.1002/ps.1001; Wang Chen-Zhu, 2007, Chinese Bulletin of Entomology, V44, P311; [王瑞龙 Wang Ruilong], 2012, [生态学报, Acta Ecologica Sinica], V32, P5191; Wei Hui, 2004, Yingyong Shengtai Xuebao, V15, P473; Xu D, 2009, J PEST SCI, V82, P195, DOI 10.1007/s10340-008-0239-4; Yang Zhong-Qi, 2007, Chinese Bulletin of Entomology, V44, P465; Yin Fei, 2013, Chinese Journal of Applied Entomology, V50, P1335, DOI 10.7679/j.issn.2095-1353.2013.183; Yuezhi Liao, 2012, Scientia Silvae Sinicae, V48, P99; Zhang YA, 2008, CN, Patent No. [CN 101228853 A, 101228853]; Zhang YL., 2008, HEBEI J FOREST ORCHA, V23, P70; Zhu L, 2000, CHINESE J ECOL, V19, P36	37	44	45	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155682	10.1371/journal.pone.0155682	http://dx.doi.org/10.1371/journal.pone.0155682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214257	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200021
J	Neumann, AD; Dias, FD; Ferreira, JD; Fontes, ANB; Rosa, PS; Macedo, RE; Oliveira, JH; Teixeira, RLD; Pessolani, MCV; Moraes, MO; Suffys, PN; Oliveira, PL; Sorgine, MHF; Lara, FA				Neumann, Arthur da Silva; Dias, Felipe de Almeida; Ferreira, Jessica da Silva; Brum Fontes, Amanda Nogueira; Rosa, Patricia Sammarco; Macedo, Rafael Enrique; Oliveira, Jose Henrique; de Figueiredo Teixeira, Raquel Lima; Vidal Pessolani, Maria Cristina; Moraes, Milton Ozorio; Suffys, Philip Noel; Oliveira, Pedro L.; Ferreira Sorgine, Marcos Henrique; Lara, Flavio Alves			Experimental Infection of Rhodnius prolixus (Hemiptera, Triatominae) with Mycobacterium leprae Indicates Potential for Leprosy Transmission	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTIONS; AEDES-AEGYPTI; WILD ARMADILLOS; CHAGAS-DISEASE; BURULI-ULCER; VIABILITY; MICE; EPIDEMIOLOGY; FLUORESCENT; RESERVOIR	Leprosy is a chronic dermato-neurological disease caused by infection with Mycobacterium leprae. In 2013 almost 200,000 new cases of leprosy were detected around the world. Since the first symptoms take from years to decades to appear, the total number of asymptomatic patients is impossible to predict. Although leprosy is one of the oldest records of human disease, the mechanisms involved with its transmission and epidemiology are still not completely understood. In the present work, we experimentally investigated the hypothesis that the mosquitoes Aedes aegypti and Culex quinquefasciatus and the hemiptera Rhodnius prolixus act as leprosy vectors. By means of real-time PCR quantification of M. leprae 16SrRNA, we found that M. leprae remained viable inside the digestive tract of Rhodnius prolixus for 20 days after oral infection. In contrast, in the gut of both mosquito species tested, we were not able to detect M. leprae RNA after a similar period of time. Inside the kissing bug Rhodnius prolixus digestive tract, M. leprae was initially restricted to the anterior midgut, but gradually moved towards the hindgut, in a time course reminiscent of the life cycle of Trypanosoma cruzi, a well-known pathogen transmitted by this insect. The maintenance of M. leprae infectivity inside the digestive tract of this kissing bug is further supported by successful mice footpad inoculation with feces collected 20 days after infection. We conclude that Rhodnius prolixus defecate infective M. leprae, justifying the evaluation of the presence of M. leprae among sylvatic and domestic kissing bugs in countries endemic for leprosy.	[Neumann, Arthur da Silva; Ferreira, Jessica da Silva; Macedo, Rafael Enrique; Vidal Pessolani, Maria Cristina; Lara, Flavio Alves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Microbiol Celular, Rio De Janeiro, Brazil; [Dias, Felipe de Almeida; Oliveira, Jose Henrique; Oliveira, Pedro L.; Ferreira Sorgine, Marcos Henrique] Univ Fed Rio de Janeiro, Lab Bioquim Artropodes Hematofagos, Rio De Janeiro, Brazil; [Brum Fontes, Amanda Nogueira; de Figueiredo Teixeira, Raquel Lima; Suffys, Philip Noel] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Aplicada Micobacterias, Rio De Janeiro, Brazil; [Rosa, Patricia Sammarco] Lauro de Sousa Lima Inst, Dept Biol, Bauru, Brazil; [Moraes, Milton Ozorio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Lara, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Microbiol Celular, Rio De Janeiro, Brazil.	flavioalveslara2000@gmail.com	suffys, philip/E-3009-2013; Moraes, Milton Ozório/G-9753-2011; Lara, Flavio Alves/L-1861-2013; Moraes, Milton/AFF-1842-2022; Fontes, Amanda N B/P-1291-2018; L. Oliveira, Pedro/A-9438-2010	Moraes, Milton Ozório/0000-0003-2653-0037; L. Oliveira, Pedro/0000-0003-0307-354X; Oliveira, Jose Henrique M./0000-0003-3814-5312	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Programa Institucional de Bolsas de Iniciacao Cientifica PIBIC from Oswaldo Cruz Foundation	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa Institucional de Bolsas de Iniciacao Cientifica PIBIC from Oswaldo Cruz Foundation(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br) and the Programa Institucional de Bolsas de Iniciacao Cientifica PIBIC, from Oswaldo Cruz Foundation(www.pibic.fiocruz.br). The sources of funds had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Otegui JA, 2012, ACTA TROP, V124, P79, DOI 10.1016/j.actatropica.2012.06.010; ASHIDA M, 1990, EUR J BIOCHEM, V188, P507, DOI 10.1111/j.1432-1033.1990.tb15429.x; BANERJEE R, 1990, TROP GEOGR MED, V42, P97; BANERJEE R, 1991, LEPROSY REV, V62, P21; Benchimol Jaime L., 2003, Hist. cienc. saude-Manguinhos, V10, P49, DOI 10.1590/S0104-59702003000400004; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; DAY JF, 1995, J WILDLIFE DIS, V31, P10, DOI 10.7589/0090-3558-31.1.10; Doannio J M C, 2011, Med Trop (Mars), V71, P53; Geater J G, 1975, Lepr Rev, V46, P279; GREGORIO EA, 1991, PARASITE IMMUNOL, V13, P551, DOI 10.1111/j.1365-3024.1991.tb00551.x; Grossi MAF, 2009, HANSENIASE BRASIL DA; Henriques C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-214; Howden CW, 2012, ALIMENT PHARM THER, V36, P399, DOI 10.1111/j.1365-2036.2012.05182.x; Irgens L M, 1980, Lepr Rev, V51 Suppl 1, pi; Joyce MP, 2012, MEM I OSWALDO CRUZ, V107, P17, DOI 10.1590/S0074-02762012000900004; KIRCHHEIMER WF, 1976, INT J LEPROSY, V44, P104; Lahiri R, 2005, J MED MICROBIOL, V54, P235, DOI 10.1099/jmm.0.45700-0; Lahiri R, 2008, LEPROSY REV, V79, P401; Lahiri R, 2005, INT J LEPROSY, V73, P194; LAINSON R, 1979, T ROY SOC TROP MED H, V73, P193, DOI 10.1016/0035-9203(79)90211-6; Lavender CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001305; Lee DS, 2012, J MICROBIOL BIOTECHN, V22, P975, DOI 10.4014/jmb.1201.01016; Lobato LS, 2014, ANTIMICROB AGENTS CH, V58, P5766, DOI 10.1128/AAC.01826-13; Lockwood DNJ, 2005, B WORLD HEALTH ORGAN, V83, P230; Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09; Matsuoka M, 1999, Indian J Lepr, V71, P61; MCDERMOTTLANCASTER RD, 1990, INT J EXP PATHOL, V71, P689; Meima A, 2002, INT J EPIDEMIOL, V31, P991, DOI 10.1093/ije/31.5.991; Montgomery G G. BGA, 1985, EVOLUTION ECOLOGY AR, P8; Narayanan E, 1977, Lepr India, V49, P181; Narayanan E, 1978, Lepr India, V50, P26; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Paige CF, 2002, AM J TROP MED HYG, V67, P528, DOI 10.4269/ajtmh.2002.67.528; Reibel F, 2015, MED MALADIES INFECT, V45, P383, DOI 10.1016/j.medmal.2015.09.002; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; Rodhain F, 2012, B ACAD NAT MED PARIS, V196, P685, DOI 10.1016/S0001-4079(19)31805-9; SAHA K, 1985, LEPROSY REV, V56, P279; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; SHEPARD CC, 1965, J BACTERIOL, V89, P365, DOI 10.1128/JB.89.2.365-372.1965; SMITH JH, 1983, J RETICULOENDOTH SOC, V34, P75; Soto H, 2014, CAD SAUDE PUBLICA, V30, P746, DOI 10.1590/0102-311X00024013; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; TRUMAN RW, 1991, EPIDEMIOL INFECT, V106, P549, DOI 10.1017/S0950268800067613; Truman RW, 2001, INT J LEPROSY, V69, P1; Turankar RP, 2012, INFECT GENET EVOL, V12, P121, DOI 10.1016/j.meegid.2011.10.023; Turvey ST, 2009, HOLOCENE EXTINCTION, P349; WALSH GP, 1975, J RETICULOENDOTH SOC, V18, P347; WALSH GP, 1986, J LEUKOCYTE BIOL, V40, P645, DOI 10.1002/jlb.40.5.645; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; WHO, 2014, LEPR GLOB SIT; Williams M, 2000, J HIST GEOGR, V26, P28, DOI 10.1006/jhge.1999.0189; YOUNG DB, 1982, ANN INST PASTEUR MIC, VB133, P53	54	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0156037	10.1371/journal.pone.0156037	http://dx.doi.org/10.1371/journal.pone.0156037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203082	Green Submitted, Green Published, gold			2022-12-26	WOS:000376291500041
J	Xu, PF; Zhang, YJ; Jiang, XH; Li, JY; Song, LY; Khoso, MH; Liu, YY; Wu, Q; Ren, GP; Li, DS				Xu, Pengfei; Zhang, Yingjie; Jiang, Xinghao; Li, Junyan; Song, Liying; Khoso, Mir Hasson; Liu, Yunye; Wu, Qiang; Ren, Guiping; Li, Deshan			Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs	PLOS ONE			English	Article							INSULIN; MELLITUS; METABOLISM; FGF21; CARBOHYDRATE; ACTIVATION; EXPRESSION; GLUCOSE; ENZYMES; FGF-21	Diabetes mellitus is a common endocrinopathy in dog. Fibroblast growth factor 21 (FGF-21) is a secreted protein, which is involved in glucose homeostasis. We speculate that the recombinant canine FGF-21 (cFGF-21) has the potential to become a powerful therapeutics to treat canine diabetes. The cFGF-21 gene was cloned and expressed in E. coli Rosetta (DE3). After purification, a cFGF-21 protein with the purity exceeding 95% was obtained. Mouse 3T3-L1 adipocytes and type 1 diabetic mice/dogs induced by STZ were used to examine the biological activity of cFGF-21 in vitro and in vivo, respectively. Results showed that cFGF-21 stimulated glucose uptake in adipocytes significantly in a dose-dependent manner, and reduced plasma glucose significantly in diabetic mice/dogs. After treatment with cFGF-21, the serum insulin level, glycosylated hemoglobin (HbA1c) level and the expressions of the hepatic gluconeogenesis genes (glucose-6-phosphatase, G6Pase and phosphoenolpyruvate carboxykinase, PCK) of the diabetic mice/dogs were attenuated significantly. In the mouse experiment, we also found that the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and the expression of suppressor of cytokine signaling 3 (SOCS3) were up-regulated significantly in the livers after treatment. Histopathological and immunohistochemical results showed that treatment with cFGF-21 promoted recovery of pancreatic islets from STZ-induced apoptosis. Besides, we also found that treatment with cFGF-21 protected liver against STZ or hyperglycemia induced damage and the mechanism of this action associated with inhibiting oxidative stress. In conclusion, cFGF-21 represents a promising candidate for canine diabetes therapeutics. The mechanism of cFGF-21 ameliorates hyperglycemia associated with inhibiting hepatic gluconeogenesis by regulation of STAT3 signal pathway and improving pancreatic beta-cell survival.	[Xu, Pengfei; Zhang, Yingjie; Jiang, Xinghao; Li, Junyan; Song, Liying; Khoso, Mir Hasson; Liu, Yunye; Wu, Qiang; Ren, Guiping; Li, Deshan] Northeast Agr Univ, Sch Life Sci, Biopharmaceut Lab, Harbin, Peoples R China	Northeast Agricultural University - China	Ren, GP; Li, DS (corresponding author), Northeast Agr Univ, Sch Life Sci, Biopharmaceut Lab, Harbin, Peoples R China.	renguiping@126.com; deshanli@163.com	Zhang, Yingjie/HHM-3016-2022					Adams JP, 2014, VET J, V202, P436, DOI 10.1016/j.tvjl.2014.09.027; Ananthan R, 2004, NUTRITION, V20, P280, DOI 10.1016/j.nut.2003.11.016; Arai T, 2002, RES VET SCI, V73, P183, DOI 10.1016/S0034-5288(02)00104-2; Carl GF, 2003, ENDOCR RES, V29, P73, DOI 10.1081/ERC-120018678; Catchpole B, 2008, J SMALL ANIM PRACT, V49, P4, DOI 10.1111/j.1748-5827.2007.00398.x; Catchpole B, 2013, VET J, V195, P139, DOI 10.1016/j.tvjl.2012.11.013; Chen Y, 2012, DIABETOLOGIA, V55, P2533, DOI 10.1007/s00125-012-2594-1; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Feldman E.C., 2004, CANINE FELINE ENDOCR; Genet S, 2002, MOL CELL BIOCHEM, V236, P7, DOI 10.1023/A:1016103131408; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoenig M, 2002, MOL CELL ENDOCRINOL, V197, P221, DOI 10.1016/S0303-7207(02)00264-2; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Marcovecchio ML, 2011, PEDIATR NEPHROL, V26, P365, DOI 10.1007/s00467-010-1624-9; Niessen S, 2010, J VET INTERN MED, V24, P685; Niessen SJM, 2012, DOMEST ANIM ENDOCRIN, V43, P16, DOI 10.1016/j.domaniend.2012.01.006; Niessen SJM, 2010, J VET INTERN MED, V24, P1098, DOI 10.1111/j.1939-1676.2010.0579.x; Niessen SJ, 2009, P BRIT SMALL AN VET, P402; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Rand JS, 2004, J NUTR, V134, p2072S, DOI 10.1093/jn/134.8.2072S; Sato T, 2011, BRIT POULTRY SCI, V52, P273, DOI 10.1080/00071668.2011.560595; Shanaka Stanislaus, 2013, Method of treating or ameliorating type 1 diabetes using fgf21, Patent No. [WO 2013033452 A2, 2013033452]; Shu RZ, 2009, LAB INVEST, V89, P1043, DOI 10.1038/labinvest.2009.63; Sindhu RK, 2004, CLIN EXP HYPERTENS, V26, P43, DOI 10.1081/CEH-120027330; Wang Cong, 2014, FEBS J, V281, P2136, DOI [10.1111/febs.12767, DOI 10.1111/FEBS.12767]; Wang HY, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-14; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu PF, 2015, J DIABETES COMPLICAT, V29, P5, DOI 10.1016/j.jdiacomp.2014.10.001; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060	37	8	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155598	10.1371/journal.pone.0155598	http://dx.doi.org/10.1371/journal.pone.0155598			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203422	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291500019
J	de Stegge, WBA; van Leeuwen, BL; Elferink, MAG; de Bock, GH				de Stegge, Wouter B. Aan; van Leeuwen, Barbara L.; Elferink, Marloes A. G.; de Bock, Geertruida H.			The Evaluation of More Lymph Nodes in Colon Cancer Is Associated with Improved Survival in Patients of All Ages	PLOS ONE			English	Article							COLORECTAL-CANCER; PROGNOSTIC VALUE; ADJUVANT CHEMOTHERAPY; QUALITY MEASURE; TUMOR-CELLS; RESECTION; NUMBER; RATIO; IMPACT; RATES	Background Improvement in survival of patients with colon cancer is reduced in elderly patients compared to younger patients. The aim of this study was to investigate whether the removal of >= 12 lymph nodes can explain differences in survival rates between elderly and younger patients diagnosed with colon cancer. Methods In a population-based cohort study, all patients (N = 41,074) diagnosed with colon cancer stage I to III from 2003 through 2010 from the Netherlands Cancer Registry were included. Age groups were defined as < 66, 66-75 and > 75 years of age. Main outcome measures were overall and relative survival, the latter as a proxy for disease specific survival. Results Over an eight years time period there was a 41.2% increase in patients with >= 12 lymph nodes removed, whereas the percentage of patients with the presence of lymph node metastases remained stable (35.7% to 37.5%). After adjustment for patient and tumour characteristics and adjuvant chemotherapy, it was found that for patients in which >= 12 lymph nodes were removed compared to patients with < 12 lymph nodes removed, there was a statistically significant higher overall survival (< 66: HR: 0.858 (95% CI, 0.789-0.933); 66-75: HR: 0.763 (95% CI, 0.714-0.814); > 75: HR: 0.734 (95% CI, 0.700-0.771)) and relative survival (< 66: RER: 0.783 (95% CI, 0.708-0.865); 66-75: RER: 0.672 (95% CI, 0.611-0.739); > 75: RER: 0.621 (95% CI, 0.567-0.681)) in all three age groups. Conclusions The removal of >= 12 lymph nodes is associated with an improvement in both overall and relative survival in all patients. This association was stronger in the elderly patient. The biology of this association needs further clarification.	[de Stegge, Wouter B. Aan] Hosp Grp Twente, Dept Surg, Almelo Hengelo, Netherlands; [van Leeuwen, Barbara L.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [Elferink, Marloes A. G.] Netherlands Comprehens Canc Org, Utrecht, Netherlands; [de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen	de Bock, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	g.h.de.bock@umcg.nl	; de Bock, Geertruida H./F-6529-2014	van Leeuwen, Barbara/0000-0002-6745-4424; de Bock, Geertruida H./0000-0003-3104-4471				Anisimov VN, 2009, BIOGERONTOLOGY, V10, P323, DOI 10.1007/s10522-008-9209-8; Baxter NN, 2005, J NATL CANCER I, V97, P219, DOI 10.1093/jnci/dji020; Belt EJT, 2012, ANN SURG ONCOL, V19, P1222, DOI 10.1245/s10434-011-2091-7; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bilimoria KY, 2008, J NATL CANCER I, V100, P1310, DOI 10.1093/jnci/djn293; Bilimoria KY, 2008, J AM COLL SURGEONS, V206, P247, DOI 10.1016/j.jamcollsurg.2007.07.044; Bui L, 2006, J SURG ONCOL, V93, P439, DOI 10.1002/jso.20499; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Ederer F., 1959, INSTRUCTIONS IBM 650; Elferink MAG, 2011, ANN ONCOL, V22, P110, DOI 10.1093/annonc/mdq312; Elferink MAG, 2010, EJSO, V36, P64; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goldstein NS, 1996, AM J CLIN PATHOL, V106, P209; Gross CP, 2006, J AM GERIATR SOC, V54, P1898, DOI 10.1111/j.1532-5415.2006.00973.x; Hegde UP, 2009, CLIN DERMATOL, V27, P537, DOI 10.1016/j.clindermatol.2008.09.012; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Jestin P, 2005, EUR J CANCER, V41, P2071, DOI 10.1016/j.ejca.2005.06.012; Kim YW, 2013, ANTICANCER RES, V33, P5143; Mitry E, 2005, EUR J CANCER, V41, P2297, DOI 10.1016/j.ejca.2005.01.028; Murphy J, 2007, DIS COLON RECTUM, V50, P1526, DOI 10.1007/s10350-007-9024-3; Nelson H, 2001, JNCI-J NATL CANCER I, V93, P583, DOI 10.1093/jnci/93.8.583; O'Shea A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104991; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Parkin DM, 2010, INT J CANCER, V127, P2918, DOI 10.1002/ijc.25517; Parnaby CN, 2015, BRIT J CANCER, V113, P212, DOI 10.1038/bjc.2015.211; Parsons HM, 2011, JAMA-J AM MED ASSOC, V306, P1089, DOI 10.1001/jama.2011.1285; Rahbari NN, 2012, J CLIN ONCOL, V30, P60, DOI 10.1200/JCO.2011.36.9504; Rosenberg R, 2010, ANN SURG, V251, P1070, DOI 10.1097/SLA.0b013e3181d7789d; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Sloothaak DAM, 2014, EJSO-EUR J SURG ONC, V40, P263, DOI 10.1016/j.ejso.2013.12.002; Steele SR, 2011, J AM COLL SURGEONS, V213, P95, DOI 10.1016/j.jamcollsurg.2011.04.013; van Erning FN, 2014, EUR J CANCER, V50, P3221, DOI 10.1016/j.ejca.2014.10.011; van Leeuwen BL, 2008, CRIT REV ONCOL HEMAT, V67, P229, DOI 10.1016/j.critrevonc.2008.03.005; van Steenbergen LN, 2010, ANN ONCOL, V21, P2206, DOI 10.1093/annonc/mdq227; van Steenbergen LN, 2010, EJSO-EUR J SURG ONC, V36, P135, DOI 10.1016/j.ejso.2009.05.012; Wittekind CGF, 2004, TNM ATLAS ILLUSTRATE; Wolpin BM, 2007, CA-CANCER J CLIN, V57, P168, DOI 10.3322/canjclin.57.3.168; Wong SL, 2007, JAMA-J AM MED ASSOC, V298, P2149, DOI 10.1001/jama.298.18.2149; Yahagi M, 2016, J GASTROINTEST SURG, V20, P648, DOI 10.1007/s11605-015-3026-6	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155608	10.1371/journal.pone.0155608	http://dx.doi.org/10.1371/journal.pone.0155608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196666	Green Published, Green Submitted, gold			2022-12-26	WOS:000376291100067
J	Bohnert, KR; Gallot, YS; Sato, S; Xiong, GY; Hindi, SM; Kumar, A				Bohnert, Kyle R.; Gallot, Yann S.; Sato, Shuichi; Xiong, Guangyan; Hindi, Sajedah M.; Kumar, Ashok			Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia	FASEB JOURNAL			English	Article						Lewis lung carcinoma; PERK; XBP-1; mTOR; autophagy	ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; TRANSCRIPTION FACTOR; UP-REGULATION; TWEAK-FN14 SYSTEM; MYOSIN ISOFORMS; TRANSGENIC MICE; IN-VIVO; ATROPHY; EXPRESSION	Cachexia is a devastating syndrome that causes morbidity and mortality in a large number of patients with cancer. However, the mechanisms of cancer cachexia remain poorly understood. Accumulation of misfolded proteins in the endoplasmic reticulum (ER) causes stress. The ER responds to this stress through activating certain pathways commonly known as the unfolding protein response (UPR). The main function of UPR is to restore homeostasis, but excessive or prolonged activation of UPR can lead to pathologic conditions. In this study, we examined the role of ER stress and UPR in regulation of skeletal muscle mass in naive conditions and during cancer cachexia. Our results demonstrate that multiple markers of ER stress are highly activated in skeletal muscle of Lewis lung carcinoma (LLC) and Apc(Min/+) mouse models of cancer cachexia. Treatment of mice with 4-phenylbutyrate (4-PBA), a chemical chaperon and a potent inhibitor of ER stress, significantly reduced skeletal muscle strength and mass in both control and LLC-bearing mice. Blocking the UPR also increased the proportion of fast-type fibers in soleus muscle of both control and LLC-bearing mice. Inhibition of UPR reduced the activity of Akt/mTOR pathway and increased the expression of the components of the ubiquitin-proteasome system and autophagy in LLC-bearing mice. Moreover, we found that the inhibition of UPR causes severe atrophy in cultured myotubes. Our study provides initial evidence that ER stress and UPR pathways are essential for maintaining skeletal muscle mass and strength and for protection against cancer cachexia.Bohnert, K. R., Gallot, Y. S., Sato, S., Xiong, G., Hindi, S. M., Kumar, A. Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.	[Bohnert, Kyle R.; Gallot, Yann S.; Sato, Shuichi; Xiong, Guangyan; Hindi, Sajedah M.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA	University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu	Gallot, Yann Simon/GQI-2372-2022; Gallot, Yann Simon/GNO-9167-2022; Gallot, Yann Simon/ABC-1826-2021	Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR059810, AR068313]; National Institute on Aging [AG029623]; U.S. National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068313, R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR059810 and AR068313 and National Institute on Aging Grant AG029623 (to A.K.). Author contributions: K. R. Bohnert, S. M. Hindi, and A. Kumar designed research and analyzed data; K. R. Bohnert, Y. S. Gallot, S. Sato, G. Xiong, and S. M. Hindi performed research; and K. R. Bohnert and A. Kumar wrote the manuscript. The authors report no conflicts of interest.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Caiozzo VJ, 1996, J APPL PHYSIOL, V81, P123, DOI 10.1152/jappl.1996.81.1.123; Chalil S, 2015, BIOCHEM BIOPH RES CO, V468, P702, DOI 10.1016/j.bbrc.2015.11.019; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Cornwell EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087776; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Gao S, 2016, AM J PHYSIOL-CELL PH, V310, pC66, DOI 10.1152/ajpcell.00052.2015; Gomes AV, 2012, FASEB J, V26, P2986, DOI 10.1096/fj.12-204495; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hindi SM, 2014, FASEB J, V28, P1398, DOI 10.1096/fj.13-242123; Hu HL, 2014, CELL PHYSIOL BIOCHEM, V33, P1899, DOI 10.1159/000362967; Hunter RB, 2001, AM J PHYSIOL-CELL PH, V281, pC1285, DOI 10.1152/ajpcell.2001.281.4.C1285; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Ikezoe K, 2007, ACTA NEUROPATHOL, V114, P527, DOI 10.1007/s00401-007-0267-9; Iwasa K, 2014, J NEUROIMMUNOL, V273, P72, DOI 10.1016/j.jneuroim.2014.05.006; Johns N, 2013, INT J BIOCHEM CELL B, V45, P2215, DOI 10.1016/j.biocel.2013.05.032; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Koh HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2851; Kuga A, 2011, HUM MOL GENET, V20, P2975, DOI 10.1093/hmg/ddr201; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Penna F, 2013, AM J PATHOL, V182, P1367, DOI 10.1016/j.ajpath.2012.12.023; Rayavarapu S, 2012, CURR RHEUMATOL REP, V14, P238, DOI 10.1007/s11926-012-0247-5; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Sandri M., 2015, CELL DEV BIOL, DOI [10.1016/j.semcdb.2015.11.002S1084-9521(15)00248-7, DOI 10.1016/J.SEMCDB.2015.11.002S1084-9521(15)00248-7]; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sato S, 2015, FASEB J, V29, P988, DOI 10.1096/fj.14-260703; Schwartz AL, 1999, ANNU REV MED, V50, P57; Seto DN, 2015, J BIOL CHEM, V290, P19976, DOI 10.1074/jbc.M115.638411; Tian M, 2010, INT J ONCOL, V37, P347, DOI 10.3892/ijo_00000683; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu AP, 2014, ACTA PHYSIOL, V211, P201, DOI 10.1111/apha.12263; Zhang GH, 2013, FASEB J, V27, P2893, DOI 10.1096/fj.12-222711; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zode GS, 2015, J CLIN INVEST, V125, P3303, DOI 10.1172/JCI82799	69	76	77	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3053	3068		10.1096/fj.201600250RR	http://dx.doi.org/10.1096/fj.201600250RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27206451	Green Published			2022-12-26	WOS:000382816300006
J	McFadden, BR; Lusk, JL				McFadden, Brandon R.; Lusk, Jayson L.			What consumers don't know about genetically modified food, and how that affects beliefs	FASEB JOURNAL			English	Article						GM food; labeling; public acceptance; public knowledge	SCIENCE; BIASES; MATTER; RISK	In the debates surrounding biotechnology and genetically modified (GM) food, data from consumer polls are often presented as evidence for precaution and labeling. But how much do consumers actually know about the issue? New data collected from a nationwide U.S. survey reveal low levels of knowledge and numerous misperceptions about GM food. Nearly equal numbers of consumers prefer mandatory labeling of foods containing DNA as do those preferring mandatory labeling of GM foods. When given the option, the majority of consumers prefer that decisions about GM food be taken out of their hands and be made by experts. After answering a list of questions testing objective knowledge of GM food, subjective, self-reported knowledge declines somewhat, and beliefs about GM food safety increase slightly. Results suggest that consumers think they know more than they actually do about GM food, and queries about GM facts cause respondents to reassess how much they know. The findings question the usefulness of results from opinion polls as a motivation for creating public policy surrounding GM food.McFadden, B. R., Lusk, J. L. What consumers don't know about genetically modified food, and how that affects beliefs.	[McFadden, Brandon R.] Univ Florida, Dept Food & Resource Econ, 1195 McCarty Hall A, Gainesville, FL 32611 USA; [Lusk, Jayson L.] Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA	State University System of Florida; University of Florida; Oklahoma State University System; Oklahoma State University - Stillwater	McFadden, BR (corresponding author), Univ Florida, Dept Food & Resource Econ, 1195 McCarty Hall A, Gainesville, FL 32611 USA.	brandon.mcfadden@ufl.edu			Hatch Research, Education, and Extension project [FLA-FRE-005422]	Hatch Research, Education, and Extension project	The authors acknowledge the Willard Sparks Endowed Chair (Oklahoma State University) and the Hatch Research, Education, and Extension project online reporting tool (REEport; FLA-FRE-005422) (U.S. Department of Agriculture; https://nifa.usda.gov/tool/reeport). Author contributions: B. R. McFadden and J. L. Lusk were involved in all parts of the research and writing of this article.	Ansolabehere S, 2014, POLIT ANAL, V22, P285, DOI 10.1093/pan/mpt025; Bensaude-Vincent B, 2001, PUBLIC UNDERST SCI, V10, P99, DOI 10.1088/0963-6625/10/1/307; Funk C., 2015, PUBLIC SCI VIEWS SCI; Gaskell G, 1999, SCIENCE, V285, P384, DOI 10.1126/science.285.5426.384; Gaskell G, 2005, SCIENCE, V310, P1908, DOI 10.1126/science.1119444; Kahan D. M., 2011, TRAGEDY RISK PERCEPT; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahneman D., 2011, THINKING FAST SLOW; Lusk JL, 2014, ANNU REV RESOUR ECON, V6, P381, DOI 10.1146/annurev-resource-100913-012735; MARRIS C, 2001, PUBLIC ATTITUDES AGR; McFadden BR, 2015, FOOD POLICY, V54, P35, DOI 10.1016/j.foodpol.2015.04.010; Onyango B., 2006, Journal of Food Distribution Research, V37, P126; PAGE BI, 1983, AM POLIT SCI REV, V77, P175, DOI 10.2307/1956018; Phillips DM, 2013, PSYCHOL MARKET, V30, P739, DOI 10.1002/mar.20642; Rabin M, 1999, Q J ECON, V114, P37, DOI 10.1162/003355399555945; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; U.S. Department of Agriculture (USDA), 2021, PROF STAND DAT; U.S. Senate Committee on Agriculture Nutrition and Forestry, NAT VOL BIOENG FOOD; ZIMAN J, 1991, SCI TECHNOL HUM VAL, V16, P99, DOI 10.1177/016224399101600106	20	50	50	1	97	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3091	3096		10.1096/fj.201600598	http://dx.doi.org/10.1096/fj.201600598			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27199295				2022-12-26	WOS:000382816300009
J	Lin, S; Yuan, ZF; Han, YM; Marchione, DM; Garcia, BA				Lin, Shu; Yuan, Zuo-Fei; Han, Yumiao; Marchione, Dylan M.; Garcia, Benjamin A.			Preferential Phosphorylation on Old Histones during Early Mitosis in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHROMOSOME CONDENSATION; H3 LYSINE-56 ACETYLATION; DROSOPHILA MALE GERMLINE; AURORA-B; IN-VIVO; POSTTRANSLATIONAL MODIFICATION; MASS-SPECTROMETRY; DNA-REPLICATION; GENE-EXPRESSION; METHYLATION	How histone post-translational modifications (PTMs) are inherited through the cell cycle remains poorly understood. Canonical histones are made in the S phase of the cell cycle. Combining mass spectrometry-based technologies and stable isotope labeling by amino acids in cell culture, we question the distribution of multiple histone PTMs on old versus new his tones in synchronized human cells. We show that histone PTMs can be grouped into three categories according to their distributions. Most lysine mono-methylation and acetylation PTMs are either symmetrically distributed on old and new histones or are enriched on new histones. In contrast, most di- and tri-methylation PTMs are enriched on old histones, suggesting that the inheritance of different PTMs is regulated distinctly. Intriguingly, old and new histones are distinct in their phosphorylation status during early mitosis in the following three human cell types: HeLa, 293T, and human foreskin fibroblast cells. The mitotic hallmark H3SlOph is predominantly associated with old H3 at early mitosis and becomes symmetric with the progression of mitosis. This same distribution was observed with other mitotic phosphorylation marks, including H3T3/T6ph, H3.1/ 2S28ph, and H1.4S26ph but not S28/S3lph on the H3 variant H3.3. Although H3SlOph often associates with the neighboring Lys -9 di- or tri-methylations, they are not required for the asymmetric distribution of Ser-10 phosphorylation on the same H3 tail. Inhibition of the kinase Aurora B does not change the distribution despite significant reduction of H3Sl0ph levels. However, K9me2 abundance on the new H3 is significantly reduced after Aurora B inhibition, suggesting a cross-talk between H3SlOph and H3K9me2.	[Lin, Shu; Yuan, Zuo-Fei; Han, Yumiao; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Epigenet Program, Philadelphia, PA 19104 USA; [Marchione, Dylan M.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lin, Shu] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Dartmouth College	Garcia, BA (corresponding author), Univ Penn, Dept Biochem & Biophys, Epigenet Program, Philadelphia, PA 19104 USA.	bgarci@mail.med.upenn.edu	Yuan, Zuofei/O-3209-2017	Yuan, Zuofei/0000-0003-1252-6766; Marchione, Dylan/0000-0001-6941-0604	National Science Foundation CAREER award; National Institutes of Health [GM110174, AI118891]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174] Funding Source: NIH RePORTER	National Science Foundation CAREER award(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation CAREER award and National Institutes of Health Grants GM110174 and AI118891 (to B. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Annunziato AT, 2015, GENES-BASEL, V6, P353, DOI 10.3390/genes6020353; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cerutti H, 2009, EPIGENETICS-US, V4, P71, DOI 10.4161/epi.4.2.7781; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Demidov D, 2009, PLANT J, V59, P221, DOI 10.1111/j.1365-313X.2009.03861.x; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Hammond SL, 2014, CELL CYCLE, V13, P440, DOI 10.4161/cc.27269; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003558; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kang B, 2011, GENE DEV, V25, P1359, DOI 10.1101/gad.2055511; Kettenbach AN, 2011, ANAL CHEM, V83, P7635, DOI 10.1021/ac201894j; Kim W, 2014, CELL CYCLE, V13, P726, DOI 10.4161/cc.28104; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li QR, 2009, J PROTEOME RES, V8, P5375, DOI 10.1021/pr900659n; Lin S, 2014, MOL CELL PROTEOMICS, V13, P2450, DOI 10.1074/mcp.O113.036459; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Oki Masaya, 2007, Subcell Biochem, V41, P319; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Perez-Cadahia B, 2010, CURR OPIN DRUG DISC, V13, P613; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Petruk S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3841; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Polioudaki H, 2004, FEBS LETT, V560, P39, DOI 10.1016/S0014-5793(04)00060-2; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Sarg B, 2006, J BIOL CHEM, V281, P6573, DOI 10.1074/jbc.M508957200; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Tran V, 2012, SCIENCE, V338, P679, DOI 10.1126/science.1226028; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002; Xu M, 2012, EMBO REP, V13, P60, DOI 10.1038/embor.2011.206; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011; Zee BM, 2012, MOL CELL BIOL, V32, P2503, DOI 10.1128/MCB.06673-11; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang Q, 2011, ONCOGENE, V30, P3943, DOI 10.1038/onc.2011.105	72	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15342	15357		10.1074/jbc.M116.726067	http://dx.doi.org/10.1074/jbc.M116.726067			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226594	Green Published, hybrid			2022-12-26	WOS:000380583200039
J	Lee, S; Kim, E; Jhun, H; Hong, J; Kwak, A; Jo, S; Bae, S; Lee, J; Kim, B; Lee, J; Youn, S; Kim, S; Kim, M; Kim, H; Lee, Y; Choi, DK; Kim, YS; Kim, S				Lee, Siyoung; Kim, Eunsom; Jhun, Hyunjhung; Hong, Jaewoo; Kwak, Areum; Jo, Seunghyun; Bae, Suyoung; Lee, Jongho; Kim, Busun; Lee, Jungmin; Youn, Sulah; Kim, Somi; Kim, Miyeon; Kim, Hyunwoo; Lee, Youngmin; Choi, Dong-Ki; Kim, Yong-Sung; Kim, Soohyun			Proinsulin Shares a Motif with Interleukin-1 (IL-1) and Induces Inflammatory Cytokine via Interleukin-1 Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; insulin; interleukin 1 (IL-1); protein motif; toll; interleukin-1 receptor (TIR)*	CELL-MEDIATED-IMMUNITY; DEPENDENT DIABETES-MELLITUS; TUMOR-NECROSIS-FACTOR; INSULIN; INFECTION; FAMILY; LYMPHOCYTES; ANTAGONIST; EXPRESSION; IL-1-ALPHA	Although it has been established that diabetes increases susceptibility to infections, the role of insulin (INS) in the immune response is unknown. Here, we investigated the immunological function of INS. Proinsulin dimer (pINSd) was a potent immune stimulus that induced inflammatory cytokines, but mature INS was unable to induce an immune response. An affinity-purified rabbit polyclonal antibody raised against mature IL-1 recognized IL-1 and pINS but failed to detect mature INS and IL-1. Analysis of the pINS sequence revealed the existence of an INS/IL-1 motif in the C-peptide of pINS. Surprisingly, the INS/IL-1 motif was recognized by monoclonal antibody raised against IL-1. Deleting the INS/IL-1 motif in pINSd and IL-1 changed their activities. To investigate the pINSd receptor, the reconstitution of IL-1 receptor 1 (IL-1R1) in Wish cells restored pINSd activity that was reversed by an IL-1R antagonist. These data suggested that pINSd needs IL-1R1 for inflammatory cytokine induction. Mouse embryo fibroblast cells of IL-1R1-deficient mice further confirmed that pINSd promotes immune responses through IL-1R1.	[Lee, Siyoung; Kim, Eunsom; Jhun, Hyunjhung; Hong, Jaewoo; Kwak, Areum; Jo, Seunghyun; Bae, Suyoung; Lee, Jongho; Kim, Busun; Lee, Jungmin; Youn, Sulah; Kim, Soohyun] Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, 120 Neungdong Ro, Seoul 05029, South Korea; [Jhun, Hyunjhung; Hong, Jaewoo; Kwak, Areum; Jo, Seunghyun; Kim, Soohyun] Konkuk Univ, Coll Vet Med, 120 Neungdong Ro, Seoul 05029, South Korea; [Kim, Somi; Kim, Miyeon; Kim, Hyunwoo] Jeju Natl Univ, Dept Internal Med, Div Nephrol, Jeju Si 63243, Jeju Do, South Korea; [Lee, Youngmin] Inje Univ, Pusan Paik Hosp, Dept Med, Coll Med, Busan 47392, South Korea; [Choi, Dong-Ki; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea	Konkuk University; Konkuk University; Jeju National University; Inje University; Ajou University	Kim, S (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, 120 Neungdong Ro, Seoul 05029, South Korea.	soohyun@konkuk.ac.kr		Hong, Jaewoo/0000-0003-3456-3672; Kim, Yong-Sung/0000-0003-2673-1509	National Research Foundation of Korea [NRF-2015R1A2A2A01003472, NRF-2014M3A6A4075058, NRF-2015R1A2A1A15051472]; Konkuk University	National Research Foundation of Korea(National Research Foundation of Korea); Konkuk University	This work was supported by National Research Foundation of Korea Grants NRF-2015R1A2A2A01003472, -2014M3A6A4075058, and -2015R1A2A1A15051472, and this paper resulted from the Konkuk University research support program. The authors declare that they have no conflicts of interest with the contents of this article.	Banting FG, 1923, BRIT MED J, V1923, P8, DOI 10.1136/bmj.1.3236.8; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; CASEY JI, 1977, J INFECT DIS, V136, P495, DOI 10.1093/infdis/136.4.495; CORDELL B, 1979, CELL, V18, P533, DOI 10.1016/0092-8674(79)90070-9; CRIADO E, 1992, SURG GYNECOL OBSTET, V175, P135; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; ELIASHIV A, 1978, ARCH SURG-CHICAGO, V113, P1180; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gasbarrini A, 1998, EUR J GASTROEN HEPAT, V10, P469, DOI 10.1097/00042737-199806000-00006; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; HOEPELMAN IM, 1994, INT J ANTIMICROB AG, V4, P113, DOI 10.1016/0924-8579(94)90043-4; Hong J, 2011, J BIOL CHEM, V286, P20078, DOI 10.1074/jbc.M111.219089; IMANI F, 1993, J EXP MED, V178, P2165, DOI 10.1084/jem.178.6.2165; Kewcharoenwong C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03363; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kim SHM, 2001, P NATL ACAD SCI USA, V98, P3304, DOI 10.1073/pnas.051634098; KITABCHI AE, 1977, METABOLISM, V26, P547, DOI 10.1016/0026-0495(77)90099-3; Knobler H, 2000, MAYO CLIN PROC, V75, P355, DOI 10.4065/75.4.355; Kumar S, 2003, AM J PATHOL, V163, P2531, DOI 10.1016/S0002-9440(10)63608-5; LAMEY PJ, 1988, J ORAL PATHOL MED, V17, P354, DOI 10.1111/j.1600-0714.1988.tb01549.x; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Macleod JJR, 1922, BRIT MED J, V1922, P833, DOI 10.1136/bmj.2.3227.833; MOORADIAN AD, 1991, DIABETES CARE, V14, P63, DOI 10.2337/diacare.14.1.63; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; MOROHOSHI M, 1995, ANN NY ACAD SCI, V748, P562; MOUTSCHEN MP, 1992, DIABETES METAB, V18, P187; Myliwska J., 1998, HORM METAB RES, V30, P158; OHNO Y, 1993, J CLIN ENDOCR METAB, V77, P1072, DOI 10.1210/jc.77.4.1072; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; PLOUFFE JF, 1978, INFECT IMMUN, V21, P425, DOI 10.1128/IAI.21.2.425-429.1978; POZZILLI P, 1984, BIOMED BIOCHIM ACTA, V43, P621; ROBERTSO.HD, 1974, SURGERY, V75, P123; SANGER F, 1951, BIOCHEM J, V49, P463, DOI 10.1042/bj0490463; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; VLASSARA H, 1988, SCIENCE, V240, P1546, DOI 10.1126/science.3259727; Watkins RA, 2016, TRANSL RES, V168, P96, DOI 10.1016/j.trsl.2015.08.010; WILLIAMS DC, 1982, SCIENCE, V215, P687, DOI 10.1126/science.7036343; Zozulinska D, 1999, DIABETOLOGIA, V42, P117	41	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14620	14627		10.1074/jbc.M116.731026	http://dx.doi.org/10.1074/jbc.M116.731026			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226621	Green Published, hybrid			2022-12-26	WOS:000380366700018
J	Zhou, Q; Hu, HQ; Li, ZY				Zhou, Qing; Hu, Huiqing; Li, Ziyin			An EF-hand-containing Protein in Trypanosoma brucei Regulates Cytokinesis Initiation by Maintaining the Stability of the Cytokinesis Initiation Factor CIF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell cycle; cytokinesis; microbiology; Trypanosoma brucei; aurora B kinase; polo-like kinase; backup cytokinesis	FLAGELLUM ATTACHMENT ZONE; POLO-LIKE KINASE; CELL-DIVISION; INDUCIBLE EXPRESSION; HELA-CELLS; MORPHOGENESIS; CALMODULIN; COMPLEX; CYCLE; INTERDEPENDENCE	Trypanosoma brucei undergoes cytokinesis uni-directionally from the anterior tip of the new flagellum attachment zone (FAZ) toward the posterior end of the cell. We recently delineated a novel signaling pathway composed of polo-like kinase, cytokinesis initiation factor 1 (CIF1), and aurora B kinase that acts in concert at the new FAZ tip to regulate cytokinesis initiation. To identify new cytokinesis regulators, we carried out proximity-dependent biotin identification and identified many CIF1 binding partners and near neighbors. Here we report a novel CIF1-binding protein, named CIF2, and its mechanistic role in cytokinesis initiation. CIF2 interacts with CIF1 in vivo and co-localizes with CIF1 at the new FAZ tip during early cell cycle stages. RNAi of CIF2 inhibited the normal, anterior-to-posterior cytokinesis but activated an alternative, posterior-to-anterior cytokinesis. CIF2 depletion destabilized CIF1 and disrupted the localization of polo-like kinase and aurora B kinase to the new FAZ tip, thus revealing the mechanistic role of CIF2 in cytokinesis initiation. Surprisingly, overexpression of CIF2 also inhibited the normal, anterior-to-posterior cytokinesis and triggered the alternative, posterior-to-anterior cytokinesis, suggesting a tight control of CIF2 protein abundance. These results identified a new regulator in the cytokinesis regulatory pathway and reiterated that a backup cytokinesis pathway is activated by inhibiting the normal cytokinesis pathway.	[Zhou, Qing; Hu, Huiqing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/A-8296-2019; Zhou, Qing/I-6223-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [R01 AI101437]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI101437 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badjatia N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005498; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Carmena M, 2008, BIOCHEM SOC T, V36, P367, DOI 10.1042/BST0360367; Choudhary A, 2013, P NATL ACAD SCI USA, V110, P13026, DOI 10.1073/pnas.1308203110; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Gonda K, 1999, J CELL SCI, V112, P3619; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hu HQ, 2015, J BIOL CHEM, V290, P30453, DOI 10.1074/jbc.M115.694109; Hu HQ, 2015, J BIOL CHEM, V290, P25012, DOI 10.1074/jbc.M115.674796; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Li CJ, 1999, J CELL SCI, V112, P1567; Li Z, 2010, EUKARYOT CELL, V9, P705, DOI 10.1128/EC.00330-09; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2012, EUKARYOT CELL, V11, P1180, DOI 10.1128/EC.00145-12; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; LIU TY, 1992, MOL BIOL CELL, V3, P1403, DOI 10.1091/mbc.3.12.1403; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Mittal S, 2015, J BIOSCIENCES, V40, P863, DOI 10.1007/s12038-015-9570-0; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Sunter JD, 2016, TRENDS PARASITOL, V32, P309, DOI 10.1016/j.pt.2015.12.010; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; Thakur J, 2012, PLOS GENET, V8, P466, DOI 10.1371/journal.pgen.1002661; Tsang WY, 2006, MOL BIOL CELL, V17, P3423, DOI 10.1091/mbc.E06-04-0371; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Webb SE, 2008, PHILOS T R SOC B, V363, P1363, DOI 10.1098/rstb.2007.2253; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wei Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073869; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Yu YY, 2005, CELL RES, V15, P548, DOI 10.1038/sj.cr.7290324; Yu YY, 2004, INT J BIOCHEM CELL B, V36, P1562, DOI 10.1016/j.biocel.2003.12.016; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2015, MOL MICROBIOL, V98, P667, DOI 10.1111/mmi.13149; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	50	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14395	14409		10.1074/jbc.M116.726133	http://dx.doi.org/10.1074/jbc.M116.726133			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226595	hybrid, Green Published			2022-12-26	WOS:000380366700001
J	Chen, J; Moinard, M; Xu, JP; Wang, SX; Foulongne-Oriol, M; Zhao, RL; Hyde, KD; Callac, P				Chen, Jie; Moinard, Magalie; Xu, Jianping; Wang, Shouxian; Foulongne-Oriol, Marie; Zhao, Ruilin; Hyde, Kevin D.; Callac, Philippe			Genetic Analyses of the Internal Transcribed Spacer Sequences Suggest Introgression and Duplication in the Medicinal Mushroom Agaricus subrufescens	PLOS ONE			English	Article							CONCERTED EVOLUTION; HETEROKARYONS; CULTIVATION; BURNETTII; LINKAGE; MARKER; REGION; BRAZIL; FUNGI; MAP	The internal transcribed spacer (ITS) region of the nuclear ribosomal RNA gene cluster is widely used in fungal taxonomy and phylogeographic studies. The medicinal and edible mushroom Agaricus subrufescens has a worldwide distribution with a high level of polymorphism in the ITS region. A previous analysis suggested notable ITS sequence heterogeneity within the wild French isolate CA487. The objective of this study was to investigate the pattern and potential mechanism of ITS sequence heterogeneity within this strain. Using PCR, cloning, and sequencing, we identified three types of ITS sequences, A, B, and C with a balanced distribution, which differed from each other at 13 polymorphic positions. The phylogenetic comparisons with samples from different continents revealed that the type C sequence was similar to those found in Oceanian and Asian specimens of A. subrufescens while types A and B sequences were close to those found in the Americas or in Europe. We further investigated the inheritance of these three ITS sequence types by analyzing their distribution among single-spore isolates from CA487. In this analysis, three co-dominant markers were used firstly to distinguish the homokaryotic offspring from the heterokaryotic offspring. The homokaryotic offspring were then analyzed for their ITS types. Our genetic analyses revealed that types A and B were two alleles segregating at one locus ITSI, while type C was not allelic with types A and B but was located at another unlinked locus ITSII. Furthermore, type C was present in only one of the two constitutive haploid nuclei (n) of the heterokaryotic (n+n) parent CA487. These data suggest that there was a relatively recent introduction of the type C sequence and a duplication of the ITS locus in this strain. Whether other genes were also transferred and duplicated and their impacts on genome structure and stability remain to be investigated.	[Chen, Jie; Moinard, Magalie; Foulongne-Oriol, Marie; Callac, Philippe] INRA, MycSA, Villenave Dornon, France; [Chen, Jie; Hyde, Kevin D.] Mae Fah Luang Univ, Ctr Excellence Fungal Res, Chiang Rai, Thailand; [Chen, Jie; Hyde, Kevin D.] Mae Fah Luang Univ, Sch Sci, Chiang Rai, Thailand; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Wang, Shouxian] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Wang, Shouxian] Beijing Engn Res Ctr Edible Mushroom, Beijing, Peoples R China; [Zhao, Ruilin] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	INRAE; Mae Fah Luang University; Mae Fah Luang University; McMaster University; Beijing Academy of Agriculture & Forestry; Chinese Academy of Sciences; Institute of Microbiology, CAS	Callac, P (corresponding author), INRA, MycSA, Villenave Dornon, France.	philippe.callac@bordeaux.inra.fr	Foulongne-Oriol, Marie/AAB-9831-2019; Hyde, Kevin D/F-7890-2010; Chen, Jie/E-6836-2019	Callac, Philippe/0000-0001-6860-0983; Foulongne-Oriol, Marie/0000-0002-5668-5286; Chen, Jie/0000-0001-9298-4892	French Ministry of Foreign Affairs; Special Science and Technology Innovation Project of Beijing Academy of Agriculture and Forestry Sciences [KJCX20151408]; National Natural Science Foundation of China [31000013, 31360014, 31470152]; Thailand Research Fund Grant [BRG 5580009]	French Ministry of Foreign Affairs; Special Science and Technology Innovation Project of Beijing Academy of Agriculture and Forestry Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thailand Research Fund Grant(Thailand Research Fund (TRF))	This research was supported by the French Ministry of Foreign Affairs ( project AGASIA of the regional program Bio-Asie; PC), the Special Science and Technology Innovation Project of Beijing Academy of Agriculture and Forestry Sciences ( KJCX20151408; SW), the National Natural Science Foundation of China ( Project ID: 31000013, 31360014 and 31470152; RZ) and the Thailand Research Fund Grant ( BRG 5580009; KDH) entitled "Taxonomy, Phylogeny and Biochemistry of Thai Basidiomycetes." The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	Callac P, 1997, FEMS MICROBIOL LETT, V146, P235, DOI 10.1111/j.1574-6968.1997.tb10199.x; Chen J, 2016, PHYTOTAXA, V252, P1, DOI 10.11646/phytotaxa.252.1.1; COEN ES, 1983, CELL, V33, P849, DOI 10.1016/0092-8674(83)90027-2; de Brito MR, 2016, APPL MICROBIOL BIOT, V100, P781, DOI 10.1007/s00253-015-7070-7; Fell JW, 2007, FEMS YEAST RES, V7, P1399, DOI 10.1111/j.1567-1364.2007.00297.x; Foulongne-Oriol M, 2016, G3-GENES GENOM GENET, V6, P1217, DOI 10.1534/g3.115.025718; Foulongne-Oriol M, 2014, APPL MICROBIOL BIOT, V98, P7879, DOI 10.1007/s00253-014-5844-y; Foulongne-Oriol M, 2010, FUNGAL GENET BIOL, V47, P226, DOI 10.1016/j.fgb.2009.12.003; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Gui Y, 2015, FUNGAL BIOL-UK, V119, P79, DOI 10.1016/j.funbio.2014.10.005; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hijri M, 1999, FUNGAL GENET BIOL, V26, P141, DOI 10.1006/fgbi.1998.1112; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; James TY, 2009, MYCOL RES, V113, P583, DOI 10.1016/j.mycres.2009.01.006; Kerrigan RW, 2005, MYCOLOGIA, V97, P12, DOI 10.3852/mycologia.97.1.12; KERRIGAN RW, 1994, EXP MYCOL, V18, P193, DOI 10.1006/emyc.1994.1020; KERRIGAN RW, 1992, MYCOLOGIA, V84, P575, DOI 10.2307/3760324; Kerrigan RW, 1993, REP TOTTORI MYCOL I, V31, P188; Largeteau ML, 2011, APPL MICROBIOL BIOT, V92, P897, DOI 10.1007/s00253-011-3630-7; Li Y, 2013, MOL PHYLOGENET EVOL, V68, P373, DOI 10.1016/j.ympev.2013.04.010; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Llarena-Hernandez CR, 2014, J SCI FOOD AGR, V94, P77, DOI 10.1002/jsfa.6200; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Rees BJ, 2013, MYCOLOGIA, V105, P1043, DOI 10.3852/12-404; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thongklang N, 2016, MYCOSCIENCE, V57, P239, DOI 10.1016/j.myc.2016.02.003; Thongklang N, 2014, FUNGAL BIOL-UK, V118, P1013, DOI 10.1016/j.funbio.2014.10.004; Wang DM, 2005, CAN J MICROBIOL, V51, P113, DOI 10.1139/W04-118; Weitemier K, 2015, PEERJ, V2, DOI 10.7717/peerj.718; Wisitrassameewong K, 2012, CHIANG MAI J SCI, V39, P281; Wisitrassameewong K, 2012, SAUDI J BIOL SCI, V19, P131, DOI 10.1016/j.sjbs.2012.01.003; Zhao RL, 2016, FUNGAL DIVERS; Zhao RL, 2011, FUNGAL DIVERS, V51, P279, DOI 10.1007/s13225-011-0136-7	35	18	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156250	10.1371/journal.pone.0156250	http://dx.doi.org/10.1371/journal.pone.0156250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228131	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500094
J	Domergue, S; Bony, C; Maumus, M; Toupet, K; Frouin, E; Rigau, V; Vozenin, MC; Magalon, G; Jorgensen, C; Noel, D				Domergue, Sophie; Bony, Claire; Maumus, Marie; Toupet, Karine; Frouin, Eric; Rigau, Valerie; Vozenin, Marie-Catherine; Magalon, Guy; Jorgensen, Christian; Noel, Daniele			Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars	PLOS ONE			English	Article							REPAIR; SCAFFOLD; THERAPY; KELOIDS; GRAFTS; UPDATE; INJURY; MODEL	Hypertrophic scars (HTS) are characterized by excessive amount of collagen deposition and principally occur following burn injuries or surgeries. In absence of effective treatments, the use of mesenchymal stem/stromal cells, which have been shown to attenuate fibrosis in various applications, seems of interest. The objectives of the present study were therefore to evaluate the effect of human adipose tissue-derived mesenchymal stem cells (hASC) on a pre-existing HTS in a humanized skin graft model in Nude mice and to compare the efficacy of hASCs versus stromal vascular fraction (SVF). We found that injection of SVF or hASCs resulted in an attenuation of HTS as noticed after clinical evaluation of skin thickness, which was associated with lower total collagen contents in the skins of treated mice and a reduced dermis thickness after histological analysis. Although both SVF and hASCs were able to significantly reduce the clinical and histological parameters of HTS, hASCs appeared to be more efficient than SVF. The therapeutic effect of hASCs was attributed to higher expression of TGF beta 3 and HGF, which are important anti-fibrotic mediators, and to higher levels of MMP-2 and MMP-2/TIMP-2 ratio, which reflect the remodelling activity responsible for fibrosis resorption. These results demonstrated the therapeutic potential of hASCs for clinical applications of hypertrophic scarring.	[Domergue, Sophie; Bony, Claire; Maumus, Marie; Toupet, Karine; Jorgensen, Christian; Noel, Daniele] Hop St Eloi, INSERM, U1183, F-34295 Montpellier, France; [Domergue, Sophie; Bony, Claire; Maumus, Marie; Toupet, Karine; Frouin, Eric; Jorgensen, Christian; Noel, Daniele] Univ Montpellier, UFR Med, F-34967 Montpellier, France; [Domergue, Sophie] Hop Gui De Chauliac, Chirurg Plast Reconstructrice & Esthet, F-34295 Montpellier, France; [Frouin, Eric; Rigau, Valerie] Hop Gui De Chauliac, Biopathol, F-34295 Montpellier, France; [Vozenin, Marie-Catherine] CHU Vaudois, Radiat Oncol Lab, Lausanne, Switzerland; [Magalon, Guy] Hop Conception, Chirurg Plast, F-13005 Marseille, France; [Jorgensen, Christian; Noel, Daniele] Hop Lapeyronie, Serv Immunorhumatol Therapeut, F-34295 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier	Noel, D (corresponding author), Hop St Eloi, INSERM, U1183, F-34295 Montpellier, France.; Noel, D (corresponding author), Univ Montpellier, UFR Med, F-34967 Montpellier, France.; Noel, D (corresponding author), Hop Lapeyronie, Serv Immunorhumatol Therapeut, F-34295 Montpellier, France.	daniele.noel@inserm.fr	Vozenin, Marie-Catherine/AAR-2268-2021; Noel, Daniele/E-5719-2016; Maumus, Marie/AAD-1725-2019	Vozenin, Marie-Catherine/0000-0002-2109-8073; Noel, Daniele/0000-0002-3498-3776; Frouin, Eric/0000-0002-8432-3194; jorgensen, christian/0000-0001-6947-8094	Inserm Institute; University of Montpellier; Centre Hospitalier Regional Universitaire of Montpellier; Agence Nationale pour la Recherche [ANR-11-INSB-005]	Inserm Institute(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier; Centre Hospitalier Regional Universitaire of Montpellier; Agence Nationale pour la Recherche(French National Research Agency (ANR))	Work in the laboratory Inserm U1183 was supported by the Inserm Institute, the University of Montpellier and funding from the Centre Hospitalier Regional Universitaire of Montpellier. We also thank the Agence Nationale pour la Recherche for support of the national infrastructure: "ECELLFRANCE: Development of a national adult mesenchymal stem cell based therapy platform" (ANR-11-INSB-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178; Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260; Ramos MLC, 2008, J BURN CARE RES, V29, P363, DOI 10.1097/BCR.0b013e3181667557; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duscher D., 2015, GERONTOLOGY; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Gimble JM, 2012, REGEN MED, V7, P225, DOI [10.2217/RME.11.119, 10.2217/rme.11.119]; Granel B, ANN RHEUM DIS; Jackson WM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt111; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kokai LE, 2014, TRANSL RES, V163, P399, DOI 10.1016/j.trsl.2013.11.009; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Laverdet B, 2014, PATHOL BIOL, V62, P108, DOI 10.1016/j.patbio.2014.01.002; Liu SY, 2014, J INVEST DERMATOL, V134, P2648, DOI 10.1038/jid.2014.169; Liu YL, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt526; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033; Rabello FB, 2014, CLINICS, V69, P565, DOI 10.6061/clinics/2014(08)11; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Semon JA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt391; Song C, 2014, ANN PLAS SURG, V73, pS108, DOI 10.1097/SAP.0000000000000256; Travers RL, 2015, INT J OBESITY, V39, P762, DOI 10.1038/ijo.2014.195; Usunier B, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/340257; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Yang DY, 2007, PLAST RECONSTR SURG, V119, P104, DOI 10.1097/01.prs.0000244828.80490.62; Yasuda K, 2012, CYTOTHERAPY, V14, P1089, DOI 10.3109/14653249.2012.693157	29	34	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156161	10.1371/journal.pone.0156161	http://dx.doi.org/10.1371/journal.pone.0156161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227960	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500074
J	Leekitcharoenphon, P; Raufu, I; Nielsen, MT; Lund, BSR; Ameh, JA; Ambali, AG; Sorensen, G; Le Hello, S; Aarestrup, FM; Hendriksen, RS				Leekitcharoenphon, Pimlapas; Raufu, Ibrahim; Nielsen, Mette T.; Lund, Birthe S. Rosenqvist; Ameh, James A.; Ambali, Abdul G.; Sorensen, Gitte; Le Hello, Simon; Aarestrup, Frank M.; Hendriksen, Rene S.			Investigating Salmonella Eko from Various Sources in Nigeria by Whole Genome Sequencing to Identify the Source of Human Infections	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; CHICKENS; PREVALENCE; RESISTANCE; SEROTYPES; SEROVARS; REGION; IBADAN	Twenty-six Salmonella enterica serovar Eko isolated from various sources in Nigeria were investigated by whole genome sequencing to identify the source of human infections. Diversity among the isolates was observed and camel and cattle were identified as the primary reservoirs and the most likely source of the human infections.	[Leekitcharoenphon, Pimlapas; Nielsen, Mette T.; Aarestrup, Frank M.; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, DK-2800 Lyngby, Denmark; [Leekitcharoenphon, Pimlapas; Nielsen, Mette T.; Aarestrup, Frank M.; Hendriksen, Rene S.] European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark; [Raufu, Ibrahim; Ambali, Abdul G.] Univ Ilorin, Dept Vet Microbiol, Fac Vet Med, Ilorin, Nigeria; [Lund, Birthe S. Rosenqvist; Sorensen, Gitte] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Ameh, James A.] Univ Abuja, Dept Vet Microbiol & Parasitol, Fac Vet Med, Abuja, Nigeria; [Le Hello, Simon] Ctr Natl Reference Salmonella, Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France	Technical University of Denmark; University of Ilorin; Technical University of Denmark; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hendriksen, RS (corresponding author), Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, DK-2800 Lyngby, Denmark.; Hendriksen, RS (corresponding author), European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark.	rshe@food.dtu.dk	Le Hello, Simon/K-6584-2018; Leekitcharoenphon, Pimlapas/AAB-5487-2021	Le Hello, Simon/0000-0001-7993-4305; Hendriksen, Rene S./0000-0003-2934-8214; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142; Aarestrup, Frank/0000-0002-7116-2723	Danish Council for Strategic Research [09067103]; Center for Genomic Epidemiology; World Health Organization Global Foodborne Infections Network	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Center for Genomic Epidemiology; World Health Organization Global Foodborne Infections Network	This work was supported by the Danish Council for Strategic Research ( grant number: 09067103), Center for Genomic Epidemiology ( www.genomicepidemiology.org), and by the World Health Organization Global Foodborne Infections Network ( www.who.int/gfn).	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Carattoli A, 2014, ANTIMICROB AGENTS CH; Fashae K, 2014, FOLIA MICROBIOL, V59, P69, DOI 10.1007/s12223-013-0270-6; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia-Migura L, 2012, MICROB DRUG RESIST, V18, P88, DOI 10.1089/mdr.2011.0064; Hendriksen RS, 2015, J CLIN MICROBIOL, V53, P262, DOI 10.1128/JCM.02026-14; Hendriksen RS, 2011, FOODBORNE PATHOG DIS; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Raufu I, 2013, J APPL MICROBIOL, V115, P1059, DOI 10.1111/jam.12304; Raufu I, 2009, FOODBORNE PATHOG DIS, V6, P425, DOI 10.1089/fpd.2008.0150; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tusevljak N, 2012, FOODBORNE PATHOG DIS, V9, P487, DOI 10.1089/fpd.2011.1063; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Wouafo M, 2010, MICROB DRUG RESIST, V16, P171, DOI 10.1089/mdr.2009.0127; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156212	10.1371/journal.pone.0156212	http://dx.doi.org/10.1371/journal.pone.0156212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228329	Green Submitted, gold, Green Published			2022-12-26	WOS:000376882500081
J	Pilo, R; Metzger, Z; Brosh, T				Pilo, Raphael; Metzger, Zvi; Brosh, Tamar			Strain Distribution in Root Surface Dentin of Maxillary Central Incisors during Lateral Compaction	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; STEEL FINGER SPREADERS; GUTTA-PERCHA; STAINLESS-STEEL; NICKEL-TITANIUM; MECHANICAL-PROPERTIES; ENDODONTIC TREATMENT; CURVED CANALS; IN-VITRO; FRACTURE-RESISTANCE	Aim To precisely quantify the circumferential strains created along the radicular dentin of maxillary incisors during a simulated clinical procedure of lateral compaction. Methods Six miniature strain gauges were bonded on the roots of fourteen recently extracted maxillary central incisors that were subjected to root canal instrumentation. The strain gauges were bonded at three levels (apical, middle, and coronal) and four aspects (buccal, lingual, mesial, and distal) of the roots. Each tooth was embedded in a PVC cylinder containing polyvinyl-siloxane impression material. Root filling was then performed by simulating the clinical procedure of lateral compaction using nickel-titanium finger spreaders. The force applied to the spreader and the strains developing in the surface root dentin were continuously recorded at a frequency of 10 Hz. Results The highest strains that developed during lateral compaction were in the mesial and distal aspects at the apical level of the root. The magnitudes of the maximal mesial/distal strains at the apical as well as the mid-root levels were approximately 2.5-3 times higher than those at the buccal/lingual aspects (p = 0.041). The strains decreased significantly (p<0.04) from the apical through the mid-root levels to the coronal level, yielding gradients of 2.5- and 6-fold, respectively. The mesial and distal strains were consistently tensile and did not differ significantly; however, the buccal strains were generally 35-65% higher than the lingual strains (p = 0.078). Lateral compaction resulted in the gradual build-up of residual strains, resulting in generation of a 'stair-step' curve. These strains declined gradually and almost completely disappeared after 1000 sec. Conclusions With proper mounting of several miniature strain gauges at various levels and aspects of the root, significant circumferential strains can be monitored under clinically relevant compaction forces. The residual strains at the end of lateral compaction are not stored in the dentin but decrease gradually to negligible levels.	[Pilo, Raphael] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Rehabil, IL-69978 Tel Aviv, Israel; [Metzger, Zvi] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Endodontol, IL-69978 Tel Aviv, Israel; [Brosh, Tamar] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Pilo, R (corresponding author), Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Rehabil, IL-69978 Tel Aviv, Israel.	rafipilo@post.tau.ac		Brosh, Tamar/0000-0001-6181-3310				Berry KA, 1998, J ENDODONT, V24, P752, DOI 10.1016/S0099-2399(98)80167-2; Blum JY, 1997, J ENDODONT, V23, P340, DOI 10.1016/S0099-2399(97)80420-7; Chai I, 2015, J ENDODONT, V41, P1515, DOI 10.1016/j.joen.2015.04.003; Chai H, 2012, J BIOMECH, V45, P1673, DOI 10.1016/j.jbiomech.2012.03.022; DANG DA, 1989, J ENDODONT, V15, P294, DOI 10.1016/S0099-2399(89)80050-0; FRIEDMAN CM, 1975, J DENT RES, V54, P921, DOI 10.1177/00220345750540052901; Fuss Z, 1999, INT ENDOD J, V32, P283, DOI 10.1046/j.1365-2591.1999.00208.x; Gharai SR, 2005, J ENDODONT, V31, P198, DOI 10.1097/01.don.0000137648.77797.ea; GIMLIN DR, 1986, J ENDODONT, V12, P235, DOI 10.1016/S0099-2399(86)80254-0; Harvey T E, 1981, J Endod, V7, P151, DOI 10.1016/S0099-2399(81)80228-2; HATTON JF, 1988, J ENDODONT, V14, P305, DOI 10.1016/S0099-2399(88)80031-1; JAMESON MW, 1993, J BIOMECH, V26, P1055, DOI 10.1016/S0021-9290(05)80005-3; JAMESON MW, 1994, ARCH ORAL BIOL, V39, P759, DOI 10.1016/0003-9969(94)90005-1; Jenkins SM, 2001, INT ENDOD J, V34, P16, DOI 10.1046/j.1365-2591.2001.00341.x; Joyce AP, 1998, J ENDODONT, V24, P714, DOI 10.1016/S0099-2399(98)80159-3; Kahler B, 2003, J BIOMECH, V36, P229, DOI 10.1016/S0021-9290(02)00327-5; Kim HC, 2013, J ENDODONT, V39, P1572, DOI 10.1016/j.joen.2013.07.021; Kim HC, 2010, J ENDODONT, V36, P1195, DOI 10.1016/j.joen.2010.02.010; Lertchirakarn V, 1999, J ENDODONT, V25, P99, DOI 10.1016/S0099-2399(99)80005-3; Lertchirakarn V, 2011, INT ENDOD J, V44, P1005, DOI 10.1111/j.1365-2591.2011.01908.x; Lertchirakarn V, 2003, J ENDODONT, V29, P523, DOI 10.1097/00004770-200308000-00008; Lertchirakarn V, 2003, J ENDODONT, V29, P529, DOI 10.1097/00004770-200308000-00009; Liu R, 2013, J ENDODONT, V39, P1054, DOI 10.1016/j.joen.2013.04.013; Lopes HP, 2011, CLIN ORAL INVEST, V15, P661, DOI 10.1007/s00784-010-0438-2; MEISTER F, 1980, ORAL SURG ORAL MED O, V49, P243, DOI 10.1016/0030-4220(80)90056-0; MURGEL CAF, 1990, ENDOD DENT TRAUMATOL, V6, P273; Nalla RK, 2003, J BIOMED MATER RES A, V67A, P484, DOI 10.1002/jbm.a.10079; Nalla RK, 2003, J BIOMED MATER RES A, V66A, P10, DOI 10.1002/jbm.a.10553; OBERMAYR G, 1991, J PROSTHET DENT, V66, P181, DOI 10.1016/S0022-3913(05)80045-9; Piskin B, 2008, INT ENDOD J, V41, P54, DOI 10.1111/j.1365-2591.2007.01314.x; Sathorn C, 2005, J ENDODONT, V31, P283, DOI 10.1097/01.don.0000140580.03121.61; Savani GM, 2014, J ENDODONT, V40, P618, DOI 10.1016/j.joen.2014.01.029; SAW LH, 1995, J ENDODONT, V21, P314, DOI 10.1016/S0099-2399(06)81008-3; Schmidt KJ, 2000, J ENDODONT, V26, P42, DOI 10.1097/00004770-200001000-00011; Shahi Shahriar, 2009, Iran Endod J, V4, P149; Shemesh H, 2011, J ENDODONT, V37, P63, DOI 10.1016/j.joen.2010.10.002; Silver-Thorn MB, 1999, J BIOMECH ENG-T ASME, V121, P108, DOI 10.1115/1.2798031; Slaus G, 2002, INT ENDOD J, V35, P759, DOI 10.1046/j.1365-2591.2002.00564.x; Sobhi Muhammad Bakhsh, 2003, J Coll Physicians Surg Pak, V13, P70; Soros C, 2008, ORAL SURG ORAL MED O, V106, pE64, DOI 10.1016/j.tripleo.2008.03.027; Tamse A, 1999, J ENDODONT, V25, P506, DOI 10.1016/S0099-2399(99)80292-1; TELLI C, 1994, ENDOD DENT TRAUMATOL, V10, P1; Telli C, 1998, BRIT DENT J, V185, P79, DOI 10.1038/sj.bdj.4809733; WALTON RE, 1984, J ENDODONT, V10, P48, DOI 10.1016/S0099-2399(84)80037-0; Wilcox LR, 1997, J ENDODONT, V23, P533, DOI 10.1016/S0099-2399(97)80316-0; YAMAN SD, 1995, J ENDODONT, V21, P321, DOI 10.1016/S0099-2399(06)81009-5	46	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156461	10.1371/journal.pone.0156461	http://dx.doi.org/10.1371/journal.pone.0156461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227404	Green Submitted, gold, Green Published			2022-12-26	WOS:000376882500143
J	Robinson, BS; Inger, R; Gaston, KJ				Robinson, Beth S.; Inger, Richard; Gaston, Kevin J.			A Rose by Any Other Name: Plant Identification Knowledge & Socio-Demographics	PLOS ONE			English	Article							BIODIVERSITY	Concern has been expressed over societal losses of plant species identification skills. These losses have potential implications for engagement with conservation issues, gaining human wellbeing benefits from biodiversity (such as those resulting from nature-based recreational activities), and early warning of the spread of problematic species. However, understanding of the prevailing level of species identification skills, and of its key drivers, remains poor. Here, we explore socio-demographic factors influencing plant identification knowledge and ability to classify plants as native or non-native, employing a novel method of using real physical plants, rather than photographs or illustrations. We conducted face-to-face surveys at three different sites chosen to capture respondents with a range of socio-demographic circumstances, in Cornwall, UK. We found that survey participants correctly identified c.60% of common plant species, were significantly worse at naming non-native than native plants, and that less than 20% of people recognised Japanese knotweed Fallopia japonica, which is a widespread high profile invasive non-native in the study region. Success at naming plants was higher if participants were female, a member of at least one environmental, conservation or gardening organisation, in an older age group (than the base category of 18-29 years), or a resident (rather than visitor) of the study area. Understanding patterns of variation in plant identification knowledge can inform the development of education and engagement strategies, for example, by targeting sectors of society where knowledge is lowest. Furthermore, greater understanding of general levels of identification of problematic invasive non-native plants can guide awareness and education campaigns to mitigate their impacts.	[Robinson, Beth S.; Inger, Richard; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9FE, Cornwall, England	University of Exeter	Robinson, BS (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9FE, Cornwall, England.	b.robinson@exeter.ac.uk	Inger, Richard/D-3445-2009	Inger, Richard/0000-0003-1660-3706; Gaston, Kevin J./0000-0002-7235-7928	Animal and Plant Health Agency; University of Exeter	Animal and Plant Health Agency; University of Exeter	This work was funded by Animal and Plant Health Agency (https://www.gov.uk/government/organisations/animal-and-plant-health-agency) and University of Exeter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COLLINS FLOWER GUIDE; Balmford A, 2002, SCI MAG, V295, P5; Barton K., 2011, MUMIN MULTIMODEL INF; Bebbington A, 2005, J BIOL EDUC, V39, P62; Bernard HR, 2011, RES METHODS ANTHR, P187; Booth JE, 2009, BIOL CONSERV, V142, P3196, DOI 10.1016/j.biocon.2009.07.024; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Christensen R, 2014, REGRESSION MODELS OR; Clayton S., 2009, CONSERVATION PSYCHOL; Crall AW, 2010, BIOL INVASIONS, V12, P3419, DOI 10.1007/s10530-010-9740-9; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Davies ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039692; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Engler J, 2011, ECOL RES, V26, P555, DOI 10.1007/s11284-011-0813-8; Gallo T, 2011, BIOSCIENCE, V61, P459, DOI 10.1525/bio.2011.61.6.8; Gatt S, 2007, J BIOL EDUC, V41, P117, DOI 10.1080/00219266.2007.9656080; Gozlan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053200; Huxham M, 2006, J BIOL EDUC, V41, P9, DOI 10.1080/00219266.2006.9656050; Kaiser FG, 2003, APPL PSYCHOL-INT REV, V52, P598, DOI 10.1111/1464-0597.00153; Lee J, 2011, J ENVIRON LAW, V23, P415, DOI 10.1093/jel/eqr014; Lin BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087422; Liu X, 2009, MAR POLLUT BULL, V58, P1514, DOI 10.1016/j.marpolbul.2009.05.015; Mackechnie C, 2011, J ENVIRON MONITOR, V13, P2687, DOI 10.1039/c1em10615e; Maskell LC, 2006, J ECOL, V94, P1052, DOI 10.1111/j.1365-2745.2006.01172.x; McDermott SM, 2013, ECOL APPL, V23, P1086, DOI 10.1890/12-0649.1; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Office for National Statistics, CENS 2011; Pilgrim SE, 2008, ENVIRON SCI TECHNOL, V42, P1004, DOI 10.1021/es070837v; Price K, 2014, FORAGING WILD FOOD U, P107; Prokop P., 2009, EURASIA J MATH SCI T, V5, P127, DOI [DOI 10.12973/ejmste/75264, 10.12973/ejmste/, DOI 10.12973/EJMSTE]; Pyle RM, 2003, ORYX, V37, P206, DOI 10.1017/S0030605303000383; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RHS, PALNTS FLOW AUG; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Royal Institution of Chartered Surveyors (RICS), 2012, JAP KNOTW RES PROP; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schussler EE, 2008, J BIOL EDUC, V42, P112, DOI 10.1080/00219266.2008.9656123; Shaw R. H., 2014, Bulletin OEPP, V44, P239, DOI 10.1111/epp.12114; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Somaweera R, 2010, BIOL CONSERV, V143, P1477, DOI 10.1016/j.biocon.2010.03.027; Stagg BC, 2013, J BIOL EDUC, V47, P104, DOI 10.1080/00219266.2013.764341; Stokes DL, 2006, BIOSCIENCE, V56, P6; United Nations Population Fund, 2007, UNFPA STAT WORLD POP; Wallace RD, 2014, CABI INVASIVE SER, V4, P219, DOI 10.1079/9781780641645.0219; Wandersee JH, 1999, AM BIOL TEACH, V61, P82, DOI 10.2307/4450624; Williams F., 2010, EC COST INVASIVE NON; Woodland Trust YouGov, 2013, YOUGOV WOODL TRUST S	50	26	26	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156572	10.1371/journal.pone.0156572	http://dx.doi.org/10.1371/journal.pone.0156572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227452	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500159
J	Boos, ADS; Kammerer, CF; Schultz, CL; Soares, MB; Ilha, ALR				Boos, Alessandra D. S.; Kammerer, Christian F.; Schultz, Cesar L.; Soares, Marina B.; Ilha, Ana L. R.			A New Dicynodont (Therapsida: Anomodontia) from the Permian of Southern Brazil and Its Implications for Bidentalian Origins	PLOS ONE			English	Article							PARANA BASIN; KUNDARAM FORMATION; ASSEMBLAGE ZONE; CRANIAL ANATOMY; SYNAPSIDA; RIO; REDESCRIPTION; DIICTODON; KAROO	Dicynodonts were a highly successful group of herbivorous therapsids that inhabited terrestrial ecosystems from the Middle Permian through the end of the Triassic periods. Permian dicynodonts are extremely abundant in African deposits, but are comparatively poorly known from the other regions of Gondwana. Here we describe a new South American dicynodont, Rastodon procurvidens gen. et sp. nov., from the Boqueirao farm site of the Rio do Rasto Formation, Parana Basin, Guadalupian/Lopingian of Brazil. Diagnostic features of R. procurvidens include uniquely anteriorly-curved maxillary tusks, well-developed ridges extending from the crista oesophagea anteriorly along the pterygoid rami, strong posterior angulation of the posterior pterygoid rami, and a bulbous, well-developed retroarticular process of the articular. Phylogenetic analysis indicates that R. procurvidens is the earliest and most basal member of Bidentalia, a cosmopolitan clade that includes Permian and Triassic dicynodonts whose dentition is usually reduced to a pair of maxillary tusks.	[Boos, Alessandra D. S.; Schultz, Cesar L.; Soares, Marina B.; Ilha, Ana L. R.] Univ Fed Rio Grande do Sul, Inst Geociencias, Porto Alegre, RS, Brazil; [Boos, Alessandra D. S.] Fundacao Univ Reg Blumenau, Dept Ciencias Nat, Blumenau, SC, Brazil; [Kammerer, Christian F.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Naturkunde, Berlin, Germany	Universidade Federal do Rio Grande do Sul; Universidade Regional de Blumenau (FURB); Leibniz Institut fur Evolutions und Biodiversitatsforschung	Boos, ADS (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Porto Alegre, RS, Brazil.; Boos, ADS (corresponding author), Fundacao Univ Reg Blumenau, Dept Ciencias Nat, Blumenau, SC, Brazil.	alessandra.boos@ufrgs.br	Schultz, Cesar/I-4127-2013; Soares, Marina Bento/M-9477-2017; Soares, Marina/AAN-8513-2020	Schultz, Cesar/0000-0001-7121-0409; Soares, Marina Bento/0000-0002-8393-2406; Soares, Marina/0000-0002-8393-2406; da Silva Boos, Alessandra Daniele/0000-0002-3259-4398	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Eigene Stelle from the Deutsche Forschungsgemeinschaft [KA 4133/1-1]; Sofja Kovalevskaja Award	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Eigene Stelle from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sofja Kovalevskaja Award	This work was partially funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) through scholarships granted to ADSB and CLS. CFK support was provided by an Eigene Stelle from the Deutsche Forschungsgemeinschaft (KA 4133/1-1) and a Sofja Kovalevskaja Award to Jorg Frobisch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdala F, 2013, GONDWANA RES, V23, P1151, DOI 10.1016/j.gr.2012.07.011; Angielczyk KD, 2003, ZOOL J LINN SOC-LOND, V139, P157, DOI 10.1046/j.1096-3642.2003.00081.x; Angielczyk KD, 2002, J PALEONTOL, V76, P1047, DOI 10.1666/0022-3360(2002)076<1047:RPPASS>2.0.CO;2; Angielczyk KD, 2008, J VERTEBR PALEONTOL, V28, P788, DOI 10.1671/0272-4634(2008)28[788:DFOADT]2.0.CO;2; Angielczyk KD, 2007, J VERTEBR PALEONTOL, V27, P116, DOI 10.1671/0272-4634(2007)27[116:NSOTTD]2.0.CO;2; Angielczyk KD, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1078342; Angielczyk KD, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.1008699; Angielczyk KD, 2014, J VERTEBR PALEONTOL, V34, P1408, DOI 10.1080/02724634.2014.880448; Angielczyk KD, 2010, J VERTEBR PALEONTOL, V30, P1396, DOI 10.1080/02724634.2010.501447; Angielczyk Kenneth D., 2001, Palaeontologia Africana, V37, P53; [Anonymous], 1973, GEOLOGICAL SURVEY RH; Antunes M.T., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P371; BARBERENA MC, 1985, NATL GEOGR RES, V1, P5; Barberena MC, 1974, ACT 1 C ARG PAL BIOE; Battail B, 2009, GEOL SOC SPEC PUBL, V315, P33, DOI 10.1144/SP315.4; Boos ADS, 2015, J S AM EARTH SCI, V63, P375, DOI 10.1016/j.jsames.2015.09.003; Boos ADS, 2013, PALAEONTOLOGY, V56, P837, DOI 10.1111/pala.12020; Botha J, 2007, PALAEONTOLOGY, V50, P1175, DOI 10.1111/j.1475-4983.2007.00697.x; Broom R., 1905, Records of the Albany Museum, Vi, P266; Castanhinha R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080974; Cisneros JC, 2012, P NATL ACAD SCI USA, V109, P1584, DOI 10.1073/pnas.1115975109; da Silva RC, 2012, J S AM EARTH SCI, V38, P31, DOI 10.1016/j.jsames.2012.05.001; Damiani R, 2007, PALAEONTOLOGY, V50, P1531, DOI 10.1111/j.1475-4983.2007.00727.x; Day MO, 2015, S AFR J SCI, V111, P78; Dentzien-Dias PC, 2012, J S AM EARTH SCI, V40, P53, DOI 10.1016/j.jsames.2012.09.008; Dias-Da-Silva S, 2012, LETHAIA, V45, P109, DOI 10.1111/j.1502-3931.2011.00263.x; Ferreira-Oliveira LG, 2007, THESIS U ESTADUAL PA; Figueiredo AEQ, 2011, AMEGHINIANA, V48, pR239; Frobisch J, 2007, ZOOL J LINN SOC-LOND, V150, P117, DOI 10.1111/j.1096-3642.2007.00285.x; Frobisch J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003733; Frobisch J, 2008, J VERTEBR PALEONTOL, V28, P770, DOI 10.1671/0272-4634(2008)28[770:ANSOES]2.0.CO;2; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hancox PJ, 2013, J VERTEBR PALEONTOL, V33, P655, DOI 10.1080/02724634.2013.723551; Holz M, 2010, J S AM EARTH SCI, V29, P381, DOI 10.1016/j.jsames.2009.04.004; Horn BLD, 2014, J S AM EARTH SCI, V55, P123, DOI 10.1016/j.jsames.2014.07.007; Jacobs LL, 2005, PALAEONTOLOGIA ELECT, V8; Jasinoski SC, 2012, FORERUNNERS MAMMALS, P149; Kammerer CF, 2015, FOSS REC, V18, P43, DOI 10.5194/fr-18-43-2015; Kammerer CF, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1030408; Kammerer CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064203; Kammerer CF, 2011, J VERTEBR PALEONTOL, V31, P1, DOI 10.1080/02724634.2011.627074; Kammerer CF, 2009, ZOOTAXA, P1; Keyser A.W., 1975, MEMOIRS GEOLOGICAL S, V67, P1; Keyser AW., 1993, GEOL SURV S AFR MEM, V82, P1; King G.M., 1988, Handbuch der Palaeoherpetologie, V17C, P1; King G. M., 1990, DICYNODONTS STUDY PA; KING GM, 1993, ZOOL J LINN SOC-LOND, V107, P131, DOI 10.1111/j.1096-3642.1993.tb00218.x; Koyabu D, 2012, P NATL ACAD SCI USA, V109, P14075, DOI 10.1073/pnas.1208693109; Kurkin AA, 2012, PALEONTOL J+, V46, P187, DOI 10.1134/S003103011201008X; Langer M.C., 1998, J AFR EARTH SCI, V27, P158; Lavina E.L., 1991, THESIS U FEDERAL RIO; Li J, 2008, CHINESE FOSSIL REPTI; Maisch Michael W., 2009, Palaeodiversity, P271; MAZIN JM, 1991, PALAEONTOLOGY, V34, P837; Milani E. J., 2007, B GEOCIENCIAS PETROB, V15, P265; Milani EJ, 2007, 1 WORKSH PROBL W GON; Newton E. T., 1893, Philosophical Transactions, Vclxxxiv, P431; Nopcsa, 1923, FAMILIEN REPTILIEN; Owen R., 1860, REPORT BRIT ASS ADV, V29, P153; Owen R., 1876, DESCRIPTIVE ILLUSTRA; Pacheco CP, 2017, J SYST PALAEONTOL, V15, P241, DOI 10.1080/14772019.2016.1164763; Ray S, 2000, PALAEONTOLOGY, V43, P375, DOI 10.1111/1475-4983.00132; Ray S, 1999, J AFR EARTH SCI, V29, P211, DOI 10.1016/S0899-5362(99)00090-1; Rohn R., 2007, 1 WORKSH PROBL W GON; Rohn R, 2005, GONDW 12 C 2005 NOV; Rohn R, 1994, THESIS U SAO PAULO; Rohn R., 1989, BOL IG USP PUBL ESP, V7, P127; Rozefelds AC, 2011, J VERTEBR PALEONTOL, V31, P1158, DOI 10.1080/02724634.2011.595858; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Schoch RR, 2012, NEUES JAHRB GEOL P-A, V263, P119, DOI 10.1127/0077-7749/2012/0216; Sulej T, 2010, EARTH ENV SCI T R SO, V101, P261, DOI 10.1017/S1755691011020123; Sullivan C, 2005, ANN CARNEGIE MUS, V74, P45, DOI 10.2992/0097-4463(2005)74[45:CAATOT]2.0.CO;2; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189; TOLLMAN S M, 1980, Annals of the South African Museum, V81, P159; Vega-Dias C, 2005, THESIS U FEDERAL RIO; Zhu Yanglong, 1989, Vertebrata Palasiatica, V27, P9	77	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155000	10.1371/journal.pone.0155000	http://dx.doi.org/10.1371/journal.pone.0155000			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224287	Green Published, gold			2022-12-26	WOS:000376881700012
J	Guo, N; Liu, ZJ; Zhao, WJ; Wang, EK; Wang, J				Guo, Na; Liu, Zuojia; Zhao, Wenjing; Wang, Erkang; Wang, Jin			Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE; INDUCED APOPTOSIS; INHIBITION; EXPRESSION; INDUCTION; PATHWAY; SEARCH	Pancreatic cancer has been found with abnormal expression or mutation in Ras proteins. Oncogenic Ras activation exploits their extensive signaling reach to affect multiple cellular processes, in which the mitogen-activated protein kinase (MAPK) signaling exerts important roles in tumorigenesis. Therapies targeted Ras are thus of major benefit for pancreatic cancer. Although small molecule APY606 has been successfully picked out by virtual drug screening based on Ras target receptor, its in-depth mechanism remains to be elucidated. We herein assessed the antitumor activity of APY606 against human pancreatic cancer Capan-1 and SW1990 cell lines and explored the effect of Ras-MAPK and apoptosis-related signaling pathway on the activity of APY606. APY606 treatment resulted in a dose- and time-dependent inhibition of cancer cell viability. Additionally, APY606 exhibited strong antitumor activity, as evidenced not only by reduction in tumor cell invasion, migration and mitochondrial membrane potential but also by alteration in several apoptotic indexes. Furthermore, APY606 treatment directly inhibited Ras-GTP and the downstream activation of MAPK, which resulted in the down-regulation of anti-apoptotic protein Bcl-2, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, cytosolic Cytochrome c and Caspase 3) and of cyclin-dependent kinase 2 and Cyclin A, E. These data suggest that impairing Ras-MAPK signaling is a novel mechanism of action for APY606 during therapeutic intervention in pancreatic cancer.	[Guo, Na; Liu, Zuojia; Zhao, Wenjing; Wang, Erkang; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, ZJ; Wang, EK; Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	zjliu@ciac.ac.cn; ekwang@ciac.ac.cn; jin.wang.1@stonybrook.edu	, 汪尔康/P-1748-2019		National Natural Science Foundation of China [81573448, 11174105, 91227114, 91430217]; National Science Foundation [MCB-0947767]; Natural Science Foundation of Jilin Province [20150101009JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); Natural Science Foundation of Jilin Province	The authors wish to acknowledge the following funding sources that supported this research: National Natural Science Foundation of China (81573448, 11174105, 91227114 and 91430217), National Science Foundation (MCB-0947767) and Natural Science Foundation of Jilin Province (20150101009JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Chowdhury I, 2014, J CELL PHYSIOL, V229, P998, DOI 10.1002/jcp.24531; Collins MA, 2014, FRONT PHYSIOL, V4, P1; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Downward J, 1997, CURR BIOL, V7, pR258, DOI 10.1016/S0960-9822(06)00116-3; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huo JX, 2004, CELL DEATH DIFFER, V11, P99, DOI 10.1038/sj.cdd.4401322; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kleger A, 2014, ANN ONCOL, V25, P1260, DOI 10.1093/annonc/mdu013; Kolodecik T, 2014, FRONT PHYSIOL, V4, P1; Li CH, 2014, P NATL ACAD SCI USA, V111, P14130, DOI 10.1073/pnas.1408628111; Li D, 2013, EUR J PHARM SCI, V48, P658, DOI 10.1016/j.ejps.2012.12.023; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Liu ZJ, 2013, CURR PHARM DESIGN, V19, P2259, DOI 10.2174/1381612811319120013; Lou ZY, 2013, J INT MED RES, V41, P1505, DOI 10.1177/0300060513490618; Mancini M, 1997, J CELL BIOL, V138, P449, DOI 10.1083/jcb.138.2.449; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Pruitt K, 2000, J BIOL CHEM, V275, P40916, DOI 10.1074/jbc.M006682200; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Remacle-Bonnet MM, 2000, CANCER RES, V60, P2007; Sa G, 2004, EXP CELL RES, V300, P427, DOI 10.1016/j.yexcr.2004.07.032; Sellers WR, 1999, J CLIN INVEST, V104, P1655, DOI 10.1172/JCI9053; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Spiegel J, 2014, NAT CHEM BIOL, V10, P613, DOI 10.1038/nchembio.1560; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Stites EC, 2007, SCIENCE, V318, P463, DOI 10.1126/science.1144642; Wang KM, 2011, ACTA BIOCH BIOPH SIN, V43, P698, DOI 10.1093/abbs/gmr063; Wang WR, 2012, BIOORG MED CHEM LETT, V22, P5766, DOI 10.1016/j.bmcl.2012.07.082; Zhang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.182; Zhao XH, 2006, FRONT BIOSCI-LANDMRK, V11, P2428, DOI 10.2741/1980; Zheng XL, 2013, CURR PHARM DESIGN, V19, P2246, DOI 10.2174/1381612811319120012	36	6	6	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155874	10.1371/journal.pone.0155874	http://dx.doi.org/10.1371/journal.pone.0155874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223122	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700035
J	Drummond, LR; Kunstetter, AC; Vaz, FF; Campos, HO; de Andrade, AGP; Coimbra, CC; Natali, AJ; Wanner, SP; Primola-Gomes, TN				Drummond, Lucas Rios; Kunstetter, Ana Cancado; Vaz, Filipe Ferreira; Campos, Helton Oliveira; Pereira de Andrade, Andre Gustavo; Coimbra, Candido Celso; Natali, Antonio Jose; Wanner, Samuel Penna; Primola-Gomes, Thales Nicolau			Brain Temperature in Spontaneously Hypertensive Rats during Physical Exercise in Temperate and Warm Environments	PLOS ONE			English	Article							HEAT-STRESS; FATIGUE; HEATSTROKE; MODEL; PERFORMANCE; INTENSITIES; RESPONSES; PRESSURE; CAPACITY; SHR	This study aimed to evaluate brain temperature (T-brain) changes in spontaneously hypertensive rats (SHRs) subjected to two different physical exercise protocols in temperate or warm environments. We also investigated whether hypertension affects the kinetics of exercise-induced increases in Tbrain relative to the kinetics of abdominal temperature (T-abd) increases. Male 16-week-old normotensive Wistar rats (NWRs) and SHRs were implanted with an abdominal temperature sensor and a guide cannula in the frontal cortex to enable the insertion of a thermistor to measure T-brain. Next, the animals were subjected to incremental-speed (initial speed of 10 m/min; speed was increased by 1 m/min every 3 min) or constant-speed (60% of the maximum speed) treadmill running until they were fatigued in a temperate (25 degrees C) or warm (32 degrees C) environment. T-brain, T-abd and tail skin temperature were measured every min throughout the exercise trials. During incremental and constant exercise at 25 degrees C and 32 degrees C, the SHR group exhibited greater increases in T-brain and T-abd relative to the NWR group. Irrespective of the environment, the heat loss threshold was attained at higher temperatures (either Tbrain or Tabd) in the SHRs. Moreover, the brain-abdominal temperature differential was lower at 32 degrees C in the SHRs than in the NWRs during treadmill running. Overall, we conclude that SHRs exhibit enhanced brain hyperthermia during exercise and that hypertension influences the kinetics of the T-brain relative to the Tabd increases, particularly during exercise in a warm environment.	[Drummond, Lucas Rios; Natali, Antonio Jose; Primola-Gomes, Thales Nicolau] Univ Fed Vicosa, Dept Educ Fis, Lab Biol Exercicio, Vicosa, MG, Brazil; [Drummond, Lucas Rios; Campos, Helton Oliveira; Coimbra, Candido Celso] Univ Fed Minas Gerais, Dept Fisiol & Biofis, Lab Endocrinol & Metab, Belo Horizonte, MG, Brazil; [Kunstetter, Ana Cancado; Vaz, Filipe Ferreira; Wanner, Samuel Penna] Univ Fed Minas Gerais, Dept Educ Fis, Lab Fisiol Exercicio, Belo Horizonte, MG, Brazil; [Pereira de Andrade, Andre Gustavo] Univ Fed Minas Gerais, Dept Esportes, Lab Biomecan, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Primola-Gomes, TN (corresponding author), Univ Fed Vicosa, Dept Educ Fis, Lab Biol Exercicio, Vicosa, MG, Brazil.	thales.gomes@ufv.br	ANDRADE, A G P/GLR-3846-2022; Gomes, Thales Nicolau Prímo NP/X-8355-2018; NATALI, ANTONIO JOSE/C-1555-2013; Wanner, Samuel P./F-9654-2012; ANDRADE, A G P/O-6142-2016	ANDRADE, A G P/0000-0003-3406-4558; Gomes, Thales Nicolau Prímo NP/0000-0002-4001-4429; NATALI, ANTONIO JOSE/0000-0002-4927-4024; Wanner, Samuel P./0000-0002-4659-1032; ANDRADE, A G P/0000-0003-3406-4558	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa Nacional de Pos-Doutorado; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa Nacional de Pos-Doutorado; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa Nacional de Pos-Doutorado (http://www.capes.gov.br/), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (http://www.fapemig.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaud L, 2007, ARCH INTERN MED, V167, P2177, DOI 10.1001/archinte.167.20.ioi70147; BERKEY DL, 1990, AM J PHYSIOL, V258, pR743, DOI 10.1152/ajpregu.1990.258.3.R743; BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009; Campos HO, 2014, J SPORT SCI MED, V13, P695; CAPUTA M, 1991, J THERM BIOL, V16, P19, DOI 10.1016/0306-4565(91)90046-5; Caputa M, 1996, J THERM BIOL, V21, P21, DOI 10.1016/0306-4565(95)00016-X; Caputa M., 2004, J THERM BIOL, P29; Carneiro MA, 2013, J MOL CELL CARDIOL, V57, P119, DOI 10.1016/j.yjmcc.2013.01.013; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Cramer MN, 2014, J APPL PHYSIOL, V116, P1123, DOI 10.1152/japplphysiol.01312.2013; ELLIS FP, 1972, ENVIRON RES, V5, P1, DOI 10.1016/0013-9351(72)90019-9; Fonseca CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111501; Fujii K, 1990, STROKE, V21, P8; Fujishima M, 1995, Hypertens Res, V18, P111, DOI 10.1291/hypres.18.111; Fuller A, 1998, J APPL PHYSIOL, V84, P877, DOI 10.1152/jappl.1998.84.3.877; Gisolfi C V, 1984, Exerc Sport Sci Rev, V12, P339; Hasegawa H, 2008, J PHYSIOL-LONDON, V586, P141, DOI 10.1113/jphysiol.2007.142190; Ho CW, 1997, J APPL PHYSIOL, V82, P1126, DOI 10.1152/jappl.1997.82.4.1126; Hom S, 2007, AM J PHYSIOL-REG I, V292, pR1881, DOI 10.1152/ajpregu.00761.2005; JUDY WV, 1976, CIRC RES, V38, P21, DOI 10.1161/01.RES.38.6.21; Kerr S, 1999, HYPERTENSION, V33, P1353, DOI 10.1161/01.HYP.33.6.1353; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kiyatkin EA, 2007, EUR J APPL PHYSIOL, V101, P3, DOI 10.1007/s00421-007-0450-7; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Kunstetter AC, 2014, BRAZ J MED BIOL RES, V47, P679, DOI 10.1590/1414-431X20143561; Lim CL, 2006, SPORTS MED, V36, P39, DOI 10.2165/00007256-200636010-00004; Lin MT, 1997, ANN NY ACAD SCI, V813, P572, DOI 10.1111/j.1749-6632.1997.tb51748.x; Melo RM, 2003, HYPERTENSION, V42, P851, DOI 10.1161/01.HYP.0000086201.27420.33; Noakes TD, 2000, SCAND J MED SCI SPOR, V10, P123, DOI 10.1034/j.1600-0838.2000.010003123.x; Nybo L, 2002, J PHYSIOL-LONDON, V545, P697, DOI 10.1113/jphysiol.2002.030023; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pires W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072005; Primola-Gomes TN, 2009, J APPL PHYSIOL, V107, P593, DOI 10.1152/japplphysiol.91218.2008; Rodrigues LOC, 2003, BRAZ J MED BIOL RES, V36, P131, DOI 10.1590/S0100-879X2003000100018; SHARMA HS, 1992, NEUROSCIENCE, V48, P889, DOI 10.1016/0306-4522(92)90277-9; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; TANAKA H, 1988, JPN J PHYSIOL, V38, P167, DOI 10.2170/jjphysiol.38.167; Tang JS, 2010, OXID MED CELL LONGEV, V3, P332, DOI 10.4161/oxim.3.5.13184; Tayebati SK, 2012, J NEUROL SCI, V322, P241, DOI 10.1016/j.jns.2012.05.047; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; TRIPPODO NC, 1981, HYPERTENSION, V3, P104, DOI 10.1161/01.HYP.3.1.104; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309; TUCKER LE, 1985, SOUTHERN MED J, V78, P20, DOI 10.1097/00007611-198501000-00006; Walters TJ, 1998, J APPL PHYSIOL, V84, P1269, DOI 10.1152/jappl.1998.84.4.1269; Wanner SP, 2007, BRAIN RES BULL, V73, P28, DOI 10.1016/j.brainresbull.2007.03.004	47	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155919	10.1371/journal.pone.0155919	http://dx.doi.org/10.1371/journal.pone.0155919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214497	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200032
J	Navalpakam, A; Dany, M; Hussein, IH				Navalpakam, Aishwarya; Dany, Mohammed; Hussein, Inaya Hajj			Behavioral Perceptions of Oakland University Female College Students towards Human Papillomavirus Vaccination	PLOS ONE			English	Article							CERVICAL-CANCER; HPV VACCINE; QUADRIVALENT VACCINE; ASSESSING KNOWLEDGE; UNITED-STATES; ATTITUDES; ADOLESCENTS; PREVENTION	Human Papillomavirus (HPV) vaccination decreases the risk for cervical cancer. However, the uptake of HPV vaccine remains low when compared with other recommended vaccines. This study evaluates the knowledge and attitudes towards HPV infection and vaccination, and the readiness for the uptake of HPV vaccine amongst female students attending Oakland University (OU) in Michigan, United States. This is a cross-sectional study targeting a randomized sample of a 1000 female OU students using an online questionnaire. The data were statistically analyzed using SPSS software. A total of 192 female students, with the mean age of 24 years completed the survey. The majority of participants had previous sexual experience with occasional use of contraceptives (78.1%), were non-smokers (92.7%), and non-alcohol drinkers (54.2%). The participants had a mean knowledge score of 53.0% with a standard error of 2.3% translating to a moderately informed population. The majority agreed that HPV is life threatening (79%), the vaccine prevents cervical cancer (62%), and that side effects would not deter themfrom vaccination (63%). Although two thirds (67%) believed that, based on sexual practices in the United States, female college students in Michigan have a higher chance of contracting HPV, about 50% did not believe they themselves were at risk. Higher knowledge correlated with increased recommendation for the vaccine (correlation-factor 0.20, p = 0.005). Results suggested that the best predictor for improvement of vaccination was the awareness level and health education. This indicates a need for an educational intervention to raise awareness, increase HPV vaccine uptake, and decrease the incidence of cervical cancer.	[Navalpakam, Aishwarya; Hussein, Inaya Hajj] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Dany, Mohammed] Med Univ S Carolina, Coll Med, Charleston, SC 29425 USA	Oakland University; Medical University of South Carolina	Hussein, IH (corresponding author), Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA.	hajjhuss@oakland.edu		Dany, Mohammed/0000-0002-7060-5385				Alaaeddine G, 2013, PUBLIC HEALTH, V127, P461, DOI 10.1016/j.puhe.2013.01.015; Ashing-Giwa KT, 2004, PSYCHO-ONCOLOGY, V13, P709, DOI 10.1002/pon.785; Bartlett JA, 2011, J SCH NURS, V27, P434, DOI 10.1177/1059840511415861; Benard VB, 2014, MMWR-MORBID MORTAL W, V63, P1004; Chelimo C, 2009, NEW ZEAL MED J, V122, P33; Dany M, 2015, VACCINE, V33, P1001, DOI 10.1016/j.vaccine.2015.01.009; Francis SA, 2010, VACCINE, V28, P8026, DOI 10.1016/j.vaccine.2010.08.090; Franco EL, 2001, CAN MED ASSOC J, V164, P1017; Frazer IH, 2006, PEDIATR INFECT DIS J, V25, pS65, DOI 10.1097/01.inf.0000196485.86376.46; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Inungu Joseph, 2009, J Health Hum Serv Adm, V32, P259; Kang HY, 2011, WOMEN HEALTH, V51, P759, DOI 10.1080/03630242.2011.627091; Liddon NC, 2012, VACCINE, V30, P2676, DOI 10.1016/j.vaccine.2012.02.007; Marek E, 2011, VACCINE, V29, P8591, DOI 10.1016/j.vaccine.2011.09.018; Siddiqui MAA, 2006, DRUGS, V66, P1263, DOI 10.2165/00003495-200666090-00008; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741	18	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155955	10.1371/journal.pone.0155955	http://dx.doi.org/10.1371/journal.pone.0155955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203284	Green Submitted, gold, Green Published			2022-12-26	WOS:000376291500034
J	Walden, E; Lindborg, R				Walden, Emelie; Lindborg, Regina			Long Term Positive Effect of Grassland Restoration on Plant Diversity - Success or Not?	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; ECOLOGICAL RESTORATION; CALCAREOUS GRASSLANDS; SPECIES RICHNESS; SEED BANK; SEMINATURAL GRASSLANDS; ECOSYSTEM SERVICES; VEGETATION CHANGES; DRY GRASSLANDS; ARABLE LAND	Restoration is important for biodiversity conservation worldwide, but surprisingly little is known about its efficiency in a long-term perspective. In this study, we re-examined Swedish semi-natural grasslands 12-20 years after the restoration, by comparing field inventories of vascular plant species diversity made in 2001 with follow-up inventories in 2012. We also analysed restoration effect in relation to six environmental factors and used continuously managed semi-natural grasslands as references of desired state after restoration. We found that total species richness increased over time but not to reference levels, while there were no significant changes in species density or number of grassland specialists. However, the overall species composition in the restored sites, as well as grassland specialist composition, now largely resembled reference conditions. Fertilisation and time between abandonment and restoration were the only environmental variables that affected total species composition change, while site area affected change in grassland specialist composition. Our results show that restoration of semi-natural grasslands can contribute to conservation of semi-natural habitats and their associated biodiversity. Yet, due to the vague restoration goals for these sites, it is difficult to evaluate the restoration success, which emphasise the general need for clear and measurable goals.	[Walden, Emelie; Lindborg, Regina] Stockholm Univ, Dept Phys Geog, S-10691 Stockholm, Sweden	Stockholm University	Walden, E (corresponding author), Stockholm Univ, Dept Phys Geog, S-10691 Stockholm, Sweden.	emelie.walden@natgeo.su.se		Walden, Emelie/0000-0002-9180-2994	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [215-2009-1105]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas)	This work was supported by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), 215-2009-1105, to RL (http://www.formas.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2008, J VEG SCI, V19, P475, DOI 10.3170/2008-8-18380; Andersson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109816; Auestad I, 2015, APPL VEG SCI, V18, P190, DOI 10.1111/avsc.12138; Auffret AG, 2011, J APPL ECOL, V48, P1278, DOI 10.1111/j.1365-2664.2011.02019.x; Austrheim G, 1999, PLANT ECOL, V145, P59, DOI 10.1023/A:1009804509239; Bakker JP, 2012, ANN BOT FENN, V49, P21, DOI 10.5735/085.049.0104; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Beaufoy G, 2011, HNV FARMING EXPLAINI; Beaufoy G, 2011, PERMANENT PASTURES M; Bokdam J, 2000, J APPL ECOL, V37, P415, DOI 10.1046/j.1365-2664.2000.00507.x; Bossuyt B, 2001, BELG J BOT, V134, P29; Bossuyt B, 2008, J VEG SCI, V19, P875, DOI 10.3170/2008-8-18462; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Choi YD, 2004, ECOL RES, V19, P75, DOI 10.1111/j.1440-1703.2003.00594.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conrad MK, 2011, ECOL ENG, V37, P1149, DOI 10.1016/j.ecoleng.2011.02.010; Critchley CNR, 2004, BIOL CONSERV, V115, P263, DOI 10.1016/S0006-3207(03)00146-0; Critchley CNR, 2002, GRASS FORAGE SCI, V57, P82, DOI 10.1046/j.1365-2494.2002.00305.x; Dahlstrom A, 2010, APPL VEG SCI, V13, P305, DOI 10.1111/j.1654-109X.2009.01068.x; Diacon-Bolli JC, 2013, J VEG SCI, V24, P1010, DOI 10.1111/jvs.12024; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; Dostalek J, 2011, BIOLOGIA, V66, P837, DOI 10.2478/s11756-011-0079-1; Drayton B, 2012, RESTOR ECOL, V20, P299, DOI 10.1111/j.1526-100X.2011.00860.x; Dzwonko Z, 1998, J VEG SCI, V9, P387, DOI 10.2307/3237103; Dzwonko Z, 2008, ACTA SOC BOT POL, V77, P67, DOI 10.5586/asbp.2008.010; Ekstam U., 1997, HAVDEN UPPHOR KARLVA; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Fagan KC, 2008, J APPL ECOL, V45, P1293, DOI 10.1111/j.1365-2664.2008.01492.x; Gazol A, 2012, ECOGRAPHY, V35, P944, DOI 10.1111/j.1600-0587.2012.07627.x; Gijbels P, 2012, ECOSCIENCE, V19, P21, DOI 10.2980/19-1-3460; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanski lkka, 2010, EXTINCTION COLONIZAT; Hansson M, 2000, J VEG SCI, V11, P31, DOI 10.2307/3236772; Hellstrom K, 2003, APPL VEG SCI, V6, P45, DOI 10.1111/j.1654-109X.2003.tb00563.x; Helsen K, 2013, J APPL ECOL, V50, P404, DOI 10.1111/1365-2664.12037; Helsen K, 2012, OIKOS, V121, P2121, DOI 10.1111/j.1600-0706.2012.20499.x; Hilderbrand RH, 2005, ECOL SOC, V10; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Hooke RL, 2012, GSA TODAY, V22, P4, DOI DOI 10.1130/GSAT151A.1; Ingerpuu N, 2007, J VEG SCI, V18, P141, DOI 10.1111/j.1654-1103.2007.tb02524.x; Jacquemyn H, 2011, BIOL CONSERV, V144, P416, DOI 10.1016/j.biocon.2010.09.020; Jakobsson S, 2015, BIOL CONSERV, V191, P1, DOI 10.1016/j.biocon.2015.06.007; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; Jutila HM, 1997, ANN BOT FENN, V34, P245; Kalamees R, 1997, FOLIA GEOBOT PHYTOTX, V32, P1, DOI 10.1007/BF02803879; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Kotiluoto R, 1998, PLANT ECOL, V136, P53, DOI 10.1023/A:1009781217847; Krahulec F, 2001, APPL VEG SCI, V4, P97, DOI 10.1111/j.1654-109X.2001.tb00239.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lengyel S, 2012, APPL VEG SCI, V15, P264, DOI 10.1111/j.1654-109X.2011.01179.x; Lindborg R, 2006, BIODIVERS CONSERV, V15, P957, DOI 10.1007/s10531-004-3508-4; Lindborg R, 2004, RESTOR ECOL, V12, P318, DOI 10.1111/j.1061-2971.2004.00334.x; Lindborg R, 2012, ECOGRAPHY, V35, P356, DOI 10.1111/j.1600-0587.2011.07286.x; Lomba A, 2014, J ENVIRON MANAGE, V143, P140, DOI 10.1016/j.jenvman.2014.04.029; Maccherini S, 2007, BASIC APPL ECOL, V8, P332, DOI 10.1016/j.baae.2006.06.002; Miteva DA, 2012, OXFORD REV ECON POL, V28, P69, DOI 10.1093/oxrep/grs009; Ockinger E, 2006, BIOL CONSERV, V133, P291, DOI 10.1016/j.biocon.2006.06.009; Ormerod SJ, 2003, J APPL ECOL, V40, P44, DOI 10.1046/j.1365-2664.2003.00799.x; Barral MP, 2015, AGR ECOSYST ENVIRON, V202, P223, DOI 10.1016/j.agee.2015.01.009; Pihlgren A, 2008, GRASS FORAGE SCI, V63, P9, DOI 10.1111/j.1365-2494.2007.00610.x; Piqueray J, 2011, ECOL INDIC, V11, P724, DOI 10.1016/j.ecolind.2010.06.007; Pykala J, 2003, BIODIVERS CONSERV, V12, P2211, DOI 10.1023/A:1024558617080; R Development Core Team, 2012, R LANG ENV STAT COMP; Benayas JMR, 2012, ECOSYSTEMS, V15, P883, DOI 10.1007/s10021-012-9552-0; Roem WJ, 2000, BIOL CONSERV, V92, P151, DOI 10.1016/S0006-3207(99)00049-X; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; Schrautzer J, 2011, FLORA, V206, P622, DOI 10.1016/j.flora.2010.11.008; Schrautzer Joachim, 2009, Tuexenia, P339; SER, 2022, US; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Soderstrom B, 2001, BIODIVERS CONSERV, V10, P1839, DOI 10.1023/A:1013153427422; Sojnekova M, 2015, ECOL ENG, V77, P373, DOI 10.1016/j.ecoleng.2015.01.042; Stadler J, 2007, BIODIVERS CONSERV, V16, P621, DOI 10.1007/s10531-005-0604-z; Stewart KEJ, 2001, J APPL ECOL, V38, P1148, DOI 10.1046/j.1365-2664.2001.00658.x; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Swart JAA, 2001, RESTOR ECOL, V9, P230, DOI 10.1046/j.1526-100x.2001.009002230.x; Swedish Board of Agriculture, 2004, SKOTS REST BET SLATT, P1102; Tarrant S, 2013, RESTOR ECOL, V21, P560, DOI 10.1111/j.1526-100X.2012.00942.x; Tikka PM, 2001, APPL VEG SCI, V4, P139, DOI 10.1111/j.1654-109X.2001.tb00244.x; Tischew S, 2007, RESTOR ECOL, V15, P321, DOI 10.1111/j.1526-100X.2007.00217.x; von Blanckenhagen B, 2007, BASE; Wahlman H, 2002, ANN BOT FENN, V39, P159; Walker KJ, 2007, J APPL ECOL, V44, P573, DOI 10.1111/j.1365-2664.2007.01311.x; Weiss L, 2015, ECOL MODEL, V303, P1, DOI 10.1016/j.ecolmodel.2015.02.002; Weiss L, 2014, OIKOS, V123, P599, DOI 10.1111/j.1600-0706.2013.00957.x; Willems JH, 2001, RESTOR ECOL, V9, P147, DOI 10.1046/j.1526-100x.2001.009002147.x; Winsa M, 2015, APPL VEG SCI, V18, P413, DOI 10.1111/avsc.12157; Woodcock BA, 2012, BIOL CONSERV, V155, P50, DOI 10.1016/j.biocon.2012.05.013; Wortley L, 2013, RESTOR ECOL, V21, P537, DOI 10.1111/rec.12028	93	28	29	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155836	10.1371/journal.pone.0155836	http://dx.doi.org/10.1371/journal.pone.0155836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196748	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291100111
J	Drel, VR; Tan, CY; Barnes, JL; Gorin, Y; Lee, DY; Wagner, B				Drel, Viktor R.; Tan, Chunyan; Barnes, Jeffrey L.; Gorin, Yves; Lee, Doug-Yoon; Wagner, Brent			Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis	FASEB JOURNAL			English	Article						nephrogenic fibrosing dermopathy; skin diseases; NADPH oxidase; chemokine CCL2; CCR2	ACTIVATION; BIODISTRIBUTION; MACROPHAGES; FIBROCYTES; OXIDASE; INJURY; AGENTS; CELLS; MICE	Systemic fibrosis can be induced in humans with gadolinium-based contrast, and cumulative doses correlate with severity. Bone marrow-derived fibrocytes accumulate in the dermis. Whether target organs liberate chemokines to recruit these fibrocytes or whether fibrocytes are stimulated to home to the affected tissue is unknown. Transgenic (tagged) donor rats were treated with gadolinium-based contrast. Bone marrow was obtained from diseased animals and age-matched controls. Rats with subtotal nephrectomies were lethally irradiated and underwent salvage transplantation with either the contrast-naive or contrast-exposed bone marrow. Groups were randomly assigned to control or contrast treatment. Contrast treatment led to dermal fibrosis, and this was exacerbated in recipients of contrast-exposed marrow. Fibronectin, C-C chemokine receptors (CCRs)2 and 7, and oxidative stress were all increased in skin from contrast-treated animalsall parameters more severe in recipients of contrast-treated animals. The respective ligands, monocyte chemoattractant protein and C-C motif ligand 19, were both elevated in skin from contrast-treated animals. Coadministration of gadolinium-based contrast and a CCR2 inhibitor reduced the severity of skin disease as well as dermal cellularity. The functional role of chemokines in the effects of gadolinium-based contrast was further confirmed in in situ coculture studies using neutralizing CCR2 antibodies. These data implicate dermal liberation of specific chemokines in the recruitment of circulating bone marrow-derived cells. The disease is augmented by bone marrow exposure to contrast, which explains why multiple exposures correlate with severity.Drel, V. R., Tan, C., Barnes, J. L., Gorin, Y., Lee, D.-Y., Wagner, B. Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis.	[Drel, Viktor R.; Tan, Chunyan; Barnes, Jeffrey L.; Gorin, Yves; Lee, Doug-Yoon; Wagner, Brent] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Barnes, Jeffrey L.; Wagner, Brent] South Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Wagner, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol, Dept Med, 7703 Floyd Curl Dr,MC 7882, San Antonio, TX 78229 USA.	wagnerb@uthscsa.edu	Wagner, Brent/AAA-8291-2020; Drel, Viktor/G-8883-2016	Wagner, Brent/0000-0002-7063-0142; Drel, Viktor/0000-0003-4542-0132	Veterans Administration Merit [I01 BX001958]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK102085, R01-DK080106, R01-DK079996, R01-DK78971]; NIH National Center for Advancing Translational Sciences/Linked Specialized Center Cooperative Agreement [UL1-TR001120]; Qatar National Research Fund, National Priorities Research Program [NPRP8-1750-3-360]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078971, R01DK080106, R01DK079996, R01DK102085] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001958] Funding Source: NIH RePORTER	Veterans Administration Merit(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Center for Advancing Translational Sciences/Linked Specialized Center Cooperative Agreement; Qatar National Research Fund, National Priorities Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by Veterans Administration Merit Award I01 BX001958 (to B.W.), U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK102085 (to B.W.), R01-DK080106 (to J.L.B.), R01-DK079996 (to Y.G.), and R01-DK78971 (to Y.G.), NIH National Center for Advancing Translational Sciences/Linked Specialized Center Cooperative Agreement Grant UL1-TR001120 (to Y.G.), and an award from the Qatar National Research Fund, National Priorities Research Program (NPRP8-1750-3-360) (to Y.G.). Author contributions: B. Wagner and Y. Gorin designed the research, analyzed the data, and wrote the paper; J. L. Barnes provided the hPAP donor animals; and C. Tan, D.-Y. Lee, and V. R. Drel performed the experiments. The authors declare no conflicts of interest.	Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bucala Richard, 2008, J Am Coll Radiol, V5, P36, DOI 10.1016/j.jacr.2007.08.016; Cowper SE, 2003, AM J DERMATOPATH, V25, P358, DOI 10.1097/00000372-200308000-00017; Cowper SE, 2000, LANCET, V356, P1000, DOI 10.1016/S0140-6736(00)02694-5; Del Galdo F, 2010, ANN RHEUM DIS, V69, P2024, DOI 10.1136/ard.2010.134858; Do C, 2014, AM J PHYSIOL-RENAL, V307, pF844, DOI 10.1152/ajprenal.00379.2014; Girardi M, 2011, J AM ACAD DERMATOL, V65, P1095, DOI 10.1016/j.jaad.2010.08.041; Gorin Y, 2015, AM J PHYSIOL-RENAL, V308, pF1276, DOI 10.1152/ajprenal.00396.2014; Gorin Y, 2013, FREE RADICAL BIO MED, V61, P130, DOI 10.1016/j.freeradbiomed.2013.03.014; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Lan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129743; Martin DR, 2008, PEDIATR RADIOL, V38, pS125, DOI 10.1007/s00247-007-0589-8; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Ramalho J, 2015, RADIOLOGY, V276, P836, DOI 10.1148/radiol.2015150872; Swaminathan S, 2013, AM J PATHOL, V183, P796, DOI 10.1016/j.ajpath.2013.06.008; TWEEDLE MF, 1995, INVEST RADIOL, V30, P372, DOI 10.1097/00004424-199506000-00008; Wadas TJ, 2010, MAGN RESON MED, V64, P1274, DOI 10.1002/mrm.22553; Wagner B, 2012, AM J PATHOL, V181, P1941, DOI 10.1016/j.ajpath.2012.08.026; Wan M, 2012, STEM CELLS, V30, P2498, DOI 10.1002/stem.1208	23	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3026	3038		10.1096/fj.201500188R	http://dx.doi.org/10.1096/fj.201500188R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27221979	Green Published			2022-12-26	WOS:000382816300004
J	Crosnier, C; Iqbal, Z; Knuepfer, E; Maciuca, S; Perrin, AJ; Kamuyu, G; Goulding, D; Bustamante, LY; Miles, A; Moore, SC; Dougan, G; Holder, AA; Kwiatkowski, DP; Rayner, JC; Pleass, RJ; Wright, GJ				Crosnier, Cecile; Iqbal, Zamin; Knuepfer, Ellen; Maciuca, Sorina; Perrin, Abigail J.; Kamuyu, Gathoni; Goulding, David; Bustamante, Leyla Y.; Miles, Alistair; Moore, Shona C.; Dougan, Gordon; Holder, Anthony A.; Kwiatkowski, Dominic P.; Rayner, Julian C.; Pleass, Richard J.; Wright, Gavin J.			Binding of Plasmodium falciparum Merozoite Surface Proteins DBLMSP and DBLMSP2 to Human Immunoglobulin M Is Conserved among Broadly Diverged Sequence Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genetic polymorphism; host-pathogen interaction; parasite; plasmodium; protein-protein interaction; immunoglobulin M (IgM); merozoite	HUMAN-IGM; INFECTED ERYTHROCYTES; MALARIA; INVASION; ANTIBODIES; DOMAINS; ANTIGEN; SELECTION; RECEPTOR; IDENTIFICATION	Diversity at pathogen genetic loci can be driven by host adaptive immune selection pressure and may reveal proteins important for parasite biology. Population-based genome sequencing of Plasmodium falciparum, the parasite responsible for the most severe form of malaria, has highlighted two related polymorphic genes called dblmsp and dblmsp2, which encode Duffy binding-like (DBL) domain-containing proteins located on the merozoite surface but whose function remains unknown. Using recombinant proteins and transgenic parasites, we show that DBLMSP and DBLMSP2 directly and avidly bind human IgM via their DBL domains. We used whole genome sequence data from over 400 African and Asian P. falciparum isolates to show that dblmsp and dblmsp2 exhibit extreme protein polymorphism in their DBL domain, with multiple variants of two major allelic classes present in every population tested. Despite this variability, the IgM binding function was retained across diverse sequence representatives. Although this interaction did not seem to have an effect on the ability of the parasite to invade red blood cells, binding of DBLMSP and DBLMSP2 to IgM inhibited the overall immunoreactivity of these proteins to IgG from patients who had been exposed to the parasite. This suggests that IgM binding might mask these proteins from the host humoral immune system.	[Crosnier, Cecile; Perrin, Abigail J.; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1SA, England; [Crosnier, Cecile; Perrin, Abigail J.; Kamuyu, Gathoni; Bustamante, Leyla Y.; Miles, Alistair; Kwiatkowski, Dominic P.; Rayner, Julian C.; Wright, Gavin J.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Goulding, David; Dougan, Gordon] Wellcome Trust Sanger Inst, Microbial Pathogenesis Lab, Cambridge CB10 1SA, England; [Iqbal, Zamin; Maciuca, Sorina; Miles, Alistair; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Knuepfer, Ellen; Holder, Anthony A.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England; [Moore, Shona C.; Pleass, Richard J.] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Moore, Shona C.] Univ Warwick, Warwick Syst Biol Ctr, Senate House, Coventry CV4 7AL, W Midlands, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; Francis Crick Institute; Liverpool School of Tropical Medicine; University of Warwick	Wright, GJ (corresponding author), Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1SA, England.	gw2@sanger.ac.uk	Holder, Anthony A/A-7554-2013; Moore, Shona C/AAY-5049-2021; Pleass, Richard/N-7831-2019	Holder, Anthony A/0000-0002-8490-6058; Moore, Shona C/0000-0001-8610-2806; Pleass, Richard/0000-0001-7438-8296; Miles, Alistair/0000-0001-9018-4680; Iqbal, Zamin/0000-0001-8466-7547; Kwiatkowski, Dominic/0000-0002-5023-0176; Knuepfer, Ellen/0000-0002-6090-1877; Perrin, Abigail/0000-0001-6682-4297; Wright, Gavin/0000-0003-0537-0863; Rayner, Julian/0000-0002-9835-1014	Wellcome Trust [098051]; Sir Henry Dale Fellowship - Wellcome Trust [102541/Z/13/Z]; Sir Henry Dale Fellowship - Royal Society [102541/Z/13/Z]; European Community [242095]; Engineering and Physical Sciences Research Council [987447] Funding Source: researchfish; Medical Research Council [MR/M006212/1, MC_PC_12017] Funding Source: researchfish; The Francis Crick Institute [10097] Funding Source: researchfish; MRC [MC_PC_12017, MR/M006212/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; European Community(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 098051 (to C.C., L. Y. B., A. J. P., D. G., G. D., D. P. K., J. C. R., and G. J. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Sir Henry Dale Fellowship 102541/Z/13/Z jointly awarded by the Wellcome Trust and the Royal Society.; Supported by European Community's Seventh Framework Programme FP7/2007-2013 under Grant 242095.	Akhouri RR, 2016, CELL REP, V14, P723, DOI 10.1016/j.celrep.2015.12.067; Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; [Anonymous], CELLS LAB MANUAL SUB; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Braathen R, 2002, J BIOL CHEM, V277, P42755, DOI 10.1074/jbc.M205502200; BROWN MH, 1994, PROTEIN ENG, V7, P515, DOI 10.1093/protein/7.4.515; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins C, 2002, EUR J IMMUNOL, V32, P1802, DOI 10.1002/1521-4141(200206)32:6<1802::AID-IMMU1802>3.0.CO;2-C; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Crosnier C, 2013, MOL CELL PROTEOMICS, V12, P3976, DOI 10.1074/mcp.O113.028357; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Crosnier C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-76; Czajkowsky DM, 2010, J IMMUNOL, V184, P4597, DOI 10.4049/jimmunol.1000203; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Ghumra A, 2008, J IMMUNOL, V181, P1988, DOI 10.4049/jimmunol.181.3.1988; Gondeau C, 2009, MOL BIOCHEM PARASIT, V165, P153, DOI 10.1016/j.molbiopara.2009.01.015; Hodder AN, 2012, J BIOL CHEM, V287, P32922, DOI 10.1074/jbc.M112.350504; Iqbal Z, 2013, BIOINFORMATICS, V29, P275, DOI 10.1093/bioinformatics/bts673; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Jeppesen A, 2015, INFECT IMMUN, V83, P3972, DOI 10.1128/IAI.00337-15; Kerr JS, 2012, JOVE-J VIS EXP, DOI 10.3791/3881; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lin CS, 2016, J BIOL CHEM, V291, P7703, DOI 10.1074/jbc.M115.698282; Lin CS, 2014, J BIOL CHEM, V289, P25655, DOI 10.1074/jbc.M114.586495; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; MACKENZIE MR, 1971, J IMMUNOL, V106, P65; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mobegi VA, 2014, MOL BIOL EVOL, V31, P1490, DOI 10.1093/molbev/msu106; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; Okenu DMN, 2000, MOL BIOCHEM PARASIT, V109, P185, DOI 10.1016/S0166-6851(00)00245-0; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Patel SD, 2013, J INFECT DIS, V208, P1679, DOI 10.1093/infdis/jit385; Pleass RJ, 2016, TRENDS PARASITOL, V32, P108, DOI 10.1016/j.pt.2015.09.007; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; RUDICH SM, 1987, MOL IMMUNOL, V24, P809, DOI 10.1016/0161-5890(87)90183-0; Sakamoto H, 2012, VACCINE, V30, P1972, DOI 10.1016/j.vaccine.2012.01.010; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Segurel L, 2012, P NATL ACAD SCI USA, V109, P18493, DOI 10.1073/pnas.1210603109; Semblat JP, 2006, MOL BIOCHEM PARASIT, V146, P192, DOI 10.1016/j.molbiopara.2005.12.007; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Sorensen V, 2000, INT IMMUNOL, V12, P19, DOI 10.1093/intimm/12.1.19; Stevenson L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005022; Sun Y, 2012, ANAL BIOCHEM, V424, P45, DOI 10.1016/j.ab.2012.01.034; TAYLOR TE, 1992, CLIN EXP IMMUNOL, V90, P357, DOI 10.1111/j.1365-2249.1992.tb05851.x; Tetteh KKA, 2013, INFECT IMMUN, V81, P3835, DOI 10.1128/IAI.00301-13; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran TM, 2014, J INFECT DIS, V209, P789, DOI 10.1093/infdis/jit553; Weedall GD, 2010, TRENDS PARASITOL, V26, P363, DOI 10.1016/j.pt.2010.04.002; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004	63	16	16	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14285	14299		10.1074/jbc.M116.722074	http://dx.doi.org/10.1074/jbc.M116.722074			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226583	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-26	WOS:000379975100032
J	Soysa, HSM; Suginta, W				Soysa, H. Sasimali M.; Suginta, Wipa			Identification and Functional Characterization of a Novel OprD-like Chitin Uptake Channel in Non-chitinolytic Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; chitin; Escherichia coli (E. coli); ion channel; sugar transport; chitin uptake channel; non-chitinolytic bacteria; single channel recordings	ACETYLGLUCOSAMINE UTILIZATION PATHWAY; N-N'-DIACETYLCHITOBIOSE; ESCHERICHIA-COLI; VIBRIO-HARVEYI; MARINE-BACTERIA; BURKHOLDERIA-PSEUDOMALLEI; SUGAR TRANSLOCATION; MOLECULAR-CLONING; STRUCTURAL BASIS; MALTOPORIN	Chitoporin from the chitinolytic marine Vibrio has been characterized as a trimeric OmpC-like channel responsible for effective chitin uptake. In this study we describe the identification and characterization of a novel OprD-like chitoporin (so-called EcChiP) from Escherichia coli. The gene was identified, cloned, and functionally expressed in the Omp-deficient E. coli BL21 (Omp8) Rosetta strain. On size exclusion chromatography, EcChiP had an apparent native molecular mass of 50 kDa, as predicted by amino acid sequencing and mass analysis, confirming that the protein is a monomer. Black lipid membrane reconstitution demonstrated that EcChiP could readily form stable, monomeric channels in artificial phospholipid membranes, with an average single channel conductance of 0.55 +/- 0.01 nanosiemens and a slight preference for cations. Single EcChiP channels showed strong specificity, interacting with long chain chitooligosaccharides but not with maltooligosaccharides. Liposome swelling assays indicated the bulk permeation of neutral monosaccharides and showed the size exclusion limit of EcChiP to be approximate to 200-300 Da for small permeants that pass through by general diffusion while allowing long chain chitooligosaccharides to pass through by a facilitated diffusion process. Taking E. coli as a model, we offer the first evidence that non-chitinolytic bacteria can activate a quiescent ChiP gene to express a functional chitoporin, enabling them to take up chitooligosaccharides for metabolism as an immediate source of energy.	[Soysa, H. Sasimali M.; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Soysa, H. Sasimali M.; Suginta, Wipa] Suranaree Univ Technol, Inst Sci, Sch Chem, Nakhon Ratchasima 30000, Thailand; [Suginta, Wipa] Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology	Suginta, W (corresponding author), Suranaree Univ Technol, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand.; Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Sch Chem, Nakhon Ratchasima 30000, Thailand.; Suginta, W (corresponding author), Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th		M. Soysa, H. Sasimali/0000-0003-3244-8670	Suranaree University of Technology; Office of the Higher Education Commission under the National Research University project of Thailand; Suranaree University of Technology through a SUT-OGRG grant; Thailand Research Fund; Suranaree University of Technology through Basic Research Grant [BRG578001]; Suranaree University of Technology [SUT1-102-57-36-18, SUT1-102-59-12-17]	Suranaree University of Technology; Office of the Higher Education Commission under the National Research University project of Thailand; Suranaree University of Technology through a SUT-OGRG grant; Thailand Research Fund(Thailand Research Fund (TRF)); Suranaree University of Technology through Basic Research Grant; Suranaree University of Technology	This work was supported by Suranaree University of Technology and the Office of the Higher Education Commission under the National Research University project of Thailand. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Suranaree University of Technology through a SUT-OGRG grant.; Supported by the Thailand Research Fund and Suranaree University of Technology through Basic Research Grant BRG578001 and Suranaree University of Technology Grants SUT1-102-57-36-18 and SUT1-102-59-12-17. To whom correspondence should be addressed. E-mail: wipa@sut.ac.th.	Aunkham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095918; BASSLER BL, 1991, J BIOL CHEM, V266, P24268; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; Bezrukov SM, 2000, FEBS LETT, V476, P224, DOI 10.1016/S0014-5793(00)01753-1; Bhamidimarri SP, 2016, BIOPHYS J, V110, P600, DOI 10.1016/j.bpj.2015.12.027; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Boulanger A, 2010, J BACTERIOL, V192, P1487, DOI 10.1128/JB.01418-09; Chumjan W, 2015, J BIOL CHEM, V290, P19184, DOI 10.1074/jbc.M115.660530; Conlan S, 2000, BIOCHEMISTRY-US, V39, P11845, DOI 10.1021/bi001065h; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; Dumas F, 2000, J BIOL CHEM, V275, P19747, DOI 10.1074/jbc.M000268200; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; Francetic O, 2000, MOL MICROBIOL, V35, P1506, DOI 10.1046/j.1365-2958.2000.01817.x; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Keyhani NO, 2000, J BIOL CHEM, V275, P33102, DOI 10.1074/jbc.M001045200; Keyhani NO, 2000, J BIOL CHEM, V275, P33091, DOI 10.1074/jbc.M001044200; Keyhani NO, 2000, J BIOL CHEM, V275, P33084, DOI 10.1074/jbc.M001043200; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P1; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Meekrathok P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149228; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; PERI KG, 1990, BIOCHEM CELL BIOL, V68, P123, DOI 10.1139/o90-017; Plumbridge J, 2014, MOL MICROBIOL, V92, P648, DOI 10.1111/mmi.12573; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Ranquin A, 2004, RES MICROBIOL, V155, P611, DOI 10.1016/j.resmic.2004.05.007; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Siritapetawee J, 2004, BIOCHEM J, V384, P609, DOI 10.1042/BJ20041102; Siritapetawee J, 2004, BIOCHEM J, V377, P579, DOI 10.1042/BJ20031118; Sritho N, 2012, APPL BIOCHEM BIOTECH, V166, P1192, DOI 10.1007/s12010-011-9504-8; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2012, BIOSCI BIOTECH BIOCH, V76, P2275, DOI 10.1271/bbb.120559; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; Takanao S, 2014, BIOSCI BIOTECH BIOCH, V78, P524, DOI 10.1080/09168451.2014.882755; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; van den Berg B, 2012, J BIOL CHEM, V287, P41044, DOI 10.1074/jbc.M112.408518; Van Gelder P, 2000, EUR J BIOCHEM, V267, P79, DOI 10.1046/j.1432-1327.2000.00960.x; Verma SC, 2012, J BACTERIOL, V194, P4959, DOI 10.1128/JB.00533-12; Vogel J, 2006, CURR OPIN MICROBIOL, V9, P605, DOI 10.1016/j.mib.2006.10.006; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; YU C, 1991, J BIOL CHEM, V266, P24260; Zobell CE, 1938, J BACTERIOL, V35, P275, DOI 10.1128/JB.35.3.275-287.1938	58	8	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2016	291	26					13622	13633		10.1074/jbc.M116.728881	http://dx.doi.org/10.1074/jbc.M116.728881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YZ	27226611	hybrid, Green Published			2022-12-26	WOS:000379771100019
J	Abualhassan, N; Sapozhnikov, L; Pawlick, RL; Kahana, M; Pepper, AR; Bruni, A; Gala-Lopez, B; Kin, T; Mitrani, E; Shapiro, AMJ				Abualhassan, Nasser; Sapozhnikov, Lena; Pawlick, Rena L.; Kahana, Meygal; Pepper, Andrew R.; Bruni, Antonio; Gala-Lopez, Boris; Kin, Tatsuya; Mitrani, Eduardo; Shapiro, A. M. James			Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation	PLOS ONE			English	Article							MEDIATED INFLAMMATORY REACTION; EXTRACELLULAR-MATRIX; PANCREATIC-ISLETS; GROWTH-FACTOR; IN-VITRO; CELL; SCAFFOLDS; SURVIVAL; APOPTOSIS; RAT	There is a need to develop three-dimensional structures that mimic the natural islet tissue microenvironment. Endocrine micro-pancreata (EMPs) made up of acellular organ-derived micro-scaffolds seeded with human islets have been shown to express high levels of key beta-cell specific genes and secrete quantities of insulin per cell similar to freshly isolated human islets in a glucose-regulated manner for more than three months in vitro. The aim of this study was to investigate the capacity of EMPs to restore euglycemia in vivo after transplantation of mouse or human islets in chemically diabetic mice. We proposed that the organ-derived EMPs would restore the extracellular components of the islet microenvironment, generating favorable conditions for islet function and survival. EMPs seeded with 500 mouse islets were implanted intraperitoneally into streptozotocin-induced diabetic mice and reverted diabetes in 67% of mice compared to 13% of controls (p = 0.018, n = 9 per group). Histological analysis of the explanted grafts 60 days post-transplantation stained positive for insulin and exhibited increased vascular density in a collagen-rich background. EMPs were also seeded with human islets and transplanted into the peritoneal cavity of immune-deficient diabetic mice at 250 islet equivalents (IEQ), 500 IEQ and 1000 IEQ. Escalating islet dose increased rates of normoglycemia (50% of the 500 IEQ group and 75% of the 1000 IEQ group, n = 3 per group). Human c-peptide levels were detected 90 days post-transplantation in a dose-response relationship. Herein, we report reversal of diabetes in mice by intraperitoneal transplantation of human islet seeded on EMPs with a human islet dose as low as 500 IEQ.	[Abualhassan, Nasser; Pawlick, Rena L.; Pepper, Andrew R.; Bruni, Antonio; Gala-Lopez, Boris; Shapiro, A. M. James] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Sapozhnikov, Lena; Kahana, Meygal; Mitrani, Eduardo] Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Jerusalem, Israel; [Kin, Tatsuya; Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada	University of Alberta; Hebrew University of Jerusalem; University of Alberta	Mitrani, E (corresponding author), Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Jerusalem, Israel.	mitrani@vms.huji.ac.il	Kin, Tatsuya/A-3776-2012	Kin, Tatsuya/0000-0002-5179-6067; Sapozhnikov, Lena/0000-0001-9191-5115	Canadian National Transplantation Research Program (CNTRP); Saudi Arabian Cultural Bureau; JDRF Canadian Clinical Trial Network Fellowship; AIHS CRIO Team Award [201201154]; CNTRP; University of Alberta; Alberta Diabetes Institute (ADI); Alberta Diabetes Foundation; Diabetes Research Institute Foundation of Canada (DRIFCan); Alberta Innovates Health Solutions (AIHS) Clinician Fellowship; Betalin Therapeutics Ltd. Israel; Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Alberta Innovates Healthcare Solutions; Alberta Innovates [201400496, 201201154, 201400106] Funding Source: researchfish	Canadian National Transplantation Research Program (CNTRP); Saudi Arabian Cultural Bureau; JDRF Canadian Clinical Trial Network Fellowship; AIHS CRIO Team Award; CNTRP; University of Alberta(University of Alberta); Alberta Diabetes Institute (ADI); Alberta Diabetes Foundation; Diabetes Research Institute Foundation of Canada (DRIFCan); Alberta Innovates Health Solutions (AIHS) Clinician Fellowship; Betalin Therapeutics Ltd. Israel; Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Alberta Innovates Healthcare Solutions; Alberta Innovates	NA is supported through the Canadian National Transplantation Research Program (CNTRP) and Saudi Arabian Cultural Bureau. AP is supported primarily through a JDRF Canadian Clinical Trial Network Fellowship, and further supplemented through an AIHS CRIO Team Award (No. 201201154) and the CNTRP. AB is supported through scholarships from the University of Alberta, the Alberta Diabetes Institute (ADI) and the Alberta Diabetes Foundation. Other funding includes: the Diabetes Research Institute Foundation of Canada (DRIFCan). BGL is supported through an Alberta Innovates Health Solutions (AIHS) Clinician Fellowship, and also receives support from the CNTRP. EM is supported by Betalin Therapeutics Ltd. (2015) Israel. AMJS is supported through a Canada Research Chair in Transplantation Surgery and Regenerative Medicine and through Alberta Innovates Healthcare Solutions as a Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Diabetes, V46, P271; AO ZL, 1993, TRANSPLANTATION, V56, P524, DOI 10.1097/00007890-199309000-00007; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x; Bruni A, 2014, DIABETES METAB SYNDR, V7, P211, DOI 10.2147/DMSO.S50789; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Citro A, 2012, J CLIN INVEST, V122, P3647, DOI 10.1172/JCI63089; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Eich T, 2007, NEW ENGL J MED, V356, P2754, DOI 10.1056/NEJMc070201; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; FRITSCHY WM, 1991, TRANSPLANTATION, V52, P777, DOI 10.1097/00007890-199111000-00004; Gala-Lopez BL, 2016, DIABETES, V65, P451, DOI 10.2337/db15-0764; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Jalili RB, 2011, J CELL PHYSIOL, V226, P1813, DOI 10.1002/jcp.22515; Johansson A, 2009, DIABETOLOGIA, V52, P2385, DOI 10.1007/s00125-009-1485-6; Kawahara T, 2011, AM J TRANSPLANT, V11, P2700, DOI 10.1111/j.1600-6143.2011.03717.x; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; LORENZ D, 1977, ACTA DIABETOL LAT, V14, P199, DOI 10.1007/BF02580968; LUCASCLERC C, 1993, MOL CELL ENDOCRINOL, V94, P9, DOI 10.1016/0303-7207(93)90046-M; Motta PM, 1997, MICROSC RES TECHNIQ, V37, P384, DOI 10.1002/(SICI)1097-0029(19970601)37:5/6<384::AID-JEMT3>3.3.CO;2-L; Nagata N, 2002, J BIOMAT SCI-POLYM E, V13, P579, DOI 10.1163/15685620260178418; Nagata N, 2001, CELL TRANSPLANT, V10, P447; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Pedraza E, 2013, CELL TRANSPLANT, V22, P1123, DOI 10.3727/096368912X657440; Pepper Andrew R, 2013, World J Transplant, V3, P48, DOI 10.5500/wjt.v3.i4.48; Pepper AR, 2009, XENOTRANSPLANTATION, V16, P502, DOI 10.1111/j.1399-3089.2009.00548.x; Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88; Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea; Senior PA, 2012, CAN J DIABETES, V36, P32, DOI 10.1016/j.jcjd.2012.01.002; Shamis Y, 2011, TISSUE ENG PART C-ME, V17, P861, DOI 10.1089/ten.tec.2010.0717; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84; Sionov RV, 2015, TISSUE ENG PT A, V21, P2691, DOI [10.1089/ten.tea.2014.0711, 10.1089/ten.TEA.2014.0711]; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1067/msy.1999.99164; VANDEIJNEN JHM, 1994, CELL TISSUE RES, V277, P115, DOI 10.1007/BF00303087; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; WAHOFF DC, 1994, SURGERY, V116, P742; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Wang RN, 1999, J HISTOCHEM CYTOCHEM, V47, P499, DOI 10.1177/002215549904700408; Wilson DB, 2005, NATURE, V438, pE5, DOI 10.1038/nature04423; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63; Zand MS, 2005, TRANSPLANTATION, V79, P1507, DOI 10.1097/01.TP.0000164159.20075.16; Zhang Y, 2012, AM J PATHOL, V181, P1296, DOI 10.1016/j.ajpath.2012.06.032; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	59	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156053	10.1371/journal.pone.0156053	http://dx.doi.org/10.1371/journal.pone.0156053			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227978	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500060
J	Gonzalez-Paredes, FJ; Mesa, GH; Arraez, DM; Reyes, RM; Abrante, B; Diaz-Flores, F; Salido, E; Quintero, E; Hernandez-Guerra, M				Javier Gonzalez-Paredes, Francisco; Hernandez Mesa, Goretti; Morales Arraez, Dalia; Marcelino Reyes, Raquel; Abrante, Beatriz; Diaz-Flores, Felicitas; Salido, Eduardo; Quintero, Enrique; Hernandez-Guerra, Manuel			Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CIRRHOTIC RAT LIVERS; NITRIC-OXIDE; INSULIN-RESISTANCE; PORTAL-HYPERTENSION; THROMBOXANE A(2); CELL ACTIVATION; STEATOHEPATITIS; MICROCIRCULATION; PROSTANOIDS; ACID	Introduction Metabolic syndrome induces endothelial dysfunction, a surrogate marker of cardiovascular disease. In parallel, metabolic syndrome is frequently associated with non-alcoholic fatty liver disease (NAFLD), which may progress to cirrhosis. The aim of the present study was to evaluate intrahepatic endothelial dysfunction related to cyclooxygenase end products and oxidative stress as possible mechanisms involved in the pathophysiology of NAFLD. Materials and Methods Sprague-Dawley rats were fed standard diet (control-diet, CD) or high-fat-diet (HFD) for 6 weeks. Metabolic syndrome was assessed by recording arterial pressure, lipids, glycemia and rat body weight. Splanchnic hemodynamics were measured, and endothelial dysfunction was evaluated using concentration-effect curves to acetylcholine. Response was assessed with either vehicle, L-N-G-Nitroarginine (L-NNA), indomethacin, tempol, or a thromboxane receptor antagonist, SQ 29548. We quantified inflammation, fibrosis, oxidative stress, nitric oxide (NO) bioavailability and thromboxane B-2 levels. Results HFD rats exhibited metabolic syndrome together with the presence of NAFLD. Compared to control-diet livers, HFD livers showed increased hepatic vascular resistance unrelated to inflammation or fibrosis, but with decreased NO activity and increased oxidative stress. Endothelial dysfunction was observed in HFD livers compared with CD rats and improved after cyclooxygenase inhibition or tempol pre-incubation. However, pre-incubation with SQ 29548 did not modify acetylcholine response. Conclusions Our study provides evidence that endothelial dysfunction at an early stage of NAFLD is associated with reduced NO bioavailability together with increased cyclooxygenase end products and oxidative stress, which suggests that both pathways are involved in the pathophysiology and may be worth exploring as therapeutic targets to prevent progression of the disease.	[Javier Gonzalez-Paredes, Francisco; Abrante, Beatriz; Salido, Eduardo; Quintero, Enrique; Hernandez-Guerra, Manuel] Univ La Laguna, Inst Biomed Technol, Tenerife, Spain; [Javier Gonzalez-Paredes, Francisco; Abrante, Beatriz; Salido, Eduardo; Quintero, Enrique; Hernandez-Guerra, Manuel] Univ La Laguna, Ctr Biomed Res Canary Isl CIBICAN, Tenerife, Spain; [Hernandez Mesa, Goretti; Morales Arraez, Dalia; Marcelino Reyes, Raquel; Quintero, Enrique; Hernandez-Guerra, Manuel] Univ Hosp Canary Isl, Dept Gastroenterol, Tenerife, Spain; [Diaz-Flores, Felicitas] Univ Hosp Canary Isl, Cent Lab, Tenerife, Spain; [Quintero, Enrique; Hernandez-Guerra, Manuel] Univ La Laguna, Dept Med & Psychiat, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Hernandez-Guerra, M (corresponding author), Univ La Laguna, Inst Biomed Technol, Tenerife, Spain.; Hernandez-Guerra, M (corresponding author), Univ La Laguna, Ctr Biomed Res Canary Isl CIBICAN, Tenerife, Spain.; Hernandez-Guerra, M (corresponding author), Univ Hosp Canary Isl, Dept Gastroenterol, Tenerife, Spain.; Hernandez-Guerra, M (corresponding author), Univ La Laguna, Dept Med & Psychiat, Tenerife, Spain.	mhernandezguerra@gmail.com	Quintero, Enrique/C-3841-2017; Salido, Eduardo/I-2232-2015	Quintero, Enrique/0000-0002-7244-8125; Salido, Eduardo/0000-0001-9599-9854; Hernandez-Guerra, Manuel/0000-0002-3478-9981				Antman EM, 2005, CIRCULATION, V112, P759, DOI 10.1161/CIRCULATIONAHA.105.568451; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Failli P, 2000, GASTROENTEROLOGY, V119, P479, DOI 10.1053/gast.2000.9354; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Francque SM, 2016, J HEPATOL IN PRESS; Francque S, 2012, LAB INVEST, V92, P1428, DOI 10.1038/labinvest.2012.103; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166; Gracia-Sancho J, 2007, J HEPATOL, V47, P220, DOI 10.1016/j.jhep.2007.03.014; Graupera M, 2005, AM J PHYSIOL-GASTR L, V288, pG763, DOI 10.1152/ajpgi.00300.2004; Graupera M, 2003, J HEPATOL, V39, P515, DOI 10.1016/S0168-8278(03)00347-7; Graupera M, 2003, HEPATOLOGY, V37, P172, DOI 10.1053/jhep.2003.50004; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Hernandez-Guerra M, 2013, HEPATOLOGY, V57, P1564, DOI 10.1002/hep.26152; Hernanz R, 2014, CLIN SCI, V126, P111, DOI 10.1042/CS20120651; Ijaz S, 2005, MICROVASC RES, V70, P129, DOI 10.1016/j.mvr.2005.08.001; Inoue E, 2012, J ENDOCRINOL, V213, P285, DOI 10.1530/JOE-12-0014; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Langer DA, 2008, HEPATOLOGY, V47, P1983, DOI 10.1002/hep.22285; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lobato NS, 2011, NUTR METAB CARDIOVAS, V21, P808, DOI 10.1016/j.numecd.2010.02.006; Marrone G, 2015, GUT, V64, P1434, DOI 10.1136/gutjnl-2014-308338; Martinez-Revelles S, 2013, ANTIOXID REDOX SIGN, V18, P51, DOI 10.1089/ars.2011.4335; Maruyama J, 1999, J APPL PHYSIOL, V86, P1687, DOI 10.1152/jappl.1999.86.5.1687; Matsumoto K, 2002, J ENDOCRINOL, V175, P217, DOI 10.1677/joe.0.1750217; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; Munzel T, 2008, ANN MED, V40, P180, DOI 10.1080/07853890701854702; NOUCHI T, 1987, ALCOHOL CLIN EXP RES, V11, P287, DOI 10.1111/j.1530-0277.1987.tb01309.x; OGLETREE ML, 1985, J PHARMACOL EXP THER, V234, P435; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rosado E, 2012, J CELL MOL MED, V16, P2461, DOI 10.1111/j.1582-4934.2012.01563.x; Sacerdoti D, 2015, PROSTAG OTH LIPID M, V120, P80, DOI 10.1016/j.prostaglandins.2015.05.008; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Steib CJ, 2007, J HEPATOL, V47, P228, DOI 10.1016/j.jhep.2007.03.019; TESFAMARIAM B, 1990, J CLIN INVEST, V85, P929, DOI 10.1172/JCI114521; Virdis A, 2007, HYPERTENSION, V49, P679; Xiang LH, 2006, AM J PHYSIOL-REG I, V290, pR134, DOI 10.1152/ajpregu.00295.2005; Yokoyama Y, 2003, AM J PHYSIOL-GASTR L, V284, pG453, DOI 10.1152/ajpgi.00315.2002	50	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156650	10.1371/journal.pone.0156650	http://dx.doi.org/10.1371/journal.pone.0156650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227672	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500161
J	Stromberg, LR; Hengartner, NW; Swingle, KL; Moxley, RA; Graves, SW; Montano, GA; Mukundan, H				Stromberg, Loreen R.; Hengartner, Nicolas W.; Swingle, Kirstie L.; Moxley, Rodney A.; Graves, Steven W.; Montano, Gabriel A.; Mukundan, Harshini			Membrane Insertion for the Detection of Lipopolysaccharides: Exploring the Dynamics of Amphiphile-in-Lipid Assays	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; HIGH-DENSITY-LIPOPROTEIN; ESCHERICHIA-COLI O26; TOLL-LIKE RECEPTORS; BINDING-PROTEIN; (LPS)-BINDING PROTEIN; BIOLOGICAL-ACTIVITIES; BACTERIAL-ENDOTOXINS; PATHOGEN DETECTION; MOLECULAR-BASIS	Shiga toxin-producing Escherichia coli is an important cause of foodborne illness, with cases attributable to beef, fresh produce and other sources. Many serotypes of the pathogen cause disease, and differentiating one serotype from another requires specific identification of the O antigen located on the lipopolysaccharide (LPS) molecule. The amphiphilic structure of LPS poses a challenge when using classical detection methods, which do not take into account its lipoglycan biochemistry. Typically, detection of LPS requires heat or chemical treatment of samples and relies on bioactivity assays for the conserved lipid A portion of the molecule. Our goal was to develop assays to facilitate the direct and discriminative detection of the entire LPS molecule and its O antigen in complex matrices using minimal sample processing. To perform serogroup identification of LPS, we used a method called membrane insertion on a waveguide biosensor, and tested three serogroups of LPS. The membrane insertion technique allows for the hydrophobic association of LPS with a lipid bilayer, where the exposed O antigen can be targeted for specific detection. Samples of beef lysate were spiked with LPS to perform O antigen specific detection of LPS from E. coli O157. To validate assay performance, we evaluated the biophysical interactions of LPS with lipid bilayers both in-and outside of a flow cell using fluorescence microscopy and fluorescently doped lipids. Our results indicate that membrane insertion allows for the qualitative and reliable identification of amphiphilic LPS in complex samples like beef homogenates. We also demonstrated that LPS-induced hole formation does not occur under the conditions of the membrane insertion assays. Together, these findings describe for the first time the serogroup-specific detection of amphiphilic LPS in complex samples using a membrane insertion assay, and highlight the importance of LPS molecular conformations in detection architectures.	[Stromberg, Loreen R.; Graves, Steven W.; Mukundan, Harshini] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Stromberg, Loreen R.; Mukundan, Harshini] Los Alamos Natl Lab, Phys Chem & Appl Spect, Los Alamos, NM USA; [Stromberg, Loreen R.; Graves, Steven W.; Mukundan, Harshini] New Mexico Consortium, Los Alamos, NM USA; [Hengartner, Nicolas W.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM USA; [Swingle, Kirstie L.; Montano, Gabriel A.] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM USA; [Moxley, Rodney A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA	University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Nebraska System; University of Nebraska Lincoln	Mukundan, H (corresponding author), Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA.	harshini@lanl.gov		Stromberg, Loreen/0000-0003-1715-1211; Moxley, Rodney/0000-0002-5377-7716; Hengartner, Nicolas/0000-0002-4157-134X	National Institute of Food and Agriculture, U.S. Department of Agriculture [2012-68003-30155]; National Nuclear Security Administration of the United States Department of Energy [DE-AC52-06NA25396]; Photosynthetic Antenna Research Center, an Energy Frontier Research Center - United States Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001035]; Los Alamos National Laboratory Directed Research and Development (LDRD); Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture's National Institute of Food and Agriculture [2012-68003-30155]; Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Nuclear Security Administration of the United States Department of Energy(National Nuclear Security Administration); Photosynthetic Antenna Research Center, an Energy Frontier Research Center - United States Department of Energy, Office of Science, Basic Energy Sciences; Los Alamos National Laboratory Directed Research and Development (LDRD)(United States Department of Energy (DOE)Los Alamos National Laboratory); Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture's National Institute of Food and Agriculture; Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance	LRS RAM SWG HM were supported in part by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2012-68003-30155. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the United States Department of Energy under contract No. DE-AC52-06NA25396. Work by G.A.M and K.L.S. was supported by Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Basic Energy Sciences under Award No. DE-SC0001035. Nicholas Hengartner was supported by a Los Alamos National Laboratory Directed Research and Development (LDRD) award (project title, Integrative Biosurveillance, PI Mukundan and McMahon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the United States Department of Energy's Office of Science. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the United States Department of Energy under contract No. DE-AC52-06NA25396. Work by G.A.M and K.L.S. was supported by Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Basic Energy Sciences under Award No. DE-SC0001035. H.M., R.A.M, S.W.G and L.R.S. were supported by Agriculture and Food Research Initiative Competitive Grant No. 2012-68003-30155 from the United States Department of Agriculture's National Institute of Food and Agriculture. N.H. was supported by Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance (Mukundan and McMahon).	Adams PG, 2015, SCI REP-UK, V5, DOI 10.1038/srep10331; Adams PG, 2014, BIOPHYS J, V106, P2395, DOI 10.1016/j.bpj.2014.04.016; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alam JM, 2011, CHEM PHYS LIPIDS, V164, P166, DOI 10.1016/j.chemphyslip.2010.12.008; Alonso-Urmeneta B, 1998, CLIN DIAGN LAB IMMUN, V5, P749, DOI 10.1128/CDLI.5.6.749-754.1998; Aurell CA, 1998, BIOCHEM BIOPH RES CO, V253, P119, DOI 10.1006/bbrc.1998.9773; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; Bergstrand A, 2006, COLLOID SURFACE B, V53, P9, DOI 10.1016/j.colsurfb.2006.06.007; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brooks BW, 2004, VET MICROBIOL, V103, P77, DOI 10.1016/j.vetmic.2004.07.008; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; DIN ZZ, 1993, BIOCHEMISTRY-US, V32, P4579, DOI 10.1021/bi00068a014; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Fode-Vaughan KA, 2003, LETT APPL MICROBIOL, V37, P239, DOI 10.1046/j.1472-765X.2003.01386.x; GALL D, 1994, J IMMUNOASSAY, V15, P277, DOI 10.1080/15321819408009578; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Harrison M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-64; Hegde NV, 2012, FOODBORNE PATHOG DIS, V9, P1044, DOI 10.1089/fpd.2012.1231; HURLEY JC, 1995, CLIN MICROBIOL REV, V8, P268, DOI 10.1128/CMR.8.2.268; James EA, 1996, APPL BIOCHEM BIOTECH, V60, P189, DOI 10.1007/BF02783583; JAY JM, 1981, J FOOD PROTECT, V44, P275, DOI 10.4315/0362-028X-44.4.275; JAY JM, 1979, APPL ENVIRON MICROB, V38, P885, DOI 10.1128/AEM.38.5.885-890.1979; Jucker BA, 1998, COLLOID SURFACE B, V11, P33, DOI 10.1016/S0927-7765(98)00029-0; Kale RR, 2008, J AM CHEM SOC, V130, P8169, DOI 10.1021/ja800842v; Karch H, 1999, DIAGN MICR INFEC DIS, V34, P229, DOI 10.1016/S0732-8893(99)00031-0; Lamoureux L, 2015, PROC SPIE, V9310, DOI 10.1117/12.2079658; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Martinez JS, 2005, J MATER CHEM, V15, P4639, DOI 10.1039/b502329g; McIntosh TJ, 2000, CURR OPIN STRUC BIOL, V10, P481, DOI 10.1016/S0959-440X(00)00118-4; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; MOHAMMED AH, 1988, VET MICROBIOL, V18, P27, DOI 10.1016/0378-1135(88)90113-7; MOROI Y, 1991, J COLLOID INTERF SCI, V141, P581, DOI 10.1016/0021-9797(91)90355-C; Mukundan H, 2012, TUBERCULOSIS, V92, P407, DOI 10.1016/j.tube.2012.05.009; Mukundan H, 2012, TUBERCULOSIS, V92, P38, DOI 10.1016/j.tube.2011.09.006; Mukundan H, 2009, PROC SPIE, V7167, DOI 10.1117/12.809530; Mukundan H, 2010, ANAL CHEM, V82, P136, DOI 10.1021/ac901497g; Mukundan H, 2009, SENSOR ACTUAT B-CHEM, V138, P453, DOI 10.1016/j.snb.2009.01.073; Mukundan H, 2009, SENSORS-BASEL, V9, P5783, DOI 10.3390/s90705783; Mukundan H, 2009, BIOCONJUGATE CHEM, V20, P222, DOI 10.1021/bc800283e; Nieradka K, 2014, SENSOR ACTUAT B-CHEM, V198, P114, DOI 10.1016/j.snb.2014.03.023; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nowotny A, 1984, HDB ENDOTOXIN, V1, P308; Perelle S, 2004, MOL CELL PROBE, V18, P185, DOI 10.1016/j.mcp.2003.12.004; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; Rangin M, 2004, J AM CHEM SOC, V126, P5038, DOI 10.1021/ja039822x; REDL H, 1993, IMMUNOBIOLOGY, V187, P330, DOI 10.1016/S0171-2985(11)80348-7; REINHOLD RB, 1971, P SOC EXP BIOL MED, V137, P334, DOI 10.3181/00379727-137-35572; RUCKENSTEIN E, 1975, J PHYS CHEM-US, V79, P2622, DOI 10.1021/j100591a010; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; Safarikova M, 2001, LETT APPL MICROBIOL, V33, P36, DOI 10.1046/j.1472-765X.2001.00941.x; Sakamuri RM, 2014, J MICROBIOL METH, V103, P112, DOI 10.1016/j.mimet.2014.05.012; Sakamuri RM, 2013, PROC SPIE, V8812, DOI 10.1117/12.2029605; Sakamuri RM, 2013, TUBERCULOSIS, V93, P301, DOI 10.1016/j.tube.2013.02.015; SAMUEL G, 2004, RELATIONSHIPS ESCHER, V186, P6536; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Seydel U, 2000, CHEM IMMUNOL, V74, P5; SHARMA S K, 1986, Biotechnology and Applied Biochemistry, V8, P5; SHNYRA A, 1993, INFECT IMMUN, V61, P5351, DOI 10.1128/IAI.61.12.5351-5360.1993; Son I, 2014, FOOD MICROBIOL, V40, P31, DOI 10.1016/j.fm.2013.11.016; Sowers EG, 1996, J CLIN MICROBIOL, V34, P1286, DOI 10.1128/JCM.34.5.1286-1289.1996; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Stromberg LR, 2015, J MICROBIOL METH, V116, P1, DOI 10.1016/j.mimet.2015.06.008; Su WQ, 2015, JALA-J LAB AUTOM, V20, P354, DOI 10.1177/2211068215572136; Sutcliffe L, 2005, TUBERCULOSIS, V85, P205, DOI 10.1016/j.tube.2004.12.002; TAKADA H, 1989, CRIT REV MICROBIOL, V16, P477, DOI 10.3109/10408418909104475; TAKAHASHI K, 1992, J IMMUNOL METHODS, V153, P67, DOI 10.1016/0022-1759(92)90306-E; Viktorov AV, 2007, BIOCHEM MOSC-SUPPL S, V1, P35, DOI 10.1134/S1990750807010052; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wurfel MM, 1997, J IMMUNOL, V158, P3925; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025	86	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156295	10.1371/journal.pone.0156295	http://dx.doi.org/10.1371/journal.pone.0156295			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227979	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500105
J	Britten, KH; Thatcher, TD; Caro, T				Britten, Kenneth H.; Thatcher, Timothy D.; Caro, Tim			Zebras and Biting Flies: Quantitative Analysis of Reflected Light from Zebra Coats in Their Natural Habitat	PLOS ONE			English	Article							GLOSSINA-MORSITANS-MORSITANS; VISUAL-ACUITY; TSETSE; PATTERNS; VISION; ADVANTAGE; BEHAVIOR; STRIPES	Experimental and comparative evidence suggests that the striped coats of zebras deter biting fly attack, but the mechanisms by which flies fail to target black-and-white mammals are still opaque. Two hypotheses have been proposed: stripes might serve either to defeat polarotaxis or to obscure the form of the animal. To test these hypotheses, we systematically photographed free-living plains zebras in Africa. We found that black and white stripes both have moderate polarization signatures with a similar angle, though the degree (magnitude) of polarization in white stripes is lower. When we modeled the visibility of these signals from different distances, we found that polarization differences between stripes are invisible to flies more than 10 m away because they are averaged out by the flies' low visual resolution. At any distance, however, a positively polarotactic insect would have a distinct signal to guide its visual approach to a zebra because we found that polarization of light reflecting from zebras is higher than from surrounding dry grasses. We also found that the stripes themselves are visible to flies at somewhat greater distances (up to 20 m) than the polarization contrast between stripes. Together, these observations support hypotheses in which zebra stripes defeat visually guided orienting behavior in flies by a mechanism independent of polarotaxis.	[Britten, Kenneth H.; Thatcher, Timothy D.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Caro, Tim] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Britten, KH (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	khbritten@ucdavis.edu			NGS [W104-10]; NEI [EY022087]; University of California at Davis; National Eye Institute; National Geographic Society	NGS; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); University of California at Davis(University of California System); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Geographic Society(National Geographic Society)	This work was supported by NGS grant no. W104-10 to TC, NEI grant no. EY022087 to KHB, University of California at Davis to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank TAWIRI, TANAPA and COSTECH for permissions; the National Eye Institute (KHB), University of California at Davis (TT), and National Geographic Society (TC) for support; Sandra Aamodt and Benjamin Lankow for helpful discussion and reading earlier versions of the paper, and four reviewers. We particularly thank Gabor Horvath for his thorough comments, even though he does not agree with our findings.	ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; Blaho M, 2013, PHYSIOL BEHAV, V119, P168, DOI 10.1016/j.physbeh.2013.06.013; Blaho M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041138; Borst A, 2014, NAT REV NEUROSCI, V15, P590, DOI 10.1038/nrn3799; BRADY J, 1988, B ENTOMOL RES, V78, P301, DOI 10.1017/S0007485300013067; BURTT ET, 1962, PROC R SOC SER B-BIO, V157, P53, DOI 10.1098/rspb.1962.0062; Caro T, ZEBRA STRIP IN PRESS; Caro T, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150323; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Cott H. B., 1940, ADAPTIVE COLOURATION; Driscoll WG., 1978, HDB OPTICS; Egri A, 2012, NATURWISSENSCHAFTEN, V99, P407, DOI 10.1007/s00114-012-0916-2; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; GIBSON G, 1992, PHYSIOL ENTOMOL, V17, P141, DOI 10.1111/j.1365-3032.1992.tb01191.x; GOTZ KG, 1987, J EXP BIOL, V128, P35; GUIOLET A, 1987, INT J COSMETIC SCI, V9, P111, DOI 10.1111/j.1467-2494.1987.tb00468.x; HARDIE R, 1989, J INSECT PHYSIOL, V35, P423, DOI 10.1016/0022-1910(89)90117-0; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Herczeg T, 2014, PARASITOL RES, V113, P4251, DOI 10.1007/s00436-014-4103-6; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; How MJ, 2014, ZOOLOGY, V117, P163, DOI 10.1016/j.zool.2013.10.004; Kennedy JS, 1940, P ZOOL SOC LOND A-GE, V109, P221, DOI 10.1111/j.1096-3642.1940.tb00831.x; Kingdon J., 1984, ENCY MAMMALS, P486; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Larison B, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140452; Lefaudeux N, 2008, TRI PRINC 3 ANN C AP; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; LUNAU K, 1995, NATURWISSENSCHAFTEN, V82, P432, DOI 10.1007/s001140050213; Melin AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145679; Morris Animal Foundation, 2022, ANIMAL WATCHING FIEL; PHELPS R J, 1976, Journal of the Entomological Society of Southern Africa, V39, P67; REICHARDT W, 1969, NATURWISSENSCHAFTEN, V56, P424, DOI 10.1007/BF00593644; Thayer GH, 1909, CONCEALING COLORATIO; TORR SJ, 1989, PHYSIOL ENTOMOL, V14, P325, DOI 10.1111/j.1365-3032.1989.tb01100.x; TURNER DA, 1973, B ENTOMOL RES, V62, P343, DOI 10.1017/S0007485300003850; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; Van Hennekeler K, 2011, MED VET ENTOMOL, V25, P17, DOI 10.1111/j.1365-2915.2010.00900.x; WAAGE J K, 1981, Journal of the Entomological Society of Southern Africa, V44, P351	39	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0154504	10.1371/journal.pone.0154504	http://dx.doi.org/10.1371/journal.pone.0154504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223616	Green Submitted, gold, Green Published			2022-12-26	WOS:000376881700007
J	Moldoveanu, C; Zbancioc, G; Mantu, D; Maftei, D; Mangalagiu, I				Moldoveanu, Costel; Zbancioc, Gheorghita; Mantu, Dorina; Maftei, Dan; Mangalagiu, Ionel			The Cycloaddition of the Benzimidazolium Ylides with Alkynes: New Mechanistic Insights	PLOS ONE			English	Article							MICROWAVE-ASSISTED REACTIONS; 1,3-DIPOLAR CYCLOADDITION; PYRROLOPYRIDAZINE DERIVATIVES; QUINOXALINE DERIVATIVES; REARRANGEMENT; REACTIVITY; STABILITY; ANALOGS; ALKENES	New insights concerning the reaction mechanism in the cycloaddition reaction of benzimidazolium ylides to activated alkynes are presented. The proposed pathway leading both to 2-(1H-pyrrol-1-yl)anilines and to pyrrolo[1,2-a]quinoxalin-4(5H)-ones involves an opening of the imidazole ring from the cycloaddition product, followed by a nucleophilic attack of the aminic nitrogen to a proximal carbonyl group and the elimination of a leaving group. The mechanistic considerations are fully supported by experimental data, including the XRD resolved structure of the key reaction intermediate.	[Moldoveanu, Costel; Zbancioc, Gheorghita; Mantu, Dorina; Maftei, Dan; Mangalagiu, Ionel] Alexandru Ioan Cuza Univ, Dept Chem, Iasi, Romania	Alexandru Ioan Cuza University	Zbancioc, G (corresponding author), Alexandru Ioan Cuza Univ, Dept Chem, Iasi, Romania.	gheorghita.zbancioc@uaic.ro	Maftei, Dan/G-2798-2014; Moldoveanu, Costel C/G-5254-2018; Mangalagiu, Ionel I./H-2421-2017; Zbancioc, Gheorghita/R-4916-2017	Moldoveanu, Costel C/0000-0002-9972-5372; Mangalagiu, Ionel I./0000-0002-4632-5076; Zbancioc, Gheorghita/0000-0001-9871-4156; Maftei, Dan/0000-0002-8880-952X; Dorina, Amariucai-Mantu/0000-0001-8744-7742	National Research Council (CNCS) [PN-II-TE/0010-79/05.10.2011]; CNCS Bucharest, Romania [PN-II-TE/0010-79/05.10.2011]; SMIS-CSNR [13984-901];  [POSCCE-O 2.2.1];  [257/28.09.2010]	National Research Council (CNCS); CNCS Bucharest, Romania; SMIS-CSNR; ; 	The work was supported by National Research Council (CNCS), Project No PN-II-TE/0010-79/05.10.2011, http://www.cncs-nrc.ro/home/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are thankful to CNCS Bucharest, Romania, project PN-II-TE/0010-79/05.10.2011 (director lect. dr. Costel Moldoveanu) for financial support and the POSCCE-O 2.2.1, SMIS-CSNR 13984-901, No. 257/28.09.2010 Project, CERNESIM, for XRD and NMR experiments.	Abbiati G, 2005, SYNTHESIS-STUTTGART, P2881, DOI 10.1055/s-2005-916033; Abbott PJ, 1972, J CHEM SOC PERK T, V1, P2182; AGER IR, 1988, J MED CHEM, V31, P1098, DOI 10.1021/jm00401a009; Balalaie S, 2011, TETRAHEDRON, V67, P7294, DOI 10.1016/j.tet.2011.07.052; Bejan V, 2009, ULTRASON SONOCHEM, V16, P312, DOI 10.1016/j.ultsonch.2008.10.012; Campiani G, 2001, J MED CHEM, V44, P305, DOI 10.1021/jm0010365; Caprosu MC, 2004, COLLECT CZECH CHEM C, V69, P426, DOI 10.1135/cccc20040426; Georgescu E, 2015, SYNTHESIS-STUTTGART, V47, P1643, DOI 10.1055/s-0034-1380185; Georgescu E, 2014, BEILSTEIN J ORG CHEM, V10, P2377, DOI 10.3762/bjoc.10.248; Komatsu M, 2003, SYNTHESIS-STUTTGART, P1398; Mangalagiu II, 2011, CURR ORG CHEM, V15, P730; MATSUDA Y, 1992, HETEROCYCLES, V33, P295, DOI 10.3987/COM-91-S35; Moldoveanu CC, 2005, HELV CHIM ACTA, V88, P2747, DOI 10.1002/hlca.200590214; Moldoveanu CC, 2005, ARKIVOC, P7, DOI 10.3998/ark.5550190.0006.102; Moldoveanu CC, 2009, TETRAHEDRON LETT, V50, P7205, DOI 10.1016/j.tetlet.2009.10.044; Nicolescu A, 2013, TETRAHEDRON LETT, V54, P1486, DOI 10.1016/j.tetlet.2013.01.036; OGURA H, 1972, J ORG CHEM, V37, P2679, DOI 10.1021/jo00982a010; Padwa A., 1984, 1 3 DIPOLAR CYCLOADD, V2; Risca M, 2010, REV CHIM-BUCHAREST, V61, P303; RODGERS JD, 1992, TETRAHEDRON LETT, V33, P3273, DOI 10.1016/S0040-4039(00)92065-3; Rotas G, 2004, TETRAHEDRON, V60, P10825, DOI 10.1016/j.tet.2004.09.048; Wang BX, 2000, J HETEROCYCLIC CHEM, V37, P1533, DOI 10.1002/jhet.5570370620; Zbancioc G, 2015, ULTRASON SONOCHEM, V23, P376, DOI 10.1016/j.ultsonch.2014.10.028; Zbancioc G, 2010, TETRAHEDRON, V66, P278, DOI 10.1016/j.tet.2009.10.110; Zbancioc G, 2009, MOLECULES, V14, P403, DOI 10.3390/molecules14010403; Zbancioc GN, 2010, TETRAHEDRON, V66, P4298, DOI 10.1016/j.tet.2010.04.050; Zbancioc GN, 2006, SYNLETT, P804, DOI 10.1055/s-2006-932459; Zhang XC, 1997, TETRAHEDRON LETT, V38, P4827, DOI 10.1016/S0040-4039(97)01021-6; Zhang XC, 1998, TETRAHEDRON, V54, P12465, DOI 10.1016/S0040-4020(98)00728-5; ZUGRAVESCU I, 1974, REV ROUM CHIM, V19, P649; Zugravescu I., 1976, N YLID CHEM	31	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156129	10.1371/journal.pone.0156129	http://dx.doi.org/10.1371/journal.pone.0156129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224656	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700064
J	Nakamura, T; Furukawa, A; Uchida, K; Ogawa, T; Tamura, T; Sakonishi, D; Wada, Y; Suzuki, Y; Ishige, Y; Minami, J; Akashi, T; Eishi, Y				Nakamura, Teruko; Furukawa, Asuka; Uchida, Keisuke; Ogawa, Tomohisa; Tamura, Tomoki; Sakonishi, Daisuke; Wada, Yuriko; Suzuki, Yoshimi; Ishige, Yuki; Minami, Junko; Akashi, Takumi; Eishi, Yoshinobu			Autophagy Induced by Intracellular Infection of Propionibacterium acnes	PLOS ONE			English	Article							LYMPH-NODES; PULMONARY SARCOIDOSIS; JAPANESE PATIENTS; CELLS; DNA; MYCOBACTERIAL; LOCALIZATION; RECOGNITION; EXPRESSION; BACTERIUM	Background Sarcoidosis is caused by Th1-type immune responses to unknown agents, and is linked to the infectious agent Propionibacterium acnes. Many strains of P. acnes isolated from sarcoid lesions cause intracellular infection and autophagy may contribute to the pathogenesis of sarcoidosis. We examined whether P. acnes induces autophagy. Methods Three cell lines from macrophages (Raw264.7), mesenchymal cells (MEF), and epithelial cells (HeLa) were infected by viable or heat-killed P. acnes (clinical isolate from sarcoid lymph node) at a multiplicity of infection (MOI) of 100 or 1000 for 1 h. Extracellular bacteria were killed by washing and culturing infected cells with antibiotics. Samples were examined by colony assay, electron-microscopy, and fluorescence-microscopy with anti-LC3 and anti-LAMP1 antibodies. Autophagy-deficient (Atg5(-/-)) MEF cells were also used. Results Small and large (>= 5 mu m in diameter) LC3-positive vacuoles containing few or many P. acnes cells (LC3-positive P. acnes) were frequently found in the three cell lines when infected by viable P. acnes at MOI 1000. LC3-positive large vacuoles were mostly LAMP1-positive. A few small LC3-positive/LAMP1-negative vacuoles were consistently observed in some infected cells for 24 h postinfection. The number of LC3-positive P. acnes was decreased at MOI 100 and completely abolished when heat-killed P. acnes was used. LC3-positive P. acnes was not found in autophagy-deficient Atg5(-/-) cells where the rate of infection was 25.3 and 17.6 times greater than that in wild-type Atg5(+/+) cells at 48 h postinfection at MOI 100 and 1000, respectively. Electron-microscopic examination revealed bacterial cells surrounded mostly by a single-membrane including the large vacuoles and sometimes a double or multi-layered membrane, with occasional undigested bacterial cells in ruptured late endosomes or in the cytoplasm. Conclusion Autophagy was induced by intracellular P. acnes infection and contributed to intracellular bacterial killing as an additional host defense mechanism to endocytosis or phagocytosis.	[Nakamura, Teruko; Furukawa, Asuka; Ogawa, Tomohisa; Sakonishi, Daisuke; Wada, Yuriko; Suzuki, Yoshimi; Ishige, Yuki; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Tokyo 1138510, Japan; [Nakamura, Teruko; Furukawa, Asuka; Ogawa, Tomohisa; Sakonishi, Daisuke; Wada, Yuriko; Suzuki, Yoshimi; Ishige, Yuki; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Fac Med, Tokyo 1138510, Japan; [Uchida, Keisuke; Tamura, Tomoki; Akashi, Takumi; Eishi, Yoshinobu] Tokyo Med & Dent Univ Hosp, Div Surg Pathol, Tokyo 1138510, Japan; [Minami, Junko] Tokyo Univ Technol, Sch Hlth Sci, Dept Clin Engn, Tokyo 1448650, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo University of Technology	Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Human Pathol, Tokyo 1138510, Japan.; Eishi, Y (corresponding author), Tokyo Med & Dent Univ, Fac Med, Tokyo 1138510, Japan.; Eishi, Y (corresponding author), Tokyo Med & Dent Univ Hosp, Div Surg Pathol, Tokyo 1138510, Japan.	eishi.path@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670				ABE C, 1984, ZBL BAKT-INT J MED M, V256, P541, DOI 10.1016/S0174-3031(84)80032-3; Bae Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090324; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Costabel U, 1999, EUR RESPIR J, V14, P735, DOI 10.1034/j.1399-3003.1999.14d02.x; Ebe Y, 2000, SARCOIDOSIS VASC DIF, V17, P256; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Eishi Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/935289; Fischer N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/603046; Furukawa A, 2009, MICROB PATHOGENESIS, V46, P80, DOI 10.1016/j.micpath.2008.10.013; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; Guo F, 2012, CELL MOL BIOL LETT, V17, P249, DOI 10.2478/s11658-012-0009-4; HOMMA JY, 1978, JPN J EXP MED, V48, P251; HUNNINGHAKE GW, 1981, NEW ENGL J MED, V305, P429, DOI 10.1056/NEJM198108203050804; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Ishige I, 2005, SARCOIDOSIS VASC DIF, V22, P33; Joshi AD, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00138; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lai Shu-Chin, 2012, Cells, V1, P396, DOI 10.3390/cells1030396; Liu PF, 2011, VACCINE, V29, P3230, DOI 10.1016/j.vaccine.2011.02.036; Moller DR, 1996, J IMMUNOL, V156, P4952; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; NAKATA Y, 1986, ACTA MED OKAYAMA, V40, P257; Negi M, 2012, MODERN PATHOL, V25, P1284, DOI 10.1038/modpathol.2012.80; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Tanabe T, 2006, BBA-MOL BASIS DIS, V1762, P794, DOI 10.1016/j.bbadis.2006.07.006; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243; Yorozu P, 2015, RESPIR INVESTIG, V53, P161, DOI 10.1016/j.resinv.2015.02.005; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967	33	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156298	10.1371/journal.pone.0156298	http://dx.doi.org/10.1371/journal.pone.0156298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219015	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880700057
J	Rodriguez-Linan, GM; Nahmad-Molinari, Y; Perez-Angel, G				Rodriguez-Linan, Gustavo M.; Nahmad-Molinari, Yuri; Perez-Angel, Gabriel			Clustering-Induced Attraction in Granular Mixtures of Rods and Spheres	PLOS ONE			English	Article							HARD-SPHERES; FORCES; GASES	Depletion-induced aggregation of rods enhanced by clustering is observed to produce a novel model of attractive pairs of rods separated by a line of spheres in a quasi-2D, vertically-shaken, granular gas of rods and spheres. We show that the stability of these peculiar granular aggregates increases as a function of shaking intensity. Velocity distributions of spheres inside and outside of a pair of rods trapping a line of spheres show a clear suppression of the momentum acquired by the trapped spheres. The condensed phase formed between the rods is caused by a clustering instability of the trapped spheres, enhanced by a vertical guidance produced by the confining rods. The liberated area corresponding to direct excluded-volume pairs and indirect depletion-aggregated pairs is measured as a function of time. The stability of rod pairs mediated by spheres reveals an attraction comparable in strength to the one purely induced by depletion forces.	[Rodriguez-Linan, Gustavo M.; Nahmad-Molinari, Yuri] Univ Autonoma San Luis Potosi, Inst Fis, San Luis Potosi, Mexico; [Perez-Angel, Gabriel] Ctr Invest & Estudios Avanzados, Dept Fis Aplicada, Yucatan, Mexico; [Rodriguez-Linan, Gustavo M.; Nahmad-Molinari, Yuri] Ave Alvaro Obregon 64, San Luis Potosi 78000, Mexico; [Perez-Angel, Gabriel] AP 73 Cordemex, Merida 97310, Yucatan, Mexico	Universidad Autonoma de San Luis Potosi	Nahmad-Molinari, Y (corresponding author), Univ Autonoma San Luis Potosi, Inst Fis, San Luis Potosi, Mexico.; Nahmad-Molinari, Y (corresponding author), Ave Alvaro Obregon 64, San Luis Potosi 78000, Mexico.	yuri@ifisica.uaslp.mx	Nahmad-Molinari, Yuri/J-4848-2012; Perez-Angel, Gabriel/AAT-1398-2021; Rodríguez-Liñán, Gustavo M./I-6196-2016	Nahmad-Molinari, Yuri/0000-0002-3477-2282; Rodríguez-Liñán, Gustavo M./0000-0001-9460-6748	Consejo Nacional de Ciencia y Tecnologia [221961, 358584]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) grant no. 221961 (YNM, GPA, GMRL) and doctoral scholarship 358584 (GMRL).	Adams M, 1998, NATURE, V393, P349, DOI 10.1038/30700; Bordallo-Favela RA, 2009, EUR PHYS J E, V28, P395, DOI 10.1140/epje/i2008-10432-2; Bose M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021305; Duran J, 1998, PHYS REV LETT, V80, P3547, DOI 10.1103/PhysRevLett.80.3547; Fisher IZ, 1964, INT MONOGRAPHS ADV M; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Galanis J, 2010, SOFT MATTER, V6, P1026, DOI 10.1039/b918034f; GOLDHIRSCH I, 1993, PHYS REV LETT, V70, P1619, DOI 10.1103/PhysRevLett.70.1619; HOOVER WG, 1968, J CHEM PHYS, V49, P3609, DOI 10.1063/1.1670641; ISRAELACHVILI JN, 1983, NATURE, V306, P249, DOI 10.1038/306249a0; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Lekkerkerker H. N., 2011, LECT NOTES PHYS, V833; Melby P, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051307; Nahmad-Molinari Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.264302; Ni R, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.018302; Olafsen JS, 1998, PHYS REV LETT, V81, P4369, DOI 10.1103/PhysRevLett.81.4369; OOSAWA F, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740346; Prigogine I., 1947, THESIS U LIBRE BRUXE; Sanders DA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.208002; SHIDA K, 1989, PHYSICA A, V162, P145, DOI 10.1016/0378-4371(89)90562-1; Spahn F, 1998, NATO ADV SCI I E-APP, V350, P401; WU X, 1993, PHYS REV LETT, V71, P1363, DOI 10.1103/PhysRevLett.71.1363	22	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156153	10.1371/journal.pone.0156153	http://dx.doi.org/10.1371/journal.pone.0156153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218804	gold, Green Submitted, Green Published			2022-12-26	WOS:000376880700046
J	Ventrella, E; Adamski, Z; Chudzinska, E; Miadowicz-Kobielska, M; Marciniak, P; Buyukguzel, E; Buyukguzel, K; Erdem, M; Falabella, P; Scrano, L; Bufo, SA				Ventrella, Emanuela; Adamski, Zbigniew; Chudzinska, Ewa; Miadowicz-Kobielska, Mariola; Marciniak, Pawel; Buyukguzel, Ender; Buyukguzel, Kemal; Erdem, Meltem; Falabella, Patrizia; Scrano, Laura; Bufo, Sabino Aurelio			Solanum tuberosum and Lycopersicon esculentum Leaf Extracts and Single Metabolites Affect Development and Reproduction of Drosophila melanogaster	PLOS ONE			English	Article							PLANT DEFENSE; POTATO GLYCOALKALOIDS; TOMATO GLYCOALKALOIDS; SECONDARY METABOLITES; ALPHA-SOLANINE; TOXICITY; RESISTANCE; ALKALOIDS; DIPTERA; LARVAE	Glycoalkaloids are secondary metabolites commonly found in Solanaceae plants. They have anti-bacterial, anti-fungal and insecticidal activities. In the present study we examine the effects of potato and tomato leaf extracts and their main components, the glycoalkaloids a-solanine, a-chaconine and a-tomatine, on development and reproduction of Drosophila melanogaster wild-type flies at different stages. Parental generation was exposed to five different concentrations of tested substances. The effects were examined also on the next, non-exposed generation. In the first (exposed) generation, addition of each extract reduced the number of organisms reaching the pupal and imaginal stages. Parent insects exposed to extracts and metabolites individually applied showed faster development. However, the effect was weaker in case of single metabolites than in case of exposure to extracts. An increase of developmental rate was also observed in the next, non-exposed generation. The imagoes of both generations exposed to extracts and pure metabolites showed some anomalies in body size and malformations, such as deformed wings and abdomens, smaller black abdominal zone. Our results further support the current idea that Solanaceae can be an impressive source of molecules, which could efficaciously be used in crop protection, as natural extract or in formulation of single pure metabolites in sustainable agriculture.	[Ventrella, Emanuela; Falabella, Patrizia; Bufo, Sabino Aurelio] Univ Basilicata, Dept Sci, I-85100 Potenza, Italy; [Adamski, Zbigniew] Adam Mickiewicz Univ, Electron & Confocal Microscope Lab, Poznan, Poland; [Adamski, Zbigniew; Marciniak, Pawel] Adam Mickiewicz Univ, Dept Anim Physiol & Dev Biol, Poznan, Poland; [Chudzinska, Ewa; Miadowicz-Kobielska, Mariola] Adam Mickiewicz Univ, Dept Genet, Poznan, Poland; [Buyukguzel, Ender] Bulent Ecevit Univ, Dept Mol Biol & Genet, Zonguldak, Turkey; [Buyukguzel, Kemal] Bulent Ecevit Univ, Fac Arts & Sci, Dept Biol, Zonguldak, Turkey; [Erdem, Meltem] Bulent Ecevit Univ, Ahmet Erdogan Vocat Sch Hlth, Zonguldak, Turkey; [Scrano, Laura] Univ Basilicata, Dept European & Mediterranean Cultures, Matera, Italy	Italfarmaco; University of Basilicata; Adam Mickiewicz University; Adam Mickiewicz University; Adam Mickiewicz University; Bulent Ecevit University; Bulent Ecevit University; Bulent Ecevit University; University of Basilicata	Bufo, SA (corresponding author), Univ Basilicata, Dept Sci, I-85100 Potenza, Italy.	sabino.bufo@unibas.it	Marciniak, Pawel/GVU-4616-2022; Marciniak, Pawel/G-7455-2012; Buyukguzel, Kemal/AAH-8750-2019; Marciniak, Pawel/P-1410-2019; Bufo, Sabino A./D-5212-2016	Marciniak, Pawel/0000-0002-4790-001X; Marciniak, Pawel/0000-0002-4790-001X; Buyukguzel, Kemal/0000-0002-9589-9383; Bufo, Sabino A./0000-0002-0857-2367; Adamski, Zbigniew/0000-0002-8696-3785; chudzinska, ewa/0000-0002-4576-4763; Buyukguzel, Kemal/0000-0002-6959-8480; Scrano, Laura/0000-0002-3716-2666				Abolaji AO., 2013, ARCH BAS APP MED, V1, P33; Adamski Z, 2005, J APPL ENTOMOL, V129, P526, DOI 10.1111/j.1439-0418.2005.01001.x; Adamski Zbigniew, 2005, Journal of Biological Research (Thessaloniki), V3, P15; Adamski Z, 2014, ARCH INSECT BIOCHEM, V87, P26, DOI 10.1002/arch.21177; Adamski Zbigniew, 2012, P169; Adamski Z, 2009, J TOXICOL ENV HEAL A, V72, P1132, DOI 10.1080/15287390903091749; Adamski Z, 2009, PESTIC BIOCHEM PHYS, V94, P73, DOI 10.1016/j.pestbp.2009.04.005; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bidlack W. R., 2000, PHYTOCHEMICALS BIOAC; Buyukguzel E, 2013, ARCH INSECT BIOCHEM, V83, P15, DOI 10.1002/arch.21089; Cataldi TRI, 2005, RAPID COMMUN MASS SP, V19, P3103, DOI 10.1002/rcm.2176; CHAN HT, 1985, J ECON ENTOMOL, V78, P305, DOI 10.1093/jee/78.2.305; Chowanski S, 2016, TOXINS, V8, DOI 10.3390/toxins8030060; Corio C, 2013, BIOL J LINN SOC, V109, P342, DOI 10.1111/bij.12036; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Crozier A., 2006, PLANT SECONDARY META; Duffey SS, 1996, ARCH INSECT BIOCHEM, V32, P3, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;3::AID-ARCH2&gt;3.0.CO;2-1; Fogleman JC, 2000, CHEM-BIOL INTERACT, V125, P93, DOI 10.1016/S0009-2797(99)00161-1; Fragoyiannis DA, 1998, ENTOMOL EXP APPL, V88, P59, DOI 10.1023/A:1003231621662; Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c; Friedman M, 1997, CRIT REV PLANT SCI, V16, P55, DOI 10.1080/713608144; Gut L, 2002, FRUIT CROP ECOLOGY M, P34; Johnson T, 1999, CRC EDMOBOTANY DES R; Ke Li-Xia, 2009, Acta Ecologica Sinica, V29, P182; KIRCHER HW, 1967, J INSECT PHYSIOL, V13, P1869, DOI 10.1016/0022-1910(67)90023-6; KIRK D, 1975, HUMANGENETIK, V26, P105; Marciniak P, 2010, B ENVIRON CONTAM TOX, V84, P153, DOI 10.1007/s00128-009-9921-3; Milner SE, 2011, J AGR FOOD CHEM, V59, P3454, DOI 10.1021/jf200439q; Nenaah G, 2011, J PEST SCI, V84, P77, DOI 10.1007/s10340-010-0329-y; Nenaah GE, 2011, J STORED PROD RES, V47, P185, DOI 10.1016/j.jspr.2010.11.003; Newman MC, 2003, FUNDAMENTALS ECOTOXI; Ong C, 2015, NANOTOXICOLOGY, V9, P396, DOI 10.3109/17435390.2014.940405; Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821; Ozkan Ferbal, 1997, Turkish Journal of Zoology, V21, P309; Panacek A, 2011, ENVIRON SCI TECHNOL, V45, P4974, DOI 10.1021/es104216b; Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008; Sanford LL, 1996, AM POTATO J, V73, P79, DOI 10.1007/BF02854762; SECOY DM, 1983, ECON BOT, V37, P28, DOI 10.1007/BF02859304; Ventrella E, 2015, INSECT SCI, V22, P251, DOI 10.1111/1744-7917.12110; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Weissenberg M, 1998, PHYTOCHEMISTRY, V47, P203, DOI 10.1016/S0031-9422(97)00565-7; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9	42	23	23	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155958	10.1371/journal.pone.0155958	http://dx.doi.org/10.1371/journal.pone.0155958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213896	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200038
J	Inoue, A; Anraku, M; Nakagawa, S; Ojima, T				Inoue, Akira; Anraku, Moe; Nakagawa, Satoshi; Ojima, Takao			Discovery of a Novel Alginate Lyase from Nitratiruptor sp SB155-2 Thriving at Deep-sea Hydrothermal Vents and Identification of the Residues Responsible for Its Heat Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-DEOXY-L-ERYTHRO-5-HEXOSEULOSE URONIC-ACID; PSEUDOMONAS-AERUGINOSA; SEQUENCE-ANALYSIS; SP-NOV.; CRYSTAL-STRUCTURE; CLONING; METABOLISM; EXPRESSION; STRAIN; VIBRIO	Extremophiles are expected to represent a source of enzymes having unique functional properties. The hypothetical protein NIS_0185, termed NitAly in this study, was identified as an alginate lyase-homolog protein in the genomic database of epsilon-Proteobacteria Nitratiruptor sp.SB155-2, which was isolated from deep-sea hydrothermal vents at a water depth of 1,000 m. Among the characterized alginate lyases in the polysaccharide lyase family 7 (PL-7), the amino acid sequence of NitAly showed the highest identity (39%) with that of red alga Pyropia yezoensis alginate lyase PyAly. Recombinant NitAly (rNitAly) was successfully expressed in Escherichia coli. Purified rNitAly degraded alginate in an endolytic manner. Among alginate block types, polyM was preferable to polyG and polyMG as a substrate, and its end degradation products were mainly tri-, tetra-, and penta-saccharides. The optimum temperature and pH values were 70 degrees C and around 6, respectively. Ahigh concentration of NaCl (0.8-1.4 M) was required for maximum activity. In addition, a 50% loss of activity was observed after incubation at 67 degrees C for 30 min. Heat stability was decreased in the presence of 5 mM DTT, and Cys-80 and Cys-232 were identified as the residues responsible for heat stability but not lyase activity. Introducing two cysteines into PyAly based on homology modeling using Pseudomonas aeruginosa alginate lyase PA1167 as the template enhanced its heat stability. Thus, NitAly is a functional alginate lyase, with its unique optimum conditions adapted to its environment. These insights into the heat stability of NitAly could be applied to improve that of other PL-7 alginate lyases.	[Inoue, Akira; Anraku, Moe; Nakagawa, Satoshi; Ojima, Takao] Hokkaido Univ, Grad Sch Fisheries Sci, Div Appl Marine Life Sci, Lab Marine Biotechnol & Microbiol, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan	Hokkaido University	Inoue, A (corresponding author), Hokkaido Univ, Grad Sch Fisheries Sci, Div Appl Marine Life Sci, Lab Marine Biotechnol & Microbiol, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	inouea21@fish.hokudai.ac.jp			Program for Constructing "Tohoku Marine Science Bases" - Ministry of Education, Culture, Sports, Science and Technology, Japan	Program for Constructing "Tohoku Marine Science Bases" - Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for Constructing "Tohoku Marine Science Bases" supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht MT, 2005, J BACTERIOL, V187, P3869, DOI 10.1128/JB.187.11.3869-3872.2005; BARON AJ, 1994, GENE, V143, P61, DOI 10.1016/0378-1119(94)90605-X; BOYD A, 1995, J IND MICROBIOL, V15, P162, DOI 10.1007/BF01569821; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN BJ, 1991, APPL ENVIRON MICROB, V57, P1870, DOI 10.1128/AEM.57.6.1870-1872.1991; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Duan GF, 2009, CAN J MICROBIOL, V55, P1113, DOI [10.1139/W09-051, 10.1139/w09-051]; Flores GE, 2012, INT J SYST EVOL MICR, V62, P1252, DOI 10.1099/ijs.0.033001-0; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Gutsche J, 2006, BIOCHIMIE, V88, P245, DOI 10.1016/j.biochi.2005.06.003; HAUG A, 1970, ACTA CHEM SCAND, V24, P843, DOI 10.3891/acta.chem.scand.24-0843; HAUG A, 1967, NATURE, V215, P757, DOI 10.1038/215757a0; Huang LS, 2013, J IND MICROBIOL BIOT, V40, P113, DOI 10.1007/s10295-012-1210-1; Inoue Akira, 2015, Curr Biotechnol, V4, P240, DOI 10.2174/2211550104666150915210434; Inoue A, 2016, ALGAL RES, V19, P355, DOI 10.1016/j.algal.2016.03.008; Inoue A, 2015, MAR DRUGS, V13, P493, DOI 10.3390/md13010493; Inoue A, 2014, MAR DRUGS, V12, P4693, DOI 10.3390/md12084693; Inoue A, 2011, MAR BIOTECHNOL, V13, P256, DOI 10.1007/s10126-010-9290-2; Kassab BH, 2004, PROTEIN EXPRES PURIF, V35, P344, DOI 10.1016/j.pep.2004.02.012; Kawamoto H, 2006, MAR BIOTECHNOL, V8, P481, DOI 10.1007/s10126-005-6157-z; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2009, MAR BIOTECHNOL, V11, P10, DOI 10.1007/s10126-008-9114-9; Kim HT, 2012, BIOTECHNOL LETT, V34, P1087, DOI 10.1007/s10529-012-0876-9; 정기철, 2007, [Journal of Life Science, 생명과학회지], V17, P625; Kobayashi T, 2009, EXTREMOPHILES, V13, P121, DOI 10.1007/s00792-008-0201-7; LE M, 1995, ANAL BIOCHEM, V229, P264, DOI 10.1006/abio.1995.1411; Li SY, 2015, J MICROBIOL BIOTECHN, V25, P681, DOI 10.4014/jmb.1409.09031; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Matsubara Y, 1998, BIOSCI BIOTECH BIOCH, V62, P1055, DOI 10.1271/bbb.62.1055; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Miyake O, 2004, J BACTERIOL, V186, P2891, DOI 10.1128/JB.186.9.2891-2896.2004; Moradali MF, 2015, MBIO, V6, DOI 10.1128/mBio.00453-15; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Oates CG, 1990, FOOD HYDROCOLLOID, V4, P215, DOI 10.1016/S0268-005X(09)80154-9; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; PREISS J, 1962, J BIOL CHEM, V237, P309; PREISS J, 1962, J BIOL CHEM, V237, P317; Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x; Schwertfeger M, 1999, ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY, P337; Sim SJ, 2012, J IND MICROBIOL BIOT, V39, P585, DOI 10.1007/s10295-011-1054-0; SMIDSROD O, 1975, FARADAY DISCUSS, V57, P263; Smith JL, 2008, INT J SYST EVOL MICR, V58, P1598, DOI 10.1099/ijs.0.65435-0; Sugimura I, 2000, MAR BIOTECHNOL, V2, P65; Takase R, 2014, J BIOL CHEM, V289, P33198, DOI 10.1074/jbc.M114.585661; Takase R, 2010, BBA-PROTEINS PROTEOM, V1804, P1925, DOI 10.1016/j.bbapap.2010.05.010; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Uchimura K, 2010, MAR BIOTECHNOL, V12, P526, DOI 10.1007/s10126-009-9237-7; Voordeckers JW, 2005, INT J SYST EVOL MICR, V55, P773, DOI 10.1099/ijs.0.63430-0; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Zhu BW, 2015, INT J BIOL MACROMOL, V75, P330, DOI 10.1016/j.ijbiomac.2015.01.053; 김희숙, 2010, [Journal of Life Science, 생명과학회지], V20, P1582	65	53	58	5	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15551	15563		10.1074/jbc.M115.713230	http://dx.doi.org/10.1074/jbc.M115.713230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231344	Green Published, hybrid			2022-12-26	WOS:000380584200012
J	De Tavernier, E; Detalle, L; Morizzo, E; Roobrouck, A; De Taeye, S; Rieger, M; Verhaeghe, T; Correia, A; Van Hegelsom, R; Figueirido, R; Noens, J; Steffensen, S; Stohr, T; Van de Velde, W; Depla, E; Dombrecht, B				De Tavernier, Evelyn; Detalle, Laurent; Morizzo, Erika; Roobrouck, Annelies; De Taeye, Severine; Rieger, Melanie; Verhaeghe, Tom; Correia, Andreia; Van Hegelsom, Rob; Figueirido, Rita; Noens, Jeroen; Steffensen, Soren; Stohr, Thomas; Van de Velde, Willem; Depla, Erik; Dombrecht, Bruno			High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; III SECRETION; V-ANTIGEN; MURINE MODEL; INFECTION; PROTEIN; TRANSLOCATION; IMMUNIZATION; MACROPHAGES	Improving potencies through concomitant blockage of multiple epitopes and avid binding by fusing multiple (different) monovalent Nanobody building blocks via linker sequences into one multivalent polypeptide chain is an elegant alternative to affinity maturation. We explored a large and random formatting library of bivalent (combinations of two identical) and biparatopic (combinations of two different) Nanobodies for functional blockade of Pseudonionas aeruginosa PcrV. PcrV is an essential part of the P. aeruginosa type III secretion system (T3SS), and its oligomeric nature allows for multiple complex binding and blocking options. The library screening yielded a large number of promising biparatopic lead candidates, revealing significant (and non-trivial) preferences in terms of Nanobody building block and epitope bin combinations and orientations. Excellent potencies were confirmed upon further characterization in two different P. aeruginosa T3SS- mediated cytotoxicity assays. Three biparatopic Nanobodies were evaluated in a lethal mouse P. aeruginosa challenge pneumonia model, conferring 100% survival upon prophylactic administration and reducing lung P. aeruginosa burden by up to 2 logs. At very low doses, they protected the mice from P. aeruginosa infection -related changes in lung histology, myeloperoxidase production, and lung weight. Importantly, the most potent Nanobody still conferred protection after therapeutic administration up to 24 h post -infection. The concept of screening such formatting libraries for potency improvement is applicable to other targets and biological therapeutic platforms.	[De Tavernier, Evelyn; Detalle, Laurent; Morizzo, Erika; Roobrouck, Annelies; De Taeye, Severine; Rieger, Melanie; Verhaeghe, Tom; Correia, Andreia; Van Hegelsom, Rob; Figueirido, Rita; Noens, Jeroen; Steffensen, Soren; Stohr, Thomas; Van de Velde, Willem; Depla, Erik; Dombrecht, Bruno] Ablynx NV, Technol Pk 21, B-9052 Ghent, Belgium; [Rieger, Melanie] Univ Hosp Munster, Inst Expt Musculoskeletal Med, Domagkstrasse 3, D-48149 Munster, Germany; [Figueirido, Rita] Immunocore Ltd, 90 Pk Dr,Milton Pk, Abingdon OX14 RY, Oxon, England; [Stohr, Thomas] A2M Pharma GmbH, Alfred Nobel Str 10, D-40789 Monheim, Germany; [Depla, Erik] VIB Discovery Sci, Gaston Geenslaan 1, B-3001 Leuven, Belgium	University of Munster; Flanders Institute for Biotechnology (VIB)	Dombrecht, B (corresponding author), Ablynx NV, Technol Pk 21, B-9052 Ghent, Belgium.	bruno.dombrecht@ablynx.com		Detalle, Laurent/0000-0001-8481-7736	Ablynx N.V.	Ablynx N.V.	This work was supported by Ablynx N.V. All authors are or have been Ablynx employees.	[Anonymous], 2010, Drug Discov Today Technol, V7, pe95, DOI 10.1016/j.ddtec.2010.03.002; Audia JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081792; Baer M, 2009, INFECT IMMUN, V77, P1083, DOI 10.1128/IAI.00815-08; Bradley ME, 2015, MOL PHARMACOL, V87, P251, DOI 10.1124/mol.114.094821; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; DiGiandomenico A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009655; Firth AE, 2005, BIOINFORMATICS, V21, P3314, DOI 10.1093/bioinformatics/bti516; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Holder IA, 2001, INFECT IMMUN, V69, P5908, DOI 10.1128/IAI.69.9.5908-5910.2001; Huet HA, 2014, MABS-AUSTIN, V6, P1560, DOI 10.4161/19420862.2014.975099; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Kim J, 2005, MICROBIOL-SGM, V151, P3575, DOI 10.1099/mic.0.28277-0; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Lunelli M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002163; Maussang D, 2013, J BIOL CHEM, V288, P29562, DOI 10.1074/jbc.M113.498436; Moriyama K, 2009, MICROBIOL IMMUNOL, V53, P587, DOI 10.1111/j.1348-0421.2009.00165.x; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Ohgita T, 2013, FASEB J, V27, P2862, DOI 10.1096/fj.13-229054; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Roovers RC, 2011, INT J CANCER, V129, P2013, DOI 10.1002/ijc.26145; Sato H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00142; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Sawa T, 2014, MICROBIOL IMMUNOL, V58, P267, DOI 10.1111/1348-0421.12147; Secher T, 2011, J ANTIMICROB CHEMOTH, V66, P1100, DOI 10.1093/jac/dkr038; Shime N, 2001, J IMMUNOL, V167, P5880, DOI 10.4049/jimmunol.167.10.5880; Stryjewski ME, 2003, P C C I D, V7, P1; Sundin C, 2004, MICROB PATHOGENESIS, V37, P313, DOI 10.1016/j.micpath.2004.10.005; Terryn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109367; Warrener P, 2014, ANTIMICROB AGENTS CH, V58, P4384, DOI 10.1128/AAC.02643-14	39	13	15	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15243	15255		10.1074/jbc.M115.684241	http://dx.doi.org/10.1074/jbc.M115.684241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226529	Green Published, hybrid			2022-12-26	WOS:000380583200031
J	Chen, XC; Stauffer, S; Chen, YH; Dong, JX				Chen, Xingcheng; Stauffer, Seth; Chen, Yuanhong; Dong, Jixin			Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; cyclin-dependent kinase (CDK); Hippo pathway; mitosis; phosphorylation; signal transduction	ORGAN SIZE CONTROL; LIM PROTEIN AJUBA; HIPPO PATHWAY; YAP; KINASE; AURORA; KIBRA; PHOSPHATASE; TAZ; ACTIVATION	Recent studies identified the adaptor protein Ajuba as a positive regulator of Yes-associated protein (YAP) oncogenic activity through inhibiting large tumor suppressor (Lats1/2) core kinases of the Hippo pathway, a signaling pathway that plays important roles in cancer. In this study, we define a novel mechanism for phospho-regulation of Ajuba in mitosis and its biological significance in cancer. We found that Ajuba is phosphorylated in vitro and in vivo by cyclin-dependent kinase 1 (CDK1) at Ser(119) and Ser(175) during the G2/M phase of the cell cycle. Mitotic phosphorylation of Ajuba controls the expression of multiple cell cycle regulators; however, it does not affect Hippo signaling activity, nor does it induce epithelial-mesenchymal transition. We further showed that mitotic phosphorylation of Ajuba is sufficient to promote cell proliferation and anchorage-independent growth in vitro and tumorigenesis in vivo. Collectively, our discoveries reveal a previously unrecognized mechanism for Ajuba regulation in mitosis and its role in tumorigenesis.	[Chen, Xingcheng; Stauffer, Seth; Chen, Yuanhong; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Chen, Xingcheng; Stauffer, Seth] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	dongj@unmc.edu	Chen, Xingcheng/AAL-3210-2020		National Institutes of Health [P30 GM106397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397, R01GM109066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All fluorescence images were acquired by Zeiss LSM 710 confocal microscope at the Advanced Microscopy Core at the University of Nebraska Medical Center. The core is supported in part by Grant P30 GM106397 from the National Institutes of Health. We also thank Dr. Joyce Solheim for critical reading and comments on the manuscript.	Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ferrand A, 2009, BIOL CELL, V101, P221, DOI 10.1042/BC20080060; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gunn-Moore FJ, 2005, FEBS LETT, V579, P5089, DOI 10.1016/j.febslet.2005.07.097; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ji M, 2012, BIOCHEM J, V447, P93, DOI 10.1042/BJ20120751; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kisseleva M, 2005, MOL CELL BIOL, V25, P3956, DOI 10.1128/MCB.25.10.3956-3966.2005; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Liang XH, 2014, CANCER SCI, V105, P660, DOI 10.1111/cas.12404; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Nishio M, 2012, J CLIN INVEST, V122, P4505, DOI 10.1172/JCI63735; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Schimizzi GV, 2015, CURR BIOL, V25, pR445, DOI 10.1016/j.cub.2015.02.034; Sharp TV, 2008, P NATL ACAD SCI USA, V105, P19932, DOI 10.1073/pnas.0805003105; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tanaka I, 2015, ONCOGENE, V34, P73, DOI 10.1038/onc.2013.528; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yang SP, 2015, J BIOL CHEM, V290, P6191, DOI 10.1074/jbc.M114.624411; Yang SP, 2014, CELL SIGNAL, V26, P343, DOI 10.1016/j.cellsig.2013.11.012; Yang SP, 2013, CANCER RES, V73, P6722, DOI 10.1158/0008-5472.CAN-13-2049; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang L, 2015, ONCOTARGET, V6, P31399, DOI 10.18632/oncotarget.5189; Zhang L, 2012, J BIOL CHEM, V287, P34069, DOI 10.1074/jbc.M112.385518; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	52	34	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14761	14772		10.1074/jbc.M116.722751	http://dx.doi.org/10.1074/jbc.M116.722751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226586	hybrid, Green Published			2022-12-26	WOS:000380366700028
J	Sundararaman, A; Amirtham, U; Rangarajan, A				Sundararaman, Ananthalakshmy; Amirtham, Usha; Rangarajan, Annapoorni			Calcium-Oxidant Signaling Network Regulates AMP-activated Protein Kinase (AMPK) Activation upon Matrix Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); anoikis; calcium; cancer biology; reactive oxygen species (ROS); matrix deprivation	OXIDATIVE STRESS; CELL-SURVIVAL; EXTRACELLULAR-MATRIX; MITOCHONDRIAL ROS; BREAST-CANCER; MEDIATED ACTIVATION; ANOIKIS RESISTANCE; ENDOTHELIAL-CELLS; NUCLEAR CALCIUM; ENERGY STRESS	The AMP-activated protein kinase (AMPK) has recently been implicated in anoikis resistance. However, the molecular mechanisms that activate AMPK upon matrix detachment remain unexplored. In this study, we show that AMPK activation is a rapid and sustained phenomenon upon matrix deprivation, whereas re-attachment to the matrix leads to its dephosphorylation and inactivation. Because matrix detachment leads to loss of integrin signaling, we investigated whether integrin signaling negatively regulates AMPK activation. However, modulation of focal adhesion kinase or Src, the major downstream components of integrin signaling, failed to cause a corresponding change in AMPK signaling. Further investigations revealed that the upstream AMPK kinases liver kinase B1 (LKB1) and Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) contribute to AMPK activation upon detachment. In LKB1-deficient cells, we found AMPK activation to be predominantly dependent on CaMKK. We observed no change in ATP levels under detached conditions at early time points suggesting that rapid AMPK activation upon detachment was not triggered by energy stress. We demonstrate that matrix deprivation leads to a spike in intracellular calcium as well as oxidant signaling, and both these intracellular messengers contribute to rapid AMPK activation upon detachment. We further show that endoplasmic reticulum calcium release-induced store-operated calcium entry contributes to intracellular calcium increase, leading to reactive oxygen species production, and AMPK activation. We additionally show that the LKB1/CaMKK-AMPK axis and intracellular calcium levels play a critical role in anchorage-independent cancer sphere formation. Thus, the Ca2+/reactive oxygen species-triggered LKB1/CaMKK-AMPK signaling cascade may provide a quick, adaptable switch to promote survival of metastasizing cancer cells.	[Sundararaman, Ananthalakshmy; Rangarajan, Annapoorni] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Amirtham, Usha] Kidwai Mem Inst Oncol, Dept Pathol, Bangalore 560030, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Kidwai Memorial Institute of Oncology	Rangarajan, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	anu@mrdg.iisc.ernet.in		Sundararaman, Ananthalakshmy/0000-0002-5661-4656	Department of Science and Technology (DST)-Fund for Improvement of Science & Technology infrastructure in universities & higher educational institutions (FIST); University Grants Commission (UGC), Govt. of India	Department of Science and Technology (DST)-Fund for Improvement of Science & Technology infrastructure in universities & higher educational institutions (FIST); University Grants Commission (UGC), Govt. of India(University Grants Commission, India)	We acknowledge Dr. Oliver Griesbeck and Dr. Lewis C. Cantley for TN-XXL and AMPK AR FRET constructs, respectively, and Dr. Graham Hardie for AMPK antibody used in kinase assays. We also acknowledge Nehanjali Dwivedi and Rachana Sathyendran for Western blotting; Manipa Saha and C. R. Madhwesh for help with in vitro kinase assay and immunocytochemistry, respectively; and members of the A. R. laboratory for their critical inputs during the course of the study and for help with manuscript preparation. We also thank Dr. Rekha V. Kumar and R. Anisha from Kidwai Memorial Institute of Oncology for help with immunohistochemistry. We acknowledge Drs. N. V. Joshi, Kumar Somasundaram, Deepak Saini, and Ramray Bhat for their input in the study and statistical analysis of the data. We acknowledge the flow cytometry facility at IISc. Support from Department of Science and Technology (DST)-Fund for Improvement of Science & Technology infrastructure in universities & higher educational institutions (FIST), and University Grants Commission (UGC), Govt. of India, to the Department of MRDG are also acknowledged.	Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL556; Auciello FR, 2014, FEBS LETT, V588, P3361, DOI 10.1016/j.febslet.2014.07.025; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Baron V, 2000, J BIOL CHEM, V275, P39318, DOI 10.1074/jbc.M003618200; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bouchekioua-Bouzaghou K, 2014, INT J CANCER, V135, P1307, DOI 10.1002/ijc.28781; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hart PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7053; Hindupur SK, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0420-z; Howe AK, 2001, J BIOL CHEM, V276, P14541, DOI 10.1074/jbc.C000797200; Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; LEBEL CP, 1992, TOXICOL APPL PHARM, V112, P161, DOI 10.1016/0041-008X(92)90292-Z; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Lewis RS, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003970; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luo LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123927; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; Ogata M, 1999, J BIOL CHEM, V274, P20717, DOI 10.1074/jbc.274.29.20717; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Peart T, 2015, ONCOTARGET, V6, P22424, DOI 10.18632/oncotarget.4211; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Sjaastad MD, 1996, MOL BIOL CELL, V7, P1025, DOI 10.1091/mbc.7.7.1025; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xu SH, 2014, DEV CELL, V31, P48, DOI 10.1016/j.devcel.2014.08.002; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	76	47	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14410	14429		10.1074/jbc.M116.731257	http://dx.doi.org/10.1074/jbc.M116.731257			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226623	Green Published, hybrid			2022-12-26	WOS:000380366700002
J	Zwick, M; Esposito, C; Hellstern, M; Seelig, A				Zwick, Matthias; Esposito, Cinzia; Hellstern, Manuel; Seelig, Anna			How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; biosensor; cyclic AMP (cAMP); cystic fibrosis transmembrane conductance regulator (CFTR); protein kinase A (PKA)	PROTEIN-KINASE-A; NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG ABC TRANSPORTER; P-GLYCOPROTEIN ACTIVATION; CHLORIDE-CHANNEL; R-DOMAIN; CL-CHANNEL; STAPHYLOCOCCUS-AUREUS; LIVING CELLS; FORSKOLIN INHIBITION	The cystic fibrosis transmembrane conductance regulator (CFTR, ABCC7), mutations of which cause cystic fibrosis, belongs to the ATP-binding cassette (ABC) transporter family and works as a channel for small anions, such as chloride and bicarbonate. Anion channel activity is known to depend on phosphorylation by cAMP-dependent protein kinase A (PKA) and CFTR-ATPase activity. Whereas anion channel activity has been extensively investigated, phosphorylation and CFTR-ATPase activity are still poorly understood. Here, we show that the two processes can be measured in a label-free and non-invasive manner in real time in live cells, stably transfected with CFTR. This study reveals three key findings. (i) The major contribution (90%) to the total CFTR-related ATP hydrolysis rate is due to phosphorylation by PKA and the minor contribution (10%) to CFTR-ATPase activity. (ii) The mutant CFTR-E1371S that is still conductive, but defective in ATP hydrolysis, is not phosphorylated, suggesting that phosphorylation requires a functional nucleotide binding domain and occurs in the post-hydrolysis transition state. (iii) CFTR-ATPase activity is inversely related to CFTR anion flux. The present data are consistent with a model in which CFTR is in a closed conformation with two ATPs bound. The open conformation is induced by ATP hydrolysis and corresponds to the post-hydrolysis transition state that is stabilized by phosphorylation and binding of chloride channel potentiators.	[Zwick, Matthias; Esposito, Cinzia; Hellstern, Manuel; Seelig, Anna] Univ Basel, Biozentrum, Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland	University of Basel	Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	anna.seelig@unibas.ch			Swiss National Science Foundation [3100A-107793]; Werner Siemens-Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Werner Siemens-Foundation	This work was supported in part by the Swiss National Science Foundation Grant 3100A-107793. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Werner Siemens-Foundation Ph.D. fellowship within the program "Opportunities for Excellence."	Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526; Ai T, 2004, MOL PHARMACOL, V65, P1415, DOI 10.1124/mol.65.6.1415; Al-Nakkash L, 1999, PFLUG ARCH EUR J PHY, V437, P553, DOI 10.1007/s004240050817; Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Baldursson O, 2000, AM J PHYSIOL-LUNG C, V279, pL835, DOI 10.1152/ajplung.2000.279.5.L835; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Beck A, 2013, BIOCHEMISTRY-US, V52, P3297, DOI 10.1021/bi400203d; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bozoky Z, 2013, FEBS J, V280, P4407, DOI 10.1111/febs.12422; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Csanady L, 2013, J GEN PHYSIOL, V142, P61, DOI 10.1085/jgp.201210954; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui GY, 2012, PFLUG ARCH EUR J PHY, V463, P405, DOI 10.1007/s00424-011-1035-1; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Egido E, 2015, MOL PHARMACEUT, V12, P4026, DOI 10.1021/acs.molpharmaceut.5b00463; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gadsby DC, 1999, ADV SEC MESS PHOSPH, V33, P79; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s; GEISBUHLER TP, 1987, PFLUG ARCH EUR J PHY, V409, P158, DOI 10.1007/BF00584765; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Guarino RD, 2004, BIOTECHNOL BIOENG, V86, P775, DOI 10.1002/bit.20072; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hafner F, 2000, BIOSENS BIOELECTRON, V15, P149, DOI 10.1016/S0956-5663(00)00069-5; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hughes LK, 2008, MOL MEMBR BIOL, V25, P528, DOI 10.1080/09687680802487967; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Ketchum CJ, 2004, BIOCHEMISTRY-US, V43, P1045, DOI 10.1021/bi035382a; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Kogan Ilana, 2004, J Cyst Fibros, V3 Suppl 2, P133, DOI 10.1016/j.jcf.2004.05.028; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s; Laohapitakworn S, 2011, AM J PHYSIOL-CELL PH, V301, pC137, DOI 10.1152/ajpcell.00001.2011; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Li-Blatter XC, 2012, BIOPHYS J, V102, P1383, DOI 10.1016/j.bpj.2012.02.018; Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Linsdell Paul, 2014, World J Biol Chem, V5, P26, DOI 10.4331/wjbc.v5.i1.26; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Luckie DB, 2001, J MEMBRANE BIOL, V179, P275, DOI 10.1007/s002320010052; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; Moran O, 2005, FEBS LETT, V579, P3979, DOI 10.1016/j.febslet.2005.06.026; Moran O, 2010, J THEOR BIOL, V262, P73, DOI 10.1016/j.jtbi.2009.08.032; Moran O, 2008, J CYST FIBROS, V7, P483, DOI 10.1016/j.jcf.2008.05.003; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; OWICKI JC, 1990, P NATL ACAD SCI USA, V87, P4007, DOI 10.1073/pnas.87.10.4007; Park JB, 1999, BIOCHEM BIOPH RES CO, V260, P568, DOI 10.1006/bbrc.1999.0890; Pereira MMC, 2007, BIOCHEM J, V405, P181, DOI 10.1042/BJ20061879; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCHULTZ BD, 1995, J GEN PHYSIOL, V105, P329, DOI 10.1085/jgp.105.3.329; Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y; SERGEANT S, 1985, J BIOL CHEM, V260, P4677; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; Tang L, 2009, J CYST FIBROS, V8, P115, DOI 10.1016/j.jcf.2008.10.004; Thedinga E, 2007, TOXICOL APPL PHARM, V220, P33, DOI 10.1016/j.taap.2006.12.027; VANVALEN F, 1988, BONE, V9, P89, DOI 10.1016/8756-3282(88)90108-1; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Vera JC, 1996, J BIOL CHEM, V271, P8719, DOI 10.1074/jbc.271.15.8719; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Wu DZ, 2008, J PHARMACOL EXP THER, V325, P256, DOI 10.1124/jpet.107.131961; Xu Y, 2014, THESIS; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	97	6	6	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14483	14498		10.1074/jbc.M116.721415	http://dx.doi.org/10.1074/jbc.M116.721415			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226582	Green Published, hybrid			2022-12-26	WOS:000380366700007
J	Christoforou, E; Anta, AF; Santos, A				Christoforou, Evgenia; Anta, Antonio Fernandez; Santos, Agustin			A Mechanism for Fair Distribution of Resources without Payments	PLOS ONE			English	Article								We design a mechanism for Fair and Efficient Distribution of Resources (FEDoR) in the presence of strategic agents. We consider a multiple-instances, Bayesian setting, where in each round the preference of an agent over the set of resources is a private information. We assume that in each of r rounds n agents are competing for k non-identical indivisible goods, (n > k). In each round the strategic agents declare how much they value receiving any of the goods in the specific round. The agent declaring the highest valuation receives the good with the highest value, the agent with the second highest valuation receives the second highest valued good, etc. Hence we assume a decision function that assigns goods to agents based on their valuations. The novelty of the mechanism is that no payment scheme is required to achieve truthfulness in a setting with rational/strategic agents. The FEDoR mechanism takes advantage of the repeated nature of the framework, and through a statistical test is able to punish the misreporting agents and be fair, truthful, and socially efficient. FEDoR is fair in the sense that, in expectation over the course of the rounds, all agents will receive the same good the same amount of times. FEDoR is an eligible candidate for applications that require fair distribution of resources over time. For example, equal share of bandwidth for nodes through the same point of access. But further on, FEDoR can be applied in less trivial settings like sponsored search, where payment is necessary and can be given in the form of a flat participation fee. FEDoR can be a good candidate in a setting like that to solve the problem of starvation of publicity slots for some advertisers that have a difficult time determining their true valuations. To this extent we perform a comparison with traditional mechanisms applied to sponsored search, presenting the advantage of FEDoR.	[Christoforou, Evgenia; Anta, Antonio Fernandez; Santos, Agustin] IMDEA Networks Inst, Madrid, Spain; [Christoforou, Evgenia] Univ Carlos III Madrid, Madrid, Spain; [Santos, Agustin] Univ Rey Juan Carlos, Madrid, Spain	Universidad Carlos III de Madrid; Universidad Rey Juan Carlos	Christoforou, E (corresponding author), IMDEA Networks Inst, Madrid, Spain.; Christoforou, E (corresponding author), Univ Carlos III Madrid, Madrid, Spain.	evgenia.christoforou@imdea.org			Regional Government of Madrid (CM) grant Cloud4BigData - FSE FEDER [S2013/ICE-2894]; Spanish Ministry of Economy and Competitiveness grant HyperAdapt [TEC2014-55713-R]; Spanish Ministry of Education grant [FPU2013-03792]; NSF of China grant [61520106005]; Real Colegio Complutense at Harvard (RCC); EC	Regional Government of Madrid (CM) grant Cloud4BigData - FSE FEDER; Spanish Ministry of Economy and Competitiveness grant HyperAdapt; Spanish Ministry of Education grant; NSF of China grant; Real Colegio Complutense at Harvard (RCC); EC(European CommissionEuropean Commission Joint Research Centre)	This work has been partially funded by the Regional Government of Madrid (CM) grant Cloud4BigData (S2013/ICE-2894) cofunded by FSE & FEDER, the Spanish Ministry of Economy and Competitiveness grant HyperAdapt (TEC2014-55713-R), the Spanish Ministry of Education grant FPU2013-03792, the NSF of China grant 61520106005, the EC H2020 grants ReCred and NOTRE, and the Real Colegio Complutense at Harvard (RCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGUS JE, 1994, SIAM REV, V36, P652, DOI 10.1137/1036146; Arrow K. J., 2012, SOCIAL CHOICE INDIVI, V3rd; Ausubel L., 2006, COMBINATORIAL AUCTIO, V17, P22; Edelman B., 2005, INTERNET ADVERTISING; Guo M., 2010, AAMAS, P881; Guo MY, 2009, LECT NOTES COMPUT SC, V5929, P244; Hartline JD, 2008, ACM S THEORY COMPUT, P75; Jackson MO, 2007, ECONOMETRICA, V75, P241, DOI 10.1111/j.1468-0262.2007.00737.x; Levin H, 2011, SIAM J COMPUT, V40, P1892, DOI 10.1137/080734017; Locher T, 2006, P 5 WORKSH HOT TOP N, P85; Moscibroda T, 2009, IEEE INFOCOM SER, P972, DOI 10.1109/INFCOM.2009.5062008; Piatek M., 2007, P NSDI, V7; Procaccia Ariel D, 2013, ACM T ECON COMPUT, V1, P1, DOI [10.1145/2542174.2542175, DOI 10.1145/2542174.2542175]; Rahman R, 2010, IEEE ICC; Santos Agustin, 2014, Networked Systems. Second International Conference, NETYS 2014. Revised Selected Papers. LNCS: 8593, P70, DOI 10.1007/978-3-319-09581-3_6; Santos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066575; SATTERTHWAITE MA, 1975, J ECON THEORY, V10, P187, DOI 10.1016/0022-0531(75)90050-2; Schummer J, 2007, ALGORITHMIC GAME THEORY, P243	18	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155962	10.1371/journal.pone.0155962	http://dx.doi.org/10.1371/journal.pone.0155962			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227992	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500046
J	Leung, NHZ; Chen, A; Yadav, P; Gallien, J				Leung, Ngai-Hang Z.; Chen, Ana; Yadav, Prashant; Gallien, Jeremie			The Impact of Inventory Management on Stock-Outs of Essential Drugs in Sub-Saharan Africa: Secondary Analysis of a Field Experiment in Zambia	PLOS ONE			English	Article								Objective To characterize the impact of widespread inventory management policies on stock-outs of essential drugs in Zambia's health clinics and develop related recommendations. Methods Daily clinic storeroom stock levels of artemether-lumefantrine (AL) products in 2009-2010 were captured in 145 facilities through photography and manual transcription of paper forms, then used to determine historical stock-out levels and estimate demand patterns. Delivery lead-times and estimates of monthly facility accessibility were obtained through worker surveys. A simulation model was constructed and validated for predictive accuracy against historical stock-outs, then used to evaluate various changes potentially affecting product availability. Findings While almost no stock-outs of AL products were observed during Q4 2009 consistent with primary analysis, up to 30% of surveyed facilities stocked out of some AL product during Q1 2010 despite ample inventory being simultaneously available at the national warehouse. Simulation experiments closely reproduced these results and linked them to the use of average past monthly issues and failure to capture lead-time variability in current inventory control policies. Several inventory policy enhancements currently recommended by USAID vertical bar DELIVER were found to have limited impact on product availability. Conclusions Inventory control policies widely recommended and used for distributing medicines in sub-Saharan Africa directly account for a substantial fraction of stock-outs observed in common situations involving demand seasonality and facility access interruptions. Developing central capabilities in peripheral demand forecasting and inventory control is critical. More rigorous independent peer-reviewed research on pharmaceutical supply chain management in low-income countries is needed.	[Leung, Ngai-Hang Z.] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA; [Chen, Ana] Analyt Operat Engn, Boston, MA USA; [Yadav, Prashant] Univ Michigan, Ross Sch Business, William Davidson Inst, Ann Arbor, MI 48109 USA; [Yadav, Prashant] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Gallien, Jeremie] London Business Sch, Regents Pk, London NW1 4SA, England; [Leung, Ngai-Hang Z.] City Univ Hong Kong, Coll Business, Dept Management Sci, Hong Kong, Hong Kong, Peoples R China	Carnegie Mellon University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of London; London Business School; City University of Hong Kong	Gallien, J (corresponding author), London Business Sch, Regents Pk, London NW1 4SA, England.	jgallien@london.edu	Gallien, Jérémie/L-6428-2013	Gallien, Jérémie/0000-0001-6292-5031; Yadav, Prashant/0000-0001-7836-6641	London Business School; Massachusetts Institute of Technology; World Bank	London Business School; Massachusetts Institute of Technology; World Bank(The World Bank India)	This work was supported by London Business School (JG), Massachusetts Institute of Technology (NHL) and The World Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K., 2005, JAVA PROGRAMMING LAN; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Bossert TJ, 2007, HEALTH POLICY PLANN, V22, P73, DOI 10.1093/heapol/czl041; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Fundafunda B, 2014, COMMUNICATION; Hopp W. J., 2004, Manufacturing & Service Operations Management, V6, P133, DOI 10.1287/msom.1030.0028; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Law A. M., 2000, SIMULATION MODELING; Luk R, 2013, LESSONS LEARNED ICTS; Makridakis S., 1998, FORECASTING METHODS; Matowe L, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-30; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Picazo OF, 2009, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-7804-5; Quick JD, 1997, DC2018020003 DEP EN; Ross DF., 2010, INTRO SUPPLY CHAIN M; Snyder LV., 2011, FUNDAMENTALS SUPPLY; USAID &VERBAR; DELIVER PROJECT Task Order 1, 2011, 1 USAID DELIVER PROJ; USAID &VERBAR; DELIVER PROJECT Task Order 3, 2011, 3 USAID DELIVER PROJ; Vledder M, 2015, 1269 ROSS SCH BUS; Waako PJ, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-21; Watson N, 2014, 17 USAID DELIVER PRO; Yadav P., 2007, ANAL PUBLIC PRIVATE	22	30	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156026	10.1371/journal.pone.0156026	http://dx.doi.org/10.1371/journal.pone.0156026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227412	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000376882500053
J	Reed, AP; Bucci, G; Abd-Wahab, F; Tucker, SJ				Reed, Alan P.; Bucci, Giovanna; Abd-Wahab, Firdaus; Tucker, Stephen J.			Dominant-Negative Effect of a Missense Variant in the TASK-2 (KCNK5) K+ Channel Associated with Balkan Endemic Nephropathy	PLOS ONE			English	Article							SENSITIVE BACKGROUND K-2P; POTASSIUM CHANNELS; K2P CHANNELS; MECHANISM; PORE; TRANSPORT; PHYSIOLOGY; MUTATION; DISEASE	TASK-2, a member of the Two-Pore Domain (K2P) subfamily of K+ channels, is encoded by the KCNK5 gene. The channel is expressed primarily in renal epithelial tissues and a potentially deleterious missense variant in KCNK5 has recently been shown to be prevalent amongst patients predisposed to the development of Balkan Endemic Nephropathy (BEN), a chronic tubulointerstitial renal disease of unknown etiology. In this study we show that this variant (T108P) results in a complete loss of channel function and is associated with a major reduction in TASK-2 channel subunits at the cell surface. Furthermore, these mutant subunits have a suppressive or 'dominant-negative' effect on channel function when coexpressed with wild-type subunits. This missense variant is located at the extracellular surface of the M2 transmembrane helix and by using a combination of structural modelling and further functional analysis we also show that this highly-conserved threonine residue is critical for the correct function of other K2P channels. These results therefore provide further structural and functional insights into the possible pathophysiological effects of this missense variant in TASK-2.	[Reed, Alan P.; Bucci, Giovanna; Abd-Wahab, Firdaus; Tucker, Stephen J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Tucker, Stephen J.] Univ Oxford, OXION Initiat Ion Channels & Dis, Oxford, England	University of Oxford; University of Oxford	Tucker, SJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.; Tucker, SJ (corresponding author), Univ Oxford, OXION Initiat Ion Channels & Dis, Oxford, England.	stephen.tucker@physics.ox.ac.uk	Tucker, Stephen J./ABE-7468-2020	Tucker, Stephen J./0000-0001-8996-2000	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; BBSRC [BB/N009274/1, BB/J00037X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N009274/1, BB/J00037X/1] Funding Source: researchfish; British Heart Foundation [PG/09/016/26992] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) and The Wellcome Trust.	Andres-Enguix I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00237; Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bayliss DA, 2015, PFLUG ARCH EUR J PHY, V467, P917, DOI 10.1007/s00424-014-1633-9; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Guo ZH, 2014, J NEUROPHYSIOL, V112, P568, DOI 10.1152/jn.00267.2014; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lopez-Cayuqueo KI, 2015, PFLUG ARCH EUR J PHY, V467, P1043, DOI 10.1007/s00424-014-1627-7; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Morton MJ, 2005, P NATL ACAD SCI USA, V102, P16102, DOI 10.1073/pnas.0506870102; Nagaoka Y, 2008, CHEMBIOCHEM, V9, P1725, DOI 10.1002/cbic.200800133; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Pathan AR, 2011, HYPERTENSION, V58, P539, DOI 10.1161/HYPERTENSIONAHA.111.179390; Pavlovic NM, 2013, CLIN KIDNEY J, V6, P257, DOI 10.1093/ckj/sft049; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Rapedius M, 2012, CHANNELS, V6, P473, DOI 10.4161/chan.22153; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Sepulveda FV, 2015, PHYSIOL REV, V95, P179, DOI 10.1152/physrev.00016.2014; Stefanovic V, 2011, PATHOL BIOL, V59, P286, DOI 10.1016/j.patbio.2009.05.002; Stefanovic V, 2015, CLIN NEPHROL, V83, pS64, DOI 10.5414/CNP83S064; Toncheva D, 1996, NEPHRON, V72, P564, DOI 10.1159/000188940; Toncheva D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/920723; Toncheva D, 1998, EUR J EPIDEMIOL, V14, P389, DOI 10.1023/A:1007445120729; Tucker SJ, 1996, J BIOL CHEM, V271, P5866, DOI 10.1074/jbc.271.10.5866; Veale EL, 2016, BRIT J PHARMACOL, V173, P1639, DOI 10.1111/bph.13465; Veale EL, 2014, MOL PHARMACOL, V85, P671, DOI 10.1124/mol.113.091199; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156456	10.1371/journal.pone.0156456	http://dx.doi.org/10.1371/journal.pone.0156456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228168	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500141
J	Ji, EH; Sun, BB; Zhao, TK; Shu, S; Chang, CH; Messadi, D; Xia, T; Zhu, YF; Hu, S				Ji, Eoon Hye; Sun, Bingbing; Zhao, Tongke; Shu, Shi; Chang, Chong Hyun; Messadi, Diana; Xia, Tian; Zhu, Yifang; Hu, Shen			Characterization of Electronic Cigarette Aerosol and Its Induction of Oxidative Stress Response in Oral Keratinocytes	PLOS ONE			English	Article							SIZE DISTRIBUTION; NANOPARTICLES; SMOKE; HYDROQUINONE; DISSOLUTION; MAINSTREAM; LIQUIDS; OXIDE; LUNG	In this study, we have generated and characterized Electronic Cigarette (EC) aerosols using a combination of advanced technologies. In the gas phase, the particle number concentration (PNC) of EC aerosols was found to be positively correlated with puff duration whereas the PNC and size distribution may vary with different flavors and nicotine strength. In the liquid phase (water or cell culture media), the size of EC nanoparticles appeared to be significantly larger than those in the gas phase, which might be due to aggregation of nanoparticles in the liquid phase. By using in vitro high-throughput cytotoxicity assays, we have demonstrated that EC aerosols significantly decrease intracellular levels of glutathione in NHOKs in a dose-dependent fashion resulting in cytotoxicity. These findings suggest that EC aerosols cause cytotoxicity to oral epithelial cells in vitro, and the underlying molecular mechanisms may be or at least partially due to oxidative stress induced by toxic substances (e.g., nanoparticles and chemicals) present in EC aerosols.	[Ji, Eoon Hye; Messadi, Diana; Hu, Shen] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Sun, Bingbing; Xia, Tian] Univ Calif Los Angeles, Sch Med, Div Nanomedcine, Los Angeles, CA USA; [Chang, Chong Hyun] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA USA; [Zhao, Tongke; Shu, Shi; Zhu, Yifang] Univ Calif Los Angeles, Dept Environm Hlth Sci, Los Angeles, CA USA; [Zhao, Tongke] Peking Univ, Sch Phys, Beijing 100871, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Peking University	Hu, S (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	shenhu@ucla.edu	Xiao, Jian/GYU-4351-2022; xia, tian/C-3158-2013; Hu, Steve/B-3799-2011; Sun, Bingbing/I-8197-2012; ZHAO, TONGKE/I-3679-2019	xia, tian/0000-0003-0123-1305; Sun, Bingbing/0000-0002-5444-5078; ZHAO, TONGKE/0000-0002-4034-3273				Cunningham FH, 2011, FOOD CHEM TOXICOL, V49, P2921, DOI 10.1016/j.fct.2011.07.019; F.D.A, 2009, SUMM RES LAB AN EL C; Fuoco FC, 2014, ENVIRON POLLUT, V184, P523, DOI 10.1016/j.envpol.2013.10.010; Garcia-Canton C, 2013, TOXICOL LETT, V223, P81, DOI 10.1016/j.toxlet.2013.08.024; Geiss O, 2015, INT J HYG ENVIR HEAL, V218, P169, DOI 10.1016/j.ijheh.2014.10.001; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Gualano MR, 2015, J PUBLIC HEALTH-UK, V37, P488, DOI 10.1093/pubmed/fdu055; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Ingebrethsen BJ, 2012, INHAL TOXICOL, V24, P976, DOI 10.3109/08958378.2012.744781; Kim HJ, 2013, J CHROMATOGR A, V1291, P48, DOI 10.1016/j.chroma.2013.03.035; Laugesen M, 2009, C SOC RES NIC TOB DU; Lerner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116732; Manzoli L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-883; McAuley TR, 2012, INHAL TOXICOL, V24, P850, DOI 10.3109/08958378.2012.724728; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Ohta K, 2011, BUNSEKI KAGAKU, V60, P791; Pellegrino R M, 2012, Ann Ig, V24, P279; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Schraufnagel DE, 2014, AM J RESP CRIT CARE, V190, P611, DOI 10.1164/rccm.201407-1198PP; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Sun BB, 2015, ACS NANO, V9, P9357, DOI 10.1021/acsnano.5b03443; Sun BB, 2013, ACS NANO, V7, P10834, DOI 10.1021/nn404211j; Sussan TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116861; Uchiyama S, 2013, ANAL SCI, V29, P1219, DOI 10.2116/analsci.29.1219; Wang X, 2014, SMALL, V10, P385, DOI 10.1002/smll.201301597; Willershausen I, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-39; Williams M, 2013, METAL SILICATE PARTI, V8; Wu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108342; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Zhang HY, 2012, ACS NANO, V6, P4349, DOI 10.1021/nn3010087; Zhang M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-223; Zhao T, 2016, ENV SCI TECHNO UNPUB	32	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0154447	10.1371/journal.pone.0154447	http://dx.doi.org/10.1371/journal.pone.0154447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223106	Green Published, gold			2022-12-26	WOS:000376881700005
J	Kendall, LV; Allaband, C; Henderson, KS				Kendall, Lon V.; Allaband, Celeste; Henderson, Kenneth S.			Pre-Natal Exposure to Mouse Parvovirus at Day 5 and 12 Gestation Does Not Induce Immune Tolerance	PLOS ONE			English	Article							C.B-17/ICR-PRKDC(SCID) MICE; MURINE NOROVIRUS; HEPATITIS-VIRUS; EMBRYO-TRANSFER; IN-UTERO; INFECTION; REDERIVATION; TRANSMISSION; BALB/C	Parvoviruses have a predilection for rapidly dividing cells such as occurs during embryonic development. Potentially, in utero exposure could lead to immune tolerance in progeny mice. To determine if MPV infection in utero results in immune tolerance, pregnant mice were inoculated by oral gavage with 50 ID50 MPV1e or sham inoculated with phosphate buffered saline at day 5 and 12 gestation. Offspring were fostered to MPV-negative recipient dams prior to development of a milk spot. After confirming the offspring were seronegative for MPV by serology and not shedding by fecal PCR, they were challenged with 50 ID50 MPV1e by oral gavage at weaning or sham inoculated. At 4 weeks post inoculation, all weanlings exposed in utero developed antibodies to MPV, and MPV was detected by fecal PCR. Similarly, all weanlings from sham-inoculated dams challenged with MPV developed antibodies and MPV was detected by fecal PCR. None of the sham inoculated weanling mice from MPV infected dams or sham infected dams developed antibodies to MPV nor was MPV detected by fecal PCR. These results demonstrate that in utero exposure to MPV1e via oral gavage was insufficient to induce immune tolerance and provides greater confidence that rederivation techniques may successfully eliminate colonies of MPV. Furthermore, our findings do not provide evidence that MPV tolerance may contribute to hidden infections in mouse colonies.	[Kendall, Lon V.; Allaband, Celeste] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Henderson, Kenneth S.] Charles River Labs Int, Wilmington, MA USA	Colorado State University	Kendall, LV (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	lon.kendall@colostate.edu	Allaband, Celeste/AAR-1834-2021; Kendall, Lon/O-7781-2018	Allaband, Celeste/0000-0003-1832-4858; Kendall, Lon/0000-0002-6488-5499	American College of Laboratory Animal Medicine Foundation; Merck Co., Inc.	American College of Laboratory Animal Medicine Foundation; Merck Co., Inc.(Merck & Company)	This work was funded by a grant from the American College of Laboratory Animal Medicine Foundation and Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca Y, 2007, COMPARATIVE MED, V57, P51; Artwohl JE, 2008, J AM ASSOC LAB ANIM, V47, P19; Besselsen DG, 2008, COMPARATIVE MED, V58, P353; Besselsen DG, 2007, COMPARATIVE MED, V57, P66; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Compton SR, 2010, J AM ASSOC LAB ANIM, V49, P11; Jerebtsova M, 2002, PEDIATR RES, V52, P95, DOI 10.1203/00006450-200207000-00018; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P175, DOI 10.1111/j.1471-0528.2010.02749.x; Mahabir E, 2007, BIOL REPROD, V76, P189, DOI 10.1095/biolreprod.106.056135; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; McKisic MD, 1996, TRANSPLANTATION, V61, P292, DOI 10.1097/00007890-199601270-00022; MCKISIC MD, 1993, J IMMUNOL, V150, P3793; PLATEAU E, 1980, AM J VET RES, V41, P2012; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Redig AJ, 2001, COMPARATIVE MED, V51, P326; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; Singletary KB, 2003, COMPARATIVE MED, V53, P259; Smirnova NP, 2009, PHYSIOL GENOMICS, V36, P129, DOI 10.1152/physiolgenomics.90276.2008; Truong P, 2009, J IMMUNOL, V183, P3895, DOI 10.4049/jimmunol.0803085; Watson J, 2005, COMPARATIVE MED, V55, P465	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156248	10.1371/journal.pone.0156248	http://dx.doi.org/10.1371/journal.pone.0156248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219540	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880700052
J	Yang, Z; Swedlund, P; Gu, QF; Hemar, Y; Chaieb, S				Yang, Zhi; Swedlund, Peter; Gu, Qinfen; Hemar, Yacine; Chaieb, Sahraoui			Retrogradation of Maize Starch after High Hydrostatic Pressure Gelation: Effect of Amylose Content and Depressurization Rate	PLOS ONE			English	Article							WAXY MAIZE; RHEOLOGICAL PROPERTIES; CORN STARCH; IN-SITU; RICE; GELATINIZATION; AMYLOPECTIN; BEHAVIOR; CRYSTALLIZATION; TEMPERATURE	High hydrostatic pressure (HHP) has been employed to gelatinize or physically modify starch dispersions. In this study, waxy maize starch, normal maize starch, and two high amylose content starch were processed by a HHP of the order of 600 MPa, at 25 degrees C for 15min. The effect of HHP processing on the crystallization of maize starches with various amylose content during storage at 4 degrees C was investigated. Crystallization kinetics of HHP treated starch gels were investigated using rheology and FTIR. The effect of crystallization on the mechanical properties of starch gel network were evaluated in terms of dynamic complex modulus (G*). The crystallization induced increase of short-range helices structures were investigated using FTIR. The pressure releasing rate does not affect the starch retrogradation behaviour. The rate and extent of retrogradation depends on the amylose content of amylose starch. The least retrogradation was observed in HHP treated waxy maize starch. The rate of retrogradation is higher for HHP treated high amylose maize starch than that of normal maize starch. A linear relationship between the extent of retrogradation (phase distribution) measured by FTIR and G* is proposed.	[Yang, Zhi; Swedlund, Peter; Hemar, Yacine] Univ Auckland, Sch Chem Sci, Private Bag 92019, Auckland 1142, New Zealand; [Gu, Qinfen] Australian Synchrotron, 800 Blackburn Rd, Clayton, Vic 3168, Australia; [Chaieb, Sahraoui] KAUST, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia; [Chaieb, Sahraoui] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, 1 Cyclotron Rd,Mailstop 6R-2100, Berkeley, CA 94720 USA	University of Auckland; King Abdullah University of Science & Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Chaieb, S (corresponding author), KAUST, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia.; Chaieb, S (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, 1 Cyclotron Rd,Mailstop 6R-2100, Berkeley, CA 94720 USA.	sahraoui.chaieb@kaust.edu.sa	Yang, Zhi/B-6595-2018; Gu, Qinfen/HCH-4243-2022	Yang, Zhi/0000-0001-8062-5737; Gu, Qinfen/0000-0001-9209-4208	KAUST	KAUST(King Abdullah University of Science & Technology)	We acknowledge the support of the plant and food research institute in providing the high pressure equipment used in this work. We thank Mr. Graeme Summers from Plant & Food Research Ltd. for his technical assistance. SC thanks KAUST for support.	Abd Karim A, 2000, FOOD CHEM, V71, P9, DOI 10.1016/S0308-8146(00)00130-8; Ahmed J, 2014, CARBOHYD POLYM, V103, P12, DOI 10.1016/j.carbpol.2013.12.014; Ai Y, 2015, STARCH-STARKE, V67, P213, DOI 10.1002/star.201400201; Ambigaipalan P, 2013, FOOD RES INT, V54, P203, DOI 10.1016/j.foodres.2013.06.012; Baier D, 2015, INT DAIRY J, V43, P51, DOI 10.1016/j.idairyj.2014.11.008; BeMiller J. N., 2007, CARBOHYDRATE CHEM FO, V2nd; BILIADERIS CG, 1991, J AGR FOOD CHEM, V39, P833, DOI 10.1021/jf00005a003; BILIADERIS CG, 1990, CEREAL CHEM, V67, P240; BILIADERIS CG, 1994, CARBOHYD POLYM, V23, P193, DOI 10.1016/0144-8617(94)90102-3; Blaszczak W, 2007, CARBOHYD POLYM, V68, P387, DOI 10.1016/j.carbpol.2006.12.023; Blaszczak W, 2005, CARBOHYD POLYM, V61, P132, DOI 10.1016/j.carbpol.2005.04.005; Bravo FI, 2012, J DAIRY SCI, V95, P6293, DOI 10.3168/jds.2012-5490; Dhital S, 2010, FOOD HYDROCOLLOID, V24, P152, DOI 10.1016/j.foodhyd.2009.08.013; Fan J, 1998, CEREAL CHEM, V75, P153, DOI 10.1094/CCHEM.1998.75.1.153; GIDLEY MJ, 1989, MACROMOLECULES, V22, P351, DOI 10.1021/ma00191a064; Gomand SV, 2010, FOOD HYDROCOLLOID, V24, P424, DOI 10.1016/j.foodhyd.2009.11.009; GUDMUNDSSON M, 1990, CARBOHYD POLYM, V13, P295, DOI 10.1016/0144-8617(90)90061-V; Guo ZB, 2015, FOOD HYDROCOLLOID, V44, P285, DOI 10.1016/j.foodhyd.2014.09.014; Hsu S, 2000, J FOOD SCI, V65, P215, DOI 10.1111/j.1365-2621.2000.tb15982.x; Hu XT, 2011, J FOOD ENG, V106, P262, DOI 10.1016/j.jfoodeng.2011.05.021; Ji Y, 2010, INT J FOOD SCI TECH, V45, P871, DOI 10.1111/j.1365-2621.2010.02203.x; Jouppila K, 1998, CARBOHYD POLYM, V36, P143, DOI 10.1016/S0144-8617(98)00024-1; KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634; King A, 2009, J THERM ANAL CALORIM, V98, P83, DOI 10.1007/s10973-009-0279-x; Li WH, 2011, J FOOD ENG, V103, P388, DOI 10.1016/j.jfoodeng.2010.11.008; Liu HS, 2007, CARBOHYD POLYM, V69, P756, DOI 10.1016/j.carbpol.2007.02.011; Liu HS, 2010, STARCH-STARKE, V62, P524, DOI 10.1002/star.201000017; MILES MJ, 1985, CARBOHYD RES, V135, P271, DOI 10.1016/S0008-6215(00)90778-X; Mua JP, 1998, J CEREAL SCI, V27, P157, DOI 10.1006/jcrs.1997.0161; Oh HE, 2008, CARBOHYD POLYM, V73, P332, DOI 10.1016/j.carbpol.2007.11.038; Ottenhof MA, 2005, J AGR FOOD CHEM, V53, P631, DOI 10.1021/jf048705y; Ratnayake WS, 2009, ADV FOOD NUTR RES, V55, P221, DOI 10.1016/S1043-4526(08)00405-1; RING SG, 1987, CARBOHYD RES, V162, P277, DOI 10.1016/0008-6215(87)80223-9; Rubens P, 1999, CARBOHYD POLYM, V39, P231, DOI 10.1016/S0144-8617(99)00005-3; Sasaki T, 2000, CEREAL CHEM, V77, P58, DOI 10.1094/CCHEM.2000.77.1.58; Sevenou O, 2002, INT J BIOL MACROMOL, V31, P79, DOI 10.1016/S0141-8130(02)00067-3; Singh S, 2010, J AGR FOOD CHEM, V58, P1180, DOI 10.1021/jf902753f; Stolt M, 1999, J FOOD ENG, V40, P293, DOI 10.1016/S0260-8774(99)00069-2; Stute R, 1996, STARCH-STARKE, V48, P399, DOI 10.1002/star.19960481104; Teo CH, 2000, FOOD CHEM, V69, P229, DOI 10.1016/S0308-8146(99)00271-X; Thygesen LG, 2003, STARCH-STARKE, V55, P241, DOI 10.1002/star.200390062; Yang Z, 2013, CARBOHYD POLYM, V97, P235, DOI 10.1016/j.carbpol.2013.04.075; YUAN RC, 1993, CEREAL CHEM, V70, P81; Zhang YJ, 2014, FOOD CHEM, V158, P255, DOI 10.1016/j.foodchem.2014.02.072; Zhou X, 2010, J CEREAL SCI, V51, P57, DOI 10.1016/j.jcs.2009.09.005; ZOBEL HF, 1988, CEREAL CHEM, V65, P443	46	7	7	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156061	10.1371/journal.pone.0156061	http://dx.doi.org/10.1371/journal.pone.0156061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219066	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700038
J	Carmean, CM; Huang, YH; Brady, MJ				Carmean, Christopher M.; Huang, Y. Hanna; Brady, Matthew J.			Glycogen Repletion in Brown Adipose Tissue upon Refeeding Is Primarily Driven by Phosphorylation-Independent Mechanisms	PLOS ONE			English	Article							PROTEIN PHOSPHATASE-1; TARGETING SUBUNIT; SYNTHASE; PTG; OVEREXPRESSION; ACCUMULATION; PURIFICATION; METABOLISM; ACTIVATION; INSULIN	Glycogen storage in brown adipose tissue (BAT) is generally thought to take place through passive, substrate-driven activation of glycogenesis rather than programmatic shifts favoring or opposing the storage and/or retention of glycogen. This perception exists despite a growing body of evidence suggesting that BAT glycogen storage is actively regulated by covalent modification of key glycogen-metabolic enzymes, protein turnover, and endocrine hormone signaling. Members of one such class of covalent-modification regulators, glycogen-binding Phosphoprotein Phosphatase-1 (PP1)-regulatory subunits (PPP1Rs), targeting PP1 to glycogen-metabolic enzymes, were dynamically regulated in response to 24 hr of starvation and/or 24 hr of starvation followed by ad libitum refeeding. Over-expression of the PPP1R Protein Targeting to Glycogen (PTG), under the control of the aP2 promoter in mice, inactivated glycogen phosphorylase (GP) and enhanced basal-and starvation-state glycogen storage. Total interscapular BAT glycogen synthase and the constitutive activity of GS were conditionally affected. During starvation, glucose-6-phosphate (G-6-P) levels and the relative phosphorylation of Akt (p-Ser-473-Akt) were both increased in PTG-overexpressing (Tg) mice, suggesting that elevated glycogen storage during starvation modifies broader cellular metabolic pathways. During refeeding, Tg and WT mice reaccumulated glycogen similarly despite altered GS and GP activities. All observations during refeeding suggest that the phosphorylation states of GS and GP are not physiologically rate-controlling, despite there being a clear balance of endogenous kinase-and phosphatase activities. The studies presented here reveal IBAT glycogen storage to be a tightly-regulated process at all levels, with potential effects on nutrient sensing in vivo.	[Carmean, Christopher M.; Brady, Matthew J.] Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA; [Huang, Y. Hanna; Brady, Matthew J.] Univ Chicago, Dept Med, Sect Endocrinol Diabet & Metab, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Carmean, Christopher M.] Kobe Univ, Grad Sch Med, Dept Mol & Metab Med, Kobe, Hyogo 6500047, Japan	University of Chicago; University of Chicago; Kobe University	Brady, MJ (corresponding author), Univ Chicago, Comm Mol Metab & Nutr, Chicago, IL 60637 USA.; Brady, MJ (corresponding author), Univ Chicago, Dept Med, Sect Endocrinol Diabet & Metab, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mbrady1@uchicago.edu			NIH [R01-DK064772]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01-DK064772.	Allaman I, 2000, GLIA, V30, P382, DOI 10.1002/(SICI)1098-1136(200006)30:4<382::AID-GLIA70>3.3.CO;2-S; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmean CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067807; Cohen PTW, 2002, J CELL SCI, V115, P241; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; Danos AM, 2009, J BIOL CHEM, V284, P19544, DOI 10.1074/jbc.M109.015073; Farkas V, 1999, ARCH BIOCHEM BIOPHYS, V365, P54, DOI 10.1006/abbi.1999.1157; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Greenberg CC, 2006, MOL CELL BIOL, V26, P334, DOI 10.1128/MCB.26.1.334-342.2006; Greenberg CC, 2003, J BIOL CHEM, V278, P30835, DOI 10.1074/jbc.M303846200; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hao Q, 2015, AM J PHYSIOL-ENDOC M, V308, pE380, DOI 10.1152/ajpendo.00277.2014; Jurczak MJ, 2008, J CELL BIOCHEM, V104, P435, DOI 10.1002/jcb.21634; Jurczak MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE952, DOI 10.1152/ajpendo.00559.2006; Jurczak MJ, 2010, OBESITY, V18, P1881, DOI 10.1038/oby.2010.32; Kelsall IR, 2011, J NEUROCHEM, V118, P596, DOI 10.1111/j.1471-4159.2011.07345.x; KUROSHIMA A, 1988, JPN J PHYSIOL, V38, P393, DOI 10.2170/jjphysiol.38.393; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; LEVER JD, 1957, ANAT REC, V128, P361, DOI 10.1002/ar.1091280302; Lidell ME, 2014, ADIPOCYTE, V3, P63, DOI 10.4161/adip.26896; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lu BB, 2014, DIABETES, V63, P2935, DOI 10.2337/db13-1531; Luo XL, 2011, DIABETES, V60, P1435, DOI 10.2337/db10-1663; MOORHEAD G, 1995, FEBS LETT, V362, P101, DOI 10.1016/0014-5793(95)00197-H; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; Ou HS, 2005, ENDOCRINOLOGY, V146, P494, DOI 10.1210/en.2004-1022; Petit JM, 2015, METAB BRAIN DIS, V30, P263, DOI 10.1007/s11011-014-9629-x; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Ros S, 2009, J BIOL CHEM, V284, P6370, DOI 10.1074/jbc.M808576200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHULMAN RG, 1995, P NATL ACAD SCI USA, V92, P8535, DOI 10.1073/pnas.92.19.8535; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; TUERKISCHER E, 1946, J PHYSIOL-LONDON, V104, P361, DOI 10.1113/jphysiol.1946.sp004128; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200	41	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156148	10.1371/journal.pone.0156148	http://dx.doi.org/10.1371/journal.pone.0156148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213961	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200061
J	Krause, R; Halwachs, B; Thallinger, GG; Klymiuk, I; Gorkiewicz, G; Hoenigl, M; Prattes, J; Valentin, T; Heidrich, K; Buzina, W; Salzer, HJF; Rabensteiner, J; Pruller, F; Raggam, RB; Meinitzer, A; Moissl-Eichinger, C; Hogenauer, C; Quehenberger, F; Kashofer, K; Zollner-Schwetz, I				Krause, Robert; Halwachs, Bettina; Thallinger, Gerhard G.; Klymiuk, Ingeborg; Gorkiewicz, Gregor; Hoenigl, Martin; Prattes, Juergen; Valentin, Thomas; Heidrich, Katharina; Buzina, Walter; Salzer, Helmut J. F.; Rabensteiner, Jasmin; Prueller, Florian; Raggam, Reinhard B.; Meinitzer, Andreas; Moissl-Eichinger, Christine; Hoegenauer, Christoph; Quehenberger, Franz; Kashofer, Karl; Zollner-Schwetz, Ines			Characterisation of Candida within the Mycobiome/Microbiome of the Lower Respiratory Tract of ICU Patients	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MULTIPLE SEQUENCE ALIGNMENT; INTENSIVE-CARE-UNIT; CRITICALLY-ILL; PSEUDOMONAS-AERUGINOSA; STATISTICAL-METHODS; PNEUMONIA; ALBICANS; IDENTIFICATION; COLONIZATION	Whether the presence of Candida spp. in lower respiratory tract (LRT) secretions is a marker of underlying disease, intensive care unit (ICU) treatment and antibiotic therapy or contributes to poor clinical outcome is unclear. We investigated healthy controls, patients with proposed risk factors for Candida growth in LRT (antibiotic therapy, ICU treatment with and without antibiotic therapy), ICU patients with pneumonia and antibiotic therapy and candidemic patients (for comparison of truly invasive and colonizing Candida spp.). Fungal patterns were determined by conventional culture based microbiology combined with molecular approaches (next generation sequencing, multilocus sequence typing) for description of fungal and concommitant bacterial microbiota in LRT, and host and fungal biomarkes were investigated. Admission to and treatment on ICUs shifted LRT fungal microbiota to Candida spp. dominated fungal profiles but antibiotic therapy did not. Compared to controls, Candida was part of fungal microbiota in LRT of ICU patients without pneumonia with and without antibiotic therapy (63% and 50% of total fungal genera) and of ICU patients with pneumonia with antibiotic therapy (73%) (p<0.05). No case of invasive candidiasis originating from Candida in the LRT was detected. There was no common bacterial microbiota profile associated or dissociated with Candida spp. in LRT. Colonizing and invasive Candida strains (from candidemic patients) did not match to certain clades withdrawing the presence of a particular pathogenic and invasive clade. The presence of Candida spp. in the LRT rather reflected rapidly occurring LRT dysbiosis driven by ICU related factors than was associated with invasive candidiasis.	[Krause, Robert; Hoenigl, Martin; Prattes, Juergen; Valentin, Thomas; Moissl-Eichinger, Christine; Zollner-Schwetz, Ines] Med Univ Graz, Sect Infect Dis & Trop Med, Dept Internal Med, Graz, Austria; [Halwachs, Bettina] Graz Univ Technol, Inst Knowledge Discovery, Bioinformat, A-8010 Graz, Austria; [Halwachs, Bettina] OMICS Ctr Graz, Graz, Austria; [Halwachs, Bettina] BioTechMed Graz, Graz, Austria; [Halwachs, Bettina; Gorkiewicz, Gregor; Kashofer, Karl] Med Univ Graz, Inst Pathol, Graz, Austria; [Thallinger, Gerhard G.] Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria; [Klymiuk, Ingeborg] Med Univ Graz, Med Res Ctr, Graz, Austria; [Heidrich, Katharina; Buzina, Walter] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria; [Heidrich, Katharina] Tech Univ Dresden, Dept Med 1, Univ Hosp Carl Gustav Carus, D-01062 Dresden, Germany; [Salzer, Helmut J. F.] Leibnitz Ctr Med & Biosci, Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Rabensteiner, Jasmin; Prueller, Florian; Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Raggam, Reinhard B.] Med Univ Graz, Div Angiol, Dept Internal Med, Graz, Austria; [Hoegenauer, Christoph] Med Univ Graz, Theodor Escherich Lab Microbiome Res, Div Gastroenterol & Hepatol, Dept Internal Med, Graz, Austria; [Quehenberger, Franz] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Graz University of Technology; Medical University of Graz; Graz University of Technology; Medical University of Graz; Medical University of Graz; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Forschungszentrum Borstel; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Krause, R (corresponding author), Med Univ Graz, Sect Infect Dis & Trop Med, Dept Internal Med, Graz, Austria.	robert.krause@medunigraz.at	Hoenigl, Martin/E-8802-2010; Prüller, Florian J./P-5326-2014; Gorkiewicz, Gregor/ABF-1602-2021; Quehenberger, Franz/N-8825-2019; Halwachs, Bettina/AAD-4347-2019; Quehenberger, Franz/AAV-1446-2020; Moissl-Eichinger, Christine/A-6682-2015; Klymiuk, Ingeborg/ABG-9952-2021; Prattes, Juergen/A-9355-2014	Hoenigl, Martin/0000-0002-1653-2824; Prüller, Florian J./0000-0002-3388-0089; Gorkiewicz, Gregor/0000-0003-1149-4782; Quehenberger, Franz/0000-0003-0764-9497; Moissl-Eichinger, Christine/0000-0001-6755-6263; Hogenauer, Christoph/0000-0003-4566-0806; Klymiuk, Ingeborg/0000-0001-8755-0037; Salzer, Helmut J.F./0000-0003-0146-8310; Prattes, Juergen/0000-0001-5751-9311; Halwachs, Bettina/0000-0002-7082-9346; Thallinger, Gerhard G./0000-0002-2864-5404	Austrian Science Fund [P 23037-B18]; Austrian Science Fund (FWF) [P 23037] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund, grant number P 23037-B18 (www.fwf.at). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arendrup MC, 2013, DRUG RESIST UPDATE, V16, P81, DOI 10.1016/j.drup.2014.01.001; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BAUM GL, 1960, NEW ENGL J MED, V263, P70, DOI 10.1056/NEJM196007142630204; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bittinger K, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0487-y; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; Bousbia S, 2013, FUTURE MICROBIOL, V8, P633, DOI [10.2217/FMB.13.26, 10.2217/fmb.13.26]; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CHAO A, 1984, SCAND J STAT, V11, P265; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Corley DE, 1997, CHEST, V112, P458, DOI 10.1378/chest.112.2.458; De Luca A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003486; Delisle MS, 2011, CAN RESPIR J, V18, P131, DOI 10.1155/2011/827692; Deliste MS, 2008, J CRIT CARE, V23, P11, DOI 10.1016/j.jcrc.2008.01.005; Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471, DOI 10.1128/AAC.41.11.2471; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; ElEbiary M, 1997, AM J RESP CRIT CARE, V156, P583, DOI 10.1164/ajrccm.156.2.9612023; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gorkiewicz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055817; Halwachs B, 2013, BIOMED ENG-BIOMED TE, V58, DOI 10.1515/bmt-2013-4312; HILLMAN JD, 1985, ARCH ORAL BIOL, V30, P791, DOI 10.1016/0003-9969(85)90133-5; Johnson AD, 2010, BIOINFORMATICS, V26, P1386, DOI 10.1093/bioinformatics/btq098; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Krause R, 2015, J INFECT DIS, V211, P445, DOI 10.1093/infdis/jiu468; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; Magurran A. E, 2013, MEASURING BIOLOGICAL; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meersseman W, 2009, INTENS CARE MED, V35, P1526, DOI 10.1007/s00134-009-1482-8; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NEELY AN, 1986, INFECT IMMUN, V52, P200, DOI 10.1128/IAI.52.1.200-204.1986; Nseir S, 2007, INTENS CARE MED, V33, P137, DOI 10.1007/s00134-006-0422-0; Posteraro B, 2011, CRIT CARE, V15, DOI 10.1186/cc10507; Pruller F, 2014, MED MYCOL, V52, P453, DOI 10.1093/mmy/myu023; Rello J, 1998, CHEST, V114, P146, DOI 10.1378/chest.114.1.146; Roux D, 2009, CRIT CARE MED, V37, P1062, DOI 10.1097/CCM.0b013e31819629d2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2	55	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155033	10.1371/journal.pone.0155033	http://dx.doi.org/10.1371/journal.pone.0155033			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27206014	gold, Green Published, Green Submitted			2022-12-26	WOS:000376291500008
J	Mouzaki, M; Wang, AY; Bandsma, R; Comelli, EM; Arendt, BM; Zhang, L; Fung, S; Fischer, SE; McGilvray, IG; Allard, JP				Mouzaki, Marialena; Wang, Alice Y.; Bandsma, Robert; Comelli, Elena M.; Arendt, Bianca M.; Zhang, Ling; Fung, Scott; Fischer, Sandra E.; McGilvray, Ian G.; Allard, Johane P.			Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; GUT MICROBIOME; CHENODEOXYCHOLIC ACID; LIPID-METABOLISM; CHOLIC-ACID; SERUM; STEATOHEPATITIS; OBESITY; 7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE; BACTERIA	Background & Aims Non-alcoholic fatty liver disease (NAFLD) is characterized by dysbiosis. The bidirectional effects between intestinal microbiota (IM) and bile acids (BA) suggest that dysbiosis may be accompanied by an altered bile acid (BA) homeostasis, which in turn can contribute to the metabolic dysregulation seen in NAFLD. This study sought to examine BA homeostasis in patients with NAFLD and to relate that with IM data. Methods This was a prospective, cross-sectional study of adults with biopsy-confirmed NAFLD (nonalcoholic fatty liver: NAFL or non-alcoholic steatohepatitis: NASH) and healthy controls (HC). Clinical and laboratory data, stool samples and 7-day food records were collected. Fecal BA profiles, serum markers of BA synthesis 7-alpha-hydroxy-4-cholesten-3-one (C4) and intestinal BA signalling, as well as IM composition were assessed. Results 53 subjects were included: 25 HC, 12 NAFL and 16 NASH. Levels of total fecal BA, cholic acid (CA), chenodeoxycholic acid (CDCA) and BA synthesis were higher in patients with NASH compared to HC (p<0.05 for all comparisons). The primary to secondary BA ratio was higher in NASH compared to HC (p = 0.004), but ratio of conjugated to unconjugated BAs was not different between the groups. Bacteroidetes and Clostridium leptum counts were decreased in in a subset of 16 patients with NASH compared to 25 HC, after adjusting for body mass index and weight-adjusted calorie intake (p = 0.028 and p = 0.030, respectively). C. leptum was positively correlated with fecal unconjugated lithocholic acid (LCA) (r = 0.526, p = 0.003) and inversely with unconjugated CA (r = -0.669, p<0.0001) and unconjugated CDCA (r = -0.630, p<0.0001). FGF19 levels were not different between the groups (p = 0.114). Conclusions In adults with NAFLD, dysbiosis is associated with altered BA homeostasis, which renders them at increased risk of hepatic injury.	[Mouzaki, Marialena; Bandsma, Robert] Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Wang, Alice Y.; Zhang, Ling] Hosp Sick Children, Res Inst, Physiol & Expt Med Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Comelli, Elena M.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Comelli, Elena M.] Univ Toronto, Ctr Child Nutr Hlth & Dev, Toronto, ON, Canada; [Arendt, Bianca M.; Fung, Scott; Fischer, Sandra E.; McGilvray, Ian G.; Allard, Johane P.] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Fung, Scott; Allard, Johane P.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Fischer, Sandra E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [McGilvray, Ian G.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto	Allard, JP (corresponding author), Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada.; Allard, JP (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	johane.allard@uhn.on.ca		Comelli, Elena/0000-0002-5201-5437; McGilvray, Ian/0000-0003-4649-546X	Canadian Institutes of Health Research (CIHR) [NMD-86922, MOP-89705, MOP-123459]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes of Health Research (CIHR), Grants NMD-86922, MOP-89705, MOP-123459 (http://webapps.cihr-irsc.gc.ca/funding/Search?p_language=E&p_version=CIHR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067160; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Aranha MM, 2008, EUR J GASTROEN HEPAT, V20, P519, DOI 10.1097/MEG.0b013e3282f4710a; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Camilleri M, 2009, NEUROGASTROENT MOTIL, V21, P734, DOI 10.1111/j.1365-2982.2009.01288.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chassaing B, 2014, HEPATOLOGY, V59, P328, DOI 10.1002/hep.26494; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; DELZENNE NM, 1992, TOXICOL LETT, V61, P291, DOI 10.1016/0378-4274(92)90156-E; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eren F, 2012, CLIN BIOCHEM, V45, P655, DOI 10.1016/j.clinbiochem.2012.03.019; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Ferslew BC, 2015, DIGEST DIS SCI, P1; Fuchs C, 2013, SEMINARS LIVER DIS; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Giorgio V, 2014, DIGEST LIVER DIS, V46, P556, DOI 10.1016/j.dld.2014.02.010; HAHN C, 1995, J LIPID RES, V36, P2059; Honda A, 2007, J LIPID RES, V48, P458, DOI 10.1194/jlr.D600032-JLR200; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Jia XF, 2014, DIGEST DIS SCI, V59, P1490, DOI 10.1007/s10620-014-3028-3; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Lake AD, 2013, TOXICOL APPL PHARM, V268, P132, DOI 10.1016/j.taap.2013.01.022; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Michail S, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu002; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Mueller M, 2015, J HEPATOL, V62, P1398, DOI 10.1016/j.jhep.2014.12.034; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raimondi F, 2008, AM J PHYSIOL-GASTR L, V294, pG906, DOI 10.1152/ajpgi.00043.2007; Sattar N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4596; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177; STELLWAG EJ, 1979, J LIPID RES, V20, P325; STELLWAG EJ, 1978, AM J CLIN NUTR, V31, pS243, DOI 10.1093/ajcn/31.10.S243; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Wojcik M, 2012, J PEDIATR ENDOCR MET, V25, P1089, DOI 10.1515/jpem-2012-0253; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	55	207	216	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0151829	10.1371/journal.pone.0151829	http://dx.doi.org/10.1371/journal.pone.0151829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203081	gold, Green Submitted, Green Published			2022-12-26	WOS:000376291500001
J	Santos, RSS; Coelho, FMS; da Silva, BC; Graciolli, FG; Dominguez, WV; Montenegro, FLD; Jorgetti, V; Moyses, RMA; Elias, RM				Silva Santos, Roberto Savio; Santos Coelho, Fernando Morgadinho; da Silva, Bruno Caldin; Graciolli, Fabiana Giorgeti; Dominguez, Wagner Velasquez; de Menezes Montenegro, Fabio Luiz; Jorgetti, Vanda; Affonso Moyses, Rosa Maria; Elias, Rosilene Motta			Parathyroidectomy Improves Restless Leg Syndrome in Patients on Hemodialysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; FETUIN-A LEVELS; DIALYSIS PATIENTS; HYPERPARATHYROIDISM; MORTALITY; SLEEP; SERUM; EVENTS; SCALE	Background Restless leg syndrome (RLS) is a sleep disorder with high prevalence among patients on hemodialysis. It has been postulated that high phosphate and high parathyroid hormone may be implicated in its pathogenesis. Standard international criteria and face-to-face interview are not always applied. Methods this was an interventional prospective study in which 19 patients (6 men, aged 48+/-11 years) with severe hyperparathyroidism were evaluated. RLS diagnosis and rating scale were accessed based on the International RLS Study Group pre- and post-parathyroidectomy. Patients also underwent standard polysomnography. Results At baseline, RLS was present in 10 patients (52.6%), and pain was the most reported symptom associated with the diagnosis. Patients with RLS had higher serum phosphate (p = 0.008) that remained independently associated with RLS in a logistic regression model, adjusted for hemoglobin, age and gender (HR = 7.28; CI = 1.14-46.3, p = 0.035). After parathyroidectomy, there was a reduction of serum parathyroid hormone, phosphate, calcium and alkaline phosphatase, and an increase of 25(OH)-vitamin D, and Fetuin-A. Parathyroidectomy alleviated RLS (from 52% to 21%; p = 0.04), which was accompanied by a decrease in severity scale, in association with relief of pain and pruritus. Polysomnography in these patients showed an improvement of sleep parameters as measured by sleep efficiency, sleep latency and percentage of REM sleep. Conclusion RLS is associated with high levels of phosphate in patients with severe secondary hyperparathyroidism on hemodialysis. Pain is most reported complain in these patients. Parathyroidectomy provided an opportunity to relief RLS. Whether the reduction of serum phosphorus or parathyroid hormone contributed to this improvement merits further investigation.	[Silva Santos, Roberto Savio; da Silva, Bruno Caldin; Graciolli, Fabiana Giorgeti; Dominguez, Wagner Velasquez; Jorgetti, Vanda; Affonso Moyses, Rosa Maria; Elias, Rosilene Motta] Univ Sao Paulo, Div Nephrol, Dept Med, BR-05508 Sao Paulo, Brazil; [Santos Coelho, Fernando Morgadinho] Univ Fed Sao Paulo, Div Neurol, Dept Med, Sao Paulo, Brazil; [Affonso Moyses, Rosa Maria] Univ Nove Julho UNINOVE, Sao Paulo, Brazil; [de Menezes Montenegro, Fabio Luiz] Univ Sao Paulo, Head & Neck Surg Div, Dept Med, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Nove de Julho; Universidade de Sao Paulo	Elias, RM (corresponding author), Univ Sao Paulo, Div Nephrol, Dept Med, BR-05508 Sao Paulo, Brazil.	rosilenemotta@hotmail.com	Aguiar, Ludmilla M S/J-7659-2012; de Menezes Montenegro, Fabio Luiz/AAN-9601-2020; Santos, Sara/AAU-4738-2020; Ascensão, Fernando/G-1513-2014; Santos-Reis, Margarida/H-4064-2011; Dominguez, Wagner/AAR-6693-2020; Elias, Rosilene M/J-1099-2012; Moyses, Rosa M A/F-8268-2012; Aguiar, Ludmilla M S/H-7339-2015; Silva, Bruno C/P-8988-2014; Silva, Bruno C/AAE-6350-2020; Montenegro, Fabio LM/F-9741-2011; JORGETTI, VANDA/C-9470-2012; Bager, Alex/I-4204-2015	de Menezes Montenegro, Fabio Luiz/0000-0002-5749-2363; Ascensão, Fernando/0000-0003-1704-0212; Elias, Rosilene M/0000-0003-2212-041X; Moyses, Rosa M A/0000-0002-7902-2127; Aguiar, Ludmilla M S/0000-0002-9180-5052; Silva, Bruno C/0000-0001-9568-0974; Silva, Bruno C/0000-0001-9568-0974; Montenegro, Fabio LM/0000-0002-5749-2363; JORGETTI, VANDA/0000-0002-4824-8879; Bager, Alex/0000-0002-6143-0413; Santos, Sara/0000-0003-4931-1080; Santos-Reis, Margarida/0000-0002-0337-963X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [12/05236-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil [304249/2013-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Operating grant 12/05236-0 provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, supported this work. R. Moyses and V. Jorgetti were supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil (operating grant 304249/2013-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bhowmik D, 2003, SLEEP MED, V4, P143, DOI 10.1016/S1389-9457(03)00005-4; Burke SK, 2008, J RENAL NUTR, V18, P27, DOI 10.1053/j.jrn.2007.10.007; Chou FF, 2005, SURGERY, V137, P426, DOI 10.1016/j.surg.2004.12.010; Costa-Hong V, 2007, SURGERY, V142, P699, DOI 10.1016/j.surg.2007.06.015; Gade K, 2013, KIDNEY BLOOD PRESS R, V37, P458, DOI 10.1159/000355727; Gigli GL, 2004, SLEEP MED, V5, P309, DOI 10.1016/j.sleep.2004.01.014; Goldenstein PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068870; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; International Restless Legs Syndrome Study Group, 2012, IRLSSG DIAGN CRIT RL; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; La Manna G, 2011, NEPHROL DIAL TRANSPL, V26, P1976, DOI 10.1093/ndt/gfq681; Li YP, 2013, NEUROLOGY, V81, P52, DOI 10.1212/WNL.0b013e318297eee0; Lin CH, 2013, EUR J NEUROL, V20, P1025, DOI 10.1111/ene.12095; Mao S, 2014, SLEEP MED, V15, P1532, DOI 10.1016/j.sleep.2014.07.017; Masuko AH, 2008, ARQ NEURO-PSIQUIAT, V66, P832, DOI 10.1590/S0004-282X2008000600011; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Rijsman RM, 2004, NEPHROLOGY, V9, P353, DOI 10.1111/j.1440-1797.2004.00330.x; Sabbatini M, 2002, NEPHROL DIAL TRANSPL, V17, P852, DOI 10.1093/ndt/17.5.852; Schneider R, 2013, WORLD J SURG, V37, P2866, DOI 10.1007/s00268-013-2185-4; Stefanidis I, 2013, SLEEP MED, V14, P1381, DOI 10.1016/j.sleep.2013.05.022; Suzuki K, 2003, SLEEP, V26, P673, DOI 10.1093/sleep/26.6.673; Takaki J, 2003, AM J KIDNEY DIS, V41, P833, DOI 10.1016/S0272-6386(03)00031-3; Trenkwalder C, 2010, NAT REV NEUROL, V6, P337, DOI 10.1038/nrneurol.2010.55; Wali S, 2015, SLEEP BREATH, V19, P579, DOI 10.1007/s11325-014-1049-y; Wang CC, 2012, CLIN NEPHROL, V77, P89, DOI [10.10.5414/CN106757, 10.5414/CN106757]	27	49	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155835	10.1371/journal.pone.0155835	http://dx.doi.org/10.1371/journal.pone.0155835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196740	Green Submitted, gold, Green Published			2022-12-26	WOS:000376291100110
J	Liu, CJ; Li, YN; Xing, Y; Cao, BJ; Yang, F; Yang, TX; Ai, ZL; Wei, YY; Jiang, JH				Liu, Chanjuan; Li, Yinan; Xing, Yang; Cao, Benjin; Yang, Fan; Yang, Tianxiao; Ai, Zhilong; Wei, Yuanyan; Jiang, Jianhai			The Interaction between Cancer Stem Cell Marker CD133 and Src Protein Promotes Focal Adhesion Kinase (FAK) Phosphorylation and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE; HEMATOPOIETIC STEM; FAMILY KINASES; ACTIVATION; EXPRESSION; IDENTIFICATION; METASTASIS; CONTRIBUTES; INHIBITION	CD133, a widely known cancer stem cell marker, has been proved to promote tumor metastasis. However, the mechanism by which CD133 regulates metastasis remains largely unknown. Here, we report that CD133 knockdown inhibits cancer cell migration, and CD133 overexpression promotes cell migration. CD133 expression is beneficial to activate the Src-focal adhesion kinase (FAK) signaling pathway. Further studies show that CD133 could interact with Src, and the region between amino acids 845 and 857 in the CD133 C-terminal domain is indispensable for its interaction with Src. The interaction activates Src to phosphorylate its substrate FAK and to promote cell migration. Likewise, a Src binding-deficient CD133 mutant loses the abilities to increase Src and FAK phosphorylation and to promote cell migration. Inhibition of Src activity by PP2, a known Src activity inhibitor, could block the activation of FAK phosphorylation and cell migration induced by CD133. In summary, our data suggest that activation of FAK by the interaction between CD133 and Src promotes cell migration, providing clues to understand the migratory mechanism of CD133(+) tumor cells.	[Liu, Chanjuan; Li, Yinan; Xing, Yang; Cao, Benjin; Yang, Fan; Yang, Tianxiao; Wei, Yuanyan; Jiang, Jianhai] Fudan Univ, Dept Biochem & Mol Biol, Key Lab Glycoconjugates Res, Shanghai Med Coll,Minist Publ Hlth, Shanghai 200032, Peoples R China; [Ai, Zhilong] Fudan Univ, Zhongshan Hosp, Div Gen Surg, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Wei, YY; Jiang, JH (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Key Lab Glycoconjugates Res, Shanghai Med Coll,Minist Publ Hlth, Shanghai 200032, Peoples R China.; Ai, ZL (corresponding author), Fudan Univ, Zhongshan Hosp, Div Gen Surg, Shanghai 200032, Peoples R China.	ai.zhilong@zs-hospital.sh.cn; yywei@fudan.edu.cn; jianhaijiang@fudan.edu.cn	Ai, Zhi-Long/AAB-1758-2021		Program for National Natural Scientific Foundation of China [81272435, 81472724, 31370807]; National Basic Research Program of China [2013CB910503]	Program for National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Program for National Natural Scientific Foundation of China Grants 81272435, 81472724, and 31370807 and National Basic Research Program of China Grant 2013CB910503. The authors declare that they have no financial and personal relationships with other people or organizations that could inappropriately influence (bias) the work in this study.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Adini A, 2013, ANGIOGENESIS, V16, P405, DOI 10.1007/s10456-012-9323-8; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Canis M, 2013, TUMOR BIOL, V34, P437, DOI 10.1007/s13277-012-0568-z; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Chen KL, 2011, CLIN EXP METASTAS, V28, P751, DOI 10.1007/s10585-011-9407-7; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Choi CW, 2015, EXP DERMATOL, V24, P361, DOI 10.1111/exd.12676; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Futschik M, 2002, GENOME LETT, V1, P26; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Han XS, 2014, INT J ONCOL, V45, P302, DOI 10.3892/ijo.2014.2432; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hou Y, 2012, CELL RES, V22, P259, DOI 10.1038/cr.2011.139; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kim HI, 2015, ONCOTARGET, V6, P42905, DOI 10.18632/oncotarget.5466; Kohga K, 2010, J HEPATOL, V52, P872, DOI 10.1016/j.jhep.2009.12.030; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Maeda S, 2008, BRIT J CANCER, V98, P1389, DOI 10.1038/sj.bjc.6604307; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Shang N, 2015, HEPATOLOGY, V61, P214, DOI 10.1002/hep.27402; Singh SK, 2003, CANCER RES, V63, P5821; Song YJ, 2013, CANCER LETT, V339, P70, DOI 10.1016/j.canlet.2013.07.021; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tai YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16408; Thiyagarajan V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141285; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Yan MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061056; Ye Q, 2013, J MOL BIOL, V425, P755, DOI 10.1016/j.jmb.2012.11.035; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85	60	42	44	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15540	15550		10.1074/jbc.M115.712976	http://dx.doi.org/10.1074/jbc.M115.712976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226554	Green Published, hybrid			2022-12-26	WOS:000380584200011
J	Smith, N; Adle, DJ; Zhao, MY; Qin, XJ; Kim, H; Lee, J				Smith, Nathan; Adle, David J.; Zhao, Miaoyun; Qin, Xiaojuan; Kim, Heejeong; Lee, Jaekwon			Endoplasmic Reticulum-associated Degradation of Pcal p, a Polytopic Protein, via Interaction with the Proteasome at the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE HUL5; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; LUMINAL PROTEIN; WASTE-DISPOSAL; AAA-ATPASE; RAT-LIVER	Endoplasmic reticulum-associated degradation (ERAD) plays a critical role in the destruction of terminally misfolded proteins at the secretory pathway. The system also regulates expression levels of several proteins such as Pcalp, a cadmium exporter in yeast. To gain better insight into the mechanisms underlying ERAD of Pcalp and other polytopic proteins by the proteasome in the cytosol, our study determined the roles for the molecular factors of ERAD in dislodging Pcalp from the endoplasmic reticulum (ER). Inactivation of the 20S proteasome leads to accumulation of ubiquitinated Pcalp in the ER membrane, suggesting a role for the proteasome in extraction of Pcalp from the ER. Pcalp formed a complex with the proteasome at the membrane in a Doal0p E3 ligase-dependent manner. Cdc48p is required for recruiting the proteasome to Pcalp. Although the Ufd2p E4 ubiquitin chain extension enzyme is involved in efficient degradation of Pcalp, Ufd2p-deficient cells did not affect the formation of a complex between Pcalp and the proteasome. Two other polytopic membrane proteins undergoing ERAD, Steh*p and Hmg2p, also displayed the same outcomes observed for Pcalp. However, poly-ubiquitinated Cpyl*p, a luminal ERAD substrate, was detected in the cytosol independent of proteolytic activities of the proteasome. These results indicate that extraction and degradation of polytopic membrane proteins at the ER is a coupled event. This mechanism would relieve the cost of exposed hydrophobic domains in the cytosol during ERAD.	[Smith, Nathan; Adle, David J.; Zhao, Miaoyun; Qin, Xiaojuan; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Smith, Nathan; Adle, David J.; Zhao, Miaoyun; Qin, Xiaojuan; Kim, Heejeong; Lee, Jaekwon] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Qin, Xiaojuan] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Shanghai Normal University	Lee, J (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.; Lee, J (corresponding author), Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA.	jlee7@unl.edu			National Institutes of Health [ES016337, P30GM103335]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES016337 (to J. L.) and P30GM103335 (to the Nebraska Redox Biology Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; Ausubel FM, 1987, CURR PROTOC MOL BIOL; Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Chen L, 2011, J BIOL CHEM, V286, P3104, DOI 10.1074/jbc.M110.135863; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Fang NN, 2012, PRION, V6, P240, DOI 10.4161/pri.19929; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; Ikeda Y, 2009, J BIOL CHEM, V284, P34889, DOI 10.1074/jbc.M109.044875; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kohlmann S, 2008, J BIOL CHEM, V283, P16374, DOI 10.1074/jbc.M801702200; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Liu C, 2010, J BIOL CHEM, V285, P10265, DOI 10.1074/jbc.M110.110551; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Oberdorf J, 2006, J CELL SCI, V119, P303, DOI 10.1242/jcs.02732; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wolf DH, 2005, CURR TOP MICROBIOL, V300, P41; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	73	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15082	15092		10.1074/jbc.M116.726265	http://dx.doi.org/10.1074/jbc.M116.726265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226596	Green Published, hybrid			2022-12-26	WOS:000380583200019
J	Elimam, H; Papillon, J; Kaufman, DR; Guillemette, J; Aoudjit, L; Gross, RW; Takano, T; Cybulsky, AV				Elimam, Hanan; Papillon, Joan; Kaufman, Daniel R.; Guillemette, Julie; Aoudjit, Lamine; Gross, Richard W.; Takano, Tomoko; Cybulsky, Andrey V.			Genetic Ablation of Calcium-independent Phospholipase A(2) Induces Glomerular Injury in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; mitochondria; Phospholipase A; podocyte; proteinuria; cell injury; glomerulonephritis	ENDOPLASMIC-RETICULUM STRESS; PROTEINURIC KIDNEY-DISEASE; MITOCHONDRIAL DYSFUNCTION; MEMBRANOUS NEPHROPATHY; PODOCYTE INJURY; CELL BIOLOGY; COMPLEMENT; AUTOPHAGY; GLOMERULOSCLEROSIS; PATHOPHYSIOLOGY	Glomerular visceral epithelial cells (podocytes) play a critical role in the maintenance of glomerular permselectivity. Podocyte injury, manifesting as proteinuria, is the cause of many glomerular diseases. We reported previously that calcium-independent phospholipase A(2) (iPLA(2)) is cytoprotective against complement-mediated glomerular epithelial cell injury. Studies in iPLA(2) KO mice have demonstrated an important role for iPLA(2) in mitochondrial lipid turnover, membrane structure, and metabolism. The aim of the present study was to employ iPLA(2) KO mice to better understand the role of iPLA(2) in normal glomerular and podocyte function as well as in glomerular injury. We show that deletion of iPLA(2) did not cause detectable albuminuria; however, it resulted in mitochondrial structural abnormalities and enhanced autophagy in podocytes as well as loss of podocytes in aging KO mice. Moreover, after induction of anti-glomerular basement membrane nephritis in young mice, iPLA(2) KO mice exhibited significantly increased levels of albuminuria, podocyte injury, and loss of podocytes compared with wild type. Thus, iPLA(2) has a protective functional role in the normal glomerulus and in glomerulonephritis. Understanding the role of iPLA(2) in glomerular pathophysiology provides opportunities for the development of novel therapeutic approaches to glomerular injury and proteinuria.	[Elimam, Hanan; Papillon, Joan; Kaufman, Daniel R.; Guillemette, Julie; Aoudjit, Lamine; Takano, Tomoko; Cybulsky, Andrey V.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H4A 3J1, Canada; [Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Elimam, Hanan] Misr Int Univ, Dept Biochem, Km 28,Cairo Ismailia Rd, Cairo, Egypt	McGill University; Washington University (WUSTL); Egyptian Knowledge Bank (EKB); Misr International University; Misr University for Science & Technology	Takano, T; Cybulsky, AV (corresponding author), Res Inst EM13244, Div Nephrol, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	tomoko.takano@mcgill.ca; andrey.cybulsky@mcgill.ca	Cybulsky, Andrey V./AAG-8238-2020; Elimam, Hanan/H-5858-2017	Cybulsky, Andrey V./0000-0003-4348-2348; Elimam, Hanan/0000-0003-2585-9957	Canadian Institutes of Health Research [MOP-53264, MOP-133492, MOP-125988, MOP-53335]; National Institutes of Health [RO1 HL118639]; Catherine McLaughlin Hakim Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catherine McLaughlin Hakim Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research Grants MOP-53264, MOP-133492, MOP-125988, and MOP-53335; National Institutes of Health Grant RO1 HL118639; and the Catherine McLaughlin Hakim Chair (to A. V. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bechtel W, 2013, J AM SOC NEPHROL, V24, P727, DOI 10.1681/ASN.2012070700; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Casalena G, 2014, AM J PHYSIOL-RENAL, V306, pF1372, DOI 10.1152/ajprenal.00608.2013; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; Cohen D, 2008, AM J PHYSIOL-RENAL, V294, pF469, DOI 10.1152/ajprenal.00372.2007; COUSER WG, 1985, KIDNEY INT, V28, P879, DOI 10.1038/ki.1985.214; Cybulsky AV, 2013, KIDNEY INT, V84, P25, DOI 10.1038/ki.2012.390; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; D'Agati VD, 2008, KIDNEY INT, V73, P399, DOI 10.1038/sj.ki.5002655; Drozdova T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.86; Elimam H, 2015, J BIOL CHEM, V290, P3009, DOI 10.1074/jbc.M114.592261; Elimam H, 2013, J BIOL CHEM, V288, P3871, DOI 10.1074/jbc.M112.396614; Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kreidberg JA, 2003, J AM SOC NEPHROL, V14, P806, DOI 10.1097/01.ASN.0000054887.42550.14; Lin F, 2002, LAB INVEST, V82, P563, DOI 10.1038/labinvest.3780451; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Muller-Deile J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00209; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Nezvitsky L, 2014, AM J PHYSIOL-RENAL, V307, pF634, DOI 10.1152/ajprenal.00191.2014; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Petermann AT, 2004, NEPHRON EXP NEPHROL, V98, pE114, DOI 10.1159/000081555; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Ramanadham S, 2015, J LIPID RES, V56, P1643, DOI 10.1194/jlr.R058701; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Takano T, 2013, SEMIN NEPHROL, V33, P586, DOI 10.1016/j.semnephrol.2013.08.009; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yoda E, 2010, J LIPID RES, V51, P3003, DOI 10.1194/jlr.M008060	47	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14468	14482		10.1074/jbc.M115.696781	http://dx.doi.org/10.1074/jbc.M115.696781			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226532	hybrid, Green Published			2022-12-26	WOS:000380366700006
J	Bai, ZG; Mao, SC; Han, YC; Feng, L; Wang, GP; Yang, BF; Zhi, XY; Fan, ZY; Lei, YP; Du, WL; Li, YB				Bai, Zhigang; Mao, Shuchun; Han, Yingchun; Feng, Lu; Wang, Guoping; Yang, Beifang; Zhi, Xiaoyu; Fan, Zhengyi; Lei, Yaping; Du, Wenli; Li, Yabing			Study on Light Interception and Biomass Production of Different Cotton Cultivars	PLOS ONE			English	Article							RADIATION USE EFFICIENCY; DRY-MATTER PRODUCTION; LEAF-AREA INDEX; CANOPY STRUCTURE; PLANT ARCHITECTURE; SPATIAL-DISTRIBUTION; SIMULATION-MODEL; SOLAR-RADIATION; PHOTOSYNTHESIS; RECONSTRUCTION	Identifying the characteristics of light interception and utilization is of great significance for improving the potential photosynthetic activity of plants. The present research investigates the differences in absorbing and converting photosynthetically active radiation (PAR) among various cotton cultivars. Field experiments were conducted in 2012, 2013 and 2014 in Anyang, Henan, China. Ten cultivars with different maturity and plant architectures were planted at a density of 60,000 plants ha(-1) in randomized blocks, with three replicates. The spatial distribution of light in canopy was measured and quantified with a geo-statistical method, according to which the cumulative amount of intercepted radiation was calculated by Simpson 3/8 rules. Finally, light interception was analyzed in association with the biomass accumulation of different cultivars. The key results were: (1) late-maturing varieties with an incompact plant architecture captured more solar radiation throughout the whole growth period than middle varieties with columnar architecture and even more than early varieties with compact architecture, and they produced more biomass; (2) the highest PAR interception ratio and the maximum biomass accumulation rate occurred during the blossoming and boll-forming stage, when leaf area index (LAI) reached its peak; (3) the distribution within the canopy presented a significant spatial heterogeneity, and at late growing stage, the PAR was mainly intercepted by upper canopies in incompact-type plant communities, but was more homogeneous in columnar-type plants; however, the majority of radiation was transmitted through the canopy in compact-type colonies; (4) there was not a consistent variation relationship between the cumulative intercepted PAR (iPAR) and biomass among these cultivars over the three years of the study. Based on these results, we attempted to clarify the distinction in light spatial distribution within different canopies and the patterns of PAR interception in diverse cotton cultivars with different hereditary characters, thereby providing a significant basis for researchers to select cultivars with appropriate growth period and optimal plant architecture for improvement of light interception and utilization.	[Bai, Zhigang; Mao, Shuchun; Han, Yingchun; Feng, Lu; Wang, Guoping; Yang, Beifang; Zhi, Xiaoyu; Fan, Zhengyi; Lei, Yaping; Du, Wenli; Li, Yabing] Chinese Acad Agr Sci, State Key Lab Cotton Biol, Inst Cotton Res, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, YB (corresponding author), Chinese Acad Agr Sci, State Key Lab Cotton Biol, Inst Cotton Res, Anyang 455000, Henan, Peoples R China.	criliyabing1@163.com	Yabing, Li/GLU-9964-2022		National Natural Science Foundation [31371561]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation (31371561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKMAN DP, 1989, J EXP BOT, V40, P855, DOI 10.1093/jxb/40.8.855; ANDRIEU B, 1995, AGR FOREST METEOROL, V75, P103, DOI 10.1016/0168-1923(94)02205-X; Bange MP, 2000, FIELD CROP RES, V68, P143, DOI 10.1016/S0378-4290(00)00116-7; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Escobar-Gutierrez AJ, 2009, AGR FOREST METEOROL, V149, P1244, DOI 10.1016/j.agrformet.2009.02.011; Fila G, 2011, AGR FOREST METEOROL, V151, P575, DOI 10.1016/j.agrformet.2011.01.004; Friday JB, 2001, AGR FOREST METEOROL, V108, P29, DOI 10.1016/S0168-1923(01)00220-9; Gonias ED, 2011, ENVIRON EXP BOT, V72, P217, DOI 10.1016/j.envexpbot.2011.03.008; GOSSE G, 1986, AGRONOMIE, V6, P47, DOI 10.1051/agro:19860103; Hall AE, 2001, CROP RESPONSE ENV, P40; HERBERT TJ, 1991, ECOLOGY, V72, P17, DOI 10.2307/1938897; Institute of Cotton Research of CAAS, 2013, COTT CULT CHIN, P123; Jost P, 2006, U GEORGIA B, P1305; Kaggwa-Asiimwe R, 2013, FIELD CROP RES, V145, P52, DOI 10.1016/j.fcr.2013.02.005; Kiniry J, 2011, AGRON J, V103, P119, DOI 10.2134/agronj2010.0280; KUROIWA S., 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Tfebon, [Czechoslovakia], 14-21 September, 1969., P79; Lambers H, 2008, PLANT PHYSL ECOLOGY, P26; Larsen DR, 1996, AGR FOREST METEOROL, V81, P61, DOI 10.1016/0168-1923(95)02307-0; Leuchner M, 2011, AGR FOREST METEOROL, V151, P1226, DOI 10.1016/j.agrformet.2011.04.014; Li YaBing, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P200; [李振华 Li Zhenhua], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P67; Louarn G, 2008, ANN BOT-LONDON, V101, P1167, DOI 10.1093/aob/mcm170; Ma YunTao, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P151; Maddonni GA, 1996, FIELD CROP RES, V48, P81, DOI 10.1016/0378-4290(96)00035-4; Melo JD, 2014, ELECTR POW SYST RES, V111, P177, DOI 10.1016/j.epsr.2014.02.019; O'Neal ME, 2002, J ECON ENTOMOL, V95, P1190, DOI 10.1603/0022-0493-95.6.1190; QUISENBERRY JE, 1976, CROP SCI, V16, P762, DOI 10.2135/cropsci1976.0011183X001600060005x; Reinhardt D, 2002, EMBO REP, V3, P846, DOI 10.1093/embo-reports/kvf177; Rey H, 2008, ANN BOT-LONDON, V101, P1139, DOI 10.1093/aob/mcm300; Ruiz RA, 2008, EUR J AGRON, V29, P144, DOI 10.1016/j.eja.2008.05.003; Russell G., 1989, Plant canopies: their growth, form and function., P21, DOI 10.1017/CBO9780511752308.003; Sarlikioti V, 2011, ANN BOT-LONDON, V107, P875, DOI 10.1093/aob/mcr006; SASSENRATHCOLE GF, 1995, AGR FOREST METEOROL, V77, P55, DOI 10.1016/0168-1923(95)02238-S; Sinclair TR, 1999, ADV AGRON, V65, P215, DOI 10.1016/S0065-2113(08)60914-1; Singer JW, 2011, FIELD CROP RES, V121, P147, DOI 10.1016/j.fcr.2010.12.007; Sinoquet H, 1998, ANN BOT-LONDON, V82, P203, DOI 10.1006/anbo.1998.0665; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; Stockle CO, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P145, DOI 10.1016/B978-0-12-374431-9.00007-4; Tang Liang, 2012, Yingyong Shengtai Xuebao, V23, P1269; Tesfaye K, 2006, EUR J AGRON, V25, P60, DOI 10.1016/j.eja.2006.04.014; Tharakan PJ, 2008, BIOENERG RES, V1, P229, DOI 10.1007/s12155-008-9023-9; TOURNEBIZE R, 1995, AGR FOREST METEOROL, V72, P277, DOI 10.1016/0168-1923(94)02162-D; Vargas LA, 2002, BIOMASS BIOENERG, V22, P1, DOI 10.1016/S0961-9534(01)00058-7; Vos J, 2010, J EXP BOT, V61, P2101, DOI 10.1093/jxb/erp345; Watanabe T, 2005, ANN BOT-LONDON, V95, P1131, DOI 10.1093/aob/mci136; Wiechers D, 2011, AGR FOREST METEOROL, V151, P906, DOI 10.1016/j.agrformet.2011.02.016; Xue HY, 2015, FIELD CROP RES, V184, P17, DOI 10.1016/j.fcr.2015.09.004; Xue XiaoPing, 2006, Cotton Science, V18, P323; Zhang WY, 2015, EUR J AGRON, V67, P1, DOI 10.1016/j.eja.2015.02.010; Zhi X., 2014, PLOS ONE, V9, DOI [DOI 10.1371/JOURNAL.PONE.0113409, 10.1371/journal.pone.0113409]	50	14	15	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156335	10.1371/journal.pone.0156335	http://dx.doi.org/10.1371/journal.pone.0156335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227675	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500116
J	Cordeiro, NM; Freitas, RHCN; Fraga, CAM; Fernandes, PD				Cordeiro, Natalia M.; Freitas, Rosana H. C. N.; Fraga, Carlos A. M.; Fernandes, Patricia D.			Discovery of Novel Orally Active Tetrahydro-Naphthyl-N-Acylhydrazones with In Vivo Anti-TNF-alpha Effect and Remarkable Anti-Inflammatory Properties	PLOS ONE			English	Article							KAPPA-B; INFLAMMATORY RESPONSES; NITRIC-OXIDE; ACTIVATION; MODEL; INHIBITION; MODULATION; EXPRESSION; CROSSTALK; PATHWAYS	LASSBio-1524 was designed as inhibitor of the IKK-beta (kappa beta kinase inhibitor) enzyme, which participates in the activation of the nuclear factor.B (NF-kappa B) canonical pathway, and its three N-acylhydrazone new analogues, LASSBio-1760, LASSBio-1763 and LASSBio-1764 are now being tested on their anti-inflammatory potential. The activity of these compounds was evaluated with the subcutaneous air pouch induced by carrageenan and by subsequent measurement of tumor necrosis factor-alpha (TNF-alpha), nitric oxide (NO) and reactive oxygen species (ROS). In the acute inflammation model, the oral pretreatment with doses from 0.3 to 30 mg/kg of N-acylhydrazone derivatives was able to significantly reduce leukocyte migration to the cavity. Pretreatment with LASSBio-1524 and its analogues also decreased NO, TNF-alpha and ROS biosynthesis an events closely involved with NF-kB pathway. The tetrahydronaphthyl-N-acylhydrazone derivative LASSBio-1764 was the most promising compound from this series, surpassing even LASSBio-1524. Additionally, none of the compounds demonstrated myelotoxicity or cytotoxicity. Cell viability was assayed and these compounds demonstrated to be safe at different concentrations. Western blot analysis demonstrated that LASSBio-1524 and LASSBio-1760 inhibited NF-kappa B expression in RAW 264.7 cell lineage. Our data indicate that the tested compounds have anti-inflammatory activity, which may be related to inhibition of leukocyte migration, reducing the production of NO, TNF-alpha and ROS. LASSBio-1524 and LASSBio-1760, in addition to these features, also reduced p65 nuclear expression assessed by western blot in RAW 264.7 murine cells.	[Cordeiro, Natalia M.; Fernandes, Patricia D.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Pharmacol Pain & Inflammat, Rio De Janeiro, Brazil; [Cordeiro, Natalia M.; Fraga, Carlos A. M.; Fernandes, Patricia D.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Grad Programm Pharmacol & Med Chem, Rio De Janeiro, Brazil; [Freitas, Rosana H. C. N.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Evaluat & Synth Bioact Subst LASSBio, Rio De Janeiro, Brazil; [Freitas, Rosana H. C. N.; Fraga, Carlos A. M.] Univ Fed Rio de Janeiro, Inst Chem, Grad Programm Chem, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Pharmacol Pain & Inflammat, Rio De Janeiro, Brazil.; Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Grad Programm Pharmacol & Med Chem, Rio De Janeiro, Brazil.	patricia.dias@icb.ufrj.br	Fraga, Carlos/G-3495-2012; Fernandes, Patricia Dias/W-1565-2019	Fraga, Carlos/0000-0001-6733-7079; Fernandes, Patricia Dias/0000-0001-6870-6745	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/210.141/2014, E-26/010.002566/2014, E-26/010.000908/2015]; Conselho Nacional de Pesquisa (CNPq) [473106/2012-4, 401683/2013-3]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ): E-26/210.141/2014 (PDF); E-26/010.002566/2014 (PDF); E-26/010.000908/2015 (PDF) Conselho Nacional de Pesquisa (CNPq): 473106/2012-4 (PDF); 401683/2013-3 (PDF).	Andina N, 2009, CELL DEATH DIFFER, V16, P1248, DOI 10.1038/cdd.2009.50; Avila CM, 2011, EUR J MED CHEM, V46, P1245, DOI 10.1016/j.ejmech.2011.01.045; Cao Q, 2015, J SURG RES, V194, P667, DOI 10.1016/j.jss.2014.12.013; de Oliveira SI, 2006, PROSTAG OTH LIPID M, V80, P62, DOI 10.1016/j.prostaglandins.2006.04.002; do Amaral DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085380; Duarte CD, 2007, MINI-REV MED CHEM, V7, P1108, DOI 10.2174/138955707782331722; Ellis L, 2000, ANN RHEUM DIS, V59, P303, DOI 10.1136/ard.59.4.303; Vigil SV, 2008, TRANSPL IMMUNOL, V19, P25, DOI 10.1016/j.trim.2008.01.003; Pinheiro MMG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121063; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guedes IA, 2016, CHEMMEDCHEM, V11, P234, DOI 10.1002/cmdc.201500266; Huynh QK, 2000, J BIOL CHEM, V275, P25883, DOI 10.1074/jbc.M000296200; Ishikawa M, 2011, J MED CHEM, V54, P1539, DOI 10.1021/jm101356p; Ji GQ, 2014, IMMUNOPHARM IMMUNOT, V36, P420, DOI 10.3109/08923973.2014.968256; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Lacerda RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091660; Laveti Durgaprasad, 2013, Inflammation & Allergy Drug Targets, V12, P349; Lelekov-Boissard T, 2009, PHILOS T R SOC A, V367, P4699, DOI 10.1098/rsta.2009.0184; Lima PC, 2000, EUR J MED CHEM, V35, P187, DOI 10.1016/S0223-5234(00)00120-3; Liu J, 2014, J TRADIT CHIN MED, V34, P657, DOI 10.1016/S0254-6272(15)30079-0; Mahat MYA, 2010, EUR J PHARMACOL, V642, P169, DOI 10.1016/j.ejphar.2010.05.062; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Nguyen DP, 2014, BJU INT, V114, P168, DOI [10.1111/bju.12488, 10.1111/j.1464-410X.2013.11397_10.x]; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Raymundo LJRP, 2011, J ETHNOPHARMACOL, V134, P725, DOI 10.1016/j.jep.2011.01.027; Reilly CM, 2000, J IMMUNOL, V164, P1498, DOI 10.4049/jimmunol.164.3.1498; Samaka RM, 2014, ANAL QUANT CYTOPATHO, V36, P245; Sampaio ALF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/741804; Schneider P, 2009, PHYTOCHEM LETT, V2, P85, DOI 10.1016/j.phytol.2008.12.004; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; SEDGWICK AD, 1984, J PHARM PHARMACOL, V36, P171, DOI 10.1111/j.2042-7158.1984.tb06933.x; Shi QH, 2014, INT IMMUNOPHARMACOL, V20, P298, DOI 10.1016/j.intimp.2014.04.004; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Wei GQ, 2015, BIOCHEM BIOPH RES CO, V457, P101, DOI 10.1016/j.bbrc.2014.12.070; Wu WY, 2015, INT J MOL MED, V35, P391, DOI 10.3892/ijmm.2014.2020; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175	39	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156271	10.1371/journal.pone.0156271	http://dx.doi.org/10.1371/journal.pone.0156271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227468	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500099
J	Hegyi, Z; Homolya, L				Hegyi, Zoltan; Homolya, Laszlo			Functional Cooperativity between ABCG4 and ABCG1 Isoforms	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE PROTEINS; CELLULAR CHOLESTEROL EFFLUX; HIGH-DENSITY-LIPOPROTEIN; SUBCELLULAR-LOCALIZATION; PLASMA-MEMBRANE; MEDIATE CHOLESTEROL; APOPTOSIS; EXPRESSION; CELLS	ABCG4 belongs to the ABCG subfamily, the members of which are half transporters composed of a single transmembrane and a single nucleotide-binding domain. ABCG proteins have a reverse domain topology as compared to other mammalian ABC transporters, and have to form functional dimers, since the catalytic sites for ATP binding and hydrolysis, as well as the transmembrane domains are composed of distinct parts of the monomers. Here we demonstrate that ABCG4 can form homodimers, but also heterodimers with its closest relative, ABCG1. Both the full-length and the short isoforms of ABCG1 can dimerize with ABCG4, whereas the ABCG2 multidrug transporter is unable to form a heterodimer with ABCG4. We also show that contrary to that reported in some previous studies, ABCG4 is predominantly localized to the plasma membrane. While both ABCG1 and ABCG4 have been suggested to be involved in lipid transport or regulation, in accordance with our previous results regarding the long version of ABCG1, here we document that the expression of both the short isoform of ABCG1 as well as ABCG4 induce apoptosis in various cell types. This apoptotic effect, as a functional read-out, allowed us to demonstrate that the dimerization between these half transporters is not only a physical interaction but functional cooperativity. Given that ABCG4 is predominantly expressed in microglial-like cells and endothelial cells in the brain, our finding of ABCG4-induced apoptosis may implicate a new role for this protein in the clearance mechanisms within the central nervous system.	[Hegyi, Zoltan; Homolya, Laszlo] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Homolya, L (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	homolya.laszlo@ttk.mta.hu	Homolya, Laszlo/N-1154-2016	Homolya, Laszlo/0000-0003-1639-8140	Momentum Program of the Hungarian Academy of Sciences [LP 2012-025]	Momentum Program of the Hungarian Academy of Sciences	This work was supported by the Momentum Program of the Hungarian Academy of Sciences (LP 2012-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Annilo T, 2001, CYTOGENET CELL GENET, V94, P196, DOI 10.1159/000048816; Ayaori M, 2006, ARTERIOSCL THROM VAS, V26, P163, DOI 10.1161/01.ATV.0000193513.29074.52; Baldan A, 2006, CURR OPIN LIPIDOL, V17, P227, DOI 10.1097/01.mol.0000226113.89812.bb; Bojanic DD, 2010, J LIPID RES, V51, P169, DOI [10.1194/jlr.M900250-JLR200, 10.1194/M900250-JLR200]; Borge OJ, 1996, BLOOD, V88, P2859, DOI 10.1182/blood.V88.8.2859.bloodjournal8882859; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; Do TM, 2012, J ALZHEIMERS DIS, V30, P155, DOI 10.3233/JAD-2012-112189; El Roz A, 2012, ANTICANCER RES, V32, P3007; Engel T, 2001, BIOCHEM BIOPH RES CO, V288, P483, DOI 10.1006/bbrc.2001.5756; Engel T, 2006, FEBS LETT, V580, P4551, DOI 10.1016/j.febslet.2006.07.006; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gelissen IC, 2010, ATHEROSCLEROSIS, V208, P75, DOI 10.1016/j.atherosclerosis.2009.06.028; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Gu HM, 2016, ARTERIOSCL THROM VAS, V36, P253, DOI 10.1161/ATVBAHA.115.306592; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Henriksen U, 2005, J CELL SCI, V118, P1417, DOI 10.1242/jcs.01729; Hirata T, 2009, BIOSCI BIOTECH BIOCH, V73, P619, DOI 10.1271/bbb.80694; Hori N, 2011, ATHEROSCLEROSIS, V215, P383, DOI 10.1016/j.atherosclerosis.2010.12.033; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Mackenzie SM, 2000, GENETICA, V108, P239, DOI 10.1023/A:1004115718597; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Nakamura K, 2004, J BIOL CHEM, V279, P45980, DOI 10.1074/jbc.M408652200; Nelissen K, 2012, J NEUROSCI RES, V90, P60, DOI 10.1002/jnr.22743; Neufeld Edward B, 2014, Biology (Basel), V3, P866, DOI 10.3390/biology3040866; Orban TI, 2008, BIOCHEM BIOPH RES CO, V367, P667, DOI 10.1016/j.bbrc.2007.12.172; Osada M, 1999, EXP HEMATOL, V27, P131, DOI 10.1016/S0301-472X(98)00007-1; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Park SW, 2014, AM J PHYSIOL-GASTR L, V307, pG863, DOI 10.1152/ajpgi.00457.2013; Raina A, 2010, APOPTOSIS, V15, P1461, DOI 10.1007/s10495-010-0541-5; Remaley AT, 2002, BIOCHEM BIOPH RES CO, V295, P276, DOI 10.1016/S0006-291X(02)00652-6; Sano O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109886; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sarvothaman S, 2015, BLOOD RES, V50, P73, DOI 10.5045/br.2015.50.2.73; Seres L, 2008, BBA-BIOMEMBRANES, V1778, P2378, DOI 10.1016/j.bbamem.2008.06.010; Sigurjonsson OE, 2004, STEM CELLS DEV, V13, P183; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; Studzian M, 2015, BBA-MOL CELL RES, V1853, P1759, DOI 10.1016/j.bbamcr.2015.04.011; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Uehara Y, 2008, BRAIN RES, V1217, P239, DOI 10.1016/j.brainres.2008.04.048; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xie Q, 2006, ARTERIOSCL THROM VAS, V26, pE143, DOI 10.1161/01.ATV.0000245790.47112.b2; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200	60	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156516	10.1371/journal.pone.0156516	http://dx.doi.org/10.1371/journal.pone.0156516			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228027	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000376882500152
J	Kanda, M; Nagai, T; Takahashi, T; Liu, ML; Kondou, N; Naito, AT; Akazawa, H; Sashida, G; Iwama, A; Komuro, I; Kobayashi, Y				Kanda, Masato; Nagai, Toshio; Takahashi, Toshinao; Liu, Mei Lan; Kondou, Naomichi; Naito, Atsuhiko T.; Akazawa, Hiroshi; Sashida, Goro; Iwama, Atsushi; Komuro, Issei; Kobayashi, Yoshio			Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; CARDIAC MYOCYTES; HEART-FAILURE; ADULT; THERAPY; RENEWAL; MECHANISMS; LIF; HYPERTROPHY; RECEPTOR	Cardiac stem cells or precursor cells regenerate cardiomyocytes; however, the mechanism underlying this effect remains unclear. We generated CreLacZ mice in which more than 99.9% of the cardiomyocytes in the left ventricular field were positive for 5-bromo-4-chloro-3-indolyl-beta-D-galactoside (X-gal) staining immediately after tamoxifen injection. Three months after myocardial infarction (MI), the MI mice had more X-gal-negative (newly generated) cells than the control mice (3.04 +/- 0.38/mm(2), MI; 0.47 +/- 0.16/mm(2), sham; p < 0.05). The cardiac side population (CSP) cell fraction contained label-retaining cells, which differentiated into X-gal-negative cardiomyocytes after MI. We injected a leukemia inhibitory factor (LIF)-expression construct at the time of MI and identified a significant functional improvement in the LIF-treated group. At 1 month after MI, in the MI border and scar area, the LIF-injected mice had 31.41 +/- 5.83 X-gal-negative cardiomyocytes/mm(2), whereas the control mice had 12.34 +/- 2.56 X-gal-negative cardiomyocytes/mm(2) (p < 0.05). Using 5-ethy-nyl-2'-deoxyurinide (EdU) administration after MI, the percentages of EdU-positive CSP cells in the LIF-treated and control mice were 29.4 +/- 2.7% and 10.6 +/- 3.7%, respectively, which suggests that LIF influenced CSP proliferation. Moreover, LIF activated the Janus kinase (JAK) signal transducer and activator of transcription (STAT), mitogen-activated protein kinase/extracellular signal-regulated (MEK) extracellular signal-regulated kinase (ERK), and phosphatidylinositol 3-kinase (PI3K)-AKT pathways in CSPs in vivo and in vitro. The enhanced green fluorescent protein (EGFP)-bone marrow-chimeric CreLacZ mouse results indicated that LIF did not stimulate cardiogenesis via circulating bone marrow-derived cells during the 4 weeks following MI. Thus, LIF stimulates, in part, stem cell-derived cardiomyocyte regeneration by activating cardiac stem or precursor cells. This approach may represent a novel therapeutic strategy for cardiogenesis.	[Kanda, Masato; Nagai, Toshio; Takahashi, Toshinao; Liu, Mei Lan; Kondou, Naomichi; Kobayashi, Yoshio] Chiba Univ, Dept Cardiovasc Med, Grad Sch Med, Chiba, Japan; [Naito, Atsuhiko T.; Akazawa, Hiroshi; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Sashida, Goro; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan	Chiba University; University of Tokyo; Chiba University	Nagai, T (corresponding author), Chiba Univ, Dept Cardiovasc Med, Grad Sch Med, Chiba, Japan.	toshi35526@yahoo.co.jp	Sashida, Goro/N-5259-2014	Sashida, Goro/0000-0003-2318-5987; Akazawa, Hiroshi/0000-0002-3574-9607	Ministry of Education, Science, Sports, and Culture JSPS KAKENHI [25293180]	Ministry of Education, Science, Sports, and Culture JSPS KAKENHI	This work was supported by a Grant-in-Aid for Scientific Research, Developmental Scientific Research, and Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture (https://www.jsps.go.jp/english/e-grants/index.html) JSPS KAKENHI Grant Number 25293180. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Braunwald E, 2008, CIRC-HEART FAIL, V1, P58, DOI 10.1161/CIRCHEARTFAILURE.107.752162; Brinsden PR, 2009, FERTIL STERIL, V91, P1445, DOI 10.1016/j.fertnstert.2008.06.047; Chong JJH, 2014, STEM CELL RES, V13, P592, DOI 10.1016/j.scr.2014.09.008; Coelho OR, 2013, CIRCULATION, V128, P1225, DOI 10.1161/CIRCULATIONAHA.112.000438; Davis ID, 2005, CLIN CANCER RES, V11, P1890, DOI 10.1158/1078-0432.CCR-04-1655; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Edoff K, 2002, J NEUROSCI RES, V67, P255, DOI 10.1002/jnr.10092; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Fisher SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064669; Foshay K, 2005, STEM CELLS, V23, P530, DOI 10.1634/stemcells.2004-0293; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hiragun T, 2000, FEBS LETT, V487, P219, DOI 10.1016/S0014-5793(00)02355-3; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Jiang BB, 2010, J CARDIOVASC TRANSL, V3, P410, DOI 10.1007/s12265-010-9193-7; Kajstura J, 2008, J MOL CELL CARDIOL, V45, P505, DOI 10.1016/j.yjmcc.2008.05.025; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kanashiro-Takeuchi RM, 2011, J MOL CELL CARDIOL, V51, P619, DOI 10.1016/j.yjmcc.2011.05.015; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357, DOI 10.1128/MCB.18.6.3357; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Metcalfe SM, 2011, GENES IMMUN, V12, P157, DOI 10.1038/gene.2011.9; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Pavo N, 2014, J MOL CELL CARDIOL, V75, P12, DOI 10.1016/j.yjmcc.2014.06.016; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shih CC, 2000, BLOOD, V95, P1957, DOI 10.1182/blood.V95.6.1957; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Uchida S, 2013, STEM CELL REP, V1, P397, DOI 10.1016/j.stemcr.2013.09.004; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Weber MA, 2005, LAB INVEST, V85, P276, DOI 10.1038/labinvest.3700216; Wu JMF, 2015, CIRC RES, V116, P633, DOI 10.1161/CIRCRESAHA.116.304564; Xu YB, 2010, ADV PHARMACOL, V59, P31, DOI 10.1016/S1054-3589(10)59002-1; Yan XX, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.004408; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zou YZ, 2003, CIRCULATION, V108, P748, DOI 10.1161/01.CIR.0000081773.76337.44	58	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156562	10.1371/journal.pone.0156562	http://dx.doi.org/10.1371/journal.pone.0156562			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227407	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500158
J	Torney, CJ; Dobson, AP; Borner, F; Lloyd-Jones, DJ; Moyer, D; Maliti, HT; Mwita, M; Fredrick, H; Borner, M; Hopcraft, JGC				Torney, Colin J.; Dobson, Andrew P.; Borner, Felix; Lloyd-Jones, David J.; Moyer, David; Maliti, Honori T.; Mwita, Machoke; Fredrick, Howard; Borner, Markus; Hopcraft, J. Grant C.			Assessing Rotation-Invariant Feature Classification for Automated Wildebeest Population Counts	PLOS ONE			English	Article								Accurate and on-demand animal population counts are the holy grail for wildlife conservation organizations throughout the world because they enable fast and responsive adaptive management policies. While the collection of image data from camera traps, satellites, and manned or unmanned aircraft has advanced significantly, the detection and identification of animals within images remains a major bottleneck since counting is primarily conducted by dedicated enumerators or citizen scientists. Recent developments in the field of computer vision suggest a potential resolution to this issue through the use of rotation-invariant object descriptors combined with machine learning algorithms. Here we implement an algorithm to detect and count wildebeest from aerial images collected in the Serengeti National Park in 2009 as part of the biennial wildebeest count. We find that the per image error rates are greater than, but comparable to, two separate human counts. For the total count, the algorithm is more accurate than both manual counts, suggesting that human counters have a tendency to systematically over or under count images. While the accuracy of the algorithm is not yet at an acceptable level for fully automatic counts, our results show this method is a promising avenue for further research and we highlight specific areas where future research should focus in order to develop fast and accurate enumeration of aerial count data. If combined with a bespoke image collection protocol, this approach may yield a fully automated wildebeest count in the near future.	[Torney, Colin J.] Univ Exeter, Ctr Math & Environm, Penryn Campus, Penryn, Cornwall, England; [Dobson, Andrew P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Borner, Felix] Serengeti Natl Pk, Frankfurt Zool Soc, Seronera, Tanzania; [Lloyd-Jones, David J.] POB 1272, Iringa, Tanzania; [Moyer, David] Field Museum Nat Hist, Integrated Res Ctr, 1400 S Lake Shore Dr, Chicago, IL 60605 USA; [Maliti, Honori T.; Mwita, Machoke] Tanzania Wildlife Res Inst, POB 661, Arusha, Tanzania; [Fredrick, Howard] Tanzania Conservat Resource Ctr, Arusha, Tanzania; [Borner, Markus; Hopcraft, J. Grant C.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Borner, Markus; Hopcraft, J. Grant C.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland	University of Exeter; Princeton University; Field Museum of Natural History (Chicago); University of Glasgow; University of Glasgow	Torney, CJ (corresponding author), Univ Exeter, Ctr Math & Environm, Penryn Campus, Penryn, Cornwall, England.	colin.j.torney@gmail.com		Lloyd-Jones, David/0000-0001-7880-5659	James S. McDonnell Foundation; Lord Kelvin Adam Smith Fellowship; British Ecological Society; European Union [641918]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Lord Kelvin Adam Smith Fellowship; British Ecological Society; European Union(European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CJT is supported by a Complex Systems Scholar Award from the James S. McDonnell Foundation. JGCH is supported by a Lord Kelvin Adam Smith Fellowship, funding from the British Ecological Society and the European Union's Horizon 2020 research and innovation programme under grant agreement No 641918 AfricanBioServices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; BAJZAK D, 1990, WILDLIFE SOC B, V18, P125; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bolger DT, 2012, METHODS ECOL EVOL, V3, P813, DOI 10.1111/j.2041-210X.2012.00212.x; Bradski G., 2000, DOBBS J SOFTWARE TOO; BRIGGS KT, 1985, J WILDLIFE MANAGE, V49, P405, DOI 10.2307/3801542; CAUGHLEY G, 1976, J WILDLIFE MANAGE, V40, P290, DOI 10.2307/3800428; Caughley G, 1979, SAMPLING TECHNIQUES, P15; Chen Ch, 2010, HDB PATTERN RECOGNIT, V27; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; EVANS CD, 1966, J WILDLIFE MANAGE, V30, P767, DOI 10.2307/3798283; Freund Y, 1995, COMPUTATIONAL LEARNI, P23, DOI [10.1007/3-540-59119-2_166, DOI 10.1007/3-540-59119-2_166]; GODDARD J, 1969, East African Wildlife Journal, V7, P105; Hsu RL, 2002, IEEE T PATTERN ANAL, V24, P696, DOI 10.1109/34.1000242; Klockner A, 2012, PARALLEL COMPUT, V38, P157, DOI 10.1016/j.parco.2011.09.001; Kuhl HS, 2013, TRENDS ECOL EVOL, V28, P432, DOI 10.1016/j.tree.2013.02.013; Laliberte AS, 2003, WILDLIFE SOC B, V31, P362; Lin Y, 2011, IEEE GEOSCI REMOTE S, V8, P426, DOI 10.1109/LGRS.2010.2079913; Liu K, 2014, INT J COMPUT VISION, V106, P342, DOI 10.1007/s11263-013-0634-z; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; McNeill S, 2011, INT GEOSCI REMOTE SE, P4312, DOI 10.1109/IGARSS.2011.6050185; Michel P., 2003, P 5 INT C MULTIMODAL, P258, DOI [10.1145/958432.958479, DOI 10.1145/958432.958479]; MORTON SR, 1990, AUST J ECOL, V15, P307, DOI 10.1111/j.1442-9993.1990.tb01035.x; Mosbech A, 1999, ARCTIC, V52, P188; NORTON-GRIFFITHS M, 1973, East African Wildlife Journal, V11, P135; Oritsland T, 1995, DEV MAR BIO, V4, P77; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Russell J., 1996, Rangifer, V16, P319; Sherley Richard B., 2010, Endangered Species Research, V11, P101, DOI 10.3354/esr00267; SINCLAIR ARE, 1995, SERENGETI, V2; Sirmacek B, 2012, MAN RES LTD PLAN 6 B; ULLMAN S, 1979, PROC R SOC SER B-BIO, V203, P405, DOI 10.1098/rspb.1979.0006; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; XU L, 1992, IEEE T SYST MAN CYB, V22, P418, DOI 10.1109/21.155943; Yang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115989	36	20	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156342	10.1371/journal.pone.0156342	http://dx.doi.org/10.1371/journal.pone.0156342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227888	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000376882500119
J	Zhang, YX; Sun, TZ; Liu, SQ; Dong, L; Liu, CY; Song, WW; Liu, JJ; Gai, SP				Zhang, Yuxi; Sun, Tingzhao; Liu, Shaoqing; Dong, Lei; Liu, Chunying; Song, Wenwen; Liu, Jingjing; Gai, Shupeng			MYC cis-Elements in PsMPT Promoter Is Involved in Chilling Response of Paeonia suffruticosa	PLOS ONE			English	Article							MITOCHONDRIAL PHOSPHATE TRANSPORTER; ARABIDOPSIS-THALIANA; BUD DORMANCY; GIBBERELLIN BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; FREEZING TOLERANCE; GENE-EXPRESSION; RELEASE; INDUCTION	The MPT transports Pi to synthesize ATP. PsMPT, a chilling-induced gene, was previously reported to promote energy metabolism during bud dormancy release in tree peony. In this study, the regulatory elements of PsMPT promoter involved in chilling response were further analyzed. The PsMPT transcript was detected in different tree peony tissues and was highly expressed in the flower organs, including petal, stigma and stamen. An 1174 bp of the PsMPT promoter was isolated by TAIL-PCR, and the PsMPT promoter::GUS transgenic Arabidopsis was generated and analyzed. GUS staining and qPCR showed that the promoter was active in mainly the flower stigma and stamen. Moreover, it was found that the promoter activity was enhanced by chilling, NaCl, GA, ACC and NAA, but inhibited by ABA, mannitol and PEG. In transgenic plants harboring 421 bp of the PsMPT promoter, the GUS gene expression and the activity were significantly increased by chilling treatment. When the fragment from -421 to -408 containing a MYC cis-element was deleted, the chilling response could not be observed. Further mutation analysis confirmed that the MYC element was one of the key motifs responding to chilling in the PsMPT promoter. The present study provides useful information for further investigation of the regulatory mechanism of PsMPT during the endo-dormancy release.	[Zhang, Yuxi; Sun, Tingzhao; Liu, Shaoqing; Dong, Lei; Liu, Chunying; Song, Wenwen; Liu, Jingjing; Gai, Shupeng] Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Univ Shandong Prov, Changcheng Rd 700, Qingdao, Peoples R China	Qingdao Agricultural University	Gai, SP (corresponding author), Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Univ Shandong Prov, Changcheng Rd 700, Qingdao, Peoples R China.	spgai@qau.edu.cn			National Natural Science Foundation of China [31071828, 31372104, 31471908]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31071828, 31372104 and 31471908).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Croos JNA, 2004, J BIOENERG BIOMEMBR, V36, P229, DOI 10.1023/B:JOBB.0000031974.35812.c9; Dolce V, 1991, DNA Seq, V2, P133, DOI 10.3109/10425179109039683; FARINI E, 1995, MOL GEN GENET, V246, P734, DOI 10.1007/BF00290720; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; FERREIRA GC, 1989, J BIOL CHEM, V264, P15628; Filichkin SA, 2004, PLANT PHYSIOL, V134, P1080, DOI 10.1104/pp.103.035998; Gai SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055297; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; HAZEBROEK JP, 1993, PLANT PHYSIOL, V102, P547, DOI 10.1104/pp.102.2.547; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Huang X, 2008, ACTA PHYSIOL PLANT, V30, P797, DOI 10.1007/s11738-008-0184-0; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kiiskinen M, 1997, PLANT MOL BIOL, V35, P271, DOI 10.1023/A:1005868715571; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kristiansen MT, 2002, HORM RES, V57, P200, DOI 10.1159/000058383; LAM E, 1989, PLANT CELL, V1, P1147, DOI 10.1105/tpc.1.12.1147; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama-Nakashita A, 2005, PLANT J, V42, P305, DOI 10.1111/j.1365-313X.2005.02363.x; Mena M, 2002, PLANT PHYSIOL, V130, P111, DOI 10.1104/pp.005561; Morita A, 1998, FEBS LETT, V423, P81, DOI 10.1016/S0014-5793(98)00067-2; Nakamori K, 2002, PLANT CELL PHYSIOL, V43, P1250, DOI 10.1093/pcp/pcf141; PHELPS A, 1991, BIOCHEMISTRY-US, V30, P248, DOI 10.1021/bi00215a035; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Rentzsch S, 2012, PLANTA, V235, P137, DOI 10.1007/s00425-011-1501-1; Rohde A, 2007, J EXP BOT, V58, P4047, DOI 10.1093/jxb/erm261; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Takabatake R, 1999, PLANT MOL BIOL, V40, P479, DOI 10.1023/A:1006285009435; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Vieweg MF, 2004, MOL PLANT MICROBE IN, V17, P62, DOI 10.1094/MPMI.2004.17.1.62; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Zheng GuoSheng, 2009, Scientia Silvae Sinicae, V45, P48; Zhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043530	45	10	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155780	10.1371/journal.pone.0155780	http://dx.doi.org/10.1371/journal.pone.0155780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228117	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500033
J	Gove, B; Williams, LJ; Beresford, AE; Roddis, P; Campbell, C; Teuten, E; Langston, RHW; Bradbury, RB				Gove, Benedict; Williams, Leah J.; Beresford, Alison E.; Roddis, Philippa; Campbell, Colin; Teuten, Emma; Langston, Rowena H. W.; Bradbury, Richard B.			Reconciling Biodiversity Conservation and Widespread Deployment of Renewable Energy Technologies in the UK	PLOS ONE			English	Article							ENVIRONMENTAL IMPACTS; BAT FATALITIES; BIOMASS CROPS; LAND-USE; MISCANTHUS; POPULATIONS; SCALE; BIRDS	Renewable energy will potentially make an important contribution towards the dual aims of meeting carbon emission reduction targets and future energy demand. However, some technologies have considerable potential to impact on the biodiversity of the environments in which they are placed. In this study, an assessment was undertaken of the realistic deployment potential of a range of renewable energy technologies in the UK, considering constraints imposed by biodiversity conservation priorities. We focused on those energy sources that have the potential to make important energy contributions but which might conflict with biodiversity conservation objectives. These included field-scale solar, bioenergy crops, wind energy (both onshore and offshore), wave and tidal stream energy. The spatially-explicit analysis considered the potential opportunity available for each technology, at various levels of ecological risk. The resultant maps highlight the energy resource available, physical and policy constraints to deployment, and ecological sensitivity (based on the distribution of protected areas and sensitive species). If the technologies are restricted to areas which currently appear not to have significant ecological constraints, the total potential energy output from these energy sources was estimated to be in the region of 5,547 TWh/yr. This would be sufficient to meet projected energy demand in the UK, and help to achieve carbon reduction targets. However, we highlight two important caveats. First, further ecological monitoring and surveillance is required to improve understanding of wildlife distributions and therefore potential impacts of utilising these energy sources. This is likely to reduce the total energy available, especially at sea. Second, some of the technologies under investigation are currently not deployed commercially. Consequently this potential energy will only be available if continued effort is put into developing these energy sources/technologies, to enable realisation of their full potential.	[Gove, Benedict; Williams, Leah J.; Langston, Rowena H. W.; Bradbury, Richard B.] Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Beresford, Alison E.] Royal Soc Protect Birds Scotland, RSPB Ctr Conservat Sci, Edinburgh EH12 9DH, Midlothian, Scotland; [Roddis, Philippa] Royal Soc Protect Birds, RSPB Sustainable Dev Policy Team, Sandy SG19 2DL, Beds, England; [Campbell, Colin; Teuten, Emma] Royal Soc Protect Birds, RSPB Conservat Data Management, Sandy SG19 2DL, Beds, England; [Bradbury, Richard B.] RSPB Ctr Conservat Sci, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England	Royal Society for Protection of Birds; Royal Society for Protection of Birds; Royal Society for Protection of Birds; Royal Society for Protection of Birds; Royal Society for Protection of Birds	Bradbury, RB (corresponding author), Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England.; Bradbury, RB (corresponding author), RSPB Ctr Conservat Sci, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England.	richard.bradbury@rspb.org.uk		Bradbury, Richard/0000-0002-1245-2763; Roddis, Philippa/0000-0002-7159-0488; Williams, Leah/0000-0001-8004-2187				[Anonymous], 2013, CLIM CHANG 2013 5 AS; [Anonymous], 2012, ARCGIS VERS 10 1; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Balmer D, 2013, BTO ATLAS 2007 11 BR; Batey L, 2014, MEGAFAUNA HOTSPOTS M; Bellamy PE, 2009, BIOMASS BIOENERG, V33, P191, DOI 10.1016/j.biombioe.2008.07.001; Ben Allen T.H., 2014, THINKING SPACE TESTI; Blake RJ, 2011, J INSECT CONSERV, V15, P221, DOI 10.1007/s10841-010-9339-6; Bourke D, 2014, GCB BIOENERGY, V6, P275, DOI 10.1111/gcbb.12089; Bradbury G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106366; Bright JA, 2006, BIRD SENSITIVITY MAP; Bright JA, 2009, MAPPED WRITTEN GUIDA; Bright JA, 2013, BIRD STUDY, V60, P357, DOI 10.1080/00063657.2013.790876; Bright J, 2008, BIOL CONSERV, V141, P2342, DOI 10.1016/j.biocon.2008.06.029; Dale VH, 2015, BIOFUEL BIOPROD BIOR, V9, P177, DOI 10.1002/bbb.1528; DECC, 2015, DIG UK EN STAT DUKES; DECC, 2013, 2050 EXPL UK CAN MEE; DECC, 2012, UPD EN EM PROJ 2014; DECC, 2012, WINDSP DAT; DEFRA (The UK Department for Environment Food and Rural Affairs), 2007, UK BIOM STRAT; Department of Energy and Climate Change (DECC), 2012, UK BIOEN STRAT; Energy Numbers, CAP FACT DAN OFFSH W; European Commission, 2013, PVGIS EUR COMM 2001; European Commission, 2011, OUR LIF INS OUR NAT; Fuller R.M., 2002, LAND COVER MAP 2000; Furness RW, 2013, J ENVIRON MANAGE, V119, P56, DOI 10.1016/j.jenvman.2013.01.025; Furness RW, 2012, ICES J MAR SCI, V69, P1466, DOI 10.1093/icesjms/fss131; Goodright V., 2014, DECC STAT; Gove B, 2013, CONV CONS EUR WILDL; Haughton AJ, 2009, J APPL ECOL, V46, P315, DOI 10.1111/j.1365-2664.2009.01623.x; Heath M.F., 2000, IMPORTANT BIRD AREAS, V2; Hernandez RR, 2015, NAT CLIM CHANGE, V5, P353, DOI 10.1038/nclimate2556; Hinsley SA, 2010, IBIS, V152, P500, DOI 10.1111/j.1474-919X.2010.01029.x; Hotker H., 2006, IMPACTS BIODIVERSITY; IPCC (Intergovernmental Panel on Climate Change), 2014, 5 ASS REP CLIM CHANG; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Kober K., 2012, 461 JNCC; Langston R.H.W., 2003, WINDFARMS BIRDS ANAL; Lovett AA, 2009, BIOENERG RES, V2, P17, DOI [10.1007/s12155-008-9030-x, 10.1007/s12155-008-9030-X]; MacKay David J.C., 2009, SUSTAINABLE ENERGY H; Mitchell PI, 2004, SEABIRD POPULATIONS; Mollison D., 1985, HYDR OC WAV EN UT IU; Pywell RF, 2006, BIOL CONSERV, V129, P192, DOI 10.1016/j.biocon.2005.10.034; Rosenberg D. M., 1997, Environmental Reviews, V5, P27, DOI 10.1139/er-5-1-27; Sage R, 2010, IBIS, V152, P487, DOI 10.1111/j.1474-919X.2010.01027.x; Scrace I, 2011, M EUR REN EN TARG HA; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Siyal SH, 2015, ENERGY, V83, P447, DOI 10.1016/j.energy.2015.02.044; SQWenergy, 2010, REN LOW CARB EN CAP; Stroud D.A., 2001, UK SPA NETWORK ITS S; Thaxter CB, 2012, BIOL CONSERV, V156, P53, DOI 10.1016/j.biocon.2011.12.009; The Offshore Valuation Group, 2010, OFFSH VAL VAL UKS OF; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Wolf J, 2009, P I CIVIL ENG-MAR EN, V162, P165, DOI 10.1680/maen.2009.162.4.165	55	13	13	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0150956	10.1371/journal.pone.0150956	http://dx.doi.org/10.1371/journal.pone.0150956			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224050	Green Submitted, gold, Green Published			2022-12-26	WOS:000376881700001
J	Hussain, T; Chang, HY; Luu, NP; Pollack, CE				Hussain, Tanvir; Chang, Hsien-Yen; Ngoc-Phuong Luu; Pollack, Craig Evan			The Value of Continuity between Primary Care and Surgical Care in Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; HOSPITAL VOLUME; MEDICARE BENEFICIARIES; PHYSICIANS; FRAGMENTATION; COORDINATION; PERFORMANCE; MORTALITY; SURGEONS; OUTCOMES	Background Improving continuity between primary care and cancer care is critical for improving cancer outcomes and curbing cancer costs. A dimension of continuity, we investigated how regularly patients receive their primary care and surgical care for colon cancer from the same hospital and whether this affects mortality and costs. Methods Using Surveillance, Epidemiology, and End Results Program Registry (SEER)-Medicare data, we performed a retrospective cohort study of stage I-III colon cancer patients diagnosed between 2000 and 2009. There were 23,305 stage I-III colon cancer patients who received primary care in the year prior to diagnosis and underwent operative care for colon cancer. Patients were assigned to the hospital where they had their surgery and to their primary care provider's main hospital, and then classified according to whether these two hospitals were same or different. Outcomes examined were hazards for all-cause mortality, subhazard for colon cancer specific mortality, and generalized linear estimate for costs at 12 months, from propensity score matched models. Results Fifty-two percent of stage I-III colon patients received primary care and surgical care from the same hospital. Primary care and surgical care from the same hospital was not associated with reduced all-cause or colon cancer specific mortality, but was associated with lower inpatient, outpatient, and total costs of care. Total cost difference was $8,836 (95% CI $2,746-$14,577), a 20% reduction in total median cost of care at 12 months. Conclusions Receiving primary care and surgical care at the same hospital, compared to different hospitals, was associated with lower costs but still similar survival among stage I-III colon cancer patients. Nonetheless, health care policy which encourages further integration between primary care and cancer care in order to improve outcomes and decrease costs will need to address the significant proportion of patients receiving health care across more than one hospital.	[Hussain, Tanvir] Univ Nebraska Med Ctr, Div Gen Internal Med, Dept Med, Omaha, NE USA; [Chang, Hsien-Yen; Pollack, Craig Evan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Ngoc-Phuong Luu; Pollack, Craig Evan] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA	University of Nebraska System; University of Nebraska Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Hussain, T (corresponding author), Univ Nebraska Med Ctr, Div Gen Internal Med, Dept Med, Omaha, NE USA.	Tanvir.Hussain@unmc.edu	Chang, Hsien-Yen/E-4627-2014	Chang, Hsien-Yen/0000-0002-7997-4822	National Cancer Institute (NCI); Office of Behavioral and Social Science Research (OBSSR) [K07CA151910]; NCI's Center to Reduce Cancer Health Disparities' Community Networks Program (CNP) of Johns Hopkins Center to Reduce Cancer Disparities [U54CA153710]; Maryland Cigarette Restitution Fund; National Heart Lung Blood Institute (NHLBI) Training Grant [5T32HL007180-38]; NATIONAL CANCER INSTITUTE [K07CA151910] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Behavioral and Social Science Research (OBSSR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI's Center to Reduce Cancer Health Disparities' Community Networks Program (CNP) of Johns Hopkins Center to Reduce Cancer Disparities; Maryland Cigarette Restitution Fund; National Heart Lung Blood Institute (NHLBI) Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by a career development award to Dr. Pollack from the National Cancer Institute (NCI) and the Office of Behavioral and Social Science Research (OBSSR) (K07CA151910), NCI's Center to Reduce Cancer Health Disparities' Community Networks Program (CNP # U54CA153710) of Johns Hopkins Center to Reduce Cancer Disparities, the Maryland Cigarette Restitution Fund, and the National Heart Lung Blood Institute (NHLBI) Training Grant 5T32HL007180-38. NCI: http://www.cancer.gov. OBSSR: http://obssr.od.nih.gov. NHLBI: http://www.nhlbi.nih.gov. Maryland Cigarette Restitution Fund: http://crf.maryland.gov. The funders had no role in the design, analysis, interpretation, or writing of this research manuscript.	Agency for Healthcare Research and Quality, US APPR PRIC IND AN; Amarasingham R, 2009, ARCH INTERN MED, V169, P108, DOI 10.1001/archinternmed.2008.520; Augestad KM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002391; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Brandenbarg D, 2014, SCAND J PRIM HEALTH, V32, P55, DOI 10.3109/02813432.2014.929811; Bynum JPW, 2007, HEALTH SERV RES, V42, P45, DOI 10.1111/j.1475-6773.2006.00633.x; Centers for Medicare and Medicaid Services, ONC CAR MOD; Chen AH, 2013, NEW ENGL J MED, V368, P2450, DOI 10.1056/NEJMp1215594; Desch CE, 2008, J CLIN ONCOL, V26, P3631, DOI 10.1200/JCO.2008.16.5068; Faul LA, 2010, CANCER CONTROL, V17, P35, DOI 10.1177/107327481001700105; Ferrante JM, 2013, ANN INTERN MED, V159, P437, DOI 10.7326/0003-4819-159-7-201310010-00003; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fisher ES, 2012, HEALTH AFFAIR, V31, P2368, DOI 10.1377/hlthaff.2012.0544; Fisher KJ, 2013, CANCER-AM CANCER SOC, V119, P2964, DOI 10.1002/cncr.28148; Goldsbury D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002325; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greenberg CC, 2013, JAMA-J AM MED ASSOC, V309, P827, DOI 10.1001/jama.2013.1503; Hempstead K, 2014, MED CARE, V52, pS67, DOI 10.1097/MLR.0000000000000049; Hewitt M, 2006, AM SOC CLIN ONC I ME; Hussain T, 2015, CANCER-AM CANCER SOC, V121, P3316, DOI 10.1002/cncr.29474; Hussain T, 2015, J ONCOL PRACT, V11, pE388, DOI 10.1200/JOP.2014.003293; Jeffery M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002200.pub2; Klabunde CN, 2009, J GEN INTERN MED, V24, P1029, DOI 10.1007/s11606-009-1058-x; Ko C, 2002, J SURG RES, V105, P53, DOI 10.1006/jsre.2002.6449; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Levit LA, 2013, DEL HIGH QUAL CANC C; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Moran JL, 2007, J EVAL CLIN PRACT, V13, P381, DOI 10.1111/j.1365-2753.2006.00711.x; Nekhlyudov Larissa, 2010, Journal of the National Cancer Institute Monographs, P11, DOI 10.1093/jncimonographs/lgq001; Paulson EC, 2008, ANN SURG, V248, P675, DOI 10.1097/SLA.0b013e318187a757; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Quah HM, 2008, DIS COLON RECTUM, V51, P503, DOI 10.1007/s10350-008-9246-z; Research Data Assistance Center, CMMI PAYM BUNDL IN; Rhoads KF, 2015, J CLIN ONCOL, V33, P854, DOI 10.1200/JCO.2014.56.8642; Rogers SO, 2009, ANN SURG, V250, P895, DOI 10.1097/SLA.0b013e3181afe0c6; Schrag D, 2003, J SURG ONCOL, V83, P68, DOI 10.1002/jso.10244; Smith AW, 2008, HEALTH CARE FINANC R, V29, P41; Snow V, 2009, J GEN INTERN MED, V24, P971, DOI 10.1007/s11606-009-0969-x; Snyder CF, 2008, J GEN INTERN MED, V23, P254, DOI 10.1007/s11606-007-0497-5; Spigelman AD, 2013, AUST HEALTH REV, V37, P449, DOI 10.1071/AH13038; Sussman Jonathan, 2010, Journal of the National Cancer Institute Monographs, P18, DOI 10.1093/jncimonographs/lgq007; Unni N, 2014, TRANSFUSION, V54, P98, DOI 10.1111/trf.12251; Young JM, 2014, COLORECTAL DIS, V16, P17, DOI 10.1111/codi.12399	47	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155789	10.1371/journal.pone.0155789	http://dx.doi.org/10.1371/journal.pone.0155789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219454	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700020
J	Zaccone, EJ; Lieu, T; Muroi, Y; Potenzieri, C; Undem, BE; Gao, PS; Han, L; Canning, BJ; Undem, BJ				Zaccone, Eric J.; Lieu, TinaMarie; Muroi, Yukiko; Potenzieri, Carl; Undem, Blair E.; Gao, Peisong; Han, Liang; Canning, Brendan J.; Undem, Bradley J.			Parainfluenza 3-Induced Cough Hypersensitivity in the Guinea Pig Airways	PLOS ONE			English	Article							VAGAL AFFERENT NEURONS; NERVE GROWTH-FACTOR; SMOOTH-MUSCLE; C-FIBERS; IODO-RESINIFERATOXIN; RESPIRATORY-TRACT; SENSORY NEURONS; SUBSTANCE-P; EXPRESSION; VIRUS	The effect of respiratory tract viral infection on evoked cough in guinea pigs was evaluated. Guinea pigs were inoculated intranasally with either parainfluenza type 3 (PIV3) and cough was quantified in conscious animals. The guinea pigs infected with PIV3 (day 4) coughed nearly three times more than those treated with the viral growth medium in response to capsaicin, citric acid, and bradykinin. Since capsaicin, citric acid, and bradykinin evoked coughing in guinea pigs can be inhibited by drugs that antagonize the transient receptor potential cation channel, subfamily V, member 1 (TRPV1), it was reasoned that the virally-induced hypertussive state may involve alterations in TPRV1 activity. PIV3 infection caused a phenotypic switch in tracheal nodose A delta "cough receptors" such that nearly 50% of neurons began to express, de novo, TRPV1 mRNA. There was also an increase TRPV1 expression in jugular C-fiber neurons as determined by qPCR. It has previously been reported that tracheal- specific nodose neurons express the BDNF receptor TrkB and jugular neurons express the NGF receptor TrkA. Jugular neurons also express the artemin receptor GFR alpha 3. All these neurotrophic factors have been associated with increases in TRPV1 expression. In an ex vivo perfused guinea pig tracheal preparation, we demonstrated that within 8 h of PIV3 infusion there was no change in NGF mRNA expression, but there was nearly a 10-fold increase in BDNF mRNA in the tissue, and a small but significant elevation in the expression of artemin mRNA. In summary, PIV3 infection leads to elevations in TRPV1 expression in the two key cough evoking nerve subtypes in the guinea pig trachea, and this is associated with a hypertussive state with respect to various TRPV1 activating stimuli.	[Zaccone, Eric J.; Lieu, TinaMarie; Muroi, Yukiko; Potenzieri, Carl; Undem, Blair E.; Gao, Peisong; Canning, Brendan J.; Undem, Bradley J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Han, Liang] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Undem, BJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA.	bundem@jhmi.edu	Canning, Brendan/ABE-5261-2020; Lieu, TinaMarie/AAM-7691-2020; Canning, Brendan/AAM-9404-2021	Canning, Brendan/0000-0003-4197-5560; Han, Liang/0000-0001-8674-6433	National Institutes of Health [R01HL112919]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109062, R21AI121768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS087088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by Bradley J. Undem, National Institutes of Health R01HL112919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braman SS, 2006, CHEST, V129, p138S, DOI 10.1378/chest.129.1_suppl.138S; BUCKNER CK, 1981, J CLIN INVEST, V67, P376, DOI 10.1172/JCI110045; BUCKNER CK, 1985, AM REV RESPIR DIS, V132, P305; Canning BJ, 2004, J PHYSIOL-LONDON, V557, P543, DOI 10.1113/jphysiol.2003.057885; Canning BJ, 2006, RESP PHYSIOL NEUROBI, V152, P223, DOI 10.1016/j.resp.2006.03.001; Carr MJ, 2003, J PHARMACOL EXP THER, V304, P1275, DOI 10.1124/jpet.102.043422; Carr MJ, 2002, AM J RESP CRIT CARE, V165, P1071, DOI 10.1164/ajrccm.165.8.2108065; Dicpinigaitis PV, 2014, PULM PHARMACOL THER, V28, P154, DOI 10.1016/j.pupt.2014.05.004; Dulek DE, 2011, BBA-GEN SUBJECTS, V1810, P1080, DOI 10.1016/j.bbagen.2011.01.012; Elitt CM, 2008, BRAIN RES, V1230, P80, DOI 10.1016/j.brainres.2008.06.119; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; EMPEY DW, 1983, EUR J RESPIR DIS, V64, P366; FEATHERSTONE RL, 1988, EUR RESPIR J, V1, P839; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Grace M, 2012, THORAX, V67, P891, DOI 10.1136/thoraxjnl-2011-201443; Grace MS, 2011, PULM PHARMACOL THER, V24, P286, DOI 10.1016/j.pupt.2010.11.002; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Hu YT, 2014, AM J PHYSIOL-GASTR L, V307, pG149, DOI 10.1152/ajpgi.00097.2014; Hunter DD, 1999, AM J RESP CRIT CARE, V159, P1943, DOI 10.1164/ajrccm.159.6.9808078; Ikeda-Miyagawa Y, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0004-7; JACOBY DB, 1990, TRENDS PHARMACOL SCI, V11, P393, DOI 10.1016/0165-6147(90)90141-T; Jacoby DB, 1998, J CLIN INVEST, V102, P242, DOI 10.1172/JCI1114; Jacoby DB, 2004, J AEROSOL MED, V17, P169, DOI 10.1089/0894268041457156; Kajekar R, 1999, J PHARMACOL EXP THER, V289, P682; Kollarik M, 2002, J PHYSIOL-LONDON, V543, P591, DOI 10.1113/jphysiol.2002.022848; LAITINEN LA, 1991, AM REV RESPIR DIS, V143, P358, DOI 10.1164/ajrccm/143.2.358; LALLOO UG, 1995, J APPL PHYSIOL, V79, P1082, DOI 10.1152/jappl.1995.79.4.1082; Larsen GL, 1999, J PEDIATR-US, V135, pS21; Lee L-Y, 2005, BRONCHOPULMONARY VAG; Lee MG, 2005, J PHYSIOL-LONDON, V566, P205, DOI 10.1113/jphysiol.2005.087577; Lieu TM, 2012, AM J PHYSIOL-LUNG C, V302, pL941, DOI 10.1152/ajplung.00366.2011; Lieu T, 2011, AM J PHYSIOL-LUNG C, V300, pL790, DOI 10.1152/ajplung.00449.2010; Mazzone SB, 2002, AM J PHYSIOL-REG I, V283, pR86, DOI 10.1152/ajpregu.00007.2002; Mazzone SB, 2009, J NEUROSCI, V29, P13662, DOI 10.1523/JNEUROSCI.4354-08.2009; MINOR TE, 1974, JAMA-J AM MED ASSOC, V227, P292, DOI 10.1001/jama.227.3.292; MIURA M, 1992, J APPL PHYSIOL, V73, P1537, DOI 10.1152/jappl.1992.73.4.1537; Myers AC, 2002, AM J PHYSIOL-LUNG C, V282, pL775, DOI 10.1152/ajplung.00353.2001; Nassenstein C, 2010, J PHYSIOL-LONDON, V588, P4769, DOI 10.1113/jphysiol.2010.195339; Oribe Y, 2005, CLIN EXP ALLERGY, V35, P262, DOI 10.1111/j.1365-2222.2005.02158.x; Othumpangat S, 2012, AM J PHYSIOL-LUNG C, V302, pL1057, DOI 10.1152/ajplung.00365.2011; Riccio MM, 1996, J PHYSIOL-LONDON, V496, P521, DOI 10.1113/jphysiol.1996.sp021703; SABAN R, 1987, AM REV RESPIR DIS, V136, P586, DOI 10.1164/ajrccm/136.3.586; Schaap-Nutt A, 2012, VIROLOGY, V433, P320, DOI 10.1016/j.virol.2012.08.027; Schomacker H, 2012, CURR OPIN VIROL, V2, P294, DOI 10.1016/j.coviro.2012.02.001; Shinoda M, 2015, PAIN; SORKNESS R, 1994, AM J RESP CRIT CARE, V150, P28, DOI 10.1164/ajrccm.150.1.8025764; Trevisani M, 2004, THORAX, V59, P769, DOI 10.1136/thx.2003.012930; Tuffaha A, 2000, CLIN CHEST MED, V21, P289, DOI 10.1016/S0272-5231(05)70267-7; Undem BJ, 2004, J PHYSIOL-LONDON, V556, P905, DOI 10.1113/jphysiol.2003.060079; Undem BJ, 2002, J PHARMACOL EXP THER, V303, P716, DOI 10.1124/jpet.102.039727; VAINIONPAA R, 1994, CLIN MICROBIOL REV, V7, P265; Ye XM, 2011, EXP LUNG RES, V37, P186, DOI 10.3109/01902148.2010.540768; Zhang GF, 2008, J PHYSIOL-LONDON, V586, P5771, DOI 10.1113/jphysiol.2008.161042	53	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155526	10.1371/journal.pone.0155526	http://dx.doi.org/10.1371/journal.pone.0155526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213574	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200014
J	Hermance, ME; Santos, RI; Kelly, BC; Valbuena, G; Thangamani, S				Hermance, Meghan E.; Santos, Rodrigo I.; Kelly, Brent C.; Valbuena, Gustavo; Thangamani, Saravanan			Immune Cell Targets of Infection at the Tick-Skin Interface during Powassan Virus Transmission	PLOS ONE			English	Article							IXODES-SCAPULARIS TICKS; HOST DEFENSES; ENCEPHALITIS; COUNTERMEASURES; FIBROBLASTS; FLAVIVIRUS; PHYLOGENY; VIMENTIN; DISEASE	Powassan virus (POWV) is a tick-borne flavivirus that can result in a severe neuroinvasive disease with 50% of survivors displaying long-term neurological sequelae. Human POWV cases have been documented in Canada, the United States, and Russia. Although the number of reported POWV human cases has increased in the past fifteen years, POWV remains one of the less studied human pathogenic flaviviruses. Ixodes ticks are the vectors for POWV, and the virus is transmitted to a host's skin very early during the tick feeding process. Central to the successful transmission of a tick-borne pathogen are complex interactions between the host immune response and early tick-mediated immunomodulation, all of which initially occur at the skin interface. In our prior work, we examined the cutaneous immune gene expression during the early stages of POWV-infected Ixodes scapularis feeding. The present study serves to further investigate the skin interface by identifying early cell targets of infection at the POWV-infected tick feeding site. An in vivo infection model consisting of POWV-infected ticks feeding on mice for short durations was used in this study. Skin biopsies from the tick feeding sites were harvested at various early time points, enabling us to examine the skin histopathology and detect POWV viral antigen in immune cells present at the tick feeding site. The histopathology from the present study demonstrates that neutrophil and mononuclear cell infiltrates are recruited earlier to the feeding site of a POWV-infected tick versus an uninfected tick. This is the first report demonstrating that macrophages and fibroblasts contain POWV antigens, which suggests that they are early cellular targets of infection at the tick feeding site. These data provide key insights towards defining the complex interactions between the host immune response and early tick-mediated immunomodulation.	[Hermance, Meghan E.; Santos, Rodrigo I.; Valbuena, Gustavo; Thangamani, Saravanan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Kelly, Brent C.] Univ Texas Med Branch, Dept Dermatol, Galveston, TX 77555 USA; [Thangamani, Saravanan] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Thangamani, Saravanan] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Thangamani, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Thangamani, S (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Thangamani, S (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.	sathanga@utmb.edu	Thangamani, Saravanan/E-7371-2010	Thangamani, Saravanan/0000-0002-4269-5993; Hermance, Meghan/0000-0003-0494-9670	NIAID/NIH [UC7 AIO94660, T32AI007526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC7AI094660, T32AI007526] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds to ST and by NIAID/NIH UC7 AIO94660. MEH was supported by NIAID/NIH T32AI007526.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Beasley DWC, 2001, VIRUS RES, V79, P81, DOI 10.1016/S0168-1702(01)00330-6; Chambers TJ, 2003, ADV VIRUS RES, V60, P273, DOI 10.1016/S0065-3527(03)60008-4; Costero A, 1996, AM J TROP MED HYG, V55, P536, DOI 10.4269/ajtmh.1996.55.536; DEIBEL R, 1975, NEW YORK STATE J MED, V75, P2337; Ebel GD, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.3.0700268; Ebel GD, 2001, J GEN VIROL, V82, P1657, DOI 10.1099/0022-1317-82-7-1657; Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446; FITCH WM, 1990, CAN FAM PHYSICIAN, V36, P1289; GOLDFIELD M, 1973, AM J TROP MED HYG, V22, P78, DOI 10.4269/ajtmh.1973.22.78; Hashimoto M, 1998, BIOCHEM BIOPH RES CO, V247, P401, DOI 10.1006/bbrc.1998.8799; Heinze DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047301; Hermance ME, 2015, J VIROL, V89, P7852, DOI 10.1128/JVI.01056-15; Hermance ME, 2014, J INVEST DERMATOL, V134, P2280, DOI 10.1038/jid.2014.150; JONES LD, 1992, MED VET ENTOMOL, V6, P261, DOI 10.1111/j.1365-2915.1992.tb00616.x; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Krause PJ, 2009, VECTOR-BORNE ZOONOT, V9, P603, DOI 10.1089/vbz.2008.0091; Kuno G, 2001, AM J TROP MED HYG, V65, P671, DOI 10.4269/ajtmh.2001.65.671; LABUDA M, 1993, MED VET ENTOMOL, V7, P193, DOI 10.1111/j.1365-2915.1993.tb00674.x; Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007; Mark Manuel, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29b04s78; McLean DM, 1959, CAN MED ASSOC J, V80, P708; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; SMITH R, 1974, AM J DIS CHILD, V127, P691, DOI 10.1001/archpedi.1974.02110240077010; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Xu HX, 2010, PHOTODERMATOL PHOTO, V26, P198, DOI 10.1111/j.1600-0781.2010.00522.x	32	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155889	10.1371/journal.pone.0155889	http://dx.doi.org/10.1371/journal.pone.0155889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203436	gold, Green Submitted, Green Published			2022-12-26	WOS:000376291500027
J	Wang, LS; Jiao, Y; Wang, YJ; Zhang, MC; Gu, WK				Wang, Lishi; Jiao, Yan; Wang, Yongjun; Zhang, Mengchen; Gu, Weikuan			Self-Confirmation and Ascertainment of the Candidate Genomic Regions of Complex Trait Loci - A None-Experimental Solution	PLOS ONE			English	Article							GENE-EXPRESSION; DETERMINANTS; MICE	Over the past half century, thousands of quantitative trait loci (QTL) have been identified by using animal models and plant populations. However, the none-reliability and imprecision of the genomic regions of these loci have remained the major hurdle for the identification of the causal genes for the correspondent traits. We used a none-experimental strategy of strain number reduction for testing accuracy and ascertainment of the candidate region for QTL. We tested the strategy in over 400 analyses with data from 47 studies. These studies include: 1) studies with recombinant inbred (RI) strains of mice. We first tested two previously mapped QTL with well-defined genomic regions; We then tested additional four studies with known QTL regions; and finally we examined the reliability of QTL in 38 sets of data which are produced from relatively large numbers of RI strains, derived from C57BL/6J (B6) X DBA/2J (D2), known as BXD RI mouse strains; 2) studies with RI strains of rats and plants; and 3) studies using F2 populations in mice, rats and plants. In these cases, our method identified the reliability of mapped QTL and localized the candidate genes into the defined genomic regions. Our data also suggests that LRS score produced by permutation tests does not necessarily confirm the reliability of the QTL. Number of strains are not the reliable indicators for the accuracy of QTL either. Our strategy determines the reliability and accuracy of the genomic region of a QTL without any additional experimental study such as congenic breeding.	[Wang, Lishi; Jiao, Yan; Gu, Weikuan] Univ Tennessee, Hlth Sci Ctr, Dept Orthoped Surg & BME, Campbell Clin, Memphis, TN 38163 USA; [Jiao, Yan] Mudanjiang Med Coll, Mudanjiang 157001, Heilongjiang, Peoples R China; [Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China; [Zhang, Mengchen] Hebei Acad Agr & Forestry Sci, Natl Ctr Soybean Res, Inst Hebei Cereal & Oil Crops, Shijiazhuang 050011, Hebei, Peoples R China; [Gu, Weikuan] Vet Affairs Med Ctr, Res Serv, 1030 Jefferson Ave, Memphis, TN 38104 USA; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Res, Inner Mongolia 010110, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Mudanjiang Medical University; Capital Medical University; Hebei Academy of Agricultural & Forestry Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Inner Mongolia Medical University	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Orthoped Surg & BME, Campbell Clin, Memphis, TN 38163 USA.; Gu, WK (corresponding author), Vet Affairs Med Ctr, Res Serv, 1030 Jefferson Ave, Memphis, TN 38104 USA.	zhangmengchen@hotmail.com			Department of Veterans Affairs [I01 BX000671]; Veterans Administration Medical Center in Memphis; National Natural Science Foundation of China [81372996]; 16 NIH Institutes and Centers - NIH Blueprint for Neuroscience Research [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Administration Medical Center in Memphis; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 16 NIH Institutes and Centers - NIH Blueprint for Neuroscience Research; McDonnell Center for Systems Neuroscience at Washington University	The study was partially supported by a merit grant (I01 BX000671 to WG) from the Department of Veterans Affairs and the Veterans Administration Medical Center in Memphis, TN; and by the National Natural Science Foundation of China (Project 81372996 to YJ). Data were provided in part by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Buresova M, 2006, PHYSIOL GENOMICS, V26, P226, DOI 10.1152/physiolgenomics.00056.2006; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Klein RF, 2002, J BONE MINER RES, V17, P1752, DOI 10.1359/jbmr.2002.17.10.1752; KLEINHOFS A, 1993, THEOR APPL GENET, V86, P705, DOI 10.1007/BF00222660; Lan H, 2006, PLOS GENET, V2, P51, DOI 10.1371/journal.pgen.0020006; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Porcu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018405; Tabakoff B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-70; Wang L., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1002/ASL2.454	12	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0153676	10.1371/journal.pone.0153676	http://dx.doi.org/10.1371/journal.pone.0153676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203862	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500007
J	Tartu, S; Bourgeon, S; Aars, J; Andersen, M; Ehrich, D; Thiemann, GW; Welker, JM; Routti, H				Tartu, Sabrina; Bourgeon, Sophie; Aars, Jon; Andersen, Magnus; Ehrich, Dorothee; Thiemann, Gregory W.; Welker, Jeffrey M.; Routti, Heli			Geographical Area and Life History Traits Influence Diet in an Arctic Marine Predator	PLOS ONE			English	Article							FEMALE POLAR BEARS; SEALS PUSA-HISPIDA; URSUS-MARITIMUS; STABLE-ISOTOPES; FOOD-WEB; ADIPOSE-TISSUE; RINGED SEALS; FATTY-ACIDS; NITROGEN-BALANCE; CLIMATE-CHANGE	Global changes are thought to affect most Arctic species, yet some populations are more at risk. Today, the Barents Sea ecoregion is suffering the strongest sea ice retreat ever measured; and these changes are suspected to modify food access and thus diet of several species. Biochemical diet tracers enable investigation of diet in species such as polar bears (Ursus maritimus). We examined individual diet variation of female polar bears in Svalbard, Norway, and related it to year, season (spring and autumn), sampling area and breeding status (solitary, with cubs of the year or yearlings). Sampling areas were split according to their ice cover: North-West (less sea ice cover), South-East (larger amplitude in sea ice extent) and North-East/South-West (NESW) as bears from that zone are more mobile among all regions of Svalbard. We measured fatty acid (FA) composition in adipose tissue and carbon (delta C-13) and nitrogen (delta N-15) stable isotopes in plasma and red blood cells. Females feeding in the North-West area had lower delta N-15 values than those from the NESW. In South-East females, delta C-13 values were lower in autumn compared to spring and females seemed less selective in their diet as depicted by large variances in stable isotope values. Considering the differences in FA composition and stable isotope values, we suggest that females from the North-West and South-East could ingest a higher proportion of avian prey. With regard to breeding status, solitary females had higher delta N-15 values and smaller variance in their stable isotopic values than females with cubs, suggesting that solitary females were more selective and prey on higher trophic level species (i.e. seals). Overall, our results indicate that prey availability for Svalbard polar bears varies according to geographical area and prey selectivity differs according to breeding status. Our findings suggest that complex changes in sea ice and prey availability will interact to affect Svalbard polar bear feeding patterns and associated nutrition.	[Tartu, Sabrina; Bourgeon, Sophie; Aars, Jon; Andersen, Magnus; Routti, Heli] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Bourgeon, Sophie; Ehrich, Dorothee] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Thiemann, Gregory W.] York Univ, Fac Environm Studies, Toronto, ON M3J 2R7, Canada; [Welker, Jeffrey M.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA; [Welker, Jeffrey M.] Univ Ctr Svalbard, Longyearbyen, Svalbard, Norway	Norwegian Polar Institute; UiT The Arctic University of Tromso; York University - Canada; University of Alaska System; University of Alaska Anchorage; University Centre Svalbard (UNIS)	Tartu, S (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	tartu.sabrina@gmail.com	Tartu, Sabrina/Q-4062-2018; aars, jon/AAB-3076-2021; Thiemann, Gregory/J-9517-2013; Ehrich, Dorothee/F-6492-2015; Routti, Heli/AAM-7884-2020	Tartu, Sabrina/0000-0002-4257-7495; aars, jon/0000-0002-0574-6712; Ehrich, Dorothee/0000-0002-3028-9488; Routti, Heli/0000-0001-5560-888X; Thiemann, Gregory/0000-0002-1888-900X	Norwegian polar institute; Research Council of Norway; Fulbright Distinguished US Arctic Chairship-Norway;  [216568/E10]	Norwegian polar institute; Research Council of Norway(Research Council of Norway); Fulbright Distinguished US Arctic Chairship-Norway; 	This study was supported by the Norwegian polar institute and the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906). The grant 216568/E10 was received by HR. This collaboration was supported in part by the Fulbright Distinguished US Arctic Chairship-Norway awarded to JM Welker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars J, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.26612; Akearok J., 2011, THESIS CARLETON U; Amstrup S. C. Polar bear, 2003, WILD MAMM N AM BIOL; Anderson D, 2004, MODEL SELECTION MULT, V2nd; ARNOULD JPY, 1994, CAN J ZOOL, V72, P1365, DOI 10.1139/z94-180; Atkinson SN, 1996, PHYSIOL ZOOL, V69, P304, DOI 10.1086/physzool.69.2.30164186; Bothma JD, 2004, J MAMMAL, V85, P756, DOI 10.1644/BNS-010; Braune BM, 2015, ECOTOX ENVIRON SAFE, V115, P7, DOI 10.1016/j.ecoenv.2015.01.027; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Budge SM, 2012, CAN J FISH AQUAT SCI, V69, P1033, DOI [10.1139/F2012-039, 10.1139/f2012-039]; Carlens H, 2006, MAR MAMMAL SCI, V22, P379, DOI 10.1111/j.1748-7692.2006.00034.x; Cavalieri DJ, 2012, CRYOSPHERE, V6, P881, DOI 10.5194/tc-6-881-2012; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Dehn LA, 2006, SCI TOTAL ENVIRON, V362, P103, DOI 10.1016/j.scitotenv.2005.11.012; Derocher AE, 2000, POLAR BIOL, V23, P675, DOI 10.1007/s003000000138; Derocher AE, 2002, POLAR BIOL, V25, P448, DOI 10.1007/s00300-002-0364-0; Derocher AE, 2002, J ZOOL, V256, P343, DOI 10.1017/S0952836902000377; DEROCHER AE, 1993, CAN J ZOOL, V71, P561, DOI 10.1139/z93-077; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Dyck MG, 2007, POLAR BIOL, V30, P1625, DOI 10.1007/s00300-007-0338-3; Falk-Petersen S, 2004, POLAR RES, V23, P43, DOI 10.1111/j.1751-8369.2004.tb00128.x; Falk-Petersen S, 2009, DEEP-SEA RES PT II, V56, P2080, DOI 10.1016/j.dsr2.2008.11.020; Folkow LP, 1996, POLAR BIOL, V16, P179, DOI 10.1007/BF02329206; Fox Anthony D., 2010, Ornis Svecica, V20, P115; Fox TA, 2006, ARDEA, V94, P691; Freitas C, 2012, MAR ECOL PROG SER, V447, P289, DOI 10.3354/meps09516; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gormezano LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128520; Gormezano LJ, 2013, ECOL EVOL, V3, P3509, DOI 10.1002/ece3.740; Grahl-Nielsen O, 2003, MAR ECOL PROG SER, V265, P275, DOI 10.3354/meps265275; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hatch Kent A., 2012, P337; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2002, DEEP-SEA RES PT II, V49, P5131, DOI 10.1016/S0967-0645(02)00182-0; Hop H, 2000, POLAR BIOL, V23, P357, DOI 10.1007/s003000050456; Hunter JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1033, DOI 10.1007/s00265-006-0336-4; Iversen M, 2013, POLAR BIOL, V36, P561, DOI 10.1007/s00300-012-1284-2; Iverson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3128; Iverson SJ, 2007, MAR ECOL PROG SER, V352, P235, DOI 10.3354/meps07073; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; Kovacs KM, 2014, POLAR RES, V33, P26034, DOI [DOI 10.3402/P0LAR.V33.26034, 10.3402/polar.v33.26034]; Krafft BA, 2006, MAR MAMMAL SCI, V22, P394, DOI 10.1111/j.1748-7692.2006.00035.x; Laidre KL, 2015, CONSERV BIOL, V29, P724, DOI 10.1111/cobi.12474; Lenth R. V., 2015, ISMEANS LEAST SQUARE; Lone K, 2013, POLAR BIOL, V36, P27, DOI 10.1007/s00300-012-1235-y; Lono O., 1970, POLAR BEAR URSUS MAR, P118; Loseto LL, 2009, J EXP MAR BIOL ECOL, V374, P12, DOI 10.1016/j.jembe.2009.03.015; Lydersen C, 2014, J MARINE SYST, V129, P452, DOI 10.1016/j.jmarsys.2013.09.006; Lydersen Christian, 1998, NAMMCO Scientific Publications, V1, P46; Ma McKinney, 2016, REV ECOLOGICAL IMPAC; Mauritzen M, 2002, J APPL ECOL, V39, P79, DOI 10.1046/j.1365-2664.2002.00690.x; Mauritzen M, 2001, CAN J ZOOL, V79, P1704, DOI 10.1139/z01-126; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; Merkel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067576; MESSIER F, 1992, J ZOOL, V226, P219, DOI 10.1111/j.1469-7998.1992.tb03835.x; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Nordoy ES, 2008, POLAR BIOL, V31, P1119, DOI 10.1007/s00300-008-0453-9; Pavlova O, 2014, J MARINE SYST, V130, P248, DOI 10.1016/j.jmarsys.2013.02.011; Pilfold NW, 2014, GLOBAL ECOL BIOGEOGR, V23, P425, DOI 10.1111/geb.12112; Pilfold NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041429; Pinheiro J, 2015, NLME LINEAR NONLINEA; Prop J, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00033; R Core Team, 2013, R LANG ENV STAT COMP; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Rode KD, 2015, FRONT ECOL ENVIRON, V13, P138, DOI 10.1890/140202; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Rogers MC, 2015, POLAR BIOL, V38, P1035, DOI 10.1007/s00300-015-1665-4; Ruiz-Olmo J, 2005, J ZOOL, V265, P339, DOI 10.1017/S0952836905006424; Ruiz-Olmo Jordi, 2005, Lutra, V48, P45; Simmonds I, 2015, ANN GLACIOL, V56, P18, DOI 10.3189/2015AoG69A909; Smith PA, 2010, POLAR BIOL, V33, P1149, DOI 10.1007/s00300-010-0791-2; SMITH TG, 1991, POLAR RES, V10, P585, DOI 10.1111/j.1751-8369.1991.tb00676.x; Speake BK, 2002, J ZOOL, V257, P533, DOI 10.1017/S0952836902001115; STEMPNIEWICZ L, 1993, POLAR RES, V12, P33, DOI 10.1111/j.1751-8369.1993.tb00420.x; Stempniewicz L, 2006, ARCTIC, V59, P247; Stempniewicz L, 2014, POLAR REC, V50, P216, DOI 10.1017/S0032247413000053; STIRLING I, 1989, J WILDLIFE DIS, V25, P159, DOI 10.7589/0090-3558-25.2.159; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Thiemann GW, 2006, J ZOOL, V269, P65, DOI 10.1111/j.1469-7998.2006.00084.x; Vikingsson GA, 2014, MAR BIOL RES, V10, P138, DOI 10.1080/17451000.2013.793812; VINJE T, 1991, POLAR RES, V10, P59, DOI 10.1111/j.1751-8369.1991.tb00635.x; Vongraven Dag, 2012, Ursus Monograph Series, V5, P1; Wang MY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052868; Wang SW, 2015, ECOL APPL, DOI [10.1890/14-2421.1, DOI 10.1890/14-2421.1]; Watt CA, 2015, MAR MAMMAL SCI, V31, P21, DOI 10.1111/mms.12131; Wiig Oystein, 2008, Science Progress, V91, P151, DOI 10.3184/003685008X324506	95	20	20	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155980	10.1371/journal.pone.0155980	http://dx.doi.org/10.1371/journal.pone.0155980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196700	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291100143
J	Zhou, BY; Ritt, DA; Morrison, DK; Der, CJ; Cox, AD				Zhou, Bingying; Ritt, Daniel A.; Morrison, Deborah K.; Der, Channing J.; Cox, Adrienne D.			Protein Kinase CK2 Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2 Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; dual specificity phosphoprotein phosphatase; extracellular signal-regulated kinase (ERK); melanoma; Ras protein; CK2; kinase suppressor of RAS 1 (KSR1)	PANCREATIC-CANCER; ACTIVATION; CK2-ALPHA; CELLS; PHOSPHORYLATES; CARCINOMA; SURVIVAL; LEUKEMIA; COMPLEX	The protein kinase casein kinase 2 (CK2) is a pleiotropic and constitutively active kinase that plays crucial roles in cellular proliferation and survival. Overexpression of CK2, particularly the catalytic subunit (CK2, CSNK2A1), has been implicated in a wide variety of cancers and is associated with poorer survival and resistance to both conventional and targeted anticancer therapies. Here, we found that CK2 protein is elevated in melanoma cell lines compared with normal human melanocytes. We then tested the involvement of CK2 in drug resistance to Food and Drug Administration-approved single agent targeted therapies for melanoma. In BRAF mutant melanoma cells, ectopic CK2 decreased sensitivity to vemurafenib (BRAF inhibitor), dabrafenib (BRAF inhibitor), and trametinib (MEK inhibitor) by a mechanism distinct from that of mutant NRAS. Conversely, knockdown of CK2 sensitized cells to inhibitor treatment. CK2-mediated RAF-MEK kinase inhibitor resistance was tightly linked to its maintenance of ERK phosphorylation. We found that CK2 post-translationally regulates the ERK-specific phosphatase dual specificity phosphatase 6 (DUSP6) in a kinase dependent-manner, decreasing its abundance. However, we unexpectedly showed, by using a kinase-inactive mutant of CK2, that RAF-MEK inhibitor resistance did not rely on CK2 kinase catalytic function, and both wild-type and kinase-inactive CK2 maintained ERK phosphorylation upon inhibition of BRAF or MEK. That both wild-type and kinase-inactive CK2 bound equally well to the RAF-MEK-ERK scaffold kinase suppressor of Ras 1 (KSR1) suggested that CK2 increases KSR facilitation of ERK phosphorylation. Accordingly, CK2 did not cause resistance to direct inhibition of ERK by the ERK1/2-selective inhibitor SCH772984. Our findings support a kinase-independent scaffolding function of CK2 that promotes resistance to RAF- and MEK-targeted therapies.	[Zhou, Bingying; Der, Channing J.; Cox, Adrienne D.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Der, Channing J.; Cox, Adrienne D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Ritt, Daniel A.; Morrison, Deborah K.] NCI, Lab Cell & Dev Signaling, Ctr Canc Res, NIH, Frederick, MD 21702 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cox, AD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	adrienne_cox@med.unc.edu		Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health [CA042978, CA179193, CA199235]; NCI [ZIA BC 010329]; Pancreatic Cancer Action Network-American Association for Cancer Research; NATIONAL CANCER INSTITUTE [U01CA199235, ZIABC010329, R21CA179193, ZIABC011107, R01CA042978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pancreatic Cancer Action Network-American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA042978, CA179193, and CA199235 (to A. D. C. and C. J. D.) and ZIA BC 010329 from the NCI (to D. K. M. and D. A. R.) and by the Pancreatic Cancer Action Network-American Association for Cancer Research (to A. D. C. and C. J. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae JS, 2015, INT J CANCER, V136, P797, DOI 10.1002/ijc.29043; Borgo C, 2013, MOL ONCOL, V7, P1103, DOI 10.1016/j.molonc.2013.08.006; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; Castelli M, 2004, J BIOL CHEM, V279, P44731, DOI 10.1074/jbc.M407669200; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Di Maira G, 2007, ONCOGENE, V26, P6915, DOI 10.1038/sj.onc.1210495; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; Hanif IM, 2010, INT J BIOCHEM CELL B, V42, P1602, DOI 10.1016/j.biocel.2010.06.010; Hayes TK, 2016, CANCER CELL, V29, P75, DOI 10.1016/j.ccell.2015.11.011; Heriche JK, 1998, ONCOGENE, V17, P13, DOI 10.1038/sj.onc.1201900; Herrero A, 2015, CANCER CELL, V28, P170, DOI 10.1016/j.ccell.2015.07.001; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Jovanovic B, 2008, J INVEST DERMATOL, V128, P2696, DOI 10.1038/jid.2008.134; Kreutzer JN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-440; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Martins LR, 2010, BLOOD, V116, P2724, DOI 10.1182/blood-2010-04-277947; Menzies AM, 2014, LANCET ONCOL, V15, pE371, DOI 10.1016/S1470-2045(14)70072-5; Mitev Vanio, 1994, Journal of Dermatological Science, V8, P45, DOI 10.1016/0923-1811(94)90320-4; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Muda M, 1996, J BIOL CHEM, V271, P4319; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ortega CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115609; Parker R, 2014, MOL CANCER THER, V13, P1894, DOI 10.1158/1535-7163.MCT-13-0938; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Plotnikov A, 2011, MOL CELL BIOL, V31, P3515, DOI 10.1128/MCB.05424-11; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Shields JM, 2007, CANCER RES, V67, P1502, DOI 10.1158/0008-5472.CAN-06-3311; Solit DB, 2014, CANCER DISCOV, V4, P27, DOI 10.1158/2159-8290.CD-13-0961; Spagnolo F, 2014, ONCOTARGET, V5, P10206, DOI 10.18632/oncotarget.2602; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Zhang HX, 2015, ONCOTARGET, V6, P34800, DOI 10.18632/oncotarget.5470; Zhang WJ, 2015, CURR OPIN PHARMACOL, V23, P68, DOI 10.1016/j.coph.2015.05.015	40	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17804	17815		10.1074/jbc.M115.712885	http://dx.doi.org/10.1074/jbc.M115.712885			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27226552	Green Published, hybrid			2022-12-26	WOS:000383241300027
J	Haeseleer, F; Williams, B; Lee, A				Haeseleer, Francoise; Williams, Brittany; Lee, Amy			Characterization of C-terminal Splice Variants of CaV1.4 Ca2+Channels in Human Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; CALCIUM-DEPENDENT INACTIVATION; PHOTORECEPTOR RIBBON SYNAPSES; OUTER PLEXIFORM LAYER; AUDITORY HAIR-CELLS; GATED CA2+ CHANNELS; CA(V)1.3 CHANNELS; MOUSE RETINA; CACNA1F GENE; CA2+-DEPENDENT INACTIVATION	Voltage-gated Ca(2+) channels (Cav) undergo extensive alternative splicing that greatly enhances their functional diversity in excitable cells. Here, we characterized novel splice variants of the cytoplasmic C-terminal domain of Cav1.4 Ca(2+) channels that regulate neurotransmitter release in photoreceptors in the retina. These variants lack a portion of exon 45 and/or the entire exon 47 (Cav1.4 Delta ex p45, Cav1.4 Delta ex 47, Cav1.4 Delta ex p45,47) and are expressed in the retina of primates but not mice. Although the electrophysiological properties of Cav1.4 Delta ex p45 are similar to those of full-length channels (Cav1.4FL), skipping of exon 47 dramatically alters Cav1.4 function. Deletion of exon 47 removes part of a C-terminal automodulatory domain (CTM) previously shown to suppress Ca(2+)-dependent inactivation (CDI) and to cause a positive shift in the voltage dependence of channel activation. Exon 47 is crucial for these effects of the CTM because variants lacking this exon show intense CDI and activate at more hyperpolarized voltages than Cav1.4FL The robust CDI of Cav1.4 Delta ex 47 is suppressed by CaBP4, a regulator of Cav1.4 channels in photoreceptors. Although CaBP4 enhances activation of Cav1.4FL, Cav1.4 Delta ex 47 shows similar voltage-dependent activation in the presence and absence of CaBP4. We conclude that exon 47 encodes structural determinants that regulate CDI and voltage-dependent activation of Cav1.4, and is necessary for modulation of channel activation by CaBP4	[Haeseleer, Francoise] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Williams, Brittany; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Williams, Brittany] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA 52242 USA	University of Washington; University of Washington Seattle; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Lee, A (corresponding author), Dept Mol Physiol & Biophys Otolaryngol Head Neck, 169 Newton Rd,PBDB 5318, Iowa City, IA 52242 USA.	amy-lee@uiowa.edu		Lee, Amy/0000-0001-8021-0443; williams, brittany/0000-0002-6597-619X	National Institutes of Health [EY020850, NS084190, DC009433]; Carver Research Program of Excellence Award; NATIONAL EYE INSTITUTE [R01EY020850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009433, R55DC009433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grants EY020850 (to F. H.), NS084190 and DC009433 (to A. L.), and a Carver Research Program of Excellence Award (to A. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Ball SL, 2011, BRAIN RES, V1412, P1, DOI 10.1016/j.brainres.2011.07.033; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Berntson A, 2004, VISUAL NEUROSCI, V21, P693, DOI 10.1017/S0952523804215048; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Doering CJ, 2007, CHANNELS, V1; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Findeisen F, 2013, J MOL BIOL, V425, P3217, DOI 10.1016/j.jmb.2013.06.024; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Hardie J, 2016, CHANNELS, V10, P33, DOI 10.1080/19336950.2015.1051273; Hauke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076414; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Jalkanen R, 2007, INVEST OPHTH VIS SCI, V48, P2498, DOI 10.1167/iovs.06-1103; Katiyar R, 2015, INVEST OPHTH VIS SCI, V56, P2312, DOI 10.1167/iovs.15-16654; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; KOSTYUK PG, 1982, J MEMBRANE BIOL, V70, P171, DOI 10.1007/BF01870560; Lee A, 2015, J BIOL CHEM, V290, P1505, DOI 10.1074/jbc.M114.607465; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Lieb A, 2014, BIOPHYS J, V106, P1467, DOI 10.1016/j.bpj.2014.02.017; Lipscombe D, 2013, TRENDS NEUROSCI, V36, P598, DOI 10.1016/j.tins.2013.06.008; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Liu XN, 2013, CHANNELS, V7, P514, DOI 10.4161/chan.26376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Oz S, 2013, J BIOL CHEM, V288, P12680, DOI 10.1074/jbc.M113.460949; Raven MA, 2008, J COMP NEUROL, V506, P745, DOI 10.1002/cne.21526; Regus-Leidig H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086769; Scharinger A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00309; Shaltiel L, 2012, J BIOL CHEM, V287, P36312, DOI 10.1074/jbc.M112.392811; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tan GMY, 2012, J BIOL CHEM, V287, P832, DOI 10.1074/jbc.M111.268722; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004	56	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15663	15673		10.1074/jbc.M116.731737	http://dx.doi.org/10.1074/jbc.M116.731737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226626	Green Published, hybrid			2022-12-26	WOS:000380584200021
J	Heidrich, J; Wulf, V; Hennig, R; Saur, M; Markl, J; Sonnichsen, C; Schneider, D				Heidrich, Jennifer; Wulf, Verena; Hennig, Raoul; Saur, Michael; Markl, Juergen; Soennichsen, Carsten; Schneider, Dirk			Organization into Higher Ordered Ring Structures Counteracts Membrane Binding of IM30, a Protein Associated with Inner Membranes in Chloroplasts and Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-SHOCK-PROTEIN; SP PCC 6803; THYLAKOID MEMBRANE; ESCHERICHIA-COLI; PLASMONIC NANOPARTICLES; VIPP1; SYNECHOCYSTIS; PSPA; DOMAIN; NANOSENSORS	The IM30 (inner membrane-associated protein of 30 kDa), also known as the Vippl (vesicle-inducing protein in plastids 1), has a crucial role in thylakoid membrane biogenesis and maintenance. Recent results suggest that the protein binds peripherally to membranes containing negatively charged lipids. However, although IM30 monomers interact and assemble into large oligomeric ring complexes with different numbers of monomers, it is still an open question whether ring formation is crucial for membrane interaction. Here we show that binding of IM30 rings to negatively charged phosphatidylglycerol membrane surfaces results in a higher ordered membrane state, both in the head group and in the inner core region of the lipid bilayer. Furthermore, by using gold nanorods covered with phosphatidylglycerol layers and single particle spectroscopy, we show that not only IM30 rings but also lower oligomeric IM30 structures interact with membranes, although with higher affinity. Thus, ring formation is not crucial for, and even counteracts, membrane interaction of IM30.	[Heidrich, Jennifer; Hennig, Raoul; Schneider, Dirk] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becher Weg 30, D-55128 Mainz, Germany; [Wulf, Verena; Soennichsen, Carsten] Johannes Gutenberg Univ Mainz, Inst Phys Chem, D-55128 Mainz, Germany; [Saur, Michael; Markl, Juergen] Johannes Gutenberg Univ Mainz, Inst Zool, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Schneider, D (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becher Weg 30, D-55128 Mainz, Germany.	Dirk.Schneider@uni-mainz.de	Sönnichsen, Carsten/A-5682-2009; Wulf, Verena/AFU-0261-2022	Sönnichsen, Carsten/0000-0003-1824-7696; Saur, Michael/0000-0002-6612-6656	Max Planck Graduate Center at the Max Planck Institutes; University of Mainz	Max Planck Graduate Center at the Max Planck Institutes; University of Mainz	This work was supported by the Max Planck Graduate Center at the Max Planck Institutes and the University of Mainz. The authors declare that they have no conflicts of interest with the contents of this article.	Adamczyk Z, 1996, J CHEM PHYS, V105, P5562, DOI 10.1063/1.472409; Ahijado-Guzman R, 2014, NANO LETT, V14, P5528, DOI 10.1021/nl501865p; Ament I, 2012, NANO LETT, V12, P1092, DOI 10.1021/nl204496g; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; Aseeva E, 2007, PLANT PHYSIOL BIOCH, V45, P119, DOI 10.1016/j.plaphy.2007.01.005; BARBER J, 1986, PHOTOSYNTH RES, V9, P239, DOI 10.1007/BF00029747; BISWAL B, 1989, BIOCHEM PHYSIOL PFL, V184, P213, DOI 10.1016/S0015-3796(89)80005-8; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Bultema Jelle B, 2010, Commun Integr Biol, V3, P162; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Fuhrmann E, 2009, MOL BIOL CELL, V20, P4620, DOI 10.1091/mbc.E09-04-0319; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200; HARRIS JR, 1994, MICRON, V25, P5; Hennig R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8018; Kobayashi R, 2007, MOL MICROBIOL, V66, P100, DOI 10.1111/j.1365-2958.2007.05893.x; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Lamy-Freund MT, 2003, CHEM PHYS LIPIDS, V122, P19, DOI 10.1016/S0009-3084(02)00175-5; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Liu CM, 2007, PLANT J, V50, P265, DOI 10.1111/j.1365-313X.2007.03047.x; MURATA N, 1992, PLANT CELL PHYSIOL, V33, P933; MURATA N, 1989, J BIOENERG BIOMEMBR, V21, P61, DOI 10.1007/BF00762212; Olson J, 2015, CHEM SOC REV, V44, P40, DOI 10.1039/c4cs00131a; Osadnik H, 2015, MOL MICROBIOL, V98, P743, DOI 10.1111/mmi.13154; Otters S, 2013, PLANTA, V237, P529, DOI 10.1007/s00425-012-1772-1; Raschke G, 2003, NANO LETT, V3, P935, DOI 10.1021/nl034223+; Rast A, 2015, BBA-BIOENERGETICS, V1847, P821, DOI 10.1016/j.bbabio.2015.01.007; Rosman C, 2013, NANO LETT, V13, P3243, DOI 10.1021/nl401354f; Sanchez SA, 2012, P NATL ACAD SCI USA, V109, P7314, DOI 10.1073/pnas.1118288109; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; vanderHeide UA, 1996, CHEM PHYS LETT, V253, P118, DOI 10.1016/0009-2614(96)00212-6; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Westphal S, 2001, FEBS LETT, V506, P257, DOI 10.1016/S0014-5793(01)02931-3; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Zhang L, 2013, BBA-GEN SUBJECTS, V1830, P2150, DOI 10.1016/j.bbagen.2012.09.016	37	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14954	14962		10.1074/jbc.M116.722686	http://dx.doi.org/10.1074/jbc.M116.722686			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226585	hybrid, Green Published			2022-12-26	WOS:000380583200008
J	Kromann-Hansen, T; Oldenburg, E; Yung, KWY; Ghassabeh, GH; Muyldermans, S; Declerck, PJ; Huang, MD; Andreasen, PA; Ngo, JCK				Kromann-Hansen, Tobias; Oldenburg, Emil; Yung, Kristen Wing Yu; Ghassabeh, Gholamreza H.; Muyldermans, Serge; Declerck, Paul J.; Huang, Mingdong; Andreasen, Peter A.; Ngo, Jacky Chi Ki			A Camelid-derived Antibody Fragment Targeting the Active Site of a Serine Protease Balances between Inhibitor and Substrate Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR; UROKINASE INHIBITOR; PLASMA KALLIKREIN; STRUCTURAL BASIS; TRYPSIN; MECHANISM; BINDING; CHYMOTRYPSIN; SPECIFICITY; AFFINITY	A peptide segment that binds the active site of a serine protease in a substrate-like manner may behave like an inhibitor or a substrate. However, there is sparse information on which factors determine the behavior a particular peptide segment will exhibit. Here, we describe the first x-ray crystal structure of a nanobody in complex with a serine protease. The nanobody displays a new type of interaction between an antibody and a serine protease as it inserts its complementary determining region-H3 loop into the active site of the protease in a substrate-like manner. The unique binding mechanism causes the nanobody to behave as a strong inhibitor as well as a poor substrate. Intriguingly, its substrate behavior is incomplete, as 30-40% of the nanobody remainedintactandinhibitoryafterprolongedincubationwiththe protease. Biochemical analysis reveals that an intra-loop interaction network within the complementary determining region-H3 of the nanobody balances its inhibitor versus substrate behavior. Collectively, our results unveil molecular factors, which may be a general mechanism to determine the substrate versus inhibitor behavior of other protease inhibitors.	[Kromann-Hansen, Tobias; Oldenburg, Emil; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Yung, Kristen Wing Yu; Ngo, Jacky Chi Ki] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Ghassabeh, Gholamreza H.; Muyldermans, Serge] Vrije Univ Brussels, Lab Cellular & Mol Immunol, B-1050 Brussels, Belgium; [Ghassabeh, Gholamreza H.] Flanders Inst Biotechnol, Nanobody Serv Facil, B-1050 Brussels, Belgium; [Declerck, Paul J.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, B-3000 Leuven, Belgium; [Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China	Aarhus University; Chinese University of Hong Kong; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Kromann-Hansen, T (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	tobiaskh@mbg.au.dk	Declerck, Paul J/A-2330-2017; Huang, Mingdong/J-4278-2017; Muyldermans, Serge/AAC-7374-2019; Ngo, Jacky C/O-8093-2017	Declerck, Paul J/0000-0003-1259-9105; Huang, Mingdong/0000-0003-0085-9141; Muyldermans, Serge/0000-0002-3678-3575; Ngo, Jacky C/0000-0002-6004-7041; Yung, Kristen Wing Yu/0000-0001-7389-3012	Danish National Research Foundation [26-331-6]; Natural Science Foundation of China [31161130356, 31170707, 31370737]; Lundbeck Foundation [R83-A7826]; Cancer Research Foundation of 1989; Research Grants Council of Hong Kong SAR [GRF 473310, CUHK1/CRF/13G]; CUHK One-off Funding for Joint Lab Project [3132980]; Graduate School of Science and Technology, Aarhus University; Carlsberg Foundation [CF15-0814]	Danish National Research Foundation(Danmarks Grundforskningsfond); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Lundbeck Foundation(Lundbeckfonden); Cancer Research Foundation of 1989; Research Grants Council of Hong Kong SAR(Hong Kong Research Grants Council); CUHK One-off Funding for Joint Lab Project; Graduate School of Science and Technology, Aarhus University; Carlsberg Foundation(Carlsberg Foundation)	This work was supported in part by Danish National Research Foundation Grant 26-331-6 (to P. A. A.), Natural Science Foundation of China Grants 31161130356, 31170707, and 31370737 (to M. H.), Lundbeck Foundation Grant R83-A7826 (to P. A. A.), The Cancer Research Foundation of 1989 (to P. A. A.), Research Grants Council of Hong Kong SAR Grants GRF 473310 and CUHK1/CRF/13G, and CUHK One-off Funding for Joint Lab Project Number 3132980 (to J. C. K. N.) the Graduate School of Science and Technology, Aarhus University (to T. K. H.), Carlsberg Foundation Grant CF15-0814 (to T. K. H.). The authors declare that they have no conflicts of interest with the content of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Cudic M, 2009, CURR PROTEIN PEPT SC, V10, P297, DOI 10.2174/138920309788922207; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; de Veer SJ, 2015, BIOCHEM J, V469, P243, DOI 10.1042/BJ20150412; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farady CJ, 2008, J MOL BIOL, V380, P351, DOI 10.1016/j.jmb.2008.05.009; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; FINKENSTADT WR, 1967, J BIOL CHEM, V242, P771; FINKENSTADT WR, 1965, J BIOL CHEM, V240, pP962; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hendrickx MLV, 2011, J THROMB HAEMOST, V9, P2268, DOI 10.1111/j.1538-7836.2011.04495.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenniston JA, 2014, J BIOL CHEM, V289, P23596, DOI 10.1074/jbc.M114.569061; Kromann-Hansen T, 2013, BIOCHEMISTRY-US, V52, P7114, DOI 10.1021/bi400491k; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; PETERSEN LC, 1985, BIOCHEM J, V225, P149, DOI 10.1042/bj2250149; Puente X O, 2008, THE CANC DEGRADOME, P3; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Stoop AA, 2003, NAT BIOTECHNOL, V21, P1063, DOI 10.1038/nbt860; Swedberg JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019302; Tarr AW, 2013, HEPATOLOGY, V58, P932, DOI 10.1002/hep.26430; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vincke Cecile, 2012, Methods Mol Biol, V907, P145, DOI 10.1007/978-1-61779-974-7_8; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Xu P, 2015, J MED CHEM, V58, P8868, DOI 10.1021/acs.jmedchem.5b01128; Zakharova E, 2008, J MOL BIOL, V382, P998, DOI 10.1016/j.jmb.2008.07.063; Zhao BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115872; Zhao GX, 2007, J STRUCT BIOL, V160, P1, DOI 10.1016/j.jsb.2007.06.003	52	29	30	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15156	15168		10.1074/jbc.M116.732503	http://dx.doi.org/10.1074/jbc.M116.732503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226628	Green Published, hybrid			2022-12-26	WOS:000380583200025
J	Chen, Z; Dempsey, DR; Thomas, SN; Hayward, D; Bolduc, DM; Cole, PA				Chen, Zan; Dempsey, Daniel R.; Thomas, Stefani N.; Hayward, Dawn; Bolduc, David M.; Cole, Philip A.			Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; phosphatase and tensin homolog (PTEN); phosphorylation; post-translational modification (PTM); protein conformation; pten	TUMOR-SUPPRESSOR PTEN; MEMBRANE ASSOCIATION; STABILITY; CANCER; GENE; TAIL	PTEN is a tumor suppressor that functions to negatively regulate the PI3K/AKT pathway as the lipid phosphatase for phosphatidylinositol 3,4,5-triphosphate. Phosphorylation of a cluster of Ser/Thr residues (amino acids 380-385) on the C-terminal tail serves to alter the conformational state of PTEN from an open active state to a closed inhibited state, resulting in a reduction of plasma membrane localization and inhibition of enzyme activity. The relative contribution of each phosphorylation site to PTEN autoinhibition and the structural basis for the conformational closure is still unclear. To further the structural understanding of PTEN regulation by C-terminal tail phosphorylation, we used protein semisynthesis to insert stoichiometric and site-specific phospho-Ser/Thr(s) in the C-terminal tail of PTEN. Additionally, we employed photo-cross-linking to map the intramolecular PTEN interactions of the phospho-tail. Systematic evaluation of the PTEN C-tail phospho-cluster showed autoinhibition, and conformational closure was influenced by the aggregate effect of multiple phospho-sites rather than dominated by a single phosphorylation site. Moreover, photo-cross-linking suggested a direct interaction between the PTEN C-tail and a segment in the N-terminal region of the catalytic domain. Mutagenesis experiments provided additional insights into how the PTEN phospho-tail interacts with both the C2 and catalytic domains.	[Chen, Zan; Dempsey, Daniel R.; Thomas, Stefani N.; Hayward, Dawn; Bolduc, David M.; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 316 Hunterian,725 N Wolfe St, Baltimore, MD 21205 USA	Johns Hopkins University	Cole, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 316 Hunterian,725 N Wolfe St, Baltimore, MD 21205 USA.	pcole@jhmi.edu	Thomas, Stefani/AAF-4212-2021; Chen, Zan/D-3531-2019	Thomas, Stefani/0000-0003-1679-5453; Chen, Zan/0000-0001-9925-872X	National Institutes of Health [CA74305]; NATIONAL CANCER INSTITUTE [R01CA074305, R29CA074305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM120855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant CA74305. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691; Chen Z, 2015, CURR OPIN CHEM BIOL, V28, P115, DOI 10.1016/j.cbpa.2015.07.001; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Masson GR, 2016, BIOCHEM J, V473, P135, DOI 10.1042/BJ20150931; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mueller-Planitz F, 2015, BIOINFORMATICS, V31, P2043, DOI 10.1093/bioinformatics/btv083; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Salvesen HB, 2001, INT J CANCER, V91, P22, DOI 10.1002/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang Q, 2010, J MOL GRAPH MODEL, V29, P102, DOI 10.1016/j.jmgm.2010.05.004; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Wei Y, 2015, J BIOL CHEM, V290, P1592, DOI 10.1074/jbc.M114.588590; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907	24	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14160	14169		10.1074/jbc.M116.728980	http://dx.doi.org/10.1074/jbc.M116.728980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226612	hybrid, Green Published			2022-12-26	WOS:000379975100023
J	Przybysz, P; Dubowik, M; Kucner, MA; Przybysz, K; Przybysz Buzala, K				Przybysz, Piotr; Dubowik, Marcin; Kucner, Marta Anna; Przybysz, Kazimierz; Przybysz Buzala, Kamila			Contribution of Hydrogen Bonds to Paper Strength Properties	PLOS ONE			English	Article							WATER; PULP	The objective of this work was to investigate the influence of hydrogen bonds between fibres on static and dynamic strength properties of paper. A commercial bleached pinewood kraft pulp was soaked in water, refined in a PFI, and used to form paper webs in different solvents, such as water, methanol, ethanol, n-propanol and n-butanol, to determine the effect of their dipole moment on static and dynamic strength properties of resulting paper sheets. Paper which was formed in water, being the solvent of the highest dipole moment among the tested ones, showed the highest breaking length and tear resistance. When paper webs were formed in n-butanol, which was the least polar among the solvents, these parameters were reduced by around 75%. These results provide evidence of the importance of water in paper web formation and strong impact of hydrogen bonds between fibres on strength properties of paper.	[Przybysz, Piotr; Przybysz, Kazimierz; Przybysz Buzala, Kamila] Lodz Univ Technol, Inst Papermaking & Printing Technol, Wolczanska Str 223, PL-90924 Lodz, Poland; [Dubowik, Marcin; Kucner, Marta Anna] Lodz Univ Technol, Fac Proc & Environm Engn, Wolczanska 213, PL-90924 Lodz, Poland	Lodz University of Technology; Lodz University of Technology	Dubowik, M (corresponding author), Lodz Univ Technol, Fac Proc & Environm Engn, Wolczanska 213, PL-90924 Lodz, Poland.	marcin.dubowik1989@gmail.com		Dubowik, Marcin/0000-0001-6809-3205; Przybysz, Piotr/0000-0003-2044-6790	 [LIDER/042/407/L-4/12/NCBR/2013]		This work was supported by LIDER/042/407/L-4/12/NCBR/2013 founded by National Centre for Research and Development, Poland (NCBiR) to PP (www.ncbr.gov.pl).	[Anonymous], 2013, FILTR SEPARAT, V50, P42; Campbell WB, 1933, FOREST SEVICE B, V84; Diniz JMBF, 2004, WOOD SCI TECHNOL, V37, P489, DOI 10.1007/s00226-003-0216-2; Ghosh A.K., 2011, EVAPORATION CONDENSA, V1st ed., DOI [10.5772/21594, DOI 10.5772/21594]; Holik H, 2006, HDB PAPER BOARD; Hubbe MA, 2007, BIORESOURCES, V2, P500; LAIVINS GV, 1994, TAPPI J, V77, P125; Maloney TC, 1998, NORD PULP PAP RES J, V13, P285, DOI 10.3183/npprj-1998-13-04-p285-291; Maloney TC, 1997, APPITA J, V50, P301; Mark R. E., 2001, HDB PHYS TESTING PAP, V1; McMurry J., 2012, ORGANIC CHEM; Monte MC, 2009, WASTE MANAGE, V29, P293, DOI 10.1016/j.wasman.2008.02.002; Niskanen, 1998, PAPER PHYS; Norman B, 2000, PAPERMAKING STOCK PR, P232; Norman B, 2009, PULP AND PAPER CHEMISTRY AND TECHNOLOGY, VOL 3: PAPER CHEMISTRY AND TECHNOLOGY, P173; O'Rourke D, 2005, J IND ECOL, V9, P115, DOI 10.1162/1088198054084608; Page DH, 1965, T FUND RES S, P313; Paulapuro H, 2000, PAPERMAKING SCIENCE; Prosinski S., 1984, WOOD CHEM; Przybysz K, 2007, POLISH PAPER REV, V63, P395; Przybysz K, 2007, POLISH PAPER REV, V63, P221; Przybysz K, 2007, PRZEGLAD PAPIERNICZY, V63, P113; Rantanen J, 2015, CELLULOSE, V22, P4003, DOI 10.1007/s10570-015-0777-x; Rantanen J, 2015, EUR POLYM J, V68, P585, DOI 10.1016/j.eurpolymj.2015.03.045; Schmied FJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02432; Stone J.E., 1968, CELLUL CHEM TECHNOL, V2, P343; Szabo L, 2009, ENVIRON SCI POLICY, V12, P257, DOI 10.1016/j.envsci.2009.01.011; Taipale T, 2010, CELLULOSE, V17, P1005, DOI 10.1007/s10570-010-9431-9; Thompson G, 2001, BIORESOURCE TECHNOL, V77, P275, DOI 10.1016/S0960-8524(00)00060-2; Turnbull PF, 1995, THESIS; Wang XS, 2005, NORD PULP PAP RES J, V20, P442, DOI 10.3183/npprj-2005-20-04-p442-447	31	30	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155809	10.1371/journal.pone.0155809	http://dx.doi.org/10.1371/journal.pone.0155809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228172	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500035
J	De Vos, D; Pirnay, JP; Bilocq, F; Jennes, S; Verbeken, G; Rose, T; Keersebilck, E; Bosmans, P; Pieters, T; Hing, M; Heuninckx, W; De Pauw, F; Soentjens, P; Merabishvili, M; Deschaght, P; Vaneechoutte, M; Bogaerts, P; Glupczynski, Y; Pot, B; van der Reijden, TJ; Dijkshoorn, L				De Vos, Daniel; Pirnay, Jean-Paul; Bilocq, Florence; Jennes, Serge; Verbeken, Gilbert; Rose, Thomas; Keersebilck, Elkana; Bosmans, Petra; Pieters, Thierry; Hing, Mony; Heuninckx, Walter; De Pauw, Frank; Soentjens, Patrick; Merabishvili, Maia; Deschaght, Pieter; Vaneechoutte, Mario; Bogaerts, Pierre; Glupczynski, Youri; Pot, Bruno; van der Reijden, Tanny J.; Dijkshoorn, Lenie			Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center	PLOS ONE			English	Article							MULTIDRUG-RESISTANT ACINETOBACTER; OXA-23 CARBAPENEMASE; REP-PCR; ANTIBIOTIC-RESISTANCE; BETA-LACTAMASES; UNITED-STATES; SP NOV.; OUTBREAK; IDENTIFICATION; INFECTION	Multidrug resistant Acinetobacter baumannii and its closely related species A. pittii and A. nosocomialis, all members of the Acinetobacter calcoaceticus-baumannii (Acb) complex, are a major cause of hospital acquired infection. In the burn wound center of the Queen Astrid military hospital in Brussels, 48 patients were colonized or infected with Acb complex over a 52-month period. We report the molecular epidemiology of these organisms, their clinical impact and infection control measures taken. A representative set of 157 Acb complex isolates was analyzed using repetitive sequence-based PCR (rep-PCR) (DiversiLab) and a multiplex PCR targeting OXA-51-like and OXA-23-like genes. We identified 31 repPCR genotypes (strains). Representatives of each rep-type were identified to species by rpoB sequence analysis: 13 types to A. baumannii, 10 to A. pittii, and 3 to A. nosocomialis. It was assumed that isolates that belonged to the same rep-type also belonged to the same species. Thus, 83.4% of all isolates were identified to A. baumannii, 9.6% to A. pittii and 4.5% to A. nosocomialis. We observed 12 extensively drug resistant Acb strains (10 A. baumannii and 2 A. nosocomialis), all carbapenem-non-susceptible/colistin-susceptible and imported into the burn wound center through patients injured in North Africa. The two most prevalent rep-types 12 and 13 harbored an OXA-23-like gene. Multilocus sequence typing allocated them to clonal complex 1 corresponding to EU (international) clone I. Both strains caused consecutive outbreaks, interspersed with periods of apparent eradication. Patients infected with carbapenem resistant A. baumannii were successfully treated with colistin/rifampicin. Extensive infection control measures were required to eradicate the organisms. Acinetobacter infection and colonization was not associated with increased attributable mortality.	[De Vos, Daniel; Pirnay, Jean-Paul; Bilocq, Florence; Verbeken, Gilbert] Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium; [Jennes, Serge; Rose, Thomas; Keersebilck, Elkana; Soentjens, Patrick] Queen Astrid Mil Hosp, Burn Wound Ctr, Brussels, Belgium; [Bosmans, Petra; Pieters, Thierry] Queen Astrid Mil Hosp, Hosp Hyg & Infect Control Team, Brussels, Belgium; [Hing, Mony; Heuninckx, Walter] Queen Astrid Mil Hosp, Clin Lab, Brussels, Belgium; [De Pauw, Frank] Queen Astrid Mil Hosp, Med Commun & Informat Syst, ACOS WB Hlth Div, Brussels, Belgium; [Merabishvili, Maia; Deschaght, Pieter; Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Bogaerts, Pierre; Glupczynski, Youri] Catholic Univ Louvain, CHU Mt Godinne, Lab Bacteriol, Yvoir, Belgium; [Pot, Bruno] Appl Maths, Sint Martens Latem, Belgium; [van der Reijden, Tanny J.; Dijkshoorn, Lenie] Leiden Univ Med Ctr, Dept Infect Dis C5 P, Leiden, Netherlands	Queen Astrid Military Hospital; Queen Astrid Military Hospital; Queen Astrid Military Hospital; Queen Astrid Military Hospital; Queen Astrid Military Hospital; Ghent University; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Leiden University; Leiden University Medical Center (LUMC)	Pirnay, JP (corresponding author), Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium.	jean-paul.pirnay@mil.be	Merabishvili, Maia/GLU-4387-2022; Vaneechoutte, Mario/A-6189-2009; Soentjens, Patrick/AAG-4388-2020; Pieters, thierry/HGA-6924-2022	Merabishvili, Maia/0000-0002-2566-0772; Vaneechoutte, Mario/0000-0002-4586-203X; Pirnay, Jean-Paul/0000-0002-6863-5219	Royal Higher Institure for Defense [MED 12, MED 19]; commercial company Applied Maths	Royal Higher Institure for Defense; commercial company Applied Maths	JPP FB and MM received funding (grant numbers MED 12 and MED 19) from the Royal Higher Institure for Defense (http://www.irsd.be/website/index.php/en/). The commercial company Applied Maths provided support in the form of a salary for author BP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of the author's salary.	Adegoke AA, 2012, J BASIC MICROB, V52, P620, DOI 10.1002/jobm.201100323; Albrecht MA, 2006, J AM COLL SURGEONS, V203, P546, DOI 10.1016/j.jamcollsurg.2006.06.013; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Berlau J, 1999, EUR J CLIN MICROBIOL, V18, P179, DOI 10.1007/s100960050254; Bogaerts P, 2013, J ANTIMICROB CHEMOTH, V68, P1576, DOI 10.1093/jac/dkt065; Bogaerts P, 2008, ANTIMICROB AGENTS CH, V52, P4205, DOI 10.1128/AAC.01121-08; Bogaerts P, 2010, ANTIMICROB AGENTS CH, V54, P4872, DOI 10.1128/AAC.00871-10; Brown S, 2005, CLIN MICROBIOL INFEC, V11, P326, DOI 10.1111/j.1469-0691.2005.01096.x; Brown S, 2005, CLIN MICROBIOL INFEC, V11, P15, DOI 10.1111/j.1469-0691.2004.01016.x; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Chusri S, 2014, ANTIMICROB AGENTS CH, V58, P4172, DOI 10.1128/AAC.02992-14; Dalla-Costa LM, 2003, J CLIN MICROBIOL, V41, P3403, DOI 10.1128/JCM.41.7.3403-3406.2003; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; Decker BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033443; Dettenkofer M, 2004, INFECT CONT HOSP EP, V25, P21, DOI 10.1086/502286; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Diene SM, 2013, INT J INFECT DIS, V17, pE209, DOI 10.1016/j.ijid.2012.09.007; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Durante-Mangoni E, 2013, CLIN INFECT DIS, V57, P349, DOI 10.1093/cid/cit253; Espinal P, 2015, ANTIMICROB AGENTS CH, V59, P6657, DOI 10.1128/AAC.01455-15; Falagas ME, 2007, CRIT CARE, V11, DOI 10.1186/cc5911; Fontana C, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-79; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; GERNERSMIDT P, 1993, APMIS, V101, P826, DOI 10.1111/j.1699-0463.1993.tb00187.x; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Giamarellos-Bourboulis EJ, 2001, DIAGN MICR INFEC DIS, V40, P117, DOI 10.1016/S0732-8893(01)00258-9; Giannouli M, 2012, INT J ANTIMICROB AG, V39, P58, DOI 10.1016/j.ijantimicag.2011.09.016; Griffith ME, 2006, INFECT CONT HOSP EP, V27, P787, DOI 10.1086/505923; Griffith ME, 2007, INFECT CONT HOSP EP, V28, P720, DOI 10.1086/518966; Halachev MR, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0070-x; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P2865, DOI 10.1093/jac/dku202; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P4174, DOI 10.1128/AAC.49.10.4174-4179.2005; Higgins PG, 2012, J CLIN MICROBIOL, V50, P3493, DOI 10.1128/JCM.01759-12; Higgins PG, 2012, J MED MICROBIOL, V61, P137, DOI 10.1099/jmm.0.036046-0; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P1317, DOI 10.1093/jac/dkq123; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Idzenga D, 2006, J HOSP INFECT, V63, P485, DOI 10.1016/j.jhin.2006.03.014; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jones A, 2006, LANCET INFECT DIS, V6, P317, DOI 10.1016/S1473-3099(06)70471-6; Keen EF, 2010, BURNS, V36, P819, DOI 10.1016/j.burns.2009.10.013; Keen EF, 2010, INFECT CONT HOSP EP, V31, P728, DOI 10.1086/653617; Kohlenberg A, 2009, J MED MICROBIOL, V58, P1499, DOI 10.1099/jmm.0.012302-0; Krizova L, 2013, J ANTIMICROB CHEMOTH, V68, P2786, DOI 10.1093/jac/dkt275; La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006; Lee Y, 2013, DIAGN MICR INFEC DIS, V77, P160, DOI 10.1016/j.diagmicrobio.2013.06.009; Lee YC, 2011, J ANTIMICROB CHEMOTH, V66, P1839, DOI 10.1093/jac/dkr200; Lee YT, 2009, J CHEMOTHERAPY, V21, P514, DOI 10.1179/joc.2009.21.5.514; Liakopoulos A, 2012, EUROSURVEILLANCE, V17, P5; Linden PK, 2006, CLIN INFECT DIS, V43, pS89, DOI 10.1086/504485; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Merino M, 2014, MICROB DRUG RESIST, V20, P259, DOI 10.1089/mdr.2013.0127; Morgan DJ, 2010, INFECT CONT HOSP EP, V31, P716, DOI 10.1086/653201; Nemec A, 2016, INT J SYST EVOL MICR, V66, P1673, DOI 10.1099/ijsem.0.000932; Nemec A, 2015, INT J SYST EVOL MICR, V65, P934, DOI 10.1099/ijs.0.000043; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; O'Shea MK, 2012, INT J ANTIMICROB AG, V39, P363, DOI 10.1016/j.ijantimicag.2012.01.018; Olaitan AO, 2013, INT J INFECT DIS, V17, pE469, DOI 10.1016/j.ijid.2012.12.008; Petersen K, 2011, J CLIN MICROBIOL, V49, P159, DOI 10.1128/JCM.00766-10; Peymani A, 2012, INT J ANTIMICROB AG, V39, P526, DOI 10.1016/j.ijantimicag.2012.02.014; Pirnay JP, 2003, J CLIN MICROBIOL, V41, P1192, DOI 10.1128/JCM.41.3.1192-1202.2003; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Roberts G, 2012, J TRAUMA ACUTE CARE, V72, P251, DOI 10.1097/TA.0b013e31824052bb; Saeed S, 2006, INFECT CONT HOSP EP, V27, P981, DOI 10.1086/507286; SATO K, 1991, J ANTIMICROB CHEMOTH, V28, P35, DOI 10.1093/jac/28.1.35; Schleicher X, 2013, CLIN MICROBIOL INFEC, V19, P737, DOI 10.1111/1469-0691.12026; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; Sebeny PJ, 2008, CLIN INFECT DIS, V47, P444, DOI 10.1086/590568; Segal H, 2005, FEMS MICROBIOL LETT, V243, P425, DOI 10.1016/j.femsle.2005.01.005; Simor AE, 2002, INFECT CONT HOSP EP, V23, P261, DOI 10.1086/502046; Snelling AM, 1996, J CLIN MICROBIOL, V34, P1193, DOI 10.1128/JCM.34.5.1193-1202.1996; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Tani ZBAK, 2014, PATHOL BIOL, V62, P169, DOI 10.1016/j.patbio.2014.01.005; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Trottier V, 2007, J BURN CARE RES, V28, P248, DOI 10.1097/BCR.0B013E318031A20F; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Turton JF, 2006, J CLIN MICROBIOL, V44, P2630, DOI 10.1128/JCM.00547-06; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Turton JF, 2005, J CLIN MICROBIOL, V43, P3074, DOI 10.1128/JCM.43.7.3074-3082.2005; Urban C, 2001, ANTIMICROB AGENTS CH, V45, P994, DOI 10.1128/AAC.45.3.994-995.2001; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Vaneechoute M, 2000, J CLIN MICROBIOL, V38, P3870, DOI 10.1128/JCM.38.10.3870-3871.2000; Vila J, 1996, J MED MICROBIOL, V44, P482, DOI 10.1099/00222615-44-6-482; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008; Wybo I, 2007, J HOSP INFECT, V67, P374, DOI 10.1016/j.jhin.2007.09.012; Zander E, 2013, INT J MED MICROBIOL, V303, P88, DOI 10.1016/j.ijmm.2012.12.007; Zanetti G, 2007, INFECT CONT HOSP EP, V28, P723, DOI 10.1086/517956; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008	92	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156237	10.1371/journal.pone.0156237	http://dx.doi.org/10.1371/journal.pone.0156237			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223476	gold, Green Submitted, Green Published			2022-12-26	WOS:000376881700076
J	Stamile, C; Kocevar, G; Cotton, F; Durand-Dubief, F; Hannoun, S; Frindel, C; Guttmann, CRG; Rousseau, D; Sappey-Marinier, D				Stamile, Claudio; Kocevar, Gabriel; Cotton, Francois; Durand-Dubief, Francoise; Hannoun, Salem; Frindel, Carole; Guttmann, Charles R. G.; Rousseau, David; Sappey-Marinier, Dominique			A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis	PLOS ONE			English	Article							IMAGING MATHEMATICS; BRAIN; MRI; DEGENERATION; TRACTOGRAPHY; STATISTICS; COEFFICIENT; INTEGRITY; INFERIOR; ATROPHY	Diffusion tensor imaging (DTI) is a sensitive tool for the assessment of microstructural alterations in brain white matter (WM). We propose a new processing technique to detect, local and global longitudinal changes of diffusivity metrics, in homologous regions along WM fiber-bundles. To this end, a reliable and automatic processing pipeline was developed in three steps: 1) co-registration and diffusion metrics computation, 2) tractography, bundle extraction and processing, and 3) longitudinal fiber-bundle analysis. The last step was based on an original Gaussian mixture model providing a fine analysis of fiber-bundle cross-sections, and allowing a sensitive detection of longitudinal changes along fibers. This method was tested on simulated and clinical data. High levels of F-Measure were obtained on simulated data. Experiments on cortico-spinal tract and inferior fronto-occipital fasciculi of five patients with Multiple Sclerosis (MS) included in a weekly follow-up protocol highlighted the greater sensitivity of this fiber scale approach to detect small longitudinal alterations.	[Stamile, Claudio; Kocevar, Gabriel; Cotton, Francois; Durand-Dubief, Francoise; Hannoun, Salem; Frindel, Carole; Rousseau, David; Sappey-Marinier, Dominique] Univ Lyon 1, CNRS, UMR5220, CREATIS,INSA Lyon, F-69622 Villeurbanne, France; [Stamile, Claudio; Kocevar, Gabriel; Cotton, Francois; Durand-Dubief, Francoise; Hannoun, Salem; Frindel, Carole; Rousseau, David; Sappey-Marinier, Dominique] Univ Lyon 1, INSA Lyon, INSERM, U1044, F-69622 Villeurbanne, France; [Cotton, Francois] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Radiol, Pierre Benite, France; [Durand-Dubief, Francoise] Hosp Civils Lyon, Hop Neurol, Serv Neurol A, Bron, France; [Guttmann, Charles R. G.] Brigham & Womens Hosp, Dept Radiol, Ctr Neurol Imaging, 75 Francis St, Boston, MA 02115 USA; [Guttmann, Charles R. G.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Imaging, 75 Francis St, Boston, MA 02115 USA; [Sappey-Marinier, Dominique] Univ Lyon, CERMEP Imagerie Vivant, Bron, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Sappey-Marinier, D (corresponding author), Univ Lyon 1, CNRS, UMR5220, CREATIS,INSA Lyon, F-69622 Villeurbanne, France.; Sappey-Marinier, D (corresponding author), Univ Lyon 1, INSA Lyon, INSERM, U1044, F-69622 Villeurbanne, France.; Sappey-Marinier, D (corresponding author), Univ Lyon, CERMEP Imagerie Vivant, Bron, France.	dominique.sappey-marinier@univ-lyon1.fr	Hannoun, Salem/I-2761-2016; Kocevar, Gabriel/I-6409-2019; Kocevar, Gabriel/N-2411-2018; Frindel, Carole/H-6484-2014; Sappey-Marinier, Dominique/L-2925-2014; DURAND-DUBIEF, Françoise/M-2187-2014; Guttmann, Charles RG/J-3093-2018; David, Rousseau/H-3586-2014; cotton, francois/F-4762-2013	Hannoun, Salem/0000-0002-5982-3242; Kocevar, Gabriel/0000-0003-4130-6498; Kocevar, Gabriel/0000-0003-4130-6498; Frindel, Carole/0000-0003-4570-0994; Sappey-Marinier, Dominique/0000-0003-4104-1514; cotton, francois/0000-0003-0046-2478; Stamile, Claudio/0000-0003-3291-2592; Guttmann, Charles/0000-0002-7006-9762	EU [316679 TRANSACT]; French National Research Agency (ANR) within the national program "Investissements d'Avenir" through the OFSEP project [ANR-10-COHO-002]; French National Research Agency (ANR) within the national program "Investissements d'Avenir" through the LABEX PRIMES of Lyon University [ANR-11-LABX-0063, ANR-11-IDEX-0007]	EU(European Commission); French National Research Agency (ANR) within the national program "Investissements d'Avenir" through the OFSEP project(French National Research Agency (ANR)); French National Research Agency (ANR) within the national program "Investissements d'Avenir" through the LABEX PRIMES of Lyon University(French National Research Agency (ANR))	Claudio Stamile is funded by an EU-funded FP7-PEOPLE-2012-ITN project 316679 TRANSACT. This work is supported by the French National Research Agency (ANR) within the national program "Investissements d'Avenir" through the OFSEP project (ANR-10-COHO-002) and the LABEX PRIMES (ANR-11-LABX-0063) of Lyon University (ANR-11-IDEX-0007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bergsland N, 2015, MULT SCLER J, V21, P1771, DOI 10.1177/1352458515576985; Cavallari M, 2013, NEUROIMAGE-CLIN, V2, P332, DOI 10.1016/j.nicl.2013.02.003; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Corouge I, 2006, MED IMAGE ANAL, V10, P786, DOI 10.1016/j.media.2006.07.003; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Grigis A, 2013, MED IMAGE ANAL, V17, P375, DOI 10.1016/j.media.2013.01.004; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hannoun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032525; Henry RG, 2009, J NEUROL SCI, V282, P61, DOI 10.1016/j.jns.2009.02.379; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P101, DOI 10.1002/cmr.a.20048; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P123, DOI 10.1002/cmr.a.20049; Klein J., 2007, BILDVERARBEITUNG MED, P272, DOI DOI 10.1007/978-3-540-71091-2_55; Lai C, 2014, ACTA RADIOL, V55, P114, DOI 10.1177/0284185113492456; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Martensson J, 2013, MAGN RESON MATER PHY, V26, P527, DOI 10.1007/s10334-013-0368-5; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7; Nicoletti G, 2006, BRAIN, V129, P2679, DOI 10.1093/brain/awl166; Nicoletti G, 2008, MOVEMENT DISORD, V23, P2370, DOI 10.1002/mds.22279; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Rovaris M, 2005, NEUROLOGY, V65, P1526, DOI 10.1212/01.wnl.0000184471.83948.e0; Server A, 2014, EUR J RADIOL, V83, pE156, DOI 10.1016/j.ejrad.2013.12.023; Steenwijk MD, 2014, RADIOLOGY, V272, P832, DOI 10.1148/radiol.14132708; Sternberg EJ, 2014, AM J NEURORADIOL, V35, P439, DOI 10.3174/ajnr.A3702; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Zhang Y, 2013, AM J NEURORADIOL, V34, P1890, DOI 10.3174/ajnr.A3535	39	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156405	10.1371/journal.pone.0156405	http://dx.doi.org/10.1371/journal.pone.0156405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224308	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700092
J	Valenzuela, W; Ferguson, SJ; Ignasiak, D; Diserens, G; Hani, L; Wiest, R; Vermathen, P; Boesch, C; Reyes, M				Valenzuela, Waldo; Ferguson, Stephen J.; Ignasiak, Dominika; Diserens, Gaelle; Hani, Levin; Wiest, Roland; Vermathen, Peter; Boesch, Chris; Reyes, Mauricio			FISICO: Fast Image SegmentatIon COrrection	PLOS ONE			English	Article							VOLUME SEGMENTATION	Background and Purpose In clinical diagnosis, medical image segmentation plays a key role in the analysis of pathological regions. Despite advances in automatic and semi-automatic segmentation techniques, time-effective correction tools are commonly needed to improve segmentation results. Therefore, these tools must provide faster corrections with a lower number of interactions, and a user-independent solution to reduce the time frame between image acquisition and diagnosis. Methods We present a new interactive method for correcting image segmentations. Our method provides 3D shape corrections through 2D interactions. This approach enables an intuitive and natural corrections of 3D segmentation results. The developed method has been implemented into a software tool and has been evaluated for the task of lumbar muscle and knee joint segmentations from MR images. Results Experimental results show that full segmentation corrections could be performed within an average correction time of 5.5+/-3.3 minutes and an average of 56.5+/-33.1 user interactions, while maintaining the quality of the final segmentation result within an average Dice coefficient of 0.92+/-0.02 for both anatomies. In addition, for users with different levels of expertise, our method yields a correction time and number of interaction decrease from 38+/-19.2 minutes to 6.4+/-4.3 minutes, and 339+/-157.1 to 67.7+/-39.6 interactions, respectively.	[Valenzuela, Waldo; Reyes, Mauricio] Univ Bern, Inst Surg Technol & Biomech, Bern, Switzerland; [Ferguson, Stephen J.; Ignasiak, Dominika] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Diserens, Gaelle; Vermathen, Peter; Boesch, Chris] Univ Hosp Inselspital, Dept Clin Res AMSM, Bern, Switzerland; [Hani, Levin; Wiest, Roland] Univ Hosp Inselspital, Inst Diagnost & Intervent Neuroradiol, Support Ctr Adv Neuroimaging, Bern, Switzerland; [Hani, Levin; Wiest, Roland] Univ Bern, Bern, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Reyes, M (corresponding author), Univ Bern, Inst Surg Technol & Biomech, Bern, Switzerland.	mauricio.reyes@istb.unibe.ch	Boesch, Chris/F-2577-2010; Vermathen, P./J-5789-2012; Ferguson, Stephen J./A-4118-2012	Boesch, Chris/0000-0001-8498-8543; Vermathen, P./0000-0001-8649-1098; Ferguson, Stephen J./0000-0003-0650-5889; Ignasiak, Dominika/0000-0001-8557-0245; Hani, Levin/0000-0001-7892-7138; Valenzuela, Waldo/0000-0002-6629-3366	AOSpine International [102163]; SNSF [320030-138150, 31003A-132935]	AOSpine International; SNSF(Swiss National Science Foundation (SNSF))	This work was supported by AOSpine International (102163) and SNSF projects #320030-138150 and #31003A-132935. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa D, 2014, COMPUT MED IMAG GRAP, V38, P57, DOI 10.1016/j.compmedimag.2013.10.002; Bauer S, 2012, ANN BIOMED ENG, V40, P2033, DOI 10.1007/s10439-012-0552-1; Bornik A, 2006, P ACM S VIRT REAL SO, P197, DOI DOI 10.1145/1180495.1180536; Brooke J., 1996, USABILITY EVALUATION, V189, P4; Cootes T., 2000, IMAGE PROCESS ANAL, V328, P223; Criminisi A, 2008, LECT NOTES COMPUT SC, V5302, P99, DOI 10.1007/978-3-540-88682-2_9; Duncan JS, 2000, IEEE T PATTERN ANAL, V22, P85, DOI 10.1109/34.824822; Egger J., 2014, SCI REPORTS, V4, P1, DOI 10.1038/srep05164; El-Baz A, 2011, MULTIMODALITY STATE, VII; Fischer MA, 2013, RADIOLOGY, V266, P555, DOI 10.1148/radiol.12120399; Grady L, 2006, LECT NOTES COMPUT SC, V4191, P888; Heckel F., 2012, EUR WORKSH VIS COMP, P73; Heckel F, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.034005; Heckel F, 2013, COMPUT GRAPH FORUM, V32, P144, DOI 10.1111/cgf.12193; Heimann T, 2009, MED IMAGE ANAL, V13, P543, DOI 10.1016/j.media.2009.05.004; HSU WM, 1992, COMP GRAPH, V26, P177, DOI 10.1145/142920.134036; Ibanez L., 2003, ITK SOFTWARE GUIDE; Ijiri T, 2013, COMPUT GRAPH FORUM, V32, P123, DOI 10.1111/cgf.12032; Ijiri T, 2010, COMPUT GRAPH FORUM, V29, P2153, DOI 10.1111/j.1467-8659.2010.01803.x; Jackowski M, 2005, LECT NOTES COMPUT SC, V3750, P717, DOI 10.1007/11566489_88; Kozic N, 2010, MED IMAGE ANAL, V14, P265, DOI 10.1016/j.media.2010.02.008; Kronman A, 2013, LECT NOTES COMPUT SC, V8150, P206, DOI 10.1007/978-3-642-40763-5_26; Ma Z, 2009, IMAGAPP 2009: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON COMPUTER IMAGING THEORY AND APPLICATIONS, P135; Marcus RL, 2012, J AGING RES, V5; Narkhede HP., 2013, INT J SCI MODERN ENG, V1, P54; Patil DD., 2013, IJCSMC, V2, P22; Peters J, 2005, INT CONGR SER, V1281, P33, DOI 10.1016/j.ics.2005.03.023; Peters J, 2010, MED IMAGE ANAL, V14, P70, DOI 10.1016/j.media.2009.10.004; Prassni JS, 2010, IEEE T VIS COMPUT GR, V16, P1358, DOI 10.1109/TVCG.2010.208; Schroeder W., 2006, VISUALIZATION TOOLKI, V4th; Schwarz T., 2008, P SPIE MED IMAGING 2, V6914; Sederberg T. W., 1986, Computer Graphics, V20, P151, DOI 10.1145/15886.15903; Sleiman HB, 2011, ANN BIOMED ENG, V39, P1720, DOI 10.1007/s10439-011-0282-9; Sridevi S., 2013, Proceedings of the 2013 International Conference on Pattern Recognition, Informatics and Mobile Engineering (PRIME), P215, DOI 10.1109/ICPRIME.2013.6496475; Steger Sebastian, 2012, Abdominal Imaging. Computational and Clinical Applications. Third International Workshop Held in Conjunction with MICCAI 2011. Revised Selected Papers, P125, DOI 10.1007/978-3-642-28557-8_16; Timinger H., 2003, INTEGRATION INTERACT, P171; Top A, 2011, LECT NOTES COMPUT SC, V6533, P204, DOI 10.1007/978-3-642-18421-5_20; Valenzuela W, 2015, INTERACTIVE MED IMAG, P1; Zaidi H., 2006, QUANTITATIVE ANAL NU	39	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156035	10.1371/journal.pone.0156035	http://dx.doi.org/10.1371/journal.pone.0156035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224061	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700051
J	Klimek, MEB; Sali, A; Rayavarapu, S; Van der Meulen, JH; Nagaraju, K				Klimek, Margaret E. Benny; Sali, Arpana; Rayavarapu, Sree; Van der Meulen, Jack H.; Nagaraju, Kanneboyina			Effect of the IL-1 Receptor Antagonist Kineret (R) on Disease Phenotype in mdx Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ANXIETY-LIKE BEHAVIOR; SKELETAL-MUSCLE DEGENERATION; LONG-TERM BENEFITS; TNF-ALPHA; REDUCES SKELETAL; RHEUMATOID-ARTHRITIS; CONTROLLED-TRIAL; INTERLEUKIN-1; INHIBITION	Duchenne muscular dystrophy (DMD) is an X-linked muscle disease caused by mutations in the dystrophin gene. The pathology of DMD manifests in patients with progressive muscle weakness, loss of ambulation and ultimately death. One of the characteristics of DMD is muscle inflammation, and dystrophin-deficient skeletal muscles produce higher levels of the pro-inflammatory cytokine interleukin 1 beta (IL-1 beta) in response to toll like receptor (TLR) stimulation compared to controls; therefore, blocking the IL-1 beta pathway could improve the disease phenotype in mdx mice, a mouse model of DMD. Kineret (R) or IL-1Ra is a recombinant IL-1 receptor antagonist approved by the FDA for treating rheumatoid arthritis. To determine the efficacy of IL-1Ra in a DMD model, we administered subcutaneous injections of saline control or IL-1Ra (25 mg/kg/day) to mdx mice daily for 45 days beginning at 5 weeks of age. Functional and histological parameters were measured at the conclusion of the study. IL-1Ra only partially inhibited this signaling pathway in this study; however, there were still interesting observations to be noted. For example, although not significantly changed, splenocytes from the IL-1Ra-treated group secreted less IL-1 beta after LPS stimulation compared to control mice indicating a blunted response and incomplete inhibition of the pathway (37% decrease). In addition, normalized forelimb grip strength was significantly increased in IL-1Ra-treated mice. There were no changes in EDL muscle-specific force measurements, histological parameters, or motor coordination assessments in the dystrophic mice after IL-1Ra treatment. There was a significant 27% decrease in the movement time and total distance traveled by the IL-1Ra treated mice, correlating with previous studies examining effects of IL-1 on behavior. Our studies indicate partial blocking of IL-1 beta with IL-1Ra significantly altered only a few behavioral and strength related disease parameters; however, treatment with inhibitors that completely block IL-1 beta, pathways upstream of IL-1 beta production or combining various inhibitors may produce more favorable outcomes.	[Klimek, Margaret E. Benny; Sali, Arpana; Rayavarapu, Sree; Van der Meulen, Jack H.; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Nagaraju, Kanneboyina] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA	Children's National Health System; George Washington University	Nagaraju, K (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.; Nagaraju, K (corresponding author), George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA.	knagaraju@cnmcresearch.org	Nagaraju, Kanneboyina/ABA-6525-2021; Nagaraju, Kanneboyina/AAV-7684-2021		National Institutes of Health [5U54HD053177, K26OD011171, P50AR060836-01]; Muscular Dystrophy Association; US Department of Defense [W81XWH-05-1-0616, W81XWH-11-1-0782, W81XWH-11-1-0330]; NICHD (National Center for Medical Rehabilitation Research) [P50AR060836-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); US Department of Defense(United States Department of Defense); NICHD (National Center for Medical Rehabilitation Research); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	K.N. is supported by the National Institutes of Health (5U54HD053177, K26OD011171, P50AR060836-01), http://www.nih.gov/, the Muscular Dystrophy Association, http://www.mda.org/, the US Department of Defense (W81XWH-05-1-0616, W81XWH-11-1-0782, W81XWH-11-1-0330), http://www. defense.gov/, and NICHD (P50AR060836-01, National Center for Medical Rehabilitation Research), https://www.nichd.nih.gov/Pages/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; ANGELINI C, 1994, MUSCLE NERVE, V17, P386, DOI 10.1002/mus.880170405; Aro AA, 2013, LIFE SCI, V92, P799, DOI 10.1016/j.lfs.2013.02.011; Biggar WD, 2006, NEUROMUSCULAR DISORD, V16, P249, DOI 10.1016/j.nmd.2006.01.010; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cragnolini AB, 2006, PEPTIDES, V27, P1451, DOI 10.1016/j.peptides.2005.10.020; Dalgic B, 2007, PEDIATR NEPHROL, V22, P1391, DOI 10.1007/s00467-007-0500-8; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Ermolova NV, 2014, NEUROMUSCULAR DISORD, V24, P583, DOI 10.1016/j.nmd.2014.04.006; GRIGGS RC, 1991, ARCH NEUROL-CHICAGO, V48, P383, DOI 10.1001/archneur.1991.00530160047012; GRIGGS RC, 1993, NEUROLOGY, V43, P520, DOI 10.1212/WNL.43.3_Part_1.520; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Grounds MD, 2005, CELL TISSUE RES, V320, P509, DOI 10.1007/s00441-005-1102-z; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; Hein AM, 2012, J NEUROIMMUNE PHARM, V7, P145, DOI 10.1007/s11481-011-9294-3; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1987, SCIENCE, V238, P347, DOI 10.1126/science.3659917; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Huynh T, 2013, J PATHOL, V231, P223, DOI 10.1002/path.4231; KOIVISTO VA, 1993, DIABETES CARE, V16, P990, DOI 10.2337/diacare.16.7.990; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006963; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Machado RV, 2011, J NEUROIMMUNOL, V232, P145, DOI 10.1016/j.jneuroim.2010.10.032; MANDRUPPOULSEN T, 1993, CYTOKINE, V5, P185, DOI 10.1016/1043-4666(93)90003-N; Manzur AY, 2008, ARCH DIS CHILD, V93, P986, DOI 10.1136/adc.2007.118141; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Maranhao JB, 2015, INT J EXP PATHOL, V96, P285, DOI 10.1111/iep.12142; Markham LW, 2008, NEUROMUSCULAR DISORD, V18, P365, DOI 10.1016/j.nmd.2008.03.002; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; Messina S, 2006, AM J PATHOL, V168, P918, DOI 10.2353/ajpath.2006.050673; MINAMI M, 1991, NEUROSCI LETT, V123, P254, DOI 10.1016/0304-3940(91)90944-O; Pinto RDM, 2013, CLIN NUTR, V32, P472, DOI 10.1016/j.clnu.2012.06.001; Nguyen KT, 1998, J NEUROSCI, V18, P2239; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Pierno S, 2007, NEUROPATH APPL NEURO, V33, P344, DOI 10.1111/j.1365-2990.2007.00798.x; Piers AT, 2011, NEUROMUSCULAR DISORD, V21, P132, DOI 10.1016/j.nmd.2010.09.013; Radley HG, 2008, NEUROMUSCULAR DISORD, V18, P227, DOI 10.1016/j.nmd.2007.11.002; Rawat R, 2010, AM J PATHOL, V176, P2891, DOI 10.2353/ajpath.2010.090058; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Tang Y, 2010, GENE THER, V17, P1476, DOI 10.1038/gt.2010.110; Tringali G, 2000, THERAPIE, V55, P171; Wakabayashi C, 2015, NEUROSCI LETT, V599, P20, DOI 10.1016/j.neulet.2015.05.019; Waters FJ, 2010, MOL CELL BIOCHEM, V337, P119, DOI 10.1007/s11010-009-0291-2; Yilmaz-Elis AS, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.58	52	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155944	10.1371/journal.pone.0155944	http://dx.doi.org/10.1371/journal.pone.0155944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213537	Green Submitted, Green Published, gold			2022-12-26	WOS:000376880200035
J	Van Hecke, L; Deforche, B; Van Dyck, D; De Bourdeaudhuij, I; Veitch, J; Van Cauwenberg, J				Van Hecke, Linde; Deforche, Benedicte; Van Dyck, Delfien; De Bourdeaudhuij, Ilse; Veitch, Jenny; Van Cauwenberg, Jelle			Social and Physical Environmental Factors Influencing Adolescents' Physical Activity in Urban Public Open Spaces: A Qualitative Study Using Walk-Along Interviews	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ACTIVITY PARTICIPATION; PARK USE; CHILDREN; HEALTH; RESOURCES; FEATURES; YOUTH; AVAILABILITY; PERCEPTIONS	Most previous studies examining physical activity in Public Open Spaces (POS) focused solely on the physical environment. However, according to socio-ecological models the social environment is important as well. The aim of this study was to determine which social and physical environmental factors affect adolescents' visitation and physical activity in POS in low-income neighbourhoods. Since current knowledge on this topic is limited, especially in Europe, qualitative walk-along interviews were used to obtain detailed and context-specific information. Participants (n = 30, aged 12-16 years, 64% boys) were recruited in POS in low-income neighbourhoods in Brussels, Ghent and Antwerp (Belgium). Participants were interviewed while walking in the POS with the interviewer. Using this method, the interviewer could observe and ask questions while the participant was actually experiencing the environment. All audio-recorded interviews were transcribed and analysed using Nvivo 10 software and thematic analysis was used to derive categories and subcategories using a grounded theory approach. The most important subcategories that were supportive of visiting POS and performing physical activity in POS were; accessibility by foot/bicycle/public transport, located close to home/school, presence of (active) friends and family, cleanliness of the POS and features, availability of sport and play facilities, large open spaces and beautiful sceneries. The most important subcategories that were unsupportive of visiting POS and physical activity in POS were; presence of undesirable users (drug users, gangs and homeless people), the behaviour of other users and the cleanliness of the POS and features. Social factors appeared often more influential than physical factors, however, it was the combination of social and physical factors that affected adolescents' behaviour in POS. Easily accessible POS with high quality features in the proximity of adolescents' home or school may stimulate physical activity, if adolescents also experience a safe and familiar social environment.	[Van Hecke, Linde; Deforche, Benedicte; Van Cauwenberg, Jelle] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, B-9000 Ghent, Belgium; [Van Hecke, Linde; Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Movement & Sport Sci, Phys Act Nutr & Hlth Res Unit, Brussels, Belgium; [Van Dyck, Delfien; Van Cauwenberg, Jelle] Fund Sci Res Flanders FWO, Brussels, Belgium; [Van Dyck, Delfien; De Bourdeaudhuij, Ilse] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Veitch, Jenny] Deakin Univ, IPAN, Geelong, Vic 3217, Australia	Ghent University; Vrije Universiteit Brussel; Ghent University; Deakin University	Van Hecke, L (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, B-9000 Ghent, Belgium.; Van Hecke, L (corresponding author), Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Movement & Sport Sci, Phys Act Nutr & Hlth Res Unit, Brussels, Belgium.	linde.vanhecke@ugent.be	Van Dyck, Delfien/AAO-8981-2020; De+Bourdeaudhuij, Ilse/AAC-5528-2019	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Dyck, Delfien/0000-0003-1783-9075; Veitch, Jenny/0000-0001-8962-0887; Van Hecke, Linde/0000-0002-3577-9785	Research Foundation Flanders [FWO: 11N0313N, FWO12/PDO/158, 54488-G0A8514N]; Australian National Health and Medical Research Council Early Career Fellowship [1053426]	Research Foundation Flanders(FWO); Australian National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	JVC was supported by a Ph.D. Fellowship of the Research Foundation Flanders: http://www.fwo.be/en/ (FWO: 11N0313N). DVD is funded by the Research Foundation Flanders: http://www.fwo.be/en/ (FWO: post-doctoral mandate FWO12/PDO/158). LVH is funded by the Research Foundation Flanders: http://www.fwo.be/en/(FWO, 54488-G0A8514N). JV is supported by an Australian National Health and Medical Research Council Early Career Fellowship: https://www.nhmrc.gov.au/ (ID 1053426).	[Anonymous], 2015, STAT BELGIUM, V3, P25; [Anonymous], 2015, WIJKMONITORING BRUSS, V3, P25; [Anonymous], 2015, BELGIAN OFFICIAL J, V12, P8; [Anonymous], 2015, GENT CIJFERS, V3, P25; [Anonymous], 2015, STAD ANTWERPEN CIJFE, V3, P25; Serrano-Sanchez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038693; Babey Susan H, 2013, Policy Brief UCLA Cent Health Policy Res, P1; Baran PK, 2014, ENVIRON BEHAV, V46, P768, DOI 10.1177/0013916512470134; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Carmona M, 2010, PUBLIC PLACES 2015 U; Carpiano RM, 2009, HEALTH PLACE, V15, P263, DOI 10.1016/j.healthplace.2008.05.003; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Carver A, 2010, SOC SCI MED, V70, P1799, DOI 10.1016/j.socscimed.2010.02.010; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Chillon P, 2011, PEDIATR EXERC SCI, V23, P207; de Farias JC, 2011, PREV MED, V52, P114, DOI 10.1016/j.ypmed.2010.12.002; de Vet E, 2011, OBES REV, V12, pe130, DOI 10.1111/j.1467-789X.2010.00784.x; Ding D, 2011, AM J PREV MED, V41, P442, DOI 10.1016/j.amepre.2011.06.036; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Dunton GF, 2007, ANN BEHAV MED, V34, P144, DOI 10.1007/BF02872669; Dunton GF, 2012, AM J HEALTH PROMOT, V26, P135, DOI 10.4278/ajhp.100211-QUAN-43; Duzenli T, 2010, SCI RES ESSAYS, V5, P201; Edwards N, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0178-4; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-50; Estabrooks PA, 2003, ANN BEHAV MED, V25, P100, DOI 10.1207/S15324796ABM2502_05; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Floyd MF, 2011, AM J PREV MED, V41, P258, DOI 10.1016/j.amepre.2011.04.013; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Humbert ML, 2006, QUAL HEALTH RES, V16, P467, DOI 10.1177/1049732305286051; Janssen I, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0187-3; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kaczynski AT, 2008, AM J PUBLIC HEALTH, V98, P1451, DOI 10.2105/AJPH.2007.129064; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Lenders S, 2015, AFBAKENING VLAAMSE P, V4, P1; Lien N, 2001, J EPIDEMIOL COMMUN H, V55, P731, DOI 10.1136/jech.55.10.731; Light Andrew, 1998, PHILOS GEOGRAPHY; Lloyd K, 2008, J PARK RECREAT ADM, V26, P21; Loebach JGJ, 2010, CHILDREN YOUTH ENV, V20, P53; Madanipour A, 2010, WHOSE PUBLIC SPACE?: INTERNATIONAL CASE STUDIES IN URBAN DESIGN AND DEVELOPMENT, P1; McCormack GR, 2010, HEALTH PLACE, V16, P712, DOI 10.1016/j.healthplace.2010.03.003; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Moore LV, 2008, AM J PREV MED, V34, P16, DOI 10.1016/j.amepre.2007.09.021; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Norman Gregory J, 2006, J Phys Act Health, V3, pS118, DOI 10.1123/jpah.3.s1.s118; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Ries AV, 2008, AM J HEALTH PROMOT, V23, P43, DOI 10.4278/ajhp.07043042; Ries AV, 2008, AM J HEALTH BEHAV, V32, P26, DOI 10.5993/AJHB.32.1.3; Ries AV, 2009, J ADOLESCENT HEALTH, V45, pS64, DOI 10.1016/j.jadohealth.2009.04.020; Romero AJ, 2005, J ADOLESCENT HEALTH, V36, P253, DOI 10.1016/j.jadohealth.2004.02.027; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; Safron M, 2011, INT J ENVIRON HEAL R, V21, P317, DOI 10.1080/09603123.2011.552713; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sandelowski M, 2001, RES NURS HEALTH, V24, P230, DOI 10.1002/nur.1025; Santos MP, 2009, HEALTH PLACE, V15, P548, DOI 10.1016/j.healthplace.2008.08.006; Scheerder J, 2013, VLAANDEREN SPORT VIE; Shaw C., 2011, GUIDELINES RES CHILD; Smith AL, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0246-9; Smith L, 2012, PREV MED, V54, P224, DOI 10.1016/j.ypmed.2012.01.006; Stone, 1992, PUBLIC SPACE; Tafforeau J., 2008, GEZONDHEIDSENQUETE; Timperio A, 2008, PREV MED, V47, P514, DOI 10.1016/j.ypmed.2008.07.015; Van Cauwenberg J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-85; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Vandendriessche JB, 2012, PEDIATR EXERC SCI, V24, P113, DOI 10.1123/pes.24.1.113; Veitch J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-600; Veitch J, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-73	71	43	43	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155686	10.1371/journal.pone.0155686	http://dx.doi.org/10.1371/journal.pone.0155686			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2FT	27214385	gold, Green Submitted, Green Published			2022-12-26	WOS:000376880200022
J	Lam, C; Lai, FC; Wang, CH; Lai, MH; Hsu, N; Chung, MH				Lam, Calvin; Lai, Fu-Chih; Wang, Chia-Hui; Lai, Mei-Hsin; Hsu, Nanly; Chung, Min-Huey			Text Mining of Journal Articles for Sleep Disorder Terminologies	PLOS ONE			English	Article							METAMAP; IDENTIFICATION; INSTRUMENTS; DYSFUNCTION; POPULATION	Objective Research on publication trends in journal articles on sleep disorders (SDs) and the associated methodologies by using text mining has been limited. The present study involved text mining for terms to determine the publication trends in sleep-related journal articles published during 2000-2013 and to identify associations between SD and methodology terms as well as conducting statistical analyses of the text mining findings. Methods SD and methodology terms were extracted from 3,720 sleep-related journal articles in the PubMed database by using MetaMap. The extracted data set was analyzed using hierarchical cluster analyses and adjusted logistic regression models to investigate publication trends and associations between SD and methodology terms. Results MetaMap had a text mining precision, recall, and false positive rate of 0.70, 0.77, and 11.51%, respectively. The most common SD term was breathing-related sleep disorder, whereas narcolepsy was the least common. Cluster analyses showed similar methodology clusters for each SD term, except narcolepsy. The logistic regression models showed an increasing prevalence of insomnia, parasomnia, and other sleep disorders but a decreasing prevalence of breathing-related sleep disorder during 2000-2013. Different SD terms were positively associated with different methodology terms regarding research design terms, measure terms, and analysis terms. Conclusion Insomnia-, parasomnia-, and other sleep disorder-related articles showed an increasing publication trend, whereas those related to breathing-related sleep disorder showed a decreasing trend. Furthermore, experimental studies more commonly focused on hypersomnia and other SDs and less commonly on insomnia, breathing-related sleep disorder, narcolepsy, and parasomnia. Thus, text mining may facilitate the exploration of the publication trends in SDs and the associated methodologies.	[Lam, Calvin; Lai, Fu-Chih; Wang, Chia-Hui; Chung, Min-Huey] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Wang, Chia-Hui] Taipei Med Univ, Dept Nursing, Shuang Ho Hosp, New Taipei, Taiwan; [Lai, Mei-Hsin] Hungkuang Univ, Dept Nursing, Taichung, Taiwan; [Hsu, Nanly] Yuanpei Univ, Dept Nursing, Hsinchu, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Hungkuang University	Chung, MH (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.	minhuey300@tmu.edu.tw		Lam, Calvin/0000-0002-8022-1633; Wang, Chia-Hui/0000-0002-8181-5097				Aronson A.R, 2001, METAMAP EVALUATION; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Beck CT, 2012, NURSING RES GENERATI; Chapman WW, 2004, STUD HEALTH TECHNOL, V107, P487; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Da Costa D, 2005, ARTHRIT RHEUM-ARTHR, V53, P272, DOI 10.1002/art.21069; Davis K, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-37; Devine EB, 2005, PHARMACOECONOMICS, V23, P889, DOI 10.2165/00019053-200523090-00003; French L, 2012, J COMP NEUROL, V520, P1772, DOI 10.1002/cne.23012; Fulda S, 2013, SLEEP, V36, P661, DOI 10.5665/sleep.2622; Hamid JS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-364; Hanauer DA, 2014, J AM MED INFORM ASSN, V21, P925, DOI 10.1136/amiajnl-2014-002767; Hearst M., 1999, 37 ANN M ASS COMP LI; Kokturk O, 2005, INT HEART J, V46, P801, DOI 10.1536/ihj.46.801; Kovacevic A, 2012, COMPUT SPEECH LANG, V26, P105, DOI [10.1016/j.csl.2011.09.001, 10.1016/j.cs1.2011.09.001]; Krallinger M, 2005, DRUG DISCOV TODAY, V10, P439, DOI 10.1016/S1359-6446(05)03376-3; Lin CF, 2007, NEW TAIPEI NURSING J, V9, P5, DOI DOI 10.6540/NTJN.2007.1; Ma Y, 2015, SLEEP MED, V16, P820, DOI 10.1016/j.sleep.2014.12.028; Maury G, 2013, J SLEEP RES, V22, P96, DOI 10.1111/j.1365-2869.2012.01035.x; Meaney C, 2016, J CLIN EPIDEMIOL, V74, P124, DOI 10.1016/j.jclinepi.2015.10.020; Merlino G, 2006, NEPHROL DIAL TRANSPL, V21, P184, DOI 10.1093/ndt/gfi144; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; NLM US, METAMAP A TOOL REC U; O'Mara-Eves A, 2015, SYST REV, V4, DOI 10.1186/2046-4053-4-5; Ouyang WZ, 2013, CHINESE ENGLISH GLOS; Pakhomov Sergeui, 2008, AMIA Annu Symp Proc, P545; Peng TQ, 2013, NEW MEDIA SOC, V15, P644, DOI 10.1177/1461444812462846; Ruud KL, 2010, INT J QUAL HEALTH C, V22, P229, DOI 10.1093/intqhc/mzq012; Sforza E, 2003, EUR RESPIR J, V21, P682, DOI 10.1183/09031936.03.00087303; Spira AP, 2012, J GERONTOL A-BIOL, V67, P433, DOI 10.1093/gerona/glr172; Stephane M, 2003, SCHIZOPHR RES, V61, P185, DOI 10.1016/S0920-9964(03)00013-6; Thomas J, 2011, RES SYNTH METHODS, V2, P1, DOI 10.1002/jrsm.27; Ulmer CS, 2011, J CLIN SLEEP MED, V7, P57; Unger ER, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-6; van de Water ATM, 2011, J SLEEP RES, V20, P183, DOI 10.1111/j.1365-2869.2009.00814.x; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]	38	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0156031	10.1371/journal.pone.0156031	http://dx.doi.org/10.1371/journal.pone.0156031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM4BV	27203858	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500039
J	Saltybaeva, N; Martini, K; Frauenfelder, T; Alkadhi, H				Saltybaeva, Natalia; Martini, Katharina; Frauenfelder, Thomas; Alkadhi, Hatem			Organ Dose and Attributable Cancer Risk in Lung Cancer Screening with Low-Dose Computed Tomography	PLOS ONE			English	Article							CHEST CT	Purpose Lung cancer screening with CT has been recently recommended for decreasing lung cancer mortality. The radiation dose of CT, however, must be kept as low as reasonably achievable for reducing potential stochastic risks from ionizing radiation. The purpose of this study was to calculate individual patients' lung doses and to estimate cancer risks in low-dose CT (LDCT) in comparison with a standard dose CT (SDCT) protocol. Materials and Methods This study included 47 adult patients (mean age 63.0 +/- 5.7 years) undergoing chest CT on a third-generation dual-source scanner. 23/47 patients (49%) had a non-enhanced chest SDCT, 24 patients (51%) underwent LDCT at 100 kVp with spectral shaping at a dose equivalent to a chest x-ray. 3D-dose distributions were obtained from Monte Carlo simulations for each patient, taking into account their body size and individual CT protocol. Based on the dose distributions, patient-specific lung doses were calculated and relative cancer risk was estimated according to BEIR VII recommendations. Results As compared to SDCT, the LDCT protocol allowed for significant organ dose and cancer risk reductions (p<0.001). On average, lung dose was reduced from 7.7 mGy to 0.3 mGy when using LDCT, which was associated with lowering of the cancer risk from 8.6 to 0.35 per 100'000 cases. A strong linear correlation between lung dose and patient effective diameter was found for both protocols (R-2 = 0.72 and R-2 = 0.75 for SDCT and LDCT, respectively). Conclusion Use of a LDCT protocol for chest CT with a dose equivalent to a chest x-ray allows for significant lung dose and cancer risk reduction from ionizing radiation.	[Saltybaeva, Natalia; Martini, Katharina; Frauenfelder, Thomas; Alkadhi, Hatem] Univ Zurich, Inst Diagnost & Intervent Radiol, Univ Zurich Hosp, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Saltybaeva, N (corresponding author), Univ Zurich, Inst Diagnost & Intervent Radiol, Univ Zurich Hosp, Zurich, Switzerland.	Natalia.Saltybaeva@usz.ch	Frauenfelder, Thomas/O-1734-2016; Martini, Katharina/AAW-7995-2020	Frauenfelder, Thomas/0000-0002-3295-6619; 				Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Angel E, 2009, AM J ROENTGENOL, V193, P1340, DOI 10.2214/AJR.09.2886; [Anonymous], 2006, HLTH RISKS EXP LOW L; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Christe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082919; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Deak P, 2008, EUR RADIOL, V18, P759, DOI 10.1007/s00330-007-0815-7; Deak PD, 2009, RADIOLOGY, V252, P140, DOI 10.1148/radiol.2522081845; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gordic S, 2014, INVEST RADIOL, V49, P465, DOI 10.1097/RLI.0000000000000037; Haubenreisser H, 2015, EUR J RADIOL, V84, P1608, DOI 10.1016/j.ejrad.2015.04.018; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Huda W, 2010, MED PHYS, V37, P842, DOI 10.1118/1.3298015; Kauczor HU, 2015, EUR RESPIR J, V46, P28, DOI 10.1183/09031936.00033015; Kramer BS, 2011, J MED SCREEN, V18, P109, DOI 10.1258/jms.2011.011055; Martin CJ, 2007, BRIT J RADIOL, V80, P639, DOI 10.1259/bjr/25922439; Martini K, 2016, EUR J RADIOL, V85, P360, DOI 10.1016/j.ejrad.2015.11.036; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Nagatani Y, 2015, EUR J RADIOL, V84, P1401, DOI 10.1016/j.ejrad.2015.03.012; Newell JD, 2015, INVEST RADIOL, V50, P40, DOI 10.1097/RLI.0000000000000093; Ru Zhao Ying, 2011, Cancer Imaging, V11 Spec No A, pS79, DOI 10.1102/1470-7330.2011.9020; Shlomi D, 2014, EUR RESPIR J, V44, P217, DOI 10.1183/09031936.00164513; Smith RA, 2015, CA-CANCER J CLIN, V65, P30, DOI 10.3322/caac.21261; van den Bergh KAM, 2008, CANCER, V113, P396, DOI 10.1002/cncr.23590; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Zhang YK, 2012, MED PHYS, V39, P3404, DOI 10.1118/1.4718710	29	13	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155722	10.1371/journal.pone.0155722	http://dx.doi.org/10.1371/journal.pone.0155722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203720	Green Accepted, gold, Green Published			2022-12-26	WOS:000376291500022
J	Won, HS; Lee, KM; Oh, JE; Nam, EM; Lee, KE				Won, Hye Sung; Lee, Kyung Mee; Oh, Ju Eon; Nam, Eun Mi; Lee, Kyoung Eun			Inhibition of beta-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; WNT/BETA-CATENIN; CYCLIN D1; PATHWAY; MECHANISMS; EXPRESSION; TARGET; ROLES	Background The beta-catenin signaling is important in cell growth and differentiation and is frequently dys-regulated in various cancers. The most well-known mechanism of endocrine resistance is cross-talk between the estrogen receptor (ER) and other growth factor signaling, such as phosphatidylinositol-3-kinase (PI3K)/Akt and the mammalian target of rapamycin (mTOR) signaling pathway. In the present study, we investigated whether beta-catenin could be a potential target to overcome endocrine resistance in breast cancer. Methods We established tamoxifen-resistant (TamR) cell line via long-term exposure of MCF-7 breast cancer cells to gradually increasing concentrations of tamoxifen. The levels of protein expression and mRNA transcripts were determined using western blot analysis and real-time quantitative PCR. The transcriptional activity of beta-catenin was measured using luciferase activity assay. Results TamR cells showed a mesenchymal phenotype, and exhibited a relatively decreased expression of ER and increased expression of human epidermal growth factor receptor 2 and the epidermal growth factor receptor. We confirmed that the expression and transcriptional activity of beta-catenin were increased in TamR cells compared with control cells. The expression and transcriptional activity of beta-catenin were inhibited by beta-catenin small-molecule inhibitor, ICG-001 or beta-catenin siRNA. The viability of TamR cells, which showed no change after treatment with tamoxifen, was reduced by ICG-001 or beta-catenin siRNA. The combination of ICG-001 and mTOR inhibitor, rapamycin, yielded an additive effect on the inhibition of viability in TamR cells. Conclusion These results suggest that beta-catenin plays a role in tamoxifen-resistant breast cancer, and the inhibition of beta-catenin may be a potential target in tamoxifen-resistant breast cancer.	[Won, Hye Sung] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea; [Lee, Kyung Mee; Oh, Ju Eon; Nam, Eun Mi; Lee, Kyoung Eun] Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Div Hematol Oncol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Ewha Womans University	Lee, KE (corresponding author), Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Div Hematol Oncol,Dept Internal Med, Seoul, South Korea.	oncolee@ewha.ac.kr			Ewha Womans University School of Medicine; Catholic University of Korea Uijeongbu St. Mary's Hospital Clinical Research Laboratory Foundation	Ewha Womans University School of Medicine; Catholic University of Korea Uijeongbu St. Mary's Hospital Clinical Research Laboratory Foundation	This study was partly supported by intramural research promotion grants from Ewha Womans University School of Medicine and by The Catholic University of Korea Uijeongbu St. Mary's Hospital Clinical Research Laboratory Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Bijnsdorp IV, 2011, METHODS MOL BIOL, V731, P421, DOI 10.1007/978-1-61779-080-5_34; Bilir B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-280; Gil EMC, 2014, CANCER TREAT REV, V40, P862, DOI 10.1016/j.ctrv.2014.03.004; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501; Eguchi M, 2005, MED CHEM, V1, P467, DOI 10.2174/1573406054864098; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Feng ZB, 2011, HUM PATHOL, V42, P659, DOI 10.1016/j.humpath.2010.07.021; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Hao YQ, 2015, ONCOL REP, V33, P2438, DOI 10.3892/or.2015.3828; Hui R, 2002, CANCER RES, V62, P6916; Kilker RL, 2004, J STEROID BIOCHEM, V92, P63, DOI 10.1016/j.jsbmb.2004.05.005; Kim MR, 2009, CANCER SCI, V100, P1834, DOI 10.1111/j.1349-7006.2009.01260.x; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Yao H, 2011, EXPERT OPIN THER TAR, V15, P873, DOI 10.1517/14728222.2011.577418; Ziauddin MF, 2014, CANCER METAST REV, V33, P791, DOI 10.1007/s10555-014-9504-6	28	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155983	10.1371/journal.pone.0155983	http://dx.doi.org/10.1371/journal.pone.0155983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196739	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291100144
J	Girer, NG; Murray, IA; Omiecinski, CJ; Perdew, GH				Girer, Nathaniel G.; Murray, Iain A.; Omiecinski, Curtis J.; Perdew, Gary H.			Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; MESSENGER-RNA; TARGET GENE; ER STRESS; LIVER; MICE; LIGAND; ALPHA; FGF21	The Aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor involved in many physiological processes. Several studies indicate that AHR is also involved in energy homeostasis. Fibroblast growth factor 21 (FGF21) is an important regulator of the fasting and feeding responses. When administered to various genetic and diet-induced mouse models of obesity, FGF21 can attenuate obesity-associated morbidities. Here, we explore the role of AHR in hepatic Fgf21 expression through the use of a conditional, hepatocyte-targeted AHR knock-out mouse model (Cre(Alb)Ahr(Fx/Fx)). Compared with the congenic parental strain (Ahr(Fx/Fx)), non-fasted Cre(Alb)Ahr(Fx/Fx) mice exhibit a 4-fold increase in hepatic Fgf21 expression, as well as elevated expression of the FGF21-target gene Igfbp1. Furthermore, in vivo agonist activation of AHR reduces hepatic Fgf21 expression during a fast. The Fgf21 promoter contains several putative dioxin response elements (DREs). Using EMSA, we demonstrate that the AHR-ARNT heterodimer binds to a specific DRE that overlaps binding sequences for peroxisome proliferator-activated receptor alpha (PPAR alpha), carbohydrate response element-binding protein (ChREBP), and cAMP response element-binding protein, hepatocyte specific (CREBH). In addition, we reveal that agonist-activated AHR impairs PPAR alpha-, ChREBP-, and CREBH-mediated promoter activity in Hepa-1 cells. Accordingly, agonist treatment in Hepa-1 cells ablates potent ER stress-driven Fgf21 expression, and pre-treatment with AHR antagonist blocks this effect. Finally, we show that pre-treatment of primary human hepatocytes with AHR agonist diminishes PPAR alpha-, glucose-, and ER stress-driven induction of FGF21 expression, indicating the effect is not mouse-specific. Together, our data show that AHR contributes to hepatic energy homeostasis, partly through the regulation of FGF21 expression and signaling.	[Girer, Nathaniel G.] Penn State Univ, Grad Program Microbiol & Mol Biol, University Pk, PA 16802 USA; [Murray, Iain A.; Omiecinski, Curtis J.; Perdew, Gary H.] Penn State Univ, Dept Vet & Biomed Sci, 309 Life Sci Bldg, University Pk, PA 16802 USA; [Murray, Iain A.; Omiecinski, Curtis J.; Perdew, Gary H.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Perdew, GH (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 309 Life Sci Bldg, University Pk, PA 16802 USA.	ghp2@psu.edu		Girer, Nathaniel/0000-0003-4327-1786	National Institutes of Health [HHSN276201200017C]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019964, R01ES004869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Denise Coslo for technical assistance with maintaining primary human hepatocyte cultures and Kelly Wagner for assistance with animal husbandry. The Liver Tissue Cell Distribution System at the University of Pittsburgh, Pittsburg, PA, is funded by National Institutes of Health Contract HHSN276201200017C.	Angrish MM, 2012, TOXICOL SCI, V128, P377, DOI 10.1093/toxsci/kfs155; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Cheng XG, 2014, TOXICOL APPL PHARM, V278, P65, DOI 10.1016/j.taap.2014.04.013; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Duan ZQ, 2014, NEUROTOXICOLOGY, V44, P149, DOI 10.1016/j.neuro.2014.06.005; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; Hsu HF, 2010, J HAZARD MATER, V182, P649, DOI 10.1016/j.jhazmat.2010.06.081; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Lu PP, 2015, HEPATOLOGY, V61, P1908, DOI 10.1002/hep.27719; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; Meyer BK, 2000, CELL STRESS CHAPERON, V5, P243, DOI 10.1379/1466-1268(2000)005<0243:AHARLA>2.0.CO;2; Page JL, 2007, TOXICOL SCI, V97, P384, DOI 10.1093/toxsci/kfm034; POLAND A, 1990, MOL PHARMACOL, V38, P306; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Smith KJ, 2011, J PHARMACOL EXP THER, V338, P318, DOI 10.1124/jpet.110.178392; Tanos R, 2012, HEPATOLOGY, V55, P1994, DOI 10.1002/hep.25571; von Holstein-Rathlou S, 2016, CELL METAB, V23, P335, DOI 10.1016/j.cmet.2015.12.003; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	32	30	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15378	15387		10.1074/jbc.M116.715151	http://dx.doi.org/10.1074/jbc.M116.715151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226639	Green Published, hybrid			2022-12-26	WOS:000380583200041
J	Kavi, H; Emelyanov, AV; Fyodorov, DV; Skoultchi, AI				Kavi, Harsh; Emelyanov, Alexander V.; Fyodorov, Dmitry V.; Skoultchi, Arthur I.			Independent Biological and Biochemical Functions for Individual Structural Domains of Drosophila Linker Histone H1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; CHROMATIN IN-VIVO; HETEROCHROMATIN FORMATION; GLOBULAR DOMAIN; NUCLEOSOME; BINDING; SU(VAR)3-9; PROTEIN; HP1; PHOSPHORYLATION	Linker histone H1 is among the most abundant components of chromatin. H1 has profound effects on chromosome architecture. H1 also helps to tether DNA-and histone-modifying enzymes to chromatin. Metazoan linker histones have a conserved tripartite structure comprising N-terminal, globular, and long, unstructured C-terminal domains. Here we utilize truncated Drosophila H1 polypeptides in vitro and H1 mutant transgenes in vivo to interrogate the roles of these domains in multiple biochemical and biological activities of H1. We demonstrate that the globular domain and the proximal part of the C-terminal domain are essential for H1 deposition into chromosomes and for the stability of H1-chromatin binding. The two domains are also essential for fly viability and the establishment of a normal polytene chromosome structure. Additionally, through interaction with the heterochromatin-specific histone H3 Lys-9 methyltransferase Su(var)3-9, the H1 C-terminal domain makes important contributions to formation and H3K9 methylation of heterochromatin as well as silencing of transposons in heterochromatin. Surprisingly, the N-terminal domain does not appear to be required for any of these functions. However, it is involved in the formation of a single chromocenter in polytene chromosomes. In summary, we have discovered that linker histone H1, similar to core histones, exerts its multiple biological functions through independent, biochemically separable activities of its individual structural domains.	[Fyodorov, Dmitry V.] Albert Einstein Coll Med, Dept Cell Biol, Chanin 414,1300 Morris Pk Ave, Bronx, NY 10461 USA; [Kavi, Harsh] North Shore Univ Hosp, Long Isl Jewish Med Ctr, Manhasset, NY 11030 USA	Yeshiva University; Albert Einstein College of Medicine; Northwell Health; North Shore University Hospital	Fyodorov, DV (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Chanin 414,1300 Morris Pk Ave, Bronx, NY 10461 USA.; Skoultchi, AI (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Chanin 402,1300 Morris Pk Ave, Bronx, NY 10461 USA.	dmitry.fyodorov@einstein.yu.edu; arthur.skoultchi@einstein.yu.edu			National Institutes of Health [GM074233, GM093190, GM116143]; NCI (National Institutes of Health) Cancer Center [CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233, R01GM093190, R01GM116143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI (National Institutes of Health) Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM074233 (to D. V. F.) and GM093190 and GM116143 (to A. I. S.) and NCI (National Institutes of Health) Cancer Center Support Grant CA013330 (to the Albert Einstein College of Medicine). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; Bierhoff H, 2014, EPIGENETICS-US, V9, P53, DOI 10.4161/epi.26485; Bonet-Costa C, 2012, J PROTEOMICS, V75, P4124, DOI 10.1016/j.jprot.2012.05.034; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Brown DT, 2001, GENOME BIOL, V2; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Caterino TL, 2011, BIOCHEM CELL BIOL, V89, P35, DOI 10.1139/O10-024; CERF C, 1993, BIOCHEMISTRY-US, V32, P11345, DOI 10.1021/bi00093a011; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Emelyanov AV, 2014, GENE DEV, V28, P2027, DOI 10.1101/gad.248583.114; Emelyanov AV, 2010, J BIOL CHEM, V285, P15027, DOI 10.1074/jbc.M109.064790; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Lu X, 2004, J BIOL CHEM, V279, P8701, DOI 10.1074/jbc.M311348200; Lu XW, 2013, SCIENCE, V340, P78, DOI 10.1126/science.1234654; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; van Holde KE., 1989, SPRINGER SERIES MOL; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Widlak P, 2005, BIOCHEMISTRY-US, V44, P7871, DOI 10.1021/bi050100n; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wolffe A., 1998, CHROMATIN STRUCTURE; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Xu N, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-16; Yang SM, 2013, P NATL ACAD SCI USA, V110, P1708, DOI 10.1073/pnas.1213266110; ZHANG P, 1995, GENETICS, V139, P659; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110	44	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15143	15155		10.1074/jbc.M116.730705	http://dx.doi.org/10.1074/jbc.M116.730705			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226620	hybrid, Green Published			2022-12-26	WOS:000380583200024
J	Nocadello, S; Minasov, G; Shuvalova, LS; Dubrovska, I; Sabini, E; Anderson, WF				Nocadello, Salvatore; Minasov, George; Shuvalova, Ludmilla S.; Dubrovska, Ievgeniia; Sabini, Elisabetta; Anderson, Wayne F.			Crystal Structures of the SpoIID Lytic Transglycosylases Essential for Bacterial Sporulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE LYSOZYME; CELL-WALL; X-RAY; BACILLUS-SUBTILIS; CATALYTIC DOMAIN; BACTERIOPHAGE-T4 LYSOZYME; PROTEIN; PURIFICATION; DEGRADATION; ENGULFMENT	Bacterial spores are the most resistant form of life known on Earth and represent a serious problem for (i) bioterrorism attack, (ii) horizontal transmission of microbial pathogens in the community, and (iii) persistence in patients and in a nosocomial environment. Stage II sporulation protein D (Spoilt)) is a lytic transglycosylase (LT) essential for sporulation. The LT superfamily is a potential drug target because it is active in essential bacterial processes involving the peptidoglycan, which is unique to bacteria. However, the absence of structural information for the sporulation-specific LT enzymes has hindered mechanistic understanding of SpoIID. Here, we report the first crystal structures with and without ligands of the SpoIID family from two community relevant spore-forming pathogens, Bacillus anthracis and Clostridium difficile. The structures allow us to visualize the overall architecture, characterize the substrate recognition model, identify critical residues, and provide the structural basis for catalysis by this new family of enzymes.	[Nocadello, Salvatore; Minasov, George; Shuvalova, Ludmilla S.; Dubrovska, Ievgeniia; Sabini, Elisabetta; Anderson, Wayne F.] Northwestern Univ, Ctr Struct Genom Infect Dis, Dept Biochem & Mol Genet, Feinberg Sch Med, Morton 7-601,303 E Chicago Ave, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Anderson, WF (corresponding author), Northwestern Univ, Ctr Struct Genom Infect Dis, Dept Biochem & Mol Genet, Feinberg Sch Med, Morton 7-601,303 E Chicago Ave, Chicago, IL 60611 USA.	wf-anderson@northwestern.edu		Minasov, George/0000-0001-5460-3462	United States Department of Energy [DE-AC02-06CH11357]	United States Department of Energy(United States Department of Energy (DOE))	X-ray data collection was done at the LS-CAT beamlines 21ID-G (3ROH) and 21ID-F (4Q7G) at the Advanced Photon Source Science User Facility operated for the United States Department of Energy (DOE), supported by the United States Department of Energy under Contract Number DE-AC02-06CH11357.	Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Anderson W. F., 2009, Infectious Disorders - Drug Targets, V9, P507; ANDERSON WF, 1981, J MOL BIOL, V147, P523, DOI 10.1016/0022-2836(81)90398-3; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Chastanet A, 2007, MOL MICROBIOL, V64, P139, DOI 10.1111/j.1365-2958.2007.05652.x; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Gutierrez J, 2010, J BACTERIOL, V192, P3174, DOI 10.1128/JB.00127-10; HADFIELD AT, 1994, J MOL BIOL, V243, P856, DOI 10.1006/jmbi.1994.1688; HARZ H, 1990, ANAL BIOCHEM, V190, P120, DOI 10.1016/0003-2697(90)90144-X; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jing X, 2012, PROTEINS, V80, P2469, DOI 10.1002/prot.24140; Kim Y, 2008, ADV PROTEIN CHEM, V75, P85, DOI 10.1016/S0065-3233(07)75003-9; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YF, 2012, J BACTERIOL, V194, P4537, DOI 10.1128/JB.00877-12; Lin YJ, 2012, BIOINFORMATICS, V28, P1172, DOI 10.1093/bioinformatics/bts095; MATTHEWS BW, 1981, J MOL BIOL, V147, P545, DOI 10.1016/0022-2836(81)90399-5; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Morlot C, 2010, GENE DEV, V24, P411, DOI 10.1101/gad.1878110; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Wu N, 2000, ACTA CRYSTALLOGR D, V56, P912, DOI 10.1107/S090744490000576X; ZHOU RQ, 1988, ANAL BIOCHEM, V171, P141, DOI 10.1016/0003-2697(88)90134-0	35	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14915	14926		10.1074/jbc.M116.729749	http://dx.doi.org/10.1074/jbc.M116.729749			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226615	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000380583200005
J	Song, L; Chen, J; Peng, GD; Tang, K; Jing, NH				Song, Lu; Chen, Jun; Peng, Guangdun; Tang, Ke; Jing, Naihe			Dynamic Heterogeneity of Brachyury in Mouse Epiblast Stem Cells Mediates Distinct Response to Extrinsic Bone Morphogenetic Protein (BMP) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; EARLY EMBRYONIC-DEVELOPMENT; PRIMITIVE-STREAK; MESODERM FORMATION; FATE DECISIONS; ID PROTEINS; INDUCTION; GENE; PLURIPOTENCY; EXPRESSION	Mouse pluripotent cells, such as embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs), provide excellent in vitro systems to study imperative pre- and postimplantation events of in vivo mammalian development. It is known that mouse ESCs are dynamic heterogeneous populations. However, it remains largely unclear whether and how EpiSCs possess heterogeneity and plasticity similar to that of ESCs. Here, we show that EpiSCs are discriminated by the expression of a specific marker '1' (Brachyury) into two populations. The T -positive (T+) and the T-negative (T-) populations can be interconverted within the same culture condition. In addition, the two populations display distinct responses to bone morphogenetic protein (BMP) signaling and different developmental potentials. The T- EpiSCs are preferentially differentiated into ectoderm lineages, whereas EpiSCs have a biased potential for mesendoderm fates. Mechanistic studies reveal that T+ EpiSCs have an earlier and faster response to BMP4 stimulation than T- EpiSCs. Idl mediates the commitment of T- EpiSCs to epidermal lineage during BMP4 treatment. On the other hand, Snail modulates the conversion of T+ EpiSCs to mesendoderm fates with the presence of BMP4. Furthermore, T expression is essential for epithelialmesenchymal transition during EpiSCs differentiation. Our findings suggest that the dynamic heterogeneity of the T+ /T-subpopulation primes EpiSCs toward particular cell lineages, providing important insights into the dynamic development of the early mouse embryo.	[Song, Lu; Chen, Jun; Peng, Guangdun; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanchang University	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	njing@sibcb.ac.cn	Peng, Guangdun/AAH-9044-2019	Peng, Guangdun/0000-0002-8586-0637	Chinese Academy of Sciences [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [31430058, 31571513, 91519314, 31501173]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the "Strategic Priority Research Program" of the Chinese Academy of Sciences, Grant XDA01010201; National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500; and National Natural Science Foundation of China Grants 31430058, 31571513, 91519314, and 31501173. The authors declare that they have no conflicts of interest with the contents of this article.	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Coppe JP, 2003, EXP CELL RES, V285, P131, DOI 10.1016/S0014-4827(03)00014-4; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Edwards YH, 1996, GENOME RES, V6, P226, DOI 10.1101/gr.6.3.226; Faial T, 2015, DEVELOPMENT, V142, P2121, DOI 10.1242/dev.117838; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Gundry RL, 2011, PROTEOMICS, V11, P3947, DOI 10.1002/pmic.201100100; Hamilton DH, 2012, SEMIN ONCOL, V39, P358, DOI 10.1053/j.seminoncol.2012.02.005; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Imajyo I, 2012, INT J ONCOL, V41, P1985, DOI 10.3892/ijo.2012.1673; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Li LY, 2015, J MOL CELL BIOL, V7, P455, DOI 10.1093/jmcb/mjv030; Li LY, 2011, GENES-BASEL, V2, P298, DOI 10.3390/genes2020298; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Naber HPH, 2013, BIOCHEM BIOPH RES CO, V435, P58, DOI 10.1016/j.bbrc.2013.04.037; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pillai S, 2011, MOL CELL BIOL, V31, P3052, DOI 10.1128/MCB.01311-10; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sun SR, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0076-4; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Tan FZ, 2015, J BIOL CHEM, V290, P4500, DOI 10.1074/jbc.M114.609016; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trevino AE, 2014, METHOD ENZYMOL, V546, P161, DOI 10.1016/B978-0-12-801185-0.00008-8; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Turner DA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0063-7; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wade M, 2015, J BIOMOL SCREEN, V20, P1027, DOI 10.1177/1087057115587916; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhu QQ, 2014, ELIFE, V3, DOI 10.7554/eLife.02224	70	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15212	15225		10.1074/jbc.M115.705418	http://dx.doi.org/10.1074/jbc.M115.705418			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226536	Green Published, hybrid			2022-12-26	WOS:000380583200029
J	Holmes, B; Lee, J; Landon, KA; Benavides-Serrato, A; Bashir, T; Jung, ME; Lichtenstein, A; Gera, J				Holmes, Brent; Lee, Jihye; Landon, Kenna A.; Benavides-Serrato, Angelica; Bashir, Tariq; Jung, Michael E.; Lichtenstein, Alan; Gera, Joseph			Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclin D1; glioblastoma; heterogeneous nuclear ribonucleoprotein (hnRNP); mechanistic target of rapamycin (mTOR); Myc (c-Myc); translation; IRES; ITAF; mRNA translation	NUCLEAR RIBONUCLEOPROTEIN A1; TRANS-ACTING FACTOR; HNRNP A1; MAMMALIAN TARGET; GROWTH; INITIATION; IMPORT	Our previous work has demonstrated an intrinsic mRNA-specific protein synthesis salvage pathway operative in glioblastoma (GBM) tumor cells that is resistant to mechanistic target of rapamycin (mTOR) inhibitors. The activation of this internal ribosome entry site (IRES)-dependent mRNA translation initiation pathway results in continued translation of critical transcripts involved in cell cycle progression in the face of global eIF-4E-mediated translation inhibition. Recently we identified compound 11 (C11), a small molecule capable of inhibiting c-MYC IRES translation as a consequence of blocking the interaction of a requisite c-MYC IRES trans-acting factor, heterogeneous nuclear ribonucleoprotein A1, with its IRES. Here we demonstrate that C11 also blocks cyclin D1 IRES-dependent initiation and demonstrates synergistic anti-GBM properties when combined with the mechanistic target of rapamycin kinase inhibitor PP242. The structure-activity relationship of C11 was investigated and resulted in the identification of IRES-J007, which displayed improved IRES-dependent initiation blockade and synergistic anti-GBM effects with PP242. Mechanistic studies with C11 and IRES-J007 revealed binding of the inhibitors within the UP1 fragment of heterogeneous nuclear ribonucleoprotein A1, and docking analysis suggested a small pocket within close proximity to RRM2 as the potential binding site. We further demonstrate that co-therapy with IRES-J007 and PP242 significantly reduces tumor growth of GBM xenografts in mice and that combined inhibitor treatments markedly reduce the mRNA translational state of cyclin D1 and c-MYC transcripts in these tumors. These data support the combined use of IRES-J007 and PP242 to achieve synergistic antitumor responses in GBM.	[Holmes, Brent; Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA; [Jung, Michael E.; Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90048 USA; [Jung, Michael E.; Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90048 USA; [Lee, Jihye; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90048 USA; [Holmes, Brent; Landon, Kenna A.; Benavides-Serrato, Angelica; Bashir, Tariq; Lichtenstein, Alan; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 91343 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Gera, J (corresponding author), 16111 Plummer St 151,Bldg 1,Rm C111A, Los Angeles, CA 91343 USA.	jgera@mednet.ucla.edu		Gera, Joseph/0000-0002-2908-6894; Holmes, Brent/0000-0002-2768-2991	National Institutes of Health [R01CA168700]; Department of Veterans Affairs MERIT Grant [I01BX002665]; NATIONAL CANCER INSTITUTE [R01CA168700] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs MERIT Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant R01CA168700 and by Department of Veterans Affairs MERIT Grant I01BX002665. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Benavides-Serrato Angelica, 2014, Genes Cancer, V5, P393; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Culjkovic B, 2005, J CELL BIOL, V169, P245, DOI 10.1083/jcb.200501019; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Fridell RA, 1997, J CELL SCI, V110, P1325; Gini B, 2013, CLIN CANCER RES, V19, P5722, DOI 10.1158/1078-0432.CCR-13-0527; Iwanami A, 2013, P NATL ACAD SCI USA, V110, P4339, DOI 10.1073/pnas.1217602110; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Ko CC, 2014, J BIOL CHEM, V289, P22078, DOI 10.1074/jbc.M114.553248; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Martin J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.205096; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Morgan CE, 2015, J MOL BIOL, V427, P3241, DOI 10.1016/j.jmb.2015.05.009; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Shi Y, 2016, ONCOGENE, V35, P1015, DOI 10.1038/onc.2015.156; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu Si-Han, 2014, Cancer Biology Medicine, V11, P255, DOI 10.7497/j.issn.2095-3941.2014.04.004	39	35	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14146	14159		10.1074/jbc.M116.726927	http://dx.doi.org/10.1074/jbc.M116.726927			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27226604	hybrid, Green Published			2022-12-26	WOS:000379975100022
J	Ruanpeng, D; Chariyalertsak, S; Kaewpoowat, Q; Supindham, T; Settakorn, J; Sukpan, K; Utaipat, U; Miura, T; Kosashunhanan, N; Saokhieo, P; Songsupa, R; Wongthanee, A				Ruanpeng, Darin; Chariyalertsak, Suwat; Kaewpoowat, Quanhathai; Supindham, Taweewat; Settakorn, Jongkolnee; Sukpan, Kornkanok; Utaipat, Utaiwan; Miura, Toshiyuki; Kosashunhanan, Natthapol; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika			Cytological Anal Squamous Intraepithelial Lesions Associated with Anal High-Risk Human Papillomavirus Infections among Men Who Have Sex with Men in Northern Thailand	PLOS ONE			English	Article							NATURAL-HISTORY; HIGH PREVALENCE; CANCER; HIV; NEOPLASIA; VACCINATION	Background Anal cancer, one of human papillomavirus (HPV) related malignancies, has increased in recent decades, particularly among men who have sex with men (MSM) and HIV-infected (HIV+) persons. We aimed to explore the prevalence of anal squamous intraepithelial lesions (ASIL) using Papanicolau (Pap) screening among MSM in northern Thailand and its associated factors. Methods Two hundreds MSM aged >= 18 years reporting receptive anal intercourse in the prior 6 months were recruited from July 2012 through January 2013. Medical history and behavioral data were collected by staff interview and computer-assisted self interview. Anal Pap smear, HPV genotyping, and HIV testing were performed. Two pathologists blinded to HPV and HIV status reported cytologic results by Bethesda classification. Results Mean age was 27.2 years (range 18-54). Overall, 86 (43.0%) had ASIL: 28 (14.2%) with atypical cells of undetermined significance (ASCUS), 1 (0.5%) with atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H), 56 (28.4%) with low-grade squamous intraepithelial lesion (LSIL), and 1 (0.5%) with high-grade squamous intraepithelial lesion (HSIL). ASIL was associated by univariate analysis (p <= 0.05) with older age, gender identity other than bisexual (i.e., gay men and transgender women), rectal douching, anal symptoms, genital warts, HIV positivity, and high-risk-HPV infection. However, on multiple logistic regression ASIL was associated only with high-risk HPV type (p = 0.002) and HIV infection (p = 0.01). Conclusions ASIL is quite common in high-risk MSM in northern Thailand and is associated with high-risk HPV types and HIV infection. Routine anal Pap screening should be considered, given the high frequency of ASIL, particularly in the HIV+. High resolution anoscopy (HRA), not done here, should be to confirm PAP smears whose sensitivity and specificity are quite variable. Timely HPV vaccination should be considered for this population.	[Ruanpeng, Darin; Chariyalertsak, Suwat; Kaewpoowat, Quanhathai; Supindham, Taweewat; Utaipat, Utaiwan; Kosashunhanan, Natthapol; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Kaewpoowat, Quanhathai] Chiang Mai Univ, Fac Med, Dept Med, Div Infect Dis, Chiang Mai 50000, Thailand; [Settakorn, Jongkolnee; Sukpan, Kornkanok] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50000, Thailand; [Miura, Toshiyuki] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Ruanpeng, Darin] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA	Chiang Mai University; Chiang Mai University; Chiang Mai University; Nagasaki University; University of Minnesota System; University of Minnesota Twin Cities	Chariyalertsak, S (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	suwat@rihes.org		Kaewpoowat, Quanhathai/0000-0002-9444-3552	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23406032]; National Research University Project under Thailand's Office of the Higher Education Commission	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research University Project under Thailand's Office of the Higher Education Commission	This study was supported by a Grant-in-Aid for Scientific Research ( B) ( 23406032) to Dr. Toshiyuki Miura from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. It was also supported in part by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2014, INT J STD AIDS, V25, P726, DOI 10.1177/0956462413518193; Berry JM, 2009, DIS COLON RECTUM, V52, P239, DOI 10.1007/DCR.0b013e31819793d9; Cheng SH, 2014, J MED VIROL, V86, P193, DOI 10.1002/jmv.23825; Chiao EY, 2008, J CLIN ONCOL, V26, P474, DOI 10.1200/JCO.2007.14.2810; Chin-Hong PV, 2008, ANN INTERN MED, V149, P300, DOI 10.7326/0003-4819-149-5-200809020-00004; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Critchlow CW, 1998, AIDS, V12, P1177, DOI 10.1097/00002030-199810000-00010; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Darragh TM, 2013, INT J GYNECOL PATHOL, V32, P76, DOI 10.1097/PGP.0b013e31826916c7; Deshmukh AA, 2014, VACCINE, V32, P6941, DOI 10.1016/j.vaccine.2014.10.052; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V91, P1; International Agency for Research on Cancer (IARC), 2012, IARC MONOGRAPHS EVAL, V100F; Lacey HB, 1999, SEX TRANSM INFECT, V75, P172, DOI 10.1136/sti.75.3.172; Li AH, 2009, SEX TRANSM INFECT, V85, P503, DOI 10.1136/sti.2009.036707; Lytwyn A, 2005, CANCER-AM CANCER SOC, V103, P1447, DOI 10.1002/cncr.20927; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Nelson RA, 2013, J CLIN ONCOL, V31, P1569, DOI 10.1200/JCO.2012.45.2524; Nielsen A, 2012, INT J CANCER, V130, P1168, DOI 10.1002/ijc.26115; Palefsky JM, 1997, J ACQ IMMUN DEF SYND, V14, P415, DOI 10.1097/00042560-199704150-00004; Phanuphak N, 2013, AIDS, V27, P1753, DOI 10.1097/QAD.0b013e328360a509; Piketty C, 2004, SEX TRANSM DIS, V31, P96, DOI 10.1097/01.OLQ.0000109515.75864.2B; Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147029; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Skamperle M, 2013, ACTA DERMATOVEN ALP, V21, P1, DOI 10.2478/v10162-012-0024-1; Soeberg MJ, 2015, CANCER EPIDEMIOL, V39, P842, DOI 10.1016/j.canep.2015.10.008; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Supindham T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124499; Swedish KA, 2012, CLIN INFECT DIS, V54, P891, DOI 10.1093/cid/cir1036; Wilkin T, 2015, NEW ENGL J MED, V373, P854, DOI 10.1056/NEJMcp1401303; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983	37	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156280	10.1371/journal.pone.0156280	http://dx.doi.org/10.1371/journal.pone.0156280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227684	gold, Green Published, Green Submitted			2022-12-26	WOS:000376882500101
J	Garzke, J; Hansen, T; Ismar, SMH; Sommer, U				Garzke, Jessica; Hansen, Thomas; Ismar, Stefanie M. H.; Sommer, Ulrich			Combined Effects of Ocean Warming and Acidification on Copepod Abundance, Body Size and Fatty Acid Content	PLOS ONE			English	Article							CLIMATE-CHANGE; CO2 CONCENTRATION; EGG-PRODUCTION; CARBONIC-ACID; REPRODUCTIVE SUCCESS; HATCHING SUCCESS; ELEVATED CO2; MARINE FISH; PHYTOPLANKTON; SEAWATER	Concerns about increasing atmospheric CO2 concentrations and global warming have initiated studies on the consequences of multiple-stressor interactions on marine organisms and ecosystems. We present a fully-crossed factorial mesocosm study and assess how warming and acidification affect the abundance, body size, and fatty acid composition of copepods as a measure of nutritional quality. The experimental set-up allowed us to determine whether the effects of warming and acidification act additively, synergistically, or antagonistically on the abundance, body size, and fatty acid content of copepods, a major group of lower level consumers in marine food webs. Copepodite (developmental stages 1-5) and nauplii abundance were antagonistically affected by warming and acidification. Higher temperature decreased copepodite and nauplii abundance, while acidification partially compensated for the temperature effect. The abundance of adult copepods was negatively affected by warming. The prosome length of copepods was significantly reduced by warming, and the interaction of warming and CO2 antagonistically affected prosome length. Fatty acid composition was also significantly affected by warming. The content of saturated fatty acids increased, and the ratios of the polyunsaturated essential fatty acids docosahexaenoic-(DHA) and arachidonic acid (ARA) to total fatty acid content increased with higher temperatures. Additionally, here was a significant additive interaction effect of both parameters on arachidonic acid. Our results indicate that in a future ocean scenario, acidification might partially counteract some observed effects of increased temperature on zooplankton, while adding to others. These may be results of a fertilizing effect on phytoplankton as a copepod food source. In summary, copepod populations will be more strongly affected by warming rather than by acidifying oceans, but ocean acidification effects can modify some temperature impacts.	[Garzke, Jessica; Hansen, Thomas; Ismar, Stefanie M. H.; Sommer, Ulrich] GEOMAR Helmholtz Ctr Ocean Res Kiel, Dept Marine Ecol, Expt Ecol Food Webs, DN5DR, Dusternbrooker Weg 20, D-24105 Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Garzke, J (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Dept Marine Ecol, Expt Ecol Food Webs, DN5DR, Dusternbrooker Weg 20, D-24105 Kiel, Germany.	jgarzke@geomar.de	Hansen, Thomas/GWZ-2858-2022; Ismar, Stefanie MH/H-1133-2017		program BIOACID as a project of the German Ministry of Education and Research (BMBF)	program BIOACID as a project of the German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was funded by the program BIOACID as a project of the German Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anlauf H, 2011, J EXP MAR BIOL ECOL, V397, P13, DOI 10.1016/j.jembe.2010.11.009; Arendt KE, 2005, MAR BIOL; Arndt C, 2014, AQUACULT NUTR, V20, P44, DOI 10.1111/anu.12051; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Bermudez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123945; Bozinovic F, 2015, ECOL EVOL, V5, P1025, DOI 10.1002/ece3.1403; BROCK TD, 1981, ECOL MODEL, V14, P1, DOI 10.1016/0304-3800(81)90011-9; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Byrne M, 2013, INTEGR COMP BIOL, V53, P582, DOI 10.1093/icb/ict049; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Christensen MR, 2006, GLOBAL CHANGE BIOL, V12, P2316, DOI 10.1111/j.1365-2486.2006.01257.x; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Cripps G, 2014, J PLANKTON RES, V36, P1165, DOI 10.1093/plankt/fbu052; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dupont S, 2009, BIOGEOSCIENCES; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Evjemo JO, 2008, J EXP MAR BIOL ECOL, V365, P31, DOI 10.1016/j.jembe.2008.07.032; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Forster J, 2011, AM NAT, V178, P668, DOI 10.1086/662174; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Garzke J, 2015, OECOLOGIA, V177, P849, DOI 10.1007/s00442-014-3130-4; HANSSON I, 1973, DEEP-SEA RES, V20, P461, DOI 10.1016/0011-7471(73)90100-9; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Havenhand JN, 2012, AMBIO, V41, P637, DOI 10.1007/s13280-012-0326-x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Horn HG, 2016, ICES J MAR SCI, V73, P772, DOI 10.1093/icesjms/fsv198; IPCC, 2014, CLIMATE CHANGE MITIG; Ismar SMH, 2008, MAR BIOL, V154, P335, DOI 10.1007/s00227-008-0928-9; Jonasdottir SH, 2009, MAR ECOL PROG SER, V382, P139, DOI 10.3354/meps07985; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Koussoroplis AM, 2014, LIMNOL OCEANOGR; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; LANE AE, 1981, PLANT PHYSIOL, V68, P439, DOI 10.1104/pp.68.2.439; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; Magozzi S, 2015, GLOBAL CHANGE BIOL, V21, P181, DOI 10.1111/gcb.12695; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mayor DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13690; Mayor DJ, 2012, J PLANKTON RES, V34, P258, DOI 10.1093/plankt/fbr107; Mazorra C, 2003, AQUACULTURE, V227, P21, DOI 10.1016/S0044-8486(03)00493-9; McConville K, 2013, MAR POLLUT BULL, V73, P428, DOI 10.1016/j.marpolbul.2013.02.010; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nguyen HD, 2012, GLOBAL CHANGE BIOL, V18, P2466, DOI 10.1111/j.1365-2486.2012.02714.x; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Paul C, 2016, LIMNOL OCEANOGR, V61, P853, DOI 10.1002/lno.10256; Paul C, 2015, MAR ECOL PROG SER, V528, P39, DOI 10.3354/meps11264; Pedersen SA, 2013, BIOGEOSCIENCES, V10, P7481, DOI 10.5194/bg-10-7481-2013; Pierrot D., 2006, ORNLCDIAC105 US DEP; Portner HO, 2004, J OCEANOGRAPHY; Przeslawski R, 2015, GLOBAL CHANGE BIOL, V21, P2122, DOI 10.1111/gcb.12833; Riebesell U., 2011, GUIDE BEST PRACTICES, DOI 10.2777/66906; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Rose JM, 2009, MAR ECOL PROG SER; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; SARGENT JR, 1988, HYDROBIOLOGIA, V167, P101, DOI 10.1007/BF00026297; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Schoo KL, 2010, AQUAT ECOL, V44, P233, DOI 10.1007/s10452-009-9265-4; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Zervoudaki S, 2014, MEDITERR MAR SCI, V15, P74, DOI 10.12681/mms.553	80	48	48	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155952	10.1371/journal.pone.0155952	http://dx.doi.org/10.1371/journal.pone.0155952			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224476	Green Published, gold, Green Accepted			2022-12-26	WOS:000376881700044
J	Jia, PP; Ma, YB; Lu, CJ; Mirza, Z; Zhang, W; Jia, YF; Li, WG; Pei, DS				Jia, Pan-Pan; Ma, Yan-Bo; Lu, Chun-Jiao; Mirza, Zakaria; Zhang, Wei; Jia, Yong-Fang; Li, Wei-Guo; Pei, De-Sheng			The Effects of Disturbance on Hypothalamus-Pituitary-Thyroid (HPT) Axis in Zebrafish Larvae after Exposure to DEHP	PLOS ONE			English	Article							PHTHALIC-ACID ESTERS; ENDOCRINE DISRUPTION; IODOTHYRONINE DEIODINASE; TERM EXPOSURE; HORMONE; PLASTICIZERS; MINNOW; WATER; EXPRESSION; THYROXINE	Di-(2-ethylhexyl) phthalate (DEHP) has the potential to disrupt the thyroid endocrine system, but the underlying mechanism is unknown. In this study, zebrafish (Danio rerio) embryos were exposed to different concentrations of DEHP (0, 40, 100, 200, 400 mu g/L) from 2 to 168 hours post fertilization (hpf). Thyroid hormones (THs) levels and transcriptional profiling of key genes related to hypothalamus-pituitary-thyroid (HPT) axis were examined. The result of whole-body thyroxine (T4) and triiodothyronine (T3) indicated that the thyroid hormone homeostasis was disrupted by DEHP in the zebrafish larvae. After exposure to DEHP, the mRNA expressions of thyroid stimulating hormone (tsh beta) and corticotrophin releasing hormone (crh) genes were increased in a concentration dependent manner, respectively. The expression level of genes involved in thyroid development (nkx2.1 and pax8) and thyroid synthesis (sodium/iodide symporter, nis, thyroglobulin, tg) were also measured. The transcripts of nkx2.1 and tg were significantly increased after DEHP exposure, while those of nis and pax8 had no significant change. Down-regulation of uridinediphosphate-glucuronosyl-transferase (ugt1ab) and up-regulation of thyronine deiodinase (dio2) might change the THs levels. In addition, the transcript of transthyretin (ttr) was up-regulated, while the mRNA levels of thyroid hormone receptors (tr alpha and tr beta) remained unchanged. All the results demonstrated that exposure to DEHP altered the whole-body thyroid hormones in the zebrafish larvae and changed the expression profiling of key genes related to HPT axis, proving that DEHP induced the thyroid endocrine toxicity and potentially affected the synthesis, regulation and action of thyroid hormones.	[Jia, Pan-Pan; Jia, Yong-Fang; Li, Wei-Guo] Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Peoples R China; [Jia, Pan-Pan; Ma, Yan-Bo; Lu, Chun-Jiao; Mirza, Zakaria; Zhang, Wei; Pei, De-Sheng] Chinese Acad Sci, Res Ctr Environm & Hlth, Chongqing Inst Green & Intelligent Technol, Ecoenvironm Inst Three Gorges, Chongqing 401122, Peoples R China	Henan Normal University; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS	Li, WG (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Peoples R China.; Pei, DS (corresponding author), Chinese Acad Sci, Res Ctr Environm & Hlth, Chongqing Inst Green & Intelligent Technol, Ecoenvironm Inst Three Gorges, Chongqing 401122, Peoples R China.	liwg0618@htu.cn; deshengpei@gmail.com	Zhang, Wei/H-2082-2012; Pei, De-Sheng/K-1466-2017	Zhang, Wei/0000-0002-9756-9994; Pei, De-Sheng/0000-0001-6408-9575; Jia, Panpan/0000-0003-3569-2433	Chinese Academy of Sciences; West Light PhD Foundation of the Chinese Academy of Sciences; Key Application and Development Program of Chongqing Science and Technology Commission [cstc2014yykfC20004, cstc2014yykfC20002]; National Natural Science Foundation of China [21407146]; Application and Development Program of Science and Technology Commission of Beibei District, Chongqing [2015-07]; Scientific Research Starting Foundation for Returned Overseas Chinese Scholars from Ministry of Education; National Technology Foundation for Selected Overseas Chinese Scholar of Chongqing Human Resources and Social Security Bureau, China	Chinese Academy of Sciences(Chinese Academy of Sciences); West Light PhD Foundation of the Chinese Academy of Sciences; Key Application and Development Program of Chongqing Science and Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Application and Development Program of Science and Technology Commission of Beibei District, Chongqing; Scientific Research Starting Foundation for Returned Overseas Chinese Scholars from Ministry of Education(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Technology Foundation for Selected Overseas Chinese Scholar of Chongqing Human Resources and Social Security Bureau, China	The authors are grateful for support from the Hundred Talents Program of Chinese Academy of Sciences (to D.S.P.), the West Light PhD Foundation of the Chinese Academy of Sciences (to Y.B.M.), the Key Application and Development Program of Chongqing Science and Technology Commission (Grant No. cstc2014yykfC20004 and cstc2014yykfC20002 to D.S.P.), the National Natural Science Foundation of China (Grant No. 21407146 to Y.B.M.), the Application and Development Program of Science and Technology Commission of Beibei District, Chongqing (2015-07 to D.S.P.), the Scientific Research Starting Foundation for Returned Overseas Chinese Scholars from Ministry of Education (to D.S.P.), and the National Technology Foundation for Selected Overseas Chinese Scholar of Chongqing Human Resources and Social Security Bureau, China (to D.S.P.).	Blanton ML, 2007, CRIT REV TOXICOL, V37, P97, DOI 10.1080/10408440601123529; Brown CL, 1995, AQUACULTURE, V135, P79, DOI 10.1016/0044-8486(95)01016-5; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Chao KP, 2015, J HAZARD MATER, V283, P53, DOI 10.1016/j.jhazmat.2014.09.010; Chen Q, 2012, AQUAT TOXICOL, V110, P141, DOI 10.1016/j.aquatox.2012.01.008; Chen XP, 2014, INT J ENV RES PUB HE, V11, P3156, DOI 10.3390/ijerph110303156; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Corradetti B, 2013, REPROD BIOL, V13, P195, DOI 10.1016/j.repbio.2013.07.003; Crane HM, 2004, GEN COMP ENDOCR, V139, P55, DOI 10.1016/j.ygcen.2004.07.004; Dai YJ, 2014, ENVIRON TOXICOL CHEM, V33, P11, DOI 10.1002/etc.2406; De Groef B, 2006, GEN COMP ENDOCR, V146, P62, DOI 10.1016/j.ygcen.2005.10.014; Erythropel HC, 2014, APPL MICROBIOL BIOT, V98, P9967, DOI 10.1007/s00253-014-6183-8; Fernie KJ, 2005, TOXICOL SCI, V88, P375, DOI 10.1093/toxsci/kfi295; Fliers E, 2014, EUR J ENDOCRINOL, V171, pR197, DOI 10.1530/EJE-14-0285; Ghisari M, 2009, TOXICOL LETT, V189, P67, DOI 10.1016/j.toxlet.2009.05.004; Guo YY, 2015, ENVIRON POLLUT, V203, P130, DOI 10.1016/j.envpol.2015.04.005; Hood A, 2000, TOXICOL SCI, V55, P78, DOI 10.1093/toxsci/55.1.78; Horn O, 2004, WATER RES, V38, P3693, DOI 10.1016/j.watres.2004.06.012; Huerta-Fontela M., 2008, V5, P143, DOI 10.1007/698_5_101; Ji YQ, 2014, J HAZARD MATER, V279, P133, DOI 10.1016/j.jhazmat.2014.06.055; LAM TJ, 1985, AQUACULTURE, V46, P179, DOI 10.1016/0044-8486(85)90203-0; Liu SY, 2011, ENVIRON TOXICOL PHAR, V32, P472, DOI 10.1016/j.etap.2011.09.002; Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Magdouli S, 2013, J ENVIRON MANAGE, V127, P36, DOI 10.1016/j.jenvman.2013.04.013; Manchado M, 2008, GEN COMP ENDOCR, V155, P447, DOI 10.1016/j.ygcen.2007.07.011; Marchand O, 2001, J MOL ENDOCRINOL, V26, P51, DOI 10.1677/jme.0.0260051; Mathieu-Denoncourt J, 2015, GEN COMP ENDOCR, V219, P74, DOI 10.1016/j.ygcen.2014.11.003; Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004; Morgado I, 2007, GEN COMP ENDOCR, V152, P189, DOI 10.1016/j.ygcen.2006.12.017; Oehlmann J, 2008, ENVIRON RES, V108, P140, DOI 10.1016/j.envres.2008.07.016; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Porazzi P, 2009, MOL CELL ENDOCRINOL, V312, P14, DOI 10.1016/j.mce.2009.05.011; Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Schnitzler JG, 2016, FISH PHYSIOL BIOCHEM, V42, P607, DOI 10.1007/s10695-015-0163-5; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Shi XJ, 2009, CHEMOSPHERE, V77, P1010, DOI 10.1016/j.chemosphere.2009.07.074; Sun HJ, 2015, ENVIRON POLLUT, V205, P145, DOI 10.1016/j.envpol.2015.05.037; Van der Geyten S, 2001, GEN COMP ENDOCR, V124, P333, DOI 10.1006/gcen.2001.7722; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457; Wang F, 2008, J HAZARD MATER, V154, P317, DOI 10.1016/j.jhazmat.2007.10.028; Wang QW, 2013, AQUAT TOXICOL, V126, P207, DOI 10.1016/j.aquatox.2012.11.009; Weir SM, 2014, CHEMOSPHERE, V103, P44, DOI 10.1016/j.chemosphere.2013.10.097; Wendl T, 2002, DEVELOPMENT, V129, P3751; WU PG, 1999, J ENV HLTH, V16, P338; Ye T, 2016, ENVIRON TOXICOL, V31, P116, DOI 10.1002/tox.22028; Yu L, 2013, AQUAT TOXICOL, V138, P35, DOI [10.1016/j.aquatox.2013.04.001, 10.1016/j.aquatox.2013.04.010]; Yu LQ, 2010, AQUAT TOXICOL, V97, P226, DOI 10.1016/j.aquatox.2009.10.022; Zeng F, 2008, ENVIRON INT, V34, P372, DOI 10.1016/j.envint.2007.09.002; Zhai WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092465; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P55, DOI 10.1080/10408440601123461	55	68	73	13	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155762	10.1371/journal.pone.0155762	http://dx.doi.org/10.1371/journal.pone.0155762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223697	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700028
J	Nakano, Y; Akamatsu, N; Mori, T; Sano, K; Satoh, K; Nagayasu, T; Miyoshi, Y; Sugio, T; Sakai, H; Sakae, E; Ichimiya, K; Hamada, M; Nakayama, T; Fujita, Y; Yanagihara, K; Nishida, N				Nakano, Yuichiro; Akamatsu, Norihiko; Mori, Tsuyoshi; Sano, Kazunori; Satoh, Katsuya; Nagayasu, Takeshi; Miyoshi, Yoshiaki; Sugio, Tomomi; Sakai, Hideyuki; Sakae, Eiji; Ichimiya, Kazuko; Hamada, Masahisa; Nakayama, Takehisa; Fujita, Yuhzo; Yanagihara, Katsunori; Nishida, Noriyuki			Sequential Washing with Electrolyzed Alkaline and Acidic Water Effectively Removes Pathogens from Metal Surfaces	PLOS ONE			English	Article							IN-VITRO; KNOCK-IN; ENDOSCOPE DISINFECTION; SURGICAL-INSTRUMENTS; STEEL SURFACES; HUMAN PRIONS; DECONTAMINATION; TRANSMISSION; SCRAPIE; STERILIZATION	Removal of pathogenic organisms from reprocessed surgical instruments is essential to prevent iatrogenic infections. Some bacteria can make persistent biofilms on medical devices. Contamination of non-disposable equipment with prions also represents a serious risk to surgical patients. Efficient disinfection of prions from endoscopes and other instruments such as high-resolution cameras remains problematic because these instruments do not tolerate aggressive chemical or heat treatments. Herein, we develop a new washing system that uses both the alkaline and acidic water produced by electrolysis. Electrolyzed acidic water, containing HCl and HOCl as active substances, has been reported to be an effective disinfectant. A 0.15% NaCl solution was electrolyzed and used immediately to wash bio-contaminated stainless steel model systems with alkaline water (pH 11.9) with sonication, and then with acidic water (pH 2.7) without sonication. Two bacterial species (Staphylococcus aureus and Pseudomonas aeruginosa) and a fungus (Candida albicans) were effectively removed or inactivated by the washing process. In addition, this process effectively removed or inactivated prions from the stainless steel surfaces. This washing system will be potentially useful for the disinfection of clinical devices such as neuroendoscopes because electrolyzed water is gentle to both patients and equipment and is environmentally sound.	[Nakano, Yuichiro; Akamatsu, Norihiko; Yanagihara, Katsunori] Nagasaki Univ, Dept Lab Med, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 852, Japan; [Mori, Tsuyoshi; Satoh, Katsuya] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki 852, Japan; [Sano, Kazunori] Fukuoka Univ, Fac Pharmaceut Sci, Dept Physiol & Pharmacol, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 81401, Japan; [Nagayasu, Takeshi] Nagasaki Univ, Dept Surg Oncol, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 852, Japan; [Miyoshi, Yoshiaki; Sugio, Tomomi; Sakai, Hideyuki] Kyowakiden Ind Co Ltd, 10-2 Kawaguchi, Nagasaki, Japan; [Sakae, Eiji; Ichimiya, Kazuko; Hamada, Masahisa; Nakayama, Takehisa] Kripton Co Ltd, Shinjuku Ku, Dai 12 Daitetsu Bldg,7F 4-3-12 Yotsuya, Tokyo, Japan; [Fujita, Yuhzo] Teraoka Seikei Geka Hosp, 3-1-52 Minami Honjo, Fukuyama, Hiroshima, Japan	Nagasaki University; Nagasaki University; Fukuoka University; Nagasaki University	Mori, T (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki 852, Japan.	morit@nagasaki-u.ac.jp			Ministry of Economy, Trade and Industry, Japan [24-084]; Kyowakiden Industry Co., Ltd.; Kripton Co., Ltd.	Ministry of Economy, Trade and Industry, Japan; Kyowakiden Industry Co., Ltd.; Kripton Co., Ltd.	This work was supported by a grant-in-aid for the "Program to support development of medical equipment and devices to solve unmet medical needs 2012, 2013" and "Development of Medical Devices through Collaboration between Medicine and Industry 2014" under the Ministry of Economy, Trade and Industry, Japan (24-084). The funders provided support in the form of salaries for authors YN and TM, but did not have any additional role in the study design, data collection and analysis, decision publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Yoshiaki Miyoshi, Tomomi Sugio and Hideyuki Sakai are employed by Kyowakiden Industry Co., Ltd. Eiji Sakae, Kazuko Ichimiya, Masahisa Hamada and Takehisa Nakayama are employed by Kripton Co., Ltd. Kyowakiden Industry Co., Ltd. and Kripton Co., Ltd. provided support in the form of salaries for authors YM, TS, HS, ES, KI, MH and TNak, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ammirati M, 2013, J NEUROL NEUROSUR PS, V84, P843, DOI 10.1136/jnnp-2012-303194; AOAC INTERNATIONAL, 2000, 99149 AOAC INT; AOAC INTERNATIONAL, 2000, 99148 AOAC INT; Ayliffe G, 2000, J HOSP INFECT, V45, P263, DOI 10.1053/jhin.2000.0767; Buss AJ, 2008, ENDOSCOPY, V40, P327, DOI 10.1055/s-2007-995477; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Gomi K, 2010, QUINTESSENCE INT, V41, pE166; Hao XX, 2013, VET J, V197, P297, DOI 10.1016/j.tvjl.2013.02.007; Ishihara R, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.02.03; Kitamoto T, 1996, BIOCHEM BIOPH RES CO, V222, P742, DOI 10.1006/bbrc.1996.0814; Kitamoto T, 2002, BIOCHEM BIOPH RES CO, V294, P280, DOI 10.1016/S0006-291X(02)00476-X; Koike T, 2013, DIGEST ENDOSC, V25, P20, DOI 10.1111/den.12047; Kovaleva J, 2013, CLIN MICROBIOL REV, V26, P231, DOI 10.1128/CMR.00085-12; Kubota A, 2009, SURG TODAY, V39, P514, DOI 10.1007/s00595-008-3914-4; Lee JH, 2004, J GASTROEN HEPATOL, V19, P897, DOI 10.1111/j.1440-1746.2004.03375.x; Lemmer K, 2004, J GEN VIROL, V85, P3805, DOI 10.1099/vir.0.80346-0; Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0; Nelson DB, 2001, GASTROINTEST ENDOSC, V54, P824, DOI 10.1016/S0016-5107(01)70086-7; Pangloli P, 2009, J FOOD PROTECT, V72, P1854, DOI 10.4315/0362-028X-72.9.1854; Plaha P, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.07.034; Rutala WA, 2001, EMERG INFECT DIS, V7, P348, DOI 10.3201/eid0702.010241; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P107, DOI 10.1086/650197; Selkon JB, 1999, J HOSP INFECT, V41, P59, DOI 10.1016/S0195-6701(99)90038-5; Tabaee A, 2009, J NEUROSURG, V111, P545, DOI 10.3171/2007.12.17635; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; Tsuji S, 1999, ENDOSCOPY, V31, P528; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	28	6	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156058	10.1371/journal.pone.0156058	http://dx.doi.org/10.1371/journal.pone.0156058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223116	gold, Green Submitted, Green Published			2022-12-26	WOS:000376881700055
J	Wierer, S; Daldrop, P; Ahmad, MUD; Boos, W; Drescher, M; Welte, W; Seidel, R				Wierer, Sebastian; Daldrop, Peter; Ahmad, Misbha Ud Din; Boos, Winfried; Drescher, Malte; Welte, Wolfram; Seidel, Ralf			TrmBL2 from Pyrococcus furiosus Interacts Both with Double-Stranded and Single-Stranded DNA	PLOS ONE			English	Article							DIRECT MECHANICAL MEASUREMENTS; ARCHAEAL CHROMATIN PROTEIN; TRANSCRIPTIONAL REGULATOR; H-NS; ESCHERICHIA-COLI; SUPERCOILED DNA; LAC REPRESSOR; THERMOCOCCUS-KODAKARENSIS; CRYSTAL-STRUCTURE; ABC TRANSPORTER	In many hyperthermophilic archaea the DNA binding protein TrmBL2 or one of its homologues is abundantly expressed. TrmBL2 is thought to play a significant role in modulating the chromatin architecture in combination with the archaeal histone proteins and Alba. However, its precise physiological role is poorly understood. It has been previously shown that upon binding TrmBL2 covers double-stranded DNA, which leads to the formation of a thick and fibrous filament. Here we investigated the filament formation process as well as the stabilization of DNA by TrmBL2 from Pyroccocus furiosus in detail. We used magnetic tweezers that allow to monitor changes of the DNA mechanical properties upon TrmBL2 binding on the single-molecule level. Extended filaments formed in a cooperative manner and were considerably stiffer than bare double-stranded DNA. Unlike Alba, TrmBL2 did not form DNA cross-bridges. The protein was found to bind double- and single-stranded DNA with similar affinities. In mechanical disruption experiments of DNA hairpins this led to stabilization of both, the double- (before disruption) and the single-stranded (after disruption) DNA forms. Combined, these findings suggest that the biological function of TrmBL2 is not limited to modulating genome architecture and acting as a global repressor but that the protein acts additionally as a stabilizer of DNA secondary structure.	[Wierer, Sebastian; Drescher, Malte] Univ Konstanz, Dept Chem, Univ Str 10, D-78464 Constance, Germany; [Wierer, Sebastian; Ahmad, Misbha Ud Din; Boos, Winfried; Welte, Wolfram] Univ Konstanz, Dept Biol, Univ Str 10, D-78464 Constance, Germany; [Daldrop, Peter; Seidel, Ralf] Univ Munster, Inst Mol Cell Biol, Schlosspl 5, D-48149 Munster, Germany; [Seidel, Ralf] Univ Leipzig, Inst Expt Phys 1, Linnestr 5, D-04103 Leipzig, Germany	University of Konstanz; University of Konstanz; University of Munster; Leipzig University	Welte, W (corresponding author), Univ Konstanz, Dept Biol, Univ Str 10, D-78464 Constance, Germany.; Seidel, R (corresponding author), Univ Munster, Inst Mol Cell Biol, Schlosspl 5, D-48149 Munster, Germany.; Seidel, R (corresponding author), Univ Leipzig, Inst Expt Phys 1, Linnestr 5, D-04103 Leipzig, Germany.	wolfram.welte@uni-konstanz.de; ralf.seidel@physik.uni-leipzig.de	Seidel, Ralf/A-6531-2010	Seidel, Ralf/0000-0002-6642-053X; Ahmad, Misbha Ud Din/0000-0002-4892-7337	Deutsche Forschungsgemeinschaft (DFG) [WE 962/12-1]; European Research Council [GA 261224]; Graduate school KoRS-CB	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Graduate school KoRS-CB	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, grant WE 962/12-1) to WW; starting grant of the European Research Council (GA 261224) to RS; Graduate school KoRS-CB to SW.	Ahmad MUD, 2015, J MOL BIOL, V427, P3216, DOI 10.1016/j.jmb.2015.08.012; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Amosova O, 2011, J BIOL CHEM, V286, P36322, DOI 10.1074/jbc.M111.272112; Bertoldo C, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P69, DOI 10.1007/0-387-30743-5_5; Borges KM, 1997, J BACTERIOL, V179, P1721, DOI 10.1128/jb.179.5.1721-1726.1997; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Brutzer H, 2010, BIOPHYS J, V98, P1267, DOI 10.1016/j.bpj.2009.12.4292; Crnigoj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058237; Daldrop P, 2015, BIOPHYS J, V108, P2550, DOI 10.1016/j.bpj.2015.04.011; Dessinges MN, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248102; Efremov AK, 2015, J BIOL CHEM, V290, P15770, DOI 10.1074/jbc.M114.626705; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; FRIEDRICH K, 1988, FEBS LETT, V229, P197, DOI 10.1016/0014-5793(88)80826-3; Gindner A, 2014, EXTREMOPHILES, V18, P925, DOI 10.1007/s00792-014-0677-2; Griese JJ, 2011, PROTEINS, V79, P558, DOI 10.1002/prot.22903; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Huhle A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6885; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kauert DJ, 2011, NANO LETT, V11, P5558, DOI 10.1021/nl203503s; Klaue D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3024; Klaue D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.028302; Komori K, 2001, J BIOL CHEM, V276, P25654, DOI 10.1074/jbc.M102423200; Krug M, 2006, J BIOL CHEM, V281, P10976, DOI 10.1074/jbc.M512809200; Krug M, 2013, PROTEIN SCI, V22, P800, DOI 10.1002/pro.2263; Laurens N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2330; Lee SJ, 2005, MOL MICROBIOL, V57, P1797, DOI 10.1111/j.1365-2958.2005.04804.x; Lee SJ, 2003, J BIOL CHEM, V278, P983, DOI 10.1074/jbc.M210236200; Lee SJ, 2008, ARCH MICROBIOL, V190, P247, DOI 10.1007/s00203-008-0378-2; Lee SJ, 2007, MOL MICROBIOL, V65, P305, DOI 10.1111/j.1365-2958.2007.05780.x; Lim CJ, 2014, NUCLEIC ACIDS RES, V42, P8369, DOI 10.1093/nar/gku566; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Liu Y, 2009, J BACTERIOL, V191, P2315, DOI 10.1128/JB.01534-08; Lu D, 2010, GENE DEV, V24, P2556, DOI 10.1101/gad.603510; Maffeo C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158101; MARKO JF, 1995, PHYS REV E, V52, P2912, DOI 10.1103/PhysRevE.52.2912; Maruyama H, 2011, MOL BIOL CELL, V22, P386, DOI 10.1091/mbc.E10-08-0668; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Peeters E, 2015, NAT REV MICROBIOL, V13, P333, DOI 10.1038/nrmicro3467; Ramanathan SP, 2009, P NATL ACAD SCI USA, V106, P1748, DOI 10.1073/pnas.0807193106; Reichelt R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2360-0; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Schmid AK, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.40; Schopflin R, 2012, BIOPHYS J, V103, P323, DOI 10.1016/j.bpj.2012.05.050; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Sochor MA, 2014, PEERJ, V2, DOI 10.7717/peerj.498; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465	49	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156098	10.1371/journal.pone.0156098	http://dx.doi.org/10.1371/journal.pone.0156098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214207	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200053
J	Ahlawat, S; Sharma, P; Sharma, R; Arora, R; De, S				Ahlawat, Sonika; Sharma, Priyanka; Sharma, Rekha; Arora, Reena; De, Sachinandan			Zinc Finger Domain of the PRDM9 Gene on Chromosome 1 Exhibits High Diversity in Ruminants but Its Paralog PRDM7 Contains Multiple Disruptive Mutations	PLOS ONE			English	Article							MEIOTIC RECOMBINATION HOTSPOTS; HYBRID STERILITY; HOT-SPOTS; INSTABILITY; EXPRESSION; DROSOPHILA; EVOLUTION; INFERENCE; SEQUENCE; HUMANS	PRDM9 is the sole hybrid sterility gene identified so far in vertebrates. PRDM9 gene encodes a protein with an immensely variable zinc-finger (ZF) domain that determines the site of meiotic recombination hotspots genome-wide. In this study, the terminal ZF domain of PRDM9 on bovine chromosome 1 and its paralog on chromosome 22 were characterized in 225 samples from five ruminant species (cattle, yak, mithun, sheep and goat). We found extraordinary variation in the number of PRDM9 zinc fingers (6 to 12). We sequenced PRDM9 ZF encoding region from 15 individuals (carrying the same ZF number in both copies) and found 43 different ZF domain sequences. Ruminant zinc fingers of PRDM9 were found to be diversifying under positive selection and concerted evolution, specifically at positions involved in defining their DNA-binding specificity, consistent with the reports from other vertebrates such as mice, humans, equids and chimpanzees. ZF-encoding regions of the PRDM7, a paralog of PRDM9 on bovine chromosome 22 and on unknown chromosomes in other studied species were found to contain 84 base repeat units as in PRDM9, but there were multiple disruptive mutations after the first repeat unit. The diversity of the ZFs suggests that PRDM9 may activate recombination hotspots that are largely unique to each ruminant species.	[Ahlawat, Sonika; Sharma, Priyanka; Sharma, Rekha; Arora, Reena] Natl Bur Anim Genet Resources, Karnal, India; [De, Sachinandan] Natl Dairy Res Inst, Karnal, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Ahlawat, S (corresponding author), Natl Bur Anim Genet Resources, Karnal, India.	sonika.ahlawat@gmail.com	Ahlawat, Sonika/AAW-9905-2020; ARORA, REENA/AAK-6892-2021; Arora, Reena/AAR-2240-2021	Ahlawat, Sonika/0000-0002-4302-2969	Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	This work was supported by Institute funding of Indian Council of Agricultural Research.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Billings T, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r35; Buard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085021; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Groeneveld LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039064; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Jeffreys AJ, 2013, P NATL ACAD SCI USA, V110, P600, DOI 10.1073/pnas.1220813110; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kono H, 2014, DNA RES, V21, P315, DOI 10.1093/dnares/dst059; Lou YN, 2014, LIVEST SCI, V160, P208, DOI 10.1016/j.livsci.2013.12.017; Ma L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005387; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neale MJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-104; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; PEREZ DE, 1995, GENETICS, V140, P201; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Raes J, 2005, TRENDS GENET, V21, P428, DOI 10.1016/j.tig.2005.05.013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sandor C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002854; Schwartz JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5370; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steiner CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061746; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; Wang S, 2012, REPROD DOMEST ANIM, V47, P455, DOI 10.1111/j.1439-0531.2011.01902.x; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zhang QB, 2008, PROG NAT SCI-MATER, V18, P1209, DOI 10.1016/j.pnsc.2008.02.012	46	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0156159	10.1371/journal.pone.0156159	http://dx.doi.org/10.1371/journal.pone.0156159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203728	gold, Green Published, Green Submitted			2022-12-26	WOS:000376291500046
J	Gauvin, J; Chagnon-Choquet, J; Poudrier, J; Roger, M				Gauvin, Julie; Chagnon-Choquet, Josiane; Poudrier, Johanne; Roger, Michel		Montreal Primary HIV Infection	Fluctuations in Blood Marginal Zone B-Cell Frequencies May Reflect Migratory Patterns Associated with HIV-1 Disease Progression Status	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS; GERMINAL-CENTERS; SIV INFECTION; EXPRESSION; CHEMOKINE; RESPONSES; IMMUNITY; CCL20; CXCL13; CCR6	We have previously shown that overexpression of BLyS/BAFF was associated with increased relative frequencies of innate "precursor" marginal zone (MZ)-like B-cells in the blood of HIV-1-infected rapid and classic progressors. However, along with relatively normal BLyS/BAFF expression levels, these cells remain unaltered in elite-controllers (EC), rather, percentages of more mature MZ-like B-cells are decreased in the blood of these individuals. Fluctuations in frequencies of blood MZ-like B-cell populations may reflect migratory patterns associated with disease progression status, suggesting an important role for these cells in HIV-1 pathogenesis. We have therefore longitudinally measured plasma levels of B-tropic chemokines by ELISA-based technology as well as their ligands by flow-cytometry on blood B-cell populations of HIV-1-infected individuals with different rates of disease progression and uninfected controls. Migration potential of B-cell populations from these individuals were determined by chemotaxis assays. We found important modulations of CXCL13-CXCR5, CXCL12-CXCR4/CXCR7, CCL20-CCR6 and CCL25-CCR9 chemokine-axes and increased cell migration patterns in HIV progressors. Interestingly, frequencies of CCR6 expressing cells were significantly elevated within the precursor MZ-like population, consistent with increased migration in response to CCL20. Although we found little modulation of chemokine-axes in EC, cell migration was greater than that observed for uninfected controls, especially for MZ-like B-cells. Overall the immune response against HIV-1 may involve recruitment of MZ-like B-cells to peripheral sites. Moreover, our findings suggest that "regulated" attraction of these cells in a preserved BLyS/BAFF non-inflammatory environment, such as encountered in EC could be beneficial to the battle and even control of HIV.	[Gauvin, Julie; Chagnon-Choquet, Josiane; Poudrier, Johanne; Roger, Michel] CRCHUM, Lab Immunogenet, Montreal, PQ, Canada; [Gauvin, Julie; Chagnon-Choquet, Josiane; Poudrier, Johanne; Roger, Michel] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Poudrier, J; Roger, M (corresponding author), CRCHUM, Lab Immunogenet, Montreal, PQ, Canada.; Poudrier, J; Roger, M (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada.	johanne.poudrier@crchum.qc.ca; michel.roger@ssss.gouv.qc.ca		Klein, Marina/0000-0002-3063-8430	Canadian Institutes of Health Research (CIHR) [CHR-126633, HB-134180]; Reseau SIDA from Fonds de Recherche du Quebec en Sante (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau SIDA from Fonds de Recherche du Quebec en Sante (FRQS)	This work was supported by grants #CHR-126633 and #HB-134180 from the Canadian Institutes of Health Research (CIHR) and by the Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS).	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Badr G, 2008, BLOOD, V111, P2744, DOI 10.1182/blood-2007-03-081232; Berahovich RD, 2013, IMMUNOL LETT, V154, P77, DOI 10.1016/j.imlet.2013.08.004; Borrow P, 2011, CURR OPIN HIV AIDS, V6, P353, DOI 10.1097/COH.0b013e3283495996; Brandes M, 2000, INT IMMUNOL, V12, P1285, DOI 10.1093/intimm/12.9.1285; Brenchley JM, 2013, MUCOSAL IMMUNOL, V6, P657, DOI 10.1038/mi.2013.15; Cagigi A, 2008, BLOOD, V112, P4401, DOI 10.1182/blood-2008-02-140426; Calmon-Hamaty F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3376; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chagnon-Choquet J, 2014, J INFECT DIS; Chagnon-Choquet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101949; Chaoul N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-43; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Hanna Z, 1998, J VIROL, V72, P121, DOI 10.1128/JVI.72.1.121-132.1998; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Johnson EL, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-62; Macpherson AJ, 2013, SEMIN IMMUNOL, V25, P358, DOI 10.1016/j.smim.2013.09.004; Marsigliante S, 2013, J CELL PHYSIOL, V228, P1873, DOI 10.1002/jcp.24349; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Peruchon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005966; Poudrier J, 2001, IMMUNITY, V15, P173, DOI 10.1016/S1074-7613(01)00177-7; Poudrier J., 2012, CLIN DEV IMMUNOL, V2012, DOI [10.1155/2012/592187, DOI 10.1155/2012/592187]; Poudrier J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/875821; Poudrier J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002154; Reinhart TA, 2009, CURR HIV RES, V7, P73, DOI 10.2174/157016209787048537; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang HS, 2012, BLOOD, V119, P465, DOI 10.1182/blood-2011-03-343608; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Widney DP, 2005, J INTERF CYTOK RES, V25, P702, DOI 10.1089/jir.2005.25.702; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	37	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155868	10.1371/journal.pone.0155868	http://dx.doi.org/10.1371/journal.pone.0155868			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203285	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500026
J	Yalon, M; Tuval-Kochen, L; Castel, D; Moshe, I; Mazal, I; Cohen, O; Avivi, C; Rosenblatt, K; Aviel-Ronen, S; Schiby, G; Yahalom, J; Amariglio, N; Pfeffer, R; Lawrence, Y; Toren, A; Rechavi, G; Paglin, S				Yalon, Michal; Tuval-Kochen, Liron; Castel, David; Moshe, Itai; Mazal, Inbal; Cohen, Osher; Avivi, Camila; Rosenblatt, Kineret; Aviel-Ronen, Sarit; Schiby, Ginette; Yahalom, Joachim; Amariglio, Ninette; Pfeffer, Raphael; Lawrence, Yaacov; Toren, Amos; Rechavi, Gideon; Paglin, Shoshana			Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; RECOMBINATION DNA-REPAIR; HOMOLOGOUS RECOMBINATION; POLY(ADP-RIBOSE) POLYMERASE; MECHANISMS; THERAPY; PATHWAY; TUMOR; 6-THIOGUANINE; THIOREDOXIN	Inhibitors of poly[ADP-ribose] polymerase 1 (PARPis) show promise for treatment of cancers which lack capacity for homologous recombination repair (HRR). However, new therapeutic strategies are required in order to overcome innate and acquired resistance to these drugs and thus expand the array of cancers that could benefit from them. We show that human cancer cell lines which respond poorly to ABT-888 (a PARPi), become sensitive to it when co-treated with vorinostat (a histone deacetylase inhibitor (HDACi)). Vorinostat also sensitized PARPis insensitive cancer cell lines to 6-thioguanine (6-TG)-a drug that targets PARPis sensitive cells. The sensitizing effect of vorinostat was associated with increased phosphorylation of eukaryotic initiation factor (eIF) 2 alpha which in and of itself increases the sensitivity of cancer cells to ABT-888. Importantly, these drug combinations did not affect survival of normal fibroblasts and breast cells, and significantly increased the inhibition of xenograft tumor growth relative to each drug alone, without affecting the mice weight or their liver and kidney function. Our results show that combination of vorinostat and ABT-888 could potentially prove useful for treatment of cancer with innate resistance to PARPis due to active HRR machinery, while the combination of vorinostat and 6-TG could potentially overcome innate or acquired resistance to PARPis due to secondary or reversal BRCA mutations, to decreased PARP-1 level or to increased expression of multiple drug resistant proteins. Importantly, drugs which increase phosphorylation of eIF2 alpha may mimic the sensitizing effect of vorinostat on cellular response to PARPis or to 6-TG, without activating all of its downstream effectors.	[Yalon, Michal; Moshe, Itai; Toren, Amos] Safra Childrens Hosp, Chaim Sheba Med Ctr, Dept Pediat Hematol Oncol, IL-52621 Ramat Gan, Israel; [Yalon, Michal; Tuval-Kochen, Liron; Mazal, Inbal; Amariglio, Ninette; Pfeffer, Raphael; Lawrence, Yaacov; Toren, Amos; Rechavi, Gideon; Paglin, Shoshana] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Ramat Gan, Israel; [Tuval-Kochen, Liron] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Castel, David] Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Ramat Gan, Israel; [Cohen, Osher] Chaim Sheba Med Ctr, Dept Surg, IL-52621 Ramat Gan, Israel; [Avivi, Camila; Rosenblatt, Kineret; Aviel-Ronen, Sarit; Schiby, Ginette] Chaim Sheba Med Ctr, Dept Pathol, IL-52621 Ramat Gan, Israel; [Yahalom, Joachim] Mem Sloan Kettering, Dept Radiat Oncol, New York, NY 10021 USA	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Memorial Sloan Kettering Cancer Center	Paglin, S (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Ramat Gan, Israel.	shoshana.paglin@sheba.health.gov.il	lawrence, yaacov richard/AFP-1121-2022	lawrence, yaacov richard/0000-0002-9959-2485	 [PCIG10-GA-2011-303795]		http://ec.europa.eu/research/mariecurieactions/ Grant # PCIG10-GA-2011-303795. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas BH, 2013, ONCOTARGET, V4, P1606, DOI 10.18632/oncotarget.1186; Brem R, 2012, CANCER RES, V72, P4787, DOI 10.1158/0008-5472.CAN-12-1278; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Chao OS, 2014, MOL CANCER RES, V12, P1755, DOI 10.1158/1541-7786.MCR-14-0173; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Gaymes TJ, 2009, HAEMATOL-HEMATOL J, V94, P638, DOI 10.3324/haematol.2008.001933; Gottesfeld JM, 2013, J NEUROCHEM, V126, P147, DOI 10.1111/jnc.12302; Ha K, 2014, ONCOTARGET, V5, P5637, DOI 10.18632/oncotarget.2154; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Issaeva N, 2010, CANCER RES, V70, P6268, DOI 10.1158/0008-5472.CAN-09-3416; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Konstantinopoulos PA, 2014, GYNECOL ONCOL, V133, P599, DOI 10.1016/j.ygyno.2014.03.007; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee JH, 2012, ADV CANCER RES, V116, P39, DOI 10.1016/B978-0-12-394387-3.00002-1; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Min W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3993; Nowsheen S, 2012, CANCER RES, V72, P4796, DOI 10.1158/0008-5472.CAN-12-1287; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Rodriguez-Enfedaque A, 2012, BBA-MOL CELL RES, V1823, P1343, DOI 10.1016/j.bbamcr.2012.05.013; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Shibata H, 2011, CANCER SCI, V102, P1882, DOI 10.1111/j.1349-7006.2011.02016.x; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Tuval-Kochen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077260; Wang W, 2010, BIOCHEM PHARMACOL, V80, P316, DOI 10.1016/j.bcp.2010.04.008; Wang YZ, 2010, CURR DRUG METAB, V11, P507, DOI 10.2174/138920010791636149; Werthmoller N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.129; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; Xu WS, 2006, P NATL ACAD SCI USA, V103, P15540, DOI 10.1073/pnas.0607518103; Xu WS, 2005, CANCER RES, V65, P7832, DOI 10.1158/0008-5472.CAN-04-4608; Zhang G, 2008, CLIN CANCER RES, V14, P5385, DOI 10.1158/1078-0432.CCR-08-0469; Zhang JX, 2012, HEPATOLOGY, V55, P1840, DOI 10.1002/hep.25566; Zheng QL, 2014, TUMOR BIOL, V35, P6255, DOI 10.1007/s13277-014-1789-0; ZIMM S, 1988, J CLIN ONCOL, V6, P696, DOI 10.1200/JCO.1988.6.4.696; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	40	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2016	11	5							e0155711	10.1371/journal.pone.0155711	http://dx.doi.org/10.1371/journal.pone.0155711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BR	27196668	Green Published, gold			2022-12-26	WOS:000376291100088
J	Wolf, J; Waetzig, GH; Chalaris, A; Reinheimer, TM; Wege, HN; Rose-John, S; Garbers, C				Wolf, Janina; Waetzig, Georg H.; Chalaris, Athena; Reinheimer, Torsten M.; Wege, Henning; Rose-John, Stefan; Garbers, Christoph			Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-INFLAMMATORY ACTIVITIES; LEUKEMIA INHIBITORY FACTOR; CORONARY-HEART-DISEASE; IL-6 RECEPTOR; EXPRESSION; RESPONSES; COMPLEX; ADAM17; CELLS; MEMBRANE	Soluble forms of the IL-6 receptor (sIL-6R) bind to the cytokine IL-6 with similar affinity as the membrane-bound IL-6R. IL-6.sIL-6R complexes initiate IL-6 trans-signaling via activation of the ubiquitously expressed membrane-bound beta-receptor glycoprotein 130 (gp130). Inhibition of IL-6 trans-signaling has been shown to be favorable in numerous inflammatory diseases. Furthermore, different soluble forms of gp130 (sgp130) exist that, together with the sIL-6R, are thought to form a buffer for IL-6 in the blood. However, a functional role for the different sgp130 forms has not been described to date. Here we demonstrate that the metalloproteases ADAM10 and ADAM17 can produce sgp130 by ectodomain shedding of gp130, even though this mechanism only accounts for a minor proportion of sgp130 in the circulation. We further show that full-length sgp130 and the shorter forms sgp130-rheumatoid arthritis-associated peptide (RAPS) and sgp130-E10 are differentially expressed in a cell type-specific manner. Remarkably, full-length sgp130 is expressed by monocytes, but this expression is completely lost during differentiation into macrophages in vitro. Using genetically engineered murine pre-B cells that secrete different forms of sgp130, we found that these secreted sgp130 proteins are able to prevent trans-signaling-driven cell proliferation of the secreting cells, whereas conditioned supernatant from these cells failed to block IL-6 trans-signaling in other cells. Thus, our data suggest that the different sgp130 forms are released from cells into their immediate surroundings and appear to form cell-associated gradients to modulate their own susceptibility for IL-6 trans-signaling.	[Wolf, Janina; Chalaris, Athena; Rose-John, Stefan; Garbers, Christoph] Univ Kiel, Inst Biochem, Rudolf Hoeber Str 1, D-24098 Kiel, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, D-24118 Kiel, Germany; [Reinheimer, Torsten M.] Ferring Pharmaceut AS, Nonclin Dev, DK-2300 Copenhagen, Denmark; [Wege, Henning] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, D-20246 Hamburg, Germany	University of Kiel; Ferring Pharmaceuticals; University of Hamburg; University Medical Center Hamburg-Eppendorf	Garbers, C (corresponding author), Univ Kiel, Inst Biochem, Rudolf Hoeber Str 1, D-24098 Kiel, Germany.	cgarbers@biochem.uni-kiel.de	Rose-John, Stefan/A-7998-2010; Garbers, Christoph/D-9932-2015; Waetzig, Georg/AAV-7486-2021	Rose-John, Stefan/0000-0002-7519-3279; Garbers, Christoph/0000-0003-4939-6950; 	Deutsche Forschungsgemeinschaft (DFG) [SFB877]; Federal Ministry of Education and Research (BMBF, E:Bio-Modul II InTraSig project B); Cluster of Excellence "Inflammation at Interfaces"; Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF, E:Bio-Modul II InTraSig project B)(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence "Inflammation at Interfaces"; Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG) (SFB877 projects A1 (to A. C. and S. R. J.) and A10 (to C. G.)), from the Federal Ministry of Education and Research (BMBF, E:Bio-Modul II InTraSig project B) and by the Cluster of Excellence "Inflammation at Interfaces." G. H. W. is employed by CONARIS Research Institute AG (a company commercially developing sgp130Fc proteins), S. R. J. is a shareholder of CONARIS, and both are inventors of patents owned by CONARIS. T. M. R. is employed at Ferring Pharmaceuticals A/S.r Supported by a grant from Ferring Pharmaceuticals A/S (Copenhagen, Denmark).	Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Diamant M, 1997, FEBS LETT, V412, P379, DOI 10.1016/S0014-5793(97)00750-3; Dietrich C, 2014, J IMMUNOL, V192, P5382, DOI 10.4049/jimmunol.1303435; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2015, CURR OPIN IMMUNOL, V34, P75, DOI 10.1016/j.coi.2015.02.008; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jones SA, 1998, EUR J IMMUNOL, V28, P3514, DOI 10.1002/(SICI)1521-4141(199811)28:11<3514::AID-IMMU3514>3.3.CO;2-K; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; MULLBERG J, 1994, J IMMUNOL, V152, P4958; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MULLBERG J, 1993, FEBS LETT, V332, P174, DOI 10.1016/0014-5793(93)80507-Q; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; SHARKEY AM, 1995, BIOL REPROD, V53, P974, DOI 10.1095/biolreprod53.4.974; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sommer J, 2014, J BIOL CHEM, V289, P22140, DOI 10.1074/jbc.M114.560938; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tanaka M, 2000, J CLIN INVEST, V106, P137, DOI 10.1172/JCI7479; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Waetzig GH, 2012, EXPERT OPIN THER TAR, V16, P225, DOI 10.1517/14728222.2012.660307; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064; Wolf J, 2016, BIOCHEM BIOPH RES CO, V470, P870, DOI 10.1016/j.bbrc.2016.01.127; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Zhang JG, 1998, J BIOL CHEM, V273, P10798, DOI 10.1074/jbc.273.17.10798	41	60	60	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16186	16196		10.1074/jbc.M116.718551	http://dx.doi.org/10.1074/jbc.M116.718551			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226573	Green Published, hybrid			2022-12-26	WOS:000380585400023
J	Ceyssens, PJ; Van Bambeke, F; Mattheus, W; Bertrand, S; Fux, F; Van Bossuyt, E; Damee, S; Nyssen, HJ; De Craeye, S; Verhaegen, J; Tulkens, PM; Vanhoof, R				Ceyssens, Pieter-Jan; Van Bambeke, Franoise; Mattheus, Wesley; Bertrand, Sophie; Fux, Frederic; Van Bossuyt, Eddie; Damee, Sabrina; Nyssen, Henry-Jean; De Craeye, Stephane; Verhaegen, Jan; Tulkens, Paul M.; Vanhoof, Raymond		Belgian Streptococcus Pneumoniae	Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014)	PLOS ONE			English	Article							PATAB ABC TRANSPORTER; EFFLUX PUMP GENE; IN-VITRO; PHYLOGENETIC ANALYSIS; QUINOLONE RESISTANCE; PARC; MUTATIONS; GYRA; SUSCEPTIBILITY; MOXIFLOXACIN	We present the results of a longitudinal surveillance study (1995-2014) on fluoroquinolone resistance (FQ-R) among Belgian non-invasive Streptococcus pneumoniae isolates (n = 5,602). For many years, the switch to respiratory fluoroquinolones for the treatment of (a) typical pneumonia had no impact on FQ-R levels. However, since 2011 we observed a significant decrease in susceptibility towards ciprofloxacin, ofloxacin and levofloxacin with peaks of 9.0%, 6.6% and 3.1% resistant isolates, respectively. Resistance to moxifloxacin arised sporadically, and remained <1% throughout the entire study period. We observed classical topoisomerase mutations in gyrA (n = 25), parC (n = 46) and parE (n = 3) in varying combinations, arguing against clonal expansion of FQ-R. The impact of recombination with co-habiting commensal streptococci on FQ-R remains marginal (10.4%). Notably, we observed that a rare combination of DNA Gyrase mutations (GyrA_S81L/GyrB_P454S) suffices for high-level moxifloxacin resistance, contrasting current model. Interestingly, 85/422 pneumococcal strains display MICCIP values which were lowered by at least four dilutions by reserpine, pointing at involvement of efflux pumps in FQ-R. In contrast to susceptible strains, isolates resistant to ciprofloxacin significantly overexpressed the ABC pump PatAB in comparison to reference strain S. pneumoniae ATCC 49619, but this could only be linked to disruptive terminator mutations in a fraction of these. Conversely, no difference in expression of the Major Facilitator PmrA, unaffected by reserpine, was noted between susceptible and resistant S. pneumoniae strains. Finally, we observed that four isolates displayed intermediate to high-level ciprofloxacin resistance without any known molecular resistance mechanism. Focusing future molecular studies on these isolates, which are also commonly found in other studies, might greatly assist in the battle against rising pneumococcal drug resistance.	[Ceyssens, Pieter-Jan; Mattheus, Wesley; Bertrand, Sophie; Fux, Frederic; Van Bossuyt, Eddie; Damee, Sabrina; Vanhoof, Raymond] Sci Inst Publ Hlth WIV ISP, Unit Bacterial Dis, B-1050 Brussels, Belgium; [Van Bambeke, Franoise; Tulkens, Paul M.] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium; [Nyssen, Henry-Jean; De Craeye, Stephane] Sci Inst Publ Hlth WIV ISP, Unit Foodborne Pathogens, B-1050 Brussels, Belgium; [Verhaegen, Jan] KULeuven, Lab Clin Bacteriol & Mycol, B-3000 Leuven, Belgium	Universite Catholique Louvain; KU Leuven	Vanhoof, R (corresponding author), Sci Inst Publ Hlth WIV ISP, Unit Bacterial Dis, B-1050 Brussels, Belgium.	raymond.vanhoof@wiv-isp.be	Van Bambeke, Françoise/H-5934-2019	Van Bambeke, Françoise/0000-0002-0052-7991; Ceyssens, Pieter-Jan/0000-0001-7735-8316	Bayer Healthcare Belgium NV/SA; GlaxoSmith Kline, Belgium; Les Amis des Institutes Pasteur a Bruxelles	Bayer Healthcare Belgium NV/SA; GlaxoSmith Kline, Belgium(GlaxoSmithKline); Les Amis des Institutes Pasteur a Bruxelles	Dr. Vanhoof reports grants and nonfinancial support from Bayer Healthcare Belgium NV/SA, grants from GlaxoSmith Kline, Belgium, grants from Les Amis des Institutes Pasteur a Bruxelles, non-financial support from Sanofi Aventis, Belgium, during the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2009, INT J ANTIMICROB AG, V34, P82, DOI 10.1016/j.ijantimicag.2009.02.002; Avrain L, 2007, J ANTIMICROB CHEMOTH, V60, P965, DOI 10.1093/jac/dkm292; Baylay AJ, 2015, ANTIMICROB AGENTS CH, V59, P3098, DOI 10.1128/AAC.04858-14; Baylay AJ, 2015, J ANTIMICROB CHEMOTH, V70, P670, DOI 10.1093/jac/dku449; Blondeau JM, 2001, INT J ANTIMICROB AG, V17, P457, DOI 10.1016/S0924-8579(01)00334-X; Boncoeur E, 2012, BIOCHEMISTRY-US, V51, P7755, DOI 10.1021/bi300762p; Bowker KE, 2013, J ANTIMICROB CHEMOTH, V68, P1130, DOI 10.1093/jac/dks537; Bridy-Pappas AE, 2005, PHARMACOTHERAPY, V25, P1193, DOI 10.1592/phco.2005.25.9.1193; El Garch F, 2010, J ANTIMICROB CHEMOTH, V65, P2076, DOI 10.1093/jac/dkq287; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; Firsov AA, 2005, INT J ANTIMICROB AG, V25, P409, DOI 10.1016/j.ijantimicag.2005.02.004; Garvey MI, 2008, ANTIMICROB AGENTS CH, V52, P1677, DOI 10.1128/AAC.01644-07; Garvey MI, 2011, ANTIMICROB AGENTS CH, V55, P190, DOI 10.1128/AAC.00672-10; Gill MJ, 1999, ANTIMICROB AGENTS CH, V43, P187, DOI 10.1128/AAC.43.1.187; Guerin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106340; Hooper DC, 1999, DRUGS, V58, P6, DOI 10.2165/00003495-199958002-00002; Jacoby GA, 2013, ANTIMICROB AGENTS CH, V57, P1930, DOI 10.1128/AAC.02080-12; Janoir C, 1996, ANTIMICROB AGENTS CH, V40, P2760, DOI 10.1128/AAC.40.12.2760; Johnson AP, 2000, J ANTIMICROB CHEMOTH, V45, P225, DOI 10.1093/jac/45.2.225; Jones ME, 2000, ANTIMICROB AGENTS CH, V44, P462, DOI 10.1128/AAC.44.2.462-466.2000; Jorgensen JH, 1999, ANTIMICROB AGENTS CH, V43, P329, DOI 10.1128/AAC.43.2.329; Jumbe NL, 2006, ANTIMICROB AGENTS CH, V50, P310, DOI 10.1128/AAC.50.1.310-317.2006; Kaatz GW, 2000, ANTIMICROB AGENTS CH, V44, P1404, DOI 10.1128/AAC.44.5.1404-1406.2000; Li XY, 2002, ANTIMICROB AGENTS CH, V46, P522, DOI 10.1128/AAC.46.2.522-524.2002; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Lupien A, 2015, J ANTIMICROB CHEMOTH, V70, P1946, DOI 10.1093/jac/dkv060; Lupien A, 2013, ANTIMICROB AGENTS CH, V57, P4911, DOI 10.1128/AAC.00418-13; Maeda Y, 2011, J ANTIMICROB CHEMOTH, V66, P476, DOI 10.1093/jac/dkq485; Marrer E, 2006, ANTIMICROB AGENTS CH, V50, P269, DOI 10.1128/AAC.50.1.269-278.2006; Patel SN, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-3; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Piddock LJV, 2002, ANTIMICROB AGENTS CH, V46, P808, DOI 10.1128/AAC.46.3.808-812.2002; Riedel S, 2014, J CLIN MICROBIOL, V52, P2216, DOI 10.1128/JCM.00957-14; Robertson GT, 2005, ANTIMICROB AGENTS CH, V49, P4781, DOI 10.1128/AAC.49.11.4781-4783.2005; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Smith HJ, 2004, ANTIMICROB AGENTS CH, V48, P3954, DOI 10.1128/AAC.48.10.3954-3958.2004; Tocci N, 2013, ANTIMICROB AGENTS CH, V57, P248, DOI 10.1128/AAC.01298-12; Dang TND, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014022; Tubau F, 2001, J ANTIMICROB CHEMOTH, V47, P675, DOI 10.1093/jac/47.5.675; Ubukata K, 1996, J CLIN MICROBIOL, V34, P592, DOI 10.1128/JCM.34.3.592-596.1996; Wang YC, 2006, P NATL ACAD SCI USA, V103, P9655, DOI 10.1073/pnas.0600636103; Zhanel GG, 2002, DRUGS, V62, P13, DOI 10.2165/00003495-200262010-00002; Zhang G, 2015, J ANTIMICROB CHEMOTH, V70, P2499, DOI 10.1093/jac/dkv134; Zhang G, 2012, J ANTIMICROB CHEMOTH, V67, P2773, DOI 10.1093/jac/dks262	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0154816	10.1371/journal.pone.0154816	http://dx.doi.org/10.1371/journal.pone.0154816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227336	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500007
J	Dong, TY; Zhang, BW; Jiang, YF; Hu, QB				Dong, Tingyan; Zhang, Bowen; Jiang, Yanfang; Hu, Qiongbo			Isolation and Classification of Fungal Whitefly Entomopathogens from Soils of Qinghai-Tibet Plateau and Gansu Corridor in China	PLOS ONE			English	Article							TABACI HEMIPTERA ALEYRODIDAE; BEMISIA-TABACI; LECANICILLIUM-PSALLIOTAE; NEMATOPHAGOUS FUNGUS; ISARIA-FUMOSOROSEA; BEAUVERIA-BASSIANA; BIOLOGICAL-CONTROL; NATURAL ENEMIES; SERINE-PROTEASE; BIOTYPE	Qinghai-Tibet Plateau and Gansu Corridor of China with distinct geographic and climatic conditions are remote and less disturbed by humans, in which are likely to find some new strains of fungal entomopathogens against B-biotype whiteflies that is a very important invading pest worldwide. In this research, nineteen strains among six species of entomogenous fungi were isolated from the soil samples collected from 32 locations in Qinghai-Tibet Plateau and Gansu Corridor. From the data of isolation rates, it was indicated that the good biodiversity of entomogenous fungi was found in the soil covered good vegetations. On the contrary, no strains were isolated from the desert areas. In addition, the dominant species, Isaria fumosorosea and Metarhizium anisopliae var. anisopliae in the Qinghai-Tibet Plateau are different from the strains of other places based on ITS genetic homology analysis. It was verified that the Qinghai-Tibet Plateau area was less disturbed by human, and the fungi in this place exchanged less compared with other regional species. All of these strains showed the pathogenicity against the B-biotype whitefly with the mortality of more than 30%. However, a few strains of Paecilomyces lilacinus, Lecanicillium psalliotae, Aspergillus ustus, I. fumosorosea and M. anisopliae var. anisopliae had better virulence with LC(50)s of 0.36-26.44x10(6) spores/mL on post-treatment day 6-7. Especially, the L. psalliotae strain LpTS01 was the greatest virulence with LC50 of 0.36x10(6) spores/mL and LT50 of 4.23d. Our research thus presents some new insights to discover new entomopathogenic fungal strains used for B-biotype whitefly biocontrol.	[Dong, Tingyan; Zhang, Bowen; Jiang, Yanfang; Hu, Qiongbo] South China Agr Univ, Coll Agr, Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Hu, QB (corresponding author), South China Agr Univ, Coll Agr, Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Guangdong, Peoples R China.	hqbscau@scau.edu.cn			Special Fund for Forest Scientific Research in the Public Welfare of China [201304408]; Key Laboratory of Forest Diseases and Insect Pests in Guangdong Province	Special Fund for Forest Scientific Research in the Public Welfare of China; Key Laboratory of Forest Diseases and Insect Pests in Guangdong Province	This work was supported by the Special Fund for Forest Scientific Research in the Public Welfare of China ( 201304408).; We are grateful to the researcher Wei Wu and Weina Hu for their field assistance. We also appreciate the Doc. Chaoyu Cui provide guidance with identifying the fungal species. At the same time, thanks for the support from the Key Laboratory of Forest Diseases and Insect Pests in Guangdong Province.	Abbott WS, 1925, J AM MOSQUITO CONTR, V3, P265; Abd-Rabou S, 2014, ENTOMOL NEWS, V124, P38, DOI 10.3157/021.124.0106; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Chen XR, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0170-8; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Cuthbertson AGS, 2011, INSECT SCI, V18, P1, DOI 10.1111/j.1744-7917.2010.01383.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Espinel C, 2008, REV COLOMB ENTOMOL, V34, P163; Faria M, 2001, CROP PROT, V20, P767, DOI 10.1016/S0261-2194(01)00110-7; Fernandez E, 2009, PEST MANAG SCI, V65, P885, DOI 10.1002/ps.1769; Florescu DF, 2009, CLIN TRANSPLANT, V23, P116, DOI 10.1111/j.1399-0012.2008.00895.x; Hewlett PS, 1972, J STORED PRODUCTS RE, V8, P159; Hu QB, 2007, J APPL ENTOMOL, V131, P262, DOI 10.1111/j.1439-0418.2007.01159.x; Hu WG, 2014, J BASIC MICROB, V54, P1331, DOI 10.1002/jobm.201400232; Islam MT, 2011, AFR J MICROBIOL RES, V5, P3409; Jaronski S. T., 2007, Use of entomopathogenic fungi in biological pest management, P91; Li M, 2010, INT J PEST MANAGE, V56, P275, DOI 10.1080/09670871003743428; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Mascarin GM, 2013, BIOL CONTROL, V66, P209, DOI 10.1016/j.biocontrol.2013.05.001; Meyling NV, 2006, MYCOL RES, V110, P188, DOI 10.1016/j.mycres.2005.09.008; Ning WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10744; Pan CC, 2015, EUR J SOIL BIOL, V68, P25, DOI 10.1016/j.ejsobi.2015.03.003; Panackal AA, 2006, EMERG INFECT DIS, V12, P403, DOI 10.3201/eid1203.050670; Quan QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092293; Sun BD, 2008, CROP PROT, V27, P1421, DOI 10.1016/j.cropro.2008.07.010; Tanaka K, 2009, STUD MYCOL, P175, DOI 10.3114/sim.2009.64.10; Wang XJ, 2012, ENTOMOL FENNICA, V23, P4; Yang JK, 2005, BIOTECHNOL LETT, V27, P1329, DOI 10.1007/s10529-005-0482-1; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Yu HY, 2012, BIOSCI BIOTECH BIOCH, V76, P1835, DOI 10.1271/bbb.120173; Zimmermann G, 2008, BIOCONTROL SCI TECHN, V18, P865, DOI 10.1080/09583150802471812; Zou CH, 2014, BIOCONTROL SCI TECHN, V24, P315, DOI 10.1080/09583157.2013.860427	33	9	10	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156087	10.1371/journal.pone.0156087	http://dx.doi.org/10.1371/journal.pone.0156087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228109	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500064
J	Ma, N; Ma, Y; Nakashima, A; Kikkawa, U; Furuyashiki, T				Ma, Ning; Ma, Yan; Nakashima, Akio; Kikkawa, Ushio; Furuyashiki, Tomoyuki			The Loss of Lam2 and Npr2-Npr3 Diminishes the Vacuolar Localization of Gtr1-Gtr2 and Disinhibits TORC1 Activity in Fission Yeast	PLOS ONE			English	Article							RAG GTPASES; COMPLEX; KINASE; DISRUPTION; ACTIVATION; EXPRESSION; RAGULATOR; RAPAMYCIN; MEDIATE; GAP	In mammalian cells, mTORC1 activity is regulated by Rag GTPases. It is thought that the Ragulator complex and the GATOR (GAP activity towards Rags) complex regulate RagA/B as its GDP/GTP exchange factor (GEF) and GTPase-activating protein (GAP), respectively. However, the functions of components in these complexes remain elusive. Using fission yeast as a model organism, here we found that the loss of Lam2 (SPBC1778.05c), a homo-log of a Ragulator component LAMTOR2, as well as the loss of Gtr1 or Gtr2 phenocopies the loss of Npr2 or Npr3, homologs of GATOR components Nprl2 or Nprl3, respectively. These phenotypes were rescued by TORC1 inhibition using pharmacological or genetic means, and the loss of Lam2, Gtr1, Gtr2, Npr2 or Npr3 disinhibited TORC1 activity under nitrogen depletion, as measured by Rps6 phosphorylation. Consistently, overexpression of GDP-locked Gtr1S20L or GTP-locked Gtr2Q60L, which suppress TORC1 activity in budding yeast, rescued the growth defect of.gtr1 cells or.gtr2 cells, respectively, and the loss of Lam2, Npr2 or Npr3 similarly diminished the vacuolar localization and the protein levels of Gtr1 and Gtr2. Furthermore, Lam2 physically interacted with Npr2 and Gtr1. These findings suggest that Lam2 and Npr2-Npr3 function together as a tether for GDP-bound Gtr1 to the vacuolar membrane, thereby suppressing TORC1 activity for multiple cellular functions.	[Ma, Ning; Ma, Yan; Furuyashiki, Tomoyuki] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan; [Nakashima, Akio; Kikkawa, Ushio] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp	Furuyashiki, Tomoyuki/AAG-5283-2019; Furuyashiki, Tomoyuki/B-8760-2014	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399	Japan Society for the Promotion of Science [26460339]; Grants-in-Aid for Scientific Research [16H05132, 15H01289] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by Grant-in-Aid for Scientific Research ( C) to YM ( No. 26460339) from Japan Society for the Promotion of Science ( https://www.jsps.go.jp/english/e-grants/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin J, 2014, J CELL SCI, V127, P1346, DOI 10.1242/jcs.146373; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Dokudovskaya S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006478; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Laor D, 2014, MOL CELL BIOL, V34, P794, DOI 10.1128/MCB.01473-13; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liu QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139045; Ma N, 2013, GENETICS, V195, P457, DOI 10.1534/genetics.113.154674; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; Ma Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144677; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Panchaud N, 2013, CELL CYCLE, V12, P2948, DOI 10.4161/cc.26000; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toda T, 1996, MOL CELL BIOL, V16, P6752; Valbuena N, 2012, J CELL SCI, V125, P1920, DOI 10.1242/jcs.094219; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Zhang TL, 2012, STRUCTURE, V20, P2151, DOI 10.1016/j.str.2012.09.019; Zilio N, 2012, YEAST, V29, P425, DOI 10.1002/yea.2920	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156239	10.1371/journal.pone.0156239	http://dx.doi.org/10.1371/journal.pone.0156239			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227887	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500089
J	Lu, H; McComas, KA; Buttke, DE; Roh, S; Wild, MA				Lu, Hang; McComas, Katherine A.; Buttke, Danielle E.; Roh, Sungjong; Wild, Margaret A.			A One Health Message about Bats Increases Intentions to Follow Public Health Guidance on Bat Rabies	PLOS ONE			English	Article							UNITED-STATES; COMMUNICATION; SURVEILLANCE; PERCEPTIONS; RISK; INFORMATION; IMPACTS; DISEASE	Since 1960, bat rabies variants have become the greatest source of human rabies deaths in the United States. Improving rabies awareness and preventing human exposure to rabid bats remains a national public health priority today. Concurrently, conservation of bats and the ecosystem benefits they provide is of increasing importance due to declining populations of many bat species. This study used a visitor-intercept experiment (N = 521) in two U. S. national parks where human and bat interactions occur on an occasional basis to examine the relative persuasiveness of four messages differing in the provision of benefit and uncertainty information on intentions to adopt a rabies exposure prevention behavior. We found that acknowledging benefits of bats in a risk message led to greater intentions to adopt the recommended rabies exposure prevention behavior without unnecessarily stigmatizing bats. These results signify the importance of communicating benefits of bats in bat rabies prevention messages to benefit both human and wildlife health.	[Lu, Hang; McComas, Katherine A.] Cornell Univ, Dept Commun, Ithaca, NY USA; [Buttke, Danielle E.; Wild, Margaret A.] Natl Pk Serv, Biol Resources Div, Wildlife Hlth Branch, Ft Collins, CO USA; [Roh, Sungjong] Singapore Management Univ, Lee Kong Chian Sch Business, Singapore 178902, Singapore	Cornell University; United States Department of the Interior; Singapore Management University	Lu, H (corresponding author), Cornell Univ, Dept Commun, Ithaca, NY USA.	hl896@cornell.edu		Roh, Sungjong/0000-0001-6751-2826	Cornell University Agricultural Experiment Station federal formula funds [NYC-131404]; National Institutes for Food and Agriculture, U.S. Department of Agriculture; National Park Service of the Great Lakes-Northern Forest Cooperative Ecosystem Studies Unit [J2340100021, H6000082000]	Cornell University Agricultural Experiment Station federal formula funds; National Institutes for Food and Agriculture, U.S. Department of Agriculture; National Park Service of the Great Lakes-Northern Forest Cooperative Ecosystem Studies Unit	This research was supported by the Cornell University Agricultural Experiment Station federal formula funds, Project No. NYC-131404, received from the National Institutes for Food and Agriculture, U.S. Department of Agriculture, and the National Park Service under Task Agreement J2340100021 of the Great Lakes-Northern Forest Cooperative Ecosystem Studies Unit under Cooperative Agreement H6000082000 between the National Park Service and the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baucells M, 2012, MANAGE SCI, V58, P831, DOI 10.1287/mnsc.1110.1450; Brashers DE, 2001, J COMMUN, V51, P477, DOI 10.1111/j.1460-2466.2001.tb02892.x; Buttke DE, 2015, J WILDLIFE DIS, V51, P1, DOI 10.7589/2014-01-004; De Serres G, 2008, CLIN INFECT DIS, V46, P1329, DOI 10.1086/586745; Decker Daniel J., 2012, Human-Wildlife Interactions, V6, P112; Decker DJ, 2010, ILAR J, V51, P255, DOI 10.1093/ilar.51.3.255; Dyer JL, 2013, JAVMA-J AM VET MED A, V243, P805, DOI 10.2460/javma.243.6.805; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Maglio SJ, 2013, CURR DIR PSYCHOL SCI, V22, P278, DOI 10.1177/0963721413480172; Patyk K, 2012, VECTOR-BORNE ZOONOT, V12, P666, DOI 10.1089/vbz.2011.0839; Regan A, 2014, FOOD QUAL PREFER, V38, P107, DOI 10.1016/j.foodqual.2014.05.019; Reynolds PC, 2001, TOURISM MANAGE, V22, P31, DOI 10.1016/S0261-5177(00)00018-2; Taylor LH, 2013, RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT, 3RD EDITION, P543, DOI 10.1016/B978-0-12-396547-9.00015-8; Vander Stichele R H, 2002, DRUG INF J, V36, P201; Verbeke W, 2014, MEAT SCI, V98, P766, DOI 10.1016/j.meatsci.2014.07.023; Wakslak CJ, 2012, ORGAN BEHAV HUM DEC, V117, P150, DOI 10.1016/j.obhdp.2011.10.004; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Witte K, 2001, EFFECTIVE HLTH RISK; Zelepsky J, 2010, J ZOO WILDLIFE MED, V41, P474, DOI 10.1638/2009-0229.1	20	14	15	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156205	10.1371/journal.pone.0156205	http://dx.doi.org/10.1371/journal.pone.0156205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GI	27224252	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700072
J	Yu, H				Yu, Hong			Sphingosine-1-Phosphate Receptor 2 Regulates Proinflammatory Cytokine Production and Osteoclastogenesis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SPHINGOSINE 1-PHOSPHATE; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; VASCULAR INFLAMMATION; SIGNALING PATHWAYS; KAPPA-B; CELLS; LPS; DIFFERENTIATION; NETWORK	Sphingosine-1-phosphate receptor 2 (S1PR2) couples with the Gi, Gq, and G(12/13) group of proteins, which modulate an array of cellular signaling pathways and affect immune responses to multiple stimuli. In this study, we demonstrated that knockdown of S1PR2 by a specific S1PR2 shRNA lentiviral vector significantly inhibited IL-1 beta, IL-6, and TNF-alpha protein levels induced by oral pathogen Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) in murine bone marrow-derived monocytes and macrophages (BMMs) compared with controls. In addition, knockdown of S1PR2 by the S1PR2 shRNA lentiviral vector suppressed p-PI3K, p-ERK, p-JNK, p-p38, and p-NF-kappa Bp65 protein expressions induced by A. actinomycetemcomitans. Furthermore, bone marrow cells treated with the S1PR2 shRNA lentiviral vector inhibited osteoclastogenesis induced by RANKL compared with controls. The S1PR2 shRNA suppressed the mRNA levels of six osteoclastogenic factors including nuclear factor of activated T-cells cytoplasmic calcineurin-dependent 1 (NFATc1), cathepsin K (Ctsk), acid phosphatase 5 (Acp5), osteoclast-associated receptor (Oscar), dendritic cells specific transmembrane protein (Dcstamp), and osteoclast stimulatory transmembrane protein (Ocstamp) in bone marrow cells. We conclude that S1PR2 plays an essential role in modulating proinflammatory cytokine production and osteoclastogenesis. Blocking S1PR2 signaling might be a novel therapeutic strategy to treat inflammatory bone loss diseases.	[Yu, Hong] Med Univ S Carolina, Ctr Oral Hlth Res, Dept Oral Hlth Sci, Charleston, SC 29425 USA	Medical University of South Carolina	Yu, H (corresponding author), Med Univ S Carolina, Ctr Oral Hlth Res, Dept Oral Hlth Sci, Charleston, SC 29425 USA.	yuho@musc.edu			National Institutes of Health [R03DE025026]; National Institute of General Medicine grant [P30GM103331]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE025026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medicine grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grant R03DE025026 from the National Institutes of Health. In addition, this project utilized the facility and resources of the Laboratory of the Center for Oral Health Research (L-COHR), which is supported by the National Institute of General Medicine grant P30GM103331. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JM, 2015, BIOCHEM BIOPH RES CO, V461, P334, DOI 10.1016/j.bbrc.2015.04.034; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Du J, 2012, PATHOL RES PRACT, V208, P82, DOI 10.1016/j.prp.2011.11.008; Gonda K, 1999, BIOCHEM J, V337, P67, DOI 10.1042/0264-6021:3370067; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Japtok L, 2015, FASEB J, V29, P3357, DOI 10.1096/fj.14-263194; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI 10.1073/pnas.1218799110; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Laufer S, 2002, OSTEOARTHR CARTILAGE, V10, P961, DOI 10.1053/joca.2002.0851; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matsuo Koichi, 2005, Nihon Rinsho, V63, P1541; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Nemeth K, 2011, J IMMUNOL, V186, P13, DOI 10.4049/jimmunol.1002483; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Oikawa T, 2013, CELL MOL LIFE SCI, V70, P3341, DOI 10.1007/s00018-012-1238-4; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Shi QH, 2014, INT IMMUNOPHARMACOL, V20, P298, DOI 10.1016/j.intimp.2014.04.004; Siehler S, 2002, BBA-MOL CELL BIOL L, V1582, P94, DOI 10.1016/S1388-1981(02)00142-7; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Tu ZD, 2009, GENOME RES, V19, P1057, DOI 10.1101/gr.087890.108; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; Vaananen K, 2005, ADV DRUG DELIVER REV, V57, P959, DOI 10.1016/j.addr.2004.12.018; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Weitzmann MN, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/125705; Xia P, 2011, CYTOKINE GROWTH F R, V22, P45, DOI 10.1016/j.cytogfr.2010.09.004; Yu H, 2016, J PERIODONTAL RES, V51, P38, DOI 10.1111/jre.12276; Yu H, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0057-7; Yu H, 2013, J LIPID RES, V54, P189, DOI 10.1194/jlr.M031427; Zhang GQ, 2013, BLOOD, V122, P443, DOI 10.1182/blood-2012-11-467191; Zhao QX, 2010, INT J BIOCHEM CELL B, V42, P576, DOI 10.1016/j.biocel.2009.12.018; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016	37	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156303	10.1371/journal.pone.0156303	http://dx.doi.org/10.1371/journal.pone.0156303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224249	Green Published, Green Submitted, gold			2022-12-26	WOS:000376881700082
J	Beziz, D; Colas, S; Collin, C; Dray-Spira, R; Zureik, M				Beziz, Dan; Colas, Sandrine; Collin, Cedric; Dray-Spira, Rosemary; Zureik, Mahmoud			Association between Exposure to Benzodiazepines and Related Drugs and Survivorship of Total Hip Replacement in Arthritis: A Population-Based Cohort Study of 246,940 Patients	PLOS ONE			English	Article							ELIMINATION HALF-LIFE; RISK-FACTORS; OLDER-PEOPLE; FRACTURE; ARTHROPLASTY; IMPACT; ADULTS; LONG; DOSAGE; METAANALYSIS	Background Total hip replacement (THR) is successful in treating hip arthritis. Prosthetic survivorship may depend on the medications taken by the patient; particularly, the role of benzodiazepines and related drugs (Z-drugs) with THR revision has been poorly investigated. Our objective was to compare THR short-term survivorship according to level of exposure to benzodiazepine and Z-drugs. Design, Setting and Participants All French patients aged 40 years or older, having undergone primary THR from January 1, 2009, through December 31, 2012, for arthritis according to French national health insurance databases were included in the cohort. Outcome of interest was THR revision, including any surgical procedure in which the implant or any component was changed or removed. Follow-up started the day the primary THR was performed. Observations were right-censored on December 31, 2014, if neither revision nor death had yet occurred. Exposure of interest was the cumulative defined daily doses per day (cDDD/day) of benzodiazepines and Z-drugs dispensed within 6 months before or after inclusion. We defined four exposure groups; cDDD/d = 0: unexposed; <0.08: low exposure;] 0.08-0.38]: mediumexposure; >0.38: high exposure. THR survivorship was assessed according to level of exposure to benzodiazepines and Z-drugs in univariate and multivariate Cox models adjusted for patient, THR and implanting center characteristics. Results The study cohort comprised 246,940 individuals: mean age at baseline, 69.9 years; women, 57.9%; unexposed: 51.7%; low exposure: 16.7%; medium exposure: 15.9%; and high exposure: 15.7%. During the median 45-month follow-up, 9043 individuals underwent prosthetic revision. Adjusted hazard ratios in low, medium and high exposed groups were 1.18 (95% CI, 1.12-1.26; P<0.001), 1.32 (95% CI, 1.24-1.40; P<0.001) and 1.37 (95% CI, 1.29-1.45; P<0.001), respectively, compared to unexposed. Conclusion and Relevance Exposure to benzodiazepines and Z-drugs is associated with an increased risk of THR revision, with a dose-response relationship. Cautious prescribing might be needed as well as careful history examination and assessment of risk for patients with a hip prosthesis.	[Beziz, Dan; Colas, Sandrine; Collin, Cedric; Dray-Spira, Rosemary; Zureik, Mahmoud] French Natl Agcy Med & Hlth Prod Safety ANSM, Div Sci & European Strategy, Dept Epidemiol Hlth Prod, St Denis, France		Colas, S (corresponding author), French Natl Agcy Med & Hlth Prod Safety ANSM, Div Sci & European Strategy, Dept Epidemiol Hlth Prod, St Denis, France.	sandrine.colas@ansm.sante.fr	; Zureik, Mahmoud/F-7855-2018	Dray-Spira, Rosemary/0000-0001-7646-3667; Zureik, Mahmoud/0000-0002-8393-4217				Allen KD, 2015, CURR OPIN RHEUMATOL, V27, P276, DOI 10.1097/BOR.0000000000000161; AMORCE , 2016, ET LIEUX INST METH D; ASHTON H, 1995, PSYCHIAT ANN, V25, P158, DOI 10.3928/0048-5713-19950301-09; Australian Orthopaedic Associated National Joint Registry, AUSTRALIAN ORTHOPAED; Bakken MS, 2014, EUR J CLIN PHARMACOL, V70, P873, DOI 10.1007/s00228-014-1684-z; Begaud B, 2013, RAPPORT SURVEILLANCE; Bouillon K, 2015, LANCET HAEMATOL, V2, pE150, DOI 10.1016/S2352-3026(15)00027-7; Boylan MR, 2015, CLIN ORTHOP; Canadian Institute for Health Information, HIP KNEE REPL CAN CA; Centre of Excellence of Joint Replacements, NASJ REG LEDDPR REP; Chang CM, 2008, AM J GERIAT PSYCHIAT, V16, P686, DOI 10.1097/JGP.0b013e31817c6a99; Colas S, 2015, JAMA SURG, V150, P979, DOI 10.1001/jamasurg.2015.1325; Cordero-Ampuero J, 2010, CLIN ORTHOP RELAT R, V468, P3268, DOI 10.1007/s11999-010-1411-8; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Egan M Y, 2001, BMC Geriatr, V1, P4, DOI 10.1186/1471-2318-1-4; El Masri F, 2010, J BONE JOINT SURG BR, V92B, P342, DOI 10.1302/0301-620X.92B3.23151; Fagot JP, 2013, DIABETES CARE, V36, P294, DOI 10.2337/dc12-0506; Fender D, 2003, J BONE JOINT SURG BR, V85B, P187, DOI 10.1302/0301-620X.85B2.12759; Gallagher HC, 2013, PHARMACY, V1, P65, DOI 10.3390/pharmacy1020065; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400; Haute Autorite de Sante, 2007, AM PRESCR PSYCH SUJ; HERINGS RMC, 1995, ARCH INTERN MED, V155, P1801, DOI 10.1001/archinte.155.16.1801; Huerta C, 2015, PHARMACOEPIDEMIOL DR; Johnsen SP, 2006, J BONE JOINT SURG BR, V88B, P1303, DOI 10.1302/0301-620X.88B10.17399; Kawakami K, 2010, RHEUMATOLOGY, V49, P341, DOI 10.1093/rheumatology/kep376; Khong TP, 2012, CALCIFIED TISSUE INT, V91, P24, DOI 10.1007/s00223-012-9603-8; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; LICHTENSTEIN MJ, 1994, AM J EPIDEMIOL, V140, P830, DOI 10.1093/oxfordjournals.aje.a117331; Malviya A, 2011, J BONE JOINT SURG BR, V93B, P443, DOI 10.1302/0301-620X.93B4.26078; Martin-Latry K, 2010, PHARMACOEPIDEM DR S, V19, P256, DOI 10.1002/pds.1912; McDonough CM, 2010, CLIN GERIATR MED, V26, P387, DOI 10.1016/j.cger.2010.04.001; Mednick RE, 2014, J BONE JOINT SURG AM, V96A, P1201, DOI 10.2106/JBJS.M.00556; National Joint Registry, NJR 11 ABB REP 2014; Netherlands Orthopaedic Association, 2012, INS QUAL ORTH CAR NE; New Zealand Joint Registry, 1999, NZ JOINT REG 14 YEAR; Ong KL, 2010, CLIN ORTHOP RELAT R, V468, P3070, DOI 10.1007/s11999-010-1399-0; Paterson JM, 2010, CAN J SURG, V53, P175; Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2; Raguideau F, 2015, PHARMACOEPIDEM DR S, V24, P526, DOI 10.1002/pds.3763; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; RAY WA, 1987, NEW ENGL J MED, V316, P363, DOI 10.1056/NEJM198702123160702; Requena G, 2015, PHARMACOEPIDEMIOL DR; Romon I, 2014, DIABETIC MED, V31, P946, DOI 10.1111/dme.12435; Sibanda N, 2008, PLOS MED, V5, P1398, DOI 10.1371/journal.pmed.0050179; Somayaji Ranjani, 2013, Open Rheumatol J, V7, P119, DOI 10.2174/1874312920131210005; Song J, 2006, ARTHRIT RHEUM-ARTHR, V55, P248, DOI 10.1002/art.21842; Swedish Hip Arthroplasty Register, 2017, SWED HIP ARTHR REG A; Tricotel A, 2015, J THROMB HAEMOST, V13, P1576, DOI 10.1111/jth.13053; Uzun S, 2010, PSYCHIAT DANUB, V22, P90; Vestergaard P, 2006, OSTEOPOROSIS INT, V17, P807, DOI 10.1007/s00198-005-0065-y; Wagner AK, 2004, ARCH INTERN MED, V164, P1567, DOI 10.1001/archinte.164.14.1567; Wang PS, 2001, AM J PSYCHIAT, V158, P892, DOI 10.1176/appi.ajp.158.6.892; Wright EA, 2012, ARTHRIT CARE RES, V64, P1879, DOI 10.1002/acr.21760; Xing D, 2014, OSTEOPOROSIS INT, V25, P105, DOI 10.1007/s00198-013-2446-y; Zint K, 2010, PHARMACOEPIDEM DR S, V19, P1248, DOI 10.1002/pds.2031	57	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0155783	10.1371/journal.pone.0155783	http://dx.doi.org/10.1371/journal.pone.0155783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219105	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700018
J	Cardona, Y; Ruiz-Ramos, DV; Baums, IB; Bracco, A				Cardona, Yuley; Ruiz-Ramos, Dannise V.; Baums, Iliana B.; Bracco, Annalisa			Potential Connectivity of Coldwater Black Coral Communities in the Northern Gulf of Mexico	PLOS ONE			English	Article							FLOWER GARDEN BANKS; GENETIC-STRUCTURE; POPULATION CONNECTIVITY; LARVAL DISPERSAL; GROWTH-RATES; DEEP; TRANSPORT; CURRENTS; IMPACTS; SHELF	The black coral Leiopathes glaberrima is a foundation species of deep-sea benthic communities but little is known of the longevity of its larvae and the timing of spawning because it inhabits environments deeper than 50 m that are logistically challenging to observe. Here, the potential connectivity of L. glaberrima in the northern Gulf of Mexico was investigated using a genetic and a physical dispersal model. The genetic analysis focused on data collected at four sites distributed to the east and west of Mississippi Canyon, provided information integrated over many (similar to 10,000) generations and revealed low but detectable realized connectivity. The physical dispersal model simulated the circulation in the northern Gulf at a 1km horizontal resolution with transport-tracking capabilities; virtual larvae were deployed 12 times over the course of 3 years and followed over intervals of 40 days. Connectivity between sites to the east and west of the canyon was hampered by the complex bathymetry, by differences in mean circulation to the east and west of the Mississippi Canyon, and by flow instabilities at scales of a few kilometers. Further, the interannual variability of the flow field surpassed seasonal changes. Together, these results suggest that a) dispersal among sites is limited, b) any recovery in the event of a large perturbation will depend on local larvae produced by surviving individuals, and c) a competency period longer than a month is required for the simulated potential connectivity to match the connectivity from multi-locus genetic data under the hypothesis that connectivity has not changed significantly over the past 10,000 generations.	[Cardona, Yuley; Bracco, Annalisa] Georgia Inst Technol, Sch Earth & Atmospher Sci, 311 Ferst Dr, Atlanta, GA 30332 USA; [Cardona, Yuley] Univ Nacl Colombia, Dept Geociencias & Medio Ambiente, Sede Medellin, Colombia; [Ruiz-Ramos, Dannise V.; Baums, Iliana B.] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA	University System of Georgia; Georgia Institute of Technology; Universidad Nacional de Colombia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bracco, A (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, 311 Ferst Dr, Atlanta, GA 30332 USA.	abracco@gatech.edu	Baums, Iliana Brigitta/G-6435-2010	Baums, Iliana Brigitta/0000-0001-6463-7308; Bracco, Annalisa/0000-0002-1619-6103; Cardona, Yuley/0000-0003-1146-5527; Ruiz-Ramos, Dannise/0000-0001-7282-0380	BP/the Gulf of Mexico Research Initiative	BP/the Gulf of Mexico Research Initiative	This work was made possible by a grant from BP/the Gulf of Mexico Research Initiative to support consortium research entitled "Ecosystem Impacts of Oil and Gas Inputs to the Gulf (ECOGIG)" administered by the University of Georgia-Athens.	Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Antonov JI, 2010, NOAA ATLAS NESDIS, V69, P184; Arbic BK, 2008, J PHYS OCEANOGR, V38, P84, DOI 10.1175/2007JPO3653.1; Baums IB, 2013, CORAL REEFS, V32, P703, DOI 10.1007/s00338-013-1012-6; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Botsford LW, 2003, ECOL APPL, V13, pS25; Bracco A, 2003, J PHYS OCEANOGR, V33, P207, DOI 10.1175/1520-0485(2003)033<0207:VGBTIL>2.0.CO;2; Bracco A, 2016, OCEAN MODEL, V101, P43, DOI 10.1016/j.ocemod.2016.03.002; Brooke S., 2007, STATE DEEP CORAL ECO, P271; Brugler MR, 2013, ZOOL J LINN SOC-LOND, V169, P312, DOI 10.1111/zoj.12060; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Cardona Y, 2016, DEEP-SEA RES PT II, V129, P332, DOI 10.1016/j.dsr2.2014.01.008; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; Carreiro-Silva M, 2013, MAR ECOL PROG SER, V473, P189, DOI 10.3354/meps10052; Chen K, 2015, OCEAN SCI, V11, P503, DOI 10.5194/os-11-503-2015; *CONT SHELF ASS, 2007, 2007044 LA OCS MMS C, P169; Cordes EE, 2008, DEEP-SEA RES PT I, V55, P777, DOI 10.1016/j.dsr.2008.03.005; Cowart DA, 2013, MOL ECOL, V22, P4147, DOI 10.1111/mec.12379; Dahl MP, 2012, CORAL REEFS, V31, P1135, DOI 10.1007/s00338-012-0937-5; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; DeLeo DM, 2016, DEEP-SEA RES PT II, V129, P137, DOI 10.1016/j.dsr2.2015.02.028; DiMarco SF, 2005, GEOPH MONOG SERIES, V161, P101; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; Doughty CL, 2014, DEEP-SEA RES PT II, V99, P71, DOI 10.1016/j.dsr2.2013.05.023; Dukhovskoy DS, 2009, OCEAN MODEL, V28, P250, DOI 10.1016/j.ocemod.2009.02.009; Etter RJ, 2015, DEEP-SEA RES PT I, V104, P159, DOI 10.1016/j.dsr.2015.06.009; Fisher CR, 2014, BIOSCIENCE, V64, P796, DOI 10.1093/biosci/biu129; Fisher CR, 2014, P NATL ACAD SCI USA, V111, P11744, DOI 10.1073/pnas.1403492111; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; GITTINGS SR, 1992, B MAR SCI, V51, P420; Gong YL, 2015, OCEAN DYNAM, V65, P1, DOI 10.1007/s10236-014-0778-6; Graham EM, 2013, CORAL REEFS, V32, P539, DOI 10.1007/s00338-012-0999-4; Hamilton P, 2001, GEOPHYS RES LETT, V28, P2867, DOI 10.1029/2001GL013039; Hamilton P, 2007, J PHYS OCEANOGR, V37, P708, DOI 10.1175/JPO2998.1; Hamilton P, 2009, PROG OCEANOGR, V82, P1, DOI 10.1016/j.pocean.2009.04.019; Hamilton SL, 2008, P NATL ACAD SCI USA, V105, P1561, DOI 10.1073/pnas.0707676105; Hanski I., 1999, METAPOPULATION ECOLO, P328; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hilario A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00006; Hill DF, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006896; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUNTER JR, 1993, J COMPUT PHYS, V106, P366; Johns WE, 2002, DEEP-SEA RES PT I, V49, P211, DOI 10.1016/S0967-0637(01)00041-3; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Larsson AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102222; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; Levy M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052756; Li C, 2014, OCS STUDY BOEM; Lugo-Fernandez A, 2001, CONT SHELF RES, V21, P47, DOI 10.1016/S0278-4343(00)00072-8; Luo H, 2016, OCEAN MODEL IN PRESS; MAXEY MR, 1983, PHYS FLUIDS, V26, P883, DOI 10.1063/1.864230; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Miller KJ, 1998, MAR ECOL PROG SER, V163, P225, DOI 10.3354/meps163225; Morrison CL, 2011, CONSERV GENET, V12, P713, DOI 10.1007/s10592-010-0178-5; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Palumbi SR, 2003, ECOL APPL, V13, pS146; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Penven P, 2008, ENVIRON MODELL SOFTW, V23, P660, DOI 10.1016/j.envsoft.2007.07.004; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Precht WF, 2014, MAR GEOL, V349, P152, DOI 10.1016/j.margeo.2013.12.012; Prouty NG, 2011, MAR ECOL PROG SER, V423, P101, DOI 10.3354/meps08953; Quattrini AM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0008; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Robins PE, 2013, LIMNOL OCEANOGR, V58, P505, DOI 10.4319/lo.2013.58.2.0505; ROGERS CS, 1993, CORAL REEFS, V12, P127, DOI 10.1007/BF00334471; Ruiz-Ramos DV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138989; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Selkoe KA, 2014, MOL ECOL, V23, P3064, DOI 10.1111/mec.12804; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Tay YC, 2011, J EXP MAR BIOL ECOL, V409, P324, DOI 10.1016/j.jembe.2011.09.013; Thomas CJ, 2014, ECOL MODEL, V272, P160, DOI 10.1016/j.ecolmodel.2013.10.002; Thresher RE, 2011, CORAL REEFS, V30, P1063, DOI 10.1007/s00338-011-0806-7; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Weatherly G, 2002, INTERMEDIATE DEPTH C; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; WISEMAN WJ, 1988, J PHYS OCEANOGR, V18, P1287, DOI 10.1175/1520-0485(1988)018<1287:SCNTMO>2.0.CO;2; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; Zavala-Hidalgo J, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001879; Zhong Y., 2012, LIMNOLOGY OCEANOGRAP, V2, P12, DOI [10.1215/21573689-1573372, DOI 10.1215/21573689-1573372]; Zhong YS, 2013, J GEOPHYS RES-OCEANS, V118, P5651, DOI 10.1002/jgrc.20402	92	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156257	10.1371/journal.pone.0156257	http://dx.doi.org/10.1371/journal.pone.0156257			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218260	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880700053
J	Liu, Y; Li, BJ; Feng, N; Pu, HS; Zhang, X; Lu, HB; Yin, H				Liu, Yang; Li, Baojuan; Feng, Na; Pu, Huangsheng; Zhang, Xi; Lu, Hongbing; Yin, Hong			Perfusion Deficits and Functional Connectivity Alterations in Memory-Related Regions of Patients with Post-Traumatic Stress Disorder	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MEDIAL PREFRONTAL CORTEX; CORPUS-CALLOSUM; SURVIVORS; NETWORKS; VOLUME; PTSD; VETERANS; EPILEPSY; MRI	To explore the potential alterations in cerebral blood flow (CBF) and functional connectivity of recent onset post-traumatic stress disorder (PTSD) induced by a single prolonged trauma exposure, we recruited 20 survivors experiencing the same coal mining flood disaster as the PTSD (n = 10) and non-PTSD (n = 10) group, respectively. The pulsed arterial spin labeling (ASL) images were acquired with a 3.0T MRI scanner and the partial volume (PV) effect in the images was corrected for better CBF estimation. Alterations in CBF were analyzed using both uncorrected and PV-corrected CBF maps. By using altered CBF regions as regions-of-interest, seed-based functional connectivity analysis was then performed. While only one CBF deficit in right corpus callosum of PTSD patients was detected using uncorrected CBF, three more regions (bilateral frontal lobes and right superior frontal gyrus) were identified using PV-corrected CBF. Furthermore, the regional CBF of right superior frontal gyrus exhibited significantly negative correlation with the symptom severity (r = -0.759, p = 0.018). The resting-state functional connectivity analysis revealed increased connectivity between left frontal lobe and right parietal lobe. The results indicated the symptom-specific perfusion deficits and an aberrant connectivity in memory-related regions of PTSD patients when using PV-corrected ASL data. It also suggested that PV-corrected CBF exhibits more subtle changes that may be beneficial to perfusion and connectivity analysis.	[Liu, Yang; Li, Baojuan; Pu, Huangsheng; Zhang, Xi; Lu, Hongbing] Fourth Mil Med Univ, Sch Biomed Engn, Xian 710032, Shaanxi, Peoples R China; [Feng, Na] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Shaanxi, Peoples R China; [Yin, Hong] Xijing Hosp, Dept Radiol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Lu, HB (corresponding author), Fourth Mil Med Univ, Sch Biomed Engn, Xian 710032, Shaanxi, Peoples R China.; Yin, H (corresponding author), Xijing Hosp, Dept Radiol, Xian, Shaanxi, Peoples R China.	luhb@fmmu.edu.cn; yinhong@fmmu.edu.cn	Yin, Hong/G-3877-2014; Yin, Hong/AAC-5784-2020	Yin, Hong/0000-0002-5215-1455; 	National Natural Science Foundation of China [81230035, 81301199]; Military Science Foundation [BWS14J038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Military Science Foundation	This work was supported in part by the National Natural Science Foundation of China under grant Nos. 81230035 and 81301199, and the Military Science Foundation under Grant No. BWS14J038.	Asllani I, 2008, MAGN RESON MED, V60, P1362, DOI 10.1002/mrm.21670; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Blackmon K, 2015, EPILEPSIA, V56, P527, DOI 10.1111/epi.12931; Braakman HMH, 2013, EPILEPSIA, V54, P446, DOI 10.1111/epi.12044; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Carrion VG, 2009, PSYCHIAT RES-NEUROIM, V172, P226, DOI 10.1016/j.pscychresns.2008.07.008; Chao L, 2013, PSYCHIAT RES-NEUROIM, V213, P193, DOI 10.1016/j.pscychresns.2013.03.002; Chen LM, 2015, P NATL ACAD SCI USA, V112, P5991, DOI 10.1073/pnas.1424106112; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048298; Chung YA, 2006, CLIN NEUROPHYSIOL, V117, P637, DOI 10.1016/j.clinph.2005.10.020; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; First M.B., 2014, STRUCTURED CLIN INTE; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gold AL, 2011, PSYCHOL MED, V41, P2563, DOI 10.1017/S0033291711000730; Hou CL, 2007, BRAIN RES, V1144, P165, DOI 10.1016/j.brainres.2007.01.089; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jann K, 2015, NEUROIMAGE, V106, P111, DOI 10.1016/j.neuroimage.2014.11.028; Kim SY, 2012, PSYCHIAT RES-NEUROIM, V201, P214, DOI 10.1016/j.pscychresns.2011.08.007; Kindler J, 2015, SCHIZOPHRENIA BULL, V41, P163, DOI 10.1093/schbul/sbt180; Liang XY, 2013, MAGN RESON MED, V69, P531, DOI 10.1002/mrm.24279; Liberzon I, 1996, Depress Anxiety, V4, P146; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039025; O'Neill A, 2015, PSYCHIAT RES-NEUROIM, V231, P25, DOI 10.1016/j.pscychresns.2014.11.002; Peres JFP, 2007, PSYCHOL MED, V37, P1481, DOI 10.1017/S003329170700997X; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Thomaes K, 2013, SOC COGN AFFECT NEUR, V8, P190, DOI 10.1093/scan/nsr084; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wu KK, 2003, SOC PSYCH PSYCH EPID, V38, P94, DOI 10.1007/s00127-003-0611-x; Yan Xiaodan, 2014, Psychiatry Res, DOI 10.1016/j.pscychresns.2014.12.001; Yin Y, 2012, NEUROSCI BULL, V28, P541, DOI 10.1007/s12264-012-1261-3; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	38	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156016	10.1371/journal.pone.0156016	http://dx.doi.org/10.1371/journal.pone.0156016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213610	Green Published, gold, Green Submitted			2022-12-26	WOS:000376880200047
J	Kisu, I; Banno, K; Soeda, E; Kurihara, Y; Okushima, M; Yamaguchi, A; Nakagawa, E; Umene, K; Aoki, D				Kisu, Iori; Banno, Kouji; Soeda, Etsuko; Kurihara, Yuki; Okushima, Miho; Yamaguchi, Ami; Nakagawa, Eriko; Umene, Kiyoko; Aoki, Daisuke			Survey of Attitudes toward Uterus Transplantation among Japanese Women of Reproductive Age: A Cross-Sectional Study	PLOS ONE			English	Article							GESTATIONAL SURROGACY; ETHICS; TRIAL; DONOR	Objective Uterus transplantation (UTx) is a potential option for women with uterine factor infertility to have a child, but there has been no large-scale survey of the views on UTx in women of reproductive age in Japan. The present study was aimed to clarify the views of Japanese women of reproductive age on UTx for uterine factor infertility. Methods A questionnaire on UTx was conducted by an Internet research company in December 2014 as a cross-sectional study in 3,892 randomly chosen women aged 25 to 39 years old. Responses were analyzed from 3,098 subjects (mean age 32.1+/-4.2 years old), after exclusion of inappropriate respondents in screening. Results Of the respondents, 62.1%, 34.7% and 18.1% favored adoption, UTx and gestational surrogacy, respectively. In contrast, 7.0%, 21.9% and 63.3% opposed adoption, UTx and gestational surrogacy, respectively. In choices of candidates for UTx based on highest priority, deceased persons (33.8%) and mothers (19.0%) were favored as donors, and women with congenital absence of the uterus (54.4%) and hysterectomy due to a malignant uterine tumor (20.0%) as recipients. Regarding societal acceptance of UTx, the answer rates were 15.7% for "UTx should be permitted", 77.6% for "UTx should be permitted with discussion", and 6.7% for "UTx should not be permitted, even with discussion". Regarding personal opinions on UTx, 44.2% were in favor, 47.5% had no opinion, and 8.3% were against. Conclusion Our results suggest that many Japanese women of reproductive age feel that UTx is socially and individually acceptable, but that concerns requiring further discussion remain among these women. There was also a tendency for UTx to be viewed more favorably than gestational surrogacy.	[Kisu, Iori; Banno, Kouji; Umene, Kiyoko; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Soeda, Etsuko] Keio Univ, Fac Nursing & Med Care, Tokyo, Japan; [Kurihara, Yuki; Okushima, Miho; Yamaguchi, Ami; Nakagawa, Eriko] Keio Univ Hosp, Dept Nursing, Tokyo, Japan	Keio University; Keio University; Keio University	Kisu, I (corresponding author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan.	iori71march@hotmail.co.jp	Aoki, Daisuke/E-6650-2014		Japan Society for the Promotion of Science (JSPS) KAKENHI [26713050]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 26713050.	Akar ME, 2013, FERTIL STERIL, V100, P1358, DOI 10.1016/j.fertnstert.2013.06.027; [Anonymous], 2014, ABC NEWS; [Anonymous], 2014, ACTA OBSTETRICA GYNA, V66, P2445; Arora KS, 2015, OBSTET GYNECOL, V125, P971, DOI 10.1097/AOG.0000000000000707; Baykal B, 2008, FERTIL STERIL, V89, P817, DOI 10.1016/j.fertnstert.2007.04.022; Brannstrom M, 2015, LANCET, V385, P607, DOI 10.1016/S0140-6736(14)61728-1; Brannstrom M, 2014, FERTIL STERIL, V101, P1228, DOI 10.1016/j.fertnstert.2014.02.024; Brinsden PR, 2003, HUM REPROD UPDATE, V9, P483, DOI 10.1093/humupd/dmg033; Chambers GM, 2009, FERTIL STERIL, V91, P2281, DOI 10.1016/j.fertnstert.2009.04.029; Constantinidis D, 2012, HUM REPROD, V27, P1080, DOI 10.1093/humrep/der470; Daniluk JC, 2012, HUM REPROD, V27, P2405, DOI 10.1093/humrep/des190; Goldfarb KE, 2015, SOC SCI MED, V143, P271, DOI 10.1016/j.socscimed.2014.11.036; Hibino Y, 2013, ENVIRON HEALTH PREV, V18, P477, DOI 10.1007/s12199-013-0345-7; Johannesson L, 2015, FERTIL STERIL, V103, P199, DOI 10.1016/j.fertnstert.2014.09.024; Johannesson L, 2014, WOMENS HEALTH, V10, P455, DOI [10.2217/WHE.14.22, 10.2217/whe.14.22]; Kian Ensiyeh Mohebbi, 2014, J Hum Reprod Sci, V7, P47, DOI 10.4103/0974-1208.130847; Kisu I, 2013, FERTIL STERIL, V100, P280, DOI 10.1016/j.fertnstert.2013.03.004; Kisu I, 2011, EUR J OBSTET GYN R B, V158, P135, DOI 10.1016/j.ejogrb.2011.04.037; Ozkan O, 2013, FERTIL STERIL, V99, P470, DOI 10.1016/j.fertnstert.2012.09.035; Poote AE, 2009, HUM REPROD, V24, P139, DOI 10.1093/humrep/den338; Saito Y, 2009, J PSYCHOSOM OBST GYN, V30, P156, DOI 10.1080/01674820802429435; Schenker JG, 1997, HUM REPROD UPDATE, V3, P173, DOI 10.1093/humupd/3.2.173; Semba Y, 2010, BIOETHICS, V24, P348, DOI 10.1111/j.1467-8519.2009.01780.x; Shirai Yasuko, 1993, J Law Med Ethics, V21, P43, DOI 10.1111/j.1748-720X.1993.tb01229.x; Suzuki K, 2006, EUR J OBSTET GYN R B, V126, P39, DOI 10.1016/j.ejogrb.2005.07.030	25	27	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0156179	10.1371/journal.pone.0156179	http://dx.doi.org/10.1371/journal.pone.0156179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DM4BV	27203855	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500047
J	Tanprasertsuk, J; Li, BX; Bernstein, PS; Vishwanathan, R; Johnson, MA; Poon, L; Johnson, EJ				Tanprasertsuk, Jirayu; Li, Binxing; Bernstein, Paul S.; Vishwanathan, Rohini; Johnson, Mary Ann; Poon, Leonard; Johnson, Elizabeth J.			Relationship between Concentrations of Lutein and StARD3 among Pediatric and Geriatric Human Brain Tissue	PLOS ONE			English	Article							PIGMENT OPTICAL-DENSITY; BINDING-PROTEIN; IDENTIFICATION; CAROTENOIDS; ZEAXANTHIN	Lutein, a dietary carotenoid, selectively accumulates in human retina and brain. While many epidemiological studies show evidence of a relationship between lutein status and cognitive health, lutein's selective uptake in human brain tissue and its potential function in early neural development and cognitive health have been poorly evaluated at a molecular level. The objective of this study was to evaluate the cross-sectional relationship between concentrations of brain lutein and StARD3 (identified as its binding protein in retinal tissue) among three age groups: infants (1-4 months, n = 10), older adults (55-86 years, n = 8), and centenarians (98-105 years, n = 10). Brain lutein concentrations were analyzed by high-performance liquid chromatography and StARD3 levels were analyzed by Western Blot analysis. The strong relationship in infant brains (r = 0.75, P < 0.001) suggests that lutein has a role in neural development. The relationship remained significant but weaker in older adults (r = 0.51, P < 0.05) and insignificant in centenarians (r = 0.08, P > 0.05), seven of whom had mild cognitive impairment (MCI) or dementia. These exploratory findings suggest an age-related decrease or abnormality of StARD3 activity in human brain. Given that StARD3 is also involved in cholesterol transportation, a process that is aberrant in neurodegenerative diseases, the potential protective function of lutein against these diseases remains to be explored.	[Tanprasertsuk, Jirayu; Vishwanathan, Rohini; Johnson, Elizabeth J.] Tufts Univ, Jean Mayer USDA Human Nutr, Res Ctr Aging, Boston, MA 02111 USA; [Li, Binxing; Bernstein, Paul S.] Univ Utah, Sch Med, Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Johnson, Mary Ann; Poon, Leonard] Univ Georgia, Inst Gerontol, Athens, GA 30602 USA	Tufts University; United States Department of Agriculture (USDA); Utah System of Higher Education; University of Utah; University System of Georgia; University of Georgia	Johnson, EJ (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr, Res Ctr Aging, Boston, MA 02111 USA.	elizabeth.johnson@tufts.edu	Li, Binxing/ABB-7775-2020; Tanprasertsuk, Jirayu/AAR-1538-2020	Li, Binxing/0000-0002-0715-7495; Tanprasertsuk, Jirayu/0000-0001-6203-3797	USDA [58-1950-4-003]; NIH [1PO1-AG17553, EY-11600, EY-14800]; Abbott Nutrition; DSM Nutritionals; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011600, P30EY014800, R29EY011600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017553] Funding Source: NIH RePORTER	USDA(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Nutrition(Abbott Laboratories); DSM Nutritionals; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by: USDA agreement 58-1950-4-003 (EJJ), NIH 1PO1-AG17553 (LP), Abbott Nutrition (EJJ), DSM Nutritionals (EJJ), NIH EY-11600 (PSB), NIH EY-14800 (PSB) and an unrestricted grant to the Moran Eye Center of the University of Utah from Research to Prevent Blindness (PSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2006, BIOCHEM SOC T, V34, P343, DOI 10.1042/BST0340343; Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954; Bhosale P, 2005, BBA-MOL BASIS DIS, V1740, P116, DOI 10.1016/j.bbadis.2005.02.002; Bhosale P, 2009, BIOCHEMISTRY-US, V48, P4798, DOI 10.1021/bi9004478; BONE RA, 1985, VISION RES, V25, P1531, DOI 10.1016/0042-6989(85)90123-3; Feeney J, 2013, NEUROBIOL AGING, V34, P2449, DOI 10.1016/j.neurobiolaging.2013.05.007; Johnson Elizabeth J, 2013, J Aging Res, V2013, P951786, DOI 10.1155/2013/951786; King SR, 2006, NEUROSCIENCE, V139, P1031, DOI 10.1016/j.neuroscience.2006.01.063; Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y; Li BX, 2010, PHOTOCH PHOTOBIO SCI, V9, P1418, DOI 10.1039/c0pp00126k; Mohn E, 2015, FASEB J, V29; Park JH, 2001, KOREAN MED J INFORM, V34, P754; Renzi LM, 2014, NEUROBIOL AGING, V35, P1695, DOI 10.1016/j.neurobiolaging.2013.12.024; Stahl W, 2001, BIOFACTORS, V15, P95, DOI 10.1002/biof.5520150209; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; Vishwanathan R, 2015, NUTR NEUROSCI; Vishwanathan R, 2014, J PEDIATR GASTR NUTR, V59, P659, DOI 10.1097/MPG.0000000000000389; Vishwanathan R, 2014, AGE AGEING, V43, P271, DOI 10.1093/ageing/aft210; Vishwanathan R, 2013, NUTR NEUROSCI, V16, P21, DOI 10.1179/1476830512Y.0000000024; Yeum KJ, 1996, AM J CLIN NUTR, V64, P594, DOI 10.1093/ajcn/64.4.594	20	22	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155488	10.1371/journal.pone.0155488	http://dx.doi.org/10.1371/journal.pone.0155488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27205891	gold, Green Published			2022-12-26	WOS:000376291500016
J	Miki, Y; Kidoguchi, Y; Sato, M; Taketomi, Y; Taya, C; Muramatsu, K; Gelb, MH; Yamamoto, K; Murakami, M				Miki, Yoshimi; Kidoguchi, Yuh; Sato, Mariko; Taketomi, Yoshitaka; Taya, Choji; Muramatsu, Kazuaki; Gelb, Michael H.; Yamamoto, Kei; Murakami, Makoto			Dual Roles of Group IID Phospholipase A(2) in Inflammation and Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; REGULATORY T-CELLS; LIPID MEDIATORS; GROUP-V; CONTACT HYPERSENSITIVITY; GROUP-X; DOCOSAHEXAENOIC ACID; HUMAN MACROPHAGES; TRANSGENIC MICE; RESOLVIN D2	Phospholipase A(2) enzymes have long been implicated in the promotion of inflammation by mobilizing pro-inflammatory lipid mediators, yet recent evidence suggests that they also contribute to anti-inflammatory or pro-resolving programs. Group IID-secreted phospholipase A(2) (sPLA(2)-IID) is abundantly expressed in dendritic cells in lymphoid tissues and resolves the Th1 immune response by controlling the steady-state levels of anti-inflammatory lipids such as docosahexaenoic acid and its metabolites. Here, we show that psoriasis and contact dermatitis were exacerbated in Pla2g2d-null mice, whereas they were ameliorated in Pla2g2d-overexpressing transgenic mice, relative to littermate wild-type mice. These phenotypes were associated with concomitant alterations in the tissue levels of omega 3 polyunsaturated fatty acid (PUFA) metabolites, which had the capacity to reduce the expression of pro-inflammatory and Th1/Th17type cytokines in dendritic cells or lymph node cells. In the context of cancer, however, Pla2g2d deficiency resulted in marked attenuation of skin carcinogenesis, likely because of the augmented anti-tumor immunity. Altogether, these results underscore a general role of sPLA(2)-IID as an immunosuppressive sPLA(2) that allows the microenvironmental lipid balance toward an anti-inflammatory state, exerting beneficial or detrimental impact depending upon distinct pathophysiological contexts in inflammation and cancer.	[Miki, Yoshimi; Kidoguchi, Yuh; Sato, Mariko; Taketomi, Yoshitaka; Yamamoto, Kei; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo 1568506, Japan; [Taya, Choji] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo 1568506, Japan; [Kidoguchi, Yuh; Sato, Mariko; Muramatsu, Kazuaki] Tokyo Denki Univ, Sch Sci & Engn, Saitama 3500394, Japan; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Yamamoto, Kei] Univ Tokushima, Fac Biosci & Bioind, Tokushima 7708513, Japan; [Yamamoto, Kei] Japan Agcy Med Res & Dev, PRIME, Tokyo 1000004, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Denki University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tokushima University	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Kamikitazawa 2-1-6, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp		gelb, michael/0000-0001-7000-5219	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H05905, 16H02613, 26461671, 25460087, 26860051]; Terumo Foundation; Takeda Foundation; Kowa Foundation; PRIME from Agency for Medical Research and Development; AMED-CREST from Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [26461671, 16H02613, 16K15122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terumo Foundation; Takeda Foundation(Takeda Science Foundation (TSF)); Kowa Foundation; PRIME from Agency for Medical Research and Development; AMED-CREST from Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 15H05905 and 16H02613 (to M. M.), 26461671 (to K. Y.), 25460087 (to Y. T.), and 26860051 (to Y. M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Terumo Foundation (to M. M.), Takeda and Kowa Foundations (to Y. T.), and by PRIME (to K. Y.) and AMED-CREST (to M. M.) from the Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Barnes MJ, 2015, J EXP MED, V212, P1011, DOI 10.1084/jem.20141827; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Diep QN, 2000, HYPERTENSION, V36, P851, DOI 10.1161/01.HYP.36.5.851; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Kim W, 2010, PROG LIPID RES, V49, P250, DOI 10.1016/j.plipres.2010.01.002; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murase R, 2016, J BIOL CHEM, V291, P6895, DOI 10.1074/jbc.M116.715672; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohta S, 2013, J IMMUNOL, V190, P5927, DOI 10.4049/jimmunol.1203202; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Ohtsuki T, 2016, J VIROL, V90, P300, DOI 10.1128/JVI.02293-15; Pernet E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6105; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Rubio JM, 2015, J IMMUNOL, V194, P3327, DOI 10.4049/jimmunol.1401026; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sawada Y, 2015, J EXP MED, V212, P1921, DOI 10.1084/jem.20150381; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Takeshita K, 2004, INT IMMUNOL, V16, P947, DOI 10.1093/intimm/dxh096; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Ueno N, 2011, J BIOL CHEM, V286, P37249, DOI 10.1074/jbc.M111.290312; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Vijay R, 2015, J EXP MED, V212, P1851, DOI 10.1084/jem.20150632; von Allmen CE, 2009, P NATL ACAD SCI USA, V106, P11673, DOI 10.1073/pnas.0812569106; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamamoto Y, 2011, AM J PATHOL, V179, P302, DOI 10.1016/j.ajpath.2011.03.047; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015	61	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15588	15601		10.1074/jbc.M116.734624	http://dx.doi.org/10.1074/jbc.M116.734624			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226632	hybrid, Green Published			2022-12-26	WOS:000380584200015
J	Liu, Y; Rodrigues, JPGLM; Bonvin, AMJJ; Zaal, EA; Berkers, CR; Heger, M; Gawarecka, K; Swiezewska, E; Breukink, E; Egmond, MR				Liu, Yao; Rodrigues, Joao P. G. L. M.; Bonvin, Alexandre M. J. J.; Zaal, Esther A.; Berkers, Celia R.; Heger, Michal; Gawarecka, Katarzyna; Swiezewska, Ewa; Breukink, Eefjan; Egmond, Maarten R.			New Insight into the Catalytic Mechanism of Bacterial MraY from Enzyme Kinetics and Docking Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLMURAMYL-PENTAPEPTIDE-TRANSLOCASE; 1ST MEMBRANE STEP; LYSIS PROTEIN-E; PEPTIDOGLYCAN SYNTHESIS; ESCHERICHIA-COLI; INHIBITION; SITE; PREDICTION; IDENTIFICATION; PURIFICATION	Phospho-MurNAc-pentapeptide translocase (MraY) catalyzes the synthesis of Lipid I, a bacterial peptidoglycan precursor. As such, MraY is essential for bacterial survival and therefore is an ideal target for developing novel antibiotics. However, the understanding of its catalytic mechanism, despite the recently determined crystal structure, remains limited. In the present study, the kinetic properties of Bacillus subtilis MraY (BsMraY) were investigated by fluorescence enhancement using dansylated UDP-MurNAc-pentapeptide and heptaprenyl phosphate (C35-P, short chain homolog of undecaprenyl phosphate, the endogenous substrate of MraY) as second substrate. Varying the concentrations of both of these substrates and fitting the kinetics data to two-substrate models showed that the concomitant binding of both UDP-MurNAc-pentapeptide-DNS and C35-P to the enzyme is required before the release of the two products, Lipid I and UMP. We built a model of BsMraY and performed docking studies with the substrate C35-P to further deepen our understanding of how MraY accommodates this lipid substrate. Based on these modeling studies, a novel catalytic role was put forward for a fully conserved histidine residue in MraY (His -289 in BsMraY), which has been experimentally confirmed to be essential for MraY activity. Using the current model of BsMraY, we propose that a small conformational change is necessary to relocate the His -289 residue, such that the translocase reaction can proceed via a nucleophilic attack of the phosphate moiety of C35 -P on bound UDP-MurNAc-pentapeptide.	[Liu, Yao; Breukink, Eefjan; Egmond, Maarten R.] Univ Utrecht, Inst Biomembranes, Dept Membrane Biochem & Biophys, NL-3584 CH Utrecht, Netherlands; [Rodrigues, Joao P. G. L. M.; Bonvin, Alexandre M. J. J.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Computat Struct Biol, NL-3584 CH Utrecht, Netherlands; [Zaal, Esther A.; Berkers, Celia R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Heger, Michal] Univ Amsterdam, Acad Med Ctr, Dept Expt Surg, NL-1105 AZ Amsterdam, Netherlands; [Gawarecka, Katarzyna; Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Utrecht University; Utrecht University; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Breukink, E (corresponding author), Univ Utrecht, Inst Biomembranes, Membrane Biochem & Biophys, NL-3584 CH Utrecht, Netherlands.	E.J.Breukink@uu.nl	RODRIGUES, JOÃO/AAC-6993-2019; Bonvin, Alexandre M.J.J./A-5420-2009; Breukink, Eefjan/I-3039-2016; Rodrigues, João/GVU-7735-2022; Rodrigues, João/J-6579-2013; Gawarecka, Katarzyna/N-6184-2014	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Breukink, Eefjan/0000-0002-7311-0660; Rodrigues, João/0000-0001-9796-3193; Swiezewska, Ewa/0000-0002-3439-8948; Berkers, Celia/0000-0003-0746-8565	Netherlands Organization for Scientific Research (NWO) [205.100.008]; VENI grant from the NWO [722.013.009]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); VENI grant from the NWO	Supported by ZonMW Grant 205.100.008 from the Netherlands Organization for Scientific Research (NWO).r Supported by a VENI grant (project 722.013.009) from the NWO.	Al-Dabbagh B, 2008, J BACTERIOL, V190, P7141, DOI 10.1128/JB.00676-08; Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Boyle DS, 1998, J BACTERIOL, V180, P6429; Brandish PE, 1996, J BIOL CHEM, V271, P7609, DOI 10.1074/jbc.271.13.7609; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang HY, 2014, J BIOL CHEM, V289, P18719, DOI 10.1074/jbc.M114.575076; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; DANILOV LL, 1989, CHEM PHYS LIPIDS, V51, P191, DOI 10.1016/0009-3084(89)90006-6; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HEYDANEK MG, 1969, BIOCHEMISTRY-US, V8, P1214, DOI 10.1021/bi00831a056; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Huang LY, 2014, ANGEW CHEM INT EDIT, V53, P8060, DOI 10.1002/anie.201402313; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Ma Y, 2011, J BIOL CHEM, V286, P38844, DOI 10.1074/jbc.M111.301085; Mendel S, 2006, MICROBIOL-SGM, V152, P2959, DOI 10.1099/mic.0.28776-0; Mihalyi A., 2014, THESIS; Mihalyi A, 2014, BIOORGAN MED CHEM, V22, P4566, DOI 10.1016/j.bmc.2014.07.035; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murakami R, 2009, J ANTIBIOT, V62, P153, DOI 10.1038/ja.2009.4; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-37; PLESS DD, 1973, J BIOL CHEM, V248, P1568; Rodolis MT, 2014, CHEMBIOCHEM, V15, P1300, DOI 10.1002/cbic.201402064; Rodrigues JPGLM, 2012, PROTEINS, V80, P1810, DOI 10.1002/prot.24078; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Stachyra T, 2004, ANTIMICROB AGENTS CH, V48, P897, DOI 10.1128/AAC.48.3.897-902.2004; Swiezewska Ewa, 1994, Acta Biochimica Polonica, V41, P221; Tanaka S, 2012, MOL MICROBIOL, V85, P975, DOI 10.1111/j.1365-2958.2012.08153.x; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zheng Y, 2008, GENETICS, V180, P1459, DOI 10.1534/genetics.108.093443	44	10	10	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15057	15068		10.1074/jbc.M116.717884	http://dx.doi.org/10.1074/jbc.M116.717884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226570	Green Published, hybrid			2022-12-26	WOS:000380583200017
J	Towner, LD; Wheat, RA; Hughes, TR; Morgan, BP				Towner, Laurence D.; Wheat, Richard A.; Hughes, Timothy R.; Morgan, B. Paul			Complement Membrane Attack and Tumorigenesis A SYSTEMS BIOLOGY APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GLOMERULAR MESANGIAL CELLS; NF-KAPPA-B; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; REGULATORY PROTEINS; PROMOTER ACTIVITY; CANCER CELLS; FACTOR-ALPHA; TUMOR-CELLS	Tumor development driven by inflammation is now an established phenomenon, but the role that complement plays remains uncertain. Recent evidence has suggested that various components of the complement (C) cascade may influence tumor development in disparate ways; however, little attention has been paid to that of the membrane attack complex (MAC). This is despite abundant evidence documenting the effects of this complex on cell behavior, including cell activation, protection from/induction of apoptosis, release of inflammatory cytokines, growth factors, and ECM components and regulators, and the triggering of the NLRP3 inflammasome. Here we present a novel approach to this issue by using global gene expression studies in conjunction with a systems biology analysis. Using network analysis of MAC -responsive expression changes, we demonstrate a cluster of co-regulated genes known to have impact in the extracellular space and on the supporting stroma and with well characterized tumor -promoting roles. Network analysis highlighted the central role for EGE receptor activation in mediating the observed responses to MAC exposure. Overall, the study sheds light on the mechanisms by which sublytic MAC causes tumor cell responses and exposes a gene expression signature that implicates MAC as a driver of tumor progression. These findings have implications for understanding of the roles of complement and the MAC in tumor development and progression, which in turn will inform future therapeutic strategies in cancer.	[Towner, Laurence D.; Wheat, Richard A.; Hughes, Timothy R.; Morgan, B. Paul] Cardiff Univ, Complement Biol Grp, Div Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Towner, Laurence D.] Thomson Reuters IP & Sci, London EC1N 8JS, England	Cardiff University; Clarivate	Morgan, BP (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Syst Immun URI, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	MorganBP@cardiff.ac.uk			Cardiff University School of Medicine	Cardiff University School of Medicine	This work was supported by a Cardiff University School of Medicine Ph.D. studentship (to L. D. T.). The authors declare that they have no conflicts of interest relevant to the contents of this article.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Ahmad R, 2007, CELL SIGNAL, V19, P2549, DOI 10.1016/j.cellsig.2007.08.013; Badea TD, 2003, J NEUROIMMUNOL, V142, P58, DOI 10.1016/S0165-5728(03)00261-3; Beadling C, 1999, J IMMUNOL, V162, P2677; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bessarabova M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S13; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Cybulsky AV, 1999, AM J PATHOL, V155, P1701, DOI 10.1016/S0002-9440(10)65485-5; D'Antonio A, 2002, INT J ONCOL, V21, P941; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Fang F, 2011, AM J PATHOL, V179, P537, DOI 10.1016/j.ajpath.2011.05.007; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Fosbrink M, 2006, J BIOL CHEM, V281, P19009, DOI 10.1074/jbc.M602055200; Gunn L, 2012, J IMMUNOL, V189, P2985, DOI 10.4049/jimmunol.1200846; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HANSCH GM, 1987, INT ARCH ALLER A IMM, V82, P317, DOI 10.1159/000234216; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Hila S, 2001, GLIA, V36, P58, DOI 10.1002/glia.1095; Huang MY, 2010, ONCOL REP, V24, P1241, DOI 10.3892/or_00000978; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; JOHNSON GR, 1993, J BIOL CHEM, V268, P2924; KILGORE KS, 1995, J IMMUNOL, V155, P1434; Kudo Y, 2012, J BIOL CHEM, V287, P38716, DOI 10.1074/jbc.M112.373159; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; LEJEUNE S, 1993, CANCER RES, V53, P3597; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; LO TN, 1979, CANCER RES, V39, P3156; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Lucas SD, 1996, HUM PATHOL, V27, P1329, DOI 10.1016/S0046-8177(96)90346-9; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2009, CANCER RES, V69, P6367, DOI 10.1158/0008-5472.CAN-09-1918; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; MORGAN BP, 1989, BIOCHEM J, V264, P1; Morgia G, 2005, UROL RES, V33, P44, DOI 10.1007/s00240-004-0440-8; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NICULESCU F, 1994, J BIOL CHEM, V269, P4417; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; O'Barr SA, 2001, J IMMUNOL, V166, P4154, DOI 10.4049/jimmunol.166.6.4154; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001; Rubie C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-178; Rus HG, 1996, J IMMUNOL, V156, P4892; Rutkowski MJ, 2010, MOL CANCER RES, V8, P1453, DOI 10.1158/1541-7786.MCR-10-0225; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Taylor RP, 2014, METHODS, V65, P18, DOI 10.1016/j.ymeth.2013.07.027; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Viedt C, 2000, FASEB J, V14, P2370; WAGNER C, 1994, EXP NEPHROL, V2, P51; Wai PY, 2005, CARCINOGENESIS, V26, P741, DOI 10.1093/carcin/bgi027; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; YAMAKAWA M, 1994, CANCER, V73, P2808, DOI 10.1002/1097-0142(19940601)73:11<2808::AID-CNCR2820731125>3.0.CO;2-P; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yee J, 1997, KIDNEY INT, V52, P120, DOI 10.1038/ki.1997.311; Ytting H, 2004, SCAND J GASTROENTERO, V39, P674, DOI 10.1080/00365520410005603; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	77	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14927	14938		10.1074/jbc.M115.708446	http://dx.doi.org/10.1074/jbc.M115.708446			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226542	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000380583200006
J	Tian, XF; Irannejad, R; Bowman, SL; Du, Y; Puthenveedu, MA; von Zastrow, M; Benovic, JL				Tian, Xufan; Irannejad, Roshanak; Bowman, Shanna L.; Du, Yang; Puthenveedu, Manojkumar A.; von Zastrow, Mark; Benovic, Jeffrey L.			The -Arrestin ARRDC3 Regulates the Endosomal Residence Time and Intracellular Signaling of the (2)-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; cell signaling; G protein-coupled receptor (GPCR); receptor recycling; trafficking; arrestin domain-containing protein 3; 2 adrenergic receptor; endosomal signaling	DOMAIN-CONTAINING PROTEINS; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; BETA-ARRESTINS; ENDOCYTIC PATHWAY; PDZ-DOMAIN; E3 LIGASE; TRAFFICKING; MEMBRANE; UBIQUITINATION	Arrestin domain-containing protein 3 (ARRDC3) is a member of the mammalian -arrestin family, which is predicted to share similar tertiary structure with visual-/-arrestins and also contains C-terminal PPXY motifs that mediate interaction with E3 ubiquitin ligases. Recently, ARRDC3 has been proposed to play a role in regulating the trafficking of G protein-coupled receptors, although mechanistic insight into this process is lacking. Here, we focused on characterizing the role of ARRDC3 in regulating the trafficking of the (2)-adrenergic receptor ((2)AR). We find that ARRDC3 primarily localizes to EEA1-positive early endosomes and directly interacts with the (2)AR in a ligand-independent manner. Although ARRDC3 has no effect on (2)AR endocytosis or degradation, it negatively regulates (2)AR entry into SNX27-occupied endosomal tubules. This results in delayed recycling of the receptor and a concomitant increase in (2)AR-dependent endosomal signaling. Thus, ARRDC3 functions as a switch to modulate the endosomal residence time and subsequent intracellular signaling of the (2)AR.	[Tian, Xufan; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Irannejad, Roshanak; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Bowman, Shanna L.; Puthenveedu, Manojkumar A.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Puthenveedu, Manojkumar A.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Jefferson University; University of California System; University of California San Francisco; Carnegie Mellon University; Stanford University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu	Puthenveedu, Manojkumar A/A-3795-2016		Sidney Kimmel Cancer Center Bioimaging Facility; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047417, R01GM068857, R01GM117425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R21DA036086, R01DA010711, R01DA012864] Funding Source: NIH RePORTER	Sidney Kimmel Cancer Center Bioimaging Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. B.T. Lobingier, M. Bouvier, and A. Marchese and the Sidney Kimmel Cancer Center Bioimaging Facility for reagents, technical advice, training, and support.	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Dores MR, 2015, MOL BIOL CELL, V26, P4660, DOI 10.1091/mbc.E15-05-0284; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hamdan FF, 2006, CURR PROTOC NEUROSCI, V5, P523, DOI DOI 10.1002/0471142301.NS0523S34; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hislop JN, 2011, METHODS MOL BIOL, V746, P425, DOI 10.1007/978-1-61779-126-0_25; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2014, METHOD ENZYMOL, V535, P403, DOI 10.1016/B978-0-12-397925-4.00023-7; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jean-Charles PY, 2016, J CELL PHYSIOL, V231, P2071, DOI 10.1002/jcp.25317; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kang DS, 2013, METHOD ENZYMOL, V521, P91, DOI 10.1016/B978-0-12-391862-8.00005-3; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Puca L, 2013, J CELL SCI, V126, P4457, DOI 10.1242/jcs.130500; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Qi SQ, 2014, PROTEIN SCI, V23, P1708, DOI 10.1002/pro.2549; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	44	43	43	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14510	14525		10.1074/jbc.M116.716589	http://dx.doi.org/10.1074/jbc.M116.716589			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226565	Green Published, hybrid			2022-12-26	WOS:000380366700009
J	Niu, LM; Cui, XL; Qi, Y; Xie, DX; Wu, Q; Chen, XX; Ge, JY; Liu, ZH				Niu, Liman; Cui, Xueling; Qi, Yan; Xie, Dongxue; Wu, Qian; Chen, Xinxin; Ge, Jingyan; Liu, Zhonghui			Involvement of TGF-beta 1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice	PLOS ONE			English	Article							ACTIVIN-A; CONNEXIN43 EXPRESSION; BETA; APOPTOSIS; STRESS; SPECIFICITY; ACTIVATION; MECHANISM; MIGRATION; SULINDAC	Transforming growth factor-beta1 (TGF-beta 1) is a major factor in pathogenesis of chronic hepatic injury. Carbon tetrachloride (CCl4) is a liver toxicant, and CCl4-induced liver injury in mouse is a classical animal model of chemical liver injury. However, it is still unclear whether TGF-beta 1 is involved in the process of CCl4-induced acute chemical liver injury. The present study aimed to evaluate the role of TGF-beta 1 and its signaling molecule Smad3 in the acute liver injury induce by CCl4. The results showed that CCl4 induced acute liver injury in mice effectively confirmed by H& E staining of liver tissues, and levels of not only liver injury markers serum ALT and AST, but also serum TGF-beta 1 were elevated significantly in CCl4-treated mice, compared with the control mice treated with olive oil. Our data further revealed that TGF-beta 1 levels in hepatic tissue homogenate increased significantly, and type II receptor of TGF-beta (T beta RII) and signaling molecules Smad2, 3, mRNA expressions and Smad3 and phospho-Smad3 protein levels also increased obviously in livers of CCl4-treated mice. To clarify the effect of the elevated TGF-beta 1/Smad3 signaling on CCl4-induced acute liver injury, Smad3 in mouse liver was overexpressed in vivo by tail vein injection of Smad3-expressing plasmids. Upon CCl4 treatment, Smad3-overexpressing mice showed more severe liver injury identified by H&E staining of liver tissues and higher serum ALT and AST levels. Simultaneously, we found that Smad3-overexpressing mice treated with CCl4 showed more macrophages and neutrophils infiltration in liver and inflammatory cytokines IL-1 beta and IL-6 levels increment in serum when compared with those in control mice treated with CCl4. Moreover, the results showed that the apoptosis of hepatocytes increased significantly, and apoptosis-associated proteins Bax, cytochrome C and the cleaved caspase 3 expressions were up-regulated in CCl4-treated Smad3-overexpressing mice as well. These results suggested that TGF-beta 1/Smad3 signaling was activated during CCl4-induced acute liver injury in mice, and Smad3 overexpression aggravated acute liver injury by promoting inflammatory cells infiltration, inflammatory cytokines release and hepatocytes apoptosis. In conclusion, the activation of TGF-beta signaling contributes to the CCl4-induced acute liver injury. Thus, TGF-beta 1/Smad3 may serve as a potential target for acute liver injury therapy.	[Niu, Liman; Qi, Yan; Wu, Qian; Chen, Xinxin; Liu, Zhonghui] Jilin Univ, Dept Immunol, Coll Basic Med Sci, Changchun 130023, Peoples R China; [Cui, Xueling; Xie, Dongxue] Jilin Univ, Dept Genet, Coll Basic Med Sci, Changchun 130023, Peoples R China; [Ge, Jingyan] Jilin Univ, Dept Physiol, Coll Basic Med Sci, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Liu, ZH (corresponding author), Jilin Univ, Dept Immunol, Coll Basic Med Sci, Changchun 130023, Peoples R China.; Ge, JY (corresponding author), Jilin Univ, Dept Physiol, Coll Basic Med Sci, Changchun 130023, Peoples R China.	gejy@jlu.edu.cn; liuzh@jlu.edu.cn			National Natural Science Foundation of China [81273199]; Science Development Project, Jilin Province, China [JF2012C006-11, 2011Z040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Development Project, Jilin Province, China	This work was supported by the National Natural Science Foundation of China (grant number 81273199) to Zhonghui Liu, and the Science Development Project, Jilin Province, China (grant number JF2012C006-11 and 2011Z040) to Zhonghui Liu.	Abdel-Moneim AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144509; Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Akel S, 2007, PLATELETS, V18, P566, DOI 10.1080/09537100701549546; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Chattopadhyay N, 2004, MOL BRAIN RES, V121, P146, DOI 10.1016/j.molbrainres.2003.11.008; Che XJ, 2015, BIOCHEM BIOPH RES CO, V464, P1260, DOI 10.1016/j.bbrc.2015.07.116; Chen L, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-18; Cheng JC, 2015, J CELL PHYSIOL, V230, P1558, DOI 10.1002/jcp.24902; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Fang L, 2012, J CELL SCI, V125, P1500, DOI 10.1242/jcs.094151; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fernandez A, 2015, J PINEAL RES, V59, P292, DOI 10.1111/jpi.12264; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Khimji AK, 2008, AM J PATHOL, V173, P716, DOI 10.2353/ajpath.2008.071121; Kremer M, 2014, TRANSPL INT, V27, P748, DOI 10.1111/tri.12322; Li TR, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0144-2; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Matsuzaki K, 2014, J GASTROENTEROL, V49, P971, DOI 10.1007/s00535-013-0910-2; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Munoz-Felix JM, 2014, BBA-MOL CELL RES, V1843, P1111, DOI 10.1016/j.bbamcr.2014.02.017; Ozaki I, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00078; Park SA, 2015, CELL MOL LIFE SCI, V72, P2023, DOI 10.1007/s00018-014-1798-6; Park SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039276; Porowski D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/934065; Qiu X, 2015, CELL SIGNAL, V27, P1956, DOI 10.1016/j.cellsig.2015.07.010; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shukla SK, 2016, CYTOKINE, V77, P176, DOI 10.1016/j.cyto.2015.07.023; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Su J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/234370; Sui YX, 2015, TUMOR BIOL, V36, P8661, DOI 10.1007/s13277-015-3626-5; Sutjarit S, 2014, TOXICOL LETT, V229, P292, DOI 10.1016/j.toxlet.2014.06.843; Suzuki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112566; Wachmann K, 2010, BIOCHEMISTRY-US, V49, P8307, DOI 10.1021/bi100968m; Wang DH, 2013, WORLD J GASTROENTERO, V19, P3802, DOI 10.3748/wjg.v19.i24.3802; Wang RQ, 2015, IRAN J BASIC MED SCI, V18, P404; Yan XH, 2016, J BIOL CHEM, V291, P382, DOI 10.1074/jbc.M115.694281; Yang CY, 2012, J CARDIOVASC PHARM, V59, P465, DOI 10.1097/FJC.0b013e31824a7b60; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056; Zou W, 2011, TOXICOLOGY, V290, P278, DOI 10.1016/j.tox.2011.10.005; Zou W, 2010, TOXICOLOGY, V272, P32, DOI 10.1016/j.tox.2010.03.015	41	33	34	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156090	10.1371/journal.pone.0156090	http://dx.doi.org/10.1371/journal.pone.0156090			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224286	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700062
J	Ramasawmy, R; Johnson, SP; Roberts, TA; Stuckey, DJ; David, AL; Pedley, RB; Lythgoe, MF; Siow, B; Walker-Samuel, S				Ramasawmy, Rajiv; Johnson, S. Peter; Roberts, Thomas A.; Stuckey, Daniel J.; David, Anna L.; Pedley, R. Barbara; Lythgoe, Mark F.; Siow, Bernard; Walker-Samuel, Simon			Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence	PLOS ONE			English	Article							IN-VIVO; COLORECTAL-CANCER; LIVER METASTASES; CELLS; MOUSE; PATHOLOGY; MACROPHAGES; RELAXATION; VOLUME; CT	Background Research using orthotopic and transgenic models of cancer requires imaging methods to non-invasively quantify tumour burden. As the choice of appropriate imaging modality is wide-ranging, this study aimed to compare low-field (1T) magnetic resonance imaging (MRI), a novel and relatively low-cost system, against established preclinical techniques: bioluminescence imaging (BLI), ultrasound imaging (US), and high-field (9.4T) MRI. Methods A model of colorectal metastasis to the liver was established in eight mice, which were imaged with each modality over four weeks post-implantation. Tumour burden was assessed from manually segmented regions. Results All four imaging systems provided sufficient contrast to detect tumours in all of the mice after two weeks. No significant difference was detected between tumour doubling times estimated by low-field MRI, ultrasound imaging or high-field MRI. A strong correlation was measured between high-field MRI estimates of tumour burden and all the other modalities (p < 0.001, Pearson). Conclusion These results suggest that both low-field MRI and ultrasound imaging are accurate modalities for characterising the growth of preclinical tumour models.	[Ramasawmy, Rajiv; Johnson, S. Peter; Roberts, Thomas A.; Stuckey, Daniel J.; Lythgoe, Mark F.; Siow, Bernard; Walker-Samuel, Simon] UCL Ctr Adv Biomed Imaging, Div Med, London, England; [Ramasawmy, Rajiv; Johnson, S. Peter; Pedley, R. Barbara] UCL Canc Inst, London, England; [David, Anna L.] UCL Inst Womens Hlth, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Ramasawmy, R (corresponding author), UCL Ctr Adv Biomed Imaging, Div Med, London, England.; Ramasawmy, R (corresponding author), UCL Canc Inst, London, England.	rajiv.ramasawmy.10@ucl.ac.uk	Siow, Bernard/ABC-4414-2020	Siow, Bernard/0000-0002-8687-8783; stuckey, daniel/0000-0001-8888-627X; Roberts, Tom/0000-0003-0385-1057; David, Anna/0000-0002-0199-6140; Lythgoe, Mark/0000-0002-4945-0171	Medical Research Council (MRC); Department of Health and British Heart Foundation (England) [C1519/A10331, C1519/A16463]; MRC [MRC 1028351, MR/J013110/1]; Medical Research Funding DPFS grant [MRC G100149]; National Centre for the Replacement, Reduction and Refinement of Animal in Research [NC3Rs]; UK Regenerative Medicine Platform Safety Hub [MRC: MR/K026739/1]; Wellcome Trust [WT100247MA]; University College London/University College London Hospital National Institute for Health Research Comprehensive Biomedical Research Centre; MRC [MR/K026739/1, G1001497] Funding Source: UKRI; British Heart Foundation [FS/15/33/31608] Funding Source: researchfish; Cancer Research UK [21030, 16463] Funding Source: researchfish; Medical Research Council [G1001497, MR/K026739/1, MR/J013110/1] Funding Source: researchfish; Rosetrees Trust [M135-F1] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health and British Heart Foundation (England); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Funding DPFS grant; National Centre for the Replacement, Reduction and Refinement of Animal in Research; UK Regenerative Medicine Platform Safety Hub; Wellcome Trust(Wellcome TrustEuropean Commission); University College London/University College London Hospital National Institute for Health Research Comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust)	This work was carried out as part of King's College London and UCL Comprehensive Cancer Imaging Centre, and The Institute of Cancer Research Cancer Imaging Centre, CR-UK & EPSRC, in association with the Medical Research Council (MRC), Department of Health and British Heart Foundation (England) (C1519/A10331, C1519/A16463). R. Ramasawmy receives funding from the MRC (MRC 1028351). R. B. Pedley receives funding from Medical Research Funding DPFS grant (MRC G100149). M. F. Lythgoe receives funding from MRC (MR/J013110/1); the National Centre for the Replacement, Reduction and Refinement of Animal in Research (NC3Rs); UK Regenerative Medicine Platform Safety Hub (MRC: MR/K026739/1). S. Walker-Samuel is a Wellcome Trust Senior Research Fellow (WT100247MA). S. P. Johnson and T. A. Roberts receive funding from the Wellcome Trust (WT100247MA). A. L. David is supported by the University College London/University College London Hospital National Institute for Health Research Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhasan MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046106; Ayers GD, 2010, J ULTRAS MED, V29, P891, DOI 10.7863/jum.2010.29.6.891; BOTTOMLEY PA, 1987, MED PHYS, V14, P1, DOI 10.1118/1.596111; Caysa H, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-69; Charo J, 2011, EUR J IMMUNOL, V41, P3187, DOI 10.1002/eji.201141452; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; de Jong GM, 2009, J SURG RES, V154, P167, DOI 10.1016/j.jss.2008.03.038; de Jong M, 2014, NAT REV CANCER, V14, P481, DOI 10.1038/nrc3751; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El Emir E, 2007, CANCER RES, V67, P11896, DOI 10.1158/0008-5472.CAN-07-2967; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fidarova EF, 2008, CLIN CANCER RES, V14, P2639, DOI 10.1158/1078-0432.CCR-07-2031; Figueiredo S, 2013, MOL IMAGING BIOL, V15, P307, DOI 10.1007/s11307-012-0603-x; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Graham KC, 2005, CANCER RES, V65, P5231, DOI 10.1158/0008-5472.CAN-05-0440; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Gruber IV, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-328; HASHINO J, 1994, CLIN EXP METASTAS, V12, P324, DOI 10.1007/BF01753839; Jost SC, 2009, MOL IMAGING, V8, P245, DOI 10.2310/7290.2009.00023; Kalber TL, 2008, J MAGN RESON IMAGING, V28, P1451, DOI 10.1002/jmri.21600; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; LEE YC, 2015, MED IMAGING, V5, P117; Lewis MA, 2013, DIAGNOSTICS, V3, P325, DOI [10.3390/diagnostics3030325, DOI 10.3390/DIAGN0STICS3030325]; Lyons SK, 2005, J PATHOL, V205, P194, DOI 10.1002/path.1697; Ma D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086576; Martic-Kehl MI, 2012, EUR J NUCL MED MOL I, V39, P1492, DOI 10.1007/s00259-012-2175-z; McPhail LD, 2006, NEOPLASIA, V8, P199, DOI 10.1593/neo.05739; Norris FC, 2013, TRENDS GENET, V29, P700, DOI 10.1016/j.tig.2013.08.004; Obenaus A, 2004, J X-RAY SCI TECHNOL, V12, P241; Oliva Maria Raquel, 2004, Cancer Imaging, V4 Spec No A, pS42, DOI 10.1102/1470-7330.2004.0011; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Panagiotaki E, 2014, CANCER RES, V74, P1902, DOI 10.1158/0008-5472.CAN-13-2511; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; Phoon CKL, 2006, PEDIATR RES, V60, P14, DOI 10.1203/01.pdr.0000219441.28206.79; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Popkov M, 2005, CANCER RES, V65, P972; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Ramasawmy R, 2014, P INT SOC MAG RESON, V22, P1153; Ramasawmy R, 2014, NMR BIOMED; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Riedl CC, 2008, EUR J NUCL MED MOL I, V35, P39, DOI 10.1007/s00259-007-0522-2; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; SARKAR SK, 1989, MAGNET RESON MED, V12, P268, DOI 10.1002/mrm.1910120216; Stuckey DJ, 2014, CIRC-CARDIOVASC IMAG, V7, P240, DOI 10.1161/CIRCIMAGING.113.000993; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Taeymans O, 2013, VET RADIOL ULTRASOUN, V54, P61, DOI 10.1111/j.1740-8261.2012.01966.x; Tempel-Brami C, 2015, TOXICOL PATHOL, V43, P633, DOI 10.1177/0192623314568390; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhang CC, 2014, CANCER MED-US, V3, P462, DOI 10.1002/cam4.215	52	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156162	10.1371/journal.pone.0156162	http://dx.doi.org/10.1371/journal.pone.0156162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27223614	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700067
J	Gao, Y; Li, XX; Han, MM; Yang, XF; Li, Z; Wang, J; Pan, QH				Gao, Yuan; Li, Xiao-Xi; Han, Mei-Mei; Yang, Xiao-Fan; Li, Zheng; Wang, Jun; Pan, Qiu-Hong			Rain-Shelter Cultivation Modifies Carbon Allocation in the Polyphenolic and Volatile Metabolism of Vitis vinifera L. Chardonnay Grapes	PLOS ONE			English	Article							CABERNET-SAUVIGNON; SENSORY CHARACTERISTICS; SHIKIMATE PATHWAY; AROMA COMPOUNDS; BERRY SKINS; WINE; BIOSYNTHESIS; LIGHT; MONOTERPENES; QUALITY	This study investigated the effect of rain-shelter cultivation on the biosynthesis of flavonoids and volatiles in grapes, with an aim of determining whether rain-shelter application could help to improve the sensory attributes and quality of grapes. Vitis vinifera L. Chardonnay grapes, grown in the Huaizhuo basin region of northern China, were selected within two consecutive years. A rain-shelter roof was constructed using a colorless polyethylene (PE) film with a light transmittance of 80%. Results showed that rain-shelter treatment did not affect the accumulation of soluble solids during grape maturation. However, the allocation of assimilated carbon in phenolic and volatile biosynthetic pathways varied significantly, leading to alterations in polyphenolic and volatile profiles. The rain-shelter cultivation enhanced the concentration of flavan-3-ols via the flavonoid-3'5'-hydroxylase (F3'5'H) pathway, but reduced the level of flavonols and flavan-3-ols via the flavonoid-3'-hydroxylase (F3'H) pathway. In addition, the rain-shelter cultivation significantly enhanced the synthesis of fatty acid-derived volatiles, isoprene-derived terpenoids and amino acid-derived branched-chain aliphatics, but led to a decrease in the accumulation of isoprene-derived norisoprenoids and amino acid-derived benzenoids. Principal component analysis revealed some key compounds that differentiated the grapes cultivated under open-field and rain-shelter conditions. Moreover, the effect of the rain-shelter application on the accumulation of these compounds appeared to be vintage dependent. The alteration of their profiles caused by the rain-shelter treatment was significant in the vintage that received higher rainfall, which usually took place in the first rapid growth and veraison phases.	[Gao, Yuan; Li, Xiao-Xi; Han, Mei-Mei; Yang, Xiao-Fan; Wang, Jun; Pan, Qiu-Hong] China Agr Univ, Coll Food Sci & Nutr Engn, Ctr Viticulture & Enol, Beijing 100094, Peoples R China; [Li, Zheng] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	China Agricultural University; State University System of Florida; University of Florida	Pan, QH (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Ctr Viticulture & Enol, Beijing 100094, Peoples R China.	panqh@cau.edu.cn	Li, Zheng/J-8721-2013	Li, Zheng/0000-0002-6968-0097; Gao, Yuan/0000-0001-5844-5190	National Natural Science Foundation of China [31272119]; China Agriculture Research System [CARS-30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31272119) and the project of China Agriculture Research System (CARS-30). Q-HP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Bureau SM, 2000, J SCI FOOD AGR, V80, P2012, DOI 10.1002/1097-0010(200011)80:14&lt;2012::AID-JSFA738&gt;3.0.CO;2-X; Chavarria G, 2007, REV BRAS FRUTIC, V29, P477, DOI 10.1590/S0100-29452007000300014; Detoni AM, 2007, REV BRAS FRUTIC, V29, P530, DOI 10.1590/S0100-29452007000300023; Downey MO, 2004, AUST J GRAPE WINE R, V10, P55, DOI 10.1111/j.1755-0238.2004.tb00008.x; Dunlevy JD, 2010, PLANT MOL BIOL, V74, P77, DOI 10.1007/s11103-010-9655-y; Feng H, 2015, FOOD CHEM, V173, P414, DOI 10.1016/j.foodchem.2014.09.149; Conceicao MAF, 2009, REV BRAS FRUTIC, V31, P423, DOI 10.1590/S0100-29452009000200016; Garrido J, 2013, FOOD RES INT, V54, P1843, DOI 10.1016/j.foodres.2013.08.001; Hu ZH, 2015, PLANT PHYSIOL BIOCH, V91, P1, DOI 10.1016/j.plaphy.2015.03.005; Jin ZM, 2010, ANAL LETT, V43, P776, DOI 10.1080/00032710903486351; Joscelyne VL, 2007, J AGR FOOD CHEM, V55, P10888, DOI 10.1021/jf072162l; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P1740, DOI 10.1021/jf001030o; Koundouras S, 2009, J AGR FOOD CHEM, V57, P7805, DOI 10.1021/jf901063a; Koyama K, 2008, J AM SOC HORTIC SCI, V133, P743, DOI 10.21273/JASHS.133.6.743; Koyama K, 2012, PHYTOCHEMISTRY, V78, P54, DOI 10.1016/j.phytochem.2012.02.026; Kwasniewski MT, 2010, J AGR FOOD CHEM, V58, P6841, DOI 10.1021/jf904555p; Li XX, 2014, MOLECULES, V19, P14843, DOI 10.3390/molecules190914843; Liang N, 2014, S AFR J ENOL VITIC, V33, P122; Lima V. L. A. G. de, 2004, Revista de Nutricao, V17, P53, DOI 10.1590/S1415-52732004000100006; Logemann E, 2000, P NATL ACAD SCI USA, V97, P1903, DOI 10.1073/pnas.97.4.1903; LopezTamames E, 1997, J AGR FOOD CHEM, V45, P1729, DOI 10.1021/jf960572w; Marais J., 1994, South African Journal for Enology and Viticulture, V15, P41; Meng JF, 2013, MOLECULES, V18, P381, DOI 10.3390/molecules18010381; Novello V, 2008, ACTA HORTIC, P353, DOI 10.17660/ActaHortic.2008.785.44; PARK SK, 1991, J AGR FOOD CHEM, V39, P514, DOI 10.1021/jf00003a017; Polat AA, 2005, SCI HORTIC-AMSTERDAM, V104, P189, DOI 10.1016/j.scienta.2004.08.010; Rana G, 2004, SCI HORTIC-AMSTERDAM, V102, P105, DOI 10.1016/j.scienta.2003.12.008; Rapp A, 1998, NAHRUNG, V42, P351, DOI 10.1002/(SICI)1521-3803(199812)42:06<351::AID-FOOD351>3.0.CO;2-2; Reynolds AG, 1996, AM J ENOL VITICULT, V47, P77; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Skinkis PA, 2010, AM J ENOL VITICULT, V61, P147; Soitamo AJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-13; Tomasino E, 2015, AUST J GRAPE WINE R, V21, P376, DOI 10.1111/ajgw.12149; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Wen YQ, 2014, FOOD CHEM, V152, P29, DOI 10.1016/j.foodchem.2013.11.092; Wu YW, 2009, J AGR FOOD CHEM, V57, P9676, DOI 10.1021/jf902144c; Xu XQ, 2015, PLANT PHYSIOL BIOCH, V89, P123, DOI 10.1016/j.plaphy.2015.02.020; Zhang ZZ, 2012, PLANT PHYSIOL BIOCH, V57, P74, DOI 10.1016/j.plaphy.2012.05.005	40	19	22	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156117	10.1371/journal.pone.0156117	http://dx.doi.org/10.1371/journal.pone.0156117			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218245	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880700043
J	Vespasiani-Gentilucci, U; Gallo, P; Piemonte, F; Riva, E; Porcari, A; Vorini, F; Tozzi, G; Piccioni, L; Galati, G; De Vincentis, A; Carotti, S; Morini, S; D'Amico, J; Angeletti, S; Pedone, C; Picardi, A				Vespasiani-Gentilucci, Umberto; Gallo, Paolo; Piemonte, Fiorella; Riva, Elisabetta; Porcari, Aldostefano; Vorini, Ferruccio; Tozzi, Giulia; Piccioni, Livia; Galati, Giovanni; De Vincentis, Antonio; Carotti, Simone; Morini, Sergio; D'Amico, Jessica; Angeletti, Silvia; Pedone, Claudio; Picardi, Antonio			Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology	PLOS ONE			English	Article							ESTER STORAGE DISEASE; LIVER-DISEASE; MUTATION	Lysosomal acid lipase deficiency (LAL-d) is a rare autosomal recessive disease in which LAL activity is almost absent, with consequent massive microvesicular steatosis evolving to cirrhosis and liver failure. We aimed to determine LAL-activity, and to investigate the most common single nucleotide polymorphism (SNP) affecting the LIPA gene and responsible for 50-70% of LAL-d cases (rs116928232 c.894G>A), in patients with cryptogenic cirrhosis. Sixty-three patients with cryptogenic cirrhosis, 88 cirrhotics of known etiology, and 97 healthy subjects were enrolled. LAL-activity was determined in dried-blood-spot (DBS). The c.894G>A mutation was analyzed by pyrosequencing method in SNP mode. LAL-activity was severely reduced in patients with cryptogenic cirrhosis with respect to healthy subjects [0.62 (0.44-0.86) Vs 0.96 (0.75-1.25) nmol/spot/h, p<0.001)], but it was also reduced in known-etiology cirrhotics [0.54 (0.42-0.79) nmol/spot/h, p<0.001 Vs healthy subjects; p = 0.5 Vs cryptogenic cirrhotics]. Fourteen percent of cryptogenic cirrhotics and 20% of known-etiology cirrhotics showed a LAL-activity in the range of heterozygous carriers of LIPA gene mutations (0.15-0.40 nmol/spot/h). However, none of the subjects with reduced LAL-activity carried the c.894G>A SNP except for one patient with HCV cirrhosis. By multivariate analysis, LAL-activity was not associated with age, sex, liver enzymes, liver function or lipid parameters, while it was independently associated with white blood cell (beta = 0.2; p<0.01) and platelet (beta = 0.4; p<0.001) counts and with the condition of cirrhosis (beta = -0.2; p = 0.04). Conclusion Liver cirrhosis is characterized by a severe acquired reduction of LAL-activity, the precise causes and consequences of which need to be further addressed. DBS-determined lysosomal enzyme activities seem to be affected by white blood cell and platelet counts, and the specificity of these tests can be reduced when applied to determined populations, such as cirrhotics.	[Vespasiani-Gentilucci, Umberto; Gallo, Paolo; Porcari, Aldostefano; Vorini, Ferruccio; Galati, Giovanni; De Vincentis, Antonio; Picardi, Antonio] Univ Campus Biomed, Internal Med & Hepatol Unit, Rome, Italy; [Piemonte, Fiorella; Tozzi, Giulia; D'Amico, Jessica] Childrens Hosp, Unit Neuromuscolar & Neurodegenerat Dis, Rome, Italy; [Piemonte, Fiorella; Tozzi, Giulia; D'Amico, Jessica] Res Inst Bambino Gesu, Rome, Italy; [Riva, Elisabetta; Piccioni, Livia] Univ Campus Biomed, Virol Unit, Rome, Italy; [Carotti, Simone; Morini, Sergio] Univ Campus Biomed, CIR, Lab Microscop & Ultrastruct Anat, Rome, Italy; [Angeletti, Silvia] Univ Campus Biomed, Clin Pathol & Microbiol Lab, Rome, Italy; [Pedone, Claudio] Univ Campus Biomed, Area Geriatr, Rome, Italy	University Campus Bio-Medico - Rome Italy; IRCCS Bambino Gesu; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy	Vespasiani-Gentilucci, U (corresponding author), Univ Campus Biomed, Internal Med & Hepatol Unit, Rome, Italy.	u.vespasiani@unicampus.it	Porcari, Aldostefano/GQI-2889-2022; Porcari, Aldostefano/AFS-2370-2022; Carotti, Simone/G-7822-2012; Pedone, Claudio/F-9488-2010; Piemonte, Fiorella/A-2809-2014; Morini, Sergio/AAB-8540-2022; Piccioni, Livia/AAA-5032-2020; Tozzi, Giulia/ABB-3829-2021; Porcari, Aldostefano/AAU-8846-2021; Gallo, Paolo/J-7941-2018; riva, elisabetta/H-7729-2016; Tozzi, Giulia/K-8605-2018; D'Amico, Jessica/AAB-5728-2020; De Vincentis, Antonio/AAB-7965-2019; Picardi, Antonio/C-2337-2012; Vespasiani-Gentilucci, Umberto/I-8357-2016	Porcari, Aldostefano/0000-0003-3307-0825; Carotti, Simone/0000-0002-3164-1500; Pedone, Claudio/0000-0003-1847-9032; Piemonte, Fiorella/0000-0003-1825-9347; Morini, Sergio/0000-0001-6137-2404; Gallo, Paolo/0000-0001-8292-1134; riva, elisabetta/0000-0002-6870-8780; Picardi, Antonio/0000-0002-0230-218X; Vespasiani-Gentilucci, Umberto/0000-0002-1138-1967; Tozzi, Giulia/0000-0002-1745-2797; De Vincentis, Antonio/0000-0003-0220-0500; Galati, Giovanni/0000-0003-2935-0795; d'amico, jessica/0000-0002-3887-3806				Baratta F, 2015, EBIOMEDICINE, V2, P750, DOI 10.1016/j.ebiom.2015.05.018; BENTFELDBARKER ME, 1982, BLOOD, V59, P472; Bernstein DL, 2013, J HEPATOL, V58, P1230, DOI 10.1016/j.jhep.2013.02.014; Boldrini R, 2004, PATHOL RES PRACT, V200, P231, DOI 10.1016/j.prp.2003.11.001; Burton BK, 2015, NEW ENGL J MED, V373, P1010, DOI 10.1056/NEJMoa1501365; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Ceci R, 2011, ADV BIOL CHEM, V1, P58, DOI [10.4236/abc.2011.13008, DOI 10.4236/ABC.2011.13008]; Civallero G, 2006, CLIN CHIM ACTA, V372, P98, DOI 10.1016/j.cca.2006.03.029; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fede G, 2012, HEPATOLOGY, V55, P1282, DOI 10.1002/hep.25573; Foresta C, 2008, J ENDOCRINOL INVEST, V31, P470, DOI 10.1007/BF03346393; Fouchier SW, 2013, CURR OPIN LIPIDOL, V24, P332, DOI 10.1097/MOL.0b013e328361f6c6; Hamilton J, 2012, CLIN CHIM ACTA, V413, P1207, DOI 10.1016/j.cca.2012.03.019; Hoffman EP, 1993, GENEREVIEWS; Hulkova H, 2012, HISTOPATHOLOGY, V60, P1107, DOI 10.1111/j.1365-2559.2011.04164.x; Lohse P, 2000, J LIPID RES, V41, P23; MORSE EE, 1990, ANN CLIN LAB SCI, V20, P169; Muntoni S, 2007, ARTERIOSCL THROM VAS, V27, P1866, DOI 10.1161/ATVBAHA.107.146639; Perry R, 2005, J CLIN ENDOCR METAB, V90, P3243, DOI 10.1210/jc.2004-0016; Reiner Z, 2014, ATHEROSCLEROSIS, V235, P21, DOI 10.1016/j.atherosclerosis.2014.04.003; Scott SA, 2013, HEPATOLOGY, V58, P958, DOI 10.1002/hep.26327; Shteyer E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030312; Stitziel NO, 2013, ARTERIOSCL THROM VAS, V33, P2909, DOI 10.1161/ATVBAHA.113.302426; Zhang BN, 2013, J PEDIATR GASTR NUTR, V56, P682, DOI 10.1097/MPG.0b013e31828b36ac; Zschenker O, 2006, J BIOCHEM, V140, P23, DOI 10.1093/jb/mvj137	25	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0156113	10.1371/journal.pone.0156113	http://dx.doi.org/10.1371/journal.pone.0156113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27219619	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700042
J	Koh, JCO; Barbulescu, DM; Salisbury, PA; Slater, AT				Koh, Joshua C. O.; Barbulescu, Denise M.; Salisbury, Phil A.; Slater, Anthony T.			Pterostilbene Is a Potential Candidate for Control of Blackleg in Canola	PLOS ONE			English	Article							LEPTOSPHAERIA-MACULANS; BRASSICA-NAPUS; OILSEED RAPE; BIOLOGICAL-ACTIVITY; RESISTANCE GENES; MAJOR GENE; RESVERATROL; PHYTOALEXINS; VIRULENCE; DISEASE	Two stilbenes, resveratrol and pterostilbene, exhibit antifungal activity against Leptosphaeria maculans, the fungal pathogen responsible for blackleg (stem canker) in canola (Brassica napus). In vitro studies on the effect of these stilbenes on L. maculans mycelial growth and conidia germination showed that pterostilbene is a potent fungicide and sporicide, but resveratrol only exerted minor inhibition on L. maculans. Cell viability of hyphae cultures was markedly reduced by pterostilbene and SYTOX green staining showed that cell membrane integrity was compromised. We demonstrate that pterostilbene exerts fungicidal activity across 10 different L. maculans isolates and the compound confers protection to the blackleg-susceptible canola cv. Westar seedlings. The potential of pterostilbene as a control agent against blackleg in canola is discussed.	[Koh, Joshua C. O.; Barbulescu, Denise M.] Dept Econ Dev Jobs Transport & Resources, Grains Innovat Pk,110 Natimuk Rd, Horsham, Vic 3401, Australia; [Salisbury, Phil A.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic 3010, Australia; [Salisbury, Phil A.; Slater, Anthony T.] La Trobe Univ, Dept Econ Dev Jobs Transport & Resources, AgriBio, Ctr AgriBiosci, 5 Ring Rd, Bundoora, Vic 3083, Australia	University of Melbourne; La Trobe University	Koh, JCO (corresponding author), Dept Econ Dev Jobs Transport & Resources, Grains Innovat Pk,110 Natimuk Rd, Horsham, Vic 3401, Australia.	Joshua.koh@ecodev.vic.gov.au		Koh, Joshua/0000-0002-3678-4789	Grains Research and Development Corporation [DAN00208]; Department of Economic Development, Jobs, Transport and Resources	Grains Research and Development Corporation(Grains R&D Corp); Department of Economic Development, Jobs, Transport and Resources	This study is funded by the Department of Economic Development, Jobs, Transport and Resources (http://economicdevelopment.vic.gov.au/) and Grains Research and Development Corporation (http://www.grdc.com.au/) under project number DAN00208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 1997, J CHEM ECOL, V23, P1689, DOI 10.1023/B:JOEC.0000006444.79951.75; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; [Anonymous], 2016, OILS WORLD MARK TRAD; [Anonymous], 2014, AUSTR GRAIN NOT CAN; Ansan-Melayah D, 1998, PLANT BREEDING, V117, P373, DOI 10.1111/j.1439-0523.1998.tb01956.x; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; Carrizzo A, 2013, FOOD CHEM TOXICOL, V61, P215, DOI 10.1016/j.fct.2013.07.021; Caruso F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025421; Delourme R, 2006, EUR J PLANT PATHOL, V114, P41, DOI 10.1007/s10658-005-2108-9; Estrela JM, 2013, CRIT REV CL LAB SCI, V50, P65, DOI 10.3109/10408363.2013.805182; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Fudal I, 2009, MOL PLANT MICROBE IN, V22, P932, DOI 10.1094/MPMI-22-8-0932; Ghanbarnia K, 2015, MOL PLANT PATHOL, V16, P699, DOI 10.1111/mpp.12228; Grayer RJ, 2001, PHYTOCHEMISTRY, V56, P253, DOI 10.1016/S0031-9422(00)00450-7; Hayward A, 2012, PLANT BIOLOGY, V14, P1, DOI 10.1111/j.1438-8677.2011.00481.x; Howlett BJ, 2015, MYCOLOGIA, V107, P441, DOI 10.3852/14-317; Howlett BJ, 2004, CAN J PLANT PATHOL, V26, P245; Hsieh MT, 2014, INT J ONCOL, V45, P782, DOI 10.3892/ijo.2014.2478; Jeandet P, 2015, MOLECULES, V20, P2770, DOI 10.3390/molecules20022770; Jeandet P, 2010, BIOFACTORS, V36, P331, DOI 10.1002/biof.108; Jeong YJ, 2015, MOL CELLS, V38, P318, DOI 10.14348/molcells.2015.2188; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Kang SY, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-67; Kaur S, 2009, THEOR APPL GENET, V120, P71, DOI 10.1007/s00122-009-1160-9; Kutcher HR, 2010, CAN J PLANT PATHOL, V32, P29, DOI 10.1080/07060661003620961; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Larkan NJ, 2015, PLANT BIOTECHNOL J, V13, P983, DOI 10.1111/pbi.12341; Lim CG, 2011, APPL ENVIRON MICROB, V77, P3451, DOI 10.1128/AEM.02186-10; Lygin AV, 2014, PHYTOPATHOLOGY, V104, P843, DOI 10.1094/PHYTO-10-13-0287-R; Marcroft SJ, 2011, 17 AUSTR RES ASS BRA; Marcroft SJ, 2012, CROP PASTURE SCI, V63, P338, DOI 10.1071/CP11341; MAURYA R, 1984, J NAT PROD, V47, P179, DOI 10.1021/np50031a029; McCormack D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/575482; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; MENGISTU A, 1993, PLANT DIS, V77, P538, DOI 10.1094/PD-77-0538; Mikstacka R, 2007, MOL NUTR FOOD RES, V51, P517, DOI 10.1002/mnfr.200600135; Nikhil K, 2015, INT IMMUNOPHARMACOL, V28, P10, DOI 10.1016/j.intimp.2015.05.003; Pan ZQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-7; Parlange F, 2009, MOL MICROBIOL, V71, P851, DOI 10.1111/j.1365-2958.2008.06547.x; Pedras MSC, 2008, FEBS J, V275, P3691, DOI 10.1111/j.1742-4658.2008.06513.x; Plissonneau C, 2016, NEW PHYTOL, V209, P1613, DOI 10.1111/nph.13736; PONT V, 1990, J PHYTOPATHOL, V130, P1, DOI 10.1111/j.1439-0434.1990.tb01147.x; Raman H., 2013, PLANT BREEDING LAB F; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Roberti M, 2003, J MED CHEM, V46, P3546, DOI 10.1021/jm030785u; Rouxel T, 2003, EUR J PLANT PATHOL, V109, P871, DOI 10.1023/A:1026189225466; SALISBURY PA, 1995, AUST J EXP AGR, V35, P665, DOI 10.1071/EA9950665; Schouten A, 2002, MOL MICROBIOL, V43, P883, DOI 10.1046/j.1365-2958.2002.02801.x; Shen T, 2009, NAT PROD REP, V26, P916, DOI 10.1039/b905960a; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; Snowdon RJ, 2002, THEOR APPL GENET, V104, P533, DOI 10.1007/s00122-001-0787-y; Soledade M, 2009, J AGR FOOD CHEM, V57, P2429, DOI 10.1021/jf803666s; Sprague S, 2007, 15 AUSTR RES ASS BRA; Sprague SJ, 2006, EUR J PLANT PATHOL, V114, P33, DOI 10.1007/s10658-005-3683-5; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; Vanetten H, 2001, PHYSIOL MOL PLANT P, V59, P83, DOI 10.1006/pmpp.2001.0350; Wang Y. C., 2015, Annals of Microbiology, V65, P817, DOI 10.1007/s13213-014-0922-z; Watt S, 2015, FUNGICIDE TOLERANCE	58	10	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156186	10.1371/journal.pone.0156186	http://dx.doi.org/10.1371/journal.pone.0156186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213274	Green Published, gold			2022-12-26	WOS:000376880200067
J	Laas, P; Satova, E; Lips, I; Lips, U; Simm, J; Kisand, V; Metsis, M				Laas, Peeter; Satova, Elina; Lips, Inga; Lips, Urmas; Simm, Jaak; Kisand, Veljo; Metsis, Madis			Near-Bottom Hypoxia Impacts Dynamics of Bacterioplankton Assemblage throughout Water Column of the Gulf of Finland (Baltic Sea)	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; MARINE BACTERIOPLANKTON; SPATIAL VARIABILITY; EMENDED DESCRIPTION; PELAGIC REDOXCLINE; SALINITY GRADIENT; ANOXIC FJORD; DIVERSITY; SUCCESSION; ECOLOGY	Over the past century the spread of hypoxia in the Baltic Sea has been drastic, reaching its 'arm' into the easternmost sub-basin, the Gulf of Finland. The hydrographic and climatological properties of the gulf offer a broad suite of discrete niches for microbial communities. The current study explores spatiotemporal dynamics of bacterioplankton community in the Gulf of Finland using massively parallel sequencing of 16S rRNA fragments obtained by amplifying community DNA from spring to autumn period. The presence of redoxcline and drastic seasonal changes make spatiotemporal dynamics of bacterioplankton community composition (BCC) and abundances in such estuary remarkably complex. To the best of our knowledge, this is the first study that analyses spatiotemporal dynamics of BCC in relation to phytoplankton bloom throughout the water column (and redoxcline), not only at the surface layer. We conclude that capability to survive (or benefit from) shifts between oxic and hypoxic conditions is vital adaptation for bacteria to thrive in such environments. Our results contribute to the understanding of emerging patterns in BCCs that occupy hydrogra-phically similar estuaries dispersed all over the world, and we suggest the presence of a global redox- and salinity-driven metacommunity. These results have important implications for understanding long-term ecological and biogeochemical impacts of hypoxia expansion in the Baltic Sea (and similar ecosystems), as well as global biogeography of bacteria specialized inhabiting similar ecosystems.	[Laas, Peeter; Lips, Inga; Lips, Urmas] Tallinn Univ Technol, Marine Syst Inst, Akad Rd 15A, EE-12618 Tallinn, Estonia; [Satova, Elina; Simm, Jaak] Tallinn Univ Technol, Dept Gene Technol, Akad Tee 15, EE-12618 Tallinn, Estonia; [Kisand, Veljo] Univ Tartu, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia; [Metsis, Madis] Tallinn Univ, Inst Math & Nat Sci, Narva Rd 25, EE-10120 Tallinn, Estonia; [Simm, Jaak] Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Kasteelpk Arenberg 10,Box 2446, B-3001 Leuven, Belgium	Tallinn University of Technology; Tallinn University of Technology; University of Tartu; Tallinn University; KU Leuven	Laas, P (corresponding author), Tallinn Univ Technol, Marine Syst Inst, Akad Rd 15A, EE-12618 Tallinn, Estonia.	peeter.laas@msi.ttu.ee	Lips, Urmas/F-8628-2011; Kisand, Veljo/H-2466-2012; Lips, Inga/N-5000-2019; Laas, Peeter/O-1466-2019; Metsis, Madis/F-7080-2016	Lips, Urmas/0000-0002-9823-6294; Kisand, Veljo/0000-0002-5535-1639; Lips, Inga/0000-0001-6556-6281; Metsis, Madis/0000-0003-1667-677X; Laas, Peeter/0000-0001-9393-9022	IUT of the Estonian Ministry of Education and Research [IUT19-6]; Estonian Science Foundation [8930, 9023]; Research Council KU Leuven [GOA/10/09, PFV/10/016]; Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO 2014); Intel; Janssen Pharmaceutica; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)	IUT of the Estonian Ministry of Education and Research; Estonian Science Foundation; Research Council KU Leuven(KU Leuven); Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO 2014); Intel(Intel Corporation); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The present work was supported by institutional research funding IUT (IUT19-6) of the Estonian Ministry of Education and Research and by the Estonian Science Foundation grants no. 8930 and 9023. Jaak Simm is funded by Research Council KU Leuven (GOA/10/09 MaNet, CoE PFV/10/016 SymBioSys) and PhD/Postdoc grants from Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO 2014), by Intel, Janssen Pharmaceutica and the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanderud ZT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00024; Alenius P., 1998, BOREAL ENVIRON RES, V3, P97; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Beck DAC, 2013, PEERJ, V1, DOI 10.7717/peerj.23; Beijerinck MW, 1913, JAARBOEK KONINKLIJKE; Bergen B, 2014, ENV MICROBIOL REP, V6, P625, DOI 10.1111/1758-2229.12178; Carstensen J, 2014, P NATL ACAD SCI USA, V111, P5628, DOI 10.1073/pnas.1323156111; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Crump BC, 2007, APPL ENVIRON MICROB, V73, P6802, DOI 10.1128/AEM.00648-07; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dupont CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089549; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elken J, 2003, J SEA RES, V49, P267, DOI 10.1016/S1385-1101(03)00018-2; Eyice O, 2015, ISME J, V9, P2336, DOI 10.1038/ismej.2015.37; Forth M, 2015, ISME J, V9, P656, DOI 10.1038/ismej.2014.172; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Glaubitz S, 2010, FEMS MICROBIOL ECOL, V74, P32, DOI 10.1111/j.1574-6941.2010.00944.x; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Hagstrom A, 2000, AQUAT MICROB ECOL, V21, P231, DOI 10.3354/ame021231; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Herlemann DPR, 2014, SYST APPL MICROBIOL, V37, P601, DOI 10.1016/j.syapm.2014.09.002; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hernandez ME, 2015, PEERJ, V3, DOI 10.7717/peerj.801; Holmfeldt K, 2009, ENVIRON MICROBIOL, V11, P2042, DOI 10.1111/j.1462-2920.2009.01925.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Hugerth LW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0834-7; Kaartokallio H, 2008, POLAR BIOL, V31, P783, DOI 10.1007/s00300-008-0416-1; Kalyuzhnaya MG, 2008, INT J SYST EVOL MICR, V58, P591, DOI 10.1099/ijs.0.65317-0; Kan J, 2007, APPL ENVIRON MICROB, V73, P6776, DOI 10.1128/AEM.00541-07; Karlson K, 2002, OCEANOGR MAR BIOL, V40, P427; Khan ST, 2002, APPL ENVIRON MICROB, V68, P3206, DOI 10.1128/AEM.68.7.3206-3214.2002; Kisand V, 2005, LIMNOL OCEANOGR, V50, P945, DOI 10.4319/lo.2005.50.3.0945; Kisand V, 2003, APPL ENVIRON MICROB, V69, P3607, DOI 10.1128/AEM.69.6.3607-3616.2003; Klindworth A, 2014, MAR GENOM, V18, P185, DOI 10.1016/j.margen.2014.08.007; Koskinen K, 2011, FEMS MICROBIOL ECOL, V75, P99, DOI 10.1111/j.1574-6941.2010.00987.x; Laas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122304; Laas P, 2014, J MARINE SYST, V129, P127, DOI 10.1016/j.jmarsys.2013.07.016; Labrenz M, 2013, INT J SYST EVOL MICR, V63, P4141, DOI 10.1099/ijs.0.048827-0; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Li HB, 2012, FEMS MICROBIOL ECOL, V79, P773, DOI 10.1111/j.1574-6941.2011.01262.x; Liblik T, 2011, BOREAL ENVIRON RES, V16, P73; Lindh MV, 2015, ENVIRON MICROBIOL, V17, P2459, DOI 10.1111/1462-2920.12720; Lindh MV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00223; Lips I, 2014, J MARINE SYST, V129, P135, DOI 10.1016/j.jmarsys.2013.06.002; Liu JF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00236; Lynch MDJ, 2015, NAT REV MICROBIOL, V13, P217, DOI 10.1038/nrmicro3400; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Moffitt SE, 2015, P NATL ACAD SCI USA, V112, P4684, DOI 10.1073/pnas.1417130112; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Oksanen J., 2007, VEGAN PACKAGE COMMUN, P10; Pinhassi J, 2000, AQUAT MICROB ECOL, V21, P245, DOI 10.3354/ame021245; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Piwosz K, 2013, LIMNOL OCEANOGR, V58, P817, DOI 10.4319/lo.2013.58.3.0817; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Riemann L, 2008, APPL ENVIRON MICROB, V74, P503, DOI 10.1128/AEM.01983-07; Salka I, 2008, APPL ENVIRON MICROB, V74, P4398, DOI 10.1128/AEM.02447-07; Salka I, 2014, ENVIRON MICROBIOL, V16, P586, DOI 10.1111/1462-2920.12185; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmale O, 2012, BIOGEOSCIENCES, V9, P4969, DOI 10.5194/bg-9-4969-2012; Schmale O, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043115; Sinkko H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067061; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Thureborn P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074983; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Voget S, 2015, ISME J, V9, P371, DOI 10.1038/ismej.2014.134; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wasmund N, 2008, STATE EVOLUTION BALT, P441; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; Zakharova YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059977	82	8	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0156147	10.1371/journal.pone.0156147	http://dx.doi.org/10.1371/journal.pone.0156147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27213812	gold, Green Published, Green Submitted			2022-12-26	WOS:000376880200060
J	Suhandynata, RT; Wan, LH; Zhou, HL; Hollingsworth, NM				Suhandynata, Raymond T.; Wan, Lihong; Zhou, Huilin; Hollingsworth, Nancy M.			Identification of Putative Mek1 Substrates during Meiosis in Saccharomyces cerevisiae Using Quantitative Phosphoproteomics	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; NUA3 HISTONE ACETYLTRANSFERASE; SYNAPTONEMAL COMPLEX-FORMATION; SISTER-CHROMATID COHESION; POLO-LIKE KINASES; MEIOTIC RECOMBINATION; AMINO-ACIDS; REC8 PHOSPHORYLATION; INTERACTING PROTEINS; CELL-CULTURE	Meiotic recombination plays a key role in sexual reproduction as it generates crossovers that, in combination with sister chromatid cohesion, physically connect homologous chromosomes, thereby promoting their proper segregation at the first meiotic division. Meiotic recombination is initiated by programmed double strand breaks (DSBs) catalyzed by the evolutionarily conserved, topoisomerase-like protein Spo11. Repair of these DSBs is highly regulated to create crossovers between homologs that are distributed throughout the genome. This repair requires the presence of the mitotic recombinase, Rad51, as well as the strand exchange activity of the meiosis-specific recombinase, Dmc1. A key regulator of meiotic DSB repair in Saccharomyces cerevisiae is the meiosis-specific kinase Mek1, which promotes interhomolog strand invasion and is required for the meiotic recombination checkpoint and the crossover/noncrossover decision. Understanding how Mek1 regulates meiotic recombination requires the identification of its substrates. Towards that end, an unbiased phosphoproteomic approach utilizing Stable Isotope Labeling by Amino Acids in Cells (SILAC) was utilized to generate a list of potential Mek1 substrates, as well as proteins containing consensus phosphorylation sites for cyclin-dependent kinase, the checkpoint kinases, Mec1/Tel1, and the polo-like kinase, Cdc5. These experiments represent the first global phosphoproteomic dataset for proteins in meiotic budding yeast.	[Suhandynata, Raymond T.; Wan, Lihong; Hollingsworth, Nancy M.] SUNY Stony Brook, Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Cellular & Mol Med, La Jolla, CA 92093 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Hollingsworth, NM (corresponding author), SUNY Stony Brook, Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Nancy.Hollingsworth@stonybrook.edu		Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [R01 GM050717]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008468, R01GM050717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM050717 to N.M.H. The funders has no role in the study desing, data collection and analysis, decision to publish or preparation of the manuscript.	Acquaviva L, 2013, SCIENCE, V339, P215, DOI 10.1126/science.1225739; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Arbel A, 1999, EMBO J, V18, P2648, DOI 10.1093/emboj/18.9.2648; Babu P, 2004, J BIOL CHEM, V279, P27138, DOI 10.1074/jbc.M403071200; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794; Brown MS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005653; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Callender TL, 2010, GENETICS, V185, P771, DOI 10.1534/genetics.110.117523; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Chen XY, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002329; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; CYR DM, 1992, J BIOL CHEM, V267, P20927; CYR DM, 1994, J BIOL CHEM, V269, P9798; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; Dong HJ, 2000, J CELL BIOL, V148, P417, DOI 10.1083/jcb.148.3.417; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Govin J, 2010, GENE DEV, V24, P1772, DOI 10.1101/gad.1954910; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P1697, DOI 10.1074/mcp.M500190-MCP200; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Ho HC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002351; Hollingsworth NM, 2016, MICROB CELL, V3, P129, DOI 10.15698/mic2016.03.487; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kurzbauer MT, 2012, PLANT CELL, V24, P2058, DOI 10.1105/tpc.112.098459; Lai YJ, 2011, MOL CELL BIOL, V31, P912, DOI 10.1128/MCB.00895-10; Lam I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016634; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Li P, 2015, J CELL BIOL, V209, P247, DOI 10.1083/jcb.201408118; Li SH, 1999, ANAL BIOCHEM, V270, P9, DOI 10.1006/abio.1999.4060; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Lo HC, 2011, METHODS MOL BIOL, V745, P135, DOI 10.1007/978-1-61779-129-1_9; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; MacCoss MJ, 2005, ANAL CHEM, V77, p295A; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nimonkar AV, 2012, J BIOL CHEM, V287, P28727, DOI 10.1074/jbc.M112.373290; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Pauling MH, 2000, MOL CELL BIOL, V20, P2176, DOI 10.1128/MCB.20.6.2176-2185.2000; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Schulze JM, 2010, MOL GENET GENOMICS, V283, P365, DOI 10.1007/s00438-010-0523-x; Schulze WX, 2005, OECOLOGIA, V142, P335, DOI 10.1007/s00442-004-1698-9; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shinohara M, 2003, GENETICS, V164, P855; Shinohara M, 1997, GENETICS, V147, P1545; Shinohara M, 2015, J CELL SCI, V128, P1494, DOI 10.1242/jcs.161554; Shiomi Y, 2002, GENES CELLS, V7, P861, DOI 10.1046/j.1365-2443.2002.00566.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Sommermeyer V, 2013, MOL CELL, V49, P43, DOI 10.1016/j.molcel.2012.11.008; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Subramanian VV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016675; Suhandynata R, 2014, G3-GENES GENOM GENET, V4, P2125, DOI 10.1534/g3.114.013888; Sury MD, 2010, MOL CELL PROTEOMICS, V9, P2173, DOI 10.1074/mcp.M110.000323; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Szekvolgyi L, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016527; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; Vicente-Munoz S, 2014, FEBS OPEN BIO, V4, P996, DOI 10.1016/j.fob.2014.11.001; WALLIS JW, 1980, CELL, V22, P799, DOI 10.1016/0092-8674(80)90556-5; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Wells SE, 1996, GENE DEV, V10, P220, DOI 10.1101/gad.10.2.220; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005	115	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2016	11	5							e0155931	10.1371/journal.pone.0155931	http://dx.doi.org/10.1371/journal.pone.0155931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FT	27214570	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880200033
J	Marechal, L; Semple, S; Majolo, B; MacLarnon, A				Marechal, Latitia; Semple, Stuart; Majolo, Bonaventura; MacLarnon, Ann			Assessing the Effects of Tourist Provisioning on the Health of Wild Barbary Macaques in Morocco	PLOS ONE			English	Article							PREDICT SURVIVAL PROBABILITIES; PHYSIOLOGICAL STRESS LEVELS; MACACA-SYLVANUS; COAT CONDITION; BODY-SIZE; BEHAVIOR; RHESUS; GORILLAS; ALOPECIA; JAPANESE	Feeding wildlife is a very popular tourist activity, largely because it facilitates the close observation of animals in their natural habitat. Such provisioning may benefit animals by improving their survival and reproductive success, especially during periods of natural food shortage. However, provisioning by tourists may also have negative impacts on the health of the animals involved; to date such impacts are poorly understood. Here, we investigated the effects of tourist provisioning on the health of wild adult Barbary macaques, Macaca sylvanus, in Morocco. We compared health measures between a heavily provisioned group and a group that received negligible food from tourists and, in the former group, we also assessed health measures in relation to the intensity of provisioning. We used a broad range of non-invasive health measures relating to birth rate and survival, disease and injury risk, body size and condition, and physiological stress. Our findings indicate that feeding by tourists may overall have negative impacts on the health of Barbary macaques, being linked in particular to larger body size, elevated stress levels and more alopecia. Finally, we propose a framework to help consider the potential costs and benefits of provisioning, which may facilitate future research and management decisions on whether-and how much-provisioning is acceptable.	[Marechal, Latitia; Semple, Stuart; MacLarnon, Ann] Univ Roehampton, Dept Life Sci, London, England; [Marechal, Latitia; Majolo, Bonaventura] Lincoln Univ, Sch Psychol, Lincoln, England	Roehampton University; University of Lincoln	Marechal, L (corresponding author), Univ Roehampton, Dept Life Sci, London, England.; Marechal, L (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	lmarechal@lincoln.ac.uk	Marechal, Laetitia/U-8364-2019	Semple, Stuart/0000-0003-0452-8104; Marechal, Laetitia/0000-0003-3499-9134; Majolo, Bonaventura/0000-0002-0235-3040; MacLarnon, Ann/0000-0003-2722-4998	University of Roehampton; International Primatological Society; Santander	University of Roehampton; International Primatological Society; Santander	This research was supported by a student bursary from the University of Roehampton. Equipment for this study was provided by the University of Roehampton and the University of Lincoln. Additional research funds were provided by the University of Roehampton, the International Primatological Society, and Santander. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amo L, 2006, BIOL CONSERV, V131, P402, DOI 10.1016/j.biocon.2006.02.015; [Anonymous], 2012, CONS ACT PLAN BARB M; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2010, LANGUAGER DATA SETS; Ballantyne R, 2009, TOURISM MANAGE, V30, P658, DOI 10.1016/j.tourman.2008.11.003; Bates D. M., 2010, LME4 MIXED EFFECTS M; Beehner JC, 2006, HORM BEHAV, V49, P688, DOI 10.1016/j.yhbeh.2005.12.016; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borg C, 2014, ANTHROZOOS, V27, P49, DOI 10.2752/175303714X13837396326378; Breuer T, 2007, AM J PHYS ANTHROPOL, V134, P369, DOI 10.1002/ajpa.20678; BUTYNSKI TM, 2008, IUCN 2010 IUCN RED L; Cabezas S, 2007, HORM BEHAV, V51, P313, DOI 10.1016/j.yhbeh.2006.11.004; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Cristobal-Azkarate J, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0168; Cunningham-Smith Petra, 2006, Aquatic Mammals, V32, P346, DOI 10.1578/AM.32.3.2006.346; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; Dubois Sara, 2013, Animals, V3, P978, DOI 10.3390/ani3040978; Fa JE, 1984, BARBARY MACAQUES CAS; Field A., 2012, DISCOVERING STAT USI; Foroughirad V, 2013, BIOL CONSERV, V160, P242, DOI 10.1016/j.biocon.2013.01.001; Fowler GS, 1999, BIOL CONSERV, V90, P143, DOI 10.1016/S0006-3207(99)00026-9; Fox J., 2014, R COMPANION APPL REG; Fuentes A, 2006, AM J PRIMATOL, V68, P880, DOI 10.1002/ajp.20295; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Hamada Y, 1996, ANTHROPOL SCI, V104, P305, DOI 10.1537/ase.104.305; Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222; Heistermann M, 2010, ADV SCI RES, V5, P1, DOI DOI 10.5194/asr-5-1-2010; Higginbottom Karen, 2004, P99; Hill DA, 1999, PRIMATES, V40, P187, DOI 10.1007/BF02557710; Hodges J. Keith, 2003, P282; Hoffman CL, 2011, PHYSIOL BEHAV, V104, P507, DOI 10.1016/j.physbeh.2011.05.021; Honess PE, 2005, ATLA-ALTERN LAB ANIM, V33, P193, DOI 10.1177/026119290503300308; Hsu MJ, 2009, AM J PRIMATOL, V71, P214, DOI 10.1002/ajp.20638; JOLICOEUR PIERRE, 1960, GROWTH, V24, P339; Jolly A, 2009, AM J PRIMATOL, V71, P191, DOI 10.1002/ajp.20647; Jungheim E., 2015, OBESITY FERTILITY; Khan M.J., 2012, AFR J BIOTECHNOL, V11, P13761, DOI [10.5897/AJBX11.064, DOI 10.5897/AJBX11.064]; Knapp CR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot032; Knight J, 2011, HUM ANIM STUD, V10, P1, DOI 10.1163/ej.9789004187931.i-629; Kurita H., 2014, PRIMATE TOURISM TOOL, P44, DOI [10.1017/CBO9781139087407.005, DOI 10.1017/CBO9781139087407.005]; Kurita H, 2012, PRIMATES, V53, P7, DOI 10.1007/s10329-011-0280-4; Majolo B., 2013, MACAQUE CONNECTION C, P167, DOI [10.1007/978-1-4614-3967-7_11, DOI 10.1007/978-1-4614-3967-7_11]; Majolo B, 2013, INT J PRIMATOL, V34, P500, DOI 10.1007/s10764-013-9678-8; Maljkovic A, 2011, BIOL CONSERV, V144, P859, DOI 10.1016/j.biocon.2010.11.019; Marechal L., 2015, THESIS U ROEHAMPTON; Marechal L, 2011, BIOL CONSERV, V144, P2188, DOI 10.1016/j.biocon.2011.05.010; Marsh KA, 1999, WALTHAM FOCUS, V9, P31; McFarland R, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0428; Menard N, 2002, EVOL ANTHROPOL, V11, P95, DOI 10.1002/evan.10067; Menard N, 1997, AM J PRIMATOL, V43, P285; Mohle U, 2005, AM J PRIMATOL, V66, P351, DOI 10.1002/ajp.20161; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Mouna M., 2006, P239; Muehlenbein M, 2014, PRIMATE TOURISM TOOL, P278, DOI DOI 10.1017/CBO9781139087407.021; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Novak MA, 2009, COMPARATIVE MED, V59, P18; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Packer, 2013, INT HDB ECOTOURISM, P520; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Perez CE, 2005, UPPER ROCK NATURE RE, P297; Alves LCPD, 2013, ACTA ETHOL, V16, P9, DOI 10.1007/s10211-012-0132-2; Pride RE, 2005, BIOL LETT-UK, V1, P60, DOI 10.1098/rsbl.2004.0245; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ram S, 2003, CURR SCI INDIA, V84, P780; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Rohlf F. J., 2010, MORPHOMETRICS SUNY S; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Sapolsky RM., 2014, PRIMATE TOURISM TOOL, P147; Semeniuk CAD, 2008, MAR ECOL PROG SER, V357, P271, DOI 10.3354/meps07299; Semeniuk CAD, 2009, BIOL CONSERV, V142, P1818, DOI 10.1016/j.biocon.2009.03.022; Shutt K, 2014, BIOL CONSERV, V172, P72, DOI 10.1016/j.biocon.2014.02.014; SOUTHWICK CH, 1967, BEHAVIOUR, V28, P182, DOI 10.1163/156853967X00235; Steinmetz HW, 2006, J MED PRIMATOL, V35, P3, DOI 10.1111/j.1600-0684.2005.00141.x; Thierry B., 2006, P29; TREGEAR RT, 1965, J APPL PHYSIOL, V20, P796, DOI 10.1152/jappl.1965.20.4.796; Usui Rie, 2014, Animals, V4, P546, DOI 10.3390/ani4030546; van Lavieren E, 2010, ORYX, V44, P133, DOI 10.1017/S0030605309990172; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Young C, 2013, HORM BEHAV, V63, P32, DOI 10.1016/j.yhbeh.2012.11.004; Zhang P, 2011, CURR ZOOL, V57, P26, DOI 10.1093/czoolo/57.1.26; ZHAO QK, 1992, FOLIA PRIMATOL, V58, P24, DOI 10.1159/000156603	88	34	34	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155920	10.1371/journal.pone.0155920	http://dx.doi.org/10.1371/journal.pone.0155920			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203861	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000376291500031
J	Cao, C; Vasilatos, SN; Bhargava, R; Fine, JL; Oesterreich, S; Davidson, NE; Huang, Y				Cao, C.; Vasilatos, S. N.; Bhargava, R.; Fine, J. L.; Oesterreich, S.; Davidson, N. E.; Huang, Y.			Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression	ONCOGENE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-II TRIAL; COLORECTAL-CANCER; STABILIZES LSD1; SILENCED GENES; CELLS; VORINOSTAT; INHIBITORS; USP28; DIFFERENTIATION	We have previously demonstrated that crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases (HDACs) facilitates breast cancer proliferation. However, the underlying mechanisms are largely unknown. Here, we report that expression of HDAC5 and LSD1 proteins were positively correlated in human breast cancer cell lines and tissue specimens of primary breast tumors. Protein expression of HDAC5 and LSD1 was significantly increased in primary breast cancer specimens in comparison with matched-normal adjacent tissues. Using HDAC5 deletion mutants and co-immunoprecipitation studies, we showed that HDAC5 physically interacted with the LSD1 complex through its domain containing nuclear localization sequence and phosphorylation sites. Although the in vitro acetylation assays revealed that HDAC5 decreased LSD1 protein acetylation, small interfering RNA (siRNA)-mediated HDAC5 knockdown did not alter the acetylation level of LSD1 in MDA-MB-231 cells. Overexpression of HDAC5 stabilized LSD1 protein and decreased the nuclear level of H3K4me1/me2 in MDA-MB-231 cells, whereas loss of HDAC5 by siRNA diminished LSD1 protein stability and demethylation activity. We further demonstrated that HDAC5 promoted the protein stability of USP28, a bona fide deubiquitinase of LSD1. Overexpression of USP28 largely reversed HDAC5-KD-induced LSD1 protein degradation, suggesting a role of HDAC5 as a positive regulator of LSD1 through upregulation of USP28 protein. Depletion of HDAC5 by shRNA hindered cellular proliferation, induced G1 cell cycle arrest, and attenuated migration and colony formation of breast cancer cells. A rescue study showed that increased growth of MDA-MB-231 cells by HDAC5 overexpression was reversed by concurrent LSD1 depletion, indicating that tumor-promoting activity of HDAC5 is an LSD1 dependent function. Moreover, overexpression of HDAC5 accelerated cellular proliferation and promoted acridine mutagen ICR191-induced transformation of MCF10A cells. Taken together, these results suggest that HDAC5 is critical in regulating LSD1 protein stability through post-translational modification, and the HDAC5-LSD1 axis has an important role in promoting breast cancer development and progression.	[Cao, C.; Vasilatos, S. N.; Bhargava, R.; Fine, J. L.; Oesterreich, S.; Davidson, N. E.; Huang, Y.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Cao, C.; Oesterreich, S.; Davidson, N. E.; Huang, Y.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Cao, C.; Vasilatos, S. N.; Bhargava, R.; Oesterreich, S.; Davidson, N. E.; Huang, Y.] Univ Pittsburgh, Womens Canc Res Ctr, Pittsburgh, PA USA; [Bhargava, R.; Fine, J. L.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huang, Y (corresponding author), Magee Womens Res Inst, Room 406,204 Craft Ave, Pittsburgh, PA 15213 USA.	yih26@pitt.edu	Huang, Yi/AAW-7892-2021; Cao, Chunyu/J-8622-2018; Fine, Jeffrey/H-6175-2013	Huang, Yi/0000-0002-9982-117X; Cao, Chunyu/0000-0003-3043-5673; Fine, Jeffrey/0000-0002-2678-8014	US Army Breast Cancer Research Program [W81XWH-14-1-0237, W81XWH-14-1-0238]; Breast Cancer Research Foundation; UPCI Genomics Core Facility - NCI [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	US Army Breast Cancer Research Program(United States Department of Defense); Breast Cancer Research Foundation; UPCI Genomics Core Facility - NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by US Army Breast Cancer Research Program (W81XWH-14-1-0237 to YH; W81XWH-14-1-0238 to NED), Breast Cancer Research Foundation (to NED and SO) and UPCI Genomics Core Facility supported by NCI P30CA047904.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Blumenschein GR, 2008, INVEST NEW DRUG, V26, P81, DOI 10.1007/s10637-007-9075-2; Chen WD, 2000, J NATL CANCER I, V92, P480, DOI 10.1093/jnci/92.6.480; Diefenbacher ME, 2014, J CLIN INVEST, V124, P3407, DOI 10.1172/JCI73733; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Han X, 2014, MOL CELL, V55, P482, DOI 10.1016/j.molcel.2014.06.006; He P, 2015, INT J CLIN EXP MED, V8, P6510; Huang Y, 2003, CLIN CANCER RES, V9, P2769; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Huang Y, 2006, J BIOL CHEM, V281, P19055, DOI 10.1074/jbc.M600910200; Huang Y, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2925; Huang Y, 2012, BREAST CANCER RES TR, V131, P777, DOI 10.1007/s10549-011-1480-8; Huang Y, 2009, ESSAYS BIOCHEM, V46, P95, DOI [10.1042/BSE0460007, 10.1042/bse0460007]; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Katz TA, 2014, BREAST CANCER RES TR, V146, P99, DOI 10.1007/s10549-014-3012-9; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Nagasawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118002; Nowotarski SL, 2015, BIOORGAN MED CHEM, V23, P1601, DOI 10.1016/j.bmc.2015.01.049; Piao L, 2015, ONCOTARGET, V6, P16939, DOI 10.18632/oncotarget.4760; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sen N, 2013, MOL CELL, V52, P406, DOI 10.1016/j.molcel.2013.09.003; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shaw PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076220; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Traynor AM, 2009, J THORAC ONCOL, V4, P522, DOI 10.1097/JTO.0b013e3181952478; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vasilatos SN, 2013, CARCINOGENESIS, V34, P1196, DOI 10.1093/carcin/bgt033; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhu QS, 2012, AMINO ACIDS, V42, P887, DOI 10.1007/s00726-011-1004-1; Zientek-Targosz H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-51	47	57	67	4	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					133	145		10.1038/onc.2016.186	http://dx.doi.org/10.1038/onc.2016.186			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27212032	Green Accepted			2022-12-26	WOS:000394069100012
J	Rebbeck, RT; Nitu, FR; Rohde, D; Most, P; Bers, DM; Thomas, DD; Cornea, RL				Rebbeck, Robyn T.; Nitu, Florentin R.; Rohde, David; Most, Patrick; Bers, Donald M.; Thomas, David D.; Cornea, Razvan L.			S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor center dot Calmodulin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM CA2+ RELEASE; TIME-RESOLVED FRET; HEART-FAILURE; SKELETAL; SITE; INHIBITION; MODULATION; ACTIVATION; LOCATIONS; INCREASES	S100A1 has been suggested as a therapeutic agent to enhance myocyte Ca2+ cycling in heart failure, but its molecular mode of action is poorly understood. Using FRET, we tested the hypothesis that S100A1 directly competes with calmodulin (CaM) for binding to intact, functional ryanodine receptors type I (RyR1) and II (RyR2) from skeletal and cardiac muscle, respectively. Our FRET readout provides an index of acceptor-labeled CaM binding near donor-labeled FKBP (FK506-binding protein 12.6) on the cytoplasmic domain of RyR in isolated sarcoplasmic reticulum vesicles. S100A1 (0.01-400 mu M) partially inhibited FRET (i.e. CaM binding), with K-i > 10 mu M, for both RyR1 and RyR2. The high [S100A1] required for partial effects on FRET indicates a lack of competition by S100A1 on CaM/RyR binding under normal physiological conditions. High-resolution analysis of time-resolved FRET detects two structural states of RyR-bound CaM, which respond to [Ca2+] and are isoform-specific. The distribution of these structural states was perturbed only by high micromolar [S100A1], which promoted a shift of bound CaM to a lower FRET orientation (without altering the amount of CaM bound to RyR). Thus, high micromolar S100A1 does alter the CaM/RyR interaction, without involving competition. Nevertheless, submicromolar S100A1 can alter RyR function, an effect that is influenced by both [Ca2+] and [CaM]. We conclude that CaM and S100A1 can concurrently bind to and functionally modulate RyR1 and RyR2, but this does not involve direct competition at the RyR CaM binding site.	[Rebbeck, Robyn T.; Nitu, Florentin R.; Thomas, David D.; Cornea, Razvan L.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St, Minneapolis, MN 55455 USA; [Rohde, David; Most, Patrick] Heidelberg Univ, Dept Internal Med 3, Ctr Mol & Translat Cardiol, INF 410, D-69120 Heidelberg, Germany; [Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; Ruprecht Karls University Heidelberg; University of California System; University of California Davis	Cornea, RL (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St, Minneapolis, MN 55455 USA.	corne002@umn.edu		Cornea, Razvan/0000-0001-5739-0992; Nitu, Florentin/0000-0001-9768-6333; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R01HL092097, R01GM027906, T32HL069764]; American Heart Association [14POST20310024, 15GRNT25610022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092097, R01HL030077, T32HL069764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants R01HL092097 (to R. L. C. and D. M. B.), R01GM027906 (to D. D. T.), and T32HL069764 (to F. R. N.) and American Heart Association Grants 14POST20310024 (to R. T. R.) and 15GRNT25610022 (to R. L. C.). P. M. holds patents on the therapeutic use of S100A1 in cardiovascular diseases. P. M. is a shareholder of UniQure N.K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bers DM, 2011, AM J PHYSIOL-CELL PH, V300, pC974, DOI 10.1152/ajpcell.00051.2011; Bolewska K, 1997, ACTA BIOCHIM POL, V44, P275; Brinks H, 2011, J AM COLL CARDIOL, V58, P966, DOI 10.1016/j.jacc.2011.03.054; BURATTI R, 1995, BIOCHEM BIOPH RES CO, V213, P1082, DOI 10.1006/bbrc.1995.2238; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; Ehlermann P, 2000, J CHROMATOGR B, V737, P39, DOI 10.1016/S0378-4347(99)00366-7; Fruen BR, 2000, AM J PHYSIOL-CELL PH, V279, pC724, DOI 10.1152/ajpcell.2000.279.3.C724; Fruen BR, 2005, BIOCHEMISTRY-US, V44, P278, DOI 10.1021/bi048246u; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Guhathakurta P, 2015, P NATL ACAD SCI USA, V112, P4660, DOI 10.1073/pnas.1420101112; Guo T, 2011, BIOPHYS J, V101, P2170, DOI 10.1016/j.bpj.2011.09.030; Huang XJ, 2012, J BIOL CHEM, V287, P30328, DOI 10.1074/jbc.M112.383109; Kettlewell S, 2005, J MOL CELL CARDIOL, V39, P900, DOI 10.1016/j.yjmcc.2005.06.018; Maier LS, 2006, J MOL CELL CARDIOL, V41, P451, DOI 10.1016/j.yjmcc.2006.04.020; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; PEDROCCHI M, 1993, BIOCHEM BIOPH RES CO, V197, P529, DOI 10.1006/bbrc.1993.2511; Pleger ST, 2006, EUR J MED RES, V11, P418; Pleger ST, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002097; Prosser BL, 2008, J BIOL CHEM, V283, P5046, DOI 10.1074/jbc.M709231200; Remppis A, 2002, BASIC RES CARDIOL S1, V97, P56; Ritterhoff J, 2015, MOL THER, V23, P1320, DOI 10.1038/mt.2015.93; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Svensson B, 2014, BIOPHYS J, V107, P2037, DOI 10.1016/j.bpj.2014.09.029; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Volkers M, 2007, CELL CALCIUM, V41, P135, DOI 10.1016/j.ceca.2006.06.001; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Xu L, 2004, BIOPHYS J, V86, P797, DOI 10.1016/S0006-3495(04)74155-7; Yamaguchi N, 2013, AM J PHYSIOL-HEART C, V305, pH86, DOI 10.1152/ajpheart.00144.2013; Yamaguchi N, 2011, AM J PHYSIOL-CELL PH, V300, pC998, DOI 10.1152/ajpcell.00370.2010; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002	42	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15896	15907		10.1074/jbc.M115.713107	http://dx.doi.org/10.1074/jbc.M115.713107			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226555	hybrid, Green Published			2022-12-26	WOS:000380584200040
J	Zhang, Z; Costa, FC; Tan, EP; Bushue, N; DiTacchio, L; Costello, CE; McComb, ME; Whelan, SA; Peterson, KR; Slawson, C				Zhang, Zhen; Costa, Flavia C.; Ee Phie Tan; Bushue, Nathan; DiTacchio, Luciano; Costello, Catherine E.; McComb, Mark E.; Whelan, Stephen A.; Peterson, Kenneth R.; Slawson, Chad			O-Linked N-Acetylglucosamine (O-GicNAc) Transferase and O-GicNAcase Interact with Mi2 beta Protein at the (A)gamma-Globin Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT ERYTHROID-CELLS; LOCUS-CONTROL REGIONS; RNA-POLYMERASE-II; GLCNAC TRANSFERASE; GENE-EXPRESSION; GLOBIN GENE; EPIGENETIC REGULATION; CHRONIC DISEASE; HISTONE CODE; GLCNACYLATION	One mode of gamma-globin gene silencing involves a GATA-1.FOG-1.Mi2 beta repressor complex that binds to the - 566 GATA site relative to the (A)gamma-globin gene cap site, However, the mechanism of how this repressor complex is assembled at the 566 GATA site is unknown. In this study, we demonstrate that the O-linked N-acetylglucosamine (O-GleNAc) processing enzymes, O-GlcNAc-transferase (OGT) and O-GIcNAcase (OGA), interact with the (A)gamma-globin promoter at the 566 GATA repressor site; however, mutation of the GATA site to GAGA significantly reduces OGT and OGA promoter interactions in /3-globin locus yeast artificial chromosome ((3-YAC) bone marrow cells. When WT (1-YAC bone marrow cells are treated with the OGA inhibitor Thiamet-G, the occupancy of OGT, OGA, and Mi2 beta at the (A)gamma-globin promoter is increased. In addition, OGT and Mi2 beta recruitment is increased at the (A)gamma-globin promoter when beta-globin becomes repressed in postconception day E18 human beta-YAC transgenic mouse fetal liver. Furthermore, we show that Mi2 beta is modified with O-GlcNAc, and both OGT and OGA interact with Mi2 beta, GATA-1, and FOG-1. Taken together, our data suggest that O-GlcNAcylation is a novel mechanism of gamma-globin gene regulation mediated by modulating the assembly of the GATA-1-FOG-1.Mi2 beta repressor complex at the 566 GATA motif within the promoter.	[Zhang, Zhen; Ee Phie Tan; Bushue, Nathan; Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Peterson, Kenneth R.] Univ Kansas, Med Ctr, Anat & Cell Biol, Kansas City, KS 66160 USA; [DiTacchio, Luciano] Univ Kansas, Med Ctr, Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA; [Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Slawson, Chad] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Kansas City, KS 66160 USA; [Costello, Catherine E.; McComb, Mark E.; Whelan, Stephen A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Costello, Catherine E.; McComb, Mark E.; Whelan, Stephen A.] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA; [Costa, Flavia C.] IntelligeneDx Canc Genom, Olathe, KS 66061 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Boston University; Boston University	Peterson, KR; Slawson, C (corresponding author), Univ Kansas, Med Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	kpeterson@kumc.edu; cslawson@kumc.edu	Tan, Ee Phie/AAC-8378-2021	/0000-0002-4249-485X; Costello, Catherine/0000-0003-1594-5122; Whelan, Stephen A/0000-0002-5439-6501	NIGMS from National Institutes of Health [P20GM104936, P41 GM104603]; NIDDK from National Institutes of Health [R01 DK100595]; NHLBI from National Institutes of Health [RO1HL111264, HHSN268201000031C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, P41GM104603] Funding Source: NIH RePORTER	NIGMS from National Institutes of Health; NIDDK from National Institutes of Health; NHLBI from National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an institutional development award from the NIGMS under Grant P20GM104936 and NIDDK Grant R01 DK100595 (to C. S. and K. R. P.), NHLBI Grant RO1HL111264 (to K. R. P.), and NHLBI Contract HHSN268201000031C and NIGMS Grant P41 GM104603 (to C. E. C.) all from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akan I, 2016, J BIOL CHEM, V291, P9906, DOI 10.1074/jbc.M115.704783; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Bauer DE, 2011, CURR OPIN PEDIATR, V23, P1, DOI 10.1097/MOP.0b013e3283420fd0; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; CIOE L, 1981, CANCER RES, V41, P237; Costa FC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003155; Dehennaut V, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00155; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Ginder GD, 2015, TRANSL RES, V165, P115, DOI 10.1016/j.trsl.2014.05.002; Gladwin MT, 2012, J AM COLL CARDIOL, V59, P1123, DOI 10.1016/j.jacc.2011.10.900; Harju-Baker S, 2008, MOL CELL BIOL, V28, P3101, DOI 10.1128/MCB.01858-07; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Lanza C, 2016, CELL CYCLE, V15, P1363, DOI 10.1080/15384101.2016.1167297; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; Peterson KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107006; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sankaran VG, 2011, HEMATOL-AM SOC HEMAT, P459, DOI 10.1182/asheducation-2011.1.459; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Verduzco LA, 2009, BLOOD, V114, P5117, DOI 10.1182/blood-2009-05-220921; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	55	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15628	15640		10.1074/jbc.M116.721928	http://dx.doi.org/10.1074/jbc.M116.721928			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231347	hybrid, Green Published			2022-12-26	WOS:000380584200018
J	Sato, W; Hitaoka, S; Inoue, K; Imai, M; Saio, T; Uchida, T; Shinzawa-Itoh, K; Yoshikawa, S; Yoshizawa, K; Ishimori, K				Sato, Wataru; Hitaoka, Seiji; Inoue, Kaoru; Imai, Mizue; Saio, Tomohide; Uchida, Takeshi; Shinzawa-Itoh, Kyoko; Yoshikawa, Shinya; Yoshizawa, Kazunari; Ishimori, Koichiro			Energetic Mechanism of Cytochrome c-Cytochrome c Oxidase Electron Transfer Complex Formation under Turnover Conditions Revealed by Mutational Effects and Docking Simulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; PARACOCCUS-DENITRIFICANS; SHAPE COMPLEMENTARITY; FERROCYTOCHROME-C; FREE-ENERGIES; BINDING SITE; ELECTROSTATICS; MOLECULES; OXIDATION; DYNAMICS	Based on the mutational effects on the steady-state kinetics of the electron transfer reaction and our NMR analysis of the interaction site (Sakamoto, K., Kamiya, M., Imai, M., Shinzawa-Itoh, K., Uchida, T., Kawano, K., Yoshikawa, S., and Ishimori, K. (2011) Proc. Natl. Acad. Sci. U.S.A. 108, 1227112276), we determined the structure of the electron transfer complex between cytochrome c (Cyt c) and cytochrome c oxidase (CcO) under turnover conditions and energetically characterized the interactions essential for complex formation. The complex structures predicted by the protein docking simulation were computationally selected and validated by the experimental kinetic data for mutant Cyt c in the electron transfer reaction to CcO. The interaction analysis using the selected Cyt c-CcO complex structure revealed the electrostatic and hydrophobic contributions of each amino acid residue to the free energy required for complex formation. Several charged residues showed large unfavorable (desolvation) electrostatic interactions that were almost cancelled out by large favorable (Columbic) electrostatic interactions but resulted in the destabilization of the complex. The residual destabilizing free energy is compensated by the van der Waals interactions mediated by hydrophobic amino acid residues to give the stabilized complex. Thus, hydrophobic interactions are the primary factors that promote complex formation between Cyt c and CcO under turnover conditions, whereas the change in the electrostatic destabilization free energy provides the variance of the binding free energy in the mutants. The distribution of favorable and unfavorable electrostatic interactions in the interaction site determines the orientation of the binding of Cyt c on CcO.	[Sato, Wataru; Imai, Mizue; Saio, Tomohide; Uchida, Takeshi; Ishimori, Koichiro] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Hitaoka, Seiji; Yoshizawa, Kazunari] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8190315, Japan; [Inoue, Kaoru] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; [Saio, Tomohide; Uchida, Takeshi; Ishimori, Koichiro] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan; [Shinzawa-Itoh, Kyoko; Yoshikawa, Shinya] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan	Hokkaido University; Kyushu University; Hokkaido University; Hokkaido University; University of Hyogo	Ishimori, K (corresponding author), Hokkaido Univ, Fac Sci, Dept Chem, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	koichiro@sci.hokudai.ac.jp	Ishimori, Koichiro/S-1247-2016; Uchida, Takeshi/A-6455-2017; Ishimori, Koichiro/AAQ-4434-2021	Ishimori, Koichiro/0000-0002-5868-0462; Uchida, Takeshi/0000-0001-9270-8329; Ishimori, Koichiro/0000-0002-5868-0462; Saio, Tomohide/0000-0003-3639-7399	Japan Society for the Promotion of Science [25288072, 25109501, 26234567, 24109014, 15K13710]; Global Center of Excellence Program; Targeted Protein Research Program; CREST from Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Grants-in-Aid for Scientific Research [26291033] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Protein Research Program; CREST from Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 25288072 and 25109501 (to K. I.), 26234567 (to S. Y.), and 24109014 and 15K13710 (to K. Y.) from the Japan Society for the Promotion of Science, the Global Center of Excellence Program, the Targeted Protein Research Program, CREST from Ministry of Education, Culture, Sports, Science and Technology (MEXT), and MEXT Projects of "Integrated Research on Chemical Synthesis" and "Elements Strategy Initiative to Form Core Research Center." The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1984, THESIS U CALIFORNIA; Autenrieth F, 2004, J COMPUT CHEM, V25, P1613, DOI 10.1002/jcc.20079; Banci L, 1999, J BIOL INORG CHEM, V4, P21, DOI 10.1007/s007750050285; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; BISSON R, 1980, BIOCHEMISTRY-US, V19, P4173, DOI 10.1021/bi00559a006; BRUNORI M, 1981, FEBS LETT, V126, P195, DOI 10.1016/0014-5793(81)80240-2; BRUNORI M, 1995, BIOCHIMIE, V77, P668, DOI 10.1016/0300-9084(96)88182-X; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Drosou V, 2002, EUR J BIOCHEM, V269, P2980, DOI 10.1046/j.1432-1033.2002.02979.x; FERGUSONMILLER S, 1978, J BIOL CHEM, V253, P149; Flock D, 2002, PROTEINS, V47, P75, DOI 10.1002/prot.10066; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Hitaoka S, 2013, J PESTIC SCI, V38, P60, DOI 10.1584/jpestics.D12-082; Hitaoka S, 2011, J CHEM INF MODEL, V51, P2706, DOI 10.1021/ci2002395; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Imai M, 2016, BIOCHEM BIOPH RES CO, V469, P978, DOI 10.1016/j.bbrc.2015.12.079; Jeng WY, 2002, J BIOENERG BIOMEMBR, V34, P423, DOI 10.1023/A:1022561924392; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MALMSTROM BG, 1979, BIOCHIM BIOPHYS ACTA, V549, P281; MARGOLIASH E., 1966, ADVANCE PROTEIN CHEM, V21, P113, DOI 10.1016/S0065-3233(08)60128-X; MICHEL B, 1989, BIOCHEMISTRY-US, V28, P244, DOI 10.1021/bi00427a034; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MINNAERT K, 1961, BIOCHIM BIOPHYS ACTA, V50, P23, DOI 10.1016/0006-3002(61)91055-1; Moore, 1987, CYTOCHROMES C BIOL A, P1, DOI 10.1007/978-3-642-72698-9_1; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PAPA S, 1982, J BIOENERG BIOMEMBR, V14, P69, DOI 10.1007/BF00745021; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Rajagopal BS, 2013, BIOCHEM J, V456, P441, DOI 10.1042/BJ20130758; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Sakamoto K, 2011, P NATL ACAD SCI USA, V108, P12271, DOI 10.1073/pnas.1108320108; Sakamoto K, 2010, BIOCHEM BIOPH RES CO, V398, P231, DOI 10.1016/j.bbrc.2010.06.065; Seifert A, 2006, PROTEINS, V64, P147, DOI 10.1002/prot.20951; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; SPECK SH, 1984, P NATL ACAD SCI-BIOL, V81, P347, DOI 10.1073/pnas.81.2.347; TAKANO T, 1973, J BIOL CHEM, V248, P5234; Tashiro M, 2005, J PHYS CHEM B, V109, P1015, DOI 10.1021/jp0462456; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Volkov AN, 2015, ACCOUNTS CHEM RES, V48, P3036, DOI 10.1021/acs.accounts.5b00343; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; WILSON MT, 1994, J BIOL CHEM, V269, P24114; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Witt H, 1998, EUR J BIOCHEM, V251, P367, DOI 10.1046/j.1432-1327.1998.2510367.x; Yoshida T, 2012, J PHYS CHEM B, V116, P10283, DOI 10.1021/jp305476x; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P395, DOI 10.1016/j.bbabio.2006.04.028; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a	60	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15320	15331		10.1074/jbc.M115.708065	http://dx.doi.org/10.1074/jbc.M115.708065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226541	Green Published, hybrid			2022-12-26	WOS:000380583200037
J	True, JD; Muldoon, JJ; Carver, MN; Poorey, K; Shetty, SJ; Bekiranov, S; Auble, DT				True, Jason D.; Muldoon, Joseph J.; Carver, Melissa N.; Poorey, Kunal; Shetty, Savera J.; Bekiranov, Stefan; Auble, David T.			The Modifier of Transcription 1 (Mott) ATPase and Spt16 Histone Chaperone Co-regulate Transcription through Preinitiation Complex Assembly and Nucleosome Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; YEAST SACCHAROMYCES-CEREVISIAE; INTEGRATIVE GENOMICS VIEWER; IN-VIVO; BASAL TRANSCRIPTION; GENE-EXPRESSION; TBP RECRUITMENT; DNA-BINDING; FACT	Modifier of transcription 1 (Mot1) is a conserved and essential Swi2/Snf2 ATPase that can remove TATA-binding protein (TBP) from DNA using ATP hydrolysis and in so doing exerts global effects on transcription. Sptl6 is also essential and functions globally in transcriptional regulation as a component of the facilitates chromatin transcription (FACT) histone chaperone complex. Here we demonstrate that Motl and Spt16 regulate a largely overlapping set of genes in Saccharotnyces cerevisiae. As expected, Motl was found to control TBP levels at co-regulated promoters. In contrast, Spt16 did not affect TBP recruitment. On a global scale, Spt16 was required for Mott promoter localization, and Motl also affected Spt16 localization to genes. Interestingly, we found that Motl has an unanticipated role in establishing or maintaining the occupancy and positioning of nucleosomes at the 5' ends of genes. Spt16 has a broad role in regulating chromatin organization in gene bodies, including those nucleosomes affected by Motl. These results suggest that the large scale overlap in Motl and Spt16 function arises from a combination of both their unique and shared functions in transcription complex assembly and chromatin structure regulation.	[True, Jason D.; Muldoon, Joseph J.; Carver, Melissa N.; Poorey, Kunal; Shetty, Savera J.; Bekiranov, Stefan; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	auble@virginia.edu			National Institutes of Health [GM55763, 5-T32-GM008136]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, R01GM055763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM55763 (to D. T. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Cell and Molecular Training Grant 5-T32-GM008136.	Adamkewicz JI, 2000, J BIOL CHEM, V275, P21158, DOI 10.1074/jbc.M002639200; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Andrau JC, 2002, EMBO J, V21, P5173, DOI 10.1093/emboj/cdf485; Arnett DR, 2008, MOL CELL PROTEOMICS, V7, P2090, DOI 10.1074/mcp.M800221-MCP200; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2006, GENETICS, V172, P837, DOI 10.1534/genetics.105.050245; Biswas D., 2005, MOL CELL BIOL, V25, P5812; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Collart MA, 1996, MOL CELL BIOL, V16, P6668; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Dasgupta A, 2005, EMBO J, V24, P1717, DOI 10.1038/sj.emboj.7600646; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; DAVIS JL, 1992, MOL CELL BIOL, V12, P1879, DOI 10.1128/MCB.12.4.1879; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Foltman M, 2013, CELL REP, V3, P892, DOI 10.1016/j.celrep.2013.02.028; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; GoldmanLevi R, 1996, NUCLEIC ACIDS RES, V24, P3121, DOI 10.1093/nar/24.16.3121; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Han JH, 2010, GENE DEV, V24, P1485, DOI 10.1101/gad.1887310; Helenius K, 2011, NUCLEIC ACIDS RES, V39, P5025, DOI 10.1093/nar/gkr107; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Jiang YW, 1996, GENE DEV, V10, P604, DOI 10.1101/gad.10.5.604; Kang SW, 2000, GENES CELLS, V5, P251, DOI 10.1046/j.1365-2443.2000.00323.x; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KARNITZ L, 1992, GENETICS, V132, P351; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Madison JM, 1997, MOL CELL BIOL, V17, P287, DOI 10.1128/MCB.17.1.287; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; PIATTI S, 1992, CHROMOSOMA, V102, pS107, DOI 10.1007/BF02451793; Poorey K, 2010, GENOME RES, V20, P1679, DOI 10.1101/gr.109504.110; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sprouse RO, 2009, J BIOL CHEM, V284, P4525, DOI 10.1074/jbc.M808951200; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TIMMERS HTM, 1992, P NATL ACAD SCI USA, V89, P8140, DOI 10.1073/pnas.89.17.8140; Topalidou I, 2004, EMBO J, V23, P1943, DOI 10.1038/sj.emboj.7600199; Tsunaka Y, 2016, GENE DEV, V30, P673, DOI 10.1101/gad.274183.115; van Bakel H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003479; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Venters BJ, 2011, MOL CELL BIOL, V31, P2253, DOI 10.1128/MCB.01464-10; Wal M, 2012, METHOD ENZYMOL, V513, P233, DOI 10.1016/B978-0-12-391938-0.00010-0; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101; Zentner GE, 2013, MOL CELL BIOL, V33, P4996, DOI 10.1128/MCB.01218-13; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003	82	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15307	15319		10.1074/jbc.M116.735134	http://dx.doi.org/10.1074/jbc.M116.735134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226635	hybrid, Green Published			2022-12-26	WOS:000380583200036
J	Abhyankar, VV; Wu, MY; Koh, CY; Hatch, AV				Abhyankar, Vinay V.; Wu, Meiye; Koh, Chung-Yan; Hatch, Anson V.			A Reversibly Sealed, Easy Access, Modular (SEAM) Microfluidic Architecture to Establish In Vitro Tissue Interfaces	PLOS ONE			English	Article							CELL-CULTURE; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; ORGANS; MEMBRANES; CHIP; MICROFABRICATION; INTEGRATION; ELASTICITY; ABSORPTION	Microfluidic barrier tissue models have emerged as advanced in vitro tools to explore interactions with external stimuli such as drug candidates, pathogens, or toxins. However, the procedures required to establish and maintain these systems can be challenging to implement for end users, particularly those without significant in-house engineering expertise. Here we present a module-based approach that provides an easy-to-use workflow to establish, maintain, and analyze microscale tissue constructs. Our approach begins with a removable culture insert that is magnetically coupled, decoupled, and transferred between standalone, prefabricated microfluidic modules for simplified cell seeding, culture, and downstream analysis. The modular approach allows several options for perfusion including standard syringe pumps or integration with a self-contained gravity-fed module for simple cell maintenance. As proof of concept, we establish a culture of primary human microvascular endothelial cells (HMVEC) and report combined surface protein imaging and gene expression after controlled apical stimulation with the bacterial endotoxin lipopolysaccharide (LPS). We also demonstrate the feasibility of incorporating hydrated biomaterial interfaces into the microfluidic architecture by integrating an ultra-thin (<1 mu m), self-assembled hyaluronic acid/peptide amphiphile culture membrane with brain-specific Young's modulus (similar to 1kPa). To highlight the importance of including biomimetic interfaces into microscale models we report multi-tiered readouts from primary rat cortical cells cultured on the self-assembled membrane and compare a panel of mRNA targets with primary brain tissue signatures. We anticipate that the modular approach and simplified operational workflows presented here will enable a wide range of research groups to incorporate microfluidic barrier tissue models into their work.	[Abhyankar, Vinay V.; Wu, Meiye; Koh, Chung-Yan; Hatch, Anson V.] Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94551 USA; [Abhyankar, Vinay V.] Univ Texas Arlington, Res Inst, Biol Microsyst, Ft Worth, TX 76118 USA	United States Department of Energy (DOE); Sandia National Laboratories; University of Texas System; University of Texas Arlington	Abhyankar, VV; Hatch, AV (corresponding author), Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94551 USA.; Abhyankar, VV (corresponding author), Univ Texas Arlington, Res Inst, Biol Microsyst, Ft Worth, TX 76118 USA.	vinay.abhyankar@gmail.com; ahatch@sandia.gov		Abhyankar, Vinay/0000-0002-8462-3920	Laboratory Directed Research and Development (LDRD) at Sandia National Laboratories; Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense (IAA) [DTRA 10027IA-3167]; NIAID [R01AI98853]; US Department of Energy [DE-AC04-94AL85000]	Laboratory Directed Research and Development (LDRD) at Sandia National Laboratories; Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense (IAA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy(United States Department of Energy (DOE))	This work was funded under Laboratory Directed Research and Development (LDRD) at Sandia National Laboratories and by the Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense (IAA number DTRA 10027IA-3167). CK was supported by NIAID grant R01AI98853. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sandia National Laboratories is a multi-program laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the US Department of Energy under contract DE-AC04-94AL85000. Illustrations contained vector art designed by Freepik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2015, LAB CHIP, V15, P882, DOI 10.1039/c4lc00999a; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097; Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002; Berry SM, 2014, INTEGR BIOL-UK, V6, P224, DOI 10.1039/c3ib40136g; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Carvajal D, 2010, SOFT MATTER, V6, P1816, DOI 10.1039/b923903k; Chosewood LC, 2009, BIOSAFETY MICROBIOLO; Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Domansky K, 2013, LAB CHIP, V13, P3956, DOI 10.1039/c3lc50558h; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Esch MB, 2015, LAB CHIP, V15, P2269, DOI 10.1039/c5lc00237k; Esch MB, 2014, ADV DRUG DELIVER REV, V69, P158, DOI 10.1016/j.addr.2013.12.003; Esch MB, 2012, BIOMED MICRODEVICES, V14, P895, DOI 10.1007/s10544-012-9669-0; Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303; Frohlich EM, 2013, LAB CHIP, V13, P2311, DOI 10.1039/c3lc50199j; Fuerstman MJ, 2007, LAB CHIP, V7, P1479, DOI 10.1039/b706549c; Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9; Geetha T, 2013, J BIOL CHEM; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; Hatch AV, 2006, ANAL CHEM, V78, P4976, DOI 10.1021/ac0600454; Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104; Hinsby AM, 2004, FRONT BIOSCI-LANDMRK, V9, P2227, DOI 10.2741/1393; Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Huynh J, 2013, CELL MOL BIOENG, V6, P138, DOI 10.1007/s12195-013-0278-7; Ismagilov RF, 2001, ANAL CHEM, V73, P5207, DOI 10.1021/ac010502a; Kang E, 2013, ADV MATER, V25, P2167, DOI 10.1002/adma.201204619; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin CC, 2010, JALA-J LAB AUTOM, V15, P253, DOI 10.1016/j.jala.2010.01.013; Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Miller JJ, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/1/015011; NAKAYAMA M, 1995, J NEUROSCI, V15, P5238; Nan L, 2014, LAB CHIP, V14, P1060, DOI 10.1039/c3lc51133b; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Reichen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052246; Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a; Temiz Y, 2015, MICROELECTRON ENG, V132, P156, DOI 10.1016/j.mee.2014.10.013; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Van Heirstraeten L, 2014, LAB CHIP, V14, P1519, DOI 10.1039/c3lc51339d; Verbist B, 2015, DRUG DISCOV TODAY, V20, P505, DOI 10.1016/j.drudis.2014.12.014; Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021; Wang JD, 2012, ANN BIOMED ENG, V40, P1862, DOI 10.1007/s10439-012-0562-z; Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x; Zhu XY, 2004, ANALYST, V129, P1026, DOI 10.1039/b407623k	65	23	24	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156341	10.1371/journal.pone.0156341	http://dx.doi.org/10.1371/journal.pone.0156341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227828	gold, Green Submitted, Green Published			2022-12-26	WOS:000376882500118
J	Al-Hadeethi, Y; Al-Jedani, S; Razvi, MAN; Saeed, A; Abdel-Daiem, AM; Ansari, MS; Babkair, SS; Salah, NA; Al-Mujtaba, A				Al-Hadeethi, Y.; Al-Jedani, S.; Razvi, M. A. N.; Saeed, A.; Abdel-Daiem, A. M.; Ansari, M. Shahnawaze; Babkair, Saeed S.; Salah, Numan A.; Al-Mujtaba, A.			Data Fitting to Study Ablated Hard Dental Tissues by Nanosecond Laser Irradiation	PLOS ONE			English	Article							CALCIUM; TEETH; PICOSECOND; THRESHOLD	Laser ablation of dental hard tissues is one of the most important laser applications in dentistry. Many works have reported the interaction of laser radiations with tooth material to optimize laser parameters such as wavelength, energy density, etc. This work has focused on determining the relationship between energy density and ablation thresholds using pulsed, 5 nanosecond, neodymium-doped yttrium aluminum garnet; Nd:Y3Al5O12 (Nd:YAG) laser at 1064 nanometer. For enamel and dentin tissues, the ablations have been performed using laser-induced breakdown spectroscopy (LIBS) technique. The ablation thresholds and relationship between energy densities and peak areas of calcium lines, which appeared in LIBS, were determined using data fitting. Furthermore, the morphological changes were studied using Scanning Electron Microscope (SEM). Moreover, the chemical stability of the tooth material after ablation has been studied using Energy-Dispersive X-Ray Spectroscopy (EDX). The differences between carbon atomic % of non-irradiated and irradiated samples were tested using statistical t-test. Results revealed that the best fitting between energy densities and peak areas of calcium lines were exponential and linear for enamel and dentin, respectively. In addition, the ablation threshold of Nd: YAG lasers in enamel was higher than that of dentin. The morphology of the surrounded ablated region of enamel showed thermal damages. For enamel, the EDX quantitative analysis showed that the atomic % of carbon increased significantly when laser energy density increased.	[Al-Hadeethi, Y.; Al-Jedani, S.; Razvi, M. A. N.; Saeed, A.; Abdel-Daiem, A. M.; Babkair, Saeed S.; Al-Mujtaba, A.] King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 21589, Saudi Arabia; [Al-Hadeethi, Y.] King Abdulaziz Univ, Lithog Devices Fabricat & Dev Res Grp, DSR, Jeddah 21589, Saudi Arabia; [Saeed, A.] Thamar Univ, Thamar, Yemen; [Abdel-Daiem, A. M.; Salah, Numan A.] Zagazig Univ, Fac Sci, Dept Phys, Zagazig, Egypt; [Ansari, M. Shahnawaze] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University; King Abdulaziz University	Saeed, A (corresponding author), King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 21589, Saudi Arabia.; Saeed, A (corresponding author), Thamar Univ, Thamar, Yemen.	Abdusaeed79@hotmail.com	Salah, Numan/I-3954-2012; Al-Hadeethi, Yas/N-7786-2019; Saeed, Abdu/N-6330-2015; Ansari, Mohammad Shahnawaze/Q-1395-2015; RAZVI, MIR ALI NAQI/D-5601-2013; Al-Hadeethi, Yas M/I-1712-2012	Salah, Numan/0000-0002-8233-7373; Al-Hadeethi, Yas/0000-0002-1350-9928; Saeed, Abdu/0000-0002-8506-7188; Ansari, Mohammad Shahnawaze/0000-0001-9082-1811; RAZVI, MIR ALI NAQI/0000-0003-2729-0813; Al-Hadeethi, Yas M/0000-0002-2284-1279	King Abdulaziz City of Science and Technology (KACST) [PS-35-266]	King Abdulaziz City of Science and Technology (KACST)	This work was supported financially by King Abdulaziz City of Science and Technology (KACST) under grant number PS-35-266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasim SA, 2006, INT ENDOD J, V39, P143, DOI 10.1111/j.1365-2591.2006.01058.x; Alrahabi M, 2015, J TAIBAH UNIV MED SC, V10, P50, DOI 10.1016/j.jtumed.2014.12.005; Alves S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/24/245401; Apel C, 2002, LASER MED SCI, V17, P246, DOI 10.1007/s101030200036; Arnold WH, 2007, ANN ANAT, V189, P183, DOI 10.1016/j.aanat.2006.09.008; Bello-Silva MS, 2013, LASER MED SCI, V28, P171, DOI 10.1007/s10103-012-1107-2; BRANNSTROM M, 1966, ORAL SURG ORAL MED O, V21, P517, DOI 10.1016/0030-4220(66)90411-7; Breschi L, 2003, AM J DENT, V16, P267; Chen H, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.2.028004; Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637; Cvetkovic M, 2011, PROG ELECTROMAGN RES, V120, P403, DOI 10.2528/PIER11080405; Daskalova A, 2010, APPL SURF SCI, V257, P1119, DOI 10.1016/j.apsusc.2010.08.037; Eason R., 2007, PULSED LASER DEPOSIT, P628, DOI [10.1002/0470052120, DOI 10.1002/9780470052129]; Frentzen M, 1990, Int Dent J, V40, P323; Gaudiuso R, 2010, SENSORS-BASEL, V10, P7434, DOI 10.3390/s100807434; GOLDMAN L, 1964, NATURE, V203, P417, DOI 10.1038/203417a0; Hamama HH, 2013, AUST DENT J, V58, P283, DOI 10.1111/adj.12093; James KA, 2010, ORAL DEV HISTOLOGY; Ji LF, 2012, LASER MED SCI, V27, P197, DOI 10.1007/s10103-011-0932-z; Kim BM, 2000, APPL PHYS LETT, V76, P4001, DOI 10.1063/1.126847; Kim KS, 2005, PHOTOMED LASER SURG, V23, P216, DOI 10.1089/pho.2005.23.216; Lin S, 2010, SCI RES ESSAYS, V5, P2128; Liu H.-Y., 2013, ADV ANTHR, V03, P71; Momma C, 1997, APPL SURF SCI, V109, P15, DOI 10.1016/S0169-4332(96)00613-7; Murray AK, 2000, PROC SPIE, V3914, P137, DOI 10.1117/12.388039; Murray MM, 1936, BIOCHEM J, V30, P1567, DOI 10.1042/bj0301567; Najeeb S, 2016, MED PRIN PRACT, V25, P201, DOI 10.1159/000443144; Nanci A, 2012, DEV STRUCTURE FUNCTI, V8; Neev J, 1996, IEEE J SEL TOP QUANT, V2, P790, DOI 10.1109/2944.577301; Niemz M. H., 2003, LASER TISSUE INTERAC; Ostertag M, 1997, LASER SURG MED, V21, P384, DOI 10.1002/(SICI)1096-9101(1997)21:4<384::AID-LSM10>3.0.CO;2-B; Poorni S, 2010, CONTEMP CLIN DENT, V1, P223, DOI 10.4103/0976-237X.76388; Quade A, 2010, THIN SOLID FILMS, V518, P4835, DOI 10.1016/j.tsf.2010.02.005; Radziemski LJ, 2000, LASERS INDUCED PLASM; Rode AV, 2002, J APPL PHYS, V92, P2153, DOI 10.1063/1.1495896; Rosalia C, 2012, STRUCTURAL CHANGES H; Rythen M, 2010, EUR J ORAL SCI, V118, P389, DOI 10.1111/j.1600-0722.2010.00755.x; Serafetinides AA, 1999, LASER MED SCI, V14, P168, DOI 10.1007/s101030050080; Sherwood IA, 2010, ESSENTIALS OPERATIVE; Siniaeva ML, 2009, LASER PHYS, V19, P1056, DOI 10.1134/S1054660X09050314; Stabholz Adam, 2003, Compend Contin Educ Dent, V24, P935; Toma S, 2012, THESIS U CALIFORNIA; Tuncdemir AR, 2013, J ADV PROSTHODONT, V5, P44, DOI 10.4047/jap.2013.5.1.44; Vorobyev AY, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3660579; Wang Z, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906447; WHITE JM, 1994, J DENT RES, V73, P1560, DOI 10.1177/00220345940730091201	46	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156093	10.1371/journal.pone.0156093	http://dx.doi.org/10.1371/journal.pone.0156093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228169	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500066
J	Finkel, ZV; Follows, MJ; Liefer, JD; Brown, CM; Benner, I; Irwin, AJ				Finkel, Zoe V.; Follows, Mick J.; Liefer, Justin D.; Brown, Chris M.; Benner, Ina; Irwin, Andrew J.			Phylogenetic Diversity in the Macromolecular Composition of Microalgae	PLOS ONE			English	Article							PROTEIN CONVERSION FACTORS; MARINE MICROALGAE; CELL-WALL; EVOLUTIONARY INHERITANCE; ELEMENTAL STOICHIOMETRY; INTRACELLULAR NITROGEN; CHEMICAL COMPOSITION; N-P; PHYTOPLANKTON; GROWTH	The elemental stoichiometry of microalgae reflects their underlying macromolecular composition and influences competitive interactions among species and their role in the food web and biogeochemistry. Here we provide a new estimate of the macromolecular composition of microalgae using a hierarchical Bayesian analysis of data compiled from the literature. The median macromolecular composition of nutrient-sufficient exponentially growing microalgae is 32.2% protein, 17.3% lipid, 15.0% carbohydrate, 17.3% ash, 5.7% RNA, 1.1% chlorophyll-a and 1.0% DNA as percent dry weight. Our analysis identifies significant phylogenetic differences in macromolecular composition undetected by previous studies due to small sample sizes and the large inherent variability in macromolecular pools. The phylogenetic differences in macromolecular composition lead to variations in carbon-tonitrogen ratios that are consistent with independent observations. These phylogenetic differences in macromolecular and elemental composition reflect adaptations in cellular architecture and biochemistry; specifically in the cell wall, the light harvesting apparatus, and storage pools.	[Finkel, Zoe V.; Liefer, Justin D.; Benner, Ina] Mt Allison Univ, Environm Sci Program, Sackville, NB E0A 3C0, Canada; [Follows, Mick J.] MIT, Dept Earth Atmosphere & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Brown, Chris M.] Mt Allison Univ, Dept Chem & Biochem, Sackville, NB E0A 3C0, Canada; [Irwin, Andrew J.] Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB E0A 3C0, Canada	Mount Allison University; Massachusetts Institute of Technology (MIT); Mount Allison University; Mount Allison University	Finkel, ZV (corresponding author), Mt Allison Univ, Environm Sci Program, Sackville, NB E0A 3C0, Canada.	zfinkel@mta.ca	Finkel, Zoe/B-9626-2008	Finkel, Zoe/0000-0003-4212-3917; Irwin, Andrew/0000-0001-7784-2319; Liefer, Justin/0000-0001-5161-940X	Gordon and Betty Moore Foundation [3778]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work is a product of Macromolecular models of Marine Microbes grant #3778 supported by the Gordon and Betty Moore Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TEXTS STAT SCI SERIE; BECKER B, 1994, PROTOPLASMA, V181, P233, DOI 10.1007/BF01666398; Becker B, 1998, J PHYCOL, V34, P779, DOI 10.1046/j.1529-8817.1998.340779.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRETT SJ, 1994, PROTOPLASMA, V181, P106, DOI 10.1007/BF01666391; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Brown MR, 1996, AQUACULTURE, V143, P341, DOI 10.1016/0044-8486(96)01286-0; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Daines SJ, 2014, ECOL LETT, V17, P414, DOI 10.1111/ele.12239; Davidson K, 1999, J PLANKTON RES, V21, P811, DOI 10.1093/plankt/21.5.811; DODGE JD, 1973, FINE STRUCTURE ALGAL; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; Flynn KJ, 2010, J PHYCOL, V46, P1, DOI 10.1111/j.1529-8817.2009.00756.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Jurgens U, 1985, FINE STRUCTURE CHEM, P41; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Laurens LML, 2012, ANAL CHEM, V84, P1879, DOI 10.1021/ac202668c; Loladze I, 2011, ECOL LETT, V14, P244, DOI 10.1111/j.1461-0248.2010.01577.x; Lourenco SO, 2004, EUR J PHYCOL, V39, P17, DOI 10.1080/0967026032000157156; Lourenco SO, 1998, J PHYCOL, V34, P798, DOI 10.1046/j.1529-8817.1998.340798.x; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; MYKLESTAD S, 1974, J EXP MAR BIOL ECOL, V15, P261, DOI 10.1016/0022-0981(74)90049-5; NORTHCOTE DH, 1958, BIOCHEM J, V70, P391, DOI 10.1042/bj0700391; Palmucci M, 2011, J PHYCOL, V47, P313, DOI 10.1111/j.1529-8817.2011.00963.x; Panagiotopoulos C, 2005, LIMNOL OCEANOGR-METH, V3, P419, DOI 10.4319/lom.2005.3.419; PARSONS TR, 1961, J FISH RES BOARD CAN, V18, P1001, DOI 10.1139/f61-063; Peramuna A, 2014, ARCH MICROBIOL, V196, P881, DOI 10.1007/s00203-014-1027-6; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; RAVEN JA, 1984, NEW PHYTOL, V98, P593, DOI 10.1111/j.1469-8137.1984.tb04152.x; Redfield A. C., 1934, P176; ROBERTS K, 1985, J CELL SCI, P105; SHUTER BJ, 1983, AM NAT, V122, P26, DOI 10.1086/284116; Smayda T. J., 1970, Oceanogr. mar. Biol., V8, P353; Stan Development Team, 2014, RSTAN R INT STAN; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strickland JDH, 1960, PRACTICAL HDB SEAWAT; Subramanian S, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-150; Talmy D, 2014, BIOGEOSCIENCES, V11, P4881, DOI 10.5194/bg-11-4881-2014; Tang EPY, 1996, J PHYCOL, V32, P80, DOI 10.1111/j.0022-3646.1996.00080.x; U.S. Department of Agriculture Agricultural Research Service, 2013, USDA NAT NUTR DAT ST; VanDonk E, 1997, LIMNOL OCEANOGR, V42, P357; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; Weber T, 2012, NATURE, V489, P419, DOI 10.1038/nature11357; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Wijffels RH, 2010, SCIENCE, P329; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818	55	100	100	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155977	10.1371/journal.pone.0155977	http://dx.doi.org/10.1371/journal.pone.0155977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228080	Green Published, Green Submitted, gold			2022-12-26	WOS:000376882500048
J	Lin, TY; Chen, KC; Liu, HJE; Liu, AJ; Wang, KL; Shih, CM				Lin, Tsung-Yao; Chen, Ku-Chung; Liu, Hsing-Jin Eugene; Liu, Ann-Jeng; Wang, Kun-Li; Shih, Chwen-Ming			MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE; C-ABL; NUCLEOCYTOPLASMIC TRANSPORT; LEPTOMYCIN-B; CML CELLS; APOPTOSIS; CANCER; MESYLATE; RECEPTOR	Chronic myeloid leukemia (CML) is a myeloproliferative disease. Imatinib (IM), the first line treatment for CML, is excessively expensive and induces various side effects in CML patients. Therefore, it is essential to investigate a new strategy for improving CML therapy. Our immunoblot data revealed that RanGTPase activating protein 1 (RanGAP1) protein levels increased by approximately 30-fold in K562 cells compared with those in normal cells. RanGAP1 is one of the important components of RanGTPase system, which regulates the export of nuclear protein. However, whether RanGAP1 level variation influences BCR-ABL nuclear export is still unknown. In this report, using shRNA to downregulate RanGAP1 expression level augmented K562 cell apoptosis by approximately 40% after treatment with 250 nM IM. Immunofluorescence assay also indicated that three-fold of nuclear BCR-ABL was detected. These data suggest that BCR-ABL nuclear entrapment induced by RanGAP1 downregulation can be used to improve IM efficacy. Moreover, our qRT-PCR data indicated a trend of inverse correlation between the RanGAP1 and microRNA (miR)-1301 levels in CML patients. MiR-1301, targeting the RanGAP1 30 untranslated region, decreased by approximately 100-fold in K562 cells compared with that in normal cells. RanGAP1 downregulation by miR-1301 transfection impairs BCR-ABL nuclear export to increase approximately 60% of cell death after treatment of 250 nM IM. This result was almost the same as treatment with 1000 nM IM alone. Furthermore, immunofluorescence assay demonstrated that Tyr-99 of nuclear P73 was phosphorylated accompanied with nuclear entrapment of BCR-ABL after transfection with RanGAP1 shRNA or miR-1301 in IM-treated K562 cells. Altogether, we demonstrated that RanGAP1 downregulation can mediate BCR-ABL nuclear entrapment to activate P73-dependent apoptosis pathway which is a novel strategy for improving current IM treatment for CML.	[Lin, Tsung-Yao; Chen, Ku-Chung; Shih, Chwen-Ming] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Tsung-Yao; Chen, Ku-Chung; Shih, Chwen-Ming] Taipei Med Univ, Dept Biochem & Mol Cell Biol, Coll Med, Taipei, Taiwan; [Liu, Hsing-Jin Eugene] Taipei Med Univ, Wan Fang Hosp, Div Hematol Oncol, Dept Med, Taipei, Taiwan; [Liu, Ann-Jeng] Taipei City Hosp, Dept Neurosurg, Ren Ai Branch, Taipei, Taiwan; [Wang, Kun-Li] Natl Taipei Univ Technol, Inst Chem Engn, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei City Hospital; National Taipei University of Technology	Shih, CM (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Shih, CM (corresponding author), Taipei Med Univ, Dept Biochem & Mol Cell Biol, Coll Med, Taipei, Taiwan.; Wang, KL (corresponding author), Natl Taipei Univ Technol, Inst Chem Engn, Taipei, Taiwan.	klwang@ntut.edu.tw; cmshih@tmu.edu.tw			Ministry of Science and Technology [MOST 104-2314-B-038-025]; Taipei City Government [104XDAA00078]; NTUT-TMU Joint Research Program [NTUT-TMU-102-03]; Taipei Medical University Aim for the Top University Project-Cancer Translational Center [TMUTOP103002-3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei City Government; NTUT-TMU Joint Research Program; Taipei Medical University Aim for the Top University Project-Cancer Translational Center	Support was provided by contract grant sponsor: Ministry of Science and Technology Contract grant number: MOST 104-2314-B-038-025 [https://www.most.gov.tw/] (Received author: Chwen-Ming Shih); contract grant sponsor: Taipei City Government Contract grant number: 104XDAA00078 [http://english.gov.taipei/] (Received author: Ann-Jeng Liu); contract grant sponsor: NTUT-TMU Joint Research Program Contract grant number: NTUT-TMU-102-03 [http://www.tmu.edu.tw/] (Received author: Chwen-Ming Shih); contract grant sponsor: Taipei Medical University Aim for the Top University Project-Cancer Translational Center, contract grant number: TMUTOP103002-3 [ http://www.tmu.edu.tw/] ( Received author: Chwen-Ming Shih). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; Allan EK, 2009, LEUKEMIA, V23, P1006, DOI 10.1038/leu.2008.367; Aloisi A, 2006, BLOOD, V107, P1591, DOI 10.1182/blood-2005-05-2123; Bayliss R, 2000, TRAFFIC, V1, P448, DOI 10.1034/j.1600-0854.2000.010602.x; Ben-Yehoyada M, 2003, J BIOL CHEM, V278, P34475, DOI 10.1074/jbc.M301051200; Bernardo PS, 2012, LEUKEMIA RES, V36, P1510, DOI 10.1016/j.leukres.2012.08.014; Chang KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079863; Cianfrocca R, 2008, CELL DEATH DIFFER, V15, P354, DOI 10.1038/sj.cdd.4402264; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; Flamant S, 2010, HAEMATOL-HEMATOL J, V95, P1325, DOI 10.3324/haematol.2009.020636; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0085-1; Hehlmann R, 2011, J CLIN ONCOL, V29, P1634, DOI 10.1200/JCO.2010.32.0598; Hershkovitz-Rokah O, 2015, CANCER LETT, V360, P245, DOI 10.1016/j.canlet.2015.02.031; Huang ZL, 2013, ONCOTARGET, V4, P2249, DOI 10.18632/oncotarget.1339; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Khorashad JS, 2015, BLOOD, V125, P1772, DOI 10.1182/blood-2014-08-588855; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Ozaki Toshinori, 2010, Int J Proteomics, V2010, P283863, DOI 10.1155/2010/283863; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pierce GL, 2009, CIRCULATION, V119, P1284, DOI 10.1161/CIRCULATIONAHA.108.804294; Preyer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017020; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tan YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111777; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	37	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156260	10.1371/journal.pone.0156260	http://dx.doi.org/10.1371/journal.pone.0156260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228340	Green Submitted, Green Published, gold			2022-12-26	WOS:000376882500096
J	Adam, CL; Gratz, SW; Peinado, DI; Thomson, LM; Garden, KE; Williams, PA; Richardson, AJ; Ross, AW				Adam, Clare L.; Gratz, Silvia W.; Peinado, Diana I.; Thomson, Lynn M.; Garden, Karen E.; Williams, Patricia A.; Richardson, Anthony J.; Ross, Alexander W.			Effects of Dietary Fibre (Pectin) and/or Increased Protein (Casein or Pea) on Satiety, Body Weight, Adiposity and Caecal Fermentation in High Fat Diet-Induced Obese Rats	PLOS ONE			English	Article							GUT MICROBIOTA; METABOLIC SYNDROME; FOOD-INTAKE; PEPTIDE YY; APPETITE; ENERGY; POLYSACCHARIDE; MECHANISMS; MORPHOLOGY; SATIATION	Dietary constituents that suppress appetite, such as dietary fibre and protein, may aid weight loss in obesity. The soluble fermentable dietary fibre pectin promotes satiety and decreases adiposity in diet-induced obese rats but effects of increased protein are unknown. Adult diet-induced obese rats reared on high fat diet (45% energy from fat) were given experimental diets ad libitum for 4 weeks (n = 8/group): high fat control, high fat with high protein (40% energy) as casein or pea protein, or these diets with added 10% w/w pectin. Dietary pectin, but not high protein, decreased food intake by 23% and induced 23% body fat loss, leading to 12% lower final body weight and 44% lower total body fat mass than controls. Plasma concentrations of satiety hormones PYY and total GLP-1 were increased by dietary pectin (168% and 151%, respectively) but not by high protein. Plasma leptin was decreased by 62% on pectin diets and 38% on high pea (but not casein) protein, while plasma insulin was decreased by 44% on pectin, 38% on high pea and 18% on high casein protein diets. Caecal weight and short-chain fatty acid concentrations in the caecum were increased in pectin-fed and high pea protein groups: caecal succinate was increased by pectin (900%), acetate and propionate by pectin (123% and 118%, respectively) and pea protein (147% and 144%, respectively), and butyrate only by pea protein (309%). Caecal branched-chain fatty acid concentrations were decreased by pectin (down 78%) but increased by pea protein (164%). Therefore, the soluble fermentable fibre pectin appeared more effective than high protein for increasing satiety and decreasing caloric intake and adiposity while on high fat diet, and produced a fermentation environment more likely to promote hindgut health. Altogether these data indicate that high fibre may be better than high protein for weight (fat) loss in obesity.	[Adam, Clare L.; Peinado, Diana I.; Thomson, Lynn M.; Garden, Karen E.; Williams, Patricia A.; Ross, Alexander W.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Obes & Metab Hlth Div, Aberdeen, Scotland; [Gratz, Silvia W.; Peinado, Diana I.; Richardson, Anthony J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Gut Hlth Div, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Adam, CL (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Obes & Metab Hlth Div, Aberdeen, Scotland.	c.adam@abdn.ac.uk		Ross, Alexander/0000-0002-1799-1432; Gratz, Silvia W/0000-0002-7367-4511	Scottish Government Rural and Environment Science and Analytical Services Division	Scottish Government Rural and Environment Science and Analytical Services Division	This work was funded by the Scottish Government Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Samra R, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-139; Adam CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140392; Adam CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115438; Adam CL, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-36; Andriamihaja M, 2010, AM J PHYSIOL-GASTR L, V299, pG1030, DOI 10.1152/ajpgi.00149.2010; Arora T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043263; Arora T, 2011, APPETITE, V56, P511, DOI 10.1016/j.appet.2011.01.016; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Brockman DA, 2014, J NUTR, V144, P1415, DOI 10.3945/jn.114.191577; Byrne CS, 2015, INT J OBESITY, V39, P1331, DOI 10.1038/ijo.2015.84; Cani PD, 2005, OBES RES, V13, P1000, DOI 10.1038/oby.2005.117; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Cooper JA, 2014, NUTR RES REV, V27, P186, DOI 10.1017/S0954422414000109; De Silva A, 2012, GUT LIVER, V6, P10, DOI 10.5009/gnl.2012.6.1.10; Douglas SM, 2015, J NUTR, V145, P1010, DOI 10.3945/jn.114.206987; Dvir I, 2000, BRIT J NUTR, V84, P469; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P7, DOI 10.1016/0031-9384(94)90255-0; Greenway F, 2007, J MED FOOD, V10, P720, DOI 10.1089/jmf.2007.405; Havenaar R, 2011, BENEF MICROBES, V2, P103, DOI 10.3920/BM2011.0003; Helou N, 2008, ANN NUTR METAB, V52, P188, DOI 10.1159/000138122; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang XF, 2011, MOL NUTR FOOD RES, V55, P1118, DOI 10.1002/mnfr.201100095; Institute of Medicine, 2005, DIET REF INT EN CARB; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Jia Y, 2010, J NUTR, V140, P1646, DOI 10.3945/jn.110.123034; Johnstone AM, 2012, P NUTR SOC, V71, P339, DOI 10.1017/S0029665112000122; Leidy HJ, 2015, AM J CLIN NUTR, V101, p1320S, DOI 10.3945/ajcn.114.084038; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lin N, 2013, MOL NUTR FOOD RES, V57, P1291, DOI 10.1002/mnfr.201200695; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Morita T, 1999, J NUTR, V129, P1333, DOI 10.1093/jn/129.7.1333; Morita T, 2004, J AOAC INT, V87, P792; Papathanasopoulos A, 2010, GASTROENTEROLOGY, V138, P65, DOI 10.1053/j.gastro.2009.11.045; Park J, 2016, J IMMUNOL, V196, P2388, DOI 10.4049/jimmunol.1502046; Reimer RA, 2010, EUR J CLIN NUTR, V64, P1186, DOI 10.1038/ejcn.2010.141; Reimer RA, 2014, NUTRIENTS, V6, P1115, DOI 10.3390/nu6031115; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; Rosenbaum M, 2015, TRENDS ENDOCRIN MET, V26, P493, DOI 10.1016/j.tem.2015.07.002; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Singh V, 2015, CELL METAB, V22, P983, DOI 10.1016/j.cmet.2015.09.028; Spreckley Eleanor, 2015, Front Nutr, V2, P23, DOI 10.3389/fnut.2015.00023; Steinert RE, 2016, INT J OBESITY, V40, P198, DOI 10.1038/ijo.2015.172; Stengel A, 2013, AM J PHYSIOL-REG I, V305, pR582, DOI 10.1152/ajpregu.00598.2012; Turner ND, 2011, ADV NUTR, V2, P151, DOI 10.3945/an.110.000281; Vasselli JR, 2013, ADV NUTR, V4, P164, DOI 10.3945/an.112.003152; Veldhorst M, 2008, PHYSIOL BEHAV, V94, P300, DOI 10.1016/j.physbeh.2008.01.003; Wakefield AP, 2011, BRIT J NUTR, V106, P656, DOI 10.1017/S0007114511000730; WHO FAO UNU, 2007, WHO TECHN REP SER, V935; Williams LM, 2012, P NUTR SOC, V71, P521, DOI 10.1017/S002966511200078X; Yadav H, 2013, J BIOL CHEM, V288, P25088, DOI 10.1074/jbc.M113.452516; Yao CK, 2016, ALIMENT PHARM THER, V43, P181, DOI 10.1111/apt.13456; Zeng HW, 2014, WORLD J GASTRO ONCOL, V6, P41, DOI 10.4251/wjgo.v6.i2.41; Zhou J, 2011, OBESITY, V19, P1568, DOI 10.1038/oby.2011.14	53	45	51	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0155871	10.1371/journal.pone.0155871	http://dx.doi.org/10.1371/journal.pone.0155871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GI	27224646	Green Submitted, Green Published, gold			2022-12-26	WOS:000376881700034
J	Pedersen, DA; Wehby, GL; Murray, JC; Christensen, K				Pedersen, Dorthe Almind; Wehby, George L.; Murray, Jeffrey C.; Christensen, Kaare			Psychiatric Diagnoses in Individuals with Non-Syndromic Oral Clefts: A Danish Population-Based Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CIVIL REGISTRATION SYSTEM; 22Q11.2 DELETION SYNDROME; CENTRAL RESEARCH REGISTER; CAVUM SEPTI PELLUCIDI; LIP AND/OR PALATE; PSYCHOSOCIAL ADJUSTMENT; OROFACIAL CLEFTS; FOLLOW-UP; CHILDREN	Background The aim of this study was to investigate the risk of psychiatric diagnoses in individuals with non-syndromic oral clefts (OC) compared with individuals without OC, including ages from 1 to 76 years. Methods Linking four Danish nationwide registers, we investigated the risk of psychiatric diagnoses at Danish psychiatric hospitals during the period 1969-2012 for individuals born with nonsyndromic OC in Denmark 1936-2009 compared with a cohort of 10 individuals without OC per individual with OC, matched by sex and birth year. The sample included 8,568 individuals with OC, observed for 247,821 person-years, and 85,653 individuals without OC followed for 2,501,129 person-years. Results A total of 953 (11.1%) of the individuals with OC (9.6% for cleft lip (CL), 10.8% for cleft lip and palate (CLP) and 13.1% for cleft palate (CP)) and 8,117 (9.5%) in the comparison group had at least one psychiatric diagnosis. Cox proportional hazard regression model revealed that individuals with OC had significantly higher risk of a psychiatric diagnosis (hazard ratio (HR) = 1.19, 95% CI: 1.12-1.28). When examining cleft type, no difference was found for CL (HR = 1.03, 95% CI: 0.90-1.17), but CLP was associated with a small increased risk (HR = 1.13, 95% CI: 1.01-1.26), whereas individuals with CP had the largest increased risk (HR = 1.45, 95% CI: 1.30-1.62). The largest differences were found in schizophrenia-like disorders, mental retardation and pervasive developmental disorders, but we found no increased risk of mood disorders and anxiety-related disorders. Conclusion Individuals with non-syndromic OC had significantly higher risk of psychiatric diagnoses compared with individuals without OC. However, the elevated risk was observed for individuals with CLP and CP but not for individuals with CL and the absolute risk increase was modest.	[Pedersen, Dorthe Almind; Christensen, Kaare] Univ Southern Denmark, Dept Publ Hlth, Epidemiol Biostat & Biodemog, Odense C, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, Dept Biochem & Pharmacol, Odense C, Denmark; [Wehby, George L.] Univ Iowa, Coll Publ Hlth, Dept Hlth Management & Policy, Iowa City, IA USA; [Murray, Jeffrey C.] Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Iowa; University of Iowa	Pedersen, DA (corresponding author), Univ Southern Denmark, Dept Publ Hlth, Epidemiol Biostat & Biodemog, Odense C, Denmark.	dapedersen@health.sdu.dk	Christensen, Kaare/C-2360-2009	Christensen, Kaare/0000-0002-5429-5292; Pedersen, Dorthe Almind/0000-0001-7758-3791	Egmont Foundation; University of Southern Denmark; Centers for Disease Control and Prevention (CDC) [1R01DD000295]; National Institute of Dental and Craniofacial Research (NIDCR) [1 R01 DE020895]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020895] Funding Source: NIH RePORTER	Egmont Foundation; University of Southern Denmark; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported financially by the Egmont Foundation, University of Southern Denmark. Data assembling and analysis was partly supported by grant 1R01DD000295 from the Centers for Disease Control and Prevention (CDC) and by 1 R01 DE020895 from the National Institute of Dental and Craniofacial Research (NIDCR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger ZE, 2009, CLEFT PALATE-CRAN J, V46, P435, DOI 10.1597/08-093.1; Bille C, 2005, CLEFT PALATE-CRAN J, V42, P255, DOI 10.1597/03-139.1; Bock Camilla, 2009, Clin Pract Epidemiol Ment Health, V5, P4, DOI 10.1186/1745-0179-5-4; Bodensteiner JB, 1998, J CHILD NEUROL, V13, P120, DOI 10.1177/088307389801300305; Christensen K, 1999, CLEFT PALATE-CRAN J, V36, P96, DOI 10.1597/1545-1569(1999)036<0096:TCDFCP>2.3.CO;2; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; CHRISTENSEN K, 1992, AM J HUM GENET, V51, P654; Christensen K, 2002, CLEFT PALATE-CRAN J, V39, P392, DOI 10.1597/1545-1569(2002)039<0392:FCAPDA>2.0.CO;2; Collett BR, 2012, CLEFT PALATE-CRAN J, V49, P397, DOI 10.1597/10-007; Demir T, 2011, GEN HOSP PSYCHIAT, V33, P594, DOI 10.1016/j.genhosppsych.2011.06.006; Fogh-Andersen, 1942, INHERITANCE HARELIP; Gourion D, 2004, PSYCHIAT RES, V125, P21, DOI 10.1016/j.psychres.2003.06.001; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hunt O, 2005, EUR J ORTHODONT, V27, P274, DOI 10.1093/ejo/cji004; Hunt O, 2006, CLEFT PALATE-CRAN J, V43, P598, DOI 10.1597/05-080; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Lorot-Marchand A, 2015, INT J PEDIATR OTORHI, V79, P1041, DOI 10.1016/j.ijporl.2015.04.024; Mani M, 2010, CLEFT PALATE-CRAN J, V47, P491, DOI 10.1597/08-281; Marcusson A, 2002, SCAND J PLAST RECONS, V36, P16, DOI 10.1080/028443102753478327; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Nilsson S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005306; Nopoulos P, 1997, BIOL PSYCHIAT, V41, P1102, DOI 10.1016/S0006-3223(96)00209-0; Nopoulos P, 2002, GENET MED, V4, P1, DOI 10.1097/00125817-200201000-00001; Nopoulos P, 2001, J NEUROIMAGING, V11, P418, DOI 10.1111/j.1552-6569.2001.tb00072.x; Nopoulos P, 2007, ARCH PEDIAT ADOL MED, V161, P753, DOI 10.1001/archpedi.161.8.753; Nopoulos P, 2010, J NEURODEV DISORD, V2, P235, DOI 10.1007/s11689-010-9060-5; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2014, JAMA PSYCHIAT, V71, P573, DOI 10.1001/jamapsychiatry.2014.16; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen MS, 2015, EUR J HEALTH ECON, V16, P603, DOI 10.1007/s10198-014-0612-6; Persson M, 2012, CLEFT PALATE-CRAN J, V49, P153, DOI 10.1597/09-047; Phung TKT, 2007, DEMENT GERIATR COGN, V24, P220, DOI 10.1159/000107084; Ramstad T, 1995, SCAND J PLAST RECONS, V29, P329, DOI 10.3109/02844319509008968; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Swillen A, 2015, AM J MED GENET C, V169, P172, DOI 10.1002/ajmg.c.31435; Tyler MC, 2013, CLEFT PALATE-CRAN J, V50, P520, DOI 10.1597/11-239; Uggerby P, 2013, DAN MED J, V60; Ward JA, 2013, CLEFT PALATE-CRAN J, V50, P174, DOI 10.1597/11-055; Wehby GL, 2012, ORAL DIS, V18, P74, DOI 10.1111/j.1601-0825.2011.01847.x; Wehby GL, 2010, ORAL DIS, V16, P3, DOI 10.1111/j.1601-0825.2009.01588.x; Wehby GL, 2014, PEDIATRICS, V133, P785, DOI 10.1542/peds.2013-3072; Wehby GL, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-58; Weinberg SM, 2013, AM J MED GENET A, V161A, P1002, DOI 10.1002/ajmg.a.35835	45	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2016	11	5							e0156261	10.1371/journal.pone.0156261	http://dx.doi.org/10.1371/journal.pone.0156261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GI	27223812	Green Published, gold, Green Submitted			2022-12-26	WOS:000376881700078
J	Finnbjornsdottir, RG; Carlsen, HK; Thorsteinsson, T; Oudin, A; Lund, SH; Gislason, T; Rafnsson, V				Finnbjornsdottir, Ragnhildur Gudrun; Carlsen, Hanne Krage; Thorsteinsson, Throstur; Oudin, Anna; Lund, Sigrun Helga; Gislason, Thorarinn; Rafnsson, Vilhjalmur			Association between Daily Hydrogen Sulfide Exposure and Incidence of Emergency Hospital Visits: A Population-Based Study	PLOS ONE			English	Article							GEOTHERMAL POWER-PLANTS; AIR-POLLUTION; SYMPTOMS; ROTORUA; SULFUR; H2S	Background The adverse health effects of high concentrations of hydrogen sulfide (H2S) exposure are well known, though the possible effects of low concentrations have not been thoroughly studied. The aim was to study short-term associations between modelled ambient low-level concentrations of intermittent hydrogen sulfide ( H2S) and emergency hospital visits with heart diseases (HD), respiratory diseases, and stroke as primary diagnosis. Methods The study is population-based, using data from patient-, and population-registers from the only acute care institution in the Reykjavik capital area, between 1 January, 2007 and 30 June, 2014. The study population was individuals (>= 18yr) living in the Reykjavik capital area. The H2S emission originates from a geothermal power plant in the vicinity. A model was used to estimate H2S exposure in different sections of the area. A generalized linear model assuming Poisson distribution was used to investigate the association between emergency hospital visits and H2S exposure. Distributed lag models were adjusted for seasonality, gender, age, traffic zones, and other relevant factors. Lag days from 0 to 4 were considered. Results The total number of emergency hospital visits was 32961 with a mean age of 70 years. In fully adjusted un-stratified models, H2S concentrations exceeding 7.00 mu g/m(3) were associated with increases in emergency hospital visits with HD as primary diagnosis at lag 0 risk ratio (RR): 1.067; 95% confidence interval (CI): 1.024-1.111, lag 2 RR: 1.049; 95% CI:1.005-1.095, and lag 4 RR: 1.046; 95% CI: 1.004-1.089. Among males an association was found between H2S concentrations exceeding 7.00 mu g/m(3), and HD at lag 0 RR: 1.087; 95% CI: 1.032-1.146 and lag 4 RR: 1080; 95% CI: 1.025-1.138; and among those 73 years and older at lag 0 RR: 1.075; 95% CI: 1.014-1.140 and lag 3 RR: 1.072; 95% CI: 1.009-1.139. No associations were found with other diseases. Conclusions The study showed an association between emergency hospital visits with HD as primary diagnosis and same day H2S concentrations exceeding 7.00 mu g/m(3), more pronounced among males and those 73 years and older than among females and younger individuals.	[Finnbjornsdottir, Ragnhildur Gudrun; Carlsen, Hanne Krage; Lund, Sigrun Helga] Univ Iceland, Ctr Publ Hlth Sci, IS-101 Reykjavik, Iceland; [Carlsen, Hanne Krage; Oudin, Anna] Umea Univ Hosp, Dept Publ Hlth & Clin Med, Occupat & Environm Med, S-90185 Umea, Sweden; [Thorsteinsson, Throstur] Univ Iceland, Environm & Nat Resources, Sturlugotu 7, IS-101 Reykjavik, Iceland; [Gislason, Thorarinn] Univ Iceland, Fac Med, Vatnsmyrarvegur 16 V Landspitala, IS-101 Reykjavik, Iceland; [Gislason, Thorarinn] Landspitali Univ Hosp, Dept Resp Med & Sleep, IS-108 Reykjavik, Iceland; [Rafnsson, Vilhjalmur] Univ Iceland, Dept Prevent Med, IS-101 Reykjavik, Iceland	University of Iceland; Umea University; University of Iceland; University of Iceland; Landspitali National University Hospital; University of Iceland	Finnbjornsdottir, RG (corresponding author), Univ Iceland, Ctr Publ Hlth Sci, IS-101 Reykjavik, Iceland.; Rafnsson, V (corresponding author), Univ Iceland, Dept Prevent Med, IS-101 Reykjavik, Iceland.	rgf1@hi.is; vilraf@hi.is	Lund, Sigrun Helga/K-9144-2015; Carlsen, Hanne Krage/AAI-4463-2020; Thorsteinsson, Throstur/A-8960-2008; Thorsteinsson, Throstur/M-5458-2019; Lund, Sigrún Helga/AAG-6042-2019; Oudin, Anna/A-5446-2013	Lund, Sigrun Helga/0000-0002-3806-2296; Carlsen, Hanne Krage/0000-0003-1656-9624; Thorsteinsson, Throstur/0000-0001-5964-866X; Thorsteinsson, Throstur/0000-0001-5964-866X; Lund, Sigrún Helga/0000-0002-3806-2296; Oudin, Anna/0000-0002-9876-0627	Doctoral Grants of The University of Iceland Research Fund [HI201090]; University of Iceland Research Fund [123240]; NordForsk under the Nordic Program on Health and Welfare [75007]	Doctoral Grants of The University of Iceland Research Fund; University of Iceland Research Fund; NordForsk under the Nordic Program on Health and Welfare	This study was supported by The Doctoral Grants of The University of Iceland Research Fund, grant number HI201090 (RGF) and the University of Iceland Research Fund; grant number 123240 (web site: http://www.sjodir.hi.is/english) (RGF). The project was partly funded by NordForsk under the Nordic Program on Health and Welfare. Project #75007: Understanding the link between air pollution and distribution of related health impacts and welfare in the Nordic countries (NordicWelfAir) (RGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Ingibjorg Richter at the National University Hospital for providing data, Thorsteinn Johannsson for his assistance in handling the air quality data, The Environment Agency of Iceland, and Drifa Palin Geirsdottir and Marino Fannar Palsson for expert programming and R support. Also we thank the Icelandic Road and Coastal Administration who helped with the residential data information. The project was partly funded by NordForsk under the Nordic Programme on Health and Welfare. Project #75007: Understanding the link between air pollution and distribution of related health impacts and welfare in the Nordiccountries (NordicWelfAir).	Andreadou I, 2015, BRIT J PHARMACOL, V172, P1587, DOI 10.1111/bph.12811; [Anonymous], TOXICOL IND HLTH; [Anonymous], 2014, R LANG ENV STAT COMP; Armstrong BG, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-122; Bates MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122062; Bates MN, 2013, ENVIRON RES, V122, P81, DOI 10.1016/j.envres.2013.02.002; Bates MN, 1997, AUST NZ J PUBL HEAL, V21, P581, DOI 10.1111/j.1467-842X.1997.tb01759.x; Bates MN, 2002, ARCH ENVIRON HEALTH, V57, P405, DOI 10.1080/00039890209601428; Bates MN, 1998, INT J EPIDEMIOL, V27, P10, DOI 10.1093/ije/27.1.10; Bhambhani Y, 1996, AM IND HYG ASSOC J, V57, P464; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Campagna D, 2004, J EXPO ANAL ENV EPID, V14, P180, DOI 10.1038/sj.jea.7500313; Carlsen HK, 2012, ENVIRON RES, V113, P33, DOI 10.1016/j.envres.2011.10.010; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Durand M, 2006, ENVIRON RES, V101, P238, DOI 10.1016/j.envres.2005.08.006; Finnbjornsdottir RG, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007272; GIFFORD FA, 1973, ATMOS ENVIRON, V7, P131, DOI 10.1016/0004-6981(73)90202-3; Icelandic Road Administration, 2012, TRAFF NUMB MAIN ROAD; Khoirunissa I, 2011, GEOTHERMAL TRAINING, P249; Kielland G, 1998, GUIDANCE REPORT PREL; Kilburn KH, 2012, J ENV PUBLIC HLTH, V2012; Lisabeth LD, 2008, ANN NEUROL, V64, P53, DOI 10.1002/ana.21403; Mostaghni AA, 2000, ARCH ENVIRON HEALTH, V55, P297, DOI 10.1080/00039890009604020; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Olafsdottir S, 2014, ATMOS ENVIRON, V82, P60, DOI 10.1016/j.atmosenv.2013.10.013; Olafsdottir S, 2013, ATMOS ENVIRON, V77, P185, DOI 10.1016/j.atmosenv.2013.04.077; ParttiPellinen K, 1996, ARCH ENVIRON HEALTH, V51, P315, DOI 10.1080/00039896.1996.9936031; Powers W., 2004, SCI SMELL 1; Reed BR, 2014, NEUROTOXICOL TERATOL, V42, P68, DOI 10.1016/j.ntt.2014.02.002; Reykjavik Energy, 2014, ENV REP REYKJ EN 201; RICHARDSON DB, 1995, AM J IND MED, V28, P99, DOI 10.1002/ajim.4700280109; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Amaral AFS, 2007, ENVIRON RES, V103, P419, DOI 10.1016/j.envres.2006.06.016; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Schwartz J, 2001, EPIDEMIOLOGY, V12, P55, DOI 10.1097/00001648-200101000-00010; Sobenin IA, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-119; Statistics Iceland, 2014, POP STAT; Thorsteinsson T, 2013, GEOTHERMICS, V45, P31, DOI 10.1016/j.geothermics.2012.10.003; United Nations Environment Programme International Labour Organization World Health Organization, 2003, 53 WHO UN ENV PROGR; Wing S, 2008, ENVIRON HEALTH PERSP, V116, P1362, DOI 10.1289/ehp.11250; World Health Organization, 2000, AIR QUALITY GUIDELIN, V2nd	41	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2016	11	5							e0154946	10.1371/journal.pone.0154946	http://dx.doi.org/10.1371/journal.pone.0154946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2FY	27218467	Green Published, Green Submitted, gold			2022-12-26	WOS:000376880700004
J	Bitew, AA; Abera, B; Seyoum, W; Endale, B; Kiber, T; Goshu, G; Admass, A				Bitew, Aschalew Afework; Abera, Bayeh; Seyoum, Walle; Endale, Befekadu; Kiber, Tibebu; Goshu, Girma; Admass, Addiss			Soil-Transmitted Helminths and Schistosoma mansoni Infections in Ethiopian Orthodox Church Students around Lake Tana, Northwest Ethiopia	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; INTEGRATED CONTROL; EPIDEMIOLOGY; PREVALENCE; CHILDREN	Background Soil-transmitted helminths (STH) and Schistosoma mansoni infections are the major neglected tropical diseases that result in serious consequences on health, education and nutrition in children in developing countries. The Ethiopian Orthodox church students, who are called Yekolotemari in Amharic, live in areas with poor sanitation and hygiene. Moreover, they are not included in the national STH control programs. Thus, STH and S. mansoni infections prevalence is unknown. Methods A cross-sectional study was conducted on 384 students in June 2014 to determine STH and S. mansoni infections prevalence. Moreover, the knowledge of students about STH and S. mansoni was assessed. Data on knowledge and clinical symptoms were collected using structured questionnaires via face to face interview. Stool specimens were examined by formol-ether concentration method. Results The overall prevalence of intestinal helminths infections was 85.9% (95% confidence interval (CI): 82.1-89%). STHs infections prevalence was 65.6%(95% CI: 60.7-70.2%). The prevalence of hookworm, Ascaris lumbricoides and Trichuris trichiura were 31.8%(95% CI: 27.3-36.6%), 29.4%(25-31%) and 3.1% (1.8-5.4%), respectively. On the other hand, S. mansoni prevalence was 14.3% (95% CI: 11.1-18.1%). Majority of students infected with S. mansoni had bloody stool with crud odds-ratio of 2.9 (95% CI: 1.5-5.5). Knowledge assessment showed that 50 (13%) and 18 (4.9%) of the respondents knew about transmission of STH and S. mansoni, respectively. Conclusions The prevalence of STH and S. mansoni infections were high thus de-worming program should include the students of Ethiopian Orthodox churches. Furthermore, provision and use of sanitary facilities, health education for students to create awareness of parasitic infections and improved personal hygiene should be in place.	[Bitew, Aschalew Afework; Seyoum, Walle; Endale, Befekadu; Kiber, Tibebu; Goshu, Girma; Admass, Addiss] ALKAN Univ Coll, Bahir Dar, Ethiopia; [Abera, Bayeh] Bahir Dar Univ, Dept Microbiol Immunol & Parasitol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University	Abera, B (corresponding author), Bahir Dar Univ, Dept Microbiol Immunol & Parasitol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	bayeabera15@gmail.com	Abera, Bayeh/AAU-8754-2020; Aschalew, Afework/GZG-3095-2022	Aschalew, Afework/0000-0003-0287-5903				Abera B, 2013, J INFECT DEV COUNTR, V7, P253, DOI 10.3855/jidc.2539; Alelign Tilahun, 2015, J Parasitol Res, V2015, P641602, DOI 10.1155/2015/641602; Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; Ayalew A., 2011, J PARASITOL VECTOR B, V3, P75; Booth M, 2006, TRENDS PARASITOL, V22, P359, DOI 10.1016/j.pt.2006.06.007; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Bundy DAP, 2013, TRENDS PARASITOL, V29, P142, DOI 10.1016/j.pt.2012.12.003; Deribe K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-240; Fleming FM, 2006, TROP MED INT HEALTH, V11, P56, DOI 10.1111/j.1365-3156.2005.01541.x; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2015, PLOS NEGLECT TROP D, V3; King JD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002223; Mathewos Biniam, 2014, BMC Res Notes, V7, P88, DOI 10.1186/1756-0500-7-88; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Tadesse Z, 2008, T ROY SOC TROP MED H, V102, P213, DOI 10.1016/j.trstmh.2007.09.005; WHO, SCHIST MAJ PUBL HLTH; World Health Organization, ACC WORK OV GLOB IMP; World Health Organization, EL SOIL TRANSM HELM; World Health Organization, FACT SHEET SOIL TRAN; Yesuf A, 2010, ETHIOP J HLTH BIOMED, V2	20	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155915	10.1371/journal.pone.0155915	http://dx.doi.org/10.1371/journal.pone.0155915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	27203749	Green Published, gold, Green Submitted			2022-12-26	WOS:000376291500030
J	Yang, FX; Mao, DQ; Zhou, H; Luo, Y				Yang, Fengxia; Mao, Daqing; Zhou, Hao; Luo, Yi			Prevalence and Fate of Carbapenemase Genes in a Wastewater Treatment Plant in Northern China	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE ISOLATE; ANTIBIOTIC-RESISTANCE GENES; HYDROLYZING ENZYME KPC-2; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PLASMIDS; ENTEROBACTERIACEAE; DISSEMINATION; VIRULENCE	Carbapenemase-producing strains of bacteria, which were primarily found in the medical field, have increasingly been found in the environment, thus posing potential risks to public health. One possible way for carbapenemase genes to enter the environment is via wastewater. Therefore, the goal of this study was to determine the occurrence and fate of five high-risk carbapenemase genes in a wastewater treatment plant (WWTP) in northern China using real-time qPCR. Results showed that the bla(KPC-2), bla(GES-1), and bla(IMP-1) genes prevailed throughout all processing stages (even in the chlorination disinfection unit) in the WWTP, whereas the bla(VIM-2) and bla(OXA-48) genes were not detected in all samples. Worryingly, considerable amounts of carbapenemase genes ((1.54 +/- 0.61) x 10(3) copies/mL to (2.14 +/- 0.41) x 10(5) copies/mL) were detected in WWTP effluent samples, while the majority of the carbapenemase genes were transported to the dewatered sludge with concentrations from (6.51 +/- 0.14) x 10(9) copies/g to (6.18 +/- 0.63) x 10(10) copies/g dry weight. Furthermore, a total of 97 KPC-2-producing strains, belonging to 8 bacterial genera, were isolated from the WWTP. Sequencing of 16S rRNA revealed that most of KPC-2 producing isolates were opportunistic pathogens, including Klebsiella spp. (10.3%), Enterococcus spp. (11.3%), Acinetobacter spp. (19.6%), Escherichia spp. (12.4%), Shigella spp. (17.5%), Stenotrophomonas spp. (10.3%) and Wautersiella spp. (9.3%). Moreover, bla(KPC-2) genes were identified for the first time in Paenibacillus spp. isolates (an indigenous bacteria), indicating an increased risk of horizontal transfer between clinical pathogens and environmental bacteria. Indeed, a conjugation experiment demonstrated transfer of the bla(KPC-2) gene to an E. coli J53 strain from a Klebsiella strain isolated from the WWTP. To our knowledge, this is the first study to obtain Paenibacillus spp. isolates carrying the carbapenemase gene and to quantify the abundance of carbapenemase genes in the environment.	[Yang, Fengxia; Mao, Daqing] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China; [Yang, Fengxia; Zhou, Hao; Luo, Yi] Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China	Tianjin University; Nankai University	Mao, DQ (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.; Luo, Y (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China.	mao@tju.edu.cn; luoy@nankai.edu.cn	Luo, Yi/C-2451-2018; Zhou, Hao/AFQ-5956-2022; Zhou, Hao/Q-2401-2018	Zhou, Hao/0000-0001-7131-3758; Zhou, Hao/0000-0001-7131-3758	National Natural Science Foundation of China [31470440, 21277075]; State Environmental Protection Commonweal Project [201309031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Environmental Protection Commonweal Project	This study was supported by the National Natural Science Foundation of China (31470440, 21277075), and the State Environmental Protection Commonweal Project (201309031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpaka PE, 2009, J CLIN MICROBIOL, V47, P2670, DOI 10.1128/JCM.00362-09; Amos GCA, 2014, VET MICROBIOL, V171, P441, DOI 10.1016/j.vetmic.2014.02.017; Baughman Robert P, 2009, J Intensive Care Med, V24, P230, DOI 10.1177/0885066609335660; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Boyd EF, 1996, GENETICS, V143, P1091; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; CALISTO F, 2011, BMC PROCEEDINGS, V5, P132, DOI DOI 10.1186/1753-6561-5-S6-P132; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2001, EMERG INFECT DIS, V7, P444, DOI 10.3201/eid0703.017314; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; CAVALLI LL, 1953, J GEN MICROBIOL, V8, P89, DOI 10.1099/00221287-8-1-89; Chen ZW, 2015, J QUANT SPECTROSC RA, V167, P1, DOI 10.1016/j.jqsrt.2015.07.018; CLSI, 2012, M100S22 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Cuzon G, 2008, ANTIMICROB AGENTS CH, V52, P796, DOI 10.1128/AAC.01180-07; Dallal MMS, 2008, INFECT DIS CLIN PRAC, V16, P41, DOI [10.1097/ipc.0b013e31815f6586, DOI 10.1097/IPC.0B013E31815F6586]; Desai P J, 2001, Indian J Med Microbiol, V19, P132; DEVRIESE LA, 1993, J APPL BACTERIOL, V75, P399, DOI 10.1111/j.1365-2672.1993.tb02794.x; Diallo AA, 2013, WATER RES, V47, P4719, DOI 10.1016/j.watres.2013.04.047; Fleurbaaij F, 2014, ANAL CHEM, V86, P9154, DOI 10.1021/ac502049p; Galler H, 2014, CLIN MICROBIOL INFEC, V20, pO132, DOI 10.1111/1469-0691.12336; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Gonullu N, 2008, J CLIN MICROBIOL, V46, P1110, DOI 10.1128/JCM.01974-07; Hays C, 2012, INT J ANTIMICROB AG, V39, P545, DOI 10.1016/j.ijantimicag.2012.03.002; Hopkins KL, 2006, ANTIMICROB AGENTS CH, V50, P3203, DOI 10.1128/AAC.00149-06; Hossain A, 2004, ANTIMICROB AGENTS CH, V48, P4438, DOI 10.1128/AAC.48.11.4438-4440.2004; Huang JJ, 2011, WATER RES, V45, P2775, DOI 10.1016/j.watres.2011.02.026; Insa R, 2007, J ANTIMICROB CHEMOTH, V59, P583, DOI 10.1093/jac/dkl496; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; Kumarasamy K, 2012, J ANTIMICROB CHEMOTH, V67, P243, DOI 10.1093/jac/dkr431; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lartigue MF, 2006, ANTIMICROB AGENTS CH, V50, P1282, DOI 10.1128/AAC.50.4.1282-1286.2006; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Manenzhe RI, 2015, J ANTIMICROB CHEMOTH, V53, P3396; Mao DQ, 2015, WATER RES, V85, P458, DOI 10.1016/j.watres.2015.09.010; Marcade G, 2009, J ANTIMICROB CHEMOTH, V63, P67, DOI 10.1093/jac/dkn428; Mavroidi A, 2012, INT J ANTIMICROB AG, V39, P247, DOI 10.1016/j.ijantimicag.2011.11.003; Montezzi LF, 2015, INT J ANTIMICROB AG, V45, P174, DOI 10.1016/j.ijantimicag.2014.10.016; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Naas T, 2011, ANTIMICROB AGENTS CH, V55, P4933, DOI 10.1128/AAC.00719-11; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128/AAC.00438-06; Nicolau DP, 2008, EXPERT OPIN PHARMACO, V9, P23, DOI 10.1517/14656566.9.1.23; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; Ojer-Usoz E, 2014, WATER RES, V56, P37, DOI 10.1016/j.watres.2014.02.041; Pan XH, 2014, BIOCHEMISTRY-US, V53, P5414, DOI 10.1021/bi401609h; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1662, DOI 10.1128/AAC.05850-11; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P3072, DOI 10.1128/AAC.00513-10; Potron A, 2011, FEMS MICROBIOL LETT, V324, P111, DOI 10.1111/j.1574-6968.2011.02392.x; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Siu LK, 2012, MICROB DRUG RESIST, V18, P380, DOI 10.1089/mdr.2011.0241; Stewart NK, 2015, BIOCHEMISTRY-US, V54, P588, DOI 10.1021/bi501052t; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P1553, DOI 10.1128/AAC.01405-06; Virgincar N, 2011, J HOSP INFECT, V78, P293, DOI 10.1016/j.jhin.2011.03.016; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang XJ, 2014, MICROB DRUG RESIST, V20, P144, DOI 10.1089/mdr.2013.0100; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zhang R, 2007, J ANTIMICROB CHEMOTH, V59, P574, DOI 10.1093/jac/dkl541; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	77	44	44	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156383	10.1371/journal.pone.0156383	http://dx.doi.org/10.1371/journal.pone.0156383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27607467	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500127
